Familial_Cancer_Genes_Syndrome	1000Genome_CS	alt_allele	HGNC_Ensembl ID(supplied by Ensembl)	annotation_transcript	dbNSFP_MutationTaster_converted_rankscore	HGNC_Entrez Gene ID(supplied by NCBI)	dbNSFP_MutationAssessor_pred	HGNC_Ensembl Gene ID	dbNSFP_phyloP46way_placental_rankscore	ESP_TotalEAsamplesCovered	dbNSFP_phastCons46way_placental	dbNSFP_FATHMM_rankscore	dbNSFP_Polyphen2_HDIV_pred	ESP_GWAS_PUBMED	1000Genome_CIPOS	dbNSFP_SIFT_pred	dbNSFP_MutationTaster_score	dbNSFP_fold-degenerate	codon_change	HGNC_VEGA IDs	dbNSFP_phyloP46way_placental	dbSNP_Val_Status	UniProt_uniprot_accession	HGNC_Locus Type	HGNC_Secondary IDs	other_transcripts	UniProt_DrugBank	gencode_xref_refseq_mRNA_id	ESP_AA_GTC	HGNC_RefSeq IDs	1000Genome_SAS_AF	COSMIC_overlapping_mutation_descriptions	CCLE_By_Gene_total_mutations_in_gene	dbNSFP_Ancestral_allele	dbNSFP_CADD_phred	Strand	variant_classification	dbNSFP_codonpos	ESP_EA_AGE	ESP_AvgEAsampleReadDepth	dbNSFP_Uniprot_acc	dbNSFP_ESP6500_AA_AF	secondary_variant_classification	HGNC_Pubmed IDs	CGC_Tumour Types (Germline Mutations)	HumanDNARepairGenes_Role	dbNSFP_Polyphen2_HVAR_score	gencode_transcript_name	HGNC_Date Name Changed	1000Genome_SVLEN	dbNSFP_Polyphen2_HVAR_rankscore	ClinVar_SYM	ESP_Chromosome	strand	1000Genome_AFR_AF	CCLE_By_GP_overlapping_mutations	dbNSFP_SIFT_score	dbNSFP_phastCons46way_primate	ESP_FG	HGNC_HGNC ID	dbNSFP_1000Gp1_AMR_AC	ESP_PP	TUMORScape_Deletion_Peaks	ESP_AA	Ensembl_so_accession	HGNC_OMIM ID(supplied by NCBI)	ESP_PH	dbNSFP_1000Gp1_AMR_AF	gene_type	COSMIC_overlapping_primary_sites	ESP_TotalAAsamplesCovered	dbNSFP_MutationTaster_pred	ORegAnno_ID	dbNSFP_phastCons100way_vertebrate	ESP_MAF	dbNSFP_Polyphen2_HVAR_pred	HGNC_Gene family description	ESP_TotalSamplesCovered	CGC_Mutation Type	dbNSFP_SiPhy_29way_pi	CGC_Cancer Germline Mut	ORegAnno_bin	TCGAScape_Deletion_Peaks	MutSig Published Results_Published_Results	ACHILLES_Lineage_Results_Top_Genes	gencode_transcript_status	dbNSFP_Ensembl_transcriptid	COSMIC_FusionGenes_fusion_genes	ref_context	dbNSFP_FATHMM_pred	HGNC_Previous Symbols	1000Genome_SVTYPE	Familial_Cancer_Genes_Synonym	Familial_Cancer_Genes_Reference	HGVS_coding_DNA_change	chr	UniProt_AA_region	dbNSFP_Ensembl_geneid	dbNSFP_phyloP46way_primate_rankscore	dbNSFP_genename	COSMIC_Tissue_tissue_types_affected	HGVS_protein_change	transcript_strand	dbNSFP_phastCons100way_vertebrate_rankscore	1000Genome_CIEND	dbNSFP_refcodon	HGNC_Chromosome	UniProt_alt_uniprot_accessions	HGNC_Name Synonyms	genome_change	UniProt_AA_natural_variation	ESP_AA_AGE	1000Genome_MEND	dbNSFP_1000Gp1_AFR_AC	ESP_EXOME_CHIP	gene_id	ESP_TAC	dbNSFP_phastCons46way_placental_rankscore	dbNSFP_CADD_raw_rankscore	dbNSFP_GERP++_NR	dbNSFP_LR_rankscore	dbNSFP_aapos_SIFT	ClinVar_TYPE	ESP_CA	dbNSFP_LRT_converted_rankscore	CGC_Cancer Molecular Genetics	dbNSFP_SLR_test_statistic	CGC_GeneID	ESP_CG	dbNSFP_GERP++_RS_rankscore	dbNSFP_1000Gp1_ASN_AC	dbNSFP_SIFT_converted_rankscore	dbNSFP_1000Gp1_ASN_AF	ESP_CP	UniProt_GO_Molecular_Function	dbNSFP_MutationAssessor_score	HGNC_Date Symbol Changed	1000Genome_MC	NCBI_Build	HGNC_Record Type	1000Genome_EUR_AF	dbNSFP_1000Gp1_AFR_AF	dbNSFP_SiPhy_29way_logOdds	ESP_EA_AC	UniProt_AA_experimental_info	UniProt_GO_Biological_Process	ESP_GTC	dbNSFP_CADD_raw	1000Genome_MLEN	COSMIC_overlapping_mutation_AAs	CGC_Other Syndrome/Disease	HGNC_CCDS IDs	ref_allele	dbNSFP_Polyphen2_HDIV_rankscore	ESP_GTS	HGNC_Accession Numbers	UniProt_GO_Cellular_Component	ESP_DP	dbNSFP_MutationAssessor_rankscore	1000Genome_NS	dbNSFP_GERP++_RS	dbSNP_RS	CGC_Cancer Syndrome	transcript_position	dbNSFP_Uniprot_aapos	dbNSFP_1000Gp1_EUR_AC	ClinVar_ASSEMBLY	HGNC_Previous Names	dbNSFP_SiPhy_29way_logOdds_rankscore	dbNSFP_hg18_pos(1-coor)	dbNSFP_cds_strand	ESP_AAC	UniProt_AAxform_aapos	HGNC_Synonyms	dbNSFP_1000Gp1_AC	COSMIC_Tissue_total_alterations_in_gene	HGNC_RefSeq(supplied by NCBI)	dbNSFP_Polyphen2_HDIV_score	transcript_exon	dbNSFP_1000Gp1_EUR_AF	dbNSFP_phyloP46way_primate	transcript_id	CGC_Tissue Type	1000Genome_DP	1000Genome_END	HGNC_UCSC ID(supplied by UCSC)	CGC_Chr Band	CGC_Tumour Types  (Somatic Mutations)	HGNC_Entrez Gene ID	ESP_DBSNP	ESP_CDP	dbNSFP_LR_score	ClinVar_HGMD_ID	protein_change	dbNSFP_Interpro_domain	COSMIC_n_overlapping_mutations	UniProt_AA_site	dbNSFP_LR_pred	CGC_Other Germline Mut	ESP_AvgAAsampleReadDepth	dbNSFP_UniSNP_ids	gc_content	HGVS_genomic_change	dbNSFP_aapos_FATHMM	gencode_transcript_type	dbNSFP_LRT_score	CGC_Name	gencode_transcript_tags	CGC_Translocation Partner	ESP_EA_GTC	ORegAnno_Values	dbNSFP_aapos	ESP_AA_AC	dbNSFP_1000Gp1_AF	dbNSFP_aaalt	1000Genome_AA	1000Genome_MSTART	dbNSFP_LRT_Omega	1000Genome_AN	CGC_Cancer Somatic Mut	UniProt_uniprot_entry_name	1000Genome_AC	HGNC_Approved Name	CGC_Chr	dbNSFP_Uniprot_id	1000Genome_AF	dbNSFP_phyloP100way_vertebrate_rankscore	end	TCGAScape_Amplification_Peaks	dbNSFP_phyloP100way_vertebrate	1000Genome_EAS_AF	variant_type	ClinVar_rs	ccds_id	build	dbNSFP_LRT_pred	1000Genome_MEINFO	1000Genome_IMPRECISE	start	dbNSFP_RadialSVM_score	HGNC_Enzyme IDs	dbNSFP_Reliability_index	Ensembl_so_term	dbNSFP_RadialSVM_pred	HGNC_Status	dbNSFP_ESP6500_EA_AF	ESP_AvgSampleReadDepth	1000Genome_TSD	transcript_change	HGNC_Date Modified	havana_transcript	HGNC_UniProt ID(supplied by UniProt)	1000Genome_AMR_AF	dbNSFP_FATHMM_score	gene	ESP_Position	dbNSFP_phastCons46way_primate_rankscore	TUMORScape_Amplification_Peaks	dbNSFP_RadialSVM_rankscore	ESP_GS	ESP_GL	ESP_GM	HGNC_Locus Group	gencode_xref_refseq_prot_acc	dbNSFP_aaref	HGNC_Primary IDs
		T	ENSG00000187961	ENST00000338591.3		339451		ENSG00000187961		4298					,				c.(715-717)Ctg>Ttg	OTTHUMG00000040721		byFrequency	Q6TDP4	gene with protein product				NM_198317.2	81,634,1486	NM_198317	0.0767					+	Silent		158.5+/-212.0	52.0				12063253				KLHL17-001	2013-01-30				1	+	0.18				coding-synonymous	24023		239/643	all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)	C	SO:0001819				protein_coding		2201				7.0498,18.0827,10.7863		"""Kelch-like"", ""BTB/POZ domain containing"""	6499					UCEC - Uterine corpus endometrioid carcinoma (11;0.00459)|Epithelial(90;1.52e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.59e-23)|Colorectal(212;0.000155)|COAD - Colon adenocarcinoma(227;0.000193)|BRCA - Breast invasive adenocarcinoma(365;0.000469)|Kidney(185;0.00227)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0339)|Lung(427;0.199)			KNOWN			CTCCCAGGTTCTGGAACTGGT						ENST00000338591.3:c.715C>T	1	BACK.				central_nervous_system(1)|kidney(2)|lung(3)|prostate(2)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		1p36	Q5SV94	"""actinfilin"""	g.chr1:897738C>T		315.8+/-294.3			no		1402,11596												5.5					1.0	protein complex scaffold (GO:0032947)				hg19	Standard	0.0507			606,7990		actin cytoskeleton organization (GO:0030036)|brain development (GO:0007420)|protein ubiquitination (GO:0016567)	114,1174,5211					CCDS30550.1	C		TT,TC,CC	AY423763	actin cytoskeleton (GO:0015629)|cell junction (GO:0030054)|dendrite cytoplasm (GO:0032839)|extracellular space (GO:0005615)|neuronal cell body (GO:0043025)|postsynaptic density (GO:0014069)|postsynaptic membrane (GO:0045211)	51		2504		rs6696971		822				"""kelch-like 17 (Drosophila)"""					239			10	NM_198317		5			ENST00000338591.3		14154		uc001aca.2			339451	dbSNP_116	715			p.L239L		0				51.0		0.637	1:g.897738C>T		protein_coding			basic|appris_principal|CCDS		33,540,3725			796,3606			C|||			5008		KLH17_HUMAN	511	kelch-like family member 17			0.102037		897738			0.0774	SNP		CCDS30550.1			,,,	False	897738				synonymous_variant		Approved		51.0		c.715C>T	2013-01-30	OTTHUMT00000097875.3	Q6TDP4	0.0994		KLHL17	897738		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			KLHL17	NM_198317.2	protein-coding gene	NP_938073.1		
		G	ENSG00000187583	ENST00000379409.2		84069		ENSG00000187583		4300					,					OTTHUMG00000040756		byFrequency	Q494U1	gene with protein product		PLEKHN1_ENST00000379410.3_Intron|PLEKHN1_ENST00000379407.3_Intron			2201,2,0	NM_032129	1.0					+	Intron			81.0				11230166				PLEKHN1-005					1	+	0.9985				intron,intron	25284		,	all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)	G	SO:0001627		,		protein_coding		2203				0.0,0.0454,0.0154		"""Pleckstrin homology (PH) domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (11;0.00459)|Epithelial(90;4.31e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.93e-23)|Colorectal(212;0.000159)|COAD - Colon adenocarcinoma(227;0.000193)|BRCA - Breast invasive adenocarcinoma(365;0.00095)|Kidney(185;0.0023)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0342)|Lung(427;0.199)			KNOWN			CTGCCTCCTGAGGTGAGTGCC						ENST00000379409.2:c.1858+24A>G	1					central_nervous_system(1)|endometrium(3)|kidney(1)|lung(2)|skin(1)|urinary_tract(1)		+		,		1p36.33	Q494U2|Q5SV98|Q9H0M7		g.chr1:909768A>G		4.2+/-10.8			no		13004,2												0.6					0.0					hg19	Standard	1.0			8600,0			6501,2,0					CCDS4.1, CCDS53256.1	A		GG,GA,AA	AL136730		79		2504		rs2340593		1888								,		DKFZP434H2010		9	NM_032129		14			ENST00000379409.2		14394		uc001acd.3			84069	dbSNP_100	,					0				74.0		0.632	1:g.909768A>G		protein_coding			basic		4300,0,0			4404,2			G|||			5008		PKHN1_HUMAN	5006	pleckstrin homology domain containing, family N member 1			0.999601		909768			1.0	SNP					,,,	False	909768				intron_variant		Approved		79.0			2013-01-11	OTTHUMT00000473256.1	Q494U1	1.0		PLEKHN1	909768		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)		,	PLEKHN1	NM_001160184.1,NM_032129.2	protein-coding gene			
		C	ENSG00000187608	ENST00000379389.4		9636		ENSG00000187608		4299					,					OTTHUMG00000040777		byFrequency	P05161	gene with protein product				NM_005101.3	1231,832,139	NM_005101	0.9765					+	5'UTR		121.7+/-180.7	52.0				3087979				ISG15-001	2006-04-28				1	+	0.7201				utr-5	4053			all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)	C	SO:0001623	147571			protein_coding		2202				4.3615,25.2044,11.4213			6501					UCEC - Uterine corpus endometrioid carcinoma (11;0.00459)|Epithelial(90;4.05e-38)|OV - Ovarian serous cystadenocarcinoma(86;4.54e-23)|Colorectal(212;5.37e-05)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00229)|BRCA - Breast invasive adenocarcinoma(365;0.00238)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.034)|Lung(427;0.199)			KNOWN			TACAGGAGCTTGTGCCGTGGC		G1P2				ENST00000379389.4:c.-33T>C	1					endometrium(1)|lung(1)|upper_aerodigestive_tract(1)		+		,		1p36.33	Q5SVA4|Q7Z2G2|Q96GF0		g.chr1:948921T>C		393.5+/-328.9			no		11517,1485												-6.1					0.0	protein tag (GO:0031386)		2006-04-28		hg19	Standard	0.9573			8223,375		cytokine-mediated signaling pathway (GO:0019221)|defense response to bacterium (GO:0042742)|defense response to virus (GO:0051607)|innate immune response (GO:0045087)|ISG15-protein conjugation (GO:0032020)|modification-dependent protein catabolic process (GO:0019941)|negative regulation of protein ubiquitination (GO:0031397)|negative regulation of type I interferon production (GO:0032480)|negative regulation of viral genome replication (GO:0045071)|positive regulation of erythrocyte differentiation (GO:0045648)|regulation of interferon-gamma production (GO:0032649)|response to type I interferon (GO:0034340)|type I interferon signaling pathway (GO:0060337)|viral process (GO:0016032)	5170,1177,154					CCDS6.1	T		CC,CT,TT	BC009507	cytosol (GO:0005829)|extracellular region (GO:0005576)	52		2504		rs15842		119				"""interferon, alpha-inducible protein (clone IFI-15K)"""						IFI15, UCRP		3	NM_005101		0			ENST00000379389.4		17183		uc001acj.4			9636	dbSNP_52						0				52.0		0.632	1:g.948921T>C		protein_coding			basic|appris_principal|CCDS		3939,345,15			3294,1110			C|||			5008		ISG15_HUMAN	4523	ISG15 ubiquitin-like modifier			0.903155		948921			0.999	SNP		CCDS6.1			,,,	False	948921				5_prime_UTR_variant		Approved		52.0			2008-02-05	OTTHUMT00000097989.1	P05161	0.9308		ISG15	948921		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			ISG15	NM_005101.3	protein-coding gene	NP_005092.1		
		A	ENSG00000187608	ENST00000379389.4	0.58432	9636	L	ENSG00000187608	0.05246	4300	0.204000	0.28895	B		,	D	1.0000000000287557E-6	0	c.(247-249)aGc>aAc	OTTHUMG00000040777	-0.675000	byFrequency	P05161	gene with protein product				NM_005101.3	388,1051,764	NM_005101	0.3558			g	2.900	+	Missense_Mutation	2	497.7+/-374.6	58.0	P05161	0.414662		3087979			0.005	ISG15-001	2006-04-28		0.10450		1	+	0.4387		0	0.152000	missense	4053	109	83/166	all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)	A	SO:0001583	147571	benign	0.3011049723756906	protein_coding		2203	P		0.000000	39.4884,41.4662,40.1584	B		6503		0.6559:0.0:0.3441:0.0			UCEC - Uterine corpus endometrioid carcinoma (11;0.00459)|Epithelial(90;4.05e-38)|OV - Ovarian serous cystadenocarcinoma(86;4.54e-23)|Colorectal(212;5.37e-05)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00229)|BRCA - Breast invasive adenocarcinoma(365;0.00238)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.034)|Lung(427;0.199)			KNOWN	ENST00000379389		GAACCTCTGAGCATCCTGGTG	T	G1P2				ENST00000379389.4:c.248G>A	1	Ubiquitin-like 2. {ECO:0000255|PROSITE- ProRule:PRU00214}.	ENSG00000187608	0.02716	ISG15	endometrium(1)|lung(1)|upper_aerodigestive_tract(1)	ENSP00000368699:p.Ser83Asn	+	0.05858	,	AGC	1p36.33	Q5SVA4|Q7Z2G2|Q96GF0		g.chr1:949608G>A	S -> N (in dbSNP:rs1921). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5, ECO:0000269|Ref.6}.	528.4+/-372.4		210	yes		5223,7783	0.23530	0.06022	3.99	0.00012	ENSP00000368699:S83N			0.00669		-21.9		-2.4	0.06663	118	0.87932	0.2062937062937063	0.2	protein tag (GO:0031386)	1.265	2006-04-28		hg19	Standard	0.3926	0.4268292682926829	9.972	3396,5204		cytokine-mediated signaling pathway (GO:0019221)|defense response to bacterium (GO:0042742)|defense response to virus (GO:0051607)|innate immune response (GO:0045087)|ISG15-protein conjugation (GO:0032020)|modification-dependent protein catabolic process (GO:0019941)|negative regulation of protein ubiquitination (GO:0031397)|negative regulation of type I interferon production (GO:0032480)|negative regulation of viral genome replication (GO:0045071)|positive regulation of erythrocyte differentiation (GO:0045648)|regulation of interferon-gamma production (GO:0032649)|response to type I interferon (GO:0034340)|type I interferon signaling pathway (GO:0060337)|viral process (GO:0016032)	1058,3107,2338	-0.227652				CCDS6.1	G	0.14438	AA,AG,GG	BC009507	cytosol (GO:0005829)|extracellular region (GO:0005576)	59	0.41236	2504	-2.36	rs1921		399	83	305		"""interferon, alpha-inducible protein (clone IFI-15K)"""	0.41761	939471	+	ASN/SER	83	IFI15, UCRP	742	3	NM_005101	0.01	2	0.4023746701846966	-0.925000	ENST00000379389.4		18347		uc001acj.4			9636	dbSNP_36	248	0.0000		p.S83N	Ubiquitin supergroup (1);Ubiquitin (1);	0		T		62.0	rs1921;rs4890;rs17651;rs1126669;rs3813185;rs17837903;rs17856313;rs52792478;rs56610207;rs59370406	0.662	1:g.949608G>A	ENSP00000368699:S83N	protein_coding	0.000631		basic|appris_principal|CCDS		670,2056,1574		83	1827,2579	0.33974358974358976	N	g|||		3.314280	5008		ISG15_HUMAN	1697	ISG15 ubiquitin-like modifier		ISG15_HUMAN	0.338858	0.02204	949608		-1.538000	0.1845	SNP		CCDS6.1		N	,,,	False	949608	-0.9028		9	missense	T	Approved	0.394884	59.0		c.248G>A	2008-02-05	OTTHUMT00000097989.1	P05161	0.2709	1.59	ISG15	949608	0.21847	all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)	0.48525	46	ISG15	NM_005101.3	protein-coding gene	NP_005092.1	S	
		C	ENSG00000188157	ENST00000379370.2		375790		ENSG00000188157		4298					,					OTTHUMG00000040778		byFrequency	O00468	gene with protein product				NM_198576.3	1140,887,174	NM_198576	0.9663					+	Intron			31.0				1851019, 12270958				AGRN-001					1	+	0.6899				intron	329			all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)	C	SO:0001627	103320			protein_coding		2201				7.9223,28.0554,14.7407		"""Proteoglycans / Extracellular Matrix : Other"""	6499					UCEC - Uterine corpus endometrioid carcinoma (11;0.00462)|Epithelial(90;5.98e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.43e-23)|Colorectal(212;5.97e-05)|COAD - Colon adenocarcinoma(227;0.000201)|Kidney(185;0.0024)|BRCA - Breast invasive adenocarcinoma(365;0.00246)|STAD - Stomach adenocarcinoma(132;0.00645)|KIRC - Kidney renal clear cell carcinoma(229;0.0354)|Lung(427;0.201)			KNOWN			CACCCCTGCGTCCTAGACCAG						ENST00000379370.2:c.1178-6T>C	1					breast(1)|central_nervous_system(2)|endometrium(8)|kidney(3)|large_intestine(2)|lung(20)|ovary(1)|prostate(1)|skin(3)|urinary_tract(1)		+		,		1p36.33	Q5SVA1|Q5SVA2|Q60FE1|Q7KYS8|Q8N4J5|Q96IC1|Q9BTD4	"""agrin proteoglycan"""	g.chr1:977330T>C					no		11082,1916												-2.8					0.0	acetylcholine receptor regulator activity (GO:0030548)|calcium ion binding (GO:0005509)|chondroitin sulfate binding (GO:0035374)|dystroglycan binding (GO:0002162)|heparan sulfate proteoglycan binding (GO:0043395)|laminin binding (GO:0043236)|sialic acid binding (GO:0033691)|structural constituent of cytoskeleton (GO:0005200)		2007-02-16		hg19	Standard	0.9245			7915,681		axon guidance (GO:0007411)|carbohydrate metabolic process (GO:0005975)|chondroitin sulfate metabolic process (GO:0030204)|clustering of voltage-gated sodium channels (GO:0045162)|extracellular matrix organization (GO:0030198)|G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|neuromuscular junction development (GO:0007528)|neurotransmitter receptor metabolic process (GO:0045213)|phototransduction, visible light (GO:0007603)|plasma membrane organization (GO:0007009)|positive regulation of filopodium assembly (GO:0051491)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Rho GTPase activity (GO:0032321)|positive regulation of synaptic growth at neuromuscular junction (GO:0045887)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|receptor clustering (GO:0043113)|retinoid metabolic process (GO:0001523)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synapse organization (GO:0050808)	4783,1516,200					CCDS30551.1	T		CC,CT,TT	XM_372195	basal lamina (GO:0005605)|cell junction (GO:0030054)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi lumen (GO:0005796)|integral component of membrane (GO:0016021)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)|synapse (GO:0045202)	31		2504		rs2799066		1227										AGRIN		42	NM_198576		7			ENST00000379370.2		12121		uc001ack.2			375790	dbSNP_100						0				32.0		0.721	1:g.977330T>C		protein_coding			basic|appris_principal|CCDS		3643,629,26			3167,1235			C|||			5008		AGRIN_HUMAN	4433	agrin			0.885184		977330			0.999	SNP		CCDS30551.1			,,,	False	977330				intron_variant		Approved		31.0			2014-09-17	OTTHUMT00000097990.2	O00468	0.9207		AGRN	977330		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			AGRN	NM_198576.3	protein-coding gene	NP_940978.2		
		G	ENSG00000188157	ENST00000379370.2		375790		ENSG00000188157		4300					,					OTTHUMG00000040778		byFrequency	O00468	gene with protein product				NM_198576.3	918,1014,271	NM_198576	0.9724					+	Intron		789.0+/-407.6	60.0				1851019, 12270958				AGRN-001					1	+	0.6225				intron	329			all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)	A	SO:0001627	103320			protein_coding		2203				7.3023,35.3155,16.7922		"""Proteoglycans / Extracellular Matrix : Other"""	6503					UCEC - Uterine corpus endometrioid carcinoma (11;0.00462)|Epithelial(90;5.98e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.43e-23)|Colorectal(212;5.97e-05)|COAD - Colon adenocarcinoma(227;0.000201)|Kidney(185;0.0024)|BRCA - Breast invasive adenocarcinoma(365;0.00246)|STAD - Stomach adenocarcinoma(132;0.00645)|KIRC - Kidney renal clear cell carcinoma(229;0.0354)|Lung(427;0.201)			KNOWN			TGCGGACATCACGTTCCTCCC						ENST00000379370.2:c.2537-26A>G	1					breast(1)|central_nervous_system(2)|endometrium(8)|kidney(3)|large_intestine(2)|lung(20)|ovary(1)|prostate(1)|skin(3)|urinary_tract(1)		+		,		1p36.33	Q5SVA1|Q5SVA2|Q60FE1|Q7KYS8|Q8N4J5|Q96IC1|Q9BTD4	"""agrin proteoglycan"""	g.chr1:981087A>G		664.9+/-401.5			no		10822,2184												-6.1					0.0	acetylcholine receptor regulator activity (GO:0030548)|calcium ion binding (GO:0005509)|chondroitin sulfate binding (GO:0035374)|dystroglycan binding (GO:0002162)|heparan sulfate proteoglycan binding (GO:0043395)|laminin binding (GO:0043236)|sialic acid binding (GO:0033691)|structural constituent of cytoskeleton (GO:0005200)		2007-02-16		hg19	Standard	0.9304			7972,628		axon guidance (GO:0007411)|carbohydrate metabolic process (GO:0005975)|chondroitin sulfate metabolic process (GO:0030204)|clustering of voltage-gated sodium channels (GO:0045162)|extracellular matrix organization (GO:0030198)|G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|neuromuscular junction development (GO:0007528)|neurotransmitter receptor metabolic process (GO:0045213)|phototransduction, visible light (GO:0007603)|plasma membrane organization (GO:0007009)|positive regulation of filopodium assembly (GO:0051491)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Rho GTPase activity (GO:0032321)|positive regulation of synaptic growth at neuromuscular junction (GO:0045887)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|receptor clustering (GO:0043113)|retinoid metabolic process (GO:0001523)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synapse organization (GO:0050808)	4611,1600,292					CCDS30551.1	A		GG,GA,AA	XM_372195	basal lamina (GO:0005605)|cell junction (GO:0030054)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi lumen (GO:0005796)|integral component of membrane (GO:0016021)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)|synapse (GO:0045202)	59		2504		rs3128098		2586										AGRIN		42	NM_198576		15			ENST00000379370.2		17548		uc001ack.2			375790	dbSNP_103						0				58.0		0.667	1:g.981087A>G		protein_coding			basic|appris_principal|CCDS		3693,586,21			2850,1556			A|||			5008		AGRIN_HUMAN	4354	agrin			0.869409		981087			0.999	SNP		CCDS30551.1			,,,	False	981087				intron_variant		Approved		59.0			2014-09-17	OTTHUMT00000097990.2	O00468	0.9179		AGRN	981087		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			AGRN	NM_198576.3	protein-coding gene	NP_940978.2		
		C	ENSG00000188157	ENST00000379370.2		375790		ENSG00000188157		4299					,					OTTHUMG00000040778		byFrequency	O00468	gene with protein product				NM_198576.3	0,58,2145	NM_198576	0.0706					+	Intron		160.5+/-213.6	41.0				1851019, 12270958				AGRN-001					1	+	0.003				intron	329			all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)	G	SO:0001627	103320			protein_coding		2203				7.5017,1.3164,5.406		"""Proteoglycans / Extracellular Matrix : Other"""	6502					UCEC - Uterine corpus endometrioid carcinoma (11;0.00462)|Epithelial(90;5.98e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.43e-23)|Colorectal(212;5.97e-05)|COAD - Colon adenocarcinoma(227;0.000201)|Kidney(185;0.0024)|BRCA - Breast invasive adenocarcinoma(365;0.00246)|STAD - Stomach adenocarcinoma(132;0.00645)|KIRC - Kidney renal clear cell carcinoma(229;0.0354)|Lung(427;0.201)			KNOWN			CGTAAGACGGGGGCGCAGCCC						ENST00000379370.2:c.3516+10G>C	1					breast(1)|central_nervous_system(2)|endometrium(8)|kidney(3)|large_intestine(2)|lung(20)|ovary(1)|prostate(1)|skin(3)|urinary_tract(1)		+		,		1p36.33	Q5SVA1|Q5SVA2|Q60FE1|Q7KYS8|Q8N4J5|Q96IC1|Q9BTD4	"""agrin proteoglycan"""	g.chr1:982844G>C		52.9+/-88.7			no		703,12301												1.6					0.1	acetylcholine receptor regulator activity (GO:0030548)|calcium ion binding (GO:0005509)|chondroitin sulfate binding (GO:0035374)|dystroglycan binding (GO:0002162)|heparan sulfate proteoglycan binding (GO:0043395)|laminin binding (GO:0043236)|sialic acid binding (GO:0033691)|structural constituent of cytoskeleton (GO:0005200)		2007-02-16		hg19	Standard	0.0825			645,7953		axon guidance (GO:0007411)|carbohydrate metabolic process (GO:0005975)|chondroitin sulfate metabolic process (GO:0030204)|clustering of voltage-gated sodium channels (GO:0045162)|extracellular matrix organization (GO:0030198)|G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|neuromuscular junction development (GO:0007528)|neurotransmitter receptor metabolic process (GO:0045213)|phototransduction, visible light (GO:0007603)|plasma membrane organization (GO:0007009)|positive regulation of filopodium assembly (GO:0051491)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Rho GTPase activity (GO:0032321)|positive regulation of synaptic growth at neuromuscular junction (GO:0045887)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|receptor clustering (GO:0043113)|retinoid metabolic process (GO:0001523)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synapse organization (GO:0050808)	26,651,5825					CCDS30551.1	G		CC,CG,GG	XM_372195	basal lamina (GO:0005605)|cell junction (GO:0030054)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi lumen (GO:0005796)|integral component of membrane (GO:0016021)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)|synapse (GO:0045202)	38		2504		rs76264143		3566										AGRIN		42	NM_198576		20			ENST00000379370.2		15428		uc001ack.2			375790	dbSNP_132						0				33.0		0.662	1:g.982844G>C		protein_coding			basic|appris_principal|CCDS		26,593,3680			58,4348			G|||			5008		AGRIN_HUMAN	194	agrin			0.038738		982844			0.001	SNP		CCDS30551.1			,,,	False	982844				intron_variant		Approved		38.0			2014-09-17	OTTHUMT00000097990.2	O00468	0.0533		AGRN	982844		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			AGRN	NM_198576.3	protein-coding gene	NP_940978.2		
		C	ENSG00000188157	ENST00000379370.2		375790		ENSG00000188157		4300					,				c.(3556-3558)ttT>ttC	OTTHUMG00000040778		byFrequency	O00468	gene with protein product				NM_198576.3	657,1075,471	NM_198576	0.9663					+	Silent		776.9+/-407.7	58.0				1851019, 12270958				AGRN-001					1	+	0.5151				coding-synonymous	329		1186/2046	all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)	T	SO:0001819	103320			protein_coding		2203				8.1279,45.7785,20.8827		"""Proteoglycans / Extracellular Matrix : Other"""	6503					UCEC - Uterine corpus endometrioid carcinoma (11;0.00462)|Epithelial(90;5.98e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.43e-23)|Colorectal(212;5.97e-05)|COAD - Colon adenocarcinoma(227;0.000201)|Kidney(185;0.0024)|BRCA - Breast invasive adenocarcinoma(365;0.00246)|STAD - Stomach adenocarcinoma(132;0.00645)|KIRC - Kidney renal clear cell carcinoma(229;0.0354)|Lung(427;0.201)			KNOWN			AGAAGGATTTTCGGAGTGTCC						ENST00000379370.2:c.3558T>C	1	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.				breast(1)|central_nervous_system(2)|endometrium(8)|kidney(3)|large_intestine(2)|lung(20)|ovary(1)|prostate(1)|skin(3)|urinary_tract(1)		+		,		1p36.33	Q5SVA1|Q5SVA2|Q60FE1|Q7KYS8|Q8N4J5|Q96IC1|Q9BTD4	"""agrin proteoglycan"""	g.chr1:982994T>C		581.7+/-385.4			no		10290,2716												-0.3					0.9	acetylcholine receptor regulator activity (GO:0030548)|calcium ion binding (GO:0005509)|chondroitin sulfate binding (GO:0035374)|dystroglycan binding (GO:0002162)|heparan sulfate proteoglycan binding (GO:0043395)|laminin binding (GO:0043236)|sialic acid binding (GO:0033691)|structural constituent of cytoskeleton (GO:0005200)		2007-02-16		hg19	Standard	0.9205			7901,699		axon guidance (GO:0007411)|carbohydrate metabolic process (GO:0005975)|chondroitin sulfate metabolic process (GO:0030204)|clustering of voltage-gated sodium channels (GO:0045162)|extracellular matrix organization (GO:0030198)|G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|neuromuscular junction development (GO:0007528)|neurotransmitter receptor metabolic process (GO:0045213)|phototransduction, visible light (GO:0007603)|plasma membrane organization (GO:0007009)|positive regulation of filopodium assembly (GO:0051491)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Rho GTPase activity (GO:0032321)|positive regulation of synaptic growth at neuromuscular junction (GO:0045887)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|receptor clustering (GO:0043113)|retinoid metabolic process (GO:0001523)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synapse organization (GO:0050808)	4282,1726,495					CCDS30551.1	T		CC,CT,TT	XM_372195	basal lamina (GO:0005605)|cell junction (GO:0030054)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi lumen (GO:0005796)|integral component of membrane (GO:0016021)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)|synapse (GO:0045202)	57		2504		rs10267		3608									1186	AGRIN		42	NM_198576		21			ENST00000379370.2		16246		uc001ack.2			375790	dbSNP_52	3558			p.F1186F		0				55.0		0.632	1:g.982994T>C		protein_coding			basic|appris_principal|CCDS		3625,651,24			2389,2017			T|||			5008		AGRIN_HUMAN	4186	agrin			0.835863		982994			0.999	SNP		CCDS30551.1			,,,	False	982994				synonymous_variant		Approved		57.0		c.3558T>C	2014-09-17	OTTHUMT00000097990.2	O00468	0.9035		AGRN	982994		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			AGRN	NM_198576.3	protein-coding gene	NP_940978.2		
		T	ENSG00000188157	ENST00000379370.2		375790		ENSG00000188157		4299					,					OTTHUMG00000040778		byFrequency	O00468	gene with protein product				NM_198576.3	474,1068,659	NM_198576	0.9018					+	Intron		782.6+/-407.6	91.0				1851019, 12270958				AGRN-001					1	+	0.4017				intron	329			all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)	C	SO:0001627	103320			protein_coding		2201				9.0021,45.7974,24.3077		"""Proteoglycans / Extracellular Matrix : Other"""	6500					UCEC - Uterine corpus endometrioid carcinoma (11;0.00462)|Epithelial(90;5.98e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.43e-23)|Colorectal(212;5.97e-05)|COAD - Colon adenocarcinoma(227;0.000201)|Kidney(185;0.0024)|BRCA - Breast invasive adenocarcinoma(365;0.00246)|STAD - Stomach adenocarcinoma(132;0.00645)|KIRC - Kidney renal clear cell carcinoma(229;0.0354)|Lung(427;0.201)			KNOWN			CGAGAGGTAACGTGCCATCCT						ENST00000379370.2:c.5651+5C>T	1					breast(1)|central_nervous_system(2)|endometrium(8)|kidney(3)|large_intestine(2)|lung(20)|ovary(1)|prostate(1)|skin(3)|urinary_tract(1)		+		,		1p36.33	Q5SVA1|Q5SVA2|Q60FE1|Q7KYS8|Q8N4J5|Q96IC1|Q9BTD4	"""agrin proteoglycan"""	g.chr1:987200C>T		558.3+/-380.0			no		9840,3160												-6.1					0.0	acetylcholine receptor regulator activity (GO:0030548)|calcium ion binding (GO:0005509)|chondroitin sulfate binding (GO:0035374)|dystroglycan binding (GO:0002162)|heparan sulfate proteoglycan binding (GO:0043395)|laminin binding (GO:0043236)|sialic acid binding (GO:0033691)|structural constituent of cytoskeleton (GO:0005200)		2007-02-16		hg19	Standard	0.9145			7824,774		axon guidance (GO:0007411)|carbohydrate metabolic process (GO:0005975)|chondroitin sulfate metabolic process (GO:0030204)|clustering of voltage-gated sodium channels (GO:0045162)|extracellular matrix organization (GO:0030198)|G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|neuromuscular junction development (GO:0007528)|neurotransmitter receptor metabolic process (GO:0045213)|phototransduction, visible light (GO:0007603)|plasma membrane organization (GO:0007009)|positive regulation of filopodium assembly (GO:0051491)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Rho GTPase activity (GO:0032321)|positive regulation of synaptic growth at neuromuscular junction (GO:0045887)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|receptor clustering (GO:0043113)|retinoid metabolic process (GO:0001523)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synapse organization (GO:0050808)	4023,1794,683					CCDS30551.1	C		TT,TC,CC	XM_372195	basal lamina (GO:0005605)|cell junction (GO:0030054)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi lumen (GO:0005796)|integral component of membrane (GO:0016021)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)|synapse (GO:0045202)	100		2504		rs9803031		5701										AGRIN		42	NM_198576		33			ENST00000379370.2		15100		uc001ack.2			375790	dbSNP_119						0				117.0		0.662	1:g.987200C>T		protein_coding			basic|appris_principal|CCDS		3549,726,24			2016,2386			C|||			5008		AGRIN_HUMAN	3950	agrin			0.788738		987200			0.9931	SNP		CCDS30551.1			,,,	False	987200				intron_variant		Approved		100.0			2014-09-17	OTTHUMT00000097990.2	O00468	0.8876		AGRN	987200		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			AGRN	NM_198576.3	protein-coding gene	NP_940978.2		
		G	ENSG00000162572	ENST00000338555.2		6339		ENSG00000162572		4276					,					OTTHUMG00000002081		byFrequency	P51172	gene with protein product		SCNN1D_ENST00000400928.3_Intron|SCNN1D_ENST00000325425.8_Intron|SCNN1D_ENST00000379116.5_Intron	Amiloride(DB00594)|Triamterene(DB00384)		924,998,252	NM_002978	0.3967					+	Intron			28.0				8661065				SCNN1D-001	2012-02-28				1	+	0.7542				intron	10601			all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)	G	SO:0001627	601328			protein_coding		2174				12.3363,34.5446,30.2403		"""Ion channels / Sodium channel, nonvoltage-gated"", ""Sodium channels"""	6450					Epithelial(90;3.01e-35)|OV - Ovarian serous cystadenocarcinoma(86;2.46e-21)|Colorectal(212;0.000157)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00229)|BRCA - Breast invasive adenocarcinoma(365;0.00251)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.034)|Lung(427;0.199)			KNOWN			GTGCACCCTCCCCCTCCAGAG						ENST00000338555.2:c.1484+15C>G	1					lung(6)|skin(1)		+		,		1p36.3-p36.2	A9Z1X6|B1PS44|Q08AQ3|Q09HT0|Q5T7L3|Q8NA24		g.chr1:1226348C>G					no		3901,8999												-4.0					0.0	ligand-gated sodium channel activity (GO:0015280)				hg19	Standard	0.1193			1055,7497		ion transmembrane transport (GO:0034220)|response to stimulus (GO:0050896)|sensory perception of taste (GO:0050909)|sodium ion transmembrane transport (GO:0035725)|sodium ion transport (GO:0006814)|transmembrane transport (GO:0055085)	992,1917,3541					CCDS44037.1, CCDS44037.2	C		GG,GC,CC	U38254	actin cytoskeleton (GO:0015629)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	29		2504		rs586965|rs373520165		2628				"""sodium channel, nonvoltage-gated 1, delta"", ""sodium channel, non-voltage-gated 1, delta"""						ENaCdelta, dNaCh		7	NM_001130413		13			ENST00000338555.2		13397		uc001adt.1			6339	dbSNP_83						0				30.0		0.647	1:g.1226348C>G		protein_coding			basic|appris_candidate		68,919,3289			2846,1502			G|||			5008		SCNND_HUMAN	2525	sodium channel, non-voltage-gated 1, delta subunit			0.504193		1226348			0.7877	SNP					,,,	False	1226348				intron_variant		Approved		29.0			2012-02-28	OTTHUMT00000005802.2	P51172	0.3256		SCNN1D	1226348		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			SCNN1D	NM_001130413.3	protein-coding gene			
		A	ENSG00000169962	ENST00000339381.5		83756		ENSG00000169962		4271					,				c.(13-15)gcT>gcA	OTTHUMG00000003071		byFrequency	Q7RTX0	gene with protein product				NM_152228.1	0,57,2138		0.0092					+	Silent			21.0				11319557				TAS1R3-001					1	+	0.0053				coding-synonymous	15661		5/853	all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)	T	SO:0001819	605865			protein_coding		2195				6.5441,1.2984,4.7634		"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6466					Epithelial(90;3.01e-35)|OV - Ovarian serous cystadenocarcinoma(86;3.88e-21)|Colorectal(212;0.000157)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00229)|BRCA - Breast invasive adenocarcinoma(365;0.00251)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.034)|Lung(427;0.146)			KNOWN			TGGGCCCTGCTGTCCTGGGCC						ENST00000339381.5:c.15T>A	1					kidney(2)|lung(8)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		1p36	Q5TA49|Q8NGW9		g.chr1:1266740T>A					no		616,12316												-1.2					0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)				hg19	Standard	0.0626			559,7983		detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)|G-protein coupled receptor signaling pathway (GO:0007186)|sensory perception of sweet taste (GO:0050916)|sensory perception of umami taste (GO:0050917)	9,598,5859					CCDS30556.1	T		AA,AT,TT	AC026283	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	20		2504		rs141430443		47									5	T1R3		12	XM_006710939		1			ENST00000339381.5		17666		uc010nyk.2			83756	dbSNP_134	15			p.A5A		0				20.0		0.687	1:g.1266740T>A		protein_coding			basic|appris_principal|CCDS		9,541,3721			57,4333			t|||			5008		TS1R3_HUMAN	95	taste receptor, type 1, member 3			0.0189696		1266740			0.0	SNP		CCDS30556.1			,,,	False	1266740				synonymous_variant		Approved		20.0		c.15T>A	2012-08-22	OTTHUMT00000008493.1	Q7RTX0	0.0231		TAS1R3	1266740		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			TAS1R3	NM_152228.1	protein-coding gene	NP_689414		
		C	ENSG00000169962	ENST00000339381.5	0.80722	83756	N	ENSG00000169962	0.05589	4287	0.001000	0.87179	B		,	T	0.0	0	c.(2269-2271)Tgc>Cgc	OTTHUMG00000003071	-0.627000	byFrequency	Q7RTX0	gene with protein product				NM_152228.1	2145,42,1		0.9172			C	0.003	+	Missense_Mutation	1		17.0	Q7RTX0	0.989945		11319557			0.0	TAS1R3-001			0.01281		1	+	0.9803		0.33	0.154000	missense	15661	357	757/853	all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)	C	SO:0001583	605865	benign	0.9861878453038674	protein_coding		2188	P		0.207000	2.9041,1.0055,2.2625	B	"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6475		0.4353:0.2184:0.1103:0.2359			Epithelial(90;3.01e-35)|OV - Ovarian serous cystadenocarcinoma(86;3.88e-21)|Colorectal(212;0.000157)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00229)|BRCA - Breast invasive adenocarcinoma(365;0.00251)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.034)|Lung(427;0.146)			KNOWN	ENST00000339381		CCAGCCGGGCTGCTACAACCG	D					ENST00000339381.5:c.2269T>C	1		ENSG00000169962	0.07423	TAS1R3	kidney(2)|lung(8)|upper_aerodigestive_tract(1)|urinary_tract(1)	ENSP00000344411:p.Cys757Arg	+	0.23482	,	TGC	1p36	Q5TA49|Q8NGW9		g.chr1:1269554T>C	C -> R (in dbSNP:rs307377).			486	yes		12657,293	0.08648	0.00133	4.59	0.00012	ENSP00000344411:C757R			0.23496		.		-0.8	0.10759	520	0.26408	0.9090909090909091	0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)	-1.79			hg19	Standard	0.9662	0.9878048780487805	1.084	8325,249		detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)|G-protein coupled receptor signaling pathway (GO:0007186)|sensory perception of sweet taste (GO:0050916)|sensory perception of umami taste (GO:0050917)	6189,279,7	-2.569503				CCDS30556.1	T	0.02656	CC,CT,TT	AC026283	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	21	0.00237	2504	-0.839	rs307377		2301	757	733			0.01648	1259417	+	ARG/CYS	757	T1R3	2096	12	XM_006710939	0.0	6	0.9670184696569921	-0.366000	ENST00000339381.5		18196		uc010nyk.2			83756	dbSNP_79	2269	0.0000		p.C757R	GPCR, family 3, C-terminal (2);	0		T		31.0	rs307377;rs61766208	0.637	1:g.1269554T>C	ENSP00000344411:C757R	protein_coding	0.047555		basic|appris_principal|CCDS		4044,237,6		757	4332,44	0.9597069597069597	R	c|||		0.457963	5008		TS1R3_HUMAN	4767	taste receptor, type 1, member 3		TS1R3_HUMAN	0.951877	0.21313	1269554		0.423000	0.9137	SNP		CCDS30556.1		N	,,,	False	1269554	-0.9480		9	missense	T	Approved	0.970959	21.0		c.2269T>C	2012-08-22	OTTHUMT00000008493.1	Q7RTX0	0.9813	-2.22	TAS1R3	1269554	0.21943	all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)	0.41945	180	TAS1R3	NM_152228.1	protein-coding gene	NP_689414	C	
		A	ENSG00000107404	ENST00000378888.5		1855		ENSG00000107404		4300									c.(949-951)gcC>gcT	OTTHUMG00000003069			O14640	gene with protein product		DVL1_ENST00000378891.5_Silent_p.A317A				NM_004421						+	Silent			73.0				8817329				DVL1-004	2013-05-22				1	-						3084			all_epithelial(116;8.75e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.128)		SO:0001819	601365			protein_coding		2202						"""Dishevelled homologs"""	6502					Epithelial(90;2.83e-35)|OV - Ovarian serous cystadenocarcinoma(86;3.77e-21)|Colorectal(212;0.000155)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00227)|BRCA - Breast invasive adenocarcinoma(365;0.0025)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0339)|Lung(427;0.145)			KNOWN			GCACCCGCACGGCATCGTCAT						ENST00000378888.5:c.951C>T	1	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.				endometrium(1)|kidney(1)|large_intestine(2)|lung(5)|ovary(1)|prostate(1)|upper_aerodigestive_tract(2)		-				1p36	Q5TA33|Q5TA35		g.chr1:1275151G>A																									enzyme binding (GO:0019899)|frizzled binding (GO:0005109)|identical protein binding (GO:0042802)|protein kinase binding (GO:0019901)|Rac GTPase binding (GO:0048365)				hg19	Standard						axon extension (GO:0048675)|axon guidance (GO:0007411)|canonical Wnt signaling pathway (GO:0060070)|cochlea morphogenesis (GO:0090103)|collateral sprouting (GO:0048668)|convergent extension (GO:0060026)|convergent extension involved in neural plate elongation (GO:0022007)|cytoplasmic microtubule organization (GO:0031122)|dendrite morphogenesis (GO:0048813)|intracellular signal transduction (GO:0035556)|negative regulation of protein binding (GO:0032091)|negative regulation of protein kinase activity (GO:0006469)|neural tube development (GO:0021915)|neuromuscular junction development (GO:0007528)|neurotransmitter secretion (GO:0007269)|planar cell polarity pathway involved in neural tube closure (GO:0090179)|positive regulation of canonical Wnt signaling pathway (GO:0090263)|positive regulation of neuron projection development (GO:0010976)|positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)|positive regulation of transcription, DNA-templated (GO:0045893)|positive regulation of Wnt signaling pathway (GO:0030177)|prepulse inhibition (GO:0060134)|protein localization to microtubule (GO:0035372)|protein localization to nucleus (GO:0034504)|receptor clustering (GO:0043113)|regulation of neurotransmitter levels (GO:0001505)|skeletal muscle acetylcholine-gated channel clustering (GO:0071340)|social behavior (GO:0035176)|synapse organization (GO:0050808)|transcription from RNA polymerase II promoter (GO:0006366)|Wnt signaling pathway, planar cell polarity pathway (GO:0060071)						CCDS22.1	G			AF006011	axon (GO:0030424)|cell cortex (GO:0005938)|clathrin-coated vesicle (GO:0030136)|cytoplasmic membrane-bounded vesicle (GO:0016023)|cytoplasmic vesicle (GO:0031410)|dendrite (GO:0030425)|growth cone (GO:0030426)|microtubule (GO:0005874)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)|synapse (GO:0045202)							1235				"""dishevelled 1 (homologous to Drosophila dsh)"", ""dishevelled, dsh homolog 1 (Drosophila)"""					317			13	NM_004421		9			ENST00000378888.5				uc001aer.4			1855					p.A317A		0				77.0		0.657	1:g.1275151G>A		protein_coding			basic|appris_principal													DVL1_HUMAN		dishevelled segment polarity protein 1					1275151				SNP							1275151				synonymous_variant		Approved		74.0		c.951C>T	2013-05-22	OTTHUMT00000008490.1	O14640			DVL1	1275151		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)					protein-coding gene			
		C	ENSG00000197785	ENST00000378755.5		55210		ENSG00000197785		4297					,					OTTHUMG00000000575		byFrequency	Q9NVI7	gene with protein product		ATAD3A_ENST00000378756.3_Intron|ATAD3A_ENST00000536055.1_Intron		NM_018188.3		NM_018188	0.3691					+	Intron			24.0				12477932				ATAD3A-003					1	+	0.7988					25567			all_epithelial(116;9.48e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Lung SC(97;0.217)		SO:0001627	612316			protein_coding		2198						"""ATPases / AAA-type"""	6495					Epithelial(90;1.12e-36)|OV - Ovarian serous cystadenocarcinoma(86;2.18e-22)|Colorectal(212;0.000164)|COAD - Colon adenocarcinoma(227;0.000195)|Kidney(185;0.00233)|BRCA - Breast invasive adenocarcinoma(365;0.00469)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0347)|Lung(427;0.147)			KNOWN			TCCCTCAGCTGCCTCTCTCCC						ENST00000378755.5:c.1759-17G>C	1					endometrium(4)|kidney(6)|large_intestine(1)|lung(5)|prostate(1)|skin(2)|urinary_tract(1)		+		,		1p36.33	B3KPB3|D2K8Q1|G3V1I6|Q5SV23|Q8N275|Q96A50		g.chr1:1469289G>C																									ATP binding (GO:0005524)		2007-02-08		hg19	Standard	0.2545					cell growth (GO:0016049)|negative regulation of apoptotic process (GO:0043066)						CCDS31.1, CCDS53259.1, CCDS53260.1	G			AK025865	integral component of membrane (GO:0016021)|mitochondrial inner membrane (GO:0005743)|mitochondrial nucleoid (GO:0042645)|mitochondrion (GO:0005739)			2504		rs28370384		1852										FLJ10709		20	NM_018188		16			ENST00000378755.5		11384		uc001afz.2			55210							0				17.0		0.682	1:g.1469289G>C		protein_coding			basic|CCDS								N|||			5008		ATD3A_HUMAN	2473	ATPase family, AAA domain containing 3A			0.49381		1469289			0.5327	SNP		CCDS31.1			,,,	False	1469289				intron_variant		Approved		22.0			2010-04-21	OTTHUMT00000001365.1	Q9NVI7	0.379		ATAD3A	1469289		all_cancers(77;0.00164)|all_epithelial(69;0.000959)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)					protein-coding gene	NP_060658.3		
		T	ENSG00000008130	ENST00000341426.5	0.39448	65220	L	ENSG00000008130	0.05626	4300	0.007000	0.44083	P;B;B;B		,	T	0.03264699999999998	2	c.(784-786)aaC>aaA	OTTHUMG00000000942	-0.622000	byFrequency	O95544	gene with protein product		NADK_ENST00000342348.5_Missense_Mutation_p.N230K|NADK_ENST00000378625.1_Missense_Mutation_p.N407K|NADK_ENST00000344463.4_Missense_Mutation_p.N407K|NADK_ENST00000341991.3_Missense_Mutation_p.N262K		NM_023018.4	20,456,1727	NM_023018	0.3057			G	6.316	+	Missense_Mutation	3	524.5+/-380.5	89.0	F5GXR5;Q9H2P2;Q5QPS4;O95544	0.112574		11594753			0.229;0.161;0.161;0.025	NADK-003			0.36608		1	-	0.0499		0.45	0.000000	missense,missense,missense,missense	29831	104	262/447,407/592,230/415,262/447	all_epithelial(116;5.61e-19)|all_lung(118;2.3e-08)|Lung NSC(185;2.38e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Medulloblastoma(700;0.123)|Lung SC(97;0.128)	A	SO:0001583	611616	benign,benign,benign,benign	0.287292817679558	protein_coding		2203	P		0.041000	42.2558,11.2574,31.7546	B;B;B;B		6503		0.527:0.0:0.473:0.0			Epithelial(90;8.75e-37)|OV - Ovarian serous cystadenocarcinoma(86;2.33e-23)|GBM - Glioblastoma multiforme(42;1.35e-07)|Colorectal(212;0.000203)|COAD - Colon adenocarcinoma(227;0.000225)|Kidney(185;0.00265)|STAD - Stomach adenocarcinoma(132;0.00655)|BRCA - Breast invasive adenocarcinoma(365;0.00855)|KIRC - Kidney renal clear cell carcinoma(229;0.0382)|Lung(427;0.207)			KNOWN	ENST00000341426;ENST00000341991;ENST00000378625;ENST00000344463;ENST00000342348		CCTGCGAGCCGTTCTCACCCA	T;T;T;T;T					ENST00000341426.5:c.786C>A	1		ENSG00000008130	0.00261	NADK	NS(1)|autonomic_ganglia(1)|endometrium(4)|large_intestine(2)|lung(4)|ovary(1)|prostate(2)|stomach(1)|urinary_tract(1)	ENSP00000341679:p.Asn262Lys	-	0.20044	,	AAC	1p36.33	A6NNN3|A8K296|B7Z434|F5GXR5|Q5QPS4|Q9H2P2|Q9H931		g.chr1:1686040G>T	N -> K (in dbSNP:rs4751). {ECO:0000269|PubMed:11594753, ECO:0000269|PubMed:15489334}.	230.1+/-244.4		26	yes		4130,8876	0.13788	0.11987	5.84	0.00012	ENSP00000341679:N262K			0.64402		-35.6144		-1.9	0.07594	170	0.19590	0.2972027972027972	0.0	ATP binding (GO:0005524)|metal ion binding (GO:0046872)|NAD+ kinase activity (GO:0003951)	1.59			hg19	Standard	0.4115	0.052845528455284556	13.1463	3634,4966		ATP metabolic process (GO:0046034)|NAD metabolic process (GO:0019674)|NADP biosynthetic process (GO:0006741)|phosphorylation (GO:0016310)|small molecule metabolic process (GO:0044281)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767)	815,2500,3188	0.426413				CCDS30565.1, CCDS55561.1, CCDS55562.1	G	0.36633	TT,TG,GG	BC001709	cytosol (GO:0005829)	90	0.50333	2504	-1.93	rs4751		1007	230;407;407;262	308			0.59463	1675900	-	LYS/ASN,LYS/ASN,LYS/ASN,LYS/ASN	262	FLJ13052	608	17	NM_023018	0.562;0.257;0.392;0.016	8	0.40633245382585753	-2.299000	ENST00000341426.5		15692		uc001aie.3			65220	dbSNP_52	786,1221,690,786	0.0000		p.N262K	ATP-NAD kinase, PpnK-type, alpha/beta (1);ATP-NAD kinase, PpnK-type (1);	0		T		92.0	rs4751;rs1062031;rs3170815;rs17162848;rs17350309;rs17353693;rs17844919;rs17857643	0.662	1:g.1686040G>T	ENSP00000341679:N262K;ENSP00000344340:N262K;ENSP00000367890:N407K;ENSP00000340925:N407K;ENSP00000339727:N230K	protein_coding	0.000005		alternative_5_UTR|basic|appris_candidate|CCDS		795,2044,1461		262;262;407;407;230	496,3910	0.2783882783882784	K	g|||		0.137095	5008		NADK_HUMAN	1249	NAD kinase		.;.;.;NADK_HUMAN	0.249401	0.04354	1686040		-0.842000	0.2837	SNP		CCDS30565.1		D	,,,	False	1686040	-0.9562	2.7.1.23	9	missense	T	Approved	0.422558	90.0		c.786C>A	2013-04-29	OTTHUMT00000002769.1	O95544	0.2651	0.93;0.93;0.93;0.93;0.94	NADK	1686040	0.00434	all_cancers(77;0.000708)|all_epithelial(69;0.000943)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)	0.40459	94,94,94,94	NADK	NM_001198993.1,NM_001198994.1,NM_001198995.1,NM_023018.4	protein-coding gene	NP_075394.3	N	
		C			0.58432		N		0.03945	4190	0.000000	.	B;B		,	T	1.0000000000287557E-6	0			-0.890000	byFrequency				TMEM52 (49474 upstream) : C1orf222 (19376 downstream)			8,310,1734		0.2055			t	5.253	+	IGR	2		189.0	Q9C0B2-2;Q9C0B2	0.079435					0.023;0.007				0.18871		1		0.0847		0.51	0.010000	missense		70	378/763		T	SO:0001628		benign	0.19337016574585636			2052	P		0.000000	20.4296,7.9435,16.3249	B;B		6242		0.0:0.5071:0.1548:0.3381							ENST00000270720		GGGATGCTGTTTCTTCCTCTT	.						1		ENSG00000142609	0.30748	C1orf222				0.05858	,	AAA				g.chr1:1900186T>C				43	yes	0	2038,10446	0.03702	0.09969	3.67	0.00039	ENSP00000270720:K378R			0.03416		-2.4306		-3.6	0.04612	65	0.16896	0.11363636363636363	0.0		0.49			hg19		0.1938	0.08739837398373984	6.9556	1712,6668			179,1680,4383	0.232159					T	0.23990	CC,CT,TT			186	0.17474	2504	-3.57	rs35269416			378;378	140			0.24570	1890046	-	ARG/LYS			318			0.095;0.012		0.18469656992084432	0.454000			19340						dbSNP_126	1133	0.0001			.	0		T		179.0	rs35269416;rs61745134	0.547	1:g.1900186T>C	.		0.205639				171,1370,2649		378	326,3778	0.14560439560439561	R	t|||		1.650180	5008			771			.;K1751_HUMAN	0.153954	0.09083	1900186		-0.230000	0.1101	SNP				N	,,,	False	1900186	-1.0546		8	intergenic_variant	T		0.204296	186.0						0.219	.	Unknown	1900186	0.07245		0.12477	26	KIAA1751	NM_001080484.1			K	
		C			0.53005		N		0.15133	4174	0.000000	.	B;B		,	T	3.2999999999949736E-5	0			0.021000	byFrequency				TMEM52 (49520 upstream) : C1orf222 (19330 downstream)			365,938,729		0.3262			c	0.012	+	IGR	1		137.0	Q9C0B2-2;Q9C0B2	0.410433					0.001;0.0				0.04013		1		0.4312		1	0.002000	missense		154	363/763		C	SO:0001628		benign	0.425414364640884			2032	P		0.015000	44.7173,41.0433,43.5143	B;B		6206		0.0:0.5676:0.0:0.4324							ENST00000270720		ATCCGACTGATGATCTCCTGC	.						1		ENSG00000142609	0.12420	C1orf222				0.18098	,	ATC				g.chr1:1900232T>C				211	yes	0	5401,7011	0.03702	0.00738	3.67	0.00012	ENSP00000270720:I363V			0.22389		-11.6336		1.7	0.24563	202	0.02654	0.3531468531468531	0.0		-1.01			hg19		0.4314	0.42886178861788615	6.7917	3733,4615			1208,2985,2013	-1.688484					T	0.06786	CC,CT,TT			134	0.01109	2504	1.74	rs16824588			363;363	319			0.23703	1890092	-	VAL/ILE			886			0.001;0.0		0.420844327176781	-0.224000			17266						dbSNP_123	1087	0.0000			.	0		T		128.0	rs16824588;rs16824588	0.582	1:g.1900232T>C	.		0.060703				843,2047,1284		363	1668,2396	0.4056776556776557	V	c|||		0.345734	5008			1942			.;K1751_HUMAN	0.38778	0.20163	1900232		0.355000	0.3125	SNP				N	,,,	False	1900232	-0.9213		8	intergenic_variant	T		0.447173	134.0						0.438	.	Unknown	1900232	0.02628		0.46133	29	KIAA1751	NM_001080484.1			I	
		A								4214																TMEM52 (66130 upstream) : C1orf222 (2720 downstream)			0,0,2101							+	IGR			75.0													1						coding-synonymous			161/763		G	SO:0001628						2101				0.0475,0.0,0.0317			6315											CCTTCAGCACGGCCTCAGTCC							1														g.chr1:1916842G>A					no	0	4,12626												-1.4					0.0					hg19					4,8424			0,4,6311						G		AA,AG,GG			73				rs369890588																													483					0				69.0		0.652	1:g.1916842G>A							0,4,4210			0,4202															1916842				SNP							1916842				intergenic_variant				73.0								Unknown	1916842					KIAA1751	NM_001080484.1				
		T		ENST00000434971.2						4114					,							byFrequency	Q69YW0						1398,439,39		0.6145					+	Intron			40.0								C1orf222-201					1	-	0.9281				intron				all_epithelial(116;6.04e-15)|all_lung(118;9.67e-07)|Lung NSC(185;5.59e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Medulloblastoma(700;0.151)|Lung SC(97;0.217)	T	SO:0001627				protein_coding		1876				45.7827,13.7793,35.7596			5990					Epithelial(90;1.82e-37)|OV - Ovarian serous cystadenocarcinoma(86;2.75e-23)|GBM - Glioblastoma multiforme(42;9e-08)|Colorectal(212;3.94e-05)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00227)|BRCA - Breast invasive adenocarcinoma(365;0.00435)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0339)|Lung(427;0.199)			KNOWN			CTGAAACTTCCGTTACTGTGA						ENST00000434971.2:c.67+25G>A	1					breast(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(6)|stomach(1)		-		,					g.chr1:1922303C>T					no		7696,4284												-3.6					0.0					hg19		0.497			4461,3767			2606,2484,900						C		TT,TC,CC			40		2504		rs13303195		100												11			2			ENST00000434971.2		16177						dbSNP_121						0				40.0		0.438	1:g.1922303C>T		protein_coding			basic		1208,2045,861			3235,517			T|||			5008		CA222_HUMAN	3253				0.649561		1922303			0.6032	SNP					,,,	False	1922303				intron_variant				40.0						0.4568		C1orf222	1922303		all_cancers(77;0.000708)|all_epithelial(69;0.000943)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			KIAA1751	NM_001080484.1				
		C	ENSG00000187730	ENST00000378585.4		2563		ENSG00000187730		4300					,				c.(328-330)ggT>ggC	OTTHUMG00000041064		byFrequency	O14764	gene with protein product			Acamprosate(DB00659)|Adinazolam(DB00546)|Alprazolam(DB00404)|Amoxapine(DB00543)|Bromazepam(DB01558)|Butabarbital(DB00237)|Butalbital(DB00241)|Chlordiazepoxide(DB00475)|Cinolazepam(DB01594)|Clobazam(DB00349)|Clonazepam(DB01068)|Clorazepate(DB00628)|Clotiazepam(DB01559)|Desflurane(DB01189)|Diazepam(DB00829)|Enflurane(DB00228)|Ergoloid mesylate(DB01049)|Estazolam(DB01215)|Eszopiclone(DB00402)|Ethchlorvynol(DB00189)|Etomidate(DB00292)|Fludiazepam(DB01567)|Flumazenil(DB01205)|Flurazepam(DB00690)|Glutethimide(DB01437)|Halazepam(DB00801)|Halothane(DB01159)|Isoflurane(DB00753)|Ketazolam(DB01587)|Lorazepam(DB00186)|Meprobamate(DB00371)|Methoxyflurane(DB01028)|Methyprylon(DB01107)|Midazolam(DB00683)|Nitrazepam(DB01595)|Olanzapine(DB00334)|Oxazepam(DB00842)|Pentobarbital(DB00312)|Prazepam(DB01588)|Primidone(DB00794)|Propofol(DB00818)|Quazepam(DB01589)|Sevoflurane(DB01236)|Talbutal(DB00306)|Temazepam(DB00231)|Topiramate(DB00273)|Triazolam(DB00897)	NM_000815.4	1183,854,166	NM_000815	0.4448					+	Silent		455.2+/-363.7	97.0				2176788, 10965146				GABRD-001					1	+	0.7474				coding-synonymous	4084		110/453	all_epithelial(116;2.7e-19)|all_lung(118;1.22e-08)|Lung NSC(185;1.24e-06)|Renal(390;0.00183)|Breast(487;0.00354)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Medulloblastoma(700;0.123)|Lung SC(97;0.128)	C	SO:0001819	137163			protein_coding		2203				33.9535,26.9178,31.57		"""GABA receptors"", ""Ligand-gated ion channels / GABA(A) receptors"""	6503					Epithelial(90;2.19e-38)|OV - Ovarian serous cystadenocarcinoma(86;3.17e-24)|GBM - Glioblastoma multiforme(42;9.56e-08)|Colorectal(212;4.12e-05)|COAD - Colon adenocarcinoma(227;0.000194)|Kidney(185;0.00231)|BRCA - Breast invasive adenocarcinoma(365;0.00441)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0344)|Lung(427;0.2)			KNOWN			AGACCCTGGGTCTGGACAGCC						ENST00000378585.4:c.330T>C	1					central_nervous_system(2)|endometrium(3)|kidney(2)|lung(8)|ovary(2)|prostate(1)|skin(2)		+		,		1p36.3	Q8N4N9	"""GABA(A) receptor, delta"""	g.chr1:1957037T>C		414.4+/-336.8			no		8900,4106												2.5					1.0	chloride channel activity (GO:0005254)|extracellular ligand-gated ion channel activity (GO:0005230)|GABA-A receptor activity (GO:0004890)				hg19	Standard	0.6809			5680,2920		signal transduction (GO:0007165)|synaptic transmission (GO:0007268)|transport (GO:0006810)	3072,2756,675					CCDS36.1	T		CC,CT,TT	BC033801	cell junction (GO:0030054)|chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|postsynaptic membrane (GO:0045211)	97		2504		rs2229110		413									110			20	NM_000815		4			ENST00000378585.4		16340		uc001aip.2			2563	dbSNP_98	330			p.G110G		0				98.0		0.617	1:g.1957037T>C		protein_coding			mRNA_start_NF|basic|appris_principal|CCDS		1889,1902,509			3220,1186			C|||			5008		GBRD_HUMAN	2811	gamma-aminobutyric acid (GABA) A receptor, delta			0.561302		1957037			0.3462	SNP		CCDS36.1			,,,	False	1957037				synonymous_variant		Approved		97.0		c.330T>C	2012-06-22	OTTHUMT00000098493.1	O14764	0.5101		GABRD	1957037		all_cancers(77;0.000708)|all_epithelial(69;0.000943)|all_lung(157;0.00963)|Lung NSC(156;0.0232)|Ovarian(185;0.0634)			GABRD	NM_000815.4	protein-coding gene	NP_000806.2		
		A	ENSG00000116151	ENST00000378531.3		79906		ENSG00000116151		4300					,					OTTHUMG00000001402		byFrequency	Q5T089	gene with protein product		MORN1_ENST00000606372.1_Intron|MORN1_ENST00000378529.3_Intron		NM_024848.1	5,231,1967	NM_024848	0.2321					+	Intron		239.0+/-270.3	33.0				12477932				MORN1-001					1	-	0.0287				intron	25852			all_epithelial(116;3.3e-15)|all_lung(118;1.15e-06)|Lung NSC(185;6.26e-05)|Renal(390;0.00571)|Breast(487;0.0183)|Hepatocellular(190;0.0268)|Myeloproliferative disorder(586;0.028)|Ovarian(437;0.127)|Medulloblastoma(700;0.151)|Lung SC(97;0.217)	G	SO:0001627				protein_coding		2203				15.6628,5.4698,12.2097			6503					Epithelial(90;2.21e-37)|OV - Ovarian serous cystadenocarcinoma(86;5.01e-23)|GBM - Glioblastoma multiforme(42;2.8e-08)|Colorectal(212;5.97e-05)|COAD - Colon adenocarcinoma(227;0.000241)|Kidney(185;0.00137)|BRCA - Breast invasive adenocarcinoma(365;0.00488)|STAD - Stomach adenocarcinoma(132;0.00665)|KIRC - Kidney renal clear cell carcinoma(229;0.0203)|Lung(427;0.212)			KNOWN			CCCCCAACTGGTTTGTGAGCT						ENST00000378531.3:c.1036+18C>T	1					breast(1)|central_nervous_system(1)|endometrium(2)|large_intestine(1)|liver(1)|lung(1)|ovary(2)		-		,		1p36.33-p36.32	A6NKZ6|Q8WW30|Q9H852		g.chr1:2288852G>A		132.9+/-169.3			no		1588,11418												-0.3					0.0					hg19	Standard	0.164			1347,7253			120,1348,5035					CCDS40.1, CCDS72688.1	G		AA,AG,GG	AK024003		32		2504		rs2645087		1210										FLJ13941		9	XM_005244798		10			ENST00000378531.3		11312		uc001ajb.1			79906	dbSNP_100						0				31.0		0.672	1:g.2288852G>A		protein_coding			basic|appris_candidate_longest|CCDS		115,1117,3068			241,4165			G|||			5008		MORN1_HUMAN	907	MORN repeat containing 1			0.18111		2288852			0.2093	SNP		CCDS40.1			,,,	False	2288852				intron_variant		Approved		32.0			2008-02-05	OTTHUMT00000004055.1	Q5T089	0.3833		MORN1	2288852		all_cancers(77;0.000194)|all_epithelial(69;9.96e-05)|all_lung(157;0.016)|Lung NSC(156;0.0376)|Ovarian(185;0.0634)			MORN1	NM_024848.1	protein-coding gene	NP_079124.1		
		C	ENSG00000157911	ENST00000447513.2		5192		ENSG00000157911		4300					,				c.(289-291)acA>acG	OTTHUMG00000001637		byFrequency	O60683	gene with protein product		PEX10_ENST00000515760.1_5'UTR|PEX10_ENST00000288774.3_Silent_p.T97T|PEX10_ENST00000507596.1_Silent_p.T97T		NM_002617.3	800,1048,355	NM_153818	0.7014					+	Silent		293.4+/-301.3	90.0				9683594				PEX10-002	2008-08-26				1	-	0.5688				coding-synonymous,coding-synonymous	8851		97/327,97/347	all_epithelial(116;5.35e-20)|all_lung(118;2.78e-08)|Lung NSC(185;2.69e-06)|Breast(487;0.00147)|Renal(390;0.00183)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Medulloblastoma(700;0.123)|Lung SC(97;0.128)	C	SO:0001819	602859	,		protein_coding		2203				18.3023,39.9001,25.6189		"""RING-type (C3HC4) zinc fingers"""	6503					Epithelial(90;1.1e-37)|OV - Ovarian serous cystadenocarcinoma(86;6.02e-23)|GBM - Glioblastoma multiforme(42;9e-08)|Colorectal(212;3.94e-05)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.00102)|BRCA - Breast invasive adenocarcinoma(365;0.00435)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0169)|Lung(427;0.199)		GBM(12;9 508 1649 13619)	KNOWN			CGGCATGCAGTGTCACCAGCA						ENST00000447513.2:c.291A>G	1					central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|lung(3)|skin(2)		-		,		1p36.32	B3KWD8|Q5T095|Q9BW90		g.chr1:2340200T>C		522.2+/-370.7			no		9674,3332												-9.2					0.0	protein C-terminus binding (GO:0008022)|zinc ion binding (GO:0008270)				hg19	Standard	0.7913			7026,1574		peroxisome organization (GO:0007031)|protein import into peroxisome matrix (GO:0016558)	3666,2342,495					CCDS41.1, CCDS44045.1	T		CC,CT,TT	AF060502	integral component of peroxisomal membrane (GO:0005779)|intracellular (GO:0005622)|peroxisomal membrane (GO:0005778)|peroxisome (GO:0005777)	90		2504		rs2494598		359				"""peroxisome biogenesis factor 10"""				,	97	RNF69		7	NM_002617		3			ENST00000447513.2		18318		uc001ajg.3			5192	dbSNP_100	291,291			p.T97T		0				91.0		0.672	1:g.2340200T>C		protein_coding			basic|CCDS		2866,1294,140			2648,1758			C|||			5008		PEX10_HUMAN	3500	peroxisomal biogenesis factor 10			0.698882		2340200			0.7282	SNP		CCDS44045.1			,,,	False	2340200				synonymous_variant		Approved		90.0		c.291A>G	2013-01-09	OTTHUMT00000367454.1	O60683	0.7666		PEX10	2340200		all_cancers(77;0.000247)|all_epithelial(69;9.96e-05)|all_lung(157;0.016)|Lung NSC(156;0.0376)|Ovarian(185;0.0634)		,	PEX10	NM_002617.3,NM_153818.1	protein-coding gene	NP_002608.1		
		A	ENSG00000157873	ENST00000355716.4	0.80722	8764	N	ENSG00000157873	0.00767	4300	0.000000	0.87650	B		,	T	0.0	0	c.(721-723)Gtc>Atc	OTTHUMG00000000792	-2.179000	byFrequency	Q92956	gene with protein product				NM_003820.2	19,353,1831		0.1738			G	0.743	+	Missense_Mutation	1	244.3+/-273.6	246.0	Q92956	0.088743		8898196, 9162061			0.002	TNFRSF14-001	2011-08-11		0.06405		1	+	0.0991		0.74	0.007000	missense	11912	43	241/284	all_epithelial(116;3.18e-20)|all_lung(118;1.67e-08)|Lung NSC(185;2.69e-06)|Breast(487;0.00147)|Renal(390;0.00183)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0122)|Ovarian(437;0.0308)|Lung SC(97;0.0847)|Medulloblastoma(700;0.123)	G	SO:0001583	602746	benign	0.11878453038674033	protein_coding		2203	P		0.000000	14.1047,8.8743,12.3328	B	"""Tumor necrosis factor receptor superfamily"", ""CD molecules"""	6503	"""Mis, N, F"""	0.0:0.1818:0.443:0.3752			Epithelial(90;1.1e-37)|OV - Ovarian serous cystadenocarcinoma(86;6.02e-23)|GBM - Glioblastoma multiforme(42;1.11e-08)|Colorectal(212;3.94e-05)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.000326)|BRCA - Breast invasive adenocarcinoma(365;0.00435)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.199)			KNOWN	ENST00000355716		GATCGTCTCCGTCCAGGTATT	D					ENST00000355716.4:c.721G>A	1		ENSG00000157873	0.05819	TNFRSF14	kidney(1)	ENSP00000347948:p.Val241Ile	+	0.05858	,	GTC	1p36.32	B3KW30|B9DI89|Q6IB95|Q8N634|Q8WXR1|Q96J31|Q9UM65	"""herpesvirus entry mediator"""	g.chr1:2494330G>A	V -> I (in dbSNP:rs2234167). {ECO:0000269|PubMed:11756979, ECO:0000269|Ref.8}.	196.7+/-221.0		56	yes		1604,11402	0.03702	0.02951	2.06	0.00724	ENSP00000347948:V241I			.	Rec	8.568	8764	-4.1	0.03916	34	0.09084	0.05944055944055944	0.0	tumor necrosis factor-activated receptor activity (GO:0005031)|ubiquitin protein ligase binding (GO:0031625)|virus receptor activity (GO:0001618)	0.345			hg19	Standard	0.1471	0.11382113821138211	5.5208	1213,7387		cell surface receptor signaling pathway (GO:0007166)|defense response to Gram-negative bacterium (GO:0050829)|defense response to Gram-positive bacterium (GO:0050830)|immune response (GO:0006955)|negative regulation of alpha-beta T cell proliferation (GO:0046642)|positive regulation of cytokine secretion involved in immune response (GO:0002741)|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|positive regulation of T cell migration (GO:2000406)|T cell costimulation (GO:0031295)|tumor necrosis factor-mediated signaling pathway (GO:0033209)|viral process (GO:0016032)	110,1384,5009	-0.775589				CCDS44046.1	G	0.23442	AA,AG,GG	U70321	external side of plasma membrane (GO:0009897)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	264	0.14661	2504	-4.12	rs2234167		1020	241	115		"""tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)"""	0.16931	2480088	+	ILE/VAL	241	HVEM, ATAR, TR2, LIGHTR, HVEA, CD270	248	1	XM_006711018	0.085	7	0.1517150395778364	-0.438000	ENST00000355716.4	L	12689		uc001ajt.1	1p36.32	follicular lymphoma	8764	dbSNP_98	721	0.0024		p.V241I	.	0		T		299.0	.	0.602	1:g.2494330G>A	ENSP00000347948:V241I	protein_coding	.	"""tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)"""	basic|appris_principal|CCDS		91,1031,3178		241	391,4015	0.11355311355311355	I	G|||		.	5008	yes	TNR14_HUMAN	570	tumor necrosis factor receptor superfamily, member 14	1	TNR14_HUMAN	0.113818	0.01313	2494330		-2.129000	0.0556	SNP		CCDS44046.1		.	,,,	False	2494330	-1.0493		8	missense	T	Approved	0.141047	264.0		c.721G>A	2012-02-27	OTTHUMT00000002088.1	Q92956	0.0937	-2.28	TNFRSF14	2494330	0.05969	all_cancers(77;0.000158)|all_epithelial(69;8.01e-05)|all_lung(157;0.0212)|Lung NSC(156;0.0376)|Ovarian(185;0.0634)	0.13872	29	TNFRSF14	NM_003820.2	protein-coding gene	NP_003811.2	V	
		A	ENSG00000169717	ENST00000378404.2	0.09310	140625	M	ENSG00000169717	0.72767	4299	0.915000	0.97089	D		,	D	0.99999892596	0	c.(739-741)Ggg>Agg	OTTHUMG00000000562	2.228000	byFrequency	Q8TDY3	gene with protein product				NM_080431.4	11,196,1996	NM_080431	0.093			G	16.11	+	Missense_Mutation	1		41.0	Q8TDY3	0.049478		11750065, 12243744			0.996	ACTRT2-001	2005-11-22		0.83275		1	+	0.0106		0	0.341000	missense	24026	57	247/378	all_epithelial(116;2.66e-20)|all_lung(118;1.56e-08)|Lung NSC(185;2.54e-06)|Breast(487;0.00156)|Renal(390;0.00183)|Hepatocellular(190;0.00826)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0308)|Lung SC(97;0.0847)|Medulloblastoma(700;0.123)	G	SO:0001583	608535	probably-damaging	0.1574585635359116	protein_coding		2203	P		1.000000	23.3659,4.9478,17.1255	D		6502		0.0907:0.0:0.9093:0.0			Epithelial(90;7.19e-38)|OV - Ovarian serous cystadenocarcinoma(86;5.15e-22)|GBM - Glioblastoma multiforme(42;1.1e-12)|Colorectal(212;3.98e-05)|COAD - Colon adenocarcinoma(227;0.000193)|Kidney(185;0.000329)|BRCA - Breast invasive adenocarcinoma(365;0.000949)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.125)			KNOWN	ENST00000378404;ENST00000543312		GCTGCCCGACGGGAACATCAT	D					ENST00000378404.2:c.739G>A	1		ENSG00000169717	0.74099	ACTRT2	breast(1)|endometrium(2)|kidney(1)|large_intestine(1)|lung(15)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	ENSP00000367658:p.Gly247Arg	+	0.71417	,	GGG	1p36.3	B1AN52|Q8NHS6|Q8TDG1		g.chr1:2938989G>A	G -> R (in dbSNP:rs3795263).			4	yes		2227,10777	0.36163	0.54790	4.85	0.01254	ENSP00000367658:G247R			0.56097		.		4.8	0.62838	96	0.87932	0.16783216783216784	0.9		3.5			hg19	Standard	0.2584	0.008130081300813009	11.1701	2009,6589			256,1715,4531	3.029664				CCDS45.1	G	0.89917	AA,AG,GG	AF440740, AB057364	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)	40	0.94142	2504	4.85	rs3795263		944	247	191			0.48567	2928849	+	ARG/GLY	247	Arp-T2, ARPM2, FLJ25424	348	26	NM_080431	1.0	1	0.2519788918205805	0.561000	ENST00000378404.2		16197		uc001ajz.3			140625	dbSNP_107	739	0.0041		p.G247R	.	0		T		36.0	rs3795263;rs17390011;rs60765657;rs3795263	0.652	1:g.2938989G>A	ENSP00000367658:G247R	protein_coding	0.000026		basic|appris_principal|CCDS		245,1519,2535		247	218,4188	0.15934065934065933	R	G|||		0.000000	5008		ACTT2_HUMAN	611	actin-related protein T2		ACTT2_HUMAN	0.122005	0.74049	2938989		6.582000	0.1607	SNP		CCDS45.1		D	,,,	False	2938989	-1.6286		9	missense	T	Approved	0.233659	40.0		c.739G>A	2008-02-05	OTTHUMT00000001331.1	Q8TDY3	0.121	-4.24	ACTRT2	2938989	0.28922	all_cancers(77;0.00205)|all_epithelial(69;0.0011)|Ovarian(185;0.0634)|Lung NSC(156;0.0893)|all_lung(157;0.0909)	0.00000	125	ACTRT2	NM_080431.4	protein-coding gene	NP_536356.3	G	
		T	ENSG00000130762	ENST00000378378.4	0.18873	27237	L	ENSG00000130762	0.75478	4300	0.610000	0.61859	B;B;B		,	T	0.9999871625	0	c.(1108-1110)Cac>Tac	OTTHUMG00000000625	2.269000	byFrequency	Q5VV41	gene with protein product		ARHGEF16_ENST00000413250.2_Missense_Mutation_p.H74Y|ARHGEF16_ENST00000378371.2_Missense_Mutation_p.H82Y|ARHGEF16_ENST00000378373.1_Missense_Mutation_p.H82Y		NM_014448.3	485,1093,625	NM_014448	0.865			C	6.952	+	Missense_Mutation	1	767.2+/-407.6	115.0	B4DJM7;B0QZD4;Q5VV41	0.468225					0.012;0.021;0.038	ARHGEF16-001	2010-04-13		0.22152		1	+	0.385		0.71	0.441000	missense	15515	264	370/710	all_epithelial(116;7.14e-21)|all_lung(118;2.24e-08)|Lung NSC(185;3.55e-06)|Breast(487;0.000765)|Renal(390;0.00121)|Hepatocellular(190;0.0046)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0308)|Lung SC(97;0.0847)|Medulloblastoma(700;0.211)	C	SO:0001583		benign	0.7292817679558011	protein_coding		2203	P		0.842000	12.7791,46.8225,26.4647	B;B;B	"""Rho guanine nucleotide exchange factors"", ""Pleckstrin homology (PH) domain containing"""	6503		0.1583:0.7572:0.0:0.0845			Epithelial(90;8.62e-38)|OV - Ovarian serous cystadenocarcinoma(86;3.62e-22)|GBM - Glioblastoma multiforme(42;2.49e-12)|Colorectal(212;4.25e-05)|COAD - Colon adenocarcinoma(227;0.000196)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000681)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.201)			KNOWN	ENST00000378378;ENST00000378373;ENST00000378371;ENST00000445297;ENST00000418137;ENST00000413250		CGCTGAGAAGCACTTCCACCC	T;T;T;T;T;T					ENST00000378378.4:c.1108C>T	1	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.|Required for RHOG activation and mediates interaction with EPHA2.	ENSG00000130762	0.69702	ARHGEF16	lung(6)|ovary(1)	ENSP00000367629:p.His370Tyr	+	0.29525	,	CAC	1p36.3	Q86TF0|Q99434	"""putative neuroblastoma protein"""	g.chr1:3389727C>T	H -> Y (in dbSNP:rs2185639). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1, ECO:0000269|Ref.2}.	567.5+/-382.2		188	yes		9564,3442	0.28997	0.13312	4.37	0.00012	ENSP00000367622:H82Y			0.64402		-27.8133		3.4	0.39272	396	0.09843	0.6923076923076923	0.6	PDZ domain binding (GO:0030165)|receptor tyrosine kinase binding (GO:0030971)|Rho GTPase binding (GO:0017048)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)	1.355			hg19	Standard	0.8638	0.3821138211382114	7.8106	7501,1099		activation of Cdc42 GTPase activity (GO:0032864)|activation of Rac GTPase activity (GO:0032863)|apoptotic signaling pathway (GO:0097190)|cell chemotaxis (GO:0060326)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of apoptotic process (GO:0043065)|positive regulation of establishment of protein localization to plasma membrane (GO:0090004)|regulation of small GTPase mediated signal transduction (GO:0051056)|small GTPase mediated signal transduction (GO:0007264)	3748,2068,687	0.545543				CCDS46.2	C	0.14805	TT,TC,CC	D89016	cytosol (GO:0005829)	130	0.43152	2504	3.43	rs2185639		1513	74;74;370	664			0.29228	3379587	+	TYR/HIS	370	NBR, GEF16	1512	7	NM_014448	0.004;0.011;0.009	7	0.8759894459102903	0.555000	ENST00000378378.4		15906		uc001akg.4			27237	dbSNP_96	1108	0.0000		p.H370Y	Dbl homology (DH) domain (5);	0		T		161.0	rs2185639;rs17844961;rs17857701;rs60580765;rs2185639	0.632	1:g.3389727C>T	ENSP00000367629:H370Y;ENSP00000367624:H82Y;ENSP00000367622:H82Y;ENSP00000411936:H82Y;ENSP00000390853:H74Y;ENSP00000408887:H74Y	protein_coding	0.000014		basic|appris_principal|CCDS		3263,975,62		370;82;82;82;74;74	2063,2343	0.6923076923076923	Y	C|||		0.066011	5008		ARHGG_HUMAN	3428	Rho guanine nucleotide exchange factor (GEF) 16		.;.;ARHGG_HUMAN	0.684505	0.41825	3389727		2.105000	0.6746	SNP		CCDS46.2		D	,,,	False	3389727	-0.9395		9	missense	T	Approved	0.872209	130.0		c.1108C>T	2013-01-10	OTTHUMT00000001515.1	Q5VV41	0.755	0.07;0.07;0.07;0.07;0.07;0.07	ARHGEF16	3389727	0.31987	all_cancers(77;0.00276)|all_epithelial(69;0.00102)|Ovarian(185;0.0634)|Lung NSC(156;0.0969)|all_lung(157;0.101)	0.43376	83	ARHGEF16	NM_014448.3	protein-coding gene	NP_055263.2	H	
		C	ENSG00000130762	ENST00000378378.4		27237		ENSG00000130762		4283					,				c.(1489-1491)tcT>tcC	OTTHUMG00000000625		byFrequency	Q5VV41	gene with protein product		ARHGEF16_ENST00000413250.2_Silent_p.S201S|ARHGEF16_ENST00000378371.2_Silent_p.S209S|ARHGEF16_ENST00000378373.1_Silent_p.S209S		NM_014448.3	1802,360,20	NM_014448	0.9959					+	Silent		6.4+/-24.3	48.0								ARHGEF16-001	2010-04-13				1	+	0.8971				coding-synonymous	15515		497/710	all_epithelial(116;7.14e-21)|all_lung(118;2.24e-08)|Lung NSC(185;3.55e-06)|Breast(487;0.000765)|Renal(390;0.00121)|Hepatocellular(190;0.0046)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0308)|Lung SC(97;0.0847)|Medulloblastoma(700;0.211)	C	SO:0001819				protein_coding		2182				0.0934,9.1659,3.1555		"""Rho guanine nucleotide exchange factors"", ""Pleckstrin homology (PH) domain containing"""	6465					Epithelial(90;8.62e-38)|OV - Ovarian serous cystadenocarcinoma(86;3.62e-22)|GBM - Glioblastoma multiforme(42;2.49e-12)|Colorectal(212;4.25e-05)|COAD - Colon adenocarcinoma(227;0.000196)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000681)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.201)			KNOWN			CACTGATCTCTGCCTCCCGGT						ENST00000378378.4:c.1491T>C	1					lung(6)|ovary(1)		+		,		1p36.3	Q86TF0|Q99434	"""putative neuroblastoma protein"""	g.chr1:3394456T>C		196.4+/-220.7			no		12522,408												-10.8					0.0	PDZ domain binding (GO:0030165)|receptor tyrosine kinase binding (GO:0030971)|Rho GTPase binding (GO:0017048)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.998			8558,8		activation of Cdc42 GTPase activity (GO:0032864)|activation of Rac GTPase activity (GO:0032863)|apoptotic signaling pathway (GO:0097190)|cell chemotaxis (GO:0060326)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of apoptotic process (GO:0043065)|positive regulation of establishment of protein localization to plasma membrane (GO:0090004)|regulation of small GTPase mediated signal transduction (GO:0051056)|small GTPase mediated signal transduction (GO:0007264)	6077,368,20					CCDS46.2	T		CC,CT,TT	D89016	cytosol (GO:0005829)	47		2504		rs4638054		1896									497	NBR, GEF16		7	NM_014448		11			ENST00000378378.4		16087		uc001akg.4			27237	dbSNP_111	1491			p.S497S		0				44.0		0.627	1:g.3394456T>C		protein_coding			basic|appris_principal|CCDS		4275,8,0			3964,400			C|||			5008		ARHGG_HUMAN	4861	Rho guanine nucleotide exchange factor (GEF) 16			0.970647		3394456			1.0	SNP		CCDS46.2			,,,	False	3394456				synonymous_variant		Approved		47.0		c.1491T>C	2013-01-10	OTTHUMT00000001515.1	Q5VV41	0.9928		ARHGEF16	3394456		all_cancers(77;0.00276)|all_epithelial(69;0.00102)|Ovarian(185;0.0634)|Lung NSC(156;0.0969)|all_lung(157;0.101)			ARHGEF16	NM_014448.3	protein-coding gene	NP_055263.2		
		A	ENSG00000130762	ENST00000378378.4		27237		ENSG00000130762		4288					,				c.(1675-1677)gtG>gtA	OTTHUMG00000000625		byFrequency	Q5VV41	gene with protein product		ARHGEF16_ENST00000413250.2_Silent_p.V263V|ARHGEF16_ENST00000378371.2_Silent_p.V271V|ARHGEF16_ENST00000378373.1_Silent_p.V271V		NM_014448.3	495,1083,621	NM_014448	0.863					+	Silent		764.3+/-407.6	83.0								ARHGEF16-001	2010-04-13				1	+	0.3873				coding-synonymous	15515		559/710	all_epithelial(116;7.14e-21)|all_lung(118;2.24e-08)|Lung NSC(185;3.55e-06)|Breast(487;0.000765)|Renal(390;0.00121)|Hepatocellular(190;0.0046)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0308)|Lung SC(97;0.0847)|Medulloblastoma(700;0.211)	G	SO:0001819				protein_coding		2199				13.0947,47.1351,26.5762		"""Rho guanine nucleotide exchange factors"", ""Pleckstrin homology (PH) domain containing"""	6487					Epithelial(90;8.62e-38)|OV - Ovarian serous cystadenocarcinoma(86;3.62e-22)|GBM - Glioblastoma multiforme(42;2.49e-12)|Colorectal(212;4.25e-05)|COAD - Colon adenocarcinoma(227;0.000196)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000681)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.201)			KNOWN			ACATCCAGGTGGAGAAGATAG						ENST00000378378.4:c.1677G>A	1	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.				lung(6)|ovary(1)		+		,		1p36.3	Q86TF0|Q99434	"""putative neuroblastoma protein"""	g.chr1:3395039G>A		564.1+/-381.3			no		9526,3448												-0.2					0.1	PDZ domain binding (GO:0030165)|receptor tyrosine kinase binding (GO:0030971)|Rho GTPase binding (GO:0017048)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.8628			7453,1123		activation of Cdc42 GTPase activity (GO:0032864)|activation of Rac GTPase activity (GO:0032863)|apoptotic signaling pathway (GO:0097190)|cell chemotaxis (GO:0060326)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of apoptotic process (GO:0043065)|positive regulation of establishment of protein localization to plasma membrane (GO:0090004)|regulation of small GTPase mediated signal transduction (GO:0051056)|small GTPase mediated signal transduction (GO:0007264)	3726,2074,687					CCDS46.2	G		AA,AG,GG	D89016	cytosol (GO:0005829)	85		2504		rs10797395		2082									559	NBR, GEF16		7	NM_014448		12			ENST00000378378.4		17081		uc001akg.4			27237	dbSNP_120	1677			p.V559V		0				89.0		0.652	1:g.3395039G>A		protein_coding			basic|appris_principal|CCDS		3231,991,66			2073,2325			G|||			5008		ARHGG_HUMAN	3436	Rho guanine nucleotide exchange factor (GEF) 16			0.686102		3395039			0.6766	SNP		CCDS46.2			,,,	False	3395039				synonymous_variant		Approved		85.0		c.1677G>A	2013-01-10	OTTHUMT00000001515.1	Q5VV41	0.7637		ARHGEF16	3395039		all_cancers(77;0.00276)|all_epithelial(69;0.00102)|Ovarian(185;0.0634)|Lung NSC(156;0.0969)|all_lung(157;0.101)			ARHGEF16	NM_014448.3	protein-coding gene	NP_055263.2		
		T	ENSG00000162591	ENST00000356575.4		1953		ENSG00000162591		4185					,				c.(268-270)acC>acA	OTTHUMG00000000611		byFrequency	O75095	gene with protein product				NM_001409.3	0,6,2027	NM_001409	0.002					+	Silent			42.0				9693030				MEGF6-007	2006-03-31				1	-	0.0008				coding-synonymous	3232		90/1542	all_epithelial(116;7.41e-22)|all_lung(118;8.3e-09)|Lung NSC(185;3.55e-06)|Breast(487;0.000659)|Renal(390;0.00121)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Lung SC(97;0.0262)|Ovarian(437;0.0308)|Medulloblastoma(700;0.211)		SO:0001819	604266			protein_coding		2033				1.135,0.1476,0.8122			6218					Epithelial(90;3.78e-37)|OV - Ovarian serous cystadenocarcinoma(86;6.86e-22)|GBM - Glioblastoma multiforme(42;1.96e-12)|Colorectal(212;6.15e-05)|COAD - Colon adenocarcinoma(227;0.000241)|Kidney(185;0.000448)|BRCA - Breast invasive adenocarcinoma(365;0.000779)|KIRC - Kidney renal clear cell carcinoma(229;0.00645)|STAD - Stomach adenocarcinoma(132;0.00669)|Lung(427;0.213)		Ovarian(73;978 3658)	KNOWN			TGTAGTAGACGGTTCTAGAAA		EGFL3				ENST00000356575.4:c.270C>A	1	EMI. {ECO:0000255|PROSITE- ProRule:PRU00384}.				cervix(2)|endometrium(3)|large_intestine(3)|lung(8)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)		-		,		1p36.3	Q4AC86|Q5VV39		g.chr1:3512008G>T					no		101,12335												-0.8					0.4	calcium ion binding (GO:0005509)		2006-03-31		hg19	Standard	0.006			95,8275			2,97,6119					CCDS41237.1	G		TT,TG,GG	AB011539	extracellular region (GO:0005576)	40		2504		rs112138743		496				"""EGF-like-domain, multiple 3"""					90			19	NM_001409		3			ENST00000356575.4		15701		uc001akl.3			1953	dbSNP_132	270			p.T90T		0				36.0		0.622	1:g.3512008G>T		protein_coding			basic|appris_principal|CCDS		2,91,4092			6,4060			g|||			5008		MEGF6_HUMAN	15	multiple EGF-like-domains 6			0.00299521		3512008			0.0	SNP		CCDS41237.1			,,,	False	3512008				synonymous_variant		Approved		40.0		c.270C>A	2008-02-05	OTTHUMT00000354866.1	O75095	0.0086		MEGF6	3512008		all_cancers(77;0.00681)|all_epithelial(69;0.00301)|Ovarian(185;0.0634)|Lung NSC(156;0.0969)|all_lung(157;0.105)			MEGF6	NM_001409.3	protein-coding gene	NP_001400.3		
		T	ENSG00000162591	ENST00000356575.4		1953		ENSG00000162591		4273					,					OTTHUMG00000000611		byFrequency	O75095	gene with protein product				NM_001409.3	414,1019,749	NM_001409	0.4448					+	Intron			21.0				9693030				MEGF6-007	2006-03-31				1	-	0.4342				intron	3232			all_epithelial(116;7.41e-22)|all_lung(118;8.3e-09)|Lung NSC(185;3.55e-06)|Breast(487;0.000659)|Renal(390;0.00121)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Lung SC(97;0.0262)|Ovarian(437;0.0308)|Medulloblastoma(700;0.211)	C	SO:0001627	604266			protein_coding		2182				35.8062,42.3236,38.0093			6455					Epithelial(90;3.78e-37)|OV - Ovarian serous cystadenocarcinoma(86;6.86e-22)|GBM - Glioblastoma multiforme(42;1.96e-12)|Colorectal(212;6.15e-05)|COAD - Colon adenocarcinoma(227;0.000241)|Kidney(185;0.000448)|BRCA - Breast invasive adenocarcinoma(365;0.000779)|KIRC - Kidney renal clear cell carcinoma(229;0.00645)|STAD - Stomach adenocarcinoma(132;0.00669)|Lung(427;0.213)		Ovarian(73;978 3658)	KNOWN			AACAGAGACACGGAGAGTCAG		EGFL3				ENST00000356575.4:c.132-15G>A	1					cervix(2)|endometrium(3)|large_intestine(3)|lung(8)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)		-		,		1p36.3	Q4AC86|Q5VV39		g.chr1:3519179C>T					no		4907,8003												-4.8					0.0	calcium ion binding (GO:0005509)		2006-03-31		hg19	Standard	0.3499			3060,5486			992,2923,2540					CCDS41237.1	C		TT,TC,CC	AB011539	extracellular region (GO:0005576)	19		2504		rs2794330		358				"""EGF-like-domain, multiple 3"""								19	NM_001409		2			ENST00000356575.4		13574		uc001akl.3			1953	dbSNP_100						0				16.0		0.687	1:g.3519179C>T		protein_coding			basic|appris_principal|CCDS		578,1904,1791			1847,2517			C|||			5008		MEGF6_HUMAN	2131	multiple EGF-like-domains 6			0.425519		3519179			0.4405	SNP		CCDS41237.1			,,,	False	3519179				intron_variant		Approved		19.0			2008-02-05	OTTHUMT00000354866.1	O75095	0.4697		MEGF6	3519179		all_cancers(77;0.00681)|all_epithelial(69;0.00301)|Ovarian(185;0.0634)|Lung NSC(156;0.0969)|all_lung(157;0.105)			MEGF6	NM_001409.3	protein-coding gene	NP_001400.3		
		T	ENSG00000078900	ENST00000378295.4		7161		ENSG00000078900		4299					,				c.(517-519)acC>acT	OTTHUMG00000000610		byFrequency	O15350	gene with protein product		TP73_ENST00000378285.1_Silent_p.T124T|TP73_ENST00000604479.1_Silent_p.T173T|TP73_ENST00000603362.1_Silent_p.T173T|TP73_ENST00000357733.3_Silent_p.T173T|TP73_ENST00000378290.4_Silent_p.T102T|TP73_ENST00000378280.1_Silent_p.T124T|TP73_ENST00000378288.4_Silent_p.T124T|TP73_ENST00000354437.4_Silent_p.T173T|TP73_ENST00000604074.1_Silent_p.T173T|TP73_ENST00000346387.4_Silent_p.T173T		NM_001204185.1|NM_005427.3	1311,779,111	NM_005427	0.728					+	Silent		773.0+/-407.7	83.0				9296498, 9288759				TP73-001					1	+	0.7738				coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous	12003		124/588,124/451,124/427,173/500,173/476,173/404,173/556,173/541,124/355,124/507,124/492,102/566,173/637	all_epithelial(116;7.42e-17)|all_lung(118;1.86e-06)|Lung NSC(185;0.000163)|Renal(390;0.00357)|Breast(487;0.00446)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Lung SC(97;0.109)|Ovarian(437;0.127)	C	SO:0001819	601990	,,,,,,,,,,,,		protein_coding		2201				11.1189,22.7397,15.0538			6500					Epithelial(90;5.57e-38)|OV - Ovarian serous cystadenocarcinoma(86;1.87e-22)|GBM - Glioblastoma multiforme(42;5.72e-16)|Colorectal(212;2.22e-05)|COAD - Colon adenocarcinoma(227;8.48e-05)|Kidney(185;0.000539)|BRCA - Breast invasive adenocarcinoma(365;0.000868)|STAD - Stomach adenocarcinoma(132;0.0072)|KIRC - Kidney renal clear cell carcinoma(229;0.00751)|Lung(427;0.226)			KNOWN			CCCCAGGCACCGCCATCCGGG						ENST00000378295.4:c.519C>T	1	DNA-binding. {ECO:0000255}.				breast(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(3)|kidney(1)|lung(8)|ovary(1)|prostate(1)		+		,		1p36.3	B7Z7J4|B7Z8Z1|B7Z9C1|C9J521|O15351|Q17RN8|Q5TBV5|Q5TBV6|Q8NHW9|Q8TDY5|Q8TDY6|Q9NTK8		g.chr1:3638674C>T		725.7+/-409.6			no		11043,1957												-4.4					0.6	chromatin binding (GO:0003682)|damaged DNA binding (GO:0003684)|double-stranded DNA binding (GO:0003690)|identical protein binding (GO:0042802)|metal ion binding (GO:0046872)|p53 binding (GO:0002039)|protein kinase binding (GO:0019901)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription factor binding (GO:0008134)|transcription regulatory region DNA binding (GO:0044212)				hg19	Standard	0.9135			7642,956		activation of MAPK activity (GO:0000187)|cell cycle arrest (GO:0007050)|cellular response to DNA damage stimulus (GO:0006974)|cellular response to UV (GO:0034644)|cerebrospinal fluid secretion (GO:0033326)|digestive tract morphogenesis (GO:0048546)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|hippocampus development (GO:0021766)|inflammatory response (GO:0006954)|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|kidney development (GO:0001822)|mismatch repair (GO:0006298)|mitotic G1 DNA damage checkpoint (GO:0031571)|negative regulation of JUN kinase activity (GO:0043508)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of neuron differentiation (GO:0045665)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neuron development (GO:0048666)|positive regulation of apoptotic process (GO:0043065)|positive regulation of cell size (GO:0045793)|positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)|positive regulation of oligodendrocyte differentiation (GO:0048714)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|post-embryonic development (GO:0009791)|protein tetramerization (GO:0051262)|release of cytochrome c from mitochondria (GO:0001836)|response to gamma radiation (GO:0010332)|response to organonitrogen compound (GO:0010243)|response to X-ray (GO:0010165)|transcription, DNA-templated (GO:0006351)	4707,1629,164					CCDS49.1, CCDS44049.1, CCDS44050.1, CCDS44051.1, CCDS55566.1, CCDS55567.1, CCDS55568.1, CCDS55569.1, CCDS59965.1	C		TT,TC,CC	AB055065	chromatin (GO:0000785)|cytosol (GO:0005829)|nucleus (GO:0005634)|transcription factor complex (GO:0005667)	85		2504		rs1801174		674								,,,,,,,,,,,,	173	P73		20	NM_001204186		5			ENST00000378295.4		16951		uc001akp.3			7161	dbSNP_89	372,372,372,519,519,519,519,519,372,372,372,306,519			p.T173T		0				88.0		0.612	1:g.3638674C>T		protein_coding			basic|appris_principal|CCDS		3396,850,53			3401,1001			C|||			5008		P73_HUMAN	3686	tumor protein p73			0.736022		3638674			0.5268	SNP		CCDS49.1			,,,	False	3638674				synonymous_variant		Approved		85.0		c.519C>T	2010-06-15	OTTHUMT00000001468.4	O15350	0.7219		TP73	3638674		all_cancers(77;0.0395)|Ovarian(185;0.0634)|Lung NSC(156;0.188)|all_lung(157;0.198)		,,,,,,,,,,,,	TP73	NM_001126240.2,NM_001126241.2,NM_001126242.2,NM_001204184.1,NM_001204185.1,NM_001204186.1,NM_001204187.1,NM_001204188.1,NM_001204189.1,NM_001204190.1,NM_001204191.1,NM_001204192.1,NM_005427.3	protein-coding gene	NP_001191114.1|NP_005418.1		
		C	ENSG00000130764	ENST00000378251.1		57470		ENSG00000130764		4300					,				c.(1180-1182)ccA>ccG	OTTHUMG00000003506		byFrequency	Q8N1G4	gene with protein product		RP1-286D6.5_ENST00000607459.1_RNA		NM_020710.2	29,512,1662	NM_020710	0.047					+	Silent		774.1+/-407.7	52.0				10574461				LRRC47-001					1	-	0.1452				coding-synonymous	29207		394/584	all_epithelial(116;1.34e-16)|all_lung(118;2.53e-06)|Lung NSC(185;0.00028)|Renal(390;0.00357)|Breast(487;0.00446)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Lung SC(97;0.0743)|Ovarian(437;0.127)	C	SO:0001819				protein_coding		2203				10.7674,12.9369,11.5024			6503					Epithelial(90;5.49e-39)|OV - Ovarian serous cystadenocarcinoma(86;1.43e-22)|GBM - Glioblastoma multiforme(42;3.69e-16)|Colorectal(212;1.21e-05)|COAD - Colon adenocarcinoma(227;5.87e-05)|Kidney(185;0.000367)|BRCA - Breast invasive adenocarcinoma(365;0.000704)|KIRC - Kidney renal clear cell carcinoma(229;0.00567)|STAD - Stomach adenocarcinoma(132;0.00645)|Lung(427;0.124)			KNOWN			TGAGGTCCTGTGGGGGCCGGG						ENST00000378251.1:c.1182A>G	1					central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)|lung(5)|ovary(2)|prostate(1)|urinary_tract(1)		-		,		1p36.32	Q9ULN5		g.chr1:3701663T>C		768.5+/-413.6			no		1496,11510												-9.5					0.1	phenylalanine-tRNA ligase activity (GO:0004826)|poly(A) RNA binding (GO:0044822)				hg19	Standard	0.1213			926,7674			77,1342,5084					CCDS51.1	T		CC,CT,TT	AB033011		52		2504		rs2298227		1209									394	KIAA1185, RP1-286D6.3		17	NM_020710		3			ENST00000378251.1		18489		uc001akx.1			57470	dbSNP_100	1182			p.P394P		0				53.0		0.602	1:g.3701663T>C		protein_coding			basic|appris_principal|CCDS		48,830,3422			570,3836			C|||			5008		LRC47_HUMAN	543	leucine rich repeat containing 47			0.108427		3701663			0.1111	SNP		CCDS51.1			,,,	False	3701663				synonymous_variant		Approved		52.0		c.1182A>G	2008-02-05	OTTHUMT00000009744.1	Q8N1G4	0.1023		LRRC47	3701663		all_cancers(77;0.0375)|Ovarian(185;0.0634)|all_lung(157;0.208)|Lung NSC(156;0.21)			LRRC47	NM_020710.2	protein-coding gene	NP_065761.1		
		A	ENSG00000116198	ENST00000378230.3		9731		ENSG00000116198		4299					,					OTTHUMG00000003507		byFrequency	O60308	gene with protein product				NM_014704.3	37,529,1637	NM_014704	0.0859					+	3'UTR		226.5+/-262.2	52.0				7488117, 21399614				CEP104-001	2011-05-06				1	-	0.1422				utr-3	24866				G	SO:0001624				protein_coding		2203				13.3171,13.6859,13.442			6502								KNOWN			CGAGCGCCGCGTCAGCGCTTG		KIAA0562				ENST00000378230.3:c.*1C>T	1					breast(2)|cervix(1)|endometrium(9)|kidney(1)|large_intestine(14)|lung(8)|prostate(1)|skin(3)		-		,		1p36.32	Q5JSQ3|Q5SR24|Q5SR25|Q6PKF5|Q86W32|Q86X14	"""glycine, glutamate, thienylcyclohexylpiperidine binding protein"""	g.chr1:3731965G>A		253.7+/-259.5			no		1748,11256												2.1					0.1	glutamate binding (GO:0016595)|glycine binding (GO:0016594)|thienylcyclohexylpiperidine binding (GO:0016596)		2011-05-06		hg19	Standard	0.1412			1145,7453			119,1510,4873					CCDS30571.1	G		AA,AG,GG	AB011134	centriole (GO:0005814)	54		2504		rs12728401		3103				"""KIAA0562"""						GlyBP, RP1-286D6.4		39	NM_014704		0			ENST00000378230.3		18103		uc001aky.2			9731	dbSNP_121						0				57.0		0.642	1:g.3731965G>A		protein_coding			basic|appris_principal|CCDS		82,981,3236			603,3803			G|||			5008		CE104_HUMAN	516	centrosomal protein 104kDa			0.103035		3731965			0.0486	SNP		CCDS30571.1			,,,	False	3731965				3_prime_UTR_variant		Approved		54.0			2014-02-20	OTTHUMT00000009747.3	O60308	0.0764		CEP104	3731965					CEP104	NM_014704.3	protein-coding gene	NP_055519.1		
		A	ENSG00000116198	ENST00000378230.3		9731		ENSG00000116198		4300					,					OTTHUMG00000003507		byFrequency	O60308	gene with protein product				NM_014704.3	637,1086,480	NM_014704	0.5051					+	Intron		689.4+/-404.4	113.0				7488117, 21399614				CEP104-001	2011-05-06				1	-	0.5741				intron	24866				A	SO:0001627				protein_coding		2203				30.1047,46.4367,38.0517			6503								KNOWN			CTAAGACACAGAAACAGTGAG		KIAA0562				ENST00000378230.3:c.2152-11C>T	1					breast(2)|cervix(1)|endometrium(9)|kidney(1)|large_intestine(14)|lung(8)|prostate(1)|skin(3)		-		,		1p36.32	Q5JSQ3|Q5SR24|Q5SR25|Q6PKF5|Q86W32|Q86X14	"""glycine, glutamate, thienylcyclohexylpiperidine binding protein"""	g.chr1:3743319G>A		566.7+/-382.0			no		4949,8057												1.8					0.0	glutamate binding (GO:0016595)|glycine binding (GO:0016594)|thienylcyclohexylpiperidine binding (GO:0016596)		2011-05-06		hg19	Standard	0.328			2589,6011			1055,2839,2609					CCDS30571.1	G		AA,AG,GG	AB011134	centriole (GO:0005814)	119		2504		rs6663840		2476				"""KIAA0562"""						GlyBP, RP1-286D6.4		39	NM_014704		16			ENST00000378230.3		19822		uc001aky.2			9731	dbSNP_116						0				130.0		0.443	1:g.3743319G>A		protein_coding			basic|appris_principal|CCDS		418,1753,2129			2360,2046			A|||			5008		CE104_HUMAN	2371	centrosomal protein 104kDa			0.473442		3743319			0.5714	SNP		CCDS30571.1			,,,	False	3743319				intron_variant		Approved		119.0			2014-02-20	OTTHUMT00000009747.3	O60308	0.3055		CEP104	3743319					CEP104	NM_014704.3	protein-coding gene	NP_055519.1		
		C	ENSG00000116198	ENST00000378230.3		9731		ENSG00000116198		4300					,					OTTHUMG00000003507		byFrequency	O60308	gene with protein product				NM_014704.3	1837,343,23	NM_014704	0.7178					+	Intron		127.2+/-185.5	41.0				7488117, 21399614				CEP104-001	2011-05-06				1	-	0.9198				intron	24866				C	SO:0001627				protein_coding		2203				4.6163,8.8289,6.0434			6503								KNOWN			ACGCGAGGTCTGCTTACCTTC		KIAA0562				ENST00000378230.3:c.1836+6A>G	1					breast(2)|cervix(1)|endometrium(9)|kidney(1)|large_intestine(14)|lung(8)|prostate(1)|skin(3)		-		,		1p36.32	Q5JSQ3|Q5SR24|Q5SR25|Q6PKF5|Q86W32|Q86X14	"""glycine, glutamate, thienylcyclohexylpiperidine binding protein"""	g.chr1:3747603T>C		196.0+/-220.5			no		12220,786												-7.8					0.0	glutamate binding (GO:0016595)|glycine binding (GO:0016594)|thienylcyclohexylpiperidine binding (GO:0016596)		2011-05-06		hg19	Standard	0.9443			8203,397			5749,722,32					CCDS30571.1	T		CC,CT,TT	AB011134	centriole (GO:0005814)	42		2504		rs6413779		2161				"""KIAA0562"""						GlyBP, RP1-286D6.4		39	NM_014704		13			ENST00000378230.3		15969		uc001aky.2			9731	dbSNP_116						0				44.0		0.597	1:g.3747603T>C		protein_coding			basic|appris_principal|CCDS		3912,379,9			4017,389			C|||			5008		CE104_HUMAN	3954	centrosomal protein 104kDa			0.789537		3747603			0.4792	SNP		CCDS30571.1			,,,	False	3747603				intron_variant		Approved		42.0			2014-02-20	OTTHUMT00000009747.3	O60308	0.8689		CEP104	3747603					CEP104	NM_014704.3	protein-coding gene	NP_055519.1		
		C	ENSG00000116198	ENST00000378230.3		9731		ENSG00000116198		4300					,				c.(742-744)gaA>gaG	OTTHUMG00000003507		byFrequency	O60308	gene with protein product				NM_014704.3	1837,343,23	NM_014704	0.7178					+	Silent		127.3+/-185.7	106.0				7488117, 21399614				CEP104-001	2011-05-06				1	-	0.9198				coding-synonymous	24866		248/926		C	SO:0001819				protein_coding		2203				4.6163,8.8289,6.0434			6503								KNOWN			TCCCAAGGCGTTCACCAACCT		KIAA0562				ENST00000378230.3:c.744A>G	1					breast(2)|cervix(1)|endometrium(9)|kidney(1)|large_intestine(14)|lung(8)|prostate(1)|skin(3)		-		,		1p36.32	Q5JSQ3|Q5SR24|Q5SR25|Q6PKF5|Q86W32|Q86X14	"""glycine, glutamate, thienylcyclohexylpiperidine binding protein"""	g.chr1:3755675T>C		196.4+/-220.7			no		12220,786												4.3					1.0	glutamate binding (GO:0016595)|glycine binding (GO:0016594)|thienylcyclohexylpiperidine binding (GO:0016596)		2011-05-06		hg19	Standard	0.9443			8203,397			5749,722,32					CCDS30571.1	T		CC,CT,TT	AB011134	centriole (GO:0005814)	109		2504		rs1891941		1068				"""KIAA0562"""					248	GlyBP, RP1-286D6.4		39	NM_014704		8			ENST00000378230.3		24113		uc001aky.2			9731	dbSNP_92	744			p.E248E		0				116.0		0.453	1:g.3755675T>C		protein_coding			basic|appris_principal|CCDS		3912,379,9			4017,389			C|||			5008		CE104_HUMAN	3954	centrosomal protein 104kDa			0.789537		3755675			0.4792	SNP		CCDS30571.1			,,,	False	3755675				synonymous_variant		Approved		109.0		c.744A>G	2014-02-20	OTTHUMT00000009747.3	O60308	0.8689		CEP104	3755675					CEP104	NM_014704.3	protein-coding gene	NP_055519.1		
		A	ENSG00000198912	ENST00000361605.3		339448		ENSG00000198912		4300					,					OTTHUMG00000003739		byFrequency	Q8IYL3	gene with protein product		C1orf174_ENST00000486765.1_Intron		NM_207356.2	593,1073,537	NM_207356	0.3528					+	Intron		684.0+/-403.9	94.0				12477932				C1orf174-001					1	-	0.5696				intron	27915			all_cancers(23;5.09e-25)|all_epithelial(116;9.35e-17)|all_lung(118;1.09e-06)|Lung NSC(185;0.000139)|all_neural(13;0.00287)|Renal(390;0.00357)|Breast(487;0.00446)|Hepatocellular(190;0.0219)|all_hematologic(16;0.027)|Colorectal(325;0.0276)|Myeloproliferative disorder(586;0.0393)|Lung SC(97;0.0743)|Ovarian(437;0.127)	A	SO:0001627				protein_coding		2203				31.1163,48.729,37.944			6503					Epithelial(90;1.55e-39)|OV - Ovarian serous cystadenocarcinoma(86;5.99e-23)|GBM - Glioblastoma multiforme(42;2.22e-17)|Colorectal(212;1.08e-05)|COAD - Colon adenocarcinoma(227;5.49e-05)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000365)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.19)			KNOWN			AGGTCCTTAGTGGAGAAGAAA						ENST00000361605.3:c.619-6A>T	1					endometrium(1)|large_intestine(5)|lung(4)|prostate(1)		-		,		1p36.32	A8K0C8|A8MUG9|Q5SR20|Q6NX36		g.chr1:3806643T>A		580.7+/-385.2			no		4935,8071												-4.7					0.0					hg19	Standard	0.3241			2676,5924			1020,2895,2588					CCDS53.1	T		AA,AT,TT	BC035643	nucleus (GO:0005634)	101		2504		rs4520357		717										RP13-531C17.2		11	NM_207356		4			ENST00000361605.3		19699		uc001alf.3			339448	dbSNP_111						0				113.0		0.498	1:g.3806643T>A		protein_coding			basic|appris_principal|CCDS		427,1822,2051			2259,2147			A|||			5008		CA174_HUMAN	2111	chromosome 1 open reading frame 174			0.421526		3806643			0.4335	SNP		CCDS53.1			,,,	False	3806643				intron_variant		Approved		101.0			2012-07-25	OTTHUMT00000010539.1	Q8IYL3	0.3602		C1orf174	3806643		all_cancers(77;0.0395)|Ovarian(185;0.0634)|all_lung(157;0.222)|Lung NSC(156;0.227)			C1orf174	NM_207356.2	protein-coding gene	NP_997239.2		
		A	ENSG00000198912	ENST00000361605.3		339448		ENSG00000198912		4300					,					OTTHUMG00000003739		byFrequency	Q8IYL3	gene with protein product		C1orf174_ENST00000486765.1_Intron		NM_207356.2	190,890,1123	NM_207356	0.1258					+	Intron		289.0+/-299.1	60.0				12477932				C1orf174-001					1	-	0.3139				intron	27915			all_cancers(23;5.09e-25)|all_epithelial(116;9.35e-17)|all_lung(118;1.09e-06)|Lung NSC(185;0.000139)|all_neural(13;0.00287)|Renal(390;0.00357)|Breast(487;0.00446)|Hepatocellular(190;0.0219)|all_hematologic(16;0.027)|Colorectal(325;0.0276)|Myeloproliferative disorder(586;0.0393)|Lung SC(97;0.0743)|Ovarian(437;0.127)	G	SO:0001627				protein_coding		2203				17.9186,28.8243,21.6131			6503					Epithelial(90;1.55e-39)|OV - Ovarian serous cystadenocarcinoma(86;5.99e-23)|GBM - Glioblastoma multiforme(42;2.22e-17)|Colorectal(212;1.08e-05)|COAD - Colon adenocarcinoma(227;5.49e-05)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000365)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.19)			KNOWN			GGAGGAAGGCGCCGCTCTTAC						ENST00000361605.3:c.618+10C>T	1					endometrium(1)|large_intestine(5)|lung(4)|prostate(1)		-		,		1p36.32	A8K0C8|A8MUG9|Q5SR20|Q6NX36		g.chr1:3807122G>A		434.3+/-343.9			no		2811,10195												-1.3					0.0					hg19	Standard	0.1958			1541,7059			334,2143,4026					CCDS53.1	G		AA,AG,GG	BC035643	nucleus (GO:0005634)	60		2504		rs7513321		717										RP13-531C17.2		11	NM_207356		3			ENST00000361605.3		18879		uc001alf.3			339448	dbSNP_116						0				62.0		0.527	1:g.3807122G>A		protein_coding			basic|appris_principal|CCDS		144,1253,2903			1270,3136			G|||			5008		CA174_HUMAN	885	chromosome 1 open reading frame 174			0.176717		3807122			0.0615	SNP		CCDS53.1			,,,	False	3807122				intron_variant		Approved		60.0			2012-07-25	OTTHUMT00000010539.1	Q8IYL3	0.1268		C1orf174	3807122		all_cancers(77;0.0395)|Ovarian(185;0.0634)|all_lung(157;0.222)|Lung NSC(156;0.227)			C1orf174	NM_207356.2	protein-coding gene	NP_997239.2		
		A	ENSG00000198912	ENST00000361605.3		339448		ENSG00000198912		4300					,				c.(361-363)ctC>ctT	OTTHUMG00000003739		byFrequency	Q8IYL3	gene with protein product		C1orf174_ENST00000486765.1_5'UTR		NM_207356.2	123,813,1267	NM_207356	0.1268					+	Silent		287.0+/-298.0	56.0				12477932				C1orf174-001					1	-	0.2458				coding-synonymous	27915		121/244	all_cancers(23;5.09e-25)|all_epithelial(116;9.35e-17)|all_lung(118;1.09e-06)|Lung NSC(185;0.000139)|all_neural(13;0.00287)|Renal(390;0.00357)|Breast(487;0.00446)|Hepatocellular(190;0.0219)|all_hematologic(16;0.027)|Colorectal(325;0.0276)|Myeloproliferative disorder(586;0.0393)|Lung SC(97;0.0743)|Ovarian(437;0.127)	G	SO:0001819				protein_coding		2203				17.7558,24.0354,19.8831			6503					Epithelial(90;1.55e-39)|OV - Ovarian serous cystadenocarcinoma(86;5.99e-23)|GBM - Glioblastoma multiforme(42;2.22e-17)|Colorectal(212;1.08e-05)|COAD - Colon adenocarcinoma(227;5.49e-05)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000365)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.19)			KNOWN			TGCAGCCACCGAGAGGAAGAC						ENST00000361605.3:c.363C>T	1					endometrium(1)|large_intestine(5)|lung(4)|prostate(1)		-		,		1p36.32	A8K0C8|A8MUG9|Q5SR20|Q6NX36		g.chr1:3807388G>A		387.5+/-326.5			no		2586,10420												-8.1					0.0					hg19	Standard	0.1829			1527,7073			263,2060,4180					CCDS53.1	G		AA,AG,GG	BC035643	nucleus (GO:0005634)	57		2504		rs4131373		461									121	RP13-531C17.2		11	NM_207356		3			ENST00000361605.3		19489		uc001alf.3			339448	dbSNP_108	363			p.L121L		0				60.0		0.562	1:g.3807388G>A		protein_coding			basic|appris_principal|CCDS		140,1247,2913			1059,3347			G|||			5008		CA174_HUMAN	732	chromosome 1 open reading frame 174			0.146166		3807388			0.0129	SNP		CCDS53.1			,,,	False	3807388				synonymous_variant		Approved		57.0		c.363C>T	2012-07-25	OTTHUMT00000010539.1	Q8IYL3	0.1239		C1orf174	3807388		all_cancers(77;0.0395)|Ovarian(185;0.0634)|all_lung(157;0.222)|Lung NSC(156;0.227)			C1orf174	NM_207356.2	protein-coding gene	NP_997239.2		
		C	ENSG00000198912	ENST00000361605.3	0.80722	339448	N	ENSG00000198912	0.30215	4297	0.056000	0.05580	B		,	T	0.0	0	c.(157-159)aCg>aGg	OTTHUMG00000003739	0.620000	byFrequency	Q8IYL3	gene with protein product		C1orf174_ENST00000486765.1_5'UTR		NM_207356.2	2191,10,0	NM_207356	0.999			C	0.007	+	Missense_Mutation	2		101.0	Q8IYL3	0.997728		12477932			0.0	C1orf174-001			0.01281		1	-	0.9992		1	0.221000	missense	27915	362	53/244	all_cancers(23;5.09e-25)|all_epithelial(116;9.35e-17)|all_lung(118;1.09e-06)|Lung NSC(185;0.000139)|all_neural(13;0.00287)|Renal(390;0.00357)|Breast(487;0.00446)|Hepatocellular(190;0.0219)|all_hematologic(16;0.027)|Colorectal(325;0.0276)|Myeloproliferative disorder(586;0.0393)|Lung SC(97;0.0743)|Ovarian(437;0.127)	C	SO:0001583		benign	1.0	protein_coding		2201	P		0.344000	0.7796,0.2272,0.5925	B		6498		0.0:0.6586:0.1659:0.1756			Epithelial(90;1.55e-39)|OV - Ovarian serous cystadenocarcinoma(86;5.99e-23)|GBM - Glioblastoma multiforme(42;2.22e-17)|Colorectal(212;1.08e-05)|COAD - Colon adenocarcinoma(227;5.49e-05)|Kidney(185;0.000342)|BRCA - Breast invasive adenocarcinoma(365;0.000365)|KIRC - Kidney renal clear cell carcinoma(229;0.00549)|STAD - Stomach adenocarcinoma(132;0.00644)|Lung(427;0.19)			KNOWN	ENST00000361605		GGACGTTCGCGTGTCTGTGGC	T					ENST00000361605.3:c.158C>G	1		ENSG00000198912	0.07601	C1orf174	endometrium(1)|large_intestine(5)|lung(4)|prostate(1)	ENSP00000355306:p.Thr53Arg	-	0.24827	,	ACG	1p36.32	A8K0C8|A8MUG9|Q5SR20|Q6NX36		g.chr1:3807593G>C	T -> R (in dbSNP:rs4274008). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3}.			492	yes		12919,77	0.19401	0.00439	5.27	0.00012	ENSP00000355306:T53R			0.56097		-22.9256		4.4	0.52297	572	0.02654	1.0	0.1		-1.895			hg19	Standard	0.993	1.0	5.5498	8527,67			6422,75,1	-1.992776				CCDS53.1	G	0.02656	CC,CG,GG	BC035643	nucleus (GO:0005634)	97	0.00186	2504	4.36	rs4274008		256	53	752			0.17083	3797453	-	ARG/THR	53	RP13-531C17.2	2178	11	NM_207356	0.0	3	0.9920844327176781	-0.357000	ENST00000361605.3		20038		uc001alf.3			339448	dbSNP_111	158	0.0000		p.T53R	.	0		T		89.0	rs4274008;rs17232294;rs52801103;rs58906342;rs4274008	0.433	1:g.3807593G>C	ENSP00000355306:T53R	protein_coding	0.000032		basic|appris_principal|CCDS		4231,65,1		53	4392,10	0.9972527472527473	R	C|||		0.188074	5008		CA174_HUMAN	4997	chromosome 1 open reading frame 174		CA174_HUMAN	0.997804	0.15292	3807593		0.103000	0.999	SNP		CCDS53.1		N	,,,	False	3807593	-1.0009		9	missense	T	Approved	0.992204	97.0		c.158C>G	2012-07-25	OTTHUMT00000010539.1	Q8IYL3	0.9986	3.42	C1orf174	3807593	0.24807	all_cancers(77;0.0395)|Ovarian(185;0.0634)|all_lung(157;0.222)|Lung NSC(156;0.227)	0.29518	71	C1orf174	NM_207356.2	protein-coding gene	NP_997239.2	T	
		A	ENSG00000196581	ENST00000378191.4	0.35888	55966	N	ENSG00000196581	0.69175	4300	0.012000	0.45276	D		,	T	0.17056800000000005	0	c.(787-789)Ggg>Agg	OTTHUMG00000000645	2.179000	byFrequency	Q9UKB5	gene with protein product		AJAP1_ENST00000378190.3_Missense_Mutation_p.G263R		NM_018836.3	150,797,1256	NM_018836	0.4131			G	10.14	+	Missense_Mutation	1	663.8+/-402.1	78.0	Q9UKB5	0.248979		14595118			0.892	AJAP1-001	2008-01-08		0.61658		1	+	0.1664		0.32	0.038000	missense,missense	30801	157	263/412,263/412	all_cancers(23;1.77e-36)|all_epithelial(116;1.26e-21)|all_lung(118;3.51e-08)|Lung NSC(185;3.47e-06)|all_neural(13;8.84e-06)|all_hematologic(16;7.61e-05)|Breast(487;0.000507)|Renal(390;0.0007)|Colorectal(325;0.00117)|Hepatocellular(190;0.0071)|Glioma(11;0.0155)|Myeloproliferative disorder(586;0.0258)|Ovarian(437;0.0409)|Lung SC(97;0.133)|Medulloblastoma(700;0.215)	G	SO:0001583	610972	probably-damaging,probably-damaging	0.43370165745856354	protein_coding		2203	P		0.858000	33.5,24.8979,47.5934	P		6503		0.0:0.0:1.0:0.0			Epithelial(90;3.89e-35)|OV - Ovarian serous cystadenocarcinoma(86;1.97e-19)|GBM - Glioblastoma multiforme(42;3.71e-19)|Colorectal(212;4.57e-06)|COAD - Colon adenocarcinoma(227;0.00019)|Kidney(185;0.000969)|BRCA - Breast invasive adenocarcinoma(365;0.00122)|STAD - Stomach adenocarcinoma(132;0.00578)|KIRC - Kidney renal clear cell carcinoma(229;0.0126)|READ - Rectum adenocarcinoma(331;0.0689)			KNOWN	ENST00000378190;ENST00000378191		CAGCAACAACGGGGAAGTCAC	T;T					ENST00000378191.4:c.787G>A	1		ENSG00000196581	0.42956	AJAP1	endometrium(4)|large_intestine(6)|lung(11)|ovary(1)|prostate(1)|urinary_tract(1)	ENSP00000367433:p.Gly263Arg	+	0.29795	,	GGG	1p36.32	Q9Y229	"""transmembrane protein SHREW1"""	g.chr1:4772717G>A	G -> R (in dbSNP:rs242056). {ECO:0000269|PubMed:16410724}.	384.9+/-325.5		100	yes		6816,6190	0.15200	0.23136	4.76	0.00012	ENSP00000367432:G263R			0.34750		-14.0393		4.8	0.60689	150	0.27082	0.26223776223776224	0.0		0.55			hg19	Standard	0.6431	0.2032520325203252	13.2654	5719,2881		cell adhesion (GO:0007155)	2039,2738,1726	1.268191				CCDS54.1	G	0.76494	AA,AG,GG	AF175409	cell junction (GO:0030054)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	76	0.19112	2504	4.76	rs242056		1168	263	481			0.60131	4672577	+	ARG/GLY,ARG/GLY	263	SHREW1, SHREW-1, MOT8	888	24	NM_001042478	0.999	2	0.6345646437994723	0.467000	ENST00000378191.4		16220		uc001aln.3			55966	dbSNP_79	787,787	0.0000		p.G263R	.	0		T		71.0	rs242056;rs487066;rs58701997;rs242056	0.607	1:g.4772717G>A	ENSP00000367432:G263R;ENSP00000367433:G263R	protein_coding	0.003703		NMD_exception|basic|appris_principal|CCDS		1889,1941,470		263	1097,3309	0.4065934065934066	R	G|||		0.236408	5008		AJAP1_HUMAN	1807	adherens junctions associated protein 1		AJAP1_HUMAN	0.360823	0.55394	4772717		3.781000	0.2728	SNP		CCDS54.1		N	,,,	False	4772717	-1.0120		9	missense	T	Approved	0.665	76.0		c.787G>A	2008-02-05	OTTHUMT00000001542.3	Q9UKB5	0.3761	0.9;0.9	AJAP1	4772717	0.13279	all_cancers(77;0.071)|Ovarian(185;0.0721)	0.25847	125,125	AJAP1	NM_001042478.1,NM_018836.3	protein-coding gene	NP_061324.1	G	
		G	ENSG00000069424	ENST00000164247.1		8514		ENSG00000069424		4300					,				c.(1030-1032)tcA>tcG	OTTHUMG00000000795		byFrequency	Q13303	gene with protein product		KCNAB2_ENST00000352527.1_Silent_p.S330S|KCNAB2_ENST00000341524.1_Silent_p.S344S|KCNAB2_ENST00000378097.1_Silent_p.S344S|KCNAB2_ENST00000378083.3_Silent_p.S392S|KCNAB2_ENST00000458166.2_Silent_p.S277S|KCNAB2_ENST00000378092.1_Silent_p.S330S|KCNAB2_ENST00000378087.3_Intron|KCNAB2_ENST00000378111.1_Intron|KCNAB2_ENST00000602612.1_3'UTR		NM_001199860.1	906,1004,292	NM_172130	0.4448					+	Silent		504.7+/-376.2	140.0				8838324				KCNAB2-006					1	+	0.6415				coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous	6229		344/368,344/368,392/416,277/301,344/368,330/354	all_cancers(23;5.85e-39)|all_epithelial(116;4.88e-22)|all_lung(118;4.21e-08)|Lung NSC(185;9.77e-07)|all_hematologic(16;2.78e-06)|all_neural(13;3.18e-06)|Acute lymphoblastic leukemia(12;0.000272)|Breast(487;0.000496)|Renal(390;0.0007)|Colorectal(325;0.00106)|Glioma(11;0.00203)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0393)|Medulloblastoma(700;0.211)	G	SO:0001819	601142	,,,,,		protein_coding		2202				39.814,36.0581,38.542		"""Potassium channels"", ""Aldo-keto reductases"""	6502					Epithelial(90;6.9e-37)|GBM - Glioblastoma multiforme(13;8.8e-31)|OV - Ovarian serous cystadenocarcinoma(86;1.45e-19)|Colorectal(212;2.46e-07)|COAD - Colon adenocarcinoma(227;2.07e-05)|Kidney(185;7.88e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.00131)|BRCA - Breast invasive adenocarcinoma(365;0.00133)|STAD - Stomach adenocarcinoma(132;0.00391)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CGAAACTGTCATCTTCCATTA						ENST00000164247.1:c.1032A>G	1					large_intestine(1)|lung(4)|skin(3)		+		,		1p36.3	A0AVM9|A8K1A4|B0AZR7|O43659|Q5TG82|Q5TG83|Q6ZNE4|Q99411		g.chr1:6158562A>G		492.9+/-362.5			no		7992,5012												-6.9					0.3	potassium channel regulator activity (GO:0015459)|voltage-gated potassium channel activity (GO:0005249)				hg19	Standard	0.6093			5176,3424		hematopoietic progenitor cell differentiation (GO:0002244)|protein heterooligomerization (GO:0051291)|synaptic transmission (GO:0007268)	2505,2982,1015					CCDS55.1, CCDS56.1, CCDS55570.1, CCDS55571.1	A		GG,GA,AA	U33429	cytoplasm (GO:0005737)|integral component of membrane (GO:0016021)|juxtaparanode region of axon (GO:0044224)|plasma membrane (GO:0005886)	143		2504		rs2229002		1596								,,,,,	344	AKR6A5, KCNA2B, HKvbeta2.1, HKvbeta2.2		8	NM_003636		16			ENST00000164247.1		21080		uc001aly.2			8514	dbSNP_98	1032,1032,1176,831,1032,990			p.S344S		0				149.0		0.537	1:g.6158562A>G		protein_coding			alternative_5_UTR|basic|appris_candidate_longest|CCDS		1599,1978,723			2816,1588			G|||			5008		KCAB2_HUMAN	2724	potassium voltage-gated channel, shaker-related subfamily, beta member 2			0.54393		6158562			0.4018	SNP		CCDS55.1			,,,	False	6158562				synonymous_variant		Approved		143.0		c.1032A>G	2008-02-05	OTTHUMT00000002114.3	Q13303	0.6095		KCNAB2	6158562		Ovarian(185;0.0634)		,,,,,	KCNAB2	NM_001199860.1,NM_001199861.1,NM_001199862.1,NM_001199863.1,NM_003636.3,NM_172130.2	protein-coding gene	NP_001186789.1		
		C	ENSG00000116254	ENST00000262450.3		26038		ENSG00000116254		4300										OTTHUMG00000000952		byFrequency	O00258	gene with protein product		CHD5_ENST00000378021.1_Intron		NM_015557.2		NM_015557						+	Intron			86.0				11889561, 12592387				CHD5-001					1	-						16816			all_cancers(23;5.36e-32)|all_epithelial(116;2.32e-17)|all_neural(13;3.68e-06)|all_lung(118;3.94e-06)|all_hematologic(16;2.39e-05)|Lung NSC(185;5.33e-05)|Acute lymphoblastic leukemia(12;0.000372)|Glioma(11;0.00127)|Renal(390;0.00188)|Colorectal(325;0.00342)|Breast(487;0.00373)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.15)		SO:0001627	610771			protein_coding		2203						"""Zinc fingers, PHD-type"""	6503					Epithelial(90;3.08e-37)|GBM - Glioblastoma multiforme(13;1.36e-31)|OV - Ovarian serous cystadenocarcinoma(86;7.7e-19)|Colorectal(212;9.97e-08)|COAD - Colon adenocarcinoma(227;1.07e-05)|Kidney(185;6.16e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.00109)|BRCA - Breast invasive adenocarcinoma(365;0.0012)|STAD - Stomach adenocarcinoma(132;0.00346)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.193)			KNOWN			CTCCCTGCCCCGTGCAGCCCT						ENST00000262450.3:c.5382+29CG>G	1					breast(3)|central_nervous_system(3)|liver(1)|lung(1)|ovary(4)|pancreas(1)|skin(1)|upper_aerodigestive_tract(2)		-				1p36.3	A8KAP8|A8MQ44|D3DSH9|O60740		g.chr1:6170424delCG																													hg19	Standard						tail-anchored membrane protein insertion into ER membrane (GO:0071816)						CCDS57.1	CG			AF425231	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nucleus (GO:0005634)					rs78789357		5482												16	NM_015557		37			ENST00000262450.3				uc001amb.2			26038							0				86.0		0.592	1:g.6170424delCG		protein_coding			basic|appris_principal|CCDS													WRB_HUMAN		chromodomain helicase DNA binding protein 5					6170424				DEL		CCDS57.1					6170424				intron_variant		Approved		86.0			2013-01-28	OTTHUMT00000002823.2	Q8TDI0			CHD5	6170424		Ovarian(185;0.0634)					protein-coding gene	NP_056372.1		
		G	ENSG00000116254	ENST00000262450.3	0.58432	26038	N	ENSG00000116254	0.37446	4300	0.862000	0.91180	B;B		,	T	1.999999999946489E-6	0	c.(4615-4617)Tcg>Ccg	OTTHUMG00000000952	0.939000	byFrequency	O00258	gene with protein product		CHD5_ENST00000378021.1_Missense_Mutation_p.S396P		NM_015557.2	796,1056,351	NM_015557	0.8323			g	11.10	+	Missense_Mutation	1	514.9+/-378.5	43.0	Q8TDI0;Q5TG85	0.600999		11889561, 12592387			0.0;0.0	CHD5-001			0.01281		1	-	0.612		0.35	0.572000	missense	16816	221	1539/1955	all_cancers(23;5.36e-32)|all_epithelial(116;2.32e-17)|all_neural(13;3.68e-06)|all_lung(118;3.94e-06)|all_hematologic(16;2.39e-05)|Lung NSC(185;5.33e-05)|Acute lymphoblastic leukemia(12;0.000372)|Glioma(11;0.00127)|Renal(390;0.00188)|Colorectal(325;0.00342)|Breast(487;0.00373)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.15)	G	SO:0001583	610771	benign	0.6104972375690608	protein_coding		2203	P		0.089000	41.8721,39.9001,41.2041	B;B	"""Zinc fingers, PHD-type"""	6503		0.4234:0.0:0.5766:0.0			Epithelial(90;3.08e-37)|GBM - Glioblastoma multiforme(13;1.36e-31)|OV - Ovarian serous cystadenocarcinoma(86;7.7e-19)|Colorectal(212;9.97e-08)|COAD - Colon adenocarcinoma(227;1.07e-05)|Kidney(185;6.16e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.00109)|BRCA - Breast invasive adenocarcinoma(365;0.0012)|STAD - Stomach adenocarcinoma(132;0.00346)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.193)			KNOWN	ENST00000262450;ENST00000378006;ENST00000378021;ENST00000536802;ENST00000538279;ENST00000377999		ACCTCGCCCGACTTCTTCCCC	D;T					ENST00000262450.3:c.4615T>C	1		ENSG00000116254	0.10007	CHD5	breast(3)|central_nervous_system(3)|liver(1)|lung(1)|ovary(4)|pancreas(1)|skin(1)|upper_aerodigestive_tract(2)	ENSP00000262450:p.Ser1539Pro	-	0.21612	,	TCG	1p36.3	A8KAP8|A8MQ44|D3DSH9|O60740		g.chr1:6184092A>G		514.4+/-368.6		299	yes		7647,5359	0.33874	0.27475	4.29	0.00012	ENSP00000262450:S1539P			0.26424		-0.334		3.3	0.38373	569	0.25106	0.9947552447552448	0.9		-0.345			hg19	Standard	0.5994	0.6077235772357723	6.1467	4999,3601		tail-anchored membrane protein insertion into ER membrane (GO:0071816)	2222,3203,1078	1.539303				CCDS57.1	A	0.02656	GG,GA,AA	AF425231	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nucleus (GO:0005634)	41	0.03608	2504	3.35	rs2843493		4714	1539;396	445			0.20289	6106679	-	PRO/SER	0		1534	16	NM_015557	0.0;0.0	31	0.5870712401055409	-0.282000	ENST00000262450.3		10404		uc001amb.2			26038	dbSNP_100	4615	0.0000		p.S1539P	.	0		T		38.0	rs2843493;rs60784055;rs2843493	0.667	1:g.6184092A>G	ENSP00000262450:S1539P;ENSP00000367260:S396P	protein_coding	0.024454		basic|appris_principal|CCDS		1426,2147,727		1539;1055;396;947;947;396	2648,1758	0.7023809523809523	P	G|||		0.315726	5008		WRB_HUMAN	3644	chromodomain helicase DNA binding protein 5		CHD5_HUMAN;.	0.727636	0.20965	6184092		0.402000	0.994	SNP		CCDS57.1		N	,,,	False	6184092	-0.9759		9	missense	T	Approved	0.581279	41.0		c.4615T>C	2013-01-28	OTTHUMT00000002823.2	Q8TDI0	0.5994	-2.8;2.15	CHD5	6184092	0.35998	Ovarian(185;0.0634)	0.36163	74	CHD5	NM_015557.2	protein-coding gene	NP_056372.1	S	
		T	ENSG00000158292	ENST00000377893.2	0.32111	387509	N	ENSG00000158292	0.19030	4295	0.331000	0.42513	B		,	T	0.589358	0	c.(625-627)cGc>cAc	OTTHUMG00000001272	0.147000	byFrequency	Q6NV75	gene with protein product				NM_207370.2			0.7035			C	5.326	+	Missense_Mutation	2		33.0	Q6NV75	.		12679517			0.011	GPR153-001			0.14578		1	-	0.702		0.44	0.025000		23618	279		all_cancers(23;8.07e-33)|all_epithelial(116;4.45e-18)|all_lung(118;1.09e-06)|all_neural(13;3.68e-06)|Lung NSC(185;1.52e-05)|all_hematologic(16;2.39e-05)|Acute lymphoblastic leukemia(12;0.000372)|Glioma(11;0.00127)|Renal(390;0.00188)|Colorectal(325;0.00342)|Breast(487;0.00475)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.15)		SO:0001583	614269		0.7707182320441989	protein_coding		2199	P		0.995000		B	"""GPCR / Class A : Orphans"""	6494		0.0:0.5669:0.0:0.4331			Epithelial(90;1.91e-37)|GBM - Glioblastoma multiforme(13;4.87e-29)|OV - Ovarian serous cystadenocarcinoma(86;3.03e-19)|Colorectal(212;1.33e-07)|COAD - Colon adenocarcinoma(227;1.36e-05)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000911)|BRCA - Breast invasive adenocarcinoma(365;0.00109)|STAD - Stomach adenocarcinoma(132;0.00313)|READ - Rectum adenocarcinoma(331;0.0642)|Lung(427;0.246)			KNOWN	ENST00000377893		GAAGGCGCGGCGGTCGGCCTG	T					ENST00000377893.2:c.626G>A	1		ENSG00000158292	0.05591	GPR153	endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(2)|liver(1)|lung(7)|skin(1)	ENSP00000367125:p.Arg209His	-	0.38212	,	CGC	1p36.31	Q5TGR5|Q6AHW8|Q86SP8		g.chr1:6313938C>T	R -> H (in dbSNP:rs12735670). {ECO:0000269|PubMed:12679517, ECO:0000269|PubMed:15489334}.			339				0.25455	0.10077	4.9	0.00012	ENSP00000367125:R209H			0.37095		-31.5101			0.26663	338	0.20046	0.5909090909090909		G-protein coupled receptor activity (GO:0004930)	0.345			hg19	Standard	0.7117	0.6890243902439024	7.4677					0.245509				CCDS64.1	C	0.15141		AY255529	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)		0.14661	2504	2.03	rs12735670		885	209	546			0.27330	6236525	-		209	PGR1	1502	14	NM_207370	0.012	3	0.7203166226912929	-0.448000	ENST00000377893.2		17470		uc001amp.2			387509			0.0000		p.R209H	GPCR, rhodopsin-like superfamily (1);	0		T		31.0	rs12735670;rs58824924	0.701	1:g.6313938C>T	ENSP00000367125:R209H	protein_coding	0.002257		basic|appris_principal|CCDS				209		0.6877289377289377	H	C|||		0.292679	5008		GP153_HUMAN	3501	G protein-coupled receptor 153		GP153_HUMAN	0.699081	0.20365	6313938		0.366000	0.6131	SNP		CCDS64.1		N	,,,	False	6313938	-1.0089		9	missense	T	Approved	.	32.0		c.626G>A	2012-08-21	OTTHUMT00000003717.2	Q6NV75	0.7939	0.97	GPR153	6313938	0.11179	Ovarian(185;0.0634)	0.26916				protein-coding gene	NP_997253.2	R	
		T	ENSG00000162408	ENST00000377705.5		79707		ENSG00000162408		4300					,					OTTHUMG00000000904		byFrequency	Q5SY16	gene with protein product				NM_024654.4	1903,283,17	NM_024654	1.0					+	Intron		2.2+/-6.3	86.0				21063389				NOL9-001					1	-	0.9266				intron	26265			all_cancers(23;2.46e-35)|all_epithelial(116;1.41e-22)|all_lung(118;7.59e-07)|Lung NSC(185;4.28e-06)|Colorectal(325;4.52e-05)|Breast(487;0.000353)|Renal(390;0.0007)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0443)	T	SO:0001627				protein_coding		2203				0.0233,7.1947,2.4527			6503					Colorectal(212;1.47e-07)|COAD - Colon adenocarcinoma(227;1.47e-05)|Kidney(185;5.27e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000971)|BRCA - Breast invasive adenocarcinoma(365;0.00113)|STAD - Stomach adenocarcinoma(132;0.0017)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CACGCTGAAACGGAAACACAG						ENST00000377705.5:c.1960-7G>A	1					central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(2)|lung(9)|skin(2)|urinary_tract(1)		-		,		1p36.31	Q2NL84|Q4VBY3|Q6P472|Q7L4D6|Q96EE0|Q9H5L4	"""polynucleotide 5'-kinase"""	g.chr1:6586070C>T		169.1+/-199.8			no		12687,319												-5.1					0.0	ATP binding (GO:0005524)|polynucleotide 5'-hydroxyl-kinase activity (GO:0051731)|RNA binding (GO:0003723)				hg19	Standard	1.0			8598,2		maturation of 5.8S rRNA (GO:0000460)	6201,285,17					CCDS80.1	C		TT,TC,CC	AK091284	membrane (GO:0016020)|nucleolus (GO:0005730)	87		2504		rs7548042		1992										FLJ23323, NET6, Grc3		19	NM_024654		12			ENST00000377705.5		20393		uc001ans.3			79707	dbSNP_116						0				89.0		0.488	1:g.6586070C>T		protein_coding			basic|appris_principal|CCDS		4298,2,0			4089,317			T|||			5008		NOL9_HUMAN	4905	nucleolar protein 9			0.979433		6586070			1.0	SNP		CCDS80.1			,,,	False	6586070				intron_variant		Approved		87.0			2012-05-02	OTTHUMT00000002625.1	Q5SY16	0.9914		NOL9	6586070		Ovarian(185;0.0212)|all_lung(157;0.154)			NOL9	NM_024654.4	protein-coding gene	NP_078930		
		G	ENSG00000173662	ENST00000333172.6	0.80722	80835	N	ENSG00000173662	0.10078	4300	0.000000	0.86297	B;B		,	T	0.0	0	c.(1039-1041)Aag>Gag	OTTHUMG00000001441	-0.214000	byFrequency	Q7RTX1	gene with protein product		TAS1R1_ENST00000328191.4_Missense_Mutation_p.K347E|TAS1R1_ENST00000351136.3_Intron		NM_138697.3	1301,766,136		0.9959			G	0.014	+	Missense_Mutation	1	4.3+/-15.6	38.0	Q7RTX1-3;Q7RTX1	0.764412					0.028;0.021	TAS1R1-001	2003-03-24		0.20184		1	+	0.7216		1	0.004000	missense,intron	14448	354	347/842,	all_cancers(23;8.73e-34)|all_epithelial(116;9.26e-22)|all_lung(118;7.57e-07)|Lung NSC(185;4.26e-06)|Breast(487;0.000353)|Renal(390;0.0007)|Colorectal(325;0.00104)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0443)	G	SO:0001583	606225	benign,	0.9779005524861878	protein_coding		2203	P		0.000000	0.0698,23.5588,8.0271	B;B	"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6503		0.4082:0.2071:0.3847:0.0			Colorectal(212;1.29e-07)|COAD - Colon adenocarcinoma(227;1.33e-05)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000896)|BRCA - Breast invasive adenocarcinoma(365;0.00108)|STAD - Stomach adenocarcinoma(132;0.0167)|READ - Rectum adenocarcinoma(331;0.0642)			KNOWN	ENST00000333172;ENST00000328191		GGCAGACAAGAAGGCCCCTAG	D;D	GPR70				ENST00000333172.6:c.1039A>G	1		ENSG00000173662	0.15052	TAS1R1	NS(2)|central_nervous_system(1)|endometrium(2)|large_intestine(7)|lung(13)|ovary(1)|skin(1)|urinary_tract(2)	ENSP00000331867:p.Lys347Glu	+	0.05858	,	AAG	1p36.23	B2RMX0|Q5SY22|Q5SY24|Q8NGZ7|Q8TDJ7|Q8TDJ8|Q8TDJ9|Q8TDK0		g.chr1:6635231A>G	K -> E (in dbSNP:rs10864628). {ECO:0000269|PubMed:11891061, ECO:0000269|PubMed:15489334}.	375.4+/-321.6		369	yes		11962,1044	0.03702	0.00887	5.4	0.00012	ENSP00000327705:K347E			0.09203		.		-0.5	0.12172	572	0.02654	1.0	0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)	0			hg19	Standard	0.999	0.75	6.901	8594,6		detection of chemical stimulus involved in sensory perception of taste (GO:0050912)|sensory perception of umami taste (GO:0050917)	5595,772,136	-1.577061				CCDS81.1, CCDS82.1	A	0.21452	GG,GA,AA		integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	39	0.08118	2504	-0.461	rs10864628		1232	347;347	757		"""G protein-coupled receptor 70"""	0.24283	6557818	+	GLU/LYS,	347	T1R1, TR1	2052	29	NM_138697	0.056;0.017	3	0.9986807387862797	-0.119000	ENST00000333172.6		19168		uc001ant.3				dbSNP_120	1039,	0.0000		p.K347E	Extracellular ligand-binding receptor (1);	0		T		40.0	rs10864628;rs59713596;rs10864628	0.602	1:g.6635231A>G	ENSP00000331867:K347E;ENSP00000327705:K347E	protein_coding	0.834398		basic|appris_principal|CCDS		4294,6,0		347	3368,1038	0.9395604395604396	E	G|||		0.933214	5008		TS1R1_HUMAN	4624	taste receptor, type 1, member 1		.;TS1R1_HUMAN	0.923323	0.21628	6635231		0.442000	1.0	SNP		CCDS81.1		N	,,,	False	6635231	-0.9711		9	missense	T	Approved	0.999302	39.0		c.1039A>G	2012-08-22	OTTHUMT00000004211.1	Q7RTX1	0.9841	-2.1;-2.1	TAS1R1	6635231	0.04260	Ovarian(185;0.0212)|all_lung(157;0.154)	0.37314	56,	TAS1R1	NM_138697.3,NM_177540.2	protein-coding gene	NP_619642.2	K	
		A	ENSG00000173662	ENST00000333172.6		80835		ENSG00000173662		4300					,					OTTHUMG00000001441		byFrequency	Q7RTX1	gene with protein product		TAS1R1_ENST00000351136.3_Intron|TAS1R1_ENST00000328191.4_Intron		NM_138697.3	19,356,1828		0.18					+	Intron		197.8+/-242.3	48.0								TAS1R1-001	2003-03-24				1	+	0.0938				intron,intron	14448		,	all_cancers(23;8.73e-34)|all_epithelial(116;9.26e-22)|all_lung(118;7.57e-07)|Lung NSC(185;4.26e-06)|Breast(487;0.000353)|Renal(390;0.0007)|Colorectal(325;0.00104)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0443)	G	SO:0001627	606225	,		protein_coding		2203				11.2442,8.9424,10.4644		"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6503					Colorectal(212;1.29e-07)|COAD - Colon adenocarcinoma(227;1.33e-05)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000896)|BRCA - Breast invasive adenocarcinoma(365;0.00108)|STAD - Stomach adenocarcinoma(132;0.0167)|READ - Rectum adenocarcinoma(331;0.0642)			KNOWN			CAGCACTCCCGGGGGCTGCAC		GPR70				ENST00000333172.6:c.1594+41G>A	1					NS(2)|central_nervous_system(1)|endometrium(2)|large_intestine(7)|lung(13)|ovary(1)|skin(1)|urinary_tract(2)		+		,		1p36.23	B2RMX0|Q5SY22|Q5SY24|Q8NGZ7|Q8TDJ7|Q8TDJ8|Q8TDJ9|Q8TDK0		g.chr1:6637171G>A		185.3+/-212.5			no		1361,11645												-6.4					0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)				hg19	Standard	0.1173			967,7633		detection of chemical stimulus involved in sensory perception of taste (GO:0050912)|sensory perception of umami taste (GO:0050917)	73,1215,5215					CCDS81.1, CCDS82.1	G		AA,AG,GG		integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	49		2504		rs12040340		1787				"""G protein-coupled receptor 70"""				,		T1R1, TR1		29	NM_138697		5			ENST00000333172.6		16950		uc001ant.3				dbSNP_120	,					0				51.0		0.642	1:g.6637171G>A		protein_coding			basic|appris_principal|CCDS		54,859,3387			394,4012			G|||			5008		TS1R1_HUMAN	617	taste receptor, type 1, member 1			0.123203		6637171			0.13	SNP		CCDS81.1			,,,	False	6637171				intron_variant		Approved		49.0			2012-08-22	OTTHUMT00000004211.1	Q7RTX1	0.098		TAS1R1	6637171		Ovarian(185;0.0212)|all_lung(157;0.154)		,	TAS1R1	NM_138697.3,NM_177540.2	protein-coding gene	NP_619642.2		
		G	ENSG00000007923	ENST00000377577.5		55735		ENSG00000007923		4300					,				c.(1078-1080)ggT>ggC	OTTHUMG00000001443		byFrequency	Q9NVH1	gene with protein product		DNAJC11_ENST00000377573.5_Silent_p.G270G|DNAJC11_ENST00000465508.1_5'UTR|DNAJC11_ENST00000294401.7_Silent_p.G360G|DNAJC11_ENST00000349363.6_Intron|DNAJC11_ENST00000542246.1_Silent_p.G322G		NM_018198.3	1691,482,30	NM_018198	0.8712					+	Silent		181.8+/-230.4	80.0				12964007				DNAJC11-001					1	-	0.8676				coding-synonymous	25570		360/560	all_cancers(23;1.97e-27)|all_epithelial(116;1.76e-17)|all_lung(118;2.27e-05)|Lung NSC(185;9.97e-05)|Renal(390;0.00188)|Breast(487;0.00289)|Colorectal(325;0.00342)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.156)	G	SO:0001819	614827			protein_coding		2203				8.8256,12.3014,10.0031		"""Heat shock proteins / DNAJ (HSP40)"""	6503					Colorectal(212;2.34e-07)|COAD - Colon adenocarcinoma(227;2.05e-05)|Kidney(185;7.67e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000639)|KIRC - Kidney renal clear cell carcinoma(229;0.00128)|STAD - Stomach adenocarcinoma(132;0.00179)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TGAGAGAAACACCCTGTGGAA						ENST00000377577.5:c.1080T>C	1					NS(1)|breast(2)|endometrium(4)|kidney(2)|large_intestine(11)|lung(8)|ovary(2)|skin(1)|urinary_tract(1)		-		,		1p36.23	Q4VWF5|Q5VZN0|Q6PK20|Q6PK70|Q8NDM2|Q96CL7		g.chr1:6704635A>G		245.9+/-254.7			no		11705,1301												-4.2					0.9					hg19	Standard	0.9245			7841,759			5262,1181,60					CCDS87.1	A		GG,GA,AA	AF306695	extracellular vesicular exosome (GO:0070062)|mitochondrial inner membrane (GO:0005743)	83		2504		rs200458		1203									360	FLJ10737		32	NM_018198		10			ENST00000377577.5		20332		uc001aof.2			55735	dbSNP_79	1080			p.G360G		0				88.0		0.512	1:g.6704635A>G		protein_coding			basic|appris_principal|CCDS		3571,699,30			3864,542			G|||			5008		DJC11_HUMAN	4172	DnaJ (Hsp40) homolog, subfamily C, member 11			0.833067		6704635			0.5704	SNP		CCDS87.1			,,,	False	6704635				synonymous_variant		Approved		83.0		c.1080T>C	2011-09-02	OTTHUMT00000004216.3	Q9NVH1	0.9625		DNAJC11	6704635		Ovarian(185;0.0265)|all_lung(157;0.154)			DNAJC11	NM_018198.3	protein-coding gene	NP_060668.2		
		G	ENSG00000171735	ENST00000303635.7		23261		ENSG00000171735		4300					,					OTTHUMG00000001212		byFrequency	Q9Y6Y1	gene with protein product		CAMTA1_ENST00000439411.2_Intron		NM_015215.2	760,1059,384	NM_015215	0.593					+	Intron		600.8+/-394.3	62.0				11925432				CAMTA1-001					1	+	0.5855				intron	18806			all_epithelial(116;8.38e-23)|all_lung(118;5.87e-07)|Lung NSC(185;3.43e-06)|Renal(390;0.000219)|Breast(487;0.000307)|Colorectal(325;0.000615)|Hepatocellular(190;0.0088)|Myeloproliferative disorder(586;0.0303)|Ovarian(437;0.0388)	A	SO:0001627	611501			protein_coding		2203				45.8605,41.4662,44.3718			6503	T				UCEC - Uterine corpus endometrioid carcinoma (279;0.101)|Colorectal(212;1.33e-05)|COAD - Colon adenocarcinoma(227;0.000235)|BRCA - Breast invasive adenocarcinoma(304;0.000864)|Kidney(185;0.00244)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0179)|READ - Rectum adenocarcinoma(331;0.133)			KNOWN			GGACGGTAAGAACAGTGCTTG						ENST00000303635.7:c.2914+6A>G	1					breast(5)|central_nervous_system(4)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(3)|kidney(3)|large_intestine(11)|lung(29)|ovary(5)|pancreas(2)|prostate(4)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(3)		+		,		1p36.31-p36.23	A7MBM4|G3V3Z7|Q5VUE1|Q6V701|Q8WYI3|Q96S92		g.chr1:7737799A>G		634.6+/-396.2			no		7235,5771									Dom		611501	-0.7					0.1	DNA binding (GO:0003677)				hg19	Standard	0.5686			4656,3944		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2018,3199,1286					CCDS30576.1, CCDS55574.1, CCDS55575.1	A		GG,GA,AA	AB020640	cytoplasm (GO:0005737)|nucleus (GO:0005634)	64		2504		rs3011926		3121										KIAA0833		85	NM_001195563		11			ENST00000303635.7	M	20085		uc001aoi.3	1p36.31-p36.23	epitheliod hemangioendothelioma	23261	dbSNP_101						0				68.0		0.572	1:g.7737799A>G		protein_coding		calmodulin binding transcription activator 1	basic|appris_candidate_longest|CCDS	WWTR1	1258,2140,902			2579,1827			A|||			5008	yes	CMTA1_HUMAN	2963	calmodulin binding transcription activator 1	1		0.591653		7737799			0.6587	SNP		CCDS30576.1			,,,	False	7737799				intron_variant		Approved		64.0			2008-07-18	OTTHUMT00000003588.3	Q9Y6Y1	0.5375		CAMTA1	7737799		Ovarian(185;0.0634)			CAMTA1	NM_015215.2	protein-coding gene	NP_056030.1		
		G	ENSG00000171735	ENST00000303635.7	0.37138|0.37138	23261	L|L	ENSG00000171735	0.46957|0.46957	4300	1.000000|1.000000	0.18960|.	B;B;B;B|.		,	T|.	0.09842700000000004|0.09842700000000004	2|0	c.(3529-3531)aaC>aaG	OTTHUMG00000001212	1.411000|1.411000	byFrequency	Q9Y6Y1	gene with protein product		CAMTA1_ENST00000439411.2_Missense_Mutation_p.N1177K		NM_015215.2	3,157,2043	NM_015215	0.1483			C|C	9.325|9.325	+	Missense_Mutation	3|2	233.2+/-266.6	60.0	Q9Y6Y1-2;B4DXR3;Q7Z7P1;Q9Y6Y1|.	0.036995|0.036995		11925432			0.038;0.016;0.034;0.013|.	CAMTA1-001			0.22152|.		1	+	0.0136		0.89|.	0.998000|0.998000	missense	18806	65|65	1177/1674	all_epithelial(116;8.38e-23)|all_lung(118;5.87e-07)|Lung NSC(185;3.43e-06)|Renal(390;0.000219)|Breast(487;0.000307)|Colorectal(325;0.000615)|Hepatocellular(190;0.0088)|Myeloproliferative disorder(586;0.0303)|Ovarian(437;0.0388)	C	SO:0001583	611501	benign	0.17955801104972377|0.17955801104972377	protein_coding		2203	P|P		0.580000|0.580000	13.1628,3.6995,9.9569	B;B;B;B|.		6503	T	0.0:0.8332:0.0:0.1668|0.0:0.8332:0.0:0.1668			UCEC - Uterine corpus endometrioid carcinoma (279;0.101)|Colorectal(212;1.33e-05)|COAD - Colon adenocarcinoma(227;0.000235)|BRCA - Breast invasive adenocarcinoma(304;0.000864)|Kidney(185;0.00244)|STAD - Stomach adenocarcinoma(132;0.00644)|KIRC - Kidney renal clear cell carcinoma(229;0.0179)|READ - Rectum adenocarcinoma(331;0.133)			KNOWN	ENST00000303635;ENST00000439411;ENST00000414738;ENST00000303646|ENST00000495233		TGGGACAGAACCCCAGAATCC	T;T|.					ENST00000303635.7:c.3531C>G	1		ENSG00000171735|ENSG00000171735	0.94253|0.94253	CAMTA1|CAMTA1	breast(5)|central_nervous_system(4)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(3)|kidney(3)|large_intestine(11)|lung(29)|ovary(5)|pancreas(2)|prostate(4)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(3)	ENSP00000306522:p.Asn1177Lys	+	0.26733|0.26733	,	AAC|ACC	1p36.31-p36.23	A7MBM4|G3V3Z7|Q5VUE1|Q6V701|Q8WYI3|Q96S92		g.chr1:7797503C>G	N -> K (in dbSNP:rs41278952). {ECO:0000269|PubMed:17222547}.	109.5+/-147.8		8|8	yes		1295,11711	0.80357|0.80357	0.19987|0.19987	5.91|5.91	0.00144|0.00144	ENSP00000306522:N1177K|.			0.50627|.	Dom	-10.3436|-10.3436	611501	5.0	0.65823|0.65823	46|46	0.06494|.	0.08041958041958042|0.08041958041958042	1.0	DNA binding (GO:0003677)	1.5|1.5			hg19	Standard	0.1163	0.016260162601626018|0.016260162601626018	9.4777|9.4777	1132,7468		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	74,1147,5282	1.059113|1.059113				CCDS30576.1, CCDS55574.1, CCDS55575.1	C	0.24317|.	GG,GC,CC	AB020640	cytoplasm (GO:0005737)|nucleus (GO:0005634)	60	0.47716|0.47716	2504	4.97|4.97	rs41278952		3738	1177;264;133;1177|.	80|80			0.38882|0.38882	7720090|7720090	+|+	LYS/ASN	1177	KIAA0833	199|199	85	NM_001195563	0.101;0.02;0.054;0.014|.	15	0.10554089709762533|0.10554089709762533	0.655000|0.655000	ENST00000303635.7	M	17819		uc001aoi.3	1p36.31-p36.23	epitheliod hemangioendothelioma	23261	dbSNP_127	3531	0.0004|0.0004		p.N1177K	.|.	0		T|T		59.0	rs41278952;rs61739456|rs41278952;rs61739456	0.572	1:g.7797503C>G	ENSP00000306522:N1177K;ENSP00000402561:N1177K|.	protein_coding	0.000113|.	calmodulin binding transcription activator 1	basic|appris_candidate_longest|CCDS	WWTR1	71,990,3239		1177;1177;264;133|134	163,4243	0.09111721611721611|0.09111721611721611	K|S	C|||		0.206906|.	5008	yes	CMTA1_HUMAN	503	calmodulin binding transcription activator 1	1	.;.;.;CMTA1_HUMAN|.	0.100439	0.24029|0.24029	7797503		0.595000|0.595000	0.0774	SNP		CCDS30576.1		D|.	,,,	False	7797503	-1.0512|-1.0512		9|4	missense	T|T	Approved	0.131628|0.131628	60.0		c.3531C>G	2008-07-18	OTTHUMT00000003588.3	Q9Y6Y1	0.2089	2.18;2.18|.	CAMTA1	7797503	0.95712|0.95712	Ovarian(185;0.0634)	0.13361|0.13361	94	CAMTA1	NM_015215.2	protein-coding gene	NP_056030.1	N|T	
		A	ENSG00000049245	ENST00000054666.6		9341		ENSG00000049245		4300					,					OTTHUMG00000001225		byFrequency	Q15836	gene with protein product		VAMP3_ENST00000470357.1_Intron		NM_004781.3	14,309,1880	NM_004781	0.2086					+	Intron		390.0+/-343.1	84.0				9885218				VAMP3-001	2012-10-17				1	+	0.0386				intron	12644			all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	603657			protein_coding		2203				27.1047,7.6487,20.5136		"""Vesicle-associated membrane proteins"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|all cancers(8;6.33e-69)|GBM - Glioblastoma multiforme(8;2.07e-34)|Colorectal(212;1.36e-07)|COAD - Colon adenocarcinoma(227;1.38e-05)|Kidney(185;4.89e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000805)|KIRC - Kidney renal clear cell carcinoma(229;0.000917)|STAD - Stomach adenocarcinoma(132;0.000985)|READ - Rectum adenocarcinoma(331;0.0642)			KNOWN			TCATGCTCATGCCTTTACATG						ENST00000054666.6:c.3-17G>A	1					breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)		+		,		1p36.23	Q9BRV4	"""cellubrevin"""	g.chr1:7833485G>A		175.9+/-205.1			no		2668,10338												-1.2					0.0					hg19	Standard	0.2932			2331,6269		calcium ion-dependent exocytosis (GO:0017156)|exocytosis (GO:0006887)|Golgi to plasma membrane protein transport (GO:0043001)|membrane fusion (GO:0061025)|positive regulation of receptor recycling (GO:0001921)|protein complex assembly (GO:0006461)|retrograde transport, endosome to Golgi (GO:0042147)|SNARE complex assembly (GO:0035493)|substrate adhesion-dependent cell spreading (GO:0034446)|vesicle docking involved in exocytosis (GO:0006904)|vesicle-mediated transport (GO:0016192)	326,2016,4161					CCDS88.1	G		AA,AG,GG	BC003570	apical plasma membrane (GO:0016324)|cell junction (GO:0030054)|cell surface (GO:0009986)|clathrin-coated vesicle (GO:0030136)|clathrin-coated vesicle membrane (GO:0030665)|integral component of membrane (GO:0016021)|neuron projection (GO:0043005)|plasma membrane (GO:0005886)|recycling endosome (GO:0055037)|secretory granule (GO:0030141)|SNARE complex (GO:0031201)|synapse (GO:0045202)	87		2504		rs11576572		117										CEB		6	NM_004781		2			ENST00000054666.6		19752		uc001aol.3			9341	dbSNP_120						0				93.0		0.388	1:g.7833485G>A		protein_coding			basic|appris_principal|CCDS		312,1707,2281			337,4069			G|||			5008		VAMP3_HUMAN	764	vesicle-associated membrane protein 3			0.152556		7833485			0.0198	SNP		CCDS88.1			,,,	False	7833485				intron_variant		Approved		87.0			2013-02-13	OTTHUMT00000003625.1	Q15836	0.2795		VAMP3	7833485		Ovarian(185;0.0634)|all_lung(157;0.178)			VAMP3	NM_004781.3	protein-coding gene	NP_004772.1		
		C	ENSG00000049246	ENST00000361923.2		8863		ENSG00000049246		4298					,					OTTHUMG00000001216		byFrequency	P56645	gene with protein product		PER3_ENST00000377532.3_Intron		NM_016831.1	2092,108,2	NM_016831	0.9806					+	Intron			19.0				9427249				PER3-002	2012-12-13				1	+	0.9796				intron	8847			all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	603427			protein_coding		2202				4.4905,2.5431,3.8308			6500					UCEC - Uterine corpus endometrioid carcinoma (279;0.0234)|all cancers(8;8.58e-70)|GBM - Glioblastoma multiforme(8;1.81e-35)|Colorectal(212;2.06e-07)|COAD - Colon adenocarcinoma(227;1.92e-05)|Kidney(185;7.18e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000472)|STAD - Stomach adenocarcinoma(132;0.00118)|KIRC - Kidney renal clear cell carcinoma(229;0.00122)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CATTTGAACAGCCAGCAATTC						ENST00000361923.2:c.1240-38G>C	1					breast(4)|central_nervous_system(3)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)		+		,		1p36.23	Q5H8X4|Q5H8X5|Q969K6|Q96S77|Q96S78|Q9C0J3|Q9NSP9|Q9UGU8		g.chr1:7869915G>C					no		12502,498												-3.2					0.0	signal transducer activity (GO:0004871)				hg19	Standard	0.9513			8210,386		circadian regulation of gene expression (GO:0032922)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of circadian sleep/wake cycle, sleep (GO:0045187)|transcription, DNA-templated (GO:0006351)	6019,464,17					CCDS89.1, CCDS72695.1	G		CC,CG,GG	BC026102	cytoplasm (GO:0005737)|nucleus (GO:0005634)	19		2504		rs228668		1414				"""period (Drosophila) homolog 3"", ""period homolog 3 (Drosophila)"""								39	XM_005263520		11			ENST00000361923.2		17632		uc001aoo.3			8863	dbSNP_79						0				19.0		0.498	1:g.7869915G>C		protein_coding			basic|appris_candidate|CCDS		3927,356,15			4292,112			C|||			5008		PER3_HUMAN	4889	period circadian clock 3			0.976238		7869915			1.0	SNP		CCDS89.1			,,,	False	7869915				intron_variant		Approved		19.0			2012-12-13	OTTHUMT00000003607.1	P56645	0.9654		PER3	7869915		Ovarian(185;0.0634)|all_lung(157;0.178)			PER3	NM_016831.1	protein-coding gene	NP_058515.1		
		C	ENSG00000049246	ENST00000361923.2		8863		ENSG00000049246		4300					,				c.(1333-1335)agT>agC	OTTHUMG00000001216		byFrequency	P56645	gene with protein product		PER3_ENST00000377532.3_Silent_p.S446S		NM_016831.1	2031,169,3	NM_016831	0.9427					+	Silent		165.4+/-217.5	89.0				9427249				PER3-002	2012-12-13				1	+	0.972				coding-synonymous	8847		445/1202	all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	603427			protein_coding		2203				7.4302,3.9719,6.2586			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0234)|all cancers(8;8.58e-70)|GBM - Glioblastoma multiforme(8;1.81e-35)|Colorectal(212;2.06e-07)|COAD - Colon adenocarcinoma(227;1.92e-05)|Kidney(185;7.18e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000472)|STAD - Stomach adenocarcinoma(132;0.00118)|KIRC - Kidney renal clear cell carcinoma(229;0.00122)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GTGAGGCCAGTGGGCACCGTG						ENST00000361923.2:c.1335T>C	1					breast(4)|central_nervous_system(3)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)		+		,		1p36.23	Q5H8X4|Q5H8X5|Q969K6|Q96S77|Q96S78|Q9C0J3|Q9NSP9|Q9UGU8		g.chr1:7870048T>C		115.0+/-153.0			no		12192,814												-3.5					0.3	signal transducer activity (GO:0004871)				hg19	Standard	0.9324			7961,639		circadian regulation of gene expression (GO:0032922)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of circadian sleep/wake cycle, sleep (GO:0045187)|transcription, DNA-templated (GO:0006351)	5722,748,33					CCDS89.1, CCDS72695.1	T		CC,CT,TT	BC026102	cytoplasm (GO:0005737)|nucleus (GO:0005634)	90		2504		rs228669		1510				"""period (Drosophila) homolog 3"", ""period homolog 3 (Drosophila)"""					445			39	XM_005263520		11			ENST00000361923.2		17506		uc001aoo.3			8863	dbSNP_79	1335			p.S445S		0				91.0		0.592	1:g.7870048T>C		protein_coding			basic|appris_candidate|CCDS		3691,579,30			4231,175			C|||			5008		PER3_HUMAN	4402	period circadian clock 3			0.878994		7870048			0.7232	SNP		CCDS89.1			,,,	False	7870048				synonymous_variant		Approved		90.0		c.1335T>C	2012-12-13	OTTHUMT00000003607.1	P56645	0.7608		PER3	7870048		Ovarian(185;0.0634)|all_lung(157;0.178)			PER3	NM_016831.1	protein-coding gene	NP_058515.1		
		G	ENSG00000049246	ENST00000361923.2	0.52099	8863	M	ENSG00000049246	0.01371	4300	0.000000	0.28069	B;P;P;B		,	D	5.3999999999998494E-5	0	c.(1915-1917)gTc>gGc	OTTHUMG00000001216	-1.725000	byFrequency	P56645	gene with protein product		RP3-467L1.4_ENST00000451646.1_RNA|PER3_ENST00000377532.3_Missense_Mutation_p.V647G		NM_016831.1	19,386,1798	NM_016831	0.1616			T	15.17	+	Missense_Mutation	2	302.9+/-306.2	66.0	A2I2N5;A6H8X0;P56645-2;P56645	0.096232		9427249			0.115;0.548;0.736;0.115	PER3-002	2012-12-13		0.53861	PER3	1	+	0.0696		0	0.010000	missense	8847	62	639/1202	all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	T	SO:0001583	603427	possibly-damaging	0.1712707182320442	protein_coding		2203	P		0.260000	19.1047,9.6232,15.8927	B;P;P;B		6503		0.0:0.4789:0.1186:0.4024			UCEC - Uterine corpus endometrioid carcinoma (279;0.0234)|all cancers(8;8.58e-70)|GBM - Glioblastoma multiforme(8;1.81e-35)|Colorectal(212;2.06e-07)|COAD - Colon adenocarcinoma(227;1.92e-05)|Kidney(185;7.18e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000472)|STAD - Stomach adenocarcinoma(132;0.00118)|KIRC - Kidney renal clear cell carcinoma(229;0.00122)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000377532;ENST00000361923		ATTGTCCATGTCCCACCCCCA	T;T					ENST00000361923.2:c.1916T>G	1	CSNK1E binding domain. {ECO:0000250}.	ENSG00000049246	0.35465	PER3	breast(4)|central_nervous_system(3)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)	ENSP00000355031:p.Val639Gly	+	0.24053	,	GTC	1p36.23	Q5H8X4|Q5H8X5|Q969K6|Q96S77|Q96S78|Q9C0J3|Q9NSP9|Q9UGU8		g.chr1:7880683T>G	V -> G (associated with delayed sleep phase syndrome (DSPS); dbSNP:rs10462020). {ECO:0000269|PubMed:11306557, ECO:0000269|PubMed:12655319}.	206.5+/-228.1		48	yes		2067,10939	0.03702	0.49362	4.43	0.00073	ENSP00000355031:V639G	M		0.27056		.		-6.9	0.01649	8	0.87932	0.013986013986013986	0.0	signal transducer activity (GO:0004871)	2.19			hg19	Standard	0.1968	0.0975609756097561	8.5405	1643,6957		circadian regulation of gene expression (GO:0032922)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of circadian sleep/wake cycle, sleep (GO:0045187)|transcription, DNA-templated (GO:0006351)	181,1705,4617	2.752957				CCDS89.1, CCDS72695.1	T	0.51791	GG,GT,TT	BC026102	cytoplasm (GO:0005737)|nucleus (GO:0005634)	71	0.72118	2504	-6.91	rs10462020		2091	639;647;647;639	140	GRCh37	"""period (Drosophila) homolog 3"", ""period homolog 3 (Drosophila)"""	0.33390	7803270	+	GLY/VAL	639		258	39	XM_005263520	0.22;0.913;0.948;0.22	15	0.18469656992084432	0.459000	ENST00000361923.2		18504		uc001aoo.3			8863	dbSNP_119	1916	0.0002	CM035907	p.V639G	.	0		T		80.0	rs10462020;rs60667815;rs10462020	0.483	1:g.7880683T>G	ENSP00000366755:V647G;ENSP00000355031:V639G	protein_coding	0.021160		basic|appris_candidate|CCDS		162,1319,2819		647;639	424,3982	0.11813186813186813	G	T|||		0.368047	5008		PER3_HUMAN	604	period circadian clock 3		.;.;.;PER3_HUMAN	0.120607	0.25306	7880683		0.680000	0.0079	SNP	rs10462020	CCDS89.1		N	,,,	False	7880683	-1.0971		9	missense	T	Approved	0.191047	71.0		c.1916T>G	2012-12-13	OTTHUMT00000003607.1	P56645	0.2133	1.7;1.63	PER3	7880683	0.07245	Ovarian(185;0.0634)|all_lung(157;0.178)	0.04178	109	PER3	NM_016831.1	protein-coding gene	NP_058515.1	V	
		C	ENSG00000049246	ENST00000361923.2	0.80722	8863	N	ENSG00000049246	0.29061	4300	0.001000	0.10382	B;B;B		,	T	0.0	0	c.(2479-2481)cTg>cCg	OTTHUMG00000001216	0.554000	byFrequency	P56645	gene with protein product		PER3_ENST00000377532.3_Missense_Mutation_p.L835P		NM_016831.1	2087,114,2	NM_016831	0.9806			C	5.782	+	Missense_Mutation	2	126.3+/-184.8	96.0	A2I2N5;P56645-2;P56645	0.973218		9427249			0.0;0.001;0.0	PER3-002	2012-12-13		0.04013		1	+	0.9758		1	0.002000	missense	8847	350	827/1202	all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	603427	benign	0.9668508287292817	protein_coding		2203	P		0.001000	4.5233,2.6782,3.8982	B;B;B		6503		0.0:0.7334:0.0:0.2666			UCEC - Uterine corpus endometrioid carcinoma (279;0.0234)|all cancers(8;8.58e-70)|GBM - Glioblastoma multiforme(8;1.81e-35)|Colorectal(212;2.06e-07)|COAD - Colon adenocarcinoma(227;1.92e-05)|Kidney(185;7.18e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000472)|STAD - Stomach adenocarcinoma(132;0.00118)|KIRC - Kidney renal clear cell carcinoma(229;0.00122)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000377532;ENST00000361923;ENST00000539773		CTGCATGGGCTGCCCTTGTCC	T;T					ENST00000361923.2:c.2480T>C	1	Pro-rich.	ENSG00000049246	0.12334	PER3	breast(4)|central_nervous_system(3)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)	ENSP00000355031:p.Leu827Pro	+	0.12720	,	CTG	1p36.23	Q5H8X4|Q5H8X5|Q969K6|Q96S77|Q96S78|Q9C0J3|Q9NSP9|Q9UGU8		g.chr1:7887493T>C	L -> P (in dbSNP:rs228696). {ECO:0000269|PubMed:11306557}.	88.7+/-127.4		475	yes		12499,507	0.08648	0.10956	3.21	0.00012	ENSP00000355031:L827P			0.06511		.		2.2	0.27623	572	0.02654	1.0	0.0	signal transducer activity (GO:0004871)	0.63			hg19	Standard	0.9513	0.9654471544715447	6.9788	8211,389		circadian regulation of gene expression (GO:0032922)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of circadian sleep/wake cycle, sleep (GO:0045187)|transcription, DNA-templated (GO:0006351)	6013,473,17	0.328617				CCDS89.1, CCDS72695.1	T	0.02656	CC,CT,TT	BC026102	cytoplasm (GO:0005737)|nucleus (GO:0005634)	96	0.21097	2504	2.16	rs228696		2655	827;835;827	720		"""period (Drosophila) homolog 3"", ""period homolog 3 (Drosophila)"""	0.24692	7810080	+	PRO/LEU	827		2117	39	XM_005263520	0.0;0.0;0.0	17	0.9498680738786279	-0.227000	ENST00000361923.2		17628		uc001aoo.3			8863	dbSNP_79	2480	0.0000		p.L827P	.	0		T		95.0	rs228696;rs479171;rs56740507	0.602	1:g.7887493T>C	ENSP00000366755:L835P;ENSP00000355031:L827P	protein_coding	0.738042		basic|appris_candidate|CCDS		3926,359,15		835;827;38	4288,118	0.9693223443223443	P	C|||		1.140210	5008		PER3_HUMAN	4884	period circadian clock 3		.;.;PER3_HUMAN	0.97524	0.28052	7887493		0.873000	1.0	SNP		CCDS89.1		N	,,,	False	7887493	-0.9645		9	missense	T	Approved	0.954767	96.0		c.2480T>C	2012-12-13	OTTHUMT00000003607.1	P56645	0.9654	2.88;2.89	PER3	7887493	0.02628	Ovarian(185;0.0634)|all_lung(157;0.178)	0.38779	98	PER3	NM_016831.1	protein-coding gene	NP_058515.1	L	
		C	ENSG00000049246	ENST00000361923.2	0.80722	8863	N	ENSG00000049246	0.10048	4300	0.002000	0.13538	B;B;B;B;B		,	T	0.0	0	c.(3082-3084)aTg>aCg	OTTHUMG00000001216	-0.216000	byFrequency	P56645	gene with protein product		PER3_ENST00000377532.3_Missense_Mutation_p.M1037T		NM_016831.1	36,488,1679	NM_016831	0.2618			-	0.008	+	Missense_Mutation	2		130.0	B4DR65;A2I2N5;A6H8X0;P56645-2;P56645	0.127099		9427249			0.001;0.0;0.001;0.013;0.0	PER3-002	2012-12-13		0.15484		1	+	0.0968		0.6	0.008000	missense	8847	91	1028/1202	all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	T	SO:0001583	603427	benign	0.2513812154696133	protein_coding		2203	P		0.019000	29.5233,12.7099,23.8275	B;B;B;B;B		6503		0.0:0.6486:0.0:0.3514			UCEC - Uterine corpus endometrioid carcinoma (279;0.0234)|all cancers(8;8.58e-70)|GBM - Glioblastoma multiforme(8;1.81e-35)|Colorectal(212;2.06e-07)|COAD - Colon adenocarcinoma(227;1.92e-05)|Kidney(185;7.18e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000472)|STAD - Stomach adenocarcinoma(132;0.00118)|KIRC - Kidney renal clear cell carcinoma(229;0.00122)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000377532;ENST00000361923;ENST00000539773		ACACTGTCCATGGGATTGCCT	T;T					ENST00000361923.2:c.3083T>C	1	5 X 18 AA tandem repeats of S-[HP]-[AP]- T-[AT]-[GST]-[ATV]-L-S-[MT]-G-[LS]-P-P- [MRS]-[EKR]-[NST]-P.|Ser-rich.	ENSG00000049246	0.03550	PER3	breast(4)|central_nervous_system(3)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)	ENSP00000355031:p.Met1028Thr	+	0.18553	,	ATG	1p36.23	Q5H8X4|Q5H8X5|Q969K6|Q96S77|Q96S78|Q9C0J3|Q9NSP9|Q9UGU8		g.chr1:7890117T>C	M -> T (only found in PER3.4 allele; dbSNP:rs2640909). {ECO:0000269|PubMed:11306557}.			58	yes		3099,9907	0.10522	0.00542	0.77	0.00012	ENSP00000355031:M1028T			0.01895		.		-1.5	0.08584	38	0.13108	0.06643356643356643	0.0	signal transducer activity (GO:0004871)	0.145			hg19	Standard	0.2932	0.11788617886178862	3.4008	2539,6061		circadian regulation of gene expression (GO:0032922)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of circadian sleep/wake cycle, sleep (GO:0045187)|transcription, DNA-templated (GO:0006351)	429,2241,3833	-1.871084				CCDS89.1, CCDS72695.1	T	0.16396	CC,CT,TT	BC026102	cytoplasm (GO:0005737)|nucleus (GO:0005634)	141	0.11560	2504	-1.54	rs2640909		3258	77;1028;1037;1037;1028	219		"""period (Drosophila) homolog 3"", ""period homolog 3 (Drosophila)"""	0.07323	7812704	+	THR/MET	1028		406	39	XM_005263520	0.0;0.0;0.0;0.017;0.0	18	0.28891820580474936	-0.736000	ENST00000361923.2		17789		uc001aoo.3			8863	dbSNP_100	3083	0.0000		p.M1028T	Period circadian-like, C-terminal (1);	0		T		162.0	rs2640909;rs10779690;rs17374481;rs34042617;rs52837510;rs2640909	0.577	1:g.7890117T>C	ENSP00000366755:M1037T;ENSP00000355031:M1028T	protein_coding	0.038848		basic|appris_candidate|CCDS		393,1753,2154		1037;1028;221	560,3846	0.1858974358974359	T	-|||		2.711880	5008		PER3_HUMAN	928	period circadian clock 3		.;.;.;.;PER3_HUMAN	0.185304	0.12993	7890117		0.000000	0.0506	SNP		CCDS89.1		N	,,,	False	7890117	-0.9389		9	missense	T	Approved	0.295233	141.0		c.3083T>C	2012-12-13	OTTHUMT00000003607.1	P56645	0.2853	2.58;2.58	PER3	7890117	0.06430	Ovarian(185;0.0634)|all_lung(157;0.178)	0.43475	81	PER3	NM_016831.1	protein-coding gene	NP_058515.1	M	
		G	ENSG00000049246	ENST00000361923.2	0.80722	8863	N	ENSG00000049246	0.00527	4300	0.000000	0.13657	B;B;B		,	T	0.0	0	c.(3445-3447)cAt>cGt	OTTHUMG00000001216	-2.475000	byFrequency	P56645	gene with protein product		PER3_ENST00000377532.3_Missense_Mutation_p.H1158R		NM_016831.1	19,385,1799	NM_016831	0.1616			A	9.503	+	Missense_Mutation	2	303.4+/-306.4	63.0	B4DR65;P56645-2;P56645	0.096005		9427249			0.003;0.001;0.002	PER3-002	2012-12-13		0.08055		1	+	0.0711		0.44	0.772000	missense	8847	62	1149/1202	all_epithelial(116;9.35e-21)|all_lung(118;7.57e-07)|Lung NSC(185;4.52e-06)|Renal(390;0.000147)|Breast(487;0.00086)|Colorectal(325;0.000959)|Hepatocellular(190;0.00825)|Ovarian(437;0.0253)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583	603427	benign	0.1712707182320442	protein_coding		2203	P		0.000000	19.1163,9.6005,15.8927	B;B;B		6503		0.2056:0.3554:0.2425:0.1965			UCEC - Uterine corpus endometrioid carcinoma (279;0.0234)|all cancers(8;8.58e-70)|GBM - Glioblastoma multiforme(8;1.81e-35)|Colorectal(212;2.06e-07)|COAD - Colon adenocarcinoma(227;1.92e-05)|Kidney(185;7.18e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000472)|STAD - Stomach adenocarcinoma(132;0.00118)|KIRC - Kidney renal clear cell carcinoma(229;0.00122)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000377532;ENST00000361923;ENST00000539773		CAGTTTTCTCATGGGCAAAAG	T;T					ENST00000361923.2:c.3446A>G	1	CRY binding domain. {ECO:0000250}.	ENSG00000049246	0.23210	PER3	breast(4)|central_nervous_system(3)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)	ENSP00000355031:p.His1149Arg	+	0.05858	,	CAT	1p36.23	Q5H8X4|Q5H8X5|Q969K6|Q96S77|Q96S78|Q9C0J3|Q9NSP9|Q9UGU8		g.chr1:7897133A>G	H -> R (in dbSNP:rs10462021). {ECO:0000269|PubMed:11306557}.	206.8+/-228.3		48	yes		2067,10939	0.03702	0.20632	4.26	0.00012	ENSP00000355031:H1149R			0.02765		.		-8.5	0.00923	8	0.20046	0.013986013986013986	0.0	signal transducer activity (GO:0004871)	0.55			hg19	Standard	0.1968	0.0975609756097561	1.3889	1644,6956		circadian regulation of gene expression (GO:0032922)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of circadian sleep/wake cycle, sleep (GO:0045187)|transcription, DNA-templated (GO:0006351)	181,1705,4617	1.103720				CCDS89.1, CCDS72695.1	A	0.09022	GG,GA,AA	BC026102	cytoplasm (GO:0005737)|nucleus (GO:0005634)	64	0.19112	2504	-8.51	rs10462021		3621	198;1158;1149	140		"""period (Drosophila) homolog 3"", ""period homolog 3 (Drosophila)"""	0.02246	7819720	+	ARG/HIS	1149		258	39	XM_005263520	0.002;0.0;0.0	20	0.18469656992084432	0.377000	ENST00000361923.2		9049		uc001aoo.3			8863	dbSNP_119	3446	0.0000		p.H1149R	Period circadian-like, C-terminal (1);	0		T		66.0	rs10462021;rs52823932;rs57558236;rs10462021	0.408	1:g.7897133A>G	ENSP00000366755:H1158R;ENSP00000355031:H1149R	protein_coding	0.119042		basic|appris_candidate|CCDS		162,1320,2818		1158;1149;342	423,3983	0.11813186813186813	R	A|||		1.810430	5008		PER3_HUMAN	606	period circadian clock 3		.;.;PER3_HUMAN	0.121006	0.13174	7897133		0.007000	0.0079	SNP		CCDS89.1		N	,,,	False	7897133	-0.9897		9	missense	T	Approved	0.191163	64.0		c.3446A>G	2012-12-13	OTTHUMT00000003607.1	P56645	0.2133	2.57;2.57	PER3	7897133	0.43724	Ovarian(185;0.0634)|all_lung(157;0.178)	0.32693	29	PER3	NM_016831.1	protein-coding gene	NP_058515.1	H	
		C	ENSG00000162426	ENST00000471889.1		50651		ENSG00000162426		4300					,					OTTHUMG00000000503		byFrequency	Q9Y2W3	gene with protein product		SLC45A1_ENST00000289877.8_Intron|SLC45A1_ENST00000377479.2_Intron			555,1107,541		0.2597					+	Intron		395.0+/-344.9	52.0				10729226				SLC45A1-001	2005-10-04				1	+	0.5507				intron	17939			all_epithelial(116;1.22e-15)|all_lung(118;0.000147)|Lung NSC(185;0.000251)|Renal(390;0.000469)|Colorectal(325;0.00578)|Breast(348;0.00686)|Hepatocellular(190;0.0228)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.11)	T	SO:0001627	605763			protein_coding		2203				28.6047,49.6823,35.9603		"""Solute carriers"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|all cancers(8;3.95e-66)|GBM - Glioblastoma multiforme(8;5.93e-33)|Colorectal(212;2.86e-07)|COAD - Colon adenocarcinoma(227;3.11e-05)|Kidney(185;5.33e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000513)|KIRC - Kidney renal clear cell carcinoma(229;0.000979)|STAD - Stomach adenocarcinoma(132;0.00199)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			AGAAGGGAACTCAAACCCTGT		DNB5				ENST00000471889.1:c.716-23T>C	1					central_nervous_system(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|liver(1)|lung(12)|ovary(2)|pancreas(2)|prostate(4)|skin(2)|urinary_tract(2)		+		,		1p36.23	Q5VY46|Q5VY49	"""H+/sugar symporter"""	g.chr1:8390246T>C		574.3+/-383.7			no		4677,8329												-3.2					0.0	symporter activity (GO:0015293)		2005-10-04		hg19	Standard	0.2932			2460,6140		carbohydrate transport (GO:0008643)	922,2833,2748					CCDS30577.1	T		CC,CT,TT	AF118274	integral component of membrane (GO:0016021)	52		2504		rs12565834		1100				"""deleted in neuroblastoma 5"""								33	XM_005263467		5			ENST00000471889.1		15806		uc001apb.3			50651	dbSNP_120						0				52.0		0.607	1:g.8390246T>C		protein_coding			basic|appris_principal|CCDS		367,1726,2207			2217,2189			T|||			5008		S45A1_HUMAN	1645	solute carrier family 45, member 1			0.328474		8390246			0.1845	SNP		CCDS30577.1			,,,	False	8390246				intron_variant		Approved		52.0			2014-01-28	OTTHUMT00000001245.5	Q9Y2W3	0.2622		SLC45A1	8390246		Ovarian(185;0.0661)|all_lung(157;0.127)			SLC45A1	NM_001080397.1	protein-coding gene			
		A	ENSG00000162426	ENST00000471889.1		50651		ENSG00000162426		4300					,				c.(1333-1335)ccG>ccA	OTTHUMG00000000503		byFrequency	Q9Y2W3	gene with protein product		SLC45A1_ENST00000481265.1_3'UTR|SLC45A1_ENST00000377479.2_Silent_p.P479P|SLC45A1_ENST00000289877.8_Silent_p.P445P			579,1107,517		0.2975					+	Silent		422.9+/-354.2	57.0				10729226				SLC45A1-001	2005-10-04				1	+	0.5363				coding-synonymous	17939		445/749	all_epithelial(116;1.22e-15)|all_lung(118;0.000147)|Lung NSC(185;0.000251)|Renal(390;0.000469)|Colorectal(325;0.00578)|Breast(348;0.00686)|Hepatocellular(190;0.0228)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.11)	G	SO:0001819	605763			protein_coding		2203				32.3256,48.5928,38.7898		"""Solute carriers"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|all cancers(8;3.95e-66)|GBM - Glioblastoma multiforme(8;5.93e-33)|Colorectal(212;2.86e-07)|COAD - Colon adenocarcinoma(227;3.11e-05)|Kidney(185;5.33e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000513)|KIRC - Kidney renal clear cell carcinoma(229;0.000979)|STAD - Stomach adenocarcinoma(132;0.00199)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CCTCTAAGCCGAGGTCATCAG		DNB5				ENST00000471889.1:c.1335G>A	1					central_nervous_system(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|liver(1)|lung(12)|ovary(2)|pancreas(2)|prostate(4)|skin(2)|urinary_tract(2)		+		,		1p36.23	Q5VY46|Q5VY49	"""H+/sugar symporter"""	g.chr1:8390888G>A		578.1+/-384.6			yes		5045,7961												-10.2					0.0	symporter activity (GO:0015293)		2005-10-04		hg19	Standard	0.325			2780,5820		carbohydrate transport (GO:0008643)	1033,2979,2491					CCDS30577.1	G		AA,AG,GG	AF118274	integral component of membrane (GO:0016021)	55		2504		rs2289731		1720				"""deleted in neuroblastoma 5"""					445			33	XM_005263467		5			ENST00000471889.1		15582		uc001apb.3			50651	dbSNP_100	1335			p.P445P		0				50.0		0.622	1:g.8390888G>A		protein_coding			basic|appris_principal|CCDS		454,1872,1974			2265,2141			G|||			5008		S45A1_HUMAN	1705	solute carrier family 45, member 1			0.340455		8390888			0.1746	SNP		CCDS30577.1			,,,	False	8390888				synonymous_variant		Approved		55.0		c.1335G>A	2014-01-28	OTTHUMT00000001245.5	Q9Y2W3	0.2911		SLC45A1	8390888		Ovarian(185;0.0661)|all_lung(157;0.127)			SLC45A1	NM_001080397.1	protein-coding gene			
		T	ENSG00000162426	ENST00000471889.1		50651		ENSG00000162426		4299					,					OTTHUMG00000000503		byFrequency	Q9Y2W3	gene with protein product		SLC45A1_ENST00000377479.2_3'UTR|SLC45A1_ENST00000289877.8_3'UTR			30,493,1680		0.2362					+	3'UTR		669.5+/-402.7	34.0				10729226				SLC45A1-001	2005-10-04				1	+	0.1051				utr-3	17939			all_epithelial(116;1.22e-15)|all_lung(118;0.000147)|Lung NSC(185;0.000251)|Renal(390;0.000469)|Colorectal(325;0.00578)|Breast(348;0.00686)|Hepatocellular(190;0.0228)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.11)	T	SO:0001624	605763			protein_coding		2203				28.7858,12.5511,23.2851		"""Solute carriers"""	6502					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|all cancers(8;3.95e-66)|GBM - Glioblastoma multiforme(8;5.93e-33)|Colorectal(212;2.86e-07)|COAD - Colon adenocarcinoma(227;3.11e-05)|Kidney(185;5.33e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000513)|KIRC - Kidney renal clear cell carcinoma(229;0.000979)|STAD - Stomach adenocarcinoma(132;0.00199)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GCCTCGACTCCGGACACGCGC		DNB5				ENST00000471889.1:c.*20C>T	1					central_nervous_system(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|liver(1)|lung(12)|ovary(2)|pancreas(2)|prostate(4)|skin(2)|urinary_tract(2)		+		,		1p36.23	Q5VY46|Q5VY49	"""H+/sugar symporter"""	g.chr1:8404093C>T		762.0+/-413.1			no		3028,9976												-0.7					0.0	symporter activity (GO:0015293)		2005-10-04		hg19	Standard	0.3062			2475,6123		carbohydrate transport (GO:0008643)	378,2272,3852					CCDS30577.1	C		TT,TC,CC	AF118274	integral component of membrane (GO:0016021)	35		2504		rs1055236		2652				"""deleted in neuroblastoma 5"""								33	XM_005263467		0			ENST00000471889.1		16473		uc001apb.3			50651	dbSNP_86						0				36.0		0.602	1:g.8404093C>T		protein_coding			basic|appris_principal|CCDS		348,1779,2172			553,3853			T|||			5008		S45A1_HUMAN	937	solute carrier family 45, member 1			0.187101		8404093			0.126	SNP		CCDS30577.1			,,,	False	8404093				3_prime_UTR_variant		Approved		35.0			2014-01-28	OTTHUMT00000001245.5	Q9Y2W3	0.1902		SLC45A1	8404093		Ovarian(185;0.0661)|all_lung(157;0.127)			SLC45A1	NM_001080397.1	protein-coding gene			
		G	ENSG00000131686	ENST00000377443.2	0.45883	765	M	ENSG00000131686	0.09459	4300	0.042000	0.68025	D;D		,	T	0.0012699999999999934	0	c.(268-270)Agc>Ggc	OTTHUMG00000001763	-0.257000	byFrequency	P23280	gene with protein product		CA6_ENST00000377442.2_Missense_Mutation_p.S30G|CA6_ENST00000377436.3_Missense_Mutation_p.S90G|CA6_ENST00000476083.1_Intron	Mafenide(DB06795)|Zonisamide(DB00909)	NM_001215.3	57,587,1559		0.455			A	19.96	+	Missense_Mutation	1	412.5+/-350.8	51.0	E7EMQ1;P23280	0.159101		9691177			0.713;0.789	CA6-001			0.55999	CA6	1	+	0.1135		0.13	0.647000	missense	1380	126	90/309	all_epithelial(116;1.02e-19)|all_lung(118;3.6e-06)|Lung NSC(185;7.94e-06)|Renal(390;0.000147)|Breast(348;0.00123)|Colorectal(325;0.00205)|Hepatocellular(190;0.00825)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583	114780	probably-damaging	0.34806629834254144	protein_coding		2203	P		0.000000	29.6279,15.9101,24.9808	P;P	"""Carbonic anhydrases"""	6503		0.4778:0.1497:0.0836:0.2889			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.9e-07)|COAD - Colon adenocarcinoma(227;8.28e-05)|Kidney(185;0.000268)|KIRC - Kidney renal clear cell carcinoma(229;0.000971)|STAD - Stomach adenocarcinoma(132;0.00184)|BRCA - Breast invasive adenocarcinoma(304;0.00192)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000549778;ENST00000377443;ENST00000377436;ENST00000377442		AGTGCAGATCAGCCTGCCCTC	T;T;T;T					ENST00000377443.2:c.268A>G	1		ENSG00000131686	0.32223	CA6	endometrium(1)|kidney(1)|large_intestine(3)|lung(3)|ovary(2)|prostate(1)|skin(5)	ENSP00000366662:p.Ser90Gly	+	0.05858	,	AGC	1p36.2	E7EMQ1|Q5FBW3|Q5FC00|Q96QX8|Q9UF03		g.chr1:9017204A>G	S -> G (in dbSNP:rs2274333). {ECO:0000269|PubMed:1899030, ECO:0000269|Ref.2, ECO:0000269|Ref.3}.	293.3+/-282.5		51	yes		3249,9757	0.18584	0.73213	5.22	0.00012	ENSP00000366654:S90G	M		0.04044		.		-0.4	0.12363	310	0.44086	0.541958041958042	0.0	carbonate dehydratase activity (GO:0004089)|zinc ion binding (GO:0008270)	2.015			hg19	Standard	0.2913	0.10365853658536585	1.5577	2548,6052		bicarbonate transport (GO:0015701)|detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)|one-carbon metabolic process (GO:0006730)|small molecule metabolic process (GO:0044281)	418,2413,3672	3.924134				CCDS30578.1, CCDS57970.1, CCDS57971.1	A	0.58970	GG,GA,AA	M57892	cytoplasm (GO:0005737)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)	56	0.65975	2504	-0.413	rs2274333		272	30;90	221	GRCh37		0.02588	8939791	+	GLY/SER	90		708	16	NM_001215	0.984;0.971	3	0.29155672823219	0.455000	ENST00000377443.2		20770		uc031plc.1			765	dbSNP_100	268	0.0000	CM065045	p.S90G	Carbonic anhydrase, alpha-class, catalytic domain (4);	0		T		64.0	rs2274333;rs61422202;rs2274333	0.597	1:g.9017204A>G	ENSP00000447108:S58G;ENSP00000366662:S90G;ENSP00000366654:S90G;ENSP00000366661:S30G	protein_coding	0.303668		basic|appris_candidate|CCDS		361,1826,2113		58;90;90;30	701,3705	0.3241758241758242	G	A|||		1.408090	5008		CAH6_HUMAN	1722	carbonic anhydrase VI		.;CAH6_HUMAN	0.34385	0.13377	9017204		0.016000	0.5575	SNP	rs2274333	CCDS30578.1		N	,,,	False	9017204	-1.0029	4.2.1.1	9	missense	T	Approved	0.296279	56.0		c.268A>G	2008-02-05	OTTHUMT00000004911.1	P23280	0.3919	0.64;-0.3;-0.3;-0.3	CA6	9017204	0.38526	Ovarian(185;0.112)|all_lung(157;0.143)	0.28902	56	CA6	NM_001215.2	protein-coding gene	NP_001206.2	S	
		T	ENSG00000131686	ENST00000377443.2		765		ENSG00000131686		4300					,				c.(766-768)aaC>aaT	OTTHUMG00000001763		byFrequency	P23280	gene with protein product		CA6_ENST00000476083.1_3'UTR|CA6_ENST00000377436.3_Silent_p.N256N|CA6_ENST00000377442.2_Silent_p.N196N	Mafenide(DB06795)|Zonisamide(DB00909)	NM_001215.3	63,589,1551		0.3405					+	Silent		319.2+/-314.1	136.0				9691177				CA6-001					1	+	0.1165				coding-synonymous	1380		256/309	all_epithelial(116;1.02e-19)|all_lung(118;3.6e-06)|Lung NSC(185;7.94e-06)|Renal(390;0.000147)|Breast(348;0.00123)|Colorectal(325;0.00205)|Hepatocellular(190;0.00825)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	114780			protein_coding		2203				20.5465,16.2279,19.0835		"""Carbonic anhydrases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.9e-07)|COAD - Colon adenocarcinoma(227;8.28e-05)|Kidney(185;0.000268)|KIRC - Kidney renal clear cell carcinoma(229;0.000971)|STAD - Stomach adenocarcinoma(132;0.00184)|BRCA - Breast invasive adenocarcinoma(304;0.00192)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			ATCACCGCAACAAGACCATCC						ENST00000377443.2:c.768C>T	1					endometrium(1)|kidney(1)|large_intestine(3)|lung(3)|ovary(2)|prostate(1)|skin(5)		+		,		1p36.2	E7EMQ1|Q5FBW3|Q5FC00|Q96QX8|Q9UF03		g.chr1:9030964C>T		298.1+/-285.1			yes		2482,10524												-2.0					0.0	carbonate dehydratase activity (GO:0004089)|zinc ion binding (GO:0008270)				hg19	Standard	0.2097			1767,6833		bicarbonate transport (GO:0015701)|detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)|one-carbon metabolic process (GO:0006730)|small molecule metabolic process (GO:0044281)	247,1988,4268					CCDS30578.1, CCDS57970.1, CCDS57971.1	C		TT,TC,CC	M57892	cytoplasm (GO:0005737)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)	140		2504		rs3737665		772									256			16	NM_001215		7			ENST00000377443.2		19477		uc031plc.1			765	dbSNP_107	768			p.N256N		0				148.0		0.502	1:g.9030964C>T		protein_coding			basic|appris_candidate|CCDS		184,1399,2717			715,3691			C|||			5008		CAH6_HUMAN	1445	carbonic anhydrase VI			0.288538		9030964			0.5357	SNP		CCDS30578.1			,,,	False	9030964		4.2.1.1		synonymous_variant		Approved		140.0		c.768C>T	2008-02-05	OTTHUMT00000004911.1	P23280	0.2983		CA6	9030964		Ovarian(185;0.112)|all_lung(157;0.143)			CA6	NM_001215.2	protein-coding gene	NP_001206.2		
		C	ENSG00000049239	ENST00000377403.2	0.21105	9563	L	ENSG00000049239	0.65973	4300	0.995000	0.98105	P		,	T	0.999788574	0	c.(451-453)gAc>gCc	OTTHUMG00000001768	2.134000	byFrequency	O95479	gene with protein product		H6PD_ENST00000602477.1_Missense_Mutation_p.D162A		NM_001282587.1|NM_004285.3	0,120,2083	NM_004285	0.1411			A	13.83	+	Missense_Mutation	2	249.7+/-276.9	67.0	O95479	0.027236		10349511			0.338	H6PD-001	2003-10-10		0.40702		1	+	0.0053		0.19	0.821000	missense	4795	44	151/792	all_epithelial(116;1.28e-19)|all_lung(118;5.22e-06)|Lung NSC(185;1.98e-05)|Renal(390;0.000147)|Breast(348;0.00109)|Colorectal(325;0.00205)|Hepatocellular(190;0.00825)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583	138090	possibly-damaging	0.12154696132596685	protein_coding		2203	P		1.000000	15.1977,2.7236,10.9719	B		6503		0.9227:0.0:0.0773:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;1.88e-07)|COAD - Colon adenocarcinoma(227;7.47e-05)|Kidney(185;0.000244)|KIRC - Kidney renal clear cell carcinoma(229;0.000905)|STAD - Stomach adenocarcinoma(132;0.00176)|BRCA - Breast invasive adenocarcinoma(304;0.00183)|READ - Rectum adenocarcinoma(331;0.0419)			KNOWN	ENST00000377403		GCCTATGAAGACATTGCCCGC	D	GDH				ENST00000377403.2:c.452A>C	1	Glucose 1-dehydrogenase.	ENSG00000049239	0.46254	H6PD	breast(1)|endometrium(2)|kidney(2)|large_intestine(5)|lung(11)|ovary(1)|upper_aerodigestive_tract(1)	ENSP00000366620:p.Asp151Ala	+	0.71417	,	GAC	1p36	Q4TT33|Q66I35|Q68DT3		g.chr1:9305445A>C	D -> A (in dbSNP:rs34603401). {ECO:0000269|PubMed:17974005}.	88.7+/-127.4		3	yes		1427,11579	0.50966	0.41700	5.31	0.09335	ENSP00000366620:D151A			0.52532		-45.1441		4.2	0.49024	1	0.37606	0.0017482517482517483	1.0	6-phosphogluconolactonase activity (GO:0017057)|carbohydrate binding (GO:0030246)|glucose 1-dehydrogenase [NAD(P)] activity (GO:0047936)|glucose-6-phosphate dehydrogenase activity (GO:0004345)|NADP binding (GO:0050661)	1.535			hg19	Standard	0.163	0.006097560975609756	11.0084	1307,7293		pentose-phosphate shunt (GO:0006098)|response to alcohol (GO:0097305)	111,1205,5187	2.353386				CCDS101.1, CCDS72697.1	A	0.40000	CC,CA,AA	AJ012590	endoplasmic reticulum (GO:0005783)|mitochondrion (GO:0005739)	65	0.48935	2504	4.17	rs34603401		754	151	119		"""glucose dehyrogenase"""	0.47649	9228032	+	ALA/ASP	151		167	23	NM_001282587	0.698	2	0.15699208443271767	0.482000	ENST00000377403.2		18024		uc001apt.3			9563	dbSNP_126	452	0.0230		p.D151A	NAD(P)-binding domain (1);Glucose-6-phosphate dehydrogenase, NAD-binding (1);	0		T		60.0	rs34603401	0.617	1:g.9305445A>C	ENSP00000366620:D151A	protein_coding	0.000066		basic|appris_principal|CCDS		111,1085,3104		151	120,4286	0.07646520146520147	A	A|||		0.168797	5008		G6PE_HUMAN	381	hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)		G6PE_HUMAN	0.0760783	0.69279	9305445		5.824000	0.001	SNP		CCDS101.1		D	,,,	False	9305445	-0.8329	1.1.1.47	9	missense	T	Approved	0.151977	65.0		c.452A>C	2008-02-05	OTTHUMT00000004928.2	O95479	0.1023	-4.72	H6PD	9305445	0.46438	all_lung(157;0.23)	0.54200	126	H6PD	NM_004285.3	protein-coding gene	NP_001269516.1|NP_004276.2	D	
		A	ENSG00000049239	ENST00000377403.2	0.80722	9563	N	ENSG00000049239	0.06349	4300	0.054000	0.98264	B		,	T	0.0	0	c.(1357-1359)cGg>cAg	OTTHUMG00000001768	-0.530000	byFrequency	O95479	gene with protein product		H6PD_ENST00000602477.1_Missense_Mutation_p.R464Q		NM_001282587.1|NM_004285.3	456,1105,642	NM_004285	0.3119			A	0.078	+	Missense_Mutation	2	723.0+/-406.4	74.0	O95479	0.457785		10349511			0.001	H6PD-001	2003-10-10		0.04013	H6PD	1	+	0.4932		0.49	0.017000	missense	4795	123	453/792	all_epithelial(116;1.28e-19)|all_lung(118;5.22e-06)|Lung NSC(185;1.98e-05)|Renal(390;0.000147)|Breast(348;0.00109)|Colorectal(325;0.00205)|Hepatocellular(190;0.00825)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583	138090	benign	0.3397790055248619	protein_coding		2203	P		0.001000	22.9186,45.7785,30.6628	B		6503		0.3753:0.0952:0.4337:0.0958			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;1.88e-07)|COAD - Colon adenocarcinoma(227;7.47e-05)|Kidney(185;0.000244)|KIRC - Kidney renal clear cell carcinoma(229;0.000905)|STAD - Stomach adenocarcinoma(132;0.00176)|BRCA - Breast invasive adenocarcinoma(304;0.00183)|READ - Rectum adenocarcinoma(331;0.0419)			KNOWN	ENST00000377403		AGCCCTGTGCGGGAGCGGGAC	D	GDH				ENST00000377403.2:c.1358G>A	1	Glucose 1-dehydrogenase.	ENSG00000049239	0.01672	H6PD	breast(1)|endometrium(2)|kidney(2)|large_intestine(5)|lung(11)|ovary(1)|upper_aerodigestive_tract(1)	ENSP00000366620:p.Arg453Gln	+	0.12720	,	CGG	1p36	Q4TT33|Q66I35|Q68DT3		g.chr1:9323910G>A	R -> Q (in CRD; less than 50% of activity than wild-type; dbSNP:rs6688832). {ECO:0000269|PubMed:12858176, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005}.	611.7+/-391.8		225	yes		3988,9018	0.19295	0.01607	5.53	0.00012	ENSP00000366620:R453Q	M	http://www.ncbi.nlm.nih.gov/sites/varvu?gene	0.14737		-13.5512		-2.1	0.07165	260	0.17832	0.45454545454545453	0.1	6-phosphogluconolactonase activity (GO:0017057)|carbohydrate binding (GO:0030246)|glucose 1-dehydrogenase [NAD(P)] activity (GO:0047936)|glucose-6-phosphate dehydrogenase activity (GO:0004345)|NADP binding (GO:0050661)	0.69			hg19	Standard	0.2485	0.4573170731707317	4.5195	1971,6629		pentose-phosphate shunt (GO:0006098)|response to alcohol (GO:0097305)	679,2630,3194	-1.188930				CCDS101.1, CCDS72697.1	G	0.06786	AA,AG,GG	AJ012590	endoplasmic reticulum (GO:0005783)|mitochondrion (GO:0005739)	71	0.22421	2504	-2.12	rs6688832		1660	453	187	GRCh37	"""glucose dehyrogenase"""	0.11952	9246497	+	GLN/ARG	453		795	23	NM_001282587	0.001	5	0.24670184696569922	-1.197000	ENST00000377403.2		18364		uc001apt.3			9563	dbSNP_116	1358	0.0000	CM031993	p.R453Q	.	0		T		64.0	rs6688832;rs17286908;rs52797480;rs58250722;rs6688832	0.597	1:g.9323910G>A	ENSP00000366620:R453Q	protein_coding	0.301437		basic|appris_principal|CCDS		223,1525,2552		453	2017,2389	0.364010989010989	Q	A|||		0.705587	5008		G6PE_HUMAN	1951	hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)		G6PE_HUMAN	0.389577	0.11146	9323910		-0.091000	0.4812	SNP	rs6688832	CCDS101.1		N	,,,	False	9323910	-0.9892	1.1.1.47	9	missense	T	Approved	0.229186	71.0		c.1358G>A	2008-02-05	OTTHUMT00000004928.2	O95479	0.3732	-4.83	H6PD	9323910	0.09413	all_lung(157;0.23)	0.32824	43	H6PD	NM_004285.3	protein-coding gene	NP_001269516.1|NP_004276.2	R	
		A	ENSG00000171621	ENST00000328089.6		80176		ENSG00000171621		4300					,				c.(199-201)gtG>gtA	OTTHUMG00000001279		byFrequency	Q96BD6	gene with protein product		SPSB1_ENST00000377399.2_Silent_p.V67V|SPSB1_ENST00000357898.3_Silent_p.V67V		NM_025106.3	147,762,1294	NM_025106	0.2781					+	Silent		350.7+/-328.0	169.0				15713673, 12076535				SPSB1-001					1	+	0.2368				coding-synonymous	30628		67/274	all_epithelial(116;4.38e-15)|all_lung(118;0.000156)|Lung NSC(185;0.000446)|Renal(390;0.000469)|Colorectal(325;0.0062)|Breast(348;0.0139)|Hepatocellular(190;0.0228)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.104)	G	SO:0001819	611657			protein_coding		2203				23.2326,23.9673,23.4815			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;2.72e-07)|COAD - Colon adenocarcinoma(227;9.12e-05)|Kidney(185;0.000296)|KIRC - Kidney renal clear cell carcinoma(229;0.00106)|STAD - Stomach adenocarcinoma(132;0.00193)|BRCA - Breast invasive adenocarcinoma(304;0.00202)|READ - Rectum adenocarcinoma(331;0.0419)			KNOWN			ATGTCTTTGTGAAGGAGGACG						ENST00000328089.6:c.201G>A	1	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.				breast(1)|endometrium(3)|kidney(2)|lung(5)|prostate(2)		+		,		1p36.22	A2A275|Q59FA1|Q5TIH9|Q9BRY9|Q9H6C5		g.chr1:9416151G>A		387.7+/-326.6			no		3054,9952												2.2					1.0					hg19	Standard	0.1998			1998,6602		intracellular signal transduction (GO:0035556)|protein ubiquitination (GO:0016567)	377,2300,3826					CCDS102.1	G		AA,AG,GG		cytoplasm (GO:0005737)	170		2504		rs9435243		542									67	SSB-1		13	NM_025106		2			ENST00000328089.6		20489		uc010oae.2			80176	dbSNP_119	201			p.V67V		0				174.0		0.582	1:g.9416151G>A		protein_coding			basic|appris_principal|CCDS		230,1538,2532			1056,3350			G|||			5008		SPSB1_HUMAN	1299	splA/ryanodine receptor domain and SOCS box containing 1			0.259385		9416151			0.2748	SNP		CCDS102.1			,,,	False	9416151				synonymous_variant		Approved		170.0		c.201G>A	2008-02-05	OTTHUMT00000003727.2	Q96BD6	0.3401		SPSB1	9416151		all_lung(157;0.194)			SPSB1	NM_025106.3	protein-coding gene	NP_079382.2		
		A	ENSG00000188807	ENST00000340381.6		199953		ENSG00000188807		4288					,					OTTHUMG00000057457		byFrequency	Q5SNT2	gene with protein product		TMEM201_ENST00000377376.4_Intron|TMEM201_ENST00000340305.5_Intron		NM_001130924.2	1157,851,190	NM_001010866	0.7924					+	Intron			17.0								TMEM201-002					1	+	0.6846				intron,intron	33719		,	all_epithelial(116;2.09e-14)|Renal(390;0.000469)|all_lung(118;0.000521)|Lung NSC(185;0.000744)|Colorectal(325;0.0062)|Breast(348;0.0157)|Hepatocellular(190;0.0228)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.104)	G	SO:0001627		,		protein_coding		2198				17.6073,28.0027,21.1301			6486					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.5e-08)|COAD - Colon adenocarcinoma(227;1.36e-05)|Kidney(185;0.000249)|KIRC - Kidney renal clear cell carcinoma(229;0.000911)|BRCA - Breast invasive adenocarcinoma(304;0.00185)|STAD - Stomach adenocarcinoma(132;0.00345)|READ - Rectum adenocarcinoma(331;0.0419)			KNOWN			TCCACAGGGCGGGGGTGGGGG						ENST00000340381.6:c.606+24G>A	1					lung(3)|upper_aerodigestive_tract(1)		+		,		1p36.22	B9EH90|Q5SNT3		g.chr1:9658707G>A					no		10231,2741												-5.5					0.0					hg19	Standard	0.8121			7066,1510		fibroblast migration (GO:0010761)|nuclear migration (GO:0007097)	4078,2075,333					CCDS30579.1, CCDS44055.1, CCDS44055.2	G		AA,AG,GG		integral component of membrane (GO:0016021)|nuclear membrane (GO:0031965)	17		2504		rs9430182		615								,		RP13-15M17.2, NET5		4	NM_001130924		4			ENST00000340381.6		13783		uc021ofy.1			199953	dbSNP_119	,					0				15.0		0.612	1:g.9658707G>A		protein_coding			basic|appris_principal|CCDS		2921,1224,143			3165,1231			G|||			5008		TM201_HUMAN	3738	transmembrane protein 201			0.746406		9658707			0.6964	SNP		CCDS44055.2			,,,	False	9658707				intron_variant		Approved		17.0			2009-11-06	OTTHUMT00000127672.1	Q5SNT2	0.7767		TMEM201	9658707		all_lung(157;0.222)		,	TMEM201	NM_001010866.3,NM_001130924.2	protein-coding gene	NP_001124396.2		
		G	ENSG00000054523	ENST00000377086.1		23095		ENSG00000054523		4300					,				c.(283-285)gcC>gcG	OTTHUMG00000001817		byFrequency	O60333	gene with protein product		KIF1B_ENST00000377093.4_Silent_p.A95A|KIF1B_ENST00000377083.1_Silent_p.A95A|KIF1B_ENST00000377081.1_Silent_p.A95A|KIF1B_ENST00000263934.6_Silent_p.A95A			26,351,1826		0.2638	Substitution - coding silent(2)				+	Silent		415.4+/-351.8	135.0				11389829, 10762626				KIF1B-001					1	+	0.056				coding-synonymous,coding-synonymous	16636		95/1771,95/1154	all_lung(284;1.31e-05)|Lung NSC(185;2.2e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	605995	,		protein_coding	stomach(2)	2203				29.686,9.1466,22.728		"""Kinesins"", ""Pleckstrin homology (PH) domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0259)|Colorectal(212;9.79e-07)|COAD - Colon adenocarcinoma(227;0.000143)|BRCA - Breast invasive adenocarcinoma(304;0.000413)|Kidney(185;0.00134)|KIRC - Kidney renal clear cell carcinoma(229;0.0037)|STAD - Stomach adenocarcinoma(132;0.0113)|READ - Rectum adenocarcinoma(331;0.0642)			NOVEL			GTATTTTTGCCTATGGGCAGA		CMT2A, CMT2				ENST00000377086.1:c.285C>G	1	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.				breast(2)|endometrium(7)|kidney(8)|large_intestine(9)|lung(29)|ovary(3)|prostate(3)|skin(5)|stomach(3)|upper_aerodigestive_tract(2)		+		,		1p36.22	A6NFS8|A6NKQ4|Q4VXC3|Q4VXC4|Q4VXC5|Q4VXC6|Q96Q94|Q9BV80|Q9P280		g.chr1:10318652C>G		197.4+/-221.5			no		2956,10050												3.8					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|kinesin binding (GO:0019894)|microtubule motor activity (GO:0003777)|plus-end-directed microtubule motor activity (GO:0008574)				hg19	Standard	0.3052			2553,6047		anterograde axon cargo transport (GO:0008089)|apoptotic process (GO:0006915)|cytoskeleton-dependent intracellular transport (GO:0030705)|microtubule-based movement (GO:0007018)|mitochondrion transport along microtubule (GO:0047497)|neuromuscular synaptic transmission (GO:0007274)|neuron-neuron synaptic transmission (GO:0007270)|vesicle-mediated transport (GO:0016192)	425,2106,3972			p.A95A(2)		CCDS111.1, CCDS112.1	C		GG,GC,CC	AF257176	cytoplasmic vesicle (GO:0031410)|cytoplasmic vesicle membrane (GO:0030659)|kinesin complex (GO:0005871)|microtubule (GO:0005874)|microtubule associated complex (GO:0005875)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)	137		2504		rs12402052		487								,	95	KIAA0591, KLP, HMSNII		71	NM_015074		4			ENST00000377086.1		17615		uc001aqw.4			23095	dbSNP_120	285,285			p.A95A		2				143.0		0.413	1:g.10318652C>G		protein_coding			basic		399,1755,2146			403,4003			C|||			5008		KIF1B_HUMAN	1152	kinesin family member 1B			0.230032		10318652			0.2887	SNP					,,,	False	10318652				synonymous_variant		Approved		137.0		c.285C>G	2014-09-17	OTTHUMT00000005102.1	O60333	0.3199		KIF1B	10318652		Ovarian(185;0.203)		,	KIF1B	NM_015074.3,NM_183416.3	protein-coding gene			
		T	ENSG00000054523	ENST00000377086.1		23095		ENSG00000054523		4300					,					OTTHUMG00000001817		byFrequency	O60333	gene with protein product		KIF1B_ENST00000377081.1_Intron|KIF1B_ENST00000377083.1_Intron|KIF1B_ENST00000377093.4_Intron|KIF1B_ENST00000263934.6_Intron			392,1020,791		0.2832					+	Intron		659.6+/-401.7	43.0				11389829, 10762626				KIF1B-001					1	+	0.4486				intron,intron	16636		,	all_lung(284;1.31e-05)|Lung NSC(185;2.2e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	605995	,		protein_coding		2203				34.9884,40.9442,37.006		"""Kinesins"", ""Pleckstrin homology (PH) domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0259)|Colorectal(212;9.79e-07)|COAD - Colon adenocarcinoma(227;0.000143)|BRCA - Breast invasive adenocarcinoma(304;0.000413)|Kidney(185;0.00134)|KIRC - Kidney renal clear cell carcinoma(229;0.0037)|STAD - Stomach adenocarcinoma(132;0.0113)|READ - Rectum adenocarcinoma(331;0.0642)			NOVEL			TTTCTTTTTCACTCTAATTCA		CMT2A, CMT2				ENST00000377086.1:c.430-31A>T	1					breast(2)|endometrium(7)|kidney(8)|large_intestine(9)|lung(29)|ovary(3)|prostate(3)|skin(5)|stomach(3)|upper_aerodigestive_tract(2)		+		,		1p36.22	A6NFS8|A6NKQ4|Q4VXC3|Q4VXC4|Q4VXC5|Q4VXC6|Q96Q94|Q9BV80|Q9P280		g.chr1:10327407A>T		625.9+/-394.6			no		4813,8193												-4.3					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|kinesin binding (GO:0019894)|microtubule motor activity (GO:0003777)|plus-end-directed microtubule motor activity (GO:0008574)				hg19	Standard	0.3608			3009,5591		anterograde axon cargo transport (GO:0008089)|apoptotic process (GO:0006915)|cytoskeleton-dependent intracellular transport (GO:0030705)|microtubule-based movement (GO:0007018)|mitochondrion transport along microtubule (GO:0047497)|neuromuscular synaptic transmission (GO:0007274)|neuron-neuron synaptic transmission (GO:0007270)|vesicle-mediated transport (GO:0016192)	939,2935,2629					CCDS111.1, CCDS112.1	A		TT,TA,AA	AF257176	cytoplasmic vesicle (GO:0031410)|cytoplasmic vesicle membrane (GO:0030659)|kinesin complex (GO:0005871)|microtubule (GO:0005874)|microtubule associated complex (GO:0005875)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)	43		2504		rs12141246		631								,		KIAA0591, KLP, HMSNII		71	NM_015074		6			ENST00000377086.1		20579		uc001aqw.4			23095	dbSNP_120	,					0				43.0		0.443	1:g.10327407A>T		protein_coding			basic		547,1915,1838			1804,2602			T|||			5008		KIF1B_HUMAN	1906	kinesin family member 1B			0.380591		10327407			0.3919	SNP					,,,	False	10327407				intron_variant		Approved		43.0			2014-09-17	OTTHUMT00000005102.1	O60333	0.4006		KIF1B	10327407		Ovarian(185;0.203)		,	KIF1B	NM_015074.3,NM_183416.3	protein-coding gene			
		G	ENSG00000054523	ENST00000377086.1		23095		ENSG00000054523		4300					,					OTTHUMG00000001817		byFrequency	O60333	gene with protein product		KIF1B_ENST00000377081.1_Intron|KIF1B_ENST00000263934.6_Intron			249,933,1021		0.2873					+	Intron		444.0+/-360.5	209.0				11389829, 10762626				KIF1B-001					1	+	0.3351				intron	16636			all_lung(284;1.31e-05)|Lung NSC(185;2.2e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	605995			protein_coding		2203				32.7093,32.4784,32.6311		"""Kinesins"", ""Pleckstrin homology (PH) domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0259)|Colorectal(212;9.79e-07)|COAD - Colon adenocarcinoma(227;0.000143)|BRCA - Breast invasive adenocarcinoma(304;0.000413)|Kidney(185;0.00134)|KIRC - Kidney renal clear cell carcinoma(229;0.0037)|STAD - Stomach adenocarcinoma(132;0.0113)|READ - Rectum adenocarcinoma(331;0.0642)			NOVEL			GTTTATCTCTCCATGGATGTT		CMT2A, CMT2				ENST00000377086.1:c.2925-42C>G	1					breast(2)|endometrium(7)|kidney(8)|large_intestine(9)|lung(29)|ovary(3)|prostate(3)|skin(5)|stomach(3)|upper_aerodigestive_tract(2)		+		,		1p36.22	A6NFS8|A6NKQ4|Q4VXC3|Q4VXC4|Q4VXC5|Q4VXC6|Q96Q94|Q9BV80|Q9P280		g.chr1:10394536C>G		464.0+/-353.7			no		4244,8762												1.2					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|kinesin binding (GO:0019894)|microtubule motor activity (GO:0003777)|plus-end-directed microtubule motor activity (GO:0008574)				hg19	Standard	0.338			2813,5787		anterograde axon cargo transport (GO:0008089)|apoptotic process (GO:0006915)|cytoskeleton-dependent intracellular transport (GO:0030705)|microtubule-based movement (GO:0007018)|mitochondrion transport along microtubule (GO:0047497)|neuromuscular synaptic transmission (GO:0007274)|neuron-neuron synaptic transmission (GO:0007270)|vesicle-mediated transport (GO:0016192)	733,2778,2992					CCDS111.1, CCDS112.1	C		GG,GC,CC	AF257176	cytoplasmic vesicle (GO:0031410)|cytoplasmic vesicle membrane (GO:0030659)|kinesin complex (GO:0005871)|microtubule (GO:0005874)|microtubule associated complex (GO:0005875)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)	216		2504		rs2276100		3126										KIAA0591, KLP, HMSNII		71	NM_015074		28			ENST00000377086.1		22310		uc001aqw.4			23095	dbSNP_100						0				228.0		0.488	1:g.10394536C>G		protein_coding			basic		484,1845,1971			1431,2975			C|||			5008		KIF1B_HUMAN	1672	kinesin family member 1B			0.333866		10394536			0.3462	SNP					,,,	False	10394536				intron_variant		Approved		216.0			2014-09-17	OTTHUMT00000005102.1	O60333	0.3732		KIF1B	10394536		Ovarian(185;0.203)			KIF1B	NM_015074.3	protein-coding gene			
		C	ENSG00000054523	ENST00000377086.1		23095		ENSG00000054523		4300					,					OTTHUMG00000001817		byFrequency	O60333	gene with protein product		KIF1B_ENST00000263934.6_Intron|KIF1B_ENST00000377081.1_Intron			62,558,1583		0.272					+	Intron		415.3+/-351.7	80.0				11389829, 10762626				KIF1B-001					1	+	0.1233				intron	16636			all_lung(284;1.31e-05)|Lung NSC(185;2.2e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	605995			protein_coding		2203				30.0349,15.4789,25.1038		"""Kinesins"", ""Pleckstrin homology (PH) domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0259)|Colorectal(212;9.79e-07)|COAD - Colon adenocarcinoma(227;0.000143)|BRCA - Breast invasive adenocarcinoma(304;0.000413)|Kidney(185;0.00134)|KIRC - Kidney renal clear cell carcinoma(229;0.0037)|STAD - Stomach adenocarcinoma(132;0.0113)|READ - Rectum adenocarcinoma(331;0.0642)			NOVEL			AGGCAGCTTTTTTCAGCTGAA		CMT2A, CMT2				ENST00000377086.1:c.4825-41T>C	1					breast(2)|endometrium(7)|kidney(8)|large_intestine(9)|lung(29)|ovary(3)|prostate(3)|skin(5)|stomach(3)|upper_aerodigestive_tract(2)		+		,		1p36.22	A6NFS8|A6NKQ4|Q4VXC3|Q4VXC4|Q4VXC5|Q4VXC6|Q96Q94|Q9BV80|Q9P280		g.chr1:10431158T>C		283.1+/-276.9			no		3265,9741												-4.6					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|kinesin binding (GO:0019894)|microtubule motor activity (GO:0003777)|plus-end-directed microtubule motor activity (GO:0008574)				hg19	Standard	0.3091			2583,6017		anterograde axon cargo transport (GO:0008089)|apoptotic process (GO:0006915)|cytoskeleton-dependent intracellular transport (GO:0030705)|microtubule-based movement (GO:0007018)|mitochondrion transport along microtubule (GO:0047497)|neuromuscular synaptic transmission (GO:0007274)|neuron-neuron synaptic transmission (GO:0007270)|vesicle-mediated transport (GO:0016192)	471,2323,3709					CCDS111.1, CCDS112.1	T		CC,CT,TT	AF257176	cytoplasmic vesicle (GO:0031410)|cytoplasmic vesicle membrane (GO:0030659)|kinesin complex (GO:0005871)|microtubule (GO:0005874)|microtubule associated complex (GO:0005875)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)	83		2504		rs17411502		5026										KIAA0591, KLP, HMSNII		71	NM_015074		45			ENST00000377086.1		19062		uc001aqw.4			23095	dbSNP_123						0				91.0		0.423	1:g.10431158T>C		protein_coding			basic		409,1765,2126			682,3724			T|||			5008		KIF1B_HUMAN	1247	kinesin family member 1B			0.249002		10431158			0.2817	SNP					,,,	False	10431158				intron_variant		Approved		83.0			2014-09-17	OTTHUMT00000005102.1	O60333	0.3213		KIF1B	10431158		Ovarian(185;0.203)			KIF1B	NM_015074.3	protein-coding gene			
		A	ENSG00000054523	ENST00000377086.1		23095		ENSG00000054523		4300					,				c.(5299-5301)acC>acA	OTTHUMG00000001817		byFrequency	O60333	gene with protein product		KIF1B_ENST00000263934.6_Silent_p.T1721T|KIF1B_ENST00000377081.1_Silent_p.T1767T			28,357,1818		0.272	Substitution - coding silent(1)				+	Silent		419.1+/-353.0	93.0				11389829, 10762626				KIF1B-001					1	+	0.0575				coding-synonymous	16636		1721/1771	all_lung(284;1.31e-05)|Lung NSC(185;2.2e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	605995			protein_coding	stomach(1)	2203				30.0581,9.3736,23.0509		"""Kinesins"", ""Pleckstrin homology (PH) domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0259)|Colorectal(212;9.79e-07)|COAD - Colon adenocarcinoma(227;0.000143)|BRCA - Breast invasive adenocarcinoma(304;0.000413)|Kidney(185;0.00134)|KIRC - Kidney renal clear cell carcinoma(229;0.0037)|STAD - Stomach adenocarcinoma(132;0.0113)|READ - Rectum adenocarcinoma(331;0.0642)			NOVEL			CACCAAACACCTTTGCTGTCT		CMT2A, CMT2				ENST00000377086.1:c.5301C>A	1	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.				breast(2)|endometrium(7)|kidney(8)|large_intestine(9)|lung(29)|ovary(3)|prostate(3)|skin(5)|stomach(3)|upper_aerodigestive_tract(2)		+		,		1p36.22	A6NFS8|A6NKQ4|Q4VXC3|Q4VXC4|Q4VXC5|Q4VXC6|Q96Q94|Q9BV80|Q9P280		g.chr1:10435324C>A		200.8+/-224.0			no		2998,10008												0.1					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|kinesin binding (GO:0019894)|microtubule motor activity (GO:0003777)|plus-end-directed microtubule motor activity (GO:0008574)				hg19	Standard	0.3091			2585,6015		anterograde axon cargo transport (GO:0008089)|apoptotic process (GO:0006915)|cytoskeleton-dependent intracellular transport (GO:0030705)|microtubule-based movement (GO:0007018)|mitochondrion transport along microtubule (GO:0047497)|neuromuscular synaptic transmission (GO:0007274)|neuron-neuron synaptic transmission (GO:0007270)|vesicle-mediated transport (GO:0016192)	437,2124,3942			p.T1721T(1)		CCDS111.1, CCDS112.1	C		AA,AC,CC	AF257176	cytoplasmic vesicle (GO:0031410)|cytoplasmic vesicle membrane (GO:0030659)|kinesin complex (GO:0005871)|microtubule (GO:0005874)|microtubule associated complex (GO:0005875)|mitochondrion (GO:0005739)|neuron projection (GO:0043005)	94		2504		rs11121552		5503									1767	KIAA0591, KLP, HMSNII		71	NM_015074		48			ENST00000377086.1		21284		uc001aqw.4			23095	dbSNP_120	5163			p.T1767T		1				97.0		0.478	1:g.10435324C>A		protein_coding			basic		409,1767,2124			413,3993			C|||			5008		KIF1B_HUMAN	1160	kinesin family member 1B			0.231629		10435324			0.2827	SNP					,,,	False	10435324				synonymous_variant		Approved		94.0		c.5301C>A	2014-09-17	OTTHUMT00000005102.1	O60333	0.3199		KIF1B	10435324		Ovarian(185;0.203)			KIF1B	NM_015074.3	protein-coding gene			
		A	ENSG00000142657	ENST00000270776.8		5226		ENSG00000142657		4300					,					OTTHUMG00000001905		byFrequency	P52209	gene with protein product		PGD_ENST00000541529.1_Intron|PGD_ENST00000538557.1_Intron	Dacarbazine(DB00851)|Furosemide(DB00695)|Gadopentetate dimeglumine(DB00789)|Ketotifen(DB00920)|Meloxicam(DB00814)|Methotrexate(DB00563)|Ritodrine(DB00867)	NM_002631.2	254,941,1008	NM_002631	0.2853					+	Intron		676.2+/-403.3	72.0								PGD-001					1	+	0.3434				intron	8891			all_lung(284;1.31e-05)|Lung NSC(185;2.19e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	A	SO:0001627	172200			protein_coding		2203				32.7791,32.887,32.8156			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.14e-07)|COAD - Colon adenocarcinoma(227;7.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000294)|Kidney(185;0.000728)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(132;0.00832)|READ - Rectum adenocarcinoma(331;0.0487)			KNOWN			GCGTGGGCGCGTTGTCTTCTC						ENST00000270776.8:c.84+18G>A	1					NS(1)|breast(1)|cervix(1)|kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|stomach(3)|upper_aerodigestive_tract(1)		+		,		1p36.22	A8K2Y9|B4DQJ8|Q9BWD8		g.chr1:10459779G>A		681.6+/-404.0			no		4268,8738												-2.8					0.0	NADP binding (GO:0050661)|phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616)				hg19	Standard	0.338			2819,5781		carbohydrate metabolic process (GO:0005975)|D-gluconate metabolic process (GO:0019521)|oxidation-reduction process (GO:0055114)|pentose biosynthetic process (GO:0019322)|pentose-phosphate shunt (GO:0006098)|pentose-phosphate shunt, oxidative branch (GO:0009051)|small molecule metabolic process (GO:0044281)	741,2786,2976					CCDS113.1	G		AA,AG,GG	BC000368	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	74		2504		rs3737155		122												14	NM_002631		2			ENST00000270776.8		12953		uc001arc.3			5226	dbSNP_107						0				76.0		0.567	1:g.10459779G>A		protein_coding			basic|appris_principal|CCDS		487,1845,1968			1449,2957			A|||			5008		6PGD_HUMAN	1675	phosphogluconate dehydrogenase			0.334465		10459779			0.3403	SNP		CCDS113.1			,,,	False	10459779		1.1.1.43		intron_variant		Approved		74.0			2012-10-02	OTTHUMT00000005398.1	P52209	0.3732		PGD	10459779		Ovarian(185;0.203)			PGD	NM_002631.2	protein-coding gene	NP_002622.2		
		C	ENSG00000142657	ENST00000270776.8	0.09310	5226	.	ENSG00000142657	0.15604	4300	0.913000	.	.		,	D	0.9999999999999991	0	c.(118-120)gaT>gaC	OTTHUMG00000001905	0.038000	byFrequency	P52209	gene with protein product		PGD_ENST00000541529.1_Silent_p.D40D|PGD_ENST00000538557.1_Silent_p.D27D	Dacarbazine(DB00851)|Furosemide(DB00695)|Gadopentetate dimeglumine(DB00789)|Ketotifen(DB00920)|Meloxicam(DB00814)|Methotrexate(DB00563)|Ritodrine(DB00867)	NM_002631.2	33,364,1806	NM_002631	0.271	Substitution - coding silent(1)		T	10.62	+	Silent	2	421.0+/-353.6	111.0	.	0.097594					.	PGD-001			.		1	+	0.0658		0	0.993000	coding-synonymous	8891	126	40/484	all_lung(284;1.31e-05)|Lung NSC(185;2.19e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	T	SO:0001819	172200		0.34806629834254144	protein_coding	stomach(1)	2203	P		0.999000	30.2674,9.7594,23.32	.		6503		0.0:0.2189:0.1402:0.641			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.14e-07)|COAD - Colon adenocarcinoma(227;7.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000294)|Kidney(185;0.000728)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(132;0.00832)|READ - Rectum adenocarcinoma(331;0.0487)			KNOWN	ENST00000543846		CCAAAGTTGATGATTTCTTGG	.					ENST00000270776.8:c.120T>C	1		ENSG00000142657	0.62120	PGD	NS(1)|breast(1)|cervix(1)|kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|stomach(3)|upper_aerodigestive_tract(1)		+	0.42202	,	ATG	1p36.22	A8K2Y9|B4DQJ8|Q9BWD8		g.chr1:10460485T>C		206.5+/-228.1		42	no		3033,9973	0.36048	0.25291	5.18	0.00012	ENSP00000438783:M18T			.		-24.6496		1.4	0.22167	172	0.87932	0.3006993006993007	0.9	NADP binding (GO:0050661)|phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616)	.			hg19	Standard	0.3111	0.08536585365853659	5.1933	2603,5997		carbohydrate metabolic process (GO:0005975)|D-gluconate metabolic process (GO:0019521)|oxidation-reduction process (GO:0055114)|pentose biosynthetic process (GO:0019322)|pentose-phosphate shunt (GO:0006098)|pentose-phosphate shunt, oxidative branch (GO:0009051)|small molecule metabolic process (GO:0044281)	452,2129,3922	1.401045		p.D40D(1)		CCDS113.1	T	.	CC,CT,TT	BC000368	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	114	.	2504	1.38	rs1049887		158	.	237			0.15223	10383072	+		40		577	14	NM_002631	.	3	0.31266490765171506	0.533000	ENST00000270776.8		19744		uc001arc.3			5226	dbSNP_86	120	0.0000		p.D40D	.	1		T		119.0	rs1049887;rs2070193;rs2229686;rs3190072;rs11547607;rs12754332	0.502	1:g.10460485T>C	.	protein_coding	.		basic|appris_principal|CCDS		419,1765,2116		18	430,3976	0.2641941391941392	T	T|||		.	5008		6PGD_HUMAN	1171	phosphogluconate dehydrogenase		.	0.233826	0.23002	10460485		0.528000	0.2817	SNP		CCDS113.1		.	,,,	False	10460485	-0.9948	1.1.1.43	4	synonymous_variant	T	Approved	0.302674	114.0		c.120T>C	2012-10-02	OTTHUMT00000005398.1	P52209	0.3199	.	PGD	10460485	0.82548	Ovarian(185;0.203)	0.31308		PGD	NM_002631.2	protein-coding gene	NP_002622.2	M	
		T	ENSG00000142657	ENST00000270776.8		5226		ENSG00000142657		4300					,				c.(730-732)gaC>gaT	OTTHUMG00000001905		byFrequency	P52209	gene with protein product		PGD_ENST00000541529.1_Silent_p.D222D|PGD_ENST00000538557.1_Silent_p.D231D	Dacarbazine(DB00851)|Furosemide(DB00695)|Gadopentetate dimeglumine(DB00789)|Ketotifen(DB00920)|Meloxicam(DB00814)|Methotrexate(DB00563)|Ritodrine(DB00867)	NM_002631.2	254,945,1004	NM_002631	0.2853	Substitution - coding silent(1)				+	Silent		676.6+/-403.3	82.0								PGD-001					1	+	0.3457				coding-synonymous	8891		244/484	all_lung(284;1.31e-05)|Lung NSC(185;2.19e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	T	SO:0001819	172200			protein_coding	stomach(1)	2203				32.7558,32.9778,32.831			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.14e-07)|COAD - Colon adenocarcinoma(227;7.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000294)|Kidney(185;0.000728)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(132;0.00832)|READ - Rectum adenocarcinoma(331;0.0487)			KNOWN			AGTTCCAAGACACCGATGGCA						ENST00000270776.8:c.732C>T	1					NS(1)|breast(1)|cervix(1)|kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|stomach(3)|upper_aerodigestive_tract(1)		+		,		1p36.22	A8K2Y9|B4DQJ8|Q9BWD8		g.chr1:10473196C>T		682.7+/-404.2			no		4270,8736												-10.1					0.0	NADP binding (GO:0050661)|phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616)				hg19	Standard	0.338			2817,5783		carbohydrate metabolic process (GO:0005975)|D-gluconate metabolic process (GO:0019521)|oxidation-reduction process (GO:0055114)|pentose biosynthetic process (GO:0019322)|pentose-phosphate shunt (GO:0006098)|pentose-phosphate shunt, oxidative branch (GO:0009051)|small molecule metabolic process (GO:0044281)	741,2788,2974			p.D244D(1)		CCDS113.1	C		TT,TC,CC	BC000368	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	83		2504		rs2229687		770									244			14	NM_002631		8			ENST00000270776.8		21311		uc001arc.3			5226	dbSNP_98	732			p.D244D		1				86.0		0.532	1:g.10473196C>T		protein_coding			basic|appris_principal|CCDS		487,1843,1970			1453,2953			c|||			5008		6PGD_HUMAN	1678	phosphogluconate dehydrogenase			0.335064		10473196			0.3403	SNP		CCDS113.1			,,,	False	10473196		1.1.1.43		synonymous_variant		Approved		83.0		c.732C>T	2012-10-02	OTTHUMT00000005398.1	P52209	0.3732		PGD	10473196		Ovarian(185;0.203)			PGD	NM_002631.2	protein-coding gene	NP_002622.2		
		G	ENSG00000142657	ENST00000270776.8		5226		ENSG00000142657		4300					,					OTTHUMG00000001905		byFrequency	P52209	gene with protein product		PGD_ENST00000538557.1_Intron|PGD_ENST00000498356.1_Intron|PGD_ENST00000541529.1_Intron	Dacarbazine(DB00851)|Furosemide(DB00695)|Gadopentetate dimeglumine(DB00789)|Ketotifen(DB00920)|Meloxicam(DB00814)|Methotrexate(DB00563)|Ritodrine(DB00867)	NM_002631.2	964,975,264	NM_002631	0.4571					+	Intron		563.6+/-388.2	82.0								PGD-001					1	+	0.7277				intron	8891			all_lung(284;1.31e-05)|Lung NSC(185;2.19e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	172200			protein_coding		2203				47.9651,34.1126,45.9634			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.14e-07)|COAD - Colon adenocarcinoma(227;7.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000294)|Kidney(185;0.000728)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(132;0.00832)|READ - Rectum adenocarcinoma(331;0.0487)			KNOWN			GCTGGCCCCTCGGGGGCGTGC						ENST00000270776.8:c.1332+39C>G	1					NS(1)|breast(1)|cervix(1)|kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|stomach(3)|upper_aerodigestive_tract(1)		+		,		1p36.22	A8K2Y9|B4DQJ8|Q9BWD8		g.chr1:10479635C>G		674.6+/-403.0			no		7028,5978												0.7					0.0	NADP binding (GO:0050661)|phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616)				hg19	Standard	0.4851			4125,4475		carbohydrate metabolic process (GO:0005975)|D-gluconate metabolic process (GO:0019521)|oxidation-reduction process (GO:0055114)|pentose biosynthetic process (GO:0019322)|pentose-phosphate shunt (GO:0006098)|pentose-phosphate shunt, oxidative branch (GO:0009051)|small molecule metabolic process (GO:0044281)	1950,3128,1425					CCDS113.1	C		GG,GC,CC	BC000368	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	83		2504		rs112492133|rs2298570		1370												14	NM_002631		12			ENST00000270776.8		18783		uc001arc.3			5226	dbSNP_100						0				85.0		0.582	1:g.10479635C>G		protein_coding			basic|appris_principal|CCDS		986,2153,1161			2903,1503			C|||			5008		6PGD_HUMAN	2593	phosphogluconate dehydrogenase			0.517772		10479635			0.3383	SNP		CCDS113.1			,,,	False	10479635		1.1.1.43		intron_variant		Approved		83.0			2012-10-02	OTTHUMT00000005398.1	P52209	0.5115		PGD	10479635		Ovarian(185;0.203)			PGD	NM_002631.2	protein-coding gene	NP_002622.2		
		A	ENSG00000142657	ENST00000270776.8		5226		ENSG00000142657		4300					,					OTTHUMG00000001905		byFrequency	P52209	gene with protein product		PGD_ENST00000498356.1_Intron|PGD_ENST00000538557.1_Intron|PGD_ENST00000541529.1_Intron	Dacarbazine(DB00851)|Furosemide(DB00695)|Gadopentetate dimeglumine(DB00789)|Ketotifen(DB00920)|Meloxicam(DB00814)|Methotrexate(DB00563)|Ritodrine(DB00867)	NM_002631.2	61,566,1576	NM_002631	0.271	Unknown(1)				+	Intron		419.7+/-353.2	125.0								PGD-001					1	+	0.1286				intron	8891			all_lung(284;1.31e-05)|Lung NSC(185;2.19e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	172200			protein_coding	stomach(1)	2203				30.1279,15.6151,25.2114			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.14e-07)|COAD - Colon adenocarcinoma(227;7.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000294)|Kidney(185;0.000728)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(132;0.00832)|READ - Rectum adenocarcinoma(331;0.0487)			KNOWN			CTACTCTCTCGTTTCCTAGGC						ENST00000270776.8:c.1333-9G>A	1					NS(1)|breast(1)|cervix(1)|kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|stomach(3)|upper_aerodigestive_tract(1)		+		,		1p36.22	A8K2Y9|B4DQJ8|Q9BWD8		g.chr1:10479678G>A		286.6+/-278.8			no		3279,9727												2.7					0.0	NADP binding (GO:0050661)|phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616)				hg19	Standard	0.3091			2591,6009		carbohydrate metabolic process (GO:0005975)|D-gluconate metabolic process (GO:0019521)|oxidation-reduction process (GO:0055114)|pentose biosynthetic process (GO:0019322)|pentose-phosphate shunt (GO:0006098)|pentose-phosphate shunt, oxidative branch (GO:0009051)|small molecule metabolic process (GO:0044281)	473,2333,3697			p.?(1)		CCDS113.1	G		AA,AG,GG	BC000368	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	132		2504		rs1889309		1370												14	NM_002631		13			ENST00000270776.8		19875		uc001arc.3			5226	dbSNP_92						1				144.0		0.592	1:g.10479678G>A		protein_coding			basic|appris_principal|CCDS		412,1767,2121			688,3718			G|||			5008		6PGD_HUMAN	1252	phosphogluconate dehydrogenase			0.25		10479678			0.2808	SNP		CCDS113.1			,,,	False	10479678		1.1.1.43		intron_variant		Approved		132.0			2012-10-02	OTTHUMT00000005398.1	P52209	0.3213		PGD	10479678		Ovarian(185;0.203)			PGD	NM_002631.2	protein-coding gene	NP_002622.2		
		C	ENSG00000241563	ENST00000377049.3		1325		ENSG00000241563		4299					,				c.(253-255)tcT>tcC	OTTHUMG00000001906		byFrequency	O00230	gene with protein product		APITD1_ENST00000602296.1_3'UTR|APITD1-CORT_ENST00000470413.2_3'UTR|APITD1_ENST00000602787.1_Silent_p.S144S|CORT_ENST00000320498.4_Silent_p.S135S|APITD1-CORT_ENST00000400900.2_Silent_p.S144S|APITD1-CORT_ENST00000465026.1_3'UTR		NM_001302.4	1804,379,17	NM_001302	0.8292	Substitution - coding silent(2)				+	Silent			23.0				9205124				CORT-001					1	+	0.8759				coding-synonymous,coding-synonymous,utr-3	2257		85/106,144/165,	all_lung(284;1.31e-05)|Lung NSC(185;2.19e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.0228)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	602784	,,		protein_coding	stomach(2)	2200				6.2456,9.3864,7.3088		"""Endogenous ligands"""	6499					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.12e-07)|COAD - Colon adenocarcinoma(227;7.07e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|Kidney(185;0.000722)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(132;0.0165)|READ - Rectum adenocarcinoma(331;0.0487)			KNOWN			CCCAGCAATCTGCGCGCCGGG						ENST00000377049.3:c.255T>C	1					breast(1)|endometrium(1)|stomach(1)		+		,		1p36.22	Q5T6G0|Q6UX11	"""prepro-cortistatin"""	g.chr1:10511589T>C					no		12048,950												2.7					0.0	G-protein coupled receptor binding (GO:0001664)|neuropeptide hormone activity (GO:0005184)				hg19	Standard	0.9344			8061,537		adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|synaptic transmission (GO:0007268)	5587,874,38			p.S144S(1)|p.S135S(1)		CCDS117.1, CCDS117.2	T		CC,CT,TT	AF013252	extracellular space (GO:0005615)	21		2504		rs666103		760								,,	85	MGC32686		3	NM_001302		2			ENST00000377049.3		14471					1325	dbSNP_83	255,432,			p.S85S		2				19.0		0.607	1:g.10511589T>C		protein_coding			upstream_ATG|basic|appris_principal|CCDS		3783,495,21			3987,413			C|||			5008		CORT_HUMAN	4345	cortistatin			0.867612		10511589			0.8591	SNP		CCDS117.2			,,,	False	10511589				synonymous_variant		Approved		21.0		c.255T>C	2013-02-25	OTTHUMT00000005410.3	O00230	0.8213		CORT	10511589		Ovarian(185;0.203)		,,	CORT,APITD1-CORT	NM_001302.4,NM_198544.3,NM_199006.2	protein-coding gene	NP_001293.3		
		A	ENSG00000009724	ENST00000400897.3		10747		ENSG00000009724		4300					,				c.(1477-1479)tcC>tcT	OTTHUMG00000002121		byFrequency	O00187	gene with protein product				NM_006610.3	303,985,915	NM_006610	0.7965	Substitution - coding silent(1)				+	Silent		751.8+/-407.4	169.0				9087411, 9777418				MASP2-001	2005-08-17				1	-	0.2973				coding-synonymous	6902		493/687	Lung NSC(185;1.04e-05)|all_lung(284;1.31e-05)|Renal(390;0.000147)|Colorectal(325;0.00205)|Breast(348;0.00262)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	605102			protein_coding	lung(1)	2203				16.6977,36.1099,32.6849			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.12e-07)|COAD - Colon adenocarcinoma(227;7.07e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|Kidney(185;0.000722)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|READ - Rectum adenocarcinoma(331;0.0487)|STAD - Stomach adenocarcinoma(313;0.192)		GBM(35;611 746 20780 22741 36496)	KNOWN			TGTCCAGGGCGGATGCATCAT		MASP1P1				ENST00000400897.3:c.1479C>T	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				biliary_tract(1)|endometrium(2)|large_intestine(6)|lung(5)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(2)		-		,		1p36.3-p36.2	A8K458|A8MWJ2|O75754|Q5TEQ5|Q5TER0|Q96QG4|Q9BZH0|Q9H498|Q9H499|Q9UBP3|Q9UC48|Q9ULC7|Q9UMV3|Q9Y270		g.chr1:11087524G>A		493.8+/-362.8			no		8755,4251												-8.3					0.0	calcium ion binding (GO:0005509)|calcium-dependent protein binding (GO:0048306)|complement component C4b binding (GO:0001855)|peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)				hg19	Standard	0.84			7164,1436		complement activation (GO:0006956)|complement activation, classical pathway (GO:0006958)|complement activation, lectin pathway (GO:0001867)|innate immune response (GO:0045087)	3296,2163,1044			p.S493S(1)		CCDS123.1, CCDS124.1	G		AA,AG,GG	X98400	extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)	172		2504		rs1782455		1494				"""mannan-binding lectin serine protease 2"", ""mannan-binding lectin serine peptidase 1 pseudogene 1"", ""mannan-binding lectin serine protease 1 pseudogene 1"""					493			23	NM_006610		11			ENST00000400897.3		19941		uc001aru.3			10747	dbSNP_89	1479			p.S493S		1				179.0		0.448	1:g.11087524G>A		protein_coding			basic|appris_principal|CCDS		2993,1178,129			1591,2815			G|||			5008		MASP2_HUMAN	3443	mannan-binding lectin serine peptidase 2			0.6875		11087524	STAD - Stomach adenocarcinoma(5;0.071)		0.8651	SNP		CCDS123.1			,,,	False	11087524				synonymous_variant		Approved		172.0		c.1479C>T	2014-09-17	OTTHUMT00000006072.1	O00187	0.7983		MASP2	11087524		Ovarian(185;0.249)			MASP2	NM_006610.3	protein-coding gene	NP_006601.2		
		A	ENSG00000009724	ENST00000400897.3	0.09310	10747	M	ENSG00000009724	0.30675	4300	0.004000	0.67698	P		,	D	0.9999999999846728	0	c.(1111-1113)Gat>Tat	OTTHUMG00000002121	0.645000	byFrequency	O00187	gene with protein product				NM_006610.3	178,829,1196	NM_006610	0.681			C	14.12	+	Missense_Mutation	1	743.3+/-407.2	67.0	O00187	0.268951		9087411, 9777418			0.566	MASP2-001	2005-08-17		0.48089		1	-	0.171		0.04	0.271000	missense	6902	270	371/687	Lung NSC(185;1.04e-05)|all_lung(284;1.31e-05)|Renal(390;0.000147)|Colorectal(325;0.00205)|Breast(348;0.00262)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	605102	probably-damaging	0.7458563535911602	protein_coding		2203	P		0.143000	18.5349,26.8951,37.0214	P		6503		0.0:0.7936:0.1339:0.0726			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.12e-07)|COAD - Colon adenocarcinoma(227;7.07e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|Kidney(185;0.000722)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|READ - Rectum adenocarcinoma(331;0.0487)|STAD - Stomach adenocarcinoma(313;0.192)		GBM(35;611 746 20780 22741 36496)	KNOWN	ENST00000400897		CTGGGTAGATCATCAGGAGGG	T	MASP1P1				ENST00000400897.3:c.1111G>T	1	Sushi 2. {ECO:0000255|PROSITE- ProRule:PRU00302}.	ENSG00000009724	0.74099	MASP2	biliary_tract(1)|endometrium(2)|large_intestine(6)|lung(5)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000383690:p.Asp371Tyr	-	0.22626	,	GAT	1p36.3-p36.2	A8K458|A8MWJ2|O75754|Q5TEQ5|Q5TER0|Q96QG4|Q9BZH0|Q9H498|Q9H499|Q9UBP3|Q9UC48|Q9ULC7|Q9UMV3|Q9Y270		g.chr1:11090916C>A	D -> Y (in dbSNP:rs12711521). {ECO:0000269|Ref.5}.	413.9+/-336.6		74	yes		8191,4815	0.12327	0.43326	5.38	0.00012	ENSP00000383690:D371Y			0.33792		.		3.5	0.40072	393	0.59425	0.6870629370629371	0.0	calcium ion binding (GO:0005509)|calcium-dependent protein binding (GO:0048306)|complement component C4b binding (GO:0001855)|peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)	3.02			hg19	Standard	0.8201	0.15040650406504066	10.5831	7006,1594		complement activation (GO:0006956)|complement activation, classical pathway (GO:0006958)|complement activation, lectin pathway (GO:0001867)|innate immune response (GO:0045087)	3045,2101,1357	2.439952				CCDS123.1, CCDS124.1	C	0.41393	AA,AC,CC	X98400	extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)	72	0.89287	2504	3.5	rs12711521		1126	371	629		"""mannan-binding lectin serine protease 2"", ""mannan-binding lectin serine peptidase 1 pseudogene 1"", ""mannan-binding lectin serine protease 1 pseudogene 1"""	0.45267	11013503	-	TYR/ASP	371		1366	23	NM_006610	0.748	9	0.8298153034300791	0.561000	ENST00000400897.3		19199		uc001aru.3			10747	dbSNP_121	1111	0.0000		p.D371Y	Complement control module (2);Sushi/SCR/CCP (3);	0		T		81.0	rs12711521;rs60678565;rs12711521	0.478	1:g.11090916C>A	ENSP00000383690:D371Y	protein_coding	0.004558		basic|appris_principal|CCDS		2867,1272,161		371	1185,3221	0.6254578754578755	Y	C|||		0.275143	5008		MASP2_HUMAN	2911	mannan-binding lectin serine peptidase 2		MASP2_HUMAN	0.58127	0.29757	11090916	STAD - Stomach adenocarcinoma(5;0.071)	0.999000	0.6657	SNP		CCDS123.1		N	,,,	False	11090916	-1.0096		9	missense	T	Approved	0.814651	72.0		c.1111G>T	2014-09-17	OTTHUMT00000006072.1	O00187	0.7536	-0.28	MASP2	11090916	0.26615	Ovarian(185;0.249)	0.26677	160	MASP2	NM_006610.3	protein-coding gene	NP_006601.2	D	
		A	ENSG00000171824	ENST00000376936.4		5394		ENSG00000171824		4300					,				c.(2167-2169)cgC>cgT	OTTHUMG00000002123		byFrequency	Q01780	gene with protein product		RP4-635E18.7_ENST00000452378.1_RNA|EXOSC10_ENST00000304457.7_Silent_p.R698R|EXOSC10_ENST00000544779.1_3'UTR		NM_001001998.1	187,899,1117	NM_001001998	0.7229					+	Silent		381.1+/-339.9	194.0				1383382, 1644924				EXOSC10-001	2004-06-16				1	-	0.2035				coding-synonymous,coding-synonymous	9138		723/886,698/861	Lung NSC(185;1.74e-05)|all_lung(284;2.05e-05)|Renal(390;0.000147)|Colorectal(325;0.00205)|Breast(348;0.00262)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	A	SO:0001819	605960	,		protein_coding		2203				26.1977,28.8924,41.4117			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;4.18e-07)|COAD - Colon adenocarcinoma(227;8.33e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000315)|Kidney(185;0.000832)|KIRC - Kidney renal clear cell carcinoma(229;0.00269)|READ - Rectum adenocarcinoma(331;0.0526)|STAD - Stomach adenocarcinoma(313;0.202)		Colon(179;105 1987 14326 27364 29542)	KNOWN			CCAGCTTCCAGCGGTTGCTGA		PMSCL2				ENST00000376936.4:c.2169C>T	1					central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(7)|lung(9)|prostate(1)|stomach(3)|upper_aerodigestive_tract(1)		-		,		1p36.22	B1AKQ0|B1AKQ1|Q15158	"""polymyositis/scleroderma autoantigen 2 (100kD)"""	g.chr1:11132217G>A		701.5+/-406.7			no		7620,5386												0.8					0.9	3'-5' exonuclease activity (GO:0008408)|exoribonuclease activity (GO:0004532)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)		2004-06-18		hg19	Standard	0.7416			6347,2253		CUT catabolic process (GO:0071034)|dosage compensation by inactivation of X chromosome (GO:0009048)|histone mRNA catabolic process (GO:0071044)|maturation of 5.8S rRNA (GO:0000460)|nuclear mRNA surveillance (GO:0071028)|nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)|nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)|nuclear-transcribed mRNA catabolic process (GO:0000956)|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	2542,2536,1425					CCDS126.1, CCDS30584.1	G		AA,AG,GG	BC073788	cytoplasm (GO:0005737)|exosome (RNase complex) (GO:0000178)|membrane (GO:0016020)|nuclear exosome (RNase complex) (GO:0000176)|nucleolus (GO:0005730)|nucleus (GO:0005634)|transcriptionally active chromatin (GO:0035327)	201		2504		rs1130683		2218				"""polymyositis/scleroderma autoantigen 2, 100kDa"""				,	723	PM-Scl, PM/Scl-100, Rrp6p, RRP6, p2, p3, p4		27	NM_001001998		20			ENST00000376936.4		18461		uc001asa.3			5394	dbSNP_86	2169,2094			p.R723R		0				216.0		0.438	1:g.11132217G>A		protein_coding			basic|appris_candidate_longest|CCDS		2355,1637,308			1273,3133			A|||			5008		EXOSX_HUMAN	3036	exosome component 10			0.60623		11132217			0.7837	SNP		CCDS30584.1			,,,	False	11132217				synonymous_variant		Approved		201.0		c.2169C>T	2008-02-05	OTTHUMT00000006078.1	Q01780	0.755		EXOSC10	11132217		Ovarian(185;0.249)		,	EXOSC10	NM_001001998.1,NM_002685.2	protein-coding gene	NP_001001998.1		
		G	ENSG00000171824	ENST00000376936.4		5394		ENSG00000171824		4300					,				c.(1387-1389)ccG>ccC	OTTHUMG00000002123		byFrequency	Q01780	gene with protein product		EXOSC10_ENST00000304457.7_Silent_p.P463P|EXOSC10_ENST00000485606.1_5'UTR|EXOSC10_ENST00000544779.1_Silent_p.P463P		NM_001001998.1	671,1118,414	NM_001001998	0.8701					+	Silent		356.3+/-330.2	49.0				1383382, 1644924				EXOSC10-001	2004-06-16				1	-	0.5378				coding-synonymous,coding-synonymous	9138		463/886,463/861	Lung NSC(185;1.74e-05)|all_lung(284;2.05e-05)|Renal(390;0.000147)|Colorectal(325;0.00205)|Breast(348;0.00262)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	605960	,		protein_coding		2203				23.8605,44.167,30.7397			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;4.18e-07)|COAD - Colon adenocarcinoma(227;8.33e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000315)|Kidney(185;0.000832)|KIRC - Kidney renal clear cell carcinoma(229;0.00269)|READ - Rectum adenocarcinoma(331;0.0526)|STAD - Stomach adenocarcinoma(313;0.202)		Colon(179;105 1987 14326 27364 29542)	KNOWN			GCAGCTGCACCGGCTGCCCGT		PMSCL2				ENST00000376936.4:c.1389G>C	1					central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(7)|lung(9)|prostate(1)|stomach(3)|upper_aerodigestive_tract(1)		-		,		1p36.22	B1AKQ0|B1AKQ1|Q15158	"""polymyositis/scleroderma autoantigen 2 (100kD)"""	g.chr1:11141187C>G		550.6+/-378.1			no		9008,3998												-11.5					0.0	3'-5' exonuclease activity (GO:0008408)|exoribonuclease activity (GO:0004532)|nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)		2004-06-18		hg19	Standard	0.7694			6548,2052		CUT catabolic process (GO:0071034)|dosage compensation by inactivation of X chromosome (GO:0009048)|histone mRNA catabolic process (GO:0071044)|maturation of 5.8S rRNA (GO:0000460)|nuclear mRNA surveillance (GO:0071028)|nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)|nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)|nuclear-transcribed mRNA catabolic process (GO:0000956)|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	3169,2670,664					CCDS126.1, CCDS30584.1	C		GG,GC,CC	BC073788	cytoplasm (GO:0005737)|exosome (RNase complex) (GO:0000178)|membrane (GO:0016020)|nuclear exosome (RNase complex) (GO:0000176)|nucleolus (GO:0005730)|nucleus (GO:0005634)|transcriptionally active chromatin (GO:0035327)	50		2504		rs2258621		1438				"""polymyositis/scleroderma autoantigen 2, 100kDa"""				,	463	PM-Scl, PM/Scl-100, Rrp6p, RRP6, p2, p3, p4		27	NM_001001998		11			ENST00000376936.4		12080		uc001asa.3			5394	dbSNP_100	1389,1389			p.P463P		0				52.0		0.597	1:g.11141187C>G		protein_coding			basic|appris_candidate_longest|CCDS		2498,1552,250			2460,1946			G|||			5008		EXOSX_HUMAN	3868	exosome component 10			0.772364		11141187			0.9405	SNP		CCDS30584.1			,,,	False	11141187				synonymous_variant		Approved		50.0		c.1389G>C	2008-02-05	OTTHUMT00000006078.1	Q01780	0.8415		EXOSC10	11141187		Ovarian(185;0.249)		,	EXOSC10	NM_001001998.1,NM_002685.2	protein-coding gene	NP_001001998.1		
		T	ENSG00000198793	ENST00000361445.4		2475		ENSG00000198793		4300					,				c.(4729-4731)gcG>gcA	OTTHUMG00000002001		byFrequency	P42345	gene with protein product		MTOR-AS1_ENST00000420480.1_RNA|MTOR_ENST00000495435.1_5'UTR|MTOR-AS1_ENST00000445982.1_RNA	Everolimus(DB01590)|Pimecrolimus(DB00337)|Sirolimus(DB00877)|Temsirolimus(DB06287)	NM_004958.3	82,615,1506	NM_004958	0.6217					+	Silent		707.3+/-405.6	109.0				8008069, 8660990				MTOR-001	2009-05-29				1	-	0.0635				coding-synonymous	3942		1577/2550		C	SO:0001819	601231			protein_coding		2203				26.5,17.6804,45.4098			6503								KNOWN			CTCCTGCCATCGCAGTTAATT		FRAP, FRAP2, FRAP1				ENST00000361445.4:c.4731G>A	1	FAT. {ECO:0000255|PROSITE- ProRule:PRU00534}.				breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)		-		,		1p36	Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	"""FK506 binding protein 12-rapamycin associated protein 2"", ""rapamycin target protein"", ""FKBP12-rapamycin complex-associated protein 1"", ""FKBP-rapamycin associated protein"", ""rapamycin associated protein FRAP2"", ""dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)"", ""rapamycin and FKBP12 target 1"", ""mammalian target of rapamycin"""	g.chr1:11205058C>T		314.7+/-293.7			no		7100,5906												-5.2					0.8	ATP binding (GO:0005524)|drug binding (GO:0008144)|kinase activity (GO:0016301)|phosphoprotein binding (GO:0051219)|protein serine/threonine kinase activity (GO:0004674)|ribosome binding (GO:0043022)|RNA polymerase III type 1 promoter DNA binding (GO:0001030)|RNA polymerase III type 2 promoter DNA binding (GO:0001031)|RNA polymerase III type 3 promoter DNA binding (GO:0001032)|TFIIIC-class transcription factor binding (GO:0001156)		2009-05-29		hg19	Standard	0.7356			6321,2279		cell growth (GO:0016049)|cellular response to hypoxia (GO:0071456)|cellular response to nutrient levels (GO:0031669)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|germ cell development (GO:0007281)|growth (GO:0040007)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|negative regulation of autophagy (GO:0010507)|negative regulation of cell size (GO:0045792)|negative regulation of macroautophagy (GO:0016242)|negative regulation of NFAT protein import into nucleus (GO:0051534)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-serine phosphorylation (GO:0018105)|peptidyl-threonine phosphorylation (GO:0018107)|phosphatidylinositol-mediated signaling (GO:0048015)|phosphorylation (GO:0016310)|positive regulation of actin filament polymerization (GO:0030838)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of gene expression (GO:0010628)|positive regulation of lamellipodium assembly (GO:0010592)|positive regulation of lipid biosynthetic process (GO:0046889)|positive regulation of myotube differentiation (GO:0010831)|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of transcription from RNA polymerase III promoter (GO:0045945)|positive regulation of translation (GO:0045727)|protein autophosphorylation (GO:0046777)|protein catabolic process (GO:0030163)|protein phosphorylation (GO:0006468)|regulation of actin cytoskeleton organization (GO:0032956)|regulation of carbohydrate utilization (GO:0043610)|regulation of fatty acid beta-oxidation (GO:0031998)|regulation of glycogen biosynthetic process (GO:0005979)|regulation of protein kinase activity (GO:0045859)|regulation of Rac GTPase activity (GO:0032314)|regulation of response to food (GO:0032095)|response to amino acid (GO:0043200)|response to nutrient (GO:0007584)|response to stress (GO:0006950)|ruffle organization (GO:0031529)|signal transduction (GO:0007165)|T cell costimulation (GO:0031295)|TOR signaling (GO:0031929)	2416,2268,1819					CCDS127.1	C		TT,TC,CC	L34075	cytoplasm (GO:0005737)|cytosol (GO:0005829)|endomembrane system (GO:0012505)|endoplasmic reticulum (GO:0005783)|Golgi apparatus (GO:0005794)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|mitochondrial outer membrane (GO:0005741)|phosphatidylinositol 3-kinase complex (GO:0005942)|PML body (GO:0016605)|TORC1 complex (GO:0031931)|TORC2 complex (GO:0031932)	115		2504		rs1057079		4807				"""FK506 binding protein 12-rapamycin associated protein 1"""					1577	RAFT1, RAPT1, FLJ44809		149	NM_004958		33			ENST00000361445.4		19784		uc001asd.3			2475	dbSNP_86	4731			p.A1577A		0				125.0		0.463	1:g.11205058C>T		protein_coding			basic|appris_principal|CCDS		2334,1653,313			779,3627			C|||			5008		MTOR_HUMAN	2742	mechanistic target of rapamycin (serine/threonine kinase)			0.547524		11205058			0.8165	SNP		CCDS127.1			,,,	False	11205058				synonymous_variant		Approved		115.0		c.4731G>A	2014-09-17	OTTHUMT00000005558.1	P42345	0.7017		MTOR	11205058					MTOR	NM_004958.3	protein-coding gene	NP_004949.1		
		A	ENSG00000198793	ENST00000361445.4		2475		ENSG00000198793		4300					,				c.(2995-2997)aaC>aaT	OTTHUMG00000002001		byFrequency	P42345	gene with protein product			Everolimus(DB01590)|Pimecrolimus(DB00337)|Sirolimus(DB00877)|Temsirolimus(DB06287)	NM_004958.3	346,1073,784	NM_004958	0.865					+	Silent		391.5+/-343.7	90.0				8008069, 8660990				MTOR-001	2009-05-29				1	-	0.3351				coding-synonymous	3942		999/2550		A	SO:0001819	601231			protein_coding		2203				27.1279,40.059,38.2439			6503								KNOWN			CTCGAATGACGTTAAGGAACG		FRAP, FRAP2, FRAP1				ENST00000361445.4:c.2997C>T	1					breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)		-		,		1p36	Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	"""FK506 binding protein 12-rapamycin associated protein 2"", ""rapamycin target protein"", ""FKBP12-rapamycin complex-associated protein 1"", ""FKBP-rapamycin associated protein"", ""rapamycin associated protein FRAP2"", ""dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)"", ""rapamycin and FKBP12 target 1"", ""mammalian target of rapamycin"""	g.chr1:11288758G>A		645.1+/-398.1			no		8032,4974												-2.4					1.0	ATP binding (GO:0005524)|drug binding (GO:0008144)|kinase activity (GO:0016301)|phosphoprotein binding (GO:0051219)|protein serine/threonine kinase activity (GO:0004674)|ribosome binding (GO:0043022)|RNA polymerase III type 1 promoter DNA binding (GO:0001030)|RNA polymerase III type 2 promoter DNA binding (GO:0001031)|RNA polymerase III type 3 promoter DNA binding (GO:0001032)|TFIIIC-class transcription factor binding (GO:0001156)		2009-05-29		hg19	Standard	0.7237			6267,2333		cell growth (GO:0016049)|cellular response to hypoxia (GO:0071456)|cellular response to nutrient levels (GO:0031669)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|germ cell development (GO:0007281)|growth (GO:0040007)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|negative regulation of autophagy (GO:0010507)|negative regulation of cell size (GO:0045792)|negative regulation of macroautophagy (GO:0016242)|negative regulation of NFAT protein import into nucleus (GO:0051534)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-serine phosphorylation (GO:0018105)|peptidyl-threonine phosphorylation (GO:0018107)|phosphatidylinositol-mediated signaling (GO:0048015)|phosphorylation (GO:0016310)|positive regulation of actin filament polymerization (GO:0030838)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of gene expression (GO:0010628)|positive regulation of lamellipodium assembly (GO:0010592)|positive regulation of lipid biosynthetic process (GO:0046889)|positive regulation of myotube differentiation (GO:0010831)|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of transcription from RNA polymerase III promoter (GO:0045945)|positive regulation of translation (GO:0045727)|protein autophosphorylation (GO:0046777)|protein catabolic process (GO:0030163)|protein phosphorylation (GO:0006468)|regulation of actin cytoskeleton organization (GO:0032956)|regulation of carbohydrate utilization (GO:0043610)|regulation of fatty acid beta-oxidation (GO:0031998)|regulation of glycogen biosynthetic process (GO:0005979)|regulation of protein kinase activity (GO:0045859)|regulation of Rac GTPase activity (GO:0032314)|regulation of response to food (GO:0032095)|response to amino acid (GO:0043200)|response to nutrient (GO:0007584)|response to stress (GO:0006950)|ruffle organization (GO:0031529)|signal transduction (GO:0007165)|T cell costimulation (GO:0031295)|TOR signaling (GO:0031929)	2629,2774,1100					CCDS127.1	G		AA,AG,GG	L34075	cytoplasm (GO:0005737)|cytosol (GO:0005829)|endomembrane system (GO:0012505)|endoplasmic reticulum (GO:0005783)|Golgi apparatus (GO:0005794)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|mitochondrial outer membrane (GO:0005741)|phosphatidylinositol 3-kinase complex (GO:0005942)|PML body (GO:0016605)|TORC1 complex (GO:0031931)|TORC2 complex (GO:0031932)	95		2504		rs1064261		3073				"""FK506 binding protein 12-rapamycin associated protein 1"""					999	RAFT1, RAPT1, FLJ44809		149	NM_004958		19			ENST00000361445.4		22818		uc001asd.3			2475	dbSNP_86	2997			p.N999N		0				104.0		0.522	1:g.11288758G>A		protein_coding			basic|appris_principal|CCDS		2283,1701,316			1765,2641			A|||			5008		MTOR_HUMAN	3508	mechanistic target of rapamycin (serine/threonine kinase)			0.700479		11288758			0.9187	SNP		CCDS127.1			,,,	False	11288758				synonymous_variant		Approved		95.0		c.2997C>T	2014-09-17	OTTHUMT00000005558.1	P42345	0.8141		MTOR	11288758					MTOR	NM_004958.3	protein-coding gene	NP_004949.1		
		G	ENSG00000198793	ENST00000361445.4		2475		ENSG00000198793		4300					,				c.(1435-1437)gaT>gaC	OTTHUMG00000002001		byFrequency	P42345	gene with protein product			Everolimus(DB01590)|Pimecrolimus(DB00337)|Sirolimus(DB00877)|Temsirolimus(DB06287)	NM_004958.3	201,946,1056	NM_004958	0.7822					+	Silent		391.7+/-343.7	95.0				8008069, 8660990				MTOR-001	2009-05-29				1	-	0.2239				coding-synonymous	3942		479/2550		G	SO:0001819	601231			protein_coding		2203		OREG0013097		27.1512,30.5946,41.4655			6503				671				KNOWN			AGACTGTGGCATCCACCTGCA		FRAP, FRAP2, FRAP1				ENST00000361445.4:c.1437T>C	1	Interaction with NBN.				breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)		-		,		1p36	Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	"""FK506 binding protein 12-rapamycin associated protein 2"", ""rapamycin target protein"", ""FKBP12-rapamycin complex-associated protein 1"", ""FKBP-rapamycin associated protein"", ""rapamycin associated protein FRAP2"", ""dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)"", ""rapamycin and FKBP12 target 1"", ""mammalian target of rapamycin"""	g.chr1:11301714A>G		693.5+/-405.7			no		7613,5393												-2.2					1.0	ATP binding (GO:0005524)|drug binding (GO:0008144)|kinase activity (GO:0016301)|phosphoprotein binding (GO:0051219)|protein serine/threonine kinase activity (GO:0004674)|ribosome binding (GO:0043022)|RNA polymerase III type 1 promoter DNA binding (GO:0001030)|RNA polymerase III type 2 promoter DNA binding (GO:0001031)|RNA polymerase III type 3 promoter DNA binding (GO:0001032)|TFIIIC-class transcription factor binding (GO:0001156)		2009-05-29		hg19	Standard	0.7237			6265,2335		cell growth (GO:0016049)|cellular response to hypoxia (GO:0071456)|cellular response to nutrient levels (GO:0031669)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|germ cell development (GO:0007281)|growth (GO:0040007)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|negative regulation of autophagy (GO:0010507)|negative regulation of cell size (GO:0045792)|negative regulation of macroautophagy (GO:0016242)|negative regulation of NFAT protein import into nucleus (GO:0051534)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-serine phosphorylation (GO:0018105)|peptidyl-threonine phosphorylation (GO:0018107)|phosphatidylinositol-mediated signaling (GO:0048015)|phosphorylation (GO:0016310)|positive regulation of actin filament polymerization (GO:0030838)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of gene expression (GO:0010628)|positive regulation of lamellipodium assembly (GO:0010592)|positive regulation of lipid biosynthetic process (GO:0046889)|positive regulation of myotube differentiation (GO:0010831)|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of transcription from RNA polymerase III promoter (GO:0045945)|positive regulation of translation (GO:0045727)|protein autophosphorylation (GO:0046777)|protein catabolic process (GO:0030163)|protein phosphorylation (GO:0006468)|regulation of actin cytoskeleton organization (GO:0032956)|regulation of carbohydrate utilization (GO:0043610)|regulation of fatty acid beta-oxidation (GO:0031998)|regulation of glycogen biosynthetic process (GO:0005979)|regulation of protein kinase activity (GO:0045859)|regulation of Rac GTPase activity (GO:0032314)|regulation of response to food (GO:0032095)|response to amino acid (GO:0043200)|response to nutrient (GO:0007584)|response to stress (GO:0006950)|ruffle organization (GO:0031529)|signal transduction (GO:0007165)|T cell costimulation (GO:0031295)|TOR signaling (GO:0031929)	2483,2647,1373					CCDS127.1	A		GG,GA,AA	L34075	cytoplasm (GO:0005737)|cytosol (GO:0005829)|endomembrane system (GO:0012505)|endoplasmic reticulum (GO:0005783)|Golgi apparatus (GO:0005794)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|mitochondrial outer membrane (GO:0005741)|phosphatidylinositol 3-kinase complex (GO:0005942)|PML body (GO:0016605)|TORC1 complex (GO:0031931)|TORC2 complex (GO:0031932)	98		2504		rs1135172		1513				"""FK506 binding protein 12-rapamycin associated protein 1"""					479	RAFT1, RAPT1, FLJ44809		149	NM_004958		10			ENST00000361445.4		20388		uc001asd.3			2475	dbSNP_86	1437			p.D479D		0				106.0		0.532	1:g.11301714A>G		protein_coding			basic|appris_principal|CCDS		2282,1701,317	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		1348,3058			G|||			5008		MTOR_HUMAN	3203	mechanistic target of rapamycin (serine/threonine kinase)			0.639577		11301714			0.878	SNP		CCDS127.1			,,,	False	11301714				synonymous_variant		Approved		98.0		c.1437T>C	2014-09-17	OTTHUMT00000005558.1	P42345	0.7622		MTOR	11301714					MTOR	NM_004958.3	protein-coding gene	NP_004949.1		
		A	ENSG00000204624	ENST00000294484.6		57540		ENSG00000204624		4165					,					OTTHUMG00000002074		byFrequency	Q9P2K9	gene with protein product		PTCHD2_ENST00000389575.3_Intron		NM_020780.1	316,936,736	XM_052561	0.3129					+	Intron			76.0				15738394				PTCHD2-001					1	+	0.3124				intron	29251			Lung NSC(185;4.16e-05)|all_lung(284;4.76e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	611251			protein_coding		1988				36.6146,39.4366,44.3523			6153					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.13e-07)|COAD - Colon adenocarcinoma(227;4.83e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000325)|Kidney(185;0.000877)|KIRC - Kidney renal clear cell carcinoma(229;0.00273)|STAD - Stomach adenocarcinoma(313;0.00766)|READ - Rectum adenocarcinoma(331;0.0549)			KNOWN			GTGGGGTTTGTGTCCCATGAG						ENST00000294484.6:c.1454-51T>A	1					NS(3)|breast(2)|endometrium(9)|kidney(4)|large_intestine(5)|lung(34)|ovary(3)|pancreas(1)|prostate(6)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(3)		+		,		1p36.22	Q5VTU9|Q9UJD6		g.chr1:11575375T>A					no		6848,5458												-1.8					0.0	hedgehog receptor activity (GO:0008158)				hg19	Standard	0.6511			5280,3050		cholesterol homeostasis (GO:0042632)|regulation of lipid transport (GO:0032368)|smoothened signaling pathway (GO:0007224)	1976,2896,1281					CCDS41247.1	T		AA,AT,TT	AB037758	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nuclear membrane (GO:0031965)	76		2504		rs2594318		1591										KIAA1337, DISP3		76	NM_020780		5			ENST00000294484.6		18898		uc001ash.4			57540	dbSNP_100						0				76.0		0.592	1:g.11575375T>A		protein_coding			basic|appris_candidate_longest|CCDS		1660,1960,545			1568,2408			T|||			5008		PTHD2_HUMAN	2099	patched domain containing 2			0.419129		11575375			0.2758	SNP		CCDS41247.1			,,,	False	11575375				intron_variant		Approved		76.0			2010-02-17	OTTHUMT00000005770.2	Q9P2K9	0.6441		PTCHD2	11575375		Ovarian(185;0.249)			PTCHD2	NM_020780.1	protein-coding gene	NP_065831.1		
		A	ENSG00000204624	ENST00000294484.6	0.80722	57540	N	ENSG00000204624	0.05197	4175	0.000000	0.89123	B		,	T	0.0	0	c.(1948-1950)Gct>Act	OTTHUMG00000002074	-0.682000	byFrequency	Q9P2K9	gene with protein product		PTCHD2_ENST00000389575.3_Missense_Mutation_p.A650T		NM_020780.1	60,446,1512	XM_052561	0.3599			g	0.242	+	Missense_Mutation	1		146.0	Q9P2K9	0.140238		15738394			0.002	PTCHD2-001			0.06405		1	+	0.0545		0.46	0.017000	missense	29251	243	650/1393	Lung NSC(185;4.16e-05)|all_lung(284;4.76e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)		SO:0001583	611251	benign	0.6712707182320442	protein_coding		2018	P		0.000000	38.4311,14.0238,46.0762	B		6193		0.608:0.0:0.2853:0.1067			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.13e-07)|COAD - Colon adenocarcinoma(227;4.83e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000325)|Kidney(185;0.000877)|KIRC - Kidney renal clear cell carcinoma(229;0.00273)|STAD - Stomach adenocarcinoma(313;0.00766)|READ - Rectum adenocarcinoma(331;0.0549)			KNOWN	ENST00000294484;ENST00000389575		CGTGTTTGCCGCTCCCGAGCA	D;D					ENST00000294484.6:c.1948G>A	1		ENSG00000204624	0.88453	PTCHD2	NS(3)|breast(2)|endometrium(9)|kidney(4)|large_intestine(5)|lung(34)|ovary(3)|pancreas(1)|prostate(6)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(3)	ENSP00000294484:p.Ala650Thr	+	0.05858	,	GCT	1p36.22	Q5VTU9|Q9UJD6		g.chr1:11579470G>A	A -> T (in dbSNP:rs2072994). {ECO:0000269|PubMed:10718198}.			30	yes		5707,6679	0.03702	0.02095	5.31	0.00012	ENSP00000294484:A650T			0.11066		0.2018		-5.8	0.02318	162	0.19147	0.28321678321678323	0.0	hedgehog receptor activity (GO:0008158)	0.49			hg19	Standard	0.6471	0.06097560975609756	8.0415	5141,3209		cholesterol homeostasis (GO:0042632)|regulation of lipid transport (GO:0032368)|smoothened signaling pathway (GO:0007224)	1613,2481,2099	-1.012886				CCDS41247.1	G	0.11235	AA,AG,GG	AB037758	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nuclear membrane (GO:0031965)	141	0.17474	2504	-5.84	rs2072994		2086	650	502			0.30523	11502057	+	THR/ALA	650	KIAA1337, DISP3	937	76	NM_020780	0.004	8	0.662269129287599	0.651000	ENST00000294484.6		18315		uc001ash.4			57540	dbSNP_96	1948	0.0000		p.A650T	.	0		T		133.0	rs2072994;rs17370621;rs2072994	0.632	1:g.11579470G>A	ENSP00000294484:A650T;ENSP00000374226:A650T	protein_coding	0.603446		basic|appris_candidate_longest|CCDS		1553,2035,587		650	566,3470	0.429029304029304	T	g|||		0.834399	5008		PTHD2_HUMAN	1802	patched domain containing 2		PTHD2_HUMAN	0.359824	0.05397	11579470		-0.647000	0.2698	SNP		CCDS41247.1		N	,,,	False	11579470	-0.9792		9	missense	T	Approved	0.615689	141.0		c.1948G>A	2010-02-17	OTTHUMT00000005770.2	Q9P2K9	0.6556	-2.47;-2.47	PTCHD2	11579470	0.09413	Ovarian(185;0.249)	0.35351	58	PTCHD2	NM_020780.1	protein-coding gene	NP_065831.1	A	
		A	ENSG00000204624	ENST00000294484.6		57540		ENSG00000204624		4144					,				c.(2995-2997)ccG>ccA	OTTHUMG00000002074		byFrequency	Q9P2K9	gene with protein product		PTCHD2_ENST00000389575.3_Silent_p.P999P		NM_020780.1	18,317,1632	XM_052561	0.2035					+	Silent			75.0				15738394				PTCHD2-001					1	+	0.0726				coding-synonymous	29251		999/1393	Lung NSC(185;4.16e-05)|all_lung(284;4.76e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	611251			protein_coding		1967				14.0685,8.9731,12.4284			6111					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.13e-07)|COAD - Colon adenocarcinoma(227;4.83e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000325)|Kidney(185;0.000877)|KIRC - Kidney renal clear cell carcinoma(229;0.00273)|STAD - Stomach adenocarcinoma(313;0.00766)|READ - Rectum adenocarcinoma(331;0.0549)			KNOWN			GCGGGAAGCCGGCGGTGCGGC						ENST00000294484.6:c.2997G>A	1					NS(3)|breast(2)|endometrium(9)|kidney(4)|large_intestine(5)|lung(34)|ovary(3)|pancreas(1)|prostate(6)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(3)		+		,		1p36.22	Q5VTU9|Q9UJD6		g.chr1:11589911G>A					no		1519,10703												-9.9					0.0	hedgehog receptor activity (GO:0008158)				hg19	Standard	0.1064			1166,7122		cholesterol homeostasis (GO:0042632)|regulation of lipid transport (GO:0032368)|smoothened signaling pathway (GO:0007224)	91,1337,4683					CCDS41247.1	G		AA,AG,GG	AB037758	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nuclear membrane (GO:0031965)	70		2504		rs2076468		3135									999	KIAA1337, DISP3		76	NM_020780		15			ENST00000294484.6		16735		uc001ash.4			57540	dbSNP_96	2997			p.P999P		0				59.0		0.622	1:g.11589911G>A		protein_coding			basic|appris_candidate_longest|CCDS		73,1020,3051			353,3581			G|||			5008		PTHD2_HUMAN	913	patched domain containing 2			0.182308		11589911			0.4385	SNP		CCDS41247.1			,,,	False	11589911				synonymous_variant		Approved		70.0		c.2997G>A	2010-02-17	OTTHUMT00000005770.2	Q9P2K9	0.0994		PTCHD2	11589911		Ovarian(185;0.249)			PTCHD2	NM_020780.1	protein-coding gene	NP_065831.1		
		G	ENSG00000116670	ENST00000235310.3		10459		ENSG00000116670		1991					,					OTTHUMG00000002231		byFrequency	Q9UI95	gene with protein product		MAD2L2_ENST00000376672.1_Intron|MAD2L2_ENST00000376667.3_Intron|MAD2L2_ENST00000376669.5_Intron|MAD2L2_ENST00000376692.4_Intron			158,420,298	NM_006341	0.4724					+	Intron			65.0				10366450		DNA polymerases (catalytic subunits)		MAD2L2-001	2001-11-28				1	-	0.4039				intron,intron	6764		,	Lung NSC(185;4.15e-05)|all_lung(284;4.76e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	604094	,		protein_coding		876				41.5369,42.0091,41.6812		"""DNA polymerases"""	2867					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.04e-06)|COAD - Colon adenocarcinoma(227;0.000245)|BRCA - Breast invasive adenocarcinoma(304;0.000295)|Kidney(185;0.000733)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			cgaccAAAGAATTTTTAAAAG						ENST00000235310.3:c.159+51T>C	1					kidney(1)|large_intestine(1)|lung(2)|ovary(1)		-		,		1p36	B3KNE3|Q5TGW7|Q9UNA7|Q9Y6I6	"""mitotic arrest deficient homolog-like 2"", ""polymerase (DNA-directed), zeta 2, accessory subunit"""	g.chr1:11740358A>G					no		2390,3344												-0.4					0.0	JUN kinase binding (GO:0008432)|RNA polymerase II activating transcription factor binding (GO:0001102)				hg19	Standard	0.4026			1654,2328		actin filament organization (GO:0007015)|DNA damage response, signal transduction resulting in transcription (GO:0042772)|DNA repair (GO:0006281)|double-strand break repair (GO:0006302)|mitotic nuclear division (GO:0007067)|mitotic spindle assembly checkpoint (GO:0007094)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)|negative regulation of epithelial to mesenchymal transition (GO:0010719)|negative regulation of mitotic anaphase-promoting complex activity (GO:0060564)|negative regulation of protein catabolic process (GO:0042177)|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|negative regulation of transcription by competitive promoter binding (GO:0010944)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription regulatory region DNA binding (GO:2000678)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cell growth (GO:0001558)|transcription, DNA-templated (GO:0006351)	500,1390,977					CCDS134.1	A		GG,GA,AA	AF139365	cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|spindle (GO:0005819)|zeta DNA polymerase complex (GO:0016035)	65		2504		rs7417320		1088				"""MAD2 (mitotic arrest deficient, yeast, homolog)-like 2"""				,		MAD2B, REV7, POLZ2		5	NM_006341		5			ENST00000235310.3		14017		uc009vnc.3			10459	dbSNP_116	,					0				66.0		0.587	1:g.11740358A>G		protein_coding			basic|appris_principal|CCDS		342,970,679			736,1016			G|||			5008		MD2L2_HUMAN	2186	MAD2 mitotic arrest deficient-like 2 (yeast)			0.436502		11740358			0.4256	SNP		CCDS134.1			,,,	False	11740358				intron_variant		Approved		65.0			2013-01-17	OTTHUMT00000006344.2	Q9UI95	0.513		MAD2L2	11740358		Ovarian(185;0.249)		,	MAD2L2	NM_001127325.1,NM_006341.3	protein-coding gene			
		G	ENSG00000162490	ENST00000294485.5		374946		ENSG00000162490		4300					,				c.(721-723)ttA>ttG	OTTHUMG00000002227		byFrequency		gene with protein product				NM_198545.3	19,385,1799	NM_198545	0.1125					+	Silent		232.1+/-265.8	61.0				19150847				DRAXIN-001	2012-08-14				1	+	0.0938				coding-synonymous	25054		241/350		A	SO:0001819	612682			protein_coding		2203				13.186,9.6005,11.9714			6503								KNOWN			ATGAAGACTTAAAACCTGATG		C1orf187				ENST00000294485.5:c.723A>G	1							+		,		1p36.22		"""dorsal repulsive axon guidance protein"", ""neural tissue-specific cysteine-rich protein"""	g.chr1:11771988A>G		204.1+/-226.4			no		1557,11449												-1.9					0.8			2012-08-14		hg19	Standard	0.1262			1134,7466			74,1409,5020					CCDS135.1	A		GG,GA,AA	AY358750		71		2504		rs17037327		858				"""chromosome 1 open reading frame 187"""						FLJ34999, Draxin, Neucrin			NM_198545		4			ENST00000294485.5		20678		uc001asr.1			374946	dbSNP_123	723			p.L241L		0				90.0		0.582	1:g.11771988A>G		protein_coding			basic|appris_principal|CCDS		55,1024,3221			423,3983			A|||			5008			484	dorsal inhibitory axon guidance protein			0.0966454		11771988			0.0655	SNP		CCDS135.1			,,,	False	11771988				synonymous_variant		Approved		71.0		c.723A>G	2012-08-20	OTTHUMT00000006325.1	Q8NBI3	0.0821		DRAXIN	11771988					C1orf187	NM_198545.3	protein-coding gene	NP_940947.3		
		T	ENSG00000177000	ENST00000376592.1	0.42732	4524	N	ENSG00000177000	0.23639	4300	1.000000	0.80909	B;B		,	T	0.006286000000000014	0	c.(1780-1782)cGg>cAg	OTTHUMG00000002277	0.336000	byFrequency	P42898	gene with protein product		MTHFR_ENST00000376590.3_Missense_Mutation_p.R594Q|MTHFR_ENST00000376585.1_Missense_Mutation_p.R635Q|MTHFR_ENST00000376583.3_Missense_Mutation_p.R635Q	Benazepril(DB00542)|Cyanocobalamin(DB00115)|Fluorouracil(DB00544)|Folic Acid(DB00158)|L-Methionine(DB00134)|Menadione(DB00170)|Methotrexate(DB00563)|Riboflavin(DB00140)|Tetrahydrofolic acid(DB00116)		1,129,2073	NM_005957	0.1646			C	8.813	+	Missense_Mutation	2	127.3+/-185.7	162.0	P42898;Q5SNW6	0.029732		7920641			0.0;0.0	MTHFR-001	2010-05-04		0.01281	MTHFR	1	-	0.0227		1	0.907000	missense	7436	16	594/657	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00826)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	607093	benign	0.04419889502762431	protein_coding		2203	P		1.000000	4.6163,2.9732,4.0597	B;B		6503		0.0:0.1498:0.0:0.8502			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376592;ENST00000376583;ENST00000376590;ENST00000376585		CTTTCCCCACCGCTCAATCCA	T;T;T;T					ENST00000376592.1:c.1781G>A	1		ENSG00000177000	0.06103	MTHFR	NS(4)|breast(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(9)|lung(6)|prostate(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000365777:p.Arg594Gln	-	0.71417	,	CGG	1p36.3	B2R7A6|Q5SNW6|Q5SNW9|Q7Z6M6|Q8IU73|Q9UQR2		g.chr1:11850927C>T	R -> Q (in dbSNP:rs2274976). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5}.	95.3+/-134.0		10	yes		528,12478	0.80357	0.18206	5.31	0.01454	ENSP00000365767:R635Q	M		0.64402		.		3.0	0.34606	57	0.02654	0.09965034965034965	1.0	flavin adenine dinucleotide binding (GO:0050660)|methylenetetrahydrofolate reductase (NAD(P)H) activity (GO:0004489)|modified amino acid binding (GO:0072341)|NADP binding (GO:0050661)	-1.405			hg19	Standard	0.0338	0.02032520325203252	9.1481	397,8203		blood circulation (GO:0008015)|cellular amino acid metabolic process (GO:0006520)|folic acid metabolic process (GO:0046655)|homocysteine metabolic process (GO:0050667)|methionine biosynthetic process (GO:0009086)|response to drug (GO:0042493)|response to folic acid (GO:0051593)|response to hypoxia (GO:0001666)|response to interleukin-1 (GO:0070555)|response to vitamin B2 (GO:0033274)|S-adenosylmethionine metabolic process (GO:0046500)|small molecule metabolic process (GO:0044281)|tetrahydrofolate interconversion (GO:0035999)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767)	7,514,5982	0.935719				CCDS137.1	C	0.02656	TT,TC,CC	BC053509	cytosol (GO:0005829)|neuron projection (GO:0043005)	168	0.00517	2504	2.99	rs2274976		1909	594;635	29	GRCh37	"""5,10-methylenetetrahydrofolate reductase (NADPH)"""	0.36946	11773514	-	GLN/ARG	594		112	33	NM_005957	0.0;0.0	11	0.03825857519788918	-0.415000	ENST00000376592.1		19254		uc001atc.2			4524	dbSNP_100	1781	0.0047	CM056008	p.R594Q	.	0		T		181.0	rs2274976;rs17854807;rs52829200;rs58316272;rs2274976	0.557	1:g.11850927C>T	ENSP00000365777:R594Q;ENSP00000365767:R635Q;ENSP00000365775:R594Q;ENSP00000365770:R635Q	protein_coding	0.000002		basic|appris_candidate|CCDS		6,385,3909		594;635;594;635	131,4275	0.05128205128205128	Q	C|||		0.104915	5008		MTHR_HUMAN	373	methylenetetrahydrofolate reductase (NAD(P)H)		MTHR_HUMAN;.	0.0744808	0.51137	11850927		3.211000	0.1181	SNP	rs2274976	CCDS137.1		N	,,,	False	11850927	-1.0106	1.5.1.20	9	missense	T	Approved	0.046163	168.0		c.1781G>A	2014-09-17	OTTHUMT00000006538.1	P42898	0.0418	-1.43;-1.42;-1.43;-1.42	MTHFR	11850927	0.53573	Ovarian(185;0.249)	0.26326	43	MTHFR	NM_005957.4	protein-coding gene		R	
		A	ENSG00000177000	ENST00000376592.1		4524		ENSG00000177000		4300					,				c.(1303-1305)ttC>ttT	OTTHUMG00000002277		byFrequency	P42898	gene with protein product		MTHFR_ENST00000376585.1_Silent_p.F476F|MTHFR_ENST00000376583.3_Silent_p.F476F|MTHFR_ENST00000376590.3_Silent_p.F435F	Benazepril(DB00542)|Cyanocobalamin(DB00115)|Fluorouracil(DB00544)|Folic Acid(DB00158)|L-Methionine(DB00134)|Menadione(DB00170)|Methotrexate(DB00563)|Riboflavin(DB00140)|Tetrahydrofolic acid(DB00116)		1033,942,228	NM_005957	0.998					+	Silent		17.3+/-56.4	105.0				7920641				MTHFR-001	2010-05-04			MTHFR	1	-	0.6558				coding-synonymous	7436		435/657	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00826)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	A	SO:0001819	607093			protein_coding		2203				0.3023,31.7295,10.9488			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GGTAAAGAACGAAGACTTCAA						ENST00000376592.1:c.1305C>T	1					NS(4)|breast(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(9)|lung(6)|prostate(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)		-		,		1p36.3	B2R7A6|Q5SNW6|Q5SNW9|Q7Z6M6|Q8IU73|Q9UQR2		g.chr1:11854457G>A		458.0+/-351.8			no		11582,1424						M						-0.2					0.5	flavin adenine dinucleotide binding (GO:0050660)|methylenetetrahydrofolate reductase (NAD(P)H) activity (GO:0004489)|modified amino acid binding (GO:0072341)|NADP binding (GO:0050661)				hg19	Standard	0.997			8574,26		blood circulation (GO:0008015)|cellular amino acid metabolic process (GO:0006520)|folic acid metabolic process (GO:0046655)|homocysteine metabolic process (GO:0050667)|methionine biosynthetic process (GO:0009086)|response to drug (GO:0042493)|response to folic acid (GO:0051593)|response to hypoxia (GO:0001666)|response to interleukin-1 (GO:0070555)|response to vitamin B2 (GO:0033274)|S-adenosylmethionine metabolic process (GO:0046500)|small molecule metabolic process (GO:0044281)|tetrahydrofolate interconversion (GO:0035999)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767)	5307,968,228					CCDS137.1	G		AA,AG,GG	BC053509	cytosol (GO:0005829)|neuron projection (GO:0043005)	102		2504		rs4846051		1433			GRCh37	"""5,10-methylenetetrahydrofolate reductase (NADPH)"""					435			33	NM_005957		7			ENST00000376592.1		21393		uc001atc.2			4524	dbSNP_111	1305		CM044675	p.F435F		0				97.0		0.552	1:g.11854457G>A		protein_coding			basic|appris_candidate|CCDS		4274,26,0			3008,1398			A|||			5008		MTHR_HUMAN	4522	methylenetetrahydrofolate reductase (NAD(P)H)			0.902955		11854457			0.996	SNP	rs4846051	CCDS137.1			,,,	False	11854457		1.5.1.20		synonymous_variant		Approved		102.0		c.1305C>T	2014-09-17	OTTHUMT00000006538.1	P42898	0.9683		MTHFR	11854457		Ovarian(185;0.249)			MTHFR	NM_005957.4	protein-coding gene			
		G	ENSG00000177000	ENST00000376592.1	0.09310	4524	L	ENSG00000177000	0.54952	4300	0.496000	0.73789	B;P		,	T	0.99999834978	0	c.(1285-1287)gAa>gCa	OTTHUMG00000002277	1.898000	byFrequency	P42898	gene with protein product		MTHFR_ENST00000376583.3_Missense_Mutation_p.E470A|MTHFR_ENST00000376585.1_Missense_Mutation_p.E470A|MTHFR_ENST00000376590.3_Missense_Mutation_p.E429A	Benazepril(DB00542)|Cyanocobalamin(DB00115)|Fluorouracil(DB00544)|Folic Acid(DB00158)|L-Methionine(DB00134)|Menadione(DB00170)|Methotrexate(DB00563)|Riboflavin(DB00140)|Tetrahydrofolic acid(DB00116)		65,553,1585	NM_005957	0.4172			T	15.29	+	Missense_Mutation	2	432.0+/-357.0	111.0	P42898;Q5SNW6	0.155016		7920641			0.009;0.065	MTHFR-001	2010-05-04		0.25987	MTHFR	1	-	0.1513		0.18	0.772000	missense	7436	65	429/657	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00826)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	T	SO:0001583	607093	benign	0.17955801104972377	protein_coding		2203	P		0.968000	31.314,15.5016,25.9573	B;B		6503		0.0:0.0:0.0:1.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376592;ENST00000376583;ENST00000376590;ENST00000376585		AAAGACACTTTCTTCACTGGT	T;T;T;T					ENST00000376592.1:c.1286A>C	1		ENSG00000177000	0.22700	MTHFR	NS(4)|breast(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(9)|lung(6)|prostate(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000365777:p.Glu429Ala	-	0.33430	,	GAA	1p36.3	B2R7A6|Q5SNW6|Q5SNW9|Q7Z6M6|Q8IU73|Q9UQR2		g.chr1:11854476T>G	E -> A (common polymorphism; thermolabile; decreased activity; decreased risk for adult acute leukemia; dbSNP:rs1801131). {ECO:0000269|PubMed:10536004, ECO:0000269|PubMed:9545395, ECO:0000269|PubMed:9719624, ECO:0000269|Ref.5}.	289.8+/-280.6		83	yes		3376,9630	0.27539	0.50102	4.74	0.00012	ENSP00000365767:E470A	M	http://www.ncbi.nlm.nih.gov/sites/varvu?gene	0.64402		.		4.7	0.60224	109	0.38643	0.19055944055944055	0.5	flavin adenine dinucleotide binding (GO:0050660)|methylenetetrahydrofolate reductase (NAD(P)H) activity (GO:0004489)|modified amino acid binding (GO:0072341)|NADP binding (GO:0050661)	1.375			hg19	Standard	0.3131	0.16869918699186992	13.7416	2693,5907		blood circulation (GO:0008015)|cellular amino acid metabolic process (GO:0006520)|folic acid metabolic process (GO:0046655)|homocysteine metabolic process (GO:0050667)|methionine biosynthetic process (GO:0009086)|response to drug (GO:0042493)|response to folic acid (GO:0051593)|response to hypoxia (GO:0001666)|response to interleukin-1 (GO:0070555)|response to vitamin B2 (GO:0033274)|S-adenosylmethionine metabolic process (GO:0046500)|small molecule metabolic process (GO:0044281)|tetrahydrofolate interconversion (GO:0035999)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767)	493,2390,3620	2.790872				CCDS137.1	T	0.34662	GG,GT,TT	BC053509	cytosol (GO:0005829)|neuron projection (GO:0043005)	109	0.43701	2504	4.74	rs1801131		1414	429;470	244	GRCh37	"""5,10-methylenetetrahydrofolate reductase (NADPH)"""	0.62852	11777063	-	ALA/GLU	429		501	33	NM_005957	0.021;0.462	7	0.32189973614775724	0.374000	ENST00000376592.1		21917		uc001atc.2			4524	dbSNP_89	1286	0.0000	CM981315	p.E429A	.	0		T		103.0	rs1801131;rs4134712;rs17367365;rs17857426;rs1801131	0.537	1:g.11854476T>G	ENSP00000365777:E429A;ENSP00000365767:E470A;ENSP00000365775:E429A;ENSP00000365770:E470A	protein_coding	0.000001		basic|appris_candidate|CCDS		428,1837,2035		429;470;429;470	683,3723	0.22939560439560439	A	T|||		0.095160	5008		MTHR_HUMAN	1249	methylenetetrahydrofolate reductase (NAD(P)H)		MTHR_HUMAN;.	0.249401	0.55476	11854476		3.792000	0.2192	SNP	rs1801131	CCDS137.1		D	,,,	False	11854476	-1.0759	1.5.1.20	9	missense	T	Approved	0.31314	109.0		c.1286A>C	2014-09-17	OTTHUMT00000006538.1	P42898	0.1513	-0.78;-0.78;-0.78;-0.78	MTHFR	11854476	0.43724	Ovarian(185;0.249)	0.07693	107	MTHFR	NM_005957.4	protein-coding gene		E	
		A	ENSG00000177000	ENST00000376592.1		4524		ENSG00000177000		4300					,				c.(1054-1056)agC>agT	OTTHUMG00000002277		byFrequency	P42898	gene with protein product		MTHFR_ENST00000376583.3_Silent_p.S393S|MTHFR_ENST00000376590.3_Silent_p.S352S|MTHFR_ENST00000376585.1_Silent_p.S393S	Benazepril(DB00542)|Cyanocobalamin(DB00115)|Fluorouracil(DB00544)|Folic Acid(DB00158)|L-Methionine(DB00134)|Menadione(DB00170)|Methotrexate(DB00563)|Riboflavin(DB00140)|Tetrahydrofolic acid(DB00116)		20,347,1836	NM_005957	0.1575					+	Silent		189.8+/-236.5	49.0				7920641				MTHFR-001	2010-05-04				1	-	0.0772				coding-synonymous	7436		352/657	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00826)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	607093			protein_coding		2203				9.7093,8.7835,9.3957			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TGGGGTGGGCGCTGAGAGCCC						ENST00000376592.1:c.1056C>T	1					NS(4)|breast(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(9)|lung(6)|prostate(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)		-		,		1p36.3	B2R7A6|Q5SNW6|Q5SNW9|Q7Z6M6|Q8IU73|Q9UQR2		g.chr1:11854896G>A		189.9+/-215.9			no		1222,11784												-5.1					0.9	flavin adenine dinucleotide binding (GO:0050660)|methylenetetrahydrofolate reductase (NAD(P)H) activity (GO:0004489)|modified amino acid binding (GO:0072341)|NADP binding (GO:0050661)				hg19	Standard	0.1024			835,7765		blood circulation (GO:0008015)|cellular amino acid metabolic process (GO:0006520)|folic acid metabolic process (GO:0046655)|homocysteine metabolic process (GO:0050667)|methionine biosynthetic process (GO:0009086)|response to drug (GO:0042493)|response to folic acid (GO:0051593)|response to hypoxia (GO:0001666)|response to interleukin-1 (GO:0070555)|response to vitamin B2 (GO:0033274)|S-adenosylmethionine metabolic process (GO:0046500)|small molecule metabolic process (GO:0044281)|tetrahydrofolate interconversion (GO:0035999)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767)	61,1100,5342					CCDS137.1	G		AA,AG,GG	BC053509	cytosol (GO:0005829)|neuron projection (GO:0043005)	48		2504		rs2066462		1184				"""5,10-methylenetetrahydrofolate reductase (NADPH)"""					352			33	NM_005957		6			ENST00000376592.1		20032		uc001atc.2			4524	dbSNP_94	1056			p.S352S		0				47.0		0.607	1:g.11854896G>A		protein_coding			basic|appris_candidate|CCDS		41,753,3506			387,4019			G|||			5008		MTHR_HUMAN	518	methylenetetrahydrofolate reductase (NAD(P)H)			0.103435		11854896			0.1181	SNP		CCDS137.1			,,,	False	11854896		1.5.1.20		synonymous_variant		Approved		48.0		c.1056C>T	2014-09-17	OTTHUMT00000006538.1	P42898	0.0576		MTHFR	11854896		Ovarian(185;0.249)			MTHFR	NM_005957.4	protein-coding gene			
		A	ENSG00000177000	ENST00000376592.1		4524		ENSG00000177000		4300					,				c.(115-117)ccC>ccT	OTTHUMG00000002277		byFrequency	P42898	gene with protein product		MTHFR_ENST00000376590.3_Silent_p.P39P|MTHFR_ENST00000376585.1_Silent_p.P80P|MTHFR_ENST00000376583.3_Silent_p.P80P	Benazepril(DB00542)|Cyanocobalamin(DB00115)|Fluorouracil(DB00544)|Folic Acid(DB00158)|L-Methionine(DB00134)|Menadione(DB00170)|Methotrexate(DB00563)|Riboflavin(DB00140)|Tetrahydrofolic acid(DB00116)		15,315,1873	NM_005957	0.1564					+	Silent		190.8+/-237.2	57.0				7920641				MTHFR-001	2010-05-04				1	-	0.0719				coding-synonymous	7436		39/657	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00826)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	607093			protein_coding		2203				9.5581,7.8302,8.9728			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CATGCCGCTCGGGGTCCAGGC						ENST00000376592.1:c.117C>T	1					NS(4)|breast(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(9)|lung(6)|prostate(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)		-		,		1p36.3	B2R7A6|Q5SNW6|Q5SNW9|Q7Z6M6|Q8IU73|Q9UQR2		g.chr1:11863057G>A		180.1+/-208.5			no		1167,11839												-11.3					0.0	flavin adenine dinucleotide binding (GO:0050660)|methylenetetrahydrofolate reductase (NAD(P)H) activity (GO:0004489)|modified amino acid binding (GO:0072341)|NADP binding (GO:0050661)				hg19	Standard	0.0984			822,7778		blood circulation (GO:0008015)|cellular amino acid metabolic process (GO:0006520)|folic acid metabolic process (GO:0046655)|homocysteine metabolic process (GO:0050667)|methionine biosynthetic process (GO:0009086)|response to drug (GO:0042493)|response to folic acid (GO:0051593)|response to hypoxia (GO:0001666)|response to interleukin-1 (GO:0070555)|response to vitamin B2 (GO:0033274)|S-adenosylmethionine metabolic process (GO:0046500)|small molecule metabolic process (GO:0044281)|tetrahydrofolate interconversion (GO:0035999)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767)	56,1055,5392					CCDS137.1	G		AA,AG,GG	BC053509	cytosol (GO:0005829)|neuron projection (GO:0043005)	58		2504		rs2066470		245				"""5,10-methylenetetrahydrofolate reductase (NADPH)"""					39			33	NM_005957		1			ENST00000376592.1		18607		uc001atc.2			4524	dbSNP_94	117			p.P39P		0				60.0		0.592	1:g.11863057G>A		protein_coding			basic|appris_candidate|CCDS		41,740,3519			345,4061			G|||			5008		MTHR_HUMAN	509	methylenetetrahydrofolate reductase (NAD(P)H)			0.101637		11863057			0.123	SNP		CCDS137.1			,,,	False	11863057		1.5.1.20		synonymous_variant		Approved		58.0		c.117C>T	2014-09-17	OTTHUMT00000006538.1	P42898	0.0548		MTHFR	11863057		Ovarian(185;0.249)			MTHFR	NM_005957.4	protein-coding gene			
		T	ENSG00000011021	ENST00000346436.6		1185		ENSG00000011021		4300					,					OTTHUMG00000002299		byFrequency	P51797	gene with protein product		CLCN6_ENST00000376492.3_Intron|CLCN6_ENST00000376496.3_Intron|CLCN6_ENST00000312413.6_Intron|CLCN6_ENST00000376487.3_Intron		NM_001286.3	31,427,1745	NM_001286	0.1881					+	Intron		755.8+/-407.5	63.0				8543009				CLCN6-001	2012-02-23				1	+	0.1082				intron,intron,intron,intron	2024		,,,	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	602726	,,,		protein_coding		2203				15.7442,11.0985,14.1704		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.000816)|KIRC - Kidney renal clear cell carcinoma(229;0.00268)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CAATGGATTTCGAGTTATGGG						ENST00000346436.6:c.454-33C>T	1					cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(12)|prostate(2)|skin(4)		+		,		1p36	A8K1T4|B4DGT7|F8W9R3|O60818|O60819|O60820|O60821|P78520|P78521|Q17R81|Q5SNW2|Q5SNW3|Q5SNX1|Q5SNX2|Q5SNX3|Q99427|Q99428|Q99429		g.chr1:11883731C>T		781.0+/-414.5			no		1843,11163												-5.6					0.0	antiporter activity (GO:0015297)|ATP binding (GO:0005524)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.1402			1354,7246		cell volume homeostasis (GO:0006884)|chloride transport (GO:0006821)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|response to mechanical stimulus (GO:0009612)|signal transduction (GO:0007165)|transmembrane transport (GO:0055085)	134,1575,4794					CCDS138.1, CCDS57972.1	C		TT,TC,CC	X83378	endosome membrane (GO:0010008)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)	63		2504		rs12567136		505				"""chloride channel 6"""				,,,		CLC-6, KIAA0046, ClC-6		36	NM_001286		7			ENST00000346436.6		18314		uc001ate.5			1185	dbSNP_120	,,,					0				64.0		0.567	1:g.11883731C>T		protein_coding			basic|appris_principal|CCDS		103,1148,3049			489,3917			T|||			5008		CLCN6_HUMAN	648	chloride channel, voltage-sensitive 6			0.129393		11883731			0.125	SNP		CCDS138.1			,,,	False	11883731				intron_variant		Approved		63.0			2012-09-26	OTTHUMT00000006639.2	P51797	0.0778		CLCN6	11883731		Ovarian(185;0.249)		,,,	CLCN6	NM_001286.2,NM_021735.2,NM_021736.2,NM_021737.2	protein-coding gene	NP_001277		
		G	ENSG00000011021	ENST00000346436.6		1185		ENSG00000011021		4300					,					OTTHUMG00000002299		byFrequency	P51797	gene with protein product		CLCN6_ENST00000376492.3_Intron|CLCN6_ENST00000376496.3_Intron|CLCN6_ENST00000312413.6_Intron|CLCN6_ENST00000376487.3_Intron		NM_001286.3	126,803,1274	NM_001286	0.1902					+	Intron		755.1+/-407.5	56.0				8543009				CLCN6-001	2012-02-23				1	+	0.2194				intron,intron,intron,intron	2024		,,,	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	602726	,,,		protein_coding		2203				15.8488,23.9446,18.5914		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.000816)|KIRC - Kidney renal clear cell carcinoma(229;0.00268)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CAGTGAAAGCATTAACCACAC						ENST00000346436.6:c.840+25A>G	1					cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(12)|prostate(2)|skin(4)		+		,		1p36	A8K1T4|B4DGT7|F8W9R3|O60818|O60819|O60820|O60821|P78520|P78521|Q17R81|Q5SNW2|Q5SNW3|Q5SNX1|Q5SNX2|Q5SNX3|Q99427|Q99428|Q99429		g.chr1:11887303A>G		725.1+/-409.6			no		2418,10588												0.9					0.0	antiporter activity (GO:0015297)|ATP binding (GO:0005524)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.1421			1363,7237		cell volume homeostasis (GO:0006884)|chloride transport (GO:0006821)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|response to mechanical stimulus (GO:0009612)|signal transduction (GO:0007165)|transmembrane transport (GO:0055085)	229,1960,4314					CCDS138.1, CCDS57972.1	A		GG,GA,AA	X83378	endosome membrane (GO:0010008)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)	56		2504		rs7537765		892				"""chloride channel 6"""				,,,		CLC-6, KIAA0046, ClC-6		36	NM_001286		10			ENST00000346436.6		15971		uc001ate.5			1185	dbSNP_116	,,,					0				57.0		0.527	1:g.11887303A>G		protein_coding			basic|appris_principal|CCDS		103,1157,3040			1055,3351			G|||			5008		CLCN6_HUMAN	808	chloride channel, voltage-sensitive 6			0.161342		11887303			0.128	SNP		CCDS138.1			,,,	False	11887303				intron_variant		Approved		56.0			2012-09-26	OTTHUMT00000006639.2	P51797	0.0865		CLCN6	11887303		Ovarian(185;0.249)		,,,	CLCN6	NM_001286.2,NM_021735.2,NM_021736.2,NM_021737.2	protein-coding gene	NP_001277		
		A	ENSG00000011021	ENST00000346436.6		1185		ENSG00000011021		4300					,					OTTHUMG00000002299		byFrequency	P51797	gene with protein product		CLCN6_ENST00000376492.3_Intron|CLCN6_ENST00000376496.3_Intron|CLCN6_ENST00000312413.6_Intron|CLCN6_ENST00000376487.3_Intron		NM_001286.3	25,374,1804	NM_001286	0.1564					+	Intron		189.8+/-236.5	48.0				8543009				CLCN6-001	2012-02-23				1	+	0.0915				intron,intron,intron,intron	2024		,,,	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	602726	,,,		protein_coding		2203				9.6744,9.6232,9.6571		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.000816)|KIRC - Kidney renal clear cell carcinoma(229;0.00268)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			AACCACACCCCCCGAATTACA						ENST00000346436.6:c.840+38C>A	1					cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(12)|prostate(2)|skin(4)		+		,		1p36	A8K1T4|B4DGT7|F8W9R3|O60818|O60819|O60820|O60821|P78520|P78521|Q17R81|Q5SNW2|Q5SNW3|Q5SNX1|Q5SNX2|Q5SNX3|Q99427|Q99428|Q99429		g.chr1:11887316C>A		205.5+/-227.4			no		1256,11750												0.9					0.0	antiporter activity (GO:0015297)|ATP binding (GO:0005524)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.0994			832,7768		cell volume homeostasis (GO:0006884)|chloride transport (GO:0006821)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|response to mechanical stimulus (GO:0009612)|signal transduction (GO:0007165)|transmembrane transport (GO:0055085)	67,1122,5314					CCDS138.1, CCDS57972.1	C		AA,AC,CC	X83378	endosome membrane (GO:0010008)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)	48		2504		rs41275478		892				"""chloride channel 6"""				,,,		CLC-6, KIAA0046, ClC-6		36	NM_001286		10			ENST00000346436.6		15781		uc001ate.5			1185	dbSNP_127	,,,					0				48.0		0.512	1:g.11887316C>A		protein_coding			basic|appris_principal|CCDS		42,748,3510			424,3982			C|||			5008		CLCN6_HUMAN	538	chloride channel, voltage-sensitive 6			0.107428		11887316			0.123	SNP		CCDS138.1			,,,	False	11887316				intron_variant		Approved		48.0			2012-09-26	OTTHUMT00000006639.2	P51797	0.0576		CLCN6	11887316		Ovarian(185;0.249)		,,,	CLCN6	NM_001286.2,NM_021735.2,NM_021736.2,NM_021737.2	protein-coding gene	NP_001277		
		A	ENSG00000011021	ENST00000346436.6		1185		ENSG00000011021		4300					,					OTTHUMG00000002299		byFrequency	P51797	gene with protein product		CLCN6_ENST00000376492.3_Intron|CLCN6_ENST00000376496.3_Intron|CLCN6_ENST00000312413.6_Intron|CLCN6_ENST00000376487.3_Intron		NM_001286.3	3,137,2063	NM_001286	0.1053					+	Intron		127.8+/-186.1	194.0				8543009				CLCN6-001	2012-02-23				1	+	0.0265				intron,intron	2024		,	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	602726	,		protein_coding		2203				4.6512,3.2456,4.175		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.000816)|KIRC - Kidney renal clear cell carcinoma(229;0.00268)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TTTCTGTGGCGTTGTAACAGC						ENST00000346436.6:c.1122-28G>A	1					cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(12)|prostate(2)|skin(4)		+		,		1p36	A8K1T4|B4DGT7|F8W9R3|O60818|O60819|O60820|O60821|P78520|P78521|Q17R81|Q5SNW2|Q5SNW3|Q5SNX1|Q5SNX2|Q5SNX3|Q99427|Q99428|Q99429		g.chr1:11889225G>A		100.7+/-139.4			no		543,12463												-11.6					0.0	antiporter activity (GO:0015297)|ATP binding (GO:0005524)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.0338			400,8200		cell volume homeostasis (GO:0006884)|chloride transport (GO:0006821)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|response to mechanical stimulus (GO:0009612)|signal transduction (GO:0007165)|transmembrane transport (GO:0055085)	9,525,5969					CCDS138.1, CCDS57972.1	G		AA,AG,GG	X83378	endosome membrane (GO:0010008)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)	195		2504		rs41275484		1173				"""chloride channel 6"""				,		CLC-6, KIAA0046, ClC-6		36	NM_001286		13			ENST00000346436.6		18540		uc001ate.5			1185	dbSNP_127	,					0				196.0		0.517	1:g.11889225G>A		protein_coding			basic|appris_principal|CCDS		6,388,3906			143,4263			G|||			5008		CLCN6_HUMAN	327	chloride channel, voltage-sensitive 6			0.0652955		11889225			0.122	SNP		CCDS138.1			,,,	False	11889225				intron_variant		Approved		195.0			2012-09-26	OTTHUMT00000006639.2	P51797	0.0461		CLCN6	11889225		Ovarian(185;0.249)		,	CLCN6	NM_001286.2,NM_021736.2	protein-coding gene	NP_001277		
		T	ENSG00000011021	ENST00000346436.6		1185		ENSG00000011021		4300					,				c.(2005-2007)ggC>ggT	OTTHUMG00000002299		byFrequency	P51797	gene with protein product		CLCN6_ENST00000376496.3_Silent_p.G669G|CLCN6_ENST00000312413.6_3'UTR|CLCN6_ENST00000376487.3_Silent_p.G647G		NM_001286.3	2,128,2073	NM_001286	0.1063					+	Silent		127.7+/-186.0	60.0				8543009				CLCN6-001	2012-02-23				1	+	0.0242				coding-synonymous	2024		669/870	Lung NSC(185;8.69e-05)|all_lung(284;9.87e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	602726			protein_coding		2203				4.6512,2.9959,4.0904		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.000816)|KIRC - Kidney renal clear cell carcinoma(229;0.00268)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CCCGGGCTGGCGAGCAGCGCA						ENST00000346436.6:c.2007C>T	1					cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(7)|lung(12)|prostate(2)|skin(4)		+		,		1p36	A8K1T4|B4DGT7|F8W9R3|O60818|O60819|O60820|O60821|P78520|P78521|Q17R81|Q5SNW2|Q5SNW3|Q5SNX1|Q5SNX2|Q5SNX3|Q99427|Q99428|Q99429		g.chr1:11897082C>T		95.3+/-134.0			no		532,12474												-9.2					0.0	antiporter activity (GO:0015297)|ATP binding (GO:0005524)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.0338			400,8200		cell volume homeostasis (GO:0006884)|chloride transport (GO:0006821)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|response to mechanical stimulus (GO:0009612)|signal transduction (GO:0007165)|transmembrane transport (GO:0055085)	8,516,5979					CCDS138.1, CCDS57972.1	C		TT,TC,CC	X83378	endosome membrane (GO:0010008)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)	60		2504		rs41275500		2059				"""chloride channel 6"""					669	CLC-6, KIAA0046, ClC-6		36	NM_001286		19			ENST00000346436.6		18861		uc001ate.5			1185	dbSNP_127	2007			p.G669G		0				62.0		0.582	1:g.11897082C>T		protein_coding			basic|appris_principal|CCDS		6,388,3906			132,4274			C|||			5008		CLCN6_HUMAN	325	chloride channel, voltage-sensitive 6			0.0648962		11897082			0.122	SNP		CCDS138.1			,,,	False	11897082				synonymous_variant		Approved		60.0		c.2007C>T	2012-09-26	OTTHUMT00000006639.2	P51797	0.0461		CLCN6	11897082		Ovarian(185;0.249)			CLCN6	NM_001286.2	protein-coding gene	NP_001277		
		T	ENSG00000175206	ENST00000376480.3	0.45216	4878	L	ENSG00000175206	0.08551	4300	0.019000	0.49720	P		,	T	0.998226	0	c.(94-96)Gtg>Atg	OTTHUMG00000002388	-0.327000	byFrequency	P01160	gene with protein product		NPPA-AS1_ENST00000400892.2_RNA|NPPA_ENST00000376476.1_Intron|NPPA-AS1_ENST00000446542.1_RNA		NM_006172.3	10,246,1947	NM_006172	0.1053			C	3.799	+	Missense_Mutation	1	128.7+/-186.9	188.0	P01160	0.060372					0.058	NPPA-001	2010-11-09		0.25140	NPPA	1	-	0.0613		0.27	0.282000	missense	7939	17	32/152	Renal(390;0.000469)|Lung NSC(185;0.00149)|all_lung(284;0.00189)|Breast(348;0.00586)|Colorectal(325;0.0062)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0556)|Ovarian(437;0.0731)	C	SO:0001583	108780	benign	0.04696132596685083	protein_coding		2203	D		0.003000	4.7093,6.0372,5.1592	B	"""Endogenous ligands"""	6503		0.1413:0.4726:0.0:0.3861			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.04e-06)|COAD - Colon adenocarcinoma(227;0.000245)|BRCA - Breast invasive adenocarcinoma(304;0.000295)|Kidney(185;0.000733)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376480		GCGTTGGACACGGCATTGTAC	T	ANP, PND				ENST00000376480.3:c.94G>A	1		ENSG00000175206	0.05967	NPPA	central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(1)|upper_aerodigestive_tract(1)	ENSP00000365663:p.Val32Met	-	0.15002	,	GTG	1p36.21	Q13766|Q5JZE1		g.chr1:11907648C>T	V -> M (in dbSNP:rs5063).	152.2+/-185.9		28	yes		671,12335	0.16419	0.07452	5.84	0.00815	ENSP00000365663:V32M	M		0.13309		-9.3274		-0.4	0.12485	51	0.30854	0.08916083916083917	0.0	receptor binding (GO:0005102)	1.065			hg19	Standard	0.0348	0.056910569105691054	4.5953	405,8195		cardiac muscle hypertrophy in response to stress (GO:0014898)|cellular response to mechanical stimulus (GO:0071260)|cGMP biosynthetic process (GO:0006182)|female pregnancy (GO:0007565)|gene expression (GO:0010467)|negative regulation of cell growth (GO:0030308)|negative regulation of systemic arterial blood pressure (GO:0003085)|receptor guanylyl cyclase signaling pathway (GO:0007168)|regulation of blood pressure (GO:0008217)|regulation of blood vessel size (GO:0050880)|response to hypoxia (GO:0001666)|response to insulin (GO:0032868)|transcription initiation from RNA polymerase II promoter (GO:0006367)	17,637,5849	-0.041992				CCDS139.1	C	0.42556	TT,TC,CC	BC005893	extracellular region (GO:0005576)|extracellular space (GO:0005615)|mast cell granule (GO:0042629)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	194	0.35487	2504	-0.381	rs5063		192	32	30	GRCh37	"""natriuretic peptide precursor A"""	0.12327	11830235	-	MET/VAL	32		126	10	NM_006172	0.783	1	0.0395778364116095	-0.424000	ENST00000376480.3		18211		uc001ati.3			4878	dbSNP_52	94	0.0027	CM057551	p.V32M	.	0		T		206.0	rs5063;rs56762574;rs5063	0.557	1:g.11907648C>T	ENSP00000365663:V32M	protein_coding	0.397680		basic|appris_principal|CCDS		7,391,3902		32	266,4140	0.057692307692307696	M	C|||		0.724342	5008		ANF_HUMAN	368	natriuretic peptide A		ANF_HUMAN	0.0734824	0.07446	11907648		-0.378000	0.1151	SNP	rs5063	CCDS139.1		N	,,,	False	11907648	-1.0727		10	missense	T	Approved	0.047093	194.0		c.94G>A	2014-09-17	OTTHUMT00000006852.1	P01160	0.0476	0.77	NPPA	11907648	0.26991	Ovarian(185;0.249)	0.08330	21	NPPA	NM_006172.3	protein-coding gene	NP_006163.1	V	
		T	ENSG00000116685	ENST00000376572.3	0.58432	90231	M	ENSG00000116685	0.37419	4300	1.000000	.	D;D			D	0.999997	0	c.(1777-1779)cTc>cAc	OTTHUMG00000002391	0.938000		Q8IYS2	gene with protein product		KIAA2013_ENST00000376576.3_Missense_Mutation_p.L593H		NM_138346.2		NM_138346				A	18.22	+	Missense_Mutation	2		41.0	Q8IYS2-2;Q8IYS2	.		12477932			0.896;0.94	KIAA2013-002			0.65987		1	-			0	0.996000		28513	.		Renal(390;0.000469)|Lung NSC(185;0.00149)|all_lung(284;0.00189)|Breast(348;0.00586)|Colorectal(325;0.0062)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0556)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		2203	D		1.000000		P;D		6503		0.8627:0.0:0.0:0.1373			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;4.88e-06)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|Kidney(185;0.000722)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376572;ENST00000376576		GAACCAGAAGAGGAAGGGCAG	.					ENST00000376572.3:c.1778T>A	1		ENSG00000116685	0.30748	KIAA2013	endometrium(1)|lung(3)|ovary(1)|prostate(1)|skin(1)	ENSP00000365756:p.Leu593His	-	0.71417		CTC	1p36.22	Q5JXC1|Q8IVF8|Q8NDI7|Q9BSY1		g.chr1:11982802A>T				.				0.80357	0.65878	5.68	0.70064	ENSP00000365756:L593H			0.64402		-20.8439			0.55395	.	0.87932	.			1.975			hg19	Standard		.	11.2163					3.574884				CCDS141.1	A	0.63046		AB095933	integral component of membrane (GO:0016021)|membrane (GO:0016020)		0.64404		4.52			1963	593;593	.			0.48827	11905389	-		593	MGC33867, RP5-1077B9.1	.	7	NM_138346	0.992;0.992	2	.	0.454000	ENST00000376572.3				uc001atk.3			90231			0.3181		p.L593H	.	0		T		43.0	.	0.612	1:g.11982802A>T	.	protein_coding	0.000001		basic|appris_principal|CCDS				593		.	H			0.000000			K2013_HUMAN		KIAA2013		.;K2013_HUMAN		0.93254	11982802		8.962000		SNP		CCDS141.1		D			11982802	-0.4478		9	missense	T	Approved	.	42.0		c.1778T>A	2011-02-09	OTTHUMT00000006858.1	Q8IYS2		.	KIAA2013	11982802	0.88848	Ovarian(185;0.249)	0.71817				protein-coding gene	NP_612355.1	L	
		T	ENSG00000120949	ENST00000263932.2		943		ENSG00000120949		4300					,				c.(268-270)gaC>gaT	OTTHUMG00000001827		byFrequency	P28908	gene with protein product		TNFRSF8_ENST00000417814.2_5'UTR	Brentuximab vedotin(DB08870)	NM_001243.3|NM_001281430.1	101,754,1348		0.3712					+	Splice_Site			89.0			Silent	1330892, 1310894				TNFRSF8-001					1	+	0.2118				coding-synonymous-near-splice	11923		90/596	Lung NSC(185;8.71e-05)|all_lung(284;9.89e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	C	SO:0001630	153243			protein_coding		2203				24.2093,21.6977,23.3584		"""Tumor necrosis factor receptor superfamily"", ""CD molecules"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GTCCCTTAGACGACCTCGTGG		CD30, D1S166E				ENST00000263932.2:c.269-1C>T	1					NS(1)|breast(2)|central_nervous_system(1)|endometrium(2)|large_intestine(4)|lung(12)|ovary(1)|pancreas(1)|skin(2)|urinary_tract(1)		+		,		1p36	B1AN79|B9EGD9|D3YTD8|Q6P4D9		g.chr1:12164437C>T					yes		3038,9968												-8.1					0.0	transmembrane signaling receptor activity (GO:0004888)				hg19	Standard	0.2296			2082,6518		cellular response to mechanical stimulus (GO:0071260)|negative regulation of cell proliferation (GO:0008285)|positive regulation of apoptotic process (GO:0043065)|positive regulation of TRAIL biosynthetic process (GO:0045556)|positive regulation of tumor necrosis factor biosynthetic process (GO:0042535)|signal transduction (GO:0007165)	348,2342,3813					CCDS144.1, CCDS59989.1	C		TT,TC,CC	M83554	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	96		2504		rs2230622		492									90	KI-1		27	XM_006711049		4			ENST00000263932.2		16676		uc001atq.3				dbSNP_98	270			p.D90D		0				109.0		0.597	1:g.12164437C>T		protein_coding			basic|appris_principal|CCDS		247,1588,2465			956,3450			C|||			5008		TNR8_HUMAN	1466	tumor necrosis factor receptor superfamily, member 8			0.292732		12164437			0.3264	SNP		CCDS144.1			,,,	False	12164437				splice_region_variant		Approved		96.0		c.270C>T	2008-02-05	OTTHUMT00000005130.1	P28908	0.379		TNFRSF8	12164437		Ovarian(185;0.249)			TNFRSF8	NM_001243.3	protein-coding gene	NP_001234.2|NP_001268359.1		
		T	ENSG00000120949	ENST00000263932.2	0.44323	943	.	ENSG00000120949	0.30945	4300	1.000000	0.69040	B		,	T	0.002794999999999992	0	c.(889-891)Cgt>Tgt	OTTHUMG00000001827	0.659000		P28908	gene with protein product		TNFRSF8_ENST00000417814.2_Missense_Mutation_p.R186C	Brentuximab vedotin(DB08870)	NM_001243.3|NM_001281430.1			1.0			T	1.558	+	Missense_Mutation	1		108.0	D3YTD8	.		1330892, 1310894			0.0	TNFRSF8-001			0.01281		1	+	1.0		1	0.751000		11923	362		Lung NSC(185;8.71e-05)|all_lung(284;9.89e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)		SO:0001583	153243		1.0	protein_coding		2203	P		1.000000		B	"""Tumor necrosis factor receptor superfamily"", ""CD molecules"""	6503		0.0:0.117:0.0:0.883			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.66e-06)|COAD - Colon adenocarcinoma(227;0.000261)|BRCA - Breast invasive adenocarcinoma(304;0.000304)|Kidney(185;0.000777)|KIRC - Kidney renal clear cell carcinoma(229;0.00261)|STAD - Stomach adenocarcinoma(313;0.0073)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000263932;ENST00000417814		CACCAACTCCCGTGCCCGCTG	T;T	CD30, D1S166E				ENST00000263932.2:c.889C>T	1		ENSG00000120949	0.04426	TNFRSF8	NS(1)|breast(2)|central_nervous_system(1)|endometrium(2)|large_intestine(4)|lung(12)|ovary(1)|pancreas(1)|skin(2)|urinary_tract(1)	ENSP00000263932:p.Arg297Cys	+	0.71417	,	CGT	1p36	B1AN79|B9EGD9|D3YTD8|Q6P4D9		g.chr1:12175729C>T	C -> R (in dbSNP:rs1763642). {ECO:0000269|PubMed:16710414}.			492				0.80357	0.04082	3.83	0.00012	ENSP00000263932:R297C			.		-0.9743			0.44106	572	0.02654	1.0		transmembrane signaling receptor activity (GO:0004888)	.			hg19	Standard	1.0	1.0	6.1411			cellular response to mechanical stimulus (GO:0071260)|negative regulation of cell proliferation (GO:0008285)|positive regulation of apoptotic process (GO:0043065)|positive regulation of TRAIL biosynthetic process (GO:0045556)|positive regulation of tumor necrosis factor biosynthetic process (GO:0042535)|signal transduction (GO:0007165)		-0.537471				CCDS144.1, CCDS59989.1	C	0.02656		M83554	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)		.	2504	3.83	rs1763642		1111	186	758			0.20261	12098316	+		297	KI-1	2184	27	XM_006711049	0.0	8	1.0	-0.516000	ENST00000263932.2		19711		uc001atq.3						0.0000		p.R297C	.	0		T		147.0	rs1763642;rs60772254;rs1763642	0.602	1:g.12175729C>T	ENSP00000263932:R297C;ENSP00000390650:R186C	protein_coding	.		basic|appris_principal|CCDS				297;186		1.0	C	T|||		.	5008		TNR8_HUMAN	5008	tumor necrosis factor receptor superfamily, member 8		.	1.0	0.40981	12175729		2.017000	1.0	SNP		CCDS144.1		.	,,,	False	12175729	-0.9386		7	missense	T	Approved	.	121.0		c.889C>T	2008-02-05	OTTHUMT00000005130.1	P28908	1.0	-0.37;-0.37	TNFRSF8	12175729	0.42716	Ovarian(185;0.249)	0.43523				protein-coding gene	NP_001234.2|NP_001268359.1	R	
		C	ENSG00000048707	ENST00000358136.3	0.09310	55187	.	ENSG00000048707	0.00745	4300	0.440000	.	.		,	.	0.999999999438343	0	c.(8656-8658)ccA>ccC	OTTHUMG00000013155	-2.202000	byFrequency		gene with protein product		VPS13D_ENST00000356315.4_Silent_p.P2861P		NM_015378.2	1279,787,137	NM_015378	0.8027			A	9.971	+	Silent	2	738.5+/-407.1	97.0	.	0.759192					.	VPS13D-001	2006-04-04		.		1	+	0.7398		.	0.986000	coding-synonymous,coding-synonymous	23595	276	2886/4389,2861/4364	Lung NSC(185;4.08e-05)|all_lung(284;4.55e-05)|Renal(390;0.000147)|Colorectal(325;0.00058)|Breast(348;0.00093)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	A	SO:0001819	608877	,	0.7624309392265194	protein_coding		2203	P		0.000000	19.6395,24.0808,21.1441	.		6503		0.176:0.4005:0.3599:0.0637			UCEC - Uterine corpus endometrioid carcinoma (279;0.0327)|Colorectal(212;4.63e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000289)|COAD - Colon adenocarcinoma(227;0.000801)|Kidney(185;0.00216)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0476)|Lung(427;0.209)			KNOWN	ENST00000011700		GCCGGCAGCCATTTGTCCCCT	.					ENST00000358136.3:c.8658A>C	1		ENSG00000048707	0.11100	VPS13D	NS(1)|breast(6)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(13)|large_intestine(28)|lung(44)|ovary(5)|pancreas(1)|prostate(8)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(4)		+	0.05858	,	CAT	1p36.21			g.chr1:12401868A>C		724.7+/-409.5		357	no		10256,2750	0.26846	0.22457	5.82	0.00012	.			.		.		-11.6	0.00059	515	.	0.9003496503496503	0.4		.			hg19	Standard	0.7913	0.725609756097561	8.5071	6911,1689			4052,2152,299	1.225393				CCDS30588.1, CCDS30589.1	A	.	CC,CA,AA	AJ608774		96	.	2504	-11.6	rs28551666		8788	.	593		"""vacuolar protein sorting 13D (yeast)"""	0.33195	12324455	+	,		FLJ10619, KIAA0453	1741	130	NM_015378	.	41	0.7823218997361477	-0.256000	ENST00000358136.3		16866		uc001atv.3			55187	dbSNP_125	8658,8583	0.0000		p.P2886P	.	0		T		95.0	rs28551666;rs60764499;rs28551666	0.567	1:g.12401868A>C	.	protein_coding	.		basic|appris_candidate_longest|CCDS		2773,1365,162		1708	3345,1061	0.7971611721611722	P	A|||		.	5008			3990	vacuolar protein sorting 13 homolog D (S. cerevisiae)		.	0.796725	0.00401	12401868		-3.659000	0.8978	SNP		CCDS30588.1		.	,,,	False	12401868	-1.0289		3	synonymous_variant	T	Approved	0.803605	96.0		c.8658A>C	2008-02-05	OTTHUMT00000036897.2	Q5THJ4	0.7579	.	VPS13D	12401868	0.74619	Ovarian(185;0.249)	0.19976	,	VPS13D	NM_015378.2,NM_018156.2	protein-coding gene	NP_056193.2	H	
		C	ENSG00000048707	ENST00000358136.3		55187		ENSG00000048707		4300					,					OTTHUMG00000013155		byFrequency		gene with protein product		VPS13D_ENST00000356315.4_Intron		NM_015378.2	2107,96,0	NM_015378	0.9346					+	Intron		780.6+/-407.7	50.0								VPS13D-001	2006-04-04				1	+	0.9962				intron,intron	23595		,	Lung NSC(185;4.08e-05)|all_lung(284;4.55e-05)|Renal(390;0.000147)|Colorectal(325;0.00058)|Breast(348;0.00093)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	608877	,		protein_coding		2203				9.6047,2.1788,7.089			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0327)|Colorectal(212;4.63e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000289)|COAD - Colon adenocarcinoma(227;0.000801)|Kidney(185;0.00216)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0476)|Lung(427;0.209)			KNOWN			AACCATTGGCTGATGACCTCA						ENST00000358136.3:c.10141+43T>C	1					NS(1)|breast(6)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(13)|large_intestine(28)|lung(44)|ovary(5)|pancreas(1)|prostate(8)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(4)		+		,		1p36.21			g.chr1:12418700T>C		816.3+/-416.2			no		12084,922												-4.2					0.0					hg19	Standard	0.9165			7774,826			5624,836,43					CCDS30588.1, CCDS30589.1	T		CC,CT,TT	AJ608774		51		2504		rs10864552		10271				"""vacuolar protein sorting 13D (yeast)"""				,		FLJ10619, KIAA0453		130	NM_015378		50			ENST00000358136.3		21238		uc001atv.3			55187	dbSNP_120	,					0				53.0		0.488	1:g.12418700T>C		protein_coding			basic|appris_candidate_longest|CCDS		3517,740,43			4310,96			T|||			5008			4828	vacuolar protein sorting 13 homolog D (S. cerevisiae)			0.964058		12418700			0.999	SNP		CCDS30588.1			,,,	False	12418700				intron_variant		Approved		51.0			2008-02-05	OTTHUMT00000036897.2	Q5THJ4	0.9625		VPS13D	12418700		Ovarian(185;0.249)		,	VPS13D	NM_015378.2,NM_018156.2	protein-coding gene	NP_056193.2		
		G	ENSG00000048707	ENST00000358136.3		55187		ENSG00000048707							,					OTTHUMG00000013155		byFrequency		gene with protein product		VPS13D_ENST00000356315.4_Intron|VPS13D_ENST00000543710.1_Intron|VPS13D_ENST00000471923.1_Intron|VPS13D_ENST00000543766.1_Intron|VPS13D_ENST00000496628.1_Intron		NM_015378.2		NM_015378	0.9877					+	Intron											VPS13D-001	2006-04-04					+	0.9977					23595			Lung NSC(185;4.08e-05)|all_lung(284;4.55e-05)|Renal(390;0.000147)|Colorectal(325;0.00058)|Breast(348;0.00093)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)		SO:0001627	608877			protein_coding														UCEC - Uterine corpus endometrioid carcinoma (279;0.0327)|Colorectal(212;4.63e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000289)|COAD - Colon adenocarcinoma(227;0.000801)|Kidney(185;0.00216)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0476)|Lung(427;0.209)			KNOWN			CTCAGCAGGAACTCATTTAGG						ENST00000358136.3:c.13035+85A>G	1					NS(1)|breast(6)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(13)|large_intestine(28)|lung(44)|ovary(5)|pancreas(1)|prostate(8)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(4)		+		,		1p36.21			g.chr1:12567232A>G																													hg19	Standard	0.9732											CCDS30588.1, CCDS30589.1	A			AJ608774				2504		rs7554257		13165				"""vacuolar protein sorting 13D (yeast)"""						FLJ10619, KIAA0453		130	NM_015378		69			ENST00000358136.3		18914		uc001atv.3			55187							0						0.647	1:g.12567232A>G		protein_coding			basic|appris_candidate_longest|CCDS								G|||			5008			4956	vacuolar protein sorting 13 homolog D (S. cerevisiae)			0.989617		12567232			0.997	SNP		CCDS30588.1			,,,	False	12567232				intron_variant		Approved					2008-02-05	OTTHUMT00000036897.2	Q5THJ4	0.9899		VPS13D			Ovarian(185;0.249)					protein-coding gene	NP_056193.2		
		C	ENSG00000162496	ENST00000376223.2		9249		ENSG00000162496		4300					,				c.(478-480)ccA>ccG	OTTHUMG00000001885		byFrequency	O75911	gene with protein product			Vitamin A(DB00162)	NM_004753.4	1505,636,62	NM_004753	0.8988					+	Silent		754.7+/-407.5	31.0				9705317, 12226107, 19027726				DHRS3-001					1	-	0.8011				coding-synonymous	17693		160/303	Lung NSC(185;4.11e-05)|all_lung(284;4.58e-05)|Renal(390;0.000147)|Colorectal(325;0.000585)|Breast(348;0.000596)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	612830			protein_coding		2203				14.3605,17.2492,15.3391		"""Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 3"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.023)|Colorectal(212;9.25e-07)|COAD - Colon adenocarcinoma(227;0.000326)|BRCA - Breast invasive adenocarcinoma(304;0.000344)|Kidney(185;0.00235)|KIRC - Kidney renal clear cell carcinoma(229;0.00656)|STAD - Stomach adenocarcinoma(313;0.00798)|READ - Rectum adenocarcinoma(331;0.0419)			KNOWN			CCAGCATACGTGGCAGGAAGG						ENST00000376223.2:c.480A>G	1					cervix(1)|large_intestine(4)|lung(2)|prostate(1)|skin(1)		-		,		1p36.1	B2R7F3|Q5VUY3|Q6UY38|Q9BUC8	"""short chain dehydrogenase/reductase family 16C, member 1"""	g.chr1:12638964T>C		742.6+/-411.4			no		11011,1995												-11.3					0.1	electron carrier activity (GO:0009055)|NADP-retinol dehydrogenase activity (GO:0052650)|nucleotide binding (GO:0000166)|retinol dehydrogenase activity (GO:0004745)				hg19	Standard	0.8469			7365,1235		bone morphogenesis (GO:0060349)|cardiac septum morphogenesis (GO:0060411)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|outflow tract morphogenesis (GO:0003151)|palate development (GO:0060021)|phototransduction, visible light (GO:0007603)|regulation of ossification (GO:0030278)|retinoid metabolic process (GO:0001523)|retinol metabolic process (GO:0042572)|visual perception (GO:0007601)	4667,1677,159					CCDS146.1	T		CC,CT,TT	AF061741	integral component of membrane (GO:0016021)|photoreceptor outer segment membrane (GO:0042622)	32		2504		rs2275875		863									160	retSDR1, Rsdr1, SDR1, RDH17, SDR16C1		9	XM_005263533		4			ENST00000376223.2		20562		uc001auc.3			9249	dbSNP_100	480			p.P160P		0				34.0		0.607	1:g.12638964T>C		protein_coding			basic|appris_principal|CCDS		3162,1041,97			3646,760			t|||			5008		DHRS3_HUMAN	4030	dehydrogenase/reductase (SDR family) member 3			0.804712		12638964			0.7282	SNP		CCDS146.1			,,,	False	12638964		1.1.-.-		synonymous_variant		Approved		32.0		c.480A>G	2011-09-20	OTTHUMT00000005318.1	O75911	0.7291		DHRS3	12638964		Ovarian(185;0.249)			DHRS3	NM_004753.4	protein-coding gene	NP_004744.2		
		T	ENSG00000188984	ENST00000359318.5	0.09310	126767	.	ENSG00000188984	0.02475	4197	0.064000	0.05258	B		,	T	0.9999999653933	0		OTTHUMG00000001887	-1.257000	byFrequency	Q5VUY0	gene with protein product		AADACL3_ENST00000332530.3_Start_Codon_SNP_p.M1L		NM_001103170.1	529,1022,488	NM_001103170	0.7423			a	2.908	+	De_novo_Start_OutOfFrame	1		158.0	Q5VUY0-2	0.510054					0.0	AADACL3-002			0.01281		1	+	0.4009		1	0.096000	missense,utr-5	32037	306	1/281,	Lung NSC(185;8.27e-05)|all_lung(284;9.47e-05)|Renal(390;0.000147)|Colorectal(325;0.000583)|Breast(348;0.000596)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	G			,	0.8453038674033149	protein_coding		2039	P		0.000000	16.8692,48.9946,27.3733	B		6236		0.1677:0.3222:0.2479:0.2622			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.00217)|KIRC - Kidney renal clear cell carcinoma(229;0.00579)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332530		TGCTGTTGACATGGGTGAGTT	T					ENST00000359318.5:c.-7A>T	1		ENSG00000188984	0.04230	AADACL3	breast(1)|kidney(1)|large_intestine(2)|lung(8)|ovary(1)|prostate(1)|skin(1)		+	0.05858	,	ATG	1p36.21	B3KXR9|Q5VUY1		g.chr1:12776344A>T				203	yes		9058,3414	0.19789	0.06022	5.0	0.00012	ENSP00000333352:M1L			.		.		-10.0	0.00425	361	0.02654	0.6311188811188811	0.1	hydrolase activity (GO:0016787)	.			hg19	Standard	0.8151	0.41260162601626016	1.0789	6978,1416			3420,2218,598	-0.226085				CCDS41253.1	A	0.02656	TT,TA,AA			165	.	2504	-10.0	rs3000859		199	1	618			0.01638	12698931	+	LEU/MET,		OTTHUMG00000001887	1488	15	XM_006710337	0.0	0	0.8153034300791556	-0.545000	ENST00000359318.5		19887		uc009vnn.1			126767	dbSNP_101	1,	0.0000			.	0		T		177.0	rs3000859;rs52831660;rs3000859	0.512	1:g.12776344A>T	ENSP00000333352:M1L	protein_coding	.		basic|appris_principal|CCDS		2891,1196,110		1	2080,1998	0.6813186813186813	L	a|||		.	5008		ADCL3_HUMAN	3288	arylacetamide deacetylase-like 3		.	0.65655	0.01112	12776344		-2.328000	0.619	SNP		CCDS41253.1		.	,,,	False	12776344	-0.9074		7		T	Approved	0.831308	165.0			2014-07-17	OTTHUMT00000005324.2	Q5VUY0	0.8473	3.47	AADACL3	12776344	0.18686	Ovarian(185;0.249)	0.47983	15,	AADACL3	NM_001103169.1,NM_001103170.1	protein-coding gene	NP_001096640.1	M	
		C	ENSG00000188984	ENST00000359318.5		126767		ENSG00000188984		4155					,				c.(79-81)gaT>gaC	OTTHUMG00000001887		byFrequency	Q5VUY0	gene with protein product		AADACL3_ENST00000332530.3_Intron		NM_001103170.1	1636,309,12	NM_001103170	0.817					+	Silent			162.0								AADACL3-002					1	+	0.9228				intron,coding-synonymous	32037		,27/351	Lung NSC(185;8.27e-05)|all_lung(284;9.47e-05)|Renal(390;0.000147)|Colorectal(325;0.000583)|Breast(348;0.000596)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819		,		protein_coding		1957				17.0638,8.5079,14.3243			6112					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.00217)|KIRC - Kidney renal clear cell carcinoma(229;0.00579)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TAAAGTATGATCCCGATGTTG						ENST00000359318.5:c.81T>C	1					breast(1)|kidney(1)|large_intestine(2)|lung(8)|ovary(1)|prostate(1)|skin(1)		+		,		1p36.21	B3KXR9|Q5VUY1		g.chr1:12779560T>C					no		10473,1751												-6.3					0.0	hydrolase activity (GO:0016787)				hg19	Standard	0.83			6892,1418			4500,1473,139					CCDS41253.1	T		CC,CT,TT			160		2504		rs3010876		286								,	27	OTTHUMG00000001887		15	XM_006710337		2			ENST00000359318.5		8510		uc009vnn.1			126767	dbSNP_101	,81			p.D27D		0				157.0		0.483	1:g.12779560T>C		protein_coding			basic|appris_principal|CCDS		2864,1164,127			3581,333			C|||			5008		ADCL3_HUMAN	4254	arylacetamide deacetylase-like 3			0.849441		12779560			0.7817	SNP		CCDS41253.1			,,,	False	12779560				synonymous_variant		Approved		160.0		c.81T>C	2014-07-17	OTTHUMT00000005324.2	Q5VUY0	0.8818		AADACL3	12779560		Ovarian(185;0.249)		,	AADACL3	NM_001103169.1,NM_001103170.1	protein-coding gene	NP_001096640.1		
		C	ENSG00000188984	ENST00000359318.5	0.58432	126767	N	ENSG00000188984	0.41662	4168	0.397000	0.02656	B		,	T	9.99999999995449E-6	0	c.(139-141)Tcc>Ccc	OTTHUMG00000001887	1.108000	byFrequency	Q5VUY0	gene with protein product		AADACL3_ENST00000332530.3_Intron		NM_001103170.1	1670,316,10	NM_001103170	0.816			C	0.175	+	Missense_Mutation	1		110.0	Q5VUY0	0.915832					0.0	AADACL3-002			0.01281		1	+	0.9228		1	0.034000	intron,missense	32037	316	,47/351	Lung NSC(185;8.27e-05)|all_lung(284;9.47e-05)|Renal(390;0.000147)|Colorectal(325;0.000583)|Breast(348;0.000596)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583		,benign	0.8729281767955801	protein_coding		1996	P		0.996000	17.0465,8.4168,14.2521	B		6164		0.0:0.9025:0.0:0.0975			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.00217)|KIRC - Kidney renal clear cell carcinoma(229;0.00579)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000359318		GCTGTACCAATCCAAGGCATC	T					ENST00000359318.5:c.139T>C	1		ENSG00000188984	0.08662	AADACL3	breast(1)|kidney(1)|large_intestine(2)|lung(8)|ovary(1)|prostate(1)|skin(1)	ENSP00000352268:p.Ser47Pro	+	0.38824	,	TCC	1p36.21	B3KXR9|Q5VUY1		g.chr1:12779618T>C	S -> P (in dbSNP:rs3010877).			451	yes		10571,1757	0.26308	0.01934	4.44	0.00012	ENSP00000352268:S47P			0.64402		-17.4213		4.4	0.53790	463	0.02654	0.8094405594405595	0.4	hydrolase activity (GO:0016787)	-2.67			hg19	Standard	0.826	0.9166666666666666	9.7469	6915,1421			4523,1525,116	-1.067753				CCDS41253.1	T	0.02656	CC,CT,TT			109	0.00026	2504	4.44	rs3010877		344	47	630			0.40453	12702205	+	,PRO/SER	47	OTTHUMG00000001887	1860	15	XM_006710337	0.0	2	0.8311345646437994	-0.320000	ENST00000359318.5		18666		uc009vnn.1			126767	dbSNP_101	,139	0.0000		p.S47P	.	0		T		105.0	rs3010877;rs52820652;rs59887427;rs3010877	0.517	1:g.12779618T>C	ENSP00000352268:S47P	protein_coding	0.000001		basic|appris_principal|CCDS		2853,1209,106		47	3656,336	0.8516483516483516	P	C|||		0.055747	5008		ADCL3_HUMAN	4247	arylacetamide deacetylase-like 3		ADCL3_HUMAN	0.848043	0.42963	12779618		2.226000	0.7817	SNP		CCDS41253.1		N	,,,	False	12779618	-1.0170		9	missense	T	Approved	0.829535	109.0		c.139T>C	2014-07-17	OTTHUMT00000005324.2	Q5VUY0	0.879	4.21	AADACL3	12779618	0.12701	Ovarian(185;0.249)	0.24083	,74	AADACL3	NM_001103169.1,NM_001103170.1	protein-coding gene	NP_001096640.1	S	
		T	ENSG00000188984	ENST00000359318.5	0.58432	126767	N	ENSG00000188984	0.84457	4094	0.464000	0.06849	B;B		,	T	1.0000000000287557E-6	0	c.(583-585)tGt>tTt	OTTHUMG00000001887	2.504000	byFrequency	Q5VUY0	gene with protein product		AADACL3_ENST00000332530.3_Missense_Mutation_p.C125F		NM_001103170.1	519,904,431	NM_001103170	0.7342			G	4.099	+	Missense_Mutation	2		137.0	Q5VUY0;Q5VUY0-2	0.523732					0.22;0.037	AADACL3-002			0.36244		1	+	0.4849		1	0.038000	missense,missense	32037	272	125/281,195/351	Lung NSC(185;8.27e-05)|all_lung(284;9.47e-05)|Renal(390;0.000147)|Colorectal(325;0.000583)|Breast(348;0.000596)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583		benign,benign	0.7513812154696132	protein_coding		1854	P		0.093000	26.7953,47.6268,33.2885	B;B		5948		0.1565:0.0:0.6728:0.1707			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.13e-06)|COAD - Colon adenocarcinoma(227;0.000274)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.00217)|KIRC - Kidney renal clear cell carcinoma(229;0.00579)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332530;ENST00000359318		ATCTGCTACTGTTTTTTTCAA	T;T					ENST00000359318.5:c.584G>T	1		ENSG00000188984	0.47621	AADACL3	breast(1)|kidney(1)|large_intestine(2)|lung(8)|ovary(1)|prostate(1)|skin(1)	ENSP00000352268:p.Cys195Phe	+	0.21703	,	TGT	1p36.21	B3KXR9|Q5VUY1		g.chr1:12785494G>T	C -> F (in dbSNP:rs7513079). {ECO:0000269|PubMed:14702039}.			238	yes		7936,3960	0.27143	0.07959	5.35	0.00012	ENSP00000333352:C125F			0.64402		-17.2471		5.3	0.76521	457	0.02654	0.798951048951049	0.5	hydrolase activity (GO:0016787)	-0.24			hg19	Standard	0.7296	0.483739837398374	5.3591	5994,2194			2700,2536,712	0.016412				CCDS41253.1	G	0.25719	TT,TG,GG			140	0.04275	2504	5.35	rs7513079		789	195;125	562			0.16077	12708081	+	PHE/CYS,PHE/CYS	195	OTTHUMG00000001887	1529	15	XM_006710337	0.132;0.017	4	0.741424802110818	0.484000	ENST00000359318.5		20711		uc009vnn.1			126767	dbSNP_116	374,584	0.0000		p.C195F	.	0		T		148.0	rs7513079;rs60105455;rs7513079	0.458	1:g.12785494G>T	ENSP00000333352:C125F;ENSP00000352268:C195F	protein_coding	0.000004		basic|appris_principal|CCDS		2181,1632,281		125;195	1942,1766	0.700091575091575	F	G|||		0.108387	5008		ADCL3_HUMAN	3417	arylacetamide deacetylase-like 3		ADCL3_HUMAN;.	0.682308	0.33746	12785494		1.327000	0.7798	SNP		CCDS41253.1		N	,,,	False	12785494	-0.9627		9	missense	T	Approved	0.732047	140.0		c.584G>T	2014-07-17	OTTHUMT00000005324.2	Q5VUY0	0.7752	3.25;3.52	AADACL3	12785494	0.13279	Ovarian(185;0.249)	0.39165	205,205	AADACL3	NM_001103169.1,NM_001103170.1	protein-coding gene	NP_001096640.1	C	
		C	ENSG00000157330	ENST00000288048.5	0.80722	93190	N	ENSG00000157330	0.01043	4300	0.000000	0.38077	B		,	T	0.0	0	c.(571-573)Ttc>Ctc	OTTHUMG00000001888	-1.940000	byFrequency	Q8N1D5	gene with protein product		C1orf158_ENST00000376210.3_Missense_Mutation_p.F153L		NM_152290.2	1756,424,23	NM_152290	0.7587			.	5.655	+	Missense_Mutation	1		66.0	Q8N1D5	0.893327		12477932			0.0	C1orf158-001			0.01281		1	+	0.9153		0.58	0.003000	missense	28567	302	191/195	Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)	C	SO:0001583		benign	0.8342541436464088	protein_coding		2203	P		0.000000	21.0581,10.6673,17.5381	B		6503		0.2301:0.3027:0.1124:0.3547			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;6.06e-06)|COAD - Colon adenocarcinoma(227;0.000273)|BRCA - Breast invasive adenocarcinoma(304;0.000311)|Kidney(185;0.00216)|KIRC - Kidney renal clear cell carcinoma(229;0.00575)|STAD - Stomach adenocarcinoma(313;0.00743)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000288048;ENST00000376210		CCTGCATCCTTTCCCACACTT	T;T					ENST00000288048.5:c.571T>C	1		ENSG00000157330	0.00189	C1orf158	central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|lung(1)|ovary(1)|skin(2)|urinary_tract(3)	ENSP00000288048:p.Phe191Leu	+	0.05858	,	TTC	1p36.21	Q5VUY4		g.chr1:12820870T>C	F -> L (in dbSNP:rs1132185). {ECO:0000269|PubMed:15489334}.			449	yes		10725,2281	0.03702	0.10678	4.34	0.00012	ENSP00000288048:F191L			0.01330		0.0239		-8.7	0.00859	457	0.13853	0.798951048951049	0.0		0			hg19	Standard	0.7873	0.9126016260162602	1.1769	6789,1811			4437,1851,215	0.305549				CCDS147.1	T	0.02656	CC,CT,TT	BX647383		68	0.08118	2504	-8.68	rs1132185		787	191	604			0.01837	12743457	+	LEU/PHE	191	MGC35194	1812	10	NM_152290	0.0	4	0.7968337730870713	-2.508000	ENST00000288048.5		18125		uc001auh.3			93190	dbSNP_86	571	0.0000		p.F191L	.	0		T		73.0	rs1132185;rs3192730;rs9430817;rs17038529;rs17038532;rs17845913;rs17858888;rs60888644;rs1132185	0.572	1:g.12820870T>C	ENSP00000288048:F191L;ENSP00000365383:F153L	protein_coding	0.011232		basic|appris_principal|CCDS		2681,1427,192		191;153	3936,470	0.8296703296703297	L	C|||		2.467460	5008		CA158_HUMAN	4124	chromosome 1 open reading frame 158		CA158_HUMAN	0.823482	0.04684	12820870		-0.774000	0.7808	SNP		CCDS147.1		N	,,,	False	12820870	-0.9927		9	missense	T	Approved	0.789419	68.0		c.571T>C	2008-02-05	OTTHUMT00000005325.1	Q8N1D5	0.8545	1.17;1.16	C1orf158	12820870	0.03518	Ovarian(185;0.249)	0.31888	22	C1orf158	NM_152290.2	protein-coding gene	NP_689503.2	F	
		C	ENSG00000116726	ENST00000357726.4	0.80722	390999	N	ENSG00000116726	0.03587	4300	0.000000	0.00949	B		,	T	0.0	0	c.(469-471)aTg>aCg	OTTHUMG00000001927	-0.966000	byFrequency	O95522	gene with protein product				NM_001080830.1	810,1053,340	XM_372760	0.7546			.	0.004	+	Missense_Mutation	2		125.0	O95522	0.606673					0.0	PRAMEF12-001			0.01281		1	+	0.5696		0.56	0.010000	missense	22125	294	157/484	Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)	C	SO:0001583		benign	0.8121546961325967	protein_coding		2203	P		0.000000	19.6512,39.3327,26.3186	B	"""-"""	6503		0.0:0.2483:0.5078:0.2439			UCEC - Uterine corpus endometrioid carcinoma (279;0.00818)|Colorectal(212;5.04e-06)|Kidney(185;4.99e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000198)|COAD - Colon adenocarcinoma(227;0.000245)|BRCA - Breast invasive adenocarcinoma(304;0.000295)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000357726		AAGAATGGGATGCTGGATGAA	T					ENST00000357726.4:c.470T>C	1		ENSG00000116726	0.03749	PRAMEF12	NS(2)|central_nervous_system(1)|cervix(1)|endometrium(2)|large_intestine(3)|lung(9)|ovary(3)|skin(1)|urinary_tract(1)	ENSP00000350358:p.Met157Thr	+	0.05858	,	ATG	1p36.21			g.chr1:12835868T>C	M -> T (in dbSNP:rs1812242).			283	yes		9583,3423	0.03702	0.00235	2.67	0.00012	ENSP00000350358:M157T			0.01490		.		-2.4	0.06602	418	0.14656	0.7307692307692307	0.0		-2.24			hg19	Standard	0.7982	0.5752032520325203	5.42	6910,1690		negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)	3564,2455,484	-2.316973				CCDS41254.1	T	0.02656	CC,CT,TT			123	0.00077	2504	-2.39	rs1812242|rs386628595		497	157	616			0.16396	12758455	+	THR/MET	157	OTTHUMG00000001927	1611	23	NM_001080830	0.0	2	0.8126649076517151	-0.684000	ENST00000357726.4		19544		uc001aui.3			390999	dbSNP_92	470	0.0000		p.M157T	.	0		T		119.0	rs1812242;rs2076217;rs56421762;rs59705408;rs1812242	0.532	1:g.12835868T>C	ENSP00000350358:M157T	protein_coding	0.017038		basic|appris_principal|CCDS		2754,1402,144		157	2673,1733	0.7376373626373627	T	t|||		2.671990	5008		PRA12_HUMAN	3588	PRAME family member 12		PRA12_HUMAN	0.716454	0.02194	12835868		-1.543000	0.7183	SNP		CCDS41254.1		N	,,,	False	12835868	-0.9952		9	missense	T	Approved	0.803488	123.0		c.470T>C	2013-01-17	OTTHUMT00000005457.1	O95522	0.8213	5.51	PRAMEF12	12835868	0.07245	Ovarian(185;0.249)	0.31194	81	PRAMEF12	NM_001080830.1	protein-coding gene	NP_001074299.1	M	
		C	ENSG00000116721	ENST00000332296.7		65121		ENSG00000116721		4293					,				c.(25-27)ctA>ctC	OTTHUMG00000001928		byFrequency	O95521	gene with protein product				NM_023013.2		NM_023013	0.4509					+	Silent			95.0								PRAMEF1-001					1	+	0.2466					28840			Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001819				protein_coding		2196						"""-"""	6489					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CACCCAGACTACTGGAGCTGG						ENST00000332296.7:c.27A>C	1					cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)		+		,		1p36.21	Q9UQP2		g.chr1:12853403A>C																													hg19	Standard	0.3767					negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)						CCDS148.1	A			AL049686				2504		rs1737157		130									9			35	NM_023013		2			ENST00000332296.7		23798		uc001auj.2			65121					p.L9L		0				90.0		0.542	1:g.12853403A>C		protein_coding			basic|appris_principal|CCDS								c|||			5008		PRAM1_HUMAN	1950	PRAME family member 1			0.389377		12853403			0.5595	SNP		CCDS148.1			,,,	False	12853403				synonymous_variant		Approved		93.0		c.27A>C	2013-01-17	OTTHUMT00000005458.1	O95521	0.3458		PRAMEF1	12853403		Ovarian(185;0.249)					protein-coding gene	NP_075389.1		
		A	ENSG00000116721	ENST00000332296.7	0.24544	65121	.	ENSG00000116721	0.40200	4300	0.261000	.	.			T	0.994052	0	c.(313-315)tTg>tAg	OTTHUMG00000001928	1.044000	byFrequency	O95521	gene with protein product				NM_023013.2		NM_023013				.	18.44	+	Nonsense_Mutation	2		152.0	.	.					.	PRAMEF1-001			.		1	+			1	0.196000		28840	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001587			.	protein_coding		2203	N		0.003000		.	"""-"""	6503		0.0:0.0:0.0:1.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296		GTGCTGGATTTGCGGGATGTT	.					ENST00000332296.7:c.314T>A	1		ENSG00000116721	0.28831	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Leu105*	+	0.15002		TTG	1p36.21	Q9UQP2		g.chr1:12854090T>A				.				0.24466	0.66901	1.7	.	ENSP00000332134:L105X			0.33875		.			0.24286	.	0.02654	.			.			hg19	Standard		.	5.5234			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		3.623770				CCDS148.1	T	.		AL049686			.		1.7	rs79698223		417	.	.			0.16945	12776677	+		105		.	35	NM_023013	.	3	.	0.438000	ENST00000332296.7				uc001auj.2			65121			.		p.L105*	.	0		.		139.0	.	0.522	1:g.12854090T>A	.	protein_coding	0.004477		basic|appris_principal|CCDS				105		.	X			0.186099			PRAM1_HUMAN		PRAME family member 1		.		0.33724	12854090		1.325000		SNP		CCDS148.1		N			12854090	.		.	stop_gained	.	Approved	.	147.0		c.314T>A	2013-01-17	OTTHUMT00000005458.1	O95521		.	PRAMEF1	12854090	0.23810	Ovarian(185;0.249)	.				protein-coding gene	NP_075389.1	L	
		C	ENSG00000116721	ENST00000332296.7		65121		ENSG00000116721		4300					,				c.(319-321)gaT>gaC	OTTHUMG00000001928		byFrequency	O95521	gene with protein product				NM_023013.2		NM_023013	0.3824					+	Silent			176.0								PRAMEF1-001					1	+	0.1619					28840			Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001819				protein_coding		2203						"""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			ATTTGCGGGATGTTGACGAGA						ENST00000332296.7:c.321T>C	1					cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)		+		,		1p36.21	Q9UQP2		g.chr1:12854097T>C																													hg19	Standard	0.4205					negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)						CCDS148.1	T			AL049686				2504		rs76193255		424									107			35	NM_023013		3			ENST00000332296.7		31810		uc001auj.2			65121					p.D107D		0				161.0		0.522	1:g.12854097T>C		protein_coding			basic|appris_principal|CCDS								t|||			5008		PRAM1_HUMAN	1640	PRAME family member 1			0.327476		12854097			0.3631	SNP		CCDS148.1			,,,	False	12854097				synonymous_variant		Approved		171.0		c.321T>C	2013-01-17	OTTHUMT00000005458.1	O95521	0.379		PRAMEF1	12854097		Ovarian(185;0.249)					protein-coding gene	NP_075389.1		
		G	ENSG00000116721	ENST00000332296.7	0.09310	65121	M	ENSG00000116721	0.18790	4300	0.000000	0.18338	P			T	1	0	c.(328-330)gAg>gGg	OTTHUMG00000001928	0.138000	byFrequency	O95521	gene with protein product				NM_023013.2		NM_023013				.	8.447	+	Missense_Mutation	2		188.0	O95521	.					0.2	PRAMEF1-001			0.35312		1	+			0.11	0.018000		28840	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		2203	N		0.001000		B	"""-"""	6503		0.7905:0.0:0.2095:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296		GATGTTGACGAGAATTTCTGG	T					ENST00000332296.7:c.329A>G	1		ENSG00000116721	0.06015	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Glu110Gly	+	0.12720		GAG	1p36.21	Q9UQP2		g.chr1:12854105A>G				.				0.03702	0.17034	1.7	0.23171	ENSP00000332134:E110G			0.02597		.			0.17114	.	0.46703	.			2.4			hg19	Standard		.	3.6651			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		0.852159				CCDS148.1	A	0.34587		AL049686			0.78223		0.532	rs76648802		432	110	.			0.08253	12776692	+		110		.	35	NM_023013	0.458	3	.	-0.419000	ENST00000332296.7				uc001auj.2			65121			0.0560		p.E110G	.	0		T		172.0	.	0.537	1:g.12854105A>G	ENSP00000332134:E110G	protein_coding	0.100687		basic|appris_principal|CCDS				110		.	G			1.946400			PRAM1_HUMAN		PRAME family member 1		PRAM1_HUMAN		0.22212	12854105		0.478000		SNP		CCDS148.1		N			12854105	-1.0254		10	missense	T	Approved	.	182.0		c.329A>G	2013-01-17	OTTHUMT00000005458.1	O95521		2.22	PRAMEF1	12854105	0.09664	Ovarian(185;0.249)	0.21143				protein-coding gene	NP_075389.1	E	
		T	ENSG00000116721	ENST00000332296.7	0.80722	65121	N	ENSG00000116721	0.11274	4300	0.000000	0.14640	B			T	0.0	0	c.(652-654)Cca>Tca	OTTHUMG00000001928	-0.146000		O95521	gene with protein product				NM_023013.2	7,945,1251	NM_023013				.	0.007	+	Missense_Mutation	1		273.0	O95521	0.217658					0.029	PRAMEF1-001			0.20384		1	+			0.44	0.001000	missense	28840	101	218/475	Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)	G	SO:0001583		benign	0.27900552486187846	protein_coding		2203	P		0.000000	31.5698,21.7658,28.2485	B	"""-"""	6503		0.0:0.4561:0.3162:0.2277			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296		CATGTCCTGGCCACGTCTGAT	T					ENST00000332296.7:c.652C>T	1		ENSG00000116721	0.05633	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Pro218Ser	+	0.05858		CCA	1p36.21	Q9UQP2		g.chr1:12854428C>T	P -> S (in dbSNP:rs1769774).			87	no		3674,9332	0.03702	0.00426	1.61	0.00012	ENSP00000332134:P218S			0.02045		.		-0.5	0.12064	215	0.20046	0.3758741258741259	0.0		-0.09			hg19	Standard		0.17682926829268292	2.601	2715,5885		negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)	268,3138,3097	-2.005143				CCDS148.1	C	0.15719	TT,TC,CC	AL049686		282	0.05230		-0.486	rs1769774		755	218	223			0.04867	12777015	+	SER/PRO	218		626	35	NM_023013	0.014	3	0.2941952506596306	-0.445000	ENST00000332296.7				uc001auj.2			65121	dbSNP_89	652	0.0000		p.P218S	.	0		T		298.0	rs1769774	0.393	1:g.12854428C>T	ENSP00000332134:P218S	protein_coding	0.049591		basic|appris_principal|CCDS		261,2193,1846		218	959,3447	0.2866300366300366	S			2.279790			PRAM1_HUMAN		PRAME family member 1		PRAM1_HUMAN		0.10741	12854428		-0.115000		SNP		CCDS148.1		N			12854428	-0.9126		9	missense	T	Approved	0.315698	282.0		c.652C>T	2013-01-17	OTTHUMT00000005458.1	O95521		2.49	PRAMEF1	12854428	0.01503	Ovarian(185;0.249)	0.47328	74	PRAMEF1	NM_023013.2	protein-coding gene	NP_075389.1	P	
		G	ENSG00000116721	ENST00000332296.7	0.80722	65121	N	ENSG00000116721	0.03168	4299	0.000000	0.00892	B		,	T	0.0	0	c.(754-756)Caa>Gaa	OTTHUMG00000001928	-1.065000	byFrequency	O95521	gene with protein product				NM_023013.2	1820,350,33	NM_023013	0.8446			.	0	+	Missense_Mutation	1		158.0	O95521	0.905583					0.001	PRAMEF1-001			0.04013		1	+	0.9259		1	0.000000	missense	28840	323	252/475	Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)	G	SO:0001583		benign	0.8922651933701657	protein_coding		2203	P		0.000000	14.3987,9.4417,12.7192	B	"""-"""	6502		.			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296		TAATGAACTCCAAGGACGGTT	T					ENST00000332296.7:c.754C>G	1		ENSG00000116721	0.05651	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Gln252Glu	+	0.05858	,	CAA	1p36.21	Q9UQP2		g.chr1:12854530C>G	Q -> E (in dbSNP:rs1063776).			453	no		11350,1654	0.03702	0.00076	0.725	0.00012	ENSP00000332134:Q252E			0.05509		.		-0.5	0.12100	460	0.02654	0.8041958041958042	0.0		-0.275			hg19	Standard	0.8638	0.9207317073170732	.	7360,1238		negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)	4986,1378,138	-2.797543				CCDS148.1	C	0.02656	GG,GC,CC	AL049686		158	0.04116	2504	-0.476	rs1063776		857	252	662			.	12777117	+	GLU/GLN	252		1898	35	NM_023013	0.0	3	0.8733509234828496	-0.444000	ENST00000332296.7		22877		uc001auj.2			65121	dbSNP_86	754	0.0000		p.Q252E	.	0		T		157.0	rs1063776;rs1737153;rs17038702;rs1063776	0.438	1:g.12854530C>G	ENSP00000332134:Q252E	protein_coding	0.559892		basic|appris_principal|CCDS		3166,1028,105		252	3990,416	0.8690476190476191	E	g|||		1.534590	5008		PRAM1_HUMAN	4343	PRAME family member 1		PRAM1_HUMAN	0.867212	0.00652	12854530		-3.001000	0.7986	SNP		CCDS148.1		N	,,,	False	12854530	-0.9996		8	missense	T	Approved	0.856013	158.0		c.754C>G	2013-01-17	OTTHUMT00000005458.1	O95521	0.8919	5.57	PRAMEF1	12854530	0.00434	Ovarian(185;0.249)	0.29912	29	PRAMEF1	NM_023013.2	protein-coding gene	NP_075389.1	Q	
		C	ENSG00000116721	ENST00000332296.7		65121		ENSG00000116721		4299					,				c.(766-768)gtT>gtC	OTTHUMG00000001928		byFrequency	O95521	gene with protein product				NM_023013.2	151,813,1239	NM_023013	0.4192					+	Silent			147.0								PRAMEF1-001					1	+	0.2254				coding-synonymous	28840		256/475	Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)	C	SO:0001819				protein_coding		2203				36.0084,25.3064,32.3823		"""-"""	6502					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GACGGTTAGTTGCCAAATTCA						ENST00000332296.7:c.768T>C	1					cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)		+		,		1p36.21	Q9UQP2		g.chr1:12854544T>C					no		4211,8793												-2.3					0.0					hg19	Standard	0.3509			3096,5502		negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)	787,2637,3078					CCDS148.1	T		CC,CT,TT	AL049686		147		2504		rs1063778		871									256			35	NM_023013		3			ENST00000332296.7		21791		uc001auj.2			65121	dbSNP_86	768			p.V256V		0				148.0		0.448	1:g.12854544T>C		protein_coding			basic|appris_principal|CCDS		636,1824,1839			1115,3291			c|||			5008		PRAM1_HUMAN	1798	PRAME family member 1			0.359026		12854544			0.5159	SNP		CCDS148.1			,,,	False	12854544				synonymous_variant		Approved		147.0		c.768T>C	2013-01-17	OTTHUMT00000005458.1	O95521	0.3127		PRAMEF1	12854544		Ovarian(185;0.249)			PRAMEF1	NM_023013.2	protein-coding gene	NP_075389.1		
		G	ENSG00000116721	ENST00000332296.7	0.58432	65121	M	ENSG00000116721	0.02652	4267	0.336000	0.13420	B		,	T	8.000000000008E-6	0	c.(1114-1116)gCc>gGc	OTTHUMG00000001928	-1.203000		O95521	gene with protein product		PRAMEF1_ENST00000400814.3_Missense_Mutation_p.A127G		NM_023013.2		NM_023013	1.0			.	3.589	+	Missense_Mutation	2		35.0	O95521	.					0.001	PRAMEF1-001			0.04013		1	+	1.0		0.09	0.001000		28840	337		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			0.930939226519337	protein_coding		2198	P		0.229000		B	"""-"""	6465		0.0:0.6091:0.2434:0.1474			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296;ENST00000400814		ATCCTGCCTGCCCTGAGCCGG	T;T					ENST00000332296.7:c.1115C>G	1		ENSG00000116721	0.00127	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Ala372Gly	+	0.23729	,	GCC	1p36.21	Q9UQP2		g.chr1:12855835C>G	A -> G (in dbSNP:rs1063795).			421				0.25522	0.07097	1.56	0.00012	ENSP00000332134:A372G			0.46758		.			0.07571	528	0.49607	0.9230769230769231			2.38			hg19	Standard	1.0	0.8556910569105691	6.1012			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-0.084054				CCDS148.1	C	0.12013		AL049686			0.77616	2504	-1.94	rs1063795		1218	372	677			0.20049	12778422	+		372		1963	35	NM_023013	0.005	4	0.8931398416886543	-2.740000	ENST00000332296.7		14792		uc001auj.2			65121			0.0000		p.A372G	.	0		T		34.0	rs1063795;rs3204827;rs1063795	0.577	1:g.12855835C>G	ENSP00000332134:A372G;ENSP00000383616:A127G	protein_coding	0.000267		basic|appris_principal|CCDS				372;127		0.8988095238095238	G	.|||		0.146955	5008		PRAM1_HUMAN	5008	PRAME family member 1		PRAM1_HUMAN	1.0	0.04963	12855835		-0.721000	1.0	SNP		CCDS148.1		N	,,,	False	12855835	-1.0583		9	missense	T	Approved	.	35.0		c.1115C>G	2013-01-17	OTTHUMT00000005458.1	O95521	1.0	2.59;2.59	PRAMEF1	12855835	0.01503	Ovarian(185;0.249)	0.11542				protein-coding gene	NP_075389.1	A	
		C	ENSG00000116721	ENST00000332296.7		65121		ENSG00000116721		4285					,				c.(1123-1125)cgG>cgC	OTTHUMG00000001928			O95521	gene with protein product		PRAMEF1_ENST00000400814.3_Silent_p.R130R		NM_023013.2		NM_023013	1.0					+	Silent			37.0								PRAMEF1-001					1	+	1.0					28840			Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001819				protein_coding		2202						"""-"""	6487					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CCCTGAGCCGGTGCTCCCAGC						ENST00000332296.7:c.1125G>C	1					cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)		+		,		1p36.21	Q9UQP2		g.chr1:12855845G>C	R -> C (in dbSNP:rs17039307).																												hg19	Standard	1.0					negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)						CCDS148.1	G			AL049686				2504		rs1063797		1228									375			35	NM_023013		4			ENST00000332296.7		14003		uc001auj.2			65121					p.R375R		0				37.0		0.557	1:g.12855845G>C		protein_coding			basic|appris_principal|CCDS								.|||			5008		PRAM1_HUMAN	5008	PRAME family member 1			1.0		12855845			1.0	SNP		CCDS148.1			,,,	False	12855845				synonymous_variant		Approved		37.0		c.1125G>C	2013-01-17	OTTHUMT00000005458.1	O95521	1.0		PRAMEF1	12855845		Ovarian(185;0.249)					protein-coding gene	NP_075389.1		
		C	ENSG00000116721	ENST00000332296.7	0.80722	65121	N	ENSG00000116721	0.20645	4296	0.004000	0.08102	B			T	0.0	2	c.(1156-1158)agA>agC	OTTHUMG00000001928	0.209000	byFrequency	O95521	gene with protein product		PRAMEF1_ENST00000400814.3_Missense_Mutation_p.R141S		NM_023013.2		NM_023013				.	5.873	+	Missense_Mutation	3		61.0	O95521	.					0.001	PRAMEF1-001			0.04013		1	+			0.27	0.001000		28840	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		2201	P		0.000000		B	"""-"""	6497		0.2595:0.0:0.7405:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296;ENST00000400814		ACTTTGGCAGAAATTGCATGT	T;T					ENST00000332296.7:c.1158A>C	1		ENSG00000116721	0.16884	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Arg386Ser	+	0.05858		AGA	1p36.21	Q9UQP2		g.chr1:12855878A>C	R -> S (in dbSNP:rs1052908).			.				0.12327	0.11126	1.56	0.02727	ENSP00000332134:R386S			0.17233		.			0.17524	.	0.30854	.			-0.49			hg19	Standard		.	3.6665			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		0.345180				CCDS148.1	A	0.02656		AL049686			0.02802		0.6	rs1052908		1261	386	.			0.08258	12778465	+		386		.	35	NM_023013	0.0	4	.	0.172000	ENST00000332296.7				uc001auj.2			65121			0.0082		p.R386S	.	0		T		68.0	rs1052908;rs1737156;rs3193394;rs4113156;rs17846294;rs17859318	0.572	1:g.12855878A>C	ENSP00000332134:R386S;ENSP00000383616:R141S	protein_coding	0.181858		basic|appris_principal|CCDS				386;141		.	S			0.582484			PRAM1_HUMAN		PRAME family member 1		PRAM1_HUMAN		0.01842	12855878		-1.738000		SNP		CCDS148.1		N			12855878	-0.9879		9	missense	T	Approved	.	63.0		c.1158A>C	2013-01-17	OTTHUMT00000005458.1	O95521		3.13;3.13	PRAMEF1	12855878	0.01503	Ovarian(185;0.249)	0.33163				protein-coding gene	NP_075389.1	R	
		G	ENSG00000116721	ENST00000332296.7	0.09310	65121	N	ENSG00000116721	0.18926	4299	0.001000	0.44881	B			T	1	2	c.(1288-1290)ttC>ttG	OTTHUMG00000001928	0.143000		O95521	gene with protein product		PRAMEF1_ENST00000400814.3_Missense_Mutation_p.F185L		NM_023013.2		NM_023013				.	0.006	+	Missense_Mutation	3		140.0	O95521	.					0.016	PRAMEF1-001			0.16722		1	+			1	0.006000		28840	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		2203	N		0.000000		B	"""-"""	6502		0.0:0.6631:0.0:0.3369			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296;ENST00000400814		GGGAGATCTTCACCCCACTTC	T;T					ENST00000332296.7:c.1290C>G	1		ENSG00000116721	0.17691	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Phe430Leu	+	0.05858		TTC	1p36.21	Q9UQP2		g.chr1:12856010C>G				.				0.08648	0.00382	1.56	0.13841	ENSP00000332134:F430L			0.07649		.			0.16825	.	0.02654	.			-0.605			hg19	Standard		.	3.3877			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-2.065489				CCDS148.1	C	0.12630		AL049686			0.02296		0.484	rs61775053		1393	430	.			0.07277	12778597	+		430		.	35	NM_023013	0.006	4	.	0.205000	ENST00000332296.7				uc001auj.2			65121			0.0335		p.F430L	.	0		T		139.0	rs61775053	0.567	1:g.12856010C>G	ENSP00000332134:F430L;ENSP00000383616:F185L	protein_coding	0.931547		basic|appris_principal|CCDS				430;185		.	L			1.036330			PRAM1_HUMAN		PRAME family member 1		PRAM1_HUMAN		0.01871	12856010		-1.720000		SNP		CCDS148.1		N			12856010	-0.9982		10	missense	T	Approved	.	140.0		c.1290C>G	2013-01-17	OTTHUMT00000005458.1	O95521		0.91;0.91	PRAMEF1	12856010	0.05464	Ovarian(185;0.249)	0.30327				protein-coding gene	NP_075389.1	F	
		T	ENSG00000116721	ENST00000332296.7	0.09310	65121	L	ENSG00000116721	0.12307	4101	0.000000	0.03413	B			T	1	0	c.(1390-1392)cCg>cTg	OTTHUMG00000001928	-0.097000		O95521	gene with protein product		PRAMEF1_ENST00000400814.3_Missense_Mutation_p.P219L		NM_023013.2		NM_023013				.	2.489	+	Missense_Mutation	2		35.0	O95521	.					0.029	PRAMEF1-001			0.20384		1	+			0.58	0.042000		28840	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		2060	N		0.000000		B	"""-"""	6161		.			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000332296;ENST00000400814		GGCTCATCACCGTCTGAGGAA	T;T					ENST00000332296.7:c.1391C>T	1		ENSG00000116721	0.02594	PRAMEF1	cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000332134:p.Pro464Leu	+	0.05858		CCG	1p36.21	Q9UQP2		g.chr1:12856111C>T				.				0.03702	0.05386	0.732	0.03651	ENSP00000332134:P464L			0.00166		.			0.13047	.	0.13853	.			1.15			hg19	Standard		.	.			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-0.317927				CCDS148.1	C	0.24092		AL049686			0.38175		-0.24	rs61775054		1494	464	.			.	12778698	+		464		.	35	NM_023013	0.097	4	.	-0.974000	ENST00000332296.7				uc001auj.2			65121			0.0104		p.P464L	.	0		T		29.0	rs61775054	0.557	1:g.12856111C>T	ENSP00000332134:P464L;ENSP00000383616:P219L	protein_coding	0.000000		basic|appris_principal|CCDS				464;219		.	L			15.581000			PRAM1_HUMAN		PRAME family member 1		PRAM1_HUMAN		0.11007	12856111		-0.099000		SNP		CCDS148.1		N			12856111	-0.9436		9	missense	T	Approved	.	33.0		c.1391C>T	2013-01-17	OTTHUMT00000005458.1	O95521		5.17;3.94	PRAMEF1	12856111	0.13812	Ovarian(185;0.249)	0.42699				protein-coding gene	NP_075389.1	P	
		A	ENSG00000116721	ENST00000332296.7		65121		ENSG00000116721		4246										OTTHUMG00000001928		byFrequency	O95521	gene with protein product		PRAMEF1_ENST00000400814.3_3'UTR		NM_023013.2		NM_023013						+	3'UTR			17.0								PRAMEF1-001					1	+						28840			Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.0042)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001624				protein_coding		2169						"""-"""	6415					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TTGCTGCTAGGGAAGGCGTGC						ENST00000332296.7:c.*1G>A	1					cervix(1)|endometrium(2)|kidney(3)|large_intestine(6)|lung(14)|ovary(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)		+				1p36.21	Q9UQP2		g.chr1:12856146G>A																													hg19	Standard						negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)						CCDS148.1	G			AL049686						rs1974302		1529												35	NM_023013		0			ENST00000332296.7				uc001auj.2			65121							0				14.0		0.512	1:g.12856146G>A		protein_coding			basic|appris_principal|CCDS													PRAM1_HUMAN		PRAME family member 1					12856146				SNP		CCDS148.1					12856146				3_prime_UTR_variant		Approved		16.0			2013-01-17	OTTHUMT00000005458.1	O95521			PRAMEF1	12856146		Ovarian(185;0.249)					protein-coding gene	NP_075389.1		
		C	ENSG00000179172	ENST00000317869.6		343069		ENSG00000179172		4299									c.(859-861)acC>acG	OTTHUMG00000001931			O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631		Substitution - coding silent(1)				+	Silent			135.0								HNRNPCL1-001					1	-						29295					SO:0001819				protein_coding	stomach(1)	2203						"""RNA binding motif (RRM) containing"""	6502								KNOWN			CCTGGCCATTGGTGCTGTCTC		HNRPCL1				ENST00000317869.6:c.861C>G	1					NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)		-				1p36.21	B2RP44		g.chr1:12907282G>C																									nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)		2008-04-18		hg19	Standard										p.T287T(1)		CCDS30591.1	G			BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)					rs139731855		1086									287			29	NM_001013631		2			ENST00000317869.6							343069					p.T287T		1				125.0		0.433	1:g.12907282G>C		protein_coding			basic|appris_principal|CCDS													HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1					12907282				SNP		CCDS30591.1					12907282				synonymous_variant		Approved		132.0		c.861C>G	2013-02-12	OTTHUMT00000005462.1	O60812			HNRNPCL1	12907282							protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1		
		C	ENSG00000179172	ENST00000317869.6	0.09310	343069	N	ENSG00000179172	0.07117	4299	0.023000	0.08102	B			T	0.999998	0	c.(859-861)Acc>Gcc	OTTHUMG00000001931	-0.449000		O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631		Substitution - Missense(1)		.	0.001	+	Missense_Mutation	1		135.0	O60812	.					0.001	HNRNPCL1-001			0.04013		1	-			1	0.004000		29295	.				SO:0001583			.	protein_coding	lung(1)	2203	N		1.000000		B	"""RNA binding motif (RRM) containing"""	6502		0.0:0.6152:0.0:0.3848						KNOWN	ENST00000317869		TGGCCATTGGTGCTGTCTCTG	T	HNRPCL1				ENST00000317869.6:c.859A>G	1		ENSG00000179172	0.01516	HNRNPCL1	NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)	ENSP00000365370:p.Thr287Ala	-	0.71417		ACC	1p36.21	B2RP44		g.chr1:12907284T>C				.				0.16930	0.00022	1.09	0.02342	ENSP00000365370:T287A			0.11722		.			0.09585	.	0.02654	.		nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)	-0.49	2008-04-18		hg19	Standard		.	5.5476					-3.254567		p.T287A(1)		CCDS30591.1	T	0.02656		BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)		0.02802		-1.19	rs149796618		1084	287	.			0.17073	12829871	-		287		.	29	NM_001013631	0.0	2	.	-1.249000	ENST00000317869.6							343069			0.0072		p.T287A	.	1		T		125.0	.	0.438	1:g.12907284T>C	ENSP00000365370:T287A	protein_coding	0.535811		basic|appris_principal|CCDS				287		.	A			0.678176			HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1		HNRCL_HUMAN		0.25794	12907284		0.713000		SNP		CCDS30591.1		N			12907284	-0.9317		10	missense	T	Approved	.	131.0		c.859A>G	2013-02-12	OTTHUMT00000005462.1	O60812		3.13	HNRNPCL1	12907284	0.04260		0.44605				protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1	T	
		C	ENSG00000179172	ENST00000317869.6	0.39889	343069	M	ENSG00000179172	0.07087		0.032000	0.14640	B			T	0.973741	2	c.(856-858)agC>agG	OTTHUMG00000001931	-0.452000		O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631		Substitution - Missense(1)		.	0.230	+	Missense_Mutation	3			O60812	.					0.002	HNRNPCL1-001			0.06405			-			0.12	0.003000		29295	.				SO:0001583			.	protein_coding	stomach(1)		D		1.000000		B	"""RNA binding motif (RRM) containing"""			0.1847:0.0:0.5685:0.2468						KNOWN	ENST00000317869		GGCCATTGGTGCTGTCTCTGT	T	HNRPCL1				ENST00000317869.6:c.858C>G	1		ENSG00000179172	0.00326	HNRNPCL1	NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)	ENSP00000365370:p.Ser286Arg	-	0.71417		AGC	1p36.21	B2RP44		g.chr1:12907285G>C				.				0.17829	0.02061	1.09	0.11410	ENSP00000365370:S286R			0.44483		.			0.08006	.	0.45353	.		nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)	2.045	2008-04-18		hg19	Standard		.	3.3012					-1.021841		p.S286R(1)		CCDS30591.1	G	0.09022		BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)		0.66939		-1.76	rs148930640		1083	286	.			0.06984	12829872	-		286		.	29	NM_001013631	0.002	2	.	-2.162000	ENST00000317869.6							343069			0.0278		p.S286R	.	1		T			.	0.438	1:g.12907285G>C	ENSP00000365370:S286R	protein_coding	0.000458		basic|appris_principal|CCDS				286		.	R			0.179946			HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1		HNRCL_HUMAN		0.22435	12907285		0.492000		SNP		CCDS30591.1		N			12907285	-1.0755		10	missense	T	Approved	.			c.858C>G	2013-02-12	OTTHUMT00000005462.1	O60812		2.49	HNRNPCL1		0.03518		0.07770				protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1	S	
		C	ENSG00000179172	ENST00000317869.6	0.24078	343069	M	ENSG00000179172	0.31285	4300	0.919000	0.13420	B			T	0.99595418	0	c.(826-828)gAg>gGg	OTTHUMG00000001931	0.676000		O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631				.	5.365	+	Missense_Mutation	2		155.0	O60812	.					0.0	HNRNPCL1-001			0.01281		1	-			0.1	0.134000		29295	.				SO:0001583			.	protein_coding		2203	P		1.000000		B	"""RNA binding motif (RRM) containing"""	6503		0.0:0.0:0.0:1.0						KNOWN	ENST00000317869		TTCCTCAGCCTCTTTTTCATC	T	HNRPCL1				ENST00000317869.6:c.827A>G	1		ENSG00000179172	0.16022	HNRNPCL1	NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)	ENSP00000365370:p.Glu276Gly	-	0.71417		GAG	1p36.21	B2RP44		g.chr1:12907316T>C				.				0.36401	0.10185	0.926	0.13200	ENSP00000365370:E276G			0.47093		.			0.19430	.	0.48119	.		nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)	2.045	2008-04-18		hg19	Standard		.	6.0631					0.252609				CCDS30591.1	T	0.06786		BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)		0.66939		0.926	rs112607517		1052	276	.			0.19848	12829903	-		276		.	29	NM_001013631	0.001	2	.	0.145000	ENST00000317869.6							343069			0.0320		p.E276G	.	0		T		135.0	.	0.483	1:g.12907316T>C	ENSP00000365370:E276G	protein_coding	0.000254		basic|appris_principal|CCDS				276		.	G			0.134611			HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1		HNRCL_HUMAN		0.40134	12907316		1.931000		SNP		CCDS30591.1		N			12907316	-1.0922		9	missense	T	Approved	.	148.0		c.827A>G	2013-02-12	OTTHUMT00000005462.1	O60812		2.59	HNRNPCL1	12907316	0.20937		0.04855				protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1	E	
		C	ENSG00000179172	ENST00000317869.6	0.25560	343069	L	ENSG00000179172	0.02574	4300	0.119000	0.10192	B			T	0.9870089	2	c.(343-345)ttT>ttG	OTTHUMG00000001931	-1.226000		O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631				.	9.385	+	Missense_Mutation	3		78.0	O60812	.					0.002	HNRNPCL1-001			0.06405		1	-			0.41	0.023000		29295	.				SO:0001583			.	protein_coding		2203	P		0.995000		B	"""RNA binding motif (RRM) containing"""	6503		0.6448:0.0:0.3552:0.0						KNOWN	ENST00000317869		AATCCCGTTGAAAGCCATAGT	T	HNRPCL1				ENST00000317869.6:c.345T>G	1		ENSG00000179172	0.01277	HNRNPCL1	NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)	ENSP00000365370:p.Phe115Leu	-	0.38212		TTT	1p36.21	B2RP44		g.chr1:12907798A>C				.				0.21687	0.20227	1.09	0.08358	ENSP00000365370:F115L			0.32258		.			0.07037	.	0.21540	.		nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)	1.82	2008-04-18		hg19	Standard		.	5.2817					1.074129				CCDS30591.1	A	0.06786		BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)		0.58583		-2.18	rs150096254		570	115	.			0.15678	12830385	-		115		.	29	NM_001013631	0.001	2	.	-1.328000	ENST00000317869.6							343069			0.0208		p.F115L	.	0		T		80.0	.	0.502	1:g.12907798A>C	ENSP00000365370:F115L	protein_coding	0.006349		basic|appris_principal|CCDS				115		.	L			0.199522			HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1		HNRCL_HUMAN		0.11431	12907798		-0.075000		SNP		CCDS30591.1		U			12907798	-0.9893		9	missense	T	Approved	.	79.0		c.345T>G	2013-02-12	OTTHUMT00000005462.1	O60812		2.9	HNRNPCL1	12907798	0.10783		0.32798				protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1	F	
		T	ENSG00000179172	ENST00000317869.6	0.50313	343069	N	ENSG00000179172	0.13244	4300	0.488000	0.08546	B			T	1.40000000000029E-4	0	c.(340-342)gGc>gAc	OTTHUMG00000001931	-0.055000		O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631				.	0.016	+	Missense_Mutation	2		80.0	O60812	.					0.0	HNRNPCL1-001			0.01281		1	-			0.43	0.048000		29295	.				SO:0001583			.	protein_coding		2203	P		0.998000		B	"""RNA binding motif (RRM) containing"""	6503		0.0:0.2867:0.0:0.7133						KNOWN	ENST00000317869		CCGTTGAAAGCCATAGTCCAA	T	HNRPCL1				ENST00000317869.6:c.341G>A	1		ENSG00000179172	0.03482	HNRNPCL1	NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)	ENSP00000365370:p.Gly114Asp	-	0.40836		GGC	1p36.21	B2RP44		g.chr1:12907802C>T				.				0.27440	0.00951	1.09	0.01092	ENSP00000365370:G114D			0.26971		.			0.12015	.	0.20519	.		nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)	-2.44	2008-04-18		hg19	Standard		.	3.125					-1.531386				CCDS30591.1	C	0.02656		BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)		0.00046		-0.499	rs138087690		566	114	.			0.06405	12830389	-		114		.	29	NM_001013631	0.0	2	.	-0.755000	ENST00000317869.6							343069			0.0036		p.G114D	.	0		T		82.0	.	0.502	1:g.12907802C>T	ENSP00000365370:G114D	protein_coding	0.021572		basic|appris_principal|CCDS				114		.	D			0.201041			HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1		HNRCL_HUMAN		0.34589	12907802		1.401000		SNP		CCDS30591.1		N			12907802	-0.9492		9	missense	T	Approved	.	81.0		c.341G>A	2013-02-12	OTTHUMT00000005462.1	O60812		3.08	HNRNPCL1	12907802	0.14542		0.41734				protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1	G	
		T	ENSG00000179172	ENST00000317869.6	0.52099	343069	N	ENSG00000179172	0.36871	4300	0.732000	0.10288	B			T	5.599999999994498E-5	0	c.(340-342)Ggc>Agc	OTTHUMG00000001931	0.916000		O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631				.	10.08	+	Missense_Mutation	1		81.0	O60812	.					0.0	HNRNPCL1-001			0.01281		1	-			0.41	0.060000		29295	.				SO:0001583			.	protein_coding		2203	P		1.000000		B	"""RNA binding motif (RRM) containing"""	6503		0.0:1.0:0.0:0.0						KNOWN	ENST00000317869		CGTTGAAAGCCATAGTCCAAG	T	HNRPCL1				ENST00000317869.6:c.340G>A	1		ENSG00000179172	0.27883	HNRNPCL1	NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)	ENSP00000365370:p.Gly114Ser	-	0.71417		GGC	1p36.21	B2RP44		g.chr1:12907803C>T				.				0.30844	0.22880	1.09	0.04182	ENSP00000365370:G114S			0.26971		.			0.20402	.	0.21540	.		nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)	0	2008-04-18		hg19	Standard		.	5.5784					1.251013				CCDS30591.1	C	0.02656		BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)		0.08118		1.09	rs141460546		565	114	.			0.17236	12830390	-		114		.	29	NM_001013631	0.0	2	.	0.416000	ENST00000317869.6							343069			0.0116		p.G114S	.	0		T		83.0	.	0.502	1:g.12907803C>T	ENSP00000365370:G114S	protein_coding	0.021572		basic|appris_principal|CCDS				114		.	S			0.201041			HNRC1_HUMAN		heterogeneous nuclear ribonucleoprotein C-like 1		HNRCL_HUMAN		0.33412	12907803		1.298000		SNP		CCDS30591.1		U			12907803	-1.0099		9	missense	T	Approved	.	82.0		c.340G>A	2013-02-12	OTTHUMT00000005462.1	O60812		2.89	HNRNPCL1	12907803	0.15804		0.26573				protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1	G	
		T	ENSG00000179172	ENST00000317869.6		343069		ENSG00000179172							,				c.(304-306)gcG>gcA	OTTHUMG00000001931		byFrequency	O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631	0.0031					+	Silent											HNRNPCL1-001						-	0.0182					29295					SO:0001819				protein_coding								"""RNA binding motif (RRM) containing"""									KNOWN			CGTACATCTCCGCTGCTGATC		HNRPCL1				ENST00000317869.6:c.306G>A	1					NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)		-		,		1p36.21	B2RP44		g.chr1:12907837C>T																									nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)		2008-04-18		hg19	Standard	0.005											CCDS30591.1	C			BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)			2504		rs1736811		531									102			29	NM_001013631		2			ENST00000317869.6		19760					343069					p.A102A		0						0.493	1:g.12907837C>T		protein_coding			basic|appris_principal|CCDS								.|||			5008		HNRC1_HUMAN	37	heterogeneous nuclear ribonucleoprotein C-like 1			0.00738818		12907837			0.0	SNP		CCDS30591.1			,,,	False	12907837				synonymous_variant		Approved				c.306G>A	2013-02-12	OTTHUMT00000005462.1	O60812	0.0072		HNRNPCL1								protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1		
		C	ENSG00000179172	ENST00000317869.6		343069		ENSG00000179172							,				c.(256-258)gcA>gcG	OTTHUMG00000001931		byFrequency	O60812	gene with protein product				NM_001013631.1|NM_001136561.2|NM_001146181.1		NM_001013631	0.9254					+	Silent											HNRNPCL1-001						-	0.9614					29295					SO:0001819				protein_coding								"""RNA binding motif (RRM) containing"""									KNOWN			CTTTTGGCTCTGCAGCCAGGT		HNRPCL1				ENST00000317869.6:c.258A>G	1	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.				NS(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(15)|prostate(1)|skin(1)|stomach(2)		-		,		1p36.21	B2RP44		g.chr1:12907885T>C																									nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)		2008-04-18		hg19	Standard	0.9433											CCDS30591.1	T			BC002696	nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)			2504		rs848418		483									86			29	NM_001013631		2			ENST00000317869.6		21034					343069					p.A86A		0						0.483	1:g.12907885T>C		protein_coding			basic|appris_principal|CCDS								.|||			5008		HNRC1_HUMAN	4577	heterogeneous nuclear ribonucleoprotein C-like 1			0.913938		12907885			0.8125	SNP		CCDS30591.1			,,,	False	12907885				synonymous_variant		Approved				c.258A>G	2013-02-12	OTTHUMT00000005462.1	O60812	0.9121		HNRNPCL1								protein-coding gene	NP_001013653.1|NP_001130033.2|NP_001139653.1		
		C	ENSG00000120952	ENST00000240189.2	0.29017	65122	N	ENSG00000120952	0.13244	4294	0.645000	0.08984	B		,	T	0.886535	0	c.(1123-1125)Tgc>Cgc	OTTHUMG00000001986	-0.055000	byFrequency	O60811	gene with protein product				NM_023014.1		NM_023014	0.407			C	0.004	+	Missense_Mutation	1		118.0	O60811	.					0.001	PRAMEF2-001			0.04013		1	+	0.4728		1	0.002000		28841	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		2201	N		0.000000		B	"""-"""	6495		0.0:0.6873:0.0:0.3127			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;2.4e-06)|Kidney(185;4.89e-05)|COAD - Colon adenocarcinoma(227;0.000152)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000240189		TGGCCTGAGCTGCTGCTCCCA	T					ENST00000240189.2:c.1123T>C	1		ENSG00000120952	0.01644	PRAMEF2	breast(2)|endometrium(1)|kidney(2)|large_intestine(2)|lung(22)|prostate(6)|skin(3)|upper_aerodigestive_tract(4)	ENSP00000240189:p.Cys375Arg	+	0.05858	,	TGC	1p36.21			g.chr1:12921332T>C	C -> R (in dbSNP:rs17039307).			.				0.29479	0.00254	0.824	0.01940	ENSP00000240189:C375R			0.04798		.			0.18818	.	0.02654	.			-1.355			hg19	Standard	0.3449	.	3.343			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-2.280337				CCDS149.1	T	0.02656					0.00583	2504	0.824	rs17039307		1210	375	.			0.07126	12843919	+		375	FLJ43580	.	42	NM_023014	0.0	4	.	-1.206000	ENST00000240189.2		27939		uc001aum.1			65122			0.0061		p.C375R	.	0		T		111.0	rs17039307	0.557	1:g.12921332T>C	ENSP00000240189:C375R	protein_coding	0.433017		basic|appris_principal|CCDS				375		.	R	.|||		1.330770	5008		PRAM2_HUMAN	2053	PRAME family member 2		PRAM2_HUMAN	0.409944	0.06688	12921332		-0.464000	0.4385	SNP		CCDS149.1		N	,,,	False	12921332	-0.9337		10	missense	T	Approved	.	115.0		c.1123T>C	2013-01-17	OTTHUMT00000005517.1	O60811	0.3473	3.03	PRAMEF2	12921332	0.02628	Ovarian(185;0.249)	0.44298				protein-coding gene	NP_075390.1	C	
		T	ENSG00000243073	ENST00000235349.5	0.09310	400735	M	ENSG00000243073	0.04988	2414	0.000000	0.18016	B		,	T	1	0	c.(328-330)Gtc>Atc	OTTHUMG00000001987	-0.712000	byFrequency	O60810	gene with protein product				NM_001009611.2	0,8,1281	NM_001009611	0.0041			c	7.132	+	Missense_Mutation	1		23.0	O60810	0.003103					0.041	PRAMEF4-001			0.22753		1	-	0.0		0.16	0.033000	missense	31971	.	110/479	Lung NSC(185;3.67e-05)|all_lung(284;4.03e-05)|Renal(390;0.000147)|Breast(348;0.000278)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583		benign	.	protein_coding		1289	N		0.000000	2.8583,0.3103,1.9714	B	"""-"""	3703		0.2531:0.3812:0.0:0.3657			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000235349		TTCTCACAGACATCCTGTAAA	T					ENST00000235349.5:c.328G>A	1		ENSG00000243073	0.26472	PRAMEF4	breast(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(10)|ovary(2)|prostate(3)|skin(1)	ENSP00000235349:p.Val110Ile	-	0.05858	,	GTC	1p36.21	Q5LJB5		g.chr1:12942222C>T				.	no		146,7260	0.03702	0.13686	1.48	0.06690	ENSP00000235349:V110I			0.05554		.		-2.3	0.06765	.	0.40728	.	0.0		2.415			hg19	Standard	0.0388	.	2.0725	138,4690		negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)	0,146,3557	0.580141				CCDS30592.1	C	0.15930	TT,TC,CC			21	0.78456	2504	-2.31	rs139729752		398	110	.			0.03617	12864809	-	ILE/VAL	110	RP5-845O24.6	.	24	NM_001009611	0.015	3	.	0.400000	ENST00000235349.5		21411		uc001aun.2			400735	dbSNP_134	328	0.0171		p.V110I	.	0		T		17.0	.	0.453	1:g.12942222C>T	ENSP00000235349:V110I	protein_coding	0.568046		basic|appris_principal|CCDS		0,138,2276		110	8,2570	.	I	c|||		1.262780	5008		PRAM4_HUMAN	56	PRAME family member 4		PRAM4_HUMAN	0.0111821	0.06704	12942222		-0.462000	0.0	SNP		CCDS30592.1		N	,,,	False	12942222	-0.9784		10	missense	T	Approved	0.028583	21.0		c.328G>A	2013-01-17	OTTHUMT00000005518.1	O60810	0.0187	2.24	PRAMEF4	12942222	0.12548	Ovarian(185;0.249)	0.35549	29	PRAMEF4	NM_001009611.2	protein-coding gene	NP_001009611.1	V	
		T	ENSG00000232423	ENST00000376189.1	0.80722	440561	N		0.02758	2621	0.000000	0.04015	B			T	0.0	0	c.(496-498)tGc>tAc	OTTHUMG00000001984	-1.173000		Q5VXH4	gene with protein product		PRAMEF6_ENST00000415464.2_Missense_Mutation_p.C166Y|PRAMEF6_ENST00000376192.5_Intron		NM_001010889.2		NM_001010889		Substitution - Missense(1)		.	0.001	+	Missense_Mutation	2		88.0	Q5VXH4	.					0.084	PRAMEF6-202			0.27887		1	-			1	0.000000		30583	.		Lung NSC(185;3.67e-05)|all_lung(284;4.03e-05)|Renal(390;0.000147)|Breast(348;0.000278)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)		SO:0001583			.	protein_coding	NS(1)	1436	P		0.000000		B	"""-"""	4057		0.2587:0.1856:0.0:0.5557			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376189;ENST00000415464;ENST00000355096		TAGAAGGAGGCAGGTGAGGTA	T;T;T					ENST00000376189.1:c.497G>A	1		ENSG00000232423	0.00779	PRAMEF6	NS(1)|kidney(1)|lung(5)|urinary_tract(2)	ENSP00000365360:p.Cys166Tyr	-	0.05858		TGC	1p36.21	A0AUJ9		g.chr1:13001186C>T				.				0.03702	0.00021	1.52	0.01254	ENSP00000347211:C166Y			0.12225		.			0.05429	.	0.02654	.			-0.75			hg19	Standard		.	2.6526			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-3.262924		p.C166Y(1)		CCDS30594.1	C	0.27229					0.01729		-3.03	rs200795385		596	166	.			0.05003	12923773	-		166		.	9	NM_001010889	0.172	3	.	-1.634000	ENST00000376189.1				uc001auq.2			440561			0.0041		p.C166Y	.	1		T		51.0	.	0.483	1:g.13001186C>T	ENSP00000365360:C166Y;ENSP00000401281:C166Y;ENSP00000347211:C166Y	protein_coding	0.488004		basic|appris_candidate_longest|CCDS				166		.	Y			0.745300			PRAM6_HUMAN		PRAME family member 6		PRAM6_HUMAN		0.10840	13001186		-0.109000		SNP		CCDS30594.1		N			13001186	-0.9629		9	missense	T	Approved	.	75.0		c.497G>A	2013-01-17		Q5VXH4		3.73;3.73;3.73	PRAMEF6	13001186	0.00434	Ovarian(185;0.249)	0.39121				protein-coding gene	NP_001010889.1	C	
		G	ENSG00000232423	ENST00000376189.1	0.80722	440561	L		0.19458	2707	0.001000	0.18016	P			T	0.0	0	c.(370-372)tGc>tCc	OTTHUMG00000001984	0.161000		Q5VXH4	gene with protein product		PRAMEF6_ENST00000415464.2_Missense_Mutation_p.C124S|PRAMEF6_ENST00000376192.5_Intron		NM_001010889.2		NM_001010889				.	4.406	+	Missense_Mutation	2		478.0	Q5VXH4	.					0.215	PRAMEF6-202			0.35971		1	-			0.36	0.002000		30583	.		Lung NSC(185;3.67e-05)|all_lung(284;4.03e-05)|Renal(390;0.000147)|Breast(348;0.000278)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)		SO:0001583			.	protein_coding		1510	P		0.001000		B	"""-"""	4217		0.0:0.6405:0.3595:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376189;ENST00000415464;ENST00000355096		ATTGAGGAAGCACCCACGGGC	T;T;T					ENST00000376189.1:c.371G>C	1		ENSG00000232423	0.25728	PRAMEF6	NS(1)|kidney(1)|lung(5)|urinary_tract(2)	ENSP00000365360:p.Cys124Ser	-	0.12720		TGC	1p36.21	A0AUJ9		g.chr1:13001312C>G				.				0.08648	0.08485	1.52	0.14700	ENSP00000347211:C124S			0.04624		.			0.16706	.	0.24483	.			1.63			hg19	Standard		.	5.4323			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		0.075063				CCDS30594.1	C	0.40476					0.52126		0.464	rs61779367		470	124	.			0.16460	12923899	-		124		.	9	NM_001010889	0.718	3	.	0.386000	ENST00000376189.1				uc001auq.2			440561			0.0355		p.C124S	.	0		T		309.0	.	0.498	1:g.13001312C>G	ENSP00000365360:C124S;ENSP00000401281:C124S;ENSP00000347211:C124S	protein_coding	0.402516		basic|appris_candidate_longest|CCDS				124		.	S			1.371720			PRAM6_HUMAN		PRAME family member 6		PRAM6_HUMAN		0.16422	13001312		0.158000		SNP		CCDS30594.1		N			13001312	-1.0039		9	missense	T	Approved	.	418.0		c.371G>C	2013-01-17		Q5VXH4		2.24;2.24;2.24	PRAMEF6	13001312	0.02628	Ovarian(185;0.249)	0.28586				protein-coding gene	NP_001010889.1	C	
		T		ENST00000376187.1	0.80722	653606	L	ENSG00000204508	0.05042	4299	0.000000	0.08807	B			T	0.0	0	c.(658-660)cCg>cTg	OTTHUMG00000074726	-0.704000	byFrequency	A3QJZ6	gene with protein product		PRAMEF6_ENST00000376192.5_Intron		NM_001100631.1		NM_001100631				.	0.006	+	Missense_Mutation	2		207.0	A3QJZ6	.					0.003	PRAMEF22-001			0.08055		1	+			1	0.000000		34393	.				SO:0001583			.	protein_coding		2201	P		0.000000		B	"""-"""	6500		0.0:0.2311:0.0:0.7689						KNOWN	ENST00000376187		ATGTGCTGGCCGTGTATGATA	T					ENST00000376187.1:c.659C>T	1		ENSG00000204508	0.02071	PRAMEF22	kidney(1)|large_intestine(2)|lung(1)|skin(1)	ENSP00000365358:p.Pro220Leu	+	0.05858		CCG	1p36.21	A6NMM3		g.chr1:13036587C>T				.				0.03702	0.00398	1.18	0.08044	ENSP00000365358:P220L			0.01519		.			0.06684	.	0.02654	.			1.87			hg19	Standard		.	5.0787			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-2.045179					C	0.06786					0.60455		-2.35	rs61780078		659	220	.			0.14646	12959174	+		220	PRAMEF3L	.	5	NM_001100631	0.001	2	.	-1.111000	ENST00000376187.1				uc009vnq.1			653606			0.0201		p.P220L	.	0		T		175.0	.	0.428	1:g.13036587C>T	ENSP00000365358:P220L	protein_coding	0.018283		mRNA_start_NF|mRNA_end_NF|cds_end_NF|basic|appris_principal|CCDS				220		.	L			2.874040			PRA22_HUMAN		PRAME family member 22		PRA22_HUMAN		0.17037	13036587		0.189000		SNP		CCDS41256.1		N			13036587	-0.9611		9	missense	T	Approved	.	196.0		c.659C>T	2013-01-17	OTTHUMT00000158511.1	A3QJZ6		3.05	PRAMEF22	13036587	0.00434		0.39502				protein-coding gene	NP_001094101.1	P	
		T		ENST00000376132.3	0.80722		N	ENSG00000204495	0.00806	901	0.000000	0.47869	B;B			T	0.0	0	c.(1276-1278)Gat>Aat	OTTHUMG00000008034	-2.140000		Q5VWM6	gene with protein product				NM_001024661.1		XM_375688				C	0.059	+	Missense_Mutation	1		1.0	Q5VWM6;A6NFR9	.					0.001;0.001	PRAMEF13-001			0.04013		1	-			0.33	0.003000		13262	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		933	P		0.000000		B;B	"""-"""	1834		0.1748:0.207:0.2245:0.3937			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;9.86e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|COAD - Colon adenocarcinoma(227;0.000502)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376132		ATCTCCCAATCGACACGAACC	T					ENST00000376132.3:c.1276G>A	1		ENSG00000204495	0.00466	PRAMEF13	breast(1)|large_intestine(1)|lung(3)|skin(2)	ENSP00000365302:p.Asp426Asn	-	0.05858		GAT	1p36.21			g.chr1:13448199C>T				.				0.03702	0.01518	1.2	0.17959	ENSP00000365302:D426N			0.04094		.			0.06562	.	0.26408	.			-0.755			hg19	Standard		.	0.489			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-1.229050					C	0.02656					0.01705		-2.41	rs143762964		1378	426;426	.			0.00561	13320786	-		426	OTTHUMG00000008034	.	7	NG_005159	0.0;0.0	4	.	-1.969000	ENST00000376132.3				uc010obi.1			400736			0.0431		p.D426N	.	0		T		4.0	.	0.567	1:g.13448199C>T	ENSP00000365302:D426N	protein_coding	0.311766		not_best_in_genome_evidence|basic|appris_principal|CCDS				426		.	N			1.467820			PRA13_HUMAN		PRAME family member 13		PRA13_HUMAN;.		0.03138	13448199		-1.163000		SNP		CCDS41257.1		N			13448199	-1.1040		9	missense	T	Approved	.	3.0		c.1276G>A	2013-01-17	OTTHUMT00000022040.1	Q5VWM6		0.83	PRAMEF13	13448199	0.03518	Ovarian(185;0.249)	0.03403				protein-coding gene	NP_001019832.1	D	
		G		ENST00000376132.3				ENSG00000204495		4297									c.(1192-1194)Ttg>Ctg	OTTHUMG00000008034		byFrequency	Q5VWM6	gene with protein product				NM_001024661.1		XM_375688						+	Silent			71.0								PRAMEF13-001					1	-						13262			Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001819				protein_coding		2203						"""-"""	6500					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;9.86e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|COAD - Colon adenocarcinoma(227;0.000502)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GTGTGGCGCAACAGGTCCTTC						ENST00000376132.3:c.1192T>C	1					breast(1)|large_intestine(1)|lung(3)|skin(2)		-				1p36.21			g.chr1:13448283A>G																													hg19	Standard						negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)							A									rs80327699		1294									398	OTTHUMG00000008034		7	NG_005159		4			ENST00000376132.3				uc010obi.1			400736					p.L398L		0				77.0		0.552	1:g.13448283A>G		protein_coding			not_best_in_genome_evidence|basic|appris_principal|CCDS													PRA13_HUMAN		PRAME family member 13					13448283				SNP		CCDS41257.1					13448283				synonymous_variant		Approved		73.0		c.1192T>C	2013-01-17	OTTHUMT00000022040.1	Q5VWM6			PRAMEF13	13448283		Ovarian(185;0.249)					protein-coding gene	NP_001019832.1		
		C		ENST00000376132.3	0.80722		N	ENSG00000204495	0.01632	3466	0.069000	0.08984	B;B			T	0.0	0	c.(1123-1125)cAc>cGc	OTTHUMG00000008034	-1.586000	byFrequency	Q5VWM6	gene with protein product				NM_001024661.1		XM_375688				T	0	+	Missense_Mutation	2		10.0	Q5VWM6;A6NFR9	.					0.001;0.0	PRAMEF13-001			0.04013		1	-			1	0.009000		13262	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		1832	P		0.064000		B;B	"""-"""	5298		0.0:0.3485:0.0:0.6515			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;9.86e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|COAD - Colon adenocarcinoma(227;0.000502)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376132		CTGGGAGCAGTGGCTCAGGCC	T					ENST00000376132.3:c.1124A>G	1		ENSG00000204495	0.00472	PRAMEF13	breast(1)|large_intestine(1)|lung(3)|skin(2)	ENSP00000365302:p.His375Arg	-	0.20934		CAC	1p36.21			g.chr1:13448351T>C				.				0.20011	0.00105	1.2	0.02455	ENSP00000365302:H375R			0.06173		.			0.06562	.	0.02654	.			-0.75			hg19	Standard		.	6.0386			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-2.668736					T	0.02656					0.01729		-2.41	rs71183793		1226	375;375	.			0.19722	13320938	-		375	OTTHUMG00000008034	.	7	NG_005159	0.0;0.0	4	.	-1.964000	ENST00000376132.3				uc010obi.1			400736			0.0075		p.H375R	.	0		T		10.0	.	0.547	1:g.13448351T>C	ENSP00000365302:H375R	protein_coding	0.678136		not_best_in_genome_evidence|basic|appris_principal|CCDS				375		.	R			1.164400			PRA13_HUMAN		PRAME family member 13		PRA13_HUMAN;.		0.07305	13448351		-0.393000		SNP		CCDS41257.1		N			13448351	-0.9534		9	missense	T	Approved	.	10.0		c.1124A>G	2013-01-17	OTTHUMT00000022040.1	Q5VWM6		3.03	PRAMEF13	13448351	0.06853	Ovarian(185;0.249)	0.40979				protein-coding gene	NP_001019832.1	H	
		G	ENSG00000204480	ENST00000376101.2	0.09310	645414	N	ENSG00000204480	0.06046	4066	0.001000	0.61510	B		,	T	1	0	c.(970-972)gGt>gCt	OTTHUMG00000007919	-0.567000	byFrequency	Q5SWL8	gene with protein product		PRAMEF19_ENST00000540591.1_Missense_Mutation_p.G393A				NM_001099790	0.9949			C	0.003	+	Missense_Mutation	2		8.0	F5H544	.					0.0	PRAMEF19-001			0.01281		1	-	0.9864		0.86	0.025000		24908	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		1973	N		0.000000		B	"""-"""	6039		0.4515:0.3142:0.2343:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376101;ENST00000540591		GTCCTTCAGACCATCCATGGA	T;T					ENST00000376101.2:c.971G>C	1		ENSG00000204480	0.00515	PRAMEF19	lung(3)	ENSP00000365269:p.Gly324Ala	-	0.05858	,	GGT	1p36.21			g.chr1:13695787C>G				.				0.08648	0.00188	1.18	0.22898	ENSP00000365269:G324A			0.01288		.			0.13535	.	0.06891	.			-1.015			hg19	Standard	0.9821	.	2.244			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-2.421381					C	0.02656					0.01096	2504	-0.121	rs202245256		970	393	.			0.04026	13568374	-		324	OTTHUMG00000007919	.	3	NM_001099790	0.0	3	.	-1.920000	ENST00000376101.2		14994		uc009vnu.1			645414			0.0553		p.G324A	.	0		T		7.0	.	0.567	1:g.13695787C>G	ENSP00000365269:G324A;ENSP00000446004:G393A	protein_coding	0.009937		basic				324;393		.	A	c|||		2.732730	5008		PRA19_HUMAN	4964	PRAME family member 19		.	0.991214	0.01582	13695787		-1.912000	0.999	SNP				N	,,,	False	13695787	-1.0023		10	missense	T	Approved	.	8.0		c.971G>C	2013-01-17	OTTHUMT00000021794.2	Q5SWL8	0.9971	0.1;3.09	PRAMEF19	13695787	0.11179	Ovarian(185;0.249)	0.29088				protein-coding gene		G	
		A	ENSG00000204480	ENST00000376101.2		645414		ENSG00000204480		3987									c.(940-942)tgC>tgT	OTTHUMG00000007919		byFrequency	Q5SWL8	gene with protein product		PRAMEF19_ENST00000540591.1_Silent_p.C383C				NM_001099790						+	Silent			41.0								PRAMEF19-001					1	-						24908			Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001819				protein_coding		1966						"""-"""	5953					UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TGCCGTGAAAGCAGAAAGTGG						ENST00000376101.2:c.942C>T	1					lung(3)		-				1p36.21			g.chr1:13695816G>A																													hg19	Standard						negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)							G									rs148990958		941									314	OTTHUMG00000007919		3	NM_001099790		3			ENST00000376101.2				uc009vnu.1			645414					p.C314C		0				32.0		0.567	1:g.13695816G>A		protein_coding			basic													PRA19_HUMAN		PRAME family member 19					13695816				SNP							13695816				synonymous_variant		Approved		38.0		c.942C>T	2013-01-17	OTTHUMT00000021794.2	Q5SWL8			PRAMEF19	13695816		Ovarian(185;0.249)					protein-coding gene			
		C	ENSG00000204480	ENST00000376101.2	0.80722	645414	L	ENSG00000204480	0.05959	1902	0.000000	0.50548	B		,	T	0.0	0	c.(784-786)Aca>Gca	OTTHUMG00000007919	-0.578000	byFrequency	Q5SWL8	gene with protein product		PRAMEF19_ENST00000540591.1_Missense_Mutation_p.T331A				NM_001099790	0.998			T	1.103	+	Missense_Mutation	1		2.0	F5H544	.					0.001	PRAMEF19-001			0.04013		1	-	0.9947		0.59	0.019000		24908	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		804	P		0.000000		B	"""-"""	2706		0.0:0.2317:0.0:0.7683			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376101;ENST00000540591		AAGCGCAGTGTACCATGACTC	T;T					ENST00000376101.2:c.784A>G	1		ENSG00000204480	0.00730	PRAMEF19	lung(3)	ENSP00000365269:p.Thr262Ala	-	0.05858	,	ACA	1p36.21			g.chr1:13695974T>C				.				0.03702	0.03454	1.18	0.35393	ENSP00000365269:T262A			0.01706		.			0.13531	.	0.13470	.			1.125			hg19	Standard	0.9831	.	4.9058			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-0.660587					T	0.02656					0.37697	2504	-0.122	rs142734546		783	331	.			0.13797	13568561	-		262	OTTHUMG00000007919	.	3	NM_001099790	0.0	3	.	-1.687000	ENST00000376101.2		11601		uc009vnu.1			645414			0.0930		p.T262A	.	0		T		2.0	.	0.502	1:g.13695974T>C	ENSP00000365269:T262A;ENSP00000446004:T331A	protein_coding	0.027433		basic				262;331		.	A	t|||		2.165120	5008		PRA19_HUMAN	4977	PRAME family member 19		.	0.99381	0.11357	13695974		-0.079000	0.998	SNP				N	,,,	False	13695974	-1.0880		9	missense	T	Approved	.	2.0		c.784A>G	2013-01-17	OTTHUMT00000021794.2	Q5SWL8	0.9957	0.74;0.74	PRAMEF19	13695974	0.09904	Ovarian(185;0.249)	0.05517				protein-coding gene		T	
		T	ENSG00000204480	ENST00000376101.2	0.80722	645414	N	ENSG00000204480	0.02503	2677	0.000000	0.39056	B		,	T	0.0	2	c.(709-711)gaT>gaA	OTTHUMG00000007919	-1.248000	byFrequency	Q5SWL8	gene with protein product		PRAMEF19_ENST00000540591.1_Missense_Mutation_p.D306E				NM_001099790	0.9969			A	1.767	+	Missense_Mutation	3		2.0	F5H544	.					0.0	PRAMEF19-001			0.01281		1	-	0.9992		0.09	0.126000		24908	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		1191	P		0.000000		B	"""-"""	3868		0.5078:0.2841:0.0:0.2081			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376101;ENST00000540591		AGTCCTCTTCATCTAGGGAGC	T;T					ENST00000376101.2:c.711T>A	1		ENSG00000204480	0.00732	PRAMEF19	lung(3)	ENSP00000365269:p.Asp237Glu	-	0.05858	,	GAT	1p36.21			g.chr1:13696047A>T				.				0.03702	0.04352	1.18	0.19927	ENSP00000365269:D237E			0.06049		.			0.06663	.	0.49607	.			0			hg19	Standard	0.9722	.	2.5232			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-0.485379					A	0.02656					0.08118	2504	-2.36	rs2101624		710	306	.			0.04685	13568634	-		237	OTTHUMG00000007919	.	3	NM_001099790	0.0	3	.	-1.686000	ENST00000376101.2		12719		uc009vnu.1			645414			0.0479		p.D237E	.	0		T		2.0	.	0.517	1:g.13696047A>T	ENSP00000365269:D237E;ENSP00000446004:D306E	protein_coding	0.656322		basic				237;306		.	E	a|||		1.191720	5008		PRA19_HUMAN	4973	PRAME family member 19		.	0.993011	0.00948	13696047		-2.524000	0.999	SNP				N	,,,	False	13696047	-1.0544		9	missense	T	Approved	.	2.0		c.711T>A	2013-01-17	OTTHUMT00000021794.2	Q5SWL8	0.9971	1.1;1.1	PRAMEF19	13696047	0.20510	Ovarian(185;0.249)	0.12528				protein-coding gene		D	
		A	ENSG00000204480	ENST00000376101.2	0.80722	645414	N	ENSG00000204480	0.03775	2503	0.000000	0.54279	B		,	T	0.0	0	c.(703-705)tCc>tTc	OTTHUMG00000007919	-0.925000	byFrequency	Q5SWL8	gene with protein product		PRAMEF19_ENST00000540591.1_Missense_Mutation_p.S304F				NM_001099790	0.9969			G	1.241	+	Missense_Mutation	2		2.0	F5H544	.					0.002	PRAMEF19-001			0.06405		1	-	0.9992		0.69	0.207000		24908	.		Renal(390;0.000469)|Lung NSC(185;0.00143)|all_lung(284;0.00181)|Colorectal(325;0.00215)|Breast(348;0.00224)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0731)		SO:0001583			.	protein_coding		1114	P		0.000000		B	"""-"""	3617		0.3415:0.0:0.3866:0.2719			UCEC - Uterine corpus endometrioid carcinoma (279;0.00812)|Colorectal(212;4.88e-06)|Kidney(185;4.89e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.000194)|COAD - Colon adenocarcinoma(227;0.000241)|BRCA - Breast invasive adenocarcinoma(304;0.000293)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000376101;ENST00000540591		TTCATCTAGGGAGCCATAAGT	T;T					ENST00000376101.2:c.704C>T	1		ENSG00000204480	0.16502	PRAMEF19	lung(3)	ENSP00000365269:p.Ser235Phe	-	0.05858	,	TCC	1p36.21			g.chr1:13696054G>A				.				0.03702	0.03636	1.18	0.29093	ENSP00000365269:S235F			0.01139		.			0.06663	.	0.10377	.			0.345			hg19	Standard	0.9761	.	1.9492			negative regulation of apoptotic process (GO:0043066)|negative regulation of cell differentiation (GO:0045596)|negative regulation of retinoic acid receptor signaling pathway (GO:0048387)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of cell proliferation (GO:0008284)		-0.621243					G	0.02656					0.14661	2504	-2.36	rs200378484		703	304	.			0.03363	13568641	-		235	OTTHUMG00000007919	.	3	NM_001099790	0.0	3	.	0.162000	ENST00000376101.2		13169		uc009vnu.1			645414			0.0723		p.S235F	.	0		T		1.0	.	0.507	1:g.13696054G>A	ENSP00000365269:S235F;ENSP00000446004:S304F	protein_coding	0.006148		basic				235;304		.	F	g|||		3.404900	5008		PRA19_HUMAN	4977	PRAME family member 19		.	0.99381	0.02518	13696054		-1.394000	0.999	SNP				N	,,,	False	13696054	-1.0810		9	missense	T	Approved	.	2.0		c.704C>T	2013-01-17	OTTHUMT00000021794.2	Q5SWL8	0.9971	0.58;5.43	PRAMEF19	13696054	0.24258	Ovarian(185;0.249)	0.06734				protein-coding gene		S	
		G	ENSG00000162493	ENST00000509009.1	0.58432	10630	N	ENSG00000162493	0.49373	4300	0.078000	0.12147	B;B;B;B		,	T	1.0000000000287557E-6	0	c.(424-426)gCa>gGa	OTTHUMG00000007912	1.545000	byFrequency		gene with protein product		PDPN_ENST00000294489.6_Missense_Mutation_p.A223G|PDPN_ENST00000475043.1_Missense_Mutation_p.A105G|PDPN_ENST00000513143.1_Missense_Mutation_p.A105G|PDPN_ENST00000487038.1_Missense_Mutation_p.A105G|PDPN_ENST00000376057.4_Missense_Mutation_p.A223G|PDPN_ENST00000376061.4_Missense_Mutation_p.A105G			2161,42,0	NM_006474	0.9867			G	5.245	+	Missense_Mutation	2	125.0+/-183.6	185.0	Q86YL7;E9PB68;Q86YL7-3;Q86YL7-4	0.990468		10393083, 9651190			0.0;0.0;0.0;0.0	PDPN-009			0.01281		1	+	0.9985		1	0.849000	missense,missense,missense,missense	29602	359	105/121,105/119,223/239,223/237	all_lung(284;2.29e-05)|Lung NSC(185;4.37e-05)|Renal(390;0.000147)|Breast(348;0.000162)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583	608863	benign,benign,benign,benign	0.9917127071823204	protein_coding		2203	P		0.896000	4.5233,0.9532,3.3139	B;B;B;B		6503		0.0:0.1576:0.8424:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00969)|Colorectal(212;4.48e-06)|COAD - Colon adenocarcinoma(227;0.000194)|BRCA - Breast invasive adenocarcinoma(304;0.000347)|Kidney(185;0.00087)|KIRC - Kidney renal clear cell carcinoma(229;0.0027)|STAD - Stomach adenocarcinoma(313;0.00802)|READ - Rectum adenocarcinoma(331;0.0678)			PUTATIVE	ENST00000294489;ENST00000376057;ENST00000510906;ENST00000509009;ENST00000376061;ENST00000513143;ENST00000487038;ENST00000475043		TTCATTGGTGCAATCATCGTT	T;T;T;T;T;T;T;T					ENST00000509009.1:c.425C>G	1		ENSG00000162493	0.15030	PDPN	endometrium(3)|kidney(2)|large_intestine(2)|liver(2)|lung(3)|ovary(2)|skin(1)|upper_aerodigestive_tract(1)	ENSP00000422977:p.Ala142Gly	+	0.30565	,	GCA	1p36.21		"""lung type I cell membrane associated glycoprotein"""	g.chr1:13940864C>G		46.0+/-80.4		492	yes		12575,431	0.20375	0.09969	5.93	0.00012	ENSP00000294489:A223G			0.27696		-11.227		5.9	0.95920	572	0.02654	1.0	0.1		-1.5			hg19	Standard	0.9304	1.0	13.3703	8211,389			6084,407,12	0.230654				CCDS30602.1, CCDS41266.1, CCDS44060.1, CCDS53270.1	C	0.02656	GG,GC,CC	AB127958, AY194238		189	0.00436	2504	5.93	rs2486188		469	147;105;223;223	701			0.60709	13813451	+	GLY/ALA,GLY/ALA,GLY/ALA,GLY/ALA		T1A-2, Gp38, aggrus, GP40, PA2.26	2124	16	NM_006474	0.0;0.0;0.0;0.0	5	0.924802110817942	-0.120000	ENST00000509009.1		17966		uc001avd.3			10630	dbSNP_100	314,314,668,668	0.0000		p.A142G	.	0		T		197.0	rs2486188;rs17390230;rs17856466;rs17856680;rs52832288;rs57538275;rs2486188	0.438	1:g.13940864C>G	ENSP00000294489:A223G;ENSP00000365225:A223G;ENSP00000426302:A214G;ENSP00000422977:A142G;ENSP00000365229:A105G;ENSP00000425304:A105G;ENSP00000427537:A105G;ENSP00000426063:A105G	protein_coding	0.018233		basic|exp_conf		3923,365,12		223;223;214;142;105;105;105;105	4364,42	0.9725274725274725	G	G|||		0.341118	5008			4915	podoplanin		PDPN_HUMAN;.;.;.	0.98143	0.22893	13940864	GBM - Glioblastoma multiforme(2;0.00182)	0.521000	1.0	SNP				N	,,,	False	13940864	-0.9471		9	missense	T	Approved	0.954767	189.0		c.425C>G	2008-02-05	OTTHUMT00000367736.1	Q86YL7	0.9885	2.71;2.71;2.71;2.71;2.71;2.71;2.71;2.71	PDPN	13940864	0.48306	Ovarian(185;0.249)	0.42103	60,60,60,60	PDPN	NM_001006624.1,NM_001006625.1,NM_006474.4,NM_198389.2	protein-coding gene		A	
		A	ENSG00000116731	ENST00000235372.7		7799		ENSG00000116731		4300					,				c.(1006-1008)gaG>gaA	OTTHUMG00000007917		byFrequency	Q13029	gene with protein product		PRDM2_ENST00000376048.5_Intron|PRDM2_ENST00000503842.1_Intron|PRDM2_ENST00000343137.4_Silent_p.E135E|PRDM2_ENST00000505823.1_Intron|PRDM2_ENST00000413440.1_Silent_p.E135E|PRDM2_ENST00000311066.5_Silent_p.E336E		NM_012231.4	130,813,1260	NM_012231	0.2618					+	Silent		460.9+/-365.3	95.0				7538672				PRDM2-001					1	+	0.2012				coding-synonymous,intron,coding-synonymous,coding-synonymous	9347		135/1482,,336/1719,336/1683	all_lung(284;2.56e-05)|Lung NSC(185;4.94e-05)|Renal(390;0.000147)|Breast(348;0.000162)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	601196	,,,		protein_coding		2203				34.4651,24.3532,31.0395		"""Chromatin-modifying enzymes / K-methyltransferases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00224)|Colorectal(212;3.23e-08)|BRCA - Breast invasive adenocarcinoma(304;2.16e-05)|COAD - Colon adenocarcinoma(227;2.53e-05)|Kidney(185;0.000762)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.00446)|READ - Rectum adenocarcinoma(331;0.0276)|Lung(427;0.145)			KNOWN			ACTGCTCAGAGGTAACACCTG						ENST00000235372.7:c.1008G>A	1					endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(16)|lung(20)|ovary(3)|prostate(3)|skin(1)|urinary_tract(2)		+		,		1p36	B1AJZ4|B5MC68|Q13149|Q14550|Q5THJ1|Q5VUL9	"""retinoblastoma protein-binding zinc finger protein"", ""retinoblastoma protein-interacting zinc finger protein"", ""MTE-binding protein"", ""zinc-finger DNA-binding protein"", ""GATA-3 binding protein G3B"""	g.chr1:14105298G>A		388.6+/-327.0			no		4037,8969												-0.2					0.0	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|sequence-specific DNA binding transcription factor activity (GO:0003700)|zinc ion binding (GO:0008270)				hg19	Standard	0.3101			2964,5636	EV -> DL (in Ref. 6; AAA87023). {ECO:0000305}.	regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	605,2827,3071					CCDS150.1, CCDS151.1, CCDS30603.1, CCDS44061.1	G		AA,AG,GG	U17838	nucleus (GO:0005634)	96		2504		rs1203678		1864								,,,	336	RIZ, RIZ1, RIZ2, KMT8, MTB-ZF, HUMHOXY1		55	NM_012231		8			ENST00000235372.7		20390		uc001avi.3			7799	dbSNP_87	405,,1008,1008			p.E336E		0				98.0		0.398	1:g.14105298G>A		protein_coding			basic|appris_candidate_longest|CCDS		475,2014,1811			1073,3333			G|||			5008		PRDM2_HUMAN	1584	PR domain containing 2, with ZNF domain			0.316294		14105298	GBM - Glioblastoma multiforme(2;0.00182)		0.373	SNP		CCDS150.1			,,,	False	14105298				synonymous_variant		Approved		96.0		c.1008G>A	2011-07-01	OTTHUMT00000021792.2	Q13029	0.5389		PRDM2	14105298		Ovarian(185;0.249)		,,,	PRDM2	NM_001007257.2,NM_001135610.1,NM_012231.4,NM_015866.4	protein-coding gene	NP_036363.2		
		ACTCCTCCT	ENSG00000116731	ENST00000235372.7		7799		ENSG00000116731		4300									c.(2104-2106)ACTCCTact>ACTCCTCCTactcctact	OTTHUMG00000007917			Q13029	gene with protein product		PRDM2_ENST00000311066.5_In_Frame_Ins_p.702_702T>TPPTPT|PRDM2_ENST00000503842.1_Intron|PRDM2_ENST00000505823.1_Intron|PRDM2_ENST00000413440.1_In_Frame_Ins_p.501_501T>TPPTPT|PRDM2_ENST00000376048.5_Intron|PRDM2_ENST00000343137.4_In_Frame_Ins_p.501_501T>TPPTPT		NM_012231.4		NM_012231		Insertion - In frame(1)				+	In_Frame_Ins			80.0				7538672				PRDM2-001					1	+						9347			all_lung(284;2.56e-05)|Lung NSC(185;4.94e-05)|Renal(390;0.000147)|Breast(348;0.000162)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)		SO:0001652	601196			protein_coding	ovary(1)	2203						"""Chromatin-modifying enzymes / K-methyltransferases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00224)|Colorectal(212;3.23e-08)|BRCA - Breast invasive adenocarcinoma(304;2.16e-05)|COAD - Colon adenocarcinoma(227;2.53e-05)|Kidney(185;0.000762)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.00446)|READ - Rectum adenocarcinoma(331;0.0276)|Lung(427;0.145)			KNOWN			AGATAAACTAACTCCTGCAGG						Exception_encountered	1					endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(16)|lung(20)|ovary(3)|prostate(3)|skin(1)|urinary_tract(2)	Exception_encountered	+				1p36	B1AJZ4|B5MC68|Q13149|Q14550|Q5THJ1|Q5VUL9	"""retinoblastoma protein-binding zinc finger protein"", ""retinoblastoma protein-interacting zinc finger protein"", ""MTE-binding protein"", ""zinc-finger DNA-binding protein"", ""GATA-3 binding protein G3B"""	g.chr1:14106394_14106394insACTCCTCCT																									DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|sequence-specific DNA binding transcription factor activity (GO:0003700)|zinc ion binding (GO:0008270)				hg19	Standard						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)				p.P703_A704insP(1)		CCDS150.1, CCDS151.1, CCDS30603.1, CCDS44061.1	ACTCCT			U17838	nucleus (GO:0005634)					rs2308040|rs148293494|rs59028030		2960									702	RIZ, RIZ1, RIZ2, KMT8, MTB-ZF, HUMHOXY1		55	NM_012231		8			ENST00000235372.7				uc001avi.3			7799					p.702_702T>TPPTPT		1				80.0		0.398	1:g.14106394_14106394insACTCCTCCT		protein_coding			basic|appris_candidate_longest|CCDS													PRDM2_HUMAN		PR domain containing 2, with ZNF domain					14106394	GBM - Glioblastoma multiforme(2;0.00182)			INS		CCDS150.1					14106394				inframe_insertion		Approved		80.0		c.2104_2104insACTCCTCCT	2011-07-01	OTTHUMT00000021792.2	Q13029			PRDM2	14106394		Ovarian(185;0.249)					protein-coding gene	NP_036363.2		
		G	ENSG00000116731	ENST00000235372.7		7799		ENSG00000116731		4300					,				c.(4822-4824)tcA>tcG	OTTHUMG00000007917		byFrequency	Q13029	gene with protein product		PRDM2_ENST00000376048.5_Intron|PRDM2_ENST00000503842.1_Intron|PRDM2_ENST00000343137.4_Silent_p.S1407S|PRDM2_ENST00000505823.1_Intron|PRDM2_ENST00000413440.1_Silent_p.S1407S|PRDM2_ENST00000311066.5_Silent_p.S1608S		NM_012231.4	156,851,1196	NM_012231	0.4223					+	Silent		656.3+/-401.3	74.0				7538672				PRDM2-001					1	+	0.2322				coding-synonymous,intron,coding-synonymous,coding-synonymous	9347		1407/1482,,1608/1719,1608/1683	all_lung(284;2.56e-05)|Lung NSC(185;4.94e-05)|Renal(390;0.000147)|Breast(348;0.000162)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	601196	,,,		protein_coding		2203				36.5116,26.3958,33.0847		"""Chromatin-modifying enzymes / K-methyltransferases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00224)|Colorectal(212;3.23e-08)|BRCA - Breast invasive adenocarcinoma(304;2.16e-05)|COAD - Colon adenocarcinoma(227;2.53e-05)|Kidney(185;0.000762)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.00446)|READ - Rectum adenocarcinoma(331;0.0276)|Lung(427;0.145)			KNOWN			GCAAAACATCACGGAGCCTGC						ENST00000235372.7:c.4824A>G	1					endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(16)|lung(20)|ovary(3)|prostate(3)|skin(1)|urinary_tract(2)		+		,		1p36	B1AJZ4|B5MC68|Q13149|Q14550|Q5THJ1|Q5VUL9	"""retinoblastoma protein-binding zinc finger protein"", ""retinoblastoma protein-interacting zinc finger protein"", ""MTE-binding protein"", ""zinc-finger DNA-binding protein"", ""GATA-3 binding protein G3B"""	g.chr1:14109114A>G		713.4+/-408.2			no		4303,8703												0.7					0.0	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|sequence-specific DNA binding transcription factor activity (GO:0003700)|zinc ion binding (GO:0008270)				hg19	Standard	0.328			3140,5460		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	689,2925,2889					CCDS150.1, CCDS151.1, CCDS30603.1, CCDS44061.1	A		GG,GA,AA	U17838	nucleus (GO:0005634)	73		2504		rs1203651		5680								,,,	1608	RIZ, RIZ1, RIZ2, KMT8, MTB-ZF, HUMHOXY1		55	NM_012231		8			ENST00000235372.7		20761		uc001avi.3			7799	dbSNP_87	4221,,4824,4824			p.S1608S		0				73.0		0.433	1:g.14109114A>G		protein_coding			basic|appris_candidate_longest|CCDS		533,2074,1693			1163,3243			G|||			5008		PRDM2_HUMAN	1828	PR domain containing 2, with ZNF domain			0.365016		14109114	GBM - Glioblastoma multiforme(2;0.00182)		0.3988	SNP		CCDS150.1			,,,	False	14109114				synonymous_variant		Approved		73.0		c.4824A>G	2011-07-01	OTTHUMT00000021792.2	Q13029	0.5418		PRDM2	14109114		Ovarian(185;0.249)		,,,	PRDM2	NM_001007257.2,NM_001135610.1,NM_012231.4,NM_015866.4	protein-coding gene	NP_036363.2		
		G	ENSG00000116731	ENST00000235372.7	0.58432	7799	.	ENSG00000116731	0.01448	4300	0.000000	0.54675	B		,	T	1.999999999946489E-6	0	c.(5116-5118)ccA>ccG	OTTHUMG00000007917	-1.681000	byFrequency	Q13029	gene with protein product		PRDM2_ENST00000503842.1_Missense_Mutation_p.Q34R|PRDM2_ENST00000505823.1_Missense_Mutation_p.Q34R|PRDM2_ENST00000376048.5_Missense_Mutation_p.Q198R		NM_012231.4	1926,266,11	NM_012231	0.727			G	4.681	+	Silent	2	263.1+/-284.8	65.0	B1AJZ4	0.934635		7538672			0.0	PRDM2-001			0.01281		1	+	0.9319		0.49	0.431000	missense,coding-synonymous	9347	321	198/227,1706/1719	all_lung(284;2.56e-05)|Lung NSC(185;4.94e-05)|Renal(390;0.000147)|Breast(348;0.000162)|Colorectal(325;0.00058)|Ovarian(437;0.00965)|Hepatocellular(190;0.0245)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	601196	,	0.8867403314917127	protein_coding		2203	P		0.000000	15.6395,6.5365,12.5557	B	"""Chromatin-modifying enzymes / K-methyltransferases"""	6503		0.5513:0.2342:0.2145:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00224)|Colorectal(212;3.23e-08)|BRCA - Breast invasive adenocarcinoma(304;2.16e-05)|COAD - Colon adenocarcinoma(227;2.53e-05)|Kidney(185;0.000762)|KIRC - Kidney renal clear cell carcinoma(229;0.00258)|STAD - Stomach adenocarcinoma(313;0.00446)|READ - Rectum adenocarcinoma(331;0.0276)|Lung(427;0.145)			KNOWN	ENST00000376048;ENST00000503842;ENST00000505823		TCAAAGCTCCAGCTGCAGCCC	T					ENST00000235372.7:c.5118A>G	1		ENSG00000116731	0.03155	PRDM2	endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(16)|lung(20)|ovary(3)|prostate(3)|skin(1)|urinary_tract(2)		+	0.05858	,	CAG	1p36	B1AJZ4|B5MC68|Q13149|Q14550|Q5THJ1|Q5VUL9	"""retinoblastoma protein-binding zinc finger protein"", ""retinoblastoma protein-interacting zinc finger protein"", ""MTE-binding protein"", ""zinc-finger DNA-binding protein"", ""GATA-3 binding protein G3B"""	g.chr1:14143003A>G		160.0+/-192.4		452	yes		11373,1633	0.03702	0.08931	5.07	0.00012	ENSP00000365216:Q198R			.		.		-4.3	0.03677	402	0.17832	0.7027972027972028	0.0	DNA binding (GO:0003677)|histone-lysine N-methyltransferase activity (GO:0018024)|sequence-specific DNA binding transcription factor activity (GO:0003700)|zinc ion binding (GO:0008270)	.			hg19	Standard	0.8569	0.9186991869918699	7.1999	7255,1345		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	4988,1397,118	0.126580				CCDS150.1, CCDS151.1, CCDS30603.1, CCDS44061.1	A	0.02656	GG,GA,AA	U17838	nucleus (GO:0005634)	65	.	2504	-4.33	rs1046331		5974	198	646			0.25874	14015590	+	ARG/GLN,	1706	RIZ, RIZ1, RIZ2, KMT8, MTB-ZF, HUMHOXY1	1821	55	NM_012231	0.0	9	0.8522427440633246	-0.812000	ENST00000235372.7		18792		uc001avi.3			7799	dbSNP_86	593,5118	0.0000		p.P1706P	.	0		T		66.0	rs1046331;rs60453526;rs1046331	0.577	1:g.14143003A>G	ENSP00000365216:Q198R	protein_coding	.		basic|appris_candidate_longest|CCDS		3062,1131,107		198;34;34	4118,288	0.8337912087912088	R	G|||		.	5008		PRDM2_HUMAN	4113	PR domain containing 2, with ZNF domain		.	0.821286	0.01627	14143003	GBM - Glioblastoma multiforme(2;0.00182)	-1.880000	0.7073	SNP		CCDS150.1		.	,,,	False	14143003	-1.0378		7	synonymous_variant	T	Approved	0.843605	65.0		c.5118A>G	2011-07-01	OTTHUMT00000021792.2	Q13029	0.8573	0.56	PRDM2	14143003	0.31685	Ovarian(185;0.249)	0.17167	43,	PRDM2	NM_001135610.1,NM_012231.4	protein-coding gene	NP_036363.2	Q	
		G	ENSG00000189337	ENST00000376030.2		23254		ENSG00000189337		4300					,					OTTHUMG00000002042		byFrequency	Q674X7	gene with protein product		KAZN_ENST00000361144.5_Intron|KAZN_ENST00000503743.1_Intron|KAZN_ENST00000400798.2_Intron|KAZN_ENST00000422387.2_Intron|KAZN_ENST00000400797.3_Intron		NM_201628.2	766,1069,368	NM_001017999	0.3497					+	Intron		720.0+/-406.3	80.0				15337775, 18840647				KAZN-001	2011-01-31				1	+	0.6301				intron,intron,intron,intron,intron	29173		,,,,		G	SO:0001627		,,,,		protein_coding		2203				23.4186,40.9669,35.4836		"""Sterile alpha motif (SAM) domain containing"""	6503								KNOWN			TGGCCACTTGAACCCTCCCTC						ENST00000376030.2:c.1098+27A>G	1					central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(9)|liver(1)|lung(6)|ovary(1)|prostate(2)		+		,		1p36.21	B0QYQ0|B1AK78|Q5TGF1|Q674X4|Q674X6|Q6ZUD1|Q8IYN7|Q8N409|Q9UIL2|Q9UPX4		g.chr1:15390145A>G		530.1+/-372.8			no		4615,8391												2.6					0.0					hg19	Standard	0.2406			2014,6586		keratinization (GO:0031424)	1004,2607,2892					CCDS30604.1, CCDS41267.1, CCDS152.2, CCDS41268.1	A		GG,GA,AA	AY505119	cornified envelope (GO:0001533)|cytoplasm (GO:0005737)|desmosome (GO:0030057)|nucleus (GO:0005634)	86		2504		rs2076565		1392								,,,,		KIAA1026, KAZRIN, FLJ43806		25	NM_015209		7			ENST00000376030.2		19522		uc001avm.4			23254	dbSNP_96	,,,,					0				98.0		0.577	1:g.15390145A>G		protein_coding			basic|appris_principal|CCDS		238,1538,2524			2601,1805			G|||			5008		KAZRN_HUMAN	2305	kazrin, periplakin interacting protein			0.460264		15390145			0.7133	SNP		CCDS152.2			,,,	False	15390145				intron_variant		Approved		86.0			2014-02-12	OTTHUMT00000005690.2	Q674X7	0.2435		KAZN	15390145				,,,,	KAZN	NM_001017999.2,NM_001018000.3,NM_001018001.2,NM_015209.2,NM_201628.2	protein-coding gene	NP_963922.2		
		A	ENSG00000171729	ENST00000428417.1		55092		ENSG00000171729		4300					,				c.(598-600)ccG>ccA	OTTHUMG00000002046		byFrequency	Q9NW97	gene with protein product		TMEM51_ENST00000400796.3_Silent_p.P200P|TMEM51_ENST00000434578.2_3'UTR|TMEM51_ENST00000376008.2_Silent_p.P200P|TMEM51_ENST00000376014.3_Silent_p.P200P		NM_001136217.1	29,477,1697	NM_018022	0.3661					+	Silent		468.0+/-367.2	81.0				12477932				TMEM51-201	2005-05-22				1	+	0.0741				coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous	25488		200/254,200/254,200/254,200/254	Renal(390;0.00145)|Breast(348;0.00186)|Colorectal(325;0.00215)|all_lung(284;0.00459)|Lung NSC(340;0.0104)|Myeloproliferative disorder(586;0.0393)|Hepatocellular(190;0.0623)|Ovarian(437;0.0798)	G	SO:0001819		,,,		protein_coding		2203				35.3488,12.1425,27.4873			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0265)|Colorectal(212;2.07e-06)|COAD - Colon adenocarcinoma(227;7.14e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000175)|KIRC - Kidney renal clear cell carcinoma(229;0.00141)|STAD - Stomach adenocarcinoma(313;0.00644)|READ - Rectum adenocarcinoma(331;0.0751)			KNOWN			GACTGAAACCGCTGAAAGTTC		C1orf72				ENST00000428417.1:c.600G>A	1					breast(1)|central_nervous_system(1)|cervix(3)|large_intestine(2)|lung(5)|prostate(2)		+		,		1p36.21	A8K819		g.chr1:15546077G>A		242.1+/-252.3			no		3575,9431												-8.2					0.6			2005-05-22		hg19	Standard	0.3499			3040,5560			595,2385,3523					CCDS154.1	G		AA,AG,GG	AK098467	integral component of membrane (GO:0016021)	77		2504		rs3753313		1046				"""chromosome 1 open reading frame 72"""				,,,	200	FLJ10199		14	NM_018022		3			ENST00000428417.1		17895		uc001avx.3			55092	dbSNP_107	600,600,600,600			p.P200P		0				70.0		0.532	1:g.15546077G>A		protein_coding			basic|appris_principal|CCDS		566,1908,1826			535,3871			G|||			5008		TMM51_HUMAN	1023	transmembrane protein 51			0.204273		15546077			0.0754	SNP		CCDS154.1			,,,	False	15546077				synonymous_variant		Approved		77.0		c.600G>A	2008-02-05	OTTHUMT00000005699.3	Q9NW97	0.2003		TMEM51	15546077				,,,	TMEM51	NM_001136216.1,NM_001136217.1,NM_001136218.1,NM_018022.2	protein-coding gene	NP_001129689.1		
		GCCC	ENSG00000162438	ENST00000375949.4		11330		ENSG00000162438		4300										OTTHUMG00000002255			Q99895	gene with protein product		CTRC_ENST00000375943.2_Intron|CTRC_ENST00000483406.1_Intron		NM_007272.2		NM_007272						+	Intron			179.0				8635596				CTRC-001					1	+						2523			Breast(348;0.000207)|all_lung(284;0.00021)|Colorectal(325;0.000257)|Lung NSC(340;0.000269)|Renal(390;0.000518)|Ovarian(437;0.0129)|Myeloproliferative disorder(586;0.0255)|Hepatocellular(190;0.0634)		SO:0001627	601405			protein_coding		2203							6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.96e-07)|COAD - Colon adenocarcinoma(227;3.56e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000115)|KIRC - Kidney renal clear cell carcinoma(229;0.00244)|STAD - Stomach adenocarcinoma(313;0.0072)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TGGGGCCAGGGCCTCCTGCCC						ENST00000375949.4:c.357-38GCC>GCCC	1					endometrium(3)|kidney(1)|large_intestine(2)|lung(6)|prostate(1)		+				1p36.21	A8K082|O00765|Q9NUH5	"""elastase 4"""	g.chr1:15769876_15769876insGCCC																									peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)				hg19	Standard						proteolysis (GO:0006508)						CCDS156.1	GCC			BC015118						rs397730661|rs371696568|rs35149641		382										CLCR, ELA4		13	NM_007272		5			ENST00000375949.4				uc001awi.1			11330							0				178.0		0.592	1:g.15769876_15769876insGCCC		protein_coding			basic|appris_principal|CCDS													CTRC_HUMAN		chymotrypsin C (caldecrin)					15769876				INS		CCDS156.1					15769876		3.4.21.2		intron_variant		Approved		179.0			2009-02-18	OTTHUMT00000006435.1	Q99895			CTRC	15769876							protein-coding gene	NP_009203.2		
		G	ENSG00000215704	ENST00000375910.3	0.80722	51032	N	ENSG00000215704	0.02723	4300	0.000000	0.88431	B		,	T	0.0	0	c.(529-531)cAg>cGg	OTTHUMG00000002259	-1.183000	byFrequency	P08218	gene with protein product				NM_015849.2	2113,89,1	NM_015849	1.0			G	5.395	+	Missense_Mutation	2	2.2+/-6.3	155.0	P08218	0.979346		3646943, 16327289			0.0	CELA2B-001			0.01281		1	+	0.9773		0.37	0.678000	missense	29995	361	177/270		G	SO:0001583	609444	benign	0.9972375690607734	protein_coding		2203	P		0.000000	0.0233,2.0654,0.7151	B		6503		0.2883:0.1251:0.2086:0.3779						KNOWN	ENST00000375910		AAGCAGGGCCAGTTGCTGGTT	D					ENST00000375910.3:c.530A>G	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.	ENSG00000215704	0.09462	CELA2B	breast(1)|endometrium(1)|large_intestine(1)|lung(4)|ovary(1)	ENSP00000365075:p.Gln177Arg	+	0.05858	,	CAG	1p36.21	Q14D16|Q6ISM5|Q96QV5	"""pancreatic elastase IIB"""	g.chr1:15812432A>G	Q -> R (in dbSNP:rs6429745). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:3646943}.	75.2+/-113.4		480	yes		12913,93	0.03702	0.10239	3.82	0.00012	ENSP00000365075:Q177R			0.14678		.		-2.8	0.05769	572	0.23891	1.0	0.0	serine-type endopeptidase activity (GO:0004252)	-0.63			hg19	Standard	1.0	0.975609756097561	0.4607	8598,2			6411,91,1	0.258013				CCDS30605.1	A	0.02656	GG,GA,AA		extracellular region (GO:0005576)	155	0.02225	2504	-2.83	rs6429745		555	177	758			0.00516	15685019	+	ARG/GLN	177	RP11-265F14.2, ELA2B	2171	8	NM_015849	0.0	6	1.0	-0.298000	ENST00000375910.3		17830		uc001awl.3			51032	dbSNP_116	530	0.0000		p.Q177R	Peptidase cysteine/serine, trypsin-like (1);Peptidase S1/S6, chymotrypsin/Hap (3);	0		T		154.0	rs6429745;rs16851678;rs6429745	0.572	1:g.15812432A>G	ENSP00000365075:Q177R	protein_coding	0.304906		basic|appris_principal|CCDS		4298,2,0		177	4315,91	0.9940476190476191	R	G|||		0.570866	5008		CEL2B_HUMAN	4974	chymotrypsin-like elastase family, member 2B		CEL2B_HUMAN	0.993211	0.01395	15812432		-2.057000	1.0	SNP		CCDS30605.1		N	,,,	False	15812432	-0.9712		9	missense	T	Approved	0.999767	155.0		c.530A>G	2009-07-09	OTTHUMT00000006448.1	P08218	0.9942	-2.38	CELA2B	15812432	0.39670		0.37291	43	CELA2B	NM_015849.2	protein-coding gene	NP_056933	Q	
		T	ENSG00000215704	ENST00000375910.3		51032		ENSG00000215704		4300					,					OTTHUMG00000002259			P08218	gene with protein product				NM_015849.2	2202,1,0	NM_015849	1.0					+	Intron			51.0				3646943, 16327289				CELA2B-001					1	+	1.0				intron	29995				T	SO:0001627	609444			protein_coding		2203				0.0,0.0227,0.0077			6503								KNOWN			CCTCCCACTTCAACTCCCTAT						ENST00000375910.3:c.640-29C>T	1					breast(1)|endometrium(1)|large_intestine(1)|lung(4)|ovary(1)		+		,		1p36.21	Q14D16|Q6ISM5|Q96QV5	"""pancreatic elastase IIB"""	g.chr1:15813751C>T		2.1+/-5.4			no		13005,1												-1.8					0.0	serine-type endopeptidase activity (GO:0004252)				hg19	Standard	1.0			8600,0			6502,1,0					CCDS30605.1	C		TT,TC,CC		extracellular region (GO:0005576)	50		2504		rs2011159		664										RP11-265F14.2, ELA2B		8	NM_015849		7			ENST00000375910.3		18124		uc001awl.3			51032	dbSNP_92						0				50.0		0.567	1:g.15813751C>T		protein_coding			basic|appris_principal|CCDS		4300,0,0			4405,1			T|||			5008		CEL2B_HUMAN	5008	chymotrypsin-like elastase family, member 2B			1.0		15813751			1.0	SNP		CCDS30605.1			,,,	False	15813751				intron_variant		Approved		50.0			2009-07-09	OTTHUMT00000006448.1	P08218	1.0		CELA2B	15813751					CELA2B	NM_015849.2	protein-coding gene	NP_056933		
		T	ENSG00000116138	ENST00000375847.3	0.24712	23341	N	ENSG00000116138	0.70478	4300	1.000000	0.73047	B;B			T	0.993196	0	c.(319-321)cAg>cTg	OTTHUMG00000002358	2.197000		Q9Y2G8	gene with protein product		DNAJC16_ENST00000375849.1_Missense_Mutation_p.Q107L|DNAJC16_ENST00000375838.1_Missense_Mutation_p.Q107L		NM_015291.2		NM_015291				A	11.54	+	Missense_Mutation	2		76.0	Q9Y2G8;Q5TDG9	.					0.075;0.154	DNAJC16-001			0.32864		1	+			0.38	0.990000		29157	.		Colorectal(325;0.00108)|Renal(390;0.00145)|Breast(348;0.00173)|all_lung(284;0.00459)|Lung NSC(340;0.00499)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0798)		SO:0001583			.	protein_coding		2203	N		1.000000		B;B	"""Heat shock proteins / DNAJ (HSP40)"""	6503		0.8492:0.1508:0.0:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;9.18e-07)|COAD - Colon adenocarcinoma(227;4.5e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000133)|KIRC - Kidney renal clear cell carcinoma(229;0.00262)|STAD - Stomach adenocarcinoma(313;0.00774)|READ - Rectum adenocarcinoma(331;0.0657)			KNOWN	ENST00000375847;ENST00000375838;ENST00000375849;ENST00000546230		CAGCAACAGCAGCGAGAGTAT	T;T;T					ENST00000375847.3:c.320A>T	1	Poly-Gln.	ENSG00000116138	0.62120	DNAJC16	central_nervous_system(1)|endometrium(1)|kidney(4)|large_intestine(4)|lung(7)|urinary_tract(1)	ENSP00000365007:p.Gln107Leu	+	0.71417		CAG	1p36.1	Q68D57|Q86X32|Q8N5P4		g.chr1:15863055A>T				.				0.80357	0.29604	5.78	0.49029	ENSP00000364998:Q107L			0.40222		-25.564			0.57074	.	0.23302	.			0			hg19	Standard		.	12.2681			cell redox homeostasis (GO:0045454)		1.668213				CCDS30606.1, CCDS72710.1	A	0.32245		AB023179	integral component of membrane (GO:0016021)		0.08118		4.6			484	107;107	.			0.54689	15735642	+		107	KIAA0962	.	18	NM_015291	0.361;0.361	4	.	0.533000	ENST00000375847.3				uc001aws.3			23341			0.1533		p.Q107L	Heat shock protein DnaJ, N-terminal (1);	0		T		68.0	.	0.388	1:g.15863055A>T	ENSP00000365007:Q107L;ENSP00000364998:Q107L;ENSP00000365009:Q107L	protein_coding	0.001149		basic|appris_principal|CCDS				107		.	L			0.175517			DJC16_HUMAN		DnaJ (Hsp40) homolog, subfamily C, member 16		DJC16_HUMAN;.		0.27805	15863055		0.855000		SNP		CCDS30606.1		N			15863055	-0.9546		10	missense	T	Approved	.	73.0		c.320A>T	2011-09-02	OTTHUMT00000006764.1	Q9Y2G8		-0.71;-0.71;-0.71	DNAJC16	15863055	0.78478		0.40757				protein-coding gene	NP_056106.1	Q	
		T	ENSG00000162458	ENST00000375766.3		54751		ENSG00000162458		4300					,					OTTHUMG00000003079		byFrequency	Q8WUP2	gene with protein product		FBLIM1_ENST00000441801.2_Intron|FBLIM1_ENST00000400773.1_Intron|FBLIM1_ENST00000332305.5_Intron|FBLIM1_ENST00000375771.1_Intron		NM_017556.2	24,404,1775	NM_001024215	0.4213					+	Intron		334.5+/-321.0	53.0				12679033, 12496242				FBLIM1-002					1	+	0.0976				intron,intron,intron	24686		,,	Colorectal(325;0.000257)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0129)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	607747	,,		protein_coding		2203				22.2791,10.2587,18.207			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.96e-07)|COAD - Colon adenocarcinoma(227;3.56e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000115)|KIRC - Kidney renal clear cell carcinoma(229;0.00244)|READ - Rectum adenocarcinoma(331;0.0649)|STAD - Stomach adenocarcinoma(313;0.138)			KNOWN			CCTGTGTCTCCCCTACCCCAG						ENST00000375766.3:c.542-11C>T	1					large_intestine(2)|lung(4)|prostate(4)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2)		+		,		1p36.13	B3KNY0|Q5VVE0|Q5VVE1|Q8IX23|Q96T00|Q9UFD6		g.chr1:16096893C>T		216.1+/-234.9			no		2368,10638												-0.5					0.0	filamin binding (GO:0031005)|zinc ion binding (GO:0008270)				hg19	Standard	0.1968			1916,6684		cell junction assembly (GO:0034329)|regulation of cell shape (GO:0008360)|regulation of integrin activation (GO:0033623)|single organismal cell-cell adhesion (GO:0016337)	245,1878,4380					CCDS163.1, CCDS30609.1, CCDS44064.1	C		TT,TC,CC		cytosol (GO:0005829)|focal adhesion (GO:0005925)|stress fiber (GO:0001725)	54		2504		rs12146078		1181								,,		FBLP-1, CAL, migfilin		16	XM_005245900		6			ENST00000375766.3		17479		uc001axe.1			54751	dbSNP_120	,,					0				57.0		0.592	1:g.16096893C>T		protein_coding			alternative_5_UTR|basic|appris_principal|CCDS		221,1474,2605			452,3954			C|||			5008		FBLI1_HUMAN	968	filamin binding LIM protein 1			0.193291		16096893			0.0784	SNP		CCDS163.1			,,,	False	16096893				intron_variant		Approved		54.0			2014-04-07	OTTHUMT00000008511.3	Q8WUP2	0.2161		FBLIM1	16096893				,,	FBLIM1	NM_001024215.1,NM_001024216.1,NM_017556.2	protein-coding gene	NP_060026.2		
		T	ENSG00000162458	ENST00000375766.3	0.29515	54751	L	ENSG00000162458	0.88619	4300	1.000000	0.44083	D;D;D		,	T	0.853925	0	c.(571-573)tCc>tTc	OTTHUMG00000003079	2.618000	byFrequency	Q8WUP2	gene with protein product		FBLIM1_ENST00000375771.1_Missense_Mutation_p.S191F|FBLIM1_ENST00000400773.1_Missense_Mutation_p.S94F|FBLIM1_ENST00000332305.5_Missense_Mutation_p.S94F|FBLIM1_ENST00000441801.2_Missense_Mutation_p.S191F		NM_017556.2	420,1058,725	NM_001024215	0.7556			C	21.0	+	Missense_Mutation	2	689.3+/-404.3	64.0	Q8WUP2-3;Q8WUP2-2;Q8WUP2	0.430776		12679033, 12496242			0.916;0.916;0.76	FBLIM1-002			0.63597	FBLIM1	1	+	0.3843		0.73	0.994000	missense,missense,missense	24686	222	191/375,94/277,191/374	Colorectal(325;0.000257)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0129)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	607747	probably-damaging,probably-damaging,probably-damaging	0.6132596685082873	protein_coding		2203	P		1.000000	28.814,43.0776,38.3362	D;D;P		6503		0.0:0.8431:0.1569:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;5.96e-07)|COAD - Colon adenocarcinoma(227;3.56e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000115)|KIRC - Kidney renal clear cell carcinoma(229;0.00244)|READ - Rectum adenocarcinoma(331;0.0649)|STAD - Stomach adenocarcinoma(313;0.138)			KNOWN	ENST00000375771;ENST00000375766;ENST00000400773;ENST00000502739;ENST00000441801;ENST00000332305		AAGACCGTGTCCCCCCGAGAG	T;T;T;T;T;T					ENST00000375766.3:c.572C>T	1	LIM zinc-binding 1. {ECO:0000255|PROSITE- ProRule:PRU00125}.	ENSG00000162458	0.81541	FBLIM1	large_intestine(2)|lung(4)|prostate(4)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2)	ENSP00000364921:p.Ser191Phe	+	0.71417	,	TCC	1p36.13	B3KNY0|Q5VVE0|Q5VVE1|Q8IX23|Q96T00|Q9UFD6		g.chr1:16096934C>T	S -> F (in dbSNP:rs10927851). {ECO:0000269|PubMed:12496242, ECO:0000269|PubMed:12679033, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	538.5+/-375.0		193	yes		8020,4986	0.80357	0.76528	5.24	0.00012	ENSP00000364920:S94F	M		0.22510		.		5.2	0.73138	463	0.09338	0.8094405594405595	1.0	filamin binding (GO:0031005)|zinc ion binding (GO:0008270)	1.125			hg19	Standard	0.6501	0.39227642276422764	14.6067	6122,2478		cell junction assembly (GO:0034329)|regulation of cell shape (GO:0008360)|regulation of integrin activation (GO:0033623)|single organismal cell-cell adhesion (GO:0016337)	2591,2838,1074	4.080246				CCDS163.1, CCDS30609.1, CCDS44064.1	C	0.69078	TT,TC,CC		cytosol (GO:0005829)|focal adhesion (GO:0005925)|stress fiber (GO:0001725)	66	0.37697	2504	5.24	rs10927851		1212	94;191;191	486	GRCh37		0.68483	15969521	+	PHE/SER,PHE/SER,PHE/SER	191	FBLP-1, CAL, migfilin	1364	16	XM_005245900	0.996;0.997;0.973	6	0.6411609498680739	0.591000	ENST00000375766.3		17332		uc001axe.1			54751	dbSNP_120	572,281,572	0.0000	CM066072	p.S191F	Zinc finger, LIM-type (5);	0		T		69.0	rs10927851;rs17858520;rs52815710;rs10927851	0.642	1:g.16096934C>T	ENSP00000364926:S191F;ENSP00000364921:S191F;ENSP00000383584:S94F;ENSP00000424920:S94F;ENSP00000416387:S191F;ENSP00000364920:S94F	protein_coding	0.059120		alternative_5_UTR|basic|appris_principal|CCDS		2171,1780,349		191;191;94;94;191;94	1898,2508	0.6245421245421245	F	C|||		0.456371	5008		FBLI1_HUMAN	3217	filamin binding LIM protein 1		.;.;FBLI1_HUMAN	0.642372	0.53805	16096934		3.566000	0.8284	SNP	rs10927851	CCDS163.1		N	,,,	False	16096934	-1.0811		9	missense	T	Approved	0.71186	66.0		c.572C>T	2014-04-07	OTTHUMT00000008511.3	Q8WUP2	0.6931	0.93;0.93;0.93;0.93;0.93;0.93	FBLIM1	16096934	0.84299		0.06716	155,155,155	FBLIM1	NM_001024215.1,NM_001024216.1,NM_017556.2	protein-coding gene	NP_060026.2	S	
		C	ENSG00000065526	ENST00000375759.3	0.58432	23013	N	ENSG00000065526	0.25702	4300	0.520000	0.07327	B		,	T	1.0000000000287557E-6	0	c.(3271-3273)cTa>cCa	OTTHUMG00000009376	0.411000	byFrequency	Q96T58	gene with protein product				NM_015001.2	1827,335,41	NM_015001	0.5941			C	0.188	+	Missense_Mutation	2	522.8+/-380.2	45.0	Q96T58	0.905356		10451362, 11331609			0.0	SPEN-001	2013-10-17		0.01281		1	+	0.9758		0.43	0.397000	missense	17575	252	1091/3665	Colorectal(325;0.000258)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0129)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	613484	benign	0.6961325966850829	protein_coding		2203	P		0.064000	42.3721,9.4644,31.2241	B	"""RNA binding motif (RRM) containing"""	6503		0.0:0.7988:0.0:0.2012			UCEC - Uterine corpus endometrioid carcinoma (279;0.0185)|Colorectal(212;5.96e-07)|COAD - Colon adenocarcinoma(227;3.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000115)|Kidney(64;0.000212)|KIRC - Kidney renal clear cell carcinoma(64;0.003)|STAD - Stomach adenocarcinoma(313;0.013)|READ - Rectum adenocarcinoma(331;0.0681)			KNOWN	ENST00000375759		CTGGGAGAACTAGCAGGTGAA	T					ENST00000375759.3:c.3272T>C	1		ENSG00000065526	0.14901	SPEN	NS(1)|breast(13)|central_nervous_system(3)|cervix(5)|endometrium(16)|kidney(18)|large_intestine(27)|liver(2)|lung(37)|ovary(7)|prostate(7)|skin(7)|upper_aerodigestive_tract(5)|urinary_tract(1)	ENSP00000364912:p.Leu1091Pro	+	0.20934	,	CTA	1p36	Q9H9A8|Q9NWH5|Q9UQ01|Q9Y556		g.chr1:16256007T>C	L -> P (in dbSNP:rs848209). {ECO:0000269|PubMed:14702039}.	198.4+/-222.2		469	yes		8945,4061	0.27837	0.01965	5.39	0.00012	ENSP00000364912:L1091P			.		-0.1843		3.5	0.40186	174	0.20519	0.3041958041958042	0.5	nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA polymerase II transcription factor binding (GO:0001085)|RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription (GO:0001191)|sequence-specific DNA binding transcription factor activity (GO:0003700)|single-stranded DNA binding (GO:0003697)|transcription corepressor activity (GO:0003714)	-0.665			hg19	Standard	0.5577	0.9532520325203252	11.1582	4956,3644		negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|Notch signaling pathway (GO:0007219)|positive regulation of neurogenesis (GO:0050769)|positive regulation of transcription, DNA-templated (GO:0045893)|viral process (GO:0016032)	3253,2439,811	-1.056057				CCDS164.1	T	0.02656	CC,CT,TT		extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)|transcriptional repressor complex (GO:0017053)	44	0.02142	2504	3.51	rs848209|rs386628859		3476	1091	425		"""SPEN homolog, transcriptional regulator (Drosophila)"", ""spen homolog, transcriptional regulator (Drosophila)"""	0.48499	16128594	+	PRO/LEU	1091	KIAA0929, MINT, SHARP, RBM15C	1320	149	NM_015001	0.0	11	0.5606860158311345	-0.128000	ENST00000375759.3		18084		uc001axk.1			23013	dbSNP_86	3272	0.0000		p.L1091P	.	0		T		42.0	rs848209;rs17387129;rs52796232;rs57983056;rs848209	0.478	1:g.16256007T>C	ENSP00000364912:L1091P	protein_coding	.		basic|appris_principal|CCDS		1426,2104,770		1091	3989,417	0.6043956043956044	P	C|||		.	5008		MINT_HUMAN	3250	spen family transcriptional repressor		MINT_HUMAN	0.648962	0.30165	16256007		1.031000	0.3214	SNP		CCDS164.1		.	,,,	False	16256007	-1.0295		8	missense	T	Approved	0.576279	44.0		c.3272T>C	2013-10-17	OTTHUMT00000025993.1	Q96T58	0.7118	3.2	SPEN	16256007	0.30659		0.19778	98	SPEN	NM_015001.2	protein-coding gene	NP_055816.2	L	
		G	ENSG00000065526	ENST00000375759.3	0.80722	23013	N	ENSG00000065526	0.17919	4300	0.003000	0.08102	B		,	T	0.0	0	c.(7078-7080)Aac>Gac	OTTHUMG00000009376	0.110000	byFrequency	Q96T58	gene with protein product				NM_015001.2	1826,362,15	NM_015001	0.5941			G	2.912	+	Missense_Mutation	1	524.0+/-380.4	110.0	Q96T58	0.91103		10451362, 11331609			0.0	SPEN-001	2013-10-17		0.01281		1	+	0.9758		0.63	0.181000	missense	17575	252	2360/3665	Colorectal(325;0.000258)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0129)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583	613484	benign	0.6961325966850829	protein_coding		2203	P		0.499000	42.3837,8.897,31.0395	B	"""RNA binding motif (RRM) containing"""	6503		0.1608:0.1321:0.7072:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0185)|Colorectal(212;5.96e-07)|COAD - Colon adenocarcinoma(227;3.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000115)|Kidney(64;0.000212)|KIRC - Kidney renal clear cell carcinoma(64;0.003)|STAD - Stomach adenocarcinoma(313;0.013)|READ - Rectum adenocarcinoma(331;0.0681)			KNOWN	ENST00000375759		CCCTGAATCCAACCAAGCTCA	T					ENST00000375759.3:c.7078A>G	1	Interaction with MSX2. {ECO:0000250}.|RID.	ENSG00000065526	0.07637	SPEN	NS(1)|breast(13)|central_nervous_system(3)|cervix(5)|endometrium(16)|kidney(18)|large_intestine(27)|liver(2)|lung(37)|ovary(7)|prostate(7)|skin(7)|upper_aerodigestive_tract(5)|urinary_tract(1)	ENSP00000364912:p.Asn2360Asp	+	0.26083	,	AAC	1p36	Q9H9A8|Q9NWH5|Q9UQ01|Q9Y556		g.chr1:16259813A>G	N -> D (in dbSNP:rs848210).	195.3+/-220.0		469	yes		8969,4037	0.11579	0.06022	5.15	0.00012	ENSP00000364912:N2360D			.		-1.0705		3.1	0.35709	174	0.12103	0.3041958041958042	0.0	nucleotide binding (GO:0000166)|poly(A) RNA binding (GO:0044822)|RNA polymerase II transcription factor binding (GO:0001085)|RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription (GO:0001191)|sequence-specific DNA binding transcription factor activity (GO:0003700)|single-stranded DNA binding (GO:0003697)|transcription corepressor activity (GO:0003714)	-1.355			hg19	Standard	0.5577	0.9532520325203252	7.596	4955,3645		negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|Notch signaling pathway (GO:0007219)|positive regulation of neurogenesis (GO:0050769)|positive regulation of transcription, DNA-templated (GO:0045893)|viral process (GO:0016032)	3251,2467,785	-0.225237				CCDS164.1	A	0.02656	GG,GA,AA		extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)|transcriptional repressor complex (GO:0017053)	104	0.00583	2504	3.1	rs848210		7282	2360	425		"""SPEN homolog, transcriptional regulator (Drosophila)"", ""spen homolog, transcriptional regulator (Drosophila)"""	0.28048	16132400	+	ASP/ASN	2360	KIAA0929, MINT, SHARP, RBM15C	1320	149	NM_015001	0.0	11	0.5606860158311345	-0.355000	ENST00000375759.3		17756		uc001axk.1			23013	dbSNP_86	7078	0.0000		p.N2360D	.	0		T		93.0	rs848210;rs1619706;rs61684002;rs848210	0.532	1:g.16259813A>G	ENSP00000364912:N2360D	protein_coding	.		basic|appris_principal|CCDS		1425,2105,770		2360	4014,392	0.6043956043956044	D	G|||		.	5008		MINT_HUMAN	3250	spen family transcriptional repressor		MINT_HUMAN	0.648962	0.42705	16259813		2.198000	0.3214	SNP		CCDS164.1		.	,,,	False	16259813	-1.0417		8	missense	T	Approved	0.576163	104.0		c.7078A>G	2013-10-17	OTTHUMT00000025993.1	Q96T58	0.7118	3.13	SPEN	16259813	0.23173		0.16012	23	SPEN	NM_015001.2	protein-coding gene	NP_055816.2	N	
		A	ENSG00000116809	ENST00000375743.4		7709		ENSG00000116809		4300					,				c.(1000-1002)ttC>ttT	OTTHUMG00000009377		byFrequency	Q13105	gene with protein product		ZBTB17_ENST00000448462.2_Silent_p.F271F|ZBTB17_ENST00000375733.2_Silent_p.F334F|ZBTB17_ENST00000537142.1_Silent_p.F252F		NM_003443.2	27,424,1752	NM_003443	0.41					+	Silent		412.5+/-350.8	43.0								ZBTB17-001	2004-07-16				1	-	0.0779				coding-synonymous,coding-synonymous	12936		252/722,334/804	Colorectal(325;0.000257)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	604084	,		protein_coding		2203				30.2558,10.8488,23.6814		"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|Colorectal(212;4.12e-07)|COAD - Colon adenocarcinoma(227;2.43e-05)|BRCA - Breast invasive adenocarcinoma(304;9.97e-05)|Kidney(64;0.000182)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CCCGGCACGAGAAGGGCTTCT		ZNF151, ZNF60				ENST00000375743.4:c.1002C>T	1					breast(2)|endometrium(4)|large_intestine(1)|lung(4)|ovary(2)|prostate(2)		-		,		1p36.13	A0AV07|B4DXB4|B7ZLQ9|F5H411|Q15932|Q5JYB2|Q9NUC9		g.chr1:16271260G>A		216.4+/-235.1			no		3080,9926												5.5					1.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)		2004-07-16		hg19	Standard	0.3052			2602,5998	F -> S (in Ref. 2; BAG63326). {ECO:0000305}.	activation of signaling protein activity involved in unfolded protein response (GO:0006987)|cellular protein metabolic process (GO:0044267)|ectoderm development (GO:0007398)|endoplasmic reticulum unfolded protein response (GO:0030968)|gastrulation with mouth forming second (GO:0001702)|negative regulation of cell cycle (GO:0045786)|positive regulation of transcription, DNA-templated (GO:0045893)|transcription, DNA-templated (GO:0006351)	440,2200,3863					CCDS165.1, CCDS55576.1, CCDS72712.1	G		AA,AG,GG	U20647	nucleoplasm (GO:0005654)	43		2504		rs9661939		1234				"""zinc finger protein 151 (pHZ-67)"", ""zinc finger protein 60"""				,	334	MIZ1, pHZ-67		15	NM_003443		8			ENST00000375743.4		16462		uc001axl.4			7709	dbSNP_119	756,1002			p.F334F		0				42.0		0.667	1:g.16271260G>A		protein_coding			basic|appris_principal|CCDS		413,1776,2111			478,3928			G|||			5008		ZBT17_HUMAN	1043	zinc finger and BTB domain containing 17			0.208267		16271260			0.0169	SNP		CCDS165.1			,,,	False	16271260				synonymous_variant		Approved		43.0		c.1002C>T	2013-01-08	OTTHUMT00000025998.1	Q13105	0.3098		ZBTB17	16271260				,	ZBTB17	NM_001242884.1,NM_003443.2	protein-coding gene	NP_003434.2		
		G	ENSG00000116809	ENST00000375743.4		7709		ENSG00000116809		4290					,				c.(619-621)gcT>gcC	OTTHUMG00000009377		byFrequency	Q13105	gene with protein product		ZBTB17_ENST00000448462.2_Silent_p.A144A|ZBTB17_ENST00000375733.2_Silent_p.A207A|ZBTB17_ENST00000537142.1_Silent_p.A125A		NM_003443.2	483,1047,669	NM_003443	0.544					+	Silent			34.0								ZBTB17-001	2004-07-16				1	-	0.472				coding-synonymous,coding-synonymous	12936		125/722,207/804	Colorectal(325;0.000257)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	604084	,		protein_coding		2199				48.7179,45.7708,47.7192		"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6489					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|Colorectal(212;4.12e-07)|COAD - Colon adenocarcinoma(227;2.43e-05)|BRCA - Breast invasive adenocarcinoma(304;9.97e-05)|Kidney(64;0.000182)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CAGCTTCTGCAGCAGCCATGC		ZNF151, ZNF60				ENST00000375743.4:c.621T>C	1					breast(2)|endometrium(4)|large_intestine(1)|lung(4)|ovary(2)|prostate(2)		-		,		1p36.13	A0AV07|B4DXB4|B7ZLQ9|F5H411|Q15932|Q5JYB2|Q9NUC9		g.chr1:16272250A>G					no		6193,6785												-6.8					0.6	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)		2004-07-16		hg19	Standard	0.502			4180,4400		activation of signaling protein activity involved in unfolded protein response (GO:0006987)|cellular protein metabolic process (GO:0044267)|ectoderm development (GO:0007398)|endoplasmic reticulum unfolded protein response (GO:0030968)|gastrulation with mouth forming second (GO:0001702)|negative regulation of cell cycle (GO:0045786)|positive regulation of transcription, DNA-templated (GO:0045893)|transcription, DNA-templated (GO:0006351)	1555,3083,1851					CCDS165.1, CCDS55576.1, CCDS72712.1	A		GG,GA,AA	U20647	nucleoplasm (GO:0005654)	33		2504		rs848217		853				"""zinc finger protein 151 (pHZ-67)"", ""zinc finger protein 60"""				,	207	MIZ1, pHZ-67		15	NM_003443		6			ENST00000375743.4		15001		uc001axl.4			7709	dbSNP_86	375,621			p.A207A		0				31.0		0.687	1:g.16272250A>G		protein_coding			basic|appris_principal|CCDS		1072,2036,1182			2013,2385			G|||			5008		ZBT17_HUMAN	2419	zinc finger and BTB domain containing 17			0.483027		16272250			0.3175	SNP		CCDS165.1			,,,	False	16272250				synonymous_variant		Approved		33.0		c.621T>C	2013-01-08	OTTHUMT00000025998.1	Q13105	0.6311		ZBTB17	16272250				,	ZBTB17	NM_001242884.1,NM_003443.2	protein-coding gene	NP_003434.2		
		T	ENSG00000184908	ENST00000375679.4	0.09310	1188	M	ENSG00000184908	0.34445	4300	0.994000	0.84944	P		,	T	0.99999209961	0	c.(79-81)cGc>cTc	OTTHUMG00000009530	0.817000	byFrequency	P51801	gene with protein product				NM_000085.4	208,906,1089	NM_000085	0.6646			g	14.22	+	Missense_Mutation	2		60.0	P51801	0.300045					0.162	CLCNKB-001	2012-02-23		0.33339		1	+	0.2549		0.22	0.988000	missense	2027	252	27/688	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583	602023	possibly-damaging	0.6961325966850829	protein_coding		2203	P		0.000000	35.7791,30.0045,47.3704	B	"""Ion channels / Chloride channels : Voltage-sensitive"""	6503		0.1078:0.1895:0.7027:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000375679;ENST00000331579		CCCTGTCCCCGCATCCGCCGA	D					ENST00000375679.4:c.80G>T	1		ENSG00000184908	0.41574	CLCNKB	breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)	ENSP00000364831:p.Arg27Leu	+	0.05858	,	CGC	1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16371067G>T	R -> L (in dbSNP:rs2015352). {ECO:0000269|PubMed:8041726, ECO:0000269|PubMed:8544406}.			141	yes		6845,6161	0.49952	0.43942	4.08	0.00012	ENSP00000332055:R27L			0.20378		.		3.2	0.36331	405	0.34782	0.708041958041958	1.0	adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)	2.14			hg19	Standard	0.6561	0.2865853658536585	6.1466	5523,3077		excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)	1974,2897,1632	2.470803				CCDS168.1, CCDS57974.1	G	0.34780	TT,TG,GG	AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	60	0.70595	2504	3.16	rs2015352		191	27	505		"""chloride channel Kb"""	0.20289	16243654	+	LEU/ARG	27	hClC-Kb	1303	21	NM_000085	0.468	2	0.6662269129287599	0.462000	ENST00000375679.4		17154					1188	dbSNP_92	80	0.0000		p.R27L	Chloride channel, core (1);	0		T		59.0	rs2015352;rs58094612	0.652	1:g.16371067G>T	ENSP00000364831:R27L	protein_coding	0.093508		basic|appris_principal|CCDS		1766,1991,543		27	1322,3084	0.5966117216117216	L	G|||		0.420899	5008		CLCKB_HUMAN	2782	chloride channel, voltage-sensitive Kb		CLCKB_HUMAN	0.555511	0.06664	16371067		-0.467000	0.6498	SNP		CCDS168.1		N	,,,	False	16371067	-0.9027		9	missense	T	Approved	0.642209	60.0		c.80G>T	2012-09-26	OTTHUMT00000026331.1	P51801	0.6916	-1.92	CLCNKB	16371067	0.76386		0.48536	102	CLCNKB	NM_000085.3	protein-coding gene	NP_000076.2	R	
		G	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4300					,				c.(322-324)tcA>tcG	OTTHUMG00000009530		byFrequency	P51801	gene with protein product				NM_000085.4	361,1039,803	NM_000085	0.8896					+	Silent		742.1+/-407.2	90.0								CLCNKB-001	2012-02-23				1	+	0.3147				coding-synonymous	2027		108/688	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	A	SO:0001819	602023			protein_coding		2203				18.8256,39.9682,32.7849		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CTTTCTCTTCAGGCTTCTCTC						ENST00000375679.4:c.324A>G	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16373124A>G		521.2+/-370.5			no		8742,4264												-8.6					0.7	adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.832			6981,1619		excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)	3200,2342,961					CCDS168.1, CCDS57974.1	A		GG,GA,AA	AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	99		2504		rs5257		435				"""chloride channel Kb"""					108	hClC-Kb		21	NM_000085		4			ENST00000375679.4		19914					1188	dbSNP_52	324			p.S108S		0				118.0		0.607	1:g.16373124A>G		protein_coding			basic|appris_principal|CCDS		2839,1303,158			1761,2645			A|||			5008		CLCKB_HUMAN	3708	chloride channel, voltage-sensitive Kb			0.740415		16373124			0.9881	SNP		CCDS168.1			,,,	False	16373124				synonymous_variant		Approved		99.0		c.324A>G	2012-09-26	OTTHUMT00000026331.1	P51801	0.8487		CLCNKB	16373124					CLCNKB	NM_000085.3	protein-coding gene	NP_000076.2		
		CCT	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4300										OTTHUMG00000009530		byFrequency	P51801	gene with protein product				NM_000085.4		NM_000085						+	Intron			35.0								CLCNKB-001	2012-02-23				1	+						2027			Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)		SO:0001627	602023			protein_coding		2203						"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CTGGCCAAAACCTTCTCAGAT						ENST00000375679.4:c.358+41CCTTCT>CCT	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+				1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16373199delCCTTCT																									adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard						excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)						CCDS168.1, CCDS57974.1	CCTTCT			AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)					rs72506933|rs375546236|rs35820664		469				"""chloride channel Kb"""						hClC-Kb		21	NM_000085		4			ENST00000375679.4							1188							0				46.0		0.577	1:g.16373199delCCTTCT		protein_coding			basic|appris_principal|CCDS													CLCKB_HUMAN		chloride channel, voltage-sensitive Kb					16373199				DEL		CCDS168.1					16373199				intron_variant		Approved		39.0			2012-09-26	OTTHUMT00000026331.1	P51801			CLCNKB	16373199							protein-coding gene	NP_000076.2		
		C	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4300					,				c.(490-492)ggG>ggC	OTTHUMG00000009530		byFrequency	P51801	gene with protein product				NM_000085.4	1285,802,116	NM_000085	0.9417					+	Silent			67.0								CLCNKB-001	2012-02-23				1	+	0.7231				coding-synonymous	2027		164/688	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	602023			protein_coding		2203				6.3605,23.468,12.1559		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TCTTCCTCGGGAAAGTGGTAT						ENST00000375679.4:c.492G>C	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16374533G>C					no		11425,1581												0.3					1.0	adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.9394			8053,547		excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)	5055,1315,133					CCDS168.1, CCDS57974.1	G		CC,CG,GG	AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	68		2504		rs2014562		603				"""chloride channel Kb"""					164	hClC-Kb		21	NM_000085		5			ENST00000375679.4		14592					1188	dbSNP_92	492			p.G164G		0				70.0		0.627	1:g.16374533G>C		protein_coding			basic|appris_principal|CCDS		3770,513,17			3372,1034			C|||			5008		CLCKB_HUMAN	4477	chloride channel, voltage-sensitive Kb			0.89397		16374533			0.999	SNP		CCDS168.1			,,,	False	16374533				synonymous_variant		Approved		68.0		c.492G>C	2012-09-26	OTTHUMT00000026331.1	P51801	0.9337		CLCNKB	16374533					CLCNKB	NM_000085.3	protein-coding gene	NP_000076.2		
		T	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4276					,					OTTHUMG00000009530		byFrequency	P51801	gene with protein product				NM_000085.4		NM_000085	0.8875					+	Intron			53.0								CLCNKB-001	2012-02-23				1	+	0.3094					2027			Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)		SO:0001627	602023			protein_coding		2202						"""Ion channels / Chloride channels : Voltage-sensitive"""	6478					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			ACTCGGATCCCCCAGAACAAG						ENST00000375679.4:c.577-5C>T	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16374994C>T																									adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.832					excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)						CCDS168.1, CCDS57974.1	C			AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)			2504		rs1889788		687				"""chloride channel Kb"""						hClC-Kb		21	NM_000085		7			ENST00000375679.4		14244					1188							0				50.0		0.627	1:g.16374994C>T		protein_coding			basic|appris_principal|CCDS								C|||			5008		CLCKB_HUMAN	3699	chloride channel, voltage-sensitive Kb			0.738618		16374994			0.9881	SNP		CCDS168.1			,,,	False	16374994				intron_variant		Approved		52.0			2012-09-26	OTTHUMT00000026331.1	P51801	0.8487		CLCNKB	16374994							protein-coding gene	NP_000076.2		
		G	ENSG00000184908	ENST00000375679.4	0.26717	1188	N	ENSG00000184908	0.16574	4300	0.003000	0.91124	B		,	T	0.9708548	0	c.(640-642)gCa>gGa	OTTHUMG00000009530	0.068000	byFrequency	P51801	gene with protein product				NM_000085.4		NM_000085	0.9407			g	0.122	+	Missense_Mutation	2		49.0	P51801	.					0.0	CLCNKB-001	2012-02-23		0.01281		1	+	0.4992		0.54	0.425000		2027	284		Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)		SO:0001583	602023		0.7845303867403315	protein_coding		2203	P		0.004000		B	"""Ion channels / Chloride channels : Voltage-sensitive"""	6503		0.0:0.4447:0.4633:0.092			UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000375679		ACAGTCTTTGCAGCTCCCTTC	D					ENST00000375679.4:c.641C>G	1		ENSG00000184908	0.03352	CLCNKB	breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)	ENSP00000364831:p.Ala214Gly	+	0.15560	,	GCA	1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16375063C>G	A -> G (in dbSNP:rs1889789). {ECO:0000269|PubMed:8041726, ECO:0000269|PubMed:8544406}.			216				0.11579	0.01770	4.67	0.00012	ENSP00000364831:A214G			0.42420		.			0.32032	495	0.15499	0.8653846153846154		adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)	-1.365			hg19	Standard	0.9264	0.43902439024390244	10.1298			excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)		-1.124289				CCDS168.1, CCDS57974.1	C	0.02656		AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)		0.00569	2504	2.71	rs71493533|rs1889789		752	214	577		"""chloride channel Kb"""	0.42672	16247650	+		214	hClC-Kb	1572	21	NM_000085	0.0	7	0.7612137203166227	-0.782000	ENST00000375679.4		12598					1188			0.0000		p.A214G	Chloride channel, core (2);	0		T		47.0	rs45612832	0.657	1:g.16375063C>G	ENSP00000364831:A214G	protein_coding	0.000707		basic|appris_principal|CCDS				214		0.7197802197802198	G	G|||		0.237700	5008		CLCKB_HUMAN	4143	chloride channel, voltage-sensitive Kb		CLCKB_HUMAN	0.827276	0.12164	16375063		-0.037000	0.998	SNP		CCDS168.1		N	,,,	False	16375063	-0.9240		9	missense	T	Approved	.	48.0		c.641C>G	2012-09-26	OTTHUMT00000026331.1	P51801	0.9006	-2.79	CLCNKB	16375063	0.31504		0.45745				protein-coding gene	NP_000076.2	A	
		C	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4300					,				c.(640-642)gcA>gcC	OTTHUMG00000009530		byFrequency	P51801	gene with protein product				NM_000085.4		NM_000085	0.9407					+	Silent			49.0								CLCNKB-001	2012-02-23				1	+	0.4992					2027			Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)		SO:0001819	602023			protein_coding		2203						"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CAGTCTTTGCAGCTCCCTTCA						ENST00000375679.4:c.642A>C	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16375064A>C	A -> G (in dbSNP:rs1889789). {ECO:0000269|PubMed:8041726, ECO:0000269|PubMed:8544406}.																								adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.9264					excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)						CCDS168.1, CCDS57974.1	A			AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)			2504		rs71493533|rs1889790		753				"""chloride channel Kb"""					214	hClC-Kb		21	NM_000085		7			ENST00000375679.4		12651					1188					p.A214A		0				48.0		0.652	1:g.16375064A>C		protein_coding			basic|appris_principal|CCDS								C|||			5008		CLCKB_HUMAN	4143	chloride channel, voltage-sensitive Kb			0.827276		16375064			0.998	SNP		CCDS168.1			,,,	False	16375064				synonymous_variant		Approved		49.0		c.642A>C	2012-09-26	OTTHUMT00000026331.1	P51801	0.9006		CLCNKB	16375064							protein-coding gene	NP_000076.2		
		C	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4300					,				c.(874-876)tgT>tgC	OTTHUMG00000009530		byFrequency	P51801	gene with protein product		CLCNKB_ENST00000375667.3_Silent_p.C123C		NM_000085.4	749,1059,395	NM_000085	0.9417					+	Silent			169.0								CLCNKB-001	2012-02-23				1	+	0.4939				coding-synonymous,coding-synonymous	2027		292/688,123/519	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	602023	,		protein_coding		2203				6.4651,41.9655,18.4915		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GGGGTCTCTGTGGCATCCTGG						ENST00000375679.4:c.876T>C	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16376319T>C					no		10601,2405												-9.1					0.1	adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.9384			8044,556		excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)	4511,1579,413					CCDS168.1, CCDS57974.1	T		CC,CT,TT	AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	174		2504		rs7368151		987				"""chloride channel Kb"""				,	292	hClC-Kb		21	NM_000085		10			ENST00000375679.4		15344					1188	dbSNP_116	876,369			p.C292C		0				184.0		0.592	1:g.16376319T>C		protein_coding			basic|appris_principal|CCDS		3762,520,18			2557,1849			C|||			5008		CLCKB_HUMAN	4157	chloride channel, voltage-sensitive Kb			0.830072		16376319			0.999	SNP		CCDS168.1			,,,	False	16376319				synonymous_variant		Approved		174.0		c.876T>C	2012-09-26	OTTHUMT00000026331.1	P51801	0.9107		CLCNKB	16376319				,	CLCNKB	NM_000085.3,NM_001165945.1	protein-coding gene	NP_000076.2		
		C	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4300					,					OTTHUMG00000009530		byFrequency	P51801	gene with protein product		CLCNKB_ENST00000375667.3_Intron		NM_000085.4	6,201,1996	NM_000085	0.2883					+	Intron		368.2+/-335.0	61.0								CLCNKB-001	2012-02-23				1	+	0.0159				intron,intron	2027		,	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	602023	,		protein_coding		2203				24.8837,4.8343,18.0917		"""Ion channels / Chloride channels : Voltage-sensitive"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			AAGGGGCCTTGAGTGGGGTGG						ENST00000375679.4:c.1053+13G>C	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16377108G>C		129.0+/-165.8			no		2353,10653												1.0					0.0	adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.2684			2140,6460		excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)	260,1833,4410					CCDS168.1, CCDS57974.1	G		CC,CG,GG	AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	63		2504		rs35480349		1164				"""chloride channel Kb"""				,		hClC-Kb		21	NM_000085		11			ENST00000375679.4		16262					1188	dbSNP_126	,					0				67.0		0.582	1:g.16377108G>C		protein_coding			basic|appris_principal|CCDS		254,1632,2414			213,4193			G|||			5008		CLCKB_HUMAN	814	chloride channel, voltage-sensitive Kb			0.16254		16377108			0.0109	SNP		CCDS168.1			,,,	False	16377108				intron_variant		Approved		63.0			2012-09-26	OTTHUMT00000026331.1	P51801	0.3314		CLCNKB	16377108				,	CLCNKB	NM_000085.3,NM_001165945.1	protein-coding gene	NP_000076.2		
		C	ENSG00000184908	ENST00000375679.4	0.80722	1188	N	ENSG00000184908	0.03038	4298	0.001000	0.92299	B;B		,	T	0.0	0	c.(1684-1686)aTg>aCg	OTTHUMG00000009530	-1.098000	byFrequency	P51801	gene with protein product		CLCNKB_ENST00000375667.3_Missense_Mutation_p.M393T		NM_000085.4	1085,917,201	NM_000085	0.91			t	0.006	+	Missense_Mutation	2	812.0+/-407.1	77.0	Q5T5Q7;P51801	0.700635					0.003;0.0	CLCNKB-001	2012-02-23		0.08055		1	+	0.646		0.44	0.397000	missense,missense	2027	332	562/688,393/519	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	T	SO:0001583	602023	benign,benign	0.9171270718232044	protein_coding		2203	P		0.000000	1.5589,29.9365,11.1752	B;B	"""Ion channels / Chloride channels : Voltage-sensitive"""	6501		0.1267:0.2777:0.0:0.5956			UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000375668;ENST00000375679;ENST00000375667;ENST00000431772		GCCAAGGACATGCCACTGGAG	D;D;D					ENST00000375679.4:c.1685T>C	1	CBS 1. {ECO:0000255|PROSITE- ProRule:PRU00703}.	ENSG00000184908	0.00561	CLCNKB	breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)	ENSP00000364831:p.Met562Thr	+	0.05858	,	ATG	1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16380196T>C	M -> T (in dbSNP:rs5253). {ECO:0000269|PubMed:8041726, ECO:0000269|PubMed:8544406}.	693.3+/-405.7		301	yes		11549,1453	0.08648	0.00346	4.59	0.00012	ENSP00000364819:M393T			0.08176		.		-3.7	0.04398	465	0.20046	0.8129370629370629	0.0	adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)	-1.56			hg19	Standard	0.9692	0.6117886178861789	7.1107	8462,134		excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)	5250,1049,202	-2.118749				CCDS168.1, CCDS57974.1	T	0.02656	CC,CT,TT	AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	87	0.00389	2504	-3.73	rs5253		1796	393;562	724		"""chloride channel Kb"""	0.25388	16252783	+	THR/MET,THR/MET	562	hClC-Kb	1822	21	NM_000085	0.0;0.0	16	0.9551451187335093	-1.860000	ENST00000375679.4		18785					1188	dbSNP_52	1685,1178	0.0000		p.M562T	Cystathionine beta-synthase, core (3);	0		T		106.0	rs5253;rs3978483;rs6423943;rs16852329;rs5253	0.622	1:g.16380196T>C	ENSP00000364831:M562T;ENSP00000364819:M393T;ENSP00000389344:M51T	protein_coding	0.986258		basic|appris_principal|CCDS		4165,132,1		60;562;393;51	3087,1319	0.8342490842490843	T	T|||		0.993807	5008		CLCKB_HUMAN	4198	chloride channel, voltage-sensitive Kb		.;CLCKB_HUMAN	0.838259	0.04000	16380196		-0.923000	0.8353	SNP		CCDS168.1		N	,,,	False	16380196	-0.9828		9	missense	T	Approved	0.984411	87.0		c.1685T>C	2012-09-26	OTTHUMT00000026331.1	P51801	0.9179	-3.01;-3.01;-2.2	CLCNKB	16380196	0.30659		0.34453	81,81	CLCNKB	NM_000085.3,NM_001165945.1	protein-coding gene	NP_000076.2	M	
		T	ENSG00000184908	ENST00000375679.4		1188		ENSG00000184908		4293					,					OTTHUMG00000009530		byFrequency	P51801	gene with protein product		CLCNKB_ENST00000375667.3_Intron		NM_000085.4		NM_000085	0.3569					+	Intron			42.0								CLCNKB-001	2012-02-23				1	+	0.2231					2027			Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)		SO:0001627	602023			protein_coding		2203						"""Ion channels / Chloride channels : Voltage-sensitive"""	6496					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.04e-08)|COAD - Colon adenocarcinoma(227;5.46e-06)|BRCA - Breast invasive adenocarcinoma(304;9.02e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00655)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			ACCTCCACCCCCTTTCTCTGT						ENST00000375679.4:c.2017-16C>T	1					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|ovary(2)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)		+		,		1p36	B3KUY3|Q5T5Q7|Q5T5Q8		g.chr1:16383348C>T																									adenyl nucleotide binding (GO:0030554)|metal ion binding (GO:0046872)|voltage-gated chloride channel activity (GO:0005247)				hg19	Standard	0.3151					excretion (GO:0007588)|ion transmembrane transport (GO:0034220)|regulation of anion transport (GO:0044070)|transmembrane transport (GO:0055085)|transport (GO:0006810)						CCDS168.1, CCDS57974.1	C			AK098217	chloride channel complex (GO:0034707)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)			2504		rs61769892		2127				"""chloride channel Kb"""						hClC-Kb		21	NM_000085		20			ENST00000375679.4		10768					1188							0				52.0		0.552	1:g.16383348C>T		protein_coding			basic|appris_principal|CCDS								C|||			5008		CLCKB_HUMAN	1259	chloride channel, voltage-sensitive Kb			0.251398		16383348			0.0188	SNP		CCDS168.1			,,,	False	16383348				intron_variant		Approved		45.0			2012-09-26	OTTHUMT00000026331.1	P51801	0.402		CLCNKB	16383348							protein-coding gene	NP_000076.2		
		A	ENSG00000185519	ENST00000375662.4		348487		ENSG00000185519		4246					,				c.(397-399)gaC>gaT	OTTHUMG00000009525		byFrequency	Q96AQ9	gene with protein product		FAM131C_ENST00000494078.1_5'UTR		NM_182623.2	625,1054,446	NM_182623	0.8139					+	Silent			25.0				12477932				FAM131C-001	2007-03-20				1	-	0.4871				coding-synonymous	26717		133/281	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819				protein_coding		2125				24.317,45.7882,31.4786			6371					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.32e-08)|COAD - Colon adenocarcinoma(227;5.56e-06)|BRCA - Breast invasive adenocarcinoma(304;9.12e-05)|Kidney(64;0.000163)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00656)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			AGTAATGCTCGTCCTCAGCTG		C1orf117				ENST00000375662.4:c.399C>T	1					large_intestine(2)|lung(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)		-		,		1p36.13	Q5T5Q5|Q8N3X3|Q8N9P9		g.chr1:16386416G>A					no		8731,4011												-3.1					0.8			2007-03-20		hg19	Standard	0.7584			6427,2065			3059,2613,699					CCDS41270.1	G		AA,AG,GG			24		2504		rs9442230		582				"""chromosome 1 open reading frame 117"""					133	FLJ36766		8	NM_182623		5			ENST00000375662.4		12397		uc001axz.4			348487	dbSNP_119	399			p.D133D		0				22.0		0.692	1:g.16386416G>A		protein_coding			basic|appris_principal|CCDS		2434,1559,253			2304,1946			G|||			5008		F131C_HUMAN	3558	family with sequence similarity 131, member C			0.710463		16386416			0.8155	SNP		CCDS41270.1			,,,	False	16386416				synonymous_variant		Approved		24.0		c.399C>T	2008-02-05	OTTHUMT00000026319.1	Q96AQ9	0.768		FAM131C	16386416					FAM131C	NM_182623.2	protein-coding gene	NP_872429.2		
		C	ENSG00000185519	ENST00000375662.4		348487		ENSG00000185519		4180					,				c.(214-216)agA>agG	OTTHUMG00000009525		byFrequency	Q96AQ9	gene with protein product		FAM131C_ENST00000494078.1_5'UTR		NM_182623.2	1029,895,124	NM_182623	0.8497					+	Silent			77.0				12477932				FAM131C-001	2007-03-20				1	-	0.7163				coding-synonymous	26717		72/281	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819				protein_coding		2048				12.8828,27.9053,17.8227			6228					UCEC - Uterine corpus endometrioid carcinoma (279;0.0178)|Colorectal(212;8.32e-08)|COAD - Colon adenocarcinoma(227;5.56e-06)|BRCA - Breast invasive adenocarcinoma(304;9.12e-05)|Kidney(64;0.000163)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.00656)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CGGGGCGGGATCTGGAGTCGG		C1orf117				ENST00000375662.4:c.216A>G	1					large_intestine(2)|lung(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)		-		,		1p36.13	Q5T5Q5|Q8N3X3|Q8N9P9		g.chr1:16388646T>C					no		10236,2220												-4.1					0.9			2007-03-20		hg19	Standard	0.8738			7283,1077			4146,1944,138					CCDS41270.1	T		CC,CT,TT			77		2504		rs2863456		399				"""chromosome 1 open reading frame 117"""					72	FLJ36766		8	NM_182623		4			ENST00000375662.4		14577		uc001axz.4			348487	dbSNP_101	216			p.R72R		0				76.0		0.657	1:g.16388646T>C		protein_coding			basic|appris_principal|CCDS		3117,1049,14			2953,1143			C|||			5008		F131C_HUMAN	4090	family with sequence similarity 131, member C			0.816693		16388646			0.8304	SNP		CCDS41270.1			,,,	False	16388646				synonymous_variant		Approved		77.0		c.216A>G	2008-02-05	OTTHUMT00000026319.1	Q96AQ9	0.8588		FAM131C	16388646					FAM131C	NM_182623.2	protein-coding gene	NP_872429.2		
		A	ENSG00000142627	ENST00000358432.5		1969		ENSG00000142627		4300					,				c.(2872-2874)atC>atT	OTTHUMG00000009527		byFrequency	P29317	gene with protein product			Dasatinib(DB01254)|Regorafenib(DB08896)	NM_004431.3	32,481,1690	NM_004431	0.3507					+	Silent		396.7+/-345.5	47.0				9119409				EPHA2-001	2004-10-28				1	-	0.1135				coding-synonymous	3386		958/977	Colorectal(325;3.46e-05)|Breast(348;0.000278)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.000567)|Ovarian(437;0.0221)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	176946			protein_coding		2203				28.1279,12.3695,22.7895		"""EPH receptors"", ""Sterile alpha motif (SAM) domain containing"", ""Fibronectin type III domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|Colorectal(212;3.63e-07)|COAD - Colon adenocarcinoma(227;2.25e-05)|BRCA - Breast invasive adenocarcinoma(304;9.58e-05)|Kidney(64;0.000175)|KIRC - Kidney renal clear cell carcinoma(64;0.00261)|STAD - Stomach adenocarcinoma(313;0.00669)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GGCTGTAGGCGATGCGCTTCT		ECK				ENST00000358432.5:c.2874C>T	1	Negatively regulates interaction with ARHGEF16.|SAM. {ECO:0000255|PROSITE- ProRule:PRU00184}.				NS(1)|biliary_tract(1)|breast(3)|central_nervous_system(3)|cervix(2)|endometrium(1)|kidney(1)|large_intestine(6)|lung(12)|ovary(2)|pancreas(1)|prostate(3)|stomach(2)|upper_aerodigestive_tract(3)|urinary_tract(1)		-		,		1p36	B5A968|Q8N3Z2		g.chr1:16451767G>A		244.3+/-253.7			yes		2964,10042							http://www.ncbi.nlm.nih.gov/sites/varvu?gene					-6.9					0.8	ATP binding (GO:0005524)|ephrin receptor activity (GO:0005003)|transmembrane receptor protein tyrosine kinase activity (GO:0004714)				hg19	Standard	0.3161			2419,6181		activation of Rac GTPase activity (GO:0032863)|angiogenesis (GO:0001525)|axial mesoderm formation (GO:0048320)|bone remodeling (GO:0046849)|branching involved in mammary gland duct morphogenesis (GO:0060444)|cell adhesion (GO:0007155)|cell chemotaxis (GO:0060326)|cell migration (GO:0016477)|ephrin receptor signaling pathway (GO:0048013)|intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)|keratinocyte differentiation (GO:0030216)|lens fiber cell morphogenesis (GO:0070309)|mammary gland epithelial cell proliferation (GO:0033598)|multicellular organismal development (GO:0007275)|negative regulation of protein kinase B signaling (GO:0051898)|neural tube development (GO:0021915)|neuron differentiation (GO:0030182)|notochord cell development (GO:0060035)|notochord formation (GO:0014028)|osteoblast differentiation (GO:0001649)|osteoclast differentiation (GO:0030316)|peptidyl-tyrosine phosphorylation (GO:0018108)|positive regulation of establishment of protein localization to plasma membrane (GO:0090004)|post-anal tail morphogenesis (GO:0036342)|protein kinase B signaling (GO:0043491)|regulation of angiogenesis (GO:0045765)|regulation of blood vessel endothelial cell migration (GO:0043535)|regulation of cell adhesion mediated by integrin (GO:0033628)|regulation of ERK1 and ERK2 cascade (GO:0070372)|regulation of lamellipodium assembly (GO:0010591)|response to growth factor (GO:0070848)|skeletal system development (GO:0001501)|vasculogenesis (GO:0001570)|viral process (GO:0016032)	376,2212,3915					CCDS169.1	G		AA,AG,GG	BC037166	cell projection (GO:0042995)|cell surface (GO:0009986)|focal adhesion (GO:0005925)|integral component of plasma membrane (GO:0005887)|leading edge membrane (GO:0031256)|plasma membrane (GO:0005886)	52		2504		rs3754334		3028				"""EphA2"""					958			42	NM_004431		17			ENST00000358432.5		12121		uc001aya.2			1969	dbSNP_107	2874			p.I958I		0				61.0		0.642	1:g.16451767G>A		protein_coding			basic|appris_principal|CCDS		344,1731,2225			545,3861			G|||			5008		EPHA2_HUMAN	1185	EPH receptor A2			0.236621		16451767			0.1548	SNP		CCDS169.1			,,,	False	16451767		2.7.10.1		synonymous_variant		Approved		52.0		c.2874C>T	2013-02-11	OTTHUMT00000026322.1	P29317	0.3141		EPHA2	16451767					EPHA2	NM_004431.3	protein-coding gene	NP_004422.2		
		T	ENSG00000142632	ENST00000270747.3		128272		ENSG00000142632		4300					,					OTTHUMG00000002219		byFrequency	Q8IW93	gene with protein product		ARHGEF19_ENST00000478117.1_5'UTR		NM_153213.3	55,549,1599	NM_153213	0.4264					+	3'UTR		372.5+/-336.7	60.0				12477932				ARHGEF19-001					1	-	0.1316				utr-3	26604			Colorectal(325;0.000147)|Renal(390;0.00145)|Breast(348;0.00224)|Lung NSC(340;0.00566)|all_lung(284;0.00831)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0646)	G	SO:0001624	612496			protein_coding		2203				25.6395,14.9569,22.0206		"""Rho guanine nucleotide exchange factors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.018)|Colorectal(212;3.48e-07)|COAD - Colon adenocarcinoma(227;2.19e-05)|BRCA - Breast invasive adenocarcinoma(304;9.46e-05)|Kidney(64;0.000171)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.0117)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			AGGCATGGAGGTGGGGTCCTA						ENST00000270747.3:c.*26C>A	1					cervix(1)|endometrium(1)|lung(3)|ovary(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)		-		,		1p36.13	A6NJ04|Q5TEV2|Q6PJQ4|Q8N244		g.chr1:16525056G>T		279.0+/-274.6			no		2864,10142												-3.0					0.0	GTPase activator activity (GO:0005096)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.2624			2205,6395		regulation of actin cytoskeleton organization (GO:0032956)|wound healing (GO:0042060)	341,2182,3980					CCDS170.1	G		TT,TG,GG	BC012982		60		2504		rs451260		2571										FLJ33962, WGEF		12	NM_153213		0			ENST00000270747.3		17875		uc001ayc.1			128272	dbSNP_80						0				61.0		0.627	1:g.16525056G>T		protein_coding			basic|appris_principal|CCDS		286,1633,2381			659,3747			G|||			5008		ARHGJ_HUMAN	1286	Rho guanine nucleotide exchange factor (GEF) 19			0.256789		16525056			0.1498	SNP		CCDS170.1			,,,	False	16525056				3_prime_UTR_variant		Approved		60.0			2011-11-16	OTTHUMT00000006289.1	Q8IW93	0.4035		ARHGEF19	16525056					ARHGEF19	NM_153213.3	protein-coding gene	NP_694945.2		
		G	ENSG00000142632	ENST00000270747.3	0.40022	128272	L	ENSG00000142632	0.78162	4298	0.474000	0.71579	B		,	T	0.024572999999999956	0	c.(712-714)Gag>Cag	OTTHUMG00000002219	2.316000	byFrequency	Q8IW93	gene with protein product				NM_153213.3	79,620,1504	NM_153213	0.4233			C	19.69	+	Missense_Mutation	1	367.8+/-334.9	49.0	Q8IW93	0.176577		12477932			0.018	ARHGEF19-001			0.17433		1	-	0.1664		0.5	0.043000	missense	26604	123	238/803	Colorectal(325;0.000147)|Renal(390;0.00145)|Breast(348;0.00224)|Lung NSC(340;0.00566)|all_lung(284;0.00831)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0646)	C	SO:0001583	612496	benign	0.3397790055248619	protein_coding		2203	P		0.961000	26.0586,17.6577,23.2118	B	"""Rho guanine nucleotide exchange factors"""	6501		0.0:1.0:0.0:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.018)|Colorectal(212;3.48e-07)|COAD - Colon adenocarcinoma(227;2.19e-05)|BRCA - Breast invasive adenocarcinoma(304;9.46e-05)|Kidney(64;0.000171)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.0117)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000270747;ENST00000421561;ENST00000375607		CTTCGAGCCTCCATTCCAGAT	T;T					ENST00000270747.3:c.712G>C	1		ENSG00000142632	0.68633	ARHGEF19	cervix(1)|endometrium(1)|lung(3)|ovary(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)	ENSP00000270747:p.Glu238Gln	-	0.32948	,	GAG	1p36.13	A6NJ04|Q5TEV2|Q6PJQ4|Q8N244		g.chr1:16534255C>G	E -> Q (in dbSNP:rs221057). {ECO:0000269|PubMed:14702039}.	305.5+/-289.0		73	yes		3018,9984	0.27266	0.72180	4.94	0.00012	ENSP00000270747:E238Q			0.00702		.		4.9	0.65067	74	0.17369	0.12937062937062938	0.5	GTPase activator activity (GO:0005096)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)	1.59			hg19	Standard	0.2654	0.1483739837398374	13.8258	2240,6356		regulation of actin cytoskeleton organization (GO:0032956)|wound healing (GO:0042060)	377,2264,3860	3.874660				CCDS170.1	C	0.20052	GG,GC,CC	BC012982		48	0.50333	2504	4.94	rs221057		848	238	210			0.63351	16406842	-	GLN/GLU	238	FLJ33962, WGEF	480	12	NM_153213	0.041	4	0.2770448548812665	0.549000	ENST00000270747.3		14901		uc001ayc.1			128272	dbSNP_79	712	0.0000		p.E238Q	.	0		T		46.0	rs221057;rs221057	0.682	1:g.16534255C>G	ENSP00000270747:E238Q;ENSP00000396001:E238Q	protein_coding	0.000785		basic|appris_principal|CCDS		298,1644,2356		238	778,3628	0.21978021978021978	Q	C|||		4.578340	5008		ARHGJ_HUMAN	1337	Rho guanine nucleotide exchange factor (GEF) 19		ARHGJ_HUMAN	0.266973	0.55628	16534255		3.812000	0.1528	SNP		CCDS170.1		N	,,,	False	16534255	-1.0973		9	missense	T	Approved	0.260586	48.0		c.712G>C	2011-11-16	OTTHUMT00000006289.1	Q8IW93	0.4063	-0.58;1.81	ARHGEF19	16534255	0.13939		0.04153	29	ARHGEF19	NM_153213.3	protein-coding gene	NP_694945.2	E	
		G	ENSG00000142632	ENST00000270747.3	0.45390	128272	L	ENSG00000142632	0.20860	4300	0.967000	0.50001	B		,	T	0.001623000000000041	0	c.(487-489)Ggc>Cgc	OTTHUMG00000002219	0.220000	byFrequency	Q8IW93	gene with protein product				NM_153213.3	35,383,1785	NM_153213	0.4223			C	10.83	+	Missense_Mutation	1	370.2+/-335.8	61.0	Q8IW93	0.102814		12477932			0.011	ARHGEF19-001			0.14578		1	-	0.0862		0.28	0.118000	missense	26604	118	163/803	Colorectal(325;0.000147)|Renal(390;0.00145)|Breast(348;0.00224)|Lung NSC(340;0.00566)|all_lung(284;0.00831)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0646)	C	SO:0001583	612496	benign	0.3259668508287293	protein_coding		2203	P		0.296000	25.9651,10.2814,20.652	B	"""Rho guanine nucleotide exchange factors"""	6503		0.0:0.6669:0.0:0.3331			UCEC - Uterine corpus endometrioid carcinoma (279;0.018)|Colorectal(212;3.48e-07)|COAD - Colon adenocarcinoma(227;2.19e-05)|BRCA - Breast invasive adenocarcinoma(304;9.46e-05)|Kidney(64;0.000171)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(313;0.0117)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000270747;ENST00000421561;ENST00000375607		ACTACCTGGCCAGGCTCTAGG	T;T					ENST00000270747.3:c.487G>C	1		ENSG00000142632	0.74099	ARHGEF19	cervix(1)|endometrium(1)|lung(3)|ovary(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)	ENSP00000270747:p.Gly163Arg	-	0.24398	,	GGC	1p36.13	A6NJ04|Q5TEV2|Q6PJQ4|Q8N244		g.chr1:16534646C>G	G -> R (in dbSNP:rs221058). {ECO:0000269|PubMed:14702039}.	209.2+/-230.0		47	yes		2686,10320	0.41034	0.26248	5.21	0.00012	ENSP00000270747:G163R			0.05817		.		2.1	0.27403	74	0.30078	0.12937062937062938	1.0	GTPase activator activity (GO:0005096)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)	0.975			hg19	Standard	0.2654	0.09552845528455285	6.6718	2233,6367		regulation of actin cytoskeleton organization (GO:0032956)|wound healing (GO:0042060)	330,2026,4147	1.459937				CCDS170.1	C	0.15719	GG,GC,CC	BC012982		59	0.32530	2504	2.13	rs221058		623	163	211			0.23072	16407233	-	ARG/GLY	163	FLJ33962, WGEF	450	12	NM_153213	0.014	3	0.2783641160949868	0.561000	ENST00000270747.3		16480		uc001ayc.1			128272	dbSNP_79	487	0.0000		p.G163R	.	0		T		56.0	rs221058;rs221058	0.657	1:g.16534646C>G	ENSP00000270747:G163R;ENSP00000396001:G163R	protein_coding	0.615075		basic|appris_principal|CCDS		295,1643,2362		163	453,3953	0.20604395604395603	R	C|||		1.238380	5008		ARHGJ_HUMAN	1222	Rho guanine nucleotide exchange factor (GEF) 19		ARHGJ_HUMAN	0.24401	0.25203	16534646		0.673000	0.1528	SNP		CCDS170.1		N	,,,	False	16534646	-0.9954		9	missense	T	Approved	0.259651	59.0		c.487G>C	2011-11-16	OTTHUMT00000006289.1	Q8IW93	0.3948	0.76;0.76	ARHGEF19	16534646	0.20060		0.31138	125	ARHGEF19	NM_153213.3	protein-coding gene	NP_694945.2	G	
		G	ENSG00000187144	ENST00000335496.1	0.52099	374955	N	ENSG00000187144	0.18452	4300	0.986000	0.73789	B;B		,	T	5.299999999996974E-5	0	c.(763-765)Gtg>Ctg	OTTHUMG00000002312	0.127000	byFrequency	Q7Z572	gene with protein product		SPATA21_ENST00000540400.1_Missense_Mutation_p.V232L|SPATA21_ENST00000466212.1_5'UTR		NM_198546.1	93,696,1414	NM_198546	0.4734			C	0.019	+	Missense_Mutation	1	359.8+/-331.7	85.0	F5GXP5;Q7Z572	0.200182					0.003;0.005	SPATA21-001			0.10450		1	-	0.2027		1	0.223000	missense	28026	122	255/470	Colorectal(325;0.000147)|Renal(390;0.00145)|Lung NSC(340;0.00215)|Breast(348;0.00224)|all_lung(284;0.00351)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0646)	C	SO:0001583		benign	0.3370165745856354	protein_coding		2203	P		0.965000	24.1512,20.0182,22.751	B;B	"""EF-hand domain containing"""	6503		0.2244:0.2828:0.3244:0.1683			UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|COAD - Colon adenocarcinoma(227;1.15e-05)|BRCA - Breast invasive adenocarcinoma(304;4.2e-05)|Kidney(64;0.000183)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(313;0.0122)|READ - Rectum adenocarcinoma(331;0.0651)			KNOWN	ENST00000335496;ENST00000540400		GCCAGCGTCACAGAGAAGCCC	T;T					ENST00000335496.1:c.763G>C	1	EF-hand. {ECO:0000255|PROSITE- ProRule:PRU00448}.	ENSG00000187144	0.20887	SPATA21	breast(1)|endometrium(2)|lung(8)|ovary(2)|pancreas(3)|stomach(1)|urinary_tract(2)	ENSP00000335612:p.Val255Leu	-	0.33210	,	GTG	1p36.13	B9EK40|F5GXP5		g.chr1:16731510C>G	V -> L (in dbSNP:rs525409). {ECO:0000269|PubMed:15489334}.	343.1+/-307.5		91	yes		2959,10047	0.45419	0.01080	4.53	0.00012	ENSP00000335612:V255L			0.16178		-1.6805		-0.3	0.12683	69	0.02654	0.12062937062937062	1.0	calcium ion binding (GO:0005509)	-1.485			hg19	Standard	0.2416	0.18495934959349594	0.875	2077,6523			344,2271,3888	-1.448705				CCDS172.1	C	0.06786	GG,GC,CC			90	0.00453	2504	-0.33	rs525409		1245	232;255	190			0.01222	16604097	-	LEU/VAL	255	spergen-2, spergen2	472	19	NM_198546	0.001;0.001	8	0.25065963060686014	0.313000	ENST00000335496.1		19702		uc001ayn.3			374955	dbSNP_83	763	0.0000		p.V255L	EF-hand-like domain (1);	0		T		101.0	rs525409;rs52801517;rs56634096;rs525409	0.582	1:g.16731510C>G	ENSP00000335612:V255L;ENSP00000440046:V232L	protein_coding	0.225994		basic|appris_candidate_longest|CCDS		251,1575,2474		255;232	882,3524	0.21611721611721613	L	C|||		0.515634	5008		SPT21_HUMAN	1403	spermatogenesis associated 21		.;SPT21_HUMAN	0.280152	0.14279	16731510		0.057000	0.1488	SNP		CCDS172.1		N	,,,	False	16731510	-1.0256		9	missense	T	Approved	0.241512	90.0		c.763G>C	2013-01-10	OTTHUMT00000006677.2	Q7Z572	0.402	-0.78;-0.78	SPATA21	16731510	0.24884		0.21075	32	SPATA21	NM_198546.1	protein-coding gene	NP_940948.1	V	
		C	ENSG00000187144	ENST00000335496.1		374955		ENSG00000187144		4299					,					OTTHUMG00000002312		byFrequency	Q7Z572	gene with protein product		SPATA21_ENST00000466212.1_Intron|SPATA21_ENST00000540400.1_Intron		NM_198546.1	1745,409,49	NM_198546	1.0					+	Intron		1.2+/-3.3	40.0								SPATA21-001					1	-	0.8608				intron	28026			Colorectal(325;0.000147)|Renal(390;0.00145)|Lung NSC(340;0.00215)|Breast(348;0.00224)|all_lung(284;0.00351)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0646)	C	SO:0001627				protein_coding		2203				0.0582,11.507,3.9373		"""EF-hand domain containing"""	6502					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|COAD - Colon adenocarcinoma(227;1.15e-05)|BRCA - Breast invasive adenocarcinoma(304;4.2e-05)|Kidney(64;0.000183)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(313;0.0122)|READ - Rectum adenocarcinoma(331;0.0651)			KNOWN			TTCTTGTTTCTGTCATTCATC						ENST00000335496.1:c.674-47A>G	1					breast(1)|endometrium(2)|lung(8)|ovary(2)|pancreas(3)|stomach(1)|urinary_tract(2)		-		,		1p36.13	B9EK40|F5GXP5		g.chr1:16731646T>C		176.6+/-205.7			no		12492,512												-2.8					0.0	calcium ion binding (GO:0005509)				hg19	Standard	1.0			8593,5			6040,412,50					CCDS172.1	T		CC,CT,TT			43		2504		rs3106498|rs386628916		1156										spergen-2, spergen2		19	NM_198546		8			ENST00000335496.1		17704		uc001ayn.3			374955	dbSNP_103						0				47.0		0.522	1:g.16731646T>C		protein_coding			basic|appris_candidate_longest|CCDS		4295,3,1			3899,507			C|||			5008		SPT21_HUMAN	4813	spermatogenesis associated 21			0.961062		16731646			1.0	SNP		CCDS172.1			,,,	False	16731646				intron_variant		Approved		43.0			2013-01-10	OTTHUMT00000006677.2	Q7Z572	0.9841		SPATA21	16731646					SPATA21	NM_198546.1	protein-coding gene	NP_940948.1		
		T	ENSG00000157191	ENST00000337132.5		55707		ENSG00000157191		4300					,					OTTHUMG00000002313		byFrequency	Q9NVZ3	gene with protein product		NECAP2_ENST00000457722.2_Intron|NECAP2_ENST00000504551.2_Intron|NECAP2_ENST00000443980.2_Intron|NECAP2_ENST00000406746.1_Intron		NM_001145278.1|NM_018090.4	0,14,2189	NM_018090	0.002					+	Intron		88.1+/-150.5	58.0				14555962, 15494011				NECAP2-001					1	+	0.003				intron,intron,intron	25528		,,	Colorectal(325;0.000147)|Renal(390;0.00145)|Lung NSC(340;0.00215)|Breast(348;0.00224)|all_lung(284;0.00351)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0646)	C	SO:0001627	611624	,,		protein_coding		2203				2.4767,0.3177,1.7453			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|COAD - Colon adenocarcinoma(227;1.13e-05)|BRCA - Breast invasive adenocarcinoma(304;4.13e-05)|Kidney(64;0.000181)|KIRC - Kidney renal clear cell carcinoma(64;0.00268)|STAD - Stomach adenocarcinoma(196;0.012)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			CATGTTCTCTCCCCAGGTGGG						ENST00000337132.5:c.381-6C>T	1					endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)|lung(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)		+		,		1p36.13	B4DY19|E9PGQ8|Q5VSU4|Q5VSU5|Q9H7L1|Q9H8L1		g.chr1:16775582C>T		20.2+/-43.8			no		227,12779												3.4					0.7					hg19	Standard	0.0338			213,8387		endocytosis (GO:0006897)|protein transport (GO:0015031)	1,225,6277					CCDS173.1, CCDS44066.1, CCDS44067.1	C		TT,TC,CC	AK021938	clathrin vesicle coat (GO:0030125)|coated pit (GO:0005905)|intracellular (GO:0005622)|plasma membrane (GO:0005886)	62		2504		rs61769455		470								,,		FLJ10420		9	NM_001145277		5			ENST00000337132.5		22021		uc001ayq.3			55707	dbSNP_129	,,					0				70.0		0.542	1:g.16775582C>T		protein_coding			basic|appris_principal|CCDS		1,211,4088			14,4392			C|||			5008		NECP2_HUMAN	52	NECAP endocytosis associated 2			0.0103834		16775582			0.0	SNP		CCDS173.1			,,,	False	16775582				intron_variant		Approved		62.0			2008-02-05	OTTHUMT00000006680.2	Q9NVZ3	0.0173		NECAP2	16775582				,,	NECAP2	NM_001145277.1,NM_001145278.1,NM_018090.4	protein-coding gene	NP_001138750.1|NP_060560.1		
		G	ENSG00000058453	ENST00000375541.5		9696		ENSG00000058453		4299									c.(211-213)acA>acG	OTTHUMG00000002200		byFrequency		gene with protein product		CROCC_ENST00000467938.1_Intron		NM_014675.3	0,1667,536	NM_014675						+	Silent			33.0				12427867, 17971504				CROCC-001	2009-03-04				1	+					coding-synonymous	21299		71/2018	Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000174)|all_lung(284;0.000234)|Renal(390;0.000518)|Ovarian(437;0.00669)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	615776			protein_coding		2203				32.2284,37.8348,34.128			6502					UCEC - Uterine corpus endometrioid carcinoma (279;0.00459)|BRCA - Breast invasive adenocarcinoma(304;7.63e-06)|COAD - Colon adenocarcinoma(227;1.07e-05)|Kidney(64;0.000163)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.181)			KNOWN			TGCCGGCCACAGAGATGGCAT						ENST00000375541.5:c.213A>G	1					breast(3)|central_nervous_system(2)|cervix(3)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(12)|large_intestine(1)|lung(20)|ovary(3)|prostate(9)|skin(3)|urinary_tract(1)		+				1p36.13		"""rootletin, ciliary rootlet protein"""	g.chr1:17250836A>G					no		4438,8566												-7.0					0.0			2009-03-04		hg19	Standard				2771,5827			0,4438,2064					CCDS30616.1	A		GG,GA,AA	AB007914		35				rs57174186		282										rootletin, ROLT		62	XM_006711056		3			ENST00000375541.5				uc001azt.2			9696	dbSNP_129	213			p.T71T		0				38.0		0.657	1:g.17250836A>G		protein_coding			basic|appris_principal|CCDS		0,2771,1528			1667,2739										ciliary rootlet coiled-coil, rootletin					17250836				SNP		CCDS30616.1					17250836				synonymous_variant		Approved		35.0		c.213A>G	2010-06-04	OTTHUMT00000006249.2	Q5TZA2			CROCC	17250836					CROCC	NM_014675.3	protein-coding gene	NP_055490.3		
		T	ENSG00000058453	ENST00000375541.5		9696		ENSG00000058453		4293					,					OTTHUMG00000002200		byFrequency		gene with protein product				NM_014675.3	418,995,787	NM_014675	0.6616					+	Intron			16.0				12427867, 17971504				CROCC-001	2009-03-04				1	+	0.329				intron	21299			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000174)|all_lung(284;0.000234)|Renal(390;0.000518)|Ovarian(437;0.00669)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	615776			protein_coding		2200				27.1838,41.6136,37.756			6493					UCEC - Uterine corpus endometrioid carcinoma (279;0.00459)|BRCA - Breast invasive adenocarcinoma(304;7.63e-06)|COAD - Colon adenocarcinoma(227;1.07e-05)|Kidney(64;0.000163)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.181)			KNOWN			TCCGGGACCCCAACTTCATCC						ENST00000375541.5:c.5784+27C>T	1					breast(3)|central_nervous_system(2)|cervix(3)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(12)|large_intestine(1)|lung(20)|ovary(3)|prostate(9)|skin(3)|urinary_tract(1)		+		,		1p36.13		"""rootletin, ciliary rootlet protein"""	g.chr1:17297289C>T					no		8083,4903												1.8					0.0			2009-03-04		hg19	Standard	0.7505			6252,2334			2697,2689,1107					CCDS30616.1	C		TT,TC,CC	AB007914		16		2504		rs9435656		5853										rootletin, ROLT		62	XM_006711056		35			ENST00000375541.5		17560		uc001azt.2			9696	dbSNP_119						0				15.0		0.667	1:g.17297289C>T		protein_coding			basic|appris_principal|CCDS		2279,1694,320			1831,2569			C|||			5008			3201	ciliary rootlet coiled-coil, rootletin			0.639177		17297289			0.8512	SNP		CCDS30616.1			,,,	False	17297289				intron_variant		Approved		16.0			2010-06-04	OTTHUMT00000006249.2	Q5TZA2	0.7291		CROCC	17297289					CROCC	NM_014675.3	protein-coding gene	NP_055490.3		
Familial Paragangliomas;Cowden syndrome;Carney-Stratakis syndrome		T	ENSG00000117118	ENST00000375499.3		6390		ENSG00000117118		4300					,					OTTHUMG00000002289		byFrequency	P21912	gene with protein product		SDHB_ENST00000466613.1_Intron	Succinic acid(DB00139)	NM_003000.2	64,604,1535	NM_003000	0.0644					+	Intron		167.1+/-218.9	89.0					"""paraganglioma, pheochromocytoma"""			SDHB-001					1	-	0.1899				intron	10681			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000419)|Renal(390;0.000518)|all_lung(284;0.00054)|Ovarian(437;0.00669)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	185470			protein_coding		2203				7.7907,16.6137,10.7796		"""Mitochondrial respiratory chain complex / Complex II"""	6503	"""Mis, N, F"""		yes		UCEC - Uterine corpus endometrioid carcinoma (279;0.0049)|COAD - Colon adenocarcinoma(227;1.18e-05)|BRCA - Breast invasive adenocarcinoma(304;2.41e-05)|Kidney(64;0.000188)|KIRC - Kidney renal clear cell carcinoma(64;0.00273)|STAD - Stomach adenocarcinoma(196;0.00656)|READ - Rectum adenocarcinoma(331;0.0656)|Lung(427;0.19)			KNOWN			CAAGAACTCTCCTTCAATAGC		SDH1, SDH		Hereditary Glomus Tumors, Familial Paragangliomas, Hereditary Paragangliomas, type 1-3: PGL1, PGL2, PGL3, incl. Familial Carotid Body Paraganglioma and Sensorineural Hearing Loss;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;Carney-Stratakis dyad, Paraganglioma-Gastric Stromal Sarcoma dyad	Familial Cancer Database	ENST00000375499.3:c.200+32G>A	1					breast(1)|cervix(1)|endometrium(1)|kidney(1)|large_intestine(2)|lung(4)		-		,		1p36.1-p35	B2R545|Q0QEY7|Q9NQ12		g.chr1:17371223C>T		295.3+/-283.6			no		1402,11604									Rec		6390	0.4					0.0	2 iron, 2 sulfur cluster binding (GO:0051537)|3 iron, 4 sulfur cluster binding (GO:0051538)|4 iron, 4 sulfur cluster binding (GO:0051539)|electron carrier activity (GO:0009055)|metal ion binding (GO:0046872)|succinate dehydrogenase (ubiquinone) activity (GO:0008177)|ubiquinone binding (GO:0048039)				hg19	Standard	0.0954			670,7930		aerobic respiration (GO:0009060)|cellular metabolic process (GO:0044237)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)|succinate metabolic process (GO:0006105)|tricarboxylic acid cycle (GO:0006099)	87,1228,5188					CCDS176.1	C		TT,TC,CC	U17248	extracellular vesicular exosome (GO:0070062)|mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex II (GO:0005749)|mitochondrion (GO:0005739)	89		2504		rs2647169	Familial paraganglioma	351												10	NM_003000		2			ENST00000375499.3	O	18648		uc001bae.3	1p36.1-p35		6390	dbSNP_100						0				90.0		0.403	1:g.17371223C>T		protein_coding		"""succinate dehydrogenase complex, subunit B, iron sulfur (Ip)"""	basic|appris_principal|CCDS		23,624,3653			732,3674			C|||			5008		SDHB_HUMAN	532	succinate dehydrogenase complex, subunit B, iron sulfur (Ip)	1		0.10623		17371223			0.0813	SNP		CCDS176.1			,,,	False	17371223		1.3.99.1		intron_variant		Approved		89.0			2014-09-17	OTTHUMT00000006603.1	P21912	0.0576		SDHB	17371223					SDHB	NM_003000.2	protein-coding gene	NP_002991.2		
		C	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,				c.(1642-1644)ctA>ctG	OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000444885.2_Silent_p.L432L|PADI2_ENST00000466151.1_5'UTR	L-Citrulline(DB00155)	NM_007365.2	334,1060,809		0.4663					+	Silent		506.6+/-376.6	136.0				2768262				PADI2-001					1	-	0.3094				coding-synonymous	18341		548/666	Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	607935			protein_coding		2203				40.1047,39.2192,47.109		"""Peptidyl arginine deiminases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			GGTTCCAGTCTAGGCAGCGCT						ENST00000375486.4:c.1644A>G	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17396703T>C		649.3+/-398.9			no		6879,6127												1.7					1.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.5905			5151,3449		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	1848,3183,1472					CCDS177.1	T		CC,CT,TT	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	139		2504		rs2076595		1707									548	KIAA0994, PDI2		29	NM_007365		15			ENST00000375486.4		19975		uc001baf.3			11240	dbSNP_96	1644			p.L548L		0				145.0		0.602	1:g.17396703T>C		protein_coding			basic|appris_principal|CCDS		1514,2123,663			1728,2678			C|||			5008		PADI2_HUMAN	2227	peptidyl arginine deiminase, type II			0.444688		17396703			0.3929	SNP		CCDS177.1			,,,	False	17396703		3.5.3.15		synonymous_variant		Approved		139.0		c.1644A>G	2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.536		PADI2	17396703					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		C	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000444885.2_Intron|PADI2_ENST00000466151.1_5'UTR	L-Citrulline(DB00155)	NM_007365.2	645,1094,464		0.5378					+	Intron			41.0				2768262				PADI2-001					1	-	0.4834				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	607935			protein_coding		2203		OREG0013145		34.6163,45.892,38.4361		"""Peptidyl arginine deiminases"""	6503				717	UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			ATTGGTTTGCTGCTACCCCAT						ENST00000375486.4:c.1455+38A>G	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17402135T>C					no		8007,4999												1.3					0.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.6561			5623,2977		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	2493,3021,989					CCDS177.1	T		CC,CT,TT	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	40		2504		rs3818034		1519										KIAA0994, PDI2		29	NM_007365		12			ENST00000375486.4		15807		uc001baf.3			11240	dbSNP_107						0				37.0		0.552	1:g.17402135T>C		protein_coding			basic|appris_principal|CCDS		1848,1927,525	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		2384,2022			C|||			5008		PADI2_HUMAN	2635	peptidyl arginine deiminase, type II			0.526158		17402135			0.4028	SNP		CCDS177.1			,,,	False	17402135		3.5.3.15		intron_variant		Approved		40.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.5821		PADI2	17402135					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		A	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000466151.1_5'UTR|PADI2_ENST00000444885.2_Intron	L-Citrulline(DB00155)	NM_007365.2	644,1097,462		0.5378					+	Intron		455.6+/-363.8	63.0				2768262				PADI2-001					1	-	0.4826				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	A	SO:0001627	607935			protein_coding		2203		OREG0013145		34.6744,45.8693,38.4669		"""Peptidyl arginine deiminases"""	6503				717	UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			CTCCAGCCTCGGGAGGCTAGC						ENST00000375486.4:c.1455+14C>T	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17402159G>A		556.4+/-379.5			no		8003,5003												-9.2					0.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.6561			5618,2982		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	2487,3029,987					CCDS177.1	G		AA,AG,GG	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	62		2504		rs3818033		1519										KIAA0994, PDI2		29	NM_007365		12			ENST00000375486.4		16476		uc001baf.3			11240	dbSNP_107						0				60.0		0.572	1:g.17402159G>A		protein_coding			basic|appris_principal|CCDS		1843,1932,525	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		2385,2021			A|||			5008		PADI2_HUMAN	2633	peptidyl arginine deiminase, type II			0.525759		17402159			0.4018	SNP		CCDS177.1			,,,	False	17402159		3.5.3.15		intron_variant		Approved		62.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.5821		PADI2	17402159					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		T	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,				c.(1372-1374)gcG>gcA	OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000444885.2_Silent_p.A342A|PADI2_ENST00000466151.1_5'UTR	L-Citrulline(DB00155)	NM_007365.2	643,1098,462		0.5378					+	Silent		665.8+/-402.3	95.0				2768262				PADI2-001					1	-	0.4834				coding-synonymous	18341		458/666	Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	607935			protein_coding		2203		OREG0013145		34.6977,45.892,38.4899		"""Peptidyl arginine deiminases"""	6503				717	UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			GCTCCACGGGCGCCTGCACCT						ENST00000375486.4:c.1374G>A	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17402255C>T		612.8+/-392.0			no		8000,5006												-8.2					0.3	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.6561			5616,2984		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	2484,3032,987					CCDS177.1	C		TT,TC,CC	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	96		2504		rs3818032		1437									458	KIAA0994, PDI2		29	NM_007365		12			ENST00000375486.4		18334		uc001baf.3			11240	dbSNP_107	1374			p.A458A		0				98.0		0.592	1:g.17402255C>T		protein_coding			basic|appris_principal|CCDS		1841,1934,525	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		2384,2022			C|||			5008		PADI2_HUMAN	2634	peptidyl arginine deiminase, type II			0.525958		17402255			0.4028	SNP		CCDS177.1			,,,	False	17402255		3.5.3.15		synonymous_variant		Approved		96.0		c.1374G>A	2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.5807		PADI2	17402255					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		T	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000466151.1_Intron|PADI2_ENST00000444885.2_Intron	L-Citrulline(DB00155)	NM_007365.2	2041,161,1		0.9918					+	Intron		90.6+/-152.8	50.0				2768262				PADI2-001					1	-	0.9705				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	607935			protein_coding		2203		OREG0013145		2.5116,3.6995,2.914		"""Peptidyl arginine deiminases"""	6503				717	UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			GGAGTTTCAGCAAATTACCCA						ENST00000375486.4:c.1311-29G>A	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17402347C>T		108.6+/-147.0			no		12627,379												-5.6					0.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.9732			8384,216		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	6125,377,1					CCDS177.1	C		TT,TC,CC	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	50		2504		rs2647205		1374										KIAA0994, PDI2		29	NM_007365		12			ENST00000375486.4		18747		uc001baf.3			11240	dbSNP_100						0				51.0		0.602	1:g.17402347C>T		protein_coding			basic|appris_principal|CCDS		4084,216,0	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		4243,163			T|||			5008		PADI2_HUMAN	4924	peptidyl arginine deiminase, type II			0.983227		17402347			0.996	SNP		CCDS177.1			,,,	False	17402347		3.5.3.15		intron_variant		Approved		50.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.9914		PADI2	17402347					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		A	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,				c.(1258-1260)aaC>aaT	OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000466151.1_5'UTR|PADI2_ENST00000375481.1_Silent_p.N420N|PADI2_ENST00000444885.2_Silent_p.N304N	L-Citrulline(DB00155)	NM_007365.2	275,1043,885		0.4642					+	Silent		624.5+/-397.6	65.0				2768262				PADI2-001					1	-	0.295				coding-synonymous	18341		420/666	Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	607935			protein_coding		2203				42.186,36.1552,49.5233		"""Peptidyl arginine deiminases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			ATGTCTTGCCGTTCACGGTCA						ENST00000375486.4:c.1260C>T	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17405809G>A		495.1+/-363.2			no		6565,6441												-5.9					1.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.5726			4972,3628		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	1698,3169,1636					CCDS177.1	G		AA,AG,GG	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	64		2504		rs2057096		1323									420	KIAA0994, PDI2		29	NM_007365		11			ENST00000375486.4		14866		uc001baf.3			11240	dbSNP_94	1260			p.N420N		0				64.0		0.592	1:g.17405809G>A		protein_coding			basic|appris_principal|CCDS		1423,2126,751			1593,2813			G|||			5008		PADI2_HUMAN	2176	peptidyl arginine deiminase, type II			0.434505		17405809			0.3879	SNP		CCDS177.1			,,,	False	17405809		3.5.3.15		synonymous_variant		Approved		64.0		c.1260C>T	2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.5259		PADI2	17405809					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		T	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000375481.1_Intron|PADI2_ENST00000444885.2_Intron|PADI2_ENST00000466151.1_Intron	L-Citrulline(DB00155)	NM_007365.2	275,1043,885		0.4642					+	Intron		621.1+/-397.1	47.0				2768262				PADI2-001					1	-	0.2935				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	607935			protein_coding		2203				42.2209,36.1552,49.5464		"""Peptidyl arginine deiminases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			GGGCCCTAGGCAGAGGGCACA						ENST00000375486.4:c.1159-6G>A	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17405916C>T		492.5+/-362.4			no		6562,6444												-2.0					0.2	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.5726			4969,3631		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	1695,3172,1636					CCDS177.1	C		TT,TC,CC	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	48		2504		rs2057095		1222										KIAA0994, PDI2		29	NM_007365		11			ENST00000375486.4		16209		uc001baf.3			11240	dbSNP_94						0				49.0		0.592	1:g.17405916C>T		protein_coding			basic|appris_principal|CCDS		1420,2129,751			1593,2813			C|||			5008		PADI2_HUMAN	2174	peptidyl arginine deiminase, type II			0.434105		17405916			0.3879	SNP		CCDS177.1			,,,	False	17405916		3.5.3.15		intron_variant		Approved		48.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.5259		PADI2	17405916					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		G	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000375481.1_Intron|PADI2_ENST00000444885.2_Intron	L-Citrulline(DB00155)	NM_007365.2	2016,183,4		0.9918					+	Intron		137.9+/-194.8	79.0				2768262				PADI2-001					1	-	0.9667				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	607935			protein_coding		2203				5.3837,4.335,5.0284		"""Peptidyl arginine deiminases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			TCTAGGCTGGACTGGGCTGGG						ENST00000375486.4:c.655+19T>C	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17418883A>G		120.0+/-157.7			no		12352,654												1.1					0.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.9463			8137,463		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	5859,634,10					CCDS177.1	A		GG,GA,AA	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	84		2504		rs2647184		719										KIAA0994, PDI2		29	NM_007365		6			ENST00000375486.4		18679		uc001baf.3			11240	dbSNP_100						0				94.0		0.562	1:g.17418883A>G		protein_coding			basic|appris_principal|CCDS		3843,451,6			4215,191			G|||			5008		PADI2_HUMAN	4886	peptidyl arginine deiminase, type II			0.975639		17418883			0.997	SNP		CCDS177.1			,,,	False	17418883		3.5.3.15		intron_variant		Approved		84.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.9813		PADI2	17418883					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		G	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000375481.1_Intron|PADI2_ENST00000444885.2_Intron	L-Citrulline(DB00155)	NM_007365.2	451,1126,626		0.4959					+	Intron		486.7+/-371.9	91.0				2768262				PADI2-001					1	-	0.4266				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	607935			protein_coding		2203				37.5465,46.0281,43.1109		"""Peptidyl arginine deiminases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			CTGGGCTGGGATCACTCACTC						ENST00000375486.4:c.655+8T>C	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17418894A>G		611.0+/-391.7			no		7399,5607												1.6					0.1	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.6332			5371,3229		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	2140,3119,1244					CCDS177.1	A		GG,GA,AA	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	97		2504		rs2273111		719										KIAA0994, PDI2		29	NM_007365		6			ENST00000375486.4		18436		uc001baf.3			11240	dbSNP_100						0				108.0		0.577	1:g.17418894A>G		protein_coding			basic|appris_principal|CCDS		1689,1993,618			2028,2378			G|||			5008		PADI2_HUMAN	2440	peptidyl arginine deiminase, type II			0.48722		17418894			0.4048	SNP		CCDS177.1			,,,	False	17418894		3.5.3.15		intron_variant		Approved		97.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.4986		PADI2	17418894					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		C	ENSG00000117115	ENST00000375486.4		11240		ENSG00000117115		4300					,					OTTHUMG00000002295		byFrequency	Q9Y2J8	gene with protein product		PADI2_ENST00000375481.1_Intron|PADI2_ENST00000444885.2_Intron	L-Citrulline(DB00155)	NM_007365.2	451,1126,626		0.4959					+	Intron		487.1+/-372.0	40.0				2768262				PADI2-001					1	-	0.4274				intron	18341			Colorectal(325;3.46e-05)|Breast(348;0.000162)|Lung NSC(340;0.000422)|Renal(390;0.000518)|all_lung(284;0.000546)|Ovarian(437;0.00671)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	607935			protein_coding		2203				37.5,46.0281,43.0801		"""Peptidyl arginine deiminases"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00583)|BRCA - Breast invasive adenocarcinoma(304;1.49e-05)|COAD - Colon adenocarcinoma(227;1.54e-05)|Kidney(64;0.000258)|KIRC - Kidney renal clear cell carcinoma(64;0.00348)|STAD - Stomach adenocarcinoma(196;0.0072)|READ - Rectum adenocarcinoma(331;0.0698)|Lung(427;0.201)			KNOWN			GATCTATCTGTTGCTGGAGCC						ENST00000375486.4:c.530-38A>G	1					breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(12)|ovary(4)|pancreas(1)|skin(5)|urinary_tract(3)		-		,		1p35.2-p35.1	Q96DA7|Q9UPN2		g.chr1:17419066T>C		611.2+/-391.7			no		7403,5603												-3.7					0.0	calcium ion binding (GO:0005509)|estrogen receptor binding (GO:0030331)|protein-arginine deiminase activity (GO:0004668)				hg19	Standard	0.6332			5375,3225		chromatin-mediated maintenance of transcription (GO:0048096)|histone H3-R26 citrullination (GO:0036413)|intracellular estrogen receptor signaling pathway (GO:0030520)|negative regulation of chemokine-mediated signaling pathway (GO:0070100)|negative regulation of lymphocyte chemotaxis (GO:1901624)|protein citrullination (GO:0018101)|regulation of chromatin disassembly (GO:0010848)|substantia nigra development (GO:0021762)	2142,3119,1242					CCDS177.1	T		CC,CT,TT	AB030176	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|transcriptionally active chromatin (GO:0035327)	41		2504		rs11203298		593										KIAA0994, PDI2		29	NM_007365		6			ENST00000375486.4		19786		uc001baf.3			11240	dbSNP_120						0				42.0		0.483	1:g.17419066T>C		protein_coding			basic|appris_principal|CCDS		1691,1993,616			2028,2378			C|||			5008		PADI2_HUMAN	2441	peptidyl arginine deiminase, type II			0.48742		17419066			0.4048	SNP		CCDS177.1			,,,	False	17419066		3.5.3.15		intron_variant		Approved		41.0			2008-02-05	OTTHUMT00000006624.1	Q9Y2J8	0.4986		PADI2	17419066					PADI2	NM_007365.2	protein-coding gene	NP_031391.2		
		T	ENSG00000074964	ENST00000361221.3		55160		ENSG00000074964		4300					,				c.(1759-1761)atC>atT	OTTHUMG00000002514		byFrequency	Q9HCE6	gene with protein product		ARHGEF10L_ENST00000452522.1_Silent_p.I548I|ARHGEF10L_ENST00000375408.3_Silent_p.I360I|ARHGEF10L_ENST00000375415.1_Silent_p.I548I|ARHGEF10L_ENST00000469726.1_3'UTR|ARHGEF10L_ENST00000434513.1_Silent_p.I582I|ARHGEF10L_ENST00000375420.3_Silent_p.I345I|ARHGEF10L_ENST00000167825.4_Silent_p.I290I		NM_018125.3	5,167,2031	NM_018125	0.0736					+	Silent		296.2+/-302.8	40.0				10997877, 16112081				ARHGEF10L-001					1	+	0.0061				coding-synonymous,coding-synonymous	25540		548/1241,587/1280	Colorectal(325;3.46e-05)|Breast(348;0.000162)|all_lung(284;0.000337)|Lung NSC(340;0.000419)|Renal(390;0.000518)|Ovarian(437;0.00409)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	612494	,		protein_coding		2203				19.1047,4.0172,13.9935		"""Rho guanine nucleotide exchange factors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00598)|COAD - Colon adenocarcinoma(227;1.62e-05)|BRCA - Breast invasive adenocarcinoma(304;1.68e-05)|Kidney(64;0.000269)|KIRC - Kidney renal clear cell carcinoma(64;0.00361)|STAD - Stomach adenocarcinoma(196;0.00656)|READ - Rectum adenocarcinoma(331;0.0718)|Lung(427;0.204)			KNOWN			AGCTGGAGATCAGCAGCCTGG						ENST00000361221.3:c.1761C>T	1					NS(1)|breast(1)|central_nervous_system(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|liver(2)|lung(16)|ovary(4)|pancreas(1)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)		+		,		1p36.13	B7ZKS1|Q17RW1|Q3YFJ4|Q5VXI5|Q5VXI6|Q66K51|Q6P0L7|Q8NAV5|Q9NVT3	"""GrinchGEF"""	g.chr1:17961345C>T		113.3+/-151.4			no		1820,11186												2.9					1.0	Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.1859			1643,6957			163,1494,4846					CCDS182.1, CCDS30617.1	C		TT,TC,CC	AB046846	cytoplasm (GO:0005737)	39		2504		rs34725104		1920								,	587	FLJ10521, KIAA1626		43	XM_005245923		18			ENST00000361221.3		15918		uc001ban.3			55160	dbSNP_126	1644,1761			p.I587I		0				39.0		0.667	1:g.17961345C>T		protein_coding			basic|CCDS		158,1327,2815			177,4229			C|||			5008		ARGAL_HUMAN	407	Rho guanine nucleotide exchange factor (GEF) 10-like			0.08127		17961345			0.0724	SNP		CCDS182.1			,,,	False	17961345				synonymous_variant		Approved		39.0		c.1761C>T	2011-11-16	OTTHUMT00000007147.1	Q9HCE6	0.0965		ARHGEF10L	17961345				,	ARHGEF10L	NM_001011722.2,NM_018125.3	protein-coding gene	NP_060595		
		C	ENSG00000074964	ENST00000361221.3	0.58432	55160	N	ENSG00000074964	0.19760	4300	0.951000	0.27104	B;B;B;B;B;B		,	T	1.0000000000287557E-6	0	c.(2971-2973)Tgg>Cgg	OTTHUMG00000002514	0.172000		Q9HCE6	gene with protein product		ARHGEF10L_ENST00000375408.3_Missense_Mutation_p.W764R|ARHGEF10L_ENST00000469726.1_3'UTR|ARHGEF10L_ENST00000434513.1_Missense_Mutation_p.W986R|ARHGEF10L_ENST00000375415.1_Missense_Mutation_p.W952R|ARHGEF10L_ENST00000452522.1_Missense_Mutation_p.W952R|ARHGEF10L_ENST00000167825.4_Missense_Mutation_p.W694R		NM_018125.3	2200,3,0	NM_018125	1.0			C	3.913	+	Missense_Mutation	1		46.0	Q5VXI4;Q9HCE6-5;Q9HCE6-4;Q9HCE6-3;Q9HCE6-2;Q9HCE6	0.999319		10997877, 16112081			0.0;0.0;0.0;0.0;0.0;0.0	ARHGEF10L-001			0.01281		1	+	0.9992		0.89	0.864000	missense,missense	25540	362	952/1241,991/1280	Colorectal(325;3.46e-05)|Breast(348;0.000162)|all_lung(284;0.000337)|Lung NSC(340;0.000419)|Renal(390;0.000518)|Ovarian(437;0.00409)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	612494	benign,benign	1.0	protein_coding		2203	P		0.000000	0.0,0.0681,0.0231	B;B;B;B;B;B	"""Rho guanine nucleotide exchange factors"""	6503		0.408:0.5012:0.0:0.0908			UCEC - Uterine corpus endometrioid carcinoma (279;0.00598)|COAD - Colon adenocarcinoma(227;1.62e-05)|BRCA - Breast invasive adenocarcinoma(304;1.68e-05)|Kidney(64;0.000269)|KIRC - Kidney renal clear cell carcinoma(64;0.00361)|STAD - Stomach adenocarcinoma(196;0.00656)|READ - Rectum adenocarcinoma(331;0.0718)|Lung(427;0.204)			KNOWN	ENST00000361221;ENST00000452522;ENST00000434513;ENST00000375415;ENST00000375408;ENST00000457829;ENST00000167825		CTGTGGGCCCTGGGTCACTGT	T;T;T;T;T;T					ENST00000361221.3:c.2971T>C	1		ENSG00000074964	0.07637	ARHGEF10L	NS(1)|breast(1)|central_nervous_system(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|liver(2)|lung(16)|ovary(4)|pancreas(1)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)	ENSP00000355060:p.Trp991Arg	+	0.05858	,	TGG	1p36.13	B7ZKS1|Q17RW1|Q3YFJ4|Q5VXI5|Q5VXI6|Q66K51|Q6P0L7|Q8NAV5|Q9NVT3	"""GrinchGEF"""	g.chr1:17991052T>C	W -> R (in dbSNP:rs6695710). {ECO:0000269|PubMed:10997877, ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16112081}.	6.2+/-15.9		492	yes		13003,3	0.38953	0.07634	4.22	0.00012	ENSP00000167825:W694R			0.29676		-20.1888		3.2	0.36227	572	0.06494	1.0	1.0	Rho guanyl-nucleotide exchange factor activity (GO:0005089)	-1.905			hg19	Standard	1.0	1.0	6.1301	8600,0			6500,3,0	-0.019640				CCDS182.1, CCDS30617.1	T	0.02656	CC,CT,TT	AB046846	cytoplasm (GO:0005737)	47	0.00182	2504	3.15	rs6695710		3130	764;986;694;947;952;991	758			0.20201	17863639	+	ARG/TRP,ARG/TRP	991	FLJ10521, KIAA1626	2184	43	XM_005245923	0.0;0.0;0.0;0.0;0.0;0.0	26	1.0	-0.355000	ENST00000361221.3		16989		uc001ban.3			55160	dbSNP_116	2854,2971	0.0000		p.W991R	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	0		T		49.0	rs6695710	0.652	1:g.17991052T>C	ENSP00000355060:W991R;ENSP00000399401:W952R;ENSP00000394621:W986R;ENSP00000364564:W952R;ENSP00000364557:W764R;ENSP00000167825:W694R	protein_coding	0.011494		basic|CCDS		4300,0,0		991;952;986;952;764;764;694	4403,3	1.0	R	C|||		0.314237	5008		ARGAL_HUMAN	5007	Rho guanine nucleotide exchange factor (GEF) 10-like		.;.;.;.;.;ARGAL_HUMAN	0.9998	0.18478	17991052		0.263000	1.0	SNP		CCDS182.1		N	,,,	False	17991052	-0.9950		9	missense	T	Approved	1.0	47.0		c.2971T>C	2011-11-16	OTTHUMT00000007147.1	Q9HCE6	1.0	1.69;1.69;1.69;1.69;1.69;1.69	ARHGEF10L	17991052	0.49448		0.31251	101,101	ARHGEF10L	NM_001011722.2,NM_018125.3	protein-coding gene	NP_060595	W	
		T	ENSG00000074964	ENST00000361221.3		55160		ENSG00000074964		4300					,				c.(3328-3330)aaC>aaT	OTTHUMG00000002514		byFrequency	Q9HCE6	gene with protein product		ARHGEF10L_ENST00000375408.3_Silent_p.N883N|ARHGEF10L_ENST00000469726.1_3'UTR|ARHGEF10L_ENST00000375415.1_Silent_p.N1071N|ARHGEF10L_ENST00000167825.4_Silent_p.N813N|ARHGEF10L_ENST00000452522.1_Silent_p.N1071N		NM_018125.3	892,1012,299	NM_018125	0.909					+	Silent		747.6+/-407.3	39.0				10997877, 16112081				ARHGEF10L-001					1	+	0.5855				coding-synonymous,coding-synonymous	25540		1071/1241,1110/1280	Colorectal(325;3.46e-05)|Breast(348;0.000162)|all_lung(284;0.000337)|Lung NSC(340;0.000419)|Renal(390;0.000518)|Ovarian(437;0.00409)|Myeloproliferative disorder(586;0.0255)	T	SO:0001819	612494	,		protein_coding		2203		OREG0013156		16.8488,36.5411,23.5199		"""Rho guanine nucleotide exchange factors"""	6503				722	UCEC - Uterine corpus endometrioid carcinoma (279;0.00598)|COAD - Colon adenocarcinoma(227;1.62e-05)|BRCA - Breast invasive adenocarcinoma(304;1.68e-05)|Kidney(64;0.000269)|KIRC - Kidney renal clear cell carcinoma(64;0.00361)|STAD - Stomach adenocarcinoma(196;0.00656)|READ - Rectum adenocarcinoma(331;0.0718)|Lung(427;0.204)			KNOWN			TCTCACTCAACGGGCACTGTG						ENST00000361221.3:c.3330C>T	1					NS(1)|breast(1)|central_nervous_system(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|liver(2)|lung(16)|ovary(4)|pancreas(1)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)		+		,		1p36.13	B7ZKS1|Q17RW1|Q3YFJ4|Q5VXI5|Q5VXI6|Q66K51|Q6P0L7|Q8NAV5|Q9NVT3	"""GrinchGEF"""	g.chr1:18023365C>T		659.9+/-400.6			no		9947,3059												-4.8					0.9	Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.8171			7151,1449			3871,2205,427					CCDS182.1, CCDS30617.1	C		TT,TC,CC	AB046846	cytoplasm (GO:0005737)	39		2504		rs2270978		3489								,	1110	FLJ10521, KIAA1626		43	XM_005245923		29			ENST00000361221.3		17076		uc001ban.3			55160	dbSNP_100	3213,3330			p.N1110N		0				41.0		0.632	1:g.18023365C>T		protein_coding			basic|CCDS		2979,1193,128	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		2796,1610			c|||			5008		ARGAL_HUMAN	3930	Rho guanine nucleotide exchange factor (GEF) 10-like			0.784744		18023365			0.8363	SNP		CCDS182.1			,,,	False	18023365				synonymous_variant		Approved		39.0		c.3330C>T	2011-11-16	OTTHUMT00000007147.1	Q9HCE6	0.8674		ARHGEF10L	18023365				,	ARHGEF10L	NM_001011722.2,NM_018125.3	protein-coding gene	NP_060595		
		A	ENSG00000179023	ENST00000400664.1	0.09310	127707	N	ENSG00000179023	0.10078	4170	0.000000	0.72615	B			T	1	0	c.(379-381)gGc>gAc	OTTHUMG00000002431	-0.214000		Q5VTJ3	gene with protein product				NM_152375.2		NM_152375				G	12.90	+	Missense_Mutation	2		29.0	Q5VTJ3	.					0.006	KLHDC7A-001			0.11329		1	+			0.24	0.001000		26791	.		Colorectal(325;3.46e-05)|all_lung(284;0.000152)|Lung NSC(340;0.000185)|Breast(348;0.00046)|Renal(390;0.000518)|Ovarian(437;0.0014)|Myeloproliferative disorder(586;0.0255)		SO:0001583			.	protein_coding		2023	N		0.000000		B		6193		0.2957:0.3649:0.3394:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.41e-05)|Kidney(64;0.00017)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000400664;ENST00000540290		GAGGAGCGGGGCGGGCAGGGC	T					ENST00000400664.1:c.380G>A	1		ENSG00000179023	0.12294	KLHDC7A	endometrium(1)|kidney(1)|large_intestine(4)|lung(11)|ovary(2)|skin(1)|upper_aerodigestive_tract(2)	ENSP00000383505:p.Gly127Asp	+	0.05858		GGC	1p36.13	Q8N8W6		g.chr1:18807855G>A				.				0.03702	0.36662	5.17	0.47116	ENSP00000383505:G127D			.		.			0.05064	.	0.33141	.			0.345			hg19	Standard		.	6.7132					2.077022				CCDS185.2	G	0.12013		AK096072	integral component of membrane (GO:0016021)		0.14661		-3.26			432	127	.			0.23288	18680442	+		127	FLJ38753	.	22	NM_152375	0.005	1	.	-0.229000	ENST00000400664.1				uc001bax.3			127707			0.1428		p.G127D	.	0		T		23.0	.	0.637	1:g.18807855G>A	ENSP00000383505:G127D	protein_coding	.		basic|appris_principal|CCDS				127;64		.	D			.			KLD7A_HUMAN		kelch domain containing 7A		KLD7A_HUMAN		0.03724	18807855		-0.992000		SNP		CCDS185.2		.			18807855	-1.0025		9	missense	T	Approved	.	27.0		c.380G>A	2008-02-05	OTTHUMT00000006923.3	Q5VTJ3		-0.67	KLHDC7A	18807855	0.01503		0.29027				protein-coding gene	NP_689588.2	G	
		G	ENSG00000179023	ENST00000400664.1	0.80722	127707	N	ENSG00000179023	0.10853	4190	0.000000	0.72725	B		,	T	0.0	0	c.(421-423)cCc>cGc	OTTHUMG00000002431	-0.168000	byFrequency	Q5VTJ3	gene with protein product				NM_152375.2	728,966,339	NM_152375	0.4847			G	10.17	+	Missense_Mutation	2		35.0	Q5VTJ3	0.595671					0.0	KLHDC7A-001			0.01281		1	+	0.5688		0.39	0.000000	missense	26791	247	141/778	Colorectal(325;3.46e-05)|all_lung(284;0.000152)|Lung NSC(340;0.000185)|Breast(348;0.00046)|Renal(390;0.000518)|Ovarian(437;0.0014)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583		benign	0.6823204419889503	protein_coding		2033	P		0.000000	36.6229,40.4329,37.8676	B		6223		0.3998:0.1386:0.4616:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.41e-05)|Kidney(64;0.00017)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000400664;ENST00000540290		CCTTGCTGCCCCAGCCAGGAA	T					ENST00000400664.1:c.422C>G	1		ENSG00000179023	0.02672	KLHDC7A	endometrium(1)|kidney(1)|large_intestine(4)|lung(11)|ovary(2)|skin(1)|upper_aerodigestive_tract(2)	ENSP00000383505:p.Pro141Arg	+	0.05858	,	CCC	1p36.13	Q8N8W6		g.chr1:18807897C>G	P -> R (in dbSNP:rs2992755).			286	yes		7733,4713	0.03702	0.23307	5.16	0.00012	ENSP00000383505:P141R			.		.		1.2	0.20946	523	0.22706	0.9143356643356644	0.0		0			hg19	Standard	0.6113	0.5813008130081301	5.2538	5311,3069			2410,2913,900	1.275745				CCDS185.2	C	0.02656	GG,GC,CC	AK096072	integral component of membrane (GO:0016021)	33	0.08118	2504	1.18	rs2992755		474	141	467			0.15537	18680484	+	ARG/PRO	141	FLJ38753	1523	22	NM_152375	0.0	1	0.6160949868073878	-0.946000	ENST00000400664.1		17597		uc001bax.3			127707	dbSNP_101	422	0.0000		p.P141R	.	0		T		29.0	rs2992755	0.637	1:g.18807897C>G	ENSP00000383505:P141R	protein_coding	.		basic|appris_principal|CCDS		1682,1947,561		141;78	2422,1644	0.6973443223443223	R	G|||		.	5008		KLD7A_HUMAN	3240	kelch domain containing 7A		KLD7A_HUMAN	0.646965	0.12104	18807897		-0.040000	0.8958	SNP		CCDS185.2		.	,,,	False	18807897	-1.0150		8	missense	T	Approved	0.633771	33.0		c.422C>G	2008-02-05	OTTHUMT00000006923.3	Q5VTJ3	0.7147	-0.68	KLHDC7A	18807897	0.00434		0.24799	103	KLHDC7A	NM_152375.2	protein-coding gene	NP_689588.2	P	
		A	ENSG00000179023	ENST00000400664.1	0.80722	127707	N	ENSG00000179023	0.06549	4228	0.000000	0.72051	B		,	T	0.0	0	c.(478-480)Cgc>Agc	OTTHUMG00000002431	-0.507000	byFrequency	Q5VTJ3	gene with protein product				NM_152375.2	137,765,1181	NM_152375	0.2352			C	11.86	+	Missense_Mutation	1		37.0	Q5VTJ3	0.2494					0.008	KLHDC7A-001			0.12837		1	+	0.2534		0.62	0.010000	missense	26791	105	160/778	Colorectal(325;3.46e-05)|all_lung(284;0.000152)|Lung NSC(340;0.000185)|Breast(348;0.00046)|Renal(390;0.000518)|Ovarian(437;0.0014)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583		benign	0.2900552486187845	protein_coding		2083	P		0.000000	35.1466,24.94,31.7778	B		6311		0.1147:0.3232:0.3378:0.2243			UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.41e-05)|Kidney(64;0.00017)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000400664;ENST00000540290		CCATTTCCCCCGCTTGGGCAG	T					ENST00000400664.1:c.478C>A	1		ENSG00000179023	0.12614	KLHDC7A	endometrium(1)|kidney(1)|large_intestine(4)|lung(11)|ovary(2)|skin(1)|upper_aerodigestive_tract(2)	ENSP00000383505:p.Arg160Ser	+	0.05858	,	CGC	1p36.13	Q8N8W6		g.chr1:18807953C>A	R -> S (in dbSNP:rs11261022).			140	yes		4011,8611	0.03702	0.31228	4.65	0.00012	ENSP00000383505:R160S			0.05457		.		-4.0	0.04069	139	0.12430	0.243006993006993	0.0		0			hg19	Standard	0.3628	0.2845528455284553	2.446	2972,5484			646,2719,2946	1.764864				CCDS185.2	C	0.18166	AA,AC,CC	AK096072	integral component of membrane (GO:0016021)	35	0.08118	2504	-3.99	rs11261022		530	160	286			0.04506	18680540	+	SER/ARG	160	FLJ38753	670	22	NM_152375	0.026	1	0.37730870712401055	-0.216000	ENST00000400664.1		17782		uc001bax.3			127707	dbSNP_120	478	0.0000		p.R160S	.	0		T		32.0	rs11261022	0.642	1:g.18807953C>A	ENSP00000383505:R160S	protein_coding	0.550465		basic|appris_principal|CCDS		509,1954,1765		160;97	1039,3127	0.3067765567765568	S	C|||		3.517270	5008		KLD7A_HUMAN	1400	kelch domain containing 7A		KLD7A_HUMAN	0.279553	0.00287	18807953		-4.138000	0.2321	SNP		CCDS185.2		U	,,,	False	18807953	-1.0491		9	missense	T	Approved	0.351466	35.0		c.478C>A	2008-02-05	OTTHUMT00000006923.3	Q5VTJ3	0.3401	-0.62	KLHDC7A	18807953	0.07245		0.13926	110	KLHDC7A	NM_152375.2	protein-coding gene	NP_689588.2	R	
		A	ENSG00000179023	ENST00000400664.1	0.80722	127707	N	ENSG00000179023	0.32145	4300	0.650000	0.68181	B		,	T	0.0	0	c.(817-819)Cat>Aat	OTTHUMG00000002431	0.717000	byFrequency	Q5VTJ3	gene with protein product				NM_152375.2	967,996,240	NM_152375	0.4847			A	0.017	+	Missense_Mutation	1	479.0+/-370.0	82.0	Q5VTJ3	0.665002					0.0	KLHDC7A-001			0.01281		1	+	0.6604		1	0.277000	missense	26791	254	273/778	Colorectal(325;3.46e-05)|all_lung(284;0.000152)|Lung NSC(340;0.000185)|Breast(348;0.00046)|Renal(390;0.000518)|Ovarian(437;0.0014)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583		benign	0.7016574585635359	protein_coding		2203	P		0.998000	37.1279,33.4998,35.8988	B		6503		0.6915:0.3085:0.0:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.41e-05)|Kidney(64;0.00017)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000400664;ENST00000540290		AATGGAGGAGCATTTCATACA	T					ENST00000400664.1:c.817C>A	1		ENSG00000179023	0.03097	KLHDC7A	endometrium(1)|kidney(1)|large_intestine(4)|lung(11)|ovary(2)|skin(1)|upper_aerodigestive_tract(2)	ENSP00000383505:p.His273Asn	+	0.40836	,	CAT	1p36.13	Q8N8W6		g.chr1:18808292C>A	H -> N (in dbSNP:rs2992753). {ECO:0000269|PubMed:14702039}.	471.8+/-356.2		330	yes		8337,4669	0.29550	0.01001	4.92	0.00012	ENSP00000383505:H273N			0.17223		.		4.9	0.64577	523	0.02654	0.9143356643356644	0.6		-0.895			hg19	Standard	0.6113	0.6707317073170732	10.5437	5407,3193			2664,3009,830	-1.498345				CCDS185.2	C	0.02656	AA,AC,CC	AK096072	integral component of membrane (GO:0016021)	81	0.01352	2504	4.92	rs372156529|rs2992753		869	273	467			0.45047	18680879	+	ASN/HIS	273	FLJ38753	1574	22	NM_152375	0.0	1	0.6160949868073878	-0.824000	ENST00000400664.1		19405		uc001bax.3			127707	dbSNP_101	817	0.0000		p.H273N	.	0		T		79.0	rs2992753;rs58143972;rs2992753	0.592	1:g.18808292C>A	ENSP00000383505:H273N	protein_coding	0.182256		basic|appris_principal|CCDS		1697,2013,590		273;210	2930,1476	0.7206959706959707	N	A|||		0.547006	5008		KLD7A_HUMAN	3370	kelch domain containing 7A		KLD7A_HUMAN	0.672923	0.45896	18808292		2.560000	0.8958	SNP		CCDS185.2		N	,,,	False	18808292	-0.9483		9	missense	T	Approved	0.628721	81.0		c.817C>A	2008-02-05	OTTHUMT00000006923.3	Q5VTJ3	0.7277	-0.31	KLHDC7A	18808292	0.26821		0.41893	68	KLHDC7A	NM_152375.2	protein-coding gene	NP_689588.2	H	
		A	ENSG00000179002	ENST00000375371.3		80834		ENSG00000179002		4300					,				c.(2317-2319)tcC>tcT	OTTHUMG00000002442		byFrequency	Q8TE23	gene with protein product			Aspartame(DB00168)	NM_152232.2	117,830,1256		0.2689					+	Silent		453.0+/-363.1	111.0								TAS1R2-001	2003-03-07				1	-	0.2254				coding-synonymous	14905		773/840	Colorectal(325;3.46e-05)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Renal(390;0.000518)|Breast(348;0.000812)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	606226			protein_coding		2203				33.5814,24.1489,30.386		"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00466)|BRCA - Breast invasive adenocarcinoma(304;3.56e-05)|Kidney(64;0.000177)|KIRC - Kidney renal clear cell carcinoma(64;0.00262)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			NOVEL			AGAGGGAGACGGATGAGGTGA		GPR71				ENST00000375371.3:c.2319C>T	1					NS(1)|breast(1)|central_nervous_system(1)|endometrium(5)|kidney(4)|large_intestine(10)|lung(14)|ovary(1)|pancreas(3)|prostate(1)|skin(3)|stomach(1)		-		,		1p36.13	Q5TZ19		g.chr1:19166294G>A		388.6+/-327.0			no		3952,9054												-2.1					0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)				hg19	Standard	0.3181			2888,5712		detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)|G-protein coupled receptor signaling pathway (GO:0007186)|positive regulation of cytokinesis (GO:0032467)|sensory perception of sweet taste (GO:0050916)	620,2712,3171					CCDS187.1	G		AA,AG,GG		integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	124		2504		rs12033832		2340				"""G protein-coupled receptor 71"""					773	T1R2, TR2		45	NM_152232		6			ENST00000375371.3		20022		uc001bba.1			80834	dbSNP_120	2319			p.S773S		0				148.0		0.567	1:g.19166294G>A		protein_coding			basic|appris_principal|exp_conf|CCDS		503,1882,1915			1064,3342			G|||			5008		TS1R2_HUMAN	1500	taste receptor, type 1, member 2			0.299521		19166294			0.4583	SNP		CCDS187.1			,,,	False	19166294				synonymous_variant		Approved		124.0		c.2319C>T	2012-08-22	OTTHUMT00000006953.1	Q8TE23	0.2262		TAS1R2	19166294					TAS1R2	NM_152232.2	protein-coding gene	NP_689418.2		
		A	ENSG00000179002	ENST00000375371.3		80834		ENSG00000179002		4300					,					OTTHUMG00000002442		byFrequency	Q8TE23	gene with protein product		RP13-279N23.2_ENST00000494072.3_Intron	Aspartame(DB00168)	NM_152232.2	0,31,2172		0.0031					+	Intron		94.0+/-155.9	75.0								TAS1R2-001	2003-03-07				1	-	0.0015				intron	14905			Colorectal(325;3.46e-05)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Renal(390;0.000518)|Breast(348;0.000812)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	606226			protein_coding		2203				2.7558,0.7036,2.0606		"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00466)|BRCA - Breast invasive adenocarcinoma(304;3.56e-05)|Kidney(64;0.000177)|KIRC - Kidney renal clear cell carcinoma(64;0.00262)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			NOVEL			ACTTCCAGCCCCACACTGGAG		GPR71				ENST00000375371.3:c.182+16G>T	1					NS(1)|breast(1)|central_nervous_system(1)|endometrium(5)|kidney(4)|large_intestine(10)|lung(14)|ovary(1)|pancreas(3)|prostate(1)|skin(3)|stomach(1)		-		,		1p36.13	Q5TZ19		g.chr1:19185956C>A		35.2+/-66.4			no		268,12738												-3.1					0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)				hg19	Standard	0.0398			237,8363		detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)|G-protein coupled receptor signaling pathway (GO:0007186)|positive regulation of cytokinesis (GO:0032467)|sensory perception of sweet taste (GO:0050916)	4,260,6239					CCDS187.1	C		AA,AC,CC		integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	77		2504		rs76539818		204				"""G protein-coupled receptor 71"""						T1R2, TR2		45	NM_152232		1			ENST00000375371.3		18361		uc001bba.1			80834	dbSNP_132						0				79.0		0.607	1:g.19185956C>A		protein_coding			basic|appris_principal|exp_conf|CCDS		4,229,4067			31,4375			C|||			5008		TS1R2_HUMAN	54	taste receptor, type 1, member 2			0.0107827		19185956			0.0	SNP		CCDS187.1			,,,	False	19185956				intron_variant		Approved		77.0			2012-08-22	OTTHUMT00000006953.1	Q8TE23	0.013		TAS1R2	19185956					TAS1R2	NM_152232.2	protein-coding gene	NP_689418.2		
		C	ENSG00000179002	ENST00000375371.3	0.80722	80834	N	ENSG00000179002	0.17047	4300	0.001000	0.89123	B		,	T	0.0	0	c.(25-27)tCc>tGc	OTTHUMG00000002442	0.083000	byFrequency	Q8TE23	gene with protein product		RP13-279N23.2_ENST00000494072.3_3'UTR	Aspartame(DB00168)	NM_152232.2	1516,626,61		0.7751			c	0.014	+	Missense_Mutation	2	344.1+/-325.2	102.0	Q8TE23	0.830232					0.0	TAS1R2-001	2003-03-07		0.01281		1	-	0.8207		1	0.042000	missense	14905	302	9/840	Colorectal(325;3.46e-05)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Renal(390;0.000518)|Breast(348;0.000812)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)		SO:0001583	606226	benign	0.8342541436464088	protein_coding		2203	P		0.000000	22.6744,16.9768,20.7443	B	"""Taste receptors / Type 1"", ""GPCR / Unclassified : Taste receptors"""	6503		0.0:0.4759:0.4326:0.0916			UCEC - Uterine corpus endometrioid carcinoma (279;0.00466)|BRCA - Breast invasive adenocarcinoma(304;3.56e-05)|Kidney(64;0.000177)|KIRC - Kidney renal clear cell carcinoma(64;0.00262)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			NOVEL	ENST00000375371		GAACAGGGAGGAGATGGTCTT	D	GPR71				ENST00000375371.3:c.26C>G	1		ENSG00000179002	0.03794	TAS1R2	NS(1)|breast(1)|central_nervous_system(1)|endometrium(5)|kidney(4)|large_intestine(10)|lung(14)|ovary(1)|pancreas(3)|prostate(1)|skin(3)|stomach(1)	ENSP00000364520:p.Ser9Cys	-	0.05858	,	TCC	1p36.13	Q5TZ19		g.chr1:19186129G>C	S -> C (in dbSNP:rs9701796). {ECO:0000269|PubMed:11917125}.	308.3+/-290.5		388	yes		10308,2698	0.08648	0.00864	4.46	0.00012	ENSP00000364520:S9C			.		.		1.1	0.20703	418	0.02654	0.7307692307692307	0.0	protein heterodimerization activity (GO:0046982)|taste receptor activity (GO:0008527)	-1.1			hg19	Standard	0.7833	0.7886178861788617	8.4868	6650,1950		detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)|G-protein coupled receptor signaling pathway (GO:0007186)|positive regulation of cytokinesis (GO:0032467)|sensory perception of sweet taste (GO:0050916)	4087,2134,282	-1.590631				CCDS187.1	G	0.02656	CC,CG,GG		integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	105	0.00926	2504	1.14	rs9701796		47	9	598		"""G protein-coupled receptor 71"""	0.33076	19058716	-	CYS/SER	9	T1R2, TR2	1706	45	NM_152232	0.0	1	0.7889182058047494	-0.674000	ENST00000375371.3		19772		uc001bba.1			80834	dbSNP_119	26	0.0000		p.S9C	.	0		T		110.0	rs9701796;rs52807298;rs61540313;rs9701796	0.582	1:g.19186129G>C	ENSP00000364520:S9C	protein_coding	.		basic|appris_principal|exp_conf|CCDS		2571,1508,221		9	3658,748	0.7811355311355311	C	c|||		.	5008		TS1R2_HUMAN	3996	taste receptor, type 1, member 2		TS1R2_HUMAN	0.797923	0.12144	19186129		-0.038000	0.7748	SNP		CCDS187.1		.	,,,	False	19186129	-0.9627		8	missense	T	Approved	0.773256	105.0		c.26C>G	2012-08-22	OTTHUMT00000006953.1	Q8TE23	0.8415	-2.47	TAS1R2	19186129	0.13812		0.39165	112	TAS1R2	NM_152232.2	protein-coding gene	NP_689418.2	S	
		G	ENSG00000159423	ENST00000375341.3		8659		ENSG00000159423		4300					,				c.(1378-1380)gaT>gaC	OTTHUMG00000002443		byFrequency	P30038	gene with protein product		ALDH4A1_ENST00000538839.1_Silent_p.D409D|ALDH4A1_ENST00000538309.1_Silent_p.D400D|RP13-279N23.2_ENST00000494072.3_3'UTR|ALDH4A1_ENST00000290597.5_Silent_p.D460D		NM_003748.3	1024,945,234		0.7587					+	Silent		404.8+/-348.3	109.0				8621661				ALDH4A1-001					1	-	0.705				coding-synonymous,coding-synonymous,coding-synonymous	406		400/504,460/564,460/564	Colorectal(325;3.46e-05)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Renal(390;0.000518)|Breast(348;0.000812)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	606811	,,		protein_coding		2203		OREG0013164		28.6047,32.0699,29.7786		"""Aldehyde dehydrogenases"""	6503				731	UCEC - Uterine corpus endometrioid carcinoma (279;0.00479)|BRCA - Breast invasive adenocarcinoma(304;3.67e-05)|Kidney(64;0.000182)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			TGTACTTGTCATCCGGGTAGA		ALDH4				ENST00000375341.3:c.1380T>C	1					cervix(2)|endometrium(1)|large_intestine(3)|lung(8)|prostate(1)		-		,		1p36	A8K1Q7|B4DGE4|D2D4A3|Q16882|Q53HU4|Q5JNV6|Q8IZ38|Q96IF0|Q9UDI6		g.chr1:19201956A>G		462.1+/-353.1			no		9133,3873												-10.2					0.0	1-pyrroline-5-carboxylate dehydrogenase activity (GO:0003842)|aldehyde dehydrogenase (NAD) activity (GO:0004029)|electron carrier activity (GO:0009055)|identical protein binding (GO:0042802)				hg19	Standard	0.7386			6140,2460		4-hydroxyproline catabolic process (GO:0019470)|cellular nitrogen compound metabolic process (GO:0034641)|glutamate biosynthetic process (GO:0006537)|proline biosynthetic process (GO:0006561)|proline catabolic process (GO:0006562)|proline catabolic process to glutamate (GO:0010133)|proline metabolic process (GO:0006560)|small molecule metabolic process (GO:0044281)	3215,2703,585					CCDS188.1, CCDS53272.1	A		GG,GA,AA	U24266	mitochondrial matrix (GO:0005759)	112		2504		rs2230708		1637								,,	460	P5CDh		15	NM_003748		13			ENST00000375341.3		18480		uc001bbc.3			8659	dbSNP_98	1200,1380,1380			p.D460D		0				118.0		0.632	1:g.19201956A>G		protein_coding			basic|appris_principal|CCDS		2191,1758,351	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		2993,1413			G|||			5008		AL4A1_HUMAN	3692	aldehyde dehydrogenase 4 family, member A1			0.73722		19201956			0.7063	SNP		CCDS188.1			,,,	False	19201956		1.5.1.12		synonymous_variant		Approved		112.0		c.1380T>C	2008-02-05	OTTHUMT00000006954.1	P30038	0.8112		ALDH4A1	19201956				,,	ALDH4A1	NM_001161504.1,NM_003748.3,NM_170726.2	protein-coding gene	NP_003739.2		
		G	ENSG00000159423	ENST00000375341.3		8659		ENSG00000159423		4298					,				c.(1048-1050)gcG>gcC	OTTHUMG00000002443		byFrequency	P30038	gene with protein product		RP13-279N23.2_ENST00000494072.3_3'UTR|ALDH4A1_ENST00000538309.1_Silent_p.A290A|ALDH4A1_ENST00000538839.1_Silent_p.A350A|ALDH4A1_ENST00000290597.5_Silent_p.A350A		NM_003748.3	1138,892,172		0.5573					+	Silent			31.0				8621661				ALDH4A1-001					1	-	0.733				coding-synonymous,coding-synonymous,coding-synonymous	406		290/504,350/564,350/564	Colorectal(325;3.46e-05)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Renal(390;0.000518)|Breast(348;0.000812)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	606811	,,		protein_coding		2202				29.2462,28.0654,28.8462		"""Aldehyde dehydrogenases"""	6500					UCEC - Uterine corpus endometrioid carcinoma (279;0.00479)|BRCA - Breast invasive adenocarcinoma(304;3.67e-05)|Kidney(64;0.000182)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GACGCGAGCACGCGGAACACT		ALDH4				ENST00000375341.3:c.1050G>C	1					cervix(2)|endometrium(1)|large_intestine(3)|lung(8)|prostate(1)		-		,		1p36	A8K1Q7|B4DGE4|D2D4A3|Q16882|Q53HU4|Q5JNV6|Q8IZ38|Q96IF0|Q9UDI6		g.chr1:19203997C>G					no		9250,3750												1.7					0.9	1-pyrroline-5-carboxylate dehydrogenase activity (GO:0003842)|aldehyde dehydrogenase (NAD) activity (GO:0004029)|electron carrier activity (GO:0009055)|identical protein binding (GO:0042802)				hg19	Standard	0.7117			6082,2514		4-hydroxyproline catabolic process (GO:0019470)|cellular nitrogen compound metabolic process (GO:0034641)|glutamate biosynthetic process (GO:0006537)|proline biosynthetic process (GO:0006561)|proline catabolic process (GO:0006562)|proline catabolic process to glutamate (GO:0010133)|proline metabolic process (GO:0006560)|small molecule metabolic process (GO:0044281)	3299,2652,549					CCDS188.1, CCDS53272.1	C		GG,GC,CC	U24266	mitochondrial matrix (GO:0005759)	32		2504		rs2230705		1307								,,	350	P5CDh		15	NM_003748		10			ENST00000375341.3		14511		uc001bbc.3			8659	dbSNP_98	870,1050,1050			p.A350A		0				33.0		0.647	1:g.19203997C>G		protein_coding			basic|appris_principal|CCDS		2161,1760,377			3168,1236			G|||			5008		AL4A1_HUMAN	3213	aldehyde dehydrogenase 4 family, member A1			0.641573		19203997			0.4683	SNP		CCDS188.1			,,,	False	19203997		1.5.1.12		synonymous_variant		Approved		32.0		c.1050G>C	2008-02-05	OTTHUMT00000006954.1	P30038	0.7363		ALDH4A1	19203997				,,	ALDH4A1	NM_001161504.1,NM_003748.3,NM_170726.2	protein-coding gene	NP_003739.2		
		T	ENSG00000053372	ENST00000330263.4		51154		ENSG00000053372		4300					,				c.(268-270)caC>caT	OTTHUMG00000002496		byFrequency	Q9UKD2	gene with protein product				NM_016183.3	43,509,1651	NM_016183	0.1973					+	Silent		292.8+/-301.0	174.0								MRTO4-001	2006-12-21				1	+	0.1293				coding-synonymous	18477		90/240	Colorectal(325;3.46e-05)|Renal(390;0.000147)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Breast(348;0.00049)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819				protein_coding		2203				18.0581,13.5043,16.5155			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.87e-05)|Kidney(64;0.000171)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|GBM - Glioblastoma multiforme(114;0.00301)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)		GBM(192;2418 3032 7540 48714)	KNOWN			ACAACCTGCACCAGGTAAGTC		C1orf33				ENST00000330263.4:c.270C>T	1					breast(1)|endometrium(1)|large_intestine(1)|liver(2)|ovary(1)|pancreas(1)|stomach(1)		+		,		1p36.13	B3KNB3|Q5TG55|Q96SS6|Q9BPV9		g.chr1:19583636C>T		261.0+/-264.0			no		2148,10858												0.2					1.0	poly(A) RNA binding (GO:0044822)		2007-01-05		hg19	Standard	0.2008			1553,7047		ribosome biogenesis (GO:0042254)	184,1780,4539					CCDS191.1	C		TT,TC,CC	AK027569	nuclear membrane (GO:0031965)|nucleolus (GO:0005730)|nucleus (GO:0005634)	178		2504		rs1126682		567				"""chromosome 1 open reading frame 33"", ""MRT4, mRNA turnover 4, homolog (S. cerevisiae)"""					90	dJ657E11.4, MRT4		8	NM_016183		4			ENST00000330263.4		20981		uc001bbs.3			51154	dbSNP_86	270			p.H90H		0				184.0		0.557	1:g.19583636C>T		protein_coding			basic|appris_principal|CCDS		141,1271,2888			595,3811			C|||			5008		MRT4_HUMAN	681	mRNA turnover 4 homolog (S. cerevisiae)			0.135982		19583636			0.0238	SNP		CCDS191.1			,,,	False	19583636				synonymous_variant		Approved		178.0		c.270C>T	2008-02-05	OTTHUMT00000007075.2	Q9UKD2	0.1311		MRTO4	19583636					MRTO4	NM_016183.3	protein-coding gene	NP_057267.2		
		A	ENSG00000053372	ENST00000330263.4		51154		ENSG00000053372		4300					,					OTTHUMG00000002496		byFrequency	Q9UKD2	gene with protein product				NM_016183.3	43,509,1651	NM_016183	0.1973					+	Intron		292.6+/-300.9	96.0								MRTO4-001	2006-12-21				1	+	0.1293				intron	18477			Colorectal(325;3.46e-05)|Renal(390;0.000147)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Breast(348;0.00049)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627				protein_coding		2203				18.0465,13.5043,16.5078			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.87e-05)|Kidney(64;0.000171)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|GBM - Glioblastoma multiforme(114;0.00301)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)		GBM(192;2418 3032 7540 48714)	KNOWN			GCTGAGGAACGGAGGGAAAGA		C1orf33				ENST00000330263.4:c.341+20G>A	1					breast(1)|endometrium(1)|large_intestine(1)|liver(2)|ovary(1)|pancreas(1)|stomach(1)		+		,		1p36.13	B3KNB3|Q5TG55|Q96SS6|Q9BPV9		g.chr1:19584035G>A		261.0+/-264.0			no		2147,10859												-0.0					0.0	poly(A) RNA binding (GO:0044822)		2007-01-05		hg19	Standard	0.2008			1552,7048		ribosome biogenesis (GO:0042254)	184,1779,4540					CCDS191.1	G		AA,AG,GG	AK027569	nuclear membrane (GO:0031965)|nucleolus (GO:0005730)|nucleus (GO:0005634)	96		2504		rs11811927		638				"""chromosome 1 open reading frame 33"", ""MRT4, mRNA turnover 4, homolog (S. cerevisiae)"""						dJ657E11.4, MRT4		8	NM_016183		5			ENST00000330263.4		21414		uc001bbs.3			51154	dbSNP_120						0				96.0		0.527	1:g.19584035G>A		protein_coding			basic|appris_principal|CCDS		141,1270,2889			595,3811			G|||			5008		MRT4_HUMAN	681	mRNA turnover 4 homolog (S. cerevisiae)			0.135982		19584035			0.0238	SNP		CCDS191.1			,,,	False	19584035				intron_variant		Approved		96.0			2008-02-05	OTTHUMT00000007075.2	Q9UKD2	0.1311		MRTO4	19584035					MRTO4	NM_016183.3	protein-coding gene	NP_057267.2		
		T	ENSG00000211454	ENST00000429712.1	0.80722	246181	.	ENSG00000211454	0.05775	4300	0.000000	0.04234	B		,	T	0.0	0		OTTHUMG00000002520	-0.602000	byFrequency	Q8NHP1	gene with protein product		AKR7L_ENST00000420396.2_RNA			420,1088,695	NM_201252	0.8119			C	9.264	+	RNA	1	672.7+/-403.0	78.0	Q8NHP1	0.437585		12879023			0.011	AKR7L-001			0.14578		1	-	0.3964		0.35	0.000000	intergenic	24056	261			C		608478		0.7209944751381215	polymorphic_pseudogene		2203	P		0.000000	33.4419,43.7585,41.1656	B		6503		0.1344:0.7035:0.0:0.1621						KNOWN	ENST00000420396;ENST00000457194;ENST00000429712;ENST00000388886		GCGCCATACGCGGCCTGCAGG	T					ENST00000429712.1:	1		ENSG00000211454	0.06662	AKR7L	breast(1)|endometrium(2)|ovary(1)|prostate(1)|urinary_tract(1)		-	0.05858	,	GCG	1p36.1-p35	Q5U614		g.chr1:19595137C>T		549.3+/-377.7		200	no		7652,5354	0.03702	0.19748	3.73	0.00012	ENSP00000373538:A220T			0.24341		.		-4.5	0.03525	462	0.25106	0.8076923076923077	0.0	oxidoreductase activity (GO:0016491)	.			hg19	Standard	0.6918	0.4065040650406504	7.7709	5724,2876			2345,2962,1196	1.043913					C	0.10296	TT,TC,CC		extracellular vesicular exosome (GO:0070062)	81	.	2504	-4.47	rs2235795		882	255	515			0.29008	19467724	-			AFAR3	1438	6	NR_040288	0.003	0	0.679419525065963	-0.384000	ENST00000429712.1		16175		uc021ohn.1			246181	dbSNP_98		0.0000			NADP-dependent oxidoreductase domain (3);	0		T		86.0	rs2235795;rs57845732;rs2235795	0.642	1:g.19595137C>T	ENSP00000406430:A77T	polymorphic_pseudogene	0.039380		basic		1925,1874,501		77;145;255;220	1928,2478	0.6584249084249084	T	.|||		0.456904	5008		ARK74_HUMAN	3331	aldo-keto reductase family 7-like		ARK74_HUMAN	0.665136	0.11750	19595137		-0.058000	0.8016	SNP				N	,,,	False	19595137	-1.0413		8		T	Approved	0.665581	81.0			2008-12-09	OTTHUMT00000007163.3	Q8NHP1	0.7334	3.67	AKR7L	19595137	0.00434		0.16129				protein-coding gene		A	
		C	ENSG00000162482	ENST00000361640.4	0.58432	22977	.	ENSG00000162482	0.27698	4299	0.524000	0.04015	B		,	T	5.000000000032756E-6	0	c.(967-969)Act>Gct	OTTHUMG00000002523	0.487000	byFrequency	O95154	gene with protein product				NM_012067.2	1256,772,171	NM_012067	0.8937			C	0.012	+	Missense_Mutation	1	285.4+/-297.1	51.0	O95154	0.746703		10383892			0.0	AKR7A3-001			0.01281		1	-	0.7451		1	0.017000	missense	390	316	323/332	Colorectal(325;3.46e-05)|Renal(390;0.000147)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Breast(348;0.00049)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	608477	benign	0.8729281767955801	protein_coding		2199	P		1.000000	17.6785,25.3297,20.2678	B	"""Aldo-keto reductases"""	6498		0.0:0.8832:0.0:0.1168			UCEC - Uterine corpus endometrioid carcinoma (279;0.00459)|BRCA - Breast invasive adenocarcinoma(304;1.78e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|GBM - Glioblastoma multiforme(114;0.00276)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000361640		CATTCGTGAGTAACCAAATGC	T					ENST00000361640.4:c.967A>G	1		ENSG00000162482	0.02607	AKR7A3	NS(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|lung(4)|ovary(1)|stomach(2)	ENSP00000355377:p.Thr323Ala	-	0.71417	,	ACT	1p36.13	Q86SR4|Q8IVN6|Q8N5V6|Q8TAX1|Q9NUC3		g.chr1:19609254T>C	T -> A (in dbSNP:rs1738025). {ECO:0000269|PubMed:10383892, ECO:0000269|PubMed:12879023, ECO:0000269|PubMed:15489334}.	397.0+/-330.2		348	no		10362,2634	0.27887	0.00758	3.59	0.00012	ENSP00000355377:T323A			0.64402		.		3.6	0.41128	476	0.02654	0.8321678321678322	0.5	aldo-keto reductase (NADP) activity (GO:0004033)|electron carrier activity (GO:0009055)	.			hg19	Standard	0.8499	0.7073170731707317	8.8928	7078,1520		cellular aldehyde metabolic process (GO:0006081)	4182,1998,318	-1.670557				CCDS193.1	T	0.02656	CC,CT,TT	AF040639	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)	51	.	2504	3.59	rs1738025		1507	323	632			0.35444	19481841	-	ALA/THR	323		1772	13	NM_012067	0.0	7	0.8337730870712401	-0.971000	ENST00000361640.4		16255		uc001bbv.1			22977	dbSNP_89	967	0.0000		p.T323A	NADP-dependent oxidoreductase domain (2);	0		T		51.0	rs1738025;rs17856730;rs58068318;rs1738025	0.527	1:g.19609254T>C	ENSP00000355377:T323A	protein_coding	0.000007		basic|appris_principal|CCDS		2926,1226,147		323	3284,1114	0.8113553113553114	A	C|||		0.109175	5008		ARK73_HUMAN	4164	aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)		ARK73_HUMAN	0.83147	0.54424	19609254		3.650000	0.8413	SNP		CCDS193.1		N	,,,	False	19609254	-0.9891		8	missense	T	Approved	0.823215	51.0		c.967A>G	2008-05-14	OTTHUMT00000007166.1	O95154	0.8674	3.73	AKR7A3	19609254	0.09413		0.32851	58	AKR7A3	NM_012067.2	protein-coding gene	NP_036199.2	T	
		C	ENSG00000162482	ENST00000361640.4	0.58432	22977	.	ENSG00000162482	0.27926	4300	0.954000	0.23754	B		,	T	1.999999999946489E-6	0	c.(643-645)Aat>Gat	OTTHUMG00000002523	0.497000	byFrequency	O95154	gene with protein product				NM_012067.2	995,920,284	NM_012067	0.8967			.	0.021	+	Missense_Mutation	1		125.0	O95154	0.661664		10383892			0.001	AKR7A3-001			0.04013	AKR7A3	1	-	0.6415		1	0.013000	missense	390	318	215/332	Colorectal(325;3.46e-05)|Renal(390;0.000147)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Breast(348;0.00049)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	608477	benign	0.8784530386740331	protein_coding		2199	P		1.000000	16.907,33.8336,22.6343	B	"""Aldo-keto reductases"""	6499		0.0:0.8837:0.0:0.1163			UCEC - Uterine corpus endometrioid carcinoma (279;0.00459)|BRCA - Breast invasive adenocarcinoma(304;1.78e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|GBM - Glioblastoma multiforme(114;0.00276)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000361640		TGTTTCCCATTCTTGTCCTCA	T					ENST00000361640.4:c.643A>G	1		ENSG00000162482	0.01791	AKR7A3	NS(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|lung(4)|ovary(1)|stomach(2)	ENSP00000355377:p.Asn215Asp	-	0.71417	,	AAT	1p36.13	Q86SR4|Q8IVN6|Q8N5V6|Q8TAX1|Q9NUC3		g.chr1:19611241T>C	N -> D (in dbSNP:rs1738023). {ECO:0000269|PubMed:10383892, ECO:0000269|PubMed:12879023, ECO:0000269|PubMed:15489334}.			311	yes		10056,2942	0.39281	0.01126	3.02	0.00012	ENSP00000355377:N215D	M		0.64402		.		3.0	0.34903	478	0.02654	0.8356643356643356	1.0	aldo-keto reductase (NADP) activity (GO:0004033)|electron carrier activity (GO:0009055)	.			hg19	Standard	0.8579	0.6321138211382114	8.9792	7146,1454		cellular aldehyde metabolic process (GO:0006081)	3970,2116,413	-1.421962				CCDS193.1	T	0.02656	CC,CT,TT	AF040639	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)	121	.	2504	3.02	rs1738023		1183	215	643	GRCh37		0.35955	19483828	-	ASP/ASN	215		1750	13	NM_012067	0.0	5	0.8482849604221636	-1.160000	ENST00000361640.4		16861		uc001bbv.1			22977	dbSNP_89	643	0.0000	CM062419	p.N215D	NADP-dependent oxidoreductase domain (3);	0		T		115.0	rs1738023;rs16862665;rs17856731;rs57955981;rs1738023	0.597	1:g.19611241T>C	ENSP00000355377:N215D	protein_coding	0.000001		basic|appris_principal|CCDS		2975,1196,129		215	2910,1488	0.8012820512820513	D	C|||		0.093383	5008		ARK73_HUMAN	4045	aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)		ARK73_HUMAN	0.807708	0.32636	19611241		1.232000	0.8502	SNP	rs1738023	CCDS193.1		N	,,,	False	19611241	-0.9574		8	missense	T	Approved	0.83093	121.0		c.643A>G	2008-05-14	OTTHUMT00000007166.1	O95154	0.8646	1.89	AKR7A3	19611241	0.08279		0.40232	23	AKR7A3	NM_012067.2	protein-coding gene	NP_036199.2	N	
		T	ENSG00000162482	ENST00000361640.4	0.41505	22977	M	ENSG00000162482	0.49330	4300	1.000000	0.23348	B		,	T	0.011692999999999953	0	c.(412-414)Gtg>Atg	OTTHUMG00000002523	1.542000	byFrequency	O95154	gene with protein product				NM_012067.2	319,976,904	NM_012067	0.3896			.	6.831	+	Missense_Mutation	1		54.0	O95154	0.366985		10383892			0.057	AKR7A3-001			0.24974		1	-	0.3646		0.15	0.263000	missense	390	194	138/332	Colorectal(325;3.46e-05)|Renal(390;0.000147)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Breast(348;0.00049)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	608477	benign	0.5359116022099447	protein_coding		2199	P		1.000000	36.1628,36.6985,36.3441	B	"""Aldo-keto reductases"""	6499		0.0:0.8521:0.0:0.1479			UCEC - Uterine corpus endometrioid carcinoma (279;0.00459)|BRCA - Breast invasive adenocarcinoma(304;1.78e-05)|Kidney(64;0.00016)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|GBM - Glioblastoma multiforme(114;0.00276)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN	ENST00000361640		CCAAGCTCCACGAACTTGCCC	T					ENST00000361640.4:c.412G>A	1		ENSG00000162482	0.17425	AKR7A3	NS(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|lung(4)|ovary(1)|stomach(2)	ENSP00000355377:p.Val138Met	-	0.71417	,	GTG	1p36.13	Q86SR4|Q8IVN6|Q8N5V6|Q8TAX1|Q9NUC3		g.chr1:19612477C>T	V -> M (in dbSNP:rs2231198). {ECO:0000269|PubMed:10383892, ECO:0000269|PubMed:15489334}.			187	no		4724,8274	0.80357	0.13066	3.04	0.00012	ENSP00000355377:V138M			0.40640		.		3.0	0.35103	411	0.41790	0.7185314685314685	1.0	aldo-keto reductase (NADP) activity (GO:0004033)|electron carrier activity (GO:0009055)	2.61			hg19	Standard	0.3817	0.3800813008130081	5.9087	3110,5490		cellular aldehyde metabolic process (GO:0006081)	883,2958,2658	0.522560				CCDS193.1	C	0.32543	TT,TC,CC	AF040639	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)	55	0.82823	2504	3.04	rs2231198		952	138	280			0.19016	19485064	-	MET/VAL	138		1072	13	NM_012067	0.375	3	0.36939313984168864	0.194000	ENST00000361640.4		19169		uc001bbv.1			22977	dbSNP_98	412	0.0000		p.V138M	NADP-dependent oxidoreductase domain (3);	0		T		58.0	rs2231198;rs11539611;rs13374777;rs17852954;rs59246333	0.612	1:g.19612477C>T	ENSP00000355377:V138M	protein_coding	0.001046		basic|appris_principal|CCDS		564,1982,1754		138	1614,2784	0.4908424908424908	M	C|||		0.240515	5008		ARK73_HUMAN	2320	aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)		ARK73_HUMAN	0.463259	0.44027	19612477		2.346000	0.6905	SNP		CCDS193.1		N	,,,	False	19612477	-0.9828		9	missense	T	Approved	0.361628	55.0		c.412G>A	2008-05-14	OTTHUMT00000007166.1	O95154	0.5432	1.91	AKR7A3	19612477	0.26337		0.34453	21	AKR7A3	NM_012067.2	protein-coding gene	NP_036199.2	V	
		C	ENSG00000173436	ENST00000322753.6		440574		ENSG00000173436		4300					,				c.(205-207)caT>caC	OTTHUMG00000002712		byFrequency	Q5TGZ0	gene with protein product		MINOS1_ENST00000486890.1_3'UTR|MINOS1-NBL1_ENST00000602662.1_Intron		NM_001032363.3|NM_001204082.1|NM_001204083.1	929,1007,267	NM_001032363	0.2853					+	Silent		736.3+/-407.0	116.0				21944719				MINOS1-001	2011-10-04				1	+	0.705				coding-synonymous,coding-synonymous,coding-synonymous,intron,intron	32068		69/79,53/63,69/141,,		C	SO:0001819		,,,,		protein_coding		2203				20.2209,34.975,35.399			6503								KNOWN			ATCTTCTACATGGAAAATATG		C1orf151				ENST00000322753.6:c.207T>C	1							+		,		1p36.13	Q96G68		g.chr1:19950062T>C		484.9+/-360.2			no		4604,8402												0.9					1.0			2011-10-04		hg19	Standard	0.2346			1739,6861			1137,2330,3036					CCDS30620.1, CCDS72719.1	T		CC,CT,TT	AK094318	integral component of membrane (GO:0016021)|mitochondrial inner membrane (GO:0005743)|mitochondrion (GO:0005739)	117		2504		rs1737428		263				"""chromosome 1 open reading frame 151"""				,,,,	69	RP5-1056L3.2, FLJ36999, MIO10			NM_001032363		3			ENST00000322753.6		19847		uc021ohu.1			440574	dbSNP_89	207,159,207,,			p.H69H		0				119.0		0.383	1:g.19950062T>C		protein_coding			basic|appris_principal|CCDS		208,1323,2769			2865,1541			C|||			5008		MIC10_HUMAN	1731	mitochondrial inner membrane organizing system 1			0.345647		19950062			0.1419	SNP		CCDS30620.1			,,,	False	19950062				synonymous_variant		Approved		117.0		c.207T>C	2013-10-11	OTTHUMT00000007697.2	Q5TGZ0	0.2032		MINOS1	19950062				,,,,	MINOS1,C1orf151-NBL1	NM_001032363.3,NM_001204082.1,NM_001204083.1,NM_001204088.1,NM_001204089.1	protein-coding gene	NP_001027535.1|NP_001191011.1|NP_001191012.1		
		A	ENSG00000188257	ENST00000375111.3		5320		ENSG00000188257		4300					,					OTTHUMG00000002699		byFrequency	P14555	gene with protein product		PLA2G2A_ENST00000400520.3_Intron|PLA2G2A_ENST00000496748.1_5'UTR	Diclofenac(DB00586)|Ginkgo biloba(DB01381)|Indomethacin(DB00328)|Suramin(DB04786)	NM_000300.3|NM_001161727.1	26,406,1771	NM_000300	0.0951					+	Intron		328.8+/-318.4	43.0				8838795				PLA2G2A-001					1	-	0.0953				intron,intron,intron,intron	9031		,,,	Colorectal(325;0.000147)|Renal(390;0.000469)|all_lung(284;0.00459)|Lung NSC(340;0.00475)|Breast(348;0.00526)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0427)	G	SO:0001627	172411	,,,		protein_coding		2203				21.6628,10.3949,17.8456			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.018)|COAD - Colon adenocarcinoma(152;1.11e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000138)|Kidney(64;0.000171)|GBM - Glioblastoma multiforme(114;0.00032)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)			KNOWN			GGGTAGGGAGGGATAGGTGGC		PLA2B, PLA2L				ENST00000375111.3:c.185+15C>T	1					central_nervous_system(1)|lung(6)|prostate(1)|stomach(1)		-		,		1p35	A8K5I7|Q6DN24|Q6IBD9|Q9UCD2		g.chr1:20304857G>A		218.7+/-236.7			no		2321,10685												0.3					0.0	calcium ion binding (GO:0005509)|calcium-dependent phospholipase A2 activity (GO:0047498)|phospholipase A2 activity (GO:0004623)|phospholipid binding (GO:0005543)				hg19	Standard	0.2087			1863,6737		defense response to Gram-positive bacterium (GO:0050830)|glycerophospholipid biosynthetic process (GO:0046474)|lipid catabolic process (GO:0016042)|low-density lipoprotein particle remodeling (GO:0034374)|negative regulation of epithelial cell proliferation (GO:0050680)|phosphatidic acid biosynthetic process (GO:0006654)|phosphatidic acid metabolic process (GO:0046473)|phosphatidylcholine acyl-chain remodeling (GO:0036151)|phosphatidylethanolamine acyl-chain remodeling (GO:0036152)|phosphatidylglycerol acyl-chain remodeling (GO:0036148)|phosphatidylinositol acyl-chain remodeling (GO:0036149)|phosphatidylserine acyl-chain remodeling (GO:0036150)|phospholipid metabolic process (GO:0006644)|positive regulation of inflammatory response (GO:0050729)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|small molecule metabolic process (GO:0044281)|somatic stem cell maintenance (GO:0035019)	225,1871,4407					CCDS201.1	G		AA,AG,GG	BC005919	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|mitochondrion (GO:0005739)|secretory granule (GO:0030141)	43		2504		rs2307246		457								,,,				9	NM_000300		4			ENST00000375111.3		17551		uc010odb.2			5320	dbSNP_100	,,,					0				42.0		0.622	1:g.20304857G>A		protein_coding			basic|appris_principal|CCDS		199,1465,2636			458,3948			G|||			5008		PA2GA_HUMAN	530	phospholipase A2, group IIA (platelets, synovial fluid)			0.105831		20304857			0.0278	SNP		CCDS201.1			,,,	False	20304857		3.1.1.4		intron_variant		Approved		43.0			2008-09-19	OTTHUMT00000007675.1	P14555	0.1052		PLA2G2A	20304857				,,,	PLA2G2A	NM_000300.3,NM_001161727.1,NM_001161728.1,NM_001161729.1	protein-coding gene	NP_000291.1|NP_001155199.1		
		C	ENSG00000117215	ENST00000375105.3	0.80722	26279	N	ENSG00000117215	0.03827	4300	0.000000	0.27256	B		,	T	0.0	0	c.(238-240)Agc>Ggc	OTTHUMG00000002701	-0.914000	byFrequency	Q9UNK4	gene with protein product				NM_012400.2	1800,379,24		0.7485			C	0.323	+	Missense_Mutation	1	520.4+/-379.7	114.0	Q9UNK4	0.903087		10455175			0.0	PLA2G2D-001			0.01281		1	-	0.966		0.83	0.000000	missense	9033	242	80/146	Colorectal(325;0.000147)|Renal(390;0.000469)|Lung NSC(340;0.00412)|all_lung(284;0.00419)|Breast(348;0.00526)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0427)	C	SO:0001583	605630	benign	0.6685082872928176	protein_coding		2203	P		0.000000	41.7791,9.6913,30.9088	B		6503		0.1934:0.1781:0.1844:0.4441			UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|COAD - Colon adenocarcinoma(152;1.15e-05)|BRCA - Breast invasive adenocarcinoma(304;8.01e-05)|Kidney(64;0.000175)|GBM - Glioblastoma multiforme(114;0.000798)|KIRC - Kidney renal clear cell carcinoma(64;0.00261)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)	Multiple Myeloma(11;0.12)	Melanoma(60;742 1548 31762 39240)	KNOWN	ENST00000375105		TTGTAGATGCTGCACCCCTGG	T					ENST00000375105.3:c.238A>G	1		ENSG00000117215	0.00195	PLA2G2D	endometrium(1)|lung(2)	ENSP00000364246:p.Ser80Gly	-	0.05858	,	AGC	1p36.12	A8K2Z1|B1AEL9|Q9UK01		g.chr1:20442054T>C	S -> G (in dbSNP:rs584367). {ECO:0000269|PubMed:10455175, ECO:0000269|PubMed:14702039, ECO:0000269|Ref.4}.	206.8+/-228.3		464	yes		8986,4020	0.03702	0.02249	5.6	0.00012	ENSP00000364246:S80G			0.01492		-0.4767		-4.4	0.03622	434	0.07325	0.7587412587412588	0.0	calcium ion binding (GO:0005509)|phospholipase A2 activity (GO:0004623)	0.47			hg19	Standard	0.5934	0.943089430894309	1.1808	5007,3593		glycerophospholipid biosynthetic process (GO:0046474)|inflammatory response (GO:0006954)|lipid catabolic process (GO:0016042)|phosphatidic acid biosynthetic process (GO:0006654)|phosphatidylcholine acyl-chain remodeling (GO:0036151)|phosphatidylethanolamine acyl-chain remodeling (GO:0036152)|phosphatidylglycerol acyl-chain remodeling (GO:0036148)|phosphatidylinositol acyl-chain remodeling (GO:0036149)|phosphatidylserine acyl-chain remodeling (GO:0036150)|phospholipid metabolic process (GO:0006644)|small molecule metabolic process (GO:0044281)	3235,2516,752	-0.960936				CCDS203.1, CCDS72721.1	T	0.02656	CC,CT,TT	AF112982	extracellular region (GO:0005576)	119	0.17278	2504	-4.38	rs584367		296	80	440			0.01844	20314641	-	GLY/SER	80	sPLA2S	1580	3	NM_012400	0.0	3	0.5804749340369393	-2.488000	ENST00000375105.3		19128		uc001bcz.4			26279	dbSNP_83	238	0.0000		p.S80G	Phospholipase A2 (3);	0		T		129.0	rs584367;rs1751980;rs17354755;rs59656386;rs584367	0.587	1:g.20442054T>C	ENSP00000364246:S80G	protein_coding	0.017155		basic|appris_principal|CCDS		1435,2137,728		80	3979,427	0.7234432234432234	G	C|||		2.250350	5008		PA2GD_HUMAN	3853	phospholipase A2, group IID		PA2GD_HUMAN	0.769369	0.08794	20442054		-0.253000	0.7569	SNP		CCDS203.1		N	,,,	False	20442054	-0.9749	3.1.1.4	9	missense	T	Approved	0.582209	119.0		c.238A>G	2008-09-19	OTTHUMT00000007683.1	Q9UNK4	0.6974	1.68	PLA2G2D	20442054	0.00434		0.36407	56	PLA2G2D	NM_012400.2	protein-coding gene	NP_036532.1	S	
		TCC	ENSG00000158825	ENST00000375071.3		978		ENSG00000158825		4300										OTTHUMG00000002845		byFrequency	P32320	gene with protein product		CDA_ENST00000461985.1_3'UTR	Azacitidine(DB00928)|Capecitabine(DB01101)|Cytarabine(DB00987)|Gemcitabine(DB00441)	NM_001785.2		NM_001785						+	5'UTR			43.0				8422236, 9878810				CDA-001					1	+						1712			Lung NSC(340;1.75e-08)|all_lung(284;5.99e-08)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)		SO:0001623	123920			protein_coding		2203							6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|GBM - Glioblastoma multiforme(114;1.06e-08)|COAD - Colon adenocarcinoma(152;1.22e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000148)|Kidney(64;0.000184)|KIRC - Kidney renal clear cell carcinoma(64;0.0027)|STAD - Stomach adenocarcinoma(196;0.00308)|READ - Rectum adenocarcinoma(331;0.0652)|Lung(427;0.199)		Pancreas(74;49 1356 2772 27818 40529)	KNOWN			AGCTCCTGTTTCCCGCTGCTC						ENST00000375071.3:c.-34TCCC>TCC	1					endometrium(1)|large_intestine(1)|lung(2)|ovary(1)|prostate(1)|stomach(1)		+				1p36.2-p35			g.chr1:20915589delTCCC																									cytidine deaminase activity (GO:0004126)|nucleoside binding (GO:0001882)|protein homodimerization activity (GO:0042803)|zinc ion binding (GO:0008270)				hg19	Standard						cell surface receptor signaling pathway (GO:0007166)|cytidine deamination (GO:0009972)|cytosine metabolic process (GO:0019858)|negative regulation of cell growth (GO:0030308)|negative regulation of nucleotide metabolic process (GO:0045980)|nucleobase-containing small molecule metabolic process (GO:0055086)|protein homotetramerization (GO:0051289)|pyrimidine nucleobase metabolic process (GO:0006206)|pyrimidine nucleoside salvage (GO:0043097)|pyrimidine-containing compound salvage (GO:0008655)|small molecule metabolic process (GO:0044281)						CCDS210.1	TCCC			BC054036	cytosol (GO:0005829)|extracellular region (GO:0005576)					rs3215400|rs397721610		149										CDD		7	NM_001785		0			ENST00000375071.3				uc001bdk.3			978							0				45.0		0.667	1:g.20915589delTCCC		protein_coding			basic|appris_principal|CCDS													CDD_HUMAN		cytidine deaminase					20915589				DEL		CCDS210.1					20915589		3.5.4.5		5_prime_UTR_variant		Approved		43.0			2008-02-05	OTTHUMT00000007965.1	P32320			CDA	20915589							protein-coding gene	NP_001776.1		
		T	ENSG00000158825	ENST00000375071.3		978		ENSG00000158825		4300					,				c.(433-435)acC>acT	OTTHUMG00000002845		byFrequency	P32320	gene with protein product		CDA_ENST00000461985.1_3'UTR	Azacitidine(DB00928)|Capecitabine(DB01101)|Cytarabine(DB00987)|Gemcitabine(DB00441)	NM_001785.2	349,1046,808	NM_001785	0.272	Substitution - coding silent(1)				+	Silent		431.7+/-356.9	61.0				8422236, 9878810				CDA-001					1	+	0.379				coding-synonymous	1712		145/147	Lung NSC(340;1.75e-08)|all_lung(284;5.99e-08)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	123920			protein_coding	stomach(1)	2203				31.4884,39.5824,34.2304			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|GBM - Glioblastoma multiforme(114;1.06e-08)|COAD - Colon adenocarcinoma(152;1.22e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000148)|Kidney(64;0.000184)|KIRC - Kidney renal clear cell carcinoma(64;0.0027)|STAD - Stomach adenocarcinoma(196;0.00308)|READ - Rectum adenocarcinoma(331;0.0652)|Lung(427;0.199)		Pancreas(74;49 1356 2772 27818 40529)	KNOWN			TGCAGAAGACCCAGTGACAGC						ENST00000375071.3:c.435C>T	1					endometrium(1)|large_intestine(1)|lung(2)|ovary(1)|prostate(1)|stomach(1)		+		,		1p36.2-p35			g.chr1:20945055C>T		518.0+/-369.6			no		4452,8554												1.7					0.0	cytidine deaminase activity (GO:0004126)|nucleoside binding (GO:0001882)|protein homodimerization activity (GO:0042803)|zinc ion binding (GO:0008270)				hg19	Standard	0.3231			2708,5892		cell surface receptor signaling pathway (GO:0007166)|cytidine deamination (GO:0009972)|cytosine metabolic process (GO:0019858)|negative regulation of cell growth (GO:0030308)|negative regulation of nucleotide metabolic process (GO:0045980)|nucleobase-containing small molecule metabolic process (GO:0055086)|protein homotetramerization (GO:0051289)|pyrimidine nucleobase metabolic process (GO:0006206)|pyrimidine nucleoside salvage (GO:0043097)|pyrimidine-containing compound salvage (GO:0008655)|small molecule metabolic process (GO:0044281)	778,2896,2829			p.T145T(1)		CCDS210.1	C		TT,TC,CC	BC054036	cytosol (GO:0005829)|extracellular region (GO:0005576)	65		2504		rs1048977		617									145	CDD		7	NM_001785		4			ENST00000375071.3		18751		uc001bdk.3			978	dbSNP_86	435			p.T145T		1				71.0		0.587	1:g.20945055C>T		protein_coding			basic|appris_principal|CCDS		429,1850,2021			1744,2662			C|||			5008		CDD_HUMAN	1558	cytidine deaminase			0.311102		20945055			0.244	SNP		CCDS210.1			,,,	False	20945055		3.5.4.5		synonymous_variant		Approved		65.0		c.435C>T	2008-02-05	OTTHUMT00000007965.1	P32320	0.317		CDA	20945055					CDA	NM_001785.2	protein-coding gene	NP_001776.1		
		G	ENSG00000158828	ENST00000321556.4		65018		ENSG00000158828		4300					,					OTTHUMG00000002841		byFrequency	Q9BXM7	gene with protein product				NM_032409.2	1310,780,113	NM_032409	0.8732					+	Intron		769.1+/-407.6	57.0				11494141, 15349860				PINK1-001					1	+	0.7405				intron	14581			all_lung(284;2.72e-05)|Lung NSC(340;2.94e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	608309			protein_coding		2203				11.9884,22.8325,15.662		"""Parkinson disease"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|COAD - Colon adenocarcinoma(152;1.21e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000146)|Kidney(64;0.000182)|GBM - Glioblastoma multiforme(114;0.000497)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(196;0.00308)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)		Esophageal Squamous(145;853 1803 8146 34412 35011)	KNOWN			TTCTTTTCTCATCACAGGCAA		PARK6				ENST00000321556.4:c.388-7A>G	1					central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(4)|ovary(2)		+		,		1p36.12	Q8N6T9|Q8NBU3|Q96DE4		g.chr1:20964328A>G		724.2+/-409.5			no		10969,2037												-1.2					0.0	ATP binding (GO:0005524)|C3HC4-type RING finger domain binding (GO:0055131)|calcium-dependent protein kinase activity (GO:0010857)|kinase activity (GO:0016301)|magnesium ion binding (GO:0000287)|peptidase activator activity (GO:0016504)|protease binding (GO:0002020)|protein kinase B binding (GO:0043422)|protein serine/threonine kinase activity (GO:0004674)|ubiquitin protein ligase binding (GO:0031625)				hg19	Standard	0.8976			7569,1031		activation of protein kinase B activity (GO:0032148)|cell death (GO:0008219)|cellular response to hypoxia (GO:0071456)|cellular response to toxic substance (GO:0097237)|intracellular signal transduction (GO:0035556)|mitochondrion degradation (GO:0000422)|mitochondrion organization (GO:0007005)|negative regulation of gene expression (GO:0010629)|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)|negative regulation of JNK cascade (GO:0046329)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of oxidative stress-induced cell death (GO:1903202)|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)|negative regulation of oxidative stress-induced neuron death (GO:1903204)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|peptidyl-serine autophosphorylation (GO:0036289)|peptidyl-serine phosphorylation (GO:0018105)|phosphorylation (GO:0016310)|positive regulation of dopamine secretion (GO:0033603)|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)|positive regulation of peptidase activity (GO:0010952)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of release of cytochrome c from mitochondria (GO:0090200)|positive regulation of synaptic transmission, dopaminergic (GO:0032226)|positive regulation of ubiquitin-protein transferase activity (GO:0051443)|protein phosphorylation (GO:0006468)|protein ubiquitination (GO:0016567)|regulation of mitochondrial membrane potential (GO:0051881)|regulation of mitochondrion degradation (GO:1903146)|regulation of protein complex assembly (GO:0043254)|regulation of protein ubiquitination (GO:0031396)|regulation of reactive oxygen species metabolic process (GO:2000377)|regulation of synaptic vesicle transport (GO:1902803)|response to oxidative stress (GO:0006979)|response to stress (GO:0006950)|TORC2 signaling (GO:0038203)|ubiquitin-dependent protein catabolic process (GO:0006511)	4645,1679,179					CCDS211.1	A		GG,GA,AA	AB053323	astrocyte projection (GO:0097449)|axon (GO:0030424)|cell body (GO:0044297)|chromatin (GO:0000785)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|integral component of mitochondrial outer membrane (GO:0031307)|Lewy body (GO:0097413)|membrane (GO:0016020)|mitochondrial inner membrane (GO:0005743)|mitochondrial intermembrane space (GO:0005758)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	55		2504		rs2298298		481				"""Parkinson disease (autosomal recessive) 6"""								14	NM_032409		2			ENST00000321556.4		18491		uc001bdm.3			65018	dbSNP_100						0				51.0		0.572	1:g.20964328A>G		protein_coding			basic|appris_principal|CCDS		3335,899,66			3400,1006			N|||			5008		PINK1_HUMAN	4116	PTEN induced putative kinase 1			0.821885		20964328			0.8165	SNP		CCDS211.1			,,,	False	20964328				intron_variant		Approved		55.0			2011-07-21	OTTHUMT00000007954.1	Q9BXM7	0.8026		PINK1	20964328					PINK1	NM_032409.2	protein-coding gene	NP_115785.1		
		A	ENSG00000158828	ENST00000321556.4		65018		ENSG00000158828		4300					,					OTTHUMG00000002841		byFrequency	Q9BXM7	gene with protein product		PINK1_ENST00000492302.1_Intron|PINK1-AS_ENST00000451424.1_RNA		NM_032409.2	1316,783,104	NM_032409	0.8783					+	Intron		219.2+/-257.4	41.0				11494141, 15349860				PINK1-001					1	+	0.7352				intron	14581			all_lung(284;2.72e-05)|Lung NSC(340;2.94e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	A	SO:0001627	608309			protein_coding		2203				12.0349,22.4921,15.5774		"""Parkinson disease"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|COAD - Colon adenocarcinoma(152;1.21e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000146)|Kidney(64;0.000182)|GBM - Glioblastoma multiforme(114;0.000497)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(196;0.00308)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)		Esophageal Squamous(145;853 1803 8146 34412 35011)	KNOWN			TCCCCTCTCCGCCAGCTATCC		PARK6				ENST00000321556.4:c.960-5G>A	1					central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(4)|ovary(2)		+		,		1p36.12	Q8N6T9|Q8NBU3|Q96DE4		g.chr1:20972048G>A		372.7+/-320.5			no		10980,2026												-5.6					0.0	ATP binding (GO:0005524)|C3HC4-type RING finger domain binding (GO:0055131)|calcium-dependent protein kinase activity (GO:0010857)|kinase activity (GO:0016301)|magnesium ion binding (GO:0000287)|peptidase activator activity (GO:0016504)|protease binding (GO:0002020)|protein kinase B binding (GO:0043422)|protein serine/threonine kinase activity (GO:0004674)|ubiquitin protein ligase binding (GO:0031625)				hg19	Standard	0.8956			7565,1035		activation of protein kinase B activity (GO:0032148)|cell death (GO:0008219)|cellular response to hypoxia (GO:0071456)|cellular response to toxic substance (GO:0097237)|intracellular signal transduction (GO:0035556)|mitochondrion degradation (GO:0000422)|mitochondrion organization (GO:0007005)|negative regulation of gene expression (GO:0010629)|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)|negative regulation of JNK cascade (GO:0046329)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of oxidative stress-induced cell death (GO:1903202)|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)|negative regulation of oxidative stress-induced neuron death (GO:1903204)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|peptidyl-serine autophosphorylation (GO:0036289)|peptidyl-serine phosphorylation (GO:0018105)|phosphorylation (GO:0016310)|positive regulation of dopamine secretion (GO:0033603)|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)|positive regulation of peptidase activity (GO:0010952)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of release of cytochrome c from mitochondria (GO:0090200)|positive regulation of synaptic transmission, dopaminergic (GO:0032226)|positive regulation of ubiquitin-protein transferase activity (GO:0051443)|protein phosphorylation (GO:0006468)|protein ubiquitination (GO:0016567)|regulation of mitochondrial membrane potential (GO:0051881)|regulation of mitochondrion degradation (GO:1903146)|regulation of protein complex assembly (GO:0043254)|regulation of protein ubiquitination (GO:0031396)|regulation of reactive oxygen species metabolic process (GO:2000377)|regulation of synaptic vesicle transport (GO:1902803)|response to oxidative stress (GO:0006979)|response to stress (GO:0006950)|TORC2 signaling (GO:0038203)|ubiquitin-dependent protein catabolic process (GO:0006511)	4646,1688,169					CCDS211.1	G		AA,AG,GG	AB053323	astrocyte projection (GO:0097449)|axon (GO:0030424)|cell body (GO:0044297)|chromatin (GO:0000785)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|integral component of mitochondrial outer membrane (GO:0031307)|Lewy body (GO:0097413)|membrane (GO:0016020)|mitochondrial inner membrane (GO:0005743)|mitochondrial intermembrane space (GO:0005758)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	41		2504		rs3131713		1053				"""Parkinson disease (autosomal recessive) 6"""								14	NM_032409		5			ENST00000321556.4		15317		uc001bdm.3			65018	dbSNP_103						0				42.0		0.572	1:g.20972048G>A		protein_coding			basic|appris_principal|CCDS		3330,905,65			3415,991			A|||			5008		PINK1_HUMAN	4110	PTEN induced putative kinase 1			0.820687		20972048			0.8145	SNP		CCDS211.1			,,,	False	20972048				intron_variant		Approved		41.0			2011-07-21	OTTHUMT00000007954.1	Q9BXM7	0.8026		PINK1	20972048					PINK1	NM_032409.2	protein-coding gene	NP_115785.1		
		C	ENSG00000158828	ENST00000321556.4	0.80722	65018	L	ENSG00000158828	0.24878	4300	0.242000	0.74106	B;B		,	T	0.0	0	c.(1561-1563)aAt>aCt	OTTHUMG00000002841	0.382000	byFrequency	Q9BXM7	gene with protein product		PINK1-AS_ENST00000451424.1_RNA|PINK1_ENST00000492302.1_3'UTR		NM_032409.2	167,845,1191	NM_032409	0.4008			A	13.74	+	Missense_Mutation	2	390.2+/-343.2	66.0	Q9BXM7-2;Q9BXM7	0.26759		11494141, 15349860			0.005;0.006	PINK1-001			0.11329		1	+	0.2458		0.24	0.980000	missense	14581	80	521/582	all_lung(284;2.72e-05)|Lung NSC(340;2.94e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583	608309	benign	0.22099447513812154	protein_coding		2203	P		0.208000	27.1279,26.759,27.0029	B;B	"""Parkinson disease"""	6503		0.6411:0.0:0.3589:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0182)|COAD - Colon adenocarcinoma(152;1.21e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000146)|Kidney(64;0.000182)|GBM - Glioblastoma multiforme(114;0.000497)|KIRC - Kidney renal clear cell carcinoma(64;0.00269)|STAD - Stomach adenocarcinoma(196;0.00308)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)		Esophageal Squamous(145;853 1803 8146 34412 35011)	KNOWN	ENST00000321556		GCCCTGAAGAATCTGAAGTTA	T	PARK6				ENST00000321556.4:c.1562A>C	1		ENSG00000158828	0.26972	PINK1	central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(4)|ovary(2)	ENSP00000364204:p.Asn521Thr	+	0.23494	,	AAT	1p36.12	Q8N6T9|Q8NBU3|Q96DE4		g.chr1:20977000A>C	N -> T (in dbSNP:rs1043424). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16257123, ECO:0000269|PubMed:16482571, ECO:0000269|PubMed:17344846}.	413.9+/-336.6		109	yes		3512,9494	0.24170	0.41197	5.83	0.00012	ENSP00000364204:N521T			0.17574		-7.6155		1.5	0.23275	208	0.33141	0.36363636363636365	0.2	ATP binding (GO:0005524)|C3HC4-type RING finger domain binding (GO:0055131)|calcium-dependent protein kinase activity (GO:0010857)|kinase activity (GO:0016301)|magnesium ion binding (GO:0000287)|peptidase activator activity (GO:0016504)|protease binding (GO:0002020)|protein kinase B binding (GO:0043422)|protein serine/threonine kinase activity (GO:0004674)|ubiquitin protein ligase binding (GO:0031625)	1.1			hg19	Standard	0.2922	0.22154471544715448	7.3998	2333,6267		activation of protein kinase B activity (GO:0032148)|cell death (GO:0008219)|cellular response to hypoxia (GO:0071456)|cellular response to toxic substance (GO:0097237)|intracellular signal transduction (GO:0035556)|mitochondrion degradation (GO:0000422)|mitochondrion organization (GO:0007005)|negative regulation of gene expression (GO:0010629)|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)|negative regulation of JNK cascade (GO:0046329)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of oxidative stress-induced cell death (GO:1903202)|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)|negative regulation of oxidative stress-induced neuron death (GO:1903204)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|peptidyl-serine autophosphorylation (GO:0036289)|peptidyl-serine phosphorylation (GO:0018105)|phosphorylation (GO:0016310)|positive regulation of dopamine secretion (GO:0033603)|positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)|positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)|positive regulation of peptidase activity (GO:0010952)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of release of cytochrome c from mitochondria (GO:0090200)|positive regulation of synaptic transmission, dopaminergic (GO:0032226)|positive regulation of ubiquitin-protein transferase activity (GO:0051443)|protein phosphorylation (GO:0006468)|protein ubiquitination (GO:0016567)|regulation of mitochondrial membrane potential (GO:0051881)|regulation of mitochondrion degradation (GO:1903146)|regulation of protein complex assembly (GO:0043254)|regulation of protein ubiquitination (GO:0031396)|regulation of reactive oxygen species metabolic process (GO:2000377)|regulation of synaptic vesicle transport (GO:1902803)|response to oxidative stress (GO:0006979)|response to stress (GO:0006950)|TORC2 signaling (GO:0038203)|ubiquitin-dependent protein catabolic process (GO:0006511)	476,2560,3467	2.327369				CCDS211.1	A	0.17465	CC,CA,AA	AB053323	astrocyte projection (GO:0097449)|axon (GO:0030424)|cell body (GO:0044297)|chromatin (GO:0000785)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|integral component of mitochondrial outer membrane (GO:0031307)|Lewy body (GO:0097413)|membrane (GO:0016020)|mitochondrial inner membrane (GO:0005743)|mitochondrial intermembrane space (GO:0005758)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	69	0.36672	2504	1.55	rs1043424		1656	214;521	217		"""Parkinson disease (autosomal recessive) 6"""	0.26956	20849587	+	THR/ASN	521		614	14	NM_032409	0.004;0.022	8	0.2862796833773087	0.402000	ENST00000321556.4		21372		uc001bdm.3			65018	dbSNP_86	1562	0.0000		p.N521T	.	0		T		74.0	rs1043424;rs60071348;rs1043424	0.498	1:g.20977000A>C	ENSP00000364204:N521T	protein_coding	0.169362		basic|appris_principal|CCDS		309,1715,2276		521	1179,3227	0.28113553113553114	T	A|||		0.653207	5008		PINK1_HUMAN	1505	PTEN induced putative kinase 1		.;PINK1_HUMAN	0.300519	0.24119	20977000		0.601000	0.3571	SNP		CCDS211.1		N	,,,	False	20977000	-1.0329		9	missense	T	Approved	0.271279	69.0		c.1562A>C	2011-07-21	OTTHUMT00000007954.1	Q9BXM7	0.1931	-0.81	PINK1	20977000	0.70556		0.18681	65	PINK1	NM_032409.2	protein-coding gene	NP_115785.1	N	
		ACC	ENSG00000244038	ENST00000375048.3		1650		ENSG00000244038		4300										OTTHUMG00000002844		byFrequency	P39656	gene with protein product		DDOST_ENST00000602624.2_Intron|DDOST_ENST00000415136.2_Intron		NM_005216.4		NM_005216						+	Intron			51.0				9367678				DDOST-001	2013-03-06				1	-						2728			all_lung(284;2.98e-05)|Lung NSC(340;3.25e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)		SO:0001627	602202			protein_coding		2203							6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|COAD - Colon adenocarcinoma(152;1.17e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000141)|Kidney(64;0.000177)|GBM - Glioblastoma multiforme(114;0.00046)|KIRC - Kidney renal clear cell carcinoma(64;0.00262)|STAD - Stomach adenocarcinoma(196;0.00303)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			AGCTTGGCAAACCCTTTGGGC						ENST00000375048.3:c.993+34GGGT>GGT	1					endometrium(2)|kidney(1)|large_intestine(6)|lung(2)|ovary(1)|skin(1)		-				1p36.1	B2RDQ4|B4DJE3|B4DLI2|O43244|Q5VWA5|Q8NI93|Q9BUI2	"""oligosaccharyltransferase subunit 48"""	g.chr1:20980085delACCC																									dolichyl-diphosphooligosaccharide-protein glycotransferase activity (GO:0004579)				hg19	Standard						cellular protein metabolic process (GO:0044267)|gene expression (GO:0010467)|innate immune response (GO:0045087)|post-translational protein modification (GO:0043687)|protein glycosylation (GO:0006486)|protein N-linked glycosylation (GO:0006487)|protein N-linked glycosylation via asparagine (GO:0018279)|response to cytokine (GO:0034097)|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|T cell activation (GO:0042110)|translation (GO:0006412)						CCDS212.1	ACCC			D29643	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|integral component of membrane (GO:0016021)|intracellular membrane-bounded organelle (GO:0043231)|membrane (GO:0016020)|oligosaccharyltransferase complex (GO:0008250)|protein complex (GO:0043234)					rs35610874		1099				"""dolichyl-diphosphooligosaccharide-protein glycosyltransferase"", ""dolichyl-diphosphooligosaccharide--protein glycosyltransferase"""						OST, KIAA0115, OST48, WBP1		13	NM_005216		8			ENST00000375048.3				uc001bdo.1			1650							0				60.0		0.502	1:g.20980085delACCC		protein_coding			basic|CCDS													OST48_HUMAN		dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)					20980085				DEL		CCDS212.1					20980085		2.4.1.119		intron_variant		Approved		54.0			2013-03-06	OTTHUMT00000007961.2	P39656			DDOST	20980085							protein-coding gene	NP_005207		
		A	ENSG00000244038	ENST00000375048.3		1650		ENSG00000244038		4300					,				c.(364-366)ggC>ggT	OTTHUMG00000002844		byFrequency	P39656	gene with protein product		DDOST_ENST00000415136.2_Silent_p.G85G|DDOST_ENST00000602624.2_Silent_p.G105G		NM_005216.4	1161,886,156	NM_005216	0.4918					+	Silent		497.3+/-374.5	96.0				9367678				DDOST-001	2013-03-06				1	-	0.7579				coding-synonymous	2728		122/457	all_lung(284;2.98e-05)|Lung NSC(340;3.25e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000147)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	A	SO:0001819	602202			protein_coding		2203				38.9651,27.1902,34.9762			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|COAD - Colon adenocarcinoma(152;1.17e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000141)|Kidney(64;0.000177)|GBM - Glioblastoma multiforme(114;0.00046)|KIRC - Kidney renal clear cell carcinoma(64;0.00262)|STAD - Stomach adenocarcinoma(196;0.00303)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			CACTGCCTCCGCCGTCAATAA						ENST00000375048.3:c.366C>T	1					endometrium(2)|kidney(1)|large_intestine(6)|lung(2)|ovary(1)|skin(1)		-		,		1p36.1	B2RDQ4|B4DJE3|B4DLI2|O43244|Q5VWA5|Q8NI93|Q9BUI2	"""oligosaccharyltransferase subunit 48"""	g.chr1:20982631G>A		421.3+/-339.3			no		8457,4549												-6.5					0.8	dolichyl-diphosphooligosaccharide-protein glycotransferase activity (GO:0004579)				hg19	Standard	0.6292			5249,3351		cellular protein metabolic process (GO:0044267)|gene expression (GO:0010467)|innate immune response (GO:0045087)|post-translational protein modification (GO:0043687)|protein glycosylation (GO:0006486)|protein N-linked glycosylation (GO:0006487)|protein N-linked glycosylation via asparagine (GO:0018279)|response to cytokine (GO:0034097)|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|T cell activation (GO:0042110)|translation (GO:0006412)	2789,2879,835					CCDS212.1	G		AA,AG,GG	D29643	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|integral component of membrane (GO:0016021)|intracellular membrane-bounded organelle (GO:0043231)|membrane (GO:0016020)|oligosaccharyltransferase complex (GO:0008250)|protein complex (GO:0043234)	102		2504		rs4704		471				"""dolichyl-diphosphooligosaccharide-protein glycosyltransferase"", ""dolichyl-diphosphooligosaccharide--protein glycosyltransferase"""					122	OST, KIAA0115, OST48, WBP1		13	NM_005216		3			ENST00000375048.3		21225		uc001bdo.1			1650	dbSNP_52	366			p.G122G		0				115.0		0.557	1:g.20982631G>A		protein_coding			basic|CCDS		1628,1993,679			3208,1198			A|||			5008		OST48_HUMAN	2941	dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)			0.58726		20982631			0.4117	SNP		CCDS212.1			,,,	False	20982631		2.4.1.119		synonymous_variant		Approved		102.0		c.366C>T	2013-03-06	OTTHUMT00000007961.2	P39656	0.5908		DDOST	20982631					DDOST	NM_005216.4	protein-coding gene	NP_005207		
		C	ENSG00000117245	ENST00000247986.2	0.54753	57576	N	ENSG00000117245	0.19655	4300	1.000000	0.63096	B;B		,	T	1.799999999996249E-5	2	c.(2797-2799)gaC>gaG	OTTHUMG00000002863	0.168000	byFrequency	Q9P2E2	gene with protein product		KIF17_ENST00000400463.3_Missense_Mutation_p.D932E|KIF17_ENST00000375044.1_Missense_Mutation_p.D833E|KIF17_ENST00000490034.1_5'UTR			1273,806,124	NM_020816	0.636			C	0.020	+	Missense_Mutation	3	307.0+/-308.2	132.0	Q9P2E2-3;Q9P2E2	0.760781		10846156			0.0;0.0	KIF17-009			0.01281		1	-	0.7572		1	0.068000	missense,missense	19167	282	932/1029,933/1030	all_lung(284;2.99e-05)|Lung NSC(340;3.26e-05)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	605037	benign,benign	0.7790055248618785	protein_coding		2203	P		1.000000	19.4651,23.9219,20.9749	B;B	"""Kinesins"""	6503		0.0:0.2209:0.1358:0.6433			UCEC - Uterine corpus endometrioid carcinoma (279;0.0185)|COAD - Colon adenocarcinoma(152;1.43e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000168)|Kidney(64;0.000221)|GBM - Glioblastoma multiforme(114;0.000651)|KIRC - Kidney renal clear cell carcinoma(64;0.0031)|STAD - Stomach adenocarcinoma(196;0.00336)|READ - Rectum adenocarcinoma(331;0.0686)|Lung(427;0.209)			KNOWN	ENST00000375044;ENST00000400463;ENST00000247986;ENST00000321188		TGTAGCGGTCGTCCTCCTGCC	T;T;T					ENST00000247986.2:c.2799C>G	1		ENSG00000117245	0.01301	KIF17	NS(2)|endometrium(3)|kidney(3)|large_intestine(9)|liver(1)|lung(23)|ovary(4)|pancreas(1)|prostate(1)|skin(1)|stomach(1)|urinary_tract(1)	ENSP00000247986:p.Asp933Glu	-	0.71417	,	GAC	1p36.13	A2A3Q7|A2A3Q8|O95077|Q53YS6|Q5VWA9|Q6GSA8|Q8N411	"""kinesin-like protein KIF17"", ""KIF3-related motor protein"", ""KIF17 variant protein"""	g.chr1:20992819G>C	D -> E (in dbSNP:rs631357). {ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:14673085, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.6}.	387.9+/-326.7		364	yes		10278,2728	0.80357	0.01108	5.95	0.00012	ENSP00000247986:D933E			.		.		3.7	0.41972	319	0.02654	0.5576923076923077	1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|plus-end-directed microtubule motor activity (GO:0008574)	-1.135			hg19	Standard	0.8241	0.7398373983739838	5.559	6926,1674		ATP catabolic process (GO:0006200)|cell projection organization (GO:0030030)|metabolic process (GO:0008152)|microtubule-based movement (GO:0007018)|neurogenesis (GO:0022008)|protein complex localization (GO:0031503)|protein transport (GO:0015031)|vesicle-mediated transport (GO:0016192)	4081,2116,306	-1.433156				CCDS213.1, CCDS44079.1, CCDS72722.1	G	0.02656	CC,CG,GG	AB037826	cytoplasm (GO:0005737)|intraciliary transport particle B (GO:0030992)|kinesin complex (GO:0005871)|microtubule (GO:0005874)	140	0.00864	2504	3.66	rs631357		3109	932;933	620			0.17133	20865406	-	GLU/ASP,GLU/ASP	933	KIAA1405, KIF3X, KIF17B, OSM-3, KLP-2	1585	50	XR_241202	0.0;0.0	14	0.8179419525065963	-1.315000	ENST00000247986.2		17319		uc001bdr.4			57576	dbSNP_83	2796,2799	0.0000		p.D933E	.	0		T		154.0	rs631357;rs16824400;rs17846197;rs17859212;rs631357	0.617	1:g.20992819G>C	ENSP00000364184:D833E;ENSP00000383311:D932E;ENSP00000247986:D933E	protein_coding	.		basic|appris_candidate_longest|CCDS		2808,1310,182		833;932;933;314	3352,1054	0.7257326007326007	E	C|||		.	5008		KIF17_HUMAN	3528	kinesin family member 17		.;KIF17_HUMAN	0.704473	0.28037	20992819		0.872000	0.5536	SNP		CCDS213.1		.	,,,	False	20992819	-0.9416		8	missense	T	Approved	0.805349	140.0		c.2799C>G	2012-08-01	OTTHUMT00000276995.1	Q9P2E2	0.7464	-0.02;0.03;0.04	KIF17	20992819	0.16541		0.43032	45,45	KIF17	NM_001122819.1,NM_020816.2	protein-coding gene		D	
		T	ENSG00000189410	ENST00000444387.2		400745		ENSG00000189410		4138					,				c.(559-561)caG>caA	OTTHUMG00000002620		byFrequency	Q6ZV89	gene with protein product		SH2D5_ENST00000375031.1_Silent_p.Q103Q|SH2D5_ENST00000460804.1_5'UTR		NM_001103161.1	1780,159,4	XM_375698	0.8282					+	Silent			29.0								SH2D5-003					1	-	0.9849				coding-synonymous,coding-synonymous	28819		103/340,187/424	Colorectal(325;3.46e-05)|all_lung(284;5.32e-05)|Lung NSC(340;5.51e-05)|Renal(390;9.67e-05)|Breast(348;0.00179)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0255)	T	SO:0001819		,		protein_coding		1943				24.3958,4.2975,17.974			6081					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|COAD - Colon adenocarcinoma(152;1.17e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000142)|GBM - Glioblastoma multiforme(114;0.000465)|Kidney(64;0.000476)|STAD - Stomach adenocarcinoma(196;0.00303)|KIRC - Kidney renal clear cell carcinoma(64;0.00634)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			TCTGAGAGAGCTGATCACGGC						ENST00000444387.2:c.561G>A	1					lung(4)|prostate(1)|upper_aerodigestive_tract(1)		-		,		1p36.12	B7Z3W3|Q5SSJ2		g.chr1:21050958C>T					no		9976,2186												1.7					1.0					hg19	Standard	0.7714			6257,2019			4138,1700,243					CCDS41280.1, CCDS44080.1	C		TT,TC,CC	AK124869, AK123236		27		2504		rs592060		958								,	187			6	NM_001103161		6			ENST00000444387.2		17563		uc009vpy.1			400745	dbSNP_83	309,561			p.Q187Q		0				23.0		0.697	1:g.21050958C>T		protein_coding			basic|appris_principal|CCDS		2358,1541,239			3719,167			T|||			5008		SH2D5_HUMAN	4405	SH2 domain containing 5			0.879593		21050958			0.9802	SNP		CCDS44080.1			,,,	False	21050958				synonymous_variant		Approved		27.0		c.561G>A	2008-02-05	OTTHUMT00000007455.2	Q6ZV89	0.7622		SH2D5	21050958				,	SH2D5	NM_001103160.1,NM_001103161.1	protein-coding gene	NP_001096631.1		
		G	ENSG00000075151	ENST00000264211.8		8672		ENSG00000075151		4300					,				c.(3838-3840)Tta>Cta	OTTHUMG00000002624		byFrequency	O43432	gene with protein product		EIF4G3_ENST00000537738.1_Silent_p.L770L|EIF4G3_ENST00000602326.1_Silent_p.L1286L|EIF4G3_ENST00000374937.3_Silent_p.L1286L|EIF4G3_ENST00000400422.1_Silent_p.L1280L|EIF4G3_ENST00000374935.3_Silent_p.L1000L|EIF4G3_ENST00000536266.1_Silent_p.L884L		NM_003760.4	1461,668,74	NM_003760	1.0					+	Silent		3.0+/-9.4	114.0				9418880				EIF4G3-001					1	-	0.7769				coding-synonymous,coding-synonymous,coding-synonymous	3298		1316/1622,1286/1592,1280/1586	all_lung(284;2.61e-06)|Lung NSC(340;2.81e-06)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00149)|Ovarian(437;0.00338)|Myeloproliferative disorder(586;0.0256)	G	SO:0001819	603929	,,		protein_coding		2203				0.0581,18.5202,6.3125			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.023)|COAD - Colon adenocarcinoma(152;5.42e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000327)|GBM - Glioblastoma multiforme(114;0.000696)|Kidney(64;0.0018)|STAD - Stomach adenocarcinoma(196;0.00644)|KIRC - Kidney renal clear cell carcinoma(64;0.0185)|READ - Rectum adenocarcinoma(331;0.124)|Lung(427;0.191)			KNOWN			TGATAGAGTAATTGGCCCATG						ENST00000264211.8:c.3838T>C	1	MI. {ECO:0000255|PROSITE- ProRule:PRU00698}.				endometrium(12)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(18)|lung(20)|ovary(1)|prostate(4)|skin(3)|stomach(1)|urinary_tract(3)		-		,		1p36.12	B9EGQ7|Q15597|Q504Z1|Q5SWC3|Q8NEN1		g.chr1:21167404A>G		324.5+/-298.6			no		12185,821												2.0					0.3	poly(A) RNA binding (GO:0044822)|RNA cap binding (GO:0000339)|translation factor activity, nucleic acid binding (GO:0008135)|translation initiation factor activity (GO:0003743)				hg19	Standard	1.0			8595,5		cytokine-mediated signaling pathway (GO:0019221)|positive regulation of meiosis I (GO:0060903)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of translation (GO:0045727)|regulation of translational initiation (GO:0006446)|spermatogenesis (GO:0007283)|viral process (GO:0016032)	5756,673,74					CCDS214.1, CCDS55580.1, CCDS59192.1, CCDS72723.1	A		GG,GA,AA	AF012072	cytosol (GO:0005829)|eukaryotic translation initiation factor 4F complex (GO:0016281)	117		2504		rs2230573		4032								,,	1280	eIF4GII		70	NM_001198801		24			ENST00000264211.8		16791		uc001bef.3			8672	dbSNP_116	3946,3856,3838			p.L1280L		0				124.0		0.483	1:g.21167404A>G		protein_coding			basic|appris_candidate|CCDS		4295,5,0			3590,816			G|||			5008		IF4G3_HUMAN	4696	eukaryotic translation initiation factor 4 gamma, 3			0.9377		21167404			1.0	SNP		CCDS214.1			,,,	False	21167404				synonymous_variant		Approved		117.0		c.3838T>C	2008-02-05	OTTHUMT00000007467.3	O43432	0.9755		EIF4G3	21167404				,,	EIF4G3	NM_001198801.1,NM_001198802.1,NM_003760.4	protein-coding gene	NP_003751.2		
		T	ENSG00000075151	ENST00000264211.8		8672		ENSG00000075151		4300					,					OTTHUMG00000002624		byFrequency	O43432	gene with protein product		EIF4G3_ENST00000536266.1_Intron|EIF4G3_ENST00000374935.3_Intron|EIF4G3_ENST00000537738.1_Intron|EIF4G3_ENST00000602326.1_Intron|EIF4G3_ENST00000400422.1_Intron|EIF4G3_ENST00000374937.3_Intron		NM_003760.4	364,1051,788	NM_003760	0.6074					+	Intron		607.1+/-395.2	86.0				9418880				EIF4G3-001					1	-	0.3714				intron,intron,intron	3298		,,	all_lung(284;2.61e-06)|Lung NSC(340;2.81e-06)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00149)|Ovarian(437;0.00338)|Myeloproliferative disorder(586;0.0256)	C	SO:0001627	603929	,,		protein_coding		2203				44.5,40.3768,49.6233			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.023)|COAD - Colon adenocarcinoma(152;5.42e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000327)|GBM - Glioblastoma multiforme(114;0.000696)|Kidney(64;0.0018)|STAD - Stomach adenocarcinoma(196;0.00644)|KIRC - Kidney renal clear cell carcinoma(64;0.0185)|READ - Rectum adenocarcinoma(331;0.124)|Lung(427;0.191)			KNOWN			CTACACATGTCGAGGATTTAG						ENST00000264211.8:c.3266-11G>A	1					endometrium(12)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(18)|lung(20)|ovary(1)|prostate(4)|skin(3)|stomach(1)|urinary_tract(3)		-		,		1p36.12	B9EGQ7|Q15597|Q504Z1|Q5SWC3|Q8NEN1		g.chr1:21180181C>T		523.8+/-371.2			no		6552,6454												-0.3					0.0	poly(A) RNA binding (GO:0044822)|RNA cap binding (GO:0000339)|translation factor activity, nucleic acid binding (GO:0008135)|translation initiation factor activity (GO:0003743)				hg19	Standard	0.5477			4773,3827		cytokine-mediated signaling pathway (GO:0019221)|positive regulation of meiosis I (GO:0060903)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of translation (GO:0045727)|regulation of translational initiation (GO:0006446)|spermatogenesis (GO:0007283)|viral process (GO:0016032)	1670,3212,1621					CCDS214.1, CCDS55580.1, CCDS59192.1, CCDS72723.1	C		TT,TC,CC	AF012072	cytosol (GO:0005829)|eukaryotic translation initiation factor 4F complex (GO:0016281)	87		2504		rs2305463		3460								,,		eIF4GII		70	NM_001198801		21			ENST00000264211.8		19331		uc001bef.3			8672	dbSNP_100	,,					0				89.0		0.468	1:g.21180181C>T		protein_coding			basic|appris_candidate|CCDS		1306,2161,833			1779,2627			C|||			5008		IF4G3_HUMAN	2868	eukaryotic translation initiation factor 4 gamma, 3			0.572684		21180181			0.8313	SNP		CCDS214.1			,,,	False	21180181				intron_variant		Approved		87.0			2008-02-05	OTTHUMT00000007467.3	O43432	0.5677		EIF4G3	21180181				,,	EIF4G3	NM_001198801.1,NM_001198802.1,NM_003760.4	protein-coding gene	NP_003751.2		
		T	ENSG00000117298	ENST00000374893.6		1889		ENSG00000117298		4300					,					OTTHUMG00000002625		byFrequency	P42892	gene with protein product		ECE1_ENST00000436918.2_Intron|ECE1_ENST00000415912.2_Intron|ECE1_ENST00000357071.4_Intron|ECE1_ENST00000264205.6_Intron		NM_001397.2	0,62,2141	NM_001397	0.0112					+	Intron		102.1+/-163.3	53.0				7805846, 7864876, 17592116				ECE1-002					1	-	0.0076				intron,intron,intron,intron	3146		,,,	Lung NSC(340;1.14e-05)|all_lung(284;1.23e-05)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00147)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	600423	,,,		protein_coding		2203				3.1163,1.4072,2.5373			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0183)|OV - Ovarian serous cystadenocarcinoma(117;4.83e-27)|COAD - Colon adenocarcinoma(152;1.36e-06)|GBM - Glioblastoma multiforme(114;1.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000162)|STAD - Stomach adenocarcinoma(196;0.00326)|KIRC - Kidney renal clear cell carcinoma(1967;0.00755)|READ - Rectum adenocarcinoma(331;0.0678)|Lung(427;0.206)			KNOWN			TGGGACCGTGCGCGTGTGGGG		ECE				ENST00000374893.6:c.2040+24G>A	1					endometrium(5)|kidney(1)|large_intestine(7)|lung(8)|ovary(2)|prostate(1)|skin(1)		-		,		1p36.1	A8K3P1|B4E291|Q14217|Q17RN5|Q2Z2K8|Q58GE7|Q5THM5|Q5THM7|Q5THM8|Q9UJQ6|Q9UPF4|Q9UPM4|Q9Y501		g.chr1:21551718C>T		59.3+/-96.0			no		330,12676												-0.1					0.0	endopeptidase activity (GO:0004175)|metal ion binding (GO:0046872)|metalloendopeptidase activity (GO:0004222)|peptide hormone binding (GO:0017046)|protein homodimerization activity (GO:0042803)				hg19	Standard	0.0408			268,8332		bradykinin catabolic process (GO:0010815)|calcitonin catabolic process (GO:0010816)|ear development (GO:0043583)|embryonic digit morphogenesis (GO:0042733)|endothelin maturation (GO:0034959)|heart development (GO:0007507)|hormone catabolic process (GO:0042447)|peptide hormone processing (GO:0016486)|pharyngeal system development (GO:0060037)|positive regulation of receptor recycling (GO:0001921)|protein processing (GO:0016485)|regulation of systemic arterial blood pressure by endothelin (GO:0003100)|regulation of vasoconstriction (GO:0019229)|substance P catabolic process (GO:0010814)	4,322,6177					CCDS215.1, CCDS44081.1, CCDS44082.1, CCDS44083.1	C		TT,TC,CC	D49471	early endosome (GO:0005769)|endosome (GO:0005768)|external side of plasma membrane (GO:0009897)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|intrinsic component of endosome membrane (GO:0031302)|lysosomal membrane (GO:0005765)|membrane (GO:0016020)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|vesicle (GO:0031982)|Weibel-Palade body (GO:0033093)	53		2504		rs71636966		2115								,,,				25	NM_001397		17			ENST00000374893.6		16817		uc001bei.2			1889	dbSNP_130	,,,					0				54.0		0.672	1:g.21551718C>T		protein_coding			basic|CCDS		4,260,4036			62,4344			C|||			5008		ECE1_HUMAN	74	endothelin converting enzyme 1			0.0147764		21551718			0.0	SNP		CCDS215.1			,,,	False	21551718				intron_variant		Approved		53.0			2008-02-05	OTTHUMT00000007470.2	P42892	0.0173		ECE1	21551718				,,,	ECE1	NM_001113347.1,NM_001113348.1,NM_001113349.1,NM_001397.2	protein-coding gene	NP_001388.1		
		T	ENSG00000117298	ENST00000374893.6		1889		ENSG00000117298		4300					,					OTTHUMG00000002625		byFrequency	P42892	gene with protein product		ECE1_ENST00000436918.2_Intron|ECE1_ENST00000415912.2_Intron|ECE1_ENST00000357071.4_Intron|ECE1_ENST00000264205.6_Intron		NM_001397.2	0,61,2142	NM_001397	0.0102					+	Intron		103.1+/-164.3	123.0				7805846, 7864876, 17592116				ECE1-002					1	-	0.0076				intron,intron,intron,intron	3146		,,,	Lung NSC(340;1.14e-05)|all_lung(284;1.23e-05)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00147)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	600423	,,,		protein_coding		2203				3.1395,1.3845,2.545			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0183)|OV - Ovarian serous cystadenocarcinoma(117;4.83e-27)|COAD - Colon adenocarcinoma(152;1.36e-06)|GBM - Glioblastoma multiforme(114;1.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000162)|STAD - Stomach adenocarcinoma(196;0.00326)|KIRC - Kidney renal clear cell carcinoma(1967;0.00755)|READ - Rectum adenocarcinoma(331;0.0678)|Lung(427;0.206)			KNOWN			TAAGGCCCTGGAGGGAAAGAC		ECE				ENST00000374893.6:c.1782-4C>A	1					endometrium(5)|kidney(1)|large_intestine(7)|lung(8)|ovary(2)|prostate(1)|skin(1)		-		,		1p36.1	A8K3P1|B4E291|Q14217|Q17RN5|Q2Z2K8|Q58GE7|Q5THM5|Q5THM7|Q5THM8|Q9UJQ6|Q9UPF4|Q9UPM4|Q9Y501		g.chr1:21553723G>T		58.7+/-95.3			no		331,12675												4.2					1.0	endopeptidase activity (GO:0004175)|metal ion binding (GO:0046872)|metalloendopeptidase activity (GO:0004222)|peptide hormone binding (GO:0017046)|protein homodimerization activity (GO:0042803)				hg19	Standard	0.0408			270,8330		bradykinin catabolic process (GO:0010815)|calcitonin catabolic process (GO:0010816)|ear development (GO:0043583)|embryonic digit morphogenesis (GO:0042733)|endothelin maturation (GO:0034959)|heart development (GO:0007507)|hormone catabolic process (GO:0042447)|peptide hormone processing (GO:0016486)|pharyngeal system development (GO:0060037)|positive regulation of receptor recycling (GO:0001921)|protein processing (GO:0016485)|regulation of systemic arterial blood pressure by endothelin (GO:0003100)|regulation of vasoconstriction (GO:0019229)|substance P catabolic process (GO:0010814)	4,323,6176					CCDS215.1, CCDS44081.1, CCDS44082.1, CCDS44083.1	G		TT,TG,GG	D49471	early endosome (GO:0005769)|endosome (GO:0005768)|external side of plasma membrane (GO:0009897)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|intrinsic component of endosome membrane (GO:0031302)|lysosomal membrane (GO:0005765)|membrane (GO:0016020)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|vesicle (GO:0031982)|Weibel-Palade body (GO:0033093)	131		2504		rs3026903		1856								,,,				25	NM_001397		16			ENST00000374893.6		20755		uc001bei.2			1889	dbSNP_102	,,,					0				145.0		0.507	1:g.21553723G>T		protein_coding			basic|CCDS		4,262,4034			61,4345			G|||			5008		ECE1_HUMAN	73	endothelin converting enzyme 1			0.0145767		21553723			0.0	SNP		CCDS215.1			,,,	False	21553723				intron_variant		Approved		131.0			2008-02-05	OTTHUMT00000007470.2	P42892	0.0173		ECE1	21553723				,,,	ECE1	NM_001113347.1,NM_001113348.1,NM_001113349.1,NM_001397.2	protein-coding gene	NP_001388.1		
		G	ENSG00000117298	ENST00000374893.6		1889		ENSG00000117298		4300					,				c.(1639-1641)gaT>gaC	OTTHUMG00000002625		byFrequency	P42892	gene with protein product		ECE1_ENST00000436918.2_Silent_p.D547D|ECE1_ENST00000415912.2_Silent_p.D531D|ECE1_ENST00000357071.4_Silent_p.D535D|ECE1_ENST00000264205.6_Silent_p.D544D		NM_001397.2	299,1034,870	NM_001397	0.0256					+	Silent		805.9+/-407.3	62.0				7805846, 7864876, 17592116				ECE1-002					1	-	0.4486				coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous	3146		535/759,531/755,544/768,547/771	Lung NSC(340;1.14e-05)|all_lung(284;1.23e-05)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00147)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	600423	,,,		protein_coding		2203				3.5465,37.0404,14.8931			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0183)|OV - Ovarian serous cystadenocarcinoma(117;4.83e-27)|COAD - Colon adenocarcinoma(152;1.36e-06)|GBM - Glioblastoma multiforme(114;1.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000162)|STAD - Stomach adenocarcinoma(196;0.00326)|KIRC - Kidney renal clear cell carcinoma(1967;0.00755)|READ - Rectum adenocarcinoma(331;0.0678)|Lung(427;0.206)			KNOWN			TCCTGAGCTGATCGGCAGTGA		ECE				ENST00000374893.6:c.1641T>C	1					endometrium(5)|kidney(1)|large_intestine(7)|lung(8)|ovary(2)|prostate(1)|skin(1)		-		,		1p36.1	A8K3P1|B4E291|Q14217|Q17RN5|Q2Z2K8|Q58GE7|Q5THM5|Q5THM7|Q5THM8|Q9UJQ6|Q9UPF4|Q9UPM4|Q9Y501		g.chr1:21560080A>G		660.9+/-400.8			no		1937,11069												4.4					1.0	endopeptidase activity (GO:0004175)|metal ion binding (GO:0046872)|metalloendopeptidase activity (GO:0004222)|peptide hormone binding (GO:0017046)|protein homodimerization activity (GO:0042803)				hg19	Standard	0.0467			305,8295		bradykinin catabolic process (GO:0010815)|calcitonin catabolic process (GO:0010816)|ear development (GO:0043583)|embryonic digit morphogenesis (GO:0042733)|endothelin maturation (GO:0034959)|heart development (GO:0007507)|hormone catabolic process (GO:0042447)|peptide hormone processing (GO:0016486)|pharyngeal system development (GO:0060037)|positive regulation of receptor recycling (GO:0001921)|protein processing (GO:0016485)|regulation of systemic arterial blood pressure by endothelin (GO:0003100)|regulation of vasoconstriction (GO:0019229)|substance P catabolic process (GO:0010814)	304,1329,4870					CCDS215.1, CCDS44081.1, CCDS44082.1, CCDS44083.1	A		GG,GA,AA	D49471	early endosome (GO:0005769)|endosome (GO:0005768)|external side of plasma membrane (GO:0009897)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|intrinsic component of endosome membrane (GO:0031302)|lysosomal membrane (GO:0005765)|membrane (GO:0016020)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|vesicle (GO:0031982)|Weibel-Palade body (GO:0033093)	60		2504		rs2228321		1715								,,,	547			25	NM_001397		14			ENST00000374893.6		19100		uc001bei.2			1889	dbSNP_102	1605,1593,1632,1641			p.D547D		0				57.0		0.547	1:g.21560080A>G		protein_coding			basic|CCDS		5,295,4000			1632,2774			G|||			5008		ECE1_HUMAN	714	endothelin converting enzyme 1			0.142572		21560080			0.004	SNP		CCDS215.1			,,,	False	21560080				synonymous_variant		Approved		60.0		c.1641T>C	2008-02-05	OTTHUMT00000007470.2	P42892	0.0648		ECE1	21560080				,,,	ECE1	NM_001113347.1,NM_001113348.1,NM_001113349.1,NM_001397.2	protein-coding gene	NP_001388.1		
		A	ENSG00000117298	ENST00000374893.6	0.19575	1889	L	ENSG00000117298	0.86390	4300	0.994000	0.74106	B;B;B;B;B		,	T	0.999969	0	c.(1021-1023)aCc>aTc	OTTHUMG00000002625	2.561000	byFrequency	P42892	gene with protein product		ECE1_ENST00000436918.2_Splice_Site_p.T341I|ECE1_ENST00000415912.2_Splice_Site_p.T325I|ECE1_ENST00000357071.4_Splice_Site_p.T329I|ECE1_ENST00000264205.6_Splice_Site_p.T338I|ECE1_ENST00000528294.1_5'UTR		NM_001397.2	1,64,2138	NM_001397	0.0378			G	11.68	+	Splice_Site	2	165.9+/-218.0	121.0	B4DKB2;Q2Z2K8;P42892;P42892-2;P42892-4	0.01498	Missense_Mutation	7805846, 7864876, 17592116			0.063;0.022;0.032;0.008;0.013	ECE1-002			0.25759		1	-	0.0038		0.18	0.855000	missense-near-splice,missense-near-splice,missense-near-splice,missense-near-splice	3146	16	329/759,325/755,338/768,341/771	Lung NSC(340;1.14e-05)|all_lung(284;1.23e-05)|Colorectal(325;3.46e-05)|Renal(390;9.67e-05)|Breast(348;0.00147)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)	G	SO:0001630	600423	benign,benign,benign,benign	0.04419889502762431	protein_coding		2203	N		0.005000	7.5465,1.498,5.4975	B;B;B;B;B		6503		0.0819:0.0:0.6686:0.2494			UCEC - Uterine corpus endometrioid carcinoma (279;0.0183)|OV - Ovarian serous cystadenocarcinoma(117;4.83e-27)|COAD - Colon adenocarcinoma(152;1.36e-06)|GBM - Glioblastoma multiforme(114;1.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000162)|STAD - Stomach adenocarcinoma(196;0.00326)|KIRC - Kidney renal clear cell carcinoma(1967;0.00755)|READ - Rectum adenocarcinoma(331;0.0678)|Lung(427;0.206)			KNOWN	ENST00000415912;ENST00000357071;ENST00000374893;ENST00000436918;ENST00000264205		GGGTGCCAAGGTCTGCAAGGG	T;T;T;T;T	ECE				ENST00000374893.6:c.1021-1C>T	1		ENSG00000117298	0.69702	ECE1	endometrium(5)|kidney(1)|large_intestine(7)|lung(8)|ovary(2)|prostate(1)|skin(1)		-	0.15991	,	ACC	1p36.1	A8K3P1|B4E291|Q14217|Q17RN5|Q2Z2K8|Q58GE7|Q5THM5|Q5THM7|Q5THM8|Q9UJQ6|Q9UPF4|Q9UPM4|Q9Y501		g.chr1:21573855G>A	T -> I (in dbSNP:rs1076669). {ECO:0000269|Ref.6}.	62.3+/-99.4		2	yes		715,12291	0.49952	0.30322	5.48	0.05547	ENSP00000264205:T338I			0.18408		-15.5264		4.6	0.56223	0	0.38643	0.0	1.0	endopeptidase activity (GO:0004175)|metal ion binding (GO:0046872)|metalloendopeptidase activity (GO:0004222)|peptide hormone binding (GO:0017046)|protein homodimerization activity (GO:0042803)	1.09			hg19	Standard	0.0785	0.0040650406504065045	7.4439	649,7951		bradykinin catabolic process (GO:0010815)|calcitonin catabolic process (GO:0010816)|ear development (GO:0043583)|embryonic digit morphogenesis (GO:0042733)|endothelin maturation (GO:0034959)|heart development (GO:0007507)|hormone catabolic process (GO:0042447)|peptide hormone processing (GO:0016486)|pharyngeal system development (GO:0060037)|positive regulation of receptor recycling (GO:0001921)|protein processing (GO:0016485)|regulation of systemic arterial blood pressure by endothelin (GO:0003100)|regulation of vasoconstriction (GO:0019229)|substance P catabolic process (GO:0010814)	26,663,5814	1.711809				CCDS215.1, CCDS44081.1, CCDS44082.1, CCDS44083.1	G	0.19935	AA,AG,GG	D49471	early endosome (GO:0005769)|endosome (GO:0005768)|external side of plasma membrane (GO:0009897)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|intrinsic component of endosome membrane (GO:0031302)|lysosomal membrane (GO:0005765)|membrane (GO:0016020)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|vesicle (GO:0031982)|Weibel-Palade body (GO:0033093)	124	0.35793	2504	4.56	rs1076669		1096	341;325;341;329;338	65			0.27201	21446442	-	ILE/THR,ILE/THR,ILE/THR,ILE/THR	341		83	25	NM_001397	0.04;0.011;0.007;0.013;0.009	9	0.08575197889182058	0.555000	ENST00000374893.6		18119		uc001bei.2			1889	dbSNP_86	986,974,1013,1022	0.0146		p.T341I	Peptidase M13 (1);	0		T		128.0	rs1076669;rs17355495;rs58761677;rs1076669	0.537	1:g.21573855G>A	ENSP00000405088:T325I;ENSP00000349581:T329I;ENSP00000364028:T341I;ENSP00000388439:T341I;ENSP00000264205:T338I	protein_coding	0.142134		basic|CCDS		25,599,3676		325;329;341;341;338	66,4340	0.038003663003663	I	G|||		0.599354	5008		ECE1_HUMAN	143	endothelin converting enzyme 1		.;.;ECE1_HUMAN;.;.	0.0285543	0.27198	21573855		0.811000	0.0	SNP		CCDS215.1		N	,,,	False	21573855	-1.1024		10	splice_region_variant	T	Approved	0.075465	124.0		c.1022C>T	2008-02-05	OTTHUMT00000007470.2	P42892	0.0317	-0.81;-0.81;-0.81;-0.81;-0.81	ECE1	21573855	0.48748		0.03566	89,89,89,89	ECE1	NM_001113347.1,NM_001113348.1,NM_001113349.1,NM_001397.2	protein-coding gene	NP_001388.1	T	
		G	ENSG00000142794	ENST00000318249.5		84224		ENSG00000142794		4300					,					OTTHUMG00000002944		byFrequency	Q9H094	gene with protein product		NBPF3_ENST00000454000.2_Intron|NBPF3_ENST00000318220.6_Intron|NBPF3_ENST00000342104.5_Intron		NM_032264.3	1453,676,74	NM_032264	1.0					+	Intron			167.0				11230166, 16079250				NBPF3-201					1	+	0.7965				intron	25076			all_lung(284;2.16e-05)|Lung NSC(340;2.19e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	612992			protein_coding		2203				0.1047,18.7018,6.4047		"""neuroblastoma breakpoint family"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|OV - Ovarian serous cystadenocarcinoma(117;7.53e-27)|COAD - Colon adenocarcinoma(152;1.18e-05)|GBM - Glioblastoma multiforme(114;3.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000143)|STAD - Stomach adenocarcinoma(196;0.00306)|KIRC - Kidney renal clear cell carcinoma(1967;0.00645)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			GTACTCCATTTTGAAGGTGAT						ENST00000318249.5:c.1156+15T>G	1					breast(1)|endometrium(3)|kidney(1)|large_intestine(2)|lung(4)|ovary(2)|prostate(3)|skin(2)|upper_aerodigestive_tract(2)		+		,		1p36.12	A8K965|B4DSP2|I3L0I8|Q3BBW1|Q5VTG2|Q5VTG3|Q5VTG4|Q8IX78|Q8ND86|Q8TC96		g.chr1:21804815T>G					no		12173,833												-2.0					0.0					hg19	Standard	0.998			8591,9			5744,685,74					CCDS216.1, CCDS57976.1, CCDS57977.1	T		GG,GT,TT	BC024011	cytoplasm (GO:0005737)	166		2504		rs7535654		1506										AE2		20	NM_032264		9			ENST00000318249.5		20801		uc001ber.4			84224	dbSNP_116						0				163.0		0.507	1:g.21804815T>G		protein_coding			basic|appris_candidate_longest|CCDS		4291,9,0			3582,824			.|||			5008		NBPF3_HUMAN	4718	neuroblastoma breakpoint family, member 3			0.942093		21804815			1.0	SNP		CCDS216.1			,,,	False	21804815				intron_variant		Approved		166.0			2013-01-17		Q9H094	0.9726		NBPF3	21804815					NBPF3	NM_032264.2	protein-coding gene	NP_115640.1		
		T	ENSG00000142794	ENST00000318249.5		84224		ENSG00000142794		4215					,					OTTHUMG00000002944		byFrequency	Q9H094	gene with protein product		NBPF3_ENST00000454000.2_Intron|NBPF3_ENST00000318220.6_Intron|NBPF3_ENST00000342104.5_Intron		NM_032264.3	2,126,2043	NM_032264	0.3252					+	Intron			22.0				11230166, 16079250				NBPF3-201					1	+	0.0144				intron	25076			all_lung(284;2.16e-05)|Lung NSC(340;2.19e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)	A	SO:0001627	612992			protein_coding		2171				15.5279,2.994,11.2668		"""neuroblastoma breakpoint family"""	6386					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|OV - Ovarian serous cystadenocarcinoma(117;7.53e-27)|COAD - Colon adenocarcinoma(152;1.18e-05)|GBM - Glioblastoma multiforme(114;3.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000143)|STAD - Stomach adenocarcinoma(196;0.00306)|KIRC - Kidney renal clear cell carcinoma(1967;0.00645)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			CTTATTCTTTACTTTTCCTAC						ENST00000318249.5:c.1209-19A>T	1					breast(1)|endometrium(3)|kidney(1)|large_intestine(2)|lung(4)|ovary(2)|prostate(3)|skin(2)|upper_aerodigestive_tract(2)		+		,		1p36.12	A8K965|B4DSP2|I3L0I8|Q3BBW1|Q5VTG2|Q5VTG3|Q5VTG4|Q8IX78|Q8ND86|Q8TC96		g.chr1:21806525A>T					no		1439,11333												-0.4					0.0					hg19	Standard	0.163			1309,7121			139,1161,5086					CCDS216.1, CCDS57976.1, CCDS57977.1	A		TT,TA,AA	BC024011	cytoplasm (GO:0005737)	23		2504		rs41290414		1558										AE2		20	NM_032264		11			ENST00000318249.5		17876		uc001ber.4			84224	dbSNP_127						0				26.0		0.423	1:g.21806525A>T		protein_coding			basic|appris_candidate_longest|CCDS		137,1035,3043			130,4212			.|||			5008		NBPF3_HUMAN	714	neuroblastoma breakpoint family, member 3			0.142572		21806525			0.1498	SNP		CCDS216.1			,,,	False	21806525				intron_variant		Approved		23.0			2013-01-17		Q9H094	0.0893		NBPF3	21806525					NBPF3	NM_032264.2	protein-coding gene	NP_115640.1		
		A	ENSG00000142794	ENST00000318249.5		84224		ENSG00000142794		4262					,				c.(1501-1503)tcG>tcA	OTTHUMG00000002944		byFrequency	Q9H094	gene with protein product		NBPF3_ENST00000454000.2_Silent_p.S431S|NBPF3_ENST00000342104.5_Silent_p.S489S|NBPF3_ENST00000318220.6_Silent_p.S445S		NM_032264.3		NM_032264	0.6063					+	Silent			41.0				11230166, 16079250				NBPF3-201					1	+	0.3192					25076			all_lung(284;2.16e-05)|Lung NSC(340;2.19e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)		SO:0001819	612992			protein_coding		2182						"""neuroblastoma breakpoint family"""	6444					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|OV - Ovarian serous cystadenocarcinoma(117;7.53e-27)|COAD - Colon adenocarcinoma(152;1.18e-05)|GBM - Glioblastoma multiforme(114;3.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000143)|STAD - Stomach adenocarcinoma(196;0.00306)|KIRC - Kidney renal clear cell carcinoma(1967;0.00645)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			GATGGTATTCGACTCCTTTCA						ENST00000318249.5:c.1503G>A	1	NBPF 4. {ECO:0000255|PROSITE- ProRule:PRU00647}.				breast(1)|endometrium(3)|kidney(1)|large_intestine(2)|lung(4)|ovary(2)|prostate(3)|skin(2)|upper_aerodigestive_tract(2)		+		,		1p36.12	A8K965|B4DSP2|I3L0I8|Q3BBW1|Q5VTG2|Q5VTG3|Q5VTG4|Q8IX78|Q8ND86|Q8TC96		g.chr1:21808159G>A																													hg19	Standard	0.495											CCDS216.1, CCDS57976.1, CCDS57977.1	G			BC024011	cytoplasm (GO:0005737)			2504		rs71512991		1853									501	AE2		20	NM_032264		13			ENST00000318249.5		23166		uc001ber.4			84224					p.S501S		0				36.0		0.478	1:g.21808159G>A		protein_coding			basic|appris_candidate_longest|CCDS								.|||			5008		NBPF3_HUMAN	2339	neuroblastoma breakpoint family, member 3			0.467053		21808159			0.4871	SNP		CCDS216.1			,,,	False	21808159				synonymous_variant		Approved		39.0		c.1503G>A	2013-01-17		Q9H094	0.4827		NBPF3	21808159							protein-coding gene	NP_115640.1		
		C	ENSG00000142794	ENST00000318249.5		84224		ENSG00000142794		4282									c.(1549-1551)ggA>ggC	OTTHUMG00000002944			Q9H094	gene with protein product		NBPF3_ENST00000454000.2_Silent_p.G447G|NBPF3_ENST00000342104.5_Silent_p.G505G|NBPF3_ENST00000318220.6_Silent_p.G461G		NM_032264.3		NM_032264						+	Silent			31.0				11230166, 16079250				NBPF3-201					1	+						25076			all_lung(284;2.16e-05)|Lung NSC(340;2.19e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00432)|Myeloproliferative disorder(586;0.0255)		SO:0001819	612992			protein_coding		2199						"""neuroblastoma breakpoint family"""	6481					UCEC - Uterine corpus endometrioid carcinoma (279;0.0181)|OV - Ovarian serous cystadenocarcinoma(117;7.53e-27)|COAD - Colon adenocarcinoma(152;1.18e-05)|GBM - Glioblastoma multiforme(114;3.47e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000143)|STAD - Stomach adenocarcinoma(196;0.00306)|KIRC - Kidney renal clear cell carcinoma(1967;0.00645)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN			AGCCCTACGGAAGTTGCTTTT						ENST00000318249.5:c.1551A>C	1	NBPF 4. {ECO:0000255|PROSITE- ProRule:PRU00647}.				breast(1)|endometrium(3)|kidney(1)|large_intestine(2)|lung(4)|ovary(2)|prostate(3)|skin(2)|upper_aerodigestive_tract(2)		+				1p36.12	A8K965|B4DSP2|I3L0I8|Q3BBW1|Q5VTG2|Q5VTG3|Q5VTG4|Q8IX78|Q8ND86|Q8TC96		g.chr1:21808207A>C																													hg19	Standard												CCDS216.1, CCDS57976.1, CCDS57977.1	A			BC024011	cytoplasm (GO:0005737)					rs146564096		1901									517	AE2		20	NM_032264		13			ENST00000318249.5				uc001ber.4			84224					p.G517G		0				28.0		0.478	1:g.21808207A>C		protein_coding			basic|appris_candidate_longest|CCDS													NBPF3_HUMAN		neuroblastoma breakpoint family, member 3					21808207				SNP		CCDS216.1					21808207				synonymous_variant		Approved		30.0		c.1551A>C	2013-01-17		Q9H094			NBPF3	21808207							protein-coding gene	NP_115640.1		
		A	ENSG00000162551	ENST00000374840.3		249		ENSG00000162551		2309					,					OTTHUMG00000002949		byFrequency	P05186	gene with protein product		ALPL_ENST00000425315.2_Intron|ALPL_ENST00000539907.1_Intron|ALPL_ENST00000468526.1_Intron|ALPL_ENST00000374832.1_Intron|ALPL_ENST00000540617.1_Intron	Amifostine(DB01143)|Fospropofol(DB06716)	NM_000478.4	97,508,722	NM_000478	0.2485					+	Intron			24.0				3532105, 3446011				ALPL-001					1	+	0.2428				intron,intron,intron	438		,,	all_lung(284;2.19e-05)|Lung NSC(340;2.22e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	171760	,,		protein_coding		1327				39.476,26.4506,34.7222			3636					UCEC - Uterine corpus endometrioid carcinoma (279;0.0192)|OV - Ovarian serous cystadenocarcinoma(117;8.7e-28)|COAD - Colon adenocarcinoma(152;1.57e-05)|GBM - Glioblastoma multiforme(114;2.66e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000177)|STAD - Stomach adenocarcinoma(196;0.00645)|KIRC - Kidney renal clear cell carcinoma(1967;0.00856)|READ - Rectum adenocarcinoma(331;0.0623)|Lung(427;0.146)			KNOWN			TAGCTAGGAGCCCCGGGAGCC		HOPS				ENST00000374840.3:c.181+52C>A	1					breast(1)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(1)|lung(11)|ovary(3)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)		+		,		1p36.12	A1A4E7|B2RMP8|B7Z387|B7Z4Y6|O75090|Q2TAI7|Q59EJ7|Q5BKZ5|Q5VTG5|Q6NZI8|Q8WU32|Q9UBK0		g.chr1:21887290C>A					no		2525,4747												-2.7					0.0	alkaline phosphatase activity (GO:0004035)|metal ion binding (GO:0046872)|pyrophosphatase activity (GO:0016462)				hg19	Standard	0.4235			1823,2795		cellular response to organic cyclic compound (GO:0071407)|cementum mineralization (GO:0071529)|developmental process involved in reproduction (GO:0003006)|endochondral ossification (GO:0001958)|osteoblast differentiation (GO:0001649)|response to antibiotic (GO:0046677)|response to glucocorticoid (GO:0051384)|response to lipopolysaccharide (GO:0032496)|response to vitamin D (GO:0033280)|skeletal system development (GO:0001501)	479,1567,1590					CCDS217.1, CCDS53274.1, CCDS53275.1	C		AA,AC,CC	BC021289	anchored component of membrane (GO:0031225)|extracellular matrix (GO:0031012)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	24		2504		rs1767430		431								,,		TNSALP		26	NM_001127501		3			ENST00000374840.3		18259		uc001bet.3			249	dbSNP_89	,,					0				22.0		0.582	1:g.21887290C>A		protein_coding			basic|appris_candidate_longest|CCDS		382,1059,868			702,1952			C|||			5008		PPBT_HUMAN	1312	alkaline phosphatase, liver/bone/kidney			0.261981		21887290			0.1359	SNP		CCDS217.1			,,,	False	21887290		3.1.3.1		intron_variant		Approved		24.0			2008-02-05	OTTHUMT00000008202.1	P05186	0.2666		ALPL	21887290				,,	ALPL	NM_000478.4,NM_001127501.2,NM_001177520.1	protein-coding gene	NP_000469.3		
		C	ENSG00000162551	ENST00000374840.3		249		ENSG00000162551		4300					,				c.(328-330)agT>agC	OTTHUMG00000002949		byFrequency	P05186	gene with protein product		ALPL_ENST00000468526.1_3'UTR|ALPL_ENST00000540617.1_Silent_p.S55S|ALPL_ENST00000425315.2_Silent_p.S110S|ALPL_ENST00000539907.1_Silent_p.S33S|ALPL_ENST00000374832.1_Silent_p.S110S	Amifostine(DB01143)|Fospropofol(DB06716)	NM_000478.4	1671,482,50	NM_000478	0.9581					+	Silent		132.5+/-190.1	64.0				3532105, 3446011				ALPL-001					1	+	0.8495				coding-synonymous,coding-synonymous,coding-synonymous	438		110/525,55/470,33/448	all_lung(284;2.19e-05)|Lung NSC(340;2.22e-05)|Colorectal(325;3.46e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	171760	,,		protein_coding		2203				5.0698,13.2093,7.8272			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0192)|OV - Ovarian serous cystadenocarcinoma(117;8.7e-28)|COAD - Colon adenocarcinoma(152;1.57e-05)|GBM - Glioblastoma multiforme(114;2.66e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000177)|STAD - Stomach adenocarcinoma(196;0.00645)|KIRC - Kidney renal clear cell carcinoma(1967;0.00856)|READ - Rectum adenocarcinoma(331;0.0623)|Lung(427;0.146)			KNOWN			TCCCTGACAGTGCCGGCACCG		HOPS				ENST00000374840.3:c.330T>C	1					breast(1)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(1)|lung(11)|ovary(3)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)		+		,		1p36.12	A1A4E7|B2RMP8|B7Z387|B7Z4Y6|O75090|Q2TAI7|Q59EJ7|Q5BKZ5|Q5VTG5|Q6NZI8|Q8WU32|Q9UBK0		g.chr1:21889635T>C		251.2+/-258.0			no		11988,1018												-3.6					0.8	alkaline phosphatase activity (GO:0004035)|metal ion binding (GO:0046872)|pyrophosphatase activity (GO:0016462)				hg19	Standard	0.9374			8164,436		cellular response to organic cyclic compound (GO:0071407)|cementum mineralization (GO:0071529)|developmental process involved in reproduction (GO:0003006)|endochondral ossification (GO:0001958)|osteoblast differentiation (GO:0001649)|response to antibiotic (GO:0046677)|response to glucocorticoid (GO:0051384)|response to lipopolysaccharide (GO:0032496)|response to vitamin D (GO:0033280)|skeletal system development (GO:0001501)	5543,902,58					CCDS217.1, CCDS53274.1, CCDS53275.1	T		CC,CT,TT	BC021289	anchored component of membrane (GO:0031225)|extracellular matrix (GO:0031012)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	67		2504		rs1780316|rs200166222		580								,,	110	TNSALP		26	NM_001127501		5			ENST00000374840.3		16617		uc001bet.3			249	dbSNP_89	330,165,99			p.S110S		0				72.0		0.667	1:g.21889635T>C		protein_coding			basic|appris_candidate_longest|CCDS		3872,420,8			3824,582			C|||			5008		PPBT_HUMAN	4655	alkaline phosphatase, liver/bone/kidney			0.929513		21889635			0.9821	SNP		CCDS217.1			,,,	False	21889635		3.1.3.1		synonymous_variant		Approved		67.0		c.330T>C	2008-02-05	OTTHUMT00000008202.1	P05186	0.9539		ALPL	21889635				,,	ALPL	NM_000478.4,NM_001127501.2,NM_001177520.1	protein-coding gene	NP_000469.3		
		C	ENSG00000076864	ENST00000374765.4		5909		ENSG00000076864		4300					,					OTTHUMG00000007513		byFrequency	P47736	gene with protein product		RAP1GAP_ENST00000542643.2_Intron|RAP1GAP_ENST00000374763.2_Intron|RAP1GAP_ENST00000290101.4_Intron|RAP1GAP_ENST00000374761.2_Intron		NM_002885.2	22,396,1785	NM_002885	0.1881					+	Intron		232.2+/-265.9	50.0				1904317				RAP1GAP-001	2006-04-12				1	-	0.09				intron,intron,intron	9858		,,	Colorectal(325;0.000147)|Renal(390;0.000734)|Lung NSC(340;0.000861)|all_lung(284;0.000901)|Breast(348;0.012)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0427)	T	SO:0001627	600278	,,		protein_coding		2203				13.314,9.9864,12.1867			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0192)|OV - Ovarian serous cystadenocarcinoma(117;2.3e-26)|COAD - Colon adenocarcinoma(152;1.59e-05)|GBM - Glioblastoma multiforme(114;2.7e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000354)|STAD - Stomach adenocarcinoma(196;0.00645)|KIRC - Kidney renal clear cell carcinoma(1967;0.00862)|READ - Rectum adenocarcinoma(331;0.0625)|Lung(427;0.146)			KNOWN			CAGTTAGACCTGGGGCCCTTC		RAP1GA1				ENST00000374765.4:c.1296+12A>G	1					breast(2)|central_nervous_system(1)|endometrium(1)|large_intestine(3)|lung(7)|ovary(2)|skin(1)		-		,		1p36.1-p35	J3QSS6|O75062|Q5T3S9|Q5T3T4|Q7Z5S8|Q9UQ51		g.chr1:21934693T>C		204.1+/-226.4			no		1585,11421												-4.4					0.0	GTPase activator activity (GO:0005096)|GTPase activity (GO:0003924)|protein homodimerization activity (GO:0042803)|Rap GTPase activator activity (GO:0046582)|Ras GTPase binding (GO:0017016)		2006-04-12		hg19	Standard	0.1441			1145,7455		GTP catabolic process (GO:0006184)|positive regulation of Rap GTPase activity (GO:0032854)|regulation of Ras GTPase activity (GO:0032318)|signal transduction (GO:0007165)	95,1395,5013					CCDS218.1, CCDS53276.1, CCDS53277.1	T		CC,CT,TT	BC054490	cytosol (GO:0005829)|Golgi apparatus (GO:0005794)|membrane (GO:0016020)	48		2504		rs72660316		1497				"""RAP1, GTPase activating protein 1"""				,,		KIAA0474, RAP1GAP1, RAP1GAPII		17	NM_001145657		17			ENST00000374765.4		12560		uc001bew.3			5909	dbSNP_130	,,					0				44.0		0.637	1:g.21934693T>C		protein_coding			basic|appris_candidate|CCDS		73,999,3228			440,3966			T|||			5008		RPGP1_HUMAN	539	RAP1 GTPase activating protein			0.107628		21934693			0.0327	SNP		CCDS218.1			,,,	False	21934693				intron_variant		Approved		48.0			2009-09-14	OTTHUMT00000019759.2	P47736	0.0836		RAP1GAP	21934693				,,	RAP1GAP	NM_001145657.1,NM_001145658.1,NM_002885.2	protein-coding gene	NP_002876.2		
		C	ENSG00000076864	ENST00000374765.4		5909		ENSG00000076864		4300					,					OTTHUMG00000007513		byFrequency	P47736	gene with protein product		RAP1GAP_ENST00000374763.2_Intron|RAP1GAP_ENST00000374761.2_Intron|RAP1GAP_ENST00000542643.2_Intron|RAP1GAP_ENST00000374757.3_Intron|RAP1GAP_ENST00000290101.4_Intron		NM_002885.2	367,1077,759	NM_002885	0.4601					+	Intron		530.4+/-381.8	67.0				1904317				RAP1GAP-001	2006-04-12				1	-	0.4085				intron,intron,intron	9858		,,	Colorectal(325;0.000147)|Renal(390;0.000734)|Lung NSC(340;0.000861)|all_lung(284;0.000901)|Breast(348;0.012)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0427)	G	SO:0001627	600278	,,		protein_coding		2203				43.6395,41.103,42.7803			6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0192)|OV - Ovarian serous cystadenocarcinoma(117;2.3e-26)|COAD - Colon adenocarcinoma(152;1.59e-05)|GBM - Glioblastoma multiforme(114;2.7e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000354)|STAD - Stomach adenocarcinoma(196;0.00645)|KIRC - Kidney renal clear cell carcinoma(1967;0.00862)|READ - Rectum adenocarcinoma(331;0.0625)|Lung(427;0.146)			KNOWN			GGAGATAAGGGAGGGGTGTGA		RAP1GA1				ENST00000374765.4:c.475-19C>G	1					breast(2)|central_nervous_system(1)|endometrium(1)|large_intestine(3)|lung(7)|ovary(2)|skin(1)		-		,		1p36.1-p35	J3QSS6|O75062|Q5T3S9|Q5T3T4|Q7Z5S8|Q9UQ51		g.chr1:21939741G>C		530.6+/-373.0			no		5564,7442												2.8					0.0	GTPase activator activity (GO:0005096)|GTPase activity (GO:0003924)|protein homodimerization activity (GO:0042803)|Rap GTPase activator activity (GO:0046582)|Ras GTPase binding (GO:0017016)		2006-04-12		hg19	Standard	0.4264			3753,4847		GTP catabolic process (GO:0006184)|positive regulation of Rap GTPase activity (GO:0032854)|regulation of Ras GTPase activity (GO:0032318)|signal transduction (GO:0007165)	1180,3204,2119					CCDS218.1, CCDS53276.1, CCDS53277.1	G		CC,CG,GG	BC054490	cytosol (GO:0005829)|Golgi apparatus (GO:0005794)|membrane (GO:0016020)	73		2504		rs1256282		675				"""RAP1, GTPase activating protein 1"""				,,		KIAA0474, RAP1GAP1, RAP1GAPII		17	NM_001145657		10			ENST00000374765.4		18699		uc001bew.3			5909	dbSNP_87	,,					0				84.0		0.597	1:g.21939741G>C		protein_coding			basic|appris_candidate|CCDS		813,2127,1360			1811,2595			G|||			5008		RPGP1_HUMAN	2409	RAP1 GTPase activating protein			0.48103		21939741			0.5357	SNP		CCDS218.1			,,,	False	21939741				intron_variant		Approved		73.0			2009-09-14	OTTHUMT00000019759.2	P47736	0.6484		RAP1GAP	21939741				,,	RAP1GAP	NM_001145657.1,NM_001145658.1,NM_002885.2	protein-coding gene	NP_002876.2		
		T	ENSG00000142798	ENST00000374695.3		3339		ENSG00000142798		4298					,					OTTHUMG00000002674		byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	53,527,1622	NM_005529	0.3292					+	Intron			22.0				1685141, 11941538				HSPG2-001	2007-02-16				1	-	0.0772				intron	5273			Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	142461			protein_coding		2202				49.2206,14.3733,37.4154		"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6500					UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN			CCTTGGCCCACGGCTCCAGGG		SJS1				ENST00000374695.3:c.10831-41G>A	1					breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-		,		1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22160148C>T					no		4864,8136												-7.2					0.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)		2007-02-16		hg19	Standard	0.4821			4231,4365		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	1108,2648,2744					CCDS30625.1	C		TT,TC,CC	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	23		2504		rs7547731		10910				"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""						perlecan, PRCAN		127	XM_005245863		79			ENST00000374695.3		21219		uc001bfj.3			3339	dbSNP_116						0				24.0		0.622	1:g.22160148C>T		protein_coding			basic|appris_principal|CCDS		1055,2121,1122			633,3771			C|||			5008		PGBM_HUMAN	1878	heparan sulfate proteoglycan 2			0.375		22160148			0.6478	SNP		CCDS30625.1			,,,	False	22160148				intron_variant		Approved		23.0			2013-01-29	OTTHUMT00000007598.1	P98160	0.4553		HSPG2	22160148					HSPG2	NM_005529.5	protein-coding gene	NP_005520.4		
		T	ENSG00000142798	ENST00000374695.3		3339		ENSG00000142798		4300					,					OTTHUMG00000002674		byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	572,1060,571	NM_005529	0.6288					+	Intron		666.2+/-402.3	49.0				1685141, 11941538				HSPG2-001	2007-02-16				1	-	0.4607				intron	5273			Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	142461			protein_coding		2203				33.814,49.9773,39.2896		"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN			TGGTCCTTCTCGTGTCTTGGT		SJS1				ENST00000374695.3:c.9194-50G>A	1					breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-		,		1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22168216C>T		581.7+/-385.4			no		7896,5110												2.1					0.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)		2007-02-16		hg19	Standard	0.6769			5692,2908		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	2451,2994,1058					CCDS30625.1	C		TT,TC,CC	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	50		2504		rs7556412		9273				"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""						perlecan, PRCAN		127	XM_005245863		70			ENST00000374695.3		19517		uc001bfj.3			3339	dbSNP_116						0				53.0		0.587	1:g.22168216C>T		protein_coding			basic|appris_principal|CCDS		1879,1934,487			2204,2202			C|||			5008		PGBM_HUMAN	3124	heparan sulfate proteoglycan 2			0.623802		22168216			0.8075	SNP		CCDS30625.1			,,,	False	22168216				intron_variant		Approved		50.0			2013-01-29	OTTHUMT00000007598.1	P98160	0.5836		HSPG2	22168216					HSPG2	NM_005529.5	protein-coding gene	NP_005520.4		
		G	ENSG00000142798	ENST00000374695.3		3339		ENSG00000142798		4296					,					OTTHUMG00000002674		byFrequency	P98160	gene with protein product		HSPG2_ENST00000430507.1_Intron	Palifermin(DB00039)	NM_005529.5	1119,896,178	NM_005529	0.8415					+	Intron			17.0				1685141, 11941538				HSPG2-001	2007-02-16				1	-	0.6664				intron	5273			Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	G	SO:0001627	142461			protein_coding		2193				18.075,28.5454,21.6135		"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6489					UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN			CAGGAAGCAGATGGCAGGAGG		SJS1				ENST00000374695.3:c.7738-14T>C	1					breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-		,		1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22174600A>G					no		10173,2805												2.7					0.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)		2007-02-16		hg19	Standard	0.8231			7039,1553		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	4006,2161,322					CCDS30625.1	A		GG,GA,AA	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	20		2504		rs3767138		7817				"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""						perlecan, PRCAN		127	XM_005245863		60			ENST00000374695.3		19776		uc001bfj.3			3339	dbSNP_107						0				25.0		0.652	1:g.22174600A>G		protein_coding			basic|appris_principal|CCDS		2887,1265,144			3134,1252			G|||			5008		PGBM_HUMAN	3816	heparan sulfate proteoglycan 2			0.761981		22174600			0.8085	SNP		CCDS30625.1			,,,	False	22174600				intron_variant		Approved		20.0			2013-01-29	OTTHUMT00000007598.1	P98160	0.6758		HSPG2	22174600					HSPG2	NM_005529.5	protein-coding gene	NP_005520.4		
		C	ENSG00000142798	ENST00000374695.3	0.23036	3339	L	ENSG00000142798	0.60594	4300	1.000000	0.61392	B		,	T	0.99839211	0	c.(2293-2295)aAt>aGt	OTTHUMG00000002674	2.044000	byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	1440,691,72	NM_005529	0.999			T	15.74	+	Missense_Mutation	2	818.7+/-406.8	57.0	P98160	0.810486		1685141, 11941538			0.016	HSPG2-001	2007-02-16		0.16722		1	-	0.7466		0.24	0.998000	missense	5273	353	765/4392	Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	T	SO:0001583	142461	benign	0.9751381215469613	protein_coding		2203	P		1.000000	0.093,18.9514,6.4816	B	"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503		0.0:0.0:0.0:1.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN	ENST00000374695		GCCATTGCAATTGCAACCAGA	T	SJS1				ENST00000374695.3:c.2294A>G	1	Laminin EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00460}.	ENSG00000142798	0.62120	HSPG2	breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)	ENSP00000363827:p.Asn765Ser	-	0.71417	,	AAT	1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22206649T>C	N -> S (in dbSNP:rs989994). {ECO:0000269|PubMed:11101850, ECO:0000269|PubMed:1569102, ECO:0000269|PubMed:1730768}.	746.2+/-411.7		384	yes		12163,843	0.80357	0.52653	5.38	0.00012	ENSP00000363827:N765S			0.28327		.		5.4	0.77491	572	0.33141	1.0	1.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)	1.45	2007-02-16		hg19	Standard	1.0	0.7804878048780488	13.348	8592,8		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	5732,699,72	2.921300				CCDS30625.1	T	0.10296	CC,CT,TT	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	57	0.46567	2504	5.38	rs989994		2373	765	758		"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""	0.60584	22079236	-	SER/ASN	765	perlecan, PRCAN	2067	127	XM_005245863	0.003	17	1.0	0.533000	ENST00000374695.3		21137		uc001bfj.3			3339	dbSNP_86	2294	0.0000		p.N765S	EGF-like, laminin (3);	0		T		56.0	rs989994;rs2229480;rs61654739;rs989994	0.562	1:g.22206649T>C	ENSP00000363827:N765S	protein_coding	0.015750		basic|appris_principal|CCDS		4292,8,0		765	3571,835	0.9464285714285714	S	T|||		0.166433	5008		PGBM_HUMAN	4657	heparan sulfate proteoglycan 2		PGBM_HUMAN	0.929912	0.27083	22206649		0.803000	1.0	SNP		CCDS30625.1		N	,,,	False	22206649	-0.9672		9	missense	T	Approved	0.99907	57.0		c.2294A>G	2013-01-29	OTTHUMT00000007598.1	P98160	0.9784	0.11	HSPG2	22206649	0.95712		0.38200	46	HSPG2	NM_005529.5	protein-coding gene	NP_005520.4	N	
		A	ENSG00000142798	ENST00000374695.3		3339		ENSG00000142798		4300					,				c.(2107-2109)gcC>gcT	OTTHUMG00000002674		byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	1440,691,72	NM_005529	0.999					+	Silent		818.0+/-406.9	63.0				1685141, 11941538				HSPG2-001	2007-02-16				1	-	0.7466				coding-synonymous	5273		703/4392	Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	142461			protein_coding		2203				0.093,18.9514,6.4816		"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN			GTCCCACGCTGGCCATCTTGG		SJS1				ENST00000374695.3:c.2109C>T	1	Laminin IV type A 1. {ECO:0000255|PROSITE-ProRule:PRU00458}.				breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-		,		1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22206942G>A		745.3+/-411.6			no		12163,843												5.2					1.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)		2007-02-16		hg19	Standard	1.0			8592,8		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	5732,699,72					CCDS30625.1	G		AA,AG,GG	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	69		2504		rs1874793		2188				"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""					703	perlecan, PRCAN		127	XM_005245863		16			ENST00000374695.3		21137		uc001bfj.3			3339	dbSNP_92	2109			p.A703A		0				79.0		0.657	1:g.22206942G>A		protein_coding			basic|appris_principal|CCDS		4292,8,0			3571,835			G|||			5008		PGBM_HUMAN	4657	heparan sulfate proteoglycan 2			0.929912		22206942			1.0	SNP		CCDS30625.1			,,,	False	22206942				synonymous_variant		Approved		69.0		c.2109C>T	2013-01-29	OTTHUMT00000007598.1	P98160	0.9784		HSPG2	22206942					HSPG2	NM_005529.5	protein-coding gene	NP_005520.4		
		ACCCAGG	ENSG00000142798	ENST00000374695.3		3339		ENSG00000142798		4288										OTTHUMG00000002674		byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5		NM_005529						+	Intron			50.0				1685141, 11941538				HSPG2-001	2007-02-16				1	-						5273			Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)		SO:0001627	142461			protein_coding		2202						"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6490					UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN			TTCTTTCCCCACCCAGGGTGG		SJS1				ENST00000374695.3:c.1818+27CCTGGGCTGCCACCCTGGGT>CCTGGGT	1					breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-				1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22207804delACCCAGGGTGGCAGCCCAGG																									metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)		2007-02-16		hg19	Standard						angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)						CCDS30625.1	ACCCAGGGTGGCAGCCCAGG			M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)					rs386629398|rs139046040|rs60267433		1898				"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""						perlecan, PRCAN		127	XM_005245863		14			ENST00000374695.3				uc001bfj.3			3339							0				48.0		0.612	1:g.22207804delACCCAGGGTGGCAGCCCAGG		protein_coding			basic|appris_principal|CCDS													PGBM_HUMAN		heparan sulfate proteoglycan 2					22207804				DEL		CCDS30625.1					22207804				intron_variant		Approved		49.0			2013-01-29	OTTHUMT00000007598.1	P98160			HSPG2	22207804							protein-coding gene	NP_005520.4		
		A	ENSG00000142798	ENST00000374695.3	0.45477	3339	.	ENSG00000142798	0.20427	4300	0.928000	0.57595	P		,	T	0.0015579999999999483	0	c.(472-474)ggG>ggT	OTTHUMG00000002674	0.199000	byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	180,975,1048	NM_005529	0.6217			C	9.554	+	Silent	2	678.8+/-403.5	153.0	Q5SZI5	0.302996		1685141, 11941538			0.226	HSPG2-001	2007-02-16		0.36504		1	-	0.2163		0.24	0.027000	coding-synonymous	5273	162	158/4392	Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	142461		0.44751381215469616	protein_coding		2203	P		0.000000	32.3023,30.2996,44.9716	B	"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503		0.1331:0.26:0.4793:0.1276			UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN	ENST00000412328		GAATCTGAGCCCCATCCGCAT	T	SJS1				ENST00000374695.3:c.474G>T	1	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.	ENSG00000142798	0.86243	HSPG2	breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-	0.05858	,	GGG	1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22216574C>A		446.5+/-348.0		117	no		7157,5849	0.36995	0.20795	5.44	0.00012	ENSP00000405412:G81V			0.23960		.		0.4	0.16097	202	0.33141	0.3531468531468531	0.9	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)	.	2007-02-16		hg19	Standard	0.6839	0.23780487804878048	3.7839	5822,2778		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	2148,2861,1494	1.116592				CCDS30625.1	C	0.38078	AA,AC,CC	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	161	.	2504	0.36	rs2254358		553	81	507		"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""	0.08692	22089161	-		158	perlecan, PRCAN	988	127	XM_005245863	0.617	6	0.6688654353562006	0.650000	ENST00000374695.3		17731		uc001bfj.3			3339	dbSNP_100	474	0.0000		p.G158G	.	0		T		176.0	rs2254358;rs52790258;rs57772567;rs2254358	0.622	1:g.22216574C>A	ENSP00000405412:G81V	protein_coding	0.042880		basic|appris_principal|CCDS		1968,1886,446		81	1335,3071	0.4523809523809524	V	C|||		0.206543	5008		PGBM_HUMAN	2226	heparan sulfate proteoglycan 2		.	0.444489	0.05496	22216574		-0.631000	0.3522	SNP		CCDS30625.1		N	,,,	False	22216574	-0.9603		8	synonymous_variant	T	Approved	0.676977	161.0		c.474G>T	2013-01-29	OTTHUMT00000007598.1	P98160	0.4164	0.39	HSPG2	22216574	0.11550		0.39663		HSPG2	NM_005529.5	protein-coding gene	NP_005520.4	G	
		G	ENSG00000142798	ENST00000374695.3	0.09310	3339	.	ENSG00000142798	0.97791	4300	1.000000	0.54675	P		,	T	1.0	0	c.(442-444)ctG>ctC	OTTHUMG00000002674	2.837000	byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	180,975,1048	NM_005529	0.6217			C	4.543	+	Silent	2	678.6+/-403.5	129.0	Q5SZI5	0.302996		1685141, 11941538			0.509	HSPG2-001	2007-02-16		0.46253		1	-	0.2163		0.91	0.871000	coding-synonymous	5273	162	148/4392	Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	142461		0.44751381215469616	protein_coding		2203	P		1.000000	32.2907,30.2996,44.9639	P	"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503		0.0:0.8371:0.1629:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN	ENST00000412328		AGCCCACATCCAGCTCCACAA	T	SJS1				ENST00000374695.3:c.444G>C	1	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.	ENSG00000142798	0.94253	HSPG2	breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-	0.71417	,	TGG	1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22216604C>G		446.3+/-348.0		117	no		7158,5848	0.80357	0.08731	5.44	0.00012	ENSP00000405412:W71S			.		.		4.5	0.54988	202	0.06236	0.3531468531468531	1.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)	.	2007-02-16		hg19	Standard	0.6839	0.23780487804878048	14.0504	5823,2777		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	2148,2862,1493	0.100844				CCDS30625.1	C	0.51537	GG,GC,CC	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	135	.	2504	4.5	rs2254357		523	71	507		"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""	0.64732	22089191	-		148	perlecan, PRCAN	988	127	XM_005245863	0.946	6	0.6688654353562006	0.655000	ENST00000374695.3		17434		uc001bfj.3			3339	dbSNP_100	444	0.0000		p.L148L	.	0		T		147.0	rs2254357;rs52790015;rs57827752;rs2254357	0.612	1:g.22216604C>G	ENSP00000405412:W71S	protein_coding	.		basic|appris_principal|CCDS		1968,1887,445		71	1335,3071	0.4523809523809524	S	C|||		.	5008		PGBM_HUMAN	2226	heparan sulfate proteoglycan 2		.	0.444489	0.35343	22216604		1.469000	0.3522	SNP		CCDS30625.1		.	,,,	False	22216604	-1.0502		7	synonymous_variant	T	Approved	0.677093	135.0		c.444G>C	2013-01-29	OTTHUMT00000007598.1	P98160	0.4164	0.56	HSPG2	22216604	0.50021		0.13629		HSPG2	NM_005529.5	protein-coding gene	NP_005520.4	W	
		A	ENSG00000142798	ENST00000374695.3		3339		ENSG00000142798		4300					,				c.(322-324)ttC>ttT	OTTHUMG00000002674		byFrequency	P98160	gene with protein product			Palifermin(DB00039)	NM_005529.5	1645,523,35	NM_005529	1.0					+	Silent		818.9+/-406.8	105.0				1685141, 11941538				HSPG2-001	2007-02-16				1	-	0.8139				coding-synonymous	5273		108/4392	Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	142461			protein_coding		2203				0.093,13.4589,4.6209		"""Proteoglycans / Extracellular Matrix : Other"", ""Immunoglobulin superfamily / I-set domain containing"", ""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)			KNOWN			ACACCTCTCGGAACTCTCTGG		SJS1				ENST00000374695.3:c.324C>T	1	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.				breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)		-		,		1p36.1-p35	Q16287|Q5SZI3|Q9H3V5	"""perlecan proteoglycan"""	g.chr1:22217108G>A		770.9+/-413.8			no		12405,601												5.6					1.0	metal ion binding (GO:0046872)|protein C-terminus binding (GO:0008022)		2007-02-16		hg19	Standard	1.0			8592,8		angiogenesis (GO:0001525)|brain development (GO:0007420)|carbohydrate metabolic process (GO:0005975)|cardiac muscle tissue development (GO:0048738)|cartilage development involved in endochondral bone morphogenesis (GO:0060351)|chondrocyte differentiation (GO:0002062)|chondroitin sulfate metabolic process (GO:0030204)|embryonic skeletal system morphogenesis (GO:0048704)|endochondral ossification (GO:0001958)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|lipoprotein metabolic process (GO:0042157)|phototransduction, visible light (GO:0007603)|protein localization (GO:0008104)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)	5937,531,35					CCDS30625.1	G		AA,AG,GG	M85289	basal lamina (GO:0005605)|extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)	104		2504		rs2501260		403				"""Schwartz-Jampel syndrome 1 (chondrodystrophic myotonia)"""					108	perlecan, PRCAN		127	XM_005245863		4			ENST00000374695.3		17196		uc001bfj.3			3339	dbSNP_100	324			p.F108F		0				102.0		0.592	1:g.22217108G>A		protein_coding			basic|appris_principal|CCDS		4292,8,0			3813,593			G|||			5008		PGBM_HUMAN	4748	heparan sulfate proteoglycan 2			0.948083		22217108			1.0	SNP		CCDS30625.1			,,,	False	22217108				synonymous_variant		Approved		104.0		c.324C>T	2013-01-29	OTTHUMT00000007598.1	P98160	0.9798		HSPG2	22217108					HSPG2	NM_005529.5	protein-coding gene	NP_005520.4		
		T	ENSG00000219073	ENST00000337107.6	0.80722	23436	M	ENSG00000219073	0.12550	4300	0.029000	0.89270	D		,	T	0.0	2	c.(235-237)Cgg>Tgg	OTTHUMG00000002758	-0.086000	byFrequency	P08861	gene with protein product				NM_007352.2	1620,536,47	NM_007352	0.9519			C	11.01	+	Missense_Mutation	1	816.3+/-406.9	72.0	P08861	0.857013		2826474, 2460440			0.598	CELA3B-001	2009-05-05		0.49012		1	+	0.8442		0.18	0.036000	missense	15945	352	79/271		C	SO:0001583		benign	0.9723756906077348	protein_coding		2203	P	OREG0013210	0.000000	0.7907,14.2987,5.3668	P		6503		0.2774:0.4235:0.1354:0.1637		755				KNOWN	ENST00000337107;ENST00000374666		CAGGAGCTCCCGGACCTACCA	D;D	ELA3B				ENST00000337107.6:c.235C>T	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.	ENSG00000219073	0.86243	CELA3B	breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)	ENSP00000338369:p.Arg79Trp	+	0.05858	,	CGG	1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22307538C>T	R -> W (in dbSNP:rs7528405). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16710414}.	767.3+/-413.5		432	yes		12308,698	0.17559	0.27123	4.89	0.00012	ENSP00000338369:R79W			0.10084		-1.9495		-0.8	0.10995	405	0.38643	0.708041958041958	0.0	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)	2.33	2009-05-05		hg19	Standard	0.992	0.8780487804878049	1.8471	8532,68		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5853,602,48	1.513694				CCDS219.1	C	0.53745	TT,TC,CC	M18692		74	0.76328	2504	-0.773	rs7528405		254	79	756		"""elastase 3B, pancreatic"""	0.03161	22180125	+	TRP/ARG	79	CBPP	1945	8	NM_007352	0.962	4	0.9973614775725593	0.650000	ENST00000337107.6		16094		uc001bfk.3			23436	dbSNP_116	235	0.0000		p.R79W	Peptidase cysteine/serine, trypsin-like (1);Peptidase S1/S6, chymotrypsin/Hap (3);	0		T		76.0	rs7528405;rs11541413;rs17849947;rs58308146;rs7528405	0.657	1:g.22307538C>T	ENSP00000338369:R79W;ENSP00000363798:R95W	protein_coding	0.718025		basic|appris_principal|CCDS		4233,66,1	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)	79;95	3776,630	0.8905677655677655	W	C|||		0.863771	5008		CEL3B_HUMAN	4474	chymotrypsin-like elastase family, member 3B		CEL3B_HUMAN	0.893371	0.09642	22307538		-0.188000	0.755	SNP		CCDS219.1		N	,,,	False	22307538	-0.9226	3.4.21.70	9	missense	T	Approved	0.992093	74.0		c.235C>T	2009-05-05	OTTHUMT00000007797.1	P08861	0.9625	-2.49;-2.49	CELA3B	22307538	0.12997		0.45948	101	CELA3B	NM_007352.2	protein-coding gene	NP_031378.1	R	
		G	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4299										OTTHUMG00000002758		byFrequency	P08861	gene with protein product				NM_007352.2		NM_007352						+	Intron			33.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+						15945					SO:0001627				protein_coding		2202							6501								KNOWN			AAGGTAGGACTTGGGCCGGCT		ELA3B				ENST00000337107.6:c.363-48T>G	1					breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+				1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310139T>G																									peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard						cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)						CCDS219.1	T			M18692						rs10733031		381				"""elastase 3B, pancreatic"""						CBPP		8	NM_007352		5			ENST00000337107.6				uc001bfk.3			23436							0				33.0		0.592	1:g.22310139T>G		protein_coding			basic|appris_principal|CCDS													CEL3B_HUMAN		chymotrypsin-like elastase family, member 3B					22310139				SNP		CCDS219.1					22310139		3.4.21.70		intron_variant		Approved		33.0			2009-05-05	OTTHUMT00000007797.1	P08861			CELA3B	22310139							protein-coding gene	NP_031378.1		
		T	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4299					,					OTTHUMG00000002758		byFrequency	P08861	gene with protein product				NM_007352.2		NM_007352	0.9448					+	Intron			34.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+	0.7095					15945					SO:0001627				protein_coding		2202							6501								KNOWN			GGACTTGGGCCGGCTGGAGGA		ELA3B				ENST00000337107.6:c.363-42C>T	1					breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+		,		1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310145C>T																									peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.9672					cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)						CCDS219.1	C			M18692				2504		rs10733032|rs200714766		381				"""elastase 3B, pancreatic"""						CBPP		8	NM_007352		5			ENST00000337107.6		18367		uc001bfk.3			23436							0				34.0		0.607	1:g.22310145C>T		protein_coding			basic|appris_principal|CCDS								C|||			5008		CEL3B_HUMAN	4246	chymotrypsin-like elastase family, member 3B			0.847843		22310145			0.755	SNP		CCDS219.1			,,,	False	22310145		3.4.21.70		intron_variant		Approved		34.0			2009-05-05	OTTHUMT00000007797.1	P08861	0.9366		CELA3B	22310145							protein-coding gene	NP_031378.1		
		C	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4297					,				c.(436-438)ccG>ccC	OTTHUMG00000002758		byFrequency	P08861	gene with protein product				NM_007352.2	1476,609,118	NM_007352	0.9519					+	Silent		42.2+/-99.7	66.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+	0.7958				coding-synonymous	15945		146/271		C	SO:0001819				protein_coding		2203				0.9542,19.1784,7.1308			6500								KNOWN			CACTCCCTCCGGCTGGTGACA		ELA3B				ENST00000337107.6:c.438G>C	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+		,		1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310262G>C		306.9+/-289.7			no		12073,927												-9.1					0.0	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.992			8512,82		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5693,687,120					CCDS219.1	G		CC,CG,GG	M18692		73		2504		rs10733033		457				"""elastase 3B, pancreatic"""					146	CBPP		8	NM_007352		5			ENST00000337107.6		19098		uc001bfk.3			23436	dbSNP_120	438			p.P146P		0				87.0		0.627	1:g.22310262G>C		protein_coding			basic|appris_principal|CCDS		4217,78,2			3561,845			C|||			5008		CEL3B_HUMAN	4404	chymotrypsin-like elastase family, member 3B			0.879393		22310262			0.755	SNP		CCDS219.1			,,,	False	22310262		3.4.21.70		synonymous_variant		Approved		73.0		c.438G>C	2009-05-05	OTTHUMT00000007797.1	P08861	0.9539		CELA3B	22310262					CELA3B	NM_007352.2	protein-coding gene	NP_031378.1		
		T	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4300					,					OTTHUMG00000002758		byFrequency	P08861	gene with protein product				NM_007352.2	1265,792,146	NM_007352	0.9417					+	Intron		791.5+/-407.5	40.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+	0.7095				intron	15945				T	SO:0001627				protein_coding		2203				5.7093,24.6028,12.1098			6503								KNOWN			CCCCTGACTCGGTGCTTTTTA		ELA3B				ENST00000337107.6:c.500-20G>T	1					breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+		,		1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310662G>T		711.2+/-408.0			no		11431,1575												-1.8					0.0	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.9423			8109,491		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5088,1255,160					CCDS219.1	G		TT,TG,GG	M18692		40		2504		rs6426735		518				"""elastase 3B, pancreatic"""						CBPP		8	NM_007352		6			ENST00000337107.6		17501		uc001bfk.3			23436	dbSNP_116						0				40.0		0.627	1:g.22310662G>T		protein_coding			basic|appris_principal|CCDS		3823,463,14			3322,1084			g|||			5008		CEL3B_HUMAN	4209	chymotrypsin-like elastase family, member 3B			0.840455		22310662			0.754	SNP		CCDS219.1			,,,	False	22310662		3.4.21.70		intron_variant		Approved		40.0			2009-05-05	OTTHUMT00000007797.1	P08861	0.9251		CELA3B	22310662					CELA3B	NM_007352.2	protein-coding gene	NP_031378.1		
		T	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4300					,					OTTHUMG00000002758		byFrequency	P08861	gene with protein product				NM_007352.2	1279,786,138	NM_007352	0.9468					+	Intron		808.5+/-407.2	44.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+	0.7095				intron	15945				C	SO:0001627				protein_coding		2203				2.5233,24.1035,9.8339			6503								KNOWN			TGCTTTTTATCGCTGCAGCCA		ELA3B				ENST00000337107.6:c.500-8C>T	1					breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+		,		1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310674C>T		720.6+/-409.1			no		11727,1279												-1.0					0.0	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.9722			8383,217		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5363,1001,139					CCDS219.1	C		TT,TC,CC	M18692		45		2504		rs7538207		518				"""elastase 3B, pancreatic"""						CBPP		8	NM_007352		6			ENST00000337107.6		17747		uc001bfk.3			23436	dbSNP_116						0				45.0		0.622	1:g.22310674C>T		protein_coding			basic|appris_principal|CCDS		4084,215,1			3344,1062			C|||			5008		CEL3B_HUMAN	4253	chymotrypsin-like elastase family, member 3B			0.849241		22310674			0.755	SNP		CCDS219.1			,,,	False	22310674		3.4.21.70		intron_variant		Approved		45.0			2009-05-05	OTTHUMT00000007797.1	P08861	0.9366		CELA3B	22310674					CELA3B	NM_007352.2	protein-coding gene	NP_031378.1		
		C	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4300									c.(541-543)ccG>ccC	OTTHUMG00000002758		byFrequency	P08861	gene with protein product				NM_007352.2	1271,788,144	NM_007352						+	Silent		142.5+/-198.7	76.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+					coding-synonymous	15945		181/271		T	SO:0001819				protein_coding		2203				5.7209,24.4212,12.056			6503								KNOWN			CCCTGCTGCCGGTGGTGGACT		ELA3B				ENST00000337107.6:c.543G>C	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+				1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310725G>C		392.8+/-328.6			no		11438,1568												-6.1					0.7	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard				8108,492		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5093,1252,158					CCDS219.1	G		CC,CG,GG	M18692		77				rs3820287		562				"""elastase 3B, pancreatic"""					181	CBPP		8	NM_007352		6			ENST00000337107.6				uc001bfk.3			23436	dbSNP_107	543			p.P181P		0				79.0		0.627	1:g.22310725G>C		protein_coding			basic|appris_principal|CCDS		3822,464,14			3330,1076								CEL3B_HUMAN		chymotrypsin-like elastase family, member 3B					22310725				SNP		CCDS219.1					22310725		3.4.21.70		synonymous_variant		Approved		77.0		c.543G>C	2009-05-05	OTTHUMT00000007797.1	P08861			CELA3B	22310725					CELA3B	NM_007352.2	protein-coding gene	NP_031378.1		
		C	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4298					,				c.(640-642)aaT>aaC	OTTHUMG00000002758		byFrequency	P08861	gene with protein product		CELA3B_ENST00000473526.1_3'UTR		NM_007352.2	1622,533,48	NM_007352	0.9519					+	Splice_Site		41.7+/-99.0	87.0			Silent	2826474, 2460440				CELA3B-001	2009-05-05				1	+	0.8434				coding-synonymous-near-splice	15945		214/271		C	SO:0001630				protein_coding		2203				0.8027,14.276,5.3684			6501								KNOWN			CCGGCTGCAATGTGAGTCAGC		ELA3B				ENST00000337107.6:c.642+1T>C	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+		,		1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22310824T>C		272.8+/-271.0			no		12304,698												-8.8					0.6	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.992			8527,69		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5852,600,49					CCDS219.1	T		CC,CT,TT	M18692		90		2504		rs1803531		661				"""elastase 3B, pancreatic"""					214	CBPP		8	NM_007352		6			ENST00000337107.6		19347		uc001bfk.3			23436	dbSNP_89	642			p.N214N		0				95.0		0.602	1:g.22310824T>C		protein_coding			basic|appris_principal|CCDS		4230,67,1			3777,629			C|||			5008		CEL3B_HUMAN	4473	chymotrypsin-like elastase family, member 3B			0.893171		22310824			0.755	SNP		CCDS219.1			,,,	False	22310824		3.4.21.70		splice_region_variant		Approved		90.0		c.642T>C	2009-05-05	OTTHUMT00000007797.1	P08861	0.9625		CELA3B	22310824					CELA3B	NM_007352.2	protein-coding gene	NP_031378.1		
		C	ENSG00000219073	ENST00000337107.6		23436		ENSG00000219073		4300					,				c.(778-780)atT>atC	OTTHUMG00000002758		byFrequency	P08861	gene with protein product		CELA3B_ENST00000473526.1_3'UTR		NM_007352.2	1439,677,87	NM_007352	0.9591					+	Silent		46.7+/-105.8	37.0				2826474, 2460440				CELA3B-001	2009-05-05				1	+	0.792				coding-synonymous	15945		260/271		C	SO:0001819				protein_coding		2203				0.9302,19.3146,7.1582			6503								KNOWN			CCGCCTTCATTGACTGGATTG		ELA3B				ENST00000337107.6:c.780T>C	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				breast(2)|kidney(2)|large_intestine(1)|lung(1)|ovary(1)|urinary_tract(1)		+		,		1p36.12	B2RE44|P11423|Q5VU28|Q5VU29|Q5VU30	"""proteinase E"", ""elastase 1"", ""cholesterol-binding pancreatic protease"", ""pancreatic endopeptidase E"""	g.chr1:22313161T>C		330.4+/-301.5			no		12075,931												0.3					0.3	peptidase activity (GO:0008233)|serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.992			8520,80		cholesterol metabolic process (GO:0008203)|proteolysis (GO:0006508)	5660,755,88					CCDS219.1	T		CC,CT,TT	M18692		39		2504		rs1803530		799				"""elastase 3B, pancreatic"""					260	CBPP		8	NM_007352		7			ENST00000337107.6		12954		uc001bfk.3			23436	dbSNP_89	780			p.I260I		0				42.0		0.602	1:g.22313161T>C		protein_coding			basic|appris_principal|CCDS		4221,78,1			3555,851			C|||			5008		CEL3B_HUMAN	4411	chymotrypsin-like elastase family, member 3B			0.880791		22313161			0.7629	SNP		CCDS219.1			,,,	False	22313161		3.4.21.70		synonymous_variant		Approved		39.0		c.780T>C	2009-05-05	OTTHUMT00000007797.1	P08861	0.9496		CELA3B	22313161					CELA3B	NM_007352.2	protein-coding gene	NP_031378.1		
		G	ENSG00000142789	ENST00000290122.3	0.80722	10136	N	ENSG00000142789	0.20781	4300	0.000000	0.17528	B		,	T	0.0	0	c.(721-723)gCc>gGc	OTTHUMG00000002755	0.216000	byFrequency	P09093	gene with protein product				NM_005747.4	1876,295,26	NM_005747	0.953			G	0.007	+	Missense_Mutation	2	89.9+/-152.1	71.0	P09093	0.921029		2826474, 2460440			0.004	CELA3A-001	2009-05-05		0.09377		1	+	0.9047		0.59	0.011000	missense	15944	329	241/271		G	SO:0001583			0.9088397790055248	protein_coding		2197	P		0.000000	2.4302,7.8971,4.2789	B		6497		0.0:0.4438:0.5562:0.0						KNOWN	ENST00000290122;ENST00000400271		TTTGTTTCTGCCTTTGGCTGC	T;T	ELA3A				ENST00000290122.3:c.722C>G	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.	ENSG00000142789	0.07208	CELA3A	endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(8)|upper_aerodigestive_tract(1)|urinary_tract(1)	ENSP00000290122:p.Ala241Gly	+	0.05858	,	GCC	1p36.12	B1AQ53|Q9BRW4	"""protease E"""	g.chr1:22336277C>G	A -> G (in dbSNP:rs3820285). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2460440, ECO:0000269|PubMed:2826474}.	180.1+/-208.5		459	yes		12438,556	0.03702	0.00475	3.65	0.00012	ENSP00000290122:A241G			.		-1.8593		1.7	0.24356	405	0.13470	0.708041958041958	0.0	serine-type endopeptidase activity (GO:0004252)	0.155	2009-05-05		hg19	Standard	0.9771	0.9329268292682927	11.3991	8391,209		cholesterol metabolic process (GO:0008203)|digestion (GO:0007586)|proteolysis (GO:0006508)	5972,494,31	-1.949341				CCDS220.1	C	0.02656	GG,GC,CC	D00306		75	0.11673	2504	1.71	rs3820285		741	241	744		"""elastase 3A, pancreatic (protease E)"", ""elastase 3A, pancreatic"""	0.49860	22208864	+	GLY/ALA	241	ELA3	1937	18	NM_005747	0.0	7	0.9815303430079155	-0.371000	ENST00000290122.3		14755					10136	dbSNP_107	722	0.0000		p.A241G	Peptidase cysteine/serine, trypsin-like (1);Peptidase S1/S6, chymotrypsin/Hap (3);	0		T		82.0	rs3820285;rs17856156;rs17856197;rs17856248;rs17856480;rs58781531;rs3820285	0.612	1:g.22336277C>G	ENSP00000290122:A241G;ENSP00000383130:A49G	protein_coding	.		basic|appris_principal|CCDS		4096,199,5		241;49	4047,347	0.8869047619047619	G	c|||		.	5008		CEL3A_HUMAN	4486	chymotrypsin-like elastase family, member 3A		CEL3A_HUMAN	0.895767	0.10085	22336277		-0.157000	0.7431	SNP		CCDS220.1		.	,,,	False	22336277	-0.9938		8	missense	T	Approved	0.975698	75.0		c.722C>G	2009-05-05	OTTHUMT00000007791.1	P09093	0.902	2.27;2.27	CELA3A	22336277	0.07611		0.31586	60	CELA3A	NM_005747.4	protein-coding gene	NP_005738.4	A	
		T	ENSG00000142789	ENST00000290122.3		10136		ENSG00000142789		4300					,				c.(748-750)ccC>ccT	OTTHUMG00000002755		byFrequency	P09093	gene with protein product				NM_005747.4	191,766,1246	NM_005747	0.2219					+	Silent			69.0				2826474, 2460440				CELA3A-001	2009-05-05				1	+	0.2315				coding-synonymous	15944		250/271		T	SO:0001819				protein_coding		2203				22.7907,26.0554,23.8967			6503								KNOWN			TCTGGAAGCCCACGGTGTTCA		ELA3A				ENST00000290122.3:c.750C>T	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(8)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		1p36.12	B1AQ53|Q9BRW4	"""protease E"""	g.chr1:22336305C>T					no		3108,9898												0.6					1.0	serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.2207			1960,6640		cholesterol metabolic process (GO:0008203)|digestion (GO:0007586)|proteolysis (GO:0006508)	441,2226,3836					CCDS220.1	C		TT,TC,CC	D00306		72		2504		rs9187		769				"""elastase 3A, pancreatic (protease E)"", ""elastase 3A, pancreatic"""					250	ELA3		18	NM_005747		7			ENST00000290122.3		16390					10136	dbSNP_52	750			p.P250P		0				77.0		0.607	1:g.22336305C>T		protein_coding			basic|appris_principal|CCDS		250,1460,2590			1148,3258			c|||			5008		CEL3A_HUMAN	1435	chymotrypsin-like elastase family, member 3A			0.286542		22336305			0.4018	SNP		CCDS220.1			,,,	False	22336305				synonymous_variant		Approved		72.0		c.750C>T	2009-05-05	OTTHUMT00000007791.1	P09093	0.4107		CELA3A	22336305					CELA3A	NM_005747.4	protein-coding gene	NP_005738.4		
		A	ENSG00000142789	ENST00000290122.3		10136		ENSG00000142789		4300					,				c.(751-753)acG>acA	OTTHUMG00000002755		byFrequency	P09093	gene with protein product				NM_005747.4	180,780,1243	NM_005747	0.2219					+	Silent		311.3+/-310.3	68.0				2826474, 2460440				CELA3A-001	2009-05-05				1	+	0.2307				coding-synonymous	15944		251/271		G	SO:0001819				protein_coding		2203				22.5465,25.8738,23.6737			6503								KNOWN			GGAAGCCCACGGTGTTCACTC		ELA3A				ENST00000290122.3:c.753G>A	1	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.				endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(8)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		1p36.12	B1AQ53|Q9BRW4	"""protease E"""	g.chr1:22336308G>A		383.0+/-324.7			no		3079,9927												-7.3					0.5	serine-type endopeptidase activity (GO:0004252)		2009-05-05		hg19	Standard	0.2207			1939,6661		cholesterol metabolic process (GO:0008203)|digestion (GO:0007586)|proteolysis (GO:0006508)	412,2255,3836					CCDS220.1	G		AA,AG,GG	D00306		70		2504		rs12908		772				"""elastase 3A, pancreatic (protease E)"", ""elastase 3A, pancreatic"""					251	ELA3		18	NM_005747		7			ENST00000290122.3		16710					10136	dbSNP_52	753			p.T251T		0				74.0		0.607	1:g.22336308G>A		protein_coding			basic|appris_principal|CCDS		232,1475,2593			1140,3266			G|||			5008		CEL3A_HUMAN	1430	chymotrypsin-like elastase family, member 3A			0.285543		22336308			0.3998	SNP		CCDS220.1			,,,	False	22336308				synonymous_variant		Approved		70.0		c.753G>A	2009-05-05	OTTHUMT00000007791.1	P09093	0.4078		CELA3A	22336308					CELA3A	NM_005747.4	protein-coding gene	NP_005738.4		
		T	ENSG00000184677	ENST00000375647.4		9923		ENSG00000184677		4300					,					OTTHUMG00000002897		byFrequency	Q9NUA8	gene with protein product		ZBTB40_ENST00000404138.1_Intron|ZBTB40_ENST00000374651.4_Intron		NM_014870.3	1734,435,34	NM_014870	0.6943					+	Intron		487.3+/-372.1	52.0								ZBTB40-001					1	+	0.9357				intron,intron	29045		,	Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	T	SO:0001627	612106	,		protein_coding		2203				38.3605,11.4163,29.2327		"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;2.86e-26)|Colorectal(126;8.55e-08)|COAD - Colon adenocarcinoma(152;4.1e-06)|GBM - Glioblastoma multiforme(114;1.39e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000712)|KIRC - Kidney renal clear cell carcinoma(1967;0.00374)|STAD - Stomach adenocarcinoma(196;0.00645)|READ - Rectum adenocarcinoma(331;0.0693)|Lung(427;0.216)			KNOWN			AGGTATTAGTAAATTGTTGAC						ENST00000375647.4:c.1360+9A>T	1					endometrium(4)|kidney(4)|large_intestine(6)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)		+		,		1p36	O75066|Q5TFU5|Q8N1R1		g.chr1:22832743A>T		212.2+/-232.1			no		9204,3802												4.4					1.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.6272			5301,3299		bone mineralization (GO:0030282)|cellular response to DNA damage stimulus (GO:0006974)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	3375,2454,674					CCDS224.1	A		TT,TA,AA	AB007947	nucleus (GO:0005634)	49		2504		rs209732		1567								,		KIAA0478, ZNF923		26	NM_014870		6			ENST00000375647.4		20585		uc001bfu.2			9923	dbSNP_79	,					0				45.0		0.448	1:g.22832743A>T		protein_coding			basic|appris_principal|CCDS		1641,2019,640			3903,503			T|||			5008		ZBT40_HUMAN	4002	zinc finger and BTB domain containing 40			0.799121		22832743			0.8929	SNP		CCDS224.1			,,,	False	22832743				intron_variant		Approved		49.0			2013-01-08	OTTHUMT00000008094.1	Q9NUA8	0.7997		ZBTB40	22832743				,	ZBTB40	NM_001083621.1,NM_014870.3	protein-coding gene	NP_055685.3		
		G	ENSG00000184677	ENST00000375647.4	0.80722	9923	N	ENSG00000184677	0.08476	4300	0.000000	0.40476	B;B		,	T	0.0	0	c.(1783-1785)tAc>tGc	OTTHUMG00000002897	-0.333000	byFrequency	Q9NUA8	gene with protein product		ZBTB40_ENST00000404138.1_Missense_Mutation_p.Y595C|ZBTB40_ENST00000374651.4_Missense_Mutation_p.Y483C		NM_014870.3	1808,367,28	NM_014870	0.6861			G	9.371	+	Missense_Mutation	2	401.6+/-347.2	134.0	F8WAI8;Q9NUA8	0.903995					0.0;0.0	ZBTB40-001			0.01281		1	+	0.9395		0.24	0.001000	missense,missense	29045	298	595/1240,595/1240	Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583	612106	benign,benign	0.8232044198895028	protein_coding		2203	P		0.005000	28.0814,9.6005,21.8207	B;B	"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6503		0.2256:0.0705:0.3909:0.313			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;2.86e-26)|Colorectal(126;8.55e-08)|COAD - Colon adenocarcinoma(152;4.1e-06)|GBM - Glioblastoma multiforme(114;1.39e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000712)|KIRC - Kidney renal clear cell carcinoma(1967;0.00374)|STAD - Stomach adenocarcinoma(196;0.00645)|READ - Rectum adenocarcinoma(331;0.0693)|Lung(427;0.216)			KNOWN	ENST00000404138;ENST00000375647;ENST00000374651		AAGATTGAGTACAAGCTCTTT	T;T;T					ENST00000375647.4:c.1784A>G	1		ENSG00000184677	0.02270	ZBTB40	endometrium(4)|kidney(4)|large_intestine(6)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000364798:p.Tyr595Cys	+	0.15991	,	TAC	1p36	O75066|Q5TFU5|Q8N1R1		g.chr1:22835677A>G	Y -> C (in dbSNP:rs209729). {ECO:0000269|PubMed:9455484}.	204.8+/-226.9		460	yes		10168,2838	0.03702	0.20147	5.95	0.00012	ENSP00000363782:Y483C			0.10496		0.3201		0.9	0.19424	520	0.33141	0.9090909090909091	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-0.345			hg19	Standard	0.7167	0.9349593495934959	2.8661	6185,2415		bone mineralization (GO:0030282)|cellular response to DNA damage stimulus (GO:0006974)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	4039,2090,374	1.070475				CCDS224.1	A	0.02656	GG,GA,AA	AB007947	nucleus (GO:0005634)	134	0.03608	2504	0.925	rs209729		1991	483;595	553			0.05602	22708264	+	CYS/TYR,CYS/TYR	595	KIAA0478, ZNF923	1831	26	NM_014870	0.0;0.0	9	0.7295514511873351	-1.068000	ENST00000375647.4		17714		uc001bfu.2			9923	dbSNP_79	1784,1784	0.0000		p.Y595C	.	0		T		134.0	rs209729;rs535560;rs17277764;rs52789802;rs61611872;rs209729	0.473	1:g.22835677A>G	ENSP00000384527:Y595C;ENSP00000364798:Y595C;ENSP00000363782:Y483C	protein_coding	0.667812		basic|appris_principal|CCDS		2231,1723,346		595;595;483	3983,423	0.8383699633699634	C	G|||		0.817059	5008		ZBT40_HUMAN	4119	zinc finger and BTB domain containing 40		.;ZBT40_HUMAN	0.822484	0.17719	22835677		0.223000	0.8929	SNP		CCDS224.1		N	,,,	False	22835677	-1.0501		9	missense	T	Approved	0.719186	134.0		c.1784A>G	2013-01-08	OTTHUMT00000008094.1	Q9NUA8	0.8429	1.03;1.03;1.03	ZBTB40	22835677	0.01503		0.13656	194,194	ZBTB40	NM_001083621.1,NM_014870.3	protein-coding gene	NP_055685.3	Y	
		T	ENSG00000184677	ENST00000375647.4		9923		ENSG00000184677		4300					,					OTTHUMG00000002897		byFrequency	Q9NUA8	gene with protein product		ZBTB40_ENST00000404138.1_Intron|ZBTB40_ENST00000374651.4_Intron		NM_014870.3	1080,917,206	NM_014870	0.2658					+	Intron		461.7+/-365.5	39.0								ZBTB40-001					1	+	0.7632				intron,intron	29045		,	Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	612106	,		protein_coding		2203				34.7907,30.1634,46.6631		"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;2.86e-26)|Colorectal(126;8.55e-08)|COAD - Colon adenocarcinoma(152;4.1e-06)|GBM - Glioblastoma multiforme(114;1.39e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000712)|KIRC - Kidney renal clear cell carcinoma(1967;0.00374)|STAD - Stomach adenocarcinoma(196;0.00645)|READ - Rectum adenocarcinoma(331;0.0693)|Lung(427;0.216)			KNOWN			TGGTAAGGAACGGGCCAGGTG						ENST00000375647.4:c.2002+9C>T	1					endometrium(4)|kidney(4)|large_intestine(6)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)		+		,		1p36	O75066|Q5TFU5|Q8N1R1		g.chr1:22837849C>T		692.9+/-405.6			no		6069,6937												-2.3					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.3231			2992,5608		bone mineralization (GO:0030282)|cellular response to DNA damage stimulus (GO:0006974)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	1582,2905,2016					CCDS224.1	C		TT,TC,CC	AB007947	nucleus (GO:0005634)	39		2504		rs209727		2209								,		KIAA0478, ZNF923		26	NM_014870		10			ENST00000375647.4		19346		uc001bfu.2			9923	dbSNP_79	,					0				38.0		0.478	1:g.22837849C>T		protein_coding			basic|appris_principal|CCDS		502,1988,1810			3077,1329			C|||			5008		ZBT40_HUMAN	2422	zinc finger and BTB domain containing 40			0.483626		22837849			0.3978	SNP		CCDS224.1			,,,	False	22837849				intron_variant		Approved		39.0			2013-01-08	OTTHUMT00000008094.1	Q9NUA8	0.6153		ZBTB40	22837849				,	ZBTB40	NM_001083621.1,NM_014870.3	protein-coding gene	NP_055685.3		
		A	ENSG00000184677	ENST00000375647.4	0.53005	9923	N	ENSG00000184677	0.39654	4300	1.000000	0.04917	B;B		,	T	3.900000000001125E-5	0	c.(2989-2991)Gtg>Atg	OTTHUMG00000002897	1.023000	byFrequency	Q9NUA8	gene with protein product		ZBTB40_ENST00000404138.1_Missense_Mutation_p.V997M|ZBTB40_ENST00000374651.4_Missense_Mutation_p.V885M		NM_014870.3	2198,5,0	NM_014870	1.0			A	6.919	+	Missense_Mutation	1	29.6+/-80.5	78.0	F8WAI8;Q9NUA8	0.998865					0.0;0.001	ZBTB40-001			0.04013		1	+	1.0		0.3	0.962000	missense,missense	29045	361	997/1240,997/1240	Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	A	SO:0001583	612106	benign,benign	0.9972375690607734	protein_coding		2203	P		1.000000	0.5349,0.1135,0.3921	B;B	"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6503		0.8466:0.0:0.1534:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;2.86e-26)|Colorectal(126;8.55e-08)|COAD - Colon adenocarcinoma(152;4.1e-06)|GBM - Glioblastoma multiforme(114;1.39e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000712)|KIRC - Kidney renal clear cell carcinoma(1967;0.00374)|STAD - Stomach adenocarcinoma(196;0.00645)|READ - Rectum adenocarcinoma(331;0.0693)|Lung(427;0.216)			KNOWN	ENST00000404138;ENST00000375647;ENST00000374651		GGAGCGGCACGTGGTGACCCA	T;T;T					ENST00000375647.4:c.2989G>A	1		ENSG00000184677	0.07541	ZBTB40	endometrium(4)|kidney(4)|large_intestine(6)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000364798:p.Val997Met	+	0.71417	,	GTG	1p36	O75066|Q5TFU5|Q8N1R1		g.chr1:22846709G>A	V -> M (in dbSNP:rs209720). {ECO:0000269|PubMed:9455484}.	9.9+/-24.2		491	yes		12955,51	0.80357	0.13250	5.79	0.00012	ENSP00000363782:V885M			0.64402		-19.4659		5.8	0.91817	572	0.28530	1.0	1.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-0.105			hg19	Standard	0.994	0.9979674796747967	8.2823	8554,46		bone mineralization (GO:0030282)|cellular response to DNA damage stimulus (GO:0006974)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	6452,51,0	0.539123				CCDS224.1	G	0.06786	AA,AG,GG	AB007947	nucleus (GO:0005634)	85	0.05158	2504	5.79	rs209720		3196	885;997	753			0.31908	22719296	+	MET/VAL,MET/VAL	997	KIAA0478, ZNF923	2177	26	NM_014870	0.001;0.001	14	0.9934036939313984	-0.361000	ENST00000375647.4		21334		uc001bfu.2			9923	dbSNP_79	2989,2989	0.0000		p.V997M	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	0		T		99.0	rs209720;rs575900;rs58446511;rs209720	0.622	1:g.22846709G>A	ENSP00000384527:V997M;ENSP00000364798:V997M;ENSP00000363782:V885M	protein_coding	0.000003		basic|appris_principal|CCDS		4254,46,0		997;997;885	4401,5	0.9967948717948718	M	A|||		0.000000	5008		ZBT40_HUMAN	5000	zinc finger and BTB domain containing 40		.;ZBT40_HUMAN	0.998403	0.43620	22846709		2.300000	1.0	SNP		CCDS224.1		N	,,,	False	22846709	-0.9439		9	missense	T	Approved	0.994651	85.0		c.2989G>A	2013-01-08	OTTHUMT00000008094.1	Q9NUA8	0.9971	3.53;3.53;3.53	ZBTB40	22846709	0.63368		0.42649	21,21	ZBTB40	NM_001083621.1,NM_014870.3	protein-coding gene	NP_055685.3	V	
		C	ENSG00000184677	ENST00000375647.4	0.33714	9923	L	ENSG00000184677	0.31325	4300	1.000000	0.09538	P;P		,	T	0.616155	2	c.(3709-3711)gaG>gaC	OTTHUMG00000002897	0.678000	byFrequency	Q9NUA8	gene with protein product		ZBTB40_ENST00000404138.1_Missense_Mutation_p.E1237D|ZBTB40_ENST00000374651.4_Missense_Mutation_p.E1125D		NM_014870.3	0,31,2172	NM_014870	0.0818			G	15.08	+	Missense_Mutation	3	110.2+/-170.6	118.0	F8WAI8;Q9NUA8	0.007036					0.507;0.31	ZBTB40-001			0.46208		1	+	0.0015		0.12	0.986000	missense,missense	29045	11	1237/1240,1237/1240	Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	G	SO:0001583	612106	benign,benign	0.03038674033149171	protein_coding		2203	D		1.000000	3.5349,0.7036,2.5757	P;B	"""-"", ""Zinc fingers, C2H2-type"", ""BTB/POZ domain containing"""	6503		0.2788:0.0:0.7212:0.0			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;2.86e-26)|Colorectal(126;8.55e-08)|COAD - Colon adenocarcinoma(152;4.1e-06)|GBM - Glioblastoma multiforme(114;1.39e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000712)|KIRC - Kidney renal clear cell carcinoma(1967;0.00374)|STAD - Stomach adenocarcinoma(196;0.00645)|READ - Rectum adenocarcinoma(331;0.0693)|Lung(427;0.216)			KNOWN	ENST00000404138;ENST00000375647;ENST00000374651		TCTGTGGTGAGGCCAAATGAG	T;T;T					ENST00000375647.4:c.3711G>C	1		ENSG00000184677	0.94253	ZBTB40	endometrium(4)|kidney(4)|large_intestine(6)|lung(8)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000364798:p.Glu1237Asp	+	0.71417	,	GAG	1p36	O75066|Q5TFU5|Q8N1R1		g.chr1:22852880G>C		36.8+/-68.6		2	yes		335,12671	0.80357	0.48833	5.7	0.02156	ENSP00000363782:E1125D			0.56097		-26.467		3.7	0.42951	0	0.45353	0.0	1.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	0.975			hg19	Standard	0.0368	0.0040650406504065045	7.6071	304,8296		bone mineralization (GO:0030282)|cellular response to DNA damage stimulus (GO:0006974)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	6,323,6174	2.726291				CCDS224.1	G	0.46784	CC,CG,GG	AB007947	nucleus (GO:0005634)	122	0.32530	2504	3.74	rs45502998		3918	1125;1237	28			0.28107	22725467	+	ASP/GLU,ASP/GLU	1237	KIAA0478, ZNF923	41	26	NM_014870	0.884;0.816	18	0.036939313984168866	0.655000	ENST00000375647.4		20073		uc001bfu.2			9923	dbSNP_127	3711,3711	0.0067		p.E1237D	.	0		T		131.0	rs45502998;rs61741571	0.597	1:g.22852880G>C	ENSP00000384527:E1237D;ENSP00000364798:E1237D;ENSP00000363782:E1125D	protein_coding	0.000030		basic|appris_principal|CCDS		6,292,4002		1237;1237;1125	31,4375	0.018772893772893772	D	G|||		0.000000	5008		ZBT40_HUMAN	132	zinc finger and BTB domain containing 40		.;ZBT40_HUMAN	0.0263578	0.37313	22852880		1.652000	0.0	SNP		CCDS224.1		D	,,,	False	22852880	-1.0311		10	missense	T	Approved	0.035349	122.0		c.3711G>C	2013-01-08	OTTHUMT00000008094.1	Q9NUA8	0.0187	2.97;2.97;2.99	ZBTB40	22852880	0.74619		0.19257	45,45	ZBTB40	NM_001083621.1,NM_014870.3	protein-coding gene	NP_055685.3	E	
		C	ENSG00000070886	ENST00000166244.3	0.80722	2046	.	ENSG00000070886	0.06366	4300	0.000000	0.01335	B		,	.	0.0	0		OTTHUMG00000002892	-0.528000	byFrequency	P29322	gene with protein product		EPHA8_ENST00000538803.1_Missense_Mutation_p.S457P|EPHA8_ENST00000374644.4_Missense_Mutation_p.S457P		NM_020526.3	938,1008,256	NM_020526	0.5491			C	7.448	+	Intron	1	632.9+/-398.7	36.0	P29322-2	0.654859		1648701			0.0	EPHA8-001	2004-10-28		0.01281		1	+	0.7126		.	0.029000	missense,intron	3391	141	457/496,	Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)	C	SO:0001627	176945	,	0.38950276243093923	protein_coding		2202	P		0.001000	35.6628,34.5141,45.7628	B	"""EPH receptors"", ""Sterile alpha motif (SAM) domain containing"", ""Fibronectin type III domain containing"""	6502		0.0:0.3927:0.2509:0.3564			UCEC - Uterine corpus endometrioid carcinoma (279;0.0227)|OV - Ovarian serous cystadenocarcinoma(117;7.29e-27)|Colorectal(126;1.61e-07)|COAD - Colon adenocarcinoma(152;1.14e-05)|GBM - Glioblastoma multiforme(114;1.74e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000554)|KIRC - Kidney renal clear cell carcinoma(1967;0.00272)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.199)			KNOWN	ENST00000374644;ENST00000538803		TTCCCCTGCCTCAGACCCATC	T;T	EEK				ENST00000166244.3:c.1315+54T>C	1		ENSG00000070886	0.02607	EPHA8	breast(3)|central_nervous_system(5)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|kidney(9)|large_intestine(6)|lung(22)|prostate(2)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)		+	0.12720	,	TCA	1p36.12	Q6IN80|Q8IUX6|Q9NUA9|Q9P269		g.chr1:22915753T>C		454.2+/-350.6		338	yes		5951,7053	0.03702	0.14451	1.67	0.00012	.			.		.		-0.5	0.12030	167	.	0.291958041958042	0.0	ATP binding (GO:0005524)|GPI-linked ephrin receptor activity (GO:0005004)	.			hg19	Standard	0.3777	0.6869918699186992	2.7548	3067,5533		axon guidance (GO:0007411)|cell adhesion (GO:0007155)|ephrin receptor signaling pathway (GO:0048013)|neuron projection development (GO:0031175)|neuron remodeling (GO:0016322)|positive regulation of MAPK cascade (GO:0043410)|positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)|protein autophosphorylation (GO:0046777)|regulation of cell adhesion (GO:0030155)|regulation of cell adhesion mediated by integrin (GO:0033628)|substrate-dependent cell migration (GO:0006929)	1474,3003,2025	0.641996				CCDS225.1, CCDS30626.1	T	0.02656	CC,CT,TT	BC038796	endosome (GO:0005768)|integral component of plasma membrane (GO:0005887)|neuron projection (GO:0043005)	36	.	2504	-0.495	rs606002		1387	457	285		"""EphA8"""	0.05290	22788340	+	PRO/SER,		Hek3	931	61	NM_001006943	0.0	5	0.3759894459102902	-0.971000	ENST00000166244.3		17459		uc001bfx.1			2046	dbSNP_83	1369,	0.0000			.	0		T		34.0	rs606002;rs61099646;rs606002	0.672	1:g.22915753T>C	ENSP00000363775:S457P;ENSP00000440274:S457P	protein_coding	.		basic|appris_principal|CCDS		536,1995,1769		457	2884,1520	0.42628205128205127	P	C|||		.	5008		EPHA8_HUMAN	2413	EPH receptor A8		.	0.481829	0.03720	22915753		-0.993000	0.2907	SNP		CCDS225.1		.	,,,	False	22915753	-1.1090	2.7.10.1	6	intron_variant	T	Approved	0.356628	36.0			2013-02-11	OTTHUMT00000008085.1	P29322	0.3761	5.0;5.0	EPHA8	22915753	0.11900		0.02950	74,	EPHA8	NM_001006943.1,NM_020526.3	protein-coding gene	NP_065387.1	S	
		T	ENSG00000173372	ENST00000374642.3	0.09310|0.09310	712	N|N	ENSG00000173372	0.06953|0.06953	4300	0.000000|0.000000	0.21361|.	B|.			T|D	1|1	2|0	c.(424-426)gaA>gaT	OTTHUMG00000002893	-0.465000|-0.465000		P02745	gene with protein product		C1QA_ENST00000402322.1_Missense_Mutation_p.E142D	Abciximab(DB00054)|Adalimumab(DB00051)|Alefacept(DB00092)|Alemtuzumab(DB00087)|Basiliximab(DB00074)|Bevacizumab(DB00112)|Cetuximab(DB00002)|Daclizumab(DB00111)|Efalizumab(DB00095)|Etanercept(DB00005)|Gemtuzumab ozogamicin(DB00056)|Ibritumomab(DB00078)|Muromonab(DB00075)|Natalizumab(DB00108)|Palivizumab(DB00110)|Rituximab(DB00073)|Tositumomab(DB00081)|Trastuzumab(DB00072)	NM_015991.2		NM_015991				A|A	0.248|0.248	+	Missense_Mutation	3|2		71.0	P02745|.	.|.		1537612			0.0|.	C1QA-001	2006-02-09		0.01281|.		1	+			0.75|0.02	0.003000|0.003000		1241	.|.		Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00262)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)		SO:0001583	120550		.|.	protein_coding		2203	N|N		0.000000|0.000000		B|.	"""Complement system"""	6503		0.1153:0.3797:0.3669:0.1381|0.1153:0.3797:0.3669:0.1381			UCEC - Uterine corpus endometrioid carcinoma (279;0.0227)|OV - Ovarian serous cystadenocarcinoma(117;6.41e-27)|Colorectal(126;1.52e-07)|COAD - Colon adenocarcinoma(152;1.12e-05)|GBM - Glioblastoma multiforme(114;1.63e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000541)|KIRC - Kidney renal clear cell carcinoma(1967;0.00269)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.197)			KNOWN	ENST00000374642;ENST00000438241;ENST00000402322|ENST00000339353		ACCAGGAAGAACCGTACCAGA	T;T;T|.					ENST00000374642.3:c.426A>T	1	C1q. {ECO:0000255|PROSITE- ProRule:PRU00368}.	ENSG00000173372|ENSG00000173372	0.01453|0.01453	C1QA|C1QA	autonomic_ganglia(1)|liver(1)|lung(3)|skin(1)	ENSP00000363773:p.Glu142Asp	+	0.05858|0.05858		GAA|AAC	1p36.3-p34.1	B2R4X2|Q5T963		g.chr1:22965588A>T				.|.				0.03702|0.03702	0.02112|0.02112	5.67|5.67	0.18087|0.18087	ENSP00000363773:E142D|ENSP00000341271:N137I			.|0.05568		2.2267|2.2267			0.09936|0.09936	.|.	0.08837|0.66056	.|.			-0.175|-0.175			hg19	Standard		.|.	4.2133|4.2133			cell-cell signaling (GO:0007267)|complement activation (GO:0006956)|complement activation, classical pathway (GO:0006958)|innate immune response (GO:0045087)		-1.008593|-1.008593				CCDS226.1	A	0.02656|.		AF135157	collagen trimer (GO:0005581)|complement component C1 complex (GO:0005602)|extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)		0.04724|0.04724		-1.08|-1.08			630	142|.	.|.		"""complement component 1, q subcomponent, alpha polypeptide"""	0.10522|0.10522	22838175|22838175	+|+		142		.|.	6	NM_015991	0.0|.	3	.|.	-1.262000|-1.262000	ENST00000374642.3				uc001bfy.3			712			0.0434|0.0434		p.E142D	Tumour necrosis factor-like (2);Complement C1q protein (4);|.	0		T|T		81.0	.|.	0.597	1:g.22965588A>T	ENSP00000363773:E142D;ENSP00000416841:E142D;ENSP00000385564:E142D|.	protein_coding	.|0.570585		basic|appris_principal|CCDS				142|137		.|.	D|I			.|1.295150			C1QA_HUMAN		complement component 1, q subcomponent, A chain		C1QA_HUMAN|.		0.10692|0.10692	22965588		-0.118000|-0.118000		SNP		CCDS226.1		.|N			22965588	-1.0177|-1.0177		9|7	missense	T|T	Approved	.|.	75.0		c.426A>T	2014-09-17	OTTHUMT00000008087.2	P02745		2.01;2.01;2.01|.	C1QA	22965588	0.03518|0.03518		0.23833|0.23833				protein-coding gene	NP_057075.1	E|N	
		C	ENSG00000133216	ENST00000400191.3		2048		ENSG00000133216		4300					,				c.(1543-1545)ggT>ggC	OTTHUMG00000002881		byFrequency	P29323	gene with protein product		EPHB2_ENST00000374632.3_Silent_p.G515G|EPHB2_ENST00000374630.3_Silent_p.G515G|EPHB2_ENST00000374627.1_Silent_p.G510G|EPHB2_ENST00000465676.1_3'UTR		NM_004442.6|NM_017449.3	2193,10,0	NM_017449	1.0					+	Silent		39.3+/-95.6	67.0				1648701				EPHB2-001	2004-10-28				1	+	0.9992				coding-synonymous,coding-synonymous	3393		515/988,515/987	Colorectal(325;3.46e-05)|Lung NSC(340;3.7e-05)|all_lung(284;5.45e-05)|Renal(390;0.000228)|Breast(348;0.0027)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0258)	C	SO:0001819	600997	,		protein_coding		2203				0.7674,0.227,0.5843		"""EPH receptors"", ""Sterile alpha motif (SAM) domain containing"", ""Fibronectin type III domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0348)|OV - Ovarian serous cystadenocarcinoma(117;3.67e-26)|Colorectal(126;3.23e-08)|COAD - Colon adenocarcinoma(152;9.32e-07)|GBM - Glioblastoma multiforme(114;2.93e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000606)|KIRC - Kidney renal clear cell carcinoma(1967;0.00371)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.126)|Lung(427;0.153)			KNOWN			CCGTGGCAGGTTACGGGCGCT		DRT, ERK, EPHT3				ENST00000400191.3:c.1545T>C	1	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.				NS(1)|breast(1)|endometrium(6)|kidney(2)|large_intestine(10)|lung(17)|ovary(4)|pancreas(2)|prostate(3)|skin(8)|stomach(1)|urinary_tract(1)		+		,		1p36.1-p35	O43477|Q5T0U6|Q5T0U7|Q5T0U8		g.chr1:23219493T>C		15.5+/-35.6			no		12930,76												5.2					1.0	ATP binding (GO:0005524)|axon guidance receptor activity (GO:0008046)|protein tyrosine kinase activity (GO:0004713)|transmembrane-ephrin receptor activity (GO:0005005)				hg19	Standard	0.995			8534,66		angiogenesis (GO:0001525)|axon guidance (GO:0007411)|axonal fasciculation (GO:0007413)|camera-type eye morphogenesis (GO:0048593)|central nervous system projection neuron axonogenesis (GO:0021952)|commissural neuron axon guidance (GO:0071679)|corpus callosum development (GO:0022038)|dendritic spine development (GO:0060996)|dendritic spine morphogenesis (GO:0060997)|ephrin receptor signaling pathway (GO:0048013)|inner ear morphogenesis (GO:0042472)|learning (GO:0007612)|negative regulation of axonogenesis (GO:0050771)|nervous system development (GO:0007399)|optic nerve morphogenesis (GO:0021631)|palate development (GO:0060021)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphorylation (GO:0016310)|positive regulation of long-term neuronal synaptic plasticity (GO:0048170)|positive regulation of synapse assembly (GO:0051965)|regulation of body fluid levels (GO:0050878)|retinal ganglion cell axon guidance (GO:0031290)|urogenital system development (GO:0001655)	6427,76,0					CCDS229.2, CCDS230.1	T		CC,CT,TT	AF025304	axon (GO:0030424)|dendrite (GO:0030425)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)	67		2504		rs309472		1563				"""EphB2"""				,	515	Hek5, Tyro5		56	NM_017449		7			ENST00000400191.3		19594		uc001bge.3			2048	dbSNP_79	1545,1545			p.G515G		0				67.0		0.592	1:g.23219493T>C		protein_coding			basic		4234,66,0			4396,10			C|||			5008		EPHB2_HUMAN	4999	EPH receptor B2			0.998203		23219493			1.0	SNP					,,,	False	23219493		2.7.10.1		synonymous_variant		Approved		67.0		c.1545T>C	2014-09-17	OTTHUMT00000008060.2	P29323	0.9957		EPHB2	23219493				,	EPHB2	NM_004442.6,NM_017449.3	protein-coding gene	NP_004433.2|NP_059145.2		
		G	ENSG00000133216	ENST00000400191.3		2048		ENSG00000133216		4300					,				c.(2623-2625)caA>caG	OTTHUMG00000002881		byFrequency	P29323	gene with protein product		EPHB2_ENST00000374627.1_Silent_p.Q870Q|EPHB2_ENST00000374632.3_Silent_p.Q876Q|EPHB2_ENST00000374630.3_Silent_p.Q875Q		NM_004442.6|NM_017449.3	0,12,2191	NM_017449	0.0					+	Silent		54.4+/-115.2	79.0				1648701				EPHB2-001	2004-10-28				1	+	0.0				coding-synonymous,coding-synonymous	3393		876/988,875/987	Colorectal(325;3.46e-05)|Lung NSC(340;3.7e-05)|all_lung(284;5.45e-05)|Renal(390;0.000228)|Breast(348;0.0027)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0258)	A	SO:0001819	600997	,		protein_coding		2203				1.1395,0.2724,0.8458		"""EPH receptors"", ""Sterile alpha motif (SAM) domain containing"", ""Fibronectin type III domain containing"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0348)|OV - Ovarian serous cystadenocarcinoma(117;3.67e-26)|Colorectal(126;3.23e-08)|COAD - Colon adenocarcinoma(152;9.32e-07)|GBM - Glioblastoma multiforme(114;2.93e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000606)|KIRC - Kidney renal clear cell carcinoma(1967;0.00371)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.126)|Lung(427;0.153)			KNOWN			AGTTCGGCCAAATTGTCAACA		DRT, ERK, EPHT3				ENST00000400191.3:c.2625A>G	1	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.				NS(1)|breast(1)|endometrium(6)|kidney(2)|large_intestine(10)|lung(17)|ovary(4)|pancreas(2)|prostate(3)|skin(8)|stomach(1)|urinary_tract(1)		+		,		1p36.1-p35	O43477|Q5T0U6|Q5T0U7|Q5T0U8		g.chr1:23236997A>G		19.1+/-41.9			no		110,12896												3.5					1.0	ATP binding (GO:0005524)|axon guidance receptor activity (GO:0008046)|protein tyrosine kinase activity (GO:0004713)|transmembrane-ephrin receptor activity (GO:0005005)				hg19	Standard	0.0149			98,8502		angiogenesis (GO:0001525)|axon guidance (GO:0007411)|axonal fasciculation (GO:0007413)|camera-type eye morphogenesis (GO:0048593)|central nervous system projection neuron axonogenesis (GO:0021952)|commissural neuron axon guidance (GO:0071679)|corpus callosum development (GO:0022038)|dendritic spine development (GO:0060996)|dendritic spine morphogenesis (GO:0060997)|ephrin receptor signaling pathway (GO:0048013)|inner ear morphogenesis (GO:0042472)|learning (GO:0007612)|negative regulation of axonogenesis (GO:0050771)|nervous system development (GO:0007399)|optic nerve morphogenesis (GO:0021631)|palate development (GO:0060021)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphorylation (GO:0016310)|positive regulation of long-term neuronal synaptic plasticity (GO:0048170)|positive regulation of synapse assembly (GO:0051965)|regulation of body fluid levels (GO:0050878)|retinal ganglion cell axon guidance (GO:0031290)|urogenital system development (GO:0001655)	0,110,6393					CCDS229.2, CCDS230.1	A		GG,GA,AA	AF025304	axon (GO:0030424)|dendrite (GO:0030425)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)	89		2504		rs55993650		2643				"""EphB2"""				,	875	Hek5, Tyro5		56	NM_017449		14			ENST00000400191.3		19104		uc001bge.3			2048	dbSNP_129	2628,2625			p.Q875Q		0				107.0		0.627	1:g.23236997A>G		protein_coding			basic		0,98,4202			12,4394			A|||			5008		EPHB2_HUMAN	15	EPH receptor B2			0.00299521		23236997			0.0	SNP					,,,	False	23236997		2.7.10.1		synonymous_variant		Approved		89.0		c.2625A>G	2014-09-17	OTTHUMT00000008060.2	P29323	0.0		EPHB2	23236997				,	EPHB2	NM_004442.6,NM_017449.3	protein-coding gene	NP_004433.2|NP_059145.2		
		G	ENSG00000179546	ENST00000374619.1		3352		ENSG00000179546		4300					,				c.(1078-1080)aaT>aaC	OTTHUMG00000003235		byFrequency	P28221	gene with protein product		HTR1D_ENST00000314113.3_Silent_p.N360N	Almotriptan(DB00918)|Amitriptyline(DB00321)|Apomorphine(DB00714)|Aripiprazole(DB01238)|Bromocriptine(DB01200)|Cabergoline(DB00248)|Clozapine(DB00363)|Dihydroergotamine(DB00320)|Eletriptan(DB00216)|Ergoloid mesylate(DB01049)|Ergotamine(DB00696)|Frovatriptan(DB00998)|Ketamine(DB01221)|Lisuride(DB00589)|Loxapine(DB00408)|Naratriptan(DB00952)|Olanzapine(DB00334)|Paliperidone(DB01267)|Pergolide(DB01186)|Pramipexole(DB00413)|Quetiapine(DB01224)|Risperidone(DB00734)|Rizatriptan(DB00953)|Ropinirole(DB00268)|Sumatriptan(DB00669)|Trimipramine(DB00726)|Yohimbine(DB01392)|Ziprasidone(DB00246)|Zolmitriptan(DB00315)	NM_000864.4	74,638,1491	NM_000864	0.364					+	Silent		199.0+/-243.2	67.0				2541503, 1662665				HTR1D-001	2012-02-03				1	-	0.1581				coding-synonymous	5289		360/378	Colorectal(325;0.000147)|Renal(390;0.000734)|Lung NSC(340;0.000779)|all_lung(284;0.00135)|Breast(348;0.0385)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.0561)	A	SO:0001819	182133			protein_coding		2203				10.5,17.8393,12.9863		"""5-HT (serotonin) receptors"", ""GPCR / Class A : 5-HT (serotonin) receptors, GPCR only"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0227)|OV - Ovarian serous cystadenocarcinoma(117;4.69e-27)|Colorectal(126;4.86e-08)|COAD - Colon adenocarcinoma(152;2.86e-06)|GBM - Glioblastoma multiforme(114;0.00012)|BRCA - Breast invasive adenocarcinoma(304;0.000949)|KIRC - Kidney renal clear cell carcinoma(1967;0.00122)|STAD - Stomach adenocarcinoma(196;0.0123)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.083)|LUSC - Lung squamous cell carcinoma(448;0.185)			KNOWN			GAAACTCTTCATTAAACACAG		HTRL				ENST00000374619.1:c.1080T>C	1					NS(1)|large_intestine(3)|lung(3)|prostate(1)|upper_aerodigestive_tract(1)		-		,		1p36.3-p34.3			g.chr1:23519633A>G		311.1+/-291.9			no		1689,11317												-6.8					0.8	serotonin binding (GO:0051378)|serotonin receptor activity (GO:0004993)				hg19	Standard	0.0934			903,7697		adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|intestine smooth muscle contraction (GO:0014827)|regulation of behavior (GO:0050795)|regulation of locomotion (GO:0040012)|response to toxic substance (GO:0009636)|serotonin receptor signaling pathway (GO:0007210)|synaptic transmission (GO:0007268)|vasoconstriction (GO:0042310)	119,1451,4933					CCDS231.1	A		GG,GA,AA	M89955	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	65		2504		rs6300		1589				"""5-hydroxytryptamine (serotonin) receptor 1D"""					360	RDC4, HT1DA, 5-HT1D		9	NM_000864		1			ENST00000374619.1		14943		uc001bgn.3			3352	dbSNP_52	1080			p.N360N		0				62.0		0.463	1:g.23519633A>G		protein_coding			basic|appris_principal|CCDS		45,813,3442			786,3620			A|||			5008		5HT1D_HUMAN	1033	5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled			0.20627		23519633			0.1845	SNP		CCDS231.1			,,,	False	23519633				synonymous_variant		Approved		65.0		c.1080T>C	2012-08-08	OTTHUMT00000008924.1	P28221	0.2709		HTR1D	23519633					HTR1D	NM_000864.4	protein-coding gene	NP_000855.1		
		A	ENSG00000007968	ENST00000361729.2	0.26452	1870	L	ENSG00000007968	0.48983	4300	1.000000	0.85556	D		,	T	0.9755961	2	c.(676-678)caG>caT	OTTHUMG00000003223	1.521000	byFrequency	Q14209	gene with protein product				NM_004091.3	40,484,1679	NM_004091	0.3037			C	14.92	+	Missense_Mutation	3	579.2+/-390.8	101.0	Q14209	0.128007		8246995, 8246996			0.669	E2F2-001			0.51415		1	-	0.062		0.36	0.981000	missense	3114	136	226/438	Colorectal(325;3.46e-05)|Lung NSC(340;4.15e-05)|all_lung(284;6.64e-05)|Renal(390;0.000219)|Breast(348;0.00262)|Ovarian(437;0.00539)|Myeloproliferative disorder(586;0.0255)	C	SO:0001583	600426	probably-damaging	0.3756906077348066	protein_coding		2203	P		0.943000	49.7209,12.8007,37.5827	P		6503		0.0:0.9271:0.0:0.0729			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.52e-24)|Colorectal(126;6.25e-08)|COAD - Colon adenocarcinoma(152;3.42e-06)|GBM - Glioblastoma multiforme(114;8.98e-06)|BRCA - Breast invasive adenocarcinoma(304;0.00102)|KIRC - Kidney renal clear cell carcinoma(1967;0.00366)|STAD - Stomach adenocarcinoma(196;0.0132)|READ - Rectum adenocarcinoma(331;0.0652)|Lung(427;0.0888)|LUSC - Lung squamous cell carcinoma(448;0.19)			KNOWN	ENST00000361729		TCTGGATGAGCTGGTCCAAGG	D					ENST00000361729.2:c.678G>T	1	Dimerization. {ECO:0000255}.	ENSG00000007968	0.94253	E2F2	endometrium(4)|large_intestine(2)|lung(1)|ovary(3)|skin(2)|urinary_tract(1)	ENSP00000355249:p.Gln226His	-	0.32029	,	CAG	1p36	B2R9W1|Q7Z6H1		g.chr1:23847464C>A	Q -> H (in dbSNP:rs2075995). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3}.	250.0+/-257.2		32	yes		4888,8118	0.80357	0.47886	5.97	0.00012	ENSP00000355249:Q226H			0.45867		-21.0358		5.1	0.68205	367	0.24483	0.6416083916083916	1.0	core promoter binding (GO:0001047)|DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription factor binding (GO:0008134)	1.7			hg19	Standard	0.5089	0.06504065040650407	14.1362	4324,4276		intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|lens fiber cell apoptotic process (GO:1990086)|mitotic cell cycle (GO:0000278)|regulation of cell cycle (GO:0051726)|transcription initiation from RNA polymerase II promoter (GO:0006367)	1119,2650,2734	2.679578				CCDS236.1	C	0.59357	AA,AC,CC	L22846	nucleoplasm (GO:0005654)|transcription factor complex (GO:0005667)	105	0.54323	2504	5.06	rs2075995		1104	226	391			0.65289	23720051	-	HIS/GLN	226	E2F-2	926	13	NM_004091	0.985	4	0.5158311345646438	0.655000	ENST00000361729.2		15948		uc001bhe.2			1870	dbSNP_96	678	0.0000		p.Q226H	.	0		T		112.0	rs2075995;rs2228221;rs3218171;rs17846515;rs17859587;rs57250008;rs2075995	0.577	1:g.23847464C>A	ENSP00000355249:Q226H	protein_coding	0.000332		basic|appris_principal|CCDS		1079,2166,1055		226	564,3842	0.423992673992674	H	C|||		0.171574	5008		E2F2_HUMAN	1779	E2F transcription factor 2		E2F2_HUMAN	0.355232	0.13621	23847464		0.027000	0.5992	SNP		CCDS236.1		D	,,,	False	23847464	-0.8762		9	missense	T	Approved	0.502791	105.0		c.678G>T	2008-02-05	OTTHUMT00000008885.1	Q14209	0.4092	-2.0	E2F2	23847464	0.71138		0.50988	24	E2F2	NM_004091.3	protein-coding gene	NP_004082.1	Q	
		G	ENSG00000007968	ENST00000361729.2		1870		ENSG00000007968		4300									c.(457-459)ctG>ctC	OTTHUMG00000003223			Q14209	gene with protein product				NM_004091.3		NM_004091						+	Silent			103.0				8246995, 8246996				E2F2-001					1	-						3114			Colorectal(325;3.46e-05)|Lung NSC(340;4.15e-05)|all_lung(284;6.64e-05)|Renal(390;0.000219)|Breast(348;0.00262)|Ovarian(437;0.00539)|Myeloproliferative disorder(586;0.0255)		SO:0001819	600426			protein_coding		2203							6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.52e-24)|Colorectal(126;6.25e-08)|COAD - Colon adenocarcinoma(152;3.42e-06)|GBM - Glioblastoma multiforme(114;8.98e-06)|BRCA - Breast invasive adenocarcinoma(304;0.00102)|KIRC - Kidney renal clear cell carcinoma(1967;0.00366)|STAD - Stomach adenocarcinoma(196;0.0132)|READ - Rectum adenocarcinoma(331;0.0652)|Lung(427;0.0888)|LUSC - Lung squamous cell carcinoma(448;0.19)			KNOWN			AGTTCAGGTCCAGGACCCCAT						ENST00000361729.2:c.459G>C	1					endometrium(4)|large_intestine(2)|lung(1)|ovary(3)|skin(2)|urinary_tract(1)		-				1p36	B2R9W1|Q7Z6H1		g.chr1:23848448C>G																									core promoter binding (GO:0001047)|DNA binding (GO:0003677)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription factor binding (GO:0008134)				hg19	Standard						intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|lens fiber cell apoptotic process (GO:1990086)|mitotic cell cycle (GO:0000278)|regulation of cell cycle (GO:0051726)|transcription initiation from RNA polymerase II promoter (GO:0006367)						CCDS236.1	C			L22846	nucleoplasm (GO:0005654)|transcription factor complex (GO:0005667)							885									153	E2F-2		13	NM_004091		3			ENST00000361729.2				uc001bhe.2			1870					p.L153L		0				109.0		0.592	1:g.23848448C>G		protein_coding			basic|appris_principal|CCDS													E2F2_HUMAN		E2F transcription factor 2					23848448				SNP		CCDS236.1					23848448				synonymous_variant		Approved		105.0		c.459G>C	2008-02-05	OTTHUMT00000008885.1	Q14209			E2F2	23848448							protein-coding gene	NP_004082.1		
		G	ENSG00000142676	ENST00000374550.3		6135		ENSG00000142676		4300					,					OTTHUMG00000002926		byFrequency	P62913	gene with protein product				NM_000975.3|NM_001199802.1	2000,199,4	NM_000975	0.9959					+	5'UTR		3.0+/-9.4	74.0				9582194, 10343117				RPL11-001					1	+	0.9213				utr-5,utr-5	10301		,	Colorectal(325;3.46e-05)|Lung NSC(340;0.000112)|all_lung(284;0.00016)|Renal(390;0.000219)|Breast(348;0.0044)|Ovarian(437;0.00539)|Myeloproliferative disorder(586;0.0255)	G	SO:0001623	604175	,		protein_coding		2203		OREG0013231		0.0349,4.6981,1.6146		"""L ribosomal proteins"""	6503				768	UCEC - Uterine corpus endometrioid carcinoma (279;0.0227)|OV - Ovarian serous cystadenocarcinoma(117;2.13e-24)|Colorectal(126;5.06e-08)|COAD - Colon adenocarcinoma(152;2.92e-06)|GBM - Glioblastoma multiforme(114;4.4e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000954)|KIRC - Kidney renal clear cell carcinoma(1967;0.00322)|STAD - Stomach adenocarcinoma(196;0.0124)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.0837)|LUSC - Lung squamous cell carcinoma(448;0.185)			KNOWN			ATAAGGCCCTCGGCCGGAAGC						ENST00000374550.3:c.-37C>G	1					central_nervous_system(1)|kidney(1)|large_intestine(2)|lung(2)		+		,		1p36.1-p35	P25121|P39026|Q8TDH2|Q9Y674		g.chr1:24018277C>G		128.2+/-165.1			no		12796,210												4.4					1.0	poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|rRNA binding (GO:0019843)|structural constituent of ribosome (GO:0003735)				hg19	Standard	0.999			8597,3		cellular protein metabolic process (GO:0044267)|gene expression (GO:0010467)|mRNA metabolic process (GO:0016071)|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|protein localization to nucleus (GO:0034504)|protein targeting (GO:0006605)|ribosomal large subunit biogenesis (GO:0042273)|RNA metabolic process (GO:0016070)|rRNA processing (GO:0006364)|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|translation (GO:0006412)|translational elongation (GO:0006414)|translational initiation (GO:0006413)|translational termination (GO:0006415)|viral life cycle (GO:0019058)|viral process (GO:0016032)|viral transcription (GO:0019083)	6297,202,4					CCDS238.1	C		GG,GC,CC	L05092	cytosol (GO:0005829)|cytosolic large ribosomal subunit (GO:0022625)|extracellular vesicular exosome (GO:0070062)|membrane (GO:0016020)|nucleolus (GO:0005730)	72		2504		rs112392885|rs10917413		9								,		L11		6	NM_000975		0			ENST00000374550.3		16947		uc001bhk.3			6135	dbSNP_120	,					0				68.0		0.597	1:g.24018277C>G		protein_coding			basic|appris_principal|CCDS		4297,3,0	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		4199,207			G|||			5008		RL11_HUMAN	4892	ribosomal protein L11			0.976837		24018277			0.996	SNP		CCDS238.1			,,,	False	24018277				5_prime_UTR_variant		Approved		72.0			2011-04-06	OTTHUMT00000008168.1	P62913	0.9957		RPL11	24018277				,	RPL11	NM_000975.3,NM_001199802.1	protein-coding gene	NP_000966.2|NP_001186731.1		
		C	ENSG00000117305	ENST00000374490.3	0.09310	3155	.	ENSG00000117305	0.33290	4300	1.000000	.	.		,	.	1.0	0	c.(652-654)ctA>ctG	OTTHUMG00000002963	0.768000	byFrequency	P35914	gene with protein product		HMGCL_ENST00000374483.4_Silent_p.L193L|HMGCL_ENST00000436439.2_Silent_p.L147L|HMGCL_ENST00000509389.1_Intron		NM_000191.2	2033,168,2	NM_000191	0.8415			C	8.919	+	Silent	2	187.3+/-234.6	126.0	.	0.960962		8102917, 8978493			.	HMGCL-002	2010-04-30		.		1	-	0.9728		.	0.758000	coding-synonymous,coding-synonymous	5005	331	218/326,147/255	Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.0044)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	613898	,	0.914364640883978	protein_coding		2203	P		0.301000	9.1512,3.9038,7.3735	.		6503		0.13:0.7308:0.0:0.1392			UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;2.38e-24)|Colorectal(126;5.58e-08)|COAD - Colon adenocarcinoma(152;3.12e-06)|GBM - Glioblastoma multiforme(114;4.9e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000982)|KIRC - Kidney renal clear cell carcinoma(1967;0.0034)|STAD - Stomach adenocarcinoma(196;0.0128)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.0856)|LUSC - Lung squamous cell carcinoma(448;0.188)			KNOWN	ENST00000235958		TGACAGCAGATAGCATGTCTT	.					ENST00000374490.3:c.654A>G	1		ENSG00000117305	0.15052	HMGCL	central_nervous_system(1)|endometrium(2)|large_intestine(2)|lung(3)|ovary(1)|prostate(1)|stomach(1)|upper_aerodigestive_tract(1)		-	0.24444	,	TAT	1p36.1-p35	B4DUP4|B7UCC6|D3Y5K7|Q6IBC0|Q96FP8	"""hydroxymethylglutaricaciduria"""	g.chr1:24134721T>C		112.5+/-150.6		472	no		12047,959	0.80357	0.18583	5.65	0.00012	.			.		-8.2697		4.7	0.60224	455	.	0.7954545454545454	1.0	carboxylic acid binding (GO:0031406)|fatty-acyl-CoA binding (GO:0000062)|hydroxymethylglutaryl-CoA lyase activity (GO:0004419)|magnesium ion binding (GO:0000287)|manganese ion binding (GO:0030145)|metal ion binding (GO:0046872)|protein homodimerization activity (GO:0042803)|receptor binding (GO:0005102)	.			hg19	Standard	0.9254	0.959349593495935	7.9682	7813,787		acyl-CoA metabolic process (GO:0006637)|cellular ketone body metabolic process (GO:0046950)|cellular lipid metabolic process (GO:0044255)|ketone body biosynthetic process (GO:0046951)|leucine catabolic process (GO:0006552)|liver development (GO:0001889)|mitochondrion organization (GO:0007005)|protein tetramerization (GO:0051262)|response to fatty acid (GO:0070542)|response to nutrient (GO:0007584)|response to starvation (GO:0042594)|small molecule metabolic process (GO:0044281)	5578,891,34	0.960563				CCDS243.1, CCDS53279.1	T	.	CC,CT,TT	BC010570	mitochondrial inner membrane (GO:0005743)|mitochondrial matrix (GO:0005759)|mitochondrion (GO:0005739)|peroxisome (GO:0005777)	129	.	2504	4.74	rs719400		697	.	697		"""3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase"""	0.30111	24007308	-	,	218	HL	1955	12	NM_001166059	.	7	0.9195250659630607	-0.119000	ENST00000374490.3		22168		uc001bib.3			3155	dbSNP_86	654,441	0.0000		p.L218L	.	0		T		136.0	rs719400;rs17845267;rs17858097;rs59154801;rs719400	0.557	1:g.24134721T>C	.	protein_coding	.		basic|appris_principal|CCDS		3545,723,32		75	4234,172	0.8951465201465202	C	C|||		.	5008		HMGCL_HUMAN	4444	3-hydroxymethyl-3-methylglutaryl-CoA lyase		.	0.88738	0.28052	24134721		0.873000	0.7817	SNP		CCDS243.1		.	,,,	False	24134721	-1.0243	4.1.3.4	3	synonymous_variant	T	Approved	0.908488	129.0		c.654A>G	2010-04-30	OTTHUMT00000008253.2	P35914	0.8876	.	HMGCL	24134721	0.43043		0.21518	,	HMGCL	NM_000191.2,NM_001166059.1	protein-coding gene	NP_000182.2	Y	
		C	ENSG00000188822	ENST00000374472.4		1269		ENSG00000188822							,					OTTHUMG00000013892		byFrequency	P34972	gene with protein product		CNR2_ENST00000536471.1_3'UTR	Dronabinol(DB00470)|Nabilone(DB00486)	NM_001841.2		NM_001841	0.6973					+	3'UTR											CNR2-001						-	0.7943					2160			Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.00957)|Myeloproliferative disorder(586;0.0255)		SO:0001624	605051			protein_coding								"""GPCR / Class A : Cannabinoid receptors"""						UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.32e-24)|Colorectal(126;6.09e-08)|COAD - Colon adenocarcinoma(152;3.33e-06)|GBM - Glioblastoma multiforme(114;2.9e-05)|BRCA - Breast invasive adenocarcinoma(304;0.00101)|KIRC - Kidney renal clear cell carcinoma(1967;0.00359)|STAD - Stomach adenocarcinoma(196;0.0131)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.146)			KNOWN			CCTCTCTCTCTTCCAGGGAGT						ENST00000374472.4:c.*56A>G	1					breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(9)|pancreas(1)|skin(2)|stomach(6)|upper_aerodigestive_tract(2)		-		,		1p	C6ES44|Q4VBK8|Q5JRH7|Q6B0G7|Q6NSY0		g.chr1:24200969T>C																									cannabinoid receptor activity (GO:0004949)				hg19	Standard	0.5875					G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|immune response (GO:0006955)|inflammatory response (GO:0006954)|negative regulation of action potential (GO:0045759)|negative regulation of inflammatory response (GO:0050728)|negative regulation of mast cell activation (GO:0033004)|negative regulation of nitric-oxide synthase activity (GO:0051001)|negative regulation of synaptic transmission, GABAergic (GO:0032229)|response to amphetamine (GO:0001975)|response to lipopolysaccharide (GO:0032496)|sensory perception of pain (GO:0019233)						CCDS245.1	T			X74328	dendrite (GO:0030425)|extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)			2504		rs2229584		1300										CB2		26	NM_001841		0			ENST00000374472.4		21065		uc001bif.3			1269							0						0.493	1:g.24200969T>C		protein_coding			basic|appris_principal|CCDS								C|||			5008		CNR2_HUMAN	3272	cannabinoid receptor 2 (macrophage)			0.653355		24200969			0.502	SNP		CCDS245.1			,,,	False	24200969				3_prime_UTR_variant		Approved					2012-08-08	OTTHUMT00000038949.1	P34972	0.6383		CNR2								protein-coding gene	NP_001832.1		
		T	ENSG00000188822	ENST00000374472.4		1269		ENSG00000188822		4300					,					OTTHUMG00000013892		byFrequency	P34972	gene with protein product		CNR2_ENST00000536471.1_3'UTR	Dronabinol(DB00470)|Nabilone(DB00486)	NM_001841.2	1329,741,128	NM_001841	0.6973					+	3'UTR			64.0								CNR2-001					1	-	0.823				utr-3	2160			Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.00957)|Myeloproliferative disorder(586;0.0255)	T	SO:0001624	605051			protein_coding		2198				42.6744,22.6797,35.911		"""GPCR / Class A : Cannabinoid receptors"""	6498					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.32e-24)|Colorectal(126;6.09e-08)|COAD - Colon adenocarcinoma(152;3.33e-06)|GBM - Glioblastoma multiforme(114;2.9e-05)|BRCA - Breast invasive adenocarcinoma(304;0.00101)|KIRC - Kidney renal clear cell carcinoma(1967;0.00359)|STAD - Stomach adenocarcinoma(196;0.0131)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.146)			KNOWN			AGGGAGTGAACTGATTTCTGA						ENST00000374472.4:c.*42G>A	1					breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(9)|pancreas(1)|skin(2)|stomach(6)|upper_aerodigestive_tract(2)		-		,		1p	C6ES44|Q4VBK8|Q5JRH7|Q6B0G7|Q6NSY0		g.chr1:24200983C>T					no		8329,4667												-3.7					0.0	cannabinoid receptor activity (GO:0004949)				hg19	Standard	0.5885			4930,3670		G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|immune response (GO:0006955)|inflammatory response (GO:0006954)|negative regulation of action potential (GO:0045759)|negative regulation of inflammatory response (GO:0050728)|negative regulation of mast cell activation (GO:0033004)|negative regulation of nitric-oxide synthase activity (GO:0051001)|negative regulation of synaptic transmission, GABAergic (GO:0032229)|response to amphetamine (GO:0001975)|response to lipopolysaccharide (GO:0032496)|sensory perception of pain (GO:0019233)	2731,2867,900					CCDS245.1	C		TT,TC,CC	X74328	dendrite (GO:0030425)|extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)	60		2504		rs2229583		1286										CB2		26	NM_001841		0			ENST00000374472.4		20758		uc001bif.3			1269	dbSNP_98						0				53.0		0.483	1:g.24200983C>T		protein_coding			basic|appris_principal|CCDS		1402,2126,772			3399,997			T|||			5008		CNR2_HUMAN	3312	cannabinoid receptor 2 (macrophage)			0.661342		24200983			0.502	SNP		CCDS245.1			,,,	False	24200983				3_prime_UTR_variant		Approved		60.0			2012-08-08	OTTHUMT00000038949.1	P34972	0.6398		CNR2	24200983					CNR2	NM_001841.2	protein-coding gene	NP_001832.1		
		C	ENSG00000188822	ENST00000374472.4		1269		ENSG00000188822		4300					,				c.(1012-1014)acC>acG	OTTHUMG00000013892		byFrequency	P34972	gene with protein product		CNR2_ENST00000536471.1_Silent_p.T338T	Dronabinol(DB00470)|Nabilone(DB00486)	NM_001841.2	1263,787,153	NM_001841	0.6973	Substitution - coding silent(1)				+	Silent		622.6+/-397.3	107.0								CNR2-001					1	-	0.7943				coding-synonymous	2160		338/361	Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.00957)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	605051			protein_coding	stomach(1)	2203				42.6163,24.8071,36.5831		"""GPCR / Class A : Cannabinoid receptors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.32e-24)|Colorectal(126;6.09e-08)|COAD - Colon adenocarcinoma(152;3.33e-06)|GBM - Glioblastoma multiforme(114;2.9e-05)|BRCA - Breast invasive adenocarcinoma(304;0.00101)|KIRC - Kidney renal clear cell carcinoma(1967;0.00359)|STAD - Stomach adenocarcinoma(196;0.0131)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.146)			KNOWN			CCTCTGTCTCGGTGACTGAGG						ENST00000374472.4:c.1014C>G	1					breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(9)|pancreas(1)|skin(2)|stomach(6)|upper_aerodigestive_tract(2)		-		,		1p	C6ES44|Q4VBK8|Q5JRH7|Q6B0G7|Q6NSY0		g.chr1:24201094G>C		719.6+/-409.0			no		8248,4758												-7.3					0.1	cannabinoid receptor activity (GO:0004949)				hg19	Standard	0.5875			4935,3665		G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|immune response (GO:0006955)|inflammatory response (GO:0006954)|negative regulation of action potential (GO:0045759)|negative regulation of inflammatory response (GO:0050728)|negative regulation of mast cell activation (GO:0033004)|negative regulation of nitric-oxide synthase activity (GO:0051001)|negative regulation of synaptic transmission, GABAergic (GO:0032229)|response to amphetamine (GO:0001975)|response to lipopolysaccharide (GO:0032496)|sensory perception of pain (GO:0019233)	2665,2918,920			p.T338T(1)		CCDS245.1	G		CC,CG,GG	X74328	dendrite (GO:0030425)|extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)	103		2504		rs2229581		1175									338	CB2		26	NM_001841		2			ENST00000374472.4		21376		uc001bif.3			1269	dbSNP_98	1014			p.T338T		1				96.0		0.532	1:g.24201094G>C		protein_coding			basic|appris_principal|CCDS		1402,2131,767			3313,1093			G|||			5008		CNR2_HUMAN	3272	cannabinoid receptor 2 (macrophage)			0.653355		24201094			0.502	SNP		CCDS245.1			,,,	False	24201094				synonymous_variant		Approved		103.0		c.1014C>G	2012-08-08	OTTHUMT00000038949.1	P34972	0.6383		CNR2	24201094					CNR2	NM_001841.2	protein-coding gene	NP_001832.1		
		T	ENSG00000188822	ENST00000374472.4		1269		ENSG00000188822		4300					,				c.(997-999)ccG>ccA	OTTHUMG00000013892		byFrequency	P34972	gene with protein product		CNR2_ENST00000536471.1_Silent_p.P333P	Dronabinol(DB00470)|Nabilone(DB00486)	NM_001841.2	1261,789,153	NM_001841	0.6973	Substitution - coding silent(1)				+	Silent		622.6+/-397.3	106.0								CNR2-001					1	-	0.7943				coding-synonymous	2160		333/361	Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.00957)|Myeloproliferative disorder(586;0.0255)	C	SO:0001819	605051			protein_coding	stomach(1)	2203				42.6163,24.8525,36.5985		"""GPCR / Class A : Cannabinoid receptors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.32e-24)|Colorectal(126;6.09e-08)|COAD - Colon adenocarcinoma(152;3.33e-06)|GBM - Glioblastoma multiforme(114;2.9e-05)|BRCA - Breast invasive adenocarcinoma(304;0.00101)|KIRC - Kidney renal clear cell carcinoma(1967;0.00359)|STAD - Stomach adenocarcinoma(196;0.0131)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.146)			KNOWN			CTGAGGATCTCGGGGCTTCTT						ENST00000374472.4:c.999G>A	1					breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(9)|pancreas(1)|skin(2)|stomach(6)|upper_aerodigestive_tract(2)		-		,		1p	C6ES44|Q4VBK8|Q5JRH7|Q6B0G7|Q6NSY0		g.chr1:24201109C>T		720.0+/-409.0			no		8246,4760												-9.5					0.0	cannabinoid receptor activity (GO:0004949)				hg19	Standard	0.5875			4935,3665		G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|immune response (GO:0006955)|inflammatory response (GO:0006954)|negative regulation of action potential (GO:0045759)|negative regulation of inflammatory response (GO:0050728)|negative regulation of mast cell activation (GO:0033004)|negative regulation of nitric-oxide synthase activity (GO:0051001)|negative regulation of synaptic transmission, GABAergic (GO:0032229)|response to amphetamine (GO:0001975)|response to lipopolysaccharide (GO:0032496)|sensory perception of pain (GO:0019233)	2663,2920,920			p.P333P(1)		CCDS245.1	C		TT,TC,CC	X74328	dendrite (GO:0030425)|extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)	103		2504		rs2229580		1160									333	CB2		26	NM_001841		2			ENST00000374472.4		21148		uc001bif.3			1269	dbSNP_98	999			p.P333P		1				97.0		0.557	1:g.24201109C>T		protein_coding			basic|appris_principal|CCDS		1402,2131,767			3311,1095			C|||			5008		CNR2_HUMAN	3272	cannabinoid receptor 2 (macrophage)			0.653355		24201109			0.502	SNP		CCDS245.1			,,,	False	24201109				synonymous_variant		Approved		103.0		c.999G>A	2012-08-08	OTTHUMT00000038949.1	P34972	0.6383		CNR2	24201109					CNR2	NM_001841.2	protein-coding gene	NP_001832.1		
		G	ENSG00000188822	ENST00000374472.4		1269		ENSG00000188822		4300					,				c.(844-846)gcT>gcC	OTTHUMG00000013892		byFrequency	P34972	gene with protein product		CNR2_ENST00000536471.1_Silent_p.A282A	Dronabinol(DB00470)|Nabilone(DB00486)	NM_001841.2	1261,788,154	NM_001841	0.6973	Substitution - coding silent(1)				+	Silent		526.1+/-380.9	82.0								CNR2-001					1	-	0.7943				coding-synonymous	2160		282/361	Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.00957)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	605051			protein_coding	stomach(1)	2203				42.6279,24.8752,36.6139		"""GPCR / Class A : Cannabinoid receptors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.32e-24)|Colorectal(126;6.09e-08)|COAD - Colon adenocarcinoma(152;3.33e-06)|GBM - Glioblastoma multiforme(114;2.9e-05)|BRCA - Breast invasive adenocarcinoma(304;0.00101)|KIRC - Kidney renal clear cell carcinoma(1967;0.00359)|STAD - Stomach adenocarcinoma(196;0.0131)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.146)			KNOWN			TGGAGCAGAAAGCAAAGGCCT						ENST00000374472.4:c.846T>C	1					breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(9)|pancreas(1)|skin(2)|stomach(6)|upper_aerodigestive_tract(2)		-		,		1p	C6ES44|Q4VBK8|Q5JRH7|Q6B0G7|Q6NSY0		g.chr1:24201262A>G		395.8+/-329.8			no		8244,4762												1.3					1.0	cannabinoid receptor activity (GO:0004949)				hg19	Standard	0.5875			4934,3666		G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|immune response (GO:0006955)|inflammatory response (GO:0006954)|negative regulation of action potential (GO:0045759)|negative regulation of inflammatory response (GO:0050728)|negative regulation of mast cell activation (GO:0033004)|negative regulation of nitric-oxide synthase activity (GO:0051001)|negative regulation of synaptic transmission, GABAergic (GO:0032229)|response to amphetamine (GO:0001975)|response to lipopolysaccharide (GO:0032496)|sensory perception of pain (GO:0019233)	2663,2918,922			p.A282A(1)		CCDS245.1	A		GG,GA,AA	X74328	dendrite (GO:0030425)|extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)	85		2504		rs2502993		1007									282	CB2		26	NM_001841		2			ENST00000374472.4		22050		uc001bif.3			1269	dbSNP_100	846			p.A282A		1				92.0		0.572	1:g.24201262A>G		protein_coding			basic|appris_principal|CCDS		1402,2130,768			3310,1096			G|||			5008		CNR2_HUMAN	3272	cannabinoid receptor 2 (macrophage)			0.653355		24201262			0.502	SNP		CCDS245.1			,,,	False	24201262				synonymous_variant		Approved		85.0		c.846T>C	2012-08-08	OTTHUMT00000038949.1	P34972	0.6383		CNR2	24201262					CNR2	NM_001841.2	protein-coding gene	NP_001832.1		
		G	ENSG00000188822	ENST00000374472.4		1269		ENSG00000188822		4300					,				c.(751-753)Ttg>Ctg	OTTHUMG00000013892		byFrequency	P34972	gene with protein product		CNR2_ENST00000536471.1_Silent_p.L251L	Dronabinol(DB00470)|Nabilone(DB00486)	NM_001841.2	1261,788,154	NM_001841	0.6973					+	Silent		526.0+/-380.9	74.0								CNR2-001					1	-	0.7943				coding-synonymous	2160		251/361	Colorectal(325;3.46e-05)|Renal(390;0.000219)|Lung NSC(340;0.000233)|all_lung(284;0.000321)|Ovarian(437;0.00348)|Breast(348;0.00957)|Myeloproliferative disorder(586;0.0255)	G	SO:0001819	605051			protein_coding		2203				42.6163,24.8752,36.6062		"""GPCR / Class A : Cannabinoid receptors"""	6503					UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|OV - Ovarian serous cystadenocarcinoma(117;1.32e-24)|Colorectal(126;6.09e-08)|COAD - Colon adenocarcinoma(152;3.33e-06)|GBM - Glioblastoma multiforme(114;2.9e-05)|BRCA - Breast invasive adenocarcinoma(304;0.00101)|KIRC - Kidney renal clear cell carcinoma(1967;0.00359)|STAD - Stomach adenocarcinoma(196;0.0131)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.146)			KNOWN			AGCACAGCCAACACTAGCCCT						ENST00000374472.4:c.751T>C	1					breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(9)|pancreas(1)|skin(2)|stomach(6)|upper_aerodigestive_tract(2)		-		,		1p	C6ES44|Q4VBK8|Q5JRH7|Q6B0G7|Q6NSY0		g.chr1:24201357A>G		396.0+/-329.9			no		8245,4761												1.7					1.0	cannabinoid receptor activity (GO:0004949)				hg19	Standard	0.5875			4935,3665		G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)|immune response (GO:0006955)|inflammatory response (GO:0006954)|negative regulation of action potential (GO:0045759)|negative regulation of inflammatory response (GO:0050728)|negative regulation of mast cell activation (GO:0033004)|negative regulation of nitric-oxide synthase activity (GO:0051001)|negative regulation of synaptic transmission, GABAergic (GO:0032229)|response to amphetamine (GO:0001975)|response to lipopolysaccharide (GO:0032496)|sensory perception of pain (GO:0019233)	2663,2919,921					CCDS245.1	A		GG,GA,AA	X74328	dendrite (GO:0030425)|extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)|integral component of plasma membrane (GO:0005887)|neuronal cell body (GO:0043025)|plasma membrane (GO:0005886)	80		2504		rs4649124		912									251	CB2		26	NM_001841		2			ENST00000374472.4		21118		uc001bif.3			1269	dbSNP_111	751			p.L251L		0				93.0		0.597	1:g.24201357A>G		protein_coding			basic|appris_principal|CCDS		1402,2131,767			3310,1096			G|||			5008		CNR2_HUMAN	3272	cannabinoid receptor 2 (macrophage)			0.653355		24201357			0.502	SNP		CCDS245.1			,,,	False	24201357				synonymous_variant		Approved		80.0		c.751T>C	2012-08-08	OTTHUMT00000038949.1	P34972	0.6383		CNR2	24201357					CNR2	NM_001841.2	protein-coding gene	NP_001832.1		
		T	ENSG00000186272	ENST00000601808.1		7565				4297					,				c.(1165-1167)aaC>aaT			byFrequency	P17021	gene with protein product		AC004076.7_ENST00000597410.1_Intron|ZNF17_ENST00000307658.7_Silent_p.N391N		NM_006959.2	6,172,2014	NM_006959	0.2045					+	Silent		300.2+/-304.8	88.0				2115127, 2014798				ZNF17-001	2006-05-10				19	+	0.0144				coding-synonymous	12958		389/663	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Renal(1328;0.157)	C	SO:0001819				protein_coding		2192				19.8162,4.1971,14.54		"""Zinc fingers, C2H2-type"", ""-"""	6489					UCEC - Uterine corpus endometrioid carcinoma (67;0.0234)|GBM - Glioblastoma multiforme(193;0.000426)|Lung(386;0.176)		Melanoma(149;1637 1853 29914 42869 44988)	KNOWN			ATGAATGCAACGAATGTGGGA						ENST00000601808.1:c.1167C>T	19					central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(3)|lung(6)|prostate(1)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		19q13.43	B3KXU2|B3KY20|Q8N7M1|Q8N893|Q8TF54		g.chr19:57932027C>T		103.8+/-142.4			no		1887,11091												-3.6					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.174			1703,6891		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	183,1521,4785					CCDS42636.1	C		TT,TC,CC	X52341	nucleus (GO:0005634)	87		2504		rs2158009		1380				"""zinc finger protein 17 (HPF3, KOX 10)"""					389	HPF3, KOX10, KIAA1947, FLJ40864, FLJ46058, FLJ46615		16	NM_006959		3			ENST00000601808.1		22756		uc002qoo.1			7565	dbSNP_96	1167			p.N389N		0				85.0		0.398	19:g.57932027C>T		protein_coding			basic|appris_candidate|CCDS		177,1349,2771			184,4200			C|||			5008		ZNF17_HUMAN	792	zinc finger protein 17			0.158147		57932027			0.253	SNP		CCDS42636.1			,,,	False	57932027				synonymous_variant		Approved		87.0		c.1167C>T	2013-01-08	OTTHUMT00000466384.1	P17021	0.2061		ZNF17	57932027					ZNF17	NM_006959.2	protein-coding gene	NP_008890.2		
		T	ENSG00000178201	ENST00000321039.3	0.80722	57191	N	ENSG00000178201	0.11394	4300	0.000000	0.09255	B		,	D	0.0	0	c.(805-807)gCc>gAc		-0.140000	byFrequency	Q9GZP7	gene with protein product		AC004076.9_ENST00000415705.3_5'UTR|AC004076.9_ENST00000596831.1_Missense_Mutation_p.P107T		NM_020633.3	188,966,1049	NM_020633	0.4806			G	10.04	+	Missense_Mutation	2	404.0+/-348.0	88.0	Q9GZP7	0.304585		10973240			0.123	VN1R1-001	2003-01-15		0.31016		19	-	0.3109		0.05	0.015000	missense	13548	135	269/354	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Renal(1328;0.157)|Breast(46;0.222)	G	SO:0001583	605234	possibly-damaging	0.3729281767955801	protein_coding		2203	P		0.996000	28.5349,30.4585,29.1865	B	"""Vomeronasal receptors / Type 1"", ""GPCR / Unclassified : Vomeronasal receptors, type 1"""	6503		0.3162:0.3379:0.3459:0.0			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0254)|Lung(386;0.171)			KNOWN	ENST00000321039		TGTGGCTCTGGCTTCCTGGGA	T	VNR19I1				ENST00000321039.3:c.806C>A	19		ENSG00000178201	0.86243	VN1R1	NS(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(4)|lung(8)|ovary(1)|pancreas(1)|skin(2)	ENSP00000322339:p.Ala269Asp	-	0.38824	,	GCC	19q13.4	B3KSV5|Q7Z5H8|Q7Z5H9		g.chr19:57967049G>T	A -> D (in allele VN1R1*3; dbSNP:rs61744949). {ECO:0000269|PubMed:10973240, ECO:0000269|PubMed:12826614}.	450.2+/-349.3		149	yes		3796,9210	0.03702	0.22796	4.17	0.00012	ENSP00000322339:A269D			.		.		-0.9	0.10500	368	0.56958	0.6433566433566433	0.0	pheromone receptor activity (GO:0016503)	0.705			hg19	Standard	0.2783	0.30284552845528456	4.0826	2454,6146		response to pheromone (GO:0019236)	518,2760,3225	1.242857				CCDS12951.1	G	0.25609	TT,TG,GG	AF255342	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	101	0.25060	2504	-0.913	rs61744949		805	269	225		"""vomeronasal olfactory receptor, (chromosome 19) subtype I, member 1"""	0.09932	62658861	-	ASP/ALA	269	V1RL1, ZVNR1, ZVNH1	877	19	NM_020633	0.13	1	0.29683377308707126	0.650000	ENST00000321039.3		18776		uc002qos.2			57191	dbSNP_129	806	0.0000		p.A269D	GPCR, rhodopsin-like superfamily (1);	0		T		126.0	rs61744949	0.488	19:g.57967049G>T	ENSP00000322339:A269D	protein_coding	.		basic|appris_principal|CCDS		330,1794,2176		269	1342,3064	0.4015567765567766	D	G|||		.	5008		VN1R1_HUMAN	2070	vomeronasal 1 receptor 1		VN1R1_HUMAN	0.413339	0.22832	57967049		0.517000	0.5913	SNP		CCDS12951.1		.	,,,	False	57967049	-1.0155		8	missense	T	Approved	0.285349	101.0		c.806C>A	2012-08-22	OTTHUMT00000466464.1	Q9GZP7	0.451	3.0	VN1R1	57967049	0.08874		0.24621	126	VN1R1	NM_020633.3	protein-coding gene	NP_065684.1	A	
		A	ENSG00000178201	ENST00000321039.3	0.80722	57191	L	ENSG00000178201	0.27071	4300	0.001000	0.08370	P		,	T	0.0	0	c.(721-723)tCc>tTc		0.461000	byFrequency	Q9GZP7	gene with protein product		AC004076.9_ENST00000415705.3_Intron|AC004076.9_ENST00000596831.1_Intron		NM_020633.3	189,966,1048	NM_020633	0.4806			G	11.87	+	Missense_Mutation	2	403.9+/-348.0	87.0	Q9GZP7	0.305039		10973240			0.55	VN1R1-001	2003-01-15		0.47573		19	-	0.3124		0.76	0.003000	missense	13548	135	241/354	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Renal(1328;0.157)|Breast(46;0.222)	G	SO:0001583	605234	probably-damaging	0.3729281767955801	protein_coding		2203	P		0.001000	28.5233,30.5039,29.1942	P	"""Vomeronasal receptors / Type 1"", ""GPCR / Unclassified : Vomeronasal receptors, type 1"""	6503		0.1073:0.1653:0.4256:0.3017			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0254)|Lung(386;0.171)			KNOWN	ENST00000321039		GAAGACCATGGAGCCACTGGC	T	VNR19I1				ENST00000321039.3:c.722C>T	19		ENSG00000178201	0.83216	VN1R1	NS(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(4)|lung(8)|ovary(1)|pancreas(1)|skin(2)	ENSP00000322339:p.Ser241Phe	-	0.12720	,	TCC	19q13.4	B3KSV5|Q7Z5H8|Q7Z5H9		g.chr19:57967133G>A	S -> F (in allele VN1R1*3; dbSNP:rs28649880). {ECO:0000269|PubMed:10973240, ECO:0000269|PubMed:12826614}.	450.6+/-349.4		149	yes		3797,9209	0.08648	0.31228	4.11	0.00012	ENSP00000322339:S241F			.		.		0.4	0.16244	368	0.08599	0.6433566433566433	0.0	pheromone receptor activity (GO:0016503)	1.53			hg19	Standard	0.2793	0.30284552845528456	2.0499	2453,6147		response to pheromone (GO:0019236)	519,2759,3225	1.766615				CCDS12951.1	G	0.45283	AA,AG,GG	AF255342	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	95	0.48877	2504	0.384	rs28649880		721	241	226		"""vomeronasal olfactory receptor, (chromosome 19) subtype I, member 1"""	0.03568	62658945	-	PHE/SER	241	V1RL1, ZVNR1, ZVNH1	878	19	NM_020633	0.855	1	0.29815303430079154	0.603000	ENST00000321039.3		19142		uc002qos.2			57191	dbSNP_125	722	0.0000		p.S241F	GPCR, rhodopsin-like superfamily (1);	0		T		112.0	rs28649880	0.468	19:g.57967133G>A	ENSP00000322339:S241F	protein_coding	.		basic|appris_principal|CCDS		330,1793,2177		241	1344,3062	0.40201465201465203	F	G|||		.	5008		VN1R1_HUMAN	2073	vomeronasal 1 receptor 1		VN1R1_HUMAN	0.413938	0.06062	57967133		-0.546000	0.5913	SNP		CCDS12951.1		.	,,,	False	57967133	-0.9987		8	missense	T	Approved	0.285233	95.0		c.722C>T	2012-08-22	OTTHUMT00000466464.1	Q9GZP7	0.451	3.1	VN1R1	57967133	0.03518		0.30179	155	VN1R1	NM_020633.3	protein-coding gene	NP_065684.1	S	
		G	ENSG00000197128	ENST00000343280.4		400720				4300					,				c.(1192-1194)agT>agC			byFrequency	Q68DY9	gene with protein product		ZNF772_ENST00000425074.3_3'UTR|ZNF772_ENST00000427512.2_Silent_p.S286S|AC004076.9_ENST00000596831.1_Intron|ZNF772_ENST00000601768.1_Intron|ZNF772_ENST00000600175.1_Intron|AC004076.9_ENST00000415705.3_Intron|ZNF772_ENST00000356584.3_Silent_p.S357S		NM_001024596.2	198,968,1037	NM_001024596	0.4785					+	Silent		402.6+/-347.5	121.0								ZNF772-001					19	-	0.3154				coding-synonymous,coding-synonymous	33106		398/490,357/449	Colorectal(82;0.000256)|all_neural(62;0.0577)|Ovarian(87;0.221)	A	SO:0001819		,		protein_coding		2203				28.4419,30.9578,29.2942		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.026)|Lung(386;0.174)		Melanoma(5;289 436 14293 15924 30817)	KNOWN			CAGTATGAACACTCCAATGTT						ENST00000343280.4:c.1194T>C	19					breast(1)|endometrium(1)|large_intestine(4)|lung(3)		-		,		19q13.43	A6NJK9|B4DH56|B4DYS0		g.chr19:57984918A>G		454.2+/-350.6			no		3810,9196												-1.1					1.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.2783			2446,6154		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	527,2756,3220					CCDS33133.1, CCDS46210.1	A		GG,GA,AA	BX647068	nucleus (GO:0005634)	125		2504		rs2074058		1454								,	398	DKFZp686I1569		9	NM_001024596		5			ENST00000343280.4		22319		uc002qot.3			400720	dbSNP_96	1194,1071			p.S398S		0				132.0		0.413	19:g.57984918A>G		protein_coding			basic|appris_candidate_longest|CCDS		329,1788,2183			1364,3042			A|||			5008		ZN772_HUMAN	2073	zinc finger protein 772			0.413938		57984918			0.5893	SNP		CCDS33133.1			,,,	False	57984918				synonymous_variant		Approved		125.0		c.1194T>C	2013-01-08	OTTHUMT00000397447.1	Q68DY9	0.4524		ZNF772	57984918				,	ZNF772	NM_001024596.2,NM_001144068.1	protein-coding gene	NP_001019767.1		
		A	ENSG00000197128	ENST00000343280.4	0.80722	400720	N		0.12219	4300	0.000000	0.05382	B;B;B		,	D	0.0	0	c.(652-654)Atg>Ttg		-0.101000	byFrequency	Q68DY9	gene with protein product		AC004076.9_ENST00000415705.3_Intron|ZNF772_ENST00000356584.3_Missense_Mutation_p.M177L|AC004076.9_ENST00000596831.1_Intron|ZNF772_ENST00000427512.2_Missense_Mutation_p.M106L|ZNF772_ENST00000600175.1_Intron|ZNF772_ENST00000601768.1_Intron|ZNF772_ENST00000425074.3_3'UTR		NM_001024596.2	849,1027,327	NM_001024596	0.7464			A	9.582	+	Missense_Mutation	1	479.4+/-370.1	77.0	Q68DY9-2;A6NJK9;Q68DY9	0.618475					0.0;0.0;0.0	ZNF772-001			0.01281		19	-	0.6127		0.02	0.009000	missense,missense	33106	254	218/490,177/449	Colorectal(82;0.000256)|all_neural(62;0.0577)|Ovarian(87;0.221)	A	SO:0001583		benign,benign	0.7016574585635359	protein_coding		2203	P		0.000000	36.6512,38.1525,37.1598	B;B;B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.439:0.1827:0.2022:0.1761			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.026)|Lung(386;0.174)		Melanoma(5;289 436 14293 15924 30817)	KNOWN	ENST00000343280;ENST00000427512;ENST00000319969;ENST00000356584;ENST00000291809		GACATCTCCATTGATTGCACA	T;T;T					ENST00000343280.4:c.652A>T	19		ENSG00000197128	0.04628	ZNF772	breast(1)|endometrium(1)|large_intestine(4)|lung(3)	ENSP00000341165:p.Met218Leu	-	0.05858	,	ATG	19q13.43	A6NJK9|B4DH56|B4DYS0		g.chr19:57985460T>A	M -> L (in dbSNP:rs2074059). {ECO:0000269|PubMed:17974005}.	507.3+/-366.6		302	yes		8173,4833	0.03702	0.20959	3.79	0.00012	ENSP00000291809:M143L			.		.		1.6	0.23807	411	0.66056	0.7185314685314685	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-0.66			hg19	Standard	0.6392	0.6138211382113821	0.4889	5448,3152		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2529,3115,859	1.123935				CCDS33133.1, CCDS46210.1	T	0.02656	AA,AT,TT	BX647068	nucleus (GO:0005634)	80	0.02158	2504	1.63	rs2074059		912	106;177;218	484			0.00560	62677272	-	LEU/MET,LEU/MET	218	DKFZp686I1569	1451	9	NM_001024596	0.0;0.0;0.0	5	0.6385224274406333	-0.496000	ENST00000343280.4		20866		uc002qot.3			400720	dbSNP_96	652,529	0.0000		p.M218L	.	0		T		86.0	rs2074059;rs59319118;rs2074059	0.498	19:g.57985460T>A	ENSP00000341165:M218L;ENSP00000395967:M106L;ENSP00000348992:M177L	protein_coding	.		basic|appris_candidate_longest|CCDS		1680,2088,532		218;106;164;177;143	2725,1681	0.6643772893772893	L	A|||		.	5008		ZN772_HUMAN	3388	zinc finger protein 772		.;.;ZN772_HUMAN	0.676518	0.14640	57985460		0.073000	0.7014	SNP		CCDS33133.1		.	,,,	False	57985460	-1.0393		8	missense	T	Approved	0.633488	80.0		c.652A>T	2013-01-08	OTTHUMT00000397447.1	Q68DY9	0.7176	3.58;3.45;3.54	ZNF772	57985460	0.06853		0.16719	15,15	ZNF772	NM_001024596.2,NM_001144068.1	protein-coding gene	NP_001019767.1	M	
		C	ENSG00000197128	ENST00000343280.4	0.52501|0.52501	400720	L|L		0.15604|0.15604	4300	0.018000|0.018000	0.07567|.	B;B;B|.		,	T|T	4.999999999999449E-5|4.999999999999449E-5	2|3	c.(544-546)tgC>tgG		0.038000|0.038000	byFrequency	Q68DY9	gene with protein product		AC004076.9_ENST00000415705.3_Intron|ZNF772_ENST00000356584.3_Missense_Mutation_p.C141W|AC004076.9_ENST00000596831.1_Intron|ZNF772_ENST00000427512.2_Missense_Mutation_p.C70W|ZNF772_ENST00000600175.1_Intron|ZNF772_ENST00000601768.1_Intron|ZNF772_ENST00000425074.3_3'UTR		NM_001024596.2	833,1042,328	NM_001024596	0.7464			C|C	0.004|0.004	+	Missense_Mutation	3|3	479.5+/-370.1	104.0	Q68DY9-2;A6NJK9;Q68DY9|.	0.614616|0.614616					0.0;0.0;0.0|.	ZNF772-001			0.01281|.		19	-	0.6135		0.22|0.11	0.518000|0.518000	missense,missense	33106	255|255	182/490,141/449	Colorectal(82;0.000256)|all_neural(62;0.0577)|Ovarian(87;0.221)	C	SO:0001583		benign,benign	0.7044198895027625|0.7044198895027625	protein_coding		2203	P|P		0.000000|0.000000	36.6744,38.5384,37.3059	B;B;B|.	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.3129:0.2295:0.3079:0.1498|0.3129:0.2295:0.3079:0.1498			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.026)|Lung(386;0.174)		Melanoma(5;289 436 14293 15924 30817)	KNOWN	ENST00000343280;ENST00000427512;ENST00000319969;ENST00000356584|ENST00000291809		TTGCACTGAAGCAGAACTGTT	T;T;T|.					ENST00000343280.4:c.546C>G	19		ENSG00000197128|ENSG00000197128	0.08575|0.08575	ZNF772|ZNF772	breast(1)|endometrium(1)|large_intestine(4)|lung(3)	ENSP00000341165:p.Cys182Trp	-	0.05858|0.05858	,	TGC|ATC	19q13.43	A6NJK9|B4DH56|B4DYS0		g.chr19:57985566G>C	C -> W (in dbSNP:rs2074060). {ECO:0000269|PubMed:17974005}.	512.6+/-368.1		299|299	yes		8154,4852	0.16275|0.16275	0.00237|0.00237	3.99|3.99	0.00012|0.00012	ENSP00000321015:C128W|ENSP00000291809:I107M			.|.		.|.		-1.1	0.09904|0.09904	411|411	0.34782|0.46703	0.7185314685314685|0.7185314685314685	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	0.805|0.805			hg19	Standard	0.6392	0.6077235772357723|0.6077235772357723	1.1261|1.1261	5446,3154		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2512,3130,861	-2.310840|-2.310840				CCDS33133.1, CCDS46210.1	G	0.02656|.	CC,CG,GG	BX647068	nucleus (GO:0005634)	109	0.27053|0.27053	2504	-1.09|-1.09	rs2074060		806	70;141;182|.	484|484			0.01735|0.01735	62677378|62677378	-|-	TRP/CYS,TRP/CYS	182	DKFZp686I1569	1449|1449	9	NM_001024596	0.0;0.0;0.0|.	5	0.6385224274406333|0.6385224274406333	-0.322000|-0.322000	ENST00000343280.4		22251		uc002qot.3			400720	dbSNP_96	546,423	0.0000|0.0000		p.C182W	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);|.	0		T|T		118.0	rs2074060;rs57900222;rs2074060|rs2074060;rs57900222;rs2074060	0.498	19:g.57985566G>C	ENSP00000341165:C182W;ENSP00000395967:C70W;ENSP00000348992:C141W|.	protein_coding	.|.		basic|appris_candidate_longest|CCDS		1679,2088,533		182;70;128;141|107	2708,1698	0.6634615384615384|0.6634615384615384	W|M	C|||		.|.	5008		ZN772_HUMAN	3390	zinc finger protein 772		.;.;ZN772_HUMAN|.	0.676917	0.01878|0.01878	57985566		-1.716000|-1.716000	0.7014	SNP		CCDS33133.1		.|.	,,,	False	57985566	-1.0047|-1.0047		8|5	missense	T|T	Approved	0.633256|0.633256	109.0		c.546C>G	2013-01-08	OTTHUMT00000397447.1	Q68DY9	0.719	3.18;3.18;3.18|.	ZNF772	57985566	0.34316|0.34316		0.28332|0.28332	215,215	ZNF772	NM_001024596.2,NM_001144068.1	protein-coding gene	NP_001019767.1	C|I	
		A	ENSG00000105136	ENST00000221735.7		79744		ENSG00000105136		4184					,					OTTHUMG00000037073		byFrequency	Q96HQ0	gene with protein product		ZNF419_ENST00000347466.6_Intron|ZNF419_ENST00000426954.2_Intron|ZNF419_ENST00000424930.2_Intron|AC003005.4_ENST00000601674.1_Intron|ZNF419_ENST00000442920.2_Intron|ZNF419_ENST00000520540.1_Intron|ZNF419_ENST00000518999.1_Intron|ZNF419_ENST00000415379.2_Intron|ZNF419_ENST00000354197.4_Intron			183,873,988	NM_024691	0.5552					+	Intron			141.0								ZNF419-006	2006-12-15				19	+	0.3154				intron,intron,intron,intron,intron,intron,intron	20648		,,,,,,	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Breast(46;0.0848)|Renal(1328;0.157)	T	SO:0001627		,,,,,,		protein_coding		2044				34.0225,30.3082,32.8035		"""Zinc fingers, C2H2-type"", ""-"""	6228					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0252)|Lung(386;0.171)			KNOWN			TGATTTTCCATAGGTTCCTGT		ZNF419A				ENST00000221735.7:c.34-3T>A	19					central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(8)|lung(10)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)		+		,		19q13.43	B4DXU7|B4E348|B7ZA41|E9PCP4|E9PED0|E9PET3|E9PFX9|Q9H5P0		g.chr19:58001512T>A					no		4086,8370												-1.1					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)		2006-12-15		hg19	Standard	0.3201			2847,5521		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	653,2780,2795					CCDS42637.1, CCDS46211.1, CCDS54325.1, CCDS54326.1, CCDS54327.1, CCDS54328.1	T		AA,AT,TT	AK026886	nucleus (GO:0005634)	143		2504		rs11672136		219				"""zinc finger protein 419A"""				,,,,,,				26	NM_001098492		2			ENST00000221735.7		18992		uc010ety.1			79744	dbSNP_120	,,,,,,					0				147.0		0.498	19:g.58001512T>A		protein_coding			NAGNAG_splice_site|non_canonical_polymorphism|basic|appris_candidate|CCDS		470,1907,1807			1239,2849			T|||			5008		ZN419_HUMAN	2189	zinc finger protein 419			0.437101		58001512			0.5784	SNP		CCDS54326.1			,,,	False	58001512				intron_variant		Approved		143.0			2013-01-08	OTTHUMT00000378506.1	Q96HQ0	0.4669		ZNF419	58001512				,,,,,,	ZNF419	NM_001098491.1,NM_001098492.1,NM_001098493.1,NM_001098494.1,NM_001098495.1,NM_001098496.1,NM_024691.3	protein-coding gene			
		A	ENSG00000105136	ENST00000221735.7		79744		ENSG00000105136		4300					,					OTTHUMG00000037073		byFrequency	Q96HQ0	gene with protein product		ZNF419_ENST00000347466.6_Intron|ZNF419_ENST00000426954.2_Intron|ZNF419_ENST00000424930.2_Intron|AC003005.4_ENST00000601674.1_Intron|ZNF419_ENST00000442920.2_Intron|ZNF419_ENST00000520540.1_Intron|ZNF419_ENST00000518999.1_Intron|ZNF419_ENST00000415379.2_Intron|ZNF419_ENST00000354197.4_Intron			781,1060,362	NM_024691	0.8364					+	Intron		425.1+/-354.9	141.0								ZNF419-006	2006-12-15				19	+	0.5794				intron,intron,intron,intron,intron,intron,intron	20648		,,,,,,	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Breast(46;0.0848)|Renal(1328;0.157)	A	SO:0001627		,,,,,,		protein_coding		2203				30.5581,40.4902,33.9228		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0252)|Lung(386;0.171)			KNOWN			AGATAAACTCTACTCTGTCCA		ZNF419A				ENST00000221735.7:c.73-20T>A	19					central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(8)|lung(10)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)		+		,		19q13.43	B4DXU7|B4E348|B7ZA41|E9PCP4|E9PED0|E9PET3|E9PFX9|Q9H5P0		g.chr19:58002819T>A		526.2+/-371.8			no		8594,4412												1.1					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)		2006-12-15		hg19	Standard	0.6839			5972,2628		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2818,2958,727					CCDS42637.1, CCDS46211.1, CCDS54325.1, CCDS54326.1, CCDS54327.1, CCDS54328.1	T		AA,AT,TT	AK026886	nucleus (GO:0005634)	143		2504		rs6510085		258				"""zinc finger protein 419A"""				,,,,,,				26	NM_001098492		3			ENST00000221735.7		20214		uc010ety.1			79744	dbSNP_116	,,,,,,					0				147.0		0.512	19:g.58002819T>A		protein_coding			NAGNAG_splice_site|non_canonical_polymorphism|basic|appris_candidate|CCDS		2037,1898,365			2622,1784			A|||			5008		ZN419_HUMAN	3480	zinc finger protein 419			0.694888		58002819			0.6984	SNP		CCDS54326.1			,,,	False	58002819				intron_variant		Approved		143.0			2013-01-08	OTTHUMT00000378506.1	Q96HQ0	0.7262		ZNF419	58002819				,,,,,,	ZNF419	NM_001098491.1,NM_001098492.1,NM_001098493.1,NM_001098494.1,NM_001098495.1,NM_001098496.1,NM_024691.3	protein-coding gene			
		C	ENSG00000105136	ENST00000221735.7	0.80722	79744	L	ENSG00000105136	0.24079	4300	0.008000	0.06849	P;B;B;P;P;B		,	T	0.0	0	c.(421-423)Gag>Cag	OTTHUMG00000037073	0.353000	byFrequency	Q96HQ0	gene with protein product		ZNF419_ENST00000347466.6_Missense_Mutation_p.E109Q|ZNF419_ENST00000426954.2_Missense_Mutation_p.E129Q|ZNF419_ENST00000424930.2_Missense_Mutation_p.E142Q|AC003005.4_ENST00000601674.1_Intron|ZNF419_ENST00000442920.2_Missense_Mutation_p.E128Q|ZNF419_ENST00000415379.2_Missense_Mutation_p.E95Q|ZNF419_ENST00000354197.4_Missense_Mutation_p.E129Q			781,1056,366	NM_024691	0.8405			G	2.762	+	Missense_Mutation	1	681.2+/-403.7	63.0	E9PFX9;E9PCP4;E9PET3;E9PED0;Q96HQ0-2;Q96HQ0	0.59419					0.099;0.002;0.003;0.356;0.463;0.001	ZNF419-006	2006-12-15		0.44897		19	+	0.5794		0.42	0.319000	missense,missense,missense,missense,missense,missense,missense	20648	258	142/512,129/499,128/498,109/479,96/466,95/465,141/511	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Breast(46;0.0848)|Renal(1328;0.157)	G	SO:0001583		benign,benign,benign,benign,benign,benign,benign	0.712707182320442	protein_coding		2203	P		0.029000	30.6163,40.581,33.992	B;B;B;B;P;B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.3047:0.0:0.6953:0.0			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0252)|Lung(386;0.171)			KNOWN	ENST00000284020;ENST00000524372;ENST00000424930;ENST00000426954;ENST00000354197;ENST00000442920;ENST00000517598;ENST00000347466;ENST00000415379;ENST00000521754;ENST00000221735;ENST00000521137		AAAAAGACAAGAGGGCAGGGT	T;T;T;T;T;T;T;T;T	ZNF419A				ENST00000221735.7:c.421G>C	19		ENSG00000105136	0.17691	ZNF419	central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(8)|lung(10)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	ENSP00000221735:p.Glu141Gln	+	0.19370	,	GAG	19q13.43	B4DXU7|B4E348|B7ZA41|E9PCP4|E9PED0|E9PET3|E9PFX9|Q9H5P0		g.chr19:58004346G>C	E -> Q (in dbSNP:rs2074076). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	628.1+/-395.0		290	no		8585,4421	0.14137	0.05791	2.48	0.00012	ENSP00000221735:E141Q			.		.		0.3	0.15592	410	0.21014	0.7167832167832168	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	1.09	2006-12-15		hg19	Standard	0.6839	0.5894308943089431	6.0755	5967,2633		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2816,2953,734	-0.257605				CCDS42637.1, CCDS46211.1, CCDS54325.1, CCDS54326.1, CCDS54327.1, CCDS54328.1	G	0.45827	CC,CG,GG	AK026886	nucleus (GO:0005634)	62	0.35793	2504	0.261	rs2074076		607	95;128;129;142;109;141	519		"""zinc finger protein 419A"""	0.19913	62696158	+	GLN/GLU,GLN/GLU,GLN/GLU,GLN/GLU,GLN/GLU,GLN/GLU,GLN/GLU	141		1477	26	NM_001098492	0.596;0.0;0.0;0.743;0.867;0.0	5	0.6846965699208444	0.205000	ENST00000221735.7		19751		uc010ety.1			79744	dbSNP_96	424,385,382,325,286,283,421	0.0000		p.E141Q	.	0		T		60.0	rs2074076;rs12983132;rs58731055	0.507	19:g.58004346G>C	ENSP00000388864:E142Q;ENSP00000390916:E129Q;ENSP00000346136:E129Q;ENSP00000414709:E128Q;ENSP00000299860:E109Q;ENSP00000392129:E95Q;ENSP00000428523:E96Q;ENSP00000221735:E141Q;ENSP00000429628:E108Q	protein_coding	.		NAGNAG_splice_site|non_canonical_polymorphism|basic|appris_candidate|CCDS		2035,1897,368		144;129;142;129;129;128;142;109;95;96;141;108	2618,1788	0.6762820512820513	Q	G|||		.	5008		ZN419_HUMAN	3484	zinc finger protein 419		.;.;.;.;.;ZN419_HUMAN	0.695687	0.28757	58004346		0.923000	0.6984	SNP		CCDS54326.1		.	,,,	False	58004346	-1.0697		8	missense	T	Approved	0.693837	62.0		c.421G>C	2013-01-08	OTTHUMT00000378506.1	Q96HQ0	0.7262	3.37;3.38;3.32;3.38;3.25;3.25;5.4;3.36;6.97	ZNF419	58004346	0.28217		0.08953	29,29,29,29,29,29,29	ZNF419	NM_001098491.1,NM_001098492.1,NM_001098493.1,NM_001098494.1,NM_001098495.1,NM_001098496.1,NM_024691.3	protein-coding gene		E	
		G	ENSG00000105136	ENST00000221735.7	0.80722	79744	L	ENSG00000105136	0.07495	4296	0.578000	0.00986	B;B;B;B;B;B		,	T	0.0	0	c.(1006-1008)Att>Gtt	OTTHUMG00000037073	-0.414000	byFrequency	Q96HQ0	gene with protein product		ZNF419_ENST00000347466.6_Missense_Mutation_p.I304V|ZNF419_ENST00000426954.2_Missense_Mutation_p.I324V|ZNF419_ENST00000424930.2_Missense_Mutation_p.I337V|AC003005.4_ENST00000601674.1_Intron|ZNF419_ENST00000442920.2_Missense_Mutation_p.I323V|ZNF419_ENST00000415379.2_Missense_Mutation_p.I290V|ZNF419_ENST00000354197.4_Missense_Mutation_p.I324V			772,952,476	NM_024691	0.8405			G	0.009	+	Missense_Mutation	1		65.0	E9PFX9;E9PCP4;E9PET3;E9PED0;Q96HQ0-2;Q96HQ0	0.567273					0.001;0.0;0.0;0.001;0.0;0.001	ZNF419-006	2006-12-15		0.04013		19	+	0.5787		0.4	0.727000	missense,missense,missense,missense,missense,missense,missense	20648	236	337/512,324/499,323/498,304/479,291/466,290/465,336/511	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Ovarian(87;0.0694)|Breast(46;0.0848)|Renal(1328;0.157)	G	SO:0001583		benign,benign,benign,benign,benign,benign,benign	0.6519337016574586	protein_coding		2200	P		0.000000	32.0647,43.2727,35.8605	B;B;B;B;B;B	"""Zinc fingers, C2H2-type"", ""-"""	6496		0.6093:0.1722:0.2185:0.0			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0252)|Lung(386;0.171)			KNOWN	ENST00000284020;ENST00000424930;ENST00000426954;ENST00000354197;ENST00000442920;ENST00000517598;ENST00000347466;ENST00000415379;ENST00000221735		ACATCAGAGAATTCACACTGG	T;T;T;T;T;T;T	ZNF419A				ENST00000221735.7:c.1006A>G	19		ENSG00000105136	0.02607	ZNF419	central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(8)|lung(10)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	ENSP00000221735:p.Ile336Val	+	0.05858	,	ATT	19q13.43	B4DXU7|B4E348|B7ZA41|E9PCP4|E9PED0|E9PET3|E9PFX9|Q9H5P0		g.chr19:58004931A>G	I -> V (in dbSNP:rs2074077). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.			232	no		8333,4659	0.28575	0.00568	2.36	0.00012	ENSP00000221735:I336V			.		.		-1.2	0.09617	377	0.22109	0.6590909090909091	0.6	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	0.86	2006-12-15		hg19	Standard	0.6839	0.4715447154471545	5.3392	5837,2755		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2797,2739,960	-1.847078				CCDS42637.1, CCDS46211.1, CCDS54325.1, CCDS54326.1, CCDS54327.1, CCDS54328.1	A	0.02656	GG,GA,AA	AK026886	nucleus (GO:0005634)	66	0.28504	2504	-1.18	rs2074077		1192	290;323;324;337;304;336	464		"""zinc finger protein 419A"""	0.15974	62696743	+	VAL/ILE,VAL/ILE,VAL/ILE,VAL/ILE,VAL/ILE,VAL/ILE,VAL/ILE	336		1309	26	NM_001098492	0.0;0.0;0.0;0.0;0.0;0.0	5	0.6121372031662269	-0.971000	ENST00000221735.7		19805		uc010ety.1			79744	dbSNP_96	1009,970,967,910,871,868,1006	0.0000		p.I336V	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	0		T		67.0	rs2074077;rs2074077	0.403	19:g.58004931A>G	ENSP00000388864:I337V;ENSP00000390916:I324V;ENSP00000346136:I324V;ENSP00000414709:I323V;ENSP00000299860:I304V;ENSP00000392129:I290V;ENSP00000221735:I336V	protein_coding	.		NAGNAG_splice_site|non_canonical_polymorphism|basic|appris_candidate|CCDS		2025,1787,484		311;337;324;324;323;337;304;290;336	2496,1904	0.5993589743589743	V	G|||		.	5008		ZN419_HUMAN	3483	zinc finger protein 419		.;.;.;.;.;ZN419_HUMAN	0.695487	0.05641	58004931		-0.608000	0.6984	SNP		CCDS54326.1		.	,,,	False	58004931	-1.1191		8	missense	T	Approved	0.679353	66.0		c.1006A>G	2013-01-08	OTTHUMT00000378506.1	Q96HQ0	0.7262	5.47;5.47;5.47;5.47;5.47;5.47;5.47	ZNF419	58004931	0.41649		0.02232	29,29,29,29,29,29,29	ZNF419	NM_001098491.1,NM_001098492.1,NM_001098493.1,NM_001098494.1,NM_001098495.1,NM_001098496.1,NM_024691.3	protein-coding gene		I	
		G	ENSG00000251369	ENST00000457177.1	0.80722	162972	N	ENSG00000251369	0.05767	4300	0.000000	0.06933	B		,	T	0.0	0	c.(1075-1077)aTa>aCa	OTTHUMG00000133709	-0.603000	byFrequency	Q7Z398	gene with protein product		ZNF549_ENST00000594943.1_Intron|ZNF550_ENST00000506609.2_Missense_Mutation_p.I318T|ZNF549_ENST00000602149.1_Intron|ZNF550_ENST00000601415.1_Intron|ZNF550_ENST00000325134.5_Missense_Mutation_p.I327T			1019,941,243	NM_153231	0.6677			A	11.68	+	Missense_Mutation	2	618.5+/-396.8	91.0	Q7Z398-2	0.676123		12477932			0.001	ZNF550-001			0.04013		19	-	0.7035		1	0.995000	missense	28643	202	318/382	Colorectal(82;0.000256)|all_neural(62;0.0577)|Ovarian(87;0.221)	A	SO:0001583		benign	0.5580110497237569	protein_coding		2203	P		0.000000	43.1512,32.3877,39.5048	B	"""Zinc fingers, C2H2-type"""	6503		0.4595:0.0:0.3888:0.1517			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.026)			KNOWN	ENST00000344222;ENST00000325134;ENST00000506609		CTGGTGCTGTATGAGTTCTGA	T;T					ENST00000457177.1:c.1076T>C	19		ENSG00000251369	0.50628	AC003682.1	endometrium(1)|large_intestine(1)|lung(4)|prostate(1)	ENSP00000469679:p.Ile359Thr	-	0.05858	,	ATA	19q13.43	B3KVF6|O43337|Q7Z6D7|Q8NE45		g.chr19:58058536A>G	I -> T (in dbSNP:rs1548476). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005}.	684.1+/-404.4		337	yes		7868,5138	0.03702	0.30322	3.33	0.00012	ENSP00000446224:I327T			.		1.2022		-1.6	0.08453	427	0.02654	0.7465034965034965	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-0.435			hg19	Standard	0.5547	0.6849593495934959	4.6446	4889,3711		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2402,3064,1037	1.711200				CCDS35500.1, CCDS35500.2	A	0.02656	GG,GA,AA	AL833214	nucleus (GO:0005634)	97	0.03016	2504	-1.59	rs1548476		1256	327	425			0.12566	62750348	-	THR/ILE	359	MGC41917	1391	7	NM_001277090	0.0	4	0.5606860158311345	0.523000	ENST00000457177.1		19717		uc002qpd.4			162972	dbSNP_88	953	0.0000		p.I359T	.	0		T		108.0	rs1548476;rs17853332;rs52799718;rs57971165;rs1548476	0.502	19:g.58058536A>G	ENSP00000446224:I327T;ENSP00000422344:I318T	protein_coding	.		NMD_exception|basic|appris_candidate_longest		1383,2123,794		359;327;318	2979,1427	0.6369047619047619	T	A|||		.	5008		ZN550_HUMAN	3290	zinc finger protein 550		.	0.656949	0.03356	58058536		-1.095000	0.7083	SNP				.	,,,	False	58058536	-0.9985		8	missense	T	Approved	0.568488	97.0		c.1076T>C	2013-05-22	OTTHUMT00000257992.2	Q7Z398	0.6268	3.24;3.24	ZNF550	58058536	0.86356		0.30238	89	ZNF550	NM_001039654.1	protein-coding gene		I	
		C	ENSG00000251369	ENST00000457177.1		162972		ENSG00000251369		4300					,				c.(871-873)caA>caG	OTTHUMG00000133709		byFrequency	Q7Z398	gene with protein product		ZNF549_ENST00000594943.1_Intron|ZNF550_ENST00000506609.2_Silent_p.Q250Q|ZNF549_ENST00000602149.1_Intron|ZNF550_ENST00000601415.1_Intron|ZNF550_ENST00000325134.5_Silent_p.Q259Q			661,1088,454	NM_153231	0.4724					+	Silent		550.5+/-385.8	123.0				12477932				ZNF550-001					19	-	0.5651				coding-synonymous	28643		250/382	Colorectal(82;0.000256)|all_neural(62;0.0577)|Ovarian(87;0.221)	T	SO:0001819				protein_coding		2203				46.0349,45.3019,48.9697		"""Zinc fingers, C2H2-type"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.026)			KNOWN			CCTTTCGACATTGACTACACT						ENST00000457177.1:c.873A>G	19					endometrium(1)|large_intestine(1)|lung(4)|prostate(1)		-		,		19q13.43	B3KVF6|O43337|Q7Z6D7|Q8NE45		g.chr19:58058739T>C		616.9+/-392.9			yes		6369,6637												-2.4					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.4414			3959,4641		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	1547,3275,1681					CCDS35500.1, CCDS35500.2	T		CC,CT,TT	AL833214	nucleus (GO:0005634)	125		2504		rs10410631		1053									291	MGC41917		7	NM_001277090		4			ENST00000457177.1		19113		uc002qpd.4			162972	dbSNP_119	750			p.Q291Q		0				128.0		0.483	19:g.58058739T>C		protein_coding			NMD_exception|basic|appris_candidate_longest		886,2187,1227			2410,1996			T|||			5008		ZN550_HUMAN	2441	zinc finger protein 550			0.48742		58058739			0.4097	SNP					,,,	False	58058739				synonymous_variant		Approved		125.0		c.873A>G	2013-05-22	OTTHUMT00000257992.2	Q7Z398	0.5403		ZNF550	58058739					ZNF550	NM_001039654.1	protein-coding gene			
		C	ENSG00000179909	ENST00000512439.2	0.09310	7710	L	ENSG00000179909	0.22570	4136	0.002000	0.00784	B		,	D	1	0	c.(169-171)cAt>cGt	OTTHUMG00000140375	0.295000	byFrequency	Q13106	gene with protein product		ZNF551_ENST00000596085.1_Intron|AC003006.7_ENST00000599221.1_Intron|AC003006.7_ENST00000594684.1_Intron|ZNF154_ENST00000426889.1_Missense_Mutation_p.H57R			0,37,1866		0.0082			T	7.551	+	Missense_Mutation	2		37.0	Q13106	0.009721		7557990			0.0	ZNF154-002	2006-08-22		0.01281		19	-	0.0008		0.01	0.151000	missense	12939	7	57/438	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	T	SO:0001583	604085	benign	0.019337016574585635	protein_coding		1903	N		0.000000	3.9047,0.9721,2.9806	B	"""Zinc fingers, C2H2-type"", ""-"""	6039		0.0:0.3592:0.0:0.6408			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0257)			KNOWN	ENST00000512439;ENST00000426889		CTGCTTCTGATGATGAACATC	T;T					ENST00000512439.2:c.170A>G	19	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.	ENSG00000179909	0.30748	ZNF154	endometrium(1)|kidney(1)|large_intestine(7)|lung(3)	ENSP00000421258:p.His57Arg	-	0.05858	,	CAT	19q13.4	A7MCY3|Q8IVG7|Q8NAR0		g.chr19:58214147T>C	H -> R (in dbSNP:rs34282745). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2}.			1	yes		360,11718	0.10522	0.14645	2.15	0.00241	ENSP00000442370:H57R			.		.		1.1	0.20524	0	0.72032	0.0	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)	1.265			hg19	Standard	0.0239	0.0020325203252032522	4.109	323,7949		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2,356,5681	0.662628				CCDS42639.1	T	0.02656	CC,CT,TT	U20648	nucleus (GO:0005634)	38	0.41236	2504	1.11	rs34282745		366	57	23		"""zinc finger protein 154 (pHZ-92)"""	0.10050	62905959	-	ARG/HIS	57	pHZ-92	31	12	XR_243957	0.0	3	0.030343007915567283	0.454000	ENST00000512439.2		21370		uc010euf.3			7710	dbSNP_126	170	0.0007		p.H57R	Krueppel-associated box (3);	0		T		40.0	rs34282745	0.463	19:g.58214147T>C	ENSP00000421258:H57R;ENSP00000442370:H57R	protein_coding	.		NMD_exception|basic|appris_principal|CCDS		2,319,3815		57	37,3769	0.014194139194139194	R	T|||		.	5008		ZN154_HUMAN	42	zinc finger protein 154		ZN154_HUMAN	0.00838658	0.11865	58214147		-0.052000	0.0	SNP		CCDS42639.1		.	,,,	False	58214147	-0.9045		9	missense	T	Approved	0.039047	38.0		c.170A>G	2013-01-08	OTTHUMT00000277102.2	Q13106	0.013	5.7;5.7	ZNF154	58214147	0.21798		0.48328	29	ZNF154	NM_001085384.1	protein-coding gene		H	
		G	ENSG00000198466	ENST00000339656.5		84914				4300									c.(1477-1479)gaA>gaG	OTTHUMG00000154901		byFrequency	Q96SQ5	gene with protein product		ZNF587_ENST00000423137.1_Silent_p.E492E|ZNF814_ENST00000597342.1_Intron|ZNF587_ENST00000419854.1_Silent_p.E450E|ZNF814_ENST00000595295.1_Intron|ZNF814_ENST00000596604.1_Intron|ZNF814_ENST00000597832.1_Intron		NM_001204817.1|NM_032828.3		NM_032828		Substitution - coding silent(1)				+	Silent			149.0				10520746				ZNF587-001					19	+						30955			Colorectal(82;0.000256)|all_neural(62;0.0577)|Breast(46;0.147)|Ovarian(87;0.156)		SO:0001819				protein_coding	stomach(1)	2203						"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0264)		Pancreas(59;641 1233 1885 20055 50741)	KNOWN			GGCCGTATGAATGCAGTGAAT						ENST00000339656.5:c.1479A>G	19					central_nervous_system(1)|endometrium(4)|kidney(2)|large_intestine(1)|lung(4)|ovary(1)|pancreas(1)|stomach(1)		+				19q13.43	A0AV72|G3V0H5|Q6ZMK8		g.chr19:58371259A>G																									DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)				p.E493E(1)		CCDS12964.1, CCDS56110.1	A			AF294842	nucleus (GO:0005634)					rs75951435		1661									493	ZF6, FLJ14710, UBF-fl, FLJ20813		15	NM_032828		3			ENST00000339656.5				uc002qql.3			84914					p.E493E		1				145.0		0.423	19:g.58371259A>G		protein_coding			basic|appris_candidate_longest|CCDS													ZN587_HUMAN		zinc finger protein 587					58371259				SNP		CCDS12964.1					58371259				synonymous_variant		Approved		148.0		c.1479A>G	2013-01-08	OTTHUMT00000337594.2	Q96SQ5			ZNF587	58371259							protein-coding gene	NP_001191746.1|NP_116217.1		
		T	ENSG00000198466	ENST00000339656.5		84914				4300									c.(1492-1494)ggG>ggT	OTTHUMG00000154901		byFrequency	Q96SQ5	gene with protein product		ZNF587_ENST00000423137.1_Silent_p.G497G|ZNF814_ENST00000597342.1_Intron|ZNF587_ENST00000419854.1_Silent_p.G455G|ZNF814_ENST00000595295.1_Intron|ZNF814_ENST00000596604.1_Intron|ZNF814_ENST00000597832.1_Intron		NM_001204817.1|NM_032828.3		NM_032828						+	Silent			136.0				10520746				ZNF587-001					19	+						30955			Colorectal(82;0.000256)|all_neural(62;0.0577)|Breast(46;0.147)|Ovarian(87;0.156)		SO:0001819				protein_coding		2203						"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0264)		Pancreas(59;641 1233 1885 20055 50741)	KNOWN			GTGAATGTGGGAAATCATTTC						ENST00000339656.5:c.1494G>T	19					central_nervous_system(1)|endometrium(4)|kidney(2)|large_intestine(1)|lung(4)|ovary(1)|pancreas(1)|stomach(1)		+				19q13.43	A0AV72|G3V0H5|Q6ZMK8		g.chr19:58371274G>T																									DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard						regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)						CCDS12964.1, CCDS56110.1	G			AF294842	nucleus (GO:0005634)					rs10405892		1676									498	ZF6, FLJ14710, UBF-fl, FLJ20813		15	NM_032828		3			ENST00000339656.5				uc002qql.3			84914					p.G498G		0				132.0		0.408	19:g.58371274G>T		protein_coding			basic|appris_candidate_longest|CCDS													ZN587_HUMAN		zinc finger protein 587					58371274				SNP		CCDS12964.1					58371274				synonymous_variant		Approved		134.0		c.1494G>T	2013-01-08	OTTHUMT00000337594.2	Q96SQ5			ZNF587	58371274							protein-coding gene	NP_001191746.1|NP_116217.1		
		C	ENSG00000173480	ENST00000312026.5		147687				4298					,							byFrequency	Q8TAU3	gene with protein product		CTD-2583A14.9_ENST00000602124.1_Intron|ZNF417_ENST00000595559.1_3'UTR|ZNF417_ENST00000536263.1_3'UTR		NM_152475.2	195,961,1047	NM_152475	0.32					+	3'UTR			61.0								ZNF417-002					19	-	0.2965				utr-3	20646			Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	C	SO:0001624				protein_coding		2203				37.6803,30.6627,35.3023		"""Zinc fingers, C2H2-type"", ""-"""	6501					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0151)			KNOWN			CTGTGTTTAATGAGACGGGAT						ENST00000312026.5:c.*44A>G	19					central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(7)|stomach(3)|upper_aerodigestive_tract(1)		-		,		19q13.43	B4DEU1		g.chr19:58419874T>C					no		4590,8412												-5.2					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.3767			3239,5357		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	816,2958,2727					CCDS12965.1, CCDS74469.1	T		CC,CT,TT	BC025783	nucleus (GO:0005634)	61		2504		rs10415951		1936										MGC34079		18	NM_152475		0			ENST00000312026.5		23899		uc002qqq.3			147687	dbSNP_119						0				62.0		0.458	19:g.58419874T>C		protein_coding			basic|appris_candidate_longest|CCDS		621,1997,1680			1351,3055			C|||			5008		ZN417_HUMAN	1589	zinc finger protein 417			0.317292		58419874			0.3016	SNP		CCDS12965.1			,,,	False	58419874				3_prime_UTR_variant		Approved		61.0			2013-01-08	OTTHUMT00000466860.1	Q8TAU3	0.2896		ZNF417	58419874					ZNF417	NM_152475.2	protein-coding gene	NP_689688.2		
		A	ENSG00000173480	ENST00000312026.5		147687				4296					,				c.(1492-1494)ggG>ggT			byFrequency	Q8TAU3	gene with protein product		ZNF417_ENST00000595559.1_Silent_p.G497G|ZNF417_ENST00000536263.1_Silent_p.G299G|CTD-2583A14.9_ENST00000602124.1_Intron		NM_152475.2		NM_152475	0.2965	Substitution - coding silent(1)				+	Silent			85.0								ZNF417-002					19	-	0.2761					20646			Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)		SO:0001819				protein_coding	stomach(1)	2203						"""Zinc fingers, C2H2-type"", ""-"""	6499					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0151)			KNOWN			GAAATGATTTCCCACATTCAT						ENST00000312026.5:c.1494G>T	19					central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(7)|stomach(3)|upper_aerodigestive_tract(1)		-		,		19q13.43	B4DEU1		g.chr19:58420152C>A																									DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.2992					regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)				p.G498G(1)		CCDS12965.1, CCDS74469.1	C			BC025783	nucleus (GO:0005634)			2504		rs17845779		1658									498	MGC34079		18	NM_152475		3			ENST00000312026.5		21369		uc002qqq.3			147687					p.G498G		1				104.0		0.398	19:g.58420152C>A		protein_coding			basic|appris_candidate_longest|CCDS								A|||			5008		ZN417_HUMAN	1399	zinc finger protein 417			0.279353		58420152			0.2847	SNP		CCDS12965.1			,,,	False	58420152				synonymous_variant		Approved		91.0		c.1494G>T	2013-01-08	OTTHUMT00000466860.1	Q8TAU3	0.2248		ZNF417	58420152							protein-coding gene	NP_689688.2		
		C	ENSG00000173480	ENST00000312026.5	0.80722	147687	N		0.00261	4298	0.000000	0.07216	B		,	T	0.0	0	c.(1483-1485)aAt>aGt		-3.048000	byFrequency	Q8TAU3	gene with protein product		ZNF417_ENST00000595559.1_Missense_Mutation_p.N494S|ZNF417_ENST00000536263.1_Missense_Mutation_p.N296S|CTD-2583A14.9_ENST00000602124.1_Intron		NM_152475.2	164,623,1416	NM_152475	0.32			.	0.125	+	Missense_Mutation	2		91.0	Q8TAU3	0.215842					0.001	ZNF417-002			0.04013		19	-	0.2943		1	0.166000	missense	20646	110	495/576	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	C	SO:0001583		benign	0.30386740331491713	protein_coding		2203	P		0.000000	29.06,21.5842,26.5267	B	"""Zinc fingers, C2H2-type"", ""-"""	6501		0.205:0.1385:0.2171:0.4394			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0151)			KNOWN	ENST00000312026;ENST00000536263		CCCACATTCATTGCATTCATA	T;T					ENST00000312026.5:c.1484A>G	19		ENSG00000173480	0.03846	ZNF417	central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(7)|stomach(3)|upper_aerodigestive_tract(1)	ENSP00000311319:p.Asn495Ser	-	0.05858	,	AAT	19q13.43	B4DEU1		g.chr19:58420162T>C	N -> S (in dbSNP:rs10416584). {ECO:0000269|PubMed:15489334}.			110	no		3449,9553	0.03702	0.01785	2.38	0.00012	ENSP00000311319:N495S			.		.		-4.8	0.03229	141	0.02654	0.2465034965034965	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	0.24			hg19	Standard	0.3698	0.22357723577235772	1.0708	2498,6098		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	728,1993,3780	-1.120845				CCDS12965.1, CCDS74469.1	T	0.02656	CC,CT,TT	BC025783	nucleus (GO:0005634)	98	0.12611	2504	-4.76	rs10416584		1648	495	246			0.01621	63111974	-	SER/ASN	495	MGC34079	607	18	NM_152475	0.0	3	0.3245382585751979	-0.665000	ENST00000312026.5		21501		uc002qqq.3			147687	dbSNP_119	1484	0.0000		p.N495S	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	0		T		111.0	rs10416584;rs17856733	0.408	19:g.58420162T>C	ENSP00000311319:N495S;ENSP00000442760:N296S	protein_coding	.		basic|appris_candidate_longest|CCDS		564,1370,2364		495;296	951,3455	0.27793040293040294	S	C|||		.	5008		ZN417_HUMAN	1576	zinc finger protein 417		ZN417_HUMAN	0.314696	0.00017	58420162		-8.711000	0.2996	SNP		CCDS12965.1		.	,,,	False	58420162	-0.9453		8	missense	T	Approved	0.2906	98.0		c.1484A>G	2013-01-08	OTTHUMT00000466860.1	Q8TAU3	0.2882	3.21;3.21	ZNF417	58420162	0.22503		0.42413	46	ZNF417	NM_152475.2	protein-coding gene	NP_689688.2	N	
		C	ENSG00000173480	ENST00000312026.5		147687				4299					,				c.(1477-1479)gaA>gaG			byFrequency	Q8TAU3	gene with protein product		ZNF417_ENST00000595559.1_Silent_p.E492E|ZNF417_ENST00000536263.1_Silent_p.E294E|CTD-2583A14.9_ENST00000602124.1_Intron		NM_152475.2	63,399,1741	NM_152475	0.2975	Substitution - coding silent(1)				+	Silent			93.0								ZNF417-002					19	-	0.1543				coding-synonymous	20646		493/576	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	T	SO:0001819				protein_coding	stomach(1)	2203				23.4938,11.9156,19.5709		"""Zinc fingers, C2H2-type"", ""-"""	6502					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0151)			KNOWN			ATTCATTGCATTCATACGGCC						ENST00000312026.5:c.1479A>G	19					central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(7)|stomach(3)|upper_aerodigestive_tract(1)		-		,		19q13.43	B4DEU1		g.chr19:58420167T>C					no		2545,10459												-4.8					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.2972			2020,6578		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	411,1723,4368			p.E493E(1)		CCDS12965.1, CCDS74469.1	T		CC,CT,TT	BC025783	nucleus (GO:0005634)	100		2504		rs17852300		1643									493	MGC34079		18	NM_152475		3			ENST00000312026.5		21542		uc002qqq.3			147687	dbSNP_123	1479			p.E493E		1				112.0		0.408	19:g.58420167T>C		protein_coding			basic|appris_candidate_longest|CCDS		348,1324,2627			525,3881			T|||			5008		ZN417_HUMAN	1233	zinc finger protein 417			0.246206		58420167			0.2847	SNP		CCDS12965.1			,,,	False	58420167				synonymous_variant		Approved		100.0		c.1479A>G	2013-01-08	OTTHUMT00000466860.1	Q8TAU3	0.219		ZNF417	58420167					ZNF417	NM_152475.2	protein-coding gene	NP_689688.2		
		A	ENSG00000173480	ENST00000312026.5	0.80722	147687	L		0.05135	4300	0.000000	0.25085	P		,	D	0.0	0	c.(946-948)cGt>cTt		-0.691000	byFrequency	Q8TAU3	gene with protein product		ZNF417_ENST00000595559.1_Missense_Mutation_p.R315L|ZNF417_ENST00000536263.1_Missense_Mutation_p.R117L|CTD-2583A14.9_ENST00000602124.1_Intron		NM_152475.2		NM_152475	0.3098	Substitution - Missense(1)		.	8.577	+	Missense_Mutation	2		147.0	Q8TAU3	.					0.236	ZNF417-002			0.36922		19	-	0.4153		0.02	0.128000		20646	107		Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)		SO:0001583			0.2955801104972376	protein_coding	stomach(1)	2203	P		0.000000		B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.0:0.6777:0.0:0.3223			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0151)			KNOWN	ENST00000312026;ENST00000536263		AGTGTGAACACGCTGATGGCT	T;T					ENST00000312026.5:c.947G>T	19		ENSG00000173480	0.02344	ZNF417	central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(7)|stomach(3)|upper_aerodigestive_tract(1)	ENSP00000311319:p.Arg316Leu	-	0.05858	,	CGT	19q13.43	B4DEU1		g.chr19:58420699C>A				167				0.03702	0.17467	2.15	0.00012	ENSP00000311319:R316L			.		.			0.07410	118	0.66056	0.2062937062937063		DNA binding (GO:0003677)|metal ion binding (GO:0046872)	1.86			hg19	Standard	0.3499	0.3394308943089431	7.8865		R -> L (in Ref. 3; AAH25783). {ECO:0000305}.	regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)		0.881369		p.R316L(1)		CCDS12965.1, CCDS74469.1	C	0.38335		BC025783	nucleus (GO:0005634)		0.60012	2504	-2.01	rs3745133		1111	316	253			0.29653	63112511	-		316	MGC34079	645	18	NM_152475	0.627	3	0.3337730870712401	-1.050000	ENST00000312026.5		25205		uc002qqq.3			147687			0.0000		p.R316L	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	1		T		167.0	rs3745133;rs17856732	0.458	19:g.58420699C>A	ENSP00000311319:R316L;ENSP00000442760:R117L	protein_coding	.		basic|appris_candidate_longest|CCDS				316;117		0.29532967032967034	L	C|||		.	5008		ZN417_HUMAN	1690	zinc finger protein 417		ZN417_HUMAN	0.33746	0.01037	58420699		-2.414000	0.2817	SNP		CCDS12965.1		.	,,,	False	58420699	-0.9886		8	missense	T	Approved	.	154.0		c.947G>T	2013-01-08	OTTHUMT00000466860.1	Q8TAU3	0.2911	1.82;1.82	ZNF417	58420699	0.20619		0.32981				protein-coding gene	NP_689688.2	R	
		T	ENSG00000173480	ENST00000312026.5	0.53688	147687	N		0.05105	3995	0.000000	0.06294	B;B		,	T	2.999999999997449E-5	0	c.(517-519)cGc>cAc		-0.695000	byFrequency	Q8TAU3	gene with protein product		ZNF417_ENST00000595559.1_Missense_Mutation_p.R172H|ZNF417_ENST00000536263.1_5'UTR|CTD-2583A14.9_ENST00000602124.1_Intron		NM_152475.2	296,346,1234	NM_152475	0.3722			.	0.284	+	Missense_Mutation	2		52.0	F5H0M9;Q8TAU3	0.25					0.0;0.0	ZNF417-002			0.01281		19	-	0.2496		0.15	0.001000	missense	20646	90	173/576	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	C	SO:0001583		benign	0.24861878453038674	protein_coding		1876	P		0.000000	37.7222,25.0,33.657	B;B	"""Zinc fingers, C2H2-type"", ""-"""	5871		0.0:0.4727:0.0:0.5273			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0151)			KNOWN	ENST00000312026		CCCAAACTCGCGGAAGACAAA	T					ENST00000312026.5:c.518G>A	19		ENSG00000173480	0.00325	ZNF417	central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(7)|stomach(3)|upper_aerodigestive_tract(1)	ENSP00000311319:p.Arg173His	-	0.05858	,	CGC	19q13.43	B4DEU1		g.chr19:58421128C>T				111	no		3952,7790	0.03702	0.02180	1.86	0.00012	ENSP00000311319:R173H			.		.		-3.3	0.04988	138	0.41790	0.24125874125874125	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	0.385			hg19	Standard	0.3708	0.22560975609756098	7.2829	3014,4976	R -> H (in Ref. 3; AAH25783). {ECO:0000305}.	regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	1330,1292,3249	-0.984691				CCDS12965.1, CCDS74469.1	C	0.02656	TT,TC,CC	BC025783	nucleus (GO:0005634)	51	0.16201	2504	-3.31	rs201944488		682	173;173	215			0.26322	63112940	-	HIS/ARG	173	MGC34079	554	18	NM_152475	0.0;0.0	3	0.2836411609498681	-2.164000	ENST00000312026.5		19752		uc002qqq.3			147687	dbSNP_134	518	0.0000		p.R173H	.	0		T		50.0	.	0.478	19:g.58421128C>T	ENSP00000311319:R173H	protein_coding	.		basic|appris_candidate_longest|CCDS		1034,946,2015		173	938,2814	0.25366300366300365	H	c|||		.	5008		ZN417_HUMAN	1646	zinc finger protein 417		.;ZN417_HUMAN	0.328674	0.05978	58421128		-0.558000	0.3631	SNP		CCDS12965.1		.	,,,	False	58421128	-0.9144		8	missense	T	Approved	0.377222	51.0		c.518G>A	2013-01-08	OTTHUMT00000466860.1	Q8TAU3	0.3069	3.32	ZNF417	58421128	0.01503		0.47086	29	ZNF417	NM_152475.2	protein-coding gene	NP_689688.2	R	
		C	ENSG00000152454	ENST00000282308.3		10172				4300					,				c.(832-834)caA>caG			byFrequency	Q9Y2P7	gene with protein product		ZNF256_ENST00000598928.1_3'UTR		NM_005773.2	72,623,1508		0.2965					+	Silent			108.0								ZNF256-001					19	-	0.1596				coding-synonymous	13049		278/628	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	T	SO:0001819	606956			protein_coding		2203				29.6395,17.4081,25.4959		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0155)		NSCLC(55;1313 1552 8040 11996)	KNOWN			GGCTAGAGCTTTGCCTATAGG						ENST00000282308.3:c.834A>G	19					endometrium(1)|kidney(3)|large_intestine(6)|lung(7)|skin(1)|upper_aerodigestive_tract(1)		-		,		19q13	B2RA92|Q53Y85|Q9BV71		g.chr19:58453342T>C					no		3316,9690												0.9					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.3002			2549,6051		multicellular organismal development (GO:0007275)|negative regulation of transcription, DNA-templated (GO:0045892)|transcription, DNA-templated (GO:0006351)	441,2434,3628					CCDS12966.1	T		CC,CT,TT	AF067165	nucleus (GO:0005634)	110		2504		rs959231		1030									278	BMZF-3		19	NM_005773		3			ENST00000282308.3		24363		uc002qqu.3			10172	dbSNP_86	834			p.Q278Q		0				114.0		0.393	19:g.58453342T>C		protein_coding			basic|appris_principal|CCDS		369,1811,2120			767,3639			T|||			5008		ZN256_HUMAN	1336	zinc finger protein 256			0.266773		58453342			0.3145	SNP		CCDS12966.1			,,,	False	58453342				synonymous_variant		Approved		110.0		c.834A>G	2013-01-08	OTTHUMT00000466702.1	Q9Y2P7	0.3112		ZNF256	58453342					ZNF256	NM_005773.2	protein-coding gene	NP_005764.2		
		T	ENSG00000152454	ENST00000282308.3		10172				4300					,				c.(79-81)gaG>gaA			byFrequency	Q9Y2P7	gene with protein product		ZNF256_ENST00000598928.1_Intron		NM_005773.2	2202,1,0		1.0					+	Silent			158.0								ZNF256-001					19	-	1.0				coding-synonymous	13049		27/628	Colorectal(82;5.46e-05)|all_neural(62;0.0218)|Breast(46;0.0389)|Ovarian(87;0.0443)|Renal(1328;0.157)	T	SO:0001819	606956			protein_coding		2203				0.0581,0.0227,0.0461		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0155)		NSCLC(55;1313 1552 8040 11996)	KNOWN			GAAGACCCCACTCCTTCCAGG						ENST00000282308.3:c.81G>A	19	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.				endometrium(1)|kidney(3)|large_intestine(6)|lung(7)|skin(1)|upper_aerodigestive_tract(1)		-		,		19q13	B2RA92|Q53Y85|Q9BV71		g.chr19:58455381C>T					no		13000,6												-5.3					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.993			8595,5		multicellular organismal development (GO:0007275)|negative regulation of transcription, DNA-templated (GO:0045892)|transcription, DNA-templated (GO:0006351)	6497,6,0					CCDS12966.1	C		TT,TC,CC	AF067165	nucleus (GO:0005634)	171		2504		rs257652		277									27	BMZF-3		19	NM_005773		2			ENST00000282308.3		21840		uc002qqu.3			10172	dbSNP_79	81			p.E27E		0				196.0		0.527	19:g.58455381C>T		protein_coding			basic|appris_principal|CCDS		4295,5,0			4405,1			T|||			5008		ZN256_HUMAN	4971	zinc finger protein 256			0.992612		58455381			0.9792	SNP		CCDS12966.1			,,,	False	58455381				synonymous_variant		Approved		171.0		c.81G>A	2013-01-08	OTTHUMT00000466702.1	Q9Y2P7	0.987		ZNF256	58455381					ZNF256	NM_005773.2	protein-coding gene	NP_005764.2		
		A	ENSG00000176293	ENST00000313434.5	0.54753|0.54753	7694	N|N		0.15160|0.15160	4300	0.667000|0.667000	.|0.01369	.|B;B		,	.|T	1.6000000000016E-5|1.6000000000016E-5	0|0	c.(64-66)gGc>gAc		0.022000|0.022000	byFrequency	P52742	gene with protein product		ZNF135_ENST00000359978.6_Missense_Mutation_p.G34D|ZNF135_ENST00000511556.1_Missense_Mutation_p.G22D|ZNF135_ENST00000401053.4_Missense_Mutation_p.G34D|ZNF135_ENST00000439855.2_Missense_Mutation_p.G22D|ZNF135_ENST00000506786.1_5'UTR		NM_003436.3	1900,291,12	NM_003436	0.7771			A|A	0.011|0.011	+	Missense_Mutation	1|2	248.7+/-276.3	130.0	.|E9PEV2;P52742	0.928507|0.928507		7557990, 1505991			.|0.001;0.001	ZNF135-003	2006-05-12		.|0.04013		19	+	0.9342		.|1	0.536000|0.536000	missense,missense,missense,missense,missense	12919	297|297	34/124,34/116,34/391,22/671,34/683	Colorectal(82;0.000256)|all_neural(62;0.0412)|Breast(46;0.147)|Ovarian(87;0.156)	A	SO:0001583	604077	benign,benign,benign,benign,benign	0.8204419889502762|0.8204419889502762	protein_coding		2203	P|P		0.961000|0.961000	14.3488,7.1493,11.9099	.|B;B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.7358:0.0:0.2642:0.0|0.7358:0.0:0.2642:0.0			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0161)			KNOWN	ENST00000391699|ENST00000504540;ENST00000401053;ENST00000359978;ENST00000439855;ENST00000313434;ENST00000511556		GTGGTAGTGGGCTTCAGCCAG	.|T;T;T;T;T	ZNF61, ZNF78L1				ENST00000313434.5:c.65G>A	19	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.	ENSG00000176293|ENSG00000176293	0.04426|0.04426	ZNF135|ZNF135	breast(1)|endometrium(3)|large_intestine(6)|liver(2)|lung(26)|ovary(1)|skin(1)|urinary_tract(1)	ENSP00000321406:p.Gly22Asp	+	0.32948|0.32948	,	GCT|GGC	19q13.4	B4DHH9|E9PEV2|F5GYY9|I3L0B3|Q5U5L3|Q8N1I7		g.chr19:58572979G>A	G -> D (in dbSNP:rs1469087). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	167.6+/-198.6		462|462	yes		11457,1549	0.29798|0.29798	0.00706|0.00706	2.52|2.52	0.00012|0.00012	.|ENSP00000321406:G22D			.|.		.|.		1.5	0.22813|0.22813	300|300	.|0.02654	0.5244755244755245|0.5244755244755245	0.7	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)	-2.145|-2.145			hg19	Standard	0.8598	0.9390243902439024|0.9390243902439024	5.8631|5.8631	7366,1234		cytoskeleton organization (GO:0007010)|regulation of cell morphogenesis (GO:0022604)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	5069,1319,115	-1.716744|-1.716744				CCDS12970.1, CCDS12970.2, CCDS54329.1, CCDS54330.1, CCDS74471.1, CCDS74472.1	G	.|0.02656	AA,AG,GG	U09413	nucleus (GO:0005634)	135	0.00098|0.00098	2504	1.48|1.48	rs1469087		166	.|22;22	652|652		"""zinc finger protein 61"", ""zinc finger protein 135 (clone pHZ-17)"""	0.18760|0.18760	63264791|63264791	+|+	ASP/GLY,ASP/GLY,ASP/GLY,ASP/GLY,ASP/GLY	22	pHZ-17	1711|1711	41	NM_003436	.|0.0;0.0	3	0.8601583113456465|0.8601583113456465	-0.516000|-0.516000	ENST00000313434.5		17930		uc002qrg.3			7694	dbSNP_88	101,101,101,65,101	0.0000|0.0000		p.G22D	.|Krueppel-associated box (4);	0		T|T		146.0	rs1469087;rs52799943;rs61167299;rs1469087|rs1469087;rs52799943;rs61167299;rs1469087	0.582	19:g.58572979G>A	.|ENSP00000441410:G34D;ENSP00000369437:G34D;ENSP00000444828:G22D;ENSP00000321406:G22D;ENSP00000422074:G22D	protein_coding	.|.		basic|appris_candidate		3169,1028,103		28|34;34;34;22;22;22	4091,315	0.7834249084249084|0.7834249084249084	T|D	A|||		.|.	5008		ZN135_HUMAN	3919	zinc finger protein 135		.|.;ZN135_HUMAN	0.782548	0.31110|0.31110	58572979		1.107000|1.107000	0.4871	SNP				.|.	,,,	False	58572979	-1.0664|-1.0664		4|8	missense	T|T	Approved	0.856512|0.856512	135.0		c.65G>A	2013-01-08	OTTHUMT00000361899.2	P52742	0.8184	.|4.97;4.97;4.97;4.97;4.97	ZNF135	58572979	0.34869|0.34869		0.09662|0.09662	94,94,94,94,94	ZNF135	NM_001164527.1,NM_001164529.1,NM_001164530.1,NM_003436.3,NM_007134.1	protein-coding gene	NP_003427.3	A|G	
		T	ENSG00000176293	ENST00000313434.5	0.58432	7694	.		0.00757	4300	0.000000	.	.		,	.	5.000000000032756E-6	0	c.(724-726)taC>taT		-2.190000	byFrequency	P52742	gene with protein product		ZNF135_ENST00000359978.6_Silent_p.Y254Y|ZNF135_ENST00000511556.1_Silent_p.Y254Y|ZNF135_ENST00000401053.4_Silent_p.Y266Y|ZNF135_ENST00000439855.2_Silent_p.Y242Y|ZNF135_ENST00000506786.1_Silent_p.Y200Y		NM_003436.3	252,984,967	NM_003436	0.4192			C	0.011	+	Silent	2	505.6+/-376.4	127.0	.	0.337721		7557990, 1505991			.	ZNF135-003	2006-05-12		.		19	+	0.3548		.	0.008000	utr-3,coding-synonymous,coding-synonymous,coding-synonymous	12919	163	,254/391,254/671,266/683	Colorectal(82;0.000256)|all_neural(62;0.0412)|Breast(46;0.147)|Ovarian(87;0.156)	C	SO:0001819	604077	,,,	0.45027624309392267	protein_coding		2203	P		0.000000	40.2209,33.7721,38.0363	.	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.0:0.3306:0.1105:0.5589			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0161)			KNOWN	ENST00000391699		AGAGACCTTACGAATGTCACG	.	ZNF61, ZNF78L1				ENST00000313434.5:c.726C>T	19		ENSG00000176293	0.02466	ZNF135	breast(1)|endometrium(3)|large_intestine(6)|liver(2)|lung(26)|ovary(1)|skin(1)|urinary_tract(1)		+	0.05858	,	ACG	19q13.4	B4DHH9|E9PEV2|F5GYY9|I3L0B3|Q5U5L3|Q8N1I7		g.chr19:58578578C>T		474.8+/-357.1		178	no		4947,8059	0.03702	0.00712	3.52	0.00012	.			.		.		-7.1	0.01573	138	.	0.24125874125874125	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)	.			hg19	Standard	0.4105	0.3617886178861789	8.0246	3459,5141		cytoskeleton organization (GO:0007010)|regulation of cell morphogenesis (GO:0022604)|regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	937,3073,2493	-1.709594				CCDS12970.1, CCDS12970.2, CCDS54329.1, CCDS54330.1, CCDS74471.1, CCDS74472.1	C	.	TT,TC,CC	U09413	nucleus (GO:0005634)	130	.	2504	-7.05	rs2229375		827	.	305		"""zinc finger protein 61"", ""zinc finger protein 135 (clone pHZ-17)"""	0.30430	63270390	+	,,,	242	pHZ-17	784	41	NM_003436	.	5	0.4023746701846966	-1.012000	ENST00000313434.5		20709		uc002qrg.3			7694	dbSNP_98	,762,762,798	0.0000		p.Y242Y	.	0		T		135.0	rs2229375;rs3745125;rs17307311;rs60749458;rs2229375	0.478	19:g.58578578C>T	.	protein_coding	.		basic|appris_candidate		685,2089,1526		260	1488,2918	0.358974358974359	M	C|||		.	5008		ZN135_HUMAN	1837	zinc finger protein 135		.	0.366813	0.01278	58578578		-2.161000	0.2103	SNP				.	,,,	False	58578578	-1.0088		3	synonymous_variant	T	Approved	0.402209	130.0		c.726C>T	2013-01-08	OTTHUMT00000361899.2	P52742	0.4798	.	ZNF135	58578578	0.06430		0.26950	,,,	ZNF135	NM_001164529.1,NM_001164530.1,NM_003436.3,NM_007134.1	protein-coding gene	NP_003427.3	T	
		C	ENSG00000121413	ENST00000240727.6		65982				4300					,							byFrequency	Q8TBC5	gene with protein product		ZSCAN18_ENST00000601144.1_Intron|ZSCAN18_ENST00000421612.2_Intron|ZSCAN18_ENST00000600404.1_Intron		NM_023926.4	807,1056,340	NM_023926	0.4468					+	Intron		531.4+/-382.0	47.0								ZSCAN18-003	2007-02-20				19	-	0.6475				intron,intron,intron,intron	21037		,,,	Colorectal(82;0.000256)|all_neural(62;0.0412)|Breast(46;0.114)|Ovarian(87;0.156)	C	SO:0001627		,,,		protein_coding		2203				45.0,39.4008,43.1032		"""-"", ""Zinc fingers, C2H2-type"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0152)			KNOWN			TTCTCCTCTGTGACAGCCCAC		ZNF447				ENST00000240727.6:c.403+10A>G	19					NS(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(8)|skin(3)		-		,		19q13.43	B4DG23|E9PBI0|Q9BRK7|Q9H9A0		g.chr19:58601221T>C		504.1+/-365.7			no		7400,5606												-3.0					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)		2007-02-20		hg19	Standard	0.5557			4730,3870		regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	2118,3164,1221					CCDS12971.1, CCDS46214.1, CCDS46215.1	T		CC,CT,TT	AY280799, AY279352	nucleus (GO:0005634)	47		2504		rs2547354		803				"""zinc finger protein 447"""				,,,		FLJ12895		19	NM_001145542		2			ENST00000240727.6		14973		uc010yht.1			65982	dbSNP_100	,,,					0				45.0		0.622	19:g.58601221T>C		protein_coding			alternative_5_UTR|basic|appris_candidate|CCDS		1311,2108,881			2670,1736			C|||			5008		ZSC18_HUMAN	2551	zinc finger and SCAN domain containing 18			0.509385		58601221			0.2897	SNP		CCDS12971.1			,,,	False	58601221				intron_variant		Approved		47.0			2013-01-09	OTTHUMT00000466706.1	Q8TBC5	0.5865		ZSCAN18	58601221				,,,	ZSCAN18	NM_001145542.1,NM_001145543.1,NM_001145544.1,NM_023926.4	protein-coding gene	NP_076415.3		
		C	ENSG00000121410	ENST00000263100.3	0.80722	1	N	ENSG00000121410	0.01921	4300	0.000000	0.12255	B		,	T	0.0	0	c.(154-156)cAc>cGc	OTTHUMG00000183507	-1.456000	byFrequency	P04217	gene with protein product		A1BG-AS1_ENST00000594950.1_RNA|A1BG-AS1_ENST00000600686.1_RNA|A1BG-AS1_ENST00000595302.1_RNA|CTD-2619J13.8_ENST00000599109.1_RNA|A1BG-AS1_ENST00000600379.1_RNA|A1BG-AS1_ENST00000599728.1_RNA|A1BG-AS1_ENST00000593960.1_RNA|A1BG-AS1_ENST00000593374.1_RNA		NM_130786.3	1327,755,121	NM_130786	0.8528			C	1.896	+	Missense_Mutation	2	130.0+/-188.0	89.0	P04217	0.773718		2591067			0.003	A1BG-001			0.08055		19	-	0.7216		0.79	0.014000	missense	5	315	52/496	all_cancers(17;3.04e-16)|all_epithelial(17;7.77e-12)|Lung NSC(17;3.25e-05)|Colorectal(82;5.46e-05)|all_lung(17;0.000129)|all_neural(62;0.0182)|Ovarian(87;0.0443)|Breast(46;0.0889)|Renal(17;0.157)	C	SO:0001583	138670	benign	0.8701657458563536	protein_coding		2203	P		0.000000	4.814,22.6282,10.8488	B	"""Immunoglobulin superfamily / Immunoglobulin-like domain containing"""	6503		0.134:0.1752:0.1432:0.5475			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0269)			KNOWN	ENST00000263100		AGTCTCCAGGTGGGCCTGGCA	T					ENST00000263100.3:c.155A>G	19	Ig-like V-type 1.	ENSG00000121410	0.01313	A1BG	NS(1)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(1)|lung(7)|prostate(2)	ENSP00000263100:p.His52Arg	-	0.05858	,	CAC	19q13.43	A8K052|Q68CK0|Q8IYJ6|Q96P39		g.chr19:58864479T>C	H -> R (in dbSNP:rs893184). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:3458201, ECO:0000269|Ref.2}.	373.0+/-320.6		343	yes		11595,1411	0.03702	0.04540	3.32	0.00012	ENSP00000263100:H52R			0.01108		.		-5.2	0.02866	520	0.07990	0.9090909090909091	0.0		-1.355			hg19	Standard	0.9404	0.6971544715447154	2.5552	8186,414			5224,1147,132	-0.454282				CCDS12976.1	T	0.02656	CC,CT,TT		blood microparticle (GO:0072562)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)	91	0.00583	2504	-5.15	rs893184		216	52	704			0.04758	63556291	-	ARG/HIS	52		1882	15	NM_130786	0.0	3	0.9287598944591029	-1.309000	ENST00000263100.3		15823		uc002qsd.4			1	dbSNP_86	155	0.0000		p.H52R	Immunoglobulin-like fold (1);	0		T		93.0	rs893184;rs59650452;rs893184	0.597	19:g.58864479T>C	ENSP00000263100:H52R	protein_coding	0.005508		basic|appris_principal|CCDS		3897,392,11		52	3409,997	0.8617216117216118	R	C|||		2.971620	5008		A1BG_HUMAN	4249	alpha-1-B glycoprotein		A1BG_HUMAN	0.848442	0.00895	58864479		-2.596000	0.9127	SNP		CCDS12976.1		N	,,,	False	58864479	-0.9901		9	missense	T	Approved	0.95186	91.0		c.155A>G	2013-10-15	OTTHUMT00000466930.1	P04217	0.8573	2.7	A1BG	58864479	0.08584		0.32587	29	A1BG	NM_130786.3	protein-coding gene	NP_570602.2	H	
		G	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4300					,							byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000596281.1_Intron|ZNF584_ENST00000599238.1_Intron|ZNF584_ENST00000596921.1_Intron|ZNF584_ENST00000322834.7_Intron|ZNF584_ENST00000593920.1_Intron		NM_173548.1	39,440,1724	NM_173548	0.1738					+	Intron		323.5+/-316.1	180.0								ZNF584-001					19	+	0.1225				intron	27318			all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	A	SO:0001627				protein_coding		2203				20.8488,11.7567,17.7687		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			TCTGCCCATCATTGACCCCAA						ENST00000306910.4:c.19-12A>G	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58921296A>G		235.8+/-248.2			no		2311,10695												-4.6					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.2485			1793,6807		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	226,1859,4418					CCDS12979.1	A		GG,GA,AA	AK097218	nucleus (GO:0005634)	187		2504		rs34511020		541										FLJ39899		14	NM_173548		2			ENST00000306910.4		20948		uc002qsp.3			201514	dbSNP_126						0				202.0		0.483	19:g.58921296A>G		protein_coding			basic|appris_principal|CCDS		187,1419,2694			518,3888			A|||			5008		ZN584_HUMAN	760	zinc finger protein 584			0.151757		58921296			0.0546	SNP		CCDS12979.1			,,,	False	58921296				intron_variant		Approved		187.0			2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.1772		ZNF584	58921296					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		T	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4300					,				c.(412-414)gcA>gcT			byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000596921.1_3'UTR|ZNF584_ENST00000322834.7_3'UTR|ZNF584_ENST00000593920.1_Silent_p.A93A		NM_173548.1	8,252,1943	NM_173548	0.1718					+	Silent		322.9+/-315.8	112.0								ZNF584-001					19	+	0.0401				coding-synonymous	27318		138/422	all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	A	SO:0001819				protein_coding		2203				20.814,6.0826,15.8235		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			AGCATGGGGCAGCTTTCCCAC						ENST00000306910.4:c.414A>T	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58928299A>T		151.0+/-185.0			no		2058,10948												0.7					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.2495			1790,6810		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	194,1670,4639					CCDS12979.1	A		TT,TA,AA	AK097218	nucleus (GO:0005634)	124		2504		rs11668757		937									138	FLJ39899		14	NM_173548		4			ENST00000306910.4		18513		uc002qsp.3			201514	dbSNP_120	414			p.A138A		0				148.0		0.517	19:g.58928299A>T		protein_coding			basic|appris_principal|CCDS		186,1418,2696			268,4138			A|||			5008		ZN584_HUMAN	647	zinc finger protein 584			0.129193		58928299			0.0546	SNP		CCDS12979.1			,,,	False	58928299				synonymous_variant		Approved		124.0		c.414A>T	2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.1729		ZNF584	58928299					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		C	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4300					,				c.(415-417)gcT>gcC			byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000596921.1_3'UTR|ZNF584_ENST00000322834.7_3'UTR|ZNF584_ENST00000593920.1_Silent_p.A94A		NM_173548.1	1306,767,130	NM_173548	0.3824					+	Silent		587.3+/-392.2	112.0								ZNF584-001					19	+	0.7882				coding-synonymous	27318		139/422	all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	C	SO:0001819				protein_coding		2203				48.2558,23.3091,42.1113		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			ATGGGGCAGCTTTCCCACCTG						ENST00000306910.4:c.417T>C	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58928302T>C		378.0+/-322.7			no		7529,5477												1.0					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.497			4150,4450		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2314,2901,1288					CCDS12979.1	T		CC,CT,TT	AK097218	nucleus (GO:0005634)	124		2504		rs10423138		940									139	FLJ39899		14	NM_173548		4			ENST00000306910.4		17868		uc002qsp.3			201514	dbSNP_119	417			p.A139A		0				147.0		0.517	19:g.58928302T>C		protein_coding			basic|appris_principal|CCDS		1008,2134,1158			3379,1027			C|||			5008		ZN584_HUMAN	2507	zinc finger protein 584			0.500599		58928302			0.3254	SNP		CCDS12979.1			,,,	False	58928302				synonymous_variant		Approved		124.0		c.417T>C	2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.379		ZNF584	58928302					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		T	ENSG00000171574	ENST00000306910.4	0.80722	201514	N	ENSG00000171574	0.14787	4300	0.000000	0.13901	B		,	T	0.0	0	c.(424-426)Cct>Tct		0.008000	byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000596921.1_3'UTR|ZNF584_ENST00000322834.7_3'UTR|ZNF584_ENST00000593920.1_Missense_Mutation_p.P97S		NM_173548.1	37,437,1729	NM_173548	0.1718			C	1.863	+	Missense_Mutation	1	323.3+/-315.9	109.0	Q8IVC4	0.115978					0.002	ZNF584-001			0.06405		19	+	0.118		0.35	0.084000	missense	27318	67	142/422	all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	C	SO:0001583		benign	0.1850828729281768	protein_coding		2203	P		0.000000	20.8488,11.5978,17.7149	B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.231:0.5029:0.0:0.2661			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN	ENST00000306910;ENST00000354635		AGCTTTCCCACCTGGTTCCAG	T					ENST00000306910.4:c.424C>T	19		ENSG00000171574	0.41574	ZNF584	endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)	ENSP00000306756:p.Pro142Ser	+	0.05858	,	CCT	19q13.43	A8K203		g.chr19:58928309C>T	P -> S (in dbSNP:rs11668789).	233.9+/-246.9		73	yes		2304,10702	0.03702	0.04508	2.96	0.00012	ENSP00000306756:P142S			.		.		-0.4	0.12279	32	0.25106	0.055944055944055944	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	0.55			hg19	Standard	0.2485	0.1483739837398374	2.5653	1793,6807		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	224,1856,4423	-0.462052				CCDS12979.1	C	0.14438	TT,TC,CC	AK097218	nucleus (GO:0005634)	121	0.19112	2504	-0.435	rs11668789		947	142	178			0.04782	63620121	+	SER/PRO	142	FLJ39899	350	14	NM_173548	0.01	4	0.23482849604221637	0.462000	ENST00000306910.4		18037		uc002qsp.3			201514	dbSNP_120	424	0.0000		p.P142S	.	0		T		143.0	rs11668789;rs12979849;rs11668789	0.522	19:g.58928309C>T	ENSP00000306756:P142S	protein_coding	.		basic|appris_principal|CCDS		187,1419,2694		142;1	511,3895	0.16025641025641027	S	C|||		.	5008		ZN584_HUMAN	752	zinc finger protein 584		ZN584_HUMAN	0.15016	0.03194	58928309		-1.145000	0.0546	SNP		CCDS12979.1		.	,,,	False	58928309	-0.9153		8	missense	T	Approved	0.208488	121.0		c.424C>T	2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.1772	2.55	ZNF584	58928309	0.17831		0.46965	74	ZNF584	NM_173548.1	protein-coding gene	NP_775819.1	P	
		A	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4300					,				c.(1165-1167)aaG>aaA			byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000593920.1_Silent_p.K344K		NM_173548.1	778,1032,393	NM_173548	0.3814					+	Silent		589.5+/-392.5	80.0								ZNF584-001					19	+	0.5976				coding-synonymous	27318		389/422	all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	A	SO:0001819				protein_coding		2203				48.0581,41.2619,48.3239		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			AGTGTGGGAAGGCCTTCAAAC						ENST00000306910.4:c.1167G>A	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58929052G>A		531.5+/-373.2			no		6721,6285												0.4					0.9	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.496			4133,4467		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	1776,3169,1558					CCDS12979.1	G		AA,AG,GG	AK097218	nucleus (GO:0005634)	83		2504		rs3764535		1690									389	FLJ39899		14	NM_173548		4			ENST00000306910.4		21717		uc002qsp.3			201514	dbSNP_107	1167			p.K389K		0				89.0		0.517	19:g.58929052G>A		protein_coding			basic|appris_principal|CCDS		998,2137,1165			2588,1818			A|||			5008		ZN584_HUMAN	2238	zinc finger protein 584			0.446885		58929052			0.3254	SNP		CCDS12979.1			,,,	False	58929052				synonymous_variant		Approved		83.0		c.1167G>A	2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.3573		ZNF584	58929052					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		A	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4300					,				c.(1249-1251)aaG>aaA			byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000593920.1_Silent_p.K372K		NM_173548.1	1306,765,132	NM_173548	0.3824					+	Silent		578.0+/-390.7	81.0								ZNF584-001					19	+	0.7882				coding-synonymous	27318		417/422	all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	A	SO:0001819				protein_coding		2203				48.2209,23.3545,42.1498		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			CACATGGGAAGGTCGTTAGCT						ENST00000306910.4:c.1251G>A	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58929136G>A		371.5+/-320.0			no		7524,5482												-0.2					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.497			4147,4453		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2313,2898,1292					CCDS12979.1	G		AA,AG,GG	AK097218	nucleus (GO:0005634)	81		2504		rs3764534		1774									417	FLJ39899		14	NM_173548		4			ENST00000306910.4		23025		uc002qsp.3			201514	dbSNP_107	1251			p.K417K		0				80.0		0.512	19:g.58929136G>A		protein_coding			basic|appris_principal|CCDS		1007,2133,1160			3377,1029			A|||			5008		ZN584_HUMAN	2507	zinc finger protein 584			0.500599		58929136			0.3254	SNP		CCDS12979.1			,,,	False	58929136				synonymous_variant		Approved		81.0		c.1251G>A	2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.379		ZNF584	58929136					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		G	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4298					,							byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000593920.1_3'UTR		NM_173548.1	721,1045,437	NM_173548	0.3814					+	3'UTR			49.0								ZNF584-001					19	+	0.5772				utr-3	27318			all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	G	SO:0001624				protein_coding		2203				47.8711,43.5542,49.2232		"""Zinc fingers, C2H2-type"", ""-"""	6501					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			AAAGGAGGTTAAGGAGAGTGG						ENST00000306910.4:c.*43A>G	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58929194A>G					no		6602,6400												-0.3					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.495			4115,4481		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	1722,3158,1621					CCDS12979.1	A		GG,GA,AA	AK097218	nucleus (GO:0005634)	48		2504		rs3764533		1832										FLJ39899		14	NM_173548		0			ENST00000306910.4		22132		uc002qsp.3			201514	dbSNP_107						0				46.0		0.552	19:g.58929194A>G		protein_coding			basic|appris_principal|CCDS		1001,2113,1184			2487,1919			G|||			5008		ZN584_HUMAN	2209	zinc finger protein 584			0.441094		58929194			0.3254	SNP		CCDS12979.1			,,,	False	58929194				3_prime_UTR_variant		Approved		48.0			2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.3559		ZNF584	58929194					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		C	ENSG00000171574	ENST00000306910.4		201514		ENSG00000171574		4298					,							byFrequency	Q8IVC4	gene with protein product		ZNF584_ENST00000599238.1_3'UTR|ZNF584_ENST00000593920.1_3'UTR		NM_173548.1	37,436,1730	NM_173548	0.1718					+	3'UTR			46.0								ZNF584-001					19	+	0.118				utr-3	27318			all_cancers(17;5.3e-17)|all_epithelial(17;3.71e-12)|Lung NSC(17;8.3e-05)|Colorectal(82;0.000147)|all_lung(17;0.000386)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	A	SO:0001624				protein_coding		2203				20.6491,11.5751,17.5742		"""Zinc fingers, C2H2-type"", ""-"""	6501					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0271)			KNOWN			GGTTAAGGAGAGTGGCCGTGA						ENST00000306910.4:c.*49A>C	19					endometrium(1)|kidney(3)|large_intestine(3)|lung(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)		+		,		19q13.43	A8K203		g.chr19:58929200A>C					no		2285,10717												2.0					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.2485			1775,6821		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	223,1839,4439					CCDS12979.1	A		CC,CA,AA	AK097218	nucleus (GO:0005634)	45		2504		rs35652377		1838										FLJ39899		14	NM_173548		0			ENST00000306910.4		22232		uc002qsp.3			201514	dbSNP_126						0				43.0		0.552	19:g.58929200A>C		protein_coding			basic|appris_principal|CCDS		186,1403,2709			510,3896			A|||			5008		ZN584_HUMAN	752	zinc finger protein 584			0.15016		58929200			0.0546	SNP		CCDS12979.1			,,,	False	58929200				3_prime_UTR_variant		Approved		45.0			2013-01-08	OTTHUMT00000467022.1	Q8IVC4	0.1772		ZNF584	58929200					ZNF584	NM_173548.1	protein-coding gene	NP_775819.1		
		G	ENSG00000131849	ENST00000254166.3		7691				4300					,				c.(1720-1722)aaT>aaC			byFrequency	P52740	gene with protein product				NM_003433.3	36,436,1731	NM_003433	0.1718					+	Silent		319.3+/-314.1	97.0				7557990				ZNF132-001	2006-06-13				19	-	0.118				coding-synonymous	12916		574/707	all_cancers(17;4.4e-22)|all_epithelial(17;2.15e-16)|Lung NSC(17;1.24e-06)|all_lung(17;5.41e-06)|Colorectal(82;3.46e-05)|Renal(17;0.00179)|all_neural(62;0.00607)|Ovarian(87;0.0443)|Breast(46;0.0928)|Medulloblastoma(540;0.184)	A	SO:0001819	604074			protein_coding		2203				20.4884,11.5297,17.4535		"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0171)|Lung(386;0.182)			KNOWN			TCCCACATTCATTGCACTCAT						ENST00000254166.3:c.1722T>C	19					NS(2)|endometrium(2)|kidney(2)|large_intestine(6)|lung(1)|ovary(2)|pancreas(1)|skin(2)|upper_aerodigestive_tract(1)		-		,		19q13.4	Q32MI9		g.chr19:58945089A>G		233.0+/-246.3			no		2270,10736												-3.9					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.2445			1762,6838		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	220,1830,4453					CCDS12980.1	A		GG,GA,AA	U09411	nucleus (GO:0005634)	97		2504		rs3764529		2122				"""zinc finger protein 132 (clone pHZ-12)"""					574	pHZ-12		19	NM_003433		3			ENST00000254166.3		21358		uc002qst.4			7691	dbSNP_107	1722			p.N574N		0				97.0		0.413	19:g.58945089A>G		protein_coding			basic|appris_principal|CCDS		184,1394,2722			508,3898			A|||			5008		ZN132_HUMAN	750	zinc finger protein 132			0.14976		58945089			0.0546	SNP		CCDS12980.1			,,,	False	58945089				synonymous_variant		Approved		97.0		c.1722T>C	2013-01-08	OTTHUMT00000467035.1	P52740	0.1801		ZNF132	58945089					ZNF132	NM_003433.3	protein-coding gene	NP_003424.3		
		T	ENSG00000131849	ENST00000254166.3		7691				4299					,				c.(847-849)aaG>aaA			byFrequency	P52740	gene with protein product				NM_003433.3	2165,38,0	NM_003433	0.9233					+	Silent		137.1+/-194.1	64.0				7557990				ZNF132-001	2006-06-13				19	-	0.9962				coding-synonymous	12916		283/707	all_cancers(17;4.4e-22)|all_epithelial(17;2.15e-16)|Lung NSC(17;1.24e-06)|all_lung(17;5.41e-06)|Colorectal(82;3.46e-05)|Renal(17;0.00179)|all_neural(62;0.00607)|Ovarian(87;0.0443)|Breast(46;0.0928)|Medulloblastoma(540;0.184)	T	SO:0001819	604074			protein_coding		2203				5.5129,0.8625,3.9373		"""Zinc fingers, C2H2-type"", ""-"""	6502					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0171)|Lung(386;0.182)			KNOWN			CAGTGTGAAACTTTTTATTAC						ENST00000254166.3:c.849G>A	19					NS(2)|endometrium(2)|kidney(2)|large_intestine(6)|lung(1)|ovary(2)|pancreas(1)|skin(2)|upper_aerodigestive_tract(1)		-		,		19q13.4	Q32MI9		g.chr19:58945962C>T		39.2+/-71.8			no		12492,512												2.1					0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.9284			8124,474		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	6004,484,14					CCDS12980.1	C		TT,TC,CC	U09411	nucleus (GO:0005634)	61		2504		rs9941466		1249				"""zinc finger protein 132 (clone pHZ-12)"""					283	pHZ-12		19	NM_003433		3			ENST00000254166.3		20423		uc002qst.4			7691	dbSNP_119	849			p.K283K		0				56.0		0.428	19:g.58945962C>T		protein_coding			basic|appris_principal|CCDS		3839,446,14			4368,38			T|||			5008		ZN132_HUMAN	4786	zinc finger protein 132			0.955671		58945962			0.9722	SNP		CCDS12980.1			,,,	False	58945962				synonymous_variant		Approved		61.0		c.849G>A	2013-01-08	OTTHUMT00000467035.1	P52740	0.9395		ZNF132	58945962					ZNF132	NM_003433.3	protein-coding gene	NP_003424.3		
		A	ENSG00000131849	ENST00000254166.3	0.80722	7691	N		0.14839	4300	0.002000	0.13538	B		,	T	0.0	0	c.(754-756)cCc>cTc		0.010000	byFrequency	P52740	gene with protein product				NM_003433.3	1299,774,130	NM_003433	0.3824			A	0.024	+	Missense_Mutation	2	589.8+/-392.6	100.0	P52740	0.76532		7557990			0.0	ZNF132-001	2006-06-13		0.01281		19	-	0.7882		0.46	0.024000	missense	12916	151	252/707	all_cancers(17;4.4e-22)|all_epithelial(17;2.15e-16)|Lung NSC(17;1.24e-06)|all_lung(17;5.41e-06)|Colorectal(82;3.46e-05)|Renal(17;0.00179)|all_neural(62;0.00607)|Ovarian(87;0.0443)|Breast(46;0.0928)|Medulloblastoma(540;0.184)	A	SO:0001583	604074	benign	0.4171270718232044	protein_coding		2203	P		0.000000	47.8488,23.468,42.4343	B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.511:0.0:0.3223:0.1667			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0171)|Lung(386;0.182)			KNOWN	ENST00000254166;ENST00000391695		CAGATGGTTGGGGAGAGTGGA	T					ENST00000254166.3:c.755C>T	19		ENSG00000131849	0.02293	ZNF132	NS(2)|endometrium(2)|kidney(2)|large_intestine(6)|lung(1)|ovary(2)|pancreas(1)|skin(2)|upper_aerodigestive_tract(1)	ENSP00000254166:p.Pro252Leu	-	0.05858	,	CCC	19q13.4	Q32MI9		g.chr19:58946056G>A	P -> L (in dbSNP:rs1465789).	379.7+/-323.4		397	yes		7487,5519	0.10522	0.01194	3.12	0.00012	ENSP00000254166:P252L			.		.		1.0	0.19750	184	0.19147	0.32167832167832167	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)	-1.545			hg19	Standard	0.494	0.806910569105691	3.7082	4115,4485		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	2294,2899,1310	-1.387674				CCDS12980.1	G	0.02656	AA,AG,GG	U09411	nucleus (GO:0005634)	99	0.00399	2504	0.98	rs1465789		1155	252	370		"""zinc finger protein 132 (clone pHZ-12)"""	0.08408	63637868	-	LEU/PRO	252	pHZ-12	1102	19	NM_003433	0.0	3	0.48812664907651715	-1.062000	ENST00000254166.3		21770		uc002qst.4			7691	dbSNP_88	755	0.0000		p.P252L	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	0		T		99.0	rs1465789;rs17669697;rs60250577;rs1465789	0.443	19:g.58946056G>A	ENSP00000254166:P252L	protein_coding	.		basic|appris_principal|CCDS		995,2125,1180		252;163	3372,1034	0.5045787545787546	L	A|||		.	5008		ZN132_HUMAN	2507	zinc finger protein 132		ZN132_HUMAN	0.500599	0.01840	58946056		-1.739000	0.3264	SNP		CCDS12980.1		.	,,,	False	58946056	-1.0680		8	missense	T	Approved	0.478488	99.0		c.755C>T	2013-01-08	OTTHUMT00000467035.1	P52740	0.3818	2.58	ZNF132	58946056	0.10985		0.09314	98	ZNF132	NM_003433.3	protein-coding gene	NP_003424.3	P	
		T	ENSG00000131849	ENST00000254166.3	0.80722	7691	N		0.14345	4300	0.001000	0.14640	B		,	T	0.0	0	c.(607-609)gGc>gAc		-0.007000	byFrequency	P52740	gene with protein product				NM_003433.3	31,415,1757	NM_003433	0.1718			C	0.033	+	Missense_Mutation	2	319.5+/-314.2	85.0	P52740	0.108261		7557990			0.0	ZNF132-001	2006-06-13		0.01281		19	-	0.1059		0.49	0.001000	missense	12916	66	203/707	all_cancers(17;4.4e-22)|all_epithelial(17;2.15e-16)|Lung NSC(17;1.24e-06)|all_lung(17;5.41e-06)|Colorectal(82;3.46e-05)|Renal(17;0.00179)|all_neural(62;0.00607)|Ovarian(87;0.0443)|Breast(46;0.0928)|Medulloblastoma(540;0.184)	C	SO:0001583	604074	benign	0.18232044198895028	protein_coding		2203	P		0.000000	20.4767,10.8261,17.2074	B	"""Zinc fingers, C2H2-type"", ""-"""	6503		0.0:0.1322:0.2207:0.6471			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0171)|Lung(386;0.182)			KNOWN	ENST00000254166		GTCACAGCTGCCCAGGATGAC	T					ENST00000254166.3:c.608G>A	19		ENSG00000131849	0.09829	ZNF132	NS(2)|endometrium(2)|kidney(2)|large_intestine(6)|lung(1)|ovary(2)|pancreas(1)|skin(2)|upper_aerodigestive_tract(1)	ENSP00000254166:p.Gly203Asp	-	0.05858	,	GGC	19q13.4	Q32MI9		g.chr19:58946203C>T	G -> D (in dbSNP:rs1122955).	223.0+/-239.6		60	yes		2238,10768	0.08648	0.01309	2.49	0.00012	ENSP00000254166:G203D			.		.		0.2	0.15372	32	0.17832	0.055944055944055944	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding transcription factor activity (GO:0003700)	-0.245			hg19	Standard	0.2445	0.12195121951219512	3.7817	1761,6839		regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	215,1808,4480	-1.324593				CCDS12980.1	C	0.02656	TT,TC,CC	U09411	nucleus (GO:0005634)	90	0.04260	2504	0.23	rs1122955		1008	203	174		"""zinc finger protein 132 (clone pHZ-12)"""	0.08683	63638015	-	ASP/GLY	203	pHZ-12	332	19	NM_003433	0.0	3	0.22955145118733508	-0.290000	ENST00000254166.3		19564		uc002qst.4			7691	dbSNP_86	608	0.0000		p.G203D	.	0		T		99.0	rs1122955;rs2229374;rs17747821;rs52819540;rs60515011;rs1122955	0.512	19:g.58946203C>T	ENSP00000254166:G203D	protein_coding	.		basic|appris_principal|CCDS		184,1393,2723		203	477,3929	0.152014652014652	D	C|||		.	5008		ZN132_HUMAN	732	zinc finger protein 132		ZN132_HUMAN	0.146166	0.08596	58946203		-0.269000	0.0546	SNP		CCDS12980.1		.	,,,	False	58946203	-0.9051		8	missense	T	Approved	0.204767	90.0		c.608G>A	2013-01-08	OTTHUMT00000467035.1	P52740	0.1772	2.49	ZNF132	58946203	0.01503		0.48258	94	ZNF132	NM_003433.3	protein-coding gene	NP_003424.3	G	
		G	ENSG00000083812	ENST00000536459.2		25799				4300					,				c.(523-525)agA>agG			byFrequency	O75467	gene with protein product		ZNF324_ENST00000196482.3_Silent_p.R175R|ZNF324_ENST00000535298.1_5'UTR				NM_014347	1.0					+	Silent			47.0								ZNF324-001					19	+	1.0					14096			all_cancers(17;1.81e-17)|all_epithelial(17;1.21e-12)|Lung NSC(17;2.8e-05)|all_lung(17;0.000139)|Colorectal(82;0.000147)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)		SO:0001819				protein_coding		2203						"""Zinc fingers, C2H2-type"", ""-"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0164)|Lung(386;0.179)			KNOWN			TCCGGCTTAGAGAAAAGACAC						ENST00000536459.2:c.525A>G	19					breast(3)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)|liver(1)|lung(2)|prostate(2)|urinary_tract(2)		+		,		19q13.43	B3KRX1		g.chr19:58982384A>G																									DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	1.0					regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)						CCDS12981.1	A			AF060503	nucleus (GO:0005634)			2504		rs10418774		1234									175	ZF5128, ZNF324A		16	NM_014347		4			ENST00000536459.2		18243		uc002qsw.2			25799					p.R175R		0				45.0		0.632	19:g.58982384A>G		protein_coding			basic|appris_principal|CCDS								G|||			5008		Z324A_HUMAN	5006	zinc finger protein 324			0.999601		58982384			0.998	SNP		CCDS12981.1			,,,	False	58982384				synonymous_variant		Approved		46.0		c.525A>G	2013-01-08	OTTHUMT00000467044.1	O75467	1.0		ZNF324	58982384							protein-coding gene			
		C	ENSG00000083838	ENST00000594369.1	0.80722	55663	N		0.17167	4300	0.014000	0.04603	B;B		,	T	0.0	0	c.(574-576)Aac>Cac		0.087000	byFrequency	Q9NWS9	gene with protein product		ZNF446_ENST00000335841.4_Missense_Mutation_p.N192H|ZNF446_ENST00000596341.1_Missense_Mutation_p.N192H		NM_017908.2	841,1038,324	NM_017908	0.3691			C	1.839	+	Missense_Mutation	1	603.7+/-394.7	104.0	F5H201;Q9NWS9	0.61734					0.0;0.0	ZNF446-001			0.01281		19	+	0.6089		0.44	0.260000	missense	21036	139	192/451	all_cancers(17;1.81e-17)|all_epithelial(17;1.21e-12)|Lung NSC(17;2.8e-05)|all_lung(17;0.000139)|Colorectal(82;0.000147)|Renal(17;0.00528)|all_neural(62;0.0133)|Ovarian(87;0.156)|Medulloblastoma(540;0.232)	C	SO:0001583		benign	0.3839779005524862	protein_coding		2203	P		0.000000	45.7558,38.266,48.8313	B;B	"""Zinc fingers, C2H2-type"", ""-"", ""-"", ""-"""	6503		0.1795:0.5304:0.0:0.2901			UCEC - Uterine corpus endometrioid carcinoma (67;0.168)|GBM - Glioblastoma multiforme(193;0.0164)|Lung(386;0.179)			KNOWN	ENST00000335841;ENST00000540481		CCCTGAGGGGAACCATGGACA	T					ENST00000594369.1:c.574A>C	19		ENSG00000083838	0.12591	ZNF446	endometrium(2)|large_intestine(1)|lung(3)|ovary(1)|skin(1)	ENSP00000472802:p.Asn192His	+	0.05858	,	AAC	19q13.43			g.chr19:58989495A>C	N -> H (in dbSNP:rs893185).	510.3+/-367.5		328	yes		6655,6351	0.15608	0.04476	4.31	0.00012	ENSP00000336565:N192H			0.19780		-4.4839		1.0	0.20165	175	0.20046	0.30594405594405594	0.0	DNA binding (GO:0003677)|metal ion binding (GO:0046872)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)	-0.695			hg19	Standard	0.4702	0.6666666666666666	3.4022	3935,4665		regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription from RNA polymerase II promoter (GO:0006366)	1763,3129,1611	-0.468001				CCDS12982.1	A	0.02656	CC,CA,AA		extracellular space (GO:0005615)|nucleus (GO:0005634)	115	0.01874	2504	1.05	rs893185		955	192;192	353			0.07328	63681307	+	HIS/ASN	192	ZKSCAN20, FLJ20626, ZSCAN52	995	8	NM_017908	0.0;0.0	4	0.4656992084432718	-0.217000	ENST00000594369.1		18796		uc002qsz.3			55663	dbSNP_86	574	0.0000		p.N192H	.	0		T		137.0	rs893185;rs17319584;rs17856530;rs57843950;rs893185	0.607	19:g.58989495A>C	ENSP00000336565:N192H	protein_coding	0.106248		basic|appris_candidate_longest|CCDS		922,2091,1287		192	2720,1686	0.4555860805860806	H	C|||		0.370024	5008		ZN446_HUMAN	2205	zinc finger protein 446		.;ZN446_HUMAN	0.440296	0.15995	58989495		0.137000	0.3175	SNP		CCDS12982.1		N	,,,	False	58989495	-1.0777		9	missense	T	Approved	0.457558	115.0		c.574A>C	2013-01-09	OTTHUMT00000467052.1	Q9NWS9	0.3545	3.59	ZNF446	58989495	0.26232		0.07347	68	ZNF446	NM_017908.2	protein-coding gene	NP_060378.1	N	
		A	ENSG00000130726	ENST00000253024.5		10155				4300					,							byFrequency	Q13263	gene with protein product		TRIM28_ENST00000341753.6_Intron		NM_005762.2	132,790,1281	NM_005762	0.1912					+	Intron		278.9+/-293.6	50.0				11331580, 11226167				TRIM28-001	2011-01-25				19	+	0.2443				intron	16384			all_cancers(17;4.4e-22)|all_epithelial(17;2.15e-16)|Lung NSC(17;1.24e-06)|all_lung(17;5.41e-06)|Colorectal(82;3.46e-05)|Renal(17;0.00179)|all_neural(62;0.00607)|Ovarian(87;0.0443)|Breast(46;0.0928)|Medulloblastoma(540;0.184)	G	SO:0001627	601742			protein_coding		2203				17.186,23.9219,19.4679		"""Tripartite motif containing / Tripartite motif containing"", ""RING-type (C3HC4) zinc fingers"", ""Zinc fingers, PHD-type"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.0434)|all cancers(4;1.39e-13)|Epithelial(4;1.01e-10)|OV - Ovarian serous cystadenocarcinoma(4;2.34e-09)|GBM - Glioblastoma multiforme(193;0.0102)|Lung(386;0.179)			KNOWN			TGCTTCCTGAGTTGGGGGTGG						ENST00000253024.5:c.587-50G>A	19					biliary_tract(1)|breast(2)|endometrium(2)|kidney(2)|large_intestine(3)|lung(7)|ovary(1)|urinary_tract(1)		+		,		19q13.4	O00677|Q7Z632|Q93040|Q96IM1	"""protein phosphatase 1, regulatory subunit 157"""	g.chr19:59058693G>A		382.3+/-324.4			no		2532,10474												2.4					0.0	chromo shadow domain binding (GO:0070087)|DNA binding (GO:0003677)|Krueppel-associated box domain binding (GO:0035851)|ligase activity (GO:0016874)|poly(A) RNA binding (GO:0044822)|protein kinase activity (GO:0004672)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription coactivator activity (GO:0003713)|transcription corepressor activity (GO:0003714)|ubiquitin protein ligase binding (GO:0031625)|ubiquitin-protein transferase activity (GO:0004842)|zinc ion binding (GO:0008270)				hg19	Standard	0.2167			1478,7122		convergent extension involved in axis elongation (GO:0060028)|DNA repair (GO:0006281)|embryonic placenta morphogenesis (GO:0060669)|epithelial to mesenchymal transition (GO:0001837)|gene expression (GO:0010467)|innate immune response (GO:0045087)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of viral release from host cell (GO:1902187)|positive regulation of DNA repair (GO:0045739)|positive regulation of transcription factor import into nucleus (GO:0042993)|positive regulation of transcription, DNA-templated (GO:0045893)|protein autophosphorylation (GO:0046777)|protein oligomerization (GO:0051259)|protein sumoylation (GO:0016925)|protein ubiquitination (GO:0016567)|transcription initiation from RNA polymerase II promoter (GO:0006367)	267,1998,4238					CCDS12985.1	G		AA,AG,GG		nuclear euchromatin (GO:0005719)|nuclear heterochromatin (GO:0005720)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	55		2504		rs3816329		875				"""tripartite motif-containing 28"""						TIF1B, KAP1, TF1B, RNF96, PPP1R157		19	NM_005762		4			ENST00000253024.5		15990		uc002qtg.1			10155	dbSNP_107						0				65.0		0.547	19:g.59058693G>A		protein_coding			basic|appris_principal|CCDS		135,1208,2957			1054,3352			G|||			5008		TIF1B_HUMAN	908	tripartite motif containing 28			0.18131		59058693			0.0546	SNP		CCDS12985.1			,,,	False	59058693				intron_variant		Approved		55.0			2014-06-13	OTTHUMT00000467074.1	Q13263	0.1801		TRIM28	59058693					TRIM28	NM_005762.2	protein-coding gene	NP_005753.1		
		T	ENSG00000130725	ENST00000253023.3		9040		ENSG00000130725		4300					,							byFrequency	P61081	gene with protein product				NM_003969.3	820,991,392	NM_003969	0.3098					+	Intron		329.6+/-318.8	83.0				9694792				UBE2M-001	2011-05-19				19	-	0.6452				intron	12491			all_cancers(17;4.4e-22)|all_epithelial(17;2.15e-16)|Lung NSC(17;1.24e-06)|all_lung(17;5.41e-06)|Colorectal(82;3.46e-05)|Renal(17;0.00179)|all_neural(62;0.00607)|Ovarian(87;0.0443)|Breast(46;0.0928)|Medulloblastoma(540;0.184)	C	SO:0001627	603173			protein_coding		2203				21.5116,40.286,34.4533		"""Ubiquitin-conjugating enzymes E2"""	6503					UCEC - Uterine corpus endometrioid carcinoma (67;0.0434)|all cancers(4;1.39e-13)|Epithelial(4;1.01e-10)|OV - Ovarian serous cystadenocarcinoma(4;2.34e-09)|GBM - Glioblastoma multiforme(193;0.0102)|Lung(386;0.179)			KNOWN			TAGGGGGGGTCAACAGGCCAG						ENST00000253023.3:c.412-27G>A	19					large_intestine(1)|lung(2)|ovary(1)|pancreas(1)		-		,		19q13.43	O76069|Q8VC50		g.chr19:59067623C>T		643.2+/-397.8			no		4481,8525												3.4					0.8	ATP binding (GO:0005524)|NEDD8 ligase activity (GO:0019788)|ribosomal S6-glutamic acid ligase activity (GO:0018169)|ubiquitin-protein transferase activity (GO:0004842)				hg19	Standard	0.2634			1850,6750		cellular protein modification process (GO:0006464)|positive regulation of neuron apoptotic process (GO:0043525)|protein neddylation (GO:0045116)|protein ubiquitination (GO:0016567)|transforming growth factor beta receptor signaling pathway (GO:0007179)	1018,2445,3040					CCDS12987.1	C		TT,TC,CC	AB012191	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)	81		2504		rs2305119		990				"""ubiquitin-conjugating enzyme E2M (homologous to yeast UBC12)"", ""ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)"""						hUbc12, UBC12		5	NM_003969		6			ENST00000253023.3		15376		uc002qtl.4			9040	dbSNP_100						0				78.0		0.567	19:g.59067623C>T		protein_coding			basic|appris_principal|CCDS		198,1454,2648			2631,1775			C|||			5008		UBC12_HUMAN	1839	ubiquitin-conjugating enzyme E2M			0.367212		59067623			0.1627	SNP		CCDS12987.1			,,,	False	59067623				intron_variant		Approved		81.0			2011-05-19	OTTHUMT00000467097.1	P61081	0.366		UBE2M	59067623					UBE2M	NM_003969.3	protein-coding gene	NP_003960.1		
		G	ENSG00000035115	ENST00000405430.1		26751		ENSG00000035115		4081					,				c.(781-783)agT>agC	OTTHUMG00000151359		byFrequency	Q96HL8	gene with protein product		SH3YL1_ENST00000415006.2_Splice_Site_p.S165S|SH3YL1_ENST00000403657.1_Intron|SH3YL1_ENST00000403712.2_Intron|SH3YL1_ENST00000468321.1_5'UTR|SH3YL1_ENST00000403658.1_Intron|SH3YL1_ENST00000356150.5_Splice_Site_p.S261S			71,591,1158	NM_015677	0.3139					+	Splice_Site			111.0			Silent	21624956				SH3YL1-003	2013-10-18				2	-	0.1747				intron,coding-synonymous-near-splice	29546		,261/343	all_cancers(51;0.034)	A	SO:0001630		,		protein_coding		1820				34.2686,20.1374,29.9102			5901					all cancers(51;0.000647)|Epithelial(75;0.0043)|OV - Ovarian serous cystadenocarcinoma(76;0.00871)|GBM - Glioblastoma multiforme(21;0.148)			KNOWN			CATTTCTGTTACCTGCCAAAA						ENST00000405430.1:c.782-1T>C	2					large_intestine(2)|lung(2)|ovary(1)|prostate(1)|skin(1)		-		,		2p25.3	A8K8E7|B7WNJ4|B7WPL6|Q8NEL2|Q9H5X4|Q9Y3V5		g.chr2:224919A>G					yes		3530,8272												2.6					0.7	phosphatase binding (GO:0019902)|phosphatidylinositol binding (GO:0035091)				hg19	Standard	0.331			2797,5365		phosphatidylinositol biosynthetic process (GO:0006661)|regulation of ruffle assembly (GO:1900027)	530,2470,2901					CCDS42646.1, CCDS42646.2, CCDS54332.1, CCDS62841.1	A		GG,GA,AA		ruffle membrane (GO:0032587)	114		2504		rs2290911		1159				"""SH3 domain containing, Ysc84-like 1 (S. cerevisiae)"""				,	261	Ray, DKFZP586F1318		7	NM_001282687		11			ENST00000405430.1		17201		uc002qvx.3			26751	dbSNP_100	,783			p.S261S		0				119.0		0.323	2:g.224919A>G		protein_coding			not_organism_supported|basic|appris_principal		459,1879,1743			733,2907			A|||			5008		SH3Y1_HUMAN	1280	SH3 and SYLF domain containing 1			0.255591		224919			0.248	SNP					,,,	False	224919				splice_region_variant		Approved		114.0		c.783T>C	2013-10-18	OTTHUMT00000322352.1	Q96HL8	0.2291		SH3YL1	224919		all_hematologic(175;0.0429)|Acute lymphoblastic leukemia(172;0.0627)		,	SH3YL1	NM_001159597.1,NM_015677.2	protein-coding gene			
		T	ENSG00000143727	ENST00000272065.5	0.28039	52	.	ENSG00000143727	0.95612	4300	1.000000	0.47528	D		,	T	0.9338388	0		OTTHUMG00000086933	2.779000	byFrequency	P24666	gene with protein product		ACP1_ENST00000407983.3_Missense_Mutation_p.T95I|ACP1_ENST00000484464.1_Intron|ACP1_ENST00000405233.1_Missense_Mutation_p.T53I|ACP1_ENST00000272067.6_Silent_p.D43D|ACP1_ENST00000439645.2_Silent_p.D43D	Adenine(DB00173)	NM_004300.3	63,623,1517		0.3078			C	17.56	+	Intron	2	459.5+/-364.9	149.0	B5MCC7	0.169995					0.996	ACP1-001			0.83275		2	+	0.1286		0.13	0.998000	missense,intron,coding-synonymous	122	86	95/113,,43/159	all_cancers(51;0.00175)|Lung NSC(108;0.216)|all_epithelial(98;0.236)	C	SO:0001627	171500	,,	0.23756906077348067	protein_coding		2203	P		1.000000	34.4535,16.9995,28.5407	D	"""Protein tyrosine phosphatases / Class II Cys-based PTPs"""	6503		0.0:1.0:0.0:0.0			all cancers(51;0.000391)|Epithelial(75;0.00281)|OV - Ovarian serous cystadenocarcinoma(76;0.00542)|GBM - Glioblastoma multiforme(21;0.127)			KNOWN	ENST00000407983;ENST00000405233;ENST00000449425		GGGTCATTGACAGCGGTGCTG	T;T					ENST00000272065.5:c.231+53C>T	2		ENSG00000143727	0.94253	ACP1	endometrium(1)|large_intestine(3)|lung(6)|prostate(1)|skin(1)		+	0.71417	,	ACA	2p25	A8K1L9|B5MCC7|P24667|Q16035|Q16036|Q16725|Q3KQX8|Q53RU0		g.chr2:272203C>T		306.3+/-289.4		56	yes		3712,9294	0.80357	0.62622	5.87	0.00012	ENSP00000384307:T53I			.		-21.5954		5.9	0.94306	126	0.44086	0.2202797202797203	1.0	acid phosphatase activity (GO:0003993)|non-membrane spanning protein tyrosine phosphatase activity (GO:0004726)	.			hg19	Standard	0.334	0.11382113821138211	17.6971	2963,5637			549,2614,3340	3.419926				CCDS1639.1, CCDS1640.1, CCDS46217.1	C	0.76494	TT,TC,CC	M87546	cytoplasm (GO:0005737)|cytoplasmic side of plasma membrane (GO:0009898)|extracellular vesicular exosome (GO:0070062)	161	.	2504	5.87	rs11553746		324	95	252			0.88285	262203	+	ILE/THR,,			520	12	NM_001040649	0.999	3	0.3324538258575198	0.655000	ENST00000272065.5		16562		uc002qwf.3			52	dbSNP_120	284,,129	0.0000			.	0		T		185.0	rs11553746	0.542	2:g.272203C>T	ENSP00000385404:T95I;ENSP00000384307:T53I	protein_coding	.		basic|appris_candidate_longest|CCDS		486,1991,1823		95;53;53	749,3657	0.23809523809523808	I	C|||		.	5008		PPAC_HUMAN	1219	acid phosphatase 1, soluble		.	0.243411	0.68067	272203		5.667000	0.249	SNP		CCDS1639.1		.	,,,	False	272203	-1.1293	3.1.3.2	7	intron_variant	T	Approved	0.344535	161.0			2011-06-09	OTTHUMT00000195862.3	P24666	0.232	0.91;0.84	ACP1	272203	0.95712	all_hematologic(175;0.0429)|Acute lymphoblastic leukemia(172;0.0627)	0.01697	89,,	ACP1	NM_001040649.2,NM_004300.3,NM_007099.3	protein-coding gene	NP_004291.1	T	
		A	ENSG00000143727	ENST00000272065.5		52		ENSG00000143727		4300					,					OTTHUMG00000086933		byFrequency	P24666	gene with protein product		ACP1_ENST00000484464.1_3'UTR|ACP1_ENST00000272067.6_3'UTR	Adenine(DB00173)	NM_004300.3	0,34,2169		0.0634					+	3'UTR		121.5+/-180.6	93.0								ACP1-001					2	+	0.003				utr-3,utr-3	122		,	all_cancers(51;0.00175)|Lung NSC(108;0.216)|all_epithelial(98;0.236)	G	SO:0001624	171500	,		protein_coding		2203				4.2442,0.7717,3.0678		"""Protein tyrosine phosphatases / Class II Cys-based PTPs"""	6503					all cancers(51;0.000391)|Epithelial(75;0.00281)|OV - Ovarian serous cystadenocarcinoma(76;0.00542)|GBM - Glioblastoma multiforme(21;0.127)			KNOWN			AGGCAGGTTCGTGCCCTGCTG						ENST00000272065.5:c.*10G>A	2					endometrium(1)|large_intestine(3)|lung(6)|prostate(1)|skin(1)		+		,		2p25	A8K1L9|B5MCC7|P24667|Q16035|Q16036|Q16725|Q3KQX8|Q53RU0		g.chr2:277314G>A		41.6+/-74.8			no		399,12607												-0.9					0.0	acid phosphatase activity (GO:0003993)|non-membrane spanning protein tyrosine phosphatase activity (GO:0004726)				hg19	Standard	0.0408			365,8235			10,379,6114					CCDS1639.1, CCDS1640.1, CCDS46217.1	G		AA,AG,GG	M87546	cytoplasm (GO:0005737)|cytoplasmic side of plasma membrane (GO:0009898)|extracellular vesicular exosome (GO:0070062)	96		2504		rs77927634		580								,				12	NM_001040649		0			ENST00000272065.5		15981		uc002qwf.3			52	dbSNP_131	,					0				101.0		0.572	2:g.277314G>A		protein_coding			basic|appris_candidate_longest|CCDS		10,345,3945			34,4372			G|||			5008		PPAC_HUMAN	112	acid phosphatase 1, soluble			0.0223642		277314			0.0	SNP		CCDS1639.1			,,,	False	277314		3.1.3.2		3_prime_UTR_variant		Approved		96.0			2011-06-09	OTTHUMT00000195862.3	P24666	0.0072		ACP1	277314		all_hematologic(175;0.0429)|Acute lymphoblastic leukemia(172;0.0627)		,	ACP1	NM_004300.3,NM_007099.3	protein-coding gene	NP_004291.1		
		C	ENSG00000115705	ENST00000345913.4	0.42496|0.42496	7173	N|N	ENSG00000115705	0.46038|0.46038	4300	0.064000|0.064000	0.68025|.	B;B;B;B|.		,	T|.	0.0070829999999999504|0.0070829999999999504	0|0	c.(2539-2541)gTg>gCg	OTTHUMG00000090271	1.364000|1.364000	byFrequency	P07202	gene with protein product		TPO_ENST00000329066.4_Missense_Mutation_p.V847A|TPO_ENST00000337415.3_Missense_Mutation_p.V847A|TPO_ENST00000346956.3_Missense_Mutation_p.V803A|TPO_ENST00000497517.2_3'UTR|TPO_ENST00000382201.3_Missense_Mutation_p.V790A|TPO_ENST00000349624.3_Missense_Mutation_p.V674A|TPO_ENST00000382198.1_Missense_Mutation_p.V674A	Carbimazole(DB00389)|Dextrothyroxine(DB00509)|Methimazole(DB00763)|Propylthiouracil(DB00550)	NM_000547.5	1303,792,108	NM_000547	0.6933	Substitution - Missense(1)		C|C	0.007|0.007	+	Missense_Mutation	2|1	555.0+/-386.6	71.0	P07202-4;P07202-5;P07202-2;P07202|.	0.771221|0.771221					0.0;0.001;0.001;0.0|.	TPO-202			0.04013|.		2	+	0.8283		1|.	0.001000|0.001000	missense,missense,missense,missense,missense,missense	12015	209|209	847/934,847/934,790/877,790/877,803/890,674/761	all_cancers(51;0.0338)	C	SO:0001583	606765	benign,benign,benign,benign,benign,benign	0.5773480662983426|0.5773480662983426	protein_coding	stomach(1)	2203	P|P		0.164000|0.164000	46.7674,22.8779,38.6745	B;B;B;B|.		6503		0.0:0.7477:0.1631:0.0892|0.0:0.7477:0.1631:0.0892			all cancers(51;0.0356)|OV - Ovarian serous cystadenocarcinoma(76;0.0748)|Epithelial(75;0.12)			KNOWN	ENST00000337415;ENST00000345913;ENST00000346956;ENST00000349624;ENST00000329066;ENST00000382201;ENST00000382198;ENST00000422464;ENST00000469607;ENST00000425083|ENST00000446278		CTCCCTCGGGTGACTTGGATC	T;T;T;T;T;T;T;T;T;T|.					ENST00000345913.4:c.2540T>C	2		ENSG00000115705|ENSG00000115705	0.14976|0.14976	TPO|TPO	breast(1)|central_nervous_system(3)|endometrium(8)|kidney(4)|large_intestine(14)|liver(2)|lung(33)|ovary(8)|pancreas(6)|prostate(4)|skin(7)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	ENSP00000318820:p.Val847Ala	+	0.22935|0.22935	,	GTG|TGA	2p25	P09934|P09935|Q8IUL0|Q8NF94|Q8NF95|Q8NF96|Q8NF97|Q8TCI9		g.chr2:1520676T>C	V -> A (in dbSNP:rs1126799). {ECO:0000269|PubMed:12454013, ECO:0000269|PubMed:3453124, ECO:0000269|PubMed:3475693, ECO:0000269|Ref.6}.	373.4+/-320.8		388|388	yes		7976,5030	0.19789|0.19789	0.00465|0.00465	5.52|5.52	0.00012|.	ENSP00000329869:V847A|.			0.08016|.		-21.4253|-21.4253		4.6	0.57074|0.57074	344|344	0.02654|.	0.6013986013986014|0.6013986013986014	0.1	calcium ion binding (GO:0005509)|heme binding (GO:0020037)|iodide peroxidase activity (GO:0004447)|peroxidase activity (GO:0004601)	-1.645|-1.645			hg19	Standard	0.5417	0.7886178861788617|0.7886178861788617	8.8585|8.8585	4578,4022		cellular nitrogen compound metabolic process (GO:0034641)|embryonic hemopoiesis (GO:0035162)|hormone biosynthetic process (GO:0042446)|hydrogen peroxide catabolic process (GO:0042744)|small molecule metabolic process (GO:0044281)|thyroid hormone generation (GO:0006590)	2510,2956,1037	-1.960539|-1.960539		p.V847A(1)		CCDS1643.1, CCDS1644.1, CCDS1646.1	T	0.02656|.	CC,CT,TT		extracellular space (GO:0005615)|integral component of plasma membrane (GO:0005887)|mitochondrion (GO:0005739)|plasma membrane (GO:0005886)	70	0.00325|0.00325	2504	4.6|4.6	rs1126799		2631	803;674;790;847|.	393|393			0.35242|0.35242	1499683|1499683	+|+	ALA/VAL,ALA/VAL,ALA/VAL,ALA/VAL,ALA/VAL,ALA/VAL	847	TPX	1334|1334	95	NM_175722	0.0;0.0;0.0;0.0|.	15	0.5184696569920845|0.5184696569920845	-0.124000|-0.124000	ENST00000345913.4		18488		uc002qww.3			7173	dbSNP_86	2540,2540,2369,2369,2408,2021	0.0000|.		p.V847A	.|.	1		T|.		68.0	rs1126799;rs2276703;rs3182055;rs17723536;rs52825202;rs57954584;rs1126799|rs1126799;rs2276703;rs3182055;rs17723536;rs52825202;rs57954584;rs1126799	0.592	2:g.1520676T>C	ENSP00000337263:V847A;ENSP00000318820:V847A;ENSP00000263886:V803A;ENSP00000332044:V674A;ENSP00000329869:V847A;ENSP00000371636:V790A;ENSP00000371633:V674A;ENSP00000405788:V732A;ENSP00000419461:V277A;ENSP00000389659:V68A|.	protein_coding	0.991268|.		basic|appris_candidate_longest|CCDS		1207,2164,929		847;847;803;674;847;790;674;732;277;68|322	3398,1008	0.6108058608058609|0.6108058608058609	A|R	C|||		1.004770|.	5008		PERT_HUMAN	3325	thyroid peroxidase		.;.;.;PERT_HUMAN|.	0.663938	0.24238|0.24238	1520676		0.609000|0.609000	0.5833	SNP		CCDS1643.1		N|.	,,,	False	1520676	-1.0082|.	1.11.1.7	9|.	missense	T|.	Approved	0.532326|0.532326	70.0		c.2540T>C	2008-02-05	OTTHUMT00000206594.2	P07202	0.6037	-0.13;-0.12;-0.06;0.16;-0.12;-0.07;0.16;-0.12;0.71;-0.3|.	TPO	1520676	0.01503|0.01503	all_hematologic(175;0.0487)|Acute lymphoblastic leukemia(172;0.0627)	0.27157|.	64,64,64,64,64,64	TPO	NM_000547.5,NM_001206744.1,NM_001206745.1,NM_175719.3,NM_175721.3,NM_175722.3	protein-coding gene	NP_000538.3	V|X	
		C	ENSG00000171853	ENST00000324266.5		51112		ENSG00000171853		4300					,				c.(679-681)ttT>ttC	OTTHUMG00000090328		byFrequency	Q8WVT3	gene with protein product		TRAPPC12_ENST00000382110.2_Silent_p.F227F		NM_016030.5	1070,927,206	NM_016030	0.6748					+	Silent		517.6+/-379.1	50.0				10810093, 21525244, 20562859				TRAPPC12-002	2011-12-12				2	+	0.7254				coding-synonymous	24284		227/736		C	SO:0001819	614139			protein_coding		2203				41.7093,30.3904,37.8748		"""Trafficking protein particle complex"", ""Tetratricopeptide (TTC) repeat domain containing"""	6503								KNOWN			TCGACTCCTTTACTACCTCCG		TTC15				ENST00000324266.5:c.681T>C	2							+		,		2p25.3	B3KV01|D6W4Y2|Q8WVW1|Q9Y395		g.chr2:3392075T>C		443.9+/-347.2			no		8080,4926												3.2					1.0			2011-12-12		hg19	Standard	0.6183			5013,3587		vesicle-mediated transport (GO:0016192)	2516,3048,939					CCDS1652.1	T		CC,CT,TT	BC017475		48		2504		rs10865541		876				"""tetratricopeptide repeat domain 15"""					227	CGI-87, TTC-15			NM_016030		2			ENST00000324266.5		7910		uc002qxm.1			51112	dbSNP_120	681			p.F227F		0				44.0		0.716	2:g.3392075T>C		protein_coding			alternative_5_UTR|basic|appris_principal|CCDS		1446,2121,733			3067,1339			C|||			5008		TPC12_HUMAN	3274	trafficking protein particle complex 12			0.653754		3392075			0.6806	SNP		CCDS1652.1			,,,	False	3392075				synonymous_variant		Approved		48.0		c.681T>C	2013-01-10	OTTHUMT00000206693.2	Q8WVT3	0.5		TRAPPC12	3392075					TTC15	NM_016030.5	protein-coding gene	NP_057114.5		
		C	ENSG00000171853	ENST00000324266.5	0.09310	51112	.	ENSG00000171853	0.08224	4300	0.986000	.	.		,	.	0.999999999880938	0	c.(1840-1842)gaT>gaC	OTTHUMG00000090328	-0.353000	byFrequency	Q8WVT3	gene with protein product		TRAPPC12_ENST00000382110.2_Silent_p.D614D		NM_016030.5	65,600,1538	NM_016030	0.0654			T	6.540	+	Silent	1	191.4+/-237.6	73.0	.	0.165683		10810093, 21525244, 20562859			.	TRAPPC12-002	2011-12-12		.		2	+	0.1657		.	0.633000	coding-synonymous	24284	24	614/736		T	SO:0001819	614139		0.06629834254143646	protein_coding		2203	P		0.124000	9.814,16.5683,12.1021	.	"""Trafficking protein particle complex"", ""Tetratricopeptide (TTC) repeat domain containing"""	6503		0.0:0.4395:0.0:0.5605						KNOWN	ENST00000452495		AGAAATTAGATGGACTACAGG	.	TTC15				ENST00000324266.5:c.1842T>C	2		ENSG00000171853	0.10049	TTC15			+	0.22315	,	TGG	2p25.3	B3KV01|D6W4Y2|Q8WVW1|Q9Y395		g.chr2:3481531T>C		296.7+/-284.4		93	no		1574,11432	0.45419	0.12402	5.66	0.00073	.			.		.		-2.6	0.06209	30	.	0.05244755244755245	1.0		.	2011-12-12		hg19	Standard	0.0944	0.18902439024390244	11.3558	844,7756		vesicle-mediated transport (GO:0016192)	102,1370,5031	0.467960				CCDS1652.1	T	.	CC,CT,TT	BC017475		71	.	2504	-2.59	rs11548215		2037	.	76		"""tetratricopeptide repeat domain 15"""	0.49615	3460538	+		614	CGI-87, TTC-15	223		NM_016030	.	10	0.10026385224274406	-0.280000	ENST00000324266.5		18454		uc002qxm.1			51112	dbSNP_120	1842	0.0002		p.D614D	.	0		T		69.0	rs11548215;rs17851117	0.328	2:g.3481531T>C	.	protein_coding	.		alternative_5_UTR|basic|appris_principal|CCDS		37,770,3493		16	730,3676	0.1021062271062271	R	T|||		.	5008		TPC12_HUMAN	476	trafficking protein particle complex 12		.	0.0950479	0.04782	3481531		-0.755000	0.0496	SNP		CCDS1652.1		.	,,,	False	3481531	-1.0196		3	synonymous_variant	T	Approved	0.09814	71.0		c.1842T>C	2013-01-10	OTTHUMT00000206693.2	Q8WVT3	0.0692	.	TRAPPC12	3481531	0.38033		0.23154		TTC15	NM_016030.5	protein-coding gene	NP_057114.5	W	
		T	ENSG00000171853	ENST00000324266.5	0.09310	51112	.	ENSG00000171853	0.06716	4300	0.968000	.	.		,	.	0.9999999999999999	0	c.(2179-2181)ttC>ttT	OTTHUMG00000090328	-0.489000	byFrequency	Q8WVT3	gene with protein product		TRAPPC12_ENST00000382110.2_Silent_p.F727F		NM_016030.5	709,1047,447	NM_016030	0.5133			T	9.482	+	Silent	1	643.8+/-400.0	66.0	.	0.559464		10810093, 21525244, 20562859			.	TRAPPC12-002	2011-12-12		.		2	+	0.6006		.	0.918000	coding-synonymous	24284	133	727/736		T	SO:0001819	614139		0.3674033149171271	protein_coding		2203	P		0.999000	38.686,44.0536,44.5333	.	"""Trafficking protein particle complex"", ""Tetratricopeptide (TTC) repeat domain containing"""	6503		0.0:0.3874:0.0:0.6126						KNOWN	ENST00000416918		GGGACAGCTTCAACACACAGT	.	TTC15				ENST00000324266.5:c.2181C>T	2		ENSG00000171853	0.01624	TTC15			+	0.42202	,	CAA	2p25.3	B3KV01|D6W4Y2|Q8WVW1|Q9Y395		g.chr2:3483205C>T		551.2+/-378.2		286	no		5792,7214	0.41197	0.20552	5.09	.	.			.		.		-1.1	0.09808	281	.	0.49125874125874125	1.0		.	2011-12-12		hg19	Standard	0.4185	0.5813008130081301	10.8795	3327,5273		vesicle-mediated transport (GO:0016192)	1359,3074,2070	1.098402				CCDS1652.1	C	.	TT,TC,CC	BC017475		65	.	2504	-1.12	rs6767		2376	.	315		"""tetratricopeptide repeat domain 15"""	0.46929	3462212	+		727	CGI-87, TTC-15	1015		NM_016030	.	12	0.4155672823218997	-1.213000	ENST00000324266.5		20322		uc002qxm.1			51112	dbSNP_52	2181	.		p.F727F	.	0		.		65.0	rs6767;rs17680;rs1127120;rs3171903;rs56947181;rs6767	0.542	2:g.3483205C>T	.	protein_coding	.		alternative_5_UTR|basic|appris_principal|CCDS		650,2027,1623		114	2465,1941	0.46474358974358976	X	T|||		.	5008		TPC12_HUMAN	2431	trafficking protein particle complex 12		.	0.485423	0.24164	3483205		0.604000	0.4653	SNP		CCDS1652.1		.	,,,	False	3483205	.		.	synonymous_variant	.	Approved	0.38686	65.0		c.2181C>T	2013-01-10	OTTHUMT00000206693.2	Q8WVT3	0.353	.	TRAPPC12	3483205	0.54935		.		TTC15	NM_016030.5	protein-coding gene	NP_057114.5	Q	
		G	ENSG00000182551	ENST00000327435.6		55256		ENSG00000182551		4300					,				c.(316-318)gaT>gaC	OTTHUMG00000112441		byFrequency		gene with protein product		ADI1_ENST00000382093.5_Silent_p.D100D		NM_018269.3	1431,673,99	NM_018269	0.3446	Substitution - coding silent(1)				+	Silent		469.8+/-367.7	165.0				14718544, 15938715				ADI1-001					2	-	0.8918				coding-synonymous	30576		106/180		A	SO:0001819	613400			protein_coding	stomach(1)	2203				35.5465,19.7685,49.3157			6503					OV - Ovarian serous cystadenocarcinoma(76;0.0729)|Epithelial(75;0.173)|all cancers(51;0.228)			KNOWN			TGTCCCTCACATCGAAGTACC						ENST00000327435.6:c.318T>C	2					breast(2)|large_intestine(2)|lung(4)|ovary(1)|stomach(1)		-		,		2p25.2		"""membrane-type 1 matrix metalloproteinase cytoplasmic tail binding protein-1"""	g.chr2:3504687A>G		743.8+/-411.5			no		6592,6414												-7.0					0.2					hg19	Standard	0.3887			3057,5543			1989,2614,1900			p.D106D(1)		CCDS1653.1	A		GG,GA,AA			184		2504		rs9950		566										SIPL, MTCBP-1, ARD, APL1, FLJ10913, HMFT1638, mtnD		10	NM_018269		3			ENST00000327435.6		19687		uc002qxp.4			55256	dbSNP_52	318			p.D106D		1				221.0		0.537	2:g.3504687A>G		protein_coding			basic|appris_principal|CCDS		558,1941,1801			3535,871			A|||			5008			2672	acireductone dioxygenase 1			0.533546		3504687			0.4484	SNP		CCDS1653.1			,,,	False	3504687		1.13.11.54		synonymous_variant		Approved		184.0		c.318T>C	2013-05-29	OTTHUMT00000231914.6	Q9BV57	0.451		ADI1	3504687		Acute lymphoblastic leukemia(172;0.0627)|all_hematologic(175;0.093)			ADI1	NM_018269.3	protein-coding gene	NP_060739.2		
		C	ENSG00000171865	ENST00000315212.3		246243		ENSG00000171865		4300					,				c.(496-498)ccA>ccG	OTTHUMG00000090279		byFrequency	O60930	gene with protein product				NM_002936.3	820,991,392		0.3149					+	Silent		652.1+/-400.9	124.0				12036296, 17964265				RNASEH1-001					2	-	0.6233				coding-synonymous	18466		166/287		C	SO:0001819	604123			protein_coding		2203				36.6279,40.286,44.4487			6503					OV - Ovarian serous cystadenocarcinoma(76;0.0713)|Epithelial(75;0.167)|all cancers(51;0.22)			KNOWN			AAGGATGGCCTGGCCCCCAGT						ENST00000315212.3:c.498A>G	2	RNase H. {ECO:0000255|PROSITE- ProRule:PRU00408}.				endometrium(1)|kidney(1)|lung(7)|ovary(1)|prostate(2)|skin(1)		-		,		2p25	B3KQU4|O60523|O60857|Q57Z93|Q5U0C1|Q6FHD4	"""RNase H1"""	g.chr2:3597974T>C		521.1+/-370.4			yes		5781,7225												-10.9					0.1	magnesium ion binding (GO:0000287)|nucleic acid binding (GO:0003676)|ribonuclease activity (GO:0004540)|RNA binding (GO:0003723)|RNA-DNA hybrid ribonuclease activity (GO:0004523)				hg19	Standard	0.3479			3150,5450		mitochondrial DNA replication (GO:0006264)|RNA catabolic process (GO:0006401)|RNA phosphodiester bond hydrolysis (GO:0090501)	1416,2949,2138					CCDS1647.1	T		CC,CT,TT	AF039652	mitochondrion (GO:0005739)|nucleus (GO:0005634)	119		2504		rs10186193		853									166			13	XR_244873		4			ENST00000315212.3		17040		uc002qxt.3			246243	dbSNP_119	498			p.P166P		0				110.0		0.498	2:g.3597974T>C		protein_coding			basic|appris_principal|CCDS		596,1958,1746			2631,1775			C|||			5008		RNH1_HUMAN	1881	ribonuclease H1			0.375599		3597974			0.2371	SNP		CCDS1647.1			,,,	False	3597974		3.1.26.-		synonymous_variant		Approved		119.0		c.498A>G	2008-03-11	OTTHUMT00000206605.2	O60930	0.2305		RNASEH1	3597974		Acute lymphoblastic leukemia(172;0.0627)|all_hematologic(175;0.093)			RNASEH1	NM_002936.3	protein-coding gene	NP_002927.2		
		T	ENSG00000171865	ENST00000315212.3		246243		ENSG00000171865		4300					,					OTTHUMG00000090279		byFrequency	O60930	gene with protein product				NM_002936.3	1630,519,54		0.5378					+	Intron		470.8+/-367.9	60.0				12036296, 17964265				RNASEH1-001					2	-	0.8805				intron	18466				T	SO:0001627	604123			protein_coding		2203				35.8837,14.2306,28.5484			6503					OV - Ovarian serous cystadenocarcinoma(76;0.0713)|Epithelial(75;0.167)|all cancers(51;0.22)			KNOWN			TCCTGACTGTGGTATTAAAAT						ENST00000315212.3:c.409+33C>A	2					endometrium(1)|kidney(1)|lung(7)|ovary(1)|prostate(2)|skin(1)		-		,		2p25	B3KQU4|O60523|O60857|Q57Z93|Q5U0C1|Q6FHD4	"""RNase H1"""	g.chr2:3599700G>T		268.9+/-268.7			no		9293,3713												-3.5					0.0	magnesium ion binding (GO:0000287)|nucleic acid binding (GO:0003676)|ribonuclease activity (GO:0004540)|RNA binding (GO:0003723)|RNA-DNA hybrid ribonuclease activity (GO:0004523)				hg19	Standard	0.66			5514,3086		mitochondrial DNA replication (GO:0006264)|RNA catabolic process (GO:0006401)|RNA phosphodiester bond hydrolysis (GO:0090501)	3418,2457,628					CCDS1647.1	G		TT,TG,GG	AF039652	mitochondrion (GO:0005739)|nucleus (GO:0005634)	58		2504		rs7563960		765												13	XR_244873		3			ENST00000315212.3		17182		uc002qxt.3			246243	dbSNP_116						0				56.0		0.433	2:g.3599700G>T		protein_coding			basic|appris_principal|CCDS		1788,1938,574			3779,627			T|||			5008		RNH1_HUMAN	3168	ribonuclease H1			0.632588		3599700			0.4206	SNP		CCDS1647.1			,,,	False	3599700		3.1.26.-		intron_variant		Approved		58.0			2008-03-11	OTTHUMT00000206605.2	O60930	0.562		RNASEH1	3599700		Acute lymphoblastic leukemia(172;0.0627)|all_hematologic(175;0.093)			RNASEH1	NM_002936.3	protein-coding gene	NP_002927.2		
		G	ENSG00000171863	ENST00000304921.5		6201		ENSG00000171863		4300										OTTHUMG00000090305			P62081	gene with protein product		RPS7_ENST00000407445.3_Intron|RPS7_ENST00000403564.1_Intron|RPS7_ENST00000406376.1_Intron		NM_001011.3		NM_001011						+	Intron			56.0				8522193, 10625621				RPS7-001					2	+						10440					SO:0001627	603658			protein_coding		2201						"""S ribosomal proteins"""	6501					OV - Ovarian serous cystadenocarcinoma(76;0.0963)|Epithelial(75;0.208)			KNOWN			TTGTTACATGATAATTTTTAC						ENST00000304921.5:c.292-18A>G	2					endometrium(1)|lung(2)|urinary_tract(1)		+				2p25	P23821|P24818|Q57Z92|Q6IPH1		g.chr2:3625282A>G																									poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|structural constituent of ribosome (GO:0003735)				hg19	Standard						cellular protein metabolic process (GO:0044267)|cytoplasmic translation (GO:0002181)|gene expression (GO:0010467)|mRNA metabolic process (GO:0016071)|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|ribosomal small subunit biogenesis (GO:0042274)|RNA metabolic process (GO:0016070)|rRNA processing (GO:0006364)|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|translation (GO:0006412)|translational elongation (GO:0006414)|translational initiation (GO:0006413)|translational termination (GO:0006415)|viral life cycle (GO:0019058)|viral process (GO:0016032)|viral transcription (GO:0019083)						CCDS1648.1	A				90S preribosome (GO:0030686)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|cytosolic small ribosomal subunit (GO:0022627)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|membrane (GO:0016020)|nucleolus (GO:0005730)|nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)|ribosome (GO:0005840)|small-subunit processome (GO:0032040)							455										S7		4	NM_001011		5			ENST00000304921.5				uc002qxw.3			6201							0				51.0		0.358	2:g.3625282A>G		protein_coding			basic|appris_principal|CCDS													RS7_HUMAN		ribosomal protein S7					3625282				SNP		CCDS1648.1					3625282				intron_variant		Approved		54.0			2011-04-05	OTTHUMT00000206667.1	P62081			RPS7	3625282		Acute lymphoblastic leukemia(172;0.0627)|all_hematologic(175;0.093)					protein-coding gene	NP_001002.1		
		A	ENSG00000171863	ENST00000304921.5		6201		ENSG00000171863		4300					,					OTTHUMG00000090305		byFrequency	P62081	gene with protein product		RPS7_ENST00000403564.1_Intron|RPS7_ENST00000406376.1_Intron		NM_001011.3	63,639,1500	NM_001011	0.0736					+	Intron		219.5+/-257.5	144.0				8522193, 10625621				RPS7-001					2	+	0.1997				intron	10440				C	SO:0001627	603658			protein_coding		2202				12.186,17.3706,13.9419		"""S ribosomal proteins"""	6502					OV - Ovarian serous cystadenocarcinoma(76;0.0963)|Epithelial(75;0.208)			KNOWN			TGAATTCTTTCTTTTCTTGTA						ENST00000304921.5:c.508-12C>A	2					endometrium(1)|lung(2)|urinary_tract(1)		+		,		2p25	P23821|P24818|Q57Z92|Q6IPH1		g.chr2:3628383C>A		303.5+/-288.0			no		1813,11191												-3.2					0.0	poly(A) RNA binding (GO:0044822)|RNA binding (GO:0003723)|structural constituent of ribosome (GO:0003735)				hg19	Standard	0.1103			1048,7552		cellular protein metabolic process (GO:0044267)|cytoplasmic translation (GO:0002181)|gene expression (GO:0010467)|mRNA metabolic process (GO:0016071)|nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)|ribosomal small subunit biogenesis (GO:0042274)|RNA metabolic process (GO:0016070)|rRNA processing (GO:0006364)|SRP-dependent cotranslational protein targeting to membrane (GO:0006614)|translation (GO:0006412)|translational elongation (GO:0006414)|translational initiation (GO:0006413)|translational termination (GO:0006415)|viral life cycle (GO:0019058)|viral process (GO:0016032)|viral transcription (GO:0019083)	130,1553,4819					CCDS1648.1	C		AA,AC,CC		90S preribosome (GO:0030686)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|cytosolic small ribosomal subunit (GO:0022627)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|membrane (GO:0016020)|nucleolus (GO:0005730)|nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)|ribosome (GO:0005840)|small-subunit processome (GO:0032040)	144		2504		rs2071639		671										S7		4	NM_001011		7			ENST00000304921.5		19051		uc002qxw.3			6201	dbSNP_96						0				145.0		0.343	2:g.3628383C>A		protein_coding			basic|appris_principal|CCDS		67,914,3319			765,3639			C|||			5008		RS7_HUMAN	668	ribosomal protein S7			0.133387		3628383			0.1825	SNP		CCDS1648.1			,,,	False	3628383				intron_variant		Approved		144.0			2011-04-05	OTTHUMT00000206667.1	P62081	0.0533		RPS7	3628383		Acute lymphoblastic leukemia(172;0.0627)|all_hematologic(175;0.093)			RPS7	NM_001011.3	protein-coding gene	NP_001002.1		
		G	ENSG00000151692	ENST00000320892.6	0.45979	9781	N	ENSG00000151692	0.35431	4300	0.986000	0.32515	B		,	T	0.0012010000000000076	0	c.(10-12)Aca>Gca	OTTHUMG00000090353	0.858000	byFrequency	P50876	gene with protein product		RNF144A_ENST00000467276.1_Intron		NM_014746.3	1616,544,43	NM_014746	0.9417			G	8.235	+	Missense_Mutation	1	322.2+/-315.5	79.0	P50876	0.857013		8724849, 10431818			0.0	RNF144A-001	2007-08-20		0.01281		2	+	0.8684		1	0.992000	missense	20457	281	4/293	all_cancers(51;0.226)	G	SO:0001583		benign	0.7762430939226519	protein_coding		2203	P		1.000000	20.7674,14.2987,18.576	B	"""RING-type (C3HC4) zinc fingers"""	6503		0.1333:0.0:0.8667:0.0			OV - Ovarian serous cystadenocarcinoma(76;0.195)			KNOWN	ENST00000320892;ENST00000427092;ENST00000416587;ENST00000433456		GATGACCACAACAAGGTACCG	T;T;T	RNF144				ENST00000320892.6:c.10A>G	2		ENSG00000151692	0.15052	RNF144A	breast(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(15)|ovary(1)|prostate(1)	ENSP00000321330:p.Thr4Ala	+	0.71417	,	ACA	2p25.2	D6W4Y6|Q585H5		g.chr2:7137067A>G	T -> A (in dbSNP:rs364891). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8724849, ECO:0000269|Ref.3}.	272.2+/-270.6		427	yes		10590,2416	0.45419	0.16467	5.62	0.00012	ENSP00000321330:T4A			0.64402		.		4.7	0.60224	454	0.02654	0.7937062937062938	1.0	ligase activity (GO:0016874)|zinc ion binding (GO:0008270)	0.28	2007-08-20		hg19	Standard	0.8022	0.8678861788617886	12.7793	6814,1786		protein ubiquitination (GO:0016567)	4308,1974,221	0.805546				CCDS1657.1	A	0.02656	GG,GA,AA	D79983	Golgi apparatus (GO:0005794)|integral component of membrane (GO:0016021)	81	0.12961	2504	4.74	rs364891		452	4	605		"""ring finger protein 144"""	0.57469	7054518	+	ALA/THR	4	UBCE7IP4, KIAA0161	1767	25	NM_014746	0.0	3	0.7981530343007915	-0.119000	ENST00000320892.6		17436		uc002qys.3			9781	dbSNP_80	10	0.0000		p.T4A	.	0		T		86.0	rs364891;rs3817392;rs17857379;rs52822402;rs59578938;rs364891	0.602	2:g.7137067A>G	ENSP00000321330:T4A;ENSP00000414420:T4A;ENSP00000402645:T4A	protein_coding	0.000001		basic|appris_principal|CCDS		2692,1430,178		4	3776,630	0.8090659340659341	A	G|||		0.093245	5008		R144A_HUMAN	4216	ring finger protein 144A		R144A_HUMAN	0.841853	0.65580	7137067		5.276000	0.7817	SNP		CCDS1657.1		N	,,,	False	7137067	-0.9623		9	missense	T	Approved	0.792326	81.0		c.10A>G	2008-02-05	OTTHUMT00000206725.2	P50876	0.7954	1.45;1.45;1.45	RNF144A	7137067	0.81027	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.39251	58	RNF144A	NM_014746.3	protein-coding gene	NP_055561.2	T	
		C	ENSG00000151692	ENST00000320892.6	0.09310	9781	.	ENSG00000151692	0.07394	4300	0.988000	.	.		,	.	1.0	0	c.(181-183)acT>acC	OTTHUMG00000090353	-0.423000		P50876	gene with protein product		RNF144A_ENST00000467276.1_Intron		NM_014746.3		NM_014746	1.0			C	9.410	+	Silent	2		132.0	.	.		8724849, 10431818			.	RNF144A-001	2007-08-20		.		2	+	1.0		.	0.901000		20457	362		all_cancers(51;0.226)		SO:0001819			1.0	protein_coding		2203	P		0.748000		.	"""RING-type (C3HC4) zinc fingers"""	6503		0.1282:0.0635:0.417:0.3913			OV - Ovarian serous cystadenocarcinoma(76;0.195)			KNOWN	ENST00000432850		GATTAGAAACTGCAATTAGCT	.	RNF144				ENST00000320892.6:c.183T>C	2		ENSG00000151692	0.00312	RNF144A	breast(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(15)|ovary(1)|prostate(1)		+	0.28294	,	CTG	2p25.2	D6W4Y6|Q585H5		g.chr2:7154632T>C				492				0.46212	0.20309	5.51	0.00012	.			.		.			0.07525	572	.	1.0		ligase activity (GO:0016874)|zinc ion binding (GO:0008270)	.	2007-08-20		hg19	Standard	1.0	1.0	5.5944			protein ubiquitination (GO:0016567)		1.080246				CCDS1657.1	T	.		D79983	Golgi apparatus (GO:0005794)|integral component of membrane (GO:0016021)		.	2504	-1.96	rs309325		625	.	758		"""ring finger protein 144"""	0.17319	7072083	+		61	UBCE7IP4, KIAA0161	2184	25	NM_014746	.	4	1.0	-2.189000	ENST00000320892.6		20171		uc002qys.3			9781			0.0000		p.T61T	.	0		T		129.0	rs309325;rs17854625;rs59709390	0.453	2:g.7154632T>C	.	protein_coding	.		basic|appris_principal|CCDS				57		1.0	P	C|||		.	5008		R144A_HUMAN	5007	ring finger protein 144A		.	0.9998	0.10012	7154632		-0.162000	0.999	SNP		CCDS1657.1		.	,,,	False	7154632	-1.0195		3	synonymous_variant	T	Approved	.	131.0		c.183T>C	2008-02-05	OTTHUMT00000206725.2	P50876	1.0	.	RNF144A	7154632	0.52897	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.23190				protein-coding gene	NP_055561.2	L	
		A	ENSG00000134313	ENST00000256707.3		57498		ENSG00000134313		4156					,				c.(3673-3675)Ctg>Ttg	OTTHUMG00000151658		byFrequency	Q9ULH0	gene with protein product		KIDINS220_ENST00000427284.1_Silent_p.L1206L|KIDINS220_ENST00000418530.1_Silent_p.L1126L|KIDINS220_ENST00000473731.1_Silent_p.L1206L		NM_020738.2	2,128,1852	NM_020738	0.0859					+	Silent			113.0				10998417, 10574462				KIDINS220-001					2	-	0.0227				coding-synonymous	29508		1225/1772		G	SO:0001819	615759			protein_coding		1982				7.8321,3.33,6.3783		"""Ankyrin repeat domain containing"""	6138								KNOWN			CTCTGGTCCAGCCCTTCTATT						ENST00000256707.3:c.3673C>T	2					NS(1)|breast(1)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(11)|lung(25)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2)		-		,		2p24	A1L4N4|Q4VC08|Q6MZU2|Q9H889|Q9H9E4|Q9NT37|Q9UF42	"""ankyrin repeat-rich membrane-spanning protein"""	g.chr2:8877042G>A					no		783,11493												3.9					1.0	PDZ domain binding (GO:0030165)				hg19	Standard	0.1064			651,7661		activation of MAPKK activity (GO:0000186)|cellular response to nerve growth factor stimulus (GO:1990090)|cytoplasmic transport (GO:0016482)|dendrite morphogenesis (GO:0048813)|in utero embryonic development (GO:0001701)|nerve growth factor signaling pathway (GO:0038180)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of neuron projection development (GO:0010976)	28,727,5383					CCDS42650.1	G		AA,AG,GG	AK025528	cytosol (GO:0005829)|integral component of membrane (GO:0016021)|late endosome (GO:0005770)|membrane (GO:0016020)|protein complex (GO:0043234)	114		2504		rs61742863		3854									1225	ARMS		60	NM_020738		27			ENST00000256707.3		16320		uc002qzc.2			57498	dbSNP_129	3673			p.L1225L		0				118.0		0.527	2:g.8877042G>A		protein_coding			basic|appris_principal|CCDS		26,599,3531			132,3832			G|||			5008		KDIS_HUMAN	263	kinase D-interacting substrate, 220kDa			0.052516		8877042			0.004	SNP		CCDS42650.1			,,,	False	8877042				synonymous_variant		Approved		114.0		c.3673C>T	2013-01-10	OTTHUMT00000323408.2	Q9ULH0	0.0548		KIDINS220	8877042		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			KIDINS220	NM_020738.2	protein-coding gene	NP_065789.1		
		T	ENSG00000134313	ENST00000256707.3		57498		ENSG00000134313		4065					,					OTTHUMG00000151658		byFrequency	Q9ULH0	gene with protein product		KIDINS220_ENST00000427284.1_Intron|KIDINS220_ENST00000418530.1_Intron|KIDINS220_ENST00000319688.5_Intron|KIDINS220_ENST00000473731.1_Intron		NM_020738.2	1702,89,1	NM_020738	0.9949					+	Intron			39.0				10998417, 10574462				KIDINS220-001					2	-	0.9735				intron	29508				T	SO:0001627	615759			protein_coding		1792				1.9311,2.5391,2.1171		"""Ankyrin repeat domain containing"""	5857								KNOWN			AAAAGCATTTAAAAATTAATA						ENST00000256707.3:c.2849-25T>A	2					NS(1)|breast(1)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(11)|lung(25)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2)		-		,		2p24	A1L4N4|Q4VC08|Q6MZU2|Q9H889|Q9H9E4|Q9NT37|Q9UF42	"""ankyrin repeat-rich membrane-spanning protein"""	g.chr2:8910987A>T					no		11466,248												-9.9					0.0	PDZ domain binding (GO:0030165)				hg19	Standard	0.9901			7973,157		activation of MAPKK activity (GO:0000186)|cellular response to nerve growth factor stimulus (GO:1990090)|cytoplasmic transport (GO:0016482)|dendrite morphogenesis (GO:0048813)|in utero embryonic development (GO:0001701)|nerve growth factor signaling pathway (GO:0038180)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of neuron projection development (GO:0010976)	5613,240,4					CCDS42650.1	A		TT,TA,AA	AK025528	cytosol (GO:0005829)|integral component of membrane (GO:0016021)|late endosome (GO:0005770)|membrane (GO:0016020)|protein complex (GO:0043234)	39		2504		rs12476359		3030										ARMS		60	NM_020738		22			ENST00000256707.3		15680		uc002qzc.2			57498	dbSNP_120						0				40.0		0.279	2:g.8910987A>T		protein_coding			basic|appris_principal|CCDS		3911,151,3			3493,91			T|||			5008		KDIS_HUMAN	4911	kinase D-interacting substrate, 220kDa			0.980631		8910987			0.9663	SNP		CCDS42650.1			,,,	False	8910987				intron_variant		Approved		39.0			2013-01-10	OTTHUMT00000323408.2	Q9ULH0	0.9813		KIDINS220	8910987		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			KIDINS220	NM_020738.2	protein-coding gene	NP_065789.1		
		T	ENSG00000134313	ENST00000256707.3		57498		ENSG00000134313		4081					,					OTTHUMG00000151658		byFrequency	Q9ULH0	gene with protein product		KIDINS220_ENST00000319688.5_Intron|KIDINS220_ENST00000427284.1_Intron|KIDINS220_ENST00000473731.1_Intron|KIDINS220_ENST00000418530.1_Intron		NM_020738.2	1360,430,41	NM_020738	0.9949					+	Intron			43.0				10998417, 10574462				KIDINS220-001					2	-	0.8555				intron	29508				T	SO:0001627	615759			protein_coding		1831				1.9481,13.9814,5.6749		"""Ankyrin repeat domain containing"""	5912								KNOWN			AAGCTTATTAACTATCATAGA						ENST00000256707.3:c.2848+30T>A	2					NS(1)|breast(1)|central_nervous_system(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(11)|lung(25)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2)		-		,		2p24	A1L4N4|Q4VC08|Q6MZU2|Q9H889|Q9H9E4|Q9NT37|Q9UF42	"""ankyrin repeat-rich membrane-spanning protein"""	g.chr2:8916847A>T					no		11153,671												1.5					0.0	PDZ domain binding (GO:0030165)				hg19	Standard	0.9901			8003,159		activation of MAPKK activity (GO:0000186)|cellular response to nerve growth factor stimulus (GO:1990090)|cytoplasmic transport (GO:0016482)|dendrite morphogenesis (GO:0048813)|in utero embryonic development (GO:0001701)|nerve growth factor signaling pathway (GO:0038180)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of neuron projection development (GO:0010976)	5283,587,42					CCDS42650.1	A		TT,TA,AA	AK025528	cytosol (GO:0005829)|integral component of membrane (GO:0016021)|late endosome (GO:0005770)|membrane (GO:0016020)|protein complex (GO:0043234)	44		2504		rs4669338		3030										ARMS		60	NM_020738		21			ENST00000256707.3		16956		uc002qzc.2			57498	dbSNP_111						0				45.0		0.338	2:g.8916847A>T		protein_coding			basic|appris_principal|CCDS		3923,157,1			3150,512			T|||			5008		KDIS_HUMAN	4750	kinase D-interacting substrate, 220kDa			0.948482		8916847			0.9663	SNP		CCDS42650.1			,,,	False	8916847				intron_variant		Approved		44.0			2013-01-10	OTTHUMT00000323408.2	Q9ULH0	0.9741		KIDINS220	8916847		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			KIDINS220	NM_020738.2	protein-coding gene	NP_065789.1		
		T	ENSG00000151693	ENST00000281419.3		8853		ENSG00000151693		4300					,				c.(1102-1104)ctC>ctT	OTTHUMG00000117485		byFrequency	O43150	gene with protein product		ASAP2_ENST00000315273.4_Silent_p.L368L		NM_003887.2	1204,834,165	NM_003887	0.9397					+	Silent		14.6+/-50.1	65.0				10022920, 9455477				ASAP2-001	2008-09-22				2	+	0.677				coding-synonymous,coding-synonymous	2721		368/962,368/1007		T	SO:0001819	603817	,		protein_coding		2203				0.2674,26.4185,9.1266		"""ADP-ribosylation factor GTPase activating proteins"", ""Pleckstrin homology (PH) domain containing"", ""Ankyrin repeat domain containing"""	6503								KNOWN			GCTTTGACCTCATTTCACGTA		DDEF2				ENST00000281419.3:c.1104C>T	2	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.				breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(6)|lung(15)|prostate(2)|skin(3)|upper_aerodigestive_tract(1)		+		,		2p24	D6W4Y8	"""centaurin, beta 3"""	g.chr2:9491017C>T		410.6+/-335.4			no		11819,1187												-5.9					0.9	ARF GTPase activator activity (GO:0008060)|enzyme activator activity (GO:0008047)|zinc ion binding (GO:0008270)		2008-09-22		hg19	Standard	0.998			8577,23		positive regulation of catalytic activity (GO:0043085)|regulation of ARF GTPase activity (GO:0032312)	5481,857,165					CCDS1661.1, CCDS46224.1	C		TT,TC,CC	AB007860	Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)	72		2504		rs4669385		1444				"""development and differentiation enhancing factor 2"""				,	368	KIAA0400, PAP, SHAG1, CENTB3		36	NM_003887		12			ENST00000281419.3		20584		uc002qzh.2			8853	dbSNP_111	1104,1104			p.L368L		0				83.0		0.502	2:g.9491017C>T		protein_coding			basic|appris_candidate_longest|CCDS		4277,23,0			3242,1164			T|||			5008		ASAP2_HUMAN	4412	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			0.88099		9491017			0.9196	SNP		CCDS1661.1			,,,	False	9491017				synonymous_variant		Approved		72.0		c.1104C>T	2013-01-10	OTTHUMT00000237522.1	O43150	0.9611		ASAP2	9491017				,	ASAP2	NM_001135191.1,NM_003887.2	protein-coding gene	NP_003878.1		
		C	ENSG00000151693	ENST00000281419.3		8853		ENSG00000151693		4300					,					OTTHUMG00000117485		byFrequency	O43150	gene with protein product		ASAP2_ENST00000315273.4_Intron		NM_003887.2	1690,476,37	NM_003887	0.5399					+	Intron		506.3+/-376.6	160.0				10022920, 9455477				ASAP2-001	2008-09-22				2	+	0.938				intron,intron	2721		,		C	SO:0001627	603817	,		protein_coding		2203				40.0581,12.483,30.7166		"""ADP-ribosylation factor GTPase activating proteins"", ""Pleckstrin homology (PH) domain containing"", ""Ankyrin repeat domain containing"""	6503								KNOWN			AACACAGCGTTGCTCTTGTTT		DDEF2				ENST00000281419.3:c.1161-17T>C	2					breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(6)|lung(15)|prostate(2)|skin(3)|upper_aerodigestive_tract(1)		+		,		2p24	D6W4Y8	"""centaurin, beta 3"""	g.chr2:9496291T>C		248.4+/-256.2			no		9011,3995												-5.6					0.0	ARF GTPase activator activity (GO:0008060)|enzyme activator activity (GO:0008047)|zinc ion binding (GO:0008270)		2008-09-22		hg19	Standard	0.5785			5155,3445		positive regulation of catalytic activity (GO:0043085)|regulation of ARF GTPase activity (GO:0032312)	3256,2499,748					CCDS1661.1, CCDS46224.1	T		CC,CT,TT	AB007860	Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)	161		2504		rs2709591		1500				"""development and differentiation enhancing factor 2"""				,		KIAA0400, PAP, SHAG1, CENTB3		36	NM_003887		14			ENST00000281419.3		20812		uc002qzh.2			8853	dbSNP_100	,					0				162.0		0.398	2:g.9496291T>C		protein_coding			basic|appris_candidate_longest|CCDS		1566,2023,711			3856,550			C|||			5008		ASAP2_HUMAN	2856	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			0.570288		9496291			0.1359	SNP		CCDS1661.1			,,,	False	9496291				intron_variant		Approved		161.0			2013-01-10	OTTHUMT00000237522.1	O43150	0.5317		ASAP2	9496291				,	ASAP2	NM_001135191.1,NM_003887.2	protein-coding gene	NP_003878.1		
		T	ENSG00000151693	ENST00000281419.3		8853		ENSG00000151693		4300					,				c.(1588-1590)taC>taT	OTTHUMG00000117485		byFrequency	O43150	gene with protein product		ASAP2_ENST00000315273.4_Silent_p.Y530Y		NM_003887.2	9,284,1910	NM_003887	0.2618					+	Silent		375.5+/-337.8	99.0				10022920, 9455477				ASAP2-001	2008-09-22				2	+	0.0295				coding-synonymous,coding-synonymous	2721		530/962,530/1007		C	SO:0001819	603817	,		protein_coding		2203				25.6279,6.8543,19.268		"""ADP-ribosylation factor GTPase activating proteins"", ""Pleckstrin homology (PH) domain containing"", ""Ankyrin repeat domain containing"""	6503								KNOWN			CAGCCAAGTACATCGAGAGGA		DDEF2				ENST00000281419.3:c.1590C>T	2	Arf-GAP. {ECO:0000255|PROSITE- ProRule:PRU00288}.				breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(6)|lung(15)|prostate(2)|skin(3)|upper_aerodigestive_tract(1)		+		,		2p24	D6W4Y8	"""centaurin, beta 3"""	g.chr2:9514917C>T		163.6+/-195.4			no		2506,10500												2.5					1.0	ARF GTPase activator activity (GO:0008060)|enzyme activator activity (GO:0008047)|zinc ion binding (GO:0008270)		2008-09-22		hg19	Standard	0.2594			2204,6396		positive regulation of catalytic activity (GO:0043085)|regulation of ARF GTPase activity (GO:0032312)	297,1912,4294					CCDS1661.1, CCDS46224.1	C		TT,TC,CC	AB007860	Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)	102		2504		rs33930824		1930				"""development and differentiation enhancing factor 2"""				,	530	KIAA0400, PAP, SHAG1, CENTB3		36	NM_003887		17			ENST00000281419.3		19184		uc002qzh.2			8853	dbSNP_126	1590,1590			p.Y530Y		0				106.0		0.502	2:g.9514917C>T		protein_coding			basic|appris_candidate_longest|CCDS		288,1628,2384			302,4104			C|||			5008		ASAP2_HUMAN	662	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			0.132188		9514917			0.001	SNP		CCDS1661.1			,,,	False	9514917				synonymous_variant		Approved		102.0		c.1590C>T	2013-01-10	OTTHUMT00000237522.1	O43150	0.1513		ASAP2	9514917				,	ASAP2	NM_001135191.1,NM_003887.2	protein-coding gene	NP_003878.1		
		C	ENSG00000151693	ENST00000281419.3	0.53688	8853	N	ENSG00000151693	0.46134	4300	1.000000	0.56776	B;B		,	T	2.599999999997049E-5	2	c.(2242-2244)gaG>gaC	OTTHUMG00000117485	1.369000	byFrequency	O43150	gene with protein product		ASAP2_ENST00000491413.1_3'UTR|ASAP2_ENST00000315273.4_Missense_Mutation_p.E748D		NM_003887.2	1455,663,85	NM_003887	0.2618			C	6.526	+	Missense_Mutation	3	669.5+/-402.7	63.0	O43150-2;O43150	0.81094		10022920, 9455477			0.0;0.0	ASAP2-001	2008-09-22		0.01281		2	+	0.9153		1	0.942000	missense,missense	2721	147	748/962,748/1007		C	SO:0001583	603817	benign,benign	0.40607734806629836	protein_coding		2203	P		1.000000	33.9302,18.906,49.9077	B;B	"""ADP-ribosylation factor GTPase activating proteins"", ""Pleckstrin homology (PH) domain containing"", ""Ankyrin repeat domain containing"""	6503		0.0:0.7479:0.125:0.1271						KNOWN	ENST00000281419;ENST00000315273		TTGCCAAGGAGAAGCAGAGGG	T;T	DDEF2				ENST00000281419.3:c.2244G>C	2		ENSG00000151693	0.12614	ASAP2	breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(6)|lung(15)|prostate(2)|skin(3)|upper_aerodigestive_tract(1)	ENSP00000281419:p.Glu748Asp	+	0.71417	,	GAG	2p24	D6W4Y8	"""centaurin, beta 3"""	g.chr2:9528536G>C	E -> D (in dbSNP:rs2715860). {ECO:0000269|PubMed:15489334}.	330.2+/-301.4		444	yes		6491,6515	0.80357	0.12402	5.58	0.00012	ENSP00000281419:E748D			0.16303		.		4.7	0.59074	81	0.02654	0.14160839160839161	1.0	ARF GTPase activator activity (GO:0008060)|enzyme activator activity (GO:0008047)|zinc ion binding (GO:0008270)	-0.97	2008-09-22		hg19	Standard	0.3211	0.9024390243902439	9.283	2918,5682		positive regulation of catalytic activity (GO:0043085)|regulation of ARF GTPase activity (GO:0032312)	1964,2563,1976	0.465221				CCDS1661.1, CCDS46224.1	G	0.02656	CC,CG,GG	AB007860	Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)	61	0.01188	2504	4.69	rs2715860		2584	748;748	237		"""development and differentiation enhancing factor 2"""	0.37740	9445987	+	ASP/GLU,ASP/GLU	748	KIAA0400, PAP, SHAG1, CENTB3	909	36	NM_003887	0.0;0.0	22	0.31266490765171506	-0.216000	ENST00000281419.3		16901		uc002qzh.2			8853	dbSNP_100	2244,2244	0.0000		p.E748D	.	0		T		57.0	rs2715860;rs3811595;rs17523264;rs17855822;rs52835570;rs60197679;rs2715860	0.602	2:g.9528536G>C	ENSP00000281419:E748D;ENSP00000316404:E748D	protein_coding	0.220363		basic|appris_candidate_longest|CCDS		509,1900,1891		748	3573,833	0.41620879120879123	D	C|||		0.622139	5008		ASAP2_HUMAN	2233	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2		.;ASAP2_HUMAN	0.445887	0.49050	9528536		2.946000	0.1468	SNP		CCDS1661.1		N	,,,	False	9528536	-0.9689		9	missense	T	Approved	0.339302	61.0		c.2244G>C	2013-01-10	OTTHUMT00000237522.1	O43150	0.4265	0.54;0.44	ASAP2	9528536	0.58702		0.37820	45,45	ASAP2	NM_001135191.1,NM_003887.2	protein-coding gene	NP_003878.1	E	
		T	ENSG00000119185	ENST00000360635.3		9270		ENSG00000119185		4295					,					OTTHUMG00000090414		byFrequency	O14713	gene with protein product		ITGB1BP1_ENST00000359712.3_Intron|ITGB1BP1_ENST00000355346.4_Intron|ITGB1BP1_ENST00000490426.1_Intron|ITGB1BP1_ENST00000488451.1_Intron|ITGB1BP1_ENST00000456913.2_Intron|ITGB1BP1_ENST00000238091.4_Intron			42,490,1660	NM_004763, NM_022334	0.3252					+	Intron			30.0				11854171, 9281591				ITGB1BP1-005					2	-	0.0787				intron,intron	23927		,		C	SO:0001627	607153	,		protein_coding		2192				38.6147,13.0931,29.9908			6487					Epithelial(75;0.23)			KNOWN			CAGAGAGTTACGGAATTTTTT						ENST00000360635.3:c.288+18G>A	2					kidney(2)|large_intestine(2)|lung(2)|prostate(2)		-		,		2p25.2	D6W4Y9|O14714|Q53RS0	"""integrin cytoplasmic domain-associated protein 1"", ""integrin cytoplasmic domain-associated protein 1-beta"", ""integrin cytoplasmic domain-associated protein 1-alpha"", ""bodenin"""	g.chr2:9552379C>T					no		3891,9083												-6.0					0.0	GDP-dissociation inhibitor activity (GO:0005092)|integrin binding (GO:0005178)|protein complex binding (GO:0032403)|protein transporter activity (GO:0008565)				hg19	Standard	0.3797			3317,5273		activation of protein kinase B activity (GO:0032148)|biomineral tissue development (GO:0031214)|blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)|cell differentiation (GO:0030154)|cell migration (GO:0016477)|cell-matrix adhesion (GO:0007160)|cellular response to fibroblast growth factor stimulus (GO:0044344)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|integrin activation (GO:0033622)|integrin-mediated signaling pathway (GO:0007229)|intracellular signal transduction (GO:0035556)|myoblast migration (GO:0051451)|negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of ERK1 and ERK2 cascade (GO:0070373)|negative regulation of fibroblast migration (GO:0010764)|negative regulation of focal adhesion assembly (GO:0051895)|negative regulation of protein binding (GO:0032091)|negative regulation of protein kinase activity (GO:0006469)|negative regulation of protein targeting to membrane (GO:0090315)|negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)|Notch signaling pathway (GO:0007219)|positive regulation of cell division (GO:0051781)|positive regulation of cell proliferation (GO:0008284)|positive regulation of endothelial cell migration (GO:0010595)|positive regulation of focal adhesion assembly (GO:0051894)|positive regulation of Notch signaling pathway (GO:0045747)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of protein targeting to membrane (GO:0090314)|positive regulation of stress fiber assembly (GO:0051496)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|protein transport (GO:0015031)|receptor clustering (GO:0043113)|regulation of blood vessel size (GO:0050880)|regulation of Cdc42 GTPase activity (GO:0043088)|regulation of cell adhesion mediated by integrin (GO:0033628)|regulation of integrin-mediated signaling pathway (GO:2001044)|transcription, DNA-templated (GO:0006351)|tube formation (GO:0035148)	727,2437,3323					CCDS1662.1, CCDS1663.1	C		TT,TC,CC	AF012023	cell periphery (GO:0071944)|cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|lamellipodium (GO:0030027)|membrane (GO:0016020)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|ruffle (GO:0001726)	30		2504		rs10929581		1185								,		ICAP-1A, ICAP-1B, ICAP1, ICAP1A, ICAP1B, ICAP-1alpha		8	NM_004763		5			ENST00000360635.3		14626		uc002qzj.3			9270	dbSNP_120	,					0				29.0		0.488	2:g.9552379C>T		protein_coding			alternative_5_UTR|basic|appris_principal|CCDS		685,1947,1663			574,3810			C|||			5008		ITBP1_HUMAN	989	integrin beta 1 binding protein 1			0.197484		9552379			0.0367	SNP		CCDS1662.1			,,,	False	9552379				intron_variant		Approved		30.0			2008-02-05	OTTHUMT00000314623.2	O14713	0.2133		ITGB1BP1	9552379		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)		,	ITGB1BP1	NM_004763.3,NM_022334.3	protein-coding gene			
		T	ENSG00000119203	ENST00000238112.3		51692		ENSG00000119203		4300					,					OTTHUMG00000090415		byFrequency	Q9UKF6	gene with protein product		CPSF3_ENST00000460593.1_Intron		NM_016207.3	1282,782,139	NM_016207	0.4213					+	Intron		489.8+/-372.7	42.0				8929409				CPSF3-001	2002-08-29				2	+	0.7648				intron	2326			all_cancers(51;2.39e-25)|all_epithelial(98;8.75e-19)|Lung NSC(108;2.38e-06)|Ovarian(717;0.0308)	T	SO:0001627	606029			protein_coding		2203				39.0581,24.0581,33.9766			6503					all cancers(51;2.2e-40)|Epithelial(75;6.71e-35)|OV - Ovarian serous cystadenocarcinoma(76;4.35e-21)|STAD - Stomach adenocarcinoma(1183;0.00644)		Colon(194;1259 2048 3845 5218 19985)	KNOWN			CTCTATATGGCATGTATGGTT						ENST00000238112.3:c.341+45C>T	2					NS(1)|breast(3)|endometrium(1)|kidney(2)|large_intestine(5)|lung(8)|prostate(2)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		2p25.1	O14769|Q53RS2|Q96F36		g.chr2:9571054C>T		367.8+/-318.4			no		8587,4419												-3.0					0.0	5'-3' exonuclease activity (GO:0008409)|endoribonuclease activity (GO:0004521)|metal ion binding (GO:0046872)|RNA binding (GO:0003723)				hg19	Standard	0.5825			5241,3359		gene expression (GO:0010467)|histone mRNA 3'-end processing (GO:0006398)|mRNA 3'-end processing (GO:0031124)|mRNA cleavage (GO:0006379)|mRNA export from nucleus (GO:0006406)|mRNA polyadenylation (GO:0006378)|mRNA splicing, via spliceosome (GO:0000398)|RNA splicing (GO:0008380)|termination of RNA polymerase II transcription (GO:0006369)|transcription from RNA polymerase II promoter (GO:0006366)	2912,2763,828					CCDS1664.1	C		TT,TC,CC	AF171877	mRNA cleavage and polyadenylation specificity factor complex (GO:0005847)|nucleoplasm (GO:0005654)|ribonucleoprotein complex (GO:0030529)	41		2504		rs2002044		547				"""cleavage and polyadenylation specific factor 3, 73kD subunit"""						CPSF-73, CPSF73, YSH1		24	NM_016207		4			ENST00000238112.3		20429		uc002qzo.2			51692	dbSNP_92						0				40.0		0.323	2:g.9571054C>T		protein_coding			basic|appris_principal|CCDS		1630,1981,689			3346,1060			T|||			5008		CPSF3_HUMAN	2341	cleavage and polyadenylation specific factor 3, 73kDa			0.467452		9571054			0.0546	SNP		CCDS1664.1			,,,	False	9571054				intron_variant		Approved		41.0			2009-01-06	OTTHUMT00000206843.1	Q9UKF6	0.3991		CPSF3	9571054		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			CPSF3	NM_016207.2	protein-coding gene	NP_057291.1		
		AGGGG	ENSG00000119203	ENST00000238112.3		51692		ENSG00000119203		4300										OTTHUMG00000090415		byFrequency	Q9UKF6	gene with protein product		CPSF3_ENST00000460593.1_Intron		NM_016207.3		NM_016207						+	Intron			78.0				8929409				CPSF3-001	2002-08-29				2	+						2326			all_cancers(51;2.39e-25)|all_epithelial(98;8.75e-19)|Lung NSC(108;2.38e-06)|Ovarian(717;0.0308)		SO:0001627	606029			protein_coding		2203							6503					all cancers(51;2.2e-40)|Epithelial(75;6.71e-35)|OV - Ovarian serous cystadenocarcinoma(76;4.35e-21)|STAD - Stomach adenocarcinoma(1183;0.00644)		Colon(194;1259 2048 3845 5218 19985)	KNOWN			ATTGTATTAAAGGGAAAAAAA						ENST00000238112.3:c.1242+32AGGG>AGGGG	2					NS(1)|breast(3)|endometrium(1)|kidney(2)|large_intestine(5)|lung(8)|prostate(2)|upper_aerodigestive_tract(1)|urinary_tract(1)		+				2p25.1	O14769|Q53RS2|Q96F36		g.chr2:9583822_9583822insAGGGG																									5'-3' exonuclease activity (GO:0008409)|endoribonuclease activity (GO:0004521)|metal ion binding (GO:0046872)|RNA binding (GO:0003723)				hg19	Standard						gene expression (GO:0010467)|histone mRNA 3'-end processing (GO:0006398)|mRNA 3'-end processing (GO:0031124)|mRNA cleavage (GO:0006379)|mRNA export from nucleus (GO:0006406)|mRNA polyadenylation (GO:0006378)|mRNA splicing, via spliceosome (GO:0000398)|RNA splicing (GO:0008380)|termination of RNA polymerase II transcription (GO:0006369)|transcription from RNA polymerase II promoter (GO:0006366)						CCDS1664.1	AGGG			AF171877	mRNA cleavage and polyadenylation specificity factor complex (GO:0005847)|nucleoplasm (GO:0005654)|ribonucleoprotein complex (GO:0030529)					rs34762720|rs200677553|rs397752622		1448				"""cleavage and polyadenylation specific factor 3, 73kD subunit"""						CPSF-73, CPSF73, YSH1		24	NM_016207		10			ENST00000238112.3				uc002qzo.2			51692							0				81.0		0.438	2:g.9583822_9583822insAGGGG		protein_coding			basic|appris_principal|CCDS													CPSF3_HUMAN		cleavage and polyadenylation specific factor 3, 73kDa					9583822				INS		CCDS1664.1					9583822				intron_variant		Approved		79.0			2009-01-06	OTTHUMT00000206843.1	Q9UKF6			CPSF3	9583822		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)					protein-coding gene	NP_057291.1		
		T	ENSG00000134330	ENST00000497473.1	0.80722	285148	.	ENSG00000134330	0.02053	4187	0.006000	.	.		,	.	1	0	c.(526-528)gaC>gaT	OTTHUMG00000159076	-1.403000	byFrequency	Q2TAA2	gene with protein product		IAH1_ENST00000545602.1_Silent_p.D63D|IAH1_ENST00000489468.1_3'UTR|IAH1_ENST00000470914.1_Silent_p.D63D|IAH1_ENST00000482918.1_Silent_p.D63D		NM_001039613.1	0,15,2011	NM_001039613	0.002			C	7.546	+	Silent	2		132.0	.	0.003702		12477932			.	IAH1-003			.		2	+	0.0008		.	0.882000	coding-synonymous	27696	5	176/249		C	SO:0001819			0.013812154696132596	protein_coding		2026	D		0.000000	2.4958,0.3702,1.8027	.		6213		0.0:0.5257:0.2159:0.2584						KNOWN	ENST00000481367		GTGGGACTGACGTACTTGACC	.					ENST00000497473.1:c.528C>T	2		ENSG00000134330	0.05019	IAH1	breast(1)|large_intestine(2)|lung(3)|pancreas(1)|upper_aerodigestive_tract(1)		+	0.05858	,	ACG	2p25.1	B4DMV3		g.chr2:9624643C>T				1	no		224,12202	0.13384	0.14645	4.95	0.35219	.			.		-19.9735		-6.1	0.02124	0	.	0.0	0.0	hydrolase activity, acting on ester bonds (GO:0016788)	.			hg19	Standard	0.0159	0.0020325203252032522	10.3022	209,8165		lipid catabolic process (GO:0016042)	4,216,5993	0.661789				CCDS42651.1	C	.	TT,TC,CC	BC111025	extracellular vesicular exosome (GO:0070062)	133	.	2504	-6.12	rs61737635		565	.	15			0.43659	9542094	+		176		21	8	XR_426950	.	5	0.01978891820580475	-0.471000	ENST00000497473.1		21810		uc002qzr.3			285148	dbSNP_129	528	0.0924		p.D176D	.	0		T		135.0	rs61737635	0.493	2:g.9624643C>T	.	protein_coding	.		basic|appris_principal|CCDS		4,201,3982		156	15,4037	0.009615384615384616	M	C|||		.	5008		IAH1_HUMAN	29	isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)		.	0.00579073	0.00791	9624643		-2.752000	0.0	SNP		CCDS42651.1		.	,,,	False	9624643	-0.8621		4	synonymous_variant	T	Approved	0.024958	133.0		c.528C>T	2010-08-05	OTTHUMT00000353192.1	Q2TAA2	0.0144	.	IAH1	9624643	0.50991	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.52094		IAH1	NM_001039613.1	protein-coding gene	NP_001034702.1	T	
		G	ENSG00000151694	ENST00000310823.3		6868		ENSG00000151694		4300					,				c.(1822-1824)tcT>tcC	OTTHUMG00000090425		byFrequency	P78536	gene with protein product		IAH1_ENST00000545602.1_3'UTR		NM_003183.4	1159,850,194		0.4233					+	Silent		499.6+/-375.0	91.0				9034190, 9574564				ADAM17-001	2008-07-31				2	-	0.7171				coding-synonymous	195		608/825		G	SO:0001819	603639			protein_coding		2203				39.2093,28.098,35.4452		"""ADAM metallopeptidase domain containing"", ""CD molecules"""	6503					Epithelial(75;0.225)			KNOWN			CACAGCGGCCAGAAAGGTCCC		TACE				ENST00000310823.3:c.1824T>C	2	Crambin-like.				breast(1)|cervix(4)|endometrium(2)|kidney(2)|large_intestine(7)|lung(8)|ovary(1)|prostate(2)|skin(1)		-		,		2p25	O60226		g.chr2:9634856A>G		428.5+/-341.9			no		8396,4610												-6.0					0.0	integrin binding (GO:0005178)|interleukin-6 receptor binding (GO:0005138)|metalloendopeptidase activity (GO:0004222)|metallopeptidase activity (GO:0008237)|Notch binding (GO:0005112)|PDZ domain binding (GO:0030165)|zinc ion binding (GO:0008270)				hg19	Standard	0.5845			5228,3372		apoptotic process (GO:0006915)|apoptotic signaling pathway (GO:0097190)|B cell differentiation (GO:0030183)|cell adhesion (GO:0007155)|cell adhesion mediated by integrin (GO:0033627)|cell motility (GO:0048870)|collagen catabolic process (GO:0030574)|epidermal growth factor receptor signaling pathway (GO:0007173)|epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway (GO:0035625)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|germinal center formation (GO:0002467)|JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397)|membrane protein ectodomain proteolysis (GO:0006509)|membrane protein intracellular domain proteolysis (GO:0031293)|negative regulation of interleukin-8 production (GO:0032717)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|neurotrophin TRK receptor signaling pathway (GO:0048011)|neutrophil mediated immunity (GO:0002446)|Notch receptor processing (GO:0007220)|Notch signaling pathway (GO:0007219)|PMA-inducible membrane protein ectodomain proteolysis (GO:0051088)|positive regulation of cell growth (GO:0030307)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of cellular component movement (GO:0051272)|positive regulation of chemokine production (GO:0032722)|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659)|positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)|positive regulation of leukocyte chemotaxis (GO:0002690)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of T cell chemotaxis (GO:0010820)|positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)|proteolysis (GO:0006508)|regulation of mast cell apoptotic process (GO:0033025)|response to drug (GO:0042493)|response to high density lipoprotein particle (GO:0055099)|response to hypoxia (GO:0001666)|response to lipopolysaccharide (GO:0032496)|spleen development (GO:0048536)|T cell differentiation in thymus (GO:0033077)|wound healing, spreading of epidermal cells (GO:0035313)	2783,2830,890					CCDS1665.1	A		GG,GA,AA	U69611	actin cytoskeleton (GO:0015629)|apical plasma membrane (GO:0016324)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)	91		2504		rs1048610		2006				"""tumor necrosis factor, alpha, converting enzyme"""					608	cSVP, CD156B		28	NM_003183		15			ENST00000310823.3		17764		uc002qzu.3			6868	dbSNP_86	1824			p.S608S		0				93.0		0.478	2:g.9634856A>G		protein_coding			basic|appris_principal|CCDS		1624,1980,696			3168,1238			G|||			5008		ADA17_HUMAN	2326	ADAM metallopeptidase domain 17			0.464457		9634856			0.0962	SNP		CCDS1665.1			,,,	False	9634856				synonymous_variant		Approved		91.0		c.1824T>C	2010-08-05	OTTHUMT00000206857.1	P78536	0.402		ADAM17	9634856		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			ADAM17	NM_003183.4	protein-coding gene	NP_003174.3		
		A	ENSG00000151694	ENST00000310823.3	0.80722	6868	H	ENSG00000151694	0.78349	4300	0.973000	0.26660	D;D			D	1	0	c.(1666-1668)cCg>cTg	OTTHUMG00000090425	2.318000		P78536	gene with protein product				NM_003183.4						G	24.5	+	Missense_Mutation	2		124.0	B2RNB2;P78536	.		9034190, 9574564			0.997;0.997	ADAM17-001	2008-07-31		0.85130		2	-			0	0.793000		195	.				SO:0001583	603639		.	protein_coding		2203	D		1.000000		D;D	"""ADAM metallopeptidase domain containing"", ""CD molecules"""	6503		0.0:0.0:1.0:0.0			Epithelial(75;0.225)			KNOWN	ENST00000310823		TCCTGGAGGCGGGCACTCACT	T	TACE				ENST00000310823.3:c.1667C>T	2	Disintegrin. {ECO:0000255|PROSITE- ProRule:PRU00068}.	ENSG00000151694	0.41574	ADAM17	breast(1)|cervix(4)|endometrium(2)|kidney(2)|large_intestine(7)|lung(8)|ovary(1)|prostate(2)|skin(1)	ENSP00000309968:p.Pro556Leu	-	0.71417		CCG	2p25	O60226		g.chr2:9637359G>A				.				0.42090	0.85917	5.01	0.66137	ENSP00000309968:P556L			0.85682		.			0.66863	.	0.87932	.		integrin binding (GO:0005178)|interleukin-6 receptor binding (GO:0005138)|metalloendopeptidase activity (GO:0004222)|metallopeptidase activity (GO:0008237)|Notch binding (GO:0005112)|PDZ domain binding (GO:0030165)|zinc ion binding (GO:0008270)	3.735			hg19	Standard		.	18.3467			apoptotic process (GO:0006915)|apoptotic signaling pathway (GO:0097190)|B cell differentiation (GO:0030183)|cell adhesion (GO:0007155)|cell adhesion mediated by integrin (GO:0033627)|cell motility (GO:0048870)|collagen catabolic process (GO:0030574)|epidermal growth factor receptor signaling pathway (GO:0007173)|epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway (GO:0035625)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|germinal center formation (GO:0002467)|JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397)|membrane protein ectodomain proteolysis (GO:0006509)|membrane protein intracellular domain proteolysis (GO:0031293)|negative regulation of interleukin-8 production (GO:0032717)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|neurotrophin TRK receptor signaling pathway (GO:0048011)|neutrophil mediated immunity (GO:0002446)|Notch receptor processing (GO:0007220)|Notch signaling pathway (GO:0007219)|PMA-inducible membrane protein ectodomain proteolysis (GO:0051088)|positive regulation of cell growth (GO:0030307)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of cellular component movement (GO:0051272)|positive regulation of chemokine production (GO:0032722)|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659)|positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)|positive regulation of leukocyte chemotaxis (GO:0002690)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of T cell chemotaxis (GO:0010820)|positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)|proteolysis (GO:0006508)|regulation of mast cell apoptotic process (GO:0033025)|response to drug (GO:0042493)|response to high density lipoprotein particle (GO:0055099)|response to hypoxia (GO:0001666)|response to lipopolysaccharide (GO:0032496)|spleen development (GO:0048536)|T cell differentiation in thymus (GO:0033077)|wound healing, spreading of epidermal cells (GO:0035313)		4.542638				CCDS1665.1	G	0.89917		U69611	actin cytoskeleton (GO:0015629)|apical plasma membrane (GO:0016324)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)		0.95884		5.01			1849	556;556	.		"""tumor necrosis factor, alpha, converting enzyme"""	0.90325	9554810	-		556	cSVP, CD156B	.	28	NM_003183	1.0;1.0	14	.	0.462000	ENST00000310823.3				uc002qzu.3			6868			0.2759		p.P556L	Blood coagulation inhibitor, Disintegrin (5);	0		T		142.0	.	0.478	2:g.9637359G>A	ENSP00000309968:P556L	protein_coding	0.000000		basic|appris_principal|CCDS				556		.	L			0.000000			ADA17_HUMAN		ADAM metallopeptidase domain 17		.;ADA17_HUMAN		0.97823	9637359		9.476000		SNP		CCDS1665.1		D			9637359	-0.1869		10	missense	T	Approved	.	130.0		c.1667C>T	2010-08-05	OTTHUMT00000206857.1	P78536		1.72	ADAM17	9637359	0.44817	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.79279				protein-coding gene	NP_003174.3	P	
		G	ENSG00000151694	ENST00000310823.3		6868		ENSG00000151694		4300					,					OTTHUMG00000090425		byFrequency	P78536	gene with protein product				NM_003183.4	20,403,1780		0.0971					+	Intron		316.2+/-312.6	82.0				9034190, 9574564				ADAM17-001	2008-07-31				2	-	0.0817				intron	195				-	SO:0001627	603639			protein_coding		2203				21.1744,10.0545,17.4074		"""ADAM metallopeptidase domain containing"", ""CD molecules"""	6503					Epithelial(75;0.225)			KNOWN			AGTCATAACAAAAAGAATGAG		TACE				ENST00000310823.3:c.1649-26T>C	2					breast(1)|cervix(4)|endometrium(2)|kidney(2)|large_intestine(7)|lung(8)|ovary(1)|prostate(2)|skin(1)		-		,		2p25	O60226		g.chr2:9637403A>G		202.1+/-225.0			no		2264,10742												-0.2					0.0	integrin binding (GO:0005178)|interleukin-6 receptor binding (GO:0005138)|metalloendopeptidase activity (GO:0004222)|metallopeptidase activity (GO:0008237)|Notch binding (GO:0005112)|PDZ domain binding (GO:0030165)|zinc ion binding (GO:0008270)				hg19	Standard	0.1889			1821,6779		apoptotic process (GO:0006915)|apoptotic signaling pathway (GO:0097190)|B cell differentiation (GO:0030183)|cell adhesion (GO:0007155)|cell adhesion mediated by integrin (GO:0033627)|cell motility (GO:0048870)|collagen catabolic process (GO:0030574)|epidermal growth factor receptor signaling pathway (GO:0007173)|epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway (GO:0035625)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|germinal center formation (GO:0002467)|JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397)|membrane protein ectodomain proteolysis (GO:0006509)|membrane protein intracellular domain proteolysis (GO:0031293)|negative regulation of interleukin-8 production (GO:0032717)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|neurotrophin TRK receptor signaling pathway (GO:0048011)|neutrophil mediated immunity (GO:0002446)|Notch receptor processing (GO:0007220)|Notch signaling pathway (GO:0007219)|PMA-inducible membrane protein ectodomain proteolysis (GO:0051088)|positive regulation of cell growth (GO:0030307)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of cellular component movement (GO:0051272)|positive regulation of chemokine production (GO:0032722)|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659)|positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)|positive regulation of leukocyte chemotaxis (GO:0002690)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of T cell chemotaxis (GO:0010820)|positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)|proteolysis (GO:0006508)|regulation of mast cell apoptotic process (GO:0033025)|response to drug (GO:0042493)|response to high density lipoprotein particle (GO:0055099)|response to hypoxia (GO:0001666)|response to lipopolysaccharide (GO:0032496)|spleen development (GO:0048536)|T cell differentiation in thymus (GO:0033077)|wound healing, spreading of epidermal cells (GO:0035313)	212,1840,4451					CCDS1665.1	A		GG,GA,AA	U69611	actin cytoskeleton (GO:0015629)|apical plasma membrane (GO:0016324)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)	85		2504		rs41264175		1831				"""tumor necrosis factor, alpha, converting enzyme"""						cSVP, CD156B		28	NM_003183		14			ENST00000310823.3		22371		uc002qzu.3			6868	dbSNP_127						0				90.0		0.448	2:g.9637403A>G		protein_coding			basic|appris_principal|CCDS		192,1437,2671			443,3963			A|||			5008		ADA17_HUMAN	504	ADAM metallopeptidase domain 17			0.100639		9637403			0.0188	SNP		CCDS1665.1			,,,	False	9637403				intron_variant		Approved		85.0			2010-08-05	OTTHUMT00000206857.1	P78536	0.1326		ADAM17	9637403		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			ADAM17	NM_003183.4	protein-coding gene	NP_003174.3		
		G	ENSG00000115750	ENST00000263663.5		9014		ENSG00000115750		4294					,					OTTHUMG00000151673		byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Intron		NM_005680.2	337,1008,847	NM_005680	0.317					+	Intron			26.0				7801123				TAF1B-001	2002-08-29				2	+	0.4221				intron	11533				A	SO:0001627	604904			protein_coding		2192				26.2226,38.3668,30.3269			6486								KNOWN			GTTTTGTTGCAAAAATTGCAA						ENST00000263663.5:c.808-37A>G	2					breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)		+		,		2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10044951A>G					no		3934,9038												-2.7					0.0	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)				hg19	Standard	0.2773			2252,6336		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	635,2664,3187					CCDS33143.1	A		GG,GA,AA	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	28		2504		rs2052948		995				"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""						TAFI63, SL1, RAF1B, RAFI63		14	NM_005680		9			ENST00000263663.5		18321		uc002qzz.3			9014	dbSNP_94						0				32.0		0.303	2:g.10044951A>G		protein_coding			basic|appris_principal|CCDS		298,1656,2340			1682,2702			A|||			5008		TAF1B_HUMAN	1804	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.360224		10044951			0.38	SNP		CCDS33143.1			,,,	False	10044951				intron_variant		Approved		28.0			2008-06-02	OTTHUMT00000323426.2	Q53T94	0.3948		TAF1B	10044951		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			TAF1B	NM_005680.2	protein-coding gene	NP_005671		
		T	ENSG00000115750	ENST00000263663.5		9014		ENSG00000115750		4300					,				c.(832-834)taC>taT	OTTHUMG00000151673		byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Silent_p.Y23Y		NM_005680.2	1060,936,207	NM_005680	0.8272					+	Silent		155.1+/-209.2	64.0				7801123				TAF1B-001	2002-08-29				2	+	0.6566				coding-synonymous	11533		278/589		T	SO:0001819	604904			protein_coding		2203				6.7209,30.64,14.8239			6503								KNOWN			AGGACATCTACAAAAAAACAG						ENST00000263663.5:c.834C>T	2	C-terminal cyclin fold.				breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)		+		,		2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10045014C>T		446.5+/-348.0			no		11078,1928												3.2					0.6	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)				hg19	Standard	0.9324			8022,578		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	4808,1462,233					CCDS33143.1	C		TT,TC,CC	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	68		2504		rs400917		1022				"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""					278	TAFI63, SL1, RAF1B, RAFI63		14	NM_005680		9			ENST00000263663.5		17940		uc002qzz.3			9014	dbSNP_80	834			p.Y278Y		0				75.0		0.328	2:g.10045014C>T		protein_coding			basic|appris_principal|CCDS		3748,526,26			3056,1350			T|||			5008		TAF1B_HUMAN	4105	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.819688		10045014			0.8294	SNP		CCDS33143.1			,,,	False	10045014				synonymous_variant		Approved		68.0		c.834C>T	2008-06-02	OTTHUMT00000323426.2	Q53T94	0.9424		TAF1B	10045014		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			TAF1B	NM_005680.2	protein-coding gene	NP_005671		
		A	ENSG00000115750	ENST00000263663.5	0.80722	9014	N	ENSG00000115750	0.17463	4300	0.113000	0.01397	B;B		,	.	0.0	0	c.(844-846)Gta>Ata	OTTHUMG00000151673	0.096000	byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Missense_Mutation_p.V27I		NM_005680.2	1417,690,96	NM_005680	1.0	Deletion - Frameshift(1)		A	1.008	+	Missense_Mutation	1	11.9+/-42.8	70.0	Q53T94;Q53T94-2	0.799818		7801123			0.0;0.0	TAF1B-001	2002-08-29		0.01281		2	+	0.7511		.	0.421000	missense	11533	355	282/589		A	SO:0001583	604904	benign	0.9806629834254144	protein_coding	ovary(1)	2203	P		0.006000	0.2093,20.0182,6.9199	B;B		6503		0.3656:0.3147:0.2077:0.1121						KNOWN	ENST00000263663;ENST00000396242		CAAAAAAACAGTAGAAGTTGG	T;T					ENST00000263663.5:c.844G>A	2	C-terminal cyclin fold.	ENSG00000115750	0.04426	TAF1B	breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)	ENSP00000263663:p.Val282Ile	+	0.16342	,	GTA	2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10045024G>A	V -> I (in dbSNP:rs396190). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7801123}.	340.7+/-306.4		396	yes		12106,900	0.21522	0.03328	5.67	0.00012	.			0.26627		-14.4372		3.3	0.37495	572	.	1.0	0.1	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)	-0.905			hg19	Standard	1.0	0.8048780487804879	1.7932	8582,18		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	5699,708,96	-0.688668		p.V282fs*1(1)		CCDS33143.1	G	0.02656	AA,AG,GG	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	74	0.01289	2504	3.27	rs396190		1032	282;282	758		"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""	0.03056	9962475	+	ILE/VAL	282	TAFI63, SL1, RAF1B, RAFI63	2081	14	NM_005680	0.0;0.0	9	1.0	-0.516000	ENST00000263663.5		17928		uc002qzz.3			9014	dbSNP_80	844	0.0000		p.V282I	.	1		T		81.0	rs396190;rs17845575;rs17858474;rs396190	0.338	2:g.10045024G>A	ENSP00000263663:V282I;ENSP00000379542:V27I	protein_coding	0.023330		basic|appris_principal|CCDS		4282,18,0		282;27	3524,882	0.9528388278388278	I	A|||		0.435879	5008		TAF1B_HUMAN	4668	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa		TAF1B_HUMAN;.	0.932109	0.21247	10045024		0.419000	1.0	SNP		CCDS33143.1		N	,,,	False	10045024	-1.0117		8	missense	T	Approved	0.997907	74.0		c.844G>A	2008-06-02	OTTHUMT00000323426.2	Q53T94	0.9841	4.94;4.94	TAF1B	10045024	0.31385	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.25950	29	TAF1B	NM_005680.2	protein-coding gene	NP_005671	V	
		G	ENSG00000115750	ENST00000263663.5		9014		ENSG00000115750		4300					,					OTTHUMG00000151673		byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Intron		NM_005680.2	1513,608,82	NM_005680	1.0					+	Intron		11.9+/-42.8	95.0				7801123				TAF1B-001	2002-08-29				2	+	0.7844				intron	11533				G	SO:0001627	604904			protein_coding		2203				0.2093,17.5216,6.0741			6503								KNOWN			TAAGTGTGTGACATATATTGT						ENST00000263663.5:c.955+12A>G	2					breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)		+		,		2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10045147A>G		312.2+/-292.5			no		12216,790												-8.7					0.0	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)				hg19	Standard	1.0			8582,18		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	5795,626,82					CCDS33143.1	A		GG,GA,AA	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	98		2504		rs448327		1143				"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""						TAFI63, SL1, RAF1B, RAFI63		14	NM_005680		9			ENST00000263663.5		16843		uc002qzz.3			9014	dbSNP_80						0				103.0		0.383	2:g.10045147A>G		protein_coding			basic|appris_principal|CCDS		4282,18,0			3634,772			G|||			5008		TAF1B_HUMAN	4715	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.941494		10045147			1.0	SNP		CCDS33143.1			,,,	False	10045147				intron_variant		Approved		98.0			2008-06-02	OTTHUMT00000323426.2	Q53T94	0.9885		TAF1B	10045147		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			TAF1B	NM_005680.2	protein-coding gene	NP_005671		
		C	ENSG00000115750	ENST00000263663.5		9014		ENSG00000115750		4300					,				c.(1036-1038)gcT>gcC	OTTHUMG00000151673		byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Silent_p.A91A		NM_005680.2	109,710,1384	NM_005680	0.5133					+	Silent		674.1+/-403.1	148.0				7801123				TAF1B-001	2002-08-29				2	+	0.1301				coding-synonymous	11533		346/589		T	SO:0001819	604904			protein_coding		2203				33.1977,21.0622,48.6929			6503								KNOWN			ATCCTATAGCTAAAATGGCAA						ENST00000263663.5:c.1038T>C	2	C-terminal cyclin fold.				breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)		+		,		2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10050947T>C		354.4+/-312.6			no		6673,6333												-1.9					0.9	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)				hg19	Standard	0.6551			5745,2855		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	2023,2627,1853					CCDS33143.1	T		CC,CT,TT	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	157		2504		rs1054561		1226				"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""					346	TAFI63, SL1, RAF1B, RAFI63		14	NM_005680		10			ENST00000263663.5		20033		uc002qzz.3			9014	dbSNP_86	1038			p.A346A		0				176.0		0.378	2:g.10050947T>C		protein_coding			basic|appris_principal|CCDS		1914,1917,469			928,3478			T|||			5008		TAF1B_HUMAN	2160	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.43131		10050947			0.4514	SNP		CCDS33143.1			,,,	False	10050947				synonymous_variant		Approved		157.0		c.1038T>C	2008-06-02	OTTHUMT00000323426.2	Q53T94	0.536		TAF1B	10050947		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			TAF1B	NM_005680.2	protein-coding gene	NP_005671		
		G	ENSG00000115750	ENST00000263663.5	0.80722	9014	L	ENSG00000115750	0.18479	4300	0.106000	0.03358	B;B		,	.	0.0	0	c.(1051-1053)Act>Gct	OTTHUMG00000151673	0.128000	byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Missense_Mutation_p.T96A		NM_005680.2	109,710,1384	NM_005680	0.5133			A	10.45	+	Missense_Mutation	1	673.9+/-403.1	153.0	Q53T94;Q53T94-2	0.210622		7801123			0.005;0.004	TAF1B-001	2002-08-29		0.10450		2	+	0.1301		.	0.969000	missense	11533	208	351/589		A	SO:0001583	604904	benign	0.574585635359116	protein_coding		2203	P		0.850000	33.2093,21.0622,48.7006	B;B		6503		0.6781:0.1272:0.1947:0.0						KNOWN	ENST00000263663;ENST00000396242		AATGGCAAAAACTGTTAAGTA	T;T					ENST00000263663.5:c.1051A>G	2	C-terminal cyclin fold.	ENSG00000115750	0.25322	TAF1B	breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)	ENSP00000263663:p.Thr351Ala	+	0.29656	,	ACT	2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10050960A>G	T -> A (in dbSNP:rs1054565). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7801123}.	353.8+/-312.3		75	yes		6672,6334	0.21319	0.24512	5.8	0.00012	.			0.26156		-4.6208		2.1	0.27256	275	.	0.4807692307692308	0.1	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)	0.92			hg19	Standard	0.6551	0.1524390243902439	5.882	5744,2856		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	2023,2626,1854	1.354141				CCDS33143.1	A	0.17852	GG,GA,AA	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	163	0.31294	2504	2.11	rs1054565		1239	351;351	486		"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""	0.18860	9968411	+	ALA/THR	351	TAFI63, SL1, RAF1B, RAFI63	1044	14	NM_005680	0.024;0.01	10	0.6411609498680739	0.383000	ENST00000263663.5		19827		uc002qzz.3			9014	dbSNP_86	1051	0.0000		p.T351A	.	0		T		185.0	rs1054565;rs3195101;rs17845577;rs17858476;rs52819731;rs57188445;rs1054565	0.378	2:g.10050960A>G	ENSP00000263663:T351A;ENSP00000379542:T96A	protein_coding	0.026003		basic|appris_principal|CCDS		1914,1916,470		351;96	928,3478	0.47802197802197804	A	A|||		0.449079	5008		TAF1B_HUMAN	2160	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa		TAF1B_HUMAN;.	0.43131	0.33167	10050960		1.277000	0.4514	SNP		CCDS33143.1		N	,,,	False	10050960	-1.0725		8	missense	T	Approved	0.667907	163.0		c.1051A>G	2008-06-02	OTTHUMT00000323426.2	Q53T94	0.536	3.96;3.96	TAF1B	10050960	0.65631	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.08371	58	TAF1B	NM_005680.2	protein-coding gene	NP_005671	T	
		C	ENSG00000115750	ENST00000263663.5		9014		ENSG00000115750		4300					,					OTTHUMG00000151673		byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Intron		NM_005680.2	109,709,1385	NM_005680	0.5133					+	Intron		672.4+/-402.9	113.0				7801123				TAF1B-001	2002-08-29				2	+	0.1309				intron	11533				G	SO:0001627	604904			protein_coding		2203				32.8256,21.0395,48.4546			6503								KNOWN			GTAAGTGTACGTCAATTTTAT						ENST00000263663.5:c.1133+11G>C	2					breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)		+		,		2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10051053G>C		352.1+/-311.5			no		6704,6302												-0.9					0.0	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)				hg19	Standard	0.6551			5777,2823		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	2053,2598,1852					CCDS33143.1	G		CC,CG,GG	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	124		2504		rs10495576		1321				"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""						TAFI63, SL1, RAF1B, RAFI63		14	NM_005680		10			ENST00000263663.5		19558		uc002qzz.3			9014	dbSNP_119						0				145.0		0.328	2:g.10051053G>C		protein_coding			basic|appris_principal|CCDS		1944,1889,467			927,3479			G|||			5008		TAF1B_HUMAN	2161	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			0.43151		10051053			0.4514	SNP		CCDS33143.1			,,,	False	10051053				intron_variant		Approved		124.0			2008-06-02	OTTHUMT00000323426.2	Q53T94	0.536		TAF1B	10051053		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			TAF1B	NM_005680.2	protein-coding gene	NP_005671		
		T	ENSG00000115750	ENST00000263663.5	0.80722	9014	N	ENSG00000115750	0.17824	4300	0.006000	0.38560	B;B		,	.	0.0	2	c.(1384-1386)gaG>gaT	OTTHUMG00000151673	0.107000	byFrequency	Q53T94	gene with protein product		TAF1B_ENST00000396242.3_Missense_Mutation_p.E207D		NM_005680.2	111,704,1388	NM_005680	0.5215			G	0.043	+	Missense_Mutation	3	675.4+/-403.2	74.0	Q53T94;Q53T94-2	0.210168		7801123			0.0;0.0	TAF1B-001	2002-08-29		0.01281		2	+	0.1309		.	0.611000	missense	11533	208	462/589		G	SO:0001583	604904	benign	0.574585635359116	protein_coding		2203	P		0.969000	32.8372,21.0168,48.4699	B;B		6503		0.1308:0.2187:0.1371:0.5133						KNOWN	ENST00000263663;ENST00000396242		CACTGGTCGAGTCAACAGCAA	T;T					ENST00000263663.5:c.1386G>T	2		ENSG00000115750	0.10439	TAF1B	breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)	ENSP00000263663:p.Glu462Asp	+	0.33509	,	GAG	2p25	B4DI42|F8WD72|Q15574|Q8WVC3		g.chr2:10059770G>T	E -> D (in dbSNP:rs1820965). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7801123}.	351.8+/-311.4		76	yes		6702,6304	0.13384	0.01410	5.32	0.00012	.			0.14366		-3.3893		1.7	0.24008	294	.	0.513986013986014	0.0	metal ion binding (GO:0046872)|RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164)|RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity (GO:0001187)|sequence-specific DNA binding transcription factor activity (GO:0003700)|TBP-class protein binding (GO:0017025)	-1.7			hg19	Standard	0.667	0.15447154471544716	1.416	5776,2824		gene expression (GO:0010467)|RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)|transcription, DNA-templated (GO:0006351)	2044,2614,1845	-1.277245				CCDS33143.1	G	0.02656	TT,TG,GG	L39061	extracellular vesicular exosome (GO:0070062)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|RNA polymerase I core factor complex (GO:0070860)	75	0.00289	2504	1.66	rs1820965		1574	462;462	495		"""TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD"""	0.02302	9977221	+	ASP/GLU	462	TAFI63, SL1, RAF1B, RAFI63	1073	14	NM_005680	0.0;0.0	14	0.6530343007915568	-0.264000	ENST00000263663.5		19183		uc002qzz.3			9014	dbSNP_92	1386	0.0000		p.E462D	.	0		T		78.0	rs1820965;rs17856564;rs52813657;rs57176210;rs1820965	0.393	2:g.10059770G>T	ENSP00000263663:E462D;ENSP00000379542:E207D	protein_coding	0.324097		basic|appris_principal|CCDS		1933,1910,457		462;207	926,3480	0.4913003663003663	D	G|||		0.719148	5008		TAF1B_HUMAN	2211	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa		TAF1B_HUMAN;.	0.441494	0.22084	10059770		0.470000	0.4792	SNP		CCDS33143.1		N	,,,	False	10059770	-0.9651		8	missense	T	Approved	0.671628	75.0		c.1386G>T	2008-06-02	OTTHUMT00000323426.2	Q53T94	0.5389	1.13;1.13	TAF1B	10059770	0.37282	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.38650	45	TAF1B	NM_005680.2	protein-coding gene	NP_005671	E	
		G	ENSG00000134317	ENST00000324907.9	0.80722|0.80722	29841	N|N	ENSG00000134317	0.00385|0.00385	4300	0.000000|0.000000	0.16743|0.11169	B|B		,	T|T	0.0|0.0	0|0	c.(571-573)aAt>aGt	OTTHUMG00000151704	-2.729000|-2.729000	byFrequency	Q9NZI5	gene with protein product		GRHL1_ENST00000405379.2_Missense_Mutation_p.N191S|GRHL1_ENST00000324883.5_Missense_Mutation_p.I28V		NM_198182.2	279,1039,885	NM_014552	0.0736			G|G	0.388|0.388	+	Missense_Mutation	1|2	765.5+/-407.6	118.0	Q9NZI5-2|Q9NZI5	0.36246|0.36246		10644752, 12393799			0.0|0.0	GRHL1-001	2005-07-11		0.01281|0.01281		2	+	0.438		0.82|0.53	0.440000|0.440000	missense	17923	36|36	191/619		G	SO:0001583	609786	benign	0.09944751381215469|0.09944751381215469	protein_coding		2203	P|P		0.000000|0.000000	13.4884,36.246,21.1979	B|B		6503		0.3294:0.2381:0.4325:0.0|0.3294:0.2381:0.4325:0.0			Epithelial(75;0.172)|OV - Ovarian serous cystadenocarcinoma(76;0.246)			KNOWN	ENST00000324883|ENST00000405379;ENST00000324907		CGGAATCTCAATACTGACCAG	T|T;T	TFCP2L2				ENST00000324907.9:c.572A>G	2		ENSG00000134317|ENSG00000134317	0.00491|0.00491	GRHL1|GRHL1	cervix(1)|endometrium(1)|large_intestine(2)|lung(8)|ovary(1)|pancreas(1)|skin(1)|stomach(1)|urinary_tract(1)	ENSP00000324693:p.Asn191Ser	+	0.05858|0.05858	,	ATA|AAT	2p25.2	A6NLA4|B2R7E4|B5MEC2|Q53T93|Q6NWN7|Q6NWN8|Q6NWN9|Q8NI33		g.chr2:10101468A>G	N -> S (in dbSNP:rs16867256). {ECO:0000269|PubMed:15489334}.	664.3+/-401.3		195|195	yes		2757,10249	0.03702|0.03702	0.02377|0.02377	5.5|5.5	0.00012|0.00012	ENSP00000324494:I28V|ENSP00000324693:N191S			.|0.20829		.|.		-8.9	0.00785|0.00785	4|4	0.07482|0.15952	0.006993006993006993|0.006993006993006993	0.0	DNA binding (GO:0003677)	0|0	2005-07-11		hg19	Standard	0.1461	0.39634146341463417|0.39634146341463417	10.4728|10.4728	1160,7440		cellular lipid metabolic process (GO:0044255)|multicellular organismal development (GO:0007275)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	353,2051,4099	-0.924831|-0.924831				CCDS33144.1, CCDS33144.2	A	0.02656|0.02656	GG,GA,AA	AF198489	cytoplasm (GO:0005737)|Golgi apparatus (GO:0005794)|intracellular membrane-bounded organelle (GO:0043231)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	119	0.08118|0.08118	2504	-8.89|-8.89	rs16867256		708	28|191	104|104		"""transcription factor CP2-like 2"""	0.44646|0.44646	10018919|10018919	+|+	SER/ASN	191	LBP-32, MGR	339|339	17	NM_198182	0.0|0.0	4	0.13720316622691292|0.13720316622691292	-1.945000|-1.945000	ENST00000324907.9		18383		uc002raa.3			29841	dbSNP_123	572	0.0000|0.0000		p.N191S	.|.	0		T|T		121.0	rs16867256;rs52810082;rs16867256|rs16867256;rs52810082;rs16867256	0.542	2:g.10101468A>G	ENSP00000324494:I28V|ENSP00000384209:N191S;ENSP00000324693:N191S	protein_coding	.|0.084921		basic|appris_principal|CCDS		74,1012,3214		28|191	1597,2809	0.15521978021978022|0.15521978021978022	V|S	G|||		.|0.571760	5008		GRHL1_HUMAN	883	grainyhead-like 1 (Drosophila)		.|GRHL1_HUMAN	0.176318	0.07142|0.07142	10101468		-0.411000|-0.411000	0.0119	SNP		CCDS33144.2		.|N	,,,	False	10101468	-0.9539|-0.9539		8|9	missense	T|T	Approved	0.134884|0.134884	119.0		c.572A>G	2008-02-05	OTTHUMT00000323543.2	Q9NZI5	0.1052	2.32|2.8;2.8	GRHL1	10101468	0.31957|0.31957	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.40887|0.40887	46	GRHL1	NM_198182.2	protein-coding gene	NP_937825.2	I|N	
		A	ENSG00000134317	ENST00000324907.9	0.47659	29841	N	ENSG00000134317	0.37019	4300	0.392000	0.15487	B;B		,	T	5.159999999999609E-4	0	c.(1189-1191)Gtt>Att	OTTHUMG00000151704	0.922000	byFrequency	Q9NZI5	gene with protein product		GRHL1_ENST00000405379.2_Missense_Mutation_p.V397I|GRHL1_ENST00000324883.5_Missense_Mutation_p.V208I		NM_198182.2	222,930,1051	NM_014552	0.1401	Substitution - Missense(1)		A	8.514	+	Missense_Mutation	1	731.2+/-406.8	208.0	Q9NZI5-2;Q9NZI5	0.311847		10644752, 12393799			0.001;0.001	GRHL1-001	2005-07-11		0.04013		2	+	0.3064		1	0.930000	missense	17923	142	397/619		A	SO:0001583	609786	benign	0.39226519337016574	protein_coding	stomach(1)	2203	P		1.000000	21.3023,31.1847,24.6502	B;B		6503		0.9295:0.0:0.0705:0.0			Epithelial(75;0.172)|OV - Ovarian serous cystadenocarcinoma(76;0.246)			KNOWN	ENST00000405379;ENST00000324883;ENST00000324907		TAACATTCAAGTTGATACCTA	T;T;T	TFCP2L2				ENST00000324907.9:c.1189G>A	2		ENSG00000134317	0.04691	GRHL1	cervix(1)|endometrium(1)|large_intestine(2)|lung(8)|ovary(1)|pancreas(1)|skin(1)|stomach(1)|urinary_tract(1)	ENSP00000324693:p.Val397Ile	+	0.71417	,	GTT	2p25.2	A6NLA4|B2R7E4|B5MEC2|Q53T93|Q6NWN7|Q6NWN8|Q6NWN9|Q8NI33		g.chr2:10126330G>A	V -> I (in dbSNP:rs2303920). {ECO:0000269|PubMed:15489334}.	689.5+/-405.1		168	yes		3206,9800	0.26245	0.17250	5.49	0.00012	ENSP00000324494:V208I			0.85682		-2.9841		5.5	0.81192	143	0.02654	0.25	0.4	DNA binding (GO:0003677)	-1.465	2005-07-11		hg19	Standard	0.2316	0.34146341463414637	11.4774	1832,6768		cellular lipid metabolic process (GO:0044255)|multicellular organismal development (GO:0007275)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	421,2364,3718	0.867179		p.V208I(1)		CCDS33144.1, CCDS33144.2	G	0.02656	AA,AG,GG	AF198489	cytoplasm (GO:0005737)|Golgi apparatus (GO:0005794)|intracellular membrane-bounded organelle (GO:0043231)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	207	0.00465	2504	5.49	rs2303920		1325	208;397	172		"""transcription factor CP2-like 2"""	0.50306	10043781	+	ILE/VAL	397	LBP-32, MGR	625	17	NM_198182	0.0;0.0	9	0.22691292875989447	-0.490000	ENST00000324907.9		12735		uc002raa.3			29841	dbSNP_100	1189	0.0000		p.V397I	CP2 transcription factor (1);	1		T		204.0	rs2303920;rs52812320;rs59250653;rs2303920	0.488	2:g.10126330G>A	ENSP00000384209:V397I;ENSP00000324494:V208I;ENSP00000324693:V397I	protein_coding	0.000000		basic|appris_principal|CCDS		199,1434,2667		397;208;397	1374,3032	0.28617216117216115	I	A|||		0.000000	5008		GRHL1_HUMAN	1316	grainyhead-like 1 (Drosophila)		.;GRHL1_HUMAN	0.26278	0.72905	10126330		6.326000	0.2599	SNP		CCDS33144.2		N	,,,	False	10126330	-0.9288		9	missense	T	Approved	0.213023	207.0		c.1189G>A	2008-02-05	OTTHUMT00000323543.2	Q9NZI5	0.402	2.42;2.42;2.42	GRHL1	10126330	0.56654	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.45041	29	GRHL1	NM_198182.2	protein-coding gene	NP_937825.2	V	
		G	ENSG00000134317	ENST00000324907.9		29841		ENSG00000134317		4300					,					OTTHUMG00000151704		byFrequency	Q9NZI5	gene with protein product		GRHL1_ENST00000324883.5_Intron|GRHL1_ENST00000405379.2_Intron		NM_198182.2	958,980,265	NM_014552	0.3384					+	Intron		619.2+/-396.9	137.0				10644752, 12393799				GRHL1-001	2005-07-11				2	+	0.6884				intron	17923				G	SO:0001627	609786			protein_coding		2203				43.0814,34.2714,49.2465			6503					Epithelial(75;0.172)|OV - Ovarian serous cystadenocarcinoma(76;0.246)			KNOWN			ACAAGGTAAGATCGGCAGGGA		TFCP2L2				ENST00000324907.9:c.1269+6A>G	2					cervix(1)|endometrium(1)|large_intestine(2)|lung(8)|ovary(1)|pancreas(1)|skin(1)|stomach(1)|urinary_tract(1)		+		,		2p25.2	A6NLA4|B2R7E4|B5MEC2|Q53T93|Q6NWN7|Q6NWN8|Q6NWN9|Q8NI33		g.chr2:10126416A>G		478.8+/-358.3			yes		6601,6405												-5.4					0.0	DNA binding (GO:0003677)		2005-07-11		hg19	Standard	0.4384			3705,4895		cellular lipid metabolic process (GO:0044255)|multicellular organismal development (GO:0007275)|regulation of transcription, DNA-templated (GO:0006355)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	1733,3135,1635					CCDS33144.1, CCDS33144.2	A		GG,GA,AA	AF198489	cytoplasm (GO:0005737)|Golgi apparatus (GO:0005794)|intracellular membrane-bounded organelle (GO:0043231)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	136		2504		rs16867274		1405				"""transcription factor CP2-like 2"""						LBP-32, MGR		17	NM_198182		9			ENST00000324907.9		14641		uc002raa.3			29841	dbSNP_123						0				133.0		0.423	2:g.10126416A>G		protein_coding			basic|appris_principal|CCDS		775,2155,1370			2896,1510			G|||			5008		GRHL1_HUMAN	2516	grainyhead-like 1 (Drosophila)			0.502396		10126416			0.4008	SNP		CCDS33144.2			,,,	False	10126416				intron_variant		Approved		136.0			2008-02-05	OTTHUMT00000323543.2	Q9NZI5	0.6196		GRHL1	10126416		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			GRHL1	NM_198182.2	protein-coding gene	NP_937825.2		
		T	ENSG00000172059	ENST00000305883.1		8462		ENSG00000172059		4300					,				c.(1183-1185)gtA>gtT	OTTHUMG00000119004		byFrequency	O14901	gene with protein product		KLF11_ENST00000540845.1_Silent_p.V378V|KLF11_ENST00000535335.1_Silent_p.V378V		NM_003597.4	1455,670,78	NM_003597	0.8456					+	Silent		306.9+/-308.1	91.0				9748269, 11087666				KLF11-001	2004-11-29				2	+	0.8215				coding-synonymous,coding-synonymous,coding-synonymous	11811		378/496,378/496,395/513		T	SO:0001819	603301	,,		protein_coding		2203		OREG0014425		19.3721,18.7472,19.1604		"""Kruppel-like transcription factors"", ""Zinc fingers, C2H2-type"""	6503				662	Epithelial(75;0.133)|OV - Ovarian serous cystadenocarcinoma(76;0.228)		Melanoma(56;431 1507 23687 50789)	KNOWN			GGAACTATGTATGCAGCTTCC		TIEG2				ENST00000305883.1:c.1185A>T	2					endometrium(2)|kidney(1)|large_intestine(2)|lung(5)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)		+		,		2p25	B4DZE7|Q9EPF4		g.chr2:10188649A>T		325.6+/-299.2			no		10514,2492												-4.1					0.1	metal ion binding (GO:0046872)|sequence-specific DNA binding RNA polymerase II transcription factor activity (GO:0000981)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription regulatory region DNA binding (GO:0044212)		2004-12-01		hg19	Standard	0.8201			6934,1666		apoptotic process (GO:0006915)|cellular response to peptide (GO:1901653)|negative regulation of cell proliferation (GO:0008285)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of apoptotic process (GO:0043065)|regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)|transcription from RNA polymerase II promoter (GO:0006366)	4252,2010,241					CCDS1668.1, CCDS54333.1	A		TT,TA,AA	AF028008	nucleus (GO:0005634)	91		2504		rs11687357		1347				"""TGFB inducible early growth response 2"""				,,	395	Tieg3, MODY7		16	NM_001177716		3			ENST00000305883.1		21002		uc002raf.1			8462	dbSNP_120	1134,1134,1185			p.V395V		0				92.0		0.537	2:g.10188649A>T		protein_coding			basic|appris_candidate_longest|CCDS		2797,1340,163	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		3580,826			T|||			5008		KLF11_HUMAN	4183	Kruppel-like factor 11			0.835264		10188649			0.8313	SNP		CCDS1668.1			,,,	False	10188649				synonymous_variant		Approved		91.0		c.1185A>T	2013-01-08	OTTHUMT00000239202.3	O14901	0.8746		KLF11	10188649		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)		,,	KLF11	NM_001177716.1,NM_001177718.1,NM_003597.4	protein-coding gene	NP_003588.1		
		C	ENSG00000143882	ENST00000272238.4		245973		ENSG00000143882		4300					,					OTTHUMG00000090459		byFrequency	Q8NEY4	gene with protein product		ATP6V1C2_ENST00000381661.3_Intron		NM_001039362.1	86,670,1447	NM_144583	0.4458					+	Intron		566.9+/-388.7	52.0				12384298				ATP6V1C2-002	2006-01-13				2	+	0.1399				intron,intron	18264		,		A	SO:0001627		,		protein_coding		2203				49.3605,19.1103,39.9585		"""ATPases / V-type"""	6503					Epithelial(75;0.15)|OV - Ovarian serous cystadenocarcinoma(76;0.152)		NSCLC(188;1042 2136 10807 16813 47705)	KNOWN			GTATCCAGAAACAGCAGTATT						ENST00000272238.4:c.1194+15A>C	2					endometrium(2)|kidney(1)|large_intestine(3)|lung(8)|ovary(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)		+		,		2p25.1	Q96EL8		g.chr2:10922516A>C		315.8+/-294.3			no		5197,7809												0.7					0.0	hydrogen-exporting ATPase activity, phosphorylative mechanism (GO:0008553)|protein dimerization activity (GO:0046983)				hg19	Standard	0.4771			4355,4245		ATP hydrolysis coupled proton transport (GO:0015991)|cellular iron ion homeostasis (GO:0006879)|insulin receptor signaling pathway (GO:0008286)|interaction with host (GO:0051701)|phagosome maturation (GO:0090382)|positive regulation of Wnt signaling pathway (GO:0030177)|transferrin transport (GO:0033572)|transmembrane transport (GO:0055085)	1181,2835,2487					CCDS1674.1, CCDS42653.1	A		CC,CA,AA	AY039759	cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|lysosomal membrane (GO:0005765)|proton-transporting V-type ATPase, V1 domain (GO:0033180)	55		2504		rs1686482		1303				"""ATPase, H+ transporting, lysosomal 42kD, V1 subunit C isoform 2"", ""ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C isoform 2"""				,		VMA5, ATP6C2		19	XR_426949		13			ENST00000272238.4		20177		uc002ras.3			245973	dbSNP_89	,					0				59.0		0.433	2:g.10922516A>C		protein_coding			not_organism_supported|basic|CCDS		1095,2165,1040			842,3564			A|||			5008		VATC2_HUMAN	1889	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			0.377196		10922516			0.4514	SNP		CCDS42653.1			,,,	False	10922516				intron_variant		Approved		55.0			2010-04-21	OTTHUMT00000323555.1	Q8NEY4	0.4798		ATP6V1C2	10922516		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)		,	ATP6V1C2	NM_001039362.1,NM_144583.3	protein-coding gene	NP_001034451.1		
		C	ENSG00000143870	ENST00000272227.3		10130		ENSG00000143870		4300					,					OTTHUMG00000090479		byFrequency	Q15084	gene with protein product		PDIA6_ENST00000404371.2_Intron|PDIA6_ENST00000540494.1_Intron|PDIA6_ENST00000404824.2_Intron|PDIA6_ENST00000381611.4_Intron		NM_001282707.1|NM_005742.2	178,834,1189	NM_005742	0.6339					+	Intron		507.8+/-376.9	120.0				7590364, 12204115				PDIA6-001	2005-06-29				2	-	0.1997				intron	30168				C	SO:0001627	611099			protein_coding		2201				40.4419,27.0332,48.5464		"""Protein disulfide isomerases"""	6501					Epithelial(75;0.149)|OV - Ovarian serous cystadenocarcinoma(76;0.15)		GBM(73;509 1219 34219 41343 41551)	KNOWN			CTGATTTAAATAGACAAAGTT		TXNDC7				ENST00000272227.3:c.926-11A>G	2					central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(8)|prostate(2)		-		,		2p25.1	B3KY95|B5MCQ5|B7Z254|B7Z4M8|F8WA83|Q53RC7|Q6ZSH5|Q99778	"""protein disulfide isomerase-related protein"""	g.chr2:10928906T>C		684.6+/-404.4			no		6312,6690												-0.2					0.0	protein disulfide isomerase activity (GO:0003756)		2005-03-03		hg19	Standard	0.5855			5122,3478		activation of signaling protein activity involved in unfolded protein response (GO:0006987)|apoptotic cell clearance (GO:0043277)|cell redox homeostasis (GO:0045454)|cellular protein metabolic process (GO:0044267)|endoplasmic reticulum unfolded protein response (GO:0030968)|protein folding (GO:0006457)|response to endoplasmic reticulum stress (GO:0034976)	1687,2938,1876					CCDS1675.1, CCDS62852.1, CCDS62853.1, CCDS62854.1, CCDS62855.1	T		CC,CT,TT	BC001312	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|extracellular vesicular exosome (GO:0070062)|plasma membrane (GO:0005886)	115		2504		rs1734432		1073				"""thioredoxin domain containing 7 (protein disulfide isomerase)"", ""protein disulfide isomerase-associated 6"""						P5, ERp5		18	XM_005246145		10			ENST00000272227.3		17941		uc002rau.3			10130	dbSNP_89						0				104.0		0.343	2:g.10928906T>C		protein_coding			basic|CCDS		1509,2104,687			1190,3212			C|||			5008		PDIA6_HUMAN	2307	protein disulfide isomerase family A, member 6			0.460663		10928906			0.4663	SNP		CCDS1675.1			,,,	False	10928906		5.3.4.1		intron_variant		Approved		115.0			2009-11-20	OTTHUMT00000206933.1	Q15084	0.5245		PDIA6	10928906		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)			PDIA6	NM_005742.2	protein-coding gene	NP_001269636.1|NP_005733.1		
		C	ENSG00000143870	ENST00000272227.3		10130		ENSG00000143870		4300					,					OTTHUMG00000090479		byFrequency	Q15084	gene with protein product		PDIA6_ENST00000540494.1_Intron|PDIA6_ENST00000404371.2_Intron|PDIA6_ENST00000381611.4_Intron|PDIA6_ENST00000404824.2_Intron		NM_001282707.1|NM_005742.2	179,836,1188	NM_005742	0.6339					+	Intron		509.3+/-377.2	66.0				7590364, 12204115				PDIA6-001	2005-06-29				2	-	0.1989				intron	30168				C	SO:0001627	611099			protein_coding		2203				40.3605,27.0994,48.616		"""Protein disulfide isomerases"""	6503					Epithelial(75;0.149)|OV - Ovarian serous cystadenocarcinoma(76;0.15)		GBM(73;509 1219 34219 41343 41551)	KNOWN			GCAGTTGAAGTGGTTTACCTC		TXNDC7				ENST00000272227.3:c.840+7A>G	2					central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(8)|prostate(2)		-		,		2p25.1	B3KY95|B5MCQ5|B7Z254|B7Z4M8|F8WA83|Q53RC7|Q6ZSH5|Q99778	"""protein disulfide isomerase-related protein"""	g.chr2:10929867T>C		710.2+/-407.8			no		6323,6683												-9.7					0.0	protein disulfide isomerase activity (GO:0003756)		2005-03-03		hg19	Standard	0.5845			5129,3471		activation of signaling protein activity involved in unfolded protein response (GO:0006987)|apoptotic cell clearance (GO:0043277)|cell redox homeostasis (GO:0045454)|cellular protein metabolic process (GO:0044267)|endoplasmic reticulum unfolded protein response (GO:0030968)|protein folding (GO:0006457)|response to endoplasmic reticulum stress (GO:0034976)	1690,2943,1870					CCDS1675.1, CCDS62852.1, CCDS62853.1, CCDS62854.1, CCDS62855.1	T		CC,CT,TT	BC001312	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|extracellular vesicular exosome (GO:0070062)|plasma membrane (GO:0005886)	67		2504		rs11904084		988				"""thioredoxin domain containing 7 (protein disulfide isomerase)"", ""protein disulfide isomerase-associated 6"""						P5, ERp5		18	XM_005246145		8			ENST00000272227.3		15890		uc002rau.3			10130	dbSNP_120						0				68.0		0.468	2:g.10929867T>C		protein_coding			basic|CCDS		1511,2107,682			1194,3212			C|||			5008		PDIA6_HUMAN	2305	protein disulfide isomerase family A, member 6			0.460264		10929867			0.4663	SNP		CCDS1675.1			,,,	False	10929867		5.3.4.1		intron_variant		Approved		67.0			2009-11-20	OTTHUMT00000206933.1	Q15084	0.5245		PDIA6	10929867		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)			PDIA6	NM_005742.2	protein-coding gene	NP_001269636.1|NP_005733.1		
		C	ENSG00000143870	ENST00000272227.3		10130		ENSG00000143870		4300					,					OTTHUMG00000090479		byFrequency	Q15084	gene with protein product		PDIA6_ENST00000540494.1_Intron|PDIA6_ENST00000404371.2_Intron|PDIA6_ENST00000381611.4_Intron|PDIA6_ENST00000404824.2_Intron		NM_001282707.1|NM_005742.2	179,834,1190	NM_005742	0.6339					+	Intron		632.8+/-398.7	95.0				7590364, 12204115				PDIA6-001	2005-06-29				2	-	0.1989				intron	30168				T	SO:0001627	611099			protein_coding		2203				40.5116,27.054,48.5007		"""Protein disulfide isomerases"""	6503					Epithelial(75;0.149)|OV - Ovarian serous cystadenocarcinoma(76;0.15)		GBM(73;509 1219 34219 41343 41551)	KNOWN			CATCAAACAATTGGGCCAAGA		TXNDC7				ENST00000272227.3:c.454-31A>G	2					central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(8)|prostate(2)		-		,		2p25.1	B3KY95|B5MCQ5|B7Z254|B7Z4M8|F8WA83|Q53RC7|Q6ZSH5|Q99778	"""protein disulfide isomerase-related protein"""	g.chr2:10932082T>C		413.3+/-336.4			no		6308,6698												1.3					0.0	protein disulfide isomerase activity (GO:0003756)		2005-03-03		hg19	Standard	0.5845			5116,3484		activation of signaling protein activity involved in unfolded protein response (GO:0006987)|apoptotic cell clearance (GO:0043277)|cell redox homeostasis (GO:0045454)|cellular protein metabolic process (GO:0044267)|endoplasmic reticulum unfolded protein response (GO:0030968)|protein folding (GO:0006457)|response to endoplasmic reticulum stress (GO:0034976)	1685,2938,1880					CCDS1675.1, CCDS62852.1, CCDS62853.1, CCDS62854.1, CCDS62855.1	T		CC,CT,TT	BC001312	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|extracellular vesicular exosome (GO:0070062)|plasma membrane (GO:0005886)	103		2504		rs1734421		601				"""thioredoxin domain containing 7 (protein disulfide isomerase)"", ""protein disulfide isomerase-associated 6"""						P5, ERp5		18	XM_005246145		6			ENST00000272227.3		22565		uc002rau.3			10130	dbSNP_89						0				117.0		0.333	2:g.10932082T>C		protein_coding			basic|CCDS		1506,2104,690			1192,3214			T|||			5008		PDIA6_HUMAN	2305	protein disulfide isomerase family A, member 6			0.460264		10932082			0.4663	SNP		CCDS1675.1			,,,	False	10932082		5.3.4.1		intron_variant		Approved		103.0			2009-11-20	OTTHUMT00000206933.1	Q15084	0.5245		PDIA6	10932082		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)			PDIA6	NM_005742.2	protein-coding gene	NP_001269636.1|NP_005733.1		
		T	ENSG00000143870	ENST00000272227.3		10130		ENSG00000143870		4300					,				c.(424-426)cgG>cgA	OTTHUMG00000090479		byFrequency	Q15084	gene with protein product		PDIA6_ENST00000540494.1_Silent_p.R139R|PDIA6_ENST00000404371.2_Silent_p.R194R|PDIA6_ENST00000381611.4_Silent_p.R147R|PDIA6_ENST00000404824.2_Silent_p.R190R		NM_001282707.1|NM_005742.2	118,711,1374	NM_005742	0.455					+	Silent		581.0+/-391.2	93.0				7590364, 12204115				PDIA6-001	2005-06-29				2	-	0.1619				coding-synonymous	30168		142/441		C	SO:0001819	611099			protein_coding		2203				49.3605,21.4934,40.7658		"""Protein disulfide isomerases"""	6503					Epithelial(75;0.149)|OV - Ovarian serous cystadenocarcinoma(76;0.15)		GBM(73;509 1219 34219 41343 41551)	KNOWN			ATCCTCCGCTCCGTCCCCCGA		TXNDC7				ENST00000272227.3:c.426G>A	2					central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(8)|prostate(2)		-		,		2p25.1	B3KY95|B5MCQ5|B7Z254|B7Z4M8|F8WA83|Q53RC7|Q6ZSH5|Q99778	"""protein disulfide isomerase-related protein"""	g.chr2:10933249C>T		358.4+/-314.3			no		5302,7704												1.5					0.0	protein disulfide isomerase activity (GO:0003756)		2005-03-03		hg19	Standard	0.4781			4355,4245		activation of signaling protein activity involved in unfolded protein response (GO:0006987)|apoptotic cell clearance (GO:0043277)|cell redox homeostasis (GO:0045454)|cellular protein metabolic process (GO:0044267)|endoplasmic reticulum unfolded protein response (GO:0030968)|protein folding (GO:0006457)|response to endoplasmic reticulum stress (GO:0034976)	1211,2880,2412					CCDS1675.1, CCDS62852.1, CCDS62853.1, CCDS62854.1, CCDS62855.1	C		TT,TC,CC	BC001312	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|extracellular vesicular exosome (GO:0070062)|plasma membrane (GO:0005886)	96		2504		rs4799		573				"""thioredoxin domain containing 7 (protein disulfide isomerase)"", ""protein disulfide isomerase-associated 6"""					142	P5, ERp5		18	XM_005246145		5			ENST00000272227.3		18105		uc002rau.3			10130	dbSNP_52	426			p.R142R		0				102.0		0.483	2:g.10933249C>T		protein_coding			basic|CCDS		1093,2169,1038			947,3459			C|||			5008		PDIA6_HUMAN	1934	protein disulfide isomerase family A, member 6			0.386182		10933249			0.4583	SNP		CCDS1675.1			,,,	False	10933249		5.3.4.1		synonymous_variant		Approved		96.0		c.426G>A	2009-11-20	OTTHUMT00000206933.1	Q15084	0.4784		PDIA6	10933249		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)			PDIA6	NM_005742.2	protein-coding gene	NP_001269636.1|NP_005733.1		
		T	ENSG00000143870	ENST00000272227.3		10130		ENSG00000143870		4300					,				c.(97-99)tcG>tcA	OTTHUMG00000090479		byFrequency	Q15084	gene with protein product		PDIA6_ENST00000489662.1_5'UTR|PDIA6_ENST00000540494.1_Silent_p.S30S|PDIA6_ENST00000404371.2_Silent_p.S85S|PDIA6_ENST00000381611.4_Silent_p.S38S|PDIA6_ENST00000404824.2_Silent_p.S81S		NM_001282707.1|NM_005742.2	179,834,1190	NM_005742	0.638					+	Silent		510.2+/-377.4	84.0				7590364, 12204115				PDIA6-001	2005-06-29				2	-	0.1989				coding-synonymous	30168		33/441		T	SO:0001819	611099			protein_coding		2203				40.5,27.054,48.5084		"""Protein disulfide isomerases"""	6503					Epithelial(75;0.149)|OV - Ovarian serous cystadenocarcinoma(76;0.15)		GBM(73;509 1219 34219 41343 41551)	KNOWN			GGTTGAAATTCGATGGAGTTA		TXNDC7				ENST00000272227.3:c.99G>A	2	Thioredoxin 1. {ECO:0000255|PROSITE- ProRule:PRU00691}.				central_nervous_system(1)|endometrium(3)|kidney(2)|large_intestine(2)|lung(8)|prostate(2)		-		,		2p25.1	B3KY95|B5MCQ5|B7Z254|B7Z4M8|F8WA83|Q53RC7|Q6ZSH5|Q99778	"""protein disulfide isomerase-related protein"""	g.chr2:10942687C>T		710.4+/-407.9			no		6309,6697												-6.5					0.8	protein disulfide isomerase activity (GO:0003756)		2005-03-03		hg19	Standard	0.5835			5117,3483		activation of signaling protein activity involved in unfolded protein response (GO:0006987)|apoptotic cell clearance (GO:0043277)|cell redox homeostasis (GO:0045454)|cellular protein metabolic process (GO:0044267)|endoplasmic reticulum unfolded protein response (GO:0030968)|protein folding (GO:0006457)|response to endoplasmic reticulum stress (GO:0034976)	1685,2939,1879					CCDS1675.1, CCDS62852.1, CCDS62853.1, CCDS62854.1, CCDS62855.1	C		TT,TC,CC	BC001312	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)|extracellular vesicular exosome (GO:0070062)|plasma membrane (GO:0005886)	86		2504		rs4758		246				"""thioredoxin domain containing 7 (protein disulfide isomerase)"", ""protein disulfide isomerase-associated 6"""					33	P5, ERp5		18	XM_005246145		2			ENST00000272227.3		19515		uc002rau.3			10130	dbSNP_52	99			p.S33S		0				91.0		0.358	2:g.10942687C>T		protein_coding			basic|CCDS		1506,2105,689			1192,3214			T|||			5008		PDIA6_HUMAN	2303	protein disulfide isomerase family A, member 6			0.459864		10942687			0.4613	SNP		CCDS1675.1			,,,	False	10942687		5.3.4.1		synonymous_variant		Approved		86.0		c.99G>A	2009-11-20	OTTHUMT00000206933.1	Q15084	0.5245		PDIA6	10942687		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)			PDIA6	NM_005742.2	protein-coding gene	NP_001269636.1|NP_005733.1		
		T	ENSG00000162975	ENST00000295082.1		3754		ENSG00000162975		4300					,				c.(1186-1188)atC>atT	OTTHUMG00000119054		byFrequency	Q9H3M0	gene with protein product				NM_002236.4	300,1057,846	NM_002236	0.4898					+	Silent		658.8+/-401.6	112.0				9434767, 16382104				KCNF1-001					2	+	0.3389				coding-synonymous	6246		396/495		C	SO:0001819	603787			protein_coding		2203				36.0233,37.6078,44.9562		"""Potassium channels"", ""Voltage-gated ion channels / Potassium channels"""	6503					Epithelial(75;0.115)|OV - Ovarian serous cystadenocarcinoma(76;0.128)			KNOWN			GTGGTGTCATCGCCATCGCCC		KCNF				ENST00000295082.1:c.1188C>T	2					NS(1)|endometrium(2)|large_intestine(2)|lung(10)|ovary(2)|skin(1)|urinary_tract(1)		+		,		2p25	O43527|Q585L3		g.chr2:11053740C>T		506.1+/-366.3			no		7159,5847												-6.7					0.9	delayed rectifier potassium channel activity (GO:0005251)|potassium channel activity (GO:0005267)				hg19	Standard	0.6322			5502,3098		potassium ion transport (GO:0006813)|protein homooligomerization (GO:0051260)|synaptic transmission (GO:0007268)	2054,3051,1398					CCDS1676.1	C		TT,TC,CC	AF033382	plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	125		2504		rs3732105		1678									396	Kv5.1, kH1, IK8		19	NM_002236		1			ENST00000295082.1		22218		uc002rax.3			3754	dbSNP_107	1188			p.I396I		0				152.0		0.602	2:g.11053740C>T		protein_coding			basic|appris_principal|CCDS		1754,1994,552			1657,2749			C|||			5008		KCNF1_HUMAN	2419	potassium voltage-gated channel, subfamily F, member 1			0.483027		11053740			0.5099	SNP		CCDS1676.1			,,,	False	11053740				synonymous_variant		Approved		125.0		c.1188C>T	2011-07-05	OTTHUMT00000239265.1	Q9H3M0	0.4928		KCNF1	11053740		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.191)			KCNF1	NM_002236.4	protein-coding gene	NP_002227.2		
		T	ENSG00000162976	ENST00000295083.3		130814		ENSG00000162976		4300					,					OTTHUMG00000119055		byFrequency	Q8N755	gene with protein product		PQLC3_ENST00000402361.1_Intron|PQLC3_ENST00000441908.2_Intron|PQLC3_ENST00000476787.1_Intron		NM_152391.3	103,683,1417	NM_152391	0.4939					+	Intron		570.3+/-389.3	122.0				12477932				PQLC3-001	2005-07-19				2	+	0.1324				intron	28503				C	SO:0001627				protein_coding		2203				48.8953,20.177,39.1665			6503					Epithelial(75;0.0978)|OV - Ovarian serous cystadenocarcinoma(76;0.132)			KNOWN			CCCCCTCACTCGGAGCCTCTC		C2orf22				ENST00000295083.3:c.227-19C>T	2					kidney(2)|large_intestine(2)|lung(1)|upper_aerodigestive_tract(1)		+		,		2p25.1	B2R8K1|B4DWA4		g.chr2:11300732C>T		344.1+/-307.9			no		5094,7912												2.9					0.0			2005-07-19		hg19	Standard	0.4702			4205,4395			1128,2838,2537					CCDS1679.1, CCDS62856.1, CCDS62857.1	C		TT,TC,CC	BC027625	integral component of membrane (GO:0016021)	130		2504		rs2271622		401				"""chromosome 2 open reading frame 22"""						MGC33602		6	NM_001282711		3			ENST00000295083.3		18248		uc002rbc.3			130814	dbSNP_100						0				146.0		0.572	2:g.11300732C>T		protein_coding			basic|appris_principal|CCDS		1025,2155,1120			889,3517			C|||			5008		PQLC3_HUMAN	1914	PQ loop repeat containing 3			0.382188		11300732			0.4683	SNP		CCDS1679.1			,,,	False	11300732				intron_variant		Approved		130.0			2004-02-05	OTTHUMT00000239266.4	Q8N755	0.4481		PQLC3	11300732		all_hematologic(175;0.0797)|Acute lymphoblastic leukemia(172;0.155)			PQLC3	NM_152391.3	protein-coding gene	NP_689604.1		
		T	ENSG00000134318	ENST00000315872.6	0.45837	9475	N	ENSG00000134318	0.25283	4053	0.997000	0.62498	B		,	T	0.0012950000000000461	0	c.(1291-1293)aCt>aAt	OTTHUMG00000149916	0.396000	byFrequency	O75116	gene with protein product		ROCK2_ENST00000401753.1_Missense_Mutation_p.T188N		NM_004850.3	142,695,963		0.4294	Substitution - Missense(1)		T	3.282	+	Missense_Mutation	2		69.0	O75116	0.271944		9933571			0.0	ROCK2-001			0.01281		2	-	0.2035		0.64	0.807000	missense	10252	200	431/1389		T	SO:0001583	604002	benign	0.5524861878453039	protein_coding	stomach(1)	1800	P		1.000000	47.0146,27.1944,45.0538	B	"""Pleckstrin homology (PH) domain containing"""	5853		0.0:0.0809:0.1581:0.761			Epithelial(75;0.137)|OV - Ovarian serous cystadenocarcinoma(76;0.162)			KNOWN	ENST00000315872;ENST00000401753		TATGGAATCAGTTTCTCTACA	T;T					ENST00000315872.6:c.1292C>A	2	Interaction with PPP1R12A.	ENSG00000134318	0.08231	ROCK2	breast(2)|central_nervous_system(1)|cervix(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|kidney(5)|large_intestine(6)|lung(10)|prostate(1)|skin(4)|stomach(3)|urinary_tract(2)	ENSP00000317985:p.Thr431Asn	-	0.71417	,	ACT	2p24	Q53QZ0|Q53SJ7|Q9UQN5		g.chr2:11359120G>T	T -> N (in dbSNP:rs2230774). {ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9734811, ECO:0000269|PubMed:9933571}.			100	yes		5274,6432	0.53966	0.06627	5.54	0.00012	ENSP00000261535:T431N			0.27172		.		4.4	0.52855	234	0.11794	0.4090909090909091	1.0	ATP binding (GO:0005524)|metal ion binding (GO:0046872)|poly(A) RNA binding (GO:0044822)|protein serine/threonine kinase activity (GO:0004674)|structural molecule activity (GO:0005198)	-1.795			hg19	Standard	0.5268	0.2032520325203252	6.4363	4295,3811		actin cytoskeleton organization (GO:0030036)|axon guidance (GO:0007411)|centrosome duplication (GO:0051298)|cytokinesis (GO:0000910)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|intracellular signal transduction (GO:0035556)|negative regulation of angiogenesis (GO:0016525)|neural tube closure (GO:0001843)|positive regulation of centrosome duplication (GO:0010825)|protein phosphorylation (GO:0006468)|regulation of actin cytoskeleton organization (GO:0032956)|regulation of cell adhesion (GO:0030155)|regulation of cell motility (GO:2000145)|regulation of circadian rhythm (GO:0042752)|regulation of establishment of cell polarity (GO:2000114)|regulation of focal adhesion assembly (GO:0051893)|regulation of keratinocyte differentiation (GO:0045616)|regulation of stress fiber assembly (GO:0051492)|rhythmic process (GO:0048511)|smooth muscle contraction (GO:0006939)	1288,2698,1867	-0.146893		p.T431N(1)		CCDS42654.1	G	0.02656	TT,TG,GG	D87931	centrosome (GO:0005813)|cytoplasmic ribonucleoprotein granule (GO:0036464)|cytosol (GO:0005829)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|spindle pole centrosome (GO:0031616)	72	0.00230	2504	4.39	rs2230774		1740	431	397			0.21825	11276571	-	ASN/THR	431		931	43	NM_004850	0.0	10	0.5237467018469657	-0.335000	ENST00000315872.6		16818		uc002rbd.1			9475	dbSNP_98	1292	0.0000		p.T431N	.	1		T		77.0	rs2230774;rs9808232;rs17366763;rs52790024;rs9808232	0.284	2:g.11359120G>T	ENSP00000317985:T431N;ENSP00000385509:T188N	protein_coding	0.020589		basic|appris_principal|CCDS		1146,2003,904		431;188	979,2621	0.42628205128205127	N	T|||		0.397066	5008		ROCK2_HUMAN	2002	Rho-associated, coiled-coil containing protein kinase 2		ROCK2_HUMAN	0.39976	0.32467	11359120		1.218000	0.3889	SNP		CCDS42654.1		N	,,,	False	11359120	-0.9191	2.7.11.1	9	missense	T	Approved	0.529854	72.0		c.1292C>A	2013-01-10	OTTHUMT00000313886.3	O75116	0.5634	0.02;1.05	ROCK2	11359120	0.45602	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.46442	65	ROCK2	NM_004850.3	protein-coding gene	NP_004841.2	T	
		A	ENSG00000196208	ENST00000381486.2	0.80722	9687	.	ENSG00000196208	0.05851	4300	0.000000	.	.	http://www.ncbi.nlm.nih.gov/pubmed?term	,	.	0.0	.		OTTHUMG00000141276	-0.592000	byFrequency	Q4ZG55	gene with protein product		GREB1_ENST00000263834.5_Splice_Site|GREB1_ENST00000381483.2_Intron|GREB1_ENST00000234142.5_Intron		NM_014668.3	1552,596,54	NM_014668	0.4683	Unknown(1)		A	1.031	+	Intron	.	578.4+/-390.7	136.0	.	0.840145		11103799			.	GREB1-001	2009-09-10		.		2	+	0.916		.	0.000000	intron,intron,splice-3	24885	216	,,		A	SO:0001627	611736	,,	0.5966850828729282	protein_coding	stomach(1)	2202	P		0.000000	49.9302,15.9855,38.5266	.		6502		0.4356:0.0:0.5644:0.0			Epithelial(75;0.115)|OV - Ovarian serous cystadenocarcinoma(76;0.186)		Ovarian(39;850 945 2785 23371 33093)	KNOWN	ENST00000263834		GCCCACTGCAGTATTTGTAAA	.					ENST00000381486.2:c.1160-1365G>A	2		ENSG00000196208	0.01523	GREB1	breast(3)|central_nervous_system(2)|endometrium(2)|kidney(4)|large_intestine(9)|lung(9)|ovary(1)		+	0.05858	,	.	2p25.1	A6NHD0|A6NKN0|B5MDA9|O60321|Q7Z5S2|Q9H2Q6|Q9H2Q7|Q9H2Q8	"""gene regulated by estrogen in breast cancer"""	g.chr2:11727507G>A		294.4+/-283.1		454	yes		7994,5010	0.03702	0.03353	2.02	.	.			.		.		-0.7	0.11273	303	.	0.5297202797202797	0.0		.			hg19	Standard	0.5278	0.9227642276422764	6.295	4294,4306			2609,2776,1117	-0.681773		p.?(1)		CCDS33146.1, CCDS33147.1, CCDS42655.1	G	.	AA,AG,GG		integral component of membrane (GO:0016021)	136	.	2504	-0.7	rs13394619		1459	.	389			0.21081	11644958	+	,,		KIAA0575	1362	30	NM_014668	.	10	0.5131926121372031	-1.246000	ENST00000381486.2		19435		uc002rbk.1			9687	dbSNP_121	,,	.			.	1		.		137.0	rs13394619;rs17529763;rs58035934;rs13394619	0.498	2:g.11727507G>A	.	protein_coding	.		basic|appris_principal|CCDS		1057,2180,1063		-1	3700,704	0.6236263736263736	.	A|||		.	5008		GREB1_HUMAN	3101	growth regulation by estrogen in breast cancer 1		.	0.619209	0.05446	11727507		-0.639000	0.4881	SNP		CCDS42655.1		.	,,,	False	11727507	.		.	intron_variant	.	Approved	0.499302	136.0			2010-02-17	OTTHUMT00000280490.1	Q4ZG55	0.5893	.	GREB1	11727507	0.00434	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	.	,,	GREB1	NM_014668.3,NM_033090.2,NM_148903.2	protein-coding gene	NP_055483.2	.	
		C	ENSG00000196208	ENST00000381486.2		9687		ENSG00000196208		4153					,				c.(2137-2139)caT>caC	OTTHUMG00000141276		byFrequency	Q4ZG55	gene with protein product		GREB1_ENST00000234142.5_Silent_p.H713H		NM_014668.3	1310,603,64	NM_014668	0.9611					+	Silent			176.0				11103799				GREB1-001	2009-09-10				2	+	0.7572				coding-synonymous	24885		713/1950		C	SO:0001819	611736			protein_coding		1977				0.4936,18.4876,6.2969			6130					Epithelial(75;0.115)|OV - Ovarian serous cystadenocarcinoma(76;0.186)		Ovarian(39;850 945 2785 23371 33093)	KNOWN			CTCTGCTCCATGTGTGGCATT						ENST00000381486.2:c.2139T>C	2					breast(3)|central_nervous_system(2)|endometrium(2)|kidney(4)|large_intestine(9)|lung(9)|ovary(1)		+		,		2p25.1	A6NHD0|A6NKN0|B5MDA9|O60321|Q7Z5S2|Q9H2Q6|Q9H2Q7|Q9H2Q8	"""gene regulated by estrogen in breast cancer"""	g.chr2:11738091T>C					no		11488,772												-7.4					0.1					hg19	Standard	0.995			8265,41			5422,644,64					CCDS33146.1, CCDS33147.1, CCDS42655.1	T		CC,CT,TT		integral component of membrane (GO:0016021)	179		2504		rs1435547		2439									713	KIAA0575		30	NM_014668		14			ENST00000381486.2		21061		uc002rbk.1			9687	dbSNP_88	2139			p.H713H		0				183.0		0.498	2:g.11738091T>C		protein_coding			basic|appris_principal|CCDS		4112,41,0			3223,731			C|||			5008		GREB1_HUMAN	4591	growth regulation by estrogen in breast cancer 1			0.916733		11738091			0.9692	SNP		CCDS42655.1			,,,	False	11738091				synonymous_variant		Approved		179.0		c.2139T>C	2010-02-17	OTTHUMT00000280490.1	Q4ZG55	0.9683		GREB1	11738091		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			GREB1	NM_014668.3	protein-coding gene	NP_055483.2		
		C	ENSG00000196208	ENST00000381486.2		9687		ENSG00000196208		4145					,				c.(3019-3021)atT>atC	OTTHUMG00000141276		byFrequency	Q4ZG55	gene with protein product		GREB1_ENST00000234142.5_Silent_p.I1007I|GREB1_ENST00000396123.1_Silent_p.I5I		NM_014668.3	1801,139,7	NM_014668	0.9847					+	Silent			138.0				11103799				GREB1-001	2009-09-10				2	+	0.9501				coding-synonymous	24885		1007/1950		C	SO:0001819	611736			protein_coding		1947				0.2774,3.9291,1.4445			6092					Epithelial(75;0.115)|OV - Ovarian serous cystadenocarcinoma(76;0.186)		Ovarian(39;850 945 2785 23371 33093)	KNOWN			GGCAGAAAATTGAGGATGTGG						ENST00000381486.2:c.3021T>C	2					breast(3)|central_nervous_system(2)|endometrium(2)|kidney(4)|large_intestine(9)|lung(9)|ovary(1)		+		,		2p25.1	A6NHD0|A6NKN0|B5MDA9|O60321|Q7Z5S2|Q9H2Q6|Q9H2Q7|Q9H2Q8	"""gene regulated by estrogen in breast cancer"""	g.chr2:11752635T>C					no		12008,176												-11.4					0.0					hg19	Standard	0.996			8267,23			5923,162,7					CCDS33146.1, CCDS33147.1, CCDS42655.1	T		CC,CT,TT		integral component of membrane (GO:0016021)	138		2504		rs2304399		3321									1007	KIAA0575		30	NM_014668		19			ENST00000381486.2		17977		uc002rbk.1			9687	dbSNP_100	3021			p.I1007I		0				140.0		0.547	2:g.11752635T>C		protein_coding			basic|appris_principal|CCDS		4122,23,0			3741,153			C|||			5008		GREB1_HUMAN	4890	growth regulation by estrogen in breast cancer 1			0.976438		11752635			0.9762	SNP		CCDS42655.1			,,,	False	11752635				synonymous_variant		Approved		138.0		c.3021T>C	2010-02-17	OTTHUMT00000280490.1	Q4ZG55	0.987		GREB1	11752635		all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			GREB1	NM_014668.3	protein-coding gene	NP_055483.2		
		A	ENSG00000196208	ENST00000381486.2	0.53688	9687	N	ENSG00000196208	0.08831	4250	0.861000	0.40756	B		,	T	2.199999999996649E-5	0	c.(5059-5061)Gac>Aac	OTTHUMG00000141276	-0.305000	byFrequency	Q4ZG55	gene with protein product		GREB1_ENST00000234142.5_Missense_Mutation_p.D1687N|GREB1_ENST00000396123.1_Missense_Mutation_p.D685N		NM_014668.3	399,1017,725	NM_014668	0.4509			A	2.656	+	Missense_Mutation	1		96.0	Q4ZG55	0.423867		11103799			0.002	GREB1-001	2009-09-10		0.06405		2	+	0.4213		0.99	0.137000	missense	24885	141	1687/1950		A	SO:0001583	611736	benign	0.38950276243093923	protein_coding		2141	P		0.523000	49.4,42.3867,47.8485	B		6391		0.6384:0.0:0.3616:0.0			Epithelial(75;0.115)|OV - Ovarian serous cystadenocarcinoma(76;0.186)		Ovarian(39;850 945 2785 23371 33093)	KNOWN	ENST00000381486;ENST00000234142;ENST00000396123		GGCGGCCCCCGACATCATGCA	T;T;T					ENST00000381486.2:c.5059G>A	2		ENSG00000196208	0.04368	GREB1	breast(3)|central_nervous_system(2)|endometrium(2)|kidney(4)|large_intestine(9)|lung(9)|ovary(1)	ENSP00000370896:p.Asp1687Asn	+	0.26274	,	GAC	2p25.1	A6NHD0|A6NKN0|B5MDA9|O60321|Q7Z5S2|Q9H2Q6|Q9H2Q7|Q9H2Q8	"""gene regulated by estrogen in breast cancer"""	g.chr2:11774324G>A	D -> N (in dbSNP:rs2304402). {ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5}.			223	yes		6116,6666	0.33841	0.05642	5.01	0.00012	ENSP00000234142:D1687N			0.42053		-24.3036		1.2	0.20885	176	0.05351	0.3076923076923077	0.9		-0.455			hg19	Standard	0.4771	0.4532520325203252	9.4069	4301,4199			1516,3084,1791	-0.280878				CCDS33146.1, CCDS33147.1, CCDS42655.1	G	0.06786	AA,AG,GG		integral component of membrane (GO:0016021)	94	0.02960	2504	1.17	rs2304402		5359	1687	353			0.38466	11691775	+	ASN/ASP	1687	KIAA0575	893	30	NM_014668	0.001	29	0.4656992084432718	-0.521000	ENST00000381486.2		19371		uc002rbk.1			9687	dbSNP_100	5059	0.0000		p.D1687N	.	0		T		88.0	rs2304402;rs17602548;rs58433267;rs2304402	0.617	2:g.11774324G>A	ENSP00000370896:D1687N;ENSP00000234142:D1687N;ENSP00000379429:D685N	protein_coding	0.000763		basic|appris_principal|CCDS		1117,2067,1066		1687;1687;685	1815,2467	0.4088827838827839	N	A|||		0.250963	5008		GREB1_HUMAN	2028	growth regulation by estrogen in breast cancer 1		GREB1_HUMAN	0.404952	0.32479	11774324		1.219000	0.2996	SNP		CCDS42655.1		N	,,,	False	11774324	-0.9125		9	missense	T	Approved	0.506	94.0		c.5059G>A	2010-02-17	OTTHUMT00000280490.1	Q4ZG55	0.3573	1.02;1.02;1.02	GREB1	11774324	0.21094	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)	0.47341	23	GREB1	NM_014668.3	protein-coding gene	NP_055483.2	D	
		T	ENSG00000151779	ENST00000281513.5		51594		ENSG00000151779		4300					,					OTTHUMG00000121153		byFrequency	A2RRP1	gene with protein product		NBAS_ENST00000441750.1_Intron		NM_015909.3	1173,871,159	NM_015909	0.6278					+	Intron		609.6+/-395.6	61.0				9926938, 12706883				NBAS-001					2	-	0.7935				intron	15625				T	SO:0001627	608025			protein_coding		2203				44.6279,26.9859,45.7558			6503								KNOWN			ACTCTGCTCAATAATAAGCTG						ENST00000281513.5:c.4797+28T>A	2					NS(4)|breast(4)|central_nervous_system(3)|endometrium(6)|kidney(5)|large_intestine(12)|liver(1)|lung(54)|ovary(2)|pancreas(3)|prostate(9)|skin(6)|stomach(3)		-		,		2p24.3	O95790|Q2VPJ7|Q53TK6|Q86V39|Q8NFY8|Q9Y3W5		g.chr2:15448311A>T		413.0+/-336.3			no		7055,5951												1.3					0.0					hg19	Standard	0.4334			3838,4762		negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)|nuclear-transcribed mRNA catabolic process (GO:0000956)	2036,2983,1484					CCDS1685.1	A		TT,TA,AA	BC051792	cytoplasm (GO:0005737)|membrane (GO:0016020)	60		2504		rs1318102		4823										NAG		112	NM_015909		40			ENST00000281513.5		19184		uc002rcc.2			51594	dbSNP_88						0				59.0		0.403	2:g.15448311A>T		protein_coding			basic|appris_principal|CCDS		863,2112,1325			3217,1189			T|||			5008		NBAS_HUMAN	3347	neuroblastoma amplified sequence			0.668331		15448311			0.8601	SNP		CCDS1685.1			,,,	False	15448311				intron_variant		Approved		60.0			2009-02-23	OTTHUMT00000241638.1	A2RRP1	0.549		NBAS	15448311					NBAS	NM_015909.2	protein-coding gene	NP_056993.2		
		C	ENSG00000079785	ENST00000381341.2		1653		ENSG00000079785		4300					,				c.(103-105)Ttg>Ctg	OTTHUMG00000090593		byFrequency	Q92499	gene with protein product		DDX1_ENST00000233084.3_Silent_p.L35L			8,256,1939	NM_004939	0.2035					+	Silent		301.6+/-305.5	122.0				1552844, 19058135				DDX1-001	2012-02-23				2	+	0.0333				coding-synonymous	2734		35/741	all_epithelial(98;2.96e-07)|Acute lymphoblastic leukemia(84;4.24e-05)|Ovarian(717;0.0694)	T	SO:0001819	601257			protein_coding		2203				18.8837,6.1734,14.5779		"""DEAD-boxes"""	6503					Epithelial(75;4.35e-05)|OV - Ovarian serous cystadenocarcinoma(76;0.133)			KNOWN			ATCTATCCCATTGATCTTAGG						ENST00000381341.2:c.103T>C	2	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.|Necessary for interaction with HNRNPK.|Necessary for interaction with RELA.				autonomic_ganglia(1)|breast(1)|central_nervous_system(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(4)|lung(13)|ovary(1)|stomach(1)|upper_aerodigestive_tract(1)		+		,		2p24	B4DME8|B4DPN6		g.chr2:15735648T>C		154.0+/-187.5			no		1896,11110												-5.1					0.0	ATP binding (GO:0005524)|ATP-dependent helicase activity (GO:0008026)|chromatin binding (GO:0003682)|DNA binding (GO:0003677)|DNA/RNA helicase activity (GO:0033677)|double-stranded RNA binding (GO:0003725)|exonuclease activity (GO:0004527)|nuclease activity (GO:0004518)|poly(A) binding (GO:0008143)|poly(A) RNA binding (GO:0044822)|RNA helicase activity (GO:0003724)|transcription cofactor activity (GO:0003712)				hg19	Standard	0.164			1624,6976		ATP catabolic process (GO:0006200)|DNA duplex unwinding (GO:0032508)|double-strand break repair (GO:0006302)|multicellular organismal development (GO:0007275)|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|regulation of transcription, DNA-templated (GO:0006355)|regulation of translational initiation (GO:0006446)|response to exogenous dsRNA (GO:0043330)|response to virus (GO:0009615)|spliceosomal complex assembly (GO:0000245)|transcription, DNA-templated (GO:0006351)|tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	170,1556,4777					CCDS1686.1	T		CC,CT,TT	X70649	cleavage body (GO:0071920)|cytoplasm (GO:0005737)|cytoplasmic stress granule (GO:0010494)|membrane (GO:0016020)|nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)|tRNA-splicing ligase complex (GO:0072669)	125		2504		rs2302929		492				"""DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 1"", ""DEAD (Asp-Glu-Ala-Asp) box polypeptide 1"""					35	DBP-RB		29	NM_004939		4			ENST00000381341.2		18132		uc002rce.4			1653	dbSNP_100	103			p.L35L		0				130.0		0.383	2:g.15735648T>C		protein_coding			basic|appris_principal|CCDS		162,1300,2838			272,4134			T|||			5008		DDX1_HUMAN	876	DEAD (Asp-Glu-Ala-Asp) box helicase 1			0.17492		15735648	GBM - Glioblastoma multiforme(3;0.00969)		0.371	SNP		CCDS1686.1			,,,	False	15735648				synonymous_variant		Approved		125.0		c.103T>C	2012-02-23	OTTHUMT00000207141.2	Q92499	0.1354		DDX1	15735648		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.197)			DDX1	NM_004939.1	protein-coding gene			
		T	ENSG00000079785	ENST00000381341.2		1653		ENSG00000079785		4300					,				c.(910-912)aaC>aaT	OTTHUMG00000090593		byFrequency	Q92499	gene with protein product		DDX1_ENST00000233084.3_Silent_p.N304N			1439,686,78	NM_004939	0.7791					+	Silent		525.0+/-380.7	95.0				1552844, 19058135				DDX1-001	2012-02-23				2	+	0.8389				coding-synonymous	2734		304/741	all_epithelial(98;2.96e-07)|Acute lymphoblastic leukemia(84;4.24e-05)|Ovarian(717;0.0694)	T	SO:0001819	601257			protein_coding		2203				42.5116,19.1103,34.584		"""DEAD-boxes"""	6503					Epithelial(75;4.35e-05)|OV - Ovarian serous cystadenocarcinoma(76;0.133)			KNOWN			AAACTTTGAACAACATCAAGC						ENST00000381341.2:c.912C>T	2	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.|Necessary for interaction with RELA.				autonomic_ganglia(1)|breast(1)|central_nervous_system(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(4)|lung(13)|ovary(1)|stomach(1)|upper_aerodigestive_tract(1)		+		,		2p24	B4DME8|B4DPN6		g.chr2:15747393C>T		332.5+/-302.5			no		8508,4498												-0.7					1.0	ATP binding (GO:0005524)|ATP-dependent helicase activity (GO:0008026)|chromatin binding (GO:0003682)|DNA binding (GO:0003677)|DNA/RNA helicase activity (GO:0033677)|double-stranded RNA binding (GO:0003725)|exonuclease activity (GO:0004527)|nuclease activity (GO:0004518)|poly(A) binding (GO:0008143)|poly(A) RNA binding (GO:0044822)|RNA helicase activity (GO:0003724)|transcription cofactor activity (GO:0003712)				hg19	Standard	0.5497			4944,3656		ATP catabolic process (GO:0006200)|DNA duplex unwinding (GO:0032508)|double-strand break repair (GO:0006302)|multicellular organismal development (GO:0007275)|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|regulation of transcription, DNA-templated (GO:0006355)|regulation of translational initiation (GO:0006446)|response to exogenous dsRNA (GO:0043330)|response to virus (GO:0009615)|spliceosomal complex assembly (GO:0000245)|transcription, DNA-templated (GO:0006351)|tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	2844,2820,839					CCDS1686.1	C		TT,TC,CC	X70649	cleavage body (GO:0071920)|cytoplasm (GO:0005737)|cytoplasmic stress granule (GO:0010494)|membrane (GO:0016020)|nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)|tRNA-splicing ligase complex (GO:0072669)	95		2504		rs10929378		1301				"""DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 1"", ""DEAD (Asp-Glu-Ala-Asp) box polypeptide 1"""					304	DBP-RB		29	NM_004939		14			ENST00000381341.2		16576		uc002rce.4			1653	dbSNP_120	912			p.N304N		0				96.0		0.373	2:g.15747393C>T		protein_coding			basic|appris_principal|CCDS		1405,2134,761			3564,842			T|||			5008		DDX1_HUMAN	3730	DEAD (Asp-Glu-Ala-Asp) box helicase 1			0.744808		15747393	GBM - Glioblastoma multiforme(3;0.00969)		0.869	SNP		CCDS1686.1			,,,	False	15747393				synonymous_variant		Approved		95.0		c.912C>T	2012-02-23	OTTHUMT00000207141.2	Q92499	0.6196		DDX1	15747393		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.197)			DDX1	NM_004939.1	protein-coding gene			
		G	ENSG00000079785	ENST00000381341.2		1653		ENSG00000079785		4299					,					OTTHUMG00000090593		byFrequency	Q92499	gene with protein product		DDX1_ENST00000233084.3_Intron			15,294,1894	NM_004939	0.1677					+	Intron		473.1+/-368.5	74.0				1552844, 19058135				DDX1-001	2012-02-23				2	+	0.0144				intron	2734			all_epithelial(98;2.96e-07)|Acute lymphoblastic leukemia(84;4.24e-05)|Ovarian(717;0.0694)	C	SO:0001627	601257			protein_coding		2203				36.3689,7.3536,26.538		"""DEAD-boxes"""	6502					Epithelial(75;4.35e-05)|OV - Ovarian serous cystadenocarcinoma(76;0.133)			KNOWN			TTGTAGGGCTCTATTATATTC						ENST00000381341.2:c.1875+18C>G	2					autonomic_ganglia(1)|breast(1)|central_nervous_system(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(4)|lung(13)|ovary(1)|stomach(1)|upper_aerodigestive_tract(1)		+		,		2p24	B4DME8|B4DPN6		g.chr2:15768981C>G		169.1+/-199.8			no		3451,9553												-3.5					0.0	ATP binding (GO:0005524)|ATP-dependent helicase activity (GO:0008026)|chromatin binding (GO:0003682)|DNA binding (GO:0003677)|DNA/RNA helicase activity (GO:0033677)|double-stranded RNA binding (GO:0003725)|exonuclease activity (GO:0004527)|nuclease activity (GO:0004518)|poly(A) binding (GO:0008143)|poly(A) RNA binding (GO:0044822)|RNA helicase activity (GO:0003724)|transcription cofactor activity (GO:0003712)				hg19	Standard	0.3887			3127,5471		ATP catabolic process (GO:0006200)|DNA duplex unwinding (GO:0032508)|double-strand break repair (GO:0006302)|multicellular organismal development (GO:0007275)|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|regulation of transcription, DNA-templated (GO:0006355)|regulation of translational initiation (GO:0006446)|response to exogenous dsRNA (GO:0043330)|response to virus (GO:0009615)|spliceosomal complex assembly (GO:0000245)|transcription, DNA-templated (GO:0006351)|tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	568,2315,3619					CCDS1686.1	C		GG,GC,CC	X70649	cleavage body (GO:0071920)|cytoplasm (GO:0005737)|cytoplasmic stress granule (GO:0010494)|membrane (GO:0016020)|nucleus (GO:0005634)|ribonucleoprotein complex (GO:0030529)|tRNA-splicing ligase complex (GO:0072669)	74		2504		rs62122280		2264				"""DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 1"", ""DEAD (Asp-Glu-Ala-Asp) box polypeptide 1"""						DBP-RB		29	NM_004939		24			ENST00000381341.2		15597		uc002rce.4			1653	dbSNP_129						0				74.0		0.343	2:g.15768981C>G		protein_coding			basic|appris_principal|CCDS		553,2021,1725			324,4082			C|||			5008		DDX1_HUMAN	793	DEAD (Asp-Glu-Ala-Asp) box helicase 1			0.158347		15768981	GBM - Glioblastoma multiforme(3;0.00969)		0.0149	SNP		CCDS1686.1			,,,	False	15768981				intron_variant		Approved		74.0			2012-02-23	OTTHUMT00000207141.2	Q92499	0.2939		DDX1	15768981		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.197)			DDX1	NM_004939.1	protein-coding gene			
		T	ENSG00000214842	ENST00000399080.2	0.80722	729475	N	ENSG00000214842	0.21394	4091	0.002000	0.32515	B		,	T	0.0	0	c.(3109-3111)gGt>gAt	OTTHUMG00000151761	0.246000	byFrequency	Q09MP3	gene with protein product				NM_001099218.2	136,683,1018	NM_001099218	0.7955			C	8.123	+	Missense_Mutation	2		138.0	Q09MP3	0.259935		16990250			0.063	RAD51AP2-002			0.25759		2	-	0.1339		0.28	0.043000	missense	34417	220	1037/1160		C	SO:0001583		probably-damaging	0.6077348066298343	protein_coding		1837	P		0.000000	37.5458,25.9935,48.8445	B		5928		0.0:0.5727:0.1336:0.2937						KNOWN	ENST00000399080		CATATTAGGACCTGCTATAGT	T					ENST00000399080.2:c.3110G>A	2		ENSG00000214842	0.94253	RAD51AP2	endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(10)|liver(1)|lung(17)|ovary(1)|pancreas(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	ENSP00000382030:p.Gly1037Asp	-	0.05858	,	GGT	2p24.2			g.chr2:17696573C>T	G -> D (in dbSNP:rs834514).			85	yes		6065,5791	0.10522	0.16120	5.15	0.00012	ENSP00000382030:G1037D			.		-0.2348		2.3	0.28610	500	0.30078	0.8741258741258742	0.0		0.205			hg19	Standard	0.6183	0.17276422764227642	5.6724	5110,3072			1741,2583,1604	0.781475				CCDS42656.1	C	0.23540	TT,TC,CC	AK310498		142	0.12182	2504	2.29	rs834514		3133	1037	459			0.17729	17560054	-	ASP/GLY	1037	FLJ17540	1264	49	NM_001099218	0.087	1	0.6055408970976254	0.655000	ENST00000399080.2		19259		uc002rcl.1			729475	dbSNP_86	3110	0.0000		p.G1037D	.	0		T		151.0	rs834514;rs1619596;rs2139384;rs17380198;rs52804587;rs834514	0.358	2:g.17696573C>T	ENSP00000382030:G1037D	protein_coding	.		basic|appris_principal|CCDS		1605,1900,586		1037	955,2719	0.5787545787545788	D	C|||		.	5008		R51A2_HUMAN	2908	RAD51 associated protein 2		R51A2_HUMAN	0.580671	0.19540	17696573		0.320000	0.8849	SNP		CCDS42656.1		.	,,,	False	17696573	-1.0709		8	missense	T	Approved	0.624542	142.0		c.3110G>A	2009-01-13	OTTHUMT00000323801.3	Q09MP3	0.6326	1.45	RAD51AP2	17696573	0.13939	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.08700	94	RAD51AP2	NM_001099218.2	protein-coding gene	NP_001092688.1	G	
		G	ENSG00000214842	ENST00000399080.2		729475		ENSG00000214842		4080					,				c.(1003-1005)agT>agC	OTTHUMG00000151761		byFrequency	Q09MP3	gene with protein product				NM_001099218.2	167,719,928	NM_001099218	0.8027					+	Silent			68.0				16990250				RAD51AP2-002					2	-	0.1611				coding-synonymous	34417		335/1160		G	SO:0001819				protein_coding		1814				34.1544,29.0243,45.4869			5894								KNOWN			TATTTTGGCTACTGAGTGATG						ENST00000399080.2:c.1005T>C	2					endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(10)|liver(1)|lung(17)|ovary(1)|pancreas(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2)		-		,		2p24.2			g.chr2:17698678A>G					no		6426,5362												1.7					0.2					hg19	Standard	0.6491			5373,2787			1940,2546,1408					CCDS42656.1	A		GG,GA,AA	AK310498		69		2504		rs665312		1028									335	FLJ17540		49	NM_001099218		1			ENST00000399080.2		19036		uc002rcl.1			729475	dbSNP_83	1005			p.S335S		0				74.0		0.338	2:g.17698678A>G		protein_coding			basic|appris_principal|CCDS		1773,1827,480			1053,2575			G|||			5008		R51A2_HUMAN	2999	RAD51 associated protein 2			0.598842		17698678			0.8839	SNP		CCDS42656.1			,,,	False	17698678				synonymous_variant		Approved		69.0		c.1005T>C	2009-01-13	OTTHUMT00000323801.3	Q09MP3	0.6585		RAD51AP2	17698678		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)			RAD51AP2	NM_001099218.2	protein-coding gene	NP_001092688.1		
		A	ENSG00000163032	ENST00000406397.1		7447		ENSG00000163032		4300					,					OTTHUMG00000090645		byFrequency	P62760	gene with protein product		VSNL1_ENST00000295156.4_Intron|VSNL1_ENST00000404666.2_Intron			421,1111,671	NM_003385	0.8773					+	Intron		420.9+/-353.5	91.0				8530085, 2202488				VSNL1-002					2	+	0.3691				intron	12722				A	SO:0001627	600817			protein_coding		2203				30.1279,44.3259,38.7821		"""EF-hand domain containing"""	6503								KNOWN			TTTCAACCTTGTTTTTATTCC						ENST00000406397.1:c.162+21G>A	2					NS(1)|breast(1)|kidney(1)|lung(7)|ovary(1)|skin(1)|urinary_tract(1)		+		,		2p24.3	D6W515|P28677|P29103|P42323|Q9UM20	"""hippocalcin-like protein 3"""	g.chr2:17773524G>A		622.4+/-393.9			no		7962,5044												-3.9					0.0	calcium ion binding (GO:0005509)				hg19	Standard	0.6918			6009,2591		calcium-mediated signaling (GO:0019722)	2506,2950,1047					CCDS1689.1	G		AA,AG,GG			93		2504		rs2680827		687										VILIP, HPCAL3, HUVISL1, HLP3, VILIP-1		13	NM_003385		2			ENST00000406397.1		18876		uc002rcm.3			7447	dbSNP_100						0				96.0		0.398	2:g.17773524G>A		protein_coding			not_organism_supported|basic|appris_principal|CCDS		2085,1839,376			1953,2453			A|||			5008		VISL1_HUMAN	3527	visinin-like 1			0.704273		17773524			0.9881	SNP		CCDS1689.1			,,,	False	17773524				intron_variant		Approved		93.0			2013-01-10	OTTHUMT00000323803.1	P62760	0.7046		VSNL1	17773524		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)			VSNL1	NM_003385.4	protein-coding gene			
		A	ENSG00000163029	ENST00000448223.2		79677		ENSG00000163029		4300					,					OTTHUMG00000090675		byFrequency	Q96SB8	gene with protein product		SMC6_ENST00000402989.1_Intron|SMC6_ENST00000381272.4_Intron|SMC6_ENST00000351948.4_Intron		NM_001142286.1	1285,779,138	NM_024624	0.1912					+	Intron		610.6+/-395.7	110.0				11230166				SMC6-002	2006-07-06				2	-	0.8691				intron,intron	20466		,		A	SO:0001627	609387	,		protein_coding		2202				44.3953,23.9555,44.8862		"""Structural maintenance of chromosomes proteins"""	6502								KNOWN			cagtgggaatgATACAGTAAA		SMC6L1				ENST00000448223.2:c.2006+28C>T	2					NS(1)|biliary_tract(1)|breast(6)|central_nervous_system(4)|cervix(1)|endometrium(4)|kidney(6)|large_intestine(3)|lung(13)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)		-		,		2p24.3	A8K8Q6|D6W518|Q05BV4|Q9H0X3|Q9H6M0		g.chr2:17888457G>A		382.8+/-324.6			no		7167,5837												1.5					0.0	ATP binding (GO:0005524)		2006-07-06		hg19	Standard	0.4384			3818,4782		cellular senescence (GO:0090398)|double-strand break repair via homologous recombination (GO:0000724)|telomere maintenance via recombination (GO:0000722)	2150,2867,1485					CCDS1690.1	G		AA,AG,GG	AJ310551	chromosome, telomeric region (GO:0000781)|intracellular (GO:0005622)|nucleolus (GO:0005730)|nucleus (GO:0005634)|PML body (GO:0016605)|Smc5-Smc6 complex (GO:0030915)	108		2504		rs6734462		2276				"""SMC6 structural maintenance of chromosomes 6-like 1 (yeast)"""				,		FLJ22116		43	NM_024624		18			ENST00000448223.2		19811		uc002rcn.3			79677	dbSNP_116	,					0				105.0		0.378	2:g.17888457G>A		protein_coding			basic|appris_principal|CCDS		865,2088,1347			3349,1055			A|||			5008		SMC6_HUMAN	2106	structural maintenance of chromosomes 6			0.420527		17888457			0.0804	SNP		CCDS1690.1			,,,	False	17888457				intron_variant		Approved		108.0			2008-02-05	OTTHUMT00000207359.1	Q96SB8	0.3573		SMC6	17888457		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)		,	SMC6	NM_001142286.1,NM_024624.5	protein-coding gene	NP_001135758.1		
		G	ENSG00000163029	ENST00000448223.2		79677		ENSG00000163029		4300					,					OTTHUMG00000090675		byFrequency	Q96SB8	gene with protein product		SMC6_ENST00000351948.4_Intron|SMC6_ENST00000381272.4_Intron|SMC6_ENST00000402989.1_Intron		NM_001142286.1	128,792,1282	NM_024624	0.1012					+	Intron		200.4+/-244.2	126.0				11230166				SMC6-002	2006-07-06				2	-	0.2496				intron,intron	20466		,		G	SO:0001627	609387	,		protein_coding		2202				10.4767,23.7965,14.9877		"""Structural maintenance of chromosomes proteins"""	6502								KNOWN			CACATAGATACGTGAACAAGT		SMC6L1				ENST00000448223.2:c.846+27G>C	2					NS(1)|biliary_tract(1)|breast(6)|central_nervous_system(4)|cervix(1)|endometrium(4)|kidney(6)|large_intestine(3)|lung(13)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)		-		,		2p24.3	A8K8Q6|D6W518|Q05BV4|Q9H0X3|Q9H6M0		g.chr2:17902381C>G		378.5+/-322.9			no		1949,11055												-10.3					0.0	ATP binding (GO:0005524)		2006-07-06		hg19	Standard	0.1083			901,7699		cellular senescence (GO:0090398)|double-strand break repair via homologous recombination (GO:0000724)|telomere maintenance via recombination (GO:0000722)	176,1597,4729					CCDS1690.1	C		GG,GC,CC	AJ310551	chromosome, telomeric region (GO:0000781)|intracellular (GO:0005622)|nucleolus (GO:0005730)|nucleus (GO:0005634)|PML body (GO:0016605)|Smc5-Smc6 complex (GO:0030915)	126		2504		rs11897477		1116				"""SMC6 structural maintenance of chromosomes 6-like 1 (yeast)"""				,		FLJ22116		43	NM_024624		10			ENST00000448223.2		16843		uc002rcn.3			79677	dbSNP_120	,					0				126.0		0.294	2:g.17902381C>G		protein_coding			basic|appris_principal|CCDS		48,805,3447			1048,3356			c|||			5008		SMC6_HUMAN	652	structural maintenance of chromosomes 6			0.130192		17902381			0.0337	SNP		CCDS1690.1			,,,	False	17902381				intron_variant		Approved		126.0			2008-02-05	OTTHUMT00000207359.1	Q96SB8	0.1153		SMC6	17902381		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)		,	SMC6	NM_001142286.1,NM_024624.5	protein-coding gene	NP_001135758.1		
		A	ENSG00000178295	ENST00000381254.2	0.58432	348654	N	ENSG00000178295	0.12775	4300	0.898000	0.62941	B		,	T	1.0000000000287557E-6	0	c.(274-276)Tct>Act	OTTHUMG00000121173	-0.076000	byFrequency	Q17RS7	gene with protein product		GEN1_ENST00000317402.7_Missense_Mutation_p.S92T|SMC6_ENST00000402989.1_Intron		NM_001130009.1	1278,791,134	NM_182625	0.8978			A	2.445	+	Missense_Mutation	1	487.0+/-372.0	90.0	Q17RS7	0.759646		15576351		Homologous recombination	0.002	GEN1-201	2013-06-04		0.06405		2	+	0.7708		0.64	0.215000	missense,missense	26881	271	92/909,92/909		A	SO:0001583	612449	benign,benign	0.7486187845303868	protein_coding		2203	P		0.189000	37.407,24.0354,32.8771	B		6503		0.6128:0.0:0.2761:0.1111						KNOWN	ENST00000317402;ENST00000381254;ENST00000524465;ENST00000532257		GAGGAATCAGTCTCGGTATGG	T;T;T;T					ENST00000381254.2:c.274T>A	2	N-domain.	ENSG00000178295	0.10917	GEN1	breast(6)|central_nervous_system(1)|kidney(1)|large_intestine(3)|ovary(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000370653:p.Ser92Thr	+	0.23263	,	TCT	2p24.2	Q17RS9|Q6ZN37	"""Holliday junction resolvase"""	g.chr2:17942775T>A	S -> T (in dbSNP:rs1812152). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	386.3+/-326.1		393	yes		8730,4276	0.35279	0.05314	5.35	0.00012	ENSP00000318977:S92T			0.20871		-3.1421		0.3	0.15908	559	0.11794	0.9772727272727273	0.9	crossover junction endodeoxyribonuclease activity (GO:0008821)|DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-0.47			hg19	Standard	0.6382	0.7987804878048781	6.29	5383,3217		DNA catabolic process, endonucleolytic (GO:0000737)|double-strand break repair via homologous recombination (GO:0000724)|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|regulation of centrosome duplication (GO:0010824)|resolution of mitotic recombination intermediates (GO:0071140)|resolution of recombination intermediates (GO:0071139)	2949,2832,722	-0.327812				CCDS1691.1	T	0.02656	AA,AT,TT	AK098188	centrosome (GO:0005813)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	89	0.02865	2504	0.326	rs1812152		488	92	493		"""Gen endonuclease homolog 1 (Drosophila)"""	0.21054	17806256	+	THR/SER,THR/SER	92	FLJ40869, Gen	1716	16	NM_182625	0.0	3	0.6503957783641161	-0.257000	ENST00000381254.2		16335		uc002rct.2			348654	dbSNP_92	274,274	0.0000		p.S92T	XPG N-terminal (2);	0		T		88.0	rs1812152;rs17315562;rs52822022;rs56931969;rs1812152	0.388	2:g.17942775T>A	ENSP00000318977:S92T;ENSP00000370653:S92T;ENSP00000435143:S92T;ENSP00000433180:S92T	protein_coding	0.084169		basic|appris_principal|CCDS		1671,2041,588		92	3347,1059	0.7857142857142857	T	A|||		0.471865	5008		GEN_HUMAN	4075	GEN1 Holliday junction 5' flap endonuclease		GEN_HUMAN	0.813698	0.23608	17942775		0.567000	0.9861	SNP		CCDS1691.1		N	,,,	False	17942775	-1.0053		9	missense	T	Approved	0.62593	89.0		c.274T>A	2013-06-04	OTTHUMT00000241661.2	Q17RS7	0.781	-0.01;-0.01;-0.01;-0.01	GEN1	17942775	0.24574	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.28138	58,58	GEN1	NM_001130009.1,NM_182625.3	protein-coding gene	NP_001123481.1	S	
		G	ENSG00000178295	ENST00000381254.2	0.32686	348654	L	ENSG00000178295	0.26365	4300	0.414000	0.70045	P		,	D	0.514775	0	c.(427-429)aAt>aGt	OTTHUMG00000121173	0.435000	byFrequency	Q17RS7	gene with protein product		GEN1_ENST00000317402.7_Missense_Mutation_p.N143S|SMC6_ENST00000402989.1_Intron		NM_001130009.1	116,776,1311	NM_182625	0.0992			A	15.82	+	Missense_Mutation	2	198.3+/-242.7	169.0	Q17RS7	0.228779		15576351		Homologous recombination	0.553	GEN1-201	2013-06-04		0.47645		2	+	0.2436		0.03	0.187000	missense,missense	26881	43	143/909,143/909		A	SO:0001583	612449	probably-damaging,probably-damaging	0.11878453038674033	protein_coding		2203	P		1.000000	10.2674,22.8779,14.5394	P		6503		0.8125:0.0:0.066:0.1215						KNOWN	ENST00000317402;ENST00000381254		GCTTATCTCAATGCTGGTGGT	T;T					ENST00000381254.2:c.428A>G	2	I-domain.	ENSG00000178295	0.06932	GEN1	breast(6)|central_nervous_system(1)|kidney(1)|large_intestine(3)|ovary(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000370653:p.Asn143Ser	+	0.71417	,	AAT	2p24.2	Q17RS9|Q6ZN37	"""Holliday junction resolvase"""	g.chr2:17946243A>G	N -> S (in dbSNP:rs16981869).	374.9+/-321.4		131	yes		1891,11115	0.26521	0.53079	5.71	0.00012	ENSP00000318977:N143S			0.29916		-19.2167		3.3	0.38043	17	0.62326	0.02972027972027972	0.4	crossover junction endodeoxyribonuclease activity (GO:0008821)|DNA binding (GO:0003677)|metal ion binding (GO:0046872)	1.18			hg19	Standard	0.1074	0.266260162601626	8.0275	883,7717		DNA catabolic process, endonucleolytic (GO:0000737)|double-strand break repair via homologous recombination (GO:0000724)|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|regulation of centrosome duplication (GO:0010824)|resolution of mitotic recombination intermediates (GO:0071140)|resolution of recombination intermediates (GO:0071139)	160,1571,4772	2.946009				CCDS1691.1	A	0.43607	GG,GA,AA	AK098188	centrosome (GO:0005813)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	177	0.38953	2504	3.32	rs16981869		642	143	87		"""Gen endonuclease homolog 1 (Drosophila)"""	0.30446	17809724	+	SER/ASN,SER/ASN	143	FLJ40869, Gen	278	16	NM_182625	0.812	4	0.11477572559366754	-0.377000	ENST00000381254.2		17240		uc002rct.2			348654	dbSNP_123	428,428	0.0000		p.N143S	XPG/RAD2 endonuclease (2);	0		T		193.0	rs16981869;rs52837398;rs16981869	0.483	2:g.17946243A>G	ENSP00000318977:N143S;ENSP00000370653:N143S	protein_coding	0.010865		basic|appris_principal|CCDS		44,795,3461		143	1008,3398	0.12728937728937728	S	A|||		0.296777	5008		GEN_HUMAN	641	GEN1 Holliday junction 5' flap endonuclease		GEN_HUMAN	0.127995	0.75606	17946243		6.885000	0.0337	SNP		CCDS1691.1		N	,,,	False	17946243	-1.0832		9	missense	T	Approved	0.102674	177.0		c.428A>G	2013-06-04	OTTHUMT00000241661.2	Q17RS7	0.1153	-0.45;-0.45	GEN1	17946243	0.23431	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.06338	46,46	GEN1	NM_001130009.1,NM_182625.3	protein-coding gene	NP_001123481.1	N	
		A	ENSG00000178295	ENST00000381254.2	0.80722	348654	N	ENSG00000178295	0.00167	4300	0.000000	0.48522	B		,	T	0.0	0	c.(928-930)aGt>aAt	OTTHUMG00000121173	-3.417000	byFrequency	Q17RS7	gene with protein product		GEN1_ENST00000317402.7_Missense_Mutation_p.S310N|SMC6_ENST00000402989.1_Intron		NM_001130009.1	1996,202,5	NM_182625	0.9663			G	1.940	+	Missense_Mutation	2	817.2+/-406.9	74.0	Q17RS7	0.951884		15576351		Homologous recombination	0.001	GEN1-201	2013-06-04		0.04013		2	+	0.9387		0.44	0.025000	missense,missense	26881	361	310/909,310/909		G	SO:0001583	612449	benign,benign	0.9972375690607734	protein_coding		2203	P		0.000000	0.0233,4.8116,1.6454	B		6503		0.3852:0.0687:0.4255:0.1206						KNOWN	ENST00000317402;ENST00000381254;ENST00000528873		AGGCAACTCAGTGAAGTAGAG	T;T;T					ENST00000381254.2:c.929G>A	2		ENSG00000178295	0.00055	GEN1	breast(6)|central_nervous_system(1)|kidney(1)|large_intestine(3)|ovary(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000370653:p.Ser310Asn	+	0.05858	,	AGT	2p24.2	Q17RS9|Q6ZN37	"""Holliday junction resolvase"""	g.chr2:17954027G>A	S -> N (in dbSNP:rs300175). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	804.8+/-415.8		468	yes		12792,214	0.03702	0.04604	5.63	0.00012	ENSP00000318977:S310N			0.03723		0.0746		-11.3	0.00108	572	0.20046	1.0	0.0	crossover junction endodeoxyribonuclease activity (GO:0008821)|DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-0.895			hg19	Standard	1.0	0.9512195121951219	6.7358	8598,2		DNA catabolic process, endonucleolytic (GO:0000737)|double-strand break repair via homologous recombination (GO:0000724)|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|regulation of centrosome duplication (GO:0010824)|resolution of mitotic recombination intermediates (GO:0071140)|resolution of recombination intermediates (GO:0071139)	6294,204,5	-0.443742				CCDS1691.1	G	0.06786	AA,AG,GG	AK098188	centrosome (GO:0005813)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	75	0.01352	2504	-11.3	rs300175		1143	310	758		"""Gen endonuclease homolog 1 (Drosophila)"""	0.23409	17817508	+	ASN/SER,ASN/SER	310	FLJ40869, Gen	2159	16	NM_182625	0.001	8	1.0	-3.189000	ENST00000381254.2		17724		uc002rct.2			348654	dbSNP_79	929,929	0.0000		p.S310N	-3&apos (1); exonuclease, C-terminal domain (1);5&apos (1);	0		T		78.0	rs300175;rs61253429;rs300175	0.348	2:g.17954027G>A	ENSP00000318977:S310N;ENSP00000370653:S310N;ENSP00000431542:S81N	protein_coding	0.252200		basic|appris_principal|CCDS		4298,2,0		310;310;81	4194,212	0.9885531135531136	N	G|||		1.560190	5008		GEN_HUMAN	4893	GEN1 Holliday junction 5' flap endonuclease		GEN_HUMAN	0.977037	0.01242	17954027		-2.195000	1.0	SNP		CCDS1691.1		N	,,,	False	17954027	-0.9734		9	missense	T	Approved	0.999767	75.0		c.929G>A	2013-06-04	OTTHUMT00000241661.2	Q17RS7	0.9986	0.81;0.81;0.81	GEN1	17954027	0.11179	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.36768	46,46	GEN1	NM_001130009.1,NM_182625.3	protein-coding gene	NP_001123481.1	S	
		G	ENSG00000178295	ENST00000381254.2		348654		ENSG00000178295		4300					,				c.(1969-1971)gaA>gaG	OTTHUMG00000121173		byFrequency	Q17RS7	gene with protein product		SMC6_ENST00000402989.1_Intron|GEN1_ENST00000317402.7_Silent_p.E657E		NM_001130009.1	148,788,1267	NM_182625	0.7894					+	Silent		585.7+/-391.9	70.0				15576351		Homologous recombination		GEN1-201	2013-06-04				2	+	0.1536				coding-synonymous,coding-synonymous	26881		657/909,657/909		A	SO:0001819	612449	,		protein_coding		2203				48.1628,24.6028,42.6111			6503								KNOWN			TTAGTCCTGAAGAGCATCTAC						ENST00000381254.2:c.1971A>G	2					breast(6)|central_nervous_system(1)|kidney(1)|large_intestine(3)|ovary(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)		+		,		2p24.2	Q17RS9|Q6ZN37	"""Holliday junction resolvase"""	g.chr2:17962450A>G		389.8+/-327.4			no		5542,7464												1.6					1.0	crossover junction endodeoxyribonuclease activity (GO:0008821)|DNA binding (GO:0003677)|metal ion binding (GO:0046872)				hg19	Standard	0.5249			4458,4142		DNA catabolic process, endonucleolytic (GO:0000737)|double-strand break repair via homologous recombination (GO:0000724)|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|regulation of centrosome duplication (GO:0010824)|resolution of mitotic recombination intermediates (GO:0071140)|resolution of recombination intermediates (GO:0071139)	1310,2922,2271					CCDS1691.1	A		GG,GA,AA	AK098188	centrosome (GO:0005813)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	71		2504		rs300168		2185				"""Gen endonuclease homolog 1 (Drosophila)"""				,	657	FLJ40869, Gen		16	NM_182625		14			ENST00000381254.2		19873		uc002rct.2			348654	dbSNP_79	1971,1971			p.E657E		0				72.0		0.363	2:g.17962450A>G		protein_coding			basic|appris_principal|CCDS		1162,2134,1004			1084,3322			A|||			5008		GEN_HUMAN	2874	GEN1 Holliday junction 5' flap endonuclease			0.573882		17962450			0.9226	SNP		CCDS1691.1			,,,	False	17962450				synonymous_variant		Approved		71.0		c.1971A>G	2013-06-04	OTTHUMT00000241661.2	Q17RS7	0.6354		GEN1	17962450		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)		,	GEN1	NM_001130009.1,NM_182625.3	protein-coding gene	NP_001123481.1		
		T	ENSG00000178295	ENST00000381254.2	0.80722	348654	N	ENSG00000178295	0.16863	4300	0.246000	0.21361	B		,	T	0.0	0	c.(2038-2040)aCa>aTa	OTTHUMG00000121173	0.077000	byFrequency	Q17RS7	gene with protein product		SMC6_ENST00000402989.1_Intron|GEN1_ENST00000317402.7_Missense_Mutation_p.T680I		NM_001130009.1	809,1058,336	NM_182625	0.8978			T	0.089	+	Missense_Mutation	2	484.7+/-371.5	68.0	Q17RS7	0.607354		15576351		Homologous recombination	0.0	GEN1-201	2013-06-04		0.01281		2	+	0.5719		0.96	0.862000	missense,missense	26881	263	680/909,680/909		T	SO:0001583	612449	benign,benign	0.7265193370165746	protein_coding		2203	P		0.000000	37.5465,39.2646,38.1286	B		6503		0.3066:0.181:0.1197:0.3926						KNOWN	ENST00000317402;ENST00000381254;ENST00000536097		CGAATATTTACAAAATTATCA	T;T					ENST00000381254.2:c.2039C>T	2		ENSG00000178295	0.11334	GEN1	breast(6)|central_nervous_system(1)|kidney(1)|large_intestine(3)|ovary(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	ENSP00000370653:p.Thr680Ile	+	0.05858	,	ACA	2p24.2	Q17RS9|Q6ZN37	"""Holliday junction resolvase"""	g.chr2:17962518C>T	T -> I (in dbSNP:rs300169). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	511.6+/-367.8		310	yes		8047,4959	0.24233	0.01660	5.41	0.00012	ENSP00000318977:T680I			0.17190		-2.7273		1.2	0.20824	559	0.05620	0.9772727272727273	0.2	crossover junction endodeoxyribonuclease activity (GO:0008821)|DNA binding (GO:0003677)|metal ion binding (GO:0046872)	-1.78			hg19	Standard	0.6372	0.6300813008130082	0.5453	5371,3229		DNA catabolic process, endonucleolytic (GO:0000737)|double-strand break repair via homologous recombination (GO:0000724)|positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)|regulation of centrosome duplication (GO:0010824)|resolution of mitotic recombination intermediates (GO:0071140)|resolution of recombination intermediates (GO:0071139)	2476,3095,932	-1.170832				CCDS1691.1	C	0.02656	TT,TC,CC	AK098188	centrosome (GO:0005813)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	66	0.00246	2504	1.16	rs300169		2253	680	492		"""Gen endonuclease homolog 1 (Drosophila)"""	0.00653	17825999	+	ILE/THR,ILE/THR	680	FLJ40869, Gen	1624	16	NM_182625	0.0	14	0.6490765171503958	-0.254000	ENST00000381254.2		19537		uc002rct.2			348654	dbSNP_79	2039,2039	0.0000		p.T680I	.	0		T		63.0	rs300169;rs52812493;rs61637007;rs300169	0.353	2:g.17962518C>T	ENSP00000318977:T680I;ENSP00000370653:T680I	protein_coding	0.183544		basic|appris_principal|CCDS		1667,2037,596		680;680;317	2676,1730	0.7435897435897436	I	T|||		0.537161	5008		GEN_HUMAN	3796	GEN1 Holliday junction 5' flap endonuclease		GEN_HUMAN	0.757987	0.16860	17962518		0.180000	0.9851	SNP		CCDS1691.1		N	,,,	False	17962518	-0.9967		9	missense	T	Approved	0.624535	66.0		c.2039C>T	2013-06-04	OTTHUMT00000241661.2	Q17RS7	0.7608	2.01;2.01	GEN1	17962518	0.49288	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.30765	89,89	GEN1	NM_001130009.1,NM_182625.3	protein-coding gene	NP_001123481.1	T	
		T	ENSG00000151379	ENST00000281047.3	0.80722	343930	N	ENSG00000151379	0.17167	4129	0.013000	0.16324	B		,	T	0.0	2	c.(238-240)gaA>gaT	OTTHUMG00000159089	0.087000	byFrequency	A6NI15	gene with protein product				NM_001105569.1	242,885,828	XM_292850	0.4325			T	0.004	+	Missense_Mutation	3		44.0	A6NI15	0.350128		10837126			0.0	MSGN1-001			0.01281		2	+	0.2814		0.64	0.169000	missense	14907	148	80/194		T	SO:0001583	612209	benign	0.4088397790055249	protein_coding		1955	P		0.118000	41.7292,35.0128,49.2028	B		6084		0.1587:0.1728:0.1656:0.5029					Melanoma(127;325 1712 14802 40657 49130)	KNOWN	ENST00000281047		GGGGCAGCGAAGGCTGCAGTG	T					ENST00000281047.3:c.240A>T	2		ENSG00000151379	0.10917	MSGN1	NS(1)|large_intestine(1)|lung(7)|ovary(1)|prostate(1)	ENSP00000281047:p.Glu80Asp	+	0.22208	,	GAA	2p24.2		"""paraxial mesogenin"""	g.chr2:17998025A>T	E -> D (in dbSNP:rs34069439).			146	yes		6181,5987	0.15412	0.00245	4.75	0.00012	ENSP00000281047:E80D			0.16816		-4.0966		2.3	0.28932	16	0.11794	0.027972027972027972	0.0	chromatin binding (GO:0003682)|DNA binding (GO:0003677)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)	-1.1			hg19	Standard	0.5398	0.2967479674796748	0.8901	4812,3446		cell differentiation (GO:0030154)|segment specification (GO:0007379)|somitogenesis (GO:0001756)	1667,2847,1570	-2.296235				CCDS42657.1	A	0.02656	TT,TA,AA		nucleus (GO:0005634)	42	0.00926	2504	2.33	rs34069439		263	80	410			0.01252	17861506	+	ASP/GLU	80	pMesogenin1	720	11	NM_001105569	0.0	1	0.5408970976253298	-0.257000	ENST00000281047.3		14630		uc010yjt.2			343930	dbSNP_126	240	0.0000		p.E80D	.	0		T		39.0	rs34069439;rs58519973	0.642	2:g.17998025A>T	ENSP00000281047:E80D	protein_coding	0.198368		not_organism_supported|basic|appris_principal|CCDS		1425,1962,742		80	1369,2541	0.32967032967032966	D	T|||		0.503112	5008		MSGN1_HUMAN	1612	mesogenin 1		MSGN1_HUMAN	0.321885	0.11924	17998025		-0.049000	0.0268	SNP		CCDS42657.1		N	,,,	False	17998025	-0.9706		9	missense	T	Approved	0.582708	42.0		c.240A>T	2007-07-23	OTTHUMT00000353253.1	A6NI15	0.3559	2.35	MSGN1	17998025	0.22640	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.37430	45	MSGN1	NM_001105569.1	protein-coding gene	NP_001099039.1	E	
		T	ENSG00000151379	ENST00000281047.3	0.80722	343930	N	ENSG00000151379	0.39573	4185	0.066000	0.16324	B		,	T	0.0	0	c.(310-312)Cac>Tac	OTTHUMG00000159089	1.020000	byFrequency	A6NI15	gene with protein product				NM_001105569.1	125,765,1151	XM_292850	0.4335			T	0	+	Missense_Mutation	1		38.0	A6NI15	0.248653		10837126			0.0	MSGN1-001			0.01281		2	+	0.1884		0.59	0.062000	missense	14907	143	104/194		T	SO:0001583	612209	benign	0.39502762430939226	protein_coding		2041	P		0.024000	42.724,24.8653,46.6511	B		6226		0.0:0.2062:0.0:0.7938					Melanoma(127;325 1712 14802 40657 49130)	KNOWN	ENST00000281047		CCAGCCCACCCACCTTCAGGG	T					ENST00000281047.3:c.310C>T	2		ENSG00000151379	0.11334	MSGN1	NS(1)|large_intestine(1)|lung(7)|ovary(1)|prostate(1)	ENSP00000281047:p.His104Tyr	+	0.19004	,	CAC	2p24.2		"""paraxial mesogenin"""	g.chr2:17998095C>T	H -> Y (in dbSNP:rs35858730).			96	yes		5809,6643	0.19879	0.00120	5.77	0.00012	ENSP00000281047:H104Y			0.28901		-25.2315		5.8	0.91146	17	0.13470	0.02972027972027972	0.1	chromatin binding (GO:0003682)|DNA binding (GO:0003677)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)	-1.67			hg19	Standard	0.5398	0.1951219512195122	8.8701	4794,3576		cell differentiation (GO:0030154)|segment specification (GO:0007379)|somitogenesis (GO:0001756)	1518,2773,1935	-2.614259				CCDS42657.1	C	0.02656	TT,TC,CC		nucleus (GO:0005634)	36	0.00308	2504	5.77	rs35858730		333	104	410			0.35311	17861576	+	TYR/HIS	104	pMesogenin1	666	11	NM_001105569	0.0	1	0.5408970976253298	-0.254000	ENST00000281047.3		18652		uc010yjt.2			343930	dbSNP_126	310	0.0000		p.H104Y	.	0		T		30.0	rs35858730;rs62130917	0.642	2:g.17998095C>T	ENSP00000281047:H104Y	protein_coding	0.013765		not_organism_supported|basic|appris_principal|CCDS		1393,2008,784		104	1015,3067	0.30494505494505497	Y	T|||		0.301187	5008		MSGN1_HUMAN	1482	mesogenin 1		MSGN1_HUMAN	0.295927	0.34010	17998095		1.350000	0.0278	SNP		CCDS42657.1		N	,,,	False	17998095	-0.9699		9	missense	T	Approved	0.57276	36.0		c.310C>T	2007-07-23	OTTHUMT00000353253.1	A6NI15	0.3429	2.35	MSGN1	17998095	0.15995	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.37596	83	MSGN1	NM_001105569.1	protein-coding gene	NP_001099039.1	H	
		C	ENSG00000151379	ENST00000281047.3		343930		ENSG00000151379		4185					,				c.(544-546)ctT>ctC	OTTHUMG00000159089		byFrequency	A6NI15	gene with protein product				NM_001105569.1	144,766,1125	XM_292850	0.4039					+	Silent			40.0				10837126				MSGN1-001					2	+	0.2027				coding-synonymous	14907		182/194		C	SO:0001819	612209			protein_coding		2035				42.951,25.8968,46.8569			6220							Melanoma(127;325 1712 14802 40657 49130)	KNOWN			CAGACCTCCTTAACCGCGGCA						ENST00000281047.3:c.546T>C	2					NS(1)|large_intestine(1)|lung(7)|ovary(1)|prostate(1)		+		,		2p24.2		"""paraxial mesogenin"""	g.chr2:17998331T>C					no		5829,6611												3.0					1.0	chromatin binding (GO:0003682)|DNA binding (GO:0003677)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)				hg19	Standard	0.5378			4775,3595		cell differentiation (GO:0030154)|segment specification (GO:0007379)|somitogenesis (GO:0001756)	1523,2783,1914					CCDS42657.1	T		CC,CT,TT		nucleus (GO:0005634)	39		2504		rs13001625		569									182	pMesogenin1		11	NM_001105569		1			ENST00000281047.3		18695		uc010yjt.2			343930	dbSNP_121	546			p.L182L		0				37.0		0.572	2:g.17998331T>C		protein_coding			not_organism_supported|basic|appris_principal|CCDS		1379,2017,789			1054,3016			C|||			5008		MSGN1_HUMAN	1475	mesogenin 1			0.294529		17998331			0.0278	SNP		CCDS42657.1			,,,	False	17998331				synonymous_variant		Approved		39.0		c.546T>C	2007-07-23	OTTHUMT00000353253.1	A6NI15	0.3501		MSGN1	17998331		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)			MSGN1	NM_001105569.1	protein-coding gene	NP_001099039.1		
		A	ENSG00000170745	ENST00000403915.1		3790		ENSG00000170745		4300					,				c.(196-198)gaG>gaA	OTTHUMG00000044150		byFrequency	Q9BQ31	gene with protein product		KCNS3_ENST00000304101.4_Silent_p.E66E|KCNS3_ENST00000465292.1_Intron		NM_001282428.1	1585,574,44	NM_002252	0.9928					+	Silent		104.8+/-165.8	125.0				10484328, 16382104				KCNS3-002					2	+	0.8147				coding-synonymous	6302		66/492		A	SO:0001819	603888			protein_coding		2203				3.1744,15.025,7.189		"""Potassium channels"", ""Voltage-gated ion channels / Potassium channels"""	6503								KNOWN			CCGATAAGGAGTACTACTTTG						ENST00000403915.1:c.198G>A	2					endometrium(5)|kidney(1)|large_intestine(7)|lung(11)|ovary(4)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		2p24	D6W520|O43651|Q4ZFY1|Q96B56		g.chr2:18112473G>A		282.5+/-276.6			no		12071,935												3.9					1.0	delayed rectifier potassium channel activity (GO:0005251)|potassium channel regulator activity (GO:0015459)				hg19	Standard	0.9722			8327,273		energy reserve metabolic process (GO:0006112)|potassium ion transport (GO:0006813)|protein homooligomerization (GO:0051260)|regulation of insulin secretion (GO:0050796)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)	5617,837,49					CCDS1692.1	G		AA,AG,GG	AF043472	cytoplasm (GO:0005737)|Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	125		2504		rs4240213		649									66	Kv9.3		32	NM_002252		3			ENST00000403915.1		21753		uc002rcw.3			3790	dbSNP_111	198			p.E66E		0				126.0		0.468	2:g.18112473G>A		protein_coding			basic|appris_principal|CCDS		4032,263,5			3744,662			A|||			5008		KCNS3_HUMAN	4713	potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			0.941094		18112473			1.0	SNP		CCDS1692.1			,,,	False	18112473				synonymous_variant		Approved		125.0		c.198G>A	2011-07-05	OTTHUMT00000323808.1	Q9BQ31	0.9784		KCNS3	18112473		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)			KCNS3	NM_002252.3	protein-coding gene	NP_001269357.1		
		A	ENSG00000170745	ENST00000403915.1		3790		ENSG00000170745		4300					,				c.(1231-1233)aaG>aaA	OTTHUMG00000044150		byFrequency	Q9BQ31	gene with protein product		KCNS3_ENST00000304101.4_Silent_p.K411K|KCNS3_ENST00000465292.1_Intron		NM_001282428.1	188,890,1125	NM_002252	0.4509					+	Silent		266.1+/-286.5	169.0				10484328, 16382104				KCNS3-002					2	+	0.3343				coding-synonymous	6302		411/492		G	SO:0001819	603888			protein_coding		2203				15.8023,28.7335,20.183		"""Potassium channels"", ""Voltage-gated ion channels / Potassium channels"""	6503								KNOWN			AGTTTTCCAAGTACTACCAGA						ENST00000403915.1:c.1233G>A	2					endometrium(5)|kidney(1)|large_intestine(7)|lung(11)|ovary(4)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		2p24	D6W520|O43651|Q4ZFY1|Q96B56		g.chr2:18113508G>A		433.3+/-343.5			no		2625,10381												4.1					1.0	delayed rectifier potassium channel activity (GO:0005251)|potassium channel regulator activity (GO:0015459)				hg19	Standard	0.164			1359,7241		energy reserve metabolic process (GO:0006112)|potassium ion transport (GO:0006813)|protein homooligomerization (GO:0051260)|regulation of insulin secretion (GO:0050796)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)	279,2067,4157					CCDS1692.1	G		AA,AG,GG	AF043472	cytoplasm (GO:0005737)|Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	176		2504		rs3747516		1684									411	Kv9.3		32	NM_002252		3			ENST00000403915.1		24317		uc002rcw.3			3790	dbSNP_107	1233			p.K411K		0				191.0		0.478	2:g.18113508G>A		protein_coding			basic|appris_principal|CCDS		91,1177,3032			1266,3140			G|||			5008		KCNS3_HUMAN	1788	potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			0.357029		18113508			0.4702	SNP		CCDS1692.1			,,,	False	18113508				synonymous_variant		Approved		176.0		c.1233G>A	2011-07-05	OTTHUMT00000323808.1	Q9BQ31	0.3833		KCNS3	18113508		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)			KCNS3	NM_002252.3	protein-coding gene	NP_001269357.1		
		G	ENSG00000170745	ENST00000403915.1	0.51767	3790	N	ENSG00000170745	0.34877	4300	0.730000	0.96830	B		,	T	6.399999999995298E-5	0	c.(1348-1350)Acc>Gcc	OTTHUMG00000044150	0.835000	byFrequency	Q9BQ31	gene with protein product		KCNS3_ENST00000304101.4_Missense_Mutation_p.T450A|KCNS3_ENST00000465292.1_Intron		NM_001282428.1	1142,899,162	NM_002252	0.8661			G	0.060	+	Missense_Mutation	1	477.4+/-369.6	145.0	Q9BQ31	0.722424		10484328, 16382104			0.0	KCNS3-002			0.01281		2	+	0.7383		1	0.870000	missense	6302	275	450/492		G	SO:0001583	603888	benign	0.7596685082872928	protein_coding		2203	P		1.000000	36.314,27.7576,33.4153	B	"""Potassium channels"", ""Voltage-gated ion channels / Potassium channels"""	6503		0.174:0.0:0.4937:0.3322						KNOWN	ENST00000403915;ENST00000304101		GCGGATGCACACCTTCATTAC	D;D					ENST00000403915.1:c.1348A>G	2		ENSG00000170745	0.15052	KCNS3	endometrium(5)|kidney(1)|large_intestine(7)|lung(11)|ovary(4)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	ENSP00000385968:p.Thr450Ala	+	0.71417	,	ACC	2p24	D6W520|O43651|Q4ZFY1|Q96B56		g.chr2:18113623A>G	T -> A (in dbSNP:rs4832524). {ECO:0000269|PubMed:10484328, ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4}.	424.0+/-340.3		355	yes		8660,4346	0.30809	0.01518	5.86	0.00012	ENSP00000305824:T450A			0.27710		.		3.9	0.45041	558	0.02654	0.9755244755244755	0.7	delayed rectifier potassium channel activity (GO:0005251)|potassium channel regulator activity (GO:0015459)	-0.69			hg19	Standard	0.6074	0.7215447154471545	5.3245	5477,3123		energy reserve metabolic process (GO:0006112)|potassium ion transport (GO:0006813)|protein homooligomerization (GO:0051260)|regulation of insulin secretion (GO:0050796)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)	2889,2882,732	-1.226797				CCDS1692.1	A	0.02656	GG,GA,AA	AF043472	cytoplasm (GO:0005737)|Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)|voltage-gated potassium channel complex (GO:0008076)	150	0.02011	2504	3.9	rs4832524		1799	450	467			0.15898	17977104	+	ALA/THR	450	Kv9.3	1655	32	NM_002252	0.0	3	0.6160949868073878	-0.119000	ENST00000403915.1		21769		uc002rcw.3			3790	dbSNP_111	1348	0.0000		p.T450A	.	0		T		161.0	rs4832524;rs17316360;rs17856098;rs17856121;rs17856499;rs52813731;rs58131892;rs4832524	0.453	2:g.18113623A>G	ENSP00000385968:T450A;ENSP00000305824:T450A	protein_coding	0.018168		basic|appris_principal|CCDS		1747,1983,570		450	3183,1223	0.7577838827838828	A	G|||		0.399617	5008		KCNS3_HUMAN	3987	potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3		KCNS3_HUMAN	0.796126	0.54024	18113623		3.596000	0.9831	SNP		CCDS1692.1		N	,,,	False	18113623	-0.9344		9	missense	T	Approved	0.63686	150.0		c.1348A>G	2011-07-05	OTTHUMT00000323808.1	Q9BQ31	0.8098	-4.14;-4.14	KCNS3	18113623	0.49936	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.158)	0.44190	58	KCNS3	NM_002252.3	protein-coding gene	NP_001269357.1	T	
		T	ENSG00000240857	ENST00000381249.3	0.09310	57665	N	ENSG00000240857	0.01119	4299	0.000000	0.21932	B		,	T	1	0	c.(838-840)Gta>Ata	OTTHUMG00000090705	-1.884000	byFrequency	Q9HBH5	gene with protein product		RDH14_ENST00000468071.1_5'UTR	Vitamin A(DB00162)	NM_020905.3	0,19,2184		0.0777			C	9.462	+	Missense_Mutation	1	79.8+/-142.4	143.0	Q9HBH5	0.004312		12226107, 19027726			0.013	RDH14-001	2006-05-09		0.15484		2	-	0.0038		0.35	0.977000	missense,utr-3,missense	19979	5	594/651,,280/337		C	SO:0001583		,,	0.013812154696132596	protein_coding		2203	N		0.000000	2.0005,0.4312,1.4688	B	"""Short chain dehydrogenase/reductase superfamily / Classical SDR fold cluster 2"""	6502		0.2412:0.2151:0.4253:0.1184						KNOWN	ENST00000381249		GCACCTTCTACTGGAGTTTTG	T					ENST00000381249.3:c.838G>A	2		ENSG00000240857	0.13052	RDH14	breast(2)|endometrium(1)|large_intestine(2)|lung(1)	ENSP00000370648:p.Val280Ile	-	0.05858	,	GTA	2p24.2		"""short chain dehydrogenase/reductase family 7C, member 4"""	g.chr2:18736630C>T		25.3+/-52.1		3	yes		191,12813	0.03702	0.20471	5.67	0.04272	ENSP00000370648:V280I			.		.		-9.6	0.00544	14	0.25106	0.024475524475524476	0.0	oxidoreductase activity (GO:0016491)	0.79			hg19	Standard	0.0139	0.006097560975609756	4.5154	172,8426		osteoblast differentiation (GO:0001649)	4,183,6315	1.093350				CCDS1693.1	C	0.19706	TT,TC,CC	AF237952	endoplasmic reticulum (GO:0005783)|lysosomal membrane (GO:0005765)|membrane (GO:0016020)|mitochondrion (GO:0005739)|nucleus (GO:0005634)	144	0.26092	2504	-9.63	rs74378191		945	280	12		"""retinol dehydrogenase 14 (all-trans and 9-cis)"""	0.11932	18600111	-	ILE/VAL,,ILE/VAL	280	PAN2, SDR7C4	34	6	NM_020905	0.038	2	0.0158311345646438	-0.181000	ENST00000381249.3		18131					57665	dbSNP_131	1780,,838	0.0118		p.V280I	NAD(P)-binding domain (1);	0		T		146.0	.	0.453	2:g.18736630C>T	ENSP00000370648:V280I	protein_coding	.		basic|appris_principal|CCDS		4,164,4131		280	19,4387	0.015567765567765568	I	C|||		.	5008		RDH14_HUMAN	126	retinol dehydrogenase 14 (all-trans/9-cis/11-cis)		RDH14_HUMAN	0.0251597	0.03055	18736630		-1.191000	0.0218	SNP		CCDS1693.1		.	,,,	False	18736630	-1.0263	1.1.1.-	9	missense	T	Approved	0.020005	144.0		c.838G>A	2011-09-14	OTTHUMT00000207394.1	Q9HBH5	0.013	1.98	RDH14	18736630	0.68977	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.177)	0.20840	29,,29	RDH14,NT5C1B-RDH14	NM_001199103.1,NM_001199104.1,NM_020905.3	protein-coding gene	NP_065956.1	V	
		T	ENSG00000185013	ENST00000359846.2	0.80722	93034	.	ENSG00000185013	0.96659	4300	1.000000	.	.			.	1	.	c.e3-1	OTTHUMG00000151765	2.809000		Q96P26	gene with protein product		NT5C1B-RDH14_ENST00000532967.1_Splice_Site|NT5C1B_ENST00000304081.4_Intron|NT5C1B_ENST00000600945.1_Splice_Site|NT5C1B_ENST00000460052.1_Intron		NM_001002006.2|NM_001199086.1|NM_001199087.1|NM_001199088.1						C	18.05	+	Splice_Site	.		34.0	.	.	Intron	11690631			.	NT5C1B-002			.		2	-			.	0.987000		17818	.		Ovarian(717;0.208)		SO:0001630	610526		.	protein_coding		2203	D		1.000000		.		6503		0.0:1.0:0.0:0.0						KNOWN	ENST00000532967;ENST00000359846;ENST00000416783		CACGCCTCATCTGAAAGATTG	.					ENST00000359846.2:c.121-1G>A	2		ENSG00000250741;ENSG00000185013;ENSG00000185013	0.42956	NT5C1B-RDH14;NT5C1B	endometrium(2)|kidney(2)|large_intestine(10)|lung(8)|ovary(1)|pancreas(1)|prostate(1)|skin(3)|urinary_tract(1)		-	0.71417		.	2p24.2	B5MCR0|B7ZVX7|Q53RX2|Q8N9W3|Q8NA26|Q96DU5|Q96KE6|Q96M25|Q96SA3		g.chr2:18768440C>T				.				0.80357	0.65085	5.39	.	.			.		.			0.77823	.	.	.		5'-nucleotidase activity (GO:0008253)|magnesium ion binding (GO:0000287)|nucleotide binding (GO:0000166)	.			hg19	Standard		.	14.5287			nucleobase-containing small molecule metabolic process (GO:0055086)|purine nucleobase metabolic process (GO:0006144)|purine nucleotide catabolic process (GO:0006195)|small molecule metabolic process (GO:0044281)		3.537355				CCDS33149.1, CCDS33150.1	C	.		AF356185	cytosol (GO:0005829)|nucleus (GO:0005634)		.		5.39			198	.	.			0.67909	18631921	-			AIRP, CN-IB	.	29	NM_033253	.	3	.	0.467000	ENST00000359846.2							93034			.			.	0		.		42.0	.	0.567	2:g.18768440C>T	.	protein_coding	.		basic|appris_candidate_longest|CCDS				-1		.	.			.			5NT1B_HUMAN		5'-nucleotidase, cytosolic IB		.		0.52200	18768440		3.347000		SNP		CCDS33150.1		.			18768440	.	3.1.3.5	.	splice_region_variant	.	Approved	.	36.0			2010-08-13	OTTHUMT00000323822.1	Q96P26		.	NT5C1B	18768440	0.75469	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.177)	.				protein-coding gene	NP_001002006.1|NP_001186015.1|NP_001186016.1|NP_001186017.1	.	
		G	ENSG00000185013	ENST00000359846.2		93034		ENSG00000185013		4300					,				c.(37-39)ccT>ccC	OTTHUMG00000151765		byFrequency	Q96P26	gene with protein product		NT5C1B-RDH14_ENST00000532967.1_Silent_p.P13P|NT5C1B_ENST00000304081.4_Silent_p.P13P|NT5C1B_ENST00000600945.1_Silent_p.P13P|NT5C1B_ENST00000460052.1_5'UTR		NM_001002006.2|NM_001199086.1|NM_001199087.1|NM_001199088.1	756,1078,369		0.181					+	Silent		732.1+/-406.8	138.0				11690631				NT5C1B-002					2	-	0.6649				coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous	17818		13/611,13/594,13/628,13/613,13/651,13/603,13/551	Ovarian(717;0.208)	G	SO:0001819	610526	,,,,,,		protein_coding		2203				20.8372,41.2165,33.6921			6503								KNOWN			ACCTCATTCCAGGCTCATTCT						ENST00000359846.2:c.39T>C	2					endometrium(2)|kidney(2)|large_intestine(10)|lung(8)|ovary(1)|pancreas(1)|prostate(1)|skin(3)|urinary_tract(1)		-		,		2p24.2	B5MCR0|B7ZVX7|Q53RX2|Q8N9W3|Q8NA26|Q96DU5|Q96KE6|Q96M25|Q96SA3		g.chr2:18768850A>G		528.9+/-372.5			no		4382,8624												-6.2					0.0	5'-nucleotidase activity (GO:0008253)|magnesium ion binding (GO:0000287)|nucleotide binding (GO:0000166)				hg19	Standard	0.1998			1792,6808		nucleobase-containing small molecule metabolic process (GO:0055086)|purine nucleobase metabolic process (GO:0006144)|purine nucleotide catabolic process (GO:0006195)|small molecule metabolic process (GO:0044281)	952,2478,3073					CCDS33149.1, CCDS33150.1	A		GG,GA,AA	AF356185	cytosol (GO:0005829)|nucleus (GO:0005634)	138		2504		rs16985306		116								,,,,,,	13	AIRP, CN-IB		29	NM_033253		2			ENST00000359846.2		16749					93034	dbSNP_123	39,39,39,39,39,39,39			p.P13P		0				138.0		0.373	2:g.18768850A>G		protein_coding			basic|appris_candidate_longest|CCDS		196,1400,2704			2590,1816			G|||			5008		5NT1B_HUMAN	1595	5'-nucleotidase, cytosolic IB			0.31849		18768850			0.1151	SNP		CCDS33150.1			,,,	False	18768850		3.1.3.5		synonymous_variant		Approved		138.0		c.39T>C	2010-08-13	OTTHUMT00000323822.1	Q96P26	0.3199		NT5C1B	18768850		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.177)		,,,,,,	NT5C1B,NT5C1B-RDH14	NM_001002006.2,NM_001199086.1,NM_001199087.1,NM_001199088.1,NM_001199103.1,NM_001199104.1,NM_033253.3	protein-coding gene	NP_001002006.1|NP_001186015.1|NP_001186016.1|NP_001186017.1		
		A	ENSG00000183891	ENST00000333610.3		130502		ENSG00000183891		4300					,				c.(127-129)tcC>tcT	OTTHUMG00000151776		byFrequency	Q5I0X7	gene with protein product		TTC32_ENST00000402414.1_Silent_p.S43S		NM_001008237.1	102,700,1401	NM_001008237	0.4029					+	Silent		269.4+/-288.4	58.0								TTC32-001					2	-	0.208				coding-synonymous	32954		43/152		A	SO:0001819				protein_coding		2203				16.186,20.5175,17.6534		"""Tetratricopeptide (TTC) repeat domain containing"""	6503								KNOWN			TCTCGTCGCTGGAGGCCGCGC						ENST00000333610.3:c.129C>T	2					kidney(2)|large_intestine(1)|lung(1)		-		,		2p24.1			g.chr2:20101487G>A		349.8+/-310.5			no		2296,10710												-8.4					0.0					hg19	Standard	0.175			1392,7208			229,1838,4436					CCDS33151.1	G		AA,AG,GG	BC057850		58		2504		rs2304589		260									43			4	NM_001008237		1			ENST00000333610.3		16050		uc002rdg.3			130502	dbSNP_100	129			p.S43S		0				57.0		0.637	2:g.20101487G>A		protein_coding			basic|appris_principal|CCDS		127,1138,3035			904,3502			g|||			5008		TTC32_HUMAN	1411	tetratricopeptide repeat domain 32			0.281749		20101487			0.4028	SNP		CCDS33151.1			,,,	False	20101487				synonymous_variant		Approved		58.0		c.129C>T	2013-01-10	OTTHUMT00000323868.1	Q5I0X7	0.2305		TTC32	20101487		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			TTC32	NM_001008237.1	protein-coding gene	NP_001008238.1		
		A	ENSG00000118965	ENST00000345530.3		57539		ENSG00000118965		4300					,					OTTHUMG00000090737		byFrequency	Q9P2L0	gene with protein product		WDR35_ENST00000416055.2_Intron|WDR35_ENST00000281405.4_Intron		NM_001006657.1	1801,360,41	NM_020779	0.9806					+	Intron		14.0+/-48.4	101.0				10718198				WDR35-001					2	-	0.8949				intron,intron	29250		,		A	SO:0001627	613602	,		protein_coding		2202				0.2209,10.0363,3.5451		"""WD repeat domain containing"", ""Intraflagellar transport homologs"""	6502								KNOWN			AAACATTTTTCAAAATTGAGG						ENST00000345530.3:c.2857-14G>T	2					breast(1)|endometrium(5)|kidney(8)|large_intestine(8)|lung(16)|ovary(2)|prostate(1)|skin(1)|stomach(1)		-		,		2p24.3	B3KVI5|Q4ZG01|Q8NE11		g.chr2:20131184C>A		189.9+/-215.9			no		12543,461												0.8					0.0					hg19	Standard	0.998			8581,19		cilium assembly (GO:0042384)|intraciliary retrograde transport (GO:0035721)	6082,379,41					CCDS1695.1, CCDS33152.1	C		AA,AC,CC	AB037757	axoneme (GO:0005930)|centrosome (GO:0005813)|ciliary basal body (GO:0036064)|intraciliary transport particle A (GO:0030991)	100		2504		rs1191779		2972								,		MGC33196, KIAA1336, IFT121, IFTA1		43	NM_001006657		25			ENST00000345530.3		15377		uc002rdi.3			57539	dbSNP_87	,					0				99.0		0.318	2:g.20131184C>A		protein_coding			basic|CCDS		4281,19,0			3962,442			A|||			5008		WDR35_HUMAN	4832	WD repeat domain 35			0.964856		20131184			0.999	SNP		CCDS33152.1			,,,	False	20131184				intron_variant		Approved		100.0			2014-02-21	OTTHUMT00000207472.2	Q9P2L0	0.9784		WDR35	20131184		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,	WDR35	NM_001006657.1,NM_020779.3	protein-coding gene	NP_001006658.1		
		C	ENSG00000118965	ENST00000345530.3		57539		ENSG00000118965		4300					,				c.(2527-2529)gaA>gaG	OTTHUMG00000090737		byFrequency	Q9P2L0	gene with protein product		WDR35_ENST00000281405.4_Silent_p.E832E|WDR35_ENST00000416055.2_Silent_p.E408E		NM_001006657.1	473,1044,686	NM_020779	0.5951					+	Silent		625.0+/-397.7	103.0				10718198				WDR35-001					2	-	0.472				coding-synonymous,coding-synonymous	29250		843/1182,832/1171		C	SO:0001819	613602	,		protein_coding		2203				41.8488,45.1657,42.9725		"""WD repeat domain containing"", ""Intraflagellar transport homologs"""	6503								KNOWN			TCTCTAACCCTTCATAATCCT						ENST00000345530.3:c.2529A>G	2					breast(1)|endometrium(5)|kidney(8)|large_intestine(8)|lung(16)|ovary(2)|prostate(1)|skin(1)|stomach(1)		-		,		2p24.3	B3KVI5|Q4ZG01|Q8NE11		g.chr2:20135283T>C		614.2+/-392.3			no		5589,7417												-4.0					0.2					hg19	Standard	0.4026			3599,5001		cilium assembly (GO:0042384)|intraciliary retrograde transport (GO:0035721)	1230,3129,2144					CCDS1695.1, CCDS33152.1	T		CC,CT,TT	AB037757	axoneme (GO:0005930)|centrosome (GO:0005813)|ciliary basal body (GO:0036064)|intraciliary transport particle A (GO:0030991)	104		2504		rs6741091		2644								,	843	MGC33196, KIAA1336, IFT121, IFTA1		43	NM_001006657		22			ENST00000345530.3		15149		uc002rdi.3			57539	dbSNP_116	2529,2496			p.E843E		0				106.0		0.348	2:g.20135283T>C		protein_coding			basic|CCDS		757,2085,1458			1990,2416			C|||			5008		WDR35_HUMAN	2558	WD repeat domain 35			0.510783		20135283			0.623	SNP		CCDS33152.1			,,,	False	20135283				synonymous_variant		Approved		104.0		c.2529A>G	2014-02-21	OTTHUMT00000207472.2	Q9P2L0	0.4597		WDR35	20135283		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,	WDR35	NM_001006657.1,NM_020779.3	protein-coding gene	NP_001006658.1		
		CACTTAC	ENSG00000118965	ENST00000345530.3		57539		ENSG00000118965		4300										OTTHUMG00000090737			Q9P2L0	gene with protein product		WDR35_ENST00000416055.2_Intron|WDR35_ENST00000281405.4_Intron		NM_001006657.1		NM_020779						+	Intron			74.0				10718198				WDR35-001					2	-						29250					SO:0001627	613602			protein_coding		2202						"""WD repeat domain containing"", ""Intraflagellar transport homologs"""	6502								KNOWN			CTGATGCATACACTTACTTAC						ENST00000345530.3:c.570+10GTAAGTAAGTG>GTAAGTG	2					breast(1)|endometrium(5)|kidney(8)|large_intestine(8)|lung(16)|ovary(2)|prostate(1)|skin(1)|stomach(1)		-				2p24.3	B3KVI5|Q4ZG01|Q8NE11		g.chr2:20175280delCACTTACTTAC																													hg19	Standard						cilium assembly (GO:0042384)|intraciliary retrograde transport (GO:0035721)						CCDS1695.1, CCDS33152.1	CACTTACTTAC			AB037757	axoneme (GO:0005930)|centrosome (GO:0005813)|ciliary basal body (GO:0036064)|intraciliary transport particle A (GO:0030991)							686										MGC33196, KIAA1336, IFT121, IFTA1		43	NM_001006657		6			ENST00000345530.3				uc002rdi.3			57539							0				82.0		0.299	2:g.20175280delCACTTACTTAC		protein_coding			basic|CCDS													WDR35_HUMAN		WD repeat domain 35					20175280				DEL		CCDS33152.1					20175280				intron_variant		Approved		77.0			2014-02-21	OTTHUMT00000207472.2	Q9P2L0			WDR35	20175280		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)					protein-coding gene	NP_001006658.1		
		T	ENSG00000118965	ENST00000345530.3		57539		ENSG00000118965		4300					,					OTTHUMG00000090737		byFrequency	Q9P2L0	gene with protein product		WDR35_ENST00000281405.4_Intron		NM_001006657.1	1123,870,210	NM_020779	0.6196					+	Intron		571.1+/-389.5	51.0				10718198				WDR35-001					2	-	0.7738				intron,intron	29250		,		T	SO:0001627	613602	,		protein_coding		2203				49.686,29.2783,43.1878		"""WD repeat domain containing"", ""Intraflagellar transport homologs"""	6503								KNOWN			CACGAAGGAGCTGGGAAGTAA						ENST00000345530.3:c.25-46G>A	2					breast(1)|endometrium(5)|kidney(8)|large_intestine(8)|lung(16)|ovary(2)|prostate(1)|skin(1)|stomach(1)		-		,		2p24.3	B3KVI5|Q4ZG01|Q8NE11		g.chr2:20189089C>T		431.2+/-342.8			no		7389,5617												-9.4					0.0					hg19	Standard	0.4682			4273,4327		cilium assembly (GO:0042384)|intraciliary retrograde transport (GO:0035721)	2178,3033,1292					CCDS1695.1, CCDS33152.1	C		TT,TC,CC	AB037757	axoneme (GO:0005930)|centrosome (GO:0005813)|ciliary basal body (GO:0036064)|intraciliary transport particle A (GO:0030991)	51		2504		rs3731663		140								,		MGC33196, KIAA1336, IFT121, IFTA1		43	NM_001006657		2			ENST00000345530.3		19378		uc002rdi.3			57539	dbSNP_107	,					0				50.0		0.438	2:g.20189089C>T		protein_coding			basic|CCDS		1055,2163,1082			3116,1290			T|||			5008		WDR35_HUMAN	3113	WD repeat domain 35			0.621605		20189089			0.6518	SNP		CCDS33152.1			,,,	False	20189089				intron_variant		Approved		51.0			2014-02-21	OTTHUMT00000207472.2	Q9P2L0	0.513		WDR35	20189089		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,	WDR35	NM_001006657.1,NM_020779.3	protein-coding gene	NP_001006658.1		
		T	ENSG00000115884	ENST00000254351.4	0.80722	6382	N	ENSG00000115884	0.05944	4299	0.000000	0.30981	B;B		,	D	0.0	0	c.(406-408)cTg>cAg	OTTHUMG00000090751	-0.580000	byFrequency	P18827	gene with protein product		SDC1_ENST00000403076.1_Missense_Mutation_p.L136Q|SDC1_ENST00000482879.1_5'UTR|SDC1_ENST00000381150.1_Missense_Mutation_p.L136Q		NM_002997.4	1769,409,25	NM_001006946	1.0			T	0.158	+	Missense_Mutation	2	1.2+/-3.3	87.0	E9PHH3;P18827	0.895824					0.0;0.0	SDC1-001			0.01281		2	-	0.8805		0	0.121000	missense,missense	10658	356	136/311,136/311		T	SO:0001583	186355	benign,benign	0.9834254143646409	protein_coding		2203	P		0.000000	0.0233,10.4176,3.5451	B;B	"""CD molecules"", ""Proteoglycans / Cell Surface : Syndecans"""	6502		0.1549:0.3526:0.0:0.4925			OV - Ovarian serous cystadenocarcinoma(76;0.221)			KNOWN	ENST00000254351;ENST00000381150;ENST00000403076;ENST00000429035		CGTTGAGGCCAGATGAGTGGT	T;T;T;T	SDC				ENST00000254351.4:c.407T>A	2		ENSG00000115884	0.01647	SDC1	NS(1)|breast(1)|kidney(2)|large_intestine(2)|lung(9)|ovary(4)|skin(2)	ENSP00000254351:p.Leu136Gln	-	0.05858	,	CTG	2p24.1	D6W523|Q53QV0|Q546D3|Q96HB7	"""syndecan proteoglycan 1"""	g.chr2:20403794A>T	L -> Q (in dbSNP:rs10205485). {ECO:0000269|PubMed:1339431, ECO:0000269|PubMed:15177497, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2324102, ECO:0000269|PubMed:9050911, ECO:0000269|Ref.5}.	220.4+/-237.8		428	yes		12543,461	0.03702	0.01888	3.87	0.00012	ENSP00000254351:L136Q			0.07983		-1.6428		-1.3	0.09230	572	0.87932	1.0	0.0	protein C-terminus binding (GO:0008022)	-1.1			hg19	Standard	1.0	0.8699186991869918	4.5293	8596,2		canonical Wnt signaling pathway (GO:0060070)|carbohydrate metabolic process (GO:0005975)|chondroitin sulfate metabolic process (GO:0030204)|extracellular matrix organization (GO:0030198)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan catabolic process (GO:0006027)|glycosaminoglycan metabolic process (GO:0030203)|inflammatory response (GO:0006954)|lipoprotein metabolic process (GO:0042157)|myoblast development (GO:0048627)|odontogenesis (GO:0042476)|phototransduction, visible light (GO:0007603)|response to calcium ion (GO:0051592)|response to cAMP (GO:0051591)|response to glucocorticoid (GO:0051384)|response to hydrogen peroxide (GO:0042542)|response to toxic substance (GO:0009636)|retinoid metabolic process (GO:0001523)|Sertoli cell development (GO:0060009)|small molecule metabolic process (GO:0044281)|striated muscle cell development (GO:0055002)|ureteric bud development (GO:0001657)|wound healing (GO:0042060)	6066,411,25	-1.084333				CCDS1697.1	A	0.02656	TT,TA,AA	AJ551176	cell surface (GO:0009986)|cytoplasm (GO:0005737)|external side of plasma membrane (GO:0009897)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|Golgi lumen (GO:0005796)|integral component of plasma membrane (GO:0005887)|lysosomal lumen (GO:0043202)|plasma membrane (GO:0005886)|protein complex (GO:0043234)	87	0.00926	2504	-1.31	rs10205485		651	136;136	758			0.11997	20267275	-	GLN/LEU,GLN/LEU	136	CD138, syndecan, SYND1	2114	21	XM_005262621	0.0;0.0	3	1.0	-1.205000	ENST00000254351.4		13613		uc002rdo.1			6382	dbSNP_119	407,407	0.0000		p.L136Q	.	0		T		87.0	rs10205485;rs13023107;rs17845185;rs17857995;rs52826372;rs10205485	0.687	2:g.20403794A>T	ENSP00000254351:L136Q;ENSP00000370542:L136Q;ENSP00000384613:L136Q;ENSP00000400773:L144Q	protein_coding	0.985920		basic|appris_principal|CCDS		4297,2,0		136;136;136;144	3947,459	0.967948717948718	Q	T|||		1.008270	5008		SDC1_HUMAN	4842	syndecan 1		.;SDC1_HUMAN	0.966853	0.04345	20403794		-0.844000	1.0	SNP		CCDS1697.1		N	,,,	False	20403794	-0.9911		9	missense	T	Approved	0.999767	87.0		c.407T>A	2008-02-05	OTTHUMT00000207495.1	P18827	0.9885	2.25;2.25;1.52;1.51	SDC1	20403794	0.20230	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.32322	113,113	SDC1	NM_001006946.1,NM_002997.4	protein-coding gene	NP_002988	L	
		T	ENSG00000118960	ENST00000304031.3	0.80722|0.80722	64342	N|N	ENSG00000118960	0.00367|0.00367	4300	0.000000|0.000000	.|0.30714	.|B		,	.|T	0.0|0.0	0|0	c.(778-780)Gtg>Atg	OTTHUMG00000122099	-2.766000|-2.766000	byFrequency	Q53T59	gene with protein product				NM_022460.3	240,967,996	NM_022460	0.3712			T|T	8.686|8.686	+	Missense_Mutation	2|1	520.9+/-379.8	79.0	.|Q53T59	0.328416|0.328416		10590261, 15699368			.|0.002	HS1BP3-001			.|0.06405		2	-	0.3139		.|0.13	0.000000|0.000000	missense	24979	159|159	260/393		T	SO:0001583	609359	benign	0.43922651933701656|0.43922651933701656	protein_coding		2203	P|P		0.000000|0.000000	41.9186,32.8416,49.531	.|B		6503		0.0925:0.2869:0.4934:0.1273|0.0925:0.2869:0.4934:0.1273						KNOWN	ENST00000445102|ENST00000304031;ENST00000458740		TTACGGTCCACGGATGACACG	.|T;T					ENST00000304031.3:c.778G>A	2		ENSG00000118960|ENSG00000118960	0.00118|0.00118	HS1BP3|HS1BP3	endometrium(4)|large_intestine(1)|lung(7)|ovary(1)|skin(2)	ENSP00000305193:p.Val260Met	-	0.05858|0.05858	,	CGT|GTG	2p24.1	B2RAW2|D6W529|Q86VC2|Q8N367		g.chr2:20824498C>T	V -> M (in dbSNP:rs2305458). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334}.	681.3+/-404.0		154|154	yes		6442,6564	0.03702|0.03702	0.17833|0.17833	4.38|4.38	0.00012|0.00012	.|ENSP00000305193:V260M			.|0.00678		9.7378|9.7378		-8.8	0.00830|0.00830	146|146	.|0.44086	0.25524475524475526|0.25524475524475526	0.0	phosphatidylinositol binding (GO:0035091)	-0.69|-0.69			hg19	Standard	0.5726	0.3130081300813008|0.3130081300813008	5.9354|5.9354	4995,3605			1690,3062,1751	0.906356|0.906356				CCDS1700.1	C	.|0.11235	TT,TC,CC			77	0.02011|0.02011	2504	-8.76|-8.76	rs2305458		803	.|260	434|434			0.19163|0.19163	20687979|20687979	-|-	MET/VAL	260	HS1-BP3,FLJ14249	893|893	15	NM_022460	.|0.004	5	0.5725593667546174|0.5725593667546174	-2.777000|-2.777000	ENST00000304031.3		17685		uc002rdw.1			64342	dbSNP_100	778	0.0000|0.0000		p.V260M	.|.	0		T|T		75.0	rs2305458;rs11544151;rs17857390;rs61096584;rs2305458|rs2305458;rs11544151;rs17857390;rs61096584;rs2305458	0.642	2:g.20824498C>T	.|ENSP00000305193:V260M;ENSP00000392203:V79M	protein_coding	.|0.000666		basic|appris_principal|CCDS		1450,2095,755		52|260;79	1447,2959	0.4088827838827839|0.4088827838827839	H|M	T|||		.|4.463180	5008		H1BP3_HUMAN	1913	HCLS1 binding protein 3		.|H1BP3_HUMAN	0.381989	0.01164|0.01164	20824498		-2.273000|-2.273000	0.2748	SNP		CCDS1700.1		.|N	,,,	False	20824498	-0.9766|-0.9766		4|9	missense	T|T	Approved	0.580814|0.580814	77.0		c.778G>A	2006-08-15	OTTHUMT00000242863.1	Q53T59	0.4063	.|2.28;1.52	HS1BP3	20824498	0.00434|0.00434	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.35992|0.35992	21	HS1BP3	NM_022460.3	protein-coding gene	NP_071905.3	R|V	
		A	ENSG00000118960	ENST00000304031.3		64342		ENSG00000118960		4300					,					OTTHUMG00000122099		byFrequency	Q53T59	gene with protein product				NM_022460.3	259,984,960	NM_022460	0.4796					+	Intron		387.3+/-342.2	78.0				10590261, 15699368				HS1BP3-001					2	-	0.3548				intron	24979				G	SO:0001627	609359			protein_coding		2203				28.1395,34.0899,30.1553			6503								KNOWN			TGGAGCTGGAGAATCACAGAC						ENST00000304031.3:c.624-6C>T	2					endometrium(4)|large_intestine(1)|lung(7)|ovary(1)|skin(2)		-		,		2p24.1	B2RAW2|D6W529|Q86VC2|Q8N367		g.chr2:20824658G>A		464.0+/-353.7			no		3922,9084												0.5					0.6	phosphatidylinositol binding (GO:0035091)				hg19	Standard	0.2873			2420,6180			617,2688,3198					CCDS1700.1	G		AA,AG,GG			77		2504		rs10199441		649										HS1-BP3,FLJ14249		15	NM_022460		5			ENST00000304031.3		19252		uc002rdw.1			64342	dbSNP_119						0				75.0		0.597	2:g.20824658G>A		protein_coding			basic|appris_principal|CCDS		358,1704,2238			1502,2904			G|||			5008		H1BP3_HUMAN	2124	HCLS1 binding protein 3			0.424121		20824658			0.6002	SNP		CCDS1700.1			,,,	False	20824658				intron_variant		Approved		77.0			2006-08-15	OTTHUMT00000242863.1	Q53T59	0.4207		HS1BP3	20824658		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			HS1BP3	NM_022460.3	protein-coding gene	NP_071905.3		
		A	ENSG00000118960	ENST00000304031.3		64342		ENSG00000118960		4300					,				c.(499-501)ttC>ttT	OTTHUMG00000122099		byFrequency	Q53T59	gene with protein product		HS1BP3_ENST00000402541.1_Silent_p.F167F		NM_022460.3	117,751,1335	NM_022460	0.454					+	Silent		381.0+/-339.9	141.0				10590261, 15699368				HS1BP3-001					2	-	0.2292				coding-synonymous	24979		167/393		G	SO:0001819	609359			protein_coding		2203				26.2093,22.3559,24.9039			6503								KNOWN			CAAAAAAGTCGAAAGCCTCTT						ENST00000304031.3:c.501C>T	2					endometrium(4)|large_intestine(1)|lung(7)|ovary(1)|skin(2)		-		,		2p24.1	B2RAW2|D6W529|Q86VC2|Q8N367		g.chr2:20838318G>A		367.3+/-318.2			no		3239,9767												-8.4					0.8	phosphatidylinositol binding (GO:0035091)				hg19	Standard	0.2763			2254,6346			415,2409,3679					CCDS1700.1	G		AA,AG,GG			146		2504		rs3796064		526									167	HS1-BP3,FLJ14249		15	NM_022460		4			ENST00000304031.3		19367		uc002rdw.1			64342	dbSNP_107	501			p.F167F		0				155.0		0.587	2:g.20838318G>A		protein_coding			basic|appris_principal|CCDS		298,1658,2344			985,3421			G|||			5008		H1BP3_HUMAN	1798	HCLS1 binding protein 3			0.359026		20838318			0.5565	SNP		CCDS1700.1			,,,	False	20838318				synonymous_variant		Approved		146.0		c.501C>T	2006-08-15	OTTHUMT00000242863.1	Q53T59	0.3055		HS1BP3	20838318		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			HS1BP3	NM_022460.3	protein-coding gene	NP_071905.3		
		T	ENSG00000084674	ENST00000233242.1	0.49798	338	N	ENSG00000084674	0.09899	4300	0.005000	0.37584	B		,	D	0.99982	0	c.(13441-13443)Gcc>Acc	OTTHUMG00000090785	-0.226000	byFrequency	P04114	gene with protein product				NM_000384.2	0,30,2173		0.0164			C	11.76	+	Missense_Mutation	1	117.2+/-176.8	91.0	P04114	0.006809					0.007	APOB-001	2013-05-29		0.12156		2	-	0.0023		0.05	0.093000	missense	603	13	4481/4564		C	SO:0001583	107730	benign	0.03591160220994475	protein_coding		2203	D		0.808000	3.9651,0.6809,2.8525	B	"""Apolipoproteins"""	6503		0.4201:0.2784:0.0:0.3014						KNOWN	ENST00000233242		GTCGCAATGGCCTGGCTTTTA	T					ENST00000233242.1:c.13441G>A	2		ENSG00000084674	0.81541	APOB	NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	ENSP00000233242:p.Ala4481Thr	-	0.29022	,	GCC	2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21224853C>T	A -> T (in dbSNP:rs1801695). {ECO:0000269|PubMed:22095935, ECO:0000269|PubMed:8889592}.	33.5+/-64.1		2	yes		371,12635	0.12908	0.30774	5.9	0.04770	ENSP00000233242:A4481T			0.10378		.		-1.0	0.10218	0	0.56958	0.0	0.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)	0.52			hg19	Standard	0.0278	0.0040650406504065045	5.0815	341,8259		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	7,357,6139	1.734971				CCDS1703.1	C	0.17852	TT,TC,CC	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	89	0.17764	2504	-0.996	rs1801695		13568	4481	20		"""apolipoprotein B (including Ag(x) antigen)"""	0.14659	21078358	-	THR/ALA	4481		35	305	NM_000384	0.024	29	0.026385224274406333	0.591000	ENST00000233242.1		19082		uc002red.3			338	dbSNP_89	13441	0.0129		p.A4481T	.	0		T		85.0	rs1801695;rs17247459;rs17394175;rs52809794;rs58110603	0.368	2:g.21224853C>T	ENSP00000233242:A4481T	protein_coding	0.681940		basic|appris_principal|CCDS		7,327,3966		4481	30,4376	0.016025641025641024	T	C|||		0.840251	5008		APOB_HUMAN	71	apolipoprotein B		APOB_HUMAN	0.0141773	0.14738	21224853		0.077000	0.0	SNP		CCDS1703.1		N	,,,	False	21224853	-1.0802		10	missense	T	Approved	0.039651	89.0		c.13441G>A	2013-05-29	OTTHUMT00000207571.1	P04114	0.0346	1.19	APOB	21224853	0.18481	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.06881	58	APOB	NM_000384.2	protein-coding gene	NP_000375	A	
		A	ENSG00000084674	ENST00000233242.1	0.09310	338	M	ENSG00000084674	0.82529	4300	1.000000	0.01185	D	http://www.ncbi.nlm.nih.gov/pubmed?term	,	D	1.0	0	c.(8215-8217)cCa>cTa	OTTHUMG00000090785	2.437000	byFrequency	P04114	gene with protein product				NM_000384.2	52,590,1561		0.5654			G	24.9	+	Missense_Mutation	2	331.8+/-319.8	186.0	P04114	0.157512					0.999	APOB-001	2013-05-29		0.91635	APOB	2	-	0.1241		0	0.958000	missense	603	79	2739/4564		G	SO:0001583	107730	probably-damaging	0.21823204419889503	protein_coding		2203	P		1.000000	21.6512,15.7512,19.6525	D	"""Apolipoproteins"""	6503		0.0:0.0:1.0:0.0						KNOWN	ENST00000233242;ENST00000535079		CTGGAATTCTGGTATGTGAAG	T					ENST00000233242.1:c.8216C>T	2		ENSG00000084674	0.74099	APOB	NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	ENSP00000233242:p.Pro2739Leu	-	0.71417	,	CCA	2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21231524G>A	P -> L (in dbSNP:rs676210). {ECO:0000269|PubMed:22095935, ECO:0000269|PubMed:2216805, ECO:0000269|PubMed:9490296}.	289.5+/-280.5		77	yes		2556,10450	0.80357	0.86748	5.22	0.00012	ENSP00000233242:P2739L	M		0.52532		.		5.2	0.72569	406	0.87932	0.7097902097902098	1.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)	2.24			hg19	Standard	0.2177	0.1565040650406504	18.7715	1862,6738		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	279,1998,4226	4.580663				CCDS1703.1	G	0.89917	AA,AG,GG	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	186	0.73598	2504	5.22	rs676210		8343	2739	175	GRCh37	"""apolipoprotein B (including Ag(x) antigen)"""	0.91893	21085029	-	LEU/PRO	2739		737	305	NM_000384	1.0	26	0.23087071240105542	0.561000	ENST00000233242.1		21164		uc002red.3			338	dbSNP_83	8216	0.0000	CM980093	p.P2739L	.	0		T		185.0	rs676210;rs17240903;rs52830519;rs60113879;rs676210	0.398	2:g.21231524G>A	ENSP00000233242:P2739L	protein_coding	0.000061		basic|appris_principal|CCDS		227,1408,2665		2739	694,3712	0.3374542124542125	L	G|||		0.000000	5008		APOB_HUMAN	1834	apolipoprotein B		APOB_HUMAN	0.366214	0.99136	21231524		9.803000	0.7192	SNP	rs676210	CCDS1703.1		D	,,,	False	21231524	-1.0714		9	missense	T	Approved	0.216512	186.0		c.8216C>T	2013-05-29	OTTHUMT00000207571.1	P04114	0.2493	5.21	APOB	21231524	0.62258	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.08597	98	APOB	NM_000384.2	protein-coding gene	NP_000375	P	
		A	ENSG00000084674	ENST00000233242.1		338		ENSG00000084674		4300				http://www.ncbi.nlm.nih.gov/pubmed?term	,				c.(7543-7545)acC>acT	OTTHUMG00000090785		byFrequency	P04114	gene with protein product				NM_000384.2	140,802,1261		0.2157					+	Silent		577.5+/-390.6	107.0								APOB-001	2013-05-29				2	-	0.2095				coding-synonymous	603		2515/4564		G	SO:0001819	107730			protein_coding		2203				49.9884,24.5574,41.3886		"""Apolipoproteins"""	6503								KNOWN			TATCTTCTAGGGTCTCTCGGA						ENST00000233242.1:c.7545C>T	2					NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)		-		,		2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21232195G>A		391.4+/-328.1			no		5383,7623							http://www.ncbi.nlm.nih.gov/sites/varvu?gene					3.2					0.9	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)				hg19	Standard	0.4423			4301,4299		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	1232,2919,2352					CCDS1703.1	G		AA,AG,GG	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	114		2504		rs693		7672				"""apolipoprotein B (including Ag(x) antigen)"""					2515			305	NM_000384		26			ENST00000233242.1		21485		uc002red.3			338	dbSNP_36	7545			p.T2515T		0				128.0		0.438	2:g.21232195G>A		protein_coding			basic|appris_principal|CCDS		1092,2117,1091			1082,3324			G|||			5008		APOB_HUMAN	1257	apolipoprotein B			0.250998		21232195			0.0615	SNP		CCDS1703.1			,,,	False	21232195				synonymous_variant		Approved		114.0		c.7545C>T	2013-05-29	OTTHUMT00000207571.1	P04114	0.3775		APOB	21232195		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			APOB	NM_000384.2	protein-coding gene	NP_000375		
		C	ENSG00000084674	ENST00000233242.1	0.53005	338	L	ENSG00000084674	0.02216	4300	0.002000	0.00724	B		,	T	3.399999999997849E-5	0	c.(6937-6939)Att>Gtt	OTTHUMG00000090785	-1.344000	byFrequency	P04114	gene with protein product				NM_000384.2	1975,222,6		1.0			C	0	+	Missense_Mutation	1	2.2+/-6.3	119.0	P04114	0.946891					0.003	APOB-001	2013-05-29		0.08055		2	-	0.9523		0.57	0.000000	missense	603	353	2313/4564		C	SO:0001583	107730	benign	0.9751381215469613	protein_coding		2203	P		0.000000	0.0581,5.3109,1.8376	B	"""Apolipoproteins"""	6503		0.3242:0.2091:0.0:0.4667						KNOWN	ENST00000233242;ENST00000535079		TGCTCAAGAATGTCATTTATT	T					ENST00000233242.1:c.6937A>G	2		ENSG00000084674	0.00048	APOB	NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	ENSP00000233242:p.Ile2313Val	-	0.05858	,	ATT	2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21232803T>C	I -> V (in dbSNP:rs584542). {ECO:0000269|PubMed:2883086, ECO:0000269|PubMed:3030729, ECO:0000269|PubMed:3464946, ECO:0000269|PubMed:3652907, ECO:0000269|PubMed:3676265, ECO:0000269|PubMed:3759943, ECO:0000269|PubMed:3763409, ECO:0000269|Ref.6}.	136.5+/-172.5		464	yes		12767,239	0.10522	0.00093	5.76	0.00012	ENSP00000233242:I2313V			0.15445		.		-3.8	0.04307	572	0.14252	1.0	0.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)	1.1			hg19	Standard	0.999	0.943089430894309	5.845	8595,5		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	6270,227,6	-2.714744				CCDS1703.1	T	0.09022	CC,CT,TT	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	118	0.36672	2504	-3.8	rs584542|rs386643884		7064	2313	734		"""apolipoprotein B (including Ag(x) antigen)"""	0.18661	21086308	-	VAL/ILE	2313		2123	305	NM_000384	0.002	26	0.9683377308707124	-3.274000	ENST00000233242.1		20093		uc002red.3			338	dbSNP_83	6937	0.0000		p.I2313V	.	0		T		117.0	rs584542;rs58174904;rs584542	0.348	2:g.21232803T>C	ENSP00000233242:I2313V	protein_coding	0.262017		basic|appris_principal|CCDS		4295,5,0		2313	4172,234	0.9720695970695971	V	C|||		0.635159	5008		APOB_HUMAN	4939	apolipoprotein B		APOB_HUMAN	0.986222	0.09411	21232803		-0.205000	0.998	SNP		CCDS1703.1		N	,,,	False	21232803	-0.9846		9	missense	T	Approved	0.999419	118.0		c.6937A>G	2013-05-29	OTTHUMT00000207571.1	P04114	0.9957	5.78	APOB	21232803	0.00434	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.34004	29	APOB	NM_000384.2	protein-coding gene	NP_000375	I	
		A	ENSG00000084674	ENST00000233242.1		338		ENSG00000084674		4300					,				c.(6934-6936)gaC>gaT	OTTHUMG00000090785		byFrequency	P04114	gene with protein product				NM_000384.2	139,754,1310		0.2065					+	Silent			119.0								APOB-001	2013-05-29				2	-	0.2095				coding-synonymous	603		2312/4564		G	SO:0001819	107730			protein_coding		2203				47.8837,23.4226,39.5971		"""Apolipoproteins"""	6503								KNOWN			GCTCAAGAATGTCATTTATTC						ENST00000233242.1:c.6936C>T	2					NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)		-		,		2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21232804G>A					no		5150,7856												-2.2					0.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)				hg19	Standard	0.4423			4118,4482		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	1231,2688,2584					CCDS1703.1	G		AA,AG,GG	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	118		2504		rs386643884|rs1041968		7063				"""apolipoprotein B (including Ag(x) antigen)"""					2312			305	NM_000384		26			ENST00000233242.1		20035		uc002red.3			338	dbSNP_86	6936			p.D2312D		0				116.0		0.348	2:g.21232804G>A		protein_coding			basic|appris_principal|CCDS		1092,1934,1274			1032,3374			G|||			5008		APOB_HUMAN	1248	apolipoprotein B			0.249201		21232804			0.0615	SNP		CCDS1703.1			,,,	False	21232804				synonymous_variant		Approved		118.0		c.6936C>T	2013-05-29	OTTHUMT00000207571.1	P04114	0.3775		APOB	21232804		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			APOB	NM_000384.2	protein-coding gene	NP_000375		
		C	ENSG00000084674	ENST00000233242.1	0.58432	338	N	ENSG00000084674	0.18397	4300	0.048000	0.00711	B		,	T	2.9999999999752447E-6	0	c.(4264-4266)tAt>tGt	OTTHUMG00000090785	0.125000		P04114	gene with protein product				NM_000384.2	2197,2,0		1.0			C	0.008	+	Missense_Mutation	2	1.2+/-3.3	82.0	P04114	0.999545					0.0	APOB-001	2013-05-29		0.01281		2	-	1.0		0.46	0.007000	missense	603	362	1422/4564		C	SO:0001583	107730	benign	1.0	protein_coding		2199	P		0.001000	0.0233,0.0455,0.0308	B	"""Apolipoproteins"""	6499		0.1444:0.3722:0.0:0.4833						KNOWN	ENST00000233242;ENST00000535079		AGACCCATCATATGATAGTGT	T					ENST00000233242.1:c.4265A>G	2		ENSG00000084674	0.15052	APOB	NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	ENSP00000233242:p.Tyr1422Cys	-	0.12720	,	TAT	2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21235475T>C	Y -> C (in dbSNP:rs568413). {ECO:0000269|PubMed:2883086, ECO:0000269|PubMed:3030729, ECO:0000269|PubMed:3461454, ECO:0000269|PubMed:3464946, ECO:0000269|PubMed:3652907, ECO:0000269|PubMed:3759943, ECO:0000269|PubMed:3763409, ECO:0000269|Ref.6}.	2.1+/-5.4		492	yes		12994,4	0.18961	0.00498	5.88	0.00012	ENSP00000233242:Y1422C			0.19152		.		1.9	0.25924	572	0.19147	1.0	0.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)	-1.06			hg19	Standard	1.0	1.0	4.8095	8598,2		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	6495,4,0	-1.921177				CCDS1703.1	T	0.02656	CC,CT,TT	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	81	0.01003	2504	1.93	rs568413		4392	1422	758		"""apolipoprotein B (including Ag(x) antigen)"""	0.13337	21088980	-	CYS/TYR	1422		2184	305	NM_000384	0.0	26	1.0	-0.119000	ENST00000233242.1		21804		uc002red.3			338	dbSNP_83	4265	0.0000		p.Y1422C	.	0		T		78.0	rs568413;rs58107589;rs568413	0.338	2:g.21235475T>C	ENSP00000233242:Y1422C	protein_coding	0.121421		basic|appris_principal|CCDS		4298,2,0		1422	4396,2	1.0	C	C|||		0.551000	5008		APOB_HUMAN	5008	apolipoprotein B		APOB_HUMAN	1.0	0.23699	21235475		0.573000	1.0	SNP		CCDS1703.1		N	,,,	False	21235475	-1.0078		9	missense	T	Approved	0.999767	81.0		c.4265A>G	2013-05-29	OTTHUMT00000207571.1	P04114	1.0	5.8	APOB	21235475	0.05969	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.27297	194	APOB	NM_000384.2	protein-coding gene	NP_000375	Y	
		A	ENSG00000084674	ENST00000233242.1	0.19300	338	M	ENSG00000084674	0.98803	4300	0.965000	0.72051	D		,	T	0.9999726572	0	c.(1852-1854)gCt>gTt	OTTHUMG00000090785	2.882000	byFrequency	P04114	gene with protein product		APOB_ENST00000399256.4_Missense_Mutation_p.A618V		NM_000384.2	65,649,1489		0.6513			G	29.3	+	Missense_Mutation	2	550.9+/-385.8	117.0	P04114	0.176804					0.998	APOB-001	2013-05-29		0.87578	APOB	2	-	0.1301		0.23	0.979000	missense	603	146	618/4564		G	SO:0001583	107730	probably-damaging	0.40331491712707185	protein_coding		2203	P		1.000000	46.2209,17.6804,36.5524	D	"""Apolipoproteins"""	6503		0.0:0.0:1.0:0.0						KNOWN	ENST00000233242;ENST00000535079;ENST00000399256		TTCTTTCAGAGCTTCTTTCAC	T;T					ENST00000233242.1:c.1853C>T	2	Vitellogenin. {ECO:0000255|PROSITE- ProRule:PRU00557}.	ENSG00000084674	0.94253	APOB	NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	ENSP00000233242:p.Ala618Val	-	0.71417	,	GCT	2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21250914G>A	A -> V (in dbSNP:rs679899). {ECO:0000269|PubMed:22095935, ECO:0000269|PubMed:3030729, ECO:0000269|PubMed:3759943}.	312.7+/-292.7		73	yes		4754,8252	0.40720	0.93167	5.73	0.00012	ENSP00000233242:A618V	M		0.53938		.		5.7	0.89815	483	0.33940	0.8444055944055944	1.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)	2.205			hg19	Standard	0.4742	0.1483739837398374	20.2886	3975,4625		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	990,2774,2739	4.993916				CCDS1703.1	G	0.89917	AA,AG,GG	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	115	0.72576	2504	5.73	rs679899		1980	618	370	GRCh37	"""apolipoprotein B (including Ag(x) antigen)"""	0.98538	21104419	-	VAL/ALA	618		1072	305	NM_000384	1.0	14	0.48812664907651715	0.655000	ENST00000233242.1		19326		uc002red.3			338	dbSNP_83	1853	0.0000	CM984191	p.A618V	Lipid transport protein, N-terminal (1);Vitellinogen, superhelical (2);	0		T		113.0	rs679899;rs1126420;rs3181424;rs17240681;rs52818666;rs57998826;rs679899	0.383	2:g.21250914G>A	ENSP00000233242:A618V;ENSP00000382200:A618V	protein_coding	0.000042		basic|appris_principal|CCDS		925,2125,1250		618	779,3627	0.4908424908424908	V	G|||		0.071469	5008		APOB_HUMAN	2429	apolipoprotein B		APOB_HUMAN	0.485024	0.73923	21250914		6.554000	0.8641	SNP	rs679899	CCDS1703.1		D	,,,	False	21250914	-0.9277		9	missense	T	Approved	0.462209	115.0		c.1853C>T	2013-05-29	OTTHUMT00000207571.1	P04114	0.3919	-0.62;-0.62	APOB	21250914	0.70002	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.45205	64	APOB	NM_000384.2	protein-coding gene	NP_000375	A	
		T	ENSG00000084674	ENST00000233242.1		338		ENSG00000084674		4300										OTTHUMG00000090785			P04114	gene with protein product		APOB_ENST00000399256.4_Intron		NM_000384.2								+	Intron			43.0								APOB-001	2013-05-29				2	-						603					SO:0001627	107730			protein_coding		2203						"""Apolipoproteins"""	6503								KNOWN			ATGTATTCAACACGGGCAACA						ENST00000233242.1:c.538-36G>A	2					NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)		-				2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21260163C>T																									cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)				hg19	Standard						artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)						CCDS1703.1	C			M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)							665				"""apolipoprotein B (including Ag(x) antigen)"""								305	NM_000384		6			ENST00000233242.1				uc002red.3			338							0				50.0		0.483	2:g.21260163C>T		protein_coding			basic|appris_principal|CCDS													APOB_HUMAN		apolipoprotein B					21260163				SNP		CCDS1703.1					21260163				intron_variant		Approved		45.0			2013-05-29	OTTHUMT00000207571.1	P04114			APOB	21260163		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)					protein-coding gene	NP_000375		
		A	ENSG00000084674	ENST00000233242.1	0.35685	338	M	ENSG00000084674	0.27837	4300	0.958000	0.41400	B	http://www.ncbi.nlm.nih.gov/pubmed?term	,	T	0.18562900000000004	0	c.(292-294)aCc>aTc	OTTHUMG00000090785	0.493000	byFrequency	P04114	gene with protein product		APOB_ENST00000399256.4_Missense_Mutation_p.T98I		NM_000384.2	30,499,1674		0.1329	Substitution - Missense(1)		G	16.00	+	Missense_Mutation	2	432.4+/-357.1	61.0	P04114	0.126872					0.085	APOB-001	2013-05-29		0.28011	APOB	2	-	0.0779		0.1	0.991000	missense	603	113	98/4564		G	SO:0001583	107730	benign	0.31215469613259667	protein_coding	stomach(1)	2203	P		0.983000	31.3837,12.6872,25.05	B	"""Apolipoproteins"""	6503		0.0942:0.3059:0.5999:0.0						KNOWN	ENST00000233242;ENST00000535079;ENST00000399256		CTCTTTCAGGGTGCACTGGCT	T;T					ENST00000233242.1:c.293C>T	2	Heparin-binding.|Vitellogenin. {ECO:0000255|PROSITE- ProRule:PRU00557}.	ENSG00000084674	0.94253	APOB	NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6)	ENSP00000233242:p.Thr98Ile	-	0.35010	,	ACC	2p24-p23	O00502|P78479|P78480|P78481|Q13779|Q13785|Q13786|Q13787|Q13788|Q4ZG63|Q53QC8|Q7Z600|Q9UMN0		g.chr2:21263900G>A	T -> I (polymorphism that influences plasma concentrations of low density lipoprotein cholesterol; dbSNP:rs1367117). {ECO:0000269|PubMed:12551903, ECO:0000269|PubMed:20686565, ECO:0000269|PubMed:2115173, ECO:0000269|PubMed:22095935, ECO:0000269|PubMed:3461454, ECO:0000269|PubMed:3759943}.	249.6+/-257.0		48	yes		3258,9748	0.39756	0.54147	4.86	0.00012	ENSP00000233242:T98I	M	http://www.ncbi.nlm.nih.gov/sites/varvu?gene	0.19028		.		2.9	0.34026	70	0.48119	0.12237762237762238	1.0	cholesterol transporter activity (GO:0017127)|heparin binding (GO:0008201)|lipase binding (GO:0035473)|low-density lipoprotein particle receptor binding (GO:0050750)|phospholipid binding (GO:0005543)	2.125			hg19	Standard	0.2982	0.0975609756097561	7.7562	2699,5901		artery morphogenesis (GO:0048844)|blood coagulation (GO:0007596)|cellular response to prostaglandin stimulus (GO:0071379)|cellular response to tumor necrosis factor (GO:0071356)|cholesterol efflux (GO:0033344)|cholesterol homeostasis (GO:0042632)|cholesterol metabolic process (GO:0008203)|cholesterol transport (GO:0030301)|fertilization (GO:0009566)|in utero embryonic development (GO:0001701)|leukocyte migration (GO:0050900)|lipoprotein biosynthetic process (GO:0042158)|lipoprotein catabolic process (GO:0042159)|lipoprotein metabolic process (GO:0042157)|lipoprotein transport (GO:0042953)|low-density lipoprotein particle clearance (GO:0034383)|low-density lipoprotein particle remodeling (GO:0034374)|nervous system development (GO:0007399)|phototransduction, visible light (GO:0007603)|positive regulation of cholesterol storage (GO:0010886)|positive regulation of lipid storage (GO:0010884)|positive regulation of macrophage derived foam cell differentiation (GO:0010744)|post-embryonic development (GO:0009791)|receptor-mediated endocytosis (GO:0006898)|regulation of cholesterol biosynthetic process (GO:0045540)|response to carbohydrate (GO:0009743)|response to lipopolysaccharide (GO:0032496)|response to selenium ion (GO:0010269)|response to virus (GO:0009615)|retinoid metabolic process (GO:0001523)|small molecule metabolic process (GO:0044281)|sperm motility (GO:0030317)|spermatogenesis (GO:0007283)|triglyceride catabolic process (GO:0019433)|triglyceride mobilization (GO:0006642)|very-low-density lipoprotein particle assembly (GO:0034379)	478,2302,3723	2.999255		p.T98I(1)		CCDS1703.1	G	0.25390	AA,AG,GG	M14162	actin cytoskeleton (GO:0015629)|chylomicron (GO:0042627)|chylomicron remnant (GO:0034360)|clathrin-coated endocytic vesicle membrane (GO:0030669)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|early endosome (GO:0005769)|endocytic vesicle lumen (GO:0071682)|endoplasmic reticulum lumen (GO:0005788)|endoplasmic reticulum membrane (GO:0005789)|endosome lumen (GO:0031904)|endosome membrane (GO:0010008)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|intermediate-density lipoprotein particle (GO:0034363)|intracellular membrane-bounded organelle (GO:0043231)|low-density lipoprotein particle (GO:0034362)|mature chylomicron (GO:0034359)|plasma membrane (GO:0005886)|very-low-density lipoprotein particle (GO:0034361)	63	0.69823	2504	2.93	rs1367117		420	98	218	GRCh37	"""apolipoprotein B (including Ag(x) antigen)"""	0.28925	21117405	-	ILE/THR	98		449	305	NM_000384	0.125	4	0.287598944591029	0.655000	ENST00000233242.1		20685		uc002red.3			338	dbSNP_88	293	0.0000	CM020623	p.T98I	Lipid transport protein, beta-sheet shell (1);Lipid transport protein, N-terminal (3);Vitellinogen, beta-sheet N-terminal (1);	1		T		67.0	rs1367117;rs17246849;rs57336814;rs1367117	0.507	2:g.21263900G>A	ENSP00000233242:T98I;ENSP00000382200:T98I	protein_coding	0.124629		basic|appris_principal|CCDS		448,1803,2049		98	559,3847	0.20558608058608058	I	G|||		0.480621	5008		APOB_HUMAN	848	apolipoprotein B		APOB_HUMAN	0.169329	0.47971	21263900		2.809000	0.1151	SNP	rs1367117	CCDS1703.1		N	,,,	False	21263900	-1.0458		9	missense	T	Approved	0.313837	63.0		c.293C>T	2013-05-29	OTTHUMT00000207571.1	P04114	0.2867	1.0;1.0	APOB	21263900	0.79684	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.14839	89	APOB	NM_000384.2	protein-coding gene	NP_000375	T	
		G	ENSG00000163026	ENST00000295148.4		80304		ENSG00000163026		4300					,					OTTHUMG00000125498			Q9H6R7	gene with protein product		C2orf44_ENST00000406895.3_Intron		NM_025203.2	2191,12,0	NM_025203	1.0					+	Intron			35.0				22327622				C2orf44-001					2	-	0.9992				intron,intron	26157		,		G	SO:0001627		,		protein_coding		2203				0.0,0.2724,0.0923			6503	T							KNOWN		C2orf44/ALK(2)	CAGAAGTAATCGAGTTAACAT						ENST00000295148.4:c.1819-46G>C	2					breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(6)|lung(7)|ovary(1)|pancreas(1)|skin(2)|urinary_tract(1)		-		,		2p23.3	D6W532|Q8IYK0|Q9HBP5		g.chr2:24255862C>G		19.1+/-41.9			no		12994,12									Dom		80304	1.0					0.0					hg19	Standard	1.0			8600,0			6491,12,0					CCDS1705.1, CCDS46229.1	C		GG,GC,CC	AK025598		34		2504		rs10179142		1876								,		FLJ21945		24	NM_025203		3			ENST00000295148.4	E	19004		uc002rep.2	2p23.3	NSCLC	80304	dbSNP_119	,					0				33.0		0.308	2:g.24255862C>G		protein_coding		chromosome 2 open reading frame 44	basic|appris_candidate_longest|CCDS	ALK	4300,0,0			4394,12			G|||			5008	yes	CB044_HUMAN	5007	chromosome 2 open reading frame 44	2		0.9998		24255862			1.0	SNP		CCDS1705.1			,,,	False	24255862				intron_variant		Approved		34.0			2012-07-30	OTTHUMT00000246825.1	Q9H6R7	1.0		C2orf44	24255862		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,	C2orf44	NM_001142319.1,NM_025203.2	protein-coding gene	NP_079479.1		
		A	ENSG00000163026	ENST00000295148.4	0.45490	80304	N	ENSG00000163026	0.25532	4300	0.543000	0.40225	B;B		,	T	0.0015420000000000433	0	c.(304-306)aCg>aTg	OTTHUMG00000125498	0.405000	byFrequency	Q9H6R7	gene with protein product		C2orf44_ENST00000406895.3_Missense_Mutation_p.T102M		NM_025203.2	11,310,1882	NM_025203	0.18			G	2.674	+	Missense_Mutation	2	244.4+/-273.7	89.0	Q9H6R7-2;Q9H6R7	0.075352		22327622			0.001;0.001	C2orf44-001			0.04013		2	-	0.0772		0.39	0.115000	missense,missense	26157	29	102/623,102/722		G	SO:0001583		benign,benign	0.08011049723756906	protein_coding		2203	P		1.000000	14.1047,7.5352,11.8791	B;B		6503	T	0.8524:0.0:0.1476:0.0						KNOWN	ENST00000295148;ENST00000406895;ENST00000443232	C2orf44/ALK(2)	AGTCTGAGACGTCAGCCATTT	T;T;T					ENST00000295148.4:c.305C>T	2		ENSG00000163026	0.09829	C2orf44	breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(6)|lung(7)|ovary(1)|pancreas(1)|skin(2)|urinary_tract(1)	ENSP00000295148:p.Thr102Met	-	0.71417	,	ACG	2p23.3	D6W532|Q8IYK0|Q9HBP5		g.chr2:24262060G>A	T -> M (in dbSNP:rs3731620).	174.4+/-204.0		32	yes		1545,11461	0.28128	0.05679	5.24	0.00073	ENSP00000295148:T102M			0.27214	Dom	-7.9865	80304	2.7	0.32119	19	0.22706	0.033216783216783216	0.5		-1.79			hg19	Standard	0.1402	0.06504065040650407	9.37	1213,7387			96,1353,5054	-0.276795				CCDS1705.1, CCDS46229.1	G	0.02656	AA,AG,GG	AK025598		92	0.00237	2504	2.72	rs3731620		362	102;102	107			0.38248	24115564	-	MET/THR,MET/THR	102	FLJ21945	187	24	NM_025203	0.0;0.0	2	0.14116094986807387	-0.290000	ENST00000295148.4	E	23586		uc002rep.2	2p23.3	NSCLC	80304	dbSNP_107	305,305	0.0002		p.T102M	WD40/YVTN repeat-like-containing domain (1);	0		T		97.0	rs3731620;rs17356692;rs52809153;rs60551542;rs3731620	0.507	2:g.24262060G>A	ENSP00000295148:T102M;ENSP00000385816:T102M;ENSP00000413426:T102M	protein_coding	0.020393	chromosome 2 open reading frame 44	basic|appris_candidate_longest|CCDS	ALK	85,1043,3172		102	332,4074	0.08562271062271062	M	G|||		0.460245	5008	yes	CB044_HUMAN	493	chromosome 2 open reading frame 44	2	.;CB044_HUMAN	0.0984425	0.50593	24262060		3.141000	0.0367	SNP		CCDS1705.1		N	,,,	False	24262060	-1.0502		9	missense	T	Approved	0.141047	92.0		c.305C>T	2012-07-30	OTTHUMT00000246825.1	Q9H6R7	0.0533	1.04;1.04;1.04	C2orf44	24262060	0.19883	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.13629	81,81	C2orf44	NM_001142319.1,NM_025203.2	protein-coding gene	NP_079479.1	T	
		C	ENSG00000119782	ENST00000380986.4		2281		ENSG00000119782		4300					,					OTTHUMG00000151889		byFrequency	P68106	gene with protein product		FKBP1B_ENST00000452109.1_Intron|FKBP1B_ENST00000380991.4_Intron		NM_004116.3|NM_054033.2	441,1048,714	NM_004116	0.2648					+	Intron		703.7+/-405.4	135.0				7513996				FKBP1B-001	2002-08-29				2	+	0.4455				intron,intron	3712		,		C	SO:0001627	600620	,		protein_coding		2203				27.2674,43.8039,32.8694			6503								KNOWN			TTTTCCAATATCCTACTCCTT		FKBP1L				ENST00000380986.4:c.38-36T>C	2					lung(2)		+		,		2p23.3	Q13664|Q16645|Q53TM2|Q9BQ40	"""calstabin 2"""	g.chr2:24276736T>C		623.7+/-394.2			no		4275,8731												0.6					0.0	calcium channel inhibitor activity (GO:0019855)|cyclic nucleotide binding (GO:0030551)|FK506 binding (GO:0005528)|ion channel binding (GO:0044325)|peptidyl-prolyl cis-trans isomerase activity (GO:0003755)|receptor binding (GO:0005102)				hg19	Standard	0.2475			2345,6255		'de novo' protein folding (GO:0006458)|calcium ion transmembrane transport (GO:0070588)|calcium-mediated signaling using intracellular calcium source (GO:0035584)|cell communication by electrical coupling involved in cardiac conduction (GO:0086064)|chaperone-mediated protein folding (GO:0061077)|cytosolic calcium ion homeostasis (GO:0051480)|insulin secretion (GO:0030073)|negative regulation of heart rate (GO:0010459)|negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)|negative regulation of protein phosphatase type 2B activity (GO:0032513)|negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)|negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)|neuronal action potential propagation (GO:0019227)|positive regulation of axon regeneration (GO:0048680)|positive regulation of sequestering of calcium ion (GO:0051284)|protein maturation by protein folding (GO:0022417)|protein peptidyl-prolyl isomerization (GO:0000413)|protein refolding (GO:0042026)|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)|regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)|regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)|response to glucose (GO:0009749)|response to hydrogen peroxide (GO:0042542)|response to redox state (GO:0051775)|response to vitamin E (GO:0033197)|smooth muscle contraction (GO:0006939)|T cell proliferation (GO:0042098)	764,2747,2992					CCDS1706.1, CCDS33153.1	T		CC,CT,TT	D38037	calcium channel complex (GO:0034704)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|membrane (GO:0016020)|sarcoplasmic reticulum membrane (GO:0033017)|Z disc (GO:0030018)	135		2504		rs11125393		173				"""FK506-binding protein 1B (12.6 kD)"""				,		OTK4, FKBP12.6, PPIase, FKBP9		2	NM_004116		2			ENST00000380986.4		19856		uc002rer.3			2281	dbSNP_120	,					0				133.0		0.537	2:g.24276736T>C		protein_coding			basic|appris_principal|CCDS		323,1699,2278			1930,2476			C|||			5008		FKB1B_HUMAN	1264	FK506 binding protein 1B, 12.6 kDa			0.252396		24276736			0.0456	SNP		CCDS1706.1			,,,	False	24276736				intron_variant		Approved		135.0			2013-03-20	OTTHUMT00000207622.1	P68106	0.1744		FKBP1B	24276736		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,	FKBP1B	NM_004116.3,NM_054033.2	protein-coding gene	NP_004107.1|NP_473374.1		
		C	ENSG00000115129	ENST00000238721.4	0.80722	9540	.	ENSG00000115129	0.09958	4300	0.002000	0.13657	B		,	T	0.0	0	c.(883-885)caA>caG	OTTHUMG00000090817	-0.222000	byFrequency	Q53FA7	gene with protein product		TP53I3_ENST00000313482.4_Missense_Mutation_p.T230A|TP53I3_ENST00000407482.1_Missense_Mutation_p.T230A|FAM228B_ENST00000461972.1_Intron|TP53I3_ENST00000335934.4_Silent_p.Q295Q		NM_004881.4	6,309,1888	NM_004881	0.1728			T	19.39	+	Silent	1	243.9+/-273.3	76.0	Q53FA7-2	0.072855		11919562, 10840161, 19349281			0.002	TP53I3-001			0.06405		2	-	0.0666		0.13	0.980000	missense,coding-synonymous,coding-synonymous	19373	29	230/249,295/333,295/333		T	SO:0001819	605171	,,	0.08011049723756906	protein_coding		2203	P		0.000000	14.1163,7.2855,11.8022	B		6503		0.0984:0.2928:0.2509:0.3578						KNOWN	ENST00000313482;ENST00000407482		GCAGCAGACGTTGGGGGCCCT	T;T					ENST00000238721.4:c.885A>G	2		ENSG00000115129	0.62120	TP53I3	endometrium(1)|kidney(4)|large_intestine(2)|lung(3)|urinary_tract(2)		-	0.05858	,	ACG	2p23.3	D6W533|O14679|O14685|Q38G78|Q6JLE7|Q9BWB8		g.chr2:24300563T>C		170.5+/-200.9		26	yes		1535,11471	0.10522	0.71028	5.07	0.00073	ENSP00000322298:T230A			.		-12.4048		-3.3	0.04928	19	0.44086	0.033216783216783216	0.0	NADPH binding (GO:0070402)|NADPH:quinone reductase activity (GO:0003960)|protein homodimerization activity (GO:0042803)|quinone binding (GO:0048038)|zinc ion binding (GO:0008270)	.			hg19	Standard	0.1392	0.052845528455284556	2.3949	1214,7386		NADP metabolic process (GO:0006739)	91,1353,5059	3.817677				CCDS1708.1, CCDS56112.1	T	0.02656	CC,CT,TT	AF010309	extracellular vesicular exosome (GO:0070062)	80	.	2504	-3.35	rs10209238		1739	230	106			0.04387	24154067	-	ALA/THR,,	295	PIG3	180	12	NM_004881	0.0	5	0.13984168865435356	0.533000	ENST00000238721.4		18900		uc002rez.2			9540	dbSNP_119	688,885,885	0.0002		p.Q295Q	.	0		T		86.0	rs10209238;rs10209238	0.527	2:g.24300563T>C	ENSP00000322298:T230A;ENSP00000384414:T230A	protein_coding	.		basic|appris_principal|CCDS		85,1044,3171		230	321,4085	0.08241758241758242	A	T|||		.	5008		QORX_HUMAN	471	tumor protein p53 inducible protein 3		.	0.0940495	0.05553	24300563		-0.622000	0.0367	SNP		CCDS1708.1		.	,,,	False	24300563	-0.9462		7	synonymous_variant	T	Approved	0.141163	80.0		c.885A>G	2009-06-12	OTTHUMT00000207618.2	Q53FA7	0.0533	2.57;2.57	TP53I3	24300563	0.70556	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)	0.42258	58,,	TP53I3	NM_001206802.2,NM_004881.4,NM_147184.3	protein-coding gene	NP_004872.2	T	
		G	ENSG00000176732	ENST00000313213.4		375189		ENSG00000176732		4298					,					OTTHUMG00000090816		byFrequency	Q8NHR9	gene with protein product		PFN4_ENST00000465360.1_5'UTR		NM_199346.1	12,322,1868	NM_199346	0.1718					+	3'UTR		754.8+/-407.5	50.0								PFN4-001					2	-	0.0764				utr-3	31103				G	SO:0001624				protein_coding		2202				14.053,7.8565,11.9538			6500								KNOWN			AATAATAAAATTGTCTTTCAT						ENST00000313213.4:c.*25A>C	2					breast(1)|kidney(1)|large_intestine(1)|lung(1)|ovary(1)|pancreas(1)		-		,		2p24.1	Q53TL9		g.chr2:24338428T>G		761.7+/-413.1			no		1554,11446												-2.0					0.0	lipid binding (GO:0008289)				hg19	Standard	0.1392			1208,7388		actin cytoskeleton organization (GO:0030036)	95,1364,5041					CCDS1709.1	T		GG,GT,TT	BC029523	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)	50		2504		rs1056123		786												6	NM_199346		0			ENST00000313213.4		18548		uc002rfa.1			375189	dbSNP_86						0				51.0		0.303	2:g.24338428T>G		protein_coding			basic|appris_principal|CCDS		83,1042,3173			346,4058			G|||			5008		PROF4_HUMAN	484	profilin family, member 4			0.0966454		24338428			0.0377	SNP		CCDS1709.1			,,,	False	24338428				3_prime_UTR_variant		Approved		50.0			2008-02-05	OTTHUMT00000207617.2	Q8NHR9	0.0533		PFN4	24338428		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			PFN4	NM_199346.1	protein-coding gene	NP_955378.1		
		C	ENSG00000176732	ENST00000313213.4		375189		ENSG00000176732		4300					,				c.(301-303)gtA>gtG	OTTHUMG00000090816		byFrequency	Q8NHR9	gene with protein product		PFN4_ENST00000465360.1_5'UTR		NM_199346.1	129,833,1241	NM_199346	0.4407					+	Silent		661.9+/-401.9	124.0								PFN4-001					2	-	0.2133				coding-synonymous	31103		101/130		C	SO:0001819				protein_coding		2203				35.4767,24.7617,31.8468			6503								KNOWN			TGTAAGTTGCTACCAGAAGAT						ENST00000313213.4:c.303A>G	2					breast(1)|kidney(1)|large_intestine(1)|lung(1)|ovary(1)|pancreas(1)		-		,		2p24.1	Q53TL9		g.chr2:24342505T>C		721.9+/-409.2			no		4142,8864												5.4					1.0	lipid binding (GO:0008289)				hg19	Standard	0.3738			3051,5549		actin cytoskeleton organization (GO:0030036)	666,2810,3027					CCDS1709.1	T		CC,CT,TT	BC029523	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)	129		2504		rs1056122		674									101			6	NM_199346		4			ENST00000313213.4		18510		uc002rfa.1			375189	dbSNP_86	303			p.V101V		0				137.0		0.453	2:g.24342505T>C		protein_coding			basic|appris_principal|CCDS		537,1977,1786			1091,3315			C|||			5008		PROF4_HUMAN	1387	profilin family, member 4			0.276957		24342505			0.1528	SNP		CCDS1709.1			,,,	False	24342505				synonymous_variant		Approved		129.0		c.303A>G	2008-02-05	OTTHUMT00000207617.2	Q8NHR9	0.2075		PFN4	24342505		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			PFN4	NM_199346.1	protein-coding gene	NP_955378.1		
		A	ENSG00000176732	ENST00000313213.4		375189		ENSG00000176732		4300					,				c.(274-276)gtC>gtT	OTTHUMG00000090816		byFrequency	Q8NHR9	gene with protein product		PFN4_ENST00000465360.1_5'UTR		NM_199346.1	26,504,1673	NM_199346	0.2209					+	Silent		267.9+/-287.5	101.0								PFN4-001					2	-	0.1278				coding-synonymous	31103		92/130		A	SO:0001819				protein_coding		2203				16.0698,12.6192,14.9008			6503								KNOWN			GGGTCTTCACGACAACCACAC						ENST00000313213.4:c.276C>T	2					breast(1)|kidney(1)|large_intestine(1)|lung(1)|ovary(1)|pancreas(1)		-		,		2p24.1	Q53TL9		g.chr2:24342532G>A		248.7+/-256.4			no		1938,11068												-5.6					0.1	lipid binding (GO:0008289)				hg19	Standard	0.1561			1382,7218		actin cytoskeleton organization (GO:0030036)	136,1666,4701					CCDS1709.1	G		AA,AG,GG	BC029523	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)	104		2504		rs1134516		647									92			6	NM_199346		4			ENST00000313213.4		18773		uc002rfa.1			375189	dbSNP_86	276			p.V92V		0				110.0		0.463	2:g.24342532G>A		protein_coding			basic|appris_principal|CCDS		110,1162,3028			556,3850			g|||			5008		PROF4_HUMAN	643	profilin family, member 4			0.128395		24342532			0.0456	SNP		CCDS1709.1			,,,	False	24342532				synonymous_variant		Approved		104.0		c.276C>T	2008-02-05	OTTHUMT00000207617.2	Q8NHR9	0.0793		PFN4	24342532		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			PFN4	NM_199346.1	protein-coding gene	NP_955378.1		
		T	ENSG00000186453	ENST00000295150.3		653140		ENSG00000186453		4106					,					OTTHUMG00000151903		byFrequency	Q86W67	gene with protein product		RP11-507M3.1_ENST00000584973.1_Intron		NM_001040710.1	395,908,588	NM_001040710	0.6012	Unknown(1)				+	Intron			64.0								FAM228A-001	2012-07-04				2	+	0.4425				intron	34418				A	SO:0001627				protein_coding	stomach(1)	1891				35.643,44.8969,41.7792			5997								KNOWN			AATGGAGGTGAGATAACGTGG		C2orf84				ENST00000295150.3:c.93+4A>T	2							+		,		2p23.3			g.chr2:24398446A>T					no		6983,5011												3.8					0.5			2012-07-04		hg19	Standard	0.6173			5285,2927			2103,2777,1117			p.?(1)		CCDS42659.1	A		TT,TA,AA			64		2504		rs2042468		179				"""chromosome 2 open reading frame 84"""						FLJ30851			NM_001040710		2			ENST00000295150.3		16389		uc002rfc.3			653140	dbSNP_94						1				66.0		0.483	2:g.24398446A>T		protein_coding			basic|appris_principal|CCDS		1708,1869,529			1698,2084			A|||			5008		F228A_HUMAN	3115	family with sequence similarity 228, member A			0.622005		24398446			0.7768	SNP		CCDS42659.1			,,,	False	24398446				intron_variant		Approved		64.0			2012-07-04	OTTHUMT00000324342.1	Q86W67	0.7752		FAM228A	24398446					C2orf84	NM_001040710.1	protein-coding gene	NP_001035800.1		
		A	ENSG00000186453	ENST00000295150.3		653140		ENSG00000186453		4106					,					OTTHUMG00000151903		byFrequency	Q86W67	gene with protein product		RP11-507M3.1_ENST00000584973.1_Intron		NM_001040710.1	0,22,1873	NM_001040710	0.0266					+	Intron			58.0								FAM228A-001	2012-07-04				2	+	0.0023				intron	34418				T	SO:0001627				protein_coding		1895				3.0078,0.5805,2.2413			6001								KNOWN			TGAGATAACGTGGCGTTTTGA		C2orf84				ENST00000295150.3:c.93+12T>A	2							+		,		2p23.3			g.chr2:24398454T>A					no		269,11733												-7.1					0.0			2012-07-04		hg19	Standard	0.0586			247,7965			10,249,5742					CCDS42659.1	T		AA,AT,TT			58		2504		rs116450336		179				"""chromosome 2 open reading frame 84"""						FLJ30851			NM_001040710		2			ENST00000295150.3		16492		uc002rfc.3			653140	dbSNP_132						0				60.0		0.478	2:g.24398454T>A		protein_coding			basic|appris_principal|CCDS		10,227,3869			22,3768			T|||			5008		F228A_HUMAN	107	family with sequence similarity 228, member A			0.0213658		24398454			0.0	SNP		CCDS42659.1			,,,	False	24398454				intron_variant		Approved		58.0			2012-07-04	OTTHUMT00000324342.1	Q86W67	0.0274		FAM228A	24398454					C2orf84	NM_001040710.1	protein-coding gene	NP_001035800.1		
		C	ENSG00000198399	ENST00000355123.4		50618		ENSG00000198399		4300					,					OTTHUMG00000090818		byFrequency	Q9NZM3	gene with protein product		ITSN2_ENST00000406921.3_Intron|ITSN2_ENST00000361999.3_Intron		NM_006277.2	2203,0,0	NM_006277	0.998					+	Intron		11.9+/-42.8	70.0				10922467, 11748279				ITSN2-001	2002-10-30				2	-	0.9985				intron,intron,intron	6184		,,		C	SO:0001627	604464	,,		protein_coding		2203				0.186,0.0,0.123		"""Rho guanine nucleotide exchange factors"", ""EF-hand domain containing"""	6503								KNOWN			GATTTTAATATCAAAATACCT		SH3D1B				ENST00000355123.4:c.3120+8A>G	2					breast(1)|central_nervous_system(1)|cervix(1)|endometrium(5)|kidney(8)|large_intestine(11)|liver(3)|lung(28)|ovary(2)|stomach(1)		-		,		2p23.3	O95062|Q15812|Q9HAK4|Q9NXE6|Q9NYG0|Q9NZM2|Q9ULG4	"""SH3 domain protein 1B"", ""SH3P18-like WASP associated protein"""	g.chr2:24475205T>C					no		12990,16												-2.2					0.0	calcium ion binding (GO:0005509)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)|SH3/SH2 adaptor activity (GO:0005070)				hg19	Standard	0.995			8584,16		endocytosis (GO:0006897)|positive regulation of signal transduction (GO:0009967)	6487,16,0					CCDS1710.2, CCDS1711.2, CCDS46230.1	T		CC,CT,TT	AB033082	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)	71		2504		rs4450560		3564				"""SH3 domain protein 1B"""				,,		KIAA1256, SWAP, SH3P18, SWA, PRO2015		61	NM_006277		25			ENST00000355123.4		18484		uc002rfe.2			50618	dbSNP_111	,,					0				71.0		0.308	2:g.24475205T>C		protein_coding			basic|appris_candidate_longest|CCDS		4284,16,0			4406,0			C|||			5008		ITSN2_HUMAN	4999	intersectin 2			0.998203		24475205			1.0	SNP		CCDS1710.2			,,,	False	24475205				intron_variant		Approved		71.0			2013-09-19	OTTHUMT00000207620.2	Q9NZM3	1.0		ITSN2	24475205		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	ITSN2	NM_006277.2,NM_019595.3,NM_147152.2	protein-coding gene	NP_006268.2		
		C	ENSG00000198399	ENST00000355123.4		50618		ENSG00000198399		4299					,					OTTHUMG00000090818		byFrequency	Q9NZM3	gene with protein product		ITSN2_ENST00000361999.3_Intron|ITSN2_ENST00000406921.3_Intron		NM_006277.2	2087,112,1	NM_006277	0.9509					+	Intron		77.5+/-140.1	38.0				10922467, 11748279				ITSN2-001	2002-10-30				2	-	0.9607				intron,intron,intron	6184		,,		C	SO:0001627	604464	,,		protein_coding		2200				2.0935,2.5909,2.2619		"""Rho guanine nucleotide exchange factors"", ""EF-hand domain containing"""	6499								KNOWN			TATAAGTATATTTATTTGTTT		SH3D1B				ENST00000355123.4:c.2538-31A>G	2					breast(1)|central_nervous_system(1)|cervix(1)|endometrium(5)|kidney(8)|large_intestine(11)|liver(3)|lung(28)|ovary(2)|stomach(1)		-		,		2p23.3	O95062|Q15812|Q9HAK4|Q9NXE6|Q9NYG0|Q9NZM2|Q9ULG4	"""SH3 domain protein 1B"", ""SH3P18-like WASP associated protein"""	g.chr2:24484150T>C		78.3+/-116.7			no		12704,294												-2.0					0.0	calcium ion binding (GO:0005509)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)|SH3/SH2 adaptor activity (GO:0005070)				hg19	Standard	0.9811			8418,180		endocytosis (GO:0006897)|positive regulation of signal transduction (GO:0009967)	6211,282,6					CCDS1710.2, CCDS1711.2, CCDS46230.1	T		CC,CT,TT	AB033082	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)	38		2504		rs4665680		2981				"""SH3 domain protein 1B"""				,,		KIAA1256, SWAP, SH3P18, SWA, PRO2015		61	NM_006277		22			ENST00000355123.4		18958		uc002rfe.2			50618	dbSNP_111	,,					0				38.0		0.269	2:g.24484150T>C		protein_coding			basic|appris_candidate_longest|CCDS		4124,170,5			4286,114			C|||			5008		ITSN2_HUMAN	4862	intersectin 2			0.970847		24484150			0.9931	SNP		CCDS1710.2			,,,	False	24484150				intron_variant		Approved		38.0			2013-09-19	OTTHUMT00000207620.2	Q9NZM3	0.9712		ITSN2	24484150		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	ITSN2	NM_006277.2,NM_019595.3,NM_147152.2	protein-coding gene	NP_006268.2		
		T	ENSG00000198399	ENST00000355123.4		50618		ENSG00000198399		4300					,					OTTHUMG00000090818		byFrequency	Q9NZM3	gene with protein product		ITSN2_ENST00000361999.3_Intron|ITSN2_ENST00000406921.3_Intron		NM_006277.2	2098,104,1	NM_006277	0.954					+	Intron		82.3+/-144.9	91.0				10922467, 11748279				ITSN2-001	2002-10-30				2	-	0.9675				intron,intron,intron	6184		,,		T	SO:0001627	604464	,,		protein_coding		2203				2.1047,2.4058,2.2067		"""Rho guanine nucleotide exchange factors"", ""EF-hand domain containing"""	6503								KNOWN			CAGGTAGCTCCATCATCATTC		SH3D1B				ENST00000355123.4:c.1494+40G>A	2					breast(1)|central_nervous_system(1)|cervix(1)|endometrium(5)|kidney(8)|large_intestine(11)|liver(3)|lung(28)|ovary(2)|stomach(1)		-		,		2p23.3	O95062|Q15812|Q9HAK4|Q9NXE6|Q9NYG0|Q9NZM2|Q9ULG4	"""SH3 domain protein 1B"", ""SH3P18-like WASP associated protein"""	g.chr2:24521493C>T		82.4+/-120.9			no		12719,287												-1.1					0.0	calcium ion binding (GO:0005509)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)|SH3/SH2 adaptor activity (GO:0005070)				hg19	Standard	0.9811			8419,181		endocytosis (GO:0006897)|positive regulation of signal transduction (GO:0009967)	6222,275,6					CCDS1710.2, CCDS1711.2, CCDS46230.1	C		TT,TC,CC	AB033082	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)	93		2504		rs7559133		1938				"""SH3 domain protein 1B"""				,,		KIAA1256, SWAP, SH3P18, SWA, PRO2015		61	NM_006277		13			ENST00000355123.4		17527		uc002rfe.2			50618	dbSNP_116	,,					0				97.0		0.438	2:g.24521493C>T		protein_coding			basic|appris_candidate_longest|CCDS		4124,171,5			4300,106			T|||			5008		ITSN2_HUMAN	4874	intersectin 2			0.973243		24521493			0.9931	SNP		CCDS1710.2			,,,	False	24521493				intron_variant		Approved		93.0			2013-09-19	OTTHUMT00000207620.2	Q9NZM3	0.9712		ITSN2	24521493		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	ITSN2	NM_006277.2,NM_019595.3,NM_147152.2	protein-coding gene	NP_006268.2		
		C	ENSG00000084676	ENST00000406961.1		8648		ENSG00000084676		4300					,				c.(460-462)acG>acC	OTTHUMG00000125523		byFrequency	Q15788	gene with protein product		NCOA1_ENST00000538539.1_Silent_p.T154T|NCOA1_ENST00000407230.1_Silent_p.T3T|NCOA1_ENST00000395856.3_Silent_p.T154T|NCOA1_ENST00000348332.3_Silent_p.T154T|NCOA1_ENST00000288599.5_Silent_p.T154T|NCOA1_ENST00000405141.1_Silent_p.T154T			720,1083,400	NM_147223	0.8292					+	Silent		200.9+/-244.5	85.0				7481822, 9575154				NCOA1-001					2	+	0.5242				coding-synonymous,coding-synonymous,coding-synonymous	7668		154/1442,154/1400,154/1441		C	SO:0001819	602691	,,		protein_coding		2203				10.407,42.7372,21.3594		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	6503	T							KNOWN		PAX3/NCOA1(8)	TAATGAATACGAGCGTCTACA						ENST00000406961.1:c.462G>C	2	PAS. {ECO:0000255|PROSITE- ProRule:PRU00140}.				breast(3)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(13)|lung(26)|ovary(2)|prostate(1)|skin(1)|urinary_tract(1)		+		,		2p23	O00150|O43792|O43793|Q13071|Q13420|Q2T9G5|Q53SX3|Q6GVI5|Q7KYV3		g.chr2:24905927G>C		541.9+/-375.9			no		10228,2778									Dom		8648	3.7					1.0	androgen receptor binding (GO:0050681)|chromatin binding (GO:0003682)|enzyme binding (GO:0019899)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region DNA binding (GO:0001012)|RNA polymerase II transcription coactivator activity (GO:0001105)|signal transducer activity (GO:0004871)|transcription coactivator activity (GO:0003713)				hg19	Standard	0.8966			7705,895		androgen receptor signaling pathway (GO:0030521)|cellular lipid metabolic process (GO:0044255)|cellular response to hormone stimulus (GO:0032870)|cerebellum development (GO:0021549)|cerebral cortex development (GO:0021987)|estrous cycle phase (GO:0060206)|hippocampus development (GO:0021766)|histone H4 acetylation (GO:0043967)|hypothalamus development (GO:0021854)|labyrinthine layer morphogenesis (GO:0060713)|lactation (GO:0007595)|male gonad development (GO:0008584)|male mating behavior (GO:0060179)|ovulation cycle (GO:0042698)|positive regulation of apoptotic process (GO:0043065)|positive regulation of female receptivity (GO:0045925)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cellular response to drug (GO:2001038)|response to estradiol (GO:0032355)|response to progesterone (GO:0032570)|response to retinoic acid (GO:0032526)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	4176,1876,451					CCDS1712.1, CCDS1713.1, CCDS42660.1	G		CC,CG,GG	U40396	cytoplasm (GO:0005737)|neuron projection (GO:0043005)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)	86		2504		rs11125744		1114								,,	154	SRC1, F-SRC-1, NCoA-1, KAT13A, RIP160, bHLHe74		53	XM_005264625		8			ENST00000406961.1	M	13774		uc002rfk.3	2p23	alveolar rhadomyosarcoma	8648	dbSNP_120	462,462,462			p.T154T		0				87.0		0.368	2:g.24905927G>C		protein_coding		nuclear receptor coactivator 1	basic|appris_candidate_longest|CCDS	PAX3	3456,793,51			2523,1883			C|||			5008	yes	NCOA1_HUMAN	4039	nuclear receptor coactivator 1	2		0.80651		24905927			0.996	SNP		CCDS1712.1			,,,	False	24905927				synonymous_variant		Approved		86.0		c.462G>C	2011-07-01	OTTHUMT00000246852.3	Q15788	0.9063		NCOA1	24905927		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	NCOA1	NM_003743.4,NM_147223.2,NM_147233.2	protein-coding gene			
		T	ENSG00000084676	ENST00000406961.1		8648		ENSG00000084676		4300					,				c.(1510-1512)ccA>ccT	OTTHUMG00000125523		byFrequency	Q15788	gene with protein product		NCOA1_ENST00000407230.1_Silent_p.P353P|NCOA1_ENST00000348332.3_Silent_p.P504P|NCOA1_ENST00000288599.5_Silent_p.P504P|NCOA1_ENST00000538539.1_Silent_p.P504P|NCOA1_ENST00000405141.1_Silent_p.P504P|NCOA1_ENST00000395856.3_Silent_p.P504P			25,480,1698	NM_147223	0.1012					+	Silent		148.3+/-203.6	89.0				7481822, 9575154				NCOA1-001					2	+	0.1399				coding-synonymous,coding-synonymous,coding-synonymous	7668		504/1442,504/1400,504/1441		A	SO:0001819	602691	,,		protein_coding		2203				6.1977,12.0291,8.1732		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	6503	T							KNOWN		PAX3/NCOA1(8)	CCAGGATGCCAAACAATTCCT						ENST00000406961.1:c.1512A>T	2	Interaction with STAT3.|Ser-rich.				breast(3)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(13)|lung(26)|ovary(2)|prostate(1)|skin(1)|urinary_tract(1)		+		,		2p23	O00150|O43792|O43793|Q13071|Q13420|Q2T9G5|Q53SX3|Q6GVI5|Q7KYV3		g.chr2:24929851A>T		240.3+/-251.1			no		1063,11943									Dom		8648	-2.8					1.0	androgen receptor binding (GO:0050681)|chromatin binding (GO:0003682)|enzyme binding (GO:0019899)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region DNA binding (GO:0001012)|RNA polymerase II transcription coactivator activity (GO:0001105)|signal transducer activity (GO:0004871)|transcription coactivator activity (GO:0003713)				hg19	Standard	0.0755			533,8067		androgen receptor signaling pathway (GO:0030521)|cellular lipid metabolic process (GO:0044255)|cellular response to hormone stimulus (GO:0032870)|cerebellum development (GO:0021549)|cerebral cortex development (GO:0021987)|estrous cycle phase (GO:0060206)|hippocampus development (GO:0021766)|histone H4 acetylation (GO:0043967)|hypothalamus development (GO:0021854)|labyrinthine layer morphogenesis (GO:0060713)|lactation (GO:0007595)|male gonad development (GO:0008584)|male mating behavior (GO:0060179)|ovulation cycle (GO:0042698)|positive regulation of apoptotic process (GO:0043065)|positive regulation of female receptivity (GO:0045925)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cellular response to drug (GO:2001038)|response to estradiol (GO:0032355)|response to progesterone (GO:0032570)|response to retinoic acid (GO:0032526)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	41,981,5481					CCDS1712.1, CCDS1713.1, CCDS42660.1	A		TT,TA,AA	U40396	cytoplasm (GO:0005737)|neuron projection (GO:0043005)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)	87		2504		rs3731628		2164								,,	504	SRC1, F-SRC-1, NCoA-1, KAT13A, RIP160, bHLHe74		53	XM_005264625		13			ENST00000406961.1	M	21783		uc002rfk.3	2p23	alveolar rhadomyosarcoma	8648	dbSNP_107	1512,1512,1512			p.P504P		0				84.0		0.423	2:g.24929851A>T		protein_coding		nuclear receptor coactivator 1	basic|appris_candidate_longest|CCDS	PAX3	16,501,3783			530,3876			A|||			5008	yes	NCOA1_HUMAN	540	nuclear receptor coactivator 1	2		0.107827		24929851			0.131	SNP		CCDS1712.1			,,,	False	24929851				synonymous_variant		Approved		87.0		c.1512A>T	2011-07-01	OTTHUMT00000246852.3	Q15788	0.0692		NCOA1	24929851		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	NCOA1	NM_003743.4,NM_147223.2,NM_147233.2	protein-coding gene			
		C	ENSG00000084676	ENST00000406961.1		8648		ENSG00000084676		4300					,					OTTHUMG00000125523		byFrequency	Q15788	gene with protein product		NCOA1_ENST00000538539.1_Intron|NCOA1_ENST00000407230.1_Intron|NCOA1_ENST00000405141.1_Intron|NCOA1_ENST00000348332.3_Intron|NCOA1_ENST00000288599.5_Intron|NCOA1_ENST00000395856.3_Intron			3,140,2059	NM_147223	0.0828					+	Intron		111.8+/-172.0	48.0				7481822, 9575154				NCOA1-001					2	+	0.0265				intron,intron,intron	7668		,,		A	SO:0001627	602691	,,		protein_coding		2202				3.6512,3.3152,3.5374		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	6502	T							KNOWN		PAX3/NCOA1(8)	GTATTTTATAAGGTATCAGAT						ENST00000406961.1:c.2717+27A>C	2					breast(3)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(13)|lung(26)|ovary(2)|prostate(1)|skin(1)|urinary_tract(1)		+		,		2p23	O00150|O43792|O43793|Q13071|Q13420|Q2T9G5|Q53SX3|Q6GVI5|Q7KYV3		g.chr2:24949602A>C		100.3+/-138.9			no		460,12544									Dom		8648	0.5					0.0	androgen receptor binding (GO:0050681)|chromatin binding (GO:0003682)|enzyme binding (GO:0019899)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region DNA binding (GO:0001012)|RNA polymerase II transcription coactivator activity (GO:0001105)|signal transducer activity (GO:0004871)|transcription coactivator activity (GO:0003713)				hg19	Standard	0.0457			314,8286		androgen receptor signaling pathway (GO:0030521)|cellular lipid metabolic process (GO:0044255)|cellular response to hormone stimulus (GO:0032870)|cerebellum development (GO:0021549)|cerebral cortex development (GO:0021987)|estrous cycle phase (GO:0060206)|hippocampus development (GO:0021766)|histone H4 acetylation (GO:0043967)|hypothalamus development (GO:0021854)|labyrinthine layer morphogenesis (GO:0060713)|lactation (GO:0007595)|male gonad development (GO:0008584)|male mating behavior (GO:0060179)|ovulation cycle (GO:0042698)|positive regulation of apoptotic process (GO:0043065)|positive regulation of female receptivity (GO:0045925)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cellular response to drug (GO:2001038)|response to estradiol (GO:0032355)|response to progesterone (GO:0032570)|response to retinoic acid (GO:0032526)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	8,444,6050					CCDS1712.1, CCDS1713.1, CCDS42660.1	A		CC,CA,AA	U40396	cytoplasm (GO:0005737)|neuron projection (GO:0043005)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)	48		2504		rs41281517		3369								,,		SRC1, F-SRC-1, NCoA-1, KAT13A, RIP160, bHLHe74		53	XM_005264625		15			ENST00000406961.1	M	16320		uc002rfk.3	2p23	alveolar rhadomyosarcoma	8648	dbSNP_127	,,					0				46.0		0.313	2:g.24949602A>C		protein_coding		nuclear receptor coactivator 1	basic|appris_candidate_longest|CCDS	PAX3	5,304,3991			146,4258			A|||			5008	yes	NCOA1_HUMAN	295	nuclear receptor coactivator 1	2		0.0589058		24949602			0.1012	SNP		CCDS1712.1			,,,	False	24949602				intron_variant		Approved		48.0			2011-07-01	OTTHUMT00000246852.3	Q15788	0.0447		NCOA1	24949602		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	NCOA1	NM_003743.4,NM_147223.2,NM_147233.2	protein-coding gene			
		G	ENSG00000084676	ENST00000406961.1		8648		ENSG00000084676		4300					,				c.(3799-3801)ctT>ctG	OTTHUMG00000125523		byFrequency	Q15788	gene with protein product		NCOA1_ENST00000538539.1_Silent_p.L1267L|NCOA1_ENST00000407230.1_Silent_p.L1116L|NCOA1_ENST00000395856.3_Silent_p.L1267L|NCOA1_ENST00000348332.3_Silent_p.L1267L|NCOA1_ENST00000288599.5_Silent_p.L1267L|NCOA1_ENST00000405141.1_Silent_p.L1267L			983,979,241	NM_147223	0.8303					+	Silent		200.7+/-244.4	69.0				7481822, 9575154				NCOA1-001					2	+	0.6278				coding-synonymous,coding-synonymous,coding-synonymous	7668		1267/1442,1267/1400,1267/1441		G	SO:0001819	602691	,,		protein_coding		2203				10.3953,33.1593,18.107		"""Chromatin-modifying enzymes / K-acetyltransferases"", ""Basic helix-loop-helix proteins"""	6503	T							KNOWN		PAX3/NCOA1(8)	AGAGTTCTCTTCTCCAGCAAA						ENST00000406961.1:c.3801T>G	2					breast(3)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(13)|lung(26)|ovary(2)|prostate(1)|skin(1)|urinary_tract(1)		+		,		2p23	O00150|O43792|O43793|Q13071|Q13420|Q2T9G5|Q53SX3|Q6GVI5|Q7KYV3		g.chr2:24974945T>G		471.8+/-356.2			no		10651,2355									Dom		8648	5.1					1.0	androgen receptor binding (GO:0050681)|chromatin binding (GO:0003682)|enzyme binding (GO:0019899)|histone acetyltransferase activity (GO:0004402)|ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|nuclear hormone receptor binding (GO:0035257)|protein N-terminus binding (GO:0047485)|RNA polymerase II regulatory region DNA binding (GO:0001012)|RNA polymerase II transcription coactivator activity (GO:0001105)|signal transducer activity (GO:0004871)|transcription coactivator activity (GO:0003713)				hg19	Standard	0.8976			7706,894		androgen receptor signaling pathway (GO:0030521)|cellular lipid metabolic process (GO:0044255)|cellular response to hormone stimulus (GO:0032870)|cerebellum development (GO:0021549)|cerebral cortex development (GO:0021987)|estrous cycle phase (GO:0060206)|hippocampus development (GO:0021766)|histone H4 acetylation (GO:0043967)|hypothalamus development (GO:0021854)|labyrinthine layer morphogenesis (GO:0060713)|lactation (GO:0007595)|male gonad development (GO:0008584)|male mating behavior (GO:0060179)|ovulation cycle (GO:0042698)|positive regulation of apoptotic process (GO:0043065)|positive regulation of female receptivity (GO:0045925)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cellular response to drug (GO:2001038)|response to estradiol (GO:0032355)|response to progesterone (GO:0032570)|response to retinoic acid (GO:0032526)|small molecule metabolic process (GO:0044281)|transcription, DNA-templated (GO:0006351)	4439,1773,291					CCDS1712.1, CCDS1713.1, CCDS42660.1	T		GG,GT,TT	U40396	cytoplasm (GO:0005737)|neuron projection (GO:0043005)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)	71		2504		rs11125763		4453								,,	1267	SRC1, F-SRC-1, NCoA-1, KAT13A, RIP160, bHLHe74		53	XM_005264625		20			ENST00000406961.1	M	17454		uc002rfk.3	2p23	alveolar rhadomyosarcoma	8648	dbSNP_120	3801,3801,3801			p.L1267L		0				75.0		0.532	2:g.24974945T>G		protein_coding		nuclear receptor coactivator 1	basic|appris_candidate_longest|CCDS	PAX3	3456,794,50			2945,1461			G|||			5008	yes	NCOA1_HUMAN	4187	nuclear receptor coactivator 1	2		0.836062		24974945			0.996	SNP		CCDS1712.1			,,,	False	24974945				synonymous_variant		Approved		71.0		c.3801T>G	2011-07-01	OTTHUMT00000246852.3	Q15788	0.9193		NCOA1	24974945		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	NCOA1	NM_003743.4,NM_147223.2,NM_147233.2	protein-coding gene			
		C	ENSG00000138031	ENST00000260600.5		109		ENSG00000138031		4300					,				c.(2869-2871)tcA>tcG	OTTHUMG00000094765		byFrequency	O60266	gene with protein product		ADCY3_ENST00000405392.1_Silent_p.S544S		NM_004036.3	642,1121,440		0.6851					+	Silent		450.6+/-362.4	87.0				9920776				ADCY3-001					2	-	0.5295				coding-synonymous	234		957/1145		C	SO:0001819	600291			protein_coding		2203				33.3837,45.4153,37.4596		"""Adenylate cyclases"""	6503								KNOWN			AGTCAAAATCTGAGATGATTT						ENST00000260600.5:c.2871A>G	2					NS(1)|breast(5)|endometrium(7)|kidney(1)|large_intestine(7)|lung(14)|ovary(3)|prostate(4)|skin(2)		-		,		2p23.3	B3KT86|Q53T54|Q9UDB1		g.chr2:25046090T>C		561.5+/-380.7			no		8134,4872												-8.2					0.7	adenylate cyclase activity (GO:0004016)|ATP binding (GO:0005524)|metal ion binding (GO:0046872)				hg19	Standard	0.668			5729,2871		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|sensory perception of smell (GO:0007608)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	2569,2996,938					CCDS1715.1	T		CC,CT,TT	AF033861	cilium (GO:0005929)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)	92		2504		rs1127568		3722									957	AC3		44	NM_004036		17			ENST00000260600.5		20373		uc002rfs.4			109	dbSNP_86	2871			p.S957S		0				102.0		0.502	2:g.25046090T>C		protein_coding			basic|appris_principal|CCDS		1927,1875,498			2405,2001			C|||			5008		ADCY3_HUMAN	3462	adenylate cyclase 3			0.691294		25046090			0.879	SNP		CCDS1715.1			,,,	False	25046090		4.6.1.1		synonymous_variant		Approved		92.0		c.2871A>G	2013-02-04	OTTHUMT00000211574.2	O60266	0.7695		ADCY3	25046090		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.203)			ADCY3	NM_004036.3	protein-coding gene	NP_004027.2		
		G	ENSG00000138031	ENST00000260600.5		109		ENSG00000138031		4300					,					OTTHUMG00000094765		byFrequency	O60266	gene with protein product		ADCY3_ENST00000405392.1_Intron		NM_004036.3	214,955,1034		0.5982					+	Intron		590.9+/-392.8	97.0				9920776				ADCY3-001					2	-	0.2837				intron	234				-	SO:0001627	600291			protein_coding		2203				47.9884,31.389,45.0254		"""Adenylate cyclases"""	6503								KNOWN			TTTTCTACCTACAGACACAGA						ENST00000260600.5:c.2578-3T>C	2					NS(1)|breast(5)|endometrium(7)|kidney(1)|large_intestine(7)|lung(14)|ovary(3)|prostate(4)|skin(2)		-		,		2p23.3	B3KT86|Q53T54|Q9UDB1		g.chr2:25047408A>G		455.7+/-351.1			no		5856,7150												-4.2					0.0	adenylate cyclase activity (GO:0004016)|ATP binding (GO:0005524)|metal ion binding (GO:0046872)				hg19	Standard	0.5229			4473,4127		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|sensory perception of smell (GO:0007608)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	1419,3018,2066					CCDS1715.1	A		GG,GA,AA	AF033861	cilium (GO:0005929)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)	100		2504		rs7604576		3429										AC3		44	NM_004036		16			ENST00000260600.5		20285		uc002rfs.4			109	dbSNP_116						0				106.0		0.522	2:g.25047408A>G		protein_coding			basic|appris_principal|CCDS		1205,2063,1032			1383,3023			A|||			5008		ADCY3_HUMAN	2612	adenylate cyclase 3			0.521565		25047408			0.6736	SNP		CCDS1715.1			,,,	False	25047408		4.6.1.1		intron_variant		Approved		100.0			2013-02-04	OTTHUMT00000211574.2	O60266	0.6441		ADCY3	25047408		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.203)			ADCY3	NM_004036.3	protein-coding gene	NP_004027.2		
		C	ENSG00000138031	ENST00000260600.5		109		ENSG00000138031		4300					,				c.(2224-2226)gaA>gaG	OTTHUMG00000094765		byFrequency	O60266	gene with protein product		ADCY3_ENST00000405392.1_Intron|ADCY3_ENST00000450524.1_5'UTR		NM_004036.3	424,1092,687		0.683					+	Silent		443.6+/-360.4	57.0				9920776				ADCY3-001					2	-	0.4115				coding-synonymous	234		742/1145		C	SO:0001819	600291			protein_coding		2203		OREG0014498		33.2209,44.0309,40.9273		"""Adenylate cyclases"""	6503				776				KNOWN			TGCCCTCCGTTTCCATCCCTG						ENST00000260600.5:c.2226A>G	2					NS(1)|breast(5)|endometrium(7)|kidney(1)|large_intestine(7)|lung(14)|ovary(3)|prostate(4)|skin(2)		-		,		2p23.3	B3KT86|Q53T54|Q9UDB1		g.chr2:25050977T>C		621.4+/-393.7			no		7683,5323												2.0					0.0	adenylate cyclase activity (GO:0004016)|ATP binding (GO:0005524)|metal ion binding (GO:0046872)				hg19	Standard	0.669			5743,2857		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|sensory perception of smell (GO:0007608)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	2362,2959,1182					CCDS1715.1	T		CC,CT,TT	AF033861	cilium (GO:0005929)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)	62		2504		rs7566416		3077									742	AC3		44	NM_004036		13			ENST00000260600.5		16311		uc002rfs.4			109	dbSNP_116	2226			p.E742E		0				72.0		0.592	2:g.25050977T>C		protein_coding			basic|appris_principal|CCDS		1938,1867,495	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		1940,2466			C|||			5008		ADCY3_HUMAN	3303	adenylate cyclase 3			0.659545		25050977			0.878	SNP		CCDS1715.1			,,,	False	25050977		4.6.1.1		synonymous_variant		Approved		62.0		c.2226A>G	2013-02-04	OTTHUMT00000211574.2	O60266	0.768		ADCY3	25050977		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.203)			ADCY3	NM_004036.3	protein-coding gene	NP_004027.2		
		A	ENSG00000138031	ENST00000260600.5		109		ENSG00000138031		4300					,				c.(421-423)taC>taT	OTTHUMG00000094765		byFrequency	O60266	gene with protein product				NM_004036.3	101,710,1392		0.0297					+	Silent		184.2+/-232.2	84.0				9920776				ADCY3-001					2	-	0.2179				coding-synonymous	234		141/1145		G	SO:0001819	600291			protein_coding		2203				9.093,20.699,13.0248		"""Adenylate cyclases"""	6503								KNOWN			GCCACAGCACGTAGGGCAGCA						ENST00000260600.5:c.423C>T	2					NS(1)|breast(5)|endometrium(7)|kidney(1)|large_intestine(7)|lung(14)|ovary(3)|prostate(4)|skin(2)		-		,		2p23.3	B3KT86|Q53T54|Q9UDB1		g.chr2:25141434G>A		353.8+/-312.3			no		1694,11312												2.6					1.0	adenylate cyclase activity (GO:0004016)|ATP binding (GO:0005524)|metal ion binding (GO:0046872)				hg19	Standard	0.0835			782,7818		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|sensory perception of smell (GO:0007608)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	139,1416,4948					CCDS1715.1	G		AA,AG,GG	AF033861	cilium (GO:0005929)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)	82		2504		rs61732745		1274									141	AC3		44	NM_004036		1			ENST00000260600.5		20124		uc002rfs.4			109	dbSNP_129	423			p.Y141Y		0				77.0		0.622	2:g.25141434G>A		protein_coding			basic|appris_principal|CCDS		38,706,3556			912,3494			G|||			5008		ADCY3_HUMAN	506	adenylate cyclase 3			0.101038		25141434			0.0446	SNP		CCDS1715.1			,,,	False	25141434		4.6.1.1		synonymous_variant		Approved		82.0		c.423C>T	2013-02-04	OTTHUMT00000211574.2	O60266	0.0865		ADCY3	25141434		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.203)			ADCY3	NM_004036.3	protein-coding gene	NP_004027.2		
		G	ENSG00000138031	ENST00000260600.5	0.48571	109	N	ENSG00000138031	0.17552	4300	0.047000	0.80653	B		,	T	3.229999999999622E-4	0	c.(319-321)Tcc>Ccc	OTTHUMG00000094765	0.099000	byFrequency	O60266	gene with protein product				NM_004036.3	1553,595,55		0.4744			G	0.005	+	Missense_Mutation	1	593.7+/-393.2	107.0	O60266	0.839991		9920776			0.0	ADCY3-001			0.01281		2	-	0.913		0.29	0.382000	missense	234	155	107/1145		G	SO:0001583	600291	benign	0.4281767955801105	protein_coding		2203	P		0.799000	47.1977,16.0009,40.3352	B	"""Adenylate cyclases"""	6503		0.2557:0.1545:0.5898:0.0						KNOWN	ENST00000260600;ENST00000415879;ENST00000435135;ENST00000438445		ACGGCGAGGGAAGCCAGCTTG	T;T;T					ENST00000260600.5:c.319T>C	2		ENSG00000138031	0.12676	ADCY3	NS(1)|breast(5)|endometrium(7)|kidney(1)|large_intestine(7)|lung(14)|ovary(3)|prostate(4)|skin(2)	ENSP00000260600:p.Ser107Pro	-	0.28903	,	TCC	2p23.3	B3KT86|Q53T54|Q9UDB1		g.chr2:25141538A>G	S -> P (in dbSNP:rs11676272). {ECO:0000269|PubMed:9920776}.	291.8+/-281.7		443	yes		7760,5246	0.18901	0.00318	4.8	0.00012	ENSP00000260600:S107P			0.22034		.		2.9	0.34122	242	0.29301	0.4230769230769231	0.0	adenylate cyclase activity (GO:0004016)|ATP binding (GO:0005524)|metal ion binding (GO:0046872)	-0.41			hg19	Standard	0.4642	0.9004065040650406	4.9246	4059,4541		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|sensory perception of smell (GO:0007608)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	2517,2726,1260	-2.164073				CCDS1715.1	A	0.02656	GG,GA,AA	AF033861	cilium (GO:0005929)|cytoplasm (GO:0005737)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)	104	0.03115	2504	2.94	rs11676272		1170	107	344			0.13887	24995042	-	PRO/SER	107	AC3	1184	44	NM_004036	0.0	1	0.45382585751978893	-0.213000	ENST00000260600.5		19699		uc002rfs.4			109	dbSNP_120	319	0.0000		p.S107P	.	0		T		100.0	rs11676272;rs11676272	0.612	2:g.25141538A>G	ENSP00000260600:S107P;ENSP00000389799:S107P;ENSP00000406153:S107P	protein_coding	0.065548		basic|appris_principal|CCDS		964,2131,1205		107;82;107;107	3701,705	0.5421245421245421	P	G|||		0.487586	5008		ADCY3_HUMAN	2839	adenylate cyclase 3		ADCY3_HUMAN	0.566893	0.33261	25141538		1.285000	0.4286	SNP		CCDS1715.1		N	,,,	False	25141538	-0.9944	4.6.1.1	9	missense	T	Approved	0.471977	104.0		c.319T>C	2013-02-04	OTTHUMT00000211574.2	O60266	0.3876	-1.4;-0.96;0.93	ADCY3	25141538	0.30200	Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.203)	0.31420	74	ADCY3	NM_004036.3	protein-coding gene	NP_004027.2	S	
		A	ENSG00000115137	ENST00000264711.2		51277		ENSG00000115137		4300					,				c.(31-33)ccC>ccT	OTTHUMG00000125524		byFrequency	Q9NZQ0	gene with protein product		DNAJC27-AS1_ENST00000451291.1_RNA|DNAJC27-AS1_ENST00000421904.1_RNA		NM_001198559.1|NM_016544.2	1002,951,250	NM_016544	0.6094					+	Silent		714.2+/-406.0	39.0				14980719				DNAJC27-001	2008-08-20				2	-	0.6324				coding-synonymous,coding-synonymous	30290		11/178,11/274		G	SO:0001819	613527	,		protein_coding		2203				22.7674,32.9324,26.211		"""Heat shock proteins / DNAJ (HSP40)"""	6503								KNOWN			GAGACCTGCCGGGCTCCTTCC		RBJ				ENST00000264711.2:c.33C>T	2	Required for interaction with MAPK1. {ECO:0000250|UniProtKB:Q8CFP6}.				breast(1)|endometrium(2)|large_intestine(4)|lung(4)|skin(1)|urinary_tract(1)		-		,		2p23.3	Q5JV88|Q86Y24		g.chr2:25194741G>A		672.5+/-402.6			no		9597,3409												-11.6					0.0	GTP binding (GO:0005525)		2008-08-20		hg19	Standard	0.7873			6642,1958		small GTPase mediated signal transduction (GO:0007264)	3562,2473,468					CCDS1716.1, CCDS74493.1	G		AA,AG,GG		mitochondrion (GO:0005739)	41		2504		rs7593864		222				"""rab and DnaJ domain containing"""				,	11	RabJS		13	NM_016544		1			ENST00000264711.2		14385		uc002rft.2			51277	dbSNP_116	33,33			p.P11P		0				45.0		0.692	2:g.25194741G>A		protein_coding			basic|appris_principal|CCDS		2560,1522,218			2955,1451			G|||			5008		DJC27_HUMAN	3570	DnaJ (Hsp40) homolog, subfamily C, member 27			0.712859		25194741			0.744	SNP		CCDS1716.1			,,,	False	25194741				synonymous_variant		Approved		41.0		c.33C>T	2011-09-02	OTTHUMT00000246855.3	Q9NZQ0	0.8588		DNAJC27	25194741				,	DNAJC27	NM_001198559.1,NM_016544.2	protein-coding gene	NP_001185488.1|NP_057628.1		
		T	ENSG00000119772	ENST00000264709.3		1788		ENSG00000119772		4300					,					OTTHUMG00000094777		byFrequency	Q9Y6K1	gene with protein product		DNMT3A_ENST00000321117.5_Intron|DNMT3A_ENST00000402667.1_Intron|DNMT3A_ENST00000380746.4_Intron		NM_175629.2	74,726,1403	NM_022552	0.4254					+	Intron		629.1+/-398.2	99.0				9662389, 10433969				DNMT3A-001					2	-	0.1014				intron,intron,intron	2978		,,		C	SO:0001627	602769	,,		protein_coding		2203				41.2558,19.8366,45.5636			6503	"""Mis, F, N, S"""							KNOWN			ACAGCCACACCGCAGCCAGAT						ENST00000264709.3:c.2597+29G>A	2					breast(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(964)|kidney(3)|large_intestine(10)|lung(29)|ovary(3)|prostate(3)|skin(2)|upper_aerodigestive_tract(2)		-		,		2p23	E9PEB8|Q86TE8|Q86XF5|Q8IZV0|Q8WXU9		g.chr2:25458546C>T		339.4+/-305.8			no		5926,7080									Rec		1788	-1.0					0.0	chromatin binding (GO:0003682)|DNA (cytosine-5-)-methyltransferase activity (GO:0003886)|DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates (GO:0051718)|DNA binding (GO:0003677)|identical protein binding (GO:0042802)|metal ion binding (GO:0046872)|unmethylated CpG binding (GO:0045322)				hg19	Standard	0.5785			5052,3548		C-5 methylation of cytosine (GO:0090116)|cellular response to amino acid stimulus (GO:0071230)|DNA methylation (GO:0006306)|DNA methylation involved in embryo development (GO:0043045)|DNA methylation involved in gamete generation (GO:0043046)|DNA methylation on cytosine within a CG sequence (GO:0010424)|hypermethylation of CpG island (GO:0044027)|methylation-dependent chromatin silencing (GO:0006346)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|regulation of gene expression by genetic imprinting (GO:0006349)|S-adenosylhomocysteine metabolic process (GO:0046498)|S-adenosylmethioninamine metabolic process (GO:0046499)|spermatogenesis (GO:0007283)	1553,2820,2130					CCDS1718.2, CCDS33157.1, CCDS46232.1	C		TT,TC,CC		chromosome, centromeric region (GO:0000775)|cytoplasm (GO:0005737)|euchromatin (GO:0000791)|nuclear heterochromatin (GO:0005720)|nuclear matrix (GO:0016363)|nucleus (GO:0005634)	103		2504		rs2304429		2935								,,				1021	NM_175630		22			ENST00000264709.3	L	19111		uc002rgc.4	2p23	AML	1788	dbSNP_100	,,					0				110.0		0.512	2:g.25458546C>T		protein_coding		DNA (cytosine-5-)-methyltransferase 3 alpha	basic|CCDS		1479,2094,727			874,3532			C|||			5008	yes	DNM3A_HUMAN	1807	DNA (cytosine-5-)-methyltransferase 3 alpha	2		0.360823		25458546			0.3065	SNP		CCDS33157.1			,,,	False	25458546				intron_variant		Approved		103.0			2014-09-17	OTTHUMT00000211587.1	Q9Y6K1	0.5274		DNMT3A	25458546		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)		,,	DNMT3A	NM_022552.3,NM_153759.2,NM_175629.1	protein-coding gene	NP_783328.1		
		G	ENSG00000084731	ENST00000264712.3		3797		ENSG00000084731		4300					,				c.(1825-1827)taT>taC	OTTHUMG00000094797		byFrequency	O14782	gene with protein product		KIF3C_ENST00000405914.1_Silent_p.Y609Y		NM_002254.6	137,834,1232		0.1166					+	Silent		756.2+/-407.5	70.0				9480755				KIF3C-001					2	-	0.2685				coding-synonymous	6321		609/794		G	SO:0001819	602845			protein_coding		2203				15.6628,25.1475,18.8759		"""Kinesins"""	6503								KNOWN			GCACGCGGATATACTCATCAT						ENST00000264712.3:c.1827T>C	2					breast(3)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(8)|ovary(4)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)		-		,		2p23	O43544|Q4ZG18|Q53SX5|Q562F7		g.chr2:26177198A>G		718.5+/-408.8			no		2455,10551												4.1					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)|motor activity (GO:0003774)				hg19	Standard	0.1481			1347,7253		antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|ATP catabolic process (GO:0006200)|blood coagulation (GO:0007596)|cytoskeleton-dependent intracellular transport (GO:0030705)|metabolic process (GO:0008152)|microtubule-based movement (GO:0007018)|organelle transport along microtubule (GO:0072384)	249,1957,4297					CCDS1719.1	A		GG,GA,AA		cytosol (GO:0005829)|kinesin complex (GO:0005871)|microtubule (GO:0005874)	77		2504		rs17047211		2406									609			29	NM_002254		4			ENST00000264712.3		17832		uc002rgu.2			3797	dbSNP_123	1827			p.Y609Y		0				91.0		0.627	2:g.26177198A>G		protein_coding			basic|appris_principal|CCDS		112,1123,3065			1108,3298			G|||			5008		KIF3C_HUMAN	703	kinesin family member 3C			0.140375		26177198			0.001	SNP		CCDS1719.1			,,,	False	26177198				synonymous_variant		Approved		77.0		c.1827T>C	2008-02-05	OTTHUMT00000211611.1	O14782	0.121		KIF3C	26177198		Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215)			KIF3C	NM_002254.6	protein-coding gene	NP_002245		
		G	ENSG00000165684	ENST00000298532.2		6621		ENSG00000165684		4300					,				c.(394-396)gaT>gaC	OTTHUMG00000020929		byFrequency		gene with protein product				NM_003086.2	266,1021,916	NM_003086	0.3978					+	Silent		626.9+/-397.9	102.0				9418884				SNAPC4-001	2002-08-29				9	-	0.3593				coding-synonymous	11137		132/1470	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	602777			protein_coding		2203				41.7093,35.2474,39.5202			6503					OV - Ovarian serous cystadenocarcinoma(145;5.31e-06)|Epithelial(140;7.13e-06)			KNOWN			GGCTTTTGCCATCTTTCACCT						ENST00000298532.2:c.396T>C	9					biliary_tract(1)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|lung(13)|ovary(1)|prostate(3)|skin(2)|urinary_tract(1)		-		,		9q34.3			g.chr9:139289825A>G		666.9+/-401.8			no		5140,7866												-9.4					0.0					hg19	Standard	0.3907			3587,5013			1008,3124,2371					CCDS6998.1	A		GG,GA,AA	AF032387		106		2504		rs4266763		764				"""small nuclear RNA activating complex, polypeptide 4, 190kD"""						SNAP190, PTFalpha, FLJ13451		33	XM_005266096		4			ENST00000298532.2		18187		uc004chh.3			6621	dbSNP_111	396			p.D132D		0				114.0		0.567	9:g.139289825A>G		protein_coding			basic|appris_principal|CCDS		742,2103,1455			1553,2853			a|||			5008			1983	small nuclear RNA activating complex, polypeptide 4, 190kDa			0.395966		139289825			0.3214	SNP		CCDS6998.1			,,,	False	139289825				synonymous_variant		Approved		106.0		c.396T>C	2008-07-21	OTTHUMT00000055071.1	Q5SXM2	0.5793		SNAPC4	139289825					SNAPC4	NM_003086.2	protein-coding gene	NP_003077.2		
		G	ENSG00000165684	ENST00000298532.2		6621		ENSG00000165684		4300					,					OTTHUMG00000020929		byFrequency		gene with protein product				NM_003086.2	286,1041,875	NM_003086	0.3998					+	Intron		606.2+/-395.1	86.0				9418884				SNAPC4-001	2002-08-29				9	-	0.3654				intron	11137			Myeloproliferative disorder(178;0.0511)	A	SO:0001627	602777			protein_coding		2202				45.0233,36.6258,42.1793			6502					OV - Ovarian serous cystadenocarcinoma(145;5.31e-06)|Epithelial(140;7.13e-06)			KNOWN			TGGCATGTGACGAGATGAGAC						ENST00000298532.2:c.178-29G>C	9					biliary_tract(1)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|lung(13)|ovary(1)|prostate(3)|skin(2)|urinary_tract(1)		-		,		9q34.3			g.chr9:139290251C>G		659.7+/-400.6			no		5485,7519												-3.7					0.0					hg19	Standard	0.4215			3872,4728			1164,3157,2181					CCDS6998.1	C		GG,GC,CC	AF032387		88		2504		rs4498662		546				"""small nuclear RNA activating complex, polypeptide 4, 190kD"""						SNAP190, PTFalpha, FLJ13451		33	XM_005266096		3			ENST00000298532.2		17760		uc004chh.3			6621	dbSNP_111						0				92.0		0.587	9:g.139290251C>G		protein_coding			basic|appris_principal|CCDS		878,2116,1306			1613,2791			G|||			5008			2048	small nuclear RNA activating complex, polypeptide 4, 190kDa			0.408946		139290251			0.3214	SNP		CCDS6998.1			,,,	False	139290251				intron_variant		Approved		88.0			2008-07-21	OTTHUMT00000055071.1	Q5SXM2	0.6138		SNAPC4	139290251					SNAPC4	NM_003086.2	protein-coding gene	NP_003077.2		
		T	ENSG00000165689	ENST00000357365.3	0.28814|0.28814	10807	L|L	ENSG00000165689	0.71995|0.71995	4119	1.000000|1.000000	.|0.78595	.|P;D;D		,	.|T	0.89807|0.89807	0|0	c.(910-912)cGg>cAg	OTTHUMG00000020928	2.218000|2.218000	byFrequency	Q96C92	gene with protein product		SDCCAG3_ENST00000298537.7_Missense_Mutation_p.R281Q|SDCCAG3_ENST00000371725.3_Missense_Mutation_p.R231Q|SDCCAG3_ENST00000461693.1_5'UTR		NM_001039707.1	1,93,1803	NM_006643	0.1278			C|C	11.89|11.89	+	Missense_Mutation	1|2		110.0	.|Q96C92-4;Q96C92-2;Q96C92	0.02504|0.02504		9610721			.|0.408;0.562;0.562	SDCCAG3-002			.|0.47941		9	-	0.0098		.|0.19	0.291000|0.291000	missense,missense,missense	10667	68|68	304/436,231/363,281/413	Myeloproliferative disorder(178;0.0511)	C	SO:0001583		probably-damaging,probably-damaging,probably-damaging	0.1878453038674033|0.1878453038674033	protein_coding		1897	P|P		1.000000|1.000000	12.5273,2.504,9.3667	.|B;P;P		6016		0.0:0.9132:0.0:0.0868|0.0:0.9132:0.0:0.0868			OV - Ovarian serous cystadenocarcinoma(145;8.18e-06)|Epithelial(140;9.31e-06)			KNOWN	ENST00000417512|ENST00000357365;ENST00000298537;ENST00000371725		TTCTAACTTCCGCTCAAGCGT	.|T;T;T					ENST00000357365.3:c.911G>A	9		ENSG00000165689|ENSG00000165689	0.77884|0.77884	SDCCAG3|SDCCAG3	NS(1)|breast(2)|cervix(1)|endometrium(2)|large_intestine(1)|lung(9)	ENSP00000349929:p.Arg304Gln	-	0.71417|0.71417	,	GGA|CGG	9q34.3	A6NCP1|O60525|Q5SXN1|Q5SXN2|Q5SXN3|Q5SXN4|Q5SXN8|Q6V704|Q9NVY5		g.chr9:139299637C>T	R -> Q (in dbSNP:rs3812577). {ECO:0000269|Ref.1}.			6|6	yes		1127,10905	0.80357|0.80357	0.31411|0.31411	4.53|4.53	0.00328|0.00328	.|ENSP00000298537:R281Q			.|0.43919		-15.0759|-15.0759		4.5	0.55603|0.55603	73|73	.|0.37606	0.12762237762237763|0.12762237762237763	1.0		1.83|1.83			hg19	Standard	0.1093	0.012195121951219513|0.012195121951219513	12.2017|12.2017	1032,7206			69,989,4958	1.772521|1.772521				CCDS6999.2, CCDS43903.1, CCDS43904.1	C	.|0.59767	TT,TC,CC	AF039688	cytoplasm (GO:0005737)	112	0.58810|0.58810	2504	4.53|4.53	rs3812577		1040	.|231;281;304	94|94			0.54331|0.54331	138419458|138419458	-|-	GLN/ARG,GLN/ARG,GLN/ARG	304	NY-CO-3	241|241	16	XM_005266050	.|0.956;0.986;0.986	7	0.12401055408970976|0.12401055408970976	0.563000|0.563000	ENST00000357365.3		19347		uc004chi.3			10807	dbSNP_107	911,692,842	0.0010|0.0010		p.R304Q	.|.	0		T|T		116.0	rs3812577;rs52833688;rs57736081;rs3812577|rs3812577;rs52833688;rs57736081;rs3812577	0.463	9:g.139299637C>T	.|ENSP00000349929:R304Q;ENSP00000298537:R281Q;ENSP00000360790:R231Q	protein_coding	.|0.000513		basic|appris_candidate_longest|CCDS		68,896,3155		45|304;281;231	95,3699	0.11034798534798534|0.11034798534798534	R|Q	C|||		.|0.192442	5008		SDCG3_HUMAN	548	serologically defined colon cancer antigen 3		.|.;.;SDCG3_HUMAN	0.109425	0.31932|0.31932	139299637		1.174000|1.174000	0.1359	SNP		CCDS43904.1		.|D	,,,	False	139299637	-1.0663|-1.0663		4|9	missense	T|T	Approved	0.125273|0.125273	112.0		c.911G>A	2010-10-27	OTTHUMT00000055060.2	Q96C92	0.2349	.|-1.19;-1.19;-1.19	SDCCAG3	139299637	0.27294|0.27294		0.09684|0.09684	43,43,43	SDCCAG3	NM_001039707.1,NM_001039708.1,NM_006643.3	protein-coding gene	NP_001034796.1	G|R	
		T	ENSG00000165688	ENST00000371717.3		23203		ENSG00000165688		4300					,				c.(88-90)taC>taT	OTTHUMG00000020926		byFrequency	Q10713	gene with protein product		PMPCA_ENST00000371720.1_Silent_p.Y30Y|PMPCA_ENST00000399219.3_5'UTR		NM_001282946.1|NM_015160.1	6,220,1977	NM_015160	0.1697					+	Silent		281.7+/-295.2	117.0				8590280, 7788527				PMPCA-001	2003-06-13				9	+	0.0333				coding-synonymous	18667		30/526	Myeloproliferative disorder(178;0.0821)	C	SO:0001819	613036			protein_coding		2203				17.3953,5.2655,13.2862			6503					OV - Ovarian serous cystadenocarcinoma(145;9.3e-06)|Epithelial(140;1.15e-05)			KNOWN			CTCCTGCGTACAGACGGTTTA		INPP5E				ENST00000371717.3:c.90C>T	9					endometrium(3)|kidney(1)|large_intestine(1)|lung(6)|ovary(2)|urinary_tract(1)		+		,		9q34.3	B4DKL3|E7ET61|Q16639|Q5SXM9|Q8N513		g.chr9:139306467C>T		138.0+/-173.8			no		1728,11278												4.5					0.4	metal ion binding (GO:0046872)|metalloendopeptidase activity (GO:0004222)		2003-06-20		hg19	Standard	0.1581			1496,7104		cellular protein metabolic process (GO:0044267)|protein targeting to mitochondrion (GO:0006626)|proteolysis (GO:0006508)	138,1452,4913					CCDS35180.1, CCDS65192.1	C		TT,TC,CC	D21064	extracellular space (GO:0005615)|mitochondrial inner membrane (GO:0005743)|mitochondrion (GO:0005739)	125		2504		rs10870144		99				"""inositol polyphosphate-5-phosphatase, 72 kD"""					30	KIAA0123, Alpha-MPP		14	NM_015160		2			ENST00000371717.3		19777		uc004chl.3			23203	dbSNP_120	90			p.Y30Y		0				139.0		0.488	9:g.139306467C>T		protein_coding			basic|appris_principal|CCDS		132,1232,2936			232,4174			C|||			5008		MPPA_HUMAN	696	peptidase (mitochondrial processing) alpha			0.138978		139306467			0.1419	SNP		CCDS35180.1			,,,	False	139306467				synonymous_variant		Approved		125.0		c.90C>T	2008-02-05	OTTHUMT00000055054.1	Q10713	0.2651		PMPCA	139306467					PMPCA	NM_015160.1	protein-coding gene	NP_001269875.1|NP_055975.1		
		G	ENSG00000148384	ENST00000371712.3		56623		ENSG00000148384		4299					,				c.(1246-1248)acT>acC	OTTHUMG00000020927		byFrequency	Q10713	gene with protein product				NM_019892.4	345,1057,800	NM_019892	0.3456					+	Silent		602.2+/-394.5	168.0				10764818, 10577920, 19668216				INPP5E-001					9	-	0.3896				coding-synonymous	21474		416/645	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	613037			protein_coding		2202				45.6153,39.6685,43.601			6501					OV - Ovarian serous cystadenocarcinoma(145;8.36e-06)|Epithelial(140;1.4e-05)			KNOWN			AGAGGAAGGAAGTGCCAAAAA		JBTS1				ENST00000371712.3:c.1248T>C	9					NS(1)|endometrium(1)|lung(4)|skin(3)		-		,		9q34.3	B4DKL3|E7ET61|Q16639|Q5SXM9|Q8N513		g.chr9:139327439A>G		636.1+/-396.5			no		5669,7333												3.7					1.0	metal ion binding (GO:0046872)|metalloendopeptidase activity (GO:0004222)				hg19	Standard	0.4145			3922,4676		cellular protein metabolic process (GO:0044267)|protein targeting to mitochondrion (GO:0006626)|proteolysis (GO:0006508)	1220,3229,2052					CCDS7000.1	A		GG,GA,AA	AF187891	extracellular space (GO:0005615)|mitochondrial inner membrane (GO:0005743)|mitochondrion (GO:0005739)	175		2504		rs10781542		1650				"""Joubert syndrome 1"""					0	PPI5PIV, CORS1		9	NM_019892		5			ENST00000371712.3		17746		uc004cho.3			56623	dbSNP_120	1248			p.T416T		0				189.0		0.582	9:g.139327439A>G		protein_coding			basic|appris_principal|CCDS		875,2172,1252			1747,2657			G|||			5008		MPPA_HUMAN	1895	inositol polyphosphate-5-phosphatase, 72 kDa			0.378395		139327439			0.1935	SNP		CCDS7000.1			,,,	False	139327439				synonymous_variant		Approved		175.0		c.1248T>C	2011-02-11	OTTHUMT00000055058.1	Q9NRR6	0.6196		INPP5E	139327439					INPP5E	NM_019892.4	protein-coding gene	NP_063945.2		
		A	ENSG00000148400	ENST00000277541.6		4851		ENSG00000148400		4271					,				c.(6553-6555)gaC>gaT	OTTHUMG00000020935		byFrequency	P46531	gene with protein product				NM_017617.3	891,995,297	NM_017617	0.6738	Deletion - Frameshift(1)|Deletion - In frame(1)				+	Silent			54.0				1831692				NOTCH1-001	2010-06-24				9	-	0.6278				coding-synonymous	7881		2185/2556	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	190198			protein_coding	haematopoietic_and_lymphoid_tissue(2)	2183				44.6734,36.3949,41.8733		"""Ankyrin repeat domain containing"""	6454	"""T, Mis, O"""				OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)	HNSCC(8;0.001)		KNOWN			AGCCCTTGCCGTCCTGGGACT		TAN1				ENST00000277541.6:c.6555C>T	9					breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)		-		,		9q34.3	Q59ED8|Q5SXM3		g.chr9:139391636G>A					no		7503,5405									Dom		4851	-0.8					1.0	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.5775			4726,3816		anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	2210,3083,1161			p.K2182fs*61(1)|p.S2163_T2283del(1)		CCDS43905.1	G		AA,AG,GG	AF308602	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	52		2504		rs2229974		6630				"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""					2185			1359	NM_017617		34			ENST00000277541.6	L	16337		uc004chz.3	9q34.3	T-ALL	4851	dbSNP_98	6555			p.D2185D		2				47.0		0.662	9:g.139391636G>A		protein_coding		"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""	basic|appris_principal|CCDS	TRB@	1319,2088,864			2777,1589			G|||			5008	yes	NOTC1_HUMAN	3481	notch 1	9		0.695088		139391636			0.9494	SNP		CCDS43905.1			,,,	False	139391636				synonymous_variant		Approved		52.0		c.6555C>T	2013-01-10	OTTHUMT00000055087.1	P46531	0.6542		NOTCH1	139391636		all_cancers(76;0.223)			NOTCH1	NM_017617.3	protein-coding gene	NP_060087.3		
		A	ENSG00000148400	ENST00000277541.6		4851		ENSG00000148400		4259					,				c.(5092-5094)gaC>gaT	OTTHUMG00000020935		byFrequency	P46531	gene with protein product				NM_017617.3	587,1034,514	NM_017617	0.3753	Substitution - coding silent(11)				+	Silent			67.0				1831692				NOTCH1-001	2010-06-24				9	-	0.5552				coding-synonymous	7881		1698/2556	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	190198			protein_coding	haematopoietic_and_lymphoid_tissue(11)	2135				35.3369,48.2904,40.8039		"""Ankyrin repeat domain containing"""	6394	"""T, Mis, O"""				OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)	HNSCC(8;0.001)		KNOWN			ATGCGGCCACGTCGGTGGCAC		TAN1				ENST00000277541.6:c.5094C>T	9					breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)		-		,		9q34.3	Q59ED8|Q5SXM3		g.chr9:139397707G>A					no		5218,7570									Dom		4851	-4.9					0.8	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.4046			3010,5508		anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	1132,2954,2308			p.D1699D(11)		CCDS43905.1	G		AA,AG,GG	AF308602	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	64		2504		rs10521		5169				"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""					1698			1359	NM_017617		27			ENST00000277541.6	L	17626		uc004chz.3	9q34.3	T-ALL	4851	dbSNP_52	5094			p.D1698D		11				57.0		0.632	9:g.139397707G>A		protein_coding		"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""	basic|appris_principal|CCDS	TRB@	545,1920,1794			2208,2062			G|||			5008	yes	NOTC1_HUMAN	2772	notch 1	9		0.553514		139397707			0.9018	SNP		CCDS43905.1			,,,	False	139397707				synonymous_variant		Approved		64.0		c.5094C>T	2013-01-10	OTTHUMT00000055087.1	P46531	0.5115		NOTCH1	139397707		all_cancers(76;0.223)			NOTCH1	NM_017617.3	protein-coding gene	NP_060087.3		
		C	ENSG00000148400	ENST00000277541.6		4851		ENSG00000148400		4203					,					OTTHUMG00000020935		byFrequency	P46531	gene with protein product				NM_017617.3	1655,387,41	NM_017617	0.6411					+	Intron			28.0				1831692				NOTCH1-001	2010-06-24				9	-	0.9576				intron	7881			Myeloproliferative disorder(178;0.0511)	C	SO:0001627	190198			protein_coding		2083				45.5151,11.2578,34.1632		"""Ankyrin repeat domain containing"""	6286	"""T, Mis, O"""				OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)	HNSCC(8;0.001)		KNOWN			GGACCCGAGCTGGGTGGGCAC		TAN1				ENST00000277541.6:c.3325+20A>G	9					breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)		-		,		9q34.3	Q59ED8|Q5SXM3		g.chr9:139402663T>C					no		8277,4295									Dom		4851	-0.9					0.0	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.5795			4580,3826		anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	2907,2463,916					CCDS43905.1	T		CC,CT,TT	AF308602	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	26		2504		rs3124597		3401				"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""								1359	NM_017617		20			ENST00000277541.6	L	16183		uc004chz.3	9q34.3	T-ALL	4851	dbSNP_103						0				21.0		0.672	9:g.139402663T>C		protein_coding		"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""	basic|appris_principal|CCDS	TRB@	1252,2076,875			3697,469			C|||			5008	yes	NOTC1_HUMAN	3842	notch 1	9		0.767173		139402663			0.9137	SNP		CCDS43905.1			,,,	False	139402663				intron_variant		Approved		26.0			2013-01-10	OTTHUMT00000055087.1	P46531	0.6412		NOTCH1	139402663		all_cancers(76;0.223)			NOTCH1	NM_017617.3	protein-coding gene	NP_060087.3		
		T	ENSG00000148400	ENST00000277541.6		4851		ENSG00000148400		4124					,					OTTHUMG00000020935		byFrequency	P46531	gene with protein product				NM_017617.3	782,893,301	NM_017617	0.3548					+	Intron			31.0				1831692				NOTCH1-001	2010-06-24				9	-	0.6952				intron	7881			Myeloproliferative disorder(178;0.0511)	C	SO:0001627	190198			protein_coding		1976				37.5,37.8289,45.4918		"""Ankyrin repeat domain containing"""	6100	"""T, Mis, O"""				OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)	HNSCC(8;0.001)		KNOWN			GTCTGCCCTGCGGGGCAGGAG		TAN1				ENST00000277541.6:c.2588-4G>A	9					breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)		-		,		9q34.3	Q59ED8|Q5SXM3		g.chr9:139405261C>T					no		5550,6650									Dom		4851	0.2					0.3	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.4284			3093,5155		anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	1376,2798,1926					CCDS43905.1	C		TT,TC,CC	AF308602	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	30		2504		rs3125001		2663				"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""								1359	NM_017617		17			ENST00000277541.6	L	14837		uc004chz.3	9q34.3	T-ALL	4851	dbSNP_103						0				26.0		0.697	9:g.139405261C>T		protein_coding		"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""	basic|appris_principal|CCDS	TRB@	594,1905,1625			2457,1495			C|||			5008	yes	NOTC1_HUMAN	2932	notch 1	9		0.585463		139405261			0.872	SNP		CCDS43905.1			,,,	False	139405261				intron_variant		Approved		30.0			2013-01-10	OTTHUMT00000055087.1	P46531	0.513		NOTCH1	139405261		all_cancers(76;0.223)			NOTCH1	NM_017617.3	protein-coding gene	NP_060087.3		
		G	ENSG00000148400	ENST00000277541.6		4851		ENSG00000148400		4277					,				c.(2263-2265)aaT>aaC	OTTHUMG00000020935		byFrequency	P46531	gene with protein product				NM_017617.3	864,967,358	NM_017617	0.272					+	Silent			123.0				1831692				NOTCH1-001	2010-06-24				9	-	0.6997				coding-synonymous	7881		755/2556	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	190198			protein_coding		2189				28.5831,38.4422,39.7464		"""Ankyrin repeat domain containing"""	6466	"""T, Mis, O"""				OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)	HNSCC(8;0.001)		KNOWN			ATTCACACTCATTGTTGTTGA		TAN1				ENST00000277541.6:c.2265T>C	9	EGF-like 20. {ECO:0000255|PROSITE- ProRule:PRU00076}.				breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)		-		,		9q34.3	Q59ED8|Q5SXM3		g.chr9:139407932A>G					no		5140,7792									Dom		4851	-2.3					0.0	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.335			2445,6109		anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	1222,2696,2548					CCDS43905.1	A		GG,GA,AA	AF308602	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	118		2504		rs2229971|rs587778559		2340				"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""					755			1359	NM_017617		14			ENST00000277541.6	L	19531		uc004chz.3	9q34.3	T-ALL	4851	dbSNP_98	2265			p.N755N		0				109.0		0.602	9:g.139407932A>G		protein_coding		"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""	basic|appris_principal|CCDS	TRB@	358,1729,2190			2695,1683			G|||			5008	yes	NOTC1_HUMAN	2643	notch 1	9		0.527756		139407932			0.7768	SNP		CCDS43905.1			,,,	False	139407932				synonymous_variant		Approved		118.0		c.2265T>C	2013-01-10	OTTHUMT00000055087.1	P46531	0.4784		NOTCH1	139407932		all_cancers(76;0.223)			NOTCH1	NM_017617.3	protein-coding gene	NP_060087.3		
		A	ENSG00000148400	ENST00000277541.6		4851		ENSG00000148400		4180					,					OTTHUMG00000020935		byFrequency	P46531	gene with protein product				NM_017617.3	1141,775,132	NM_017617	0.6616					+	Intron			42.0				1831692				NOTCH1-001	2010-06-24				9	-	0.7655				intron	7881			Myeloproliferative disorder(178;0.0511)	A	SO:0001627	190198			protein_coding		2048				46.0407,25.3662,44.5568		"""Ankyrin repeat domain containing"""	6228	"""T, Mis, O"""				OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)	HNSCC(8;0.001)		KNOWN			GGCCCCGGCCGACGCACCGGG		TAN1				ENST00000277541.6:c.1441+6C>T	9					breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)		-		,		9q34.3	Q59ED8|Q5SXM3		g.chr9:139412197G>A					no		6906,5550									Dom		4851	1.0					0.0	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)				hg19	Standard	0.4751			3849,4511		anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	2038,2830,1360					CCDS43905.1	G		AA,AG,GG	AF308602	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	41		2504		rs9411208		1517				"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""								1359	NM_017617		8			ENST00000277541.6	L	16850		uc004chz.3	9q34.3	T-ALL	4851	dbSNP_119						0				39.0		0.662	9:g.139412197G>A		protein_coding		"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""	basic|appris_principal|CCDS	TRB@	897,2055,1228			3057,1039			g|||			5008	yes	NOTC1_HUMAN	3487	notch 1	9		0.696286		139412197			0.9286	SNP		CCDS43905.1			,,,	False	139412197				intron_variant		Approved		41.0			2013-01-10	OTTHUMT00000055087.1	P46531	0.5965		NOTCH1	139412197		all_cancers(76;0.223)			NOTCH1	NM_017617.3	protein-coding gene	NP_060087.3		
		G	ENSG00000172889	ENST00000371699.1		51162		ENSG00000172889		3579					,					OTTHUMG00000020938		byFrequency	Q9UHF1	gene with protein product		EGFL7_ENST00000308874.7_Intron|EGFL7_ENST00000492002.1_Intron|EGFL7_ENST00000406555.3_Intron|EGFL7_ENST00000371698.3_Intron			628,712,218	NM_016215	0.7464					+	Intron			41.0								EGFL7-001					9	+	0.6346				intron,intron	20594		,	Myeloproliferative disorder(178;0.0511)	G	SO:0001627	608582	,		protein_coding		1558				36.3649,36.8421,36.5096			5137					OV - Ovarian serous cystadenocarcinoma(145;9.87e-06)|Epithelial(140;0.000123)			KNOWN			CGCATCGAAAACGCCGCTGAG						ENST00000371699.1:c.572-252A>G	9					kidney(2)|ovary(1)|prostate(2)|urinary_tract(1)		+		,		9q34.3	B3KRP0|M9VTX9|Q5M7Y5|Q5VUD5|Q96EG0		g.chr9:139565150A>G					no		6523,3751												0.1					0.0	calcium ion binding (GO:0005509)				hg19	Standard	0.6362			4555,2603		angiogenesis (GO:0001525)|blood vessel development (GO:0001568)|cell adhesion (GO:0007155)|negative regulation of cell migration (GO:0030336)|negative regulation of Notch signaling pathway (GO:0045746)|positive regulation of endothelial cell proliferation (GO:0001938)|vasculogenesis (GO:0001570)	2078,2367,692					CCDS7002.1	A		GG,GA,AA	AF186111	extracellular matrix (GO:0031012)|extracellular region (GO:0005576)|extracellular space (GO:0005615)	41		2504		rs386739594|rs4636297		1482								,		ZNEU1		6	NM_016215		8			ENST00000371699.1		14794		uc004cih.3			51162	dbSNP_111	,					0				41.0		0.617	9:g.139565150A>G		protein_coding			basic|appris_principal|CCDS		1450,1655,474			1968,1148			N|||			5008		EGFL7_HUMAN	3477	EGF-like-domain, multiple 7			0.694289		139565150			0.8135	SNP		CCDS7002.1			,,,	False	139565150				intron_variant		Approved		41.0			2008-02-05	OTTHUMT00000055094.1	Q9UHF1	0.6455		EGFL7	139565150		all_cancers(76;0.109)		,	EGFL7	NM_016215.4,NM_201446.2	protein-coding gene			
		G	ENSG00000165716	ENST00000371692.4	0.49130	138311	L	ENSG00000165716	0.12396	4300	0.998000	0.47177	B		,	T	2.469999999999972E-4	0	c.(472-474)Agc>Ggc	OTTHUMG00000020940	-0.093000	byFrequency	Q5VUD6	gene with protein product		FAM69B_ENST00000371691.1_Missense_Mutation_p.S71G|SNHG7_ENST00000414282.1_RNA		NM_152421.3	856,1023,323	NM_152421	0.8282			a	15.68	+	Missense_Mutation	1	786.0+/-407.6	29.0	Q5VUD6	0.621026		21334309			0.001	FAM69B-001			0.04013		9	+	0.5272		0.45	0.982000	missense	28290	346	158/432	Myeloproliferative disorder(178;0.0821)	A	SO:0001583	614543	benign	0.9558011049723757	protein_coding		2202	P		1.000000	4.1628,37.8974,15.5875	B		6502		0.7549:0.0:0.2451:0.0			OV - Ovarian serous cystadenocarcinoma(145;1.03e-05)|Epithelial(140;0.00013)			KNOWN	ENST00000371692;ENST00000371691		GATGACCCTCAGCTTCCTCAA	T;T					ENST00000371692.4:c.472A>G	9		ENSG00000165716	0.25879	FAM69B	NS(1)|endometrium(3)|large_intestine(2)|lung(1)|prostate(1)	ENSP00000360757:p.Ser158Gly	+	0.71417	,	AGC	9q34.3	Q5VUD7|Q8N5N0|Q8WYU5		g.chr9:139616742A>G	S -> G (in dbSNP:rs945384). {ECO:0000269|PubMed:15164053, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:15498874}.	633.1+/-396.0		273	yes		10977,2027	0.56505	0.52333	4.6	0.00012	ENSP00000360756:S71G			0.30011		-23.7354		0.9	0.18955	572	0.19590	1.0	1.0		1.74			hg19	Standard	0.9642	0.5548780487804879	8.0496	8242,358			4807,1363,332	2.903816				CCDS7004.1	A	0.02656	GG,GA,AA		endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)	28	0.55743	2504	0.846	rs945384		568	158	728			0.30570	138736563	+	GLY/SER	158	MGC20262, C9orf136	1919	8	NM_152421	0.0	4	0.9604221635883905	0.392000	ENST00000371692.4		14700		uc004cik.3			138311	dbSNP_86	472	0.0000		p.S158G	.	0		T		27.0	rs945384;rs17853012;rs58739652;rs945384	0.662	9:g.139616742A>G	ENSP00000360757:S158G;ENSP00000360756:S71G	protein_coding	0.010640		basic|appris_principal|CCDS		3951,340,9		158;71	2735,1669	0.8786630036630036	G	.|||		0.413008	5008		FA69B_HUMAN	4142	family with sequence similarity 69, member B		FA69B_HUMAN	0.827077	0.44793	139616742		2.433000	0.998	SNP		CCDS7004.1		N	,,,	False	139616742	-0.9971		9	missense	T	Approved	0.958372	28.0		c.472A>G	2012-08-03	OTTHUMT00000055102.1	Q5VUD6	0.9496	0.85;0.85	FAM69B	139616742	0.71751	all_cancers(76;0.0882)|all_epithelial(76;0.228)	0.30650	56	FAM69B	NM_152421.3	protein-coding gene	NP_689634.2	S	
		A	ENSG00000233016	ENST00000414282.1		84973				1991					,							byFrequency		RNA, long non-coding		SNHG7_ENST00000416970.1_RNA|SNHG7_ENST00000447221.1_RNA			78,344,454	NR_003672	0.4284					+	RNA			36.0				12477932				SNHG7-001	2008-08-14				9	-	0.236				near-gene-3	28254				G					antisense		876		OREG0019621		49.8744,28.5388,43.3554		"""Long non-coding RNAs"""	2867				1650				KNOWN			AGATACCAGCGAAGGAAAACA						ENST00000414282.1:	9							-		,		9q34.3		"""non-protein coding RNA 61"""	g.chr9:139621168G>A					no		2486,3248												-3.9					0.0					hg19	Standard	0.5179			1986,1996			577,1332,958						G		AA,AG,GG	CR599965, BC042369		35		2504		rs2275160		345										MGC16037, NCRNA00061			NR_003672		0			ENST00000414282.1		20159		uc004cim.2			84973	dbSNP_100						0				35.0		0.537	9:g.139621168G>A		antisense			basic		499,988,504	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		500,1252			G|||			5008			2315	small nucleolar RNA host gene 7 (non-protein coding)			0.46226		139621168			0.7391	SNP					,,,	False	139621168						Approved		35.0			2012-10-16	OTTHUMT00000055146.1		0.4582		SNHG7	139621168							non-coding RNA			
		C	ENSG00000177984	ENST00000316144.5		389812		ENSG00000177984		4300					,				c.(391-393)gcC>gcG	OTTHUMG00000020943		byFrequency	Q6UWW0	gene with protein product		LCN15_ENST00000482511.1_5'UTR		NM_203347.1	749,1095,359	NM_203347	0.6207					+	Silent		725.4+/-406.5	67.0								LCN15-002					9	-	0.5537				coding-synonymous	33777		131/185		G	SO:0001819				protein_coding		2203				22.3605,41.1484,28.7252		"""Lipocalins"""	6503								KNOWN			TGGTGCTGAGGGCCCCCTCCA						ENST00000316144.5:c.393C>G	9					endometrium(1)|lung(1)		-		,		9q34.3			g.chr9:139657834G>C		637.4+/-396.7			no		9270,3736												-2.3					0.7	small molecule binding (GO:0036094)|transporter activity (GO:0005215)				hg19	Standard	0.7823			6677,1923		lipid metabolic process (GO:0006629)	3360,2550,593					CCDS7006.1	G		CC,CG,GG		extracellular region (GO:0005576)	69		2504		rs9987876		417									131	UNQ2541, PRO6093		2	NM_203347		4			ENST00000316144.5		7244		uc004cjd.3			389812	dbSNP_119	393			p.A131A		0				73.0		0.652	9:g.139657834G>C		protein_coding			basic|appris_principal|CCDS		2611,1455,234			2593,1813			G|||			5008		LCN15_HUMAN	3527	lipocalin 15			0.704273		139657834			0.8562	SNP		CCDS7006.1			,,,	False	139657834				synonymous_variant		Approved		69.0		c.393C>G	2011-10-24	OTTHUMT00000055114.2	Q6UWW0	0.7752		LCN15	139657834					LCN15	NM_203347.1	protein-coding gene	NP_976222.1		
		C		ENST00000338005.6	0.41256		N		0.42165	4193	0.003000	0.10763	B		,	T	0.01325900000000002	0	c.(1261-1263)aAc>aCc		1.134000	byFrequency	Q5T5S1			RP11-216L13.18_ENST00000471502.1_RNA|RP11-216L13.19_ENST00000415992.1_RNA|KIAA1984-AS1_ENST00000414656.1_RNA		NM_001039374.4	1401,622,58		0.8149			C	0.692	+	Missense_Mutation	2		38.0	Q5T5S1	0.822681					0.0	KIAA1984-003			0.01281		9	+	0.8177		0.54	0.001000	missense		263	421/535	Myeloproliferative disorder(178;0.0511)	C	SO:0001583		benign	0.7265193370165746	protein_coding		2081	P		0.000000	20.3673,17.7319,19.4931	B		6274		0.1855:0.8145:0.0:0.0			OV - Ovarian serous cystadenocarcinoma(145;9.33e-06)|Epithelial(140;0.000124)			KNOWN	ENST00000423962;ENST00000338005		ATGGGCATTAACTTGCCTGCG	T					ENST00000338005.6:c.1262A>C	9		ENSG00000213213	0.12591	KIAA1984	biliary_tract(1)|breast(1)|endometrium(1)|kidney(2)|lung(4)|ovary(1)|pancreas(1)|prostate(1)|urinary_tract(1)	ENSP00000338013:p.Asn421Thr	+	0.05858	,	AAC		B2RP89|C9JD38|Q6P2D9|Q8NAI4|Q8TF18		g.chr9:139701108A>C	N -> T (in dbSNP:rs2254143). {ECO:0000269|PubMed:15164053, ECO:0000269|PubMed:15489334}.			397	yes		10102,2446	0.11579	0.02862	5.07	0.00012	ENSP00000338013:N421T			.		-0.7687		5.1	0.68467	485	0.15499	0.8479020979020979	0.0		-1.1			hg19		0.8032	0.806910569105691	11.0894	6678,1708			4067,1968,239	-0.794278					A	0.02656	CC,CA,AA			36	0.00926	2504	5.07	rs2254143		1297	421	613			0.48106	138820929	+	THR/ASN	421		1758	13		0.0	11	0.8087071240105541	-0.217000	ENST00000338005.6		19133						dbSNP_100	1262	0.0000		p.N421T	.	0		T		33.0	rs2254143;rs61409775;rs2254143	0.632	9:g.139701108A>C	ENSP00000338013:N421T	protein_coding	.		basic|appris_principal|CCDS		2666,1346,181		421	3424,738	0.804945054945055	T	C|||		.	5008		CC183_HUMAN	4039			K1984_HUMAN	0.80651	0.27267	139701108		0.816000	0.8581	SNP		CCDS43906.1		.	,,,	False	139701108	-1.0545		8	missense	T		0.796327	36.0		c.1262A>C		OTTHUMT00000354899.1		0.7032	2.84	KIAA1984	139701108	0.01503	all_cancers(76;0.0882)|all_epithelial(76;0.228)	0.12502	65	KIAA1984	NM_001039374.4		NP_001034463.4	N	
		T	ENSG00000176919	ENST00000224181.3		733		ENSG00000176919		4293					,					OTTHUMG00000020955		byFrequency	P07360	gene with protein product				NM_000606.2	881,987,328		0.5859					+	Intron			18.0								C8G-004					9	+	0.6793				intron	1354			Myeloproliferative disorder(178;0.0511)	G	SO:0001627	120930			protein_coding		2196				46.9252,37.4089,43.7047		"""Complement system"", ""Lipocalins"""	6489					OV - Ovarian serous cystadenocarcinoma(145;7.88e-06)|Epithelial(140;0.000107)			KNOWN			GGGCTGCAGGGCATGTGGGTG						ENST00000224181.3:c.346+20G>T	9					NS(1)|prostate(1)|skin(1)		+		,		9q	Q14CT8|Q14CU0|Q5SQ07		g.chr9:139840471G>T					no		7306,5672												2.8					0.0	retinol binding (GO:0019841)				hg19	Standard	0.5437			4557,4029		complement activation, alternative pathway (GO:0006957)|complement activation, classical pathway (GO:0006958)|cytolysis (GO:0019835)|innate immune response (GO:0045087)|regulation of complement activation (GO:0030449)	2117,3072,1300					CCDS7017.1	G		TT,TG,GG	X06465	blood microparticle (GO:0072562)|extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)|membrane attack complex (GO:0005579)	17		2504		rs7862602		406												3	NM_000606		3			ENST00000224181.3		15414		uc004cka.2			733	dbSNP_116						0				16.0		0.672	9:g.139840471G>T		protein_coding			basic|appris_principal|CCDS		1236,2085,972			2749,1643			G|||			5008		CO8G_HUMAN	3170	complement component 8, gamma polypeptide			0.632987		139840471	STAD - Stomach adenocarcinoma(284;0.19)		0.8363	SNP		CCDS7017.1			,,,	False	139840471				intron_variant		Approved		17.0			2011-11-15	OTTHUMT00000055178.1	P07360	0.4452		C8G	139840471		all_cancers(76;0.11)			C8G	NM_000606.2	protein-coding gene	NP_000597.2		
		G	ENSG00000176919	ENST00000224181.3	0.80722	733	N	ENSG00000176919	0.41459	4298	0.086000	0.16196	B		,	T	0.0	0	c.(352-354)gAc>gGc	OTTHUMG00000020955	1.097000	byFrequency	P07360	gene with protein product				NM_000606.2	2030,161,7		0.9826			G	5.930	+	Missense_Mutation	2		22.0	P07360	0.960191					0.0	C8G-004			0.01281		9	+	0.9493		0.52	0.308000	missense	1354	349	118/203	Myeloproliferative disorder(178;0.0511)	G	SO:0001583	120930	benign	0.9640883977900553	protein_coding		2198	P		0.206000	5.2699,3.9809,4.8337	B	"""Complement system"", ""Lipocalins"""	6496		0.0921:0.0:0.9079:0.0			OV - Ovarian serous cystadenocarcinoma(145;7.88e-06)|Epithelial(140;0.000107)			KNOWN	ENST00000371634;ENST00000224181		CCAGCCCGAGACGCCCGAGGG	T;T					ENST00000224181.3:c.353A>G	9		ENSG00000176919	0.12644	C8G	NS(1)|prostate(1)|skin(1)	ENSP00000224181:p.Asp118Gly	+	0.23470	,	GAC	9q	Q14CT8|Q14CU0|Q5SQ07		g.chr9:139840543A>G	D -> G (in dbSNP:rs7850844). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2447883, ECO:0000269|PubMed:3676249, ECO:0000269|PubMed:8172891, ECO:0000269|Ref.5}.			458	yes		12364,628	0.20670	0.11239	4.15	0.00012	ENSP00000224181:D118G			0.23840		-13.0909		4.2	0.48705	572	0.16420	1.0	0.1	retinol binding (GO:0019841)	-2.295			hg19	Standard	0.9394	0.9308943089430894	11.2325	8143,453		complement activation, alternative pathway (GO:0006957)|complement activation, classical pathway (GO:0006958)|cytolysis (GO:0019835)|innate immune response (GO:0045087)|regulation of complement activation (GO:0030449)	5889,586,21	0.355560				CCDS7017.1	A	0.02656	GG,GA,AA	X06465	blood microparticle (GO:0072562)|extracellular region (GO:0005576)|extracellular vesicular exosome (GO:0070062)|membrane attack complex (GO:0005579)	22	0.00067	2504	4.15	rs7850844		413	118	710			0.48920	138960364	+	GLY/ASP	118		2089	3	NM_000606	0.0	4	0.9366754617414248	-0.215000	ENST00000224181.3		15259		uc004cka.2			733	dbSNP_116	353	0.0000		p.D118G	Calycin-like (1);Lipocalin/cytosolic fatty-acid binding protein domain (1);Calycin (1);	0		T		21.0	rs7850844;rs59183459	0.642	9:g.139840543A>G	ENSP00000360697:D118G;ENSP00000224181:D118G	protein_coding	0.044054		basic|appris_principal|CCDS		3859,425,14		118	4221,175	0.9565018315018315	G	G|||		0.403577	5008		CO8G_HUMAN	4844	complement component 8, gamma polypeptide		CO8G_HUMAN	0.967252	0.38922	139840543	STAD - Stomach adenocarcinoma(284;0.19)	1.809000	1.0	SNP		CCDS7017.1		N	,,,	False	139840543	-0.9572		9	missense	T	Approved	0.947301	22.0		c.353A>G	2011-11-15	OTTHUMT00000055178.1	P07360	0.9726	2.75;2.36	C8G	139840543	0.27856	all_cancers(76;0.11)	0.40270	94	C8G	NM_000606.2	protein-coding gene	NP_000597.2	D	
		G	ENSG00000184925	ENST00000371633.3		286256		ENSG00000184925		4186					,					OTTHUMG00000020968		byFrequency	Q6JVE5	gene with protein product		LCN12_ENST00000466277.1_3'UTR		NM_178536.3	789,927,348	NM_178536	0.5603					+	Intron			36.0				15363845				LCN12-015	2007-12-18				9	+	0.6815				intron	28733			Myeloproliferative disorder(178;0.0511)	A	SO:0001627	612905			protein_coding		2064				43.5141,39.3169,49.184		"""Lipocalins"""	6250					OV - Ovarian serous cystadenocarcinoma(145;7.8e-06)|Epithelial(140;0.000106)			KNOWN			GCTGGCCCACAGGGATGTGAC						ENST00000371633.3:c.332-27A>G	9					endometrium(1)|kidney(1)|lung(1)|prostate(2)		+		,		9q34	A2AMJ7		g.chr9:139848273A>G					no		6148,6352												-0.9					0.0	retinoic acid binding (GO:0001972)|transporter activity (GO:0005215)				hg19	Standard	0.4374			3643,4729		lipid metabolic process (GO:0006629)	1604,2940,1706					CCDS7018.2	A		GG,GA,AA	BC041168	extracellular region (GO:0005576)	34		2504		rs2271869		331										MGC48935		5	XM_005266068		4			ENST00000371633.3		17366		uc004ckb.3			286256	dbSNP_100						0				30.0		0.657	9:g.139848273A>G		protein_coding			basic|appris_principal|CCDS		815,2013,1358			2505,1623			A|||			5008		LCN12_HUMAN	3014	lipocalin 12			0.601837		139848273	STAD - Stomach adenocarcinoma(284;0.19)		0.8373	SNP		CCDS7018.2			,,,	False	139848273				intron_variant		Approved		34.0			2011-10-24	OTTHUMT00000257990.1	Q6JVE5	0.4049		LCN12	139848273		all_cancers(76;0.11)			LCN12	NM_178536.3	protein-coding gene	NP_848631.2		
		C	ENSG00000184925	ENST00000371633.3		286256		ENSG00000184925		4190					,					OTTHUMG00000020968		byFrequency	Q6JVE5	gene with protein product		LCN12_ENST00000466277.1_3'UTR		NM_178536.3	977,844,253	NM_178536	0.5603					+	Intron			37.0				15363845				LCN12-015	2007-12-18				9	+	0.7194				intron	28733			Myeloproliferative disorder(178;0.0511)	C	SO:0001627	612905			protein_coding		2074				44.6301,32.5458,47.8129		"""Lipocalins"""	6264					OV - Ovarian serous cystadenocarcinoma(145;7.8e-06)|Epithelial(140;0.000106)			KNOWN			CCCACAGGGATGTGACGTCTG						ENST00000371633.3:c.332-22T>C	9					endometrium(1)|kidney(1)|lung(1)|prostate(2)		+		,		9q34	A2AMJ7		g.chr9:139848278T>C					no		6538,5990												-1.7					0.0	retinoic acid binding (GO:0001972)|transporter activity (GO:0005215)				hg19	Standard	0.4384			3740,4640		lipid metabolic process (GO:0006629)	1832,2874,1558					CCDS7018.2	T		CC,CT,TT	BC041168	extracellular region (GO:0005576)	35		2504		rs2271868		331										MGC48935		5	XM_005266068		4			ENST00000371633.3		17135		uc004ckb.3			286256	dbSNP_100						0				30.0		0.657	9:g.139848278T>C		protein_coding			basic|appris_principal|CCDS		855,2030,1305			2798,1350			C|||			5008		LCN12_HUMAN	3068	lipocalin 12			0.61262		139848278	STAD - Stomach adenocarcinoma(284;0.19)		0.8373	SNP		CCDS7018.2			,,,	False	139848278				intron_variant		Approved		35.0			2011-10-24	OTTHUMT00000257990.1	Q6JVE5	0.4092		LCN12	139848278		all_cancers(76;0.11)			LCN12	NM_178536.3	protein-coding gene	NP_848631.2		
		T	ENSG00000184925	ENST00000371633.3	0.58432	286256	.	ENSG00000184925	0.01682	4193	0.000000	.	.		,	D	5.000000000032756E-6	0	c.(529-531)atC>atT	OTTHUMG00000020968	-1.562000	byFrequency	Q6JVE5	gene with protein product		LCN12_ENST00000466277.1_3'UTR		NM_178536.3	1478,511,54	NM_178536	0.6585			T	6.665	+	Silent	2		26.0	.	0.848507		15363845			.	LCN12-015	2007-12-18		.		9	+	0.8646		0	0.089000	coding-synonymous	28733	216	177/193	Myeloproliferative disorder(178;0.0511)	T	SO:0001819	612905		0.5966850828729282	protein_coding		2043	P		0.000000	31.2783,15.1493,25.9942	.	"""Lipocalins"""	6236		0.0:0.367:0.1289:0.5041			OV - Ovarian serous cystadenocarcinoma(145;7.8e-06)|Epithelial(140;0.000106)			KNOWN	ENST00000371632		ATGACAACATCGTCTTCCCAG	.					ENST00000371633.3:c.531C>T	9		ENSG00000184925	0.02921	LCN12	endometrium(1)|kidney(1)|lung(1)|prostate(2)		+	0.05858	,	TCG	9q34	A2AMJ7		g.chr9:139848688C>T				404	no		9230,3242	0.03702	0.12702	2.75	0.00012	ENSP00000360695:S86L			.		-12.4307		-4.2	0.03823	486	0.87932	0.8496503496503497	0.0	retinoic acid binding (GO:0001972)|transporter activity (GO:0005215)	.			hg19	Standard	0.6869	0.8211382113821138	6.4504	5763,2623		lipid metabolic process (GO:0006629)	3507,2216,513	0.491255				CCDS7018.2	C	.	TT,TC,CC	BC041168	extracellular region (GO:0005576)	25	.	2504	-4.2	rs4880175		531	.	525			0.21900	138968509	+		177	MGC48935	1631	5	XM_005266068	.	5	0.6926121372031663	-0.893000	ENST00000371633.3		15124		uc004ckb.3			286256	dbSNP_111	531	0.0000		p.I177I	.	0		T		23.0	rs4880175;rs13286062;rs17846306;rs17859331;rs57156148	0.622	9:g.139848688C>T	.	protein_coding	.		basic|appris_principal|CCDS		2029,1705,459		86	3467,619	0.7467948717948718	L	T|||		.	5008		LCN12_HUMAN	3752	lipocalin 12		.	0.749201	0.05019	139848688	STAD - Stomach adenocarcinoma(284;0.19)	-0.711000	0.8641	SNP		CCDS7018.2		.	,,,	False	139848688	-1.0207		4	synonymous_variant	T	Approved	0.687217	25.0		c.531C>T	2011-10-24	OTTHUMT00000257990.1	Q6JVE5	0.5807	.	LCN12	139848688	0.18198	all_cancers(76;0.11)	0.22765		LCN12	NM_178536.3	protein-coding gene	NP_848631.2	S	
		G	ENSG00000107331	ENST00000371605.3		20		ENSG00000107331		4294					,				c.(6685-6687)ctT>ctC	OTTHUMG00000020958		byFrequency	Q9BZC7	gene with protein product		ABCA2_ENST00000341511.6_Silent_p.L2230L|ABCA2_ENST00000265662.5_Silent_p.L2230L			1155,862,162	NM_001606	0.7802					+	Silent		405.0+/-348.4	97.0				8088782				ABCA2-202					9	-	0.7171				coding-synonymous,coding-synonymous	32		2230/2437,2260/2467	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	600047	,		protein_coding		2179				30.1351,27.2143,29.1519		"""ATP binding cassette transporters / subfamily A"""	6473					OV - Ovarian serous cystadenocarcinoma(145;2.94e-05)|Epithelial(140;0.00048)			KNOWN			TGATGAGGTCAAGGATGAGGT		ABC2				ENST00000371605.3:c.6687T>C	9	ABC transporter 2. {ECO:0000255|PROSITE- ProRule:PRU00434}.				central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|liver(1)|lung(25)|prostate(2)|skin(1)|stomach(1)|urinary_tract(1)		-		,		9q34	A6NED5|Q5SPY5|Q5W9G5|Q76MW7|Q9HC28		g.chr9:139904037A>G		370.3+/-319.5			yes		9172,3774												-6.6					0.5	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|ATPase activity, coupled to transmembrane movement of substances (GO:0042626)|nucleotide binding (GO:0000166)				hg19	Standard	0.6759			6000,2588		ATP catabolic process (GO:0006200)|cholesterol homeostasis (GO:0042632)|lipid metabolic process (GO:0006629)|regulation of intracellular cholesterol transport (GO:0032383)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|response to drug (GO:0042493)|response to steroid hormone (GO:0048545)|transmembrane transport (GO:0055085)|transport (GO:0006810)	3262,2648,563					CCDS43909.1	A		GG,GA,AA	U18235	ATP-binding cassette (ABC) transporter complex (GO:0043190)|cytoplasmic membrane-bounded vesicle (GO:0016023)|endosome (GO:0005768)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|microtubule organizing center (GO:0005815)	92		2504		rs7048567		6834								,	2229			41	NM_212533		43			ENST00000371605.3		10338		uc022bpy.1			20	dbSNP_116	6690,6780			p.L2229L		0				81.0		0.662	9:g.139904037A>G		protein_coding			basic		2107,1786,401			3172,1186			G|||			5008		ABCA2_HUMAN	3606	ATP-binding cassette, sub-family A (ABC1), member 2			0.720048		139904037	STAD - Stomach adenocarcinoma(284;0.123)		0.8194	SNP					,,,	False	139904037				synonymous_variant		Approved		92.0		c.6687T>C	2012-03-14		Q9BZC7	0.5605		ABCA2	139904037		all_cancers(76;0.16)		,	ABCA2	NM_001606.4,NM_212533.2	protein-coding gene			
		A	ENSG00000107331	ENST00000371605.3		20		ENSG00000107331		4255					,				c.(6100-6102)gcC>gcT	OTTHUMG00000020958		byFrequency	Q9BZC7	gene with protein product		ABCA2_ENST00000265662.5_Silent_p.A2035A|ABCA2_ENST00000341511.6_Silent_p.A2035A			4,97,2050	NM_001606	0.1677					+	Silent			111.0				8088782				ABCA2-202					9	-	0.0234				coding-synonymous,coding-synonymous	32		2035/2437,2065/2467	Myeloproliferative disorder(178;0.0511)	C	SO:0001819	600047	,		protein_coding		2151				6.7215,2.4407,5.2841		"""ATP binding cassette transporters / subfamily A"""	6406					OV - Ovarian serous cystadenocarcinoma(145;2.94e-05)|Epithelial(140;0.00048)			KNOWN			GCCGCTCACTGGCCACGTCCA		ABC2				ENST00000371605.3:c.6102C>T	9					central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|liver(1)|lung(25)|prostate(2)|skin(1)|stomach(1)|urinary_tract(1)		-		,		9q34	A6NED5|Q5SPY5|Q5W9G5|Q76MW7|Q9HC28		g.chr9:139905141G>A					yes		677,12135												0.7					0.3	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|ATPase activity, coupled to transmembrane movement of substances (GO:0042626)|nucleotide binding (GO:0000166)				hg19	Standard	0.0586			572,7938		ATP catabolic process (GO:0006200)|cholesterol homeostasis (GO:0042632)|lipid metabolic process (GO:0006629)|regulation of intracellular cholesterol transport (GO:0032383)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|response to drug (GO:0042493)|response to steroid hormone (GO:0048545)|transmembrane transport (GO:0055085)|transport (GO:0006810)	19,639,5748					CCDS43909.1	G		AA,AG,GG	U18235	ATP-binding cassette (ABC) transporter complex (GO:0043190)|cytoplasmic membrane-bounded vesicle (GO:0016023)|endosome (GO:0005768)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|microtubule organizing center (GO:0005815)	107		2504		rs112887513		6249								,	2034			41	NM_212533		39			ENST00000371605.3		5333		uc022bpy.1			20	dbSNP_132	6105,6195			p.A2034A		0				99.0		0.637	9:g.139905141G>A		protein_coding			basic		15,542,3698			105,4197			g|||			5008		ABCA2_HUMAN	329	ATP-binding cassette, sub-family A (ABC1), member 2			0.0656949		139905141	STAD - Stomach adenocarcinoma(284;0.123)		0.0437	SNP					,,,	False	139905141				synonymous_variant		Approved		107.0		c.6102C>T	2012-03-14		Q9BZC7	0.0447		ABCA2	139905141		all_cancers(76;0.16)		,	ABCA2	NM_001606.4,NM_212533.2	protein-coding gene			
		A	ENSG00000107331	ENST00000371605.3		20		ENSG00000107331		4279					,				c.(5467-5469)caC>caT	OTTHUMG00000020958		byFrequency	Q9BZC7	gene with protein product		ABCA2_ENST00000341511.6_Silent_p.H1824H|ABCA2_ENST00000265662.5_Silent_p.H1824H			898,999,293	NM_001606	0.7423					+	Silent			52.0				8088782				ABCA2-202					9	-	0.6377				coding-synonymous,coding-synonymous	32		1824/2437,1854/2467	Myeloproliferative disorder(178;0.0511)	G	SO:0001819	600047	,		protein_coding		2190				30.2057,36.1872,32.2306		"""ATP binding cassette transporters / subfamily A"""	6469					OV - Ovarian serous cystadenocarcinoma(145;2.94e-05)|Epithelial(140;0.00048)			KNOWN			CAAACTGCAGGTGCTTGGCCT		ABC2				ENST00000371605.3:c.5469C>T	9					central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|liver(1)|lung(25)|prostate(2)|skin(1)|stomach(1)|urinary_tract(1)		-		,		9q34	A6NED5|Q5SPY5|Q5W9G5|Q76MW7|Q9HC28		g.chr9:139906359G>A					yes		8768,4170												2.3					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|ATPase activity, coupled to transmembrane movement of substances (GO:0042626)|nucleotide binding (GO:0000166)				hg19	Standard	0.67			5973,2585		ATP catabolic process (GO:0006200)|cholesterol homeostasis (GO:0042632)|lipid metabolic process (GO:0006629)|regulation of intracellular cholesterol transport (GO:0032383)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|response to drug (GO:0042493)|response to steroid hormone (GO:0048545)|transmembrane transport (GO:0055085)|transport (GO:0006810)	2988,2792,689					CCDS43909.1	G		AA,AG,GG	U18235	ATP-binding cassette (ABC) transporter complex (GO:0043190)|cytoplasmic membrane-bounded vesicle (GO:0016023)|endosome (GO:0005768)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|microtubule organizing center (GO:0005815)	49		2504		rs2271862		5616								,	1823			41	NM_212533		34			ENST00000371605.3		12508		uc022bpy.1			20	dbSNP_100	5472,5562			p.H1823H		0				43.0		0.627	9:g.139906359G>A		protein_coding			basic		2090,1793,396			2795,1585			G|||			5008		ABCA2_HUMAN	3442	ATP-binding cassette, sub-family A (ABC1), member 2			0.6873		139906359	STAD - Stomach adenocarcinoma(284;0.123)		0.8175	SNP					,,,	False	139906359				synonymous_variant		Approved		49.0		c.5469C>T	2012-03-14		Q9BZC7	0.5403		ABCA2	139906359		all_cancers(76;0.16)		,	ABCA2	NM_001606.4,NM_212533.2	protein-coding gene			
		G	ENSG00000107331	ENST00000371605.3		20		ENSG00000107331		4208					,				c.(2032-2034)gaT>gaC	OTTHUMG00000020958		byFrequency	Q9BZC7	gene with protein product		ABCA2_ENST00000341511.6_Silent_p.D679D|ABCA2_ENST00000265662.5_Silent_p.D679D			1859,212,8	NM_001606	0.9734					+	Silent			45.0				8088782				ABCA2-202					9	-	0.9168				coding-synonymous,coding-synonymous	32		679/2437,709/2467	Myeloproliferative disorder(178;0.0511)		SO:0001819	600047	,		protein_coding		2079				2.9824,5.4834,3.8094		"""ATP binding cassette transporters / subfamily A"""	6287					OV - Ovarian serous cystadenocarcinoma(145;2.94e-05)|Epithelial(140;0.00048)			KNOWN			GCTCCACCACATCGTGCCCCA		ABC2				ENST00000371605.3:c.2034T>C	9					central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|liver(1)|lung(25)|prostate(2)|skin(1)|stomach(1)|urinary_tract(1)		-		,		9q34	A6NED5|Q5SPY5|Q5W9G5|Q76MW7|Q9HC28		g.chr9:139912484A>G					yes		12095,479							http://www.ncbi.nlm.nih.gov/sites/varvu?gene					-2.8					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|ATPase activity, coupled to transmembrane movement of substances (GO:0042626)|nucleotide binding (GO:0000166)				hg19	Standard	0.9672			8165,251		ATP catabolic process (GO:0006200)|cholesterol homeostasis (GO:0042632)|lipid metabolic process (GO:0006629)|regulation of intracellular cholesterol transport (GO:0032383)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|response to drug (GO:0042493)|response to steroid hormone (GO:0048545)|transmembrane transport (GO:0055085)|transport (GO:0006810)	5821,453,13					CCDS43909.1	A		GG,GA,AA	U18235	ATP-binding cassette (ABC) transporter complex (GO:0043190)|cytoplasmic membrane-bounded vesicle (GO:0016023)|endosome (GO:0005768)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|microtubule organizing center (GO:0005815)	43		2504		rs908832		2181								,	678			41	NM_212533		14			ENST00000371605.3		11281		uc022bpy.1			20	dbSNP_86	2037,2127			p.D678D		0				39.0		0.662	9:g.139912484A>G		protein_coding			basic		3962,241,5			3930,228			g|||			5008		ABCA2_HUMAN	4827	ATP-binding cassette, sub-family A (ABC1), member 2			0.963858		139912484	STAD - Stomach adenocarcinoma(284;0.123)		0.999	SNP					,,,	False	139912484				synonymous_variant		Approved		43.0		c.2034T>C	2012-03-14		Q9BZC7	0.9841		ABCA2	139912484		all_cancers(76;0.16)		,	ABCA2	NM_001606.4,NM_212533.2	protein-coding gene			
		G	ENSG00000107331	ENST00000371605.3	0.31794	20	N	ENSG00000107331	0.34208	4178	0.670000	0.85629	B;B		,	T	0.629267	0	c.(1747-1749)cAc>cCc	OTTHUMG00000020958	0.807000		Q9BZC7	gene with protein product		ABCA2_ENST00000492260.1_5'UTR|ABCA2_ENST00000341511.6_Missense_Mutation_p.H584P|ABCA2_ENST00000265662.5_Missense_Mutation_p.H584P			2056,1,0	NM_001606	1.0			g	4.128	+	Missense_Mutation	2		66.0	Q9BZC7;E7ETC3	0.999757		8088782			0.0;0.0	ABCA2-202			0.01281		9	-	1.0		1	0.298000	missense,missense	32	362	584/2437,614/2467	Myeloproliferative disorder(178;0.0511)		SO:0001583	600047	benign,benign	1.0	protein_coding		2057	P		1.000000	0.0,0.0243,0.0080	B;B	"""ATP binding cassette transporters / subfamily A"""	6235		0.0:0.0:0.8428:0.1572			OV - Ovarian serous cystadenocarcinoma(145;2.94e-05)|Epithelial(140;0.00048)			KNOWN	ENST00000265662;ENST00000371605;ENST00000355090;ENST00000341511		CTCCTCGTCGTGGAAGCCCTT	D;D;D	ABC2				ENST00000371605.3:c.1748A>C	9		ENSG00000107331	0.08231	ABCA2	central_nervous_system(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|liver(1)|lung(25)|prostate(2)|skin(1)|stomach(1)|urinary_tract(1)	ENSP00000360666:p.His583Pro	-	0.71417	,	CAC	9q34	A6NED5|Q5SPY5|Q5W9G5|Q76MW7|Q9HC28		g.chr9:139913239T>G	H -> P (in dbSNP:rs908828). {ECO:0000269|PubMed:11178988, ECO:0000269|PubMed:11309290}.			492	yes		12469,1	0.29842	0.08006	4.31	0.00012	ENSP00000265662:H584P			0.12237		.		4.3	0.51392	572	0.02654	1.0	0.7	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|ATPase activity, coupled to transmembrane movement of substances (GO:0042626)|nucleotide binding (GO:0000166)	-2.015			hg19	Standard	1.0	1.0	13.5642	8356,0		ATP catabolic process (GO:0006200)|cholesterol homeostasis (GO:0042632)|lipid metabolic process (GO:0006629)|regulation of intracellular cholesterol transport (GO:0032383)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|response to drug (GO:0042493)|response to steroid hormone (GO:0048545)|transmembrane transport (GO:0055085)|transport (GO:0006810)	6234,1,0	0.022021				CCDS43909.1	T	0.02656	GG,GT,TT	U18235	ATP-binding cassette (ABC) transporter complex (GO:0043190)|cytoplasmic membrane-bounded vesicle (GO:0016023)|endosome (GO:0005768)|integral component of membrane (GO:0016021)|lysosomal membrane (GO:0005765)|lysosome (GO:0005764)|membrane (GO:0016020)|microtubule organizing center (GO:0005815)	64	0.00138	2504	4.31	rs908828		1895	583;614	758			0.61807	139033060	-	PRO/HIS,PRO/HIS	583		2184	41	NM_212533	0.0;0.0	12	1.0	-0.335000	ENST00000371605.3		10785		uc022bpy.1			20	dbSNP_86	1751,1841	0.0000		p.H583P	.	0		T		60.0	rs908828;rs58752439;rs908828	0.652	9:g.139913239T>G	ENSP00000265662:H584P;ENSP00000360666:H583P;ENSP00000344155:H584P	protein_coding	0.486936		basic		4178,0,0		584;583;614;584	4113,1	1.0	P	g|||		0.706306	5008		ABCA2_HUMAN	5008	ATP-binding cassette, sub-family A (ABC1), member 2		ABCA2_HUMAN;.	1.0	0.81952	139913239	STAD - Stomach adenocarcinoma(284;0.123)	7.529000	1.0	SNP				N	,,,	False	139913239	-0.9363		9	missense	T	Approved	1.0	64.0		c.1748A>C	2012-03-14		Q9BZC7	1.0	-2.01;-2.01;-2.01	ABCA2	139913239	0.27526	all_cancers(76;0.16)	0.43893	77,77	ABCA2	NM_001606.4,NM_212533.2	protein-coding gene		H	
		C	ENSG00000180539	ENST00000314330.2		401563		ENSG00000180539		4294					,					OTTHUMG00000020959		byFrequency	Q6ZV77	gene with protein product		FUT7_ENST00000314412.6_Intron		NM_207511.1	1100,881,219	NM_207511	0.7485					+	Intron		462.8+/-365.8	56.0								C9orf139-001					9	+	0.7148				intron,intron	31426		,	Myeloproliferative disorder(178;0.0821)		SO:0001627		,		protein_coding		2200				35.0489,29.9773,33.3308			6494					OV - Ovarian serous cystadenocarcinoma(145;2.99e-05)|Epithelial(140;0.000493)			KNOWN			TGTCCCCAGCTTGGGCCTCCC						ENST00000314330.2:c.-1066-48T>C	9					cervix(1)|lung(2)		+		,		9q34.3	A2RUA3|B9EGW2|Q5SPY0|Q8N224		g.chr9:139926402T>C		436.8+/-344.8			no		8659,4329												0.6					0.0					hg19	Standard	0.6292			5578,3010			2924,2811,759					CCDS7023.1	T		CC,CT,TT			56		2504		rs7469569		448								,		FLJ36268, FLJ42909		3	NM_207511		2			ENST00000314330.2		11275		uc004ckp.1			401563	dbSNP_116	,					0				57.0		0.647	9:g.139926402T>C		protein_coding			basic|appris_principal|CCDS		1824,1930,540			3081,1319			c|||			5008		CI139_HUMAN	3503	chromosome 9 open reading frame 139			0.699481		139926402	STAD - Stomach adenocarcinoma(284;0.123)		0.7679	SNP		CCDS7023.1			,,,	False	139926402				intron_variant		Approved		56.0			2008-02-05	OTTHUMT00000055213.2	Q6ZV77	0.6037		C9orf139	139926402		all_cancers(76;0.0893)		,	FUT7,C9orf139	NM_004479.3,NM_207511.1	protein-coding gene	NP_997394.1		
		G	ENSG00000054179	ENST00000355097.2		954		ENSG00000054179		4300					,					OTTHUMG00000020953		byFrequency	Q9Y5L3	gene with protein product		ENTPD2_ENST00000312665.5_Intron		NM_001246.3|NM_203468.2	1828,346,28	NM_203468	0.9213					+	Intron		183.7+/-231.9	62.0				9271669				ENTPD2-001					9	-	0.9115				intron,intron	3364		,	Myeloproliferative disorder(178;0.0511)	G	SO:0001627	602012	,		protein_coding		2202				10.5814,9.1281,10.0892			6502					OV - Ovarian serous cystadenocarcinoma(145;2.94e-05)|Epithelial(140;0.00048)			KNOWN			TGCCATACTGCGGGGGAGGGG		CD39L1				ENST00000355097.2:c.118-4G>C	9					endometrium(1)|lung(5)|prostate(1)|skin(2)|urinary_tract(3)		-		,		9q34	O15464|Q5SPY6|Q5SPY7	"""CD39-like-1"", ""ecto-ATPase"""	g.chr9:139946804C>G		169.4+/-200.1			no		11692,1312																	0.2	ATP binding (GO:0005524)|nucleoside-diphosphatase activity (GO:0017110)|nucleoside-triphosphatase activity (GO:0017111)				hg19	Standard	0.8897			7690,910		G-protein coupled receptor signaling pathway (GO:0007186)|platelet activation (GO:0030168)|purine ribonucleoside diphosphate catabolic process (GO:0009181)	5275,1142,85					CCDS7025.1, CCDS7026.1	C		GG,GC,CC	U91510	basal lamina (GO:0005605)|endoplasmic reticulum (GO:0005783)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	62		2504		rs2271867		165								,		NTPDase-2		12	NM_203468		2			ENST00000355097.2		15030		uc004ckw.2			954	dbSNP_100	,					0				60.0		0.622	9:g.139946804C>G		protein_coding			basic|appris_principal|CCDS		3447,796,57			4002,402			G|||			5008		ENTP2_HUMAN	4540	ectonucleoside triphosphate diphosphohydrolase 2			0.90655		139946804	STAD - Stomach adenocarcinoma(284;0.123)		0.8909	SNP		CCDS7026.1			,,,	False	139946804				intron_variant		Approved		62.0			2008-07-21	OTTHUMT00000055169.1	Q9Y5L3	0.9236		ENTPD2	139946804		all_cancers(76;0.0926)		,	ENTPD2	NM_001246.2,NM_203468.1	protein-coding gene	NP_001237.1|NP_982293.1		
		C	ENSG00000197355	ENST00000409858.3		91373		ENSG00000197355		4298					,					OTTHUMG00000020962		byFrequency	Q3KQV9	gene with protein product		UAP1L1_ENST00000476184.1_Intron|UAP1L1_ENST00000360271.3_Silent_p.R24R		NM_207309.2	23,417,1760	XM_038063	0.318					+	Intron			29.0								UAP1L1-001	2014-07-31				9	+	0.0469				intron	28082			Myeloproliferative disorder(178;0.0821)	T	SO:0001627				protein_coding		2200				37.564,10.5227,28.4087			6498					OV - Ovarian serous cystadenocarcinoma(145;2.96e-05)|Epithelial(140;0.000486)			KNOWN			CCGAGCCCCGTCTGCCTGCAG						ENST00000409858.3:c.495-54T>C	9					kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|upper_aerodigestive_tract(1)		+		,		9q34.3	A2AMJ8|Q5SPZ2|Q69YQ3|Q6ZR38		g.chr9:139972900T>C					no		3692,9304												-5.3					0.0	uridylyltransferase activity (GO:0070569)				hg19	Standard	0.3648			3229,5367			653,2386,3459					CCDS7028.2	T		CC,CT,TT	AK022632		29		2504		rs10870176		526												8	NM_207309		3			ENST00000409858.3		13190		uc010ncb.3			91373	dbSNP_120						0				29.0		0.692	9:g.139972900T>C		protein_coding			basic|appris_principal|CCDS		630,1969,1699			463,3937			T|||			5008		UAP1L_HUMAN	934	UDP-N-acetylglucosamine pyrophosphorylase 1 like 1			0.186502		139972900	STAD - Stomach adenocarcinoma(284;0.0878)		0.0268	SNP		CCDS7028.2			,,,	False	139972900				intron_variant		Approved		29.0			2014-07-31	OTTHUMT00000055216.2	Q3KQV9	0.2406		UAP1L1	139972900		all_cancers(76;0.0926)			UAP1L1	NM_207309.2	protein-coding gene	NP_997192.2		
		T	ENSG00000197355	ENST00000409858.3	0.80722	91373	L	ENSG00000197355	0.17331	4300	0.000000	0.17691	B;P		,	D	0.0	0	c.(955-957)gCc>gTc	OTTHUMG00000020962	0.092000	byFrequency	Q3KQV9	gene with protein product		UAP1L1_ENST00000360271.3_Missense_Mutation_p.A196V		NM_207309.2	489,1094,620	XM_038063	0.4519			C	10.17	+	Missense_Mutation	2	494.2+/-373.8	115.0	Q3KQV9;Q3KQV9-2	0.470268					0.158;0.34	UAP1L1-001	2014-07-31		0.40782		9	+	0.4834		0.04	0.136000	missense	28082	165	319/508	Myeloproliferative disorder(178;0.0821)	C	SO:0001583		benign	0.4558011049723757	protein_coding		2203	P		0.000000	38.6047,47.0268,41.4578	B;B		6503		0.1378:0.1826:0.6796:0.0			OV - Ovarian serous cystadenocarcinoma(145;2.96e-05)|Epithelial(140;0.000486)			KNOWN	ENST00000409858;ENST00000360271		CAGCTACGTGCCTCCGACGGG	T;T					ENST00000409858.3:c.956C>T	9		ENSG00000197355	0.48974	UAP1L1	kidney(1)|large_intestine(1)|lung(3)|ovary(1)|skin(1)|upper_aerodigestive_tract(1)	ENSP00000386935:p.Ala319Val	+	0.05858	,	GCC	9q34.3	A2AMJ8|Q5SPZ2|Q69YQ3|Q6ZR38		g.chr9:139973820C>T	A -> V (in dbSNP:rs7037849). {ECO:0000269|PubMed:14702039}.	570.2+/-382.8		216	yes		5392,7614	0.03702	0.23307	4.91	0.00012	ENSP00000353409:A196V			0.13651		.		0.1	0.14465	377	0.59425	0.6590909090909091	0.0	uridylyltransferase activity (GO:0070569)	1.59			hg19	Standard	0.3996	0.43902439024390244	11.7893	3320,5280			1137,3118,2248	1.276808				CCDS7028.2	C	0.42692	TT,TC,CC	AK022632		122	0.50333	2504	0.0909	rs7037849		988	319;196	298			0.52059	139093641	+	VAL/ALA	319		1056	8	NM_207309	0.173;0.787	5	0.39313984168865435	0.491000	ENST00000409858.3		14974		uc010ncb.3			91373	dbSNP_116	956	0.0000		p.A319V	.	0		T		134.0	rs7037849;rs60377984;rs7037849	0.637	9:g.139973820C>T	ENSP00000386935:A319V;ENSP00000353409:A196V	protein_coding	0.372274		basic|appris_principal|CCDS		648,2024,1628		319;196	2072,2334	0.4835164835164835	V	C|||		0.722083	5008		UAP1L_HUMAN	2450	UDP-N-acetylglucosamine pyrophosphorylase 1 like 1		UAP1L_HUMAN;.	0.489217	0.29847	139973820	STAD - Stomach adenocarcinoma(284;0.0878)	1.006000	0.6528	SNP		CCDS7028.2		N	,,,	False	139973820	-1.0041		9	missense	T	Approved	0.386047	122.0		c.956C>T	2014-07-31	OTTHUMT00000055216.2	Q3KQV9	0.4452	2.26;2.26	UAP1L1	139973820	0.21042	all_cancers(76;0.0926)	0.28522	64	UAP1L1	NM_207309.2	protein-coding gene	NP_997192.2	A	
		A	ENSG00000177239	ENST00000371589.4		11253		ENSG00000177239		4300					,					OTTHUMG00000020978		byFrequency	Q9UKM7	gene with protein product		MAN1B1_ENST00000474902.1_Intron|MAN1B1_ENST00000540391.1_Intron		NM_016219.4	23,481,1699	NM_016219	0.3098					+	Intron		465.0+/-366.4	59.0				10409699, 10521544				MAN1B1-004					9	+	0.062				intron	6823			Myeloproliferative disorder(178;0.0511)	C	SO:0001627	604346			protein_coding		2203				36.0349,11.961,27.8794			6503					OV - Ovarian serous cystadenocarcinoma(145;3.08e-05)|Epithelial(140;0.000513)			KNOWN			CTGCTCCGCCCACAGCCAGCA						ENST00000371589.4:c.1765-5C>A	9					autonomic_ganglia(1)|central_nervous_system(2)|kidney(1)|large_intestine(2)|liver(2)|lung(4)|ovary(2)		+		,		9q34.3	Q5VSG3|Q9BRS9|Q9Y5K7	"""endoplasmic reticulum alpha-mannosidase 1"", ""alpha 1,2-mannosidase"", ""endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase 1"", ""ER alpha 1,2-mannosidase"", ""Man9GlcNAc2-specific processing alpha-mannosidase"""	g.chr9:140001978C>A		235.5+/-248.0			no		3626,9380												0.0					0.0	calcium ion binding (GO:0005509)|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity (GO:0004571)				hg19	Standard	0.3449			3099,5501		cellular protein metabolic process (GO:0044267)|ER-associated ubiquitin-dependent protein catabolic process (GO:0030433)|oligosaccharide metabolic process (GO:0009311)|post-translational protein modification (GO:0043687)|protein folding (GO:0006457)|protein N-linked glycosylation (GO:0006487)|protein N-linked glycosylation via asparagine (GO:0018279)	590,2446,3467					CCDS7029.1	C		AA,AC,CC	AF145732	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum quality control compartment (GO:0044322)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|vesicle (GO:0031982)	58		2504		rs12115325		1837										MANA-ER, MRT15		14	NM_016219		12			ENST00000371589.4		16578		uc004cld.3			11253	dbSNP_120						0				57.0		0.672	9:g.140001978C>A		protein_coding			basic|appris_principal|CCDS		567,1965,1768			527,3879			C|||			5008		MA1B1_HUMAN	893	mannosidase, alpha, class 1B, member 1			0.178315		140001978	STAD - Stomach adenocarcinoma(284;0.0878)		0.006	SNP		CCDS7029.1			,,,	False	140001978				intron_variant		Approved		58.0			2014-05-27	OTTHUMT00000055294.2	Q9UKM7	0.2233		MAN1B1	140001978		all_cancers(76;0.0926)			MAN1B1	NM_016219.3	protein-coding gene	NP_057303.2		
		C	ENSG00000177239	ENST00000371589.4	0.09310|0.09310	11253	.|.	ENSG00000177239	0.07307|0.07307	4300	0.014000|0.014000	.|.	.|.		,	.|.	0.9999999855675|0.9999999855675	0|0	c.(2044-2046)gaT>gaC	OTTHUMG00000020978	-0.431000|-0.431000	byFrequency	Q9UKM7	gene with protein product		MAN1B1_ENST00000474902.1_Silent_p.D385D|MAN1B1_ENST00000540391.1_3'UTR		NM_016219.4	1959,239,5	NM_016219	0.7822			C|C	5.232|5.232	+	Silent	1|2	364.4+/-333.5	207.0	.|.	0.943486|0.943486		10409699, 10521544			.|.	MAN1B1-004			.|.		9	+	0.9879		.|.	0.053000|0.053000	coding-synonymous	6823	282|282	682/700	Myeloproliferative disorder(178;0.0511)	C	SO:0001819	604346		0.7790055248618785|0.7790055248618785	protein_coding		2203	P|P		0.440000|0.440000	24.4535,5.6514,18.084	.|.		6503		0.0:0.6925:0.0:0.3075|0.0:0.6925:0.0:0.3075			OV - Ovarian serous cystadenocarcinoma(145;3.08e-05)|Epithelial(140;0.000513)			KNOWN	ENST00000550113|ENST00000475449		TCAGCCTGGATGCCTACGTGT	.|.					ENST00000371589.4:c.2046T>C	9		ENSG00000177239|ENSG00000177239	0.00048|0.00048	MAN1B1|MAN1B1	autonomic_ganglia(1)|central_nervous_system(2)|kidney(1)|large_intestine(2)|liver(2)|lung(4)|ovary(2)		+	0.25618|0.25618	,	TGC|ATG	9q34.3	Q5VSG3|Q9BRS9|Q9Y5K7	"""endoplasmic reticulum alpha-mannosidase 1"", ""alpha 1,2-mannosidase"", ""endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase 1"", ""ER alpha 1,2-mannosidase"", ""Man9GlcNAc2-specific processing alpha-mannosidase"""	g.chr9:140002989T>C		143.1+/-178.2		481|481	no		10654,2352	0.15608|0.15608	0.09916|0.09916	5.44|5.44	0.00012|0.00012	.|.			.|.		.|.		1.5	0.23209|0.23209	402|402	.|.	0.7027972027972028|0.7027972027972028	0.0	calcium ion binding (GO:0005509)|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity (GO:0004571)	.|.			hg19	Standard	0.7565	0.9776422764227642|0.9776422764227642	12.2706|12.2706	6497,2103		cellular protein metabolic process (GO:0044267)|ER-associated ubiquitin-dependent protein catabolic process (GO:0030433)|oligosaccharide metabolic process (GO:0009311)|post-translational protein modification (GO:0043687)|protein folding (GO:0006457)|protein N-linked glycosylation (GO:0006487)|protein N-linked glycosylation via asparagine (GO:0018279)	4434,1786,283	0.228380|0.228380				CCDS7029.1	T	.|.	CC,CT,TT	AF145732	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum quality control compartment (GO:0044322)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|vesicle (GO:0031982)	208	.|.	2504	1.54|1.54	rs4880091		2119	.|.	568|568			0.54704|0.54704	139122810|139122810	+|+		682	MANA-ER, MRT15	1733|1733	14	NM_016219	.|.	13	0.7493403693931399|0.7493403693931399	-3.265000|-3.265000	ENST00000371589.4		17969		uc004cld.3			11253	dbSNP_111	2046	0.0000|0.0000		p.D682D	.|.	0		T|T		210.0	rs4880091;rs17850036;rs58239522;rs4880091|rs4880091;rs17850036;rs58239522;rs4880091	0.597	9:g.140002989T>C	.|.	protein_coding	.|.		basic|appris_principal|CCDS		2475,1547,278		107|108	4157,249	0.7934981684981685|0.7934981684981685	R|T	C|||		.|.	5008		MA1B1_HUMAN	4056	mannosidase, alpha, class 1B, member 1		.|.	0.809904	0.30691|0.30691	140002989	STAD - Stomach adenocarcinoma(284;0.0878)	1.073000|1.073000	0.6984	SNP		CCDS7029.1		.|.	,,,	False	140002989	-1.0025|-1.0025		3|3	synonymous_variant	T|T	Approved	0.755465|0.755465	208.0		c.2046T>C	2014-05-27	OTTHUMT00000055294.2	Q9UKM7	0.7493	.|.	MAN1B1	140002989	0.15095|0.15095	all_cancers(76;0.0926)	0.29027|0.29027		MAN1B1	NM_016219.3	protein-coding gene	NP_057303.2	C|M	
		G	ENSG00000176978	ENST00000371579.2		29952		ENSG00000176978		4296					,					OTTHUMG00000020977		byFrequency	Q9UHL4	gene with protein product				NM_013379.2	0,0,2203	NM_013379	0.0					+	3'UTR			39.0				10477574, 11139392				DPP7-003	2006-01-12				9	-	0.0				utr-3	14892				A	SO:0001624	610537			protein_coding		2203				0.1047,0.0,0.0692			6499					OV - Ovarian serous cystadenocarcinoma(145;4.25e-05)|Epithelial(140;0.000633)			KNOWN			TGAAGCCCCCACTCCATGAGG						ENST00000371579.2:c.*38T>C	9					endometrium(2)|large_intestine(2)|lung(1)|ovary(1)|skin(1)		-		,		9q34.3	A8K7U7|Q5VSF1|Q969X4		g.chr9:140005062A>G					no		9,12989												0.4					0.0	dipeptidyl-peptidase activity (GO:0008239)|serine-type peptidase activity (GO:0008236)				hg19	Standard	0.003			9,8583			0,9,6490					CCDS7030.1	A		GG,GA,AA	AF154502	cytoplasmic vesicle (GO:0031410)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|lysosome (GO:0005764)	38		2504		rs199555646		1521				"""dipeptidylpeptidase 7"""						DPPII		7	XM_005266075		0			ENST00000371579.2		16073		uc004clh.3			29952							0				35.0		0.642	9:g.140005062A>G		protein_coding			basic|appris_principal|CCDS		0,9,4287			0,4406			A|||			5008		DPP2_HUMAN	3	dipeptidyl-peptidase 7			0.000599042		140005062	STAD - Stomach adenocarcinoma(284;0.0878)		0.0	SNP		CCDS7030.1			,,,	False	140005062				3_prime_UTR_variant		Approved		38.0			2008-02-05	OTTHUMT00000055279.1	Q9UHL4	0.0		DPP7	140005062		all_cancers(76;0.0926)			DPP7	NM_013379.2	protein-coding gene	NP_037511.2		
		G	ENSG00000176978	ENST00000371579.2		29952		ENSG00000176978		4300					,				c.(1105-1107)ccG>ccC	OTTHUMG00000020977		byFrequency	Q9UHL4	gene with protein product				NM_013379.2	1652,516,35	NM_013379	0.7802					+	Silent		363.4+/-333.1	100.0				10477574, 11139392				DPP7-003	2006-01-12				9	-	0.8949				coding-synonymous	14892		369/493		G	SO:0001819	610537			protein_coding		2203				24.4884,13.3,20.6981			6503					OV - Ovarian serous cystadenocarcinoma(145;4.25e-05)|Epithelial(140;0.000633)			KNOWN			AGGGCAGGTCCGGGAACATAT						ENST00000371579.2:c.1107G>C	9					endometrium(2)|large_intestine(2)|lung(1)|ovary(1)|skin(1)		-		,		9q34.3	A8K7U7|Q5VSF1|Q969X4		g.chr9:140006425C>G		255.5+/-260.7			no		10314,2692												-6.2					0.0	dipeptidyl-peptidase activity (GO:0008239)|serine-type peptidase activity (GO:0008236)				hg19	Standard	0.7535			6494,2106			4128,2058,317					CCDS7030.1	C		GG,GC,CC	AF154502	cytoplasmic vesicle (GO:0031410)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|lysosome (GO:0005764)	96		2504		rs10747048		1111				"""dipeptidylpeptidase 7"""					369	DPPII		7	XM_005266075		10			ENST00000371579.2		13813		uc004clh.3			29952	dbSNP_120	1107			p.P369P		0				88.0		0.672	9:g.140006425C>G		protein_coding			basic|appris_principal|CCDS		2476,1542,282			3820,586			G|||			5008		DPP2_HUMAN	3918	dipeptidyl-peptidase 7			0.782348		140006425	STAD - Stomach adenocarcinoma(284;0.0878)		0.6944	SNP		CCDS7030.1			,,,	False	140006425				synonymous_variant		Approved		96.0		c.1107G>C	2008-02-05	OTTHUMT00000055279.1	Q9UHL4	0.7406		DPP7	140006425		all_cancers(76;0.0926)			DPP7	NM_013379.2	protein-coding gene	NP_037511.2		
		A	ENSG00000176884	ENST00000371561.3		2902		ENSG00000176884		4298					,					OTTHUMG00000020976		byFrequency	Q05586	gene with protein product		GRIN1_ENST00000350902.5_Intron|GRIN1_ENST00000371559.4_Intron|GRIN1_ENST00000315048.3_Intron|GRIN1_ENST00000371560.3_Intron|GRIN1_ENST00000471122.1_Intron|GRIN1_ENST00000371550.4_Intron|GRIN1_ENST00000371555.4_Intron|GRIN1_ENST00000371553.3_Intron|GRIN1_ENST00000371546.4_Intron	Acamprosate(DB00659)|Acetylcysteine(DB06151)|Atomoxetine(DB00289)|Gabapentin(DB00996)|Ketobemidone(DB06738)|Memantine(DB01043)|Milnacipran(DB04896)|Orphenadrine(DB01173)|Pentobarbital(DB00312)|Pethidine(DB00454)|Phenobarbital(DB01174)|Secobarbital(DB00418)	NM_007327.3	2101,101,1	NM_007327	0.9213					+	Intron			24.0				1350383				GRIN1-002					9	+	0.9826				intron,intron,intron,intron,intron	4584		,,,,			SO:0001627	138249	,,,,		protein_coding		2203				6.7357,2.3377,5.2453		"""Ligand-gated ion channels / Glutamate receptors, ionotropic"", ""Glutamate receptors"""	6501					OV - Ovarian serous cystadenocarcinoma(145;6.87e-05)|Epithelial(140;0.00095)		NSCLC(113;717 1653 2089 20474 37618)	KNOWN			ACCTCAGCCCGCCGTGCCCCC		NMDAR1				ENST00000371561.3:c.394-22G>A	9					NS(1)|breast(1)|endometrium(1)|kidney(1)|lung(7)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		9q34.3	A6NLK7|A6NLR1|C9K0X1|P35437|Q12867|Q12868|Q5VSF3|Q5VSF4|Q5VSF5|Q5VSF6|Q5VSF7|Q5VSF8|Q9UPF8|Q9UPF9		g.chr9:140040156G>A					no		12320,682												-2.2					0.0	calcium channel activity (GO:0005262)|calcium ion binding (GO:0005509)|calmodulin binding (GO:0005516)|extracellular-glutamate-gated ion channel activity (GO:0005234)|glutamate binding (GO:0016595)|glycine binding (GO:0016594)|N-methyl-D-aspartate selective glutamate receptor activity (GO:0004972)|neurotransmitter binding (GO:0042165)|voltage-gated cation channel activity (GO:0022843)				hg19	Standard	0.9463			8017,579		adult locomotory behavior (GO:0008344)|calcium ion homeostasis (GO:0055074)|calcium ion transmembrane transport (GO:0070588)|cation transport (GO:0006812)|cellular calcium ion homeostasis (GO:0006874)|cellular response to manganese ion (GO:0071287)|cerebral cortex development (GO:0021987)|conditioned taste aversion (GO:0001661)|ion transmembrane transport (GO:0034220)|ionotropic glutamate receptor signaling pathway (GO:0035235)|long-term memory (GO:0007616)|male mating behavior (GO:0060179)|negative regulation of neuron apoptotic process (GO:0043524)|olfactory learning (GO:0008355)|pons maturation (GO:0021586)|positive regulation of apoptotic process (GO:0043065)|positive regulation of excitatory postsynaptic membrane potential (GO:2000463)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|prepulse inhibition (GO:0060134)|propylene metabolic process (GO:0018964)|protein tetramerization (GO:0051262)|regulation of axonogenesis (GO:0050770)|regulation of dendrite morphogenesis (GO:0048814)|regulation of excitatory postsynaptic membrane potential (GO:0060079)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of membrane potential (GO:0042391)|regulation of respiratory gaseous exchange (GO:0043576)|regulation of synapse assembly (GO:0051963)|respiratory gaseous exchange (GO:0007585)|response to amphetamine (GO:0001975)|response to calcium ion (GO:0051592)|response to ethanol (GO:0045471)|response to fungicide (GO:0060992)|response to morphine (GO:0043278)|rhythmic process (GO:0048511)|sensory perception of pain (GO:0019233)|social behavior (GO:0035176)|suckling behavior (GO:0001967)|synaptic transmission (GO:0007268)|synaptic transmission, glutamatergic (GO:0035249)|visual learning (GO:0008542)	5836,648,17					CCDS7031.1, CCDS7032.1, CCDS43910.1, CCDS55354.1, CCDS55355.1	G		AA,AG,GG		cell junction (GO:0030054)|cell surface (GO:0009986)|dendrite (GO:0030425)|dendrite membrane (GO:0032590)|dendritic spine (GO:0043197)|endoplasmic reticulum (GO:0005783)|excitatory synapse (GO:0060076)|integral component of plasma membrane (GO:0005887)|N-methyl-D-aspartate selective glutamate receptor complex (GO:0017146)|neuron projection (GO:0043005)|neuronal postsynaptic density (GO:0097481)|plasma membrane (GO:0005886)|postsynaptic density (GO:0014069)|postsynaptic membrane (GO:0045211)|synapse (GO:0045202)|synaptic cleft (GO:0043083)|synaptic vesicle (GO:0008021)|terminal bouton (GO:0043195)	26		2504		rs10870196		1490				"""N-methyl-D-aspartate receptor subunit NR1"""				,,,,		GluN1		15	NM_000832		3			ENST00000371561.3		6669		uc004cln.3			2902	dbSNP_120	,,,,					0				31.0		0.721	9:g.140040156G>A		protein_coding			basic|CCDS		3735,547,16			4303,103			g|||			5008		NMDZ1_HUMAN	4750	glutamate receptor, ionotropic, N-methyl D-aspartate 1			0.948482		140040156	STAD - Stomach adenocarcinoma(284;0.0878)		0.9345	SNP		CCDS7031.1			,,,	False	140040156				intron_variant		Approved		26.0			2013-01-11	OTTHUMT00000055267.3	Q05586	0.9452		GRIN1	140040156		all_cancers(76;0.0926)		,,,,	GRIN1	NM_000832.6,NM_001185090.1,NM_001185091.1,NM_007327.3,NM_021569.3	protein-coding gene	NP_015566.1		
		A	ENSG00000176884	ENST00000371561.3		2902		ENSG00000176884		4293					,				c.(853-855)gtG>gtA	OTTHUMG00000020976		byFrequency	Q05586	gene with protein product		GRIN1_ENST00000315048.3_Silent_p.V285V|GRIN1_ENST00000371553.3_Silent_p.V306V|GRIN1_ENST00000371550.4_Silent_p.V285V|GRIN1_ENST00000371546.4_Silent_p.V306V|GRIN1_ENST00000471122.1_3'UTR|GRIN1_ENST00000350902.5_Silent_p.V285V|GRIN1_ENST00000371555.4_Silent_p.V306V|GRIN1_ENST00000371560.3_Silent_p.V306V|GRIN1_ENST00000371559.4_Silent_p.V285V	Acamprosate(DB00659)|Acetylcysteine(DB06151)|Atomoxetine(DB00289)|Gabapentin(DB00996)|Ketobemidone(DB06738)|Memantine(DB01043)|Milnacipran(DB04896)|Orphenadrine(DB01173)|Pentobarbital(DB00312)|Pethidine(DB00454)|Phenobarbital(DB01174)|Secobarbital(DB00418)	NM_007327.3	12,264,1921	NM_007327	0.1881					+	Silent			31.0				1350383				GRIN1-002					9	+	0.0265				coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous,coding-synonymous	4584		285/886,306/944,306/907,285/939,285/902		G	SO:0001819	138249	,,,,		protein_coding		2197				31.9241,6.5544,23.3359		"""Ligand-gated ion channels / Glutamate receptors, ionotropic"", ""Glutamate receptors"""	6490					OV - Ovarian serous cystadenocarcinoma(145;6.87e-05)|Epithelial(140;0.00095)		NSCLC(113;717 1653 2089 20474 37618)	KNOWN			GCGACGCCGTGGGCGTGGTGG		NMDAR1				ENST00000371561.3:c.855G>A	9					NS(1)|breast(1)|endometrium(1)|kidney(1)|lung(7)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		9q34.3	A6NLK7|A6NLR1|C9K0X1|P35437|Q12867|Q12868|Q5VSF3|Q5VSF4|Q5VSF5|Q5VSF6|Q5VSF7|Q5VSF8|Q9UPF8|Q9UPF9		g.chr9:140051376G>A					no		3029,9951												2.7					1.0	calcium channel activity (GO:0005262)|calcium ion binding (GO:0005509)|calmodulin binding (GO:0005516)|extracellular-glutamate-gated ion channel activity (GO:0005234)|glutamate binding (GO:0016595)|glycine binding (GO:0016594)|N-methyl-D-aspartate selective glutamate receptor activity (GO:0004972)|neurotransmitter binding (GO:0042165)|voltage-gated cation channel activity (GO:0022843)				hg19	Standard	0.336			2741,5845		adult locomotory behavior (GO:0008344)|calcium ion homeostasis (GO:0055074)|calcium ion transmembrane transport (GO:0070588)|cation transport (GO:0006812)|cellular calcium ion homeostasis (GO:0006874)|cellular response to manganese ion (GO:0071287)|cerebral cortex development (GO:0021987)|conditioned taste aversion (GO:0001661)|ion transmembrane transport (GO:0034220)|ionotropic glutamate receptor signaling pathway (GO:0035235)|long-term memory (GO:0007616)|male mating behavior (GO:0060179)|negative regulation of neuron apoptotic process (GO:0043524)|olfactory learning (GO:0008355)|pons maturation (GO:0021586)|positive regulation of apoptotic process (GO:0043065)|positive regulation of excitatory postsynaptic membrane potential (GO:2000463)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|prepulse inhibition (GO:0060134)|propylene metabolic process (GO:0018964)|protein tetramerization (GO:0051262)|regulation of axonogenesis (GO:0050770)|regulation of dendrite morphogenesis (GO:0048814)|regulation of excitatory postsynaptic membrane potential (GO:0060079)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of membrane potential (GO:0042391)|regulation of respiratory gaseous exchange (GO:0043576)|regulation of synapse assembly (GO:0051963)|respiratory gaseous exchange (GO:0007585)|response to amphetamine (GO:0001975)|response to calcium ion (GO:0051592)|response to ethanol (GO:0045471)|response to fungicide (GO:0060992)|response to morphine (GO:0043278)|rhythmic process (GO:0048511)|sensory perception of pain (GO:0019233)|social behavior (GO:0035176)|suckling behavior (GO:0001967)|synaptic transmission (GO:0007268)|synaptic transmission, glutamatergic (GO:0035249)|visual learning (GO:0008542)	459,2111,3920					CCDS7031.1, CCDS7032.1, CCDS43910.1, CCDS55354.1, CCDS55355.1	G		AA,AG,GG		cell junction (GO:0030054)|cell surface (GO:0009986)|dendrite (GO:0030425)|dendrite membrane (GO:0032590)|dendritic spine (GO:0043197)|endoplasmic reticulum (GO:0005783)|excitatory synapse (GO:0060076)|integral component of plasma membrane (GO:0005887)|N-methyl-D-aspartate selective glutamate receptor complex (GO:0017146)|neuron projection (GO:0043005)|neuronal postsynaptic density (GO:0097481)|plasma membrane (GO:0005886)|postsynaptic density (GO:0014069)|postsynaptic membrane (GO:0045211)|synapse (GO:0045202)|synaptic cleft (GO:0043083)|synaptic vesicle (GO:0008021)|terminal bouton (GO:0043195)	30		2504		rs1126442		1952				"""N-methyl-D-aspartate receptor subunit NR1"""				,,,,	285	GluN1		15	NM_000832		6			ENST00000371561.3		11686		uc004cln.3			2902	dbSNP_86	855,918,918,855,855			p.V285V		0				29.0		0.677	9:g.140051376G>A		protein_coding			basic|CCDS		447,1847,1999			288,4106			G|||			5008		NMDZ1_HUMAN	699	glutamate receptor, ionotropic, N-methyl D-aspartate 1			0.139577		140051376	STAD - Stomach adenocarcinoma(284;0.0878)		0.002	SNP		CCDS7031.1			,,,	False	140051376				synonymous_variant		Approved		30.0		c.855G>A	2013-01-11	OTTHUMT00000055267.3	Q05586	0.2017		GRIN1	140051376		all_cancers(76;0.0926)		,,,,	GRIN1	NM_000832.6,NM_001185090.1,NM_001185091.1,NM_007327.3,NM_021569.3	protein-coding gene	NP_015566.1		
		A	ENSG00000176884	ENST00000371561.3		2902		ENSG00000176884		4297					,					OTTHUMG00000020976		byFrequency	Q05586	gene with protein product		GRIN1_ENST00000315048.3_Intron|GRIN1_ENST00000371553.3_Intron|GRIN1_ENST00000371550.4_Intron|GRIN1_ENST00000371546.4_Intron|GRIN1_ENST00000471122.1_Intron|GRIN1_ENST00000350902.5_Intron|GRIN1_ENST00000371555.4_Intron|GRIN1_ENST00000371560.3_Intron|GRIN1_ENST00000371559.4_Intron	Acamprosate(DB00659)|Acetylcysteine(DB06151)|Atomoxetine(DB00289)|Gabapentin(DB00996)|Ketobemidone(DB06738)|Memantine(DB01043)|Milnacipran(DB04896)|Orphenadrine(DB01173)|Pentobarbital(DB00312)|Pethidine(DB00454)|Phenobarbital(DB01174)|Secobarbital(DB00418)	NM_007327.3	2090,108,1	NM_007327	0.8027					+	Intron			27.0				1350383				GRIN1-002					9	+	0.9826				intron,intron,intron,intron,intron	4584		,,,,			SO:0001627	138249	,,,,		protein_coding		2199				6.7605,2.5011,5.3187		"""Ligand-gated ion channels / Glutamate receptors, ionotropic"", ""Glutamate receptors"""	6496					OV - Ovarian serous cystadenocarcinoma(145;6.87e-05)|Epithelial(140;0.00095)		NSCLC(113;717 1653 2089 20474 37618)	KNOWN			CGGGTAGGCTGGACGGCGGGG		NMDAR1				ENST00000371561.3:c.1467+8G>A	9					NS(1)|breast(1)|endometrium(1)|kidney(1)|lung(7)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)		+		,		9q34.3	A6NLK7|A6NLR1|C9K0X1|P35437|Q12867|Q12868|Q5VSF3|Q5VSF4|Q5VSF5|Q5VSF6|Q5VSF7|Q5VSF8|Q9UPF8|Q9UPF9		g.chr9:140055876G>A					no		12301,691												2.8					0.0	calcium channel activity (GO:0005262)|calcium ion binding (GO:0005509)|calmodulin binding (GO:0005516)|extracellular-glutamate-gated ion channel activity (GO:0005234)|glutamate binding (GO:0016595)|glycine binding (GO:0016594)|N-methyl-D-aspartate selective glutamate receptor activity (GO:0004972)|neurotransmitter binding (GO:0042165)|voltage-gated cation channel activity (GO:0022843)				hg19	Standard	0.9443			8013,581		adult locomotory behavior (GO:0008344)|calcium ion homeostasis (GO:0055074)|calcium ion transmembrane transport (GO:0070588)|cation transport (GO:0006812)|cellular calcium ion homeostasis (GO:0006874)|cellular response to manganese ion (GO:0071287)|cerebral cortex development (GO:0021987)|conditioned taste aversion (GO:0001661)|ion transmembrane transport (GO:0034220)|ionotropic glutamate receptor signaling pathway (GO:0035235)|long-term memory (GO:0007616)|male mating behavior (GO:0060179)|negative regulation of neuron apoptotic process (GO:0043524)|olfactory learning (GO:0008355)|pons maturation (GO:0021586)|positive regulation of apoptotic process (GO:0043065)|positive regulation of excitatory postsynaptic membrane potential (GO:2000463)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|prepulse inhibition (GO:0060134)|propylene metabolic process (GO:0018964)|protein tetramerization (GO:0051262)|regulation of axonogenesis (GO:0050770)|regulation of dendrite morphogenesis (GO:0048814)|regulation of excitatory postsynaptic membrane potential (GO:0060079)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of membrane potential (GO:0042391)|regulation of respiratory gaseous exchange (GO:0043576)|regulation of synapse assembly (GO:0051963)|respiratory gaseous exchange (GO:0007585)|response to amphetamine (GO:0001975)|response to calcium ion (GO:0051592)|response to ethanol (GO:0045471)|response to fungicide (GO:0060992)|response to morphine (GO:0043278)|rhythmic process (GO:0048511)|sensory perception of pain (GO:0019233)|social behavior (GO:0035176)|suckling behavior (GO:0001967)|synaptic transmission (GO:0007268)|synaptic transmission, glutamatergic (GO:0035249)|visual learning (GO:0008542)	5823,655,18					CCDS7031.1, CCDS7032.1, CCDS43910.1, CCDS55354.1, CCDS55355.1	G		AA,AG,GG		cell junction (GO:0030054)|cell surface (GO:0009986)|dendrite (GO:0030425)|dendrite membrane (GO:0032590)|dendritic spine (GO:0043197)|endoplasmic reticulum (GO:0005783)|excitatory synapse (GO:0060076)|integral component of plasma membrane (GO:0005887)|N-methyl-D-aspartate selective glutamate receptor complex (GO:0017146)|neuron projection (GO:0043005)|neuronal postsynaptic density (GO:0097481)|plasma membrane (GO:0005886)|postsynaptic density (GO:0014069)|postsynaptic membrane (GO:0045211)|synapse (GO:0045202)|synaptic cleft (GO:0043083)|synaptic vesicle (GO:0008021)|terminal bouton (GO:0043195)	29		2504		rs10747050		2564				"""N-methyl-D-aspartate receptor subunit NR1"""				,,,,		GluN1		15	NM_000832		10			ENST00000371561.3		7705		uc004cln.3			2902	dbSNP_120	,,,,					0				32.0		0.667	9:g.140055876G>A		protein_coding			basic|CCDS		3733,547,17			4288,110			-|||			5008		NMDZ1_HUMAN	4675	glutamate receptor, ionotropic, N-methyl D-aspartate 1			0.933506		140055876	STAD - Stomach adenocarcinoma(284;0.0878)		0.9792	SNP		CCDS7031.1			,,,	False	140055876				intron_variant		Approved		29.0			2013-01-11	OTTHUMT00000055267.3	Q05586	0.9424		GRIN1	140055876		all_cancers(76;0.0926)		,,,,	GRIN1	NM_000832.6,NM_001185090.1,NM_001185091.1,NM_007327.3,NM_021569.3	protein-coding gene	NP_015566.1		
		A	ENSG00000176248	ENST00000323927.2		29882		ENSG00000176248		4300					,				c.(1222-1224)cgC>cgT	OTTHUMG00000020983		byFrequency	Q9UJX6	gene with protein product				NM_013366.3	6,199,1998	NM_013366	0.1728					+	Silent		378.2+/-338.8	134.0				11739784				ANAPC2-001					9	-	0.0151				coding-synonymous	19989		408/823		G	SO:0001819	606946			protein_coding		2203				25.9884,4.7889,18.8067		"""Anaphase promoting complex subunits"""	6503					OV - Ovarian serous cystadenocarcinoma(145;6.37e-05)|Epithelial(140;0.000858)			KNOWN			GGTCCAGCACGCGCAGCGCCT						ENST00000323927.2:c.1224C>T	9					breast(2)|endometrium(4)|kidney(1)|large_intestine(1)|lung(5)|ovary(1)|skin(1)		-		,		9q34.3	Q5VSG1|Q96DG5|Q96GG4|Q9P2E1		g.chr9:140077639G>A		129.8+/-166.5			no		2446,10560												-10.0					0.0					hg19	Standard	0.2425			2235,6365		anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031145)|mitotic cell cycle (GO:0000278)|mitotic nuclear division (GO:0007067)|mitotic spindle assembly checkpoint (GO:0007094)|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436)|positive regulation of axon extension (GO:0045773)|positive regulation of dendrite morphogenesis (GO:0050775)|positive regulation of synapse maturation (GO:0090129)|positive regulation of synaptic plasticity (GO:0031915)|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437)|protein K11-linked ubiquitination (GO:0070979)|regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439)	284,1878,4341					CCDS7033.1	G		AA,AG,GG	AB037827	anaphase-promoting complex (GO:0005680)|cytosol (GO:0005829)|nucleoplasm (GO:0005654)	135		2504		rs11549105		1228									408	APC2, KIAA1406		15	NM_013366		6			ENST00000323927.2		19560		uc004clr.1			29882	dbSNP_120	1224			p.R408R		0				135.0		0.627	9:g.140077639G>A		protein_coding			basic|appris_principal|CCDS		278,1679,2343			211,4195			G|||			5008		ANC2_HUMAN	511	anaphase promoting complex subunit 2			0.102037		140077639	STAD - Stomach adenocarcinoma(284;0.0698)		0.002	SNP		CCDS7033.1			,,,	False	140077639				synonymous_variant		Approved		135.0		c.1224C>T	2011-06-15	OTTHUMT00000055315.1	Q9UJX6	0.1095		ANAPC2	140077639		all_cancers(76;0.0926)			ANAPC2	NM_013366.3	protein-coding gene	NP_037498.1		
		G	ENSG00000188566	ENST00000344894.5		27158		ENSG00000188566		4231					,					OTTHUMG00000020986		byFrequency		gene with protein product		NDOR1_ENST00000458322.2_5'UTR|NDOR1_ENST00000371521.4_5'UTR|NDOR1_ENST00000427047.2_5'UTR		NM_001144028.1|NM_014434.2	352,958,858	NM_014434	0.3845					+	5'UTR			36.0				10625700, 12631275				NDOR1-001					9	+	0.41				utr-5,utr-5,utr-5,utr-5	29838		,,,		G	SO:0001623	606073	,,,		protein_coding		2168				34.7199,38.3303,35.9431			6399					OV - Ovarian serous cystadenocarcinoma(145;6.37e-05)|Epithelial(140;0.00057)			KNOWN			CACCGGGCGCACCCCGATGCC						ENST00000344894.5:c.-6A>G	9					breast(1)|endometrium(5)|large_intestine(1)|lung(5)|prostate(1)|skin(1)|urinary_tract(1)		+		,		9q34.3		"""NADPH dependent FMN and FAD containing oxidoreductase"""	g.chr9:140100224A>G					no		4600,8198												-4.8					0.0					hg19	Standard	0.3658			2938,5524			906,2788,2705					CCDS7036.1, CCDS48061.1, CCDS48062.1, CCDS48063.1	A		GG,GA,AA	BC015735		34		2504		rs7032361		78								,,,		NR1, bA350O14.9		15	XM_005266066		0			ENST00000344894.5		12862		uc004clx.3			27158	dbSNP_116	,,,					0				29.0		0.692	9:g.140100224A>G		protein_coding			basic|appris_principal|CCDS		554,1830,1847			1662,2674			G|||			5008			1800	NADPH dependent diflavin oxidoreductase 1			0.359425		140100224	STAD - Stomach adenocarcinoma(284;0.0698)		0.3065	SNP		CCDS7036.1			,,,	False	140100224				5_prime_UTR_variant		Approved		34.0			2008-02-05	OTTHUMT00000254704.1	Q9UHB4	0.2954		NDOR1	140100224		all_cancers(76;0.0926)		,,,	NDOR1	NM_001144026.1,NM_001144027.1,NM_001144028.1,NM_014434.2	protein-coding gene	NP_001137500.1|NP_055249.1		
		A	ENSG00000188163	ENST00000344774.4	0.09310	401565	.	ENSG00000188163	0.22880	4300	0.709000	.	.		,	.	0.99999999714338	.	c.e3+1	OTTHUMG00000159545	0.307000	byFrequency	Q6J272	gene with protein product		FAM166A_ENST00000388932.2_Splice_Site		NM_001001710.1	2194,9,0	NM_001001710	1.0			A	4.646	+	Splice_Site	.	57.9+/-119.4	54.0	.	0.997957	Intron				.	FAM166A-001			.		9	-	1.0		.	0.011000	splice-5	33818	362			A	SO:0001630			1.0	protein_coding		2203	P		0.168000	1.2442,0.2043,0.8919	.		6503		0.8181:0.0:0.1819:0.0						KNOWN	ENST00000344774;ENST00000388932;ENST00000484720		TCCCCTGGCTGCCTGGTGCTG	.					ENST00000344774.4:c.522+1C>T	9		ENSG00000188163	0.01280	FAM166A	kidney(3)|lung(7)|ovary(2)|prostate(1)|urinary_tract(2)		-	0.22989	,	.	9q34.3	A6NND9|Q8N830		g.chr9:140139757G>A		15.5+/-35.6		492	yes		12890,116	0.30452	0.08881	5.23	.	.			.		.		4.1	0.47781	572	.	1.0	0.7		.			hg19	Standard	0.9881	1.0	7.1366	8493,107			6388,114,1	0.120024				CCDS35186.1	G	.	AA,AG,GG	BC132916	nucleus (GO:0005634)	54	.	2504	4.09	rs9775264		577	.	750			0.25531	139259578	-				2176	15	XR_245332	.	3	0.9894459102902374	-1.327000	ENST00000344774.4		16180		uc004cmi.1			401565	dbSNP_119		.			.	0		.		53.0	rs9775264;rs58593161	0.657	9:g.140139757G>A	.	protein_coding	.		basic|appris_principal|CCDS		4194,105,1		-1	4397,9	0.9963369963369964	.	A|||		.	5008		F166A_HUMAN	4993	family with sequence similarity 166, member A		.	0.997005	0.35079	140139757		1.445000	1.0	SNP		CCDS35186.1		.	,,,	False	140139757	.		.	splice_region_variant	.	Approved	0.987558	54.0			2008-08-08	OTTHUMT00000356125.1	Q6J272	0.9957	.	FAM166A	140139757	0.07611		.		FAM166A	NM_001001710.1	protein-coding gene	NP_001001710.1	.	
		A	ENSG00000188986	ENST00000343053.4		25920		ENSG00000188986		4297					,				c.(1549-1551)ccG>ccA	OTTHUMG00000131778		byFrequency	Q8WX92	gene with protein product				NM_015456.3	661,1069,471	NM_015456	0.6759					+	Silent			20.0				11230166, 10574461, 17910036, 17659869				NELFB-001	2013-01-31				9	+	0.5129				coding-synonymous	24324		517/581			SO:0001819	611180			protein_coding		2201				24.0284,45.6838,31.3635			6498								KNOWN			GGGTGGCCCCGTCTAAGCTGG		COBRA1				ENST00000343053.4:c.1551G>A	9							+		,		9q34	A2BFA3|Q96EW5|Q9H9R4|Q9ULN8|Q9Y3W0		g.chr9:140167022G>A					no		8920,4076												-9.5					0.0			2013-01-31		hg19	Standard	0.7276			6529,2065		gene expression (GO:0010467)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of viral transcription (GO:0050434)|transcription elongation from RNA polymerase II promoter (GO:0006368)|transcription from RNA polymerase II promoter (GO:0006366)|viral process (GO:0016032)	3161,2598,739					CCDS7040.1	G		AA,AG,GG	AF464935	cytoplasm (GO:0005737)|NELF complex (GO:0032021)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	21		2504		rs3204123		1888				"""cofactor of BRCA1"""					517	KIAA1182, NELF-B			NM_015456		12			ENST00000343053.4		16657		uc004cmm.4			25920	dbSNP_105	1551			p.P517P		0				21.0		0.687	9:g.140167022G>A		protein_coding			basic|appris_principal|CCDS		2500,1529,268			2391,2011			g|||			5008		NELFB_HUMAN	3081	negative elongation factor complex member B			0.615216		140167022			0.4782	SNP		CCDS7040.1			,,,	False	140167022				synonymous_variant		Approved		21.0		c.1551G>A	2013-01-31	OTTHUMT00000254710.1	Q8WX92	0.7608		NELFB	140167022					COBRA1	NM_015456.3	protein-coding gene	NP_056271.2		
		C	ENSG00000188747	ENST00000341349.2		10811		ENSG00000188747		4300					,					OTTHUMG00000131781		byFrequency	Q86UR1	gene with protein product		NOXA1_ENST00000392815.2_Intron		NM_001256067.1|NM_006647.1	6,176,2021		0.0767					+	Intron		326.2+/-317.3	103.0				9610721				NOXA1-001	2002-12-09				9	+	0.0091				intron	10668					SO:0001627	611255			protein_coding		2203				21.0814,4.2669,15.3852			6503					OV - Ovarian serous cystadenocarcinoma(145;0.000238)|Epithelial(140;0.000982)			KNOWN			GGTGAGTACAGGGGTGCCTTG		SDCCAG31				ENST00000341349.2:c.260+10G>C	9					cervix(1)|large_intestine(2)|lung(2)|skin(3)|upper_aerodigestive_tract(1)		+		,		9q34.3	O60533|Q29VU9|Q29VV0|Q2TAM1|Q8IUS3		g.chr9:140320792G>C		120.4+/-158.0			no		2001,11005												3.4					0.0	enzyme binding (GO:0019899)|Rac GTPase binding (GO:0048365)|SH3 domain binding (GO:0017124)|superoxide-generating NADPH oxidase activator activity (GO:0016176)		2002-12-13		hg19	Standard	0.2087			1813,6787		positive regulation of catalytic activity (GO:0043085)|regulation of hydrogen peroxide metabolic process (GO:0010310)|regulation of respiratory burst (GO:0060263)|superoxide metabolic process (GO:0006801)	207,1587,4709					CCDS7042.1, CCDS59157.1	G		CC,CG,GG	AF039697	cytoplasm (GO:0005737)|NADPH oxidase complex (GO:0043020)	109		2504		rs72765154		440				"""serologically defined colon cancer antigen 31"""						NY-CO-31, FLJ25475		9	NM_001256067		2			ENST00000341349.2		19366		uc004cmu.3			10811	dbSNP_130						0				123.0		0.607	9:g.140320792G>C		protein_coding			basic|appris_principal|CCDS		201,1411,2688			188,4218			g|||			5008		NOXA1_HUMAN	407	NADPH oxidase activator 1			0.08127		140320792			0.001	SNP		CCDS7042.1			,,,	False	140320792				intron_variant		Approved		109.0			2013-09-20	OTTHUMT00000254713.1	Q86UR1	0.1571		NOXA1	140320792		all_cancers(76;0.0926)			NOXA1	NM_006647.1	protein-coding gene	NP_001242996.1|NP_006638.1		
		C	ENSG00000188833	ENST00000472938.1		377841		ENSG00000188833		4295					,				c.(781-783)gtA>gtG	OTTHUMG00000131831		byFrequency	Q5MY95	gene with protein product		ENTPD8_ENST00000344119.2_Silent_p.V261V|ENTPD8_ENST00000371506.2_Silent_p.V261V			1767,405,21	NM_198585	0.9489					+	Silent			22.0				12975309				ENTPD8-003					9	-	0.9047				coding-synonymous,coding-synonymous	24860		261/496,261/459		C	SO:0001819		,		protein_coding		2193				6.6938,10.1915,7.8761			6488					OV - Ovarian serous cystadenocarcinoma(145;0.000224)|Epithelial(140;0.000898)			KNOWN			AGCTGACCTGTACCAGCCCCA						ENST00000472938.1:c.783A>G	9					biliary_tract(1)|lung(4)|prostate(1)|skin(1)		-		,		9q34.3	A2BG17|Q6UVZ0	"""GLSR2492"""	g.chr9:140330976T>C					no		11954,1022												0.8					0.8	ATP binding (GO:0005524)|metal ion binding (GO:0046872)|nucleoside-diphosphatase activity (GO:0017110)|nucleoside-triphosphatase activity (GO:0017111)				hg19	Standard	0.9344			8015,575		nucleoside diphosphate biosynthetic process (GO:0009133)|nucleoside monophosphate biosynthetic process (GO:0009124)	5500,954,34					CCDS7043.1, CCDS43913.1	T		CC,CT,TT	AY359088	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	22		2504		rs13297080		799								,	261	UNQ2492, NTPDase-8		7	NM_198585		5			ENST00000472938.1		15279		uc004cmw.3			377841	dbSNP_121	783,783			p.V261V		0				23.0		0.662	9:g.140330976T>C		protein_coding			basic|appris_principal|CCDS		3733,549,13			3939,447			C|||			5008		ENTP8_HUMAN	4724	ectonucleoside triphosphate diphosphohydrolase 8			0.943291		140330976			0.9891	SNP		CCDS43913.1			,,,	False	140330976				synonymous_variant		Approved		22.0		c.783A>G	2013-09-20	OTTHUMT00000355991.1	Q5MY95	0.9553		ENTPD8	140330976		all_cancers(76;0.0926)		,	ENTPD8	NM_001033113.1,NM_198585.2	protein-coding gene			
		G	ENSG00000188833	ENST00000472938.1	0.27711	377841	N	ENSG00000188833	0.18424	4300	0.518000	0.10763	B;B		,	T	0.9454486	0	c.(184-186)cTg>cCg	OTTHUMG00000131831	0.126000	byFrequency	Q5MY95	gene with protein product		ENTPD8_ENST00000344119.2_Missense_Mutation_p.L62P|ENTPD8_ENST00000371506.2_Missense_Mutation_p.L62P			2147,52,1	NM_198585	0.9427			G	0.808	+	Missense_Mutation	2	154.6+/-208.8	58.0	Q5MY95-2;Q5MY95	0.987727		12975309			0.0;0.0	ENTPD8-003			0.01281		9	-	0.9955		1	0.730000	missense,missense	24860	348	62/496,62/459		G	SO:0001583		benign,benign	0.9613259668508287	protein_coding		2200	P		0.936000	6.6744,1.2273,4.8308	B;B		6500		0.1677:0.0:0.6828:0.1495			OV - Ovarian serous cystadenocarcinoma(145;0.000224)|Epithelial(140;0.000898)			KNOWN	ENST00000344119;ENST00000371506;ENST00000472938;ENST00000493135		CTTGTTCGCCAGCCACTGATA	T;T;T;T					ENST00000472938.1:c.185T>C	9		ENSG00000188833	0.12644	ENTPD8	biliary_tract(1)|lung(4)|prostate(1)|skin(1)	ENSP00000420531:p.Leu62Pro	-	0.31750	,	CTG	9q34.3	A2BG17|Q6UVZ0	"""GLSR2492"""	g.chr9:140332478A>G	L -> P (in dbSNP:rs6606582). {ECO:0000269|PubMed:12975309, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16752921, ECO:0000269|PubMed:17095758}.	50.9+/-86.3		489	yes		12372,628	0.27811	0.03041	4.37	0.00012	ENSP00000344089:L62P			0.49916		-8.2821		2.5	0.30058	571	0.02654	0.9982517482517482	0.5	ATP binding (GO:0005524)|metal ion binding (GO:0046872)|nucleoside-diphosphatase activity (GO:0017110)|nucleoside-triphosphatase activity (GO:0017111)	-2.77			hg19	Standard	0.9374	0.9939024390243902	6.1091	8026,574		nucleoside diphosphate biosynthetic process (GO:0009133)|nucleoside monophosphate biosynthetic process (GO:0009124)	5887,598,15	-0.752926				CCDS7043.1, CCDS43913.1	A	0.02656	GG,GA,AA	AY359088	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	58	0.00020	2504	2.47	rs6606582		201	62;62	706			0.20090	139452299	-	PRO/LEU,PRO/LEU	62	UNQ2492, NTPDase-8	2114	7	NM_198585	0.0;0.0	2	0.9313984168865436	-0.215000	ENST00000472938.1		17171		uc004cmw.3			377841	dbSNP_116	185,185	0.0000		p.L62P	.	0		T		58.0	rs6606582;rs6606582	0.622	9:g.140332478A>G	ENSP00000344089:L62P;ENSP00000360561:L62P;ENSP00000420531:L62P;ENSP00000420099:L49P	protein_coding	0.000138		basic|appris_principal|CCDS		3740,546,14		62;62;62;49	4346,54	0.967948717948718	P	G|||		0.083541	5008		ENTP8_HUMAN	4856	ectonucleoside triphosphate diphosphohydrolase 8		.;ENTP8_HUMAN	0.969649	0.34227	140332478		1.369000	0.998	SNP		CCDS43913.1		N	,,,	False	140332478	-1.0143		9	missense	T	Approved	0.933256	58.0		c.185T>C	2013-09-20	OTTHUMT00000355991.1	Q5MY95	0.964	2.84;2.84;2.84;2.84	ENTPD8	140332478	0.41778	all_cancers(76;0.0926)	0.25047	98,98	ENTPD8	NM_001033113.1,NM_198585.2	protein-coding gene		L	
		G	ENSG00000130653	ENST00000277531.4	0.46586	375775	N	ENSG00000130653	0.28148	4300	0.912000	0.24908	B;B;B		,	T	8.850000000000247E-4	0	c.(2407-2409)gTa>gCa	OTTHUMG00000020990	0.507000		Q6ZV29	gene with protein product		PNPLA7_ENST00000371457.1_Missense_Mutation_p.V409A|PNPLA7_ENST00000406427.1_Missense_Mutation_p.V828A		NM_152286.3		NM_152286	1.0			G	0.551	+	Missense_Mutation	2		55.0	E2QRF8;Q6ZV29-5;Q6ZV29	.		16799181, 12640454, 19029121			0.0;0.0;0.0	PNPLA7-007	2006-06-12		0.01281		9	-	1.0		1	0.026000		24768	362				SO:0001583	612122		1.0	protein_coding		2203	P		1.000000		B;B;B	"""Patatin-like phospholipase domain containing"""	6503		0.1563:0.0:0.8437:0.0			OV - Ovarian serous cystadenocarcinoma(145;0.000268)|Epithelial(140;0.000839)			KNOWN	ENST00000371457;ENST00000371446;ENST00000277531;ENST00000406427;ENST00000371451;ENST00000434090		CGTGCCATCTACCTGGTAGAG	T;T;T;T;T	C9orf111				ENST00000277531.4:c.2408T>C	9		ENSG00000130653	0.03964	PNPLA7	breast(1)|central_nervous_system(3)|endometrium(2)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(9)|lung(13)|ovary(1)|prostate(1)|skin(2)|stomach(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	ENSP00000277531:p.Val803Ala	-	0.71417	,	GTA	9q34.3	B5MDD3|Q5T364|Q658X0|Q658Y3|Q6ZTS1|Q86YU8|Q8TAY5|Q96N75|Q9H7N5		g.chr9:140374861A>G	V -> A (in dbSNP:rs1891630). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005}.			492				0.35992	0.02651	4.92	0.00012	ENSP00000277531:V803A			0.44902		-4.4993			0.46733	572	0.02654	1.0		lysophospholipase activity (GO:0004622)	-2.405	2006-06-12		hg19	Standard	1.0	1.0	10.7163			lipid metabolic process (GO:0006629)		-0.849328				CCDS7045.1, CCDS48070.1	A	0.02656		AK126267	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|lysosome (GO:0005764)|mitochondrion (GO:0005739)|nucleus (GO:0005634)		0.00050	2504	4.02	rs1891630		2594	211;828;803	758		"""chromosome 9 open reading frame 111"""	0.46015	139494682	-		803	FLJ43070, FLJ31318, FLJ44279, RP11-48C7.2, NTEL1, NTE-R1	2184	40	XM_005266082	0.0;0.0;0.0	22	1.0	-0.642000	ENST00000277531.4		16948		uc010ncj.1			375775			0.0000		p.V803A	.	0		T		74.0	rs1891630;rs6559229;rs17845767;rs17858725;rs58756062;rs1891630	0.652	9:g.140374861A>G	ENSP00000360512:V409A;ENSP00000360501:V211A;ENSP00000277531:V803A;ENSP00000384610:V828A;ENSP00000400582:V794A	protein_coding	0.000415		basic|appris_candidate|CCDS				409;211;803;828;803;794		1.0	A	G|||		0.232742	5008		PLPL7_HUMAN	5008	patatin-like phospholipase domain containing 7		.;.;PLPL7_HUMAN	1.0	0.73248	140374861		6.399000	1.0	SNP		CCDS7045.1		N	,,,	False	140374861	-0.9675		9	missense	T	Approved	.	61.0		c.2408T>C	2009-01-12	OTTHUMT00000254787.1	Q6ZV29	1.0	1.83;1.83;1.83;1.83;1.83	PNPLA7	140374861	0.11368	all_cancers(76;0.126)	0.38134				protein-coding gene	NP_689499.3	V	
		T	ENSG00000181090	ENST00000460843.1		79813		ENSG00000181090		4300					,					OTTHUMG00000020995		byFrequency	Q9H9B1	gene with protein product		EHMT1_ENST00000334856.6_Intron|EHMT1_ENST00000371394.2_Intron|EHMT1_ENST00000462484.1_Intron		NM_024757.4	0,6,2197	NM_024757	0.001					+	Intron		49.8+/-109.6	60.0				11347906, 12004135				EHMT1-001					9	+	0.0008				intron,intron	24650		,		C	SO:0001627	607001	,		protein_coding		2203				1.0349,0.1362,0.7304		"""Chromatin-modifying enzymes / K-methyltransferases"", ""Ankyrin repeat domain containing"""	6503					OV - Ovarian serous cystadenocarcinoma(145;0.000183)|Epithelial(140;0.000728)			KNOWN			CGGTAAATGCCGTGGGGGTGT						ENST00000460843.1:c.1369+9C>T	9					breast(2)|central_nervous_system(2)|cervix(2)|endometrium(3)|kidney(2)|large_intestine(4)|lung(16)|ovary(1)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2)		+		,		9q34.3	B1AQ58|B1AQ59|Q86X08|Q8TCN7|Q96F53|Q96JF1|Q96KH4		g.chr9:140648752C>T		11.4+/-27.6			no		95,12911												-2.3					0.0	histone methyltransferase activity (H3-K27 specific) (GO:0046976)|histone methyltransferase activity (H3-K9 specific) (GO:0046974)|histone-lysine N-methyltransferase activity (GO:0018024)|methyltransferase activity (GO:0008168)|p53 binding (GO:0002039)|protein-lysine N-methyltransferase activity (GO:0016279)|zinc ion binding (GO:0008270)				hg19	Standard	0.0119			89,8511		chromatin modification (GO:0016568)|DNA methylation (GO:0006306)|embryo development (GO:0009790)|histone methylation (GO:0016571)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|peptidyl-lysine dimethylation (GO:0018027)|peptidyl-lysine monomethylation (GO:0018026)	2,91,6410					CCDS7050.1, CCDS7050.2, CCDS56595.1	C		TT,TC,CC	AY083210	chromosome (GO:0005694)|cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	58		2504		rs146125583		1396				"""euchromatic histone methyltransferase 1"""				,		Eu-HMTase1, FLJ12879, KIAA1876, bA188C12.1, KMT1D		41	NM_024757		8			ENST00000460843.1		15397		uc011mfc.2			79813	dbSNP_134	,					0				55.0		0.592	9:g.140648752C>T		protein_coding			basic|appris_principal|CCDS		2,85,4213			6,4400			C|||			5008		EHMT1_HUMAN	22	euchromatic histone-lysine N-methyltransferase 1			0.00439297		140648752			0.0	SNP		CCDS7050.2			,,,	False	140648752		2.1.1.43		intron_variant		Approved		58.0			2013-09-20	OTTHUMT00000055371.2	Q9H9B1	0.0115		EHMT1	140648752		all_cancers(76;0.164)		,	EHMT1	NM_001145527.1,NM_024757.4	protein-coding gene	NP_079033.4		
		G	ENSG00000164305	ENST00000308394.4		836		ENSG00000164305		4300					,					OTTHUMG00000133681		byFrequency	P42574	gene with protein product		CASP3_ENST00000393588.4_Intron|CASP3_ENST00000523916.1_Intron|CASP3_ENST00000393585.2_Intron|CASP3_ENST00000517513.1_Intron	Minocycline(DB01017)	NM_004346.3	1473,641,89	NM_004346	0.5777					+	Intron		377.4+/-338.5	74.0				8780721				CASP3-001	2005-08-17			CASP3	4	-	0.851				intron,intron	1504		,	all_lung(41;7.57e-14)|Lung NSC(41;1.81e-13)|Colorectal(36;0.00139)|Hepatocellular(41;0.00826)|Renal(120;0.00988)|Prostate(90;0.0235)|all_neural(102;0.057)|all_hematologic(60;0.0592)	G	SO:0001627	600636	,		protein_coding		2203				26.2558,18.5883,23.6583		"""Caspases"""	6503					all cancers(43;2.05e-27)|Epithelial(43;4.27e-24)|OV - Ovarian serous cystadenocarcinoma(60;3.04e-11)|Colorectal(24;2e-05)|STAD - Stomach adenocarcinoma(60;2.35e-05)|GBM - Glioblastoma multiforme(59;4.94e-05)|COAD - Colon adenocarcinoma(29;0.00017)|BRCA - Breast invasive adenocarcinoma(30;0.000218)|LUSC - Lung squamous cell carcinoma(40;0.00904)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			TTAGAAACTGTAAAGACATTT						ENST00000308394.4:c.308-4A>C	4					endometrium(1)|kidney(1)|large_intestine(3)|lung(5)|prostate(1)|skin(1)		-		,		4q34	A8K5M2|D3DP53|Q96AN1|Q96KP2		g.chr4:185553098T>G		304.1+/-288.3			no		9929,3077						S						-2.7					0.0	aspartic-type endopeptidase activity (GO:0004190)|cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861)|cysteine-type endopeptidase activity (GO:0004197)|cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153)|cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200)|peptidase activity (GO:0008233)				hg19	Standard	0.7336			6342,2258		activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)|apoptotic DNA fragmentation (GO:0006309)|apoptotic process (GO:0006915)|apoptotic signaling pathway (GO:0097190)|B cell homeostasis (GO:0001782)|cell fate commitment (GO:0045165)|cellular component disassembly involved in execution phase of apoptosis (GO:0006921)|cellular response to DNA damage stimulus (GO:0006974)|erythrocyte differentiation (GO:0030218)|execution phase of apoptosis (GO:0097194)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|glial cell apoptotic process (GO:0034349)|heart development (GO:0007507)|hippo signaling (GO:0035329)|intrinsic apoptotic signaling pathway (GO:0097193)|intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)|keratinocyte differentiation (GO:0030216)|negative regulation of activated T cell proliferation (GO:0046007)|negative regulation of apoptotic process (GO:0043066)|negative regulation of B cell proliferation (GO:0030889)|negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)|neuron apoptotic process (GO:0051402)|neuron differentiation (GO:0030182)|neurotrophin TRK receptor signaling pathway (GO:0048011)|platelet formation (GO:0030220)|positive regulation of apoptotic process (GO:0043065)|positive regulation of neuron apoptotic process (GO:0043525)|proteolysis (GO:0006508)|regulation of apoptotic DNA fragmentation (GO:1902510)|regulation of apoptotic process (GO:0042981)|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|release of cytochrome c from mitochondria (GO:0001836)|response to tumor necrosis factor (GO:0034612)|response to UV (GO:0009411)|response to wounding (GO:0009611)|sensory perception of sound (GO:0007605)|T cell homeostasis (GO:0043029)	3794,2341,368					CCDS3836.1	T		GG,GT,TT	BC016926	cytosol (GO:0005829)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	72		2504		rs2705897		570			GRCh37	"""caspase 3, apoptosis-related cysteine protease"""				,		CPP32, CPP32B, Yama, apopain		12	NM_004346		6			ENST00000308394.4		17353		uc003iwi.3			836	dbSNP_100	,		CS084773			0				70.0		0.338	4:g.185553098T>G		protein_coding			basic|appris_principal|CCDS		2321,1700,279			3587,819			G|||			5008		CASP3_HUMAN	2968	caspase 3, apoptosis-related cysteine peptidase			0.592652		185553098			0.1964	SNP	rs2705897	CCDS3836.1			,,,	False	185553098				intron_variant		Approved		72.0			2008-02-05	OTTHUMT00000257885.2	P42574	0.4928		CASP3	185553098				,	CASP3	NM_004346.3,NM_032991.2	protein-coding gene	NP_004337.2		
		T	ENSG00000164305	ENST00000308394.4		836		ENSG00000164305		4297					,					OTTHUMG00000133681		byFrequency	P42574	gene with protein product		CASP3_ENST00000393585.2_Intron|CASP3_ENST00000393588.4_Intron|CASP3_ENST00000517513.1_Intron|CASP3_ENST00000523916.1_Intron	Minocycline(DB01017)	NM_004346.3	9,256,1938	NM_004346	0.1063					+	Intron		307.3+/-308.3	66.0				8780721				CASP3-001	2005-08-17				4	-	0.0431				intron,intron	1504		,	all_lung(41;7.57e-14)|Lung NSC(41;1.81e-13)|Colorectal(36;0.00139)|Hepatocellular(41;0.00826)|Renal(120;0.00988)|Prostate(90;0.0235)|all_neural(102;0.057)|all_hematologic(60;0.0592)	C	SO:0001627	600636	,		protein_coding		2203				20.0838,6.2188,15.3846		"""Caspases"""	6500					all cancers(43;2.05e-27)|Epithelial(43;4.27e-24)|OV - Ovarian serous cystadenocarcinoma(60;3.04e-11)|Colorectal(24;2e-05)|STAD - Stomach adenocarcinoma(60;2.35e-05)|GBM - Glioblastoma multiforme(59;4.94e-05)|COAD - Colon adenocarcinoma(29;0.00017)|BRCA - Breast invasive adenocarcinoma(30;0.000218)|LUSC - Lung squamous cell carcinoma(40;0.00904)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			GAAATGACCACGCCTTCTGTT						ENST00000308394.4:c.54-46G>A	4					endometrium(1)|kidney(1)|large_intestine(3)|lung(5)|prostate(1)|skin(1)		-		,		4q34	A8K5M2|D3DP53|Q96AN1|Q96KP2		g.chr4:185556618C>T		142.7+/-177.9			no		2000,11000												-0.7					0.0	aspartic-type endopeptidase activity (GO:0004190)|cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861)|cysteine-type endopeptidase activity (GO:0004197)|cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153)|cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200)|peptidase activity (GO:0008233)				hg19	Standard	0.1859			1726,6868		activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)|apoptotic DNA fragmentation (GO:0006309)|apoptotic process (GO:0006915)|apoptotic signaling pathway (GO:0097190)|B cell homeostasis (GO:0001782)|cell fate commitment (GO:0045165)|cellular component disassembly involved in execution phase of apoptosis (GO:0006921)|cellular response to DNA damage stimulus (GO:0006974)|erythrocyte differentiation (GO:0030218)|execution phase of apoptosis (GO:0097194)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|glial cell apoptotic process (GO:0034349)|heart development (GO:0007507)|hippo signaling (GO:0035329)|intrinsic apoptotic signaling pathway (GO:0097193)|intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)|keratinocyte differentiation (GO:0030216)|negative regulation of activated T cell proliferation (GO:0046007)|negative regulation of apoptotic process (GO:0043066)|negative regulation of B cell proliferation (GO:0030889)|negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)|neuron apoptotic process (GO:0051402)|neuron differentiation (GO:0030182)|neurotrophin TRK receptor signaling pathway (GO:0048011)|platelet formation (GO:0030220)|positive regulation of apoptotic process (GO:0043065)|positive regulation of neuron apoptotic process (GO:0043525)|proteolysis (GO:0006508)|regulation of apoptotic DNA fragmentation (GO:1902510)|regulation of apoptotic process (GO:0042981)|regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)|release of cytochrome c from mitochondria (GO:0001836)|response to tumor necrosis factor (GO:0034612)|response to UV (GO:0009411)|response to wounding (GO:0009611)|sensory perception of sound (GO:0007605)|T cell homeostasis (GO:0043029)	183,1634,4683					CCDS3836.1	C		TT,TC,CC	BC016926	cytosol (GO:0005829)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	66		2504		rs1405938		316				"""caspase 3, apoptosis-related cysteine protease"""				,		CPP32, CPP32B, Yama, apopain		12	NM_004346		4			ENST00000308394.4		16129		uc003iwi.3			836	dbSNP_88	,					0				67.0		0.338	4:g.185556618C>T		protein_coding			basic|appris_principal|CCDS		174,1378,2745			274,4132			C|||			5008		CASP3_HUMAN	436	caspase 3, apoptosis-related cysteine peptidase			0.0870607		185556618			0.0	SNP		CCDS3836.1			,,,	False	185556618				intron_variant		Approved		66.0			2008-02-05	OTTHUMT00000257885.2	P42574	0.1268		CASP3	185556618				,	CASP3	NM_004346.3,NM_032991.2	protein-coding gene	NP_004337.2		
		CTATT	ENSG00000164306	ENST00000314970.6		201973		ENSG00000164306		4300										OTTHUMG00000160495		byFrequency	Q96LW4	gene with protein product		PRIMPOL_ENST00000503752.1_Intron|PRIMPOL_ENST00000515774.1_Intron|PRIMPOL_ENST00000512834.1_Intron		NM_152683.2		NM_152683						+	Intron			49.0				12477932				PRIMPOL-001	2013-09-27				4	+						26575					SO:0001627	615421			protein_coding		2203							6503								KNOWN			TTATTTCTATCCATCTCTTCA		CCDC111				ENST00000314970.6:c.408+35C>CTATT	4							+				4q35.1	D3DP55|D6RDM1|Q5HYJ9		g.chr4:185583092_185583092insCTATT																									chromatin binding (GO:0003682)|DNA primase activity (GO:0003896)|DNA-directed DNA polymerase activity (GO:0003887)|manganese ion binding (GO:0030145)		2013-09-27		hg19	Standard						mitochondrial DNA replication (GO:0006264)|replication fork processing (GO:0031297)|response to UV (GO:0009411)|translesion synthesis (GO:0019985)						CCDS3837.1, CCDS75211.1, CCDS75212.1	C			AK057729	mitochondrial matrix (GO:0005759)|nucleus (GO:0005634)					rs77048283|rs60624489|rs4069932		841				"""coiled-coil domain containing 111"""						FLJ33167			XM_005262814		5			ENST00000314970.6				uc003iwk.2			201973							0				53.0		0.368	4:g.185583092_185583092insCTATT		protein_coding			basic|appris_candidate_longest|CCDS													PRIPO_HUMAN		primase and polymerase (DNA-directed)					185583092				INS		CCDS3837.1					185583092				intron_variant		Approved		50.0			2013-09-27	OTTHUMT00000360827.1	Q96LW4			PRIMPOL	185583092							protein-coding gene	NP_689896		
		C	ENSG00000151726	ENST00000515030.1		2180		ENSG00000151726		4300					,					OTTHUMG00000160547		byFrequency	P33121	gene with protein product		ACSL1_ENST00000437665.3_Intron|ACSL1_ENST00000513317.1_Intron|ACSL1_ENST00000454703.2_Intron|ACSL1_ENST00000281455.2_Intron|ACSL1_ENST00000504342.1_Intron|ACSL1_ENST00000507295.1_Intron	Adenosine monophosphate(DB00131)|Adenosine triphosphate(DB00171)		2181,22,0	NM_001995	1.0					+	Intron			152.0				2341402, 1531127				ACSL1-011	2004-02-19				4	-	0.9917				intron	3569			all_lung(41;7.57e-14)|Lung NSC(41;1.81e-13)|Colorectal(36;0.00172)|Hepatocellular(41;0.00826)|Renal(120;0.00988)|Prostate(90;0.0235)|all_hematologic(60;0.0315)|all_neural(102;0.107)|Medulloblastoma(177;0.146)	C	SO:0001627	152425			protein_coding		2203				0.0,0.4993,0.1692		"""Acyl-CoA synthetase family"""	6503					all cancers(43;1.33e-28)|Epithelial(43;5.3e-25)|OV - Ovarian serous cystadenocarcinoma(60;4.88e-11)|Colorectal(24;3.59e-06)|STAD - Stomach adenocarcinoma(60;2.72e-05)|GBM - Glioblastoma multiforme(59;2.83e-05)|BRCA - Breast invasive adenocarcinoma(30;7.66e-05)|COAD - Colon adenocarcinoma(29;0.000538)|LUSC - Lung squamous cell carcinoma(40;0.008)|READ - Rectum adenocarcinoma(43;0.0419)			KNOWN			ATGGCAATGTGTATGCAGCAA		FACL2				ENST00000515030.1:c.1782+35C>G	4					NS(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(3)|large_intestine(6)|liver(1)|lung(17)|ovary(2)|prostate(1)|skin(2)		-		,		4q35.1	B7Z452|D3DP57|P41215|Q8N8V7|Q8TA99	"""lignoceroyl-CoA synthase"", ""long-chain fatty-acid-coenzyme A ligase 1"""	g.chr4:185681475G>C		30.8+/-60.4			no		12984,22												0.1					0.0	ATP binding (GO:0005524)|long-chain fatty acid-CoA ligase activity (GO:0004467)		2004-02-20		hg19	Standard	1.0			8600,0		adiponectin-activated signaling pathway (GO:0033211)|alpha-linolenic acid metabolic process (GO:0036109)|cellular lipid metabolic process (GO:0044255)|linoleic acid metabolic process (GO:0043651)|lipid biosynthetic process (GO:0008610)|long-chain fatty acid import (GO:0044539)|long-chain fatty acid metabolic process (GO:0001676)|long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)|positive regulation of protein serine/threonine kinase activity (GO:0071902)|response to drug (GO:0042493)|response to nutrient (GO:0007584)|response to oleic acid (GO:0034201)|response to organic cyclic compound (GO:0014070)|small molecule metabolic process (GO:0044281)|triglyceride biosynthetic process (GO:0019432)|unsaturated fatty acid metabolic process (GO:0033559)|xenobiotic catabolic process (GO:0042178)	6481,22,0					CCDS3839.1, CCDS68825.1, CCDS68826.1, CCDS75213.1	G		CC,CG,GG	BC026290	endoplasmic reticulum membrane (GO:0005789)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739)|peroxisomal membrane (GO:0005778)|plasma membrane (GO:0005886)	150		2504		rs6825554		2108				"""fatty-acid-Coenzyme A ligase, long-chain 2"""						LACS2, LACS, ACS1, LACS1, FACL1		38	XM_005262828		18			ENST00000515030.1		18867		uc003iwu.1			2180	dbSNP_116						0				145.0		0.443	4:g.185681475G>C		protein_coding			alternative_5_UTR|basic|appris_principal|CCDS		4300,0,0			4384,22			C|||			5008		ACSL1_HUMAN	4995	acyl-CoA synthetase long-chain family member 1			0.997404		185681475			1.0	SNP		CCDS3839.1			,,,	False	185681475		6.2.1.3		intron_variant		Approved		150.0			2014-08-08	OTTHUMT00000361112.2	P33121	0.9971		ACSL1	185681475					ACSL1	NM_001995.2	protein-coding gene			
		T	ENSG00000151726	ENST00000515030.1		2180		ENSG00000151726		4300					,				c.(1405-1407)ctG>ctA	OTTHUMG00000160547		byFrequency	P33121	gene with protein product		ACSL1_ENST00000437665.3_Silent_p.L298L|ACSL1_ENST00000513317.1_Silent_p.L469L|ACSL1_ENST00000454703.2_Silent_p.L298L|ACSL1_ENST00000281455.2_Silent_p.L469L|ACSL1_ENST00000504342.1_Silent_p.L469L|ACSL1_ENST00000507295.1_Silent_p.L435L	Adenosine monophosphate(DB00131)|Adenosine triphosphate(DB00171)		1847,343,13	NM_001995	0.7536					+	Silent		668.7+/-402.6	63.0				2341402, 1531127				ACSL1-011	2004-02-19				4	-	0.9546				coding-synonymous	3569		469/699	all_lung(41;7.57e-14)|Lung NSC(41;1.81e-13)|Colorectal(36;0.00172)|Hepatocellular(41;0.00826)|Renal(120;0.00988)|Prostate(90;0.0235)|all_hematologic(60;0.0315)|all_neural(102;0.107)|Medulloblastoma(177;0.146)	C	SO:0001819	152425			protein_coding		2203				34.186,8.3749,25.4421		"""Acyl-CoA synthetase family"""	6503					all cancers(43;1.33e-28)|Epithelial(43;5.3e-25)|OV - Ovarian serous cystadenocarcinoma(60;4.88e-11)|Colorectal(24;3.59e-06)|STAD - Stomach adenocarcinoma(60;2.72e-05)|GBM - Glioblastoma multiforme(59;2.83e-05)|BRCA - Breast invasive adenocarcinoma(30;7.66e-05)|COAD - Colon adenocarcinoma(29;0.000538)|LUSC - Lung squamous cell carcinoma(40;0.008)|READ - Rectum adenocarcinoma(43;0.0419)			KNOWN			CAGGCATGGTCAGGCAGCACC		FACL2				ENST00000515030.1:c.1407G>A	4					NS(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(3)|large_intestine(6)|liver(1)|lung(17)|ovary(2)|prostate(1)|skin(2)		-		,		4q35.1	B7Z452|D3DP57|P41215|Q8N8V7|Q8TA99	"""lignoceroyl-CoA synthase"", ""long-chain fatty-acid-coenzyme A ligase 1"""	g.chr4:185686032C>T		792.4+/-415.1			no		9697,3309												2.9					0.6	ATP binding (GO:0005524)|long-chain fatty acid-CoA ligase activity (GO:0004467)		2004-02-20		hg19	Standard	0.6511			5660,2940		adiponectin-activated signaling pathway (GO:0033211)|alpha-linolenic acid metabolic process (GO:0036109)|cellular lipid metabolic process (GO:0044255)|linoleic acid metabolic process (GO:0043651)|lipid biosynthetic process (GO:0008610)|long-chain fatty acid import (GO:0044539)|long-chain fatty acid metabolic process (GO:0001676)|long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)|positive regulation of protein serine/threonine kinase activity (GO:0071902)|response to drug (GO:0042493)|response to nutrient (GO:0007584)|response to oleic acid (GO:0034201)|response to organic cyclic compound (GO:0014070)|small molecule metabolic process (GO:0044281)|triglyceride biosynthetic process (GO:0019432)|unsaturated fatty acid metabolic process (GO:0033559)|xenobiotic catabolic process (GO:0042178)	3698,2301,504					CCDS3839.1, CCDS68825.1, CCDS68826.1, CCDS75213.1	C		TT,TC,CC	BC026290	endoplasmic reticulum membrane (GO:0005789)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739)|peroxisomal membrane (GO:0005778)|plasma membrane (GO:0005886)	65		2504		rs2292898		1732				"""fatty-acid-Coenzyme A ligase, long-chain 2"""					469	LACS2, LACS, ACS1, LACS1, FACL1		38	XM_005262828		15			ENST00000515030.1		20689		uc003iwu.1			2180	dbSNP_100	1407			p.L469L		0				69.0		0.473	4:g.185686032C>T		protein_coding			alternative_5_UTR|basic|appris_principal|CCDS		1851,1958,491			4037,369			C|||			5008		ACSL1_HUMAN	4164	acyl-CoA synthetase long-chain family member 1			0.83147		185686032			0.9306	SNP		CCDS3839.1			,,,	False	185686032		6.2.1.3		synonymous_variant		Approved		65.0		c.1407G>A	2014-08-08	OTTHUMT00000361112.2	P33121	0.8242		ACSL1	185686032					ACSL1	NM_001995.2	protein-coding gene			
		A	ENSG00000151726	ENST00000515030.1		2180		ENSG00000151726		4300					,				c.(1372-1374)taC>taT	OTTHUMG00000160547		byFrequency	P33121	gene with protein product		ACSL1_ENST00000437665.3_Silent_p.Y287Y|ACSL1_ENST00000513317.1_Silent_p.Y458Y|ACSL1_ENST00000454703.2_Silent_p.Y287Y|ACSL1_ENST00000281455.2_Silent_p.Y458Y|ACSL1_ENST00000504342.1_Silent_p.Y458Y|ACSL1_ENST00000507295.1_Silent_p.Y424Y	Adenosine monophosphate(DB00131)|Adenosine triphosphate(DB00171)		0,14,2189	NM_001995	0.0194					+	Silent		80.6+/-143.3	62.0				2341402, 1531127				ACSL1-011	2004-02-19				4	-	0.0008				coding-synonymous	3569		458/699	all_lung(41;7.57e-14)|Lung NSC(41;1.81e-13)|Colorectal(36;0.00172)|Hepatocellular(41;0.00826)|Renal(120;0.00988)|Prostate(90;0.0235)|all_hematologic(60;0.0315)|all_neural(102;0.107)|Medulloblastoma(177;0.146)	G	SO:0001819	152425			protein_coding		2203				2.0814,0.3177,1.4839		"""Acyl-CoA synthetase family"""	6503					all cancers(43;1.33e-28)|Epithelial(43;5.3e-25)|OV - Ovarian serous cystadenocarcinoma(60;4.88e-11)|Colorectal(24;3.59e-06)|STAD - Stomach adenocarcinoma(60;2.72e-05)|GBM - Glioblastoma multiforme(59;2.83e-05)|BRCA - Breast invasive adenocarcinoma(30;7.66e-05)|COAD - Colon adenocarcinoma(29;0.000538)|LUSC - Lung squamous cell carcinoma(40;0.008)|READ - Rectum adenocarcinoma(43;0.0419)			KNOWN			CTGTCTGTCCGTATCCTTCAT		FACL2				ENST00000515030.1:c.1374C>T	4					NS(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(3)|large_intestine(6)|liver(1)|lung(17)|ovary(2)|prostate(1)|skin(2)		-		,		4q35.1	B7Z452|D3DP57|P41215|Q8N8V7|Q8TA99	"""lignoceroyl-CoA synthase"", ""long-chain fatty-acid-coenzyme A ligase 1"""	g.chr4:185686065G>A		21.2+/-45.6			no		193,12813												-8.2					0.3	ATP binding (GO:0005524)|long-chain fatty acid-CoA ligase activity (GO:0004467)		2004-02-20		hg19	Standard	0.0239			179,8421		adiponectin-activated signaling pathway (GO:0033211)|alpha-linolenic acid metabolic process (GO:0036109)|cellular lipid metabolic process (GO:0044255)|linoleic acid metabolic process (GO:0043651)|lipid biosynthetic process (GO:0008610)|long-chain fatty acid import (GO:0044539)|long-chain fatty acid metabolic process (GO:0001676)|long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)|positive regulation of protein serine/threonine kinase activity (GO:0071902)|response to drug (GO:0042493)|response to nutrient (GO:0007584)|response to oleic acid (GO:0034201)|response to organic cyclic compound (GO:0014070)|small molecule metabolic process (GO:0044281)|triglyceride biosynthetic process (GO:0019432)|unsaturated fatty acid metabolic process (GO:0033559)|xenobiotic catabolic process (GO:0042178)	5,183,6315					CCDS3839.1, CCDS68825.1, CCDS68826.1, CCDS75213.1	G		AA,AG,GG	BC026290	endoplasmic reticulum membrane (GO:0005789)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|mitochondrial outer membrane (GO:0005741)|mitochondrion (GO:0005739)|peroxisomal membrane (GO:0005778)|plasma membrane (GO:0005886)	64		2504		rs34107464		1699				"""fatty-acid-Coenzyme A ligase, long-chain 2"""					458	LACS2, LACS, ACS1, LACS1, FACL1		38	XM_005262828		15			ENST00000515030.1		20806		uc003iwu.1			2180	dbSNP_126	1374			p.Y458Y		0				69.0		0.478	4:g.185686065G>A		protein_coding			alternative_5_UTR|basic|appris_principal|CCDS		5,169,4126			14,4392			G|||			5008		ACSL1_HUMAN	50	acyl-CoA synthetase long-chain family member 1			0.00998403		185686065			0.0	SNP		CCDS3839.1			,,,	False	185686065		6.2.1.3		synonymous_variant		Approved		64.0		c.1374C>T	2014-08-08	OTTHUMT00000361112.2	P33121	0.0086		ACSL1	185686065					ACSL1	NM_001995.2	protein-coding gene			
		T	ENSG00000109762	ENST00000504273.1		83891		ENSG00000109762		4300										OTTHUMG00000160475			Q9H3E2	gene with protein product		SNX25_ENST00000264694.8_Intron				NM_031953						+	Intron			71.0				12461558				SNX25-001					4	+						21883			all_lung(41;1.03e-13)|Lung NSC(41;2.5e-13)|Hepatocellular(41;0.00826)|Colorectal(36;0.00886)|Renal(120;0.00988)|Prostate(90;0.0235)|all_hematologic(60;0.0592)|all_neural(102;0.243)		SO:0001627				protein_coding		2203						"""Sorting nexins"""	6503					all cancers(43;2.13e-24)|Epithelial(43;6.15e-22)|OV - Ovarian serous cystadenocarcinoma(60;5.6e-11)|BRCA - Breast invasive adenocarcinoma(30;0.00013)|Colorectal(24;0.000165)|GBM - Glioblastoma multiforme(59;0.000357)|COAD - Colon adenocarcinoma(29;0.000887)|STAD - Stomach adenocarcinoma(60;0.00118)|LUSC - Lung squamous cell carcinoma(40;0.0129)|READ - Rectum adenocarcinoma(43;0.228)			KNOWN			AAGGTAAGAGCCAGGTTGTTT						ENST00000504273.1:c.670+8C>T	4					NS(1)|breast(4)|endometrium(2)|kidney(4)|large_intestine(8)|lung(13)|ovary(2)|pancreas(2)|prostate(2)|urinary_tract(2)		+				4q35.1	Q3ZT30|Q8N6K3		g.chr4:186209244C>T																									phosphatidylinositol binding (GO:0035091)				hg19	Standard						negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|protein transport (GO:0015031)|receptor catabolic process (GO:0032801)|termination of G-protein coupled receptor signaling pathway (GO:0038032)						CCDS34116.1	C			AF113223	endosome (GO:0005768)|membrane (GO:0016020)							964										SBBI31		40	NM_031953		6			ENST00000504273.1				uc003ixh.3			83891							0				74.0		0.433	4:g.186209244C>T		protein_coding			basic|appris_principal|CCDS													SNX25_HUMAN		sorting nexin 25					186209244				SNP		CCDS34116.1					186209244				intron_variant		Approved		72.0			2011-05-03	OTTHUMT00000360756.1	Q9H3E2			SNX25	186209244							protein-coding gene			
		C	ENSG00000109762	ENST00000504273.1		83891		ENSG00000109762		4300					,					OTTHUMG00000160475		byFrequency	Q9H3E2	gene with protein product		SNX25_ENST00000512853.1_Intron|SNX25_ENST00000264694.8_Intron			1036,940,227	NM_031953	0.3793					+	Intron		681.3+/-403.7	54.0				12461558				SNX25-001					4	+	0.7685				intron	21883			all_lung(41;1.03e-13)|Lung NSC(41;2.5e-13)|Hepatocellular(41;0.00826)|Colorectal(36;0.00886)|Renal(120;0.00988)|Prostate(90;0.0235)|all_hematologic(60;0.0592)|all_neural(102;0.243)	C	SO:0001627				protein_coding		2203				31.4419,31.6387,43.9489		"""Sorting nexins"""	6503					all cancers(43;2.13e-24)|Epithelial(43;6.15e-22)|OV - Ovarian serous cystadenocarcinoma(60;5.6e-11)|BRCA - Breast invasive adenocarcinoma(30;0.00013)|Colorectal(24;0.000165)|GBM - Glioblastoma multiforme(59;0.000357)|COAD - Colon adenocarcinoma(29;0.000887)|STAD - Stomach adenocarcinoma(60;0.00118)|LUSC - Lung squamous cell carcinoma(40;0.0129)|READ - Rectum adenocarcinoma(43;0.228)			KNOWN			GGTGAGCCGTTGAAAGAGTGA						ENST00000504273.1:c.1974+10T>C	4					NS(1)|breast(4)|endometrium(2)|kidney(4)|large_intestine(8)|lung(13)|ovary(2)|pancreas(2)|prostate(2)|urinary_tract(2)		+		,		4q35.1	Q3ZT30|Q8N6K3		g.chr4:186272773T>C		453.0+/-350.2			no		5716,7290												-1.2					0.0	phosphatidylinositol binding (GO:0035091)				hg19	Standard	0.3419			2704,5896		negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|protein transport (GO:0015031)|receptor catabolic process (GO:0032801)|termination of G-protein coupled receptor signaling pathway (GO:0038032)	1455,2806,2242					CCDS34116.1	T		CC,CT,TT	AF113223	endosome (GO:0005768)|membrane (GO:0016020)	54		2504		rs3822302		2268										SBBI31		40	NM_031953		14			ENST00000504273.1		19897		uc003ixh.3			83891	dbSNP_107						0				54.0		0.438	4:g.186272773T>C		protein_coding			basic|appris_principal|CCDS		419,1866,2015			3012,1394			C|||			5008		SNX25_HUMAN	2270	sorting nexin 25			0.453275		186272773			0.2758	SNP		CCDS34116.1			,,,	False	186272773				intron_variant		Approved		54.0			2011-05-03	OTTHUMT00000360756.1	Q9H3E2	0.3761		SNX25	186272773					SNX25	NM_031953.2	protein-coding gene			
		T	ENSG00000109771	ENST00000328559.7		55805		ENSG00000109771		4300					,				c.(613-615)ggG>ggA	OTTHUMG00000160460		byFrequency	Q9P2M1	gene with protein product		LRP2BP_ENST00000505916.1_Silent_p.G205G|LRP2BP_ENST00000510776.1_Silent_p.G179G|LRP2BP_ENST00000362004.3_Silent_p.G207G|RP11-714G18.1_ENST00000514884.1_RNA		NM_018409.3	173,903,1127	NM_018409	0.1585					+	Silent		301.8+/-305.6	88.0				10718198, 12508107				LRP2BP-001					4	-	0.3177				coding-synonymous	25434		205/348	all_lung(41;1.3e-11)|Lung NSC(41;2.25e-11)|Melanoma(20;0.00109)|Colorectal(36;0.0215)|Renal(120;0.0246)|Hepatocellular(41;0.0268)|Prostate(90;0.0283)|all_hematologic(60;0.0749)	C	SO:0001819				protein_coding		2203				19.0465,28.3477,22.1974			6503					all cancers(43;2.14e-25)|Epithelial(43;1.55e-22)|OV - Ovarian serous cystadenocarcinoma(60;1.34e-11)|BRCA - Breast invasive adenocarcinoma(30;8.01e-05)|GBM - Glioblastoma multiforme(59;0.000132)|STAD - Stomach adenocarcinoma(60;0.000766)|Colorectal(24;0.00116)|LUSC - Lung squamous cell carcinoma(40;0.00904)|COAD - Colon adenocarcinoma(29;0.0101)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			ACTCCAGATTCCCATTGCCAC						ENST00000328559.7:c.615G>A	4					breast(1)|endometrium(2)|large_intestine(6)|lung(3)|prostate(1)|skin(2)		-		,		4q35.1	A6NJR7|A7E219|B3KX83|Q9NSN6		g.chr4:186294198C>T		427.8+/-341.7			no		2887,10119												-12.1					0.0					hg19	Standard	0.1918			1638,6962			329,2229,3945					CCDS3840.1	C		TT,TC,CC	AB037746	cytoplasm (GO:0005737)	89		2504		rs3797026		1426									205	DKFZp761O0113		15	NM_018409		6			ENST00000328559.7		21837		uc003ixj.2			55805	dbSNP_107	615			p.G205G		0				91.0		0.463	4:g.186294198C>T		protein_coding			basic|appris_candidate|CCDS		156,1326,2818			1249,3157			C|||			5008		LR2BP_HUMAN	1139	LRP2 binding protein			0.227436		186294198			0.1845	SNP		CCDS3840.1			,,,	False	186294198				synonymous_variant		Approved		89.0		c.615G>A	2011-05-03	OTTHUMT00000360679.2	Q9P2M1	0.2666		LRP2BP	186294198					LRP2BP	NM_018409.3	protein-coding gene	NP_060879.2		
		G	ENSG00000109771	ENST00000328559.7		55805		ENSG00000109771		4300					,				c.(79-81)ttT>ttC	OTTHUMG00000160460		byFrequency	Q9P2M1	gene with protein product		LRP2BP_ENST00000505916.1_Silent_p.F27F|LRP2BP_ENST00000362004.3_Silent_p.F27F|RP11-714G18.1_ENST00000514884.1_RNA|LRP2BP_ENST00000510776.1_5'UTR		NM_018409.3	633,1103,467	NM_018409	0.318	Substitution - coding silent(1)				+	Silent		712.0+/-405.9	137.0				10718198, 12508107				LRP2BP-001					4	-	0.612				coding-synonymous	25434		27/348	all_lung(41;1.3e-11)|Lung NSC(41;2.25e-11)|Melanoma(20;0.00109)|Colorectal(36;0.0215)|Renal(120;0.0246)|Hepatocellular(41;0.0268)|Prostate(90;0.0283)|all_hematologic(60;0.0749)	G	SO:0001819				protein_coding	prostate(1)	2203				25.5465,46.2324,35.1069			6503					all cancers(43;2.14e-25)|Epithelial(43;1.55e-22)|OV - Ovarian serous cystadenocarcinoma(60;1.34e-11)|BRCA - Breast invasive adenocarcinoma(30;8.01e-05)|GBM - Glioblastoma multiforme(59;0.000132)|STAD - Stomach adenocarcinoma(60;0.000766)|Colorectal(24;0.00116)|LUSC - Lung squamous cell carcinoma(40;0.00904)|COAD - Colon adenocarcinoma(29;0.0101)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			TCCACTGGAAAAATTTTTGGT						ENST00000328559.7:c.81T>C	4					breast(1)|endometrium(2)|large_intestine(6)|lung(3)|prostate(1)|skin(2)		-		,		4q35.1	A6NJR7|A7E219|B3KX83|Q9NSN6		g.chr4:186299260A>G		565.8+/-381.8			no		4566,8440												2.9					0.3					hg19	Standard	0.2624			2197,6403			906,2754,2843			p.F27F(1)		CCDS3840.1	A		GG,GA,AA	AB037746	cytoplasm (GO:0005737)	137		2504		rs2030802		892									27	DKFZp761O0113		15	NM_018409		1			ENST00000328559.7		19885		uc003ixj.2			55805	dbSNP_94	81			p.F27F		1				135.0		0.378	4:g.186299260A>G		protein_coding			basic|appris_candidate|CCDS		273,1651,2376			2369,2037			G|||			5008		LR2BP_HUMAN	1855	LRP2 binding protein			0.370407		186299260			0.247	SNP		CCDS3840.1			,,,	False	186299260				synonymous_variant		Approved		137.0		c.81T>C	2011-05-03	OTTHUMT00000360679.2	Q9P2M1	0.3199		LRP2BP	186299260					LRP2BP	NM_018409.3	protein-coding gene	NP_060879.2		
		A	ENSG00000168491	ENST00000307588.3		256309		ENSG00000168491		4300					,				c.(2368-2370)taC>taT	OTTHUMG00000160415		byFrequency	Q8TBZ0	gene with protein product		CCDC110_ENST00000510617.1_Silent_p.Y790Y|CCDC110_ENST00000393540.3_Silent_p.Y753Y		NM_152775.3	1883,308,12	NM_152775	1.0					+	Silent			64.0				18160854				CCDC110-001					4	-	0.9175				coding-synonymous,coding-synonymous	28504		753/797,790/834	all_lung(41;1.3e-11)|Lung NSC(41;2.25e-11)|Melanoma(20;7.86e-05)|Renal(120;0.0246)|Hepatocellular(41;0.0268)|Prostate(90;0.0283)|Colorectal(36;0.0381)|all_hematologic(60;0.0749)	A	SO:0001819	609488	,		protein_coding		2203				0.0,7.5352,2.5527			6503					OV - Ovarian serous cystadenocarcinoma(60;1.13e-10)|BRCA - Breast invasive adenocarcinoma(30;8.01e-05)|GBM - Glioblastoma multiforme(59;0.00014)|STAD - Stomach adenocarcinoma(60;0.000777)|LUSC - Lung squamous cell carcinoma(40;0.00921)|COAD - Colon adenocarcinoma(29;0.0105)|READ - Rectum adenocarcinoma(43;0.164)			KNOWN			TTCTTGAAATGTAAGTTGTTT						ENST00000307588.3:c.2370C>T	4					NS(1)|breast(1)|central_nervous_system(2)|endometrium(6)|kidney(3)|large_intestine(8)|lung(9)		-		,		4q35.1	Q86YI9|Q8N7W0	"""cancer/testis antigen 52"""	g.chr4:186379371G>A		173.7+/-203.5			no		12674,332												-1.6					0.0					hg19	Standard	1.0			8600,0			6183,308,12					CCDS3843.1, CCDS47170.1	G		AA,AG,GG	AB080722	nucleus (GO:0005634)	65		2504		rs7687202		2445								,	790	KM-HN-1, MGC33607, CT52		30	NM_152775		6			ENST00000307588.3		16570		uc003ixu.4			256309	dbSNP_116	2259,2370			p.Y790Y		0				67.0		0.368	4:g.186379371G>A		protein_coding			basic|appris_candidate|CCDS		4300,0,0			4074,332			A|||			5008		CC110_HUMAN	4895	coiled-coil domain containing 110			0.977436		186379371			1.0	SNP		CCDS3843.1			,,,	False	186379371				synonymous_variant		Approved		65.0		c.2370C>T	2010-12-24	OTTHUMT00000360519.2	Q8TBZ0	0.9942		CCDC110	186379371				,	CCDC110	NM_001145411.1,NM_152775.3	protein-coding gene	NP_689988.1		
		G	ENSG00000109794	ENST00000356371.5	0.80722	25854	M	ENSG00000109794	0.19401	4300	0.000000	0.17528	B;B		,	T	0.0	0	c.(1309-1311)Aaa>Gaa	OTTHUMG00000160565	0.159000	byFrequency	A5PLN7	gene with protein product		FAM149A_ENST00000514153.1_Missense_Mutation_p.K146E|FAM149A_ENST00000502970.1_Missense_Mutation_p.K146E|FAM149A_ENST00000503432.1_Missense_Mutation_p.K146E|FAM149A_ENST00000514829.1_3'UTR|FAM149A_ENST00000227065.4_Missense_Mutation_p.K146E|FAM149A_ENST00000389354.5_Missense_Mutation_p.K146E			1960,234,9	NM_001006655	0.8753			G	11.85	+	Missense_Mutation	1	220.8+/-258.4	108.0	A5PLN7-3;A5PLN7	0.942805					0.009;0.025	FAM149A-201			0.19391		4	+	0.9531		0.17	0.000000	missense,missense	24527	311	146/483,146/483	all_cancers(14;4.27e-52)|all_epithelial(14;7.69e-39)|all_lung(41;1.34e-13)|Lung NSC(41;3.58e-13)|Melanoma(20;1.91e-06)|Colorectal(36;0.0066)|Hepatocellular(41;0.00886)|Renal(120;0.00988)|Prostate(90;0.00996)|all_hematologic(60;0.014)|all_neural(102;0.243)	G	SO:0001583		possibly-damaging,possibly-damaging	0.8591160220994475	protein_coding		2203	P		0.014000	12.1395,5.7195,9.9646	B;B		6503		0.8092:0.1203:0.0705:0.0			OV - Ovarian serous cystadenocarcinoma(60;1.19e-10)|BRCA - Breast invasive adenocarcinoma(30;1.22e-05)|GBM - Glioblastoma multiforme(59;0.000122)|STAD - Stomach adenocarcinoma(60;0.000288)|LUSC - Lung squamous cell carcinoma(40;0.00241)|READ - Rectum adenocarcinoma(43;0.166)			KNOWN	ENST00000503432;ENST00000356371;ENST00000227065;ENST00000502970;ENST00000514153;ENST00000389354		GAAATGGCGCAAACTCGGACT	T;T;T;T;T;T					ENST00000356371.5:c.1309A>G	4		ENSG00000109794	0.02275	FAM149A	breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(8)|lung(8)|pancreas(1)|prostate(1)|skin(2)	ENSP00000348732:p.Lys437Glu	+	0.17966	,	AAA	4q35.1	B5MDB8|Q2TAN6|Q7Z2S5|Q9Y4T9		g.chr4:187077206A>G	K -> E (in dbSNP:rs4862653). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005}.	145.0+/-179.8		467	yes		11710,1296	0.03702	0.31228	5.46	0.00012	ENSP00000227065:K146E			0.34133		-13.5284		3.0	0.34707	467	0.39692	0.8164335664335665	0.0		2.125			hg19	Standard	0.8936	0.9491869918699187	9.4042	7556,1044			5280,1150,73	1.762264				CCDS34117.1	A	0.21821	GG,GA,AA	AK057166		111	0.69823	2504	3.0	rs4862653		1309	437;437	682			0.38451	187314200	+	GLU/LYS,GLU/LYS	437	DKFZP564J102, MST119, MSTP119	1927	25	NM_015398	0.021;0.061	7	0.899736147757256	-1.066000	ENST00000356371.5		16941		uc010isl.3			25854	dbSNP_111	436,436	0.0000		p.K437E	.	0		T		117.0	rs4862653;rs52791294;rs56631638;rs59194690;rs4862653	0.443	4:g.187077206A>G	ENSP00000426835:K146E;ENSP00000348732:K437E;ENSP00000227065:K146E;ENSP00000427155:K146E;ENSP00000424380:K146E;ENSP00000374005:K146E	protein_coding	0.004229		basic		3320,916,64		146;437;146;146;146;146	4154,252	0.8823260073260073	E	G|||		0.286996	5008		F149A_HUMAN	4441	family with sequence similarity 149, member A		.;F149A_HUMAN	0.886781	0.45999	187077206		2.572000	0.8204	SNP				N	,,,	False	187077206	-1.0574		9	missense	T	Approved	0.878605	111.0		c.1309A>G	2012-04-19		A5PLN7	0.8631	2.28;2.27;2.28;2.28;2.28;2.28	FAM149A	187077206	0.00434		0.11767	56,56	FAM149A	NM_001006655.2,NM_015398.2	protein-coding gene		K	
		G	ENSG00000145476	ENST00000378802.4		285440		ENSG00000145476		4300					,					OTTHUMG00000160379		byFrequency	Q6ZWL3	gene with protein product		CYP4V2_ENST00000502665.1_Intron		NM_207352.3	173,906,1124	XM_209612	0.5665					+	Intron		512.7+/-378.0	107.0				15042513				CYP4V2-001					4	+	0.2564				intron	23198			all_cancers(14;4.27e-52)|all_epithelial(14;7.69e-39)|all_lung(41;1.34e-13)|Lung NSC(41;3.58e-13)|Melanoma(20;1.91e-06)|Colorectal(36;0.0066)|Hepatocellular(41;0.00886)|Renal(120;0.00988)|Prostate(90;0.00996)|all_hematologic(60;0.014)|all_neural(102;0.243)	A	SO:0001627	608614			protein_coding		2203				40.7907,28.4158,36.5985		"""Cytochrome P450s"""	6503					OV - Ovarian serous cystadenocarcinoma(60;1.33e-10)|BRCA - Breast invasive adenocarcinoma(30;3.84e-05)|GBM - Glioblastoma multiforme(59;0.000132)|STAD - Stomach adenocarcinoma(60;0.000293)|LUSC - Lung squamous cell carcinoma(40;0.00242)|READ - Rectum adenocarcinoma(43;0.17)			KNOWN			CTTTCAGGTCATCTTATCTAC						ENST00000378802.4:c.1091-24A>G	4					breast(1)|endometrium(1)|kidney(1)|large_intestine(5)|lung(9)|skin(1)|stomach(2)		+		,		4q35.2	B7U6W2|Q6ZTM4		g.chr4:187129995A>G		429.7+/-342.3			no		4760,8246												-2.0					0.0	heme binding (GO:0020037)|iron ion binding (GO:0005506)|monooxygenase activity (GO:0004497)|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (GO:0016705)				hg19	Standard	0.4404			3508,5092		fatty acid omega-oxidation (GO:0010430)|response to stimulus (GO:0050896)|visual perception (GO:0007601)	901,2958,2644					CCDS34119.1	A		GG,GA,AA	AK022114	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)	107		2504		rs2276917		1394										CYP4AH1		20	NM_207352		9			ENST00000378802.4		19919		uc003iyw.4			285440	dbSNP_100						0				106.0		0.458	4:g.187129995A>G		protein_coding			basic|appris_principal|CCDS		728,2052,1520			1252,3154			A|||			5008		CP4V2_HUMAN	1850	cytochrome P450, family 4, subfamily V, polypeptide 2			0.369409		187129995			0.253	SNP		CCDS34119.1			,,,	False	187129995				intron_variant		Approved		107.0			2004-07-05	OTTHUMT00000360398.1	Q6ZWL3	0.3732		CYP4V2	187129995					CYP4V2	NM_207352.3	protein-coding gene	NP_997235.3		
		C	ENSG00000164344	ENST00000513864.1	0.80722|0.80722	3818	.|.	ENSG00000164344	0.00042|0.00042	4300	0.000000|0.000000	.|0.87650	.|B		,	.|T	0.0|0.0	0|0	c.(1621-1623)Tgg>Cgg	OTTHUMG00000150347	-4.563000|-4.563000	byFrequency	P03952	gene with protein product		KLKB1_ENST00000264690.6_Silent_p.N587N			969,976,258	NM_000892	0.4407			C|C	1.032|1.032	+	Missense_Mutation	2|1	431.3+/-356.8	99.0	.|E7EQA8	0.661371|0.661371		9535413, 3521732			.|0.001	KLKB1-007			.|0.04013		4	+	0.6301		.|0.09	0.021000|0.021000	coding-synonymous	6371	252|252	587/639	all_cancers(14;1.55e-52)|all_epithelial(14;7.69e-39)|all_lung(41;1.34e-13)|Lung NSC(41;3.58e-13)|Melanoma(20;1.91e-06)|Colorectal(36;0.00664)|Hepatocellular(41;0.00886)|Renal(120;0.00988)|Prostate(90;0.00996)|all_hematologic(60;0.014)|all_neural(102;0.243)	C	SO:0001583	229000		0.6961325966850829|0.6961325966850829	protein_coding		2203	P|P		0.000000|0.000000	31.3023,33.8629,32.1698	.|B	"""Kallikreins"""	6503		0.1062:0.1679:0.0632:0.6628|0.1062:0.1679:0.0632:0.6628			OV - Ovarian serous cystadenocarcinoma(60;1.29e-10)|BRCA - Breast invasive adenocarcinoma(30;3.8e-05)|GBM - Glioblastoma multiforme(59;0.000131)|STAD - Stomach adenocarcinoma(60;0.000292)|LUSC - Lung squamous cell carcinoma(40;0.00241)|READ - Rectum adenocarcinoma(43;0.168)			PUTATIVE	ENST00000511608|ENST00000513864;ENST00000418715		GCAAACACAATGGAATGTGGC	.|D	KLK3				ENST00000513864.1:c.1621T>C	4	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.	ENSG00000164344|ENSG00000164344	0.00253|0.00253	KLKB1|KLKB1	breast(2)|central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(8)|lung(15)|ovary(3)|pancreas(1)|prostate(1)|skin(4)|upper_aerodigestive_tract(1)	ENSP00000424469:p.Trp541Arg	+	0.05858|0.05858	,	ATG|TGG	4q35	A6NH96|B2R8H9|Q17RE8|Q17RE9|Q4W5C3		g.chr4:187179210T>C		477.5+/-357.9		316|316	no		8822,4184	0.03702|0.03702	0.03353|0.03353	6.04|6.04	0.00012|0.00012	.|ENSP00000397470:W503R			.|.		.|.		-12.1	0.00011|0.00011	487|487	.|0.49607	0.8513986013986014|0.8513986013986014	0.0	serine-type endopeptidase activity (GO:0004252)	.|.			hg19	Standard	0.7008	0.6422764227642277|0.6422764227642277	10.7695|10.7695	5908,2692		blood coagulation (GO:0007596)|blood coagulation, intrinsic pathway (GO:0007597)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|Factor XII activation (GO:0002542)|fibrinolysis (GO:0042730)|plasminogen activation (GO:0031639)|positive regulation of fibrinolysis (GO:0051919)|proteolysis (GO:0006508)|zymogen activation (GO:0031638)	2993,2836,674	-0.681527|-0.681527				CCDS34120.1	T	.|0.02656	CC,CT,TT	M13143	extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|plasma membrane (GO:0005886)	101	.|.	2504	-12.1|-12.1	rs925453		1692	.|503	524|524			0.46314|0.46314	187416204|187416204	+|+		0		1579|1579	40	XM_005262987	.|0.0	14	0.6912928759894459|0.6912928759894459	-2.318000|-2.318000	ENST00000513864.1		21496		uc003iyy.3			3818	dbSNP_86	1761	0.0000|0.0000		p.W541R	.|.	0		T|T		105.0	rs925453;rs1042573;rs3822054;rs61444978;rs925453|rs925453;rs1042573;rs3822054;rs61444978;rs925453	0.488	4:g.187179210T>C	.|ENSP00000424469:W541R	protein_coding	.|.		basic		2024,1860,416		635|541;503	2914,1492	0.722985347985348|0.722985347985348	T|R	.|||		.|.	5008		KLKB1_HUMAN	3296	kallikrein B, plasma (Fletcher factor) 1		.|.	0.658147	0.00340|0.00340	187179210		-3.894000|-3.894000	0.8512	SNP				.|.	,,,	False	187179210	-0.9291|-0.9291		3|7	missense	T|T	Approved	0.686977|0.686977	101.0		c.1621T>C	2008-02-05	OTTHUMT00000360468.2	P03952	0.6758	.|-2.28	KLKB1	187179210	0.10359|0.10359		0.44997|0.44997		KLKB1	NM_000892.3	protein-coding gene		M|W	
		C	ENSG00000179046	ENST00000512729.1		205860		ENSG00000179046		4300					,				c.(961-963)ggC>ggG	OTTHUMG00000160225		byFrequency	Q8N7C3	gene with protein product		TRIML2_ENST00000326754.3_Silent_p.G346G		NM_173553.1	1279,803,121	NM_173553	0.7239					+	Silent		602.9+/-394.6	157.0								TRIML2-001	2007-12-14				4	-	0.8177				coding-synonymous	26378		321/388	all_cancers(14;3.11e-44)|all_epithelial(14;7.86e-31)|all_lung(41;4.3e-13)|Lung NSC(41;9.69e-13)|Melanoma(20;7.86e-05)|Breast(6;0.000148)|all_hematologic(60;0.0202)|Hepatocellular(41;0.0218)|Renal(120;0.0376)|Prostate(90;0.0513)	C	SO:0001819				protein_coding		2203				45.7326,23.7177,43.9182			6503					OV - Ovarian serous cystadenocarcinoma(60;1.79e-11)|BRCA - Breast invasive adenocarcinoma(30;4.52e-06)|GBM - Glioblastoma multiforme(59;1.62e-05)|STAD - Stomach adenocarcinoma(60;0.000279)|LUSC - Lung squamous cell carcinoma(40;0.0091)|READ - Rectum adenocarcinoma(43;0.163)			KNOWN			CAAGGAAAACGCCAACTGTGT						ENST00000512729.1:c.963C>G	4	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.				central_nervous_system(2)|kidney(1)|large_intestine(7)|lung(25)|prostate(3)|urinary_tract(1)		-		,		4q35.2	B7Z6J6	"""SPRY domain containing 6"""	g.chr4:189012728G>C		383.5+/-324.9			no		7294,5712												-4.3					0.9	ligase activity (GO:0016874)				hg19	Standard	0.4642			3933,4667		protein ubiquitination (GO:0016567)|response to retinoic acid (GO:0032526)	2197,2900,1406					CCDS3850.1	G		CC,CG,GG	AK098667		152		2504		rs2279550		1337									321	FLJ25801, SPRYD6		39	NM_173553		7			ENST00000512729.1		19434		uc003izl.2			205860	dbSNP_100	963			p.G321G		0				141.0		0.517	4:g.189012728G>C		protein_coding			basic|CCDS		918,2097,1285			3361,1045			C|||			5008		TRIMM_HUMAN	3568	tripartite motif family-like 2			0.71246		189012728			0.9117	SNP		CCDS3850.1			,,,	False	189012728				synonymous_variant		Approved		152.0		c.963C>G	2014-02-12	OTTHUMT00000359733.1	Q8N7C3	0.5663		TRIML2	189012728					TRIML2	NM_173553.1	protein-coding gene	NP_775824.1		
		T	ENSG00000179046	ENST00000512729.1		205860		ENSG00000179046		4300					,				c.(214-216)caG>caA	OTTHUMG00000160225		byFrequency	Q8N7C3	gene with protein product		TRIML2_ENST00000536972.1_Silent_p.Q122Q|TRIML2_ENST00000326754.3_Silent_p.Q72Q		NM_173553.1	49,501,1653	NM_173553	0.1391					+	Silent		142.8+/-198.9	150.0								TRIML2-001	2007-12-14				4	-	0.152				coding-synonymous	26378		72/388	all_cancers(14;3.11e-44)|all_epithelial(14;7.86e-31)|all_lung(41;4.3e-13)|Lung NSC(41;9.69e-13)|Melanoma(20;7.86e-05)|Breast(6;0.000148)|all_hematologic(60;0.0202)|Hepatocellular(41;0.0218)|Renal(120;0.0376)|Prostate(90;0.0513)	C	SO:0001819				protein_coding		2203				5.6628,13.5951,8.35			6503					OV - Ovarian serous cystadenocarcinoma(60;1.79e-11)|BRCA - Breast invasive adenocarcinoma(30;4.52e-06)|GBM - Glioblastoma multiforme(59;1.62e-05)|STAD - Stomach adenocarcinoma(60;0.000279)|LUSC - Lung squamous cell carcinoma(40;0.0091)|READ - Rectum adenocarcinoma(43;0.163)			KNOWN			TCTGGAGATTCTGCTCACACT						ENST00000512729.1:c.216G>A	4					central_nervous_system(2)|kidney(1)|large_intestine(7)|lung(25)|prostate(3)|urinary_tract(1)		-		,		4q35.2	B7Z6J6	"""SPRY domain containing 6"""	g.chr4:189022324C>T		261.6+/-264.4			no		1086,11920												3.4					0.0	ligase activity (GO:0016874)				hg19	Standard	0.0606			487,8113		protein ubiquitination (GO:0016567)|response to retinoic acid (GO:0032526)	63,960,5480					CCDS3850.1	C		TT,TC,CC	AK098667		153		2504		rs79698746		590									72	FLJ25801, SPRYD6		39	NM_173553		3			ENST00000512729.1		15613		uc003izl.2			205860	dbSNP_131	216			p.Q72Q		0				161.0		0.423	4:g.189022324C>T		protein_coding			basic|CCDS		14,459,3827			599,3807			C|||			5008		TRIMM_HUMAN	1008	tripartite motif family-like 2			0.201278		189022324			0.4861	SNP		CCDS3850.1			,,,	False	189022324				synonymous_variant		Approved		153.0		c.216G>A	2014-02-12	OTTHUMT00000359733.1	Q8N7C3	0.1729		TRIML2	189022324					TRIML2	NM_173553.1	protein-coding gene	NP_775824.1		
		A	ENSG00000184108	ENST00000332517.3	0.26359	339976	L	ENSG00000184108	0.88918	4300	1.000000	0.61980	D		,	D	0.9770894999999999	0	c.(394-396)Gag>Aag	OTTHUMG00000160237	2.625000	byFrequency	Q8N9V2	gene with protein product				NM_178556.3	64,657,1482	NM_178556	0.2536			G	13.27	+	Missense_Mutation	1	549.9+/-385.6	42.0	Q8N9V2	0.178166		12477932			0.868	TRIML1-001			0.60068		4	+	0.1157		0.01	0.256000	missense	26698	176	132/469	all_cancers(14;1.33e-43)|all_epithelial(14;7.86e-31)|all_lung(41;4.3e-13)|Lung NSC(41;9.69e-13)|Melanoma(20;7.86e-05)|Breast(6;0.000148)|Hepatocellular(41;0.0218)|Renal(120;0.0376)|Prostate(90;0.0513)|all_hematologic(60;0.062)	G	SO:0001583		benign	0.4861878453038674	protein_coding		2203	P		0.298000	49.9419,17.8166,39.1358	P	"""RING-type (C3HC4) zinc fingers"""	6503		0.0:0.0:1.0:0.0			OV - Ovarian serous cystadenocarcinoma(60;1.52e-11)|BRCA - Breast invasive adenocarcinoma(30;4.19e-06)|GBM - Glioblastoma multiforme(59;0.000232)|STAD - Stomach adenocarcinoma(60;0.000279)|LUSC - Lung squamous cell carcinoma(40;0.00902)|READ - Rectum adenocarcinoma(43;0.156)		Melanoma(31;213 1036 16579 23968 32372)	KNOWN	ENST00000332517		CAGCGAGGCTGAGGAGCATCA	T					ENST00000332517.3:c.394G>A	4		ENSG00000184108	0.74099	TRIML1	NS(3)|breast(2)|central_nervous_system(2)|endometrium(8)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(6)|lung(30)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(1)	ENSP00000327738:p.Glu132Lys	+	0.24417	,	GAG	4q35.2	Q96BE5		g.chr4:189061106G>A	E -> K (in dbSNP:rs13131525).	296.4+/-284.2		55	yes		5090,7916	0.80357	0.38609	4.85	0.00012	ENSP00000327738:E132K			0.24472		-29.3586		4.8	0.62838	50	0.72032	0.08741258741258741	1.0	ligase activity (GO:0016874)|zinc ion binding (GO:0008270)	1.79			hg19	Standard	0.4672	0.11178861788617886	14.1946	4305,4295		multicellular organismal development (GO:0007275)|protein ubiquitination (GO:0016567)	1158,2774,2571	2.187911				CCDS3851.1	G	0.61697	AA,AG,GG	AK093499		43	0.57536	2504	4.85	rs13131525		534	132	354			0.65662	189298100	+	LYS/GLU	132	FLJ36180, RNF209	635	60	NM_178556	0.99	1	0.46701846965699206	0.561000	ENST00000332517.3		19109		uc003izm.1			339976	dbSNP_121	394	0.0000		p.E132K	.	0		T		45.0	rs13131525;rs60211754;rs13131525	0.582	4:g.189061106G>A	ENSP00000327738:E132K	protein_coding	0.038231		basic|appris_principal|CCDS		1094,2117,1089		132	785,3621	0.2907509157509158	K	G|||		0.325925	5008		TRIML_HUMAN	1280	tripartite motif family-like 1		TRIML_HUMAN	0.255591	0.46300	189061106		2.607000	0.0655	SNP		CCDS3851.1		N	,,,	False	189061106	-0.8977		9	missense	T	Approved	0.500581	43.0		c.394G>A	2013-01-09	OTTHUMT00000359813.1	Q8N9V2	0.4942	0.06	TRIML1	189061106	0.26092		0.49072	56	TRIML1	NM_178556.3	protein-coding gene	NP_848651.2	E	
		T	ENSG00000109536	ENST00000226798.4		2483		ENSG00000109536		4300					,				c.(319-321)atC>atT	OTTHUMG00000160202		byFrequency	Q14331	gene with protein product		FRG1_ENST00000514482.1_3'UTR		NM_004477.2		NM_004477	0.3303					+	Silent			43.0				8733123				FRG1-001					4	+	0.2693					3954			all_cancers(14;1.44e-58)|all_epithelial(14;6.32e-41)|all_lung(41;8.13e-17)|Lung NSC(41;2.13e-16)|Breast(6;2.54e-06)|Melanoma(20;0.000263)|Hepatocellular(41;0.00213)|Renal(120;0.0183)|all_hematologic(60;0.0358)|Prostate(90;0.0421)|all_neural(102;0.147)		SO:0001819	601278			protein_coding		2203							6503					all cancers(3;1.73e-30)|Epithelial(3;5.85e-30)|OV - Ovarian serous cystadenocarcinoma(60;5.56e-15)|BRCA - Breast invasive adenocarcinoma(30;9.14e-06)|Lung(3;3.54e-05)|STAD - Stomach adenocarcinoma(60;8.83e-05)|LUSC - Lung squamous cell carcinoma(40;0.000198)|GBM - Glioblastoma multiforme(59;0.00892)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			TGTACAGAATCGCCCTGAAGT						ENST00000226798.4:c.321C>T	4					NS(2)|breast(1)|central_nervous_system(1)|endometrium(2)|lung(11)|ovary(1)|pancreas(1)|prostate(5)|skin(7)|urinary_tract(1)		+		,		4q35	A8K775		g.chr4:190876195C>T																									poly(A) RNA binding (GO:0044822)				hg19	Standard	0.329					mRNA splicing, via spliceosome (GO:0000398)|muscle organ development (GO:0007517)|rRNA processing (GO:0006364)						CCDS34121.1	C			L76159	catalytic step 2 spliceosome (GO:0071013)|cytoplasm (GO:0005737)			2504		rs7684300		543									107	FSG1, FRG1A		32	XM_005262880		5			ENST00000226798.4		17052		uc003izs.3			2483					p.I107I		0				44.0		0.378	4:g.190876195C>T		protein_coding			basic|appris_principal|exp_conf|CCDS								.|||			5008		FRG1_HUMAN	1456	FSHD region gene 1			0.290735		190876195			0.2837	SNP		CCDS34121.1			,,,	False	190876195				synonymous_variant		Approved		44.0		c.321C>T	2008-02-05	OTTHUMT00000359622.4	Q14331	0.2305		FRG1	190876195							protein-coding gene	NP_004468.1		
		A	ENSG00000109536	ENST00000226798.4	0.80722	2483	.	ENSG00000109536	0.57103	4300	1.000000	0.54479	B			T	1	0	c.(367-369)gGa>gAa	OTTHUMG00000160202	1.964000		Q14331	gene with protein product		FRG1_ENST00000514482.1_3'UTR		NM_004477.2		NM_004477				.	17.31	+	Missense_Mutation	2		83.0	Q14331	.		8733123			0.231	FRG1-001			0.36719		4	+			0.07	0.971000		3954	.		all_cancers(14;1.44e-58)|all_epithelial(14;6.32e-41)|all_lung(41;8.13e-17)|Lung NSC(41;2.13e-16)|Breast(6;2.54e-06)|Melanoma(20;0.000263)|Hepatocellular(41;0.00213)|Renal(120;0.0183)|all_hematologic(60;0.0358)|Prostate(90;0.0421)|all_neural(102;0.147)		SO:0001583	601278		.	protein_coding		2203	D		1.000000		B		6503		0.0:0.0:1.0:0.0			all cancers(3;1.73e-30)|Epithelial(3;5.85e-30)|OV - Ovarian serous cystadenocarcinoma(60;5.56e-15)|BRCA - Breast invasive adenocarcinoma(30;9.14e-06)|Lung(3;3.54e-05)|STAD - Stomach adenocarcinoma(60;8.83e-05)|LUSC - Lung squamous cell carcinoma(40;0.000198)|GBM - Glioblastoma multiforme(59;0.00892)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN	ENST00000226798;ENST00000531991		AATTCAGATGGACTTGTTGTT	T;T					ENST00000226798.4:c.368G>A	4		ENSG00000109536	0.79289	FRG1	NS(2)|breast(1)|central_nervous_system(1)|endometrium(2)|lung(11)|ovary(1)|pancreas(1)|prostate(5)|skin(7)|urinary_tract(1)	ENSP00000226798:p.Gly123Glu	+	0.71417		GGA	4q35	A8K775		g.chr4:190876242G>A				.				0.80357	0.61403	4.04	0.52597	ENSP00000226798:G123E			0.85682		0.0644			0.47022	.	0.52906	.		poly(A) RNA binding (GO:0044822)	.			hg19	Standard		.	14.145			mRNA splicing, via spliceosome (GO:0000398)|muscle organ development (GO:0007517)|rRNA processing (GO:0006364)		3.357950				CCDS34121.1	G	0.26744		L76159	catalytic step 2 spliceosome (GO:0071013)|cytoplasm (GO:0005737)		.		4.04	rs1061653		590	123	.			0.65344	191113236	+		123	FSG1, FRG1A	.	32	XM_005262880	0.158	5	.	0.567000	ENST00000226798.4				uc003izs.3			2483			0.1744		p.G123E	Actin cross-linking (1);	0		T		83.0	rs1061653;rs3202744	0.343	4:g.190876242G>A	ENSP00000226798:G123E;ENSP00000435943:G60E	protein_coding	0.000000		basic|appris_principal|exp_conf|CCDS				123;60		.	E			0.000000			FRG1_HUMAN		FSHD region gene 1		FRG1_HUMAN		0.80104	190876242		7.413000		SNP		CCDS34121.1		D			190876242	-0.7850		9	missense	T	Approved	.	83.0		c.368G>A	2008-02-05	OTTHUMT00000359622.4	Q14331		1.33;0.57	FRG1	190876242	0.66376		0.57213				protein-coding gene	NP_004468.1	G	
		T	ENSG00000109536	ENST00000226798.4		2483		ENSG00000109536		4276									c.(475-477)tgC>tgT	OTTHUMG00000160202			Q14331	gene with protein product		FRG1_ENST00000514482.1_3'UTR		NM_004477.2		NM_004477						+	Silent			27.0				8733123				FRG1-001					4	+						3954			all_cancers(14;1.44e-58)|all_epithelial(14;6.32e-41)|all_lung(41;8.13e-17)|Lung NSC(41;2.13e-16)|Breast(6;2.54e-06)|Melanoma(20;0.000263)|Hepatocellular(41;0.00213)|Renal(120;0.0183)|all_hematologic(60;0.0358)|Prostate(90;0.0421)|all_neural(102;0.147)		SO:0001819	601278			protein_coding		2173							6449					all cancers(3;1.73e-30)|Epithelial(3;5.85e-30)|OV - Ovarian serous cystadenocarcinoma(60;5.56e-15)|BRCA - Breast invasive adenocarcinoma(30;9.14e-06)|Lung(3;3.54e-05)|STAD - Stomach adenocarcinoma(60;8.83e-05)|LUSC - Lung squamous cell carcinoma(40;0.000198)|GBM - Glioblastoma multiforme(59;0.00892)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			TTATTAGATGCAATGAAGCAG						ENST00000226798.4:c.477C>T	4					NS(2)|breast(1)|central_nervous_system(1)|endometrium(2)|lung(11)|ovary(1)|pancreas(1)|prostate(5)|skin(7)|urinary_tract(1)		+				4q35	A8K775		g.chr4:190878597C>T																									poly(A) RNA binding (GO:0044822)				hg19	Standard						mRNA splicing, via spliceosome (GO:0000398)|muscle organ development (GO:0007517)|rRNA processing (GO:0006364)						CCDS34121.1	C			L76159	catalytic step 2 spliceosome (GO:0071013)|cytoplasm (GO:0005737)					rs62345290		699									159	FSG1, FRG1A		32	XM_005262880		6			ENST00000226798.4				uc003izs.3			2483					p.C159C		0				25.0		0.368	4:g.190878597C>T		protein_coding			basic|appris_principal|exp_conf|CCDS													FRG1_HUMAN		FSHD region gene 1					190878597				SNP		CCDS34121.1					190878597				synonymous_variant		Approved		26.0		c.477C>T	2008-02-05	OTTHUMT00000359622.4	Q14331			FRG1	190878597							protein-coding gene	NP_004468.1		
		T	ENSG00000109536	ENST00000226798.4		2483		ENSG00000109536												OTTHUMG00000160202			Q14331	gene with protein product		FRG1_ENST00000514482.1_Intron		NM_004477.2		NM_004477						+	Intron							8733123				FRG1-001						+						3954			all_cancers(14;1.44e-58)|all_epithelial(14;6.32e-41)|all_lung(41;8.13e-17)|Lung NSC(41;2.13e-16)|Breast(6;2.54e-06)|Melanoma(20;0.000263)|Hepatocellular(41;0.00213)|Renal(120;0.0183)|all_hematologic(60;0.0358)|Prostate(90;0.0421)|all_neural(102;0.147)		SO:0001627	601278			protein_coding														all cancers(3;1.73e-30)|Epithelial(3;5.85e-30)|OV - Ovarian serous cystadenocarcinoma(60;5.56e-15)|BRCA - Breast invasive adenocarcinoma(30;9.14e-06)|Lung(3;3.54e-05)|STAD - Stomach adenocarcinoma(60;8.83e-05)|LUSC - Lung squamous cell carcinoma(40;0.000198)|GBM - Glioblastoma multiforme(59;0.00892)|READ - Rectum adenocarcinoma(43;0.161)			KNOWN			GATCAAGGTAATGATGACATT						ENST00000226798.4:c.537+4A>T	4					NS(2)|breast(1)|central_nervous_system(1)|endometrium(2)|lung(11)|ovary(1)|pancreas(1)|prostate(5)|skin(7)|urinary_tract(1)		+				4q35	A8K775		g.chr4:190878661A>T																									poly(A) RNA binding (GO:0044822)				hg19	Standard						mRNA splicing, via spliceosome (GO:0000398)|muscle organ development (GO:0007517)|rRNA processing (GO:0006364)						CCDS34121.1	A			L76159	catalytic step 2 spliceosome (GO:0071013)|cytoplasm (GO:0005737)					rs62345291		759										FSG1, FRG1A		32	XM_005262880		6			ENST00000226798.4				uc003izs.3			2483							0						0.353	4:g.190878661A>T		protein_coding			basic|appris_principal|exp_conf|CCDS													FRG1_HUMAN		FSHD region gene 1					190878661				SNP		CCDS34121.1					190878661				intron_variant		Approved					2008-02-05	OTTHUMT00000359622.4	Q14331			FRG1								protein-coding gene	NP_004468.1		
		T	ENSG00000153404	ENST00000283426.6		153478		ENSG00000153404		4300					,					OTTHUMG00000161570		byFrequency	Q96PX9	gene with protein product				NM_052909.3	518,1114,571	NM_052909	0.5562					+	Intron		633.1+/-398.7	64.0				11572484				PLEKHG4B-001					5	+	0.4607				intron	29399				C	SO:0001627				protein_coding		2203				40.7209,48.7971,44.2719		"""Pleckstrin homology (PH) domain containing"""	6503					Kidney(1;0.119)			KNOWN			CCGCCCGGTCCGATTGGGTGC						ENST00000283426.6:c.3153+18C>T	5					endometrium(1)|large_intestine(2)|lung(2)|prostate(3)|skin(3)		+		,		5p15.33			g.chr5:173200C>T		579.4+/-384.9			no		7248,5758												-2.8					0.0	Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.5378			5098,3502			2047,3154,1302					CCDS34124.1	C		TT,TC,CC	BC008352		64		2504		rs6885136		3203										KIAA1909		11	NM_052909		15			ENST00000283426.6		17170		uc003jak.2			153478	dbSNP_116						0				66.0		0.612	5:g.173200C>T		protein_coding			basic|appris_principal|CCDS		1529,2040,731			2150,2256			C|||			5008		PKH4B_HUMAN	2288	pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			0.456869		173200	all cancers(22;0.0253)|Lung(60;0.113)		0.2798	SNP		CCDS34124.1			,,,	False	173200				intron_variant		Approved		64.0			2013-01-11	OTTHUMT00000365359.1	Q96PX9	0.4496		PLEKHG4B	173200					PLEKHG4B	NM_052909.3	protein-coding gene	NP_443141.3		
		A	ENSG00000153404	ENST00000283426.6	0.40520	153478	L	ENSG00000153404	0.09025	4300	0.606000	0.11277	D		,	T	0.019175000000000053	0	c.(3226-3228)cGg>cAg	OTTHUMG00000161570	-0.290000	byFrequency	Q96PX9	gene with protein product				NM_052909.3	60,620,1523	NM_052909	0.5542			G	14.67	+	Missense_Mutation	2	598.3+/-393.9	72.0	Q96PX9	0.167953		11572484			0.862	PLEKHG4B-001			0.59703		5	+	0.0877		0.08	0.939000	missense	29399	142	1076/1272		G	SO:0001583		probably-damaging	0.39226519337016574	protein_coding		2203	P		1.000000	45.093,16.7953,41.996	P	"""Pleckstrin homology (PH) domain containing"""	6503		0.3331:0.0:0.6669:0.0			Kidney(1;0.119)			KNOWN	ENST00000283426		CGCAGGCGGCGGAAATCTCAG	T					ENST00000283426.6:c.3227G>A	5	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.	ENSG00000153404	0.07495	PLEKHG4B	endometrium(1)|large_intestine(2)|lung(2)|prostate(3)|skin(3)	ENSP00000283426:p.Arg1076Gln	+	0.71417	,	CGG	5p15.33			g.chr5:174106G>A	R -> Q (in dbSNP:rs4956987). {ECO:0000269|PubMed:11572484}.	299.6+/-285.9		45	yes		5462,7544	0.28943	0.46527	3.38	0.00012	ENSP00000283426:R1076Q			.		.		0.5	0.17084	150	0.51188	0.26223776223776224	0.6	Rho guanyl-nucleotide exchange factor activity (GO:0005089)	0.95			hg19	Standard	0.504	0.09146341463414634	7.0666	4722,3878			1363,2736,2404	2.605848				CCDS34124.1	G	0.64830	AA,AG,GG	BC008352		77	0.31664	2504	0.527	rs4956987		3277	1076	379			0.25156	227106	+	GLN/ARG	1076	KIAA1909	716	11	NM_052909	0.994	16	0.5	-0.363000	ENST00000283426.6		14734		uc003jak.2			153478	dbSNP_111	3227	0.0000		p.R1076Q	Pleckstrin homology-type (1);Pleckstrin homology domain (2);	0		T		86.0	rs4956987;rs61404396;rs4956987	0.562	5:g.174106G>A	ENSP00000283426:R1076Q	protein_coding	.		basic|appris_principal|CCDS		1303,2116,881		1076	740,3666	0.32783882783882784	Q	G|||		.	5008		PKH4B_HUMAN	1697	pleckstrin homology domain containing, family G (with RhoGef domain) member 4B		PKH4B_HUMAN	0.338858	0.52856	174106	all cancers(22;0.0253)|Lung(60;0.113)	3.436000	0.2659	SNP		CCDS34124.1		.	,,,	False	174106	-0.9161		8	missense	T	Approved	0.54907	77.0		c.3227G>A	2013-01-11	OTTHUMT00000365359.1	Q96PX9	0.3804	2.79	PLEKHG4B	174106	0.58152		0.46857	43	PLEKHG4B	NM_052909.3	protein-coding gene	NP_443141.3	R	
		G	ENSG00000153404	ENST00000283426.6		153478		ENSG00000153404		4300					,				c.(3364-3366)ggT>ggG	OTTHUMG00000161570		byFrequency	Q96PX9	gene with protein product				NM_052909.3	281,1026,896	NM_052909	0.5961					+	Silent		452.9+/-363.1	86.0				11572484				PLEKHG4B-001					5	+	0.2935				coding-synonymous	29399		1122/1272		G	SO:0001819				protein_coding		2203				33.8023,36.0418,44.0181		"""Pleckstrin homology (PH) domain containing"""	6503					Kidney(1;0.119)			KNOWN			CATCCATGGGTATAGGCAACC						ENST00000283426.6:c.3366T>G	5					endometrium(1)|large_intestine(2)|lung(2)|prostate(3)|skin(3)		+		,		5p15.33			g.chr5:181660T>G		666.3+/-401.7			no		7281,5725												-2.2					0.0	Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.6312			5693,2907			2177,2927,1399					CCDS34124.1	T		GG,GT,TT	BC008352		86		2504		rs7717970		3416									1122	KIAA1909		11	NM_052909		17			ENST00000283426.6		20652		uc003jak.2			153478	dbSNP_116	3366			p.G1122G		0				86.0		0.532	5:g.181660T>G		protein_coding			basic|appris_principal|CCDS		1896,1901,503			1588,2818			G|||			5008		PKH4B_HUMAN	2199	pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			0.439097		181660	all cancers(22;0.0253)|Lung(60;0.113)		0.2589	SNP		CCDS34124.1			,,,	False	181660				synonymous_variant		Approved		86.0		c.3366T>G	2013-01-11	OTTHUMT00000365359.1	Q96PX9	0.4784		PLEKHG4B	181660					PLEKHG4B	NM_052909.3	protein-coding gene	NP_443141.3		
		G	ENSG00000153404	ENST00000283426.6	0.50039	153478	N	ENSG00000153404	0.45486	4300	0.039000	0.37915	D		,	T	1.5299999999995872E-4	2	c.(3436-3438)Cgg>Ggg	OTTHUMG00000161570	1.335000	byFrequency	Q96PX9	gene with protein product				NM_052909.3	57,606,1540	NM_052909	0.5409			C	5.732	+	Missense_Mutation	1	606.8+/-395.2	114.0	Q96PX9	0.163414		11572484			0.859	PLEKHG4B-001			0.59546		5	+	0.0817		0.08	0.076000	missense	29399	140	1146/1272		C	SO:0001583		benign	0.3867403314917127	protein_coding		2203	P		.	45.3953,16.3414,41.6423	P	"""Pleckstrin homology (PH) domain containing"""	6503		0.2511:0.7489:0.0:0.0			Kidney(1;0.119)			KNOWN	ENST00000283426		GATAAGCGACCGGGCTCCCAA	T					ENST00000283426.6:c.3436C>G	5		ENSG00000153404	0.17529	PLEKHG4B	endometrium(1)|large_intestine(2)|lung(2)|prostate(3)|skin(3)	ENSP00000283426:p.Arg1146Gly	+	.	,	CGG	5p15.33			g.chr5:181730C>G	R -> G (in dbSNP:rs12519352). {ECO:0000269|PubMed:11572484}.	297.6+/-284.8		40	yes		5416,7590	0.18376	0.10845	3.21	0.00012	ENSP00000283426:R1146G			.		.		3.2	0.36854	148	0.51188	0.25874125874125875	0.0	Rho guanyl-nucleotide exchange factor activity (GO:0005089)	0.345			hg19	Standard	0.503	0.08130081300813008	7.7168	4696,3904			1343,2730,2430	0.319585				CCDS34124.1	C	0.69078	GG,GC,CC	BC008352		116	0.14661	2504	3.21	rs12519352		3486	1146	378			0.28708	234730	+	GLY/ARG	1146	KIAA1909	706	11	NM_052909	0.997	17	0.49868073878627966	0.195000	ENST00000283426.6		18110		uc003jak.2			153478	dbSNP_120	3436	0.0000		p.R1146G	.	0		T		122.0	rs12519352;rs12519352	0.587	5:g.181730C>G	ENSP00000283426:R1146G	protein_coding	.		basic|appris_principal|CCDS		1286,2124,890		1146	720,3686	0.3232600732600733	G	C|||		.	5008		PKH4B_HUMAN	1660	pleckstrin homology domain containing, family G (with RhoGef domain) member 4B		PKH4B_HUMAN	0.33147	.	181730	all cancers(22;0.0253)|Lung(60;0.113)	.	0.256	SNP		CCDS34124.1		.	,,,	False	181730	-0.9647		8	missense	T	Approved	0.546047	116.0		c.3436C>G	2013-01-11	OTTHUMT00000365359.1	Q96PX9	0.3732	1.17	PLEKHG4B	181730	0.17211		0.38735	125	PLEKHG4B	NM_052909.3	protein-coding gene	NP_443141.3	R	
		G	ENSG00000153404	ENST00000283426.6		153478		ENSG00000153404		4300					,				c.(3466-3468)cgA>cgG	OTTHUMG00000161570		byFrequency	Q96PX9	gene with protein product				NM_052909.3	251,993,959	NM_052909	0.6094					+	Silent		452.6+/-363.0	102.0				11572484				PLEKHG4B-001					5	+	0.2685				coding-synonymous	29399		1156/1272		G	SO:0001819				protein_coding		2203				33.6744,33.931,44.6486		"""Pleckstrin homology (PH) domain containing"""	6503					Kidney(1;0.119)			KNOWN			TGAGCGACCGAGTCCCCGACA						ENST00000283426.6:c.3468A>G	5					endometrium(1)|large_intestine(2)|lung(2)|prostate(3)|skin(3)		+		,		5p15.33			g.chr5:181762A>G		677.2+/-403.4			no		7199,5807												-0.5					0.0	Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.6332			5704,2896			2155,2889,1459					CCDS34124.1	A		GG,GA,AA	BC008352		106		2504		rs11133847		3518									1156	KIAA1909		11	NM_052909		17			ENST00000283426.6		17247		uc003jak.2			153478	dbSNP_120	3468			p.R1156R		0				112.0		0.617	5:g.181762A>G		protein_coding			basic|appris_principal|CCDS		1904,1896,500			1495,2911			G|||			5008		PKH4B_HUMAN	2181	pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			0.435503		181762	all cancers(22;0.0253)|Lung(60;0.113)		0.2579	SNP		CCDS34124.1			,,,	False	181762				synonymous_variant		Approved		106.0		c.3468A>G	2013-01-11	OTTHUMT00000365359.1	Q96PX9	0.4798		PLEKHG4B	181762					PLEKHG4B	NM_052909.3	protein-coding gene	NP_443141.3		
Familial Paragangliomas		T	ENSG00000073578	ENST00000264932.6	0.09310	6389	L	ENSG00000073578	0.23209	4300	0.009000	0.71934	B;B;B;B		,	T	1	0	c.(112-114)gAt>gTt	OTTHUMG00000090275	0.319000	byFrequency	P31040	gene with protein product		SDHA_ENST00000510361.1_Missense_Mutation_p.D38V|SDHA_ENST00000504309.1_Missense_Mutation_p.D38V	Succinic acid(DB00139)	NM_004168.2	0,35,2168	NM_004168	0.0511			A	10.49	+	Missense_Mutation	2	126.7+/-185.1	104.0	E9PBJ5;D6RFM5;P31040;Q59GW8	0.007944		7798181			0.002;0.002;0.001;0.001	SDHA-001			0.06405		5	+	0.0		0.57	0.801000	missense	10680	5	38/665		A	SO:0001583	600857	benign	0.013812154696132596	protein_coding		2203	N		0.961000	4.5581,0.7944,3.2831	B;B;B;B	"""Mitochondrial respiratory chain complex / Complex II"""	6503		0.7045:0.0:0.2955:0.0						KNOWN	ENST00000264932;ENST00000327872;ENST00000504309;ENST00000510361		TTCACTGTTGATGGGAACAAG	T;T;T	SDH2		Hereditary Glomus Tumors, Familial Paragangliomas, Hereditary Paragangliomas, type 1-3: PGL1, PGL2, PGL3, incl. Familial Carotid Body Paraganglioma and Sensorineural Hearing Loss	Familial Cancer Database	ENST00000264932.6:c.113A>T	5		ENSG00000073578	0.32223	SDHA	NS(1)|breast(1)|cervix(1)|endometrium(6)|kidney(3)|large_intestine(6)|liver(2)|lung(16)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1)	ENSP00000264932:p.Asp38Val	+	0.32948	,	GAT	5p15	A8K5J6|B4DJ60|E9PBJ5|Q16395|Q59GW8|Q8IW48|Q9UMY5		g.chr5:223646A>T	D -> V (in dbSNP:rs34635677). {ECO:0000269|PubMed:14702039}.	40.0+/-72.8		0	yes		427,12579	0.14445	0.24684	5.81	0.16385	ENSP00000264932:D38V			0.26734		.		1.6	0.23342	0	0.14252	0.0	0.0	flavin adenine dinucleotide binding (GO:0050660)|succinate dehydrogenase (ubiquinone) activity (GO:0008177)	1.245			hg19	Standard	0.0318	0.0	8.3967	392,8208		cellular metabolic process (GO:0044237)|nervous system development (GO:0007399)|oxidation-reduction process (GO:0055114)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)|succinate metabolic process (GO:0006105)|tricarboxylic acid cycle (GO:0006099)	8,411,6084	1.366118				CCDS3853.1	A	0.06786	TT,TA,AA	BC001380	mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex II (GO:0005749)|mitochondrion (GO:0005739)	105	0.40543	2504	1.56	rs34635677		228	38;38;38;44	21			0.32561	276646	+	VAL/ASP	38	FP, SDHF	26	40	XM_005248329	0.001;0.0;0.0;0.0	2	0.027704485488126648	0.455000	ENST00000264932.6		19506		uc003jao.4			6389	dbSNP_126	113	0.0394		p.D38V	.	0		T		108.0	rs34635677	0.428	5:g.223646A>T	ENSP00000264932:D38V;ENSP00000426514:D38V;ENSP00000427703:D38V	protein_coding	0.022772		basic|appris_principal|CCDS		8,376,3916		38	35,4371	0.011904761904761904	V	A|||		0.349316	5008		SDHA_HUMAN	93	succinate dehydrogenase complex, subunit A, flavoprotein (Fp)		.;.;DHSA_HUMAN;.	0.0185703	0.47311	223646	Epithelial(17;0.0159)|all cancers(22;0.0236)|OV - Ovarian serous cystadenocarcinoma(19;0.0674)|Lung(60;0.113)	2.727000	0.0	SNP		CCDS3853.1		U	,,,	False	223646	-1.0788		10	missense	T	Approved	0.045581	105.0		c.113A>T	2014-09-17	OTTHUMT00000206599.1	P31040	0.0159	-0.6;0.25;-0.61	SDHA	223646	0.45260		0.07139	152	SDHA	NM_004168.2	protein-coding gene	NP_004159.2	D	
Familial Paragangliomas		G	ENSG00000073578	ENST00000264932.6		6389		ENSG00000073578		4300					,					OTTHUMG00000090275		byFrequency	P31040	gene with protein product		SDHA_ENST00000510361.1_Intron|SDHA_ENST00000504309.1_Intron	Succinic acid(DB00139)	NM_004168.2	2084,118,1	NM_004168	0.9029					+	Intron			61.0				7798181				SDHA-001					5	+	0.9879				intron	10680				G	SO:0001627	600857			protein_coding		2203				11.8256,2.7236,8.7421		"""Mitochondrial respiratory chain complex / Complex II"""	6503								KNOWN			ACTGCTCTCTATTGTTTCCAG		SDH2		Hereditary Glomus Tumors, Familial Paragangliomas, Hereditary Paragangliomas, type 1-3: PGL1, PGL2, PGL3, incl. Familial Carotid Body Paraganglioma and Sensorineural Hearing Loss	Familial Cancer Database	ENST00000264932.6:c.771-11A>G	5					NS(1)|breast(1)|cervix(1)|endometrium(6)|kidney(3)|large_intestine(6)|liver(2)|lung(16)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1)		+		,		5p15	A8K5J6|B4DJ60|E9PBJ5|Q16395|Q59GW8|Q8IW48|Q9UMY5		g.chr5:230980A>G					no		11869,1137												0.5					0.0	flavin adenine dinucleotide binding (GO:0050660)|succinate dehydrogenase (ubiquinone) activity (GO:0008177)				hg19	Standard	0.8688			7583,1017		cellular metabolic process (GO:0044237)|nervous system development (GO:0007399)|oxidation-reduction process (GO:0055114)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)|succinate metabolic process (GO:0006105)|tricarboxylic acid cycle (GO:0006099)	5426,1017,60					CCDS3853.1	A		GG,GA,AA	BC001380	mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex II (GO:0005749)|mitochondrion (GO:0005739)	61		2504		rs2288461		885										FP, SDHF		40	XM_005248329		7			ENST00000264932.6		17480		uc003jao.4			6389	dbSNP_100						0				62.0		0.607	5:g.230980A>G		protein_coding			basic|appris_principal|CCDS		3342,899,59			4286,120			G|||			5008		SDHA_HUMAN	4299	succinate dehydrogenase complex, subunit A, flavoprotein (Fp)			0.858427		230980	Epithelial(17;0.0159)|all cancers(22;0.0236)|OV - Ovarian serous cystadenocarcinoma(19;0.0674)|Lung(60;0.113)		0.628	SNP		CCDS3853.1			,,,	False	230980				intron_variant		Approved		61.0			2014-09-17	OTTHUMT00000206599.1	P31040	0.8689		SDHA	230980					SDHA	NM_004168.2	protein-coding gene	NP_004159.2		
Familial Paragangliomas		C	ENSG00000073578	ENST00000264932.6		6389		ENSG00000073578		4299					,				c.(889-891)ccT>ccC	OTTHUMG00000090275		byFrequency	P31040	gene with protein product		SDHA_ENST00000510361.1_Silent_p.P249P|SDHA_ENST00000504309.1_Silent_p.P297P	Succinic acid(DB00139)	NM_004168.2	1370,737,96	NM_004168	0.6759					+	Silent			41.0				7798181				SDHA-001					5	+	0.7874				coding-synonymous	10680		297/665		C	SO:0001819	600857			protein_coding		2203				24.18,21.0849,23.1313		"""Mitochondrial respiratory chain complex / Complex II"""	6502								KNOWN			AGTTCCACCCTACAGGTAGGG		SDH2		Hereditary Glomus Tumors, Familial Paragangliomas, Hereditary Paragangliomas, type 1-3: PGL1, PGL2, PGL3, incl. Familial Carotid Body Paraganglioma and Sensorineural Hearing Loss	Familial Cancer Database	ENST00000264932.6:c.891T>C	5					NS(1)|breast(1)|cervix(1)|endometrium(6)|kidney(3)|large_intestine(6)|liver(2)|lung(16)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1)		+		,		5p15	A8K5J6|B4DJ60|E9PBJ5|Q16395|Q59GW8|Q8IW48|Q9UMY5		g.chr5:231111T>C					no		9996,3008												1.1					1.0	flavin adenine dinucleotide binding (GO:0050660)|succinate dehydrogenase (ubiquinone) activity (GO:0008177)				hg19	Standard	0.7475			6519,2079		cellular metabolic process (GO:0044237)|nervous system development (GO:0007399)|oxidation-reduction process (GO:0055114)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)|succinate metabolic process (GO:0006105)|tricarboxylic acid cycle (GO:0006099)	3868,2260,374					CCDS3853.1	T		CC,CT,TT	BC001380	mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex II (GO:0005749)|mitochondrion (GO:0005739)	43		2504		rs1126417		1006									297	FP, SDHF		40	XM_005248329		7			ENST00000264932.6		19860		uc003jao.4			6389	dbSNP_86	891			p.P297P		0				49.0		0.547	5:g.231111T>C		protein_coding			basic|appris_principal|CCDS		2498,1523,278			3477,929			C|||			5008		SDHA_HUMAN	3272	succinate dehydrogenase complex, subunit A, flavoprotein (Fp)			0.653355		231111	Epithelial(17;0.0159)|all cancers(22;0.0236)|OV - Ovarian serous cystadenocarcinoma(19;0.0674)|Lung(60;0.113)		0.3363	SNP		CCDS3853.1			,,,	False	231111				synonymous_variant		Approved		43.0		c.891T>C	2014-09-17	OTTHUMT00000206599.1	P31040	0.6902		SDHA	231111					SDHA	NM_004168.2	protein-coding gene	NP_004159.2		
		C	ENSG00000249915	ENST00000264933.4		10016		ENSG00000249915		4300					,				c.(436-438)atT>atC	OTTHUMG00000090283		byFrequency	O75340	gene with protein product		AHRR_ENST00000316418.5_Intron|PDCD6_ENST00000511482.1_3'UTR|AHRR_ENST00000505113.1_Intron|PDCD6_ENST00000507528.1_Silent_p.I144I|AHRR_ENST00000512529.1_Intron|PDCD6_ENST00000505221.1_Intron		NM_001267556.1|NM_001267558.1|NM_013232.3	1319,778,106	NM_013232	0.6544					+	Silent			83.0				8560270				PDCD6-001					5	+	0.7776				intron,coding-synonymous,intron	8765		,146/192,		C	SO:0001819	601057	,,		protein_coding		2203				29.2326,22.4694,26.9414		"""EF-hand domain containing"""	6503								KNOWN			GGGGGCAGATTGCCTTCGACG						ENST00000264933.4:c.438T>C	5	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.				breast(2)|endometrium(1)|large_intestine(4)|lung(1)		+		,		5p15.33	B2RD16|E7ESR3|Q2YDC2|Q5TZS0	"""apoptosis-linked gene-2"""	g.chr5:311478T>C					no		9502,3504												-10.4					0.0	binding, bridging (GO:0060090)|calcium ion binding (GO:0005509)|calcium-dependent cysteine-type endopeptidase activity (GO:0004198)|calcium-dependent protein binding (GO:0048306)|protein dimerization activity (GO:0046983)				hg19	Standard	0.7028			6086,2514		activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|angiogenesis (GO:0001525)|apoptotic signaling pathway (GO:0097190)|cellular response to heat (GO:0034605)|intracellular protein transport (GO:0006886)|negative regulation of protein kinase B signaling (GO:0051898)|negative regulation of TOR signaling (GO:0032007)|negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)|positive regulation of angiogenesis (GO:0045766)|positive regulation of endothelial cell migration (GO:0010595)|positive regulation of endothelial cell proliferation (GO:0001938)|proteolysis (GO:0006508)|response to calcium ion (GO:0051592)|vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	3484,2534,485					CCDS3854.1, CCDS58940.1, CCDS58941.1, CCDS75222.1, CCDS75223.1	T		CC,CT,TT	AF035606	cytoplasm (GO:0005737)|cytoplasmic vesicle (GO:0031410)|endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|extracellular vesicular exosome (GO:0070062)|membrane (GO:0016020)|nucleus (GO:0005634)	89		2504		rs2244029		538								,,	146	ALG-2, PEF1B		8	NM_013232		5			ENST00000264933.4		18860		uc003jat.1			10016	dbSNP_100	,438,			p.I146I		0				101.0		0.577	5:g.311478T>C		protein_coding			basic|appris_candidate_longest|CCDS		2165,1756,379			3416,990			C|||			5008		PDCD6_HUMAN	3033	programmed cell death 6			0.605631		311478	Epithelial(17;0.00193)|OV - Ovarian serous cystadenocarcinoma(19;0.00489)|all cancers(22;0.00511)|Lung(60;0.113)		0.2649	SNP		CCDS3854.1			,,,	False	311478				synonymous_variant		Approved		89.0		c.438T>C	2013-01-10	OTTHUMT00000206609.2	O75340	0.5634		PDCD6	311478				,,	PDCD6,AHRR	NM_001242412.1,NM_013232.3,NM_020731.4	protein-coding gene	NP_001254485.1|NP_001254487.1|NP_037364.1		
		C	ENSG00000063438	ENST00000505113.1		57491		ENSG00000063438		4210					,					OTTHUMG00000162171		byFrequency	A9YTQ3	gene with protein product		AHRR_ENST00000316418.5_Intron|AHRR_ENST00000515206.1_Intron|AHRR_ENST00000512529.1_Intron		NM_001242412.1	686,995,400	NM_020731	0.6043					+	Intron			66.0				1070014, 11423533				AHRR-002	2003-09-11				5	+	0.5408				intron,intron	346		,		C	SO:0001627	606517	,		protein_coding		2081				38.0166,43.1283,39.7075		"""Basic helix-loop-helix proteins"""	6291								KNOWN			TGCTCCCACCTGTTCACTTGA		AHH, AHHR				ENST00000505113.1:c.256+25T>C	5					breast(2)|endometrium(4)|large_intestine(1)|lung(12)|prostate(1)		+		,		5p15.33	A7MBN5|D6RAZ1|Q9HAZ3|Q9ULI6		g.chr5:354051T>C					no		7586,4996												-4.2					0.0	DNA binding (GO:0003677)|signal transducer activity (GO:0004871)		2003-09-12		hg19	Standard	0.6123			5219,3201		negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of protein sumoylation (GO:0033235)|transcription, DNA-templated (GO:0006351)	2285,3016,990					CCDS43297.1, CCDS56355.1	T		CC,CT,TT	AB033060	cytoplasm (GO:0005737)|nucleus (GO:0005634)	65		2504		rs2013782		300				"""aryl hydrocarbon receptor regulator"""				,		KIAA1234, bHLHe77		20	NM_020731		3			ENST00000505113.1		19312		uc003jaw.3			57491	dbSNP_92	,					0				63.0		0.562	5:g.354051T>C		protein_coding			basic|appris_candidate|CCDS		1599,2021,590			2367,1795			C|||			5008		AHRR_HUMAN	2546	aryl-hydrocarbon receptor repressor			0.508387		354051	Epithelial(17;0.0011)|OV - Ovarian serous cystadenocarcinoma(19;0.00353)|all cancers(22;0.00354)|Lung(60;0.0863)		0.2798	SNP		CCDS56355.1			,,,	False	354051				intron_variant		Approved		65.0			2013-05-21	OTTHUMT00000367720.1	A9YTQ3	0.4928		AHRR	354051				,	AHRR	NM_001242412.1,NM_020731.4	protein-coding gene	NP_001229341.1		
		A	ENSG00000063438	ENST00000505113.1		57491		ENSG00000063438		4233					,					OTTHUMG00000162171		byFrequency	A9YTQ3	gene with protein product		AHRR_ENST00000512529.1_Intron|AHRR_ENST00000316418.5_Intron|AHRR_ENST00000506456.1_Intron		NM_001242412.1	10,286,1842	NM_020731	0.1902					+	Intron			26.0				1070014, 11423533				AHRR-002	2003-09-11				5	+	0.0113				intron,intron	346		,		G	SO:0001627	606517	,		protein_coding		2138				37.1013,7.1562,27.0523		"""Basic helix-loop-helix proteins"""	6371								KNOWN			TGTGACACGTGTGTTTTGGCT		AHH, AHHR				ENST00000505113.1:c.584-50G>A	5					breast(2)|endometrium(4)|large_intestine(1)|lung(12)|prostate(1)		+		,		5p15.33	A7MBN5|D6RAZ1|Q9HAZ3|Q9ULI6		g.chr5:423906G>A					no		3447,9295												1.8					0.0	DNA binding (GO:0003677)|signal transducer activity (GO:0004871)		2003-09-12		hg19	Standard	0.3986			3141,5325		negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|positive regulation of protein sumoylation (GO:0033235)|transcription, DNA-templated (GO:0006351)	608,2231,3532					CCDS43297.1, CCDS56355.1	G		AA,AG,GG	AB033060	cytoplasm (GO:0005737)|nucleus (GO:0005634)	25		2504		rs55932239		627				"""aryl hydrocarbon receptor regulator"""				,		KIAA1234, bHLHe77		20	NM_020731		7			ENST00000505113.1		16721		uc003jaw.3			57491	dbSNP_129	,					0				22.0		0.627	5:g.423906G>A		protein_coding			basic|appris_candidate|CCDS		598,1945,1690			306,3970			G|||			5008		AHRR_HUMAN	770	aryl-hydrocarbon receptor repressor			0.153754		423906	Epithelial(17;0.0011)|OV - Ovarian serous cystadenocarcinoma(19;0.00353)|all cancers(22;0.00354)|Lung(60;0.0863)		0.004	SNP		CCDS56355.1			,,,	False	423906				intron_variant		Approved		25.0			2013-05-21	OTTHUMT00000367720.1	A9YTQ3	0.2363		AHRR	423906				,	AHRR	NM_001242412.1,NM_020731.4	protein-coding gene	NP_001229341.1		
		C	ENSG00000221990	ENST00000408966.2		116349		ENSG00000221990		4102					,					OTTHUMG00000162235		byFrequency	Q8N2X6	gene with protein product				NM_138464.2	10,252,1664	NM_138464	0.1902					+	3'UTR			30.0				12477932				C5orf55-001					5	-	0.0113				utr-3	25175				C	SO:0001624				protein_coding		1926				36.3237,7.0613,26.9741			6028								KNOWN			CTCCTCCAGGAAGCGACTCAG						ENST00000408966.2:c.*7T>G	5					large_intestine(1)|lung(2)		-		,		5p15.33	Q96CR9		g.chr5:442571A>C					no		3252,8804												-0.4					0.0					hg19	Standard	0.3986			2980,5224			583,2086,3359					CCDS43298.1	A		CC,CA,AA	BC014011	extracellular region (GO:0005576)	29		2504		rs56146525		687												3	NM_138464		0			ENST00000408966.2		19102		uc010ita.3			116349	dbSNP_129						0				28.0		0.607	5:g.442571A>C		protein_coding			basic|appris_principal|CCDS		573,1834,1695			272,3580			C|||			5008		CE055_HUMAN	769	chromosome 5 open reading frame 55			0.153554		442571			0.004	SNP		CCDS43298.1			,,,	False	442571				3_prime_UTR_variant		Approved		29.0			2012-02-24	OTTHUMT00000368033.1	Q8N2X6	0.2349		C5orf55	442571					C5orf55	NM_138464.2	protein-coding gene	NP_612473.1		
		T	ENSG00000066230	ENST00000264938.3		6550		ENSG00000066230		4300					,				c.(2029-2031)gcG>gcA	OTTHUMG00000090315		byFrequency	P48764	gene with protein product		SLC9A3_ENST00000514375.1_Silent_p.A668A|CTD-2228K2.7_ENST00000607286.1_RNA|CTD-2228K2.7_ENST00000606319.1_RNA		NM_004174.2	73,642,1487	NM_004174	0.2198	Substitution - coding silent(1)				+	Silent		499.2+/-374.9	60.0				8096830				SLC9A3-001	2012-03-22				5	-	0.1377				coding-synonymous	11073		677/835		C	SO:0001819	182307			protein_coding	prostate(1)	2202				39.3488,17.8928,32.0824		"""Solute carriers"""	6502								KNOWN			ACAGCTTGGCCGCCTTCTTGT		NHE3				ENST00000264938.3:c.2031G>A	5					NS(2)|biliary_tract(1)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(4)|liver(2)|lung(16)|prostate(3)|skin(2)|urinary_tract(1)		-		,		5p15.3	B7ZKR2|E9PF67|Q3MIW3		g.chr5:476353C>T		316.3+/-294.6			no		4172,8832												-9.5					0.0	PDZ domain binding (GO:0030165)|sodium:proton antiporter activity (GO:0015385)				hg19	Standard	0.4115			3384,5216		ion transport (GO:0006811)|regulation of pH (GO:0006885)|sodium ion transmembrane transport (GO:0035725)|transmembrane transport (GO:0055085)	762,2648,3092			p.A677A(1)		CCDS3855.1, CCDS64116.1	C		TT,TC,CC		apical plasma membrane (GO:0016324)|brush border (GO:0005903)|brush border membrane (GO:0031526)|cell surface (GO:0009986)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	61		2504		rs2230437		2040				"""solute carrier family 9 (sodium/hydrogen exchanger), isoform 3"", ""solute carrier family 9 (sodium/hydrogen exchanger), member 3"""					677			37	NM_004174		13			ENST00000264938.3		16387		uc003jbe.2			6550	dbSNP_98	2031			p.A677A		1				61.0		0.642	5:g.476353C>T		protein_coding			basic|appris_principal|CCDS		689,2006,1605			788,3616			C|||			5008		SL9A3_HUMAN	1062	solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3			0.212061		476353	Epithelial(17;0.000529)|OV - Ovarian serous cystadenocarcinoma(19;0.00153)|all cancers(22;0.00186)|Lung(60;0.0863)		0.0347	SNP		CCDS3855.1			,,,	False	476353				synonymous_variant		Approved		61.0		c.2031G>A	2013-05-22	OTTHUMT00000206677.2	P48764	0.3112		SLC9A3	476353					SLC9A3	NM_004174.2	protein-coding gene	NP_004165.2		
		C	ENSG00000066230	ENST00000264938.3		6550		ENSG00000066230		4300					,					OTTHUMG00000090315		byFrequency	P48764	gene with protein product		CTD-2228K2.7_ENST00000606288.1_RNA|SLC9A3_ENST00000514375.1_Intron|CTD-2228K2.7_ENST00000607005.1_RNA|CTD-2228K2.7_ENST00000607286.1_RNA		NM_004174.2	1851,332,18	NM_004174	0.7454					+	Intron		207.6+/-249.3	29.0				8096830				SLC9A3-001	2012-03-22				5	-	0.9274				intron	11073				C	SO:0001627	182307			protein_coding		2201				11.6279,8.3598,10.5215		"""Solute carriers"""	6501								KNOWN			AGCCAGTGCCAGAGCCTGCTG		NHE3				ENST00000264938.3:c.1647+45T>G	5					NS(2)|biliary_tract(1)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(4)|liver(2)|lung(16)|prostate(3)|skin(2)|urinary_tract(1)		-		,		5p15.3	B7ZKR2|E9PF67|Q3MIW3		g.chr5:479905A>C		180.5+/-208.7			no		11634,1368												-3.7					0.0	PDZ domain binding (GO:0030165)|sodium:proton antiporter activity (GO:0015385)				hg19	Standard	0.8728			7600,1000		ion transport (GO:0006811)|regulation of pH (GO:0006885)|sodium ion transmembrane transport (GO:0035725)|transmembrane transport (GO:0055085)	5223,1188,90					CCDS3855.1, CCDS64116.1	A		CC,CA,AA		apical plasma membrane (GO:0016324)|brush border (GO:0005903)|brush border membrane (GO:0031526)|cell surface (GO:0009986)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	29		2504		rs890986		1657				"""solute carrier family 9 (sodium/hydrogen exchanger), isoform 3"", ""solute carrier family 9 (sodium/hydrogen exchanger), member 3"""								37	NM_004174		10			ENST00000264938.3		15830		uc003jbe.2			6550	dbSNP_86						0				31.0		0.662	5:g.479905A>C		protein_coding			basic|appris_principal|CCDS		3372,856,72			4034,368			C|||			5008		SL9A3_HUMAN	3968	solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3			0.792332		479905	Epithelial(17;0.000529)|OV - Ovarian serous cystadenocarcinoma(19;0.00153)|all cancers(22;0.00186)|Lung(60;0.0863)		0.5694	SNP		CCDS3855.1			,,,	False	479905				intron_variant		Approved		29.0			2013-05-22	OTTHUMT00000206677.2	P48764	0.8084		SLC9A3	479905					SLC9A3	NM_004174.2	protein-coding gene	NP_004165.2		
		A	ENSG00000112877	ENST00000264935.5	0.44694	55722	M	ENSG00000112877	0.42768	4300	0.007000	0.32753	D		,	T	0.0023140000000000382	0	c.(1234-1236)Ccc>Acc	OTTHUMG00000161745	1.171000	byFrequency	Q9P209	gene with protein product		CEP72_ENST00000444221.1_3'UTR		NM_018140.3	0,169,2034	NM_018140	0.1677			C	10.31	+	Missense_Mutation	1	299.8+/-304.6	42.0	Q9P209	0.038357		10819331			0.755	CEP72-001			0.54544		5	+	0.0045		0.76	0.003000	missense	25547	50	412/648		C	SO:0001583		probably-damaging	0.13812154696132597	protein_coding		2203	P		0.003000	19.8721,3.8357,14.4395	P		6503		0.0:0.8928:0.0:0.1072						KNOWN	ENST00000264935		CTCGGCTCTACCCGGGAAGAA	T					ENST00000264935.5:c.1234C>A	5		ENSG00000112877	0.41574	CEP72	autonomic_ganglia(1)|central_nervous_system(1)|cervix(1)|endometrium(1)|large_intestine(1)|liver(1)|lung(5)|ovary(2)|prostate(3)|skin(1)|stomach(1)|urinary_tract(2)	ENSP00000264935:p.Pro412Thr	+	0.15002	,	CCC	5p15.33	B4DR26|Q9BV03|Q9BWM3|Q9NVR4		g.chr5:639231C>A	P -> T (in dbSNP:rs12522955).	106.5+/-144.9		2	yes		1878,11128	0.13788	0.23908	4.45	0.00039	ENSP00000264935:P412T			0.29266		-10.98		3.6	0.41010	5	0.08599	0.008741258741258742	0.0		2.015			hg19	Standard	0.1928	0.0040650406504065045	8.9781	1709,6891		G2/M transition of mitotic cell cycle (GO:0000086)|gamma-tubulin complex localization (GO:0033566)|mitotic cell cycle (GO:0000278)|spindle organization (GO:0007051)	175,1528,4800	1.314332				CCDS34126.1	C	0.60160	AA,AC,CC	BC000132	centrosome (GO:0005813)|cytosol (GO:0005829)	40	0.65975	2504	3.58	rs12522955		1324	412	153			0.35948	692231	+	THR/PRO	412	KIAA1519, FLJ10565	210	20	NM_018140	0.987	8	0.20184696569920843	0.462000	ENST00000264935.5		17828		uc003jbf.3			55722	dbSNP_120	1234	0.0001		p.P412T	.	0		T		37.0	rs12522955;rs12522955	0.647	5:g.639231C>A	ENSP00000264935:P412T	protein_coding	0.012641		basic|appris_candidate_longest|CCDS		175,1359,2766		412	169,4237	0.09615384615384616	T	C|||		0.286634	5008		CEP72_HUMAN	453	centrosomal protein 72kDa		CEP72_HUMAN	0.0904553	0.30014	639231	Epithelial(17;0.000339)|all cancers(22;0.00137)|OV - Ovarian serous cystadenocarcinoma(19;0.00153)|Lung(60;0.0863)	1.019000	0.0099	SNP		CCDS34126.1		N	,,,	False	639231	-1.0413		9	missense	T	Approved	0.198721	40.0		c.1234C>A	2014-02-20	OTTHUMT00000365967.3	Q9P209	0.1138	1.44	CEP72	639231	0.03518		0.16129	38	CEP72	NM_018140.3	protein-coding gene	NP_060610.2	P	
		T	ENSG00000112877	ENST00000264935.5		55722		ENSG00000112877		4300					,					OTTHUMG00000161745		byFrequency	Q9P209	gene with protein product		CEP72_ENST00000444221.1_Intron		NM_018140.3	0,168,2035	NM_018140	0.1779					+	Intron		309.6+/-309.4	148.0				10819331				CEP72-001					5	+	0.0045				intron	25547				G	SO:0001627				protein_coding		2203				19.6395,3.813,14.278			6503								KNOWN			TAAGTTGATCGTGTATTTGGT						ENST00000264935.5:c.1666+12G>T	5					autonomic_ganglia(1)|central_nervous_system(1)|cervix(1)|endometrium(1)|large_intestine(1)|liver(1)|lung(5)|ovary(2)|prostate(3)|skin(1)|stomach(1)|urinary_tract(2)		+		,		5p15.33	B4DR26|Q9BV03|Q9BWM3|Q9NVR4		g.chr5:644552G>T		113.8+/-151.8			no		1857,11149												0.5					0.0					hg19	Standard	0.1909			1689,6911		G2/M transition of mitotic cell cycle (GO:0000086)|gamma-tubulin complex localization (GO:0033566)|mitotic cell cycle (GO:0000278)|spindle organization (GO:0007051)	172,1513,4818					CCDS34126.1	G		TT,TG,GG	BC000132	centrosome (GO:0005813)|cytosol (GO:0005829)	150		2504		rs4957080		1756										KIAA1519, FLJ10565		20	NM_018140		10			ENST00000264935.5		21142		uc003jbf.3			55722	dbSNP_111						0				153.0		0.408	5:g.644552G>T		protein_coding			basic|appris_candidate_longest|CCDS		172,1345,2783			168,4238			G|||			5008		CEP72_HUMAN	502	centrosomal protein 72kDa			0.10024		644552	Epithelial(17;0.000339)|all cancers(22;0.00137)|OV - Ovarian serous cystadenocarcinoma(19;0.00153)|Lung(60;0.0863)		0.0198	SNP		CCDS34126.1			,,,	False	644552				intron_variant		Approved		150.0			2014-02-20	OTTHUMT00000365967.3	Q9P209	0.1585		CEP72	644552					CEP72	NM_018140.3	protein-coding gene	NP_060610.2		
		C	ENSG00000171368	ENST00000360578.5		11076		ENSG00000171368		4300					,				c.(595-597)tcA>tcG	OTTHUMG00000131011		byFrequency	O94811	gene with protein product		CEP72_ENST00000514507.1_Intron		NM_007030.2	1734,447,22	NM_007030	0.6094					+	Silent		640.3+/-399.6	78.0				10083737, 12093283, 15590652, 17105200				TPPP-001					5	-	0.9266				coding-synonymous	24164		199/220	Ovarian(839;0.0563)	C	SO:0001819	608773			protein_coding		2203				39.3953,11.1439,29.8247			6503					GBM - Glioblastoma multiforme(108;0.0191)			KNOWN			ACACATAGCCTGACTCGTCCA						ENST00000360578.5:c.597A>G	5					kidney(1)|large_intestine(1)|lung(2)|prostate(1)		-		,		5p15.33		"""brain specific protein p25 alpha"""	g.chr5:665280T>C		780.6+/-414.4			no		9127,3879												-10.2					0.1	microtubule binding (GO:0008017)|tubulin binding (GO:0015631)				hg19	Standard	0.6064			5212,3388		microtubule bundle formation (GO:0001578)|microtubule polymerization (GO:0046785)|positive regulation of protein complex assembly (GO:0031334)|positive regulation of protein polymerization (GO:0032273)	3316,2495,692					CCDS3856.1	T		CC,CT,TT	AB017016	cytoplasm (GO:0005737)|microtubule (GO:0005874)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	82		2504		rs1697963		718									199	p25alpha, TPPP1, p25, TPPP/p25		5	NM_007030		4			ENST00000360578.5		18015		uc003jbh.4			11076	dbSNP_89	597			p.S199S		0				88.0		0.657	5:g.665280T>C		protein_coding			basic|appris_principal|CCDS		1582,2048,670			3915,491			t|||			5008		TPPP_HUMAN	3613	tubulin polymerization promoting protein			0.721446		665280	Epithelial(17;0.000445)|all cancers(22;0.00176)|OV - Ovarian serous cystadenocarcinoma(19;0.00227)|Lung(60;0.0863)		0.6915	SNP		CCDS3856.1			,,,	False	665280				synonymous_variant		Approved		82.0		c.597A>G	2008-02-05	OTTHUMT00000253645.3	O94811	0.6988		TPPP	665280					TPPP	NM_007030.2	protein-coding gene	NP_008961.1		
		G	ENSG00000171368	ENST00000360578.5		11076		ENSG00000171368		4300					,				c.(580-582)gaT>gaC	OTTHUMG00000131011		byFrequency	O94811	gene with protein product		CEP72_ENST00000514507.1_3'UTR		NM_007030.2	0,169,2034	NM_007030	0.1524					+	Silent		738.4+/-407.1	75.0				10083737, 12093283, 15590652, 17105200				TPPP-001					5	-	0.0061				coding-synonymous	24164		194/220	Ovarian(839;0.0563)	G	SO:0001819	608773			protein_coding		2203				19.6047,3.8357,14.2626			6503					GBM - Glioblastoma multiforme(108;0.0191)			KNOWN			CGTCCACCAGATCCACGCGGC						ENST00000360578.5:c.582T>C	5					kidney(1)|large_intestine(1)|lung(2)|prostate(1)		-		,		5p15.33		"""brain specific protein p25 alpha"""	g.chr5:665295A>G		809.7+/-416.0			no		1855,11151												4.2					1.0	microtubule binding (GO:0008017)|tubulin binding (GO:0015631)				hg19	Standard	0.1909			1686,6914		microtubule bundle formation (GO:0001578)|microtubule polymerization (GO:0046785)|positive regulation of protein complex assembly (GO:0031334)|positive regulation of protein polymerization (GO:0032273)	171,1513,4819					CCDS3856.1	A		GG,GA,AA	AB017016	cytoplasm (GO:0005737)|microtubule (GO:0005874)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	79		2504		rs61731455		703									194	p25alpha, TPPP1, p25, TPPP/p25		5	NM_007030		4			ENST00000360578.5		18022		uc003jbh.4			11076	dbSNP_129	582			p.D194D		0				86.0		0.652	5:g.665295A>G		protein_coding			basic|appris_principal|CCDS		171,1344,2785			169,4237			G|||			5008		TPPP_HUMAN	481	tubulin polymerization promoting protein			0.0960463		665295	Epithelial(17;0.000445)|all cancers(22;0.00176)|OV - Ovarian serous cystadenocarcinoma(19;0.00227)|Lung(60;0.0863)		0.0208	SNP		CCDS3856.1			,,,	False	665295				synonymous_variant		Approved		79.0		c.582T>C	2008-02-05	OTTHUMT00000253645.3	O94811	0.1599		TPPP	665295					TPPP	NM_007030.2	protein-coding gene	NP_008961.1		
		A	ENSG00000171368	ENST00000360578.5		11076		ENSG00000171368		4296					,					OTTHUMG00000131011		byFrequency	O94811	gene with protein product		CEP72_ENST00000514507.1_Intron		NM_007030.2	0,159,2043	NM_007030	0.1421					+	Intron			27.0				10083737, 12093283, 15590652, 17105200				TPPP-001					5	-	0.0045				intron	24164			Ovarian(839;0.0563)	G	SO:0001627	608773			protein_coding		2202				17.8073,3.6104,12.9963			6498					GBM - Glioblastoma multiforme(108;0.0191)			KNOWN			AGGGCTGGGCGCGGGCCGGCC						ENST00000360578.5:c.312-32C>T	5					kidney(1)|large_intestine(1)|lung(2)|prostate(1)		-		,		5p15.33		"""brain specific protein p25 alpha"""	g.chr5:666270G>A					no		1689,11307												-2.7					0.0	microtubule binding (GO:0008017)|tubulin binding (GO:0015631)				hg19	Standard	0.1899			1530,7062		microtubule bundle formation (GO:0001578)|microtubule polymerization (GO:0046785)|positive regulation of protein complex assembly (GO:0031334)|positive regulation of protein polymerization (GO:0032273)	155,1379,4964					CCDS3856.1	G		AA,AG,GG	AB017016	cytoplasm (GO:0005737)|microtubule (GO:0005874)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	27		2504		rs11750269		433										p25alpha, TPPP1, p25, TPPP/p25		5	NM_007030		3			ENST00000360578.5		9336		uc003jbh.4			11076	dbSNP_120						0				26.0		0.692	5:g.666270G>A		protein_coding			basic|appris_principal|CCDS		155,1220,2921			159,4245			G|||			5008		TPPP_HUMAN	426	tubulin polymerization promoting protein			0.0850639		666270	Epithelial(17;0.000445)|all cancers(22;0.00176)|OV - Ovarian serous cystadenocarcinoma(19;0.00227)|Lung(60;0.0863)		0.0099	SNP		CCDS3856.1			,,,	False	666270				intron_variant		Approved		27.0			2008-02-05	OTTHUMT00000253645.3	O94811	0.1153		TPPP	666270					TPPP	NM_007030.2	protein-coding gene	NP_008961.1		
		G	ENSG00000171368	ENST00000360578.5		11076		ENSG00000171368		4295					,				c.(112-114)gcT>gcC	OTTHUMG00000131011		byFrequency	O94811	gene with protein product				NM_007030.2	1865,320,11	NM_007030	0.7076					+	Silent			23.0				10083737, 12093283, 15590652, 17105200				TPPP-001					5	-	0.9682				coding-synonymous	24164		38/220	Ovarian(839;0.0563)	G	SO:0001819	608773			protein_coding		2196				36.0419,7.7869,26.4828			6491					GBM - Glioblastoma multiforme(108;0.0191)			KNOWN			CCCCCTCACCAGCACCCTCCG						ENST00000360578.5:c.114T>C	5	Mediates interaction with LIMK1.				kidney(1)|large_intestine(1)|lung(2)|prostate(1)		-		,		5p15.33		"""brain specific protein p25 alpha"""	g.chr5:678062A>G					no		9544,3438												-3.7					0.0	microtubule binding (GO:0008017)|tubulin binding (GO:0015631)				hg19	Standard	0.6451			5494,3096		microtubule bundle formation (GO:0001578)|microtubule polymerization (GO:0046785)|positive regulation of protein complex assembly (GO:0031334)|positive regulation of protein polymerization (GO:0032273)	3656,2232,603					CCDS3856.1	A		GG,GA,AA	AB017016	cytoplasm (GO:0005737)|microtubule (GO:0005874)|nucleus (GO:0005634)|perinuclear region of cytoplasm (GO:0048471)	22		2504		rs450628|rs386684289		235									38	p25alpha, TPPP1, p25, TPPP/p25		5	NM_007030		2			ENST00000360578.5		15302		uc003jbh.4			11076	dbSNP_80	114			p.A38A		0				21.0		0.706	5:g.678062A>G		protein_coding			basic|appris_principal|CCDS		1791,1912,592			4050,342			G|||			5008		TPPP_HUMAN	3777	tubulin polymerization promoting protein			0.754193		678062	Epithelial(17;0.000445)|all cancers(22;0.00176)|OV - Ovarian serous cystadenocarcinoma(19;0.00227)|Lung(60;0.0863)		0.6647	SNP		CCDS3856.1			,,,	False	678062				synonymous_variant		Approved		22.0		c.114T>C	2008-02-05	OTTHUMT00000253645.3	O94811	0.7003		TPPP	678062					TPPP	NM_007030.2	protein-coding gene	NP_008961.1		
		G	ENSG00000113504	ENST00000264930.5		10723		ENSG00000113504		4300					,				c.(2995-2997)tcT>tcC	OTTHUMG00000161931		byFrequency	Q9Y666	gene with protein product			Potassium Chloride(DB00761)	NM_006598.2	216,905,1082	NM_006598	0.6135					+	Silent		666.1+/-402.3	139.0				10347194				SLC12A7-001	2013-07-18				5	-	0.2352				coding-synonymous	10915		999/1084		G	SO:0001819	604879			protein_coding		2203				34.6628,30.345,46.517		"""Solute carriers"""	6503								KNOWN			CTTTGAAACCAGATAGGCTGG						ENST00000264930.5:c.2997T>C	5					breast(1)|endometrium(3)|kidney(2)|large_intestine(3)|lung(14)|ovary(2)|prostate(1)|skin(4)|urinary_tract(2)		-		,		5p15	A6NDS8|Q4G0F3|Q96I81|Q9H7I3|Q9H7I7|Q9UFW2		g.chr5:1057615A>G		447.5+/-348.4			no		6956,6050												-5.7					0.0	potassium:chloride symporter activity (GO:0015379)|protein kinase binding (GO:0019901)				hg19	Standard	0.6372			5619,2981		cell volume homeostasis (GO:0006884)|chloride transmembrane transport (GO:1902476)|chloride transport (GO:0006821)|ion transport (GO:0006811)|potassium ion transport (GO:0006813)|transmembrane transport (GO:0055085)|transport (GO:0006810)	2048,2860,1595					CCDS34129.1	A		GG,GA,AA	AF105365	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	148		2504		rs2241606		3040									999	KCC4, DKFZP434F076		32	NM_006598		22			ENST00000264930.5		17436		uc003jbu.3			10723	dbSNP_98	2997			p.S999S		0				167.0		0.602	5:g.1057615A>G		protein_coding			non_canonical_TEC|basic|appris_principal|CCDS		1832,1955,513			1337,3069			a|||			5008		S12A7_HUMAN	2469	solute carrier family 12 (potassium/chloride transporter), member 7			0.493011		1057615	Epithelial(17;0.000497)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|all cancers(22;0.00241)|Lung(60;0.165)		0.4772	SNP		CCDS34129.1			,,,	False	1057615				synonymous_variant		Approved		148.0		c.2997T>C	2013-07-18	OTTHUMT00000366446.2	Q9Y666	0.6282		SLC12A7	1057615		Lung NSC(6;2.47e-13)|all_lung(6;1.67e-12)|all_epithelial(6;5.44e-09)			SLC12A7	NM_006598.2	protein-coding gene	NP_006589.2		
		A	ENSG00000113504	ENST00000264930.5	0.09310	10723	.	ENSG00000113504	0.33404	4300	1.000000	.	.		,	.	1.0	0	c.(2698-2700)taC>taT	OTTHUMG00000161931	0.773000	byFrequency	Q9Y666	gene with protein product			Potassium Chloride(DB00761)	NM_006598.2	19,412,1771	NM_006598	0.4325			G	6.481	+	Silent	1	557.1+/-387.0	103.0	.	0.10218		10347194			.	SLC12A7-001	2013-07-18		.		5	-	0.0295		.	0.759000	coding-synonymous	10915	136	900/1084		G	SO:0001819	604879		0.3756906077348066	protein_coding		2202	P		1.000000	47.0233,10.218,34.5586	.	"""Solute carriers"""	6502		0.206:0.0:0.794:0.0						KNOWN	ENST00000513223		TGCGCAAGTGGTACAAGAACA	.					ENST00000264930.5:c.2700C>T	5		ENSG00000113504	0.20034	SLC12A7	breast(1)|endometrium(3)|kidney(2)|large_intestine(3)|lung(14)|ovary(2)|prostate(1)|skin(4)|urinary_tract(2)		-	0.71417	,	CCA	5p15	A6NDS8|Q4G0F3|Q96I81|Q9H7I3|Q9H7I7|Q9UFW2		g.chr5:1063998G>A		214.5+/-233.7		20	no		4494,8510	0.80357	0.12283	4.25	0.00012	.			.		.		3.4	0.38596	180	.	0.3146853146853147	1.0	potassium:chloride symporter activity (GO:0015379)|protein kinase binding (GO:0019901)	.			hg19	Standard	0.4523	0.04065040650406504	7.5063	4044,4556		cell volume homeostasis (GO:0006884)|chloride transmembrane transport (GO:1902476)|chloride transport (GO:0006821)|ion transport (GO:0006811)|potassium ion transport (GO:0006813)|transmembrane transport (GO:0055085)|transport (GO:0006810)	954,2586,2962	0.456993				CCDS34129.1	G	.	AA,AG,GG	AF105365	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	114	.	2504	3.37	rs7722287		2743	.	359			0.27547	1116998	-		900	KCC4, DKFZP434F076	695	32	NM_006598	.	20	0.4736147757255937	0.305000	ENST00000264930.5		9752		uc003jbu.3			10723	dbSNP_116	2700	0.0000		p.Y900Y	.	0		T		137.0	rs7722287;rs35783179;rs57920515;rs7722287	0.637	5:g.1063998G>A	.	protein_coding	.		non_canonical_TEC|basic|appris_principal|CCDS		935,2174,1191		258	450,3954	0.3182234432234432	S	G|||		.	5008		S12A7_HUMAN	1486	solute carrier family 12 (potassium/chloride transporter), member 7		.	0.296725	0.44389	1063998	Epithelial(17;0.000497)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|all cancers(22;0.00241)|Lung(60;0.165)	2.387000	0.3175	SNP		CCDS34129.1		.	,,,	False	1063998	-0.8960		3	synonymous_variant	T	Approved	0.470233	114.0		c.2700C>T	2013-07-18	OTTHUMT00000366446.2	Q9Y666	0.3588	.	SLC12A7	1063998	0.43091	Lung NSC(6;2.47e-13)|all_lung(6;1.67e-12)|all_epithelial(6;5.44e-09)	0.49244		SLC12A7	NM_006598.2	protein-coding gene	NP_006589.2	P	
		G	ENSG00000113504	ENST00000264930.5	0.24364	10723	N	ENSG00000113504	0.11334	4300	0.789000	0.93426	B		,	T	0.994864	0	c.(2320-2322)aTg>aCg	OTTHUMG00000161931	-0.143000	byFrequency	Q9Y666	gene with protein product			Potassium Chloride(DB00761)	NM_006598.2	0,14,2189	NM_006598	0.0041			a	8.557	+	Missense_Mutation	2	85.6+/-148.0	69.0	Q9Y666	0.003177		10347194			0.001	SLC12A7-001	2013-07-18		0.04013		5	-	0.0		0.24	0.693000	missense	10915	2	774/1084		A	SO:0001583	604879	benign	0.0055248618784530384	protein_coding		2203	N		0.090000	2.2674,0.3177,1.607	B	"""Solute carriers"""	6503		0.5848:0.0:0.4152:0.0						KNOWN	ENST00000264930		CAGGTGGGACATGCCATCCCG	D					ENST00000264930.5:c.2321T>C	5		ENSG00000113504	0.25322	SLC12A7	breast(1)|endometrium(3)|kidney(2)|large_intestine(3)|lung(14)|ovary(2)|prostate(1)|skin(4)|urinary_tract(2)	ENSP00000264930:p.Met774Thr	-	0.21635	,	ATG	5p15	A6NDS8|Q4G0F3|Q96I81|Q9H7I3|Q9H7I7|Q9UFW2		g.chr5:1065514A>G		21.2+/-45.6		0	yes		209,12797	0.31954	0.17395	4.49	0.64349	ENSP00000264930:M774T			0.20357		.		0.5	0.16967	0	0.33141	0.0	0.8	potassium:chloride symporter activity (GO:0015379)|protein kinase binding (GO:0019901)	0.015			hg19	Standard	0.0209	0.0	7.1786	195,8405		cell volume homeostasis (GO:0006884)|chloride transmembrane transport (GO:1902476)|chloride transport (GO:0006821)|ion transport (GO:0006811)|potassium ion transport (GO:0006813)|transmembrane transport (GO:0055085)|transport (GO:0006810)	4,201,6298	0.876903				CCDS34129.1	A	0.02656	GG,GA,AA	AF105365	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	68	0.10645	2504	0.507	rs56350427		2364	774	19			0.25760	1118514	-	THR/MET	774	KCC4, DKFZP434F076	21	32	NM_006598	0.0	18	0.025065963060686015	0.383000	ENST00000264930.5		18614		uc003jbu.3			10723	dbSNP_129	2321	0.2590		p.M774T	.	0		T		67.0	rs56350427	0.627	5:g.1065514A>G	ENSP00000264930:M774T	protein_coding	0.093925		non_canonical_TEC|basic|appris_principal|CCDS		4,187,4109		774	14,4392	0.009615384615384616	T	A|||		0.552015	5008		S12A7_HUMAN	26	solute carrier family 12 (potassium/chloride transporter), member 7		S12A7_HUMAN	0.00519169	0.39072	1065514	Epithelial(17;0.000497)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|all cancers(22;0.00241)|Lung(60;0.165)	1.824000	0.0	SNP		CCDS34129.1		N	,,,	False	1065514	-0.6372		10	missense	T	Approved	0.022674	68.0		c.2321T>C	2013-07-18	OTTHUMT00000366446.2	Q9Y666	0.0014	-3.22	SLC12A7	1065514	0.40251	Lung NSC(6;2.47e-13)|all_lung(6;1.67e-12)|all_epithelial(6;5.44e-09)	0.64588	81	SLC12A7	NM_006598.2	protein-coding gene	NP_006589.2	M	
		G	ENSG00000113504	ENST00000264930.5		10723		ENSG00000113504		4296					,					OTTHUMG00000161931		byFrequency	Q9Y666	gene with protein product			Potassium Chloride(DB00761)	NM_006598.2	502,1083,613	NM_006598	0.8865					+	Intron			58.0				10347194				SLC12A7-001	2013-07-18				5	-	0.3699				intron	10915				G	SO:0001627	604879			protein_coding		2198				6.669,47.475,22.1897		"""Solute carriers"""	6494								KNOWN			AAGGAAAGGCAGGTCCGTGGG						ENST00000264930.5:c.1397-25T>C	5					breast(1)|endometrium(3)|kidney(2)|large_intestine(3)|lung(14)|ovary(2)|prostate(1)|skin(4)|urinary_tract(2)		-		,		5p15	A6NDS8|Q4G0F3|Q96I81|Q9H7I3|Q9H7I7|Q9UFW2		g.chr5:1078898A>G					no		10106,2882												-2.3					0.0	potassium:chloride symporter activity (GO:0015379)|protein kinase binding (GO:0019901)				hg19	Standard	0.9195			8019,573		cell volume homeostasis (GO:0006884)|chloride transmembrane transport (GO:1902476)|chloride transport (GO:0006821)|ion transport (GO:0006811)|potassium ion transport (GO:0006813)|transmembrane transport (GO:0055085)|transport (GO:0006810)	4245,1616,633					CCDS34129.1	A		GG,GA,AA	AF105365	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	64		2504		rs113958081|rs4975564		1440										KCC4, DKFZP434F076		32	NM_006598		11			ENST00000264930.5		5783		uc003jbu.3			10723	dbSNP_111						0				77.0		0.637	5:g.1078898A>G		protein_coding			non_canonical_TEC|basic|appris_principal|CCDS		3743,533,20			2087,2309			G|||			5008		S12A7_HUMAN	3855	solute carrier family 12 (potassium/chloride transporter), member 7			0.769768		1078898	Epithelial(17;0.000497)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|all cancers(22;0.00241)|Lung(60;0.165)		0.9395	SNP		CCDS34129.1			,,,	False	1078898				intron_variant		Approved		64.0			2013-07-18	OTTHUMT00000366446.2	Q9Y666	0.9035		SLC12A7	1078898		Lung NSC(6;2.47e-13)|all_lung(6;1.67e-12)|all_epithelial(6;5.44e-09)			SLC12A7	NM_006598.2	protein-coding gene	NP_006589.2		
		G	ENSG00000113504	ENST00000264930.5		10723		ENSG00000113504		4300					,				c.(1285-1287)ccT>ccC	OTTHUMG00000161931		byFrequency	Q9Y666	gene with protein product			Potassium Chloride(DB00761)	NM_006598.2	557,1072,573	NM_006598	0.4192					+	Silent		582.9+/-391.5	84.0				10347194				SLC12A7-001	2013-07-18				5	-	0.4834				coding-synonymous	10915		429/1084		G	SO:0001819	604879			protein_coding		2202				48.5581,49.6367,48.9234		"""Solute carriers"""	6502								KNOWN			CGGTCACGGAAGGGAAGTAGA						ENST00000264930.5:c.1287T>C	5					breast(1)|endometrium(3)|kidney(2)|large_intestine(3)|lung(14)|ovary(2)|prostate(1)|skin(4)|urinary_tract(2)		-		,		5p15	A6NDS8|Q4G0F3|Q96I81|Q9H7I3|Q9H7I7|Q9UFW2		g.chr5:1081702A>G		586.5+/-386.5			no		6362,6642												-6.6					0.6	potassium:chloride symporter activity (GO:0015379)|protein kinase binding (GO:0019901)				hg19	Standard	0.4791			4176,4424		cell volume homeostasis (GO:0006884)|chloride transmembrane transport (GO:1902476)|chloride transport (GO:0006821)|ion transport (GO:0006811)|potassium ion transport (GO:0006813)|transmembrane transport (GO:0055085)|transport (GO:0006810)	1556,3250,1696					CCDS34129.1	A		GG,GA,AA	AF105365	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	88		2504		rs6865765		1330									429	KCC4, DKFZP434F076		32	NM_006598		9			ENST00000264930.5		17294		uc003jbu.3			10723	dbSNP_116	1287			p.P429P		0				96.0		0.622	5:g.1081702A>G		protein_coding			non_canonical_TEC|basic|appris_principal|CCDS		999,2178,1123			2186,2218			G|||			5008		S12A7_HUMAN	2115	solute carrier family 12 (potassium/chloride transporter), member 7			0.422324		1081702	Epithelial(17;0.000497)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|all cancers(22;0.00241)|Lung(60;0.165)		0.3601	SNP		CCDS34129.1			,,,	False	1081702				synonymous_variant		Approved		88.0		c.1287T>C	2013-07-18	OTTHUMT00000366446.2	Q9Y666	0.3184		SLC12A7	1081702		Lung NSC(6;2.47e-13)|all_lung(6;1.67e-12)|all_epithelial(6;5.44e-09)			SLC12A7	NM_006598.2	protein-coding gene	NP_006589.2		
		G	ENSG00000174358	ENST00000304460.10		340024		ENSG00000174358		4300					,				c.(988-990)acA>acG	OTTHUMG00000161636		byFrequency	Q695T7	gene with protein product				NM_001003841.2	1707,469,27	XM_291120	0.8119	Substitution - coding silent(1)				+	Silent		131.2+/-189.0	158.0								SLC6A19-001					5	+	0.8835				coding-synonymous	27960		330/635		G	SO:0001819	608893			protein_coding	stomach(1)	2203				4.9186,11.8702,7.2736		"""Solute carriers"""	6503								KNOWN			TCCGCGCCACACAGCGCTACG						ENST00000304460.10:c.990A>G	5					breast(2)|central_nervous_system(1)|endometrium(3)|kidney(1)|lung(25)|prostate(3)|skin(3)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(2)		+		,		5p15	A8K446	"""Hartnup disease"""	g.chr5:1216775A>G		237.7+/-249.4			no		12060,946												-9.2					0.1	neurotransmitter:sodium symporter activity (GO:0005328)|neutral amino acid transmembrane transporter activity (GO:0015175)				hg19	Standard	0.9563			8177,423		amino acid transport (GO:0006865)|ion transport (GO:0006811)|response to nutrient (GO:0007584)|transmembrane transport (GO:0055085)	5594,872,37			p.T330T(1)		CCDS34130.1	A		GG,GA,AA	AK096054	brush border membrane (GO:0031526)|extracellular vesicular exosome (GO:0070062)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	178		2504		rs4975629		1046									330			44	NM_001003841		7			ENST00000304460.10		20848		uc003jbw.4			340024	dbSNP_111	990			p.T330T		1				219.0		0.612	5:g.1216775A>G		protein_coding			basic|appris_principal|CCDS		3887,403,10			3883,523			G|||			5008		S6A19_HUMAN	4207	solute carrier family 6 (neutral amino acid transporter), member 19			0.840056		1216775	Epithelial(17;0.000356)|all cancers(22;0.00137)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.6825	SNP		CCDS34130.1			,,,	False	1216775				synonymous_variant		Approved		178.0		c.990A>G	2013-07-19	OTTHUMT00000365557.1	Q695T7	0.8573		SLC6A19	1216775		all_cancers(3;3.55e-15)|Lung NSC(6;2.89e-14)|all_lung(6;2.2e-13)|all_epithelial(6;3.75e-10)			SLC6A19	NM_001003841.2	protein-coding gene	NP_001003841.1		
		T	ENSG00000164363	ENST00000324642.3		348932		ENSG00000164363		4300					,				c.(82-84)ctC>ctT	OTTHUMG00000090356		byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Silent_p.L28L		NM_182632.2	1,128,2074	NM_182632	0.1012					+	Silent		276.8+/-292.5	101.0				19478081				SLC6A18-001	2013-07-19				5	+	0.0076				coding-synonymous	26441		28/629		C	SO:0001819	610300			protein_coding		2203				17.0116,2.9505,12.2482		"""Solute carriers"""	6503								KNOWN			CCCAGTACCTCCTGAGCTGCA						ENST00000324642.3:c.84C>T	5					endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)		+		,		5p15			g.chr5:1225676C>T		93.4+/-132.2			no		1593,11413												-7.7					0.8	neurotransmitter:sodium symporter activity (GO:0005328)				hg19	Standard	0.16			1463,7137		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	138,1317,5048					CCDS3860.1	C		TT,TC,CC	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	107		2504		rs33978774		207				"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""					28	FLJ31236, Xtrp2		34	NM_182632		1			ENST00000324642.3		18277		uc003jby.2			348932	dbSNP_126	84			p.L28L		0				118.0		0.637	5:g.1225676C>T		protein_coding			basic|appris_principal|CCDS		137,1189,2974			130,4276			C|||			5008		S6A18_HUMAN	323	solute carrier family 6 (neutral amino acid transporter), member 18			0.0644968		1225676	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.001	SNP		CCDS3860.1			,,,	False	1225676				synonymous_variant		Approved		107.0		c.84C>T	2013-07-19	OTTHUMT00000206728.3	Q96N87	0.0749		SLC6A18	1225676		all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)			SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2		
		T	ENSG00000164363	ENST00000324642.3	0.80722	348932	N	ENSG00000164363	0.29255	4300	0.006000	0.70045	B		,	T	0.0	0	c.(94-96)aCt>aTt	OTTHUMG00000090356	0.565000	byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Missense_Mutation_p.T32I		NM_182632.2	1713,74,416	NM_182632	0.819	Substitution - Missense(1)		T	0.016	+	Missense_Mutation	2		97.0	Q96N87	0.794371		19478081			0.0	SLC6A18-001	2013-07-19		0.01281		5	+	0.879		0.73	0.006000	missense	26441	284	32/629		T	SO:0001583	610300	benign	0.7845303867403315	protein_coding	stomach(1)	2203	P		0.967000	9.4535,20.5629,13.217	B	"""Solute carriers"""	6503		0.0:0.0845:0.0:0.9155						KNOWN	ENST00000324642;ENST00000296821		CTGAGCTGCACTGGGTTTGCC	T;T					ENST00000324642.3:c.95C>T	5		ENSG00000164363	0.03123	SLC6A18	endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)	ENSP00000323549:p.Thr32Ile	+	0.33354	,	ACT	5p15			g.chr5:1225687C>T	T -> I (in dbSNP:rs7705355). {ECO:0000269|PubMed:14702039}.			334	yes		11287,1719	0.13384	0.00942	4.12	0.00012	ENSP00000296821:T32I			0.13827		.		4.1	0.48240	316	0.09338	0.5524475524475524	0.0	neurotransmitter:sodium symporter activity (GO:0005328)	-3.725			hg19	Standard	0.9553	0.6788617886178862	9.6943	7787,813		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	5548,191,764	-1.537792		p.T32I(1)		CCDS3860.1	C	0.02656	TT,TC,CC	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	102	0.00001	2504	4.12	rs7705355|rs386684404		218	32	600		"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""	0.40147	1278687	+	ILE/THR	32	FLJ31236, Xtrp2	1534	34	NM_182632	0.0	1	0.7915567282321899	-0.817000	ENST00000324642.3		17818		uc003jby.2			348932	dbSNP_116	95	0.0000		p.T32I	.	1		T		112.0	rs7705355;rs58585203	0.637	5:g.1225687C>T	ENSP00000323549:T32I;ENSP00000296821:T32I	protein_coding	0.359966		basic|appris_principal|CCDS		3835,117,348		32	3500,906	0.7023809523809523	I	T|||		0.600776	5008		S6A18_HUMAN	4121	solute carrier family 6 (neutral amino acid transporter), member 18		S6A18_HUMAN	0.822883	0.71193	1225687	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)	6.067000	0.5972	SNP		CCDS3860.1		N	,,,	False	1225687	-0.9393		9	missense	T	Approved	0.905465	102.0		c.95C>T	2013-07-19	OTTHUMT00000206728.3	Q96N87	0.8573	-0.45;-0.45	SLC6A18	1225687	0.05464	all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)	0.43410	89	SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2	T	
		C	ENSG00000164363	ENST00000324642.3		348932		ENSG00000164363		4300					,				c.(94-96)acT>acC	OTTHUMG00000090356		byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Silent_p.T32T		NM_182632.2	1243,136,824	NM_182632	0.6738	Substitution - coding silent(1)				+	Silent			96.0				19478081				SLC6A18-001	2013-07-19				5	+	0.6762				coding-synonymous	26441		32/629		C	SO:0001819	610300			protein_coding	stomach(1)	2203				42.0,40.4902,41.4885		"""Solute carriers"""	6503								KNOWN			TGAGCTGCACTGGGTTTGCCG						ENST00000324642.3:c.96T>C	5					endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)		+		,		5p15			g.chr5:1225688T>C	T -> I (in dbSNP:rs7705355). {ECO:0000269|PubMed:14702039}.				no		7610,5396												-7.1					0.0	neurotransmitter:sodium symporter activity (GO:0005328)				hg19	Standard	0.7873			4988,3612		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	3619,372,2512			p.T32T(1)		CCDS3860.1	T		CC,CT,TT	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	101		2504		rs7728814|rs386684404		219				"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""					32	FLJ31236, Xtrp2		34	NM_182632		1			ENST00000324642.3		17980		uc003jby.2			348932	dbSNP_116	96			p.T32T		1				111.0		0.632	5:g.1225688T>C		protein_coding			basic|appris_principal|CCDS		2376,236,1688			2622,1784			C|||			5008		S6A18_HUMAN	3423	solute carrier family 6 (neutral amino acid transporter), member 18			0.683506		1225688	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.5575	SNP		CCDS3860.1			,,,	False	1225688				synonymous_variant		Approved		101.0		c.96T>C	2013-07-19	OTTHUMT00000206728.3	Q96N87	0.7435		SLC6A18	1225688		all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)			SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2		
		G	ENSG00000164363	ENST00000324642.3		348932		ENSG00000164363		4300					,				c.(109-111)ggA>ggG	OTTHUMG00000090356		byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Silent_p.G37G		NM_182632.2	1746,435,22	NM_182632	0.819	Substitution - coding silent(1)				+	Silent		131.0+/-188.9	101.0				19478081				SLC6A18-001	2013-07-19				5	+	0.879				coding-synonymous	26441		37/629		G	SO:0001819	610300			protein_coding	stomach(1)	2203				5.0,10.8715,6.9891		"""Solute carriers"""	6503								KNOWN			TTGCCGTGGGACTGGGGAACA						ENST00000324642.3:c.111A>G	5					endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)		+		,		5p15			g.chr5:1225703A>G		218.7+/-236.7			no		12097,909												1.3					1.0	neurotransmitter:sodium symporter activity (GO:0005328)				hg19	Standard	0.9553			8170,430		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	5631,835,37			p.G37G(1)		CCDS3860.1	A		GG,GA,AA	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	106		2504		rs7724858|rs199774515		234				"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""					37	FLJ31236, Xtrp2		34	NM_182632		1			ENST00000324642.3		18012		uc003jby.2			348932	dbSNP_116	111			p.G37G		1				114.0		0.652	5:g.1225703A>G		protein_coding			basic|appris_principal|CCDS		3885,400,15			3927,479			G|||			5008		S6A18_HUMAN	4121	solute carrier family 6 (neutral amino acid transporter), member 18			0.822883		1225703	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.5972	SNP		CCDS3860.1			,,,	False	1225703				synonymous_variant		Approved		106.0		c.111A>G	2013-07-19	OTTHUMT00000206728.3	Q96N87	0.8573		SLC6A18	1225703		all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)			SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2		
		C	ENSG00000164363	ENST00000324642.3		348932		ENSG00000164363		4298					,					OTTHUMG00000090356		byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Intron		NM_182632.2	1968,224,5	NM_182632	0.8067					+	Intron			21.0				19478081				SLC6A18-001	2013-07-19				5	+	0.947				intron	26441				C	SO:0001627	610300			protein_coding		2197				7.8874,5.3254,7.0208		"""Solute carriers"""	6495								KNOWN			CACCGTCCTCGCTTGCCCTGA						ENST00000324642.3:c.301+17G>C	5					endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)		+		,		5p15			g.chr5:1232491G>C					no		12078,912												-3.8					0.0	neurotransmitter:sodium symporter activity (GO:0005328)				hg19	Standard	0.9205			7918,678		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	5617,844,34					CCDS3860.1	G		CC,CG,GG	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	21		2504		rs4975623		424				"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""						FLJ31236, Xtrp2		34	NM_182632		2			ENST00000324642.3		10449		uc003jby.2			348932	dbSNP_111						0				21.0		0.706	5:g.1232491G>C		protein_coding			basic|appris_principal|CCDS		3649,620,29			4160,234			C|||			5008		S6A18_HUMAN	4146	solute carrier family 6 (neutral amino acid transporter), member 18			0.827875		1232491	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.5853	SNP		CCDS3860.1			,,,	False	1232491				intron_variant		Approved		21.0			2013-07-19	OTTHUMT00000206728.3	Q96N87	0.8487		SLC6A18	1232491		all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)			SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2		
		G	ENSG00000164363	ENST00000324642.3	0.80722	348932	.	ENSG00000164363	0.03862	4300	0.000000	.	.		,	T	0.0	2	c.(955-957)taC>taG	OTTHUMG00000090356	-0.907000	byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Intron		NM_182632.2	249,1036,918	NM_182632	0.4039			C	13.94	+	Nonsense_Mutation	3	484.0+/-371.3	107.0	.	0.348162		19478081			.	SLC6A18-001	2013-07-19		.	SLC6A18	5	+	0.3638		1	0.005000	stop-gained	26441	135	319/629		C	SO:0001587	610300		0.3729281767955801	protein_coding		2203	P		0.000000	37.2791,34.8162,36.4447	.	"""Solute carriers"""	6503		0.0:0.2103:0.0:0.7897						KNOWN	ENST00000324642		CTAATGACTACGAGCACTGCC	.					ENST00000324642.3:c.957C>G	5		ENSG00000164363	0.00684	SLC6A18	endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)	ENSP00000323549:p.Tyr319*	+	0.05858	,	TAC	5p15			g.chr5:1240757C>G		484.6+/-360.1		188	yes		4740,8266	0.03702	0.42308	4.51	.	ENSP00000323549:Y319X	M		0.15102		.		-3.1	0.05250	140	0.02654	0.24475524475524477	0.0	neurotransmitter:sodium symporter activity (GO:0005328)	.			hg19	Standard	0.3688	0.3821138211382114	13.214	3206,5394		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	871,2998,2634	2.386926				CCDS3860.1	C	.	GG,GC,CC	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	119	.	2504	-3.14	rs7447815		1080	.	280	GRCh37	"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""	0.59844	1293757	+	stop/TYR	319	FLJ31236, Xtrp2	743	34	NM_182632	.	7	0.36939313984168864	-1.743000	ENST00000324642.3		19420		uc003jby.2			348932	dbSNP_116	957	.	CM086962	p.Y319*	.	0		.		142.0	rs7447815;rs7447815	0.612	5:g.1240757C>G	.	protein_coding	0.280472		basic|appris_principal|CCDS		622,1962,1716		319	1534,2872	0.3402014652014652	X	C|||		0.627859	5008		S6A18_HUMAN	1746	solute carrier family 6 (neutral amino acid transporter), member 18		.	0.348642	0.00650	1240757	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)	-3.005000	0.2351	SNP	rs7447815	CCDS3860.1		N	,,,	False	1240757	.		.	stop_gained	.	Approved	0.372791	119.0		c.957C>G	2013-07-19	OTTHUMT00000206728.3	Q96N87	0.3775	.	SLC6A18	1240757	0.04900	all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)	.		SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2	Y	
		G	ENSG00000164363	ENST00000324642.3		348932		ENSG00000164363		4299					,					OTTHUMG00000090356		byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Intron		NM_182632.2	2079,122,2	NM_182632	0.9294					+	Intron		231.0+/-265.1	33.0				19478081				SLC6A18-001	2013-07-19				5	+	0.9924				intron	26441				G	SO:0001627	610300			protein_coding		2203				13.5962,2.8597,9.9585		"""Solute carriers"""	6502								KNOWN			GTAGCCAGGCAGGGCCGTCCA						ENST00000324642.3:c.1131+31A>G	5					endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)		+		,		5p15			g.chr5:1243009A>G		87.3+/-125.9			no		11709,1295												-5.4					0.0	neurotransmitter:sodium symporter activity (GO:0005328)				hg19	Standard	0.8588			7429,1169		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	5284,1141,77					CCDS3860.1	A		GG,GA,AA	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	32		2504		rs7721679		1254				"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""						FLJ31236, Xtrp2		34	NM_182632		8			ENST00000324642.3		17730		uc003jby.2			348932	dbSNP_116						0				30.0		0.647	5:g.1243009A>G		protein_coding			basic|appris_principal|CCDS		3205,1019,75			4280,126			G|||			5008		S6A18_HUMAN	4713	solute carrier family 6 (neutral amino acid transporter), member 18			0.941094		1243009	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.9821	SNP		CCDS3860.1			,,,	False	1243009				intron_variant		Approved		32.0			2013-07-19	OTTHUMT00000206728.3	Q96N87	0.9193		SLC6A18	1243009		all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)			SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2		
		T	ENSG00000164363	ENST00000324642.3	0.35260	348932	N	ENSG00000164363	0.32252	4300	0.005000	0.72282	B		,	T	0.22053500000000004	0	c.(1432-1434)cCg>cTg	OTTHUMG00000090356	0.722000	byFrequency	Q96N87	gene with protein product		SLC6A18_ENST00000296821.4_Missense_Mutation_p.P376L		NM_182632.2	1636,531,36	NM_182632	0.6728			T	0.647	+	Missense_Mutation	2	352.4+/-328.6	155.0	Q96N87	0.863141		19478081			0.001	SLC6A18-001	2013-07-19		0.04013		5	+	0.9009		0.66	0.030000	missense	26441	263	478/629		T	SO:0001583	610300	benign	0.7265193370165746	protein_coding		2203	P		0.980000	23.593,13.6859,20.2368	B	"""Solute carriers"""	6503		0.0:0.0922:0.0:0.9078						KNOWN	ENST00000324642;ENST00000296821		GCCGCTTCCCCGAACCTGCTC	T;T					ENST00000324642.3:c.1433C>T	5		ENSG00000164363	0.07541	SLC6A18	endometrium(1)|kidney(2)|large_intestine(3)|lung(16)|ovary(1)|prostate(1)|skin(5)|stomach(4)|upper_aerodigestive_tract(1)	ENSP00000323549:p.Pro478Leu	+	0.34600	,	CCG	5p15			g.chr5:1244425C>T	P -> L (in dbSNP:rs4073918). {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:19033659}.	261.9+/-264.6		446	yes		10374,2632	0.12908	0.02798	4.87	0.00012	ENSP00000296821:P376L			0.26859		.		4.9	0.63330	161	0.11182	0.28146853146853146	0.0	neurotransmitter:sodium symporter activity (GO:0005328)	-1.945			hg19	Standard	0.7744	0.9065040650406504	8.4287	6571,2029		amino acid transmembrane transport (GO:0003333)|amino acid transport (GO:0006865)|ion transport (GO:0006811)|transmembrane transport (GO:0055085)	4138,2098,267	-0.810981				CCDS3860.1	C	0.06786	TT,TC,CC	AK055798	brush border membrane (GO:0031526)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	155	0.00165	2504	4.87	rs4073918		1556	478	583		"""solute carrier family 6 (neurotransmitter transporter), member 18"", ""solute carrier family 6, member 18"""	0.32744	1297425	+	LEU/PRO	478	FLJ31236, Xtrp2	1453	34	NM_182632	0.001	10	0.7691292875989446	-0.361000	ENST00000324642.3		14095		uc003jby.2			348932	dbSNP_108	1433	0.0000		p.P478L	.	0		T		155.0	rs4073918;rs52796423;rs58973522;rs4073918	0.582	5:g.1244425C>T	ENSP00000323549:P478L;ENSP00000296821:P376L	protein_coding	0.022133		basic|appris_principal|CCDS		2502,1567,231		478;376	3803,603	0.6652930402930403	L	T|||		0.313451	5008		S6A18_HUMAN	3386	solute carrier family 6 (neutral amino acid transporter), member 18		S6A18_HUMAN	0.676118	0.58085	1244425	Epithelial(17;0.000356)|all cancers(22;0.00124)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)	4.148000	0.2728	SNP		CCDS3860.1		N	,,,	False	1244425	-0.9588		9	missense	T	Approved	0.76407	155.0		c.1433C>T	2013-07-19	OTTHUMT00000206728.3	Q96N87	0.696	-0.64;-0.64	SLC6A18	1244425	0.12068	all_cancers(3;2.99e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.76e-10)	0.39961	98	SLC6A18	NM_182632.2	protein-coding gene	NP_872438.2	P	
TERT Mutation-Associated Haematological Disorders;Pulmonary Fibrosis, Idiopathic;Congenital Dyskeratosis		A	ENSG00000164362	ENST00000310581.5		7015		ENSG00000164362		4263					,				c.(3037-3039)caC>caT	OTTHUMG00000090357		byFrequency	O14746	gene with protein product		TERT_ENST00000334602.6_Silent_p.H950H|TERT_ENST00000296820.5_3'UTR	Zidovudine(DB00495)	NM_001193376.1|NM_198253.2	1,84,2074		0.1585					+	Silent			76.0				9252327				TERT-001					5	-	0.0053				coding-synonymous,coding-synonymous	11730		950/1070,1013/1133		G	SO:0001819	187270	,		protein_coding		2159				10.1103,1.9917,7.3809			6422								KNOWN			GCACACATGCGTGAAACCTGA				;Hamman-Rich syndrome, Fibrocystic Pulmonary Dysplasia;Zinsser-Engman-Cole syndrome, Dyskeratosis Congenita	Familial Cancer Database	ENST00000310581.5:c.3039C>T	5	CTE.				NS(1)|breast(1)|central_nervous_system(3)|endometrium(2)|kidney(4)|large_intestine(3)|lung(22)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)		-		,		5p15.33	O14783|Q2XS35|Q8N6C3|Q8NG38|Q8NG46		g.chr5:1255520G>A					no		948,11896												-3.8					0.6	metal ion binding (GO:0046872)|protein homodimerization activity (GO:0042803)|telomerase activity (GO:0003720)|telomeric DNA binding (GO:0042162)|telomeric RNA binding (GO:0070034)|telomeric template RNA reverse transcriptase activity (GO:0003721)				hg19	Standard	0.0974			862,7664		DNA strand elongation (GO:0022616)|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)|replicative senescence (GO:0090399)|telomere formation via telomerase (GO:0032203)|telomere maintenance (GO:0000723)|telomere maintenance via telomerase (GO:0007004)	58,832,5532					CCDS3861.2, CCDS54831.1	G		AA,AG,GG	AF015950	chromosome, telomeric region (GO:0000781)|cytoplasm (GO:0005737)|nuclear telomere cap complex (GO:0000783)|nucleoplasm (GO:0005654)|telomerase holoenzyme complex (GO:0005697)	75		2504		rs33954691		3096								,	1013	TRT, TP2, TCS1, hEST2, EST2		41	NM_198253		14			ENST00000310581.5		23994		uc003jcb.1				dbSNP_126	2850,3039			p.H1013H		0				71.0		0.587	5:g.1255520G>A		protein_coding			basic|appris_candidate_longest|CCDS		57,748,3458			86,4232			g|||			5008		TERT_HUMAN	590	telomerase reverse transcriptase			0.117812		1255520	Epithelial(17;0.00105)|all cancers(22;0.00178)|OV - Ovarian serous cystadenocarcinoma(19;0.00239)|Lung(60;0.185)		0.1667	SNP		CCDS3861.2			,,,	False	1255520				synonymous_variant		Approved		75.0		c.3039C>T	2014-09-17	OTTHUMT00000206729.2	O14746	0.2334		TERT	1255520		all_cancers(3;3.17e-16)|Lung NSC(6;8.55e-15)|all_lung(6;7.2e-14)|all_epithelial(6;1.87e-10)		,	TERT	NM_001193376.1,NM_198253.2	protein-coding gene	NP_001180305.1|NP_937983.2		
		G	ENSG00000153395	ENST00000283415.3	0.09310	79888	M	ENSG00000153395	0.52555	4300	0.998000	0.67523	B		,	T	0.99999418856	0	c.(1279-1281)aTg>aCg	OTTHUMG00000131017	1.793000	byFrequency	Q8NF37	gene with protein product		LPCAT1_ENST00000503252.1_5'UTR		NM_024830.3	14,334,1855	NM_024830	0.2607			A	13.64	+	Splice_Site	2	378.0+/-338.7	88.0	Q8NF37	0.082161	Missense_Mutation	8619474, 16704971			0.028	LPCAT1-002	2007-12-17		0.20184		5	-	0.0393		0.11	0.099000	missense-near-splice	25718	77	427/535		A	SO:0001630	610472	benign	0.212707182320442	protein_coding		2203	P		1.000000	25.8605,8.2161,19.8831	B	"""EF-hand domain containing"""	6503		1.0:0.0:0.0:0.0			GBM - Glioblastoma multiforme(108;0.156)			KNOWN	ENST00000283415		CGCTCCGTACATCTGCAAGGC	T	AYTL2				ENST00000283415.3:c.1279-1T>C	5		ENSG00000153395	0.35465	LPCAT1	breast(1)|endometrium(4)|kidney(1)|large_intestine(5)|lung(12)|ovary(4)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)		-	0.71417	,	ATG	5p15.33	Q1HAQ1|Q7Z4G6|Q8N3U7|Q8WUL8|Q9GZW6		g.chr5:1467004A>G		186.7+/-213.5		26	yes		2586,10420	0.56505	0.40694	4.47	0.00039	ENSP00000283415:M427T			0.85682		-55.0433		4.5	0.54385	77	0.46703	0.1346153846153846	1.0	1-acylglycerophosphocholine O-acyltransferase activity (GO:0047184)|1-alkenylglycerophosphocholine O-acyltransferase activity (GO:0047159)|1-alkylglycerophosphocholine O-acetyltransferase activity (GO:0047192)|1-alkylglycerophosphocholine O-acyltransferase activity (GO:0047191)|calcium ion binding (GO:0005509)	2.48	2007-12-17		hg19	Standard	0.2326	0.052845528455284556	12.0333	2224,6376		cellular lipid metabolic process (GO:0044255)|glycerophospholipid biosynthetic process (GO:0046474)|negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)|phosphatidic acid biosynthetic process (GO:0006654)|phosphatidylcholine acyl-chain remodeling (GO:0036151)|phosphatidylglycerol acyl-chain remodeling (GO:0036148)|phospholipid biosynthetic process (GO:0008654)|phospholipid metabolic process (GO:0006644)|positive regulation of protein catabolic process (GO:0045732)|retina development in camera-type eye (GO:0060041)|small molecule metabolic process (GO:0044281)|surfactant homeostasis (GO:0043129)|triglyceride biosynthetic process (GO:0019432)	280,2026,4197	2.298881				CCDS3864.1	A	0.22003	GG,GA,AA	BC020166	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|Golgi apparatus (GO:0005794)|integral component of membrane (GO:0016021)|lipid particle (GO:0005811)|membrane (GO:0016020)	94	0.80028	2504	4.47	rs35452723		1412	427	182		"""acyltransferase like 2"""	0.53410	1520004	-	THR/MET	427	FLJ12443	362	30	NM_024830	0.063	13	0.24010554089709762	0.459000	ENST00000283415.3		17857		uc003jcm.3			79888	dbSNP_126	1280	0.0001		p.M427T	EF-hand-like domain (1);	0		T		107.0	rs35452723;rs62331140	0.662	5:g.1467004A>G	ENSP00000283415:M427T	protein_coding	0.000000		basic|appris_principal|CCDS		266,1692,2342		427	362,4044	0.16575091575091574	T	A|||		0.039739	5008		PCAT1_HUMAN	829	lysophosphatidylcholine acyltransferase 1		PCAT1_HUMAN	0.165535	0.67391	1467004	OV - Ovarian serous cystadenocarcinoma(19;0.0274)|all cancers(22;0.0534)	5.569000	0.1319	SNP		CCDS3864.1		D	,,,	False	1467004	-1.0683		9	splice_region_variant	T	Approved	0.258605	94.0		c.1280T>C	2013-01-10	OTTHUMT00000304032.1	Q8NF37	0.2233	-0.27	LPCAT1	1467004	0.18886		0.09250	81	LPCAT1	NM_024830.3	protein-coding gene	NP_079106.3	M	
		TTGTA	ENSG00000145494	ENST00000274137.5		4726		ENSG00000145494												OTTHUMG00000090372		byFrequency	O75380	gene with protein product		NDUFS6_ENST00000469176.1_Intron		NM_004553.4		NM_004553						+	Intron							9763677				NDUFS6-001	2002-08-29					+						7713					SO:0001627	603848			protein_coding								"""Mitochondrial respiratory chain complex / Complex I"""									KNOWN			GTGGGTTAAATTGTATGTAGT						ENST00000274137.5:c.187-58TTGTATGTA>TTGTA	5					central_nervous_system(1)|endometrium(1)|large_intestine(2)|lung(2)|prostate(1)		+				5p15.33		"""complex I 13kDa subunit A"", ""NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial"""	g.chr5:1814395delTTGTATGTA																									electron carrier activity (GO:0009055)|NADH dehydrogenase (ubiquinone) activity (GO:0008137)				hg19	Standard						cardiovascular system development (GO:0072358)|cellular metabolic process (GO:0044237)|fatty acid metabolic process (GO:0006631)|mitochondrial electron transport, NADH to ubiquinone (GO:0006120)|mitochondrion morphogenesis (GO:0070584)|multicellular organism growth (GO:0035264)|multicellular organismal aging (GO:0010259)|muscle contraction (GO:0006936)|reproductive system development (GO:0061458)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)						CCDS3866.1	TTGTATGTA			BC038664	mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex I (GO:0005747)					rs36074605|rs529722791		204				"""NADH dehydrogenase (ubiquinone) Fe-S protein 6 (13kD) (NADH-coenzyme Q reductase)"""						CI-13kA		7	NM_004553		3			ENST00000274137.5				uc003jcy.3			4726							0						0.373	5:g.1814395delTTGTATGTA		protein_coding			basic|appris_principal|CCDS													NDUS6_HUMAN		NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)					1814395				DEL		CCDS3866.1					1814395		1.6.99.3, 1.6.5.3		intron_variant		Approved					2011-07-04	OTTHUMT00000206744.2	O75380			NDUFS6								protein-coding gene	NP_004544.1		
		T	ENSG00000113430	ENST00000505790.1	0.29531	50805	N	ENSG00000113430	0.52704	4300	0.014000	0.66280	P		,	T	0.852752	0	c.(355-357)Gct>Act	OTTHUMG00000090411	1.801000	byFrequency	P78413	gene with protein product		IRX4_ENST00000231357.2_Missense_Mutation_p.A119T|IRX4_ENST00000513692.1_Missense_Mutation_p.A119T|IRX4_ENST00000505938.1_5'UTR		NM_001278634.1	107,800,1295	NM_016358	0.0716			C	6.313	+	Missense_Mutation	1	315.1+/-312.1	75.0	P78413	0.230245		10625552			0.068	IRX4-004	2007-07-13		0.26310		5	-	0.2156		0.42	0.013000	missense	6129	70	119/520		C	SO:0001583	606199	benign	0.19337016574585636	protein_coding		2202	P		0.997000	20.2558,23.0245,21.1935	B	"""Homeoboxes / TALE class"""	6502		0.0:1.0:0.0:0.0			GBM - Glioblastoma multiforme(108;0.242)			KNOWN	ENST00000231357;ENST00000505790;ENST00000513692;ENST00000511126		TAGGCGGCAGCGGCTGGTGCC	T;T;T;T					ENST00000505790.1:c.355G>A	5		ENSG00000113430	0.71058	IRX4	endometrium(1)|lung(7)|ovary(1)|prostate(1)	ENSP00000423161:p.Ala119Thr	-	0.39634	,	GCT	5p15.33	B2RMW5|D3DTC5|H1AFL0|H1AFL1|Q2NL64|Q9UHR2		g.chr5:1880891C>T	A -> T (in dbSNP:rs2232376). {ECO:0000269|PubMed:15489334}.	372.5+/-320.4		112	yes		2756,10248	0.15608	0.11987	4.03	0.00012	ENSP00000231357:A119T			0.28332		-14.4145		4.0	0.46877	10	0.21014	0.017482517482517484	0.0	sequence-specific DNA binding (GO:0043565)	0.41			hg19	Standard	0.2058	0.22764227642276422	14.9752	1742,6858		establishment of organ orientation (GO:0048561)|heart development (GO:0007507)|regulation of transcription, DNA-templated (GO:0006355)	282,2192,4028	0.425811				CCDS3867.1, CCDS75225.1	C	0.37061	TT,TC,CC	AF124733	nucleus (GO:0005634)	74	0.16478	2504	4.03	rs2232376		811	119	154		"""iroquois homeobox protein 4"""	0.71267	1933891	-	THR/ALA	119		346	10	NM_016358	0.58	4	0.20316622691292877	0.557000	ENST00000505790.1		13055		uc003jcz.2			50805	dbSNP_98	355	0.0000		p.A119T	.	0		T		71.0	rs2232376;rs60328712;rs2232376	0.632	5:g.1880891C>T	ENSP00000231357:A119T;ENSP00000423161:A119T;ENSP00000424235:A119T;ENSP00000421772:A119T	protein_coding	0.015722		alternative_5_UTR|not_organism_supported|basic|appris_principal|CCDS		175,1392,2733		119	1014,3390	0.15842490842490842	T	C|||		0.359172	5008		IRX4_HUMAN	687	iroquois homeobox 4		IRX4_HUMAN	0.137181	0.54350	1880891		3.640000	0.0139	SNP		CCDS3867.1		N	,,,	False	1880891	-1.0630		9	missense	T	Approved	0.202558	74.0		c.355G>A	2011-06-20	OTTHUMT00000365500.1	P78413	0.1599	-0.2;-0.2;-0.2;-0.04	IRX4	1880891	0.08279		0.10428	58	IRX4	NM_016358.2	protein-coding gene	NP_001265563.1	A	
		A	ENSG00000170561	ENST00000382611.6	0.21184	153572	L	ENSG00000170561	0.74166	4289	1.000000	0.66280	D		,	T	0.999760849	2	c.(763-765)gaG>gaT	OTTHUMG00000090377	2.248000	byFrequency	Q9BZI1	gene with protein product		IRX2_ENST00000502957.1_5'UTR|IRX2_ENST00000302057.5_Missense_Mutation_p.E255D		NM_001134222.1	4,121,2072		0.2955			C	13.71	+	Missense_Mutation	3		22.0	Q9BZI1	0.029358		11435706			0.525	IRX2-001	2007-07-13		0.46718		5	-	0.0098		0.22	0.907000	missense,missense	14359	28	255/472,255/472		C	SO:0001583	606198	benign,benign	0.07734806629834254	protein_coding		2197	P		1.000000	15.3649,2.9358,11.1548	P	"""Homeoboxes / TALE class"""	6486		0.0:0.9174:0.0:0.0826			GBM - Glioblastoma multiforme(108;0.204)			KNOWN	ENST00000382611;ENST00000302057;ENST00000502957		TGTCCTTGCACTCCGAGCCCG	T;T;T					ENST00000382611.6:c.765G>T	5		ENSG00000170561	0.77884	IRX2	breast(1)|central_nervous_system(3)|endometrium(4)|kidney(1)|large_intestine(2)|lung(12)|prostate(1)|skin(2)	ENSP00000372056:p.Glu255Asp	-	0.71417	,	GAG	5p15.33	Q68A19|Q7Z2I7		g.chr5:2749057C>A				9	yes		1447,11525	0.80357	0.40996	4.87	0.00496	ENSP00000307006:E255D			0.20691		-20.8591		4.9	0.63330	43	0.34782	0.07517482517482517	1.0	sequence-specific DNA binding (GO:0043565)	1.59			hg19	Standard	0.1421	0.018292682926829267	11.5223	1318,7260		proximal/distal pattern formation involved in metanephric nephron development (GO:0072272)|regulation of transcription, DNA-templated (GO:0006355)|specification of loop of Henle identity (GO:0072086)	126,1195,5165	2.316921				CCDS3868.1	C	0.58268	AA,AC,CC	AF319967	nucleus (GO:0005634)	22	0.50333	2504	4.87	rs76906087		1013	255	110			0.50558	2802057	-	ASP/GLU,ASP/GLU	255		190	26	NM_033267	0.982	3	0.14511873350923482	0.563000	ENST00000382611.6		9506		uc003jdb.3			153572	dbSNP_132	765,765	0.0016		p.E255D	.	0		T		22.0	.	0.692	5:g.2749057C>A	ENSP00000372056:E255D;ENSP00000307006:E255D;ENSP00000426151:E162D	protein_coding	0.087452		basic|appris_principal|CCDS		122,1074,3093		255;255;162	129,4265	0.08699633699633699	D	C|||		0.516800	5008		IRX2_HUMAN	586	iroquois homeobox 2		IRX2_HUMAN	0.117013	0.23879	2749057		0.585000	0.0913	SNP		CCDS3868.1		N	,,,	False	2749057	-1.0427		9	missense	T	Approved	0.153649	22.0		c.765G>T	2011-06-20	OTTHUMT00000206749.2	Q9BZI1	0.0706	-0.18;-0.18;-0.2	IRX2	2749057	0.53573		0.15723	45,45	IRX2	NM_001134222.1,NM_033267.4	protein-coding gene	NP_001127694.1	E	
		G	ENSG00000145536	ENST00000274181.7	0.80722	170690	N	ENSG00000145536	0.08640	4188	0.000000	0.05786	B;B;B		,	T	0.0	0	c.(268-270)Ccc>Gcc	OTTHUMG00000161663	-0.320000	byFrequency	Q8TE57	gene with protein product		CTD-2297D10.1_ENST00000514848.1_RNA|ADAMTS16_ENST00000511368.1_Missense_Mutation_p.P90A		NM_139056.2	838,947,253	NM_139056	0.8282			G	0	+	Missense_Mutation	1		63.0	Q8TE57;Q8TE57-2;Q2XQZ0	0.643523		11867212			0.0;0.0;0.0	ADAMTS16-001	2005-08-19		0.01281		5	+	0.5696		0.85	0.003000	missense	17108	312	90/1225		G	SO:0001583	607510	benign	0.861878453038674	protein_coding		2038	P		0.000000	18.4456,35.6477,24.0765	B;B;B	"""ADAM metallopeptidases with thrombospondin type 1 motif"""	6226		0.2637:0.0886:0.4054:0.2424						KNOWN	ENST00000274181;ENST00000511368;ENST00000536857		AAGAGCAGTGCCCGTGTCCGA	T;T					ENST00000274181.7:c.268C>G	5		ENSG00000145536	0.00253	ADAMTS16	breast(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(12)|lung(72)|ovary(4)|pancreas(1)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	ENSP00000274181:p.Pro90Ala	+	0.05858	,	CCC	5p15	C6G490|Q8IVE2		g.chr5:5146335C>G				301	yes		9454,2998	0.03702	0.00126	5.55	0.00012	ENSP00000274181:P90A		http://www.ncbi.nlm.nih.gov/omim/607510,610262|http://omim.org/entry/610262|http://omim.org/entry/607510	0.21485		.		-0.9	0.10709	291	0.07030	0.5087412587412588	0.0	metalloendopeptidase activity (GO:0004222)|zinc ion binding (GO:0008270)	-1.32			hg19	Standard	0.8111	0.6117886178861789	2.1559	6831,1545	P -> A (in Ref. 1; CAC86015). {ECO:0000305}.	branching involved in ureteric bud morphogenesis (GO:0001658)	3622,2210,394	-2.590313				CCDS43299.1	C	0.02656	GG,GC,CC	AJ315734	proteinaceous extracellular matrix (GO:0005578)	63	0.00621	2504	-0.853	rs2086310		406	90;90;90	600		"""a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 16"""	0.03811	5199335	+	ALA/PRO	90	ADAMTS16s	1504	107	NM_139056	0.0;0.0;0.0	3	0.7915567282321899	-2.319000	ENST00000274181.7		17116		uc003jdl.3			170690	dbSNP_96	268	0.0000		p.P90A	Peptidase M12B, propeptide (1);	0		T		62.0	rs2086310;rs60829908;rs2086310	0.557	5:g.5146335C>G	ENSP00000274181:P90A;ENSP00000421631:P90A	protein_coding	0.073780		basic|appris_principal|CCDS		2784,1263,141		90	2623,1453	0.6886446886446886	A	G|||		0.469545	5008		ATS16_HUMAN	3483	ADAM metallopeptidase with thrombospondin type 1 motif, 16		ATS16_HUMAN;.;.	0.695487	0.08928	5146335		-0.242000	0.498	SNP		CCDS43299.1		N	,,,	False	5146335	-1.0584		9	missense	T	Approved	0.815544	63.0		c.268C>G	2008-07-18	OTTHUMT00000365657.1	Q8TE57	0.8674	3.39;3.39	ADAMTS16	5146335	0.03518		0.11518	27	ADAMTS16	NM_139056.2	protein-coding gene	NP_620687.2	P	
		G	ENSG00000145536	ENST00000274181.7	0.46823	170690	L	ENSG00000145536	0.00703	4159	0.517000	0.05199	B;B;B		,	D	7.869999999999822E-4	0	c.(328-330)Atg>Gtg	OTTHUMG00000161663	-2.247000	byFrequency	Q8TE57	gene with protein product		CTD-2297D10.1_ENST00000514848.1_RNA|ADAMTS16_ENST00000511368.1_Missense_Mutation_p.M110V		NM_139056.2	349,953,688	NM_139056	0.637			A	9.286	+	Missense_Mutation	1		80.0	Q8TE57;Q8TE57-2;Q2XQZ0	0.414824		11867212			0.004;0.001;0.001	ADAMTS16-001	2005-08-19		0.09377		5	+	0.3525		0.02	0.205000	missense	17108	165	110/1225		A	SO:0001583	607510	benign	0.4558011049723757	protein_coding		1990	P		0.006000	38.2424,41.4824,44.804	B;B;B	"""ADAM metallopeptidases with thrombospondin type 1 motif"""	6149		0.1265:0.6005:0.1182:0.1548						KNOWN	ENST00000274181;ENST00000511368;ENST00000536857		CGACTTCCACATGGATCTGAG	T;T					ENST00000274181.7:c.328A>G	5		ENSG00000145536	0.06385	ADAMTS16	breast(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(12)|lung(72)|ovary(4)|pancreas(1)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	ENSP00000274181:p.Met110Val	+	0.16342	,	ATG	5p15	C6G490|Q8IVE2		g.chr5:5146395A>G	M -> V (in dbSNP:rs1863968).			168	yes		6788,5510	0.27799	0.19827	5.74	0.00012	ENSP00000274181:M110V			0.26955		.		-11.5	0.00074	226	0.66056	0.3951048951048951	0.5	metalloendopeptidase activity (GO:0004222)|zinc ion binding (GO:0008270)	1.4			hg19	Standard	0.6133	0.34146341463414637	8.248	5137,3181		branching involved in ureteric bud morphogenesis (GO:0001658)	1946,2896,1307	1.049358				CCDS43299.1	A	0.12013	GG,GA,AA	AJ315734	proteinaceous extracellular matrix (GO:0005578)	79	0.45137	2504	-11.5	rs1863968		466	110;110;110	453		"""a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 16"""	0.31700	5199395	+	VAL/MET	110	ADAMTS16s	1012	107	NM_139056	0.005;0.0;0.0	3	0.5976253298153035	-0.400000	ENST00000274181.7		17901		uc003jdl.3			170690	dbSNP_92	328	0.0000		p.M110V	Peptidase M12B, propeptide (1);	0		T		78.0	rs1863968;rs16874855;rs52809911;rs59226841;rs1863968	0.552	5:g.5146395A>G	ENSP00000274181:M110V;ENSP00000421631:M110V	protein_coding	0.021648		basic|appris_principal|CCDS		1597,1943,619		110	1651,2329	0.4633699633699634	V	A|||		0.379381	5008		ATS16_HUMAN	2418	ADAM metallopeptidase with thrombospondin type 1 motif, 16		ATS16_HUMAN;.;.	0.482827	0.03219	5146395		-1.137000	0.4286	SNP		CCDS43299.1		N	,,,	False	5146395	-0.9025		9	missense	T	Approved	0.617576	79.0		c.328A>G	2008-07-18	OTTHUMT00000365657.1	Q8TE57	0.4035	3.48;3.48	ADAMTS16	5146395	0.24178		0.48559	21	ADAMTS16	NM_139056.2	protein-coding gene	NP_620687.2	M	
		C	ENSG00000133398	ENST00000255764.3		84246		ENSG00000133398		4300					,					OTTHUMG00000161682		byFrequency	Q9BTT4	gene with protein product				NM_032286.2	2174,27,2	NM_032286	1.0					+	5'UTR			53.0				15657623, 15175163				MED10-001	2007-07-30				5	-	0.9955				utr-5	28760				A	SO:0001623	612382			protein_coding		2203				0.0,0.7036,0.2384			6503								KNOWN			GCCCGTCCCCGACCCACACAG						ENST00000255764.3:c.-18C>G	5					kidney(1)|large_intestine(1)|ovary(1)|prostate(1)|urinary_tract(1)		-		,		5p15.31	C6G491	"""NUT2 homolog (S. cerevisiae)"""	g.chr5:6378614G>C					no		12975,31												-4.2					0.0	RNA polymerase II transcription cofactor activity (GO:0001104)				hg19	Standard	1.0			8600,0		gene expression (GO:0010467)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|stem cell maintenance (GO:0019827)|transcription initiation from RNA polymerase II promoter (GO:0006367)	6474,27,2					CCDS34134.1	G		CC,CG,GG		mediator complex (GO:0016592)|nucleoplasm (GO:0005654)	55		2504		rs7723985		93				"""mediator of RNA polymerase II transcription, subunit 10 homolog (NUT2, S. cerevisiae)"""						TRG20, L6, MGC5309, NUT2		5	NM_032286		0			ENST00000255764.3		13701		uc003jdo.3			84246	dbSNP_116						0				58.0		0.632	5:g.6378614G>C		protein_coding			basic|appris_principal|CCDS		4300,0,0			4375,31			a|||			5008		MED10_HUMAN	5002	mediator complex subunit 10			0.998802		6378614			1.0	SNP		CCDS34134.1			,,,	False	6378614				5_prime_UTR_variant		Approved		55.0			2008-02-05	OTTHUMT00000365714.1	Q9BTT4	1.0		MED10	6378614					MED10	NM_032286.2	protein-coding gene	NP_115662.2		
		C	ENSG00000037474	ENST00000264670.6		54888		ENSG00000037474		4300					,					OTTHUMG00000090455		byFrequency	Q08J23	gene with protein product		NSUN2_ENST00000506139.1_Intron|NSUN2_ENST00000539938.1_Intron		NM_017755.5	1202,850,151	NM_017755	0.635					+	Intron		434.3+/-357.7	316.0				17071714, 22541559				NSUN2-001	2012-06-12				5	-	0.7398				intron,intron	25994		,		C	SO:0001627	610916	,		protein_coding		2203				31.5233,26.1462,29.7017		"""NOP2/Sun domain containing"""	6503								KNOWN			AAGGCGTGTGTGTCTAAGGGC		MRT5				ENST00000264670.6:c.1997+29A>G	5					breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(23)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)		-		,		5p15.32	A8K529|B2RNR4|B3KP09|B4DQW2|G3V1R4|Q9BVN4|Q9H858|Q9NXD9	"""tRNA methyltransferase 4 homolog (S. cerevisiae)"", ""Myc-induced SUN-domain-containing protein"""	g.chr5:6602544T>C		410.4+/-335.4			no		9143,3863												-2.2					0.0	poly(A) RNA binding (GO:0044822)|tRNA (cytosine-5-)-methyltransferase activity (GO:0016428)|tRNA binding (GO:0000049)				hg19	Standard	0.6759			5889,2711		mitotic nuclear division (GO:0007067)|tRNA methylation (GO:0030488)	3223,2697,583					CCDS3869.1, CCDS54832.1	T		CC,CT,TT	AK000310	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|nucleolus (GO:0005730)|nucleus (GO:0005634)	335		2504		rs2303711		2309				"""NOL1/NOP2/Sun domain family, member 2"", ""NOP2/Sun domain family, member 2"", ""mental retardation, non-syndromic, autosomal recessive, 5"""				,		FLJ20303, TRM4, Misu		41	NM_017755		18			ENST00000264670.6		21543		uc003jdu.3			54888	dbSNP_100	,					0				371.0		0.483	5:g.6602544T>C		protein_coding			basic|appris_candidate_longest|CCDS		2021,1847,432			3254,1152			C|||			5008		NSUN2_HUMAN	3390	NOP2/Sun RNA methyltransferase family, member 2			0.676917		6602544			0.6746	SNP		CCDS3869.1			,,,	False	6602544				intron_variant		Approved		335.0			2014-01-31	OTTHUMT00000206902.1	Q08J23	0.621		NSUN2	6602544				,	NSUN2	NM_001193455.1,NM_017755.5	protein-coding gene	NP_060225.4		
		G	ENSG00000037474	ENST00000264670.6		54888		ENSG00000037474		4300					,					OTTHUMG00000090455		byFrequency	Q08J23	gene with protein product		NSUN2_ENST00000506139.1_Intron|NSUN2_ENST00000539938.1_Intron		NM_017755.5	48,519,1635	NM_017755	0.3497					+	Intron		689.1+/-404.3	82.0				17071714, 22541559				NSUN2-001	2012-06-12				5	-	0.1399				intron,intron	25994		,		G	SO:0001627	610916	,		protein_coding		2202				28.8837,13.9646,23.8311		"""NOP2/Sun domain containing"""	6502								KNOWN			TGCTGGCCTTATAAAGGGAAT		MRT5				ENST00000264670.6:c.1957+45T>C	5					breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(23)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)		-		,		5p15.32	A8K529|B2RNR4|B3KP09|B4DQW2|G3V1R4|Q9BVN4|Q9H858|Q9NXD9	"""tRNA methyltransferase 4 homolog (S. cerevisiae)"", ""Myc-induced SUN-domain-containing protein"""	g.chr5:6604205A>G		721.9+/-409.2			no		3099,9905												-5.2					0.0	poly(A) RNA binding (GO:0044822)|tRNA (cytosine-5-)-methyltransferase activity (GO:0016428)|tRNA binding (GO:0000049)				hg19	Standard	0.2535			2484,6116		mitotic nuclear division (GO:0007067)|tRNA methylation (GO:0030488)	400,2299,3803					CCDS3869.1, CCDS54832.1	A		GG,GA,AA	AK000310	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|nucleolus (GO:0005730)|nucleus (GO:0005634)	82		2504		rs2303709		2269				"""NOL1/NOP2/Sun domain family, member 2"", ""NOP2/Sun domain family, member 2"", ""mental retardation, non-syndromic, autosomal recessive, 5"""				,		FLJ20303, TRM4, Misu		41	NM_017755		17			ENST00000264670.6		20532		uc003jdu.3			54888	dbSNP_100	,					0				81.0		0.398	5:g.6604205A>G		protein_coding			basic|appris_candidate_longest|CCDS		352,1780,2168			615,3789			G|||			5008		NSUN2_HUMAN	1387	NOP2/Sun RNA methyltransferase family, member 2			0.276957		6604205			0.4633	SNP		CCDS3869.1			,,,	False	6604205				intron_variant		Approved		82.0			2014-01-31	OTTHUMT00000206902.1	Q08J23	0.1988		NSUN2	6604205				,	NSUN2	NM_001193455.1,NM_017755.5	protein-coding gene	NP_060225.4		
		T	ENSG00000037474	ENST00000264670.6		54888		ENSG00000037474		4300					,				c.(1747-1749)acG>acA	OTTHUMG00000090455		byFrequency	Q08J23	gene with protein product		NSUN2_ENST00000506139.1_Silent_p.T548T|NSUN2_ENST00000539938.1_Silent_p.T347T		NM_017755.5	8,239,1956	NM_017755	0.3139					+	Silent		316.6+/-312.8	83.0				17071714, 22541559				NSUN2-001	2012-06-12				5	-	0.0371				coding-synonymous,coding-synonymous	25994		548/733,583/768		C	SO:0001819	610916	,		protein_coding		2203				20.3837,5.7876,15.439		"""NOP2/Sun domain containing"""	6503								KNOWN			CTTTGATCCCCGTGTTAATAA		MRT5				ENST00000264670.6:c.1749G>A	5					breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(23)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)		-		,		5p15.32	A8K529|B2RNR4|B3KP09|B4DQW2|G3V1R4|Q9BVN4|Q9H858|Q9NXD9	"""tRNA methyltransferase 4 homolog (S. cerevisiae)"", ""Myc-induced SUN-domain-containing protein"""	g.chr5:6604787C>T		145.0+/-179.8			yes		2008,10998												-10.7					0.0	poly(A) RNA binding (GO:0044822)|tRNA (cytosine-5-)-methyltransferase activity (GO:0016428)|tRNA binding (GO:0000049)				hg19	Standard	0.1899			1753,6847		mitotic nuclear division (GO:0007067)|tRNA methylation (GO:0030488)	194,1620,4689					CCDS3869.1, CCDS54832.1	C		TT,TC,CC	AK000310	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|nucleolus (GO:0005730)|nucleus (GO:0005634)	83		2504		rs13181449		2060				"""NOL1/NOP2/Sun domain family, member 2"", ""NOP2/Sun domain family, member 2"", ""mental retardation, non-syndromic, autosomal recessive, 5"""				,	583	FLJ20303, TRM4, Misu		41	NM_017755		16			ENST00000264670.6		19971		uc003jdu.3			54888	dbSNP_121	1644,1749			p.T583T		0				81.0		0.453	5:g.6604787C>T		protein_coding			basic|appris_candidate_longest|CCDS		186,1381,2733			255,4151			C|||			5008		NSUN2_HUMAN	1112	NOP2/Sun RNA methyltransferase family, member 2			0.222045		6604787			0.4623	SNP		CCDS3869.1			,,,	False	6604787				synonymous_variant		Approved		83.0		c.1749G>A	2014-01-31	OTTHUMT00000206902.1	Q08J23	0.1427		NSUN2	6604787				,	NSUN2	NM_001193455.1,NM_017755.5	protein-coding gene	NP_060225.4		
		A	ENSG00000037474	ENST00000264670.6		54888		ENSG00000037474		4300					,					OTTHUMG00000090455		byFrequency	Q08J23	gene with protein product		NSUN2_ENST00000506139.1_Intron|NSUN2_ENST00000539938.1_Intron		NM_017755.5		NM_017755	0.635					+	Intron			90.0				17071714, 22541559				NSUN2-001	2012-06-12				5	-	0.739					25994					SO:0001627	610916			protein_coding		2203						"""NOP2/Sun domain containing"""	6503								KNOWN			CTGTACATAACAACATTGTTG		MRT5				ENST00000264670.6:c.1602-11G>T	5					breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(23)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)		-		,		5p15.32	A8K529|B2RNR4|B3KP09|B4DQW2|G3V1R4|Q9BVN4|Q9H858|Q9NXD9	"""tRNA methyltransferase 4 homolog (S. cerevisiae)"", ""Myc-induced SUN-domain-containing protein"""	g.chr5:6605532C>A																									poly(A) RNA binding (GO:0044822)|tRNA (cytosine-5-)-methyltransferase activity (GO:0016428)|tRNA binding (GO:0000049)				hg19	Standard	0.673					mitotic nuclear division (GO:0007067)|tRNA methylation (GO:0030488)						CCDS3869.1, CCDS54832.1	C			AK000310	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|nucleolus (GO:0005730)|nucleus (GO:0005634)			2504		rs2303707		1913				"""NOL1/NOP2/Sun domain family, member 2"", ""NOP2/Sun domain family, member 2"", ""mental retardation, non-syndromic, autosomal recessive, 5"""						FLJ20303, TRM4, Misu		41	NM_017755		15			ENST00000264670.6		19773		uc003jdu.3			54888							0				84.0		0.388	5:g.6605532C>A		protein_coding			basic|appris_candidate_longest|CCDS								A|||			5008		NSUN2_HUMAN	3382	NOP2/Sun RNA methyltransferase family, member 2			0.675319		6605532			0.6726	SNP		CCDS3869.1			,,,	False	6605532				intron_variant		Approved		88.0			2014-01-31	OTTHUMT00000206902.1	Q08J23	0.6182		NSUN2	6605532							protein-coding gene	NP_060225.4		
		A	ENSG00000037474	ENST00000264670.6		54888		ENSG00000037474		4300					,					OTTHUMG00000090455		byFrequency	Q08J23	gene with protein product		NSUN2_ENST00000506139.1_Intron|NSUN2_ENST00000539938.1_Intron		NM_017755.5		NM_017755	0.636					+	Intron			63.0				17071714, 22541559				NSUN2-001	2012-06-12				5	-	0.7095					25994					SO:0001627	610916			protein_coding		2203						"""NOP2/Sun domain containing"""	6503								KNOWN			CAAATGTATCCATGAAGTGCA		MRT5				ENST00000264670.6:c.891-41G>T	5					breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(23)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)		-		,		5p15.32	A8K529|B2RNR4|B3KP09|B4DQW2|G3V1R4|Q9BVN4|Q9H858|Q9NXD9	"""tRNA methyltransferase 4 homolog (S. cerevisiae)"", ""Myc-induced SUN-domain-containing protein"""	g.chr5:6617011C>A																									poly(A) RNA binding (GO:0044822)|tRNA (cytosine-5-)-methyltransferase activity (GO:0016428)|tRNA binding (GO:0000049)				hg19	Standard	0.67					mitotic nuclear division (GO:0007067)|tRNA methylation (GO:0030488)						CCDS3869.1, CCDS54832.1	C			AK000310	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|nucleolus (GO:0005730)|nucleus (GO:0005634)			2504		rs6887702		1202				"""NOL1/NOP2/Sun domain family, member 2"", ""NOP2/Sun domain family, member 2"", ""mental retardation, non-syndromic, autosomal recessive, 5"""						FLJ20303, TRM4, Misu		41	NM_017755		9			ENST00000264670.6		17537		uc003jdu.3			54888							0				67.0		0.423	5:g.6617011C>A		protein_coding			basic|appris_candidate_longest|CCDS								C|||			5008		NSUN2_HUMAN	3338	NOP2/Sun RNA methyltransferase family, member 2			0.666534		6617011			0.6736	SNP		CCDS3869.1			,,,	False	6617011				intron_variant		Approved		65.0			2014-01-31	OTTHUMT00000206902.1	Q08J23	0.6124		NSUN2	6617011							protein-coding gene	NP_060225.4		
		A	ENSG00000112941	ENST00000230859.6		11044		ENSG00000112941							,					OTTHUMG00000090457		byFrequency	Q5XG87	gene with protein product				NM_001171805.1|NM_001171806.1|NM_006999.4		NM_006999	0.3558					+	Intron							10066793, 10926539				PAPD7-001	2010-01-19					+	0.1422					16705					SO:0001627	605198			protein_coding																NSCLC(7;212 333 5667 23379 46547)	KNOWN			CCCCACACGAGTGTGTAGGCT		POLS				ENST00000230859.6:c.138-54G>A	5					cervix(1)|endometrium(2)|large_intestine(8)|lung(10)|ovary(2)|pancreas(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)		+		,		5p15	A8K1E2|M1JCE6|O43289|Q17RZ1|Q9Y6C1	"""topoisomerase-related function protein 4-1"", ""polymerase (DNA-directed) sigma"", ""DNA polymerase kappa"", ""TUTase5"""	g.chr5:6739791G>A																									DNA binding (GO:0003677)|DNA-directed DNA polymerase activity (GO:0003887)|metal ion binding (GO:0046872)|polynucleotide adenylyltransferase activity (GO:0004652)|SMC family protein binding (GO:0043221)		2010-01-19		hg19	Standard	0.3012					double-strand break repair (GO:0006302)|mitotic chromosome condensation (GO:0007076)|response to drug (GO:0042493)|sister chromatid cohesion (GO:0007062)						CCDS3871.1	G			AF089896	cytoplasm (GO:0005737)|nucleus (GO:0005634)			2504		rs419128		266				"""polymerase (DNA directed) sigma"""						POLK, TRF4, LAK-1, TRF4-1		27	NM_006999		4			ENST00000230859.6		21107		uc003jdx.1			11044							0						0.567	5:g.6739791G>A		protein_coding			basic|appris_principal|CCDS								G|||			5008		PAPD7_HUMAN	1437	PAP associated domain containing 7			0.286941		6739791			0.3909	SNP		CCDS3871.1			,,,	False	6739791				intron_variant		Approved					2010-11-18	OTTHUMT00000206904.1	Q5XG87	0.2939		PAPD7								protein-coding gene	NP_001165276.1|NP_001165277.1|NP_008930.1		
		C	ENSG00000112941	ENST00000230859.6		11044		ENSG00000112941		4300					,				c.(790-792)gcT>gcC	OTTHUMG00000090457		byFrequency	Q5XG87	gene with protein product				NM_001171805.1|NM_001171806.1|NM_006999.4	429,1092,682	NM_006999	0.6421	Substitution - coding silent(1)				+	Silent		414.3+/-351.4	263.0				10066793, 10926539				PAPD7-001	2010-01-19				5	+	0.4047				coding-synonymous,coding-synonymous,coding-synonymous	16705		264/542,84/363,264/543		C	SO:0001819	605198	,,		protein_coding	stomach(1)	2203				29.5814,44.2578,38.4438			6503							NSCLC(7;212 333 5667 23379 46547)	KNOWN			TCAGCCATGCTGTGTCACCGC		POLS				ENST00000230859.6:c.792T>C	5					cervix(1)|endometrium(2)|large_intestine(8)|lung(10)|ovary(2)|pancreas(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)		+		,		5p15	A8K1E2|M1JCE6|O43289|Q17RZ1|Q9Y6C1	"""topoisomerase-related function protein 4-1"", ""polymerase (DNA-directed) sigma"", ""DNA polymerase kappa"", ""TUTase5"""	g.chr5:6748659T>C		622.9+/-394.0			no		8006,5000												-4.9					0.6	DNA binding (GO:0003677)|DNA-directed DNA polymerase activity (GO:0003887)|metal ion binding (GO:0046872)|polynucleotide adenylyltransferase activity (GO:0004652)|SMC family protein binding (GO:0043221)		2010-01-19		hg19	Standard	0.6759			6056,2544		double-strand break repair (GO:0006302)|mitotic chromosome condensation (GO:0007076)|response to drug (GO:0042493)|sister chromatid cohesion (GO:0007062)	2573,2860,1070			p.A264A(1)		CCDS3871.1	T		CC,CT,TT	AF089896	cytoplasm (GO:0005737)|nucleus (GO:0005634)	276		2504		rs274681		921				"""polymerase (DNA directed) sigma"""				,,	494	POLK, TRF4, LAK-1, TRF4-1		27	NM_006999		8			ENST00000230859.6		20718		uc003jdx.1			11044	dbSNP_79	792,252,792			p.A264A		1				302.0		0.552	5:g.6748659T>C		protein_coding			basic|appris_principal|CCDS		2144,1768,388			1950,2456			C|||			5008		PAPD7_HUMAN	2828	PAP associated domain containing 7			0.564696		6748659			0.5754	SNP		CCDS3871.1			,,,	False	6748659				synonymous_variant		Approved		276.0		c.792T>C	2010-11-18	OTTHUMT00000206904.1	Q5XG87	0.5836		PAPD7	6748659				,,	PAPD7	NM_001171805.1,NM_001171806.1,NM_006999.4	protein-coding gene	NP_001165276.1|NP_001165277.1|NP_008930.1		
		T	ENSG00000078295	ENST00000338316.4	0.09310	108	M	ENSG00000078295	0.85829	4300	1.000000	0.76186	P		,	T	1.0	0	c.(439-441)Gtg>Ttg	OTTHUMG00000090476	2.545000	byFrequency	Q08462	gene with protein product				NM_020546.2	22,346,1835	NM_020546	0.1074			G	20.9	+	Missense_Mutation	1	367.0+/-334.5	124.0	Q08462	0.088516		1427768			0.26	ADCY2-001			0.37888		5	+	0.0545		0.06	0.998000	missense	233	41	147/1092		G	SO:0001583	103071	possibly-damaging	0.1132596685082873	protein_coding		2203	P		1.000000	24.8721,8.8516,19.4449	B	"""Adenylate cyclases"""	6503		0.0:0.0:1.0:0.0						KNOWN	ENST00000338316		CATCTTCGTGGTGTACACCAT	T					ENST00000338316.4:c.439G>T	5		ENSG00000078295	0.86243	ADCY2	NS(3)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(22)|lung(56)|ovary(8)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(7)	ENSP00000342952:p.Val147Leu	+	0.71417	,	GTG	5p15.3	B7Z2C1|Q2NKL8|Q9UDB2|Q9UPU2		g.chr5:7520881G>T	V -> L (in dbSNP:rs13166360). {ECO:0000269|PubMed:15489334}.	194.7+/-219.5		30	yes		2529,10477	0.80357	0.76415	5.45	0.00039	ENSP00000342952:V147L			0.85682		.		5.4	0.79879	0	0.54805	0.0	1.0	adenylate cyclase activity (GO:0004016)|adenylate cyclase binding (GO:0008179)|ATP binding (GO:0005524)|calcium- and calmodulin-responsive adenylate cyclase activity (GO:0008294)|metal ion binding (GO:0046872)|protein heterodimerization activity (GO:0046982)	1.995			hg19	Standard	0.2117	0.06097560975609756	16.4516	2139,6461		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|cAMP biosynthetic process (GO:0006171)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	291,1947,4265	4.072518				CCDS3872.2	G	0.37525	TT,TG,GG	AB028983	cytoplasm (GO:0005737)|dendrite (GO:0030425)|integral component of membrane (GO:0016021)|intracellular (GO:0005622)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)|protein complex (GO:0043234)	143	0.64997	2504	5.45	rs13166360		528	147	165			0.83993	7573881	+	LEU/VAL	147	HBAC2, KIAA1060, AC2	236	119	NM_020546	0.598	3	0.21767810026385223	0.650000	ENST00000338316.4		21118		uc003jdz.1			108	dbSNP_121	439	0.0001		p.V147L	.	0		T		179.0	rs13166360;rs17826984;rs60134556;rs13166360	0.507	5:g.7520881G>T	ENSP00000342952:V147L	protein_coding	0.000000		basic|appris_principal|CCDS		269,1601,2430		147	390,4016	0.10805860805860806	L	G|||		0.000000	5008		ADCY2_HUMAN	459	adenylate cyclase 2 (brain)		ADCY2_HUMAN	0.0916534	0.70639	7520881		5.996000	0.0	SNP		CCDS3872.2		D	,,,	False	7520881	-1.1303	4.6.1.1	9	missense	T	Approved	0.248721	143.0		c.439G>T	2013-02-04	OTTHUMT00000206930.2	Q08462	0.0994	-1.0	ADCY2	7520881	0.95712		0.01652	32	ADCY2	NM_020546.2	protein-coding gene	NP_065433.2	V	
		C	ENSG00000078295	ENST00000338316.4		108		ENSG00000078295		4300					,					OTTHUMG00000090476		byFrequency	Q08462	gene with protein product		ADCY2_ENST00000537121.1_Intron		NM_020546.2	1016,959,228	NM_020546	0.3333	Unknown(1)				+	Intron		613.5+/-396.1	70.0				1427768				ADCY2-001					5	+	0.7012				intron	233				-	SO:0001627	103071			protein_coding	haematopoietic_and_lymphoid_tissue(1)	2203				42.8605,32.1153,48.6622		"""Adenylate cyclases"""	6503								KNOWN			ACATGGTAAGTCCCAGAGCAC						ENST00000338316.4:c.2094+6T>C	5					NS(3)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(22)|lung(56)|ovary(8)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(7)		+		,		5p15.3	B7Z2C1|Q2NKL8|Q9UDB2|Q9UPU2		g.chr5:7757705T>C		454.4+/-350.6			no		6677,6329												-3.5					0.0	adenylate cyclase activity (GO:0004016)|adenylate cyclase binding (GO:0008179)|ATP binding (GO:0005524)|calcium- and calmodulin-responsive adenylate cyclase activity (GO:0008294)|metal ion binding (GO:0046872)|protein heterodimerization activity (GO:0046982)				hg19	Standard	0.4324			3686,4914		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|cAMP biosynthetic process (GO:0006171)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	1814,3049,1640			p.?(1)		CCDS3872.2	T		CC,CT,TT	AB028983	cytoplasm (GO:0005737)|dendrite (GO:0030425)|integral component of membrane (GO:0016021)|intracellular (GO:0005622)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)|protein complex (GO:0043234)	70		2504		rs4072341		2183										HBAC2, KIAA1060, AC2		119	NM_020546		16			ENST00000338316.4		20454		uc003jdz.1			108	dbSNP_108						1				72.0		0.552	5:g.7757705T>C		protein_coding			basic|appris_principal|CCDS		798,2090,1412			2991,1415			C|||			5008		ADCY2_HUMAN	2444	adenylate cyclase 2 (brain)			0.488019		7757705			0.3423	SNP		CCDS3872.2			,,,	False	7757705		4.6.1.1		intron_variant		Approved		70.0			2013-02-04	OTTHUMT00000206930.2	Q08462	0.5922		ADCY2	7757705					ADCY2	NM_020546.2	protein-coding gene	NP_065433.2		
		T	ENSG00000078295	ENST00000338316.4		108		ENSG00000078295		4300					,					OTTHUMG00000090476		byFrequency	Q08462	gene with protein product		ADCY2_ENST00000537121.1_Intron		NM_020546.2	1016,962,225	NM_020546	0.3323	Unknown(1)				+	Intron		528.0+/-381.3	66.0				1427768				ADCY2-001					5	+	0.7012				intron	233				-	SO:0001627	103071			protein_coding	haematopoietic_and_lymphoid_tissue(1)	2203				42.9651,32.0472,48.5699		"""Adenylate cyclases"""	6503								KNOWN			TCCCAGAGCACGGCCGTGTTC						ENST00000338316.4:c.2094+16C>T	5					NS(3)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(22)|lung(56)|ovary(8)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(7)		+		,		5p15.3	B7Z2C1|Q2NKL8|Q9UDB2|Q9UPU2		g.chr5:7757715C>T		683.5+/-404.3			no		6689,6317												-1.2					0.0	adenylate cyclase activity (GO:0004016)|adenylate cyclase binding (GO:0008179)|ATP binding (GO:0005524)|calcium- and calmodulin-responsive adenylate cyclase activity (GO:0008294)|metal ion binding (GO:0046872)|protein heterodimerization activity (GO:0046982)				hg19	Standard	0.4324			3695,4905		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|cAMP biosynthetic process (GO:0006171)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	1814,3061,1628			p.?(1)		CCDS3872.2	C		TT,TC,CC	AB028983	cytoplasm (GO:0005737)|dendrite (GO:0030425)|integral component of membrane (GO:0016021)|intracellular (GO:0005622)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)|protein complex (GO:0043234)	68		2504		rs376428226|rs4479814		2183										HBAC2, KIAA1060, AC2		119	NM_020546		16			ENST00000338316.4		20867		uc003jdz.1			108	dbSNP_111						1				70.0		0.542	5:g.7757715C>T		protein_coding			basic|appris_principal|CCDS		798,2099,1403			2994,1412			c|||			5008		ADCY2_HUMAN	2437	adenylate cyclase 2 (brain)			0.486621		7757715			0.3363	SNP		CCDS3872.2			,,,	False	7757715		4.6.1.1		intron_variant		Approved		68.0			2013-02-04	OTTHUMT00000206930.2	Q08462	0.5922		ADCY2	7757715					ADCY2	NM_020546.2	protein-coding gene	NP_065433.2		
		T	ENSG00000078295	ENST00000338316.4		108		ENSG00000078295		4300					,				c.(2659-2661)tgC>tgT	OTTHUMG00000090476		byFrequency	Q08462	gene with protein product		ADCY2_ENST00000537121.1_Silent_p.C707C		NM_020546.2	53,578,1572	NM_020546	0.18					+	Silent		385.4+/-341.5	77.0				1427768				ADCY2-001					5	+	0.1203				coding-synonymous	233		887/1092		C	SO:0001819	103071			protein_coding		2203				26.5698,15.5243,22.8279		"""Adenylate cyclases"""	6503								KNOWN			ACTGCGTCTGCGTCATGTTTG						ENST00000338316.4:c.2661C>T	5					NS(3)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(22)|lung(56)|ovary(8)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(7)		+		,		5p15.3	B7Z2C1|Q2NKL8|Q9UDB2|Q9UPU2		g.chr5:7802363C>T		288.4+/-279.8			no		2969,10037												-2.6					1.0	adenylate cyclase activity (GO:0004016)|adenylate cyclase binding (GO:0008179)|ATP binding (GO:0005524)|calcium- and calmodulin-responsive adenylate cyclase activity (GO:0008294)|metal ion binding (GO:0046872)|protein heterodimerization activity (GO:0046982)				hg19	Standard	0.2644			2285,6315		activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|cAMP biosynthetic process (GO:0006171)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|neurotrophin TRK receptor signaling pathway (GO:0048011)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|synaptic transmission (GO:0007268)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	342,2285,3876					CCDS3872.2	C		TT,TC,CC	AB028983	cytoplasm (GO:0005737)|dendrite (GO:0030425)|integral component of membrane (GO:0016021)|intracellular (GO:0005622)|membrane (GO:0016020)|membrane raft (GO:0045121)|plasma membrane (GO:0005886)|protein complex (GO:0043234)	79		2504		rs2290910		2750									887	HBAC2, KIAA1060, AC2		119	NM_020546		21			ENST00000338316.4		20942		uc003jdz.1			108	dbSNP_100	2661			p.C887C		0				82.0		0.483	5:g.7802363C>T		protein_coding			basic|appris_principal|CCDS		289,1707,2304			684,3722			C|||			5008		ADCY2_HUMAN	1169	adenylate cyclase 2 (brain)			0.233427		7802363			0.2768	SNP		CCDS3872.2			,,,	False	7802363		4.6.1.1		synonymous_variant		Approved		79.0		c.2661C>T	2013-02-04	OTTHUMT00000206930.2	Q08462	0.4164		ADCY2	7802363					ADCY2	NM_020546.2	protein-coding gene	NP_065433.2		
		TAT	ENSG00000124279	ENST00000264669.5		79072		ENSG00000124279		4300									c.(718-720)atafs	OTTHUMG00000131029		byFrequency	Q14CZ7	gene with protein product		FASTKD3_ENST00000513658.1_Intron|MTRR_ENST00000502509.1_Intron		NM_024091.3		NM_024091						+	Frame_Shift_Del			88.0				12477932				FASTKD3-001					5	-						28758					SO:0001589				protein_coding		2203							6503								KNOWN			GAAGTTGATTTATAATGAGTT						ENST00000264669.5:c.720delATTATA	5					breast(4)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(8)|liver(2)|lung(11)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	ENSP00000264669:p.Ile240fs	-				5p15.31	Q9BVD3		g.chr5:7867477delTATAAT																									poly(A) RNA binding (GO:0044822)|protein kinase activity (GO:0004672)				hg19	Standard						cellular respiration (GO:0045333)						CCDS3873.1	TATAAT			AK026927	mitochondrion (GO:0005739)					rs559182247		856									240	MGC5297, FLJ23274		39	NM_024091		2			ENST00000264669.5				uc003jeb.3			79072					p.I240fs		0				84.0		0.408	5:g.7867477delTATAAT		protein_coding			basic|appris_principal|CCDS													FAKD3_HUMAN		FAST kinase domains 3					7867477				DEL		CCDS3873.1					7867477				frameshift_variant		Approved		87.0		c.720delATTATA	2008-02-05	OTTHUMT00000253673.1	Q14CZ7			FASTKD3	7867477							protein-coding gene	NP_076996.2		
		A	ENSG00000112902	ENST00000382496.5		9037		ENSG00000112902		4300					,				c.(1657-1659)acG>acT	OTTHUMG00000090501		byFrequency	Q13591	gene with protein product				NM_003966.2	6,197,2000		0.182					+	Silent		174.6+/-224.8	65.0				8817451, 9464278				SEMA5A-001					5	-	0.0499				coding-synonymous	10736		553/1075		C	SO:0001819	609297			protein_coding		2203				8.6047,4.7435,7.2966		"""Semaphorins"""	6503								KNOWN			CATCTGTGTGCGTGCAAGGCG		SEMAF				ENST00000382496.5:c.1659G>T	5	TSP type-1 1. {ECO:0000255|PROSITE- ProRule:PRU00210}.				biliary_tract(1)|breast(4)|central_nervous_system(2)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(13)|lung(40)|ovary(2)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(1)		-		,		5p15.2	D3DTC6|O60408|Q1RLL9		g.chr5:9122890C>A		122.5+/-159.9			no		949,12057												-9.9					0.1	axon guidance receptor activity (GO:0008046)|chondroitin sulfate proteoglycan binding (GO:0035373)|heparan sulfate proteoglycan binding (GO:0043395)|semaphorin receptor binding (GO:0030215)|syndecan binding (GO:0045545)				hg19	Standard	0.0885			740,7860		axon guidance (GO:0007411)|axonal fasciculation (GO:0007413)|blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)|cell adhesion (GO:0007155)|cell chemotaxis (GO:0060326)|cell-cell signaling (GO:0007267)|diencephalon development (GO:0021536)|negative regulation of axon extension involved in axon guidance (GO:0048843)|negative regulation of cell adhesion (GO:0007162)|negative regulation of endothelial cell apoptotic process (GO:2000352)|nervous system development (GO:0007399)|patterning of blood vessels (GO:0001569)|positive chemotaxis (GO:0050918)|positive regulation of actin filament depolymerization (GO:0030836)|positive regulation of angiogenesis (GO:0045766)|positive regulation of axon extension involved in axon guidance (GO:0048842)|positive regulation of catenin import into nucleus (GO:0035413)|positive regulation of endothelial cell chemotaxis (GO:2001028)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of protein kinase B signaling (GO:0051897)|signal clustering (GO:1990256)	32,885,5586					CCDS3875.1	C		AA,AC,CC	U52840	extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	65		2504		rs17238053		2324									553	semF		81	NM_003966		14			ENST00000382496.5		13068		uc003jek.2			9037	dbSNP_123	1659			p.T553T		0				64.0		0.617	5:g.9122890C>A		protein_coding			basic|appris_principal|CCDS		26,688,3586			209,4197			C|||			5008		SEM5A_HUMAN	380	sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A			0.0758786		9122890			0.0129	SNP		CCDS3875.1			,,,	False	9122890				synonymous_variant		Approved		65.0		c.1659G>T	2008-05-15	OTTHUMT00000206989.2	Q13591	0.049		SEMA5A	9122890					SEMA5A	NM_003966.2	protein-coding gene	NP_003957.2		
		G	ENSG00000112902	ENST00000382496.5		9037		ENSG00000112902		4300					,				c.(1567-1569)acG>acC	OTTHUMG00000090501		byFrequency	Q13591	gene with protein product				NM_003966.2	6,198,1999		0.18					+	Silent		179.6+/-228.7	92.0				8817451, 9464278				SEMA5A-001					5	-	0.0492				coding-synonymous	10736		523/1075		C	SO:0001819	609297			protein_coding		2203				8.6395,4.7662,7.3274		"""Semaphorins"""	6503								KNOWN			GTTCCCACTGCGTCATGCTCA		SEMAF				ENST00000382496.5:c.1569G>C	5					biliary_tract(1)|breast(4)|central_nervous_system(2)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|large_intestine(13)|lung(40)|ovary(2)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(1)		-		,		5p15.2	D3DTC6|O60408|Q1RLL9		g.chr5:9136646C>G		128.2+/-165.1			no		953,12053												-8.2					0.7	axon guidance receptor activity (GO:0008046)|chondroitin sulfate proteoglycan binding (GO:0035373)|heparan sulfate proteoglycan binding (GO:0043395)|semaphorin receptor binding (GO:0030215)|syndecan binding (GO:0045545)				hg19	Standard	0.0905			743,7857		axon guidance (GO:0007411)|axonal fasciculation (GO:0007413)|blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)|cell adhesion (GO:0007155)|cell chemotaxis (GO:0060326)|cell-cell signaling (GO:0007267)|diencephalon development (GO:0021536)|negative regulation of axon extension involved in axon guidance (GO:0048843)|negative regulation of cell adhesion (GO:0007162)|negative regulation of endothelial cell apoptotic process (GO:2000352)|nervous system development (GO:0007399)|patterning of blood vessels (GO:0001569)|positive chemotaxis (GO:0050918)|positive regulation of actin filament depolymerization (GO:0030836)|positive regulation of angiogenesis (GO:0045766)|positive regulation of axon extension involved in axon guidance (GO:0048842)|positive regulation of catenin import into nucleus (GO:0035413)|positive regulation of endothelial cell chemotaxis (GO:2001028)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of protein kinase B signaling (GO:0051897)|signal clustering (GO:1990256)	33,887,5583					CCDS3875.1	C		GG,GC,CC	U52840	extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|membrane (GO:0016020)|plasma membrane (GO:0005886)	100		2504		rs17238609		2234									523	semF		81	NM_003966		13			ENST00000382496.5		18462		uc003jek.2			9037	dbSNP_123	1569			p.T523T		0				116.0		0.577	5:g.9136646C>G		protein_coding			basic|appris_principal|CCDS		27,689,3584			210,4196			C|||			5008		SEM5A_HUMAN	378	sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A			0.0754792		9136646			0.0129	SNP		CCDS3875.1			,,,	False	9136646				synonymous_variant		Approved		100.0		c.1569G>C	2008-05-15	OTTHUMT00000206989.2	Q13591	0.0476		SEMA5A	9136646					SEMA5A	NM_003966.2	protein-coding gene	NP_003957.2		
		G	ENSG00000169777	ENST00000382492.2		50834		ENSG00000169777		4300					,				c.(850-852)Ttg>Ctg	OTTHUMG00000090500		byFrequency	Q9NYW7	gene with protein product		CTD-2001E22.1_ENST00000504182.2_RNA		NM_019599.2	2,87,2114		0.0297					+	Silent		111.2+/-171.5	97.0				10761934, 10766242				TAS2R1-001					5	-	0.0129				coding-synonymous	14909		284/300		A	SO:0001819	604796			protein_coding		2203				3.6395,2.0654,3.1063		"""Taste receptors / Type 2"", ""GPCR / Unclassified : Taste receptors"""	6503								KNOWN			TTTTGTTTCAATTTAGGATTT						ENST00000382492.2:c.850T>C	5					breast(5)|central_nervous_system(1)|cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(19)|ovary(3)|prostate(1)|skin(1)|stomach(1)		-		,		5p15	Q646G8		g.chr5:9629295A>G		74.7+/-112.8			no		404,12602												1.6					1.0	bitter taste receptor activity (GO:0033038)|taste receptor activity (GO:0008527)				hg19	Standard	0.0457			313,8287		chemosensory behavior (GO:0007635)|detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)|G-protein coupled receptor signaling pathway (GO:0007186)	6,392,6105					CCDS3876.1	A		GG,GA,AA	AF227129	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	96		2504		rs2234235		1168									284	T2R1, TRB7		39	NM_019599		1			ENST00000382492.2		20740		uc003jem.1			50834	dbSNP_98	850			p.L284L		0				95.0		0.368	5:g.9629295A>G		protein_coding			basic|appris_principal|CCDS		4,305,3991			91,4315			A|||			5008		TA2R1_HUMAN	110	taste receptor, type 2, member 1			0.0219649		9629295			0.001	SNP		CCDS3876.1			,,,	False	9629295				synonymous_variant		Approved		96.0		c.850T>C	2012-08-22	OTTHUMT00000206988.2	Q9NYW7	0.0245		TAS2R1	9629295					TAS2R1	NM_019599.2	protein-coding gene	NP_062545.1		
		A	ENSG00000150756	ENST00000511437.1		134145		ENSG00000150756		4110					,					OTTHUMG00000161771		byFrequency	Q6P4H8	gene with protein product		FAM173B_ENST00000280330.8_3'UTR|FAM173B_ENST00000510047.1_3'UTR		NM_199133.3	1861,30,0	NM_199133	0.91					+	3'UTR			73.0				12477932				FAM173B-001					5	-	1.0				utr-3	27029				A	SO:0001624				protein_coding		1891				3.4428,0.7932,2.6079			6001								KNOWN			CACTCCCAGTCAAGTTTATGC						ENST00000511437.1:c.*5G>T	5					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(6)|skin(1)|upper_aerodigestive_tract(1)		-		,		5p15.2	B4DT41|B4DXK2|E9PBZ4		g.chr5:10227548C>A					no		11689,313												-5.2					0.0					hg19	Standard	0.9662			7937,283			5695,299,7					CCDS43301.1, CCDS58942.1	C		AA,AC,CC		integral component of membrane (GO:0016021)	73		2504		rs2136197		719												16	NM_199133		0			ENST00000511437.1		19779		uc003jeo.3			134145	dbSNP_96						0				74.0		0.428	5:g.10227548C>A		protein_coding			basic|appris_candidate_longest|CCDS		3834,269,7			3752,30			A|||			5008		F173B_HUMAN	4736	family with sequence similarity 173, member B			0.945687		10227548			0.8601	SNP		CCDS43301.1			,,,	False	10227548				3_prime_UTR_variant		Approved		73.0			2008-08-08	OTTHUMT00000366048.2	Q6P4H8	0.987		FAM173B	10227548					FAM173B	NM_199133.2	protein-coding gene	NP_954584.2		
		T	ENSG00000150756	ENST00000511437.1		134145		ENSG00000150756		4178					,				c.(205-207)ccG>ccA	OTTHUMG00000161771		byFrequency	Q6P4H8	gene with protein product		FAM173B_ENST00000280330.8_5'UTR|FAM173B_ENST00000510047.1_Silent_p.P69P|FAM173B_ENST00000510052.1_5'UTR		NM_199133.3	280,938,819	NM_199133	0.729					+	Silent			113.0				12477932				FAM173B-001					5	-	0.292				coding-synonymous	27029		69/234		C	SO:0001819				protein_coding		2037				36.7161,36.7698,45.4063			6215								KNOWN			CAGGTACAAACGGCAAACAGA						ENST00000511437.1:c.207G>A	5					breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(6)|skin(1)|upper_aerodigestive_tract(1)		-		,		5p15.2	B4DT41|B4DXK2|E9PBZ4		g.chr5:10239278C>T					yes		6786,5644												-9.5					0.1					hg19	Standard	0.6362			5288,3068			1961,2864,1390					CCDS43301.1, CCDS58942.1	C		TT,TC,CC		integral component of membrane (GO:0016021)	114		2504		rs2252505		219									69			16	NM_199133		2			ENST00000511437.1		20353		uc003jeo.3			134145	dbSNP_100	207			p.P69P		0				115.0		0.532	5:g.10239278C>T		protein_coding			basic|appris_candidate_longest|CCDS		1681,1926,571			1498,2576			C|||			5008		F173B_HUMAN	3085	family with sequence similarity 173, member B			0.616014		10239278			0.8383	SNP		CCDS43301.1			,,,	False	10239278				synonymous_variant		Approved		114.0		c.207G>A	2008-08-08	OTTHUMT00000366048.2	Q6P4H8	0.7219		FAM173B	10239278					FAM173B	NM_199133.2	protein-coding gene	NP_954584.2		
		G	ENSG00000150753	ENST00000280326.4		22948		ENSG00000150753		4300					,				c.(196-198)ggA>ggG	OTTHUMG00000131042		byFrequency	P48643	gene with protein product		CCT5_ENST00000515390.1_Intron|CCT5_ENST00000506600.1_Intron|CCT5_ENST00000515676.1_Silent_p.G28G|CCT5_ENST00000503026.1_Silent_p.G45G		NM_012073.3	451,1093,659		0.6534					+	Silent		761.4+/-407.6	145.0								CCT5-001					5	+	0.388				coding-synonymous	1618		66/542		A	SO:0001819	610150			protein_coding		2203				14.5116,45.2792,28.1332		"""Heat Shock Proteins / Chaperonins"""	6503								KNOWN			ATAAGGATGGAGATGTGACTG						ENST00000280326.4:c.198A>G	5					NS(1)|breast(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(13)|ovary(2)|pancreas(1)|prostate(2)		+		,		5p15.2	A8JZY8|A8K2X8|B4DYD8		g.chr5:10254817A>G		559.2+/-380.2			no		9347,3659												-9.3					0.2	ATP binding (GO:0005524)|G-protein beta-subunit binding (GO:0031681)				hg19	Standard	0.8539			7352,1248		'de novo' posttranslational protein folding (GO:0051084)|binding of sperm to zona pellucida (GO:0007339)|cellular protein metabolic process (GO:0044267)|protein folding (GO:0006457)|response to virus (GO:0009615)	3591,2165,747					CCDS3877.1	A		GG,GA,AA	D43950	cell body (GO:0044297)|centrosome (GO:0005813)|chaperonin-containing T-complex (GO:0005832)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|microtubule (GO:0005874)|nucleolus (GO:0005730)|zona pellucida receptor complex (GO:0002199)	152		2504		rs2578617		618									66	KIAA0098		26	NM_012073		3			ENST00000280326.4		20357		uc003jeq.3			22948	dbSNP_100	198			p.G66G		0				166.0		0.413	5:g.10254817A>G		protein_coding			basic|appris_principal|CCDS		3140,1072,88			1995,2411			A|||			5008		TCPE_HUMAN	3435	chaperonin containing TCP1, subunit 5 (epsilon)			0.685903		10254817			0.879	SNP		CCDS3877.1			,,,	False	10254817				synonymous_variant		Approved		152.0		c.198A>G	2014-09-17	OTTHUMT00000253688.2	P48643	0.7752		CCT5	10254817					CCT5	NM_012073.3	protein-coding gene	NP_036205.1		
		A	ENSG00000150753	ENST00000280326.4		22948		ENSG00000150753		4300					,					OTTHUMG00000131042		byFrequency	P48643	gene with protein product		CCT5_ENST00000515390.1_Intron|CCT5_ENST00000506600.1_Intron|CCT5_ENST00000515676.1_Intron|CCT5_ENST00000503026.1_Intron		NM_012073.3	451,1093,659		0.6534					+	Intron		249.7+/-276.9	106.0								CCT5-001					5	+	0.388				intron	1618				A	SO:0001627	610150			protein_coding		2203				14.5116,45.2792,28.1332		"""Heat Shock Proteins / Chaperonins"""	6503								KNOWN			GGTAAGGGATCTGTGCAGACT						ENST00000280326.4:c.1317+10C>A	5					NS(1)|breast(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(13)|ovary(2)|pancreas(1)|prostate(2)		+		,		5p15.2	A8JZY8|A8K2X8|B4DYD8		g.chr5:10262740C>A		616.5+/-392.8			no		9347,3659												-2.0					0.0	ATP binding (GO:0005524)|G-protein beta-subunit binding (GO:0031681)				hg19	Standard	0.8539			7352,1248		'de novo' posttranslational protein folding (GO:0051084)|binding of sperm to zona pellucida (GO:0007339)|cellular protein metabolic process (GO:0044267)|protein folding (GO:0006457)|response to virus (GO:0009615)	3591,2165,747					CCDS3877.1	C		AA,AC,CC	D43950	cell body (GO:0044297)|centrosome (GO:0005813)|chaperonin-containing T-complex (GO:0005832)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|microtubule (GO:0005874)|nucleolus (GO:0005730)|zona pellucida receptor complex (GO:0002199)	112		2504		rs2578642		1737										KIAA0098		26	NM_012073		9			ENST00000280326.4		17892		uc003jeq.3			22948	dbSNP_100						0				123.0		0.547	5:g.10262740C>A		protein_coding			basic|appris_principal|CCDS		3140,1072,88			1995,2411			A|||			5008		TCPE_HUMAN	3435	chaperonin containing TCP1, subunit 5 (epsilon)			0.685903		10262740			0.879	SNP		CCDS3877.1			,,,	False	10262740				intron_variant		Approved		112.0			2014-09-17	OTTHUMT00000253688.2	P48643	0.7752		CCT5	10262740					CCT5	NM_012073.3	protein-coding gene	NP_036205.1		
		G	ENSG00000164237	ENST00000296658.3		134147		ENSG00000164237		4300					,				c.(469-471)atT>atC	OTTHUMG00000131043		byFrequency	Q96DG6	gene with protein product		CMBL_ENST00000510532.1_Intron		NM_138809.3	557,1076,570	NM_138809	0.4233	Substitution - coding silent(1)				+	Silent		417.1+/-352.3	81.0				3804974, 20177059				CMBL-001	2006-09-12				5	-	0.4811				coding-synonymous	25090		157/246		G	SO:0001819	613379			protein_coding	stomach(1)	2203				29.7791,49.7049,36.7292			6503								KNOWN			AATCCTTGACAATGCCTGAAA						ENST00000296658.3:c.471T>C	5					endometrium(1)|large_intestine(1)|lung(9)|skin(1)|stomach(1)		-		,		5p15.2	D3DTC7|Q8TED6		g.chr5:10282396A>G		590.6+/-387.4			no		8229,4777												-5.4					0.0	hydrolase activity (GO:0016787)				hg19	Standard	0.7197			6039,2561			2664,2901,938			p.I157I(1)		CCDS3878.1	A		GG,GA,AA		cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)	81		2504		rs10067744		891				"""carboxymethylenebutenolidase-like (Pseudomonas)"""					157	FLJ23617		13	NM_138809		5			ENST00000296658.3		17088		uc003jes.3			134147	dbSNP_119	471			p.I157I		1				81.0		0.453	5:g.10282396A>G		protein_coding			basic|appris_principal|CCDS		2107,1825,368			2190,2216			G|||			5008		CMBL_HUMAN	2153	carboxymethylenebutenolidase homolog (Pseudomonas)			0.429912		10282396			0.0754	SNP		CCDS3878.1			,,,	False	10282396		3.1.-.-		synonymous_variant		Approved		81.0		c.471T>C	2010-06-25	OTTHUMT00000253689.1	Q96DG6	0.4366		CMBL	10282396					CMBL	NM_138809.3	protein-coding gene	NP_620164.1		
		C	ENSG00000169862	ENST00000304623.8		1501		ENSG00000169862		4300					,					OTTHUMG00000090511		byFrequency	Q9UQB3	gene with protein product		CTNND2_ENST00000511377.1_Intron|CTNND2_ENST00000359640.2_Intron|CTNND2_ENST00000495388.2_Intron|CTNND2_ENST00000458100.2_Intron|CTNND2_ENST00000503622.1_Intron		NM_001332.2	535,1096,572	NM_001332	0.2198					+	Intron		477.6+/-369.7	61.0				9342840, 9223106				CTNND2-001	2012-08-15				5	-	0.5008				intron	2516				T	SO:0001627	604275			protein_coding		2203		OREG0016517		36.7674,49.1602,40.9657		"""Armadillo repeat containing"""	6503				668				KNOWN			CTCTGCCTTGTCGCGGGTCAA						ENST00000304623.8:c.3343+50A>G	5					NS(1)|autonomic_ganglia(1)|breast(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(3)|kidney(3)|large_intestine(29)|liver(1)|lung(71)|ovary(4)|pancreas(2)|prostate(1)|skin(5)|upper_aerodigestive_tract(4)|urinary_tract(2)		-		,		5p15.2	B0FTZ7|O00379|O15390|O43206|O43840|Q13589|Q9UM66|Q9UPM3	"""neural plakophilin-related arm-repeat protein"""	g.chr5:10988172T>C		580.7+/-385.2			no		5328,7678												-1.5					0.0					hg19	Standard	0.3588			3162,5438		cell adhesion (GO:0007155)|learning (GO:0007612)|morphogenesis of a branching structure (GO:0001763)|multicellular organismal development (GO:0007275)|regulation of synaptic plasticity (GO:0048167)|regulation of transcription, DNA-templated (GO:0006355)|signal transduction (GO:0007165)|single organismal cell-cell adhesion (GO:0016337)|transcription, DNA-templated (GO:0006351)	1132,3064,2307					CCDS3881.1, CCDS75227.1, CCDS75228.1	T		CC,CT,TT	U52828	cell junction (GO:0030054)|cytoplasm (GO:0005737)|nucleus (GO:0005634)	59		2504		rs879353		3533				"""catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)"""						NPRAP, GT24		136	XM_005248251		20			ENST00000304623.8		13589		uc003jfa.1			1501	dbSNP_86						0				57.0		0.587	5:g.10988172T>C		protein_coding			basic|appris_principal|CCDS		597,1968,1735	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		2166,2240			T|||			5008		CTND2_HUMAN	1804	catenin (cadherin-associated protein), delta 2			0.360224		10988172			0.3671	SNP		CCDS3881.1			,,,	False	10988172				intron_variant		Approved		59.0			2013-02-14	OTTHUMT00000206999.1	Q9UQB3	0.2824		CTNND2	10988172					CTNND2	NM_001332.2	protein-coding gene	NP_001323.1		
Kartagener syndrome		C	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,				c.(13357-13359)acA>acG	OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	330,955,918	NM_001369	0.4642					+	Silent		602.6+/-394.5	76.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.3449				coding-synonymous	2950		4453/4625		T	SO:0001819	603335			protein_coding		2203				45.2791,36.6546,48.6006		"""Axonemal dyneins"""	6503								KNOWN			AGAAACCCAGTGTACTAGAAA				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.13359A>G	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13701525T>C		484.4+/-360.0			no		6321,6685												-11.6					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.5398			4706,3894		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1593,3135,1775					CCDS3882.1	T		CC,CT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	73		2504		rs3734111		13463				"""dynein, axonemal, heavy polypeptide 5"""					4453	Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		77			ENST00000265104.4		16114		uc003jfd.2			1767	dbSNP_107	13359			p.T4453T		0				68.0		0.368	5:g.13701525T>C		protein_coding			basic|appris_principal|CCDS		1263,2180,857			1615,2791			T|||			5008		DYH5_HUMAN	2242	dynein, axonemal, heavy chain 5			0.447684		13701525			0.4435	SNP		CCDS3882.1			,,,	False	13701525				synonymous_variant		Approved		73.0		c.13359A>G	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4928		DNAH5	13701525		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		C	ENSG00000039139	ENST00000265104.4	0.53005	1767	N	ENSG00000039139	0.34136	4300	1.000000	0.08282	B		,	T	3.100000000000325E-5	0	c.(13348-13350)Att>Gtt	OTTHUMG00000090533	0.804000	byFrequency	Q8TE73	gene with protein product				NM_001369.2	587,1049,567	NM_001369	0.4724			C	9.791	+	Missense_Mutation	1	530.4+/-381.8	70.0	Q8TE73	0.504539		9256245, 11788826			0.001	DNAH5-001	2006-09-04		0.04013		5	-	0.5295		0.3	0.812000	missense	2950	195	4450/4625		C	SO:0001583	603335	benign	0.5386740331491713	protein_coding		2203	P		0.999000	45.0465,49.5461,46.5708	B	"""Axonemal dyneins"""	6503		0.0:0.6802:0.1197:0.2002						KNOWN	ENST00000265104		GTACTAGAAATCCAAGAAGCC	T			Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.13348A>G	5		ENSG00000039139	0.12905	DNAH5	NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)	ENSP00000265104:p.Ile4450Val	-	0.42202	,	ATT	5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13701536T>C	I -> V (in dbSNP:rs3734110). {ECO:0000269|PubMed:10997877, ECO:0000269|PubMed:14702039}.	555.7+/-379.3		267	yes		6949,6057	0.80357	0.21787	5.78	0.00012	ENSP00000265104:I4450V			0.27478		.		4.9	0.64330	234	0.28530	0.4090909090909091	1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	0			hg19	Standard	0.5457	0.5426829268292683	7.6741	4726,3874		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1862,3225,1416	1.178017				CCDS3882.1	T	0.02656	CC,CT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	68	0.08118	2504	4.91	rs3734110		13452	4450	417		"""dynein, axonemal, heavy polypeptide 5"""	0.28476	13754536	-	VAL/ILE	4450	Dnahc5, HL1, PCD, CILD3, KTGNR	1113	378	NM_001369	0.0	77	0.5501319261213721	-0.186000	ENST00000265104.4		16237		uc003jfd.2			1767	dbSNP_107	13348	0.0000		p.I4450V	Dynein heavy chain (1);	0		T		63.0	rs3734110;rs13162128;rs61544221;rs3734110	0.363	5:g.13701536T>C	ENSP00000265104:I4450V	protein_coding	0.019187		basic|appris_principal|CCDS		1275,2176,849		4450	2223,2183	0.5096153846153846	V	C|||		0.377697	5008		DYH5_HUMAN	2522	dynein, axonemal, heavy chain 5		DYH5_HUMAN	0.503594	0.30828	13701536		1.084000	0.4474	SNP		CCDS3882.1		N	,,,	False	13701536	-0.9820		9	missense	T	Approved	0.549535	68.0		c.13348A>G	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.5187	3.11	DNAH5	13701536	0.45895	Lung NSC(4;0.00476)	0.34650	29	DNAH5	NM_001369.2	protein-coding gene	NP_001360.1	I	
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	315,959,929	NM_001369	0.4714					+	Intron		623.3+/-397.4	49.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.3548				intron	2950				A	SO:0001627	603335			protein_coding		2203				42.2674,36.0645,40.1661		"""Axonemal dyneins"""	6503								KNOWN			CTGAACAACAGACACCCCAGA				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.12910-11C>T	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13714740G>A		665.3+/-401.5			no		5224,7782												0.1					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.3946			3635,4965		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1067,3090,2346					CCDS3882.1	G		AA,AG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	52		2504		rs30175		13014				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		75			ENST00000265104.4		17839		uc003jfd.2			1767	dbSNP_76						0				57.0		0.473	5:g.13714740G>A		protein_coding			basic|appris_principal|CCDS		752,2131,1417			1589,2817			A|||			5008		DYH5_HUMAN	2054	dynein, axonemal, heavy chain 5			0.410144		13714740			0.4415	SNP		CCDS3882.1			,,,	False	13714740				intron_variant		Approved		52.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4063		DNAH5	13714740		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		G	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,				c.(12466-12468)ggA>ggC	OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	358,997,848	NM_001369	0.4714					+	Silent		623.3+/-397.4	119.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.3858				coding-synonymous	2950		4156/4625		G	SO:0001819	603335			protein_coding		2203				42.4302,38.8788,41.2271		"""Axonemal dyneins"""	6503								KNOWN			CTGCCCGGAGTCCTTGTGGAG				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.12468A>C	5	AAA 6. {ECO:0000250}.				NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13719022T>G		650.7+/-399.1			no		5362,7644												2.8					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.3966			3649,4951		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1117,3128,2258					CCDS3882.1	T		GG,GT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	118		2504		rs30169		12572				"""dynein, axonemal, heavy polypeptide 5"""					4156	Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		72			ENST00000265104.4		17429		uc003jfd.2			1767	dbSNP_76	12468			p.G4156G		0				118.0		0.428	5:g.13719022T>G		protein_coding			basic|appris_principal|CCDS		759,2131,1410			1713,2693			G|||			5008		DYH5_HUMAN	2099	dynein, axonemal, heavy chain 5			0.419129		13719022			0.4405	SNP		CCDS3882.1			,,,	False	13719022				synonymous_variant		Approved		118.0		c.12468A>C	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4107		DNAH5	13719022		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4	0.49798	1767	N	ENSG00000039139	0.10743	4300	0.664000	0.07800	B		,	T	1.7800000000001148E-4	0	c.(12400-12402)gCt>gTt	OTTHUMG00000090533	-0.174000	byFrequency	Q8TE73	gene with protein product				NM_001369.2	646,1065,492	NM_001369	0.4714			A	0.031	+	Missense_Mutation	2	623.1+/-397.4	144.0	Q8TE73	0.534952		9256245, 11788826			0.001	DNAH5-001	2006-09-04		0.04013		5	-	0.5514		1	0.024000	missense	2950	152	4134/4625		A	SO:0001583	603335	benign	0.4198895027624309	protein_coding		2203	P		0.769000	42.4884,46.5048,46.2171	B	"""Axonemal dyneins"""	6503		0.6362:0.1205:0.128:0.1153						KNOWN	ENST00000265104		CTGCTTATGAGCCTCGGTGGT	T			Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.12401C>T	5	AAA 6. {ECO:0000250}.	ENSG00000039139	0.01579	DNAH5	NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)	ENSP00000265104:p.Ala4134Val	-	0.28531	,	GCT	5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13719089G>A	A -> V (in dbSNP:rs30168). {ECO:0000269|PubMed:10997877}.	566.7+/-382.0		265	yes		6011,6995	0.29753	0.01287	5.59	0.00012	ENSP00000265104:A4134V			0.41823		.		1.7	0.24424	233	0.02654	0.40734265734265734	0.7	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	-1.535			hg19	Standard	0.3976	0.5386178861788617	3.0235	3654,4946		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1404,3203,1896	-1.335950				CCDS3882.1	G	0.02656	AA,AG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	145	0.00405	2504	1.72	rs30168		12505	4134	315		"""dynein, axonemal, heavy polypeptide 5"""	0.06083	13772089	-	VAL/ALA	4134	Dnahc5, HL1, PCD, CILD3, KTGNR	965	378	NM_001369	0.0	72	0.4155672823218997	-1.228000	ENST00000265104.4		15643		uc003jfd.2			1767	dbSNP_76	12401	0.0000		p.A4134V	Dynein heavy chain (1);	0		T		147.0	rs30168;rs3756670;rs17262811;rs52829614;rs58199971;rs30168	0.463	5:g.13719089G>A	ENSP00000265104:A4134V	protein_coding	0.000814		basic|appris_principal|CCDS		758,2138,1404		4134	2357,2049	0.44184981684981683	V	A|||		0.198108	5008		DYH5_HUMAN	2331	dynein, axonemal, heavy chain 5		DYH5_HUMAN	0.465455	0.37721	13719089		1.691000	0.4415	SNP		CCDS3882.1		N	,,,	False	13719089	-0.9692		9	missense	T	Approved	0.424884	145.0		c.12401C>T	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4265	3.16	DNAH5	13719089	0.10985	Lung NSC(4;0.00476)	0.37753	64	DNAH5	NM_001369.2	protein-coding gene	NP_001360.1	A	
Kartagener syndrome		C	ENSG00000039139	ENST00000265104.4	0.09310	1767	M	ENSG00000039139	0.70986	4300	0.547000	0.25579	B		,	D	0.999999792992	0	c.(7387-7389)cAa>cGa	OTTHUMG00000090533	2.204000	byFrequency	Q8TE73	gene with protein product				NM_001369.2	101,686,1416	NM_001369	0.1667			T	15.09	+	Missense_Mutation	2	320.9+/-314.9	93.0	Q8TE73	0.201543		9256245, 11788826			0.194	DNAH5-001	2006-09-04		0.35039		5	-	0.1884		0.02	0.422000	missense	2950	63	2463/4625		T	SO:0001583	603335	possibly-damaging	0.17403314917127072	protein_coding		2203	P		1.000000	20.4767,20.1543,20.3675	B	"""Axonemal dyneins"""	6503		0.0:0.0:0.0:1.0						KNOWN	ENST00000265104		AATCAGGCCTTGAAGCATGTT	T			Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.7388A>G	5		ENSG00000039139	0.53228	DNAH5	NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)	ENSP00000265104:p.Gln2463Arg	-	0.71417	,	CAA	5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13811775T>C	Q -> R (in dbSNP:rs10078391).	344.9+/-308.3		99	yes		2649,10357	0.28179	0.48939	5.78	0.00012	ENSP00000265104:Q2463R			0.85682		.		5.8	0.91487	293	0.66056	0.5122377622377622	0.5	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	2.65			hg19	Standard	0.2147	0.20121951219512196	16.1193	1761,6839		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	273,2103,4127	2.730316				CCDS3882.1	T	0.32893	CC,CT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	93	0.83603	2504	5.78	rs10078391		7492	2463	167		"""dynein, axonemal, heavy polypeptide 5"""	0.81336	13864775	-	ARG/GLN	2463	Dnahc5, HL1, PCD, CILD3, KTGNR	622	378	NM_001369	0.389	44	0.22031662269129287	0.528000	ENST00000265104.4		11862		uc003jfd.2			1767	dbSNP_119	7388	0.0000		p.Q2463R	.	0		T		94.0	rs10078391;rs52804450;rs10078391	0.413	5:g.13811775T>C	ENSP00000265104:Q2463R	protein_coding	0.000000		basic|appris_principal|CCDS		172,1417,2711		2463	888,3518	0.2847985347985348	R	T|||		0.000000	5008		DYH5_HUMAN	1313	dynein, axonemal, heavy chain 5		DYH5_HUMAN	0.262181	0.88081	13811775		7.977000	0.5585	SNP		CCDS3882.1		D	,,,	False	13811775	-0.9221		9	missense	T	Approved	0.204767	93.0		c.7388A>G	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.1758	1.79	DNAH5	13811775	0.31414	Lung NSC(4;0.00476)	0.46020	43	DNAH5	NM_001369.2	protein-coding gene	NP_001360.1	Q	
Kartagener syndrome		C	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	206,831,1165	NM_001369	0.1728					+	Intron			42.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.3132				intron	2950				T	SO:0001627	603335			protein_coding		2202				20.8605,28.2243,23.3544		"""Axonemal dyneins"""	6502								KNOWN			TGTTTTCCTTTTTAATTATAC				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.7230+31A>G	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13814682T>C					no		3037,9967												2.7					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.2227			1794,6806		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	388,2261,3853					CCDS3882.1	T		CC,CT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	41		2504		rs56046501		7335				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		43			ENST00000265104.4		20118		uc003jfd.2			1767	dbSNP_129						0				39.0		0.358	5:g.13814682T>C		protein_coding			basic|appris_principal|CCDS		182,1430,2688			1243,3161			T|||			5008		DYH5_HUMAN	1520	dynein, axonemal, heavy chain 5			0.303514		13814682			0.5605	SNP		CCDS3882.1			,,,	False	13814682				intron_variant		Approved		41.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.2133		DNAH5	13814682		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	451,1107,645	NM_001369	0.3108					+	Intron		477.5+/-369.7	63.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.4705				intron	2950				G	SO:0001627	603335			protein_coding		2203				36.4651,45.5969,39.5587		"""Axonemal dyneins"""	6503								KNOWN			AAGACCTCCAGGATGACACAC				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.6444+10C>T	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13829608G>A		560.5+/-380.5			no		5145,7861												3.2					0.3	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.3698			3136,5464		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1026,3093,2384					CCDS3882.1	G		AA,AG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	64		2504		rs1348691		6549				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		38			ENST00000265104.4		18467		uc003jfd.2			1767	dbSNP_88						0				66.0		0.408	5:g.13829608G>A		protein_coding			basic|appris_principal|CCDS		575,1986,1739			2009,2397			G|||			5008		DYH5_HUMAN	2221	dynein, axonemal, heavy chain 5			0.44349		13829608			0.626	SNP		CCDS3882.1			,,,	False	13829608				intron_variant		Approved		64.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4207		DNAH5	13829608		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,				c.(6262-6264)gcC>gcT	OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	451,1109,643	NM_001369	0.3098					+	Silent		478.5+/-369.9	66.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.4705				coding-synonymous	2950		2088/4625		G	SO:0001819	603335			protein_coding		2203				36.4535,45.6423,39.5664		"""Axonemal dyneins"""	6503								KNOWN			CCTGCCGTCCGGCATAGCCAG				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.6264C>T	5	AAA 1. {ECO:0000250}.				NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13829799G>A		561.5+/-380.7			no		5146,7860												-9.1					0.7	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.3698			3135,5465		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1027,3092,2384					CCDS3882.1	G		AA,AG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	67		2504		rs1348689		6368				"""dynein, axonemal, heavy polypeptide 5"""					2088	Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		38			ENST00000265104.4		21016		uc003jfd.2			1767	dbSNP_88	6264			p.A2088A		0				69.0		0.423	5:g.13829799G>A		protein_coding			basic|appris_principal|CCDS		576,1983,1741			2011,2395			G|||			5008		DYH5_HUMAN	2220	dynein, axonemal, heavy chain 5			0.443291		13829799			0.626	SNP		CCDS3882.1			,,,	False	13829799				synonymous_variant		Approved		67.0		c.6264C>T	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4207		DNAH5	13829799		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,				c.(5170-5172)gcC>gcT	OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	546,1109,548	NM_001369	0.3272					+	Silent		664.8+/-402.2	88.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.5174				coding-synonymous	2950		1724/4625		A	SO:0001819	603335			protein_coding		2203				34.8023,49.9546,39.9354		"""Axonemal dyneins"""	6503								KNOWN			TCTCTAGAAGGGCAGGATCTG				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.5172C>T	5	Stem. {ECO:0000250}.				NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13845045G>A		588.0+/-386.8			no		5194,7812												-1.3					0.4	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.3598			2993,5607		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1058,3078,2367					CCDS3882.1	G		AA,AG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	87		2504		rs10041113		5276				"""dynein, axonemal, heavy polypeptide 5"""					1724	Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		32			ENST00000265104.4		18672		uc003jfd.2			1767	dbSNP_119	5172			p.A1724A		0				84.0		0.443	5:g.13845045G>A		protein_coding			basic|appris_principal|CCDS		512,1969,1819			2201,2205			A|||			5008		DYH5_HUMAN	2277	dynein, axonemal, heavy chain 5			0.454673		13845045			0.622	SNP		CCDS3882.1			,,,	False	13845045				synonymous_variant		Approved		87.0		c.5172C>T	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4092		DNAH5	13845045		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		G	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	546,1108,549	NM_001369	0.3272					+	Intron		662.0+/-401.9	41.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.5242				intron	2950				G	SO:0001627	603335			protein_coding		2203				34.7907,49.9319,39.92		"""Axonemal dyneins"""	6503								KNOWN			AAGTACCTACAAGGAGAGGAA				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.5115-5T>C	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13845107A>G		578.0+/-384.6			no		5192,7814												-1.5					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.3598			2992,5608		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1058,3076,2369					CCDS3882.1	A		GG,GA,AA	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	41		2504		rs4429853		5219				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		32			ENST00000265104.4		17597		uc003jfd.2			1767	dbSNP_111						0				39.0		0.458	5:g.13845107A>G		protein_coding			basic|appris_principal|CCDS		512,1968,1820			2200,2206			G|||			5008		DYH5_HUMAN	2286	dynein, axonemal, heavy chain 5			0.45647		13845107			0.622	SNP		CCDS3882.1			,,,	False	13845107				intron_variant		Approved		41.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4092		DNAH5	13845107		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		G	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	208,918,1077	NM_001369	0.4683					+	Intron		517.0+/-379.0	45.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.2723				intron	2950				A	SO:0001627	603335			protein_coding		2203				41.6628,30.2769,37.8056		"""Axonemal dyneins"""	6503								KNOWN			TCAAAGAGCCAGTGAACTTAC				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.5114+10T>C	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13850750A>G		445.1+/-347.6			no		4917,8089												-1.1					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.4125			3583,5017		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	996,2925,2582					CCDS3882.1	A		GG,GA,AA	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	45		2504		rs6554820		5219				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		31			ENST00000265104.4		20797		uc003jfd.2			1767	dbSNP_116						0				45.0		0.443	5:g.13850750A>G		protein_coding			basic|appris_principal|CCDS		788,2007,1505			1334,3072			A|||			5008		DYH5_HUMAN	1712	dynein, axonemal, heavy chain 5			0.341853		13850750			0.2708	SNP		CCDS3882.1			,,,	False	13850750				intron_variant		Approved		45.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.2968		DNAH5	13850750		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		T	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	199,847,1157	NM_001369	0.4376					+	Intron			84.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.2663				intron	2950				G	SO:0001627	603335			protein_coding		2203				39.5698,28.2569,35.7374		"""Axonemal dyneins"""	6503								KNOWN			TTAGGGTTTGGTTTTGTTTTT				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.4797-29C>A	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13859743G>T					no		4648,8358												0.6					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.4076			3403,5197		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	959,2730,2814					CCDS3882.1	G		TT,TG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	84		2504		rs1502043		4901				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		30			ENST00000265104.4		19400		uc003jfd.2			1767	dbSNP_88						0				83.0		0.318	5:g.13859743G>T		protein_coding			basic|appris_principal|CCDS		760,1883,1657			1245,3161			G|||			5008		DYH5_HUMAN	1657	dynein, axonemal, heavy chain 5			0.330871		13859743			0.2629	SNP		CCDS3882.1			,,,	False	13859743				intron_variant		Approved		84.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.2911		DNAH5	13859743		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300									c.(4372-4374)cgG>cgT	OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product		CTB-51A17.1_ENST00000503244.1_RNA		NM_001369.2	229,928,1046	NM_001369		Substitution - coding silent(1)				+	Silent		537.7+/-383.3	60.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-					coding-synonymous	2950		1458/4625		C	SO:0001819	603335			protein_coding	stomach(1)	2203				44.2674,31.4571,39.9277		"""Axonemal dyneins"""	6503								KNOWN			CCTTCAAGGCCCGGGGAAGCT				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.4374G>T	5	Stem. {ECO:0000250}.				NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-				5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13864728C>A		457.5+/-351.6			no		5193,7813												0.9					1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard				3807,4793		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1122,2949,2432			p.R1458R(1)		CCDS3882.1	C		AA,AC,CC	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	60				rs6554827		4478				"""dynein, axonemal, heavy polypeptide 5"""					1458	Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		28			ENST00000265104.4				uc003jfd.2			1767	dbSNP_116	4374			p.R1458R		1				59.0		0.478	5:g.13864728C>A		protein_coding			basic|appris_principal|CCDS		893,2021,1386			1386,3020								DYH5_HUMAN		dynein, axonemal, heavy chain 5					13864728				SNP		CCDS3882.1					13864728				synonymous_variant		Approved		60.0		c.4374G>T	2008-07-18	OTTHUMT00000207057.2	Q8TE73			DNAH5	13864728		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		G	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139							,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product		CTB-51A17.1_ENST00000503244.1_RNA		NM_001369.2		NM_001369	0.5317					+	Intron							9256245, 11788826				DNAH5-001	2006-09-04					-	0.5968					2950					SO:0001627	603335			protein_coding								"""Axonemal dyneins"""									KNOWN			TTGGCTGCCTATCAAAGAGGA				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.4355+59T>C	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13865717A>G																									ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.4652					cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)						CCDS3882.1	A			AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)			2504		rs7720415		4460				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		27			ENST00000265104.4		18172		uc003jfd.2			1767							0						0.348	5:g.13865717A>G		protein_coding			basic|appris_principal|CCDS								a|||			5008		DYH5_HUMAN	2348	dynein, axonemal, heavy chain 5			0.46885		13865717			0.3323	SNP		CCDS3882.1			,,,	False	13865717				intron_variant		Approved					2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.3401		DNAH5			Lung NSC(4;0.00476)					protein-coding gene	NP_001360.1		
Kartagener syndrome		A	ENSG00000039139	ENST00000265104.4	0.30184	1767	M	ENSG00000039139	0.37341	4300	1.000000	0.47869	B		,	T	0.800164	0	c.(2296-2298)Ata>Tta	OTTHUMG00000090533	0.935000	byFrequency	Q8TE73	gene with protein product		CTB-51A17.1_ENST00000503244.1_RNA		NM_001369.2	615,1119,469	NM_001369	0.6288	Substitution - Missense(1)		T	11.42	+	Missense_Mutation	1	582.7+/-391.4	164.0	Q8TE73	0.533137		9256245, 11788826			0.032	DNAH5-001	2006-09-04		0.20955		5	-	0.5681		0.59	0.421000	missense	2950	175	766/4625		T	SO:0001583	603335	benign	0.48342541436464087	protein_coding	stomach(1)	2203	P		1.000000	49.2093,46.6863,48.3546	B	"""Axonemal dyneins"""	6503		0.0:0.1491:0.0:0.8509						KNOWN	ENST00000265104		GCAGCAGGTATTTTTGACTTC	T			Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.2296A>T	5	Stem. {ECO:0000250}.	ENSG00000039139	0.35465	DNAH5	NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)	ENSP00000265104:p.Ile766Leu	-	0.71417	,	ATA	5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13894894T>A	I -> L (in dbSNP:rs4701997).	609.7+/-391.4		281	yes		6717,6289	0.80357	0.29068	5.53	0.00012	ENSP00000265104:I766L			0.51477		.		4.4	0.52481	140	0.13470	0.24475524475524477	1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	1.975			hg19	Standard	0.5	0.5711382113821138	8.5314	4368,4232		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1742,3233,1528	1.634972		p.I766L(1)		CCDS3882.1	T	0.06786	AA,AT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	168	0.64404	2504	4.37	rs4701997		2400	766	369		"""dynein, axonemal, heavy polypeptide 5"""	0.33337	13947894	-	LEU/ILE	766	Dnahc5, HL1, PCD, CILD3, KTGNR	965	378	NM_001369	0.001	16	0.4868073878627968	0.459000	ENST00000265104.4		18015		uc003jfd.2			1767	dbSNP_111	2296	0.0000		p.I766L	Dynein heavy chain, domain-1 (1);	1		T		175.0	rs4701997;rs17210254;rs52819664;rs4701997	0.408	5:g.13894894T>A	ENSP00000265104:I766L	protein_coding	0.000098		basic|appris_principal|CCDS		1127,2114,1059		766	2349,2057	0.44184981684981683	L	T|||		0.227351	5008		DYH5_HUMAN	2443	dynein, axonemal, heavy chain 5		DYH5_HUMAN	0.487819	0.49575	13894894		3.012000	0.249	SNP		CCDS3882.1		D	,,,	False	13894894	-0.9293		9	missense	T	Approved	0.507907	168.0		c.2296A>T	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4654	0.83	DNAH5	13894894	0.31385	Lung NSC(4;0.00476)	0.44967	5	DNAH5	NM_001369.2	protein-coding gene	NP_001360.1	I	
Kartagener syndrome		G	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	24,398,1781	NM_001369	0.3671					+	Intron		398.5+/-346.1	57.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.0734				intron	2950				T	SO:0001627	603335			protein_coding		2203				28.093,10.1226,22.0052		"""Axonemal dyneins"""	6503								KNOWN			TTATTCCCATTTCACAAGGCA				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.975+29A>C	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13919255T>G		209.8+/-230.5			no		2862,10144												-0.4					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.2823			2416,6184		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	378,2106,4019					CCDS3882.1	T		GG,GT,TT	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	55		2504		rs35925547		1080				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		7			ENST00000265104.4		17090		uc003jfd.2			1767	dbSNP_126						0				51.0		0.388	5:g.13919255T>G		protein_coding			basic|appris_principal|CCDS		354,1708,2238			446,3960			T|||			5008		DYH5_HUMAN	981	dynein, axonemal, heavy chain 5			0.195887		13919255			0.0903	SNP		CCDS3882.1			,,,	False	13919255				intron_variant		Approved		55.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.2161		DNAH5	13919255		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		C	ENSG00000039139	ENST00000265104.4		1767		ENSG00000039139		4300					,					OTTHUMG00000090533		byFrequency	Q8TE73	gene with protein product				NM_001369.2	812,1044,347	NM_001369	0.3896					+	Intron		688.0+/-404.2	100.0				9256245, 11788826				DNAH5-001	2006-09-04				5	-	0.6664				intron	2950				C	SO:0001627	603335			protein_coding		2203				30.3372,39.4462,40.5736		"""Axonemal dyneins"""	6503								KNOWN			AGTGAGAAGTGAAACGCATCC				Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.192+13C>G	5					NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)		-		,		5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13931205G>C		519.4+/-370.0			no		5277,7729												0.8					0.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)				hg19	Standard	0.2853			2609,5991		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1221,2835,2447					CCDS3882.1	G		CC,CG,GG	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	101		2504		rs1530497		297				"""dynein, axonemal, heavy polypeptide 5"""						Dnahc5, HL1, PCD, CILD3, KTGNR		378	NM_001369		2			ENST00000265104.4		19137		uc003jfd.2			1767	dbSNP_88						0				104.0		0.502	5:g.13931205G>C		protein_coding			basic|appris_principal|CCDS		409,1791,2100			2668,1738			C|||			5008		DYH5_HUMAN	2572	dynein, axonemal, heavy chain 5			0.513578		13931205			0.6915	SNP		CCDS3882.1			,,,	False	13931205				intron_variant		Approved		101.0			2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4697		DNAH5	13931205		Lung NSC(4;0.00476)			DNAH5	NM_001369.2	protein-coding gene	NP_001360.1		
Kartagener syndrome		T	ENSG00000039139	ENST00000265104.4	0.44825	1767	N	ENSG00000039139	0.40578	4300	1.000000	0.19938	B		,	T	0.0021660000000000013	0	c.(70-72)gGa>gAa	OTTHUMG00000090533	1.060000	byFrequency	Q8TE73	gene with protein product				NM_001369.2	708,1064,431	NM_001369	0.3916			T	6.293	+	Missense_Mutation	2	687.2+/-404.2	88.0	Q8TE73	0.562869		9256245, 11788826			0.0	DNAH5-001	2006-09-04		0.01281		5	-	0.6112		1	0.959000	missense	2950	162	24/4625		T	SO:0001583	603335	benign	0.44751381215469616	protein_coding		2203	P		1.000000	30.2209,43.7131,39.0512	B	"""Axonemal dyneins"""	6503		0.0:0.0702:0.0:0.9298						KNOWN	ENST00000265104		TTCCTTCTCTCCCTTCAGTCT	T			Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.71G>A	5	Stem. {ECO:0000250}.	ENSG00000039139	0.10298	DNAH5	NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)	ENSP00000265104:p.Gly24Glu	-	0.71417	,	GGA	5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13931340C>T	G -> E (in dbSNP:rs1530496).	546.3+/-377.0		286	yes		5079,7927	0.80357	0.11928	5.6	0.00012	ENSP00000265104:G24E			0.85682		.		5.6	0.85130	389	0.02654	0.6800699300699301	1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	-2.455			hg19	Standard	0.2833	0.5813008130081301	11.6651	2599,6001		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	1115,2849,2539	0.422151				CCDS3882.1	C	0.02656	TT,TC,CC	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	88	0.00044	2504	5.6	rs1530496		175	24	220		"""dynein, axonemal, heavy polypeptide 5"""	0.51368	13984340	-	GLU/GLY	24	Dnahc5, HL1, PCD, CILD3, KTGNR	1057	378	NM_001369	0.0	2	0.29023746701846964	-0.269000	ENST00000265104.4		19739		uc003jfd.2			1767	dbSNP_88	71	0.0000		p.G24E	.	0		T		87.0	rs1530496;rs52796631;rs59635012;rs1530496	0.378	5:g.13931340C>T	ENSP00000265104:G24E	protein_coding	0.000000		basic|appris_principal|CCDS		407,1785,2108		24	2480,1926	0.483974358974359	E	T|||		0.000000	5008		DYH5_HUMAN	2507	dynein, axonemal, heavy chain 5		DYH5_HUMAN	0.500599	0.66010	13931340		5.349000	0.7014	SNP		CCDS3882.1		N	,,,	False	13931340	-0.9426		9	missense	T	Approved	0.302209	88.0		c.71G>A	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.4669	2.11	DNAH5	13931340	0.62525	Lung NSC(4;0.00476)	0.42865	98	DNAH5	NM_001369.2	protein-coding gene	NP_001360.1	G	
Kartagener syndrome		C	ENSG00000039139	ENST00000265104.4	0.58432	1767	N	ENSG00000039139	0.34757	4300	1.000000	0.21543	B		,	T	5.000000000032756E-6	2	c.(34-36)caT>caG	OTTHUMG00000090533	0.830000	byFrequency	Q8TE73	gene with protein product				NM_001369.2	1770,397,36	NM_001369	0.9407			C	4.461	+	Missense_Mutation	3	143.0+/-199.1	122.0	Q8TE73	0.893554		9256245, 11788826			0.0	DNAH5-001	2006-09-04		0.01281		5	-	0.8707		1	0.980000	missense	2950	347	12/4625		C	SO:0001583	603335	benign	0.9585635359116023	protein_coding		2203	P		1.000000	5.8023,10.6446,7.4427	B	"""Axonemal dyneins"""	6503		0.2137:0.5482:0.0:0.2381						KNOWN	ENST00000265104		GAGTGACGCTATGCTTCCAGA	T			Ciliary Dyskinesia, Primary (CILD1 - CILD13), Immotile Cilia Syndrome	Familial Cancer Database	ENST00000265104.4:c.36T>G	5	Stem. {ECO:0000250}.	ENSG00000039139	0.15023	DNAH5	NS(6)|breast(14)|central_nervous_system(4)|cervix(2)|endometrium(23)|haematopoietic_and_lymphoid_tissue(8)|kidney(11)|large_intestine(85)|liver(1)|lung(129)|ovary(16)|pancreas(2)|prostate(5)|skin(48)|stomach(5)|upper_aerodigestive_tract(11)|urinary_tract(8)	ENSP00000265104:p.His12Gln	-	0.71417	,	CAT	5p15.2	Q92860|Q96L74|Q9H5S7|Q9HCG9	"""dynein heavy chain 5"""	g.chr5:13944512A>C	H -> Q (in dbSNP:rs339445).	223.9+/-240.3		428	yes		12038,968	0.80357	0.08583	5.83	0.00012	ENSP00000265104:H12Q			0.31381		.		3.8	0.43845	509	0.02654	0.8898601398601399	1.0	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	-1.7			hg19	Standard	0.9324	0.8699186991869918	3.0535	8101,499		cilium movement (GO:0003341)|lateral ventricle development (GO:0021670)|left/right axis specification (GO:0070986)	5588,862,53	0.085395				CCDS3882.1	A	0.02656	CC,CA,AA	AJ132090	axonemal dynein complex (GO:0005858)|axoneme (GO:0005930)|microtubule (GO:0005874)	135	0.00289	2504	3.81	rs339445		140	12	714		"""dynein, axonemal, heavy polypeptide 5"""	0.06176	13997512	-	GLN/HIS	12	Dnahc5, HL1, PCD, CILD3, KTGNR	1998	378	NM_001369	0.0	1	0.941952506596306	-0.121000	ENST00000265104.4		18112		uc003jfd.2			1767	dbSNP_79	36	0.0000		p.H12Q	.	0		T		162.0	rs339445;rs1311008;rs60849867;rs339445	0.483	5:g.13944512A>C	ENSP00000265104:H12Q	protein_coding	0.007747		basic|appris_principal|CCDS		3818,465,17		12	3937,469	0.9148351648351648	Q	C|||		0.299168	5008		DYH5_HUMAN	4572	dynein, axonemal, heavy chain 5		DYH5_HUMAN	0.912939	0.30653	13944512		1.070000	0.8899	SNP		CCDS3882.1		N	,,,	False	13944512	-0.9818		9	missense	T	Approved	0.941977	135.0		c.36T>G	2008-07-18	OTTHUMT00000207057.2	Q8TE73	0.9597	2.0	DNAH5	13944512	0.70556	Lung NSC(4;0.00476)	0.34700	24	DNAH5	NM_001369.2	protein-coding gene	NP_001360.1	H	
		T	ENSG00000038382	ENST00000344204.4		7204		ENSG00000038382		4300					,					OTTHUMG00000131057		byFrequency	O75962	gene with protein product		TRIO_ENST00000537187.1_Intron|TRIO_ENST00000509967.2_Intron		NM_007118.2	0,44,2159	NM_007118	0.0358					+	Intron		121.0+/-180.1	74.0				8643598				TRIO-001	2012-07-12				5	+	0.0015				intron	12303				C	SO:0001627	601893			protein_coding		2203				4.1977,0.9986,3.1139		"""Rho guanine nucleotide exchange factors"", ""Immunoglobulin superfamily / I-set domain containing"""	6503								KNOWN			ATCTTAAATACCTTCTTTCAG						ENST00000344204.4:c.2392-11C>T	5					NS(2)|breast(6)|central_nervous_system(4)|endometrium(16)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(21)|lung(34)|ovary(4)|prostate(2)|skin(11)|stomach(3)|upper_aerodigestive_tract(3)|urinary_tract(4)		+		,		5p14-p15.1	D3DTD1|Q13458|Q59EQ7|Q6PJC9|Q6ZN05|Q8IWK8		g.chr5:14363830C>T		45.3+/-79.5			no		405,12601												-1.5					0.0	ATP binding (GO:0005524)|guanyl-nucleotide exchange factor activity (GO:0005085)|protein serine/threonine kinase activity (GO:0004674)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.0328			361,8239		apoptotic signaling pathway (GO:0097190)|axon guidance (GO:0007411)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of apoptotic process (GO:0043065)|positive regulation of GTPase activity (GO:0043547)|regulation of small GTPase mediated signal transduction (GO:0051056)|small GTPase mediated signal transduction (GO:0007264)|transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	8,389,6106					CCDS3883.1	C		TT,TC,CC	AF091395	cytosol (GO:0005829)	73		2504		rs55751460		2415				"""triple functional domain (PTPRF interacting)"""						ARHGEF23		118	NM_007118		14			ENST00000344204.4		20603		uc003jff.3			7204	dbSNP_129						0				70.0		0.433	5:g.14363830C>T		protein_coding			basic|appris_principal|CCDS		8,345,3947			44,4362			C|||			5008		TRIO_HUMAN	135	trio Rho guanine nucleotide exchange factor			0.0269569		14363830			0.0	SNP		CCDS3883.1			,,,	False	14363830				intron_variant		Approved		73.0			2013-01-11	OTTHUMT00000253711.2	O75962	0.0937		TRIO	14363830		Lung NSC(4;0.000742)			TRIO	NM_007118.2	protein-coding gene	NP_009049.2		
		T	ENSG00000038382	ENST00000344204.4		7204		ENSG00000038382		4300					,				c.(3031-3033)aaC>aaT	OTTHUMG00000131057		byFrequency	O75962	gene with protein product		TRIO_ENST00000509967.2_Silent_p.N962N|TRIO_ENST00000537187.1_Silent_p.N1011N		NM_007118.2	26,429,1748	NM_007118	0.2832					+	Silent		414.1+/-351.3	133.0				8643598				TRIO-001	2012-07-12				5	+	0.0794				coding-synonymous	12303		1011/3098		C	SO:0001819	601893			protein_coding		2203				29.4535,10.9169,23.1739		"""Rho guanine nucleotide exchange factors"", ""Immunoglobulin superfamily / I-set domain containing"""	6503								KNOWN			AGCTCGTCAACGCCTCTGTCG						ENST00000344204.4:c.3033C>T	5					NS(2)|breast(6)|central_nervous_system(4)|endometrium(16)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(21)|lung(34)|ovary(4)|prostate(2)|skin(11)|stomach(3)|upper_aerodigestive_tract(3)|urinary_tract(4)		+		,		5p14-p15.1	D3DTD1|Q13458|Q59EQ7|Q6PJC9|Q6ZN05|Q8IWK8		g.chr5:14368975C>T		227.5+/-242.7			no		3014,9992												-10.2					0.1	ATP binding (GO:0005524)|guanyl-nucleotide exchange factor activity (GO:0005085)|protein serine/threonine kinase activity (GO:0004674)|Rho guanyl-nucleotide exchange factor activity (GO:0005089)				hg19	Standard	0.2763			2533,6067		apoptotic signaling pathway (GO:0097190)|axon guidance (GO:0007411)|neurotrophin TRK receptor signaling pathway (GO:0048011)|positive regulation of apoptotic process (GO:0043065)|positive regulation of GTPase activity (GO:0043547)|regulation of small GTPase mediated signal transduction (GO:0051056)|small GTPase mediated signal transduction (GO:0007264)|transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	417,2180,3906					CCDS3883.1	C		TT,TC,CC	AF091395	cytosol (GO:0005829)	139		2504		rs13189406		3057				"""triple functional domain (PTPRF interacting)"""					1011	ARHGEF23		118	NM_007118		17			ENST00000344204.4		21946		uc003jff.3			7204	dbSNP_121	3033			p.N1011N		0				151.0		0.507	5:g.14368975C>T		protein_coding			basic|appris_principal|CCDS		391,1751,2158			481,3925			C|||			5008		TRIO_HUMAN	884	trio Rho guanine nucleotide exchange factor			0.176518		14368975			0.0615	SNP		CCDS3883.1			,,,	False	14368975				synonymous_variant		Approved		139.0		c.3033C>T	2013-01-11	OTTHUMT00000253711.2	O75962	0.2334		TRIO	14368975		Lung NSC(4;0.000742)			TRIO	NM_007118.2	protein-coding gene	NP_009049.2		
